PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ghatak, S; Hascall, VC; Markwald, RR; Misra, S				Ghatak, Shibnath; Hascall, Vincent C.; Markwald, Roger R.; Misra, Suniti			Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CONSTITUTIVELY REGULATES ACTIVATION; MARROW ENDOTHELIAL-CELLS; MAMMARY-CARCINOMA CELLS; HUMAN SKIN FIBROBLASTS; TUMOR-GROWTH; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; FACTOR-I; METASTASIS	The main aim of our study is to determine the significance of the stromal microenvironment in the malignant behavior of prostate cancer. The stroma-derived growth factors/cytokines and hyaluronan act in autocrine/paracrine ways with their receptors, including receptor-tyrosine kinases and CD44 variants (CD44v), to potentiate and support tumor epithelial cell survival. Overexpression of hyaluronan, CD44v9 variants, and stroma-derived growth factors/cytokines are specific features in many cancers, including prostate cancer. Androgen/androgen receptor interaction has a critical role in regulating prostate cancer growth. Our previous study showed that 1) that increased synthesis of hyaluronan in normal epithelial cells promotes expression of CD44 variants; 2) hyaluronan interaction with CD44v6-v9 promotes activation of receptor-tyrosine kinase, which stimulates phosphatidylinositol 3-kinase-induced cell survival pathways; and 3) CD44v6/short hairpin RNA reduces colon tumor growth in vivo (Misra, S., Hascall, V. C., De Gio-vanni, C., Markwald, R. R., and Ghatak, S. ( 2009) J. Biol. Chem. 284, 12432-12446). Our results now show that hepatocyte growth factor synthesized by myofibroblasts associated with prostate cancer cells induces activation of HGF-receptor/cMet and stimulates hyaluronan/CD44v9 signaling. This, in turn, stabilizes the androgen receptor functions in prostate cancer cells. The stroma-derived HGF induces a lipid raft-associated signaling complex that contains CD44v9, cMet/phosphatidylinositol 3-kinase, HSP90 and androgen receptor. CD44v9/short hairpin RNA reverses the assembly of these components in the complex and inhibits androgen receptor function. Our results provide new insight into the hyaluronan/CD44v9-regulated androgen receptor function and the consequent malignant activities in prostate cancer cells. The present study describes a physiologically relevant in vitro model for studying the molecular mechanisms by which stroma-derived HGF and hyaluronan influence androgen receptor and CD44 functions in the secretory epithelia during prostate carcinogenesis.	[Ghatak, Shibnath; Markwald, Roger R.; Misra, Suniti] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Ghatak, Shibnath; Misra, Suniti] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 171 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health [P20RR021949, P20RR016434, HL RO1 33756, 1 P30AR050953]; Mitral-07 CVD 04; Medical University of South Carolina [2204000-24330, 2204000-24329]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitral-07 CVD 04; Medical University of South Carolina; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR021949 (to S.G.) and P20RR016434 (to S.M., S.G., and R.R.M.), HL RO1 33756 and 1 P30AR050953 (to V.C.H.). This work was also supported by Mitral-07 CVD 04 (to R.R.M.), Medical University of South Carolina University Research Council Project 2204000-24330 (to S.M.) and 2204000-24329 (to S.G.).	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Bardelli A, 1999, ONCOGENE, V18, P1139, DOI 10.1038/sj.onc.1202607; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Esser C, 2004, INT IMMUNOPHARMACOL, V4, P805, DOI 10.1016/j.intimp.2004.03.006; Fujita K, 2008, PROSTATE, V68, P872, DOI 10.1002/pros.20755; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GOHDA E, 1994, CYTOKINE, V6, P633, DOI 10.1016/1043-4666(94)90051-5; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Halevy O, 2004, EXP CELL RES, V297, P224, DOI 10.1016/j.yexcr.2004.03.024; HE Q, 1992, J CELL BIOL, V119, P1711, DOI 10.1083/jcb.119.6.1711; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kosaki R, 1999, CANCER RES, V59, P1141; Levesque MC, 1997, J IMMUNOL, V159, P6184; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MATSUMOTO K, 1995, J BIOCHEM-TOKYO, V117, P458, DOI 10.1093/jb/117.2.458; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1992, P NATL ACAD SCI USA, V89, P3800, DOI 10.1073/pnas.89.9.3800; MATSUNAGA T, 1994, EXP CELL RES, V210, P326, DOI 10.1006/excr.1994.1045; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Miyake H, 1998, J UROLOGY, V160, P1562, DOI 10.1016/S0022-5347(01)62613-2; Miyake H, 1998, J UROLOGY, V160, P2004, DOI 10.1016/S0022-5347(01)62225-0; Munster PN, 2002, CANCER RES, V62, P3132; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naughton M, 2001, J UROLOGY, V165, P1325, DOI 10.1016/S0022-5347(01)69893-8; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noordzij MA, 1997, CLIN CANCER RES, V3, P805; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Reeder JA, 1998, CANCER RES, V58, P3719; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Skrtic S, 1997, ENDOCRINOLOGY, V138, P4683, DOI 10.1210/en.138.11.4683; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; SY MS, 1991, J EXP MED, V174, P859, DOI 10.1084/jem.174.4.859; THALMANN GN, 1994, CANCER RES, V54, P2577; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; VANDENHOOFF A, 1988, ADV CANCER RES, V50, P159, DOI 10.1016/S0065-230X(08)60437-6; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Webber MM, 1996, PROSTATE, V29, P386, DOI 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zeng CX, 1998, INT J CANCER, V77, P396; Zhu XP, 2000, UROLOGY, V56, P1071, DOI 10.1016/S0090-4295(00)00795-0; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	66	60	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19821	19832		10.1074/jbc.M110.104273	http://dx.doi.org/10.1074/jbc.M110.104273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20200161	Green Published, hybrid			2022-12-27	WOS:000279012000015
J	Dai, FY; Qiao, L; Tong, XL; Cao, C; Chen, P; Chen, J; Lu, C; Xiang, ZH				Dai, Fang-yin; Qiao, Liang; Tong, Xiao-ling; Cao, Cun; Chen, Peng; Chen, Jun; Lu, Cheng; Xiang, Zhong-huai			Mutations of an Arylalkylamine-N-acetyltransferase, Bm-iAANAT, Are Responsible for Silkworm Melanism Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBYX-MORI; SYNTHESIS ENZYMES; PAPILIO-XUTHUS; INSECT; PIGMENTATION; DROSOPHILA; GENETICS; SCLEROTIZATION; MELANIZATION; PURIFICATION	Coloration is one of the most variable characters in animals and provides rich material for studying the developmental genetic basis of pigment patterns. In the silkworm, more than 100 gene mutation systems are related to aberrant color patterns. The melanism (mln) is a rare body color mutant that exhibits an easily distinguishable phenotype in both larval and adult silkworms. By positional cloning, we identified the candidate gene of the mln locus, Bm-iAANAT, whose homologous gene (Dat) converts dopamine into N-acetyldopamine, a precursor for N-acetyldopamine sclerotin in Drosophila. In the mln mutant, two types of abnormal Bm-iAANAT transcripts were identified, whose expression levels are markedly lower than the wild type (WT). Moreover, dopamine content was approximately twice as high in the sclerified tissues (head, thoracic legs, and anal plate) of the mutant as in WT, resulting in phenotypic differences between the two. Quantitative reverse transcription PCR analyses showed that other genes involved in the melanin metabolism pathway were regulated by the aberrant Bm-iAANAT activity in mln mutant in different ways and degrees. We therefore propose that greater accumulation of dopamine results from the functional deficiency of BmiAANAT in the mutant, causing a darker pattern in the sclerified regions than in the WT. In summary, our results indicate that Bm-iAANAT is responsible for the color pattern of the silkworm mutant, mln. To our knowledge, this is the first report showing a role for arylalkylamine-N-acetyltransferases in color pattern mutation in Lepidoptera.	[Lu, Cheng] Southwest Univ, Inst Sericulture & Syst Biol, Key Sericultural Lab Agr Minist, Coll Biotechnol, Chongqing 400715, Peoples R China; [Tong, Xiao-ling] Chongqing Univ, Inst Agr & Life Sci, Chongqing 400030, Peoples R China	Southwest University - China; Chongqing University	Lu, C (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, Key Sericultural Lab Agr Minist, Coll Biotechnol, Chongqing 400715, Peoples R China.	lucheng@swu.edu.cn		Qiao, Liang/0000-0002-4638-3225; Dai, Fangyin/0000-0002-0215-2177; Tong, Xiaoling/0000-0002-2649-899X	National Basic Research 973 Program of China [2005CB121000]; Hi-Tech Research and Development 863 Program of China [2006AA10A117]; National Natural Science Foundation of China [30671591]; Science Foundation of Ministry of Education of China [20060635016]; Southwest University of China [2006052]	National Basic Research 973 Program of China(National Basic Research Program of China); Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China); Southwest University of China(Southwest University - China)	This work was supported by National Basic Research 973 Program of China Grant 2005CB121000, Hi-Tech Research and Development 863 Program of China Grant 2006AA10A117, National Natural Science Foundation of China Grant 30671591, Science Foundation of Ministry of Education of China Grant 20060635016, and Technological Innovative Foundation Project for postgraduates of Southwest University of China Grant 2006052.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; CZAPLA TH, 1990, J INSECT PHYSIOL, V36, P647, DOI 10.1016/0022-1910(90)90069-R; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2007, INSECT BIOCHEM MOLEC, V37, P855, DOI 10.1016/j.ibmb.2007.02.014; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Han D, 2002, BIOCHEM J, V368, P333; HIRUMA K, 1985, DEV BIOL, V110, P509, DOI 10.1016/0012-1606(85)90109-5; HIRUMA K, 1984, J EXP ZOOL, V230, P393, DOI 10.1002/jez.1402300308; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Ichihara N, 1997, INSECT BIOCHEM MOLEC, V27, P241, DOI 10.1016/S0965-1748(96)00091-4; Ichihara N, 2001, INSECT BIOCHEM MOLEC, V32, P15, DOI 10.1016/S0965-1748(01)00075-3; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; KIGUCHI K, 1981, J INSECT PHYSIOL, V27, P805, DOI 10.1016/0022-1910(81)90072-X; Koch PB, 2000, PIGM CELL RES, V13, P54, DOI 10.1111/j.0893-5785.2000.130811.x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lu Cheng, 2003, Scientia Agricultura Sinica, V36, P968; Meng Y, 2009, GENES CELLS, V14, P129, DOI 10.1111/j.1365-2443.2008.01257.x; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mizoguchi A, 2002, GEN COMP ENDOCR, V127, P181, DOI 10.1016/S0016-6480(02)00043-6; Rauschenbach IY, 2008, J COMP PHYSIOL B, V178, P315, DOI 10.1007/s00360-007-0224-x; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; SMITH TJ, 1990, BIOESSAYS, V12, P30, DOI 10.1002/bies.950120107; Suzuki Y, 2002, INSECT BIOCHEM MOLEC, V32, P599, DOI 10.1016/S0965-1748(01)00136-9; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tsugehara T, 2007, COMP BIOCHEM PHYS B, V147, P358, DOI 10.1016/j.cbpb.2006.10.112; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]	35	65	84	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19553	19560		10.1074/jbc.M109.096743	http://dx.doi.org/10.1074/jbc.M109.096743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20332088	hybrid, Green Published			2022-12-27	WOS:000278727800065
J	Ramadoss, P; Chiappini, F; Bilban, M; Hollenberg, AN				Ramadoss, Preeti; Chiappini, Franck; Bilban, Martin; Hollenberg, Anthony N.			Regulation of Hepatic Six Transmembrane Epithelial Antigen of Prostate 4 (STEAP4) Expression by STAT3 and CCAAT/Enhancer-binding Protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-RELATED PROTEIN; INSULIN-RESISTANCE; IN-VIVO; GLUCONEOGENIC GENES; OB/OB MICE; OBESITY; INTERLEUKIN-6; KINASE; TISSUE	STEAP4 is a plasma membrane metalloreductase involved in the transport of iron and copper. Recently, STEAP4 was implicated in promoting insulin sensitivity by acting in white adipose tissue to control the production of inflammatory cytokines such as interleukin 6. Indeed, the loss of STEAP4 expression in mice leads to increased production of inflammatory cytokines in visceral white adipose tissue and systemic insulin resistance. In this study, we demonstrate that in mouse liver STEAP4 is produced at significant levels and that steap4 transcription is induced by interleukin 6. We further demonstrate that the steap4 gene is a direct target of phosphorylated STAT3 in mouse liver. In addition, hepatic STEAP4 expression is regulated by feeding and fasting, and obesity leads to the induction of STEAP4 expression in the liver. Interestingly, the regulation of STEAP4 in both feeding and fasting and the obese state appears to require the transcription factor CCAAT/enhancer-binding protein alpha that may act in concert with STAT3 as they both bind to the proximal steap4 promoter in vivo. Taken together, these data suggest the transcriptional regulation of hepatic STEAP4 may play a critical role in the response to nutritional and inflammatory stress and contributes to the protective effect of STEAP4 in vivo.	[Ramadoss, Preeti; Chiappini, Franck; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Ramadoss, Preeti; Chiappini, Franck; Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bilban, Martin] Ludwig Boltzmann Inst Clin & Expt Oncol, A-1090 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Medical University of Vienna; Ludwig Boltzmann Institute	Hollenberg, AN (corresponding author), 330 Brookline Ave, Boston, MA 02215 USA.	thollenb@bidmc.harvard.edu	Chiappini, Franck/AAB-9894-2021	Bilban, Martin/0000-0001-7043-7142; Chiappini, Franck/0000-0002-2684-1241	American Diabetes Association; Takeda Pharmaceuticals	American Diabetes Association(American Diabetes Association); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	This work was supported by the Smith Family Pinnacle Award from the American Diabetes Association and a grant from Takeda Pharmaceuticals.	Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dongiovanni P, 2008, AM J PATHOL, V172, P738, DOI 10.2353/ajpath.2008.070097; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gum RJ, 2003, MOL ENDOCRINOL, V17, P1131, DOI 10.1210/me.2002-0288; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Li SY, 2005, DIABETES OBES METAB, V7, P448, DOI 10.1111/j.1463-1326.2004.00387.x; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x	35	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16453	16466		10.1074/jbc.M109.066936	http://dx.doi.org/10.1074/jbc.M109.066936			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304921	Green Published, hybrid			2022-12-27	WOS:000277982600007
J	Ramakrishnan, B; Qasba, PK				Ramakrishnan, Boopathy; Qasba, Pradman K.			Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; GALACTOSYLTRANSFERASE-I BETA-4GALT-7; ALPHA-LACTALBUMIN; HEPARAN-SULFATE; BOVINE BETA-1,4-GALACTOSYLTRANSFERASE; LACTOSE SYNTHETASE; GENE FAMILY; PROTEIN; IDENTIFICATION; MECHANISM	The beta 1,4-galactosyltransferase-7 (beta 4Gal-T7) enzyme, one of seven members of the beta 4Gal-T family, transfers in the presence of manganese Gal from UDP-Gal to an acceptor sugar (xylose) that is attached to a side chain hydroxyl group of Ser/Thr residues of proteoglycan proteins. It exhibits the least protein sequence similarity with the other family members, including the well studied family member beta 4Gal-T1, which, in the presence of manganese, transfers Gal from UDP-Gal to GlcNAc. We report here the crystal structure of the catalytic domain of beta 4Gal-T7 from Drosophila in the presence of manganese and UDP at 1.81 angstrom resolution. In the crystal structure, a new manganese ion-binding motif (HXH) has been observed. Superposition of the crystal structures of beta 4Gal-T7 and beta 4Gal-T1 shows that the catalytic pocket and the substrate-binding sites in these proteins are similar. Compared with GlcNAc, xylose has a hydroxyl group (instead of anN-acetyl group) at C2 and lacks the CH2OH group at C5; thus, these protein structures show significant differences in their acceptor-binding site. Modeling of xylose in the acceptor-binding site of the beta 4Gal-T7 crystal structure shows that the aromatic side chain of Tyr(177) interacts strongly with the C5 atom of xylose, causing steric hindrance to any additional group at C5. Because Drosophila Cd7 has a 73% protein sequence similarity to human Cd7, the present crystal structure offers a structure-based explanation for the mutations in human Cd7 that have been linked to Ehlers-Danlos syndrome.	[Qasba, Pradman K.] NCI, Struct Glycobiol Sect, SAIC Frederick Inc, CCRNP,CCR,NIH, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy] NCI, Basic Res Program, SAIC Frederick Inc, CCRNP,CCR,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), NCI, Struct Glycobiol Sect, SAIC Frederick Inc, CCRNP,CCR,NIH, Bldg 469,Rm 221, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Institutes of Health, NCI, Center for Cancer Research [HHSN261200800001E]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC009304] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E from NCI and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. Use of beam line 22-ID/BM of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory, was supported by Contract W-31-109-Eng-38 from the United States Department of Energy, Office of Science, Office of Basic Energy Sciences.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; BOEGGEMAN EE, 1993, PROTEIN ENG, V6, P779, DOI 10.1093/protein/6.7.779; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P57, DOI 10.1093/protein/4.1.57; Conrad H. E., 1998, HEPARIN BINDING PROT; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; Dauter Z, 2002, CURR OPIN STRUC BIOL, V12, P674, DOI 10.1016/S0959-440X(02)00372-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; GEREN CR, 1975, BIOCHEMISTRY-US, V14, P1461, DOI 10.1021/bi00678a017; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Krupicka M, 2009, J PHYS CHEM B, V113, P11314, DOI 10.1021/jp904716t; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2003, J BIOMOL STRUCT DYN, V21, P1; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y	43	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15619	15626		10.1074/jbc.M109.099564	http://dx.doi.org/10.1074/jbc.M109.099564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236943	Green Published, hybrid			2022-12-27	WOS:000277399000080
J	Figueroa, AA; Delaney, S				Figueroa, Amalia Avila; Delaney, Sarah			Mechanistic Studies of Hairpin to Duplex Conversion for Trinucleotide Repeat Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMERIZATION INITIATION SITE; NUCLEOCAPSID-PROTEIN; SECONDARY STRUCTURE; KISSING COMPLEX; STRAND TRANSFER; MELTING CURVES; HUMAN-DISEASE; NMR STRUCTURE; BASE-PAIRS; IN-VITRO	The expansion of a trinucleotide repeat sequence, such as CAG/CTG, has been pinpointed as the molecular basis for a number of neurodegenerative disorders. It has been proposed that as part of the expansion process, these repetitive sequences adopt non-B conformations such as hairpins. However, the prevalence of these hairpins and their contributions to the DNA expansion have not been well defined. In this work, we utilized a molecular beacon strategy to examine the stability of the (CAG)(10) hairpin and also its behavior in the presence of the complementary (CTG)(10) hairpin. We find that the two hairpins represent kinetically trapped species that can coexist but irreversibly convert to duplex upon thermal induction. Furthermore, as monitored by fluorescence and optical analysis, modifications to the base composition of either the loop or stem region have a profound effect on the ability of the trinucleotide repeat hairpins to convert to duplex. Additionally, the rate of duplex formation is also reduced with these loop and stem-modified hairpins. These results demonstrate that the trinucleotide repeat hairpins can convert to duplex via two independent mechanisms as follows: the loop-loop interactions found in kissing hairpins or the stem-stem interactions of a cruciform.	[Figueroa, Amalia Avila; Delaney, Sarah] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Figueroa, Amalia Avila] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Brown University	Delaney, S (corresponding author), Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA.	sarah_delaney@brown.edu			Brown University; Richard B. Salomon faculty research award; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	Brown University; Richard B. Salomon faculty research award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brown University in the form of start-up funds and a Richard B. Salomon faculty research award (to S. D.).; Supported by a National Science Foundation graduate research fellowship.	Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Bartos JD, 2008, J BIOL CHEM, V283, P21758, DOI 10.1074/jbc.M800856200; BEAUCAGE SL, 2000, CURR PROTOC NUCL ACI; Bernacchi S, 2005, J BIOL CHEM, V280, P40112, DOI 10.1074/jbc.M503230200; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; CHANG KY, 1994, P NATL ACAD SCI USA, V91, P8705, DOI 10.1073/pnas.91.18.8705; Chang KY, 1997, J MOL BIOL, V269, P52, DOI 10.1006/jmbi.1997.1021; Darby RAJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e39; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Ennifar E, 2006, J MOL BIOL, V356, P771, DOI 10.1016/j.jmb.2005.12.022; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; GACY AM, 1994, BIOCHEMISTRY-US, V33, P11951, DOI 10.1021/bi00205a034; Gacy AM, 1998, BIOCHEMISTRY-US, V37, P9426, DOI 10.1021/bi980157s; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; HERR W, 1985, P NATL ACAD SCI USA, V82, P8009, DOI 10.1073/pnas.82.23.8009; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kushon SA, 2001, J AM CHEM SOC, V123, P10805, DOI 10.1021/ja016310e; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Liu HW, 2005, BIOPHYS J, V89, P3470, DOI 10.1529/biophysj.105.065326; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paiva AM, 2005, J AM CHEM SOC, V127, P5581, DOI 10.1021/ja043783n; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Ramalanjaona N, 2007, J MOL BIOL, V374, P1041, DOI 10.1016/j.jmb.2007.10.001; Risitano A, 2003, BIOCHEMISTRY-US, V42, P6507, DOI 10.1021/bi026997v; Ulyanov NB, 2006, J BIOL CHEM, V281, P16168, DOI 10.1074/jbc.M601711200; Van Melckebeke H, 2008, P NATL ACAD SCI USA, V105, P9210, DOI 10.1073/pnas.0712121105; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Volker J, 2002, P NATL ACAD SCI USA, V99, P14700, DOI 10.1073/pnas.222519799; Volker J, 2007, J AM CHEM SOC, V129, P5272, DOI 10.1021/ja070258q; WARSHAW MM, 1966, J MOL BIOL, V20, P29, DOI 10.1016/0022-2836(66)90115-X; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003	44	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14648	14657		10.1074/jbc.M109.061853	http://dx.doi.org/10.1074/jbc.M109.061853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228068	hybrid, Green Published			2022-12-27	WOS:000277299700062
J	Liao, H; Hyman, MC; Baek, AE; Fukase, K; Pinsky, DJ				Liao, Hui; Hyman, Matthew C.; Baek, Amy E.; Fukase, Keigo; Pinsky, David J.			cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; SIGNALING PATHWAYS; GENE-EXPRESSION; FACTOR CREB; CAMP-PKA; T-CELLS; C-JUN; PHOSPHORYLATION; ACTIVATION	CD39 is a transmembrane enzyme that inhibits platelet reactivity and inflammation by phosphohydrolyzing ATP and ADP to AMP. Cyclic AMP (cAMP), an essential second messenger, is particularly important in regulating genes controlling vascular homeostasis. These experiments test the hypothesis that cAMP might positively regulate the expression of CD39 and thereby modulate important vascular homeostatic properties. Cd39 mRNA was induced by 13.8- fold in RAW cells treated with a membrane-permeant cAMP analogue (8-bromo-cyclic AMP; 8-Br-cAMP), stimulation of adenylate cyclase, or prostanoids known to drive cAMP response. Fluorescence-activated cell sorting, immunofluorescence, and TLC assays demonstrated that both CD39 protein expression and enzymatic activity were increased in cells treated with 8-Br-cAMP but not in cells transfected with short hairpin RNA against CD39. This analogue drove a significant increase in transcriptional activity at the Cd39 promoter although not when the promoter's cAMP-response element sites were mutated. Pretreatment with cAMP-dependent protein kinase (PKA), phosphoinositide 3-kinase (PI3K), or ERK inhibitors nearly obliterated the cAMP-driven increase in Cd39 mRNA, protein expression, and promoter activity. 8-Br-cAMP greatly increased the phosphorylation of CREB1 (Ser(133)) and ATF2 (Thr(71)) in a PKA-, PI3K-, and ERK-dependent fashion. Chromatin immunoprecipitation assays demonstrated that binding of phosphorylated CREB1 and ATF2 to cAMP-response element-like sites was significantly increased with 8-Br-cAMP treatment and that binding was reduced with PKA, PI3K, and ERK inhibition, whereas transfection of Creb1 and Atf2 overexpression constructs enhanced cAMP-driven Cd39 mRNA expression. Transfection of RAW cells with mutated Creb1 (S133A) reduced cAMP-driven Cd39 mRNA expression. Furthermore, the cAMP-mediated induction of Cd39 mRNA, protein, and phosphohydrolytic activity was replicated in primary peritoneal macrophages. These data identify cAMP as a crucial regulator of macrophage CD39 expression and demonstrate that cAMP acts through the PKA/CREB, PKA/PI3K/ATF2, and PKA/ERK/ATF2 pathways to control a key vascular homeostatic mediator.	[Liao, Hui; Fukase, Keigo; Pinsky, David J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Hyman, Matthew C.; Baek, Amy E.; Pinsky, David J.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pinsky, DJ (corresponding author), 7220 Med Sci Res Bldg 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dpinsky@umich.edu	liao, hui/GSE-5758-2022	Hyman, Matthew/0000-0002-4050-6925	National Institutes of Health [R01HL085149, R01HL086676, R01HL055397, P01HL089407]; Taubman Medical Research Institute; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086676, R01HL085149, R01HL055397, P01HL089407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Medical Research Institute; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL085149, R01HL086676, R01HL055397, and P01HL089407. This work was also supported by a Taubman Medical Research Institute Scholarship, the Ruth Professorship, and the Scleroderma Research Foundation.	Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen KQ, 2005, CELL MOL IMMUNOL, V2, P241; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Dombrowski KE, 1998, IMMUNOL REV, V161, P111, DOI 10.1111/j.1600-065X.1998.tb01575.x; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Freeland K, 2000, BIOCHEM J, V345, P233, DOI 10.1042/0264-6021:3450233; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Gerlo S, 2006, CELL MOL LIFE SCI, V63, P92, DOI 10.1007/s00018-005-5433-4; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Kang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE215, DOI 10.1152/ajpendo.00181.2006; KANSAS GS, 1991, J IMMUNOL, V146, P2235; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Langston HP, 2003, J IMMUNOL, V170, P2962, DOI 10.4049/jimmunol.170.6.2962; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcus A J, 2001, Ital Heart J, V2, P824; Marcus AJ, 2005, SEMIN THROMB HEMOST, V31, P234, DOI 10.1055/s-2005-869528; Marcus AJ, 2003, J THROMB HAEMOST, V1, P2497, DOI 10.1111/j.1538-7836.2003.00479.x; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; PINSKY D, 1993, J CLIN INVEST, V92, P2994, DOI 10.1172/JCI116922; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sperlagh B, 1999, J ENDOCRINOL, V160, P343, DOI 10.1677/joe.0.1600343; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang CY, 2000, CIRC RES, V86, P982, DOI 10.1161/01.RES.86.9.982; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; Zhang JL, 2009, INT J CLIN EXP MED, V2, P87	57	64	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14791	14805		10.1074/jbc.M110.116905	http://dx.doi.org/10.1074/jbc.M110.116905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20178980	Green Published, hybrid			2022-12-27	WOS:000277299700076
J	Lim, SY; Raftery, MJ; Goyette, J; Geczy, CL				Lim, Su Yin; Raftery, Mark J.; Goyette, Jesse; Geczy, Carolyn L.			S-Glutathionylation Regulates Inflammatory Activities of S100A9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; MICROVASCULAR ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HUMAN NEUTROPHILS; ARACHIDONIC-ACID; TRANSENDOTHELIAL MIGRATION; REDOX REGULATION; NADPH OXIDASE; MRP14 S100A9; ANTIMICROBIAL ACTIVITY	Reactive oxygen species generated by activated neutrophils can cause oxidative stress and tissue damage. S100A8 (A8) and S100A9 (A9), abundant in neutrophil cytoplasm, are exquisitely sensitive to oxidation, which may alter their functions. Murine A8 is a neutrophil chemoattractant, but it suppresses leukocyte transmigration in the microcirculation when S-nitrosylated. Glutathione (GSH) modulates intracellular redox, and S-glutathionylation can protect susceptible proteins from oxidative damage and regulate function. We characterized S-glutathionylation of A9; GSSG and GSNO generated S-glutathionylated A8 (A8-SSG) and A9 (A9-SSG) in vitro, whereas only A9-SSG was detected in cytosol of neutrophils activated with phorbol myristate acetate (PMA) but not with fMLP or opsonized zymosan. S-Glutathionylation exposed more hydrophobic regions in Zn2+-bound A9 but did not alter Zn2+ binding affinity. A9-SSG had reduced capacity to form heterocomplexes with A8, but the arachidonic acid binding capacities of A8/A9 and A8/A9-SSG were similar. A9 and A8/A9 bind endothelial cells; S-glutathionylation reduced binding. We found little effect of A9 or A9-SSG on neutrophil CD11b/CD18 expression or neutrophil adhesion to endothelial cells. However, A9, A9-SSG and A8/A9 promoted neutrophil adhesion to fibronectin but, in the presence of A8, A9-mediated adhesion was abrogated by glutathionylation. S-Glutathionylation of A9 may protect its oxidation to higher oligomers and reduce neutrophil binding to the extracellular matrix. This may regulate the magnitude of neutrophil migration in the extravasculature, and together with the functional changes we reported for S-nitrosylated A8, particular oxidative modifications of these proteins may limit tissue damage in acute inflammation.	Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Sch Med Sci, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney		c.geczy@unsw.edu.au	Goyette, Jesse/AAW-4701-2021	Goyette, Jesse/0000-0002-1008-1890; Lim, Su Yin/0000-0001-9576-5441	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council of Australia.	Achilli C, 2008, J LEUKOCYTE BIOL, V83, P181, DOI 10.1189/jlb.0707492; Al-Abed Y, 2001, MOL MED, V7, P619, DOI 10.1007/BF03401868; Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; BENGISGARBER C, 1993, J LEUKOCYTE BIOL, V54, P114, DOI 10.1002/jlb.54.2.114; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; De Lorenzo BHP, 2010, IMMUNOBIOLOGY, V215, P341, DOI 10.1016/j.imbio.2009.05.013; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Eue I, 2002, INT IMMUNOL, V14, P287, DOI 10.1093/intimm/14.3.287; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Herndon BL, 2003, J LAB CLIN MED, V141, P110, DOI 10.1067/mlc.2003.17; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hetland G, 1998, J CLIN PATHOL-MOL PA, V51, P143, DOI 10.1136/mp.51.3.143; HOGG N, 1989, EUR J IMMUNOL, V19, P1053, DOI 10.1002/eji.1830190615; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; IISMAA SE, 1994, DNA CELL BIOL, V13, P183, DOI 10.1089/dna.1994.13.183; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Kerkhoff C, 1999, PATHOBIOLOGY, V67, P230, DOI 10.1159/000028098; Kerkhoff C, 1998, BBA-MOL CELL RES, V1448, P200, DOI 10.1016/S0167-4889(98)00144-X; Kerkhoff C, 1999, FEBS LETT, V460, P134, DOI 10.1016/S0014-5793(99)01322-8; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Klempt M, 1997, FEBS LETT, V408, P81, DOI 10.1016/S0014-5793(97)00394-3; Kocher M, 1996, INFECT IMMUN, V64, P1342, DOI 10.1128/IAI.64.4.1342-1350.1996; Kumar RK, 2001, J LEUKOCYTE BIOL, V70, P59; LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lindbom L, 2002, SEMIN IMMUNOL, V14, P115, DOI 10.1006/smim.2001.0348; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; MARKERT M, 1984, BLUT, V49, P447, DOI 10.1007/BF00320487; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Newton RA, 1998, J IMMUNOL, V160, P1427; Niwa T, 2000, CLIN CHEM, V46, P82; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Raftery MJ, 2001, J BIOL CHEM, V276, P33393, DOI 10.1074/jbc.M101566200; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Richie JP, 1996, CLIN CHEM, V42, P64; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; ROTH J, 1993, BLOOD, V82, P1875; Roulin K, 1999, EXP CELL RES, V247, P410, DOI 10.1006/excr.1998.4382; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Shelton MD, 2008, MOL CELLS, V25, P332; Siegenthaler G, 1997, J BIOL CHEM, V272, P9371; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Sroussi HY, 2006, J DENT RES, V85, P829, DOI 10.1177/154405910608500910; Sroussi HY, 2007, J LEUKOCYTE BIOL, V81, P818, DOI 10.1189/jlb.0706433; Sroussi HY, 2009, FEMS IMMUNOL MED MIC, V55, P55, DOI 10.1111/j.1574-695X.2008.00498.x; Suryono, 2005, J PERIODONTOL, V76, P437, DOI 10.1902/jop.2005.76.3.437; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; vandenBos C, 1996, J IMMUNOL, V156, P1247; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Voganatsi A, 2001, J LEUKOCYTE BIOL, V70, P130; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; Yui S, 1995, J LEUKOCYTE BIOL, V58, P650, DOI 10.1002/jlb.58.6.650; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002	101	53	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14377	14388		10.1074/jbc.M109.075242	http://dx.doi.org/10.1074/jbc.M109.075242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223829	Green Published, hybrid			2022-12-27	WOS:000277299700035
J	Dutertre, S; Lewis, RJ				Dutertre, Sebastien; Lewis, Richard J.			Use of Venom Peptides to Probe Ion Channel Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTOR; NEURONAL SODIUM-CHANNELS; ALPHA-CONOTOXIN BINDING; D-ASPARTATE RECEPTOR; II VOLTAGE SENSOR; K+-CHANNEL; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; HIGH-AFFINITY; CONANTOKIN-G	Venoms of snakes, scorpions, spiders, insects, sea anemones, and cone snails are complex mixtures of mostly peptides and small proteins that have evolved for prey capture and/or defense. These deadly animals have long fascinated scientists and the public. Early studies isolated lethal components in the search for cures and understanding of their mechanisms of action. Ion channels have emerged as targets for many venom peptides, providing researchers highly selective and potent molecular probes that have proved invaluable in unraveling ion channel structure and function. This minireview highlights molecular details of their toxin-receptor interactions and opportunities for development of peptide therapeutics.	[Dutertre, Sebastien; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4067, Australia; [Dutertre, Sebastien] Atheris Labs, CH-1233 Bernex Geneva, Switzerland	University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4067, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard J/E-8674-2013; Lewis, Richard/T-8763-2019	Lewis, Richard J/0000-0003-3470-923X; Lewis, Richard/0000-0003-3470-923X; Dutertre, Sebastien/0000-0002-2945-1484	National Health and Medical Research Council; European Molecular Biology Organization	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by a National Health and Medical Research Council program grant and research fellowship (to R. J. L.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.; Recipient of a long-term postdoctoral fellowship from the European Molecular Biology Organization.	Al-Sabi A, 2004, BIOCHEMISTRY-US, V43, P8625, DOI 10.1021/bi0495681; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Barbier J, 2004, J BIOL CHEM, V279, P4680, DOI 10.1074/jbc.M309576200; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; CARBONE E, 1982, NATURE, V296, P90, DOI 10.1038/296090a0; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Cui M, 2002, J MOL BIOL, V318, P417, DOI 10.1016/S0022-2836(02)00095-5; Daly JW, 2005, CELL MOL NEUROBIOL, V25, P513, DOI 10.1007/s10571-005-3968-4; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, J MOL RECOGNIT, V17, P339, DOI 10.1002/jmr.683; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Ellis KC, 2001, BIOCHEMISTRY-US, V40, P5942, DOI 10.1021/bi010173g; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Garcia MC, 2001, J MEMBRANE BIOL, V184, P121, DOI 10.1007/s00232-001-0080-7; Gilquin B, 2005, J BIOL CHEM, V280, P27093, DOI 10.1074/jbc.M413626200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Honma T, 2006, MAR BIOTECHNOL, V8, P1, DOI 10.1007/s10126-005-5093-2; Huang XQ, 2005, J AM CHEM SOC, V127, P6836, DOI 10.1021/ja042641q; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jacobsen RB, 2000, J BIOL CHEM, V275, P24639, DOI 10.1074/jbc.C900990199; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Katoh E, 2000, BIOPOLYMERS, V54, P44, DOI 10.1002/(SICI)1097-0282(200007)54:1<44::AID-BIP50>3.0.CO;2-Z; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Leipold E, 2007, CHANNELS, V1, P253, DOI 10.4161/chan.4847; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Martin-Moutot N, 2006, MOL PHARMACOL, V69, P1931, DOI 10.1124/mol.105.021147; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Mondal Sukanta, 2007, In Silico Biology, V7, P175; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mould J, 2004, J BIOL CHEM, V279, P34705, DOI 10.1074/jbc.M310848200; Nielsen KJ, 1999, J MED CHEM, V42, P415, DOI 10.1021/jm981052q; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Schroeder CI, 2008, J BIOL CHEM, V283, P21621, DOI 10.1074/jbc.M802852200; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Verdier L, 2005, J BIOL CHEM, V280, P21246, DOI 10.1074/jbc.M502376200; Wang F, 2006, BIOCHEM BIOPH RES CO, V351, P443, DOI 10.1016/j.bbrc.2006.10.067; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wang XM, 2007, BIOCHEMISTRY-US, V46, P7590, DOI 10.1021/bi7001696; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Wittekindt B, 2001, NEUROPHARMACOLOGY, V41, P753, DOI 10.1016/S0028-3908(01)00112-5; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhang SJ, 2003, J CARDIOVASC PHARM, V42, P764, DOI 10.1097/00005344-200312000-00011	90	124	127	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13315	13320		10.1074/jbc.R109.076596	http://dx.doi.org/10.1074/jbc.R109.076596			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189991	Green Published, hybrid			2022-12-27	WOS:000276987700001
J	Rossi, A; Trotta, E; Brandi, R; Arisi, I; Coccia, M; Santoro, MG				Rossi, Antonio; Trotta, Edoardo; Brandi, Rossella; Arisi, Ivan; Coccia, Marta; Santoro, M. Gabriella			AIRAP, a New Human Heat Shock Gene Regulated by Heat Shock Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; PROSTAGLANDIN A(1); DAMAGED PROTEINS; KAPPA-B; STRESS; DROSOPHILA; PROTEOTOXICITY; DEGRADATION; ACTIVATION	Heat shock factor-1 (HSF1) is the central regulator of heat-induced transcriptional responses leading to rapid expression of molecular chaperones that protect mammalian cells against proteotoxic stress. The main targets for HSF1 are specific promoter elements (HSE) located upstream of heat shock genes encoding a variety of heat shock proteins, including HSP70, HSP90, HSP27, and other proteins of the network. Herein we report that the zinc finger AN1-type domain-2a gene, also known as AIRAP, behaves as a canonical heat shock gene, whose expression is temperature-dependent and strictly controlled by HSF1. Transcription is triggered at temperatures above 40 degrees C in different types of human cancer and primary cells, including peripheral blood monocytes. As shown by ChIP analysis, HSF1 is recruited to the AIRAP promoter rapidly after heat treatment, with a kinetics that parallels HSP70 promoter HSF1-recruitment. In transfection experiments HSF1-silencing abolished heat-induced AIRAP promoter-driven transcription, which could be rescued by exogenous Flag-HSF1 expression. The HSF1 binding HSE sequence in the AIRAP promoter critical for heat-induced transcription was identified. Because its expression is induced at febrile temperatures in human cells, AIRAP may represent a new potential component of the protective response during fever in humans.	[Coccia, Marta; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Brandi, Rossella; Arisi, Ivan] European Brain Res Inst, I-00143 Rome, Italy; [Rossi, Antonio; Trotta, Edoardo; Coccia, Marta; Santoro, M. Gabriella] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR)	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020; Arisi, Ivan/AAM-1152-2021	Trotta, Edoardo/0000-0002-1417-9238; Arisi, Ivan/0000-0002-0536-2508; ROSSI, ANTONIO/0000-0003-0383-3828; Santoro, Maria Gabriella/0000-0003-1432-4949	Italian Ministry of University and Scientific Research; Italian Ministry of Public Health; EU	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Public Health(Ministry of Health, Italy); EU(European Commission)	This work was supported in part by the Italian Ministry of University and Scientific Research, the Italian Ministry of Public Health (ISS project), and the EU EICOSANOX Project.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	31	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13607	13615		10.1074/jbc.M109.082693	http://dx.doi.org/10.1074/jbc.M109.082693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185824	hybrid, Green Published			2022-12-27	WOS:000276987700034
J	Verbruggen, V; Ek, O; Georlette, D; Delporte, F; Von Berg, V; Detry, N; Biemar, F; Coutinho, P; Martial, JA; Voz, ML; Manfroid, I; Peers, B				Verbruggen, Vincianne; Ek, Olivier; Georlette, Daphne; Delporte, Francois; Von Berg, Virginie; Detry, Nathalie; Biemar, Frederic; Coutinho, Pedro; Martial, Joseph A.; Voz, Marianne L.; Manfroid, Isabelle; Peers, Bernard			The Pax6b Homeodomain Is Dispensable for Pancreatic Endocrine Cell Differentiation in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-EYE; EMBRYONIC-DEVELOPMENT; IN-VIVO; GENES; EXPRESSION; DROSOPHILA; OVEREXPRESSION; TRANSCRIPTION; VERTEBRATE; HUMANS	Pax6 is a well conserved transcription factor that contains two DNA-binding domains, a paired domain and a homeodomain, and plays a key role in the development of eye, brain, and pancreas in vertebrates. The recent identification of the zebrafish sunrise mutant, harboring a mutation in the pax6b homeobox and presenting eye abnormalities but no obvious pancreatic defects, raised a question about the role of pax6b in zebrafish pancreas. We show here that pax6b does play an essential role in pancreatic endocrine cell differentiation, as revealed by the phenotype of a novel zebrafish pax6b null mutant and of embryos injected with pax6b morpholinos. Pax6b-depleted embryos have almost no beta cells, a strongly reduced number of delta cells, and a significant increase of epsilon cells. Through the use of various morpholinos targeting intron-exon junctions, pax6b RNA splicing was perturbed at several sites, leading either to retention of intronic sequences or to deletion of exonic sequences in the pax6b transcript. By this strategy, we show that deletion of the Pax6b homeodomain in zebrafish embryos does not disturb pancreas development, whereas lens formation is strongly affected. These data thus provide the explanation for the lack of pancreatic defects in the sunrise pax6b mutants. In addition, partial reduction of Pax6b function in zebrafish embryos performed by injection of small amounts of pax6b morpholinos caused a clear rise in alpha cell number and in glucagon expression, emphasizing the importance of the fine tuning of the Pax6b level to its biological activity.	[Verbruggen, Vincianne; Ek, Olivier; Delporte, Francois; Von Berg, Virginie; Detry, Nathalie; Martial, Joseph A.; Voz, Marianne L.; Manfroid, Isabelle; Peers, Bernard] Univ Liege, Unit Mol Biol & Genet Engn, GIGA R, B-4000 Liege, Belgium; [Georlette, Daphne; Biemar, Frederic] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Coutinho, Pedro] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XV, Midlothian, Scotland	University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Edinburgh	Peers, B (corresponding author), Univ Liege, Unit Mol Biol & Genet Engn, GIGA R, B34,Ave Hop 1, B-4000 Liege, Belgium.	bpeers@ulg.ac.be			Belgian State Program; European Union; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture	Belgian State Program; European Union(European Commission); Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was funded by the Belgian State Program on "Interuniversity Poles of Attraction" and by the 6th European Union Framework Program (Beta Cell Therapy Integrated Project).; Recipient of a doctoral fellowship from the "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture."	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Devos N, 2002, MECH DEVELOP, V115, P133, DOI 10.1016/S0925-4773(02)00082-5; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Favor J, 2001, GENETICS, V159, P1689; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kioussi C, 1999, P NATL ACAD SCI USA, V96, P14378, DOI 10.1073/pnas.96.25.14378; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Nomura T, 2004, DEVELOPMENT, V131, P787, DOI 10.1242/dev.00984; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yamaoka T, 2000, DIABETOLOGIA, V43, P332, DOI 10.1007/s001250050051	35	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13863	13873		10.1074/jbc.M110.108019	http://dx.doi.org/10.1074/jbc.M110.108019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177065	Green Published, hybrid			2022-12-27	WOS:000276987700061
J	Chokas, AL; Trivedi, CM; Lu, MM; Tucker, PW; Li, SR; Epstein, JA; Morrisey, EE				Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Tucker, Philip W.; Li, Shanru; Epstein, Jonathan A.; Morrisey, Edward E.			Foxp1/2/4-NuRD Interactions Regulate Gene Expression and Epithelial Injury Response in the Lung via Regulation of Interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; DEVELOPMENTAL DIFFERENCES; CARDIAC MORPHOGENESIS; COMPLEX; CELL; PULMONARY; PROTEINS; FOXP2; COMPONENTS; GATA6	To determine the underlying mechanism of Foxp1/2/4-mediated transcriptional repression, a yeast two-hybrid screen was performed that identified p66 beta, a transcriptional repressor and component of the NuRD chromatin-remodeling complex. We show that direct interactions between Foxp1/4 and p66 beta are mediated by the CR2 domain within p66 beta and the zinc finger/leucine zipper repression domain found in Foxp1/2/4. These direct interactions are functionally relevant as overexpression of p66 beta in combination with Foxp factors cooperatively represses Foxp target gene expression, whereas loss of p66 and Foxp factors results in de-repression of endogenous Foxp target genes in lung epithelial cells. Moreover, the NuRD components HDAC1/2 associate in a macromolecular complex with Foxp proteins, and loss of expression or inhibition of HDAC1/2 activity leads to de-repression of Foxp target gene expression. Importantly, we show in vivo that Foxp1 and HDAC2 act cooperatively to regulate expression of the cytoprotective cytokine interleukin-6, which results in increased resistance to hyperoxic lung injury in Foxp1/HDAC2 compound mutant animals. These data reveal an important interaction between the Foxp transcription factors and the NuRD chromatin-remodeling complex that modulates transcriptional	[Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Li, Shanru; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Li, Shanru; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol Mol Genet & Microbiol, Austin, TX 78712 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Austin	Morrisey, EE (corresponding author), Univ Penn, Dept Med, 956 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Trivedi, Chinmay M/ABA-4097-2021	Trivedi, Chinmay/0000-0002-3544-0474; Epstein, Jonathan/0000-0001-8637-4465	National Institutes of Health [HL071589, HL064632]; University of Pennsylvania Institute for Environmental Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064632, R01HL071589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Institute for Environmental Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071589 and HL064632 ( to E. E. M.).; Supported by an NIH postdoctoral training fellowship in the University of Pennsylvania Institute for Environmental Medicine.	ADAMSON IYR, 1974, LAB INVEST, V30, P35; Bhandari V, 2002, FRONT BIOSCI-LANDMRK, V7, pD1624, DOI 10.2741/bhan; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Chetty A, 2008, PEDIATR PULM, V43, P297, DOI 10.1002/ppul.20777; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Dos Santos CC, 2007, CRIT CARE, V11, DOI 10.1186/cc5733; EVANS MJ, 1973, AM J PATHOL, V70, P175; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Johnston CJ, 1997, EXP LUNG RES, V23, P537, DOI 10.3109/01902149709039242; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lotem J, 1996, P NATL ACAD SCI USA, V93, P12507, DOI 10.1073/pnas.93.22.12507; Lu MM, 2002, MECH DEVELOP, V119, pS197, DOI 10.1016/S0925-4773(03)00116-3; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Ramirez MI, 1999, DEV DYNAM, V215, P319, DOI 10.1002/(SICI)1097-0177(199908)215:4<319::AID-AJA4>3.0.CO;2-B; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Xu D, 2006, AM J PHYSIOL-LUNG C, V291, pL966, DOI 10.1152/ajplung.00045.2006; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	46	44	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13304	13313		10.1074/jbc.M109.088468	http://dx.doi.org/10.1074/jbc.M109.088468			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185820	Green Published, hybrid			2022-12-27	WOS:000276787800085
J	Dai, MS; Sun, XX; Lu, H				Dai, Mu-Shui; Sun, Xiao-Xin; Lu, Hua			Ribosomal Protein L11 Associates with c-Myc at 5 S rRNA and tRNA Genes and Regulates Their Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTION; DIAMOND-BLACKFAN ANEMIA; ACTIVATES P53; CELL-CYCLE; INHIBITION; IDENTIFICATION; MDM2; BIOGENESIS; MUTATIONS; PATHWAY	The c-Myc oncoprotein promotes cell growth by enhancing ribosomal biogenesis. Overexpression of c-Myc and aberrant ribosomal biogenesis lead to deregulated cell growth and tumorigenesis. Hence, c-Myc activity and ribosomal biogenesis must be tightly coordinated during normal homeostasis. We previously found that ribosomal protein L11 inhibits c-Myc activity by blocking the recruitment of its co-activator transformation/transcription domain-associated protein (TRRAP) to the promoter regions of c-Myc target genes that are transcribed by RNA polymerases I and II. In this study, we extended the role of L11 to the regulation of c-Myc-driven transcription of the 5 S rRNA and tRNA genes by RNA polymerase III. L11 co-resided with c-Myc at the 5 S rRNA and tRNA genes and significantly inhibited the binding of TRRAP to these genes. Knocking down endogenous L11 enhanced c-Myc-dependent transcription of these genes. Interestingly, in response to ribosomal stress induced by the treatment of cells with a low dose of actinomycin Dor serum starvation, L11 binding to these genes was increased, and inversely TRRAP binding to these genes was decreased. Consistently, knockdown of L11 rescued the reduction of the expression of these genes by the two treatments. These results demonstrate that L11 suppresses c-Myc-dependent and RNA polymerase III-catalyzed transcription of 5 S rRNA and tRNA genes in response to ribosomal stress, ensuring a tight coordination between c-Myc activity and ribosomal biogenesis.	[Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97239 USA; [Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Lu, Hua] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Oregon Health & Science University; Oregon Health & Science University; Indiana University System; Indiana University-Purdue University Indianapolis	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu; hualu@iupui.edu			National Institutes of Health [K99-CA124137, CA93614, CA095441, CA079721, CA129828]; Oregon Health and Science University; NATIONAL CANCER INSTITUTE [R01CA129828, R01CA079721, R01CA093614, R00CA127134, R01CA095441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K99-CA124137 (to M.-S. D.) and Grants CA93614, CA095441, CA079721, and CA129828 (to H. L.). This work was also supported by startup funds from Oregon Health and Science University (to M.-S. D.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guo QM, 2000, CANCER RES, V60, P5922; Kenneth NS, 2007, P NATL ACAD SCI USA, V104, P14917, DOI 10.1073/pnas.0702909104; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	30	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12587	12594		10.1074/jbc.M109.056259	http://dx.doi.org/10.1074/jbc.M109.056259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20194507	hybrid, Green Published			2022-12-27	WOS:000276787800016
J	Lee, BC; Kumauchi, M; Hoff, WD				Lee, Byoung-Chul; Kumauchi, Masato; Hoff, Wouter D.			Modulating Native-like Residual Structure in the Fully Denatured State of Photoactive Yellow Protein Affects Its Refolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOPHILIC PHOTOTROPHIC BACTERIUM; P-COUMARIC ACID; ECTOTHIORHODOSPIRA-HALOPHILA; UNFOLDED STATE; INTERMEDIATE; CHROMOPHORE; PHOTOCYCLE; NMR; THERMODYNAMICS; PHOTORECEPTOR	Residual structure in the fully unfolded state is a key element for understanding protein folding. We show that the residual structure in fully denatured photoactive yellow protein (PYP) is affected by isomerization of its p-coumaric acid (pCA) chromophore. The exposure of total surface area and hydrophobic surface area upon unfolding was quantified by denaturant m values and heat capacity changes (pCp), respectively. The exposure of the buried surface area upon the unfolding of the acid-denatured state of PYP containing trans-pCA is similar to 20% smaller than that of the native state. In contrast, for the partially unfolded pB photocycle intermediate containing cis-pCA, unfolding-induced exposure of the surface area is not decreased. These results show that pCA photoisomerization reduces residual structure in the fully unfolded state. Thus, residual structure in the fully unfolded state of PYP is under direct experimental control by photoexcitation. The sensitivity of the unfolded state to pCA isomerization provides a novel criterion that residual structure in the unfolded state of PYP is native-like, involving native-like protein-chromophore interactions. A largely untested prediction is that native-like residual structure facilitates the conformational search during folding. In the case of PYP, refolding from the less disordered fully unfolded state containing trans-pCA indeed is substantially accelerated. The burial of hydrophobic surface area in the fully unfolded state suggests that a significant part of the hydrophobic collapse process already has occurred in the denatured state.	[Lee, Byoung-Chul] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Nanostruct Facil, Berkeley, CA 94720 USA; [Lee, Byoung-Chul; Kumauchi, Masato; Hoff, Wouter D.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Oklahoma State University System; Oklahoma State University - Stillwater	Hoff, WD (corresponding author), 307 Life Sci E, Stillwater, OK 74078 USA.	wouter.hoff@okstate.edu			National Institutes of Health [GM063805]; United States Department of Energy [DE-AC02-05CH11231]; OCAST [HR07-135S]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); OCAST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063805 (to W.D.H.).; Both authors contributed equally to this work.; Supported by the Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231; Supported in part by OCAST Grant HR07-135S and by startup funds provided by Oklahoma State University. To whom correspondence should be addressed: 307 Life Sciences East, Stillwater, OK 74078. Tel.: 405-744-4449; Fax: 405-744-6790; E-mail: wouter. hoff@okstate.edu.	Bernard C, 2005, STRUCTURE, V13, P953, DOI 10.1016/j.str.2005.04.017; Craven CJ, 2000, BIOCHEMISTRY-US, V39, P14392, DOI 10.1021/bi001628p; DILL KA, 1995, PROTEIN SCI, V4, P561; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701; HOFF WD, 1994, BIOCHEMISTRY-US, V33, P13959, DOI 10.1021/bi00251a001; Hoff WD, 1997, BBA-BIOENERGETICS, V1322, P151, DOI 10.1016/S0005-2728(97)00082-0; Hoff WD, 1999, BIOCHEMISTRY-US, V38, P1009, DOI 10.1021/bi980504y; Khan JS, 2006, J AM CHEM SOC, V128, P1002, DOI 10.1021/ja055584p; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kort R, 1996, FEBS LETT, V382, P73, DOI 10.1016/0014-5793(96)00149-4; Lee BC, 2001, P NATL ACAD SCI USA, V98, P9062, DOI 10.1073/pnas.111153598; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Liu YF, 1996, BIOCHEMISTRY-US, V35, P3059, DOI 10.1021/bi952198j; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; MEYER TE, 1987, BIOCHEMISTRY-US, V26, P418, DOI 10.1021/bi00376a012; MEYER TE, 1985, BIOCHIM BIOPHYS ACTA, V806, P175, DOI 10.1016/0005-2728(85)90094-5; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ohishi S, 2001, BIOCHEMISTRY-US, V40, P2854, DOI 10.1021/bi001846i; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; SPRENGER WW, 1993, J BACTERIOL, V175, P3096, DOI 10.1128/JB.175.10.3096-3104.1993; Unno M, 2000, J AM CHEM SOC, V122, P4233, DOI 10.1021/ja000032m; van Gunsteren WF, 2001, ANGEW CHEM INT EDIT, V40, P351, DOI 10.1002/1521-3773(20010119)40:2<351::AID-ANIE351>3.0.CO;2-6; VanBrederode ME, 1996, BIOPHYS J, V71, P365, DOI 10.1016/S0006-3495(96)79234-2; Weinkam P, 2009, P NATL ACAD SCI USA, V106, P1796, DOI 10.1073/pnas.0813120106; Xie AH, 1996, BIOCHEMISTRY-US, V35, P14671, DOI 10.1021/bi9623035; Zhao JM, 2006, P NATL ACAD SCI USA, V103, P11561, DOI 10.1073/pnas.0601567103	34	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12579	12586		10.1074/jbc.M109.065821	http://dx.doi.org/10.1074/jbc.M109.065821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178976	hybrid, Green Published			2022-12-27	WOS:000276787800015
J	Kwon, J; Cho, HJ; Han, SH; No, JG; Kwon, JY; Kim, H				Kwon, Junhye; Cho, Hyun Jung; Han, Seung Hun; No, Jin Gu; Kwon, Jae Young; Kim, Hongtae			A Novel LZAP-binding Protein, NLBP, Inhibits Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; NF-KAPPA-B; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CDK5 ACTIVATOR; CHECKPOINT; LOCUS	LXXLL/leucine zipper-containing alternative reading frame (ARF)-binding protein (LZAP) was recently shown to function as a tumor suppressor through inhibition of the NF-kappa B signaling pathway. LZAP is also known as a negative regulator of cell invasion, and its expression was demonstrated to be reduced in several tumor tissues. However, the molecular mechanism of the negative effect of LZAP on cell invasion is unclear. In this study, we identify NLBP as a novel LZAP-binding protein using tandem affinity purification. We demonstrate the negative effects of NLBP on cell invasion and the NF-kappa B signaling pathway. NLBP expression was not detected in hepatocellular carcinoma cells with strong invasive activity, whereas its expression was detected in a hepatocellular carcinoma cell line with no invasive activity. We also demonstrate that these two proteins mutually affect the stability of each other by inhibiting ubiquitination of the other protein. Based on these results, we suggest that NLBP may act as a novel tumor suppressor by inhibiting cell invasion, blocking NF-kappa B signaling, and increasing stability of the LZAP protein.	[Cho, Hyun Jung; Han, Seung Hun; No, Jin Gu; Kwon, Jae Young; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Kwon, Junhye] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University	Kim, H (corresponding author), 300 Cheoncheon Dong, Suwon 440746, South Korea.	khtcat@skku.edu			Korean Government (MOEHRD) [2008-313-C00257]; Ministry of Education, Science and Technology [2009-0074228]	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Research Foundation Grant KRF-2008-313-C00257 funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (to H. K.) and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant 2009-0074228).	Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Kasahara K, 2002, CANCER GENET CYTOGEN, V137, P59, DOI 10.1016/S0165-4608(02)00552-6; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim HT, 2001, BIOCHEM BIOPH RES CO, V286, P886, DOI 10.1006/bbrc.2001.5496; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Saito S, 2006, ONCOL REP, V16, P949; Sun M, 2006, DNA CELL BIOL, V25, P597, DOI 10.1089/dna.2006.25.597; van Gils W, 2008, MELANOMA RES, V18, P10, DOI 10.1097/CMR.0b013e3282f1d4d9; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Wang XJ, 2000, J BIOL CHEM, V275, P31763, DOI 10.1074/jbc.M004358200; WIEDEMANN LM, 1992, EUR J CANCER, V28A, P248, DOI 10.1016/0959-8049(92)90425-2	17	46	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12232	12240		10.1074/jbc.M109.065920	http://dx.doi.org/10.1074/jbc.M109.065920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164180	Green Published, hybrid			2022-12-27	WOS:000276787100052
J	Rozenova, KA; Deevska, GM; Karakashian, AA; Nikolova-Karakashian, MN				Rozenova, Krasimira A.; Deevska, Gergana M.; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Studies on the Role of Acid Sphingomyelinase and Ceramide in the Regulation of Tumor Necrosis Factor alpha (TNF alpha)-converting Enzyme Activity and TNF alpha Secretion in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-MEDIATED PHOSPHORYLATION; RICH MEMBRANE RAFTS; CONVERTING-ENZYME; IN-VIVO; STIMULATED MACROPHAGES; CYTOKINE SECRETION; IMMUNE-RESPONSES; DOWN-REGULATION; LIPID RAFTS; LIPOPOLYSACCHARIDE	Acid sphingomyelinase (ASMase) has been proposed to mediate lipopolysaccharide (LPS) signaling in various cell types. This study shows that ASMase is a negative regulator of LPS-induced tumor necrosis factor alpha (TNF alpha) secretion in macrophages. ASMase-deficient (asm(-/-)) mice and isolated peritoneal macrophages produce severalfold more TNF alpha than their wildtype (asm(+/+)) counterparts when stimulated with LPS, whereas the addition of exogenous ceramides or sphingomyelinase reduces the differences. The underlying mechanism for these effects is not transcriptional but post-translational. The TNF alpha converting enzyme (TACE) catalyzes the maturation of the 26-kDa precursor (pro-TNF alpha) to an active 17-kDa form (soluble (s) TNF alpha). In mouse peritoneal macrophages, the activity of TACE was the rate-limiting factor regulating TNF alpha production. A substantial portion of the translated pro-TNF alpha was not processed to sTNF alpha; instead, it was rapidly internalized and degraded in the lysosomes. TACE activity was 2-3-fold higher in asm(-/-) macrophages as compared with asm(-/-) macrophages and was suppressed when cells were treated with exogenous ceramide and sphingomyelinase. Indirect immunofluorescence analyses revealed distinct TNF alpha-positive structures in the close vicinity of the plasma membrane in asm(-/-) but not in asm(+/+) macrophages. asm(-/-) cells also had a higher number of early endosomal antigen 1-positive early endosomes. Experiments that involved inhibitors of TACE, endocytosis, and lysosomal proteolysis suggest that in the asm(-/-) cells a significant portion of pro-TNF alpha was sequestered within the early endosomes, and instead of undergoing lysosomal proteolysis, it was recycled to the plasma membrane and processed to sTNF alpha.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu			NIA, National Institutes of Health [R01 AG 019223, AG 026711]; NATIONAL INSTITUTE ON AGING [R01AG026711, R01AG019223] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG 019223 and AG 026711 from NIA (to M. N. N.- K.).	Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Cook EB, 2008, INVEST OPHTH VIS SCI, V49, P3992, DOI 10.1167/iovs.08-1873; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Ermert M, 2003, CYTOKINE, V22, P89, DOI 10.1016/S1043-4666(03)00117-0; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; FIEREN MWJA, 1992, IMMUNOL LETT, V31, P85, DOI 10.1016/0165-2478(92)90015-G; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Gomez-Gaviro MV, 2002, J BIOL CHEM, V277, P38212, DOI 10.1074/jbc.M205142200; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kim JG, 2000, IMMUNOL INVEST, V29, P257, DOI 10.3109/08820130009060866; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; MacKenzie S, 2002, J LEUKOCYTE BIOL, V71, P1026; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Ng CG, 2008, P NATL ACAD SCI USA, V105, P16326, DOI 10.1073/pnas.0808720105; O'Donnell PM, 2002, J INTERF CYTOK RES, V22, P539, DOI 10.1089/10799900252982016; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Robertshaw HJ, 2005, BRIT J ANAESTH, V94, P222, DOI 10.1093/bja/aei021; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Solomon KA, 1999, J IMMUNOL, V163, P4105; Solomon KA, 1997, J IMMUNOL, V159, P4524; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thiel KW, 2006, BIOCHEM BIOPH RES CO, V350, P629, DOI 10.1016/j.bbrc.2006.09.095; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Watanabe N, 1998, EUR J BIOCHEM, V253, P576, DOI 10.1046/j.1432-1327.1998.2530576.x; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; ZENTELLA A, 1991, PROG CLIN BIOL RES, V367, P9; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	60	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21103	21113		10.1074/jbc.M109.080671	http://dx.doi.org/10.1074/jbc.M109.080671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20236926	Green Published, hybrid			2022-12-27	WOS:000279228600073
J	Kemp, MG; Akan, Z; Yilmaz, S; Grillo, M; Smith-Roe, SL; Kang, TH; Cordeiro-Stone, M; Kaufmann, WK; Abraham, RT; Sancar, A; Unsal-Kacmaz, K				Kemp, Michael G.; Akan, Zafer; Yilmaz, Secil; Grillo, Mary; Smith-Roe, Stephanie L.; Kang, Tae-Hong; Cordeiro-Stone, Marila; Kaufmann, William K.; Abraham, Robert T.; Sancar, Aziz; Unsal-Kacmaz, Keziban			Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; SINGLE-STRANDED-DNA; MINICHROMOSOME MAINTENANCE PROTEINS; HUMAN CLASPIN; ALTERNATIVE FORM; BINDING PROTEIN; CELL-CYCLE; S-PHASE; ACTIVATION	Mammalian Timeless is a multifunctional protein that performs essential roles in the circadian clock, chromosome cohesion, DNA replication fork protection, and DNA replication/DNA damage checkpoint pathways. The human Timeless exists in a tight complex with a smaller protein called Tipin (Timeless-interacting protein). Here we investigated the mechanism by which the Timeless-Tipin complex functions as a mediator in the ATR-Chk1 DNA damage checkpoint pathway. We find that the Timeless-Tipin complex specifically mediates Chk1 phosphorylation by ATR in response to DNA damage and replication stress through interaction of Tipin with the 34-kDa subunit of replication protein A (RPA). The Tipin-RPA interaction stabilizes Timeless-Tipin and Tipin-Claspin complexes on RPA-coated ssDNA and in doing so promotes Claspin-mediated phosphorylation of Chk1 by ATR. Our results therefore indicate that RPA-covered ssDNA not only supports recruitment and activation of ATR but also, through Tipin and Claspin, it plays an important role in the action of ATR on its critical downstream target Chk1.	[Grillo, Mary; Abraham, Robert T.; Unsal-Kacmaz, Keziban] Pfizer Biopharmaceut, Ctr Integrat Biol & Biotherapeut, Pearl River, NY 10965 USA; [Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Smith-Roe, Stephanie L.; Cordeiro-Stone, Marila; Kaufmann, William K.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Cordeiro-Stone, Marila; Kaufmann, William K.] Univ N Carolina, Sch Med, Ctr Environm Hlth & Susceptibil, Chapel Hill, NC 27599 USA; [Kemp, Michael G.; Cordeiro-Stone, Marila; Kaufmann, William K.; Sancar, Aziz] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Pfizer; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Unsal-Kacmaz, K (corresponding author), Pfizer Biopharmaceut, Ctr Integrat Biol & Biotherapeut, 401 N Middletown Rd, Pearl River, NY 10965 USA.	unsalkk@wyeth.com	Kemp, Michael G./AAT-1545-2021; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Kang, Tae-Hong/Y-8294-2019; Yilmaz, Secil/A-9051-2016	Kemp, Michael G./0000-0001-8203-0745; Kang, Tae-Hong/0000-0002-6013-900X; akan, zafer/0000-0002-4150-1720	National Institutes of Health [GM32833, ES014635, ES015856, T32-ES07017, T32-CA09156]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES015856, T32ES007017, P01ES014635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32833 (to A.S.), ES014635 (to W.K.K.), ES015856 (to M.C.-S.), T32-ES07017 (to S.L.S.-R.), and T32-CA09156 (to M.G.K.).	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Haring SJ, 2010, NUCLEIC ACIDS RES, V38, P846, DOI 10.1093/nar/gkp1062; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Mason AC, 2009, J BIOL CHEM, V284, P5324, DOI 10.1074/jbc.M808963200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	79	79	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16562	16571		10.1074/jbc.M110.110304	http://dx.doi.org/10.1074/jbc.M110.110304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20233725	Green Published, hybrid			2022-12-27	WOS:000277982600019
J	Thompson, RF; Fazzari, MJ; Niu, HS; Barzilai, N; Simmons, RA; Greally, JM				Thompson, Reid F.; Fazzari, Melissa J.; Niu, Hongshun; Barzilai, Nir; Simmons, Rebecca A.; Greally, John M.			Experimental Intrauterine Growth Restriction Induces Alterations in DNA Methylation and Gene Expression in Pancreatic Islets of Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL FAILURE; DIETARY-PROTEIN RESTRICTION; CYTOSINE METHYLATION; EXTRACELLULAR-MATRIX; DEVELOPMENTAL ORIGINS; INSULIN-RESISTANCE; MASS-SPECTROMETRY; GENOME; RETARDATION; SECRETION	Intrauterine growth restriction (IUGR) increases susceptibility to age-related diseases, including type 2 diabetes (T2DM), and is associated with permanent and progressive changes in gene expression. Our study was designed to test whether epigenomic dysregulation mediates the cellular memory of this intrauterine event. To test this hypothesis, we isolated pancreatic islets from control and IUGR (induced by bilateral uterine artery ligation at day 18 of fetal life) animals at 7 weeks of age. Using the HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay, we generated the first DNA methylation map at almost 1 million unique sites throughout the rat genome in normal pancreatic islet cells, allowing us to identify the changes that occur as a consequence of IUGR. We validated candidate dysregulated loci with quantitative assays of cytosine methylation and gene expression. IUGR changes cytosine methylation at similar to 1,400 loci (false discovery rate of 4.2%) in male rats at 7 weeks of age, preceding the development of diabetes and thus representing candidate loci for mediating the pathogenesis of metabolic disease that occurs later in life. Epigenetic dysregulation occurred preferentially at conserved intergenic sequences, frequently near genes regulating processes known to be abnormal in IUGR islets, such as vascularization, beta-cell proliferation, insulin secretion, and cell death, associated with concordant changes in mRNA expression. These results demonstrate that epigenetic dysregulation is a strong candidate for propagating the cellular memory of intrauterine events, causing changes in expression of nearby genes and long term susceptibility to type 2 diabetes.	[Niu, Hongshun; Simmons, Rebecca A.] Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Thompson, Reid F.; Fazzari, Melissa J.; Greally, John M.] Albert Einstein Coll Med, Dept Genet Computat Genet, Bronx, NY 10461 USA; [Fazzari, Melissa J.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Barzilai, Nir; Greally, John M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Thompson, Reid F.; Fazzari, Melissa J.; Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA	University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Simmons, RA (corresponding author), Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, 421 Curie Blvd,1308 Biomed Res Bldg 2-3, Philadelphia, PA 19104 USA.	rsimmons@mail.med.upenn.edu; john.greally@einstein.yu.edu	Greally, John/AAF-9540-2019; Stefanadis, Christodoulos/ABH-2232-2020	Greally, John/0000-0001-6069-7960; Fazzari, Melissa/0000-0002-5674-3589; Stefanadis, Christodoulos/0000-0001-5974-6454; Simmons, Rebecca/0000-0002-2901-8904; Thompson, Reid/0000-0003-3661-5296	National Institutes of Health [HG004401, HD044078, DK55704, DK062965, AG21654, AG18381]; Einstein's Center for Epigenomics; Albert Einstein Diabetes Research and Training Center [DK 20541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044078] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK062965, P30DK020541, R01DK055704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018381, R37AG018381, P01AG021654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein's Center for Epigenomics; Albert Einstein Diabetes Research and Training Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HG004401 and HD044078 (to J. M. G.), DK55704 and DK062965 (to R. A. S.), and AG21654 and AG18381 (to N. B.). This work was also supported by Einstein's Center for Epigenomics and by the Core laboratories of the Albert Einstein Diabetes Research and Training Center (Grant DK 20541).	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Antoniades C, 2008, J AM COLL CARDIOL, V52, P158, DOI 10.1016/j.jacc.2007.12.062; Arantes VC, 2002, J NUTR, V132, P3030, DOI 10.1093/jn/131.10.3030; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Ham JN, 2009, PEDIATR RES, V66, P42, DOI 10.1203/PDR.0b013e3181a282a5; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; Meininger CJ, 2004, FASEB J, V18, P1900, DOI 10.1096/fj.04-1702fje; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Simmons RA, 2007, PEDIATR RES, V61, p64R, DOI 10.1203/pdr.0b013e3180457623; Stawowy P, 2004, CIRCULATION, V109, P770, DOI 10.1161/01.CIR.0000112583.50762.DE; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	47	118	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15111	15118		10.1074/jbc.M109.095133	http://dx.doi.org/10.1074/jbc.M109.095133			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20194508	hybrid, Green Published			2022-12-27	WOS:000277399000032
J	Zhou, FL; Zhang, WG; Wei, YC; Meng, S; Bai, GG; Wang, BY; Yang, HY; Tian, W; Meng, X; Zhang, H; Chen, SP				Zhou, Fu-Ling; Zhang, Wang-Gang; Wei, Yong-Chang; Meng, Shan; Bai, Gai-Gai; Wang, Bai-Yan; Yang, Hui-Yun; Tian, Wei; Meng, Xin; Zhang, Hui; Chen, She-Ping			Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PRODUCTS; INDOLEAMINE 2,3-DIOXYGENASE; IN-VITRO; URINARY 8-HYDROXY-2'-DEOXYGUANOSINE; THIOREDOXIN REDUCTASE; PERITONEAL-DIALYSIS; DEPRESSIVE PATIENTS; ANTIOXIDANT STATUS; GENE-EXPRESSION; DNA-DAMAGE	The aims of the present study were to determine the level of oxidative stress and the salient factors leading to the relapse of acute myeloid leukemia (AML). Oxidative stress-related parameters and the expressions of specific genes were monitored in 102 cases of AML during a pretreatment period from a primary status to a relapse status. In addition, age-matched healthy subjects were classified as controls. The activities of adenosine deaminase and xanthine oxidase were higher in the relapse condition, whereas those of glutathione peroxidase, monoamine oxidase, and superoxide dismutase, and the total antioxidant capacity (T-AOC) were lower in the primary condition and in controls. Of particular note, levels of advanced oxidation protein products, malondialdehyde, and 8-hydroxydeoxyguanosine were also significantly higher in relapse patients. Furthermore, real-time PCR with SYBR Green revealed that the expression levels of human thioredoxin (TRX) and indoleamine 2,3-dioxygenase were increased in relapse patients. Pearson correlation analysis revealed that the T-AOC was positively correlated with GSH but negatively correlated with 8-OHdG, TRX, and indoleamine 2,3-dioxygenase. Linear regression showed that a low T-AOC and up-regulated TRX expression were the independent factors correlated with relapse. A strong association between oxidative stress and the incidence of disease relapse was observed, which has potential prognosis implications. These results indicate that oxidative stress is a crucial feature of AML and probably affects the development and relapse of AML.	[Tian, Wei; Meng, Xin; Zhang, Hui; Chen, She-Ping] Xi An Jiao Tong Univ, Dept Clin Hematol, Affiliated Hosp 2, Xian 710004, Peoples R China; [Wei, Yong-Chang] Xi An Jiao Tong Univ, Dept Clin Oncol, Affiliated Hosp 1, Xian 710061, Peoples R China; [Wang, Bai-Yan] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Shanghai Jiao Tong University		zhoufuling@163.com		Zhou, Fuling/0000-0003-0982-0382; Wei, Yongchang/0000-0001-7205-4663	Shaanxi Natural Science Foundation of China [2007C<INF>2</INF>17]	Shaanxi Natural Science Foundation of China	This work was supported by Shaanxi Natural Science Foundation of China Grant 2007C<INF>2</INF>17.	Al-Gayyar MMH, 2007, J PHARM PHARMACOL, V59, P409, DOI 10.1211/jpp.59.3.0011; Austin C, 2009, LEUKEMIA RES, V33, P1297, DOI 10.1016/j.leukres.2009.04.038; Battisti V, 2008, CLIN BIOCHEM, V41, P511, DOI 10.1016/j.clinbiochem.2008.01.027; Boulanger E, 2006, PERITON DIALYSIS INT, V26, P207; Chamuleau MED, 2008, HAEMATOL-HEMATOL J, V93, P1894, DOI 10.3324/haematol.13113; Chandramathi S, 2009, J CANCER RES CLIN, V135, P319, DOI 10.1007/s00432-008-0462-7; Chang D, 2008, BIOMED ENVIRON SCI, V21, P286, DOI 10.1016/S0895-3988(08)60043-4; Corm S, 2009, LEUKEMIA RES, V33, P490, DOI 10.1016/j.leukres.2008.06.014; Dorantes-Acosta E, 2008, PEDIATR BLOOD CANCER, V51, P741, DOI 10.1002/pbc.21706; Erkeland SJ, 2009, LEUKEMIA RES, V33, P1367, DOI 10.1016/j.leukres.2009.02.027; Furuya R, 2009, NEPHRON CLIN PRACT, V112, pC255, DOI 10.1159/000224792; He Yu-Lei, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P88; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Honda M, 2000, LEUKEMIA RES, V24, P461, DOI 10.1016/S0145-2126(00)00006-0; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hwang ES, 2007, TOXICOLOGY, V229, P1, DOI 10.1016/j.tox.2006.10.013; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Koptyra M, 2008, LEUKEMIA, V22, P1969, DOI 10.1038/leu.2008.78; Kosova F, 2007, ANN SURG ONCOL, V14, P2616, DOI 10.1245/s10434-007-9425-5; Li RM, 2009, CANCER BIOL THER, V8, P1402, DOI 10.4161/cbt.8.14.8882; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Marbello L, 2008, LEUKEMIA RES, V32, P1221, DOI 10.1016/j.leukres.2008.01.004; Marsche G, 2009, CIRC RES, V104, P750, DOI 10.1161/CIRCRESAHA.108.193169; Mazor D, 2008, PEDIATR BLOOD CANCER, V51, P613, DOI 10.1002/pbc.21665; Montesinos JJ, 2006, LEUKEMIA LYMPHOMA, V47, P1379, DOI 10.1080/10428190500465424; Nigro P, 2008, FREE RADICAL BIO MED, V45, P875, DOI 10.1016/j.freeradbiomed.2008.06.015; Noyan T, 2009, YONSEI MED J, V50, P677, DOI 10.3349/ymj.2009.50.5.677; Oh YK, 2004, BIOCHEM BIOPH RES CO, V319, P41, DOI 10.1016/j.bbrc.2004.04.145; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Pennington JD, 2005, DRUG RESIST UPDATE, V8, P322, DOI 10.1016/j.drup.2005.09.002; Rao AK, 2009, J MOL ENDOCRINOL, V43, P251, DOI 10.1677/JME-09-0053; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Selmeci L, 2008, ACTA PHYSIOL HUNG, V95, P209, DOI 10.1556/APhysiol.95.2008.2.5; Selmeci L, 2005, CLIN CHEM LAB MED, V43, P294, DOI 10.1515/CCLM.2005.050; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; Smits ELJM, 2009, ONCOLOGIST, V14, P240, DOI 10.1634/theoncologist.2008-0165; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Voso MT, 2008, LEUKEMIA, V22, P1685, DOI 10.1038/leu.2008.169; Wei YC, 2009, INT J NEUROPSYCHOPH, V12, P1089, DOI 10.1017/S1461145709000091; WITKO V, 1992, J CLIN LAB ANAL, V6, P47, DOI 10.1002/jcla.1860060110; Yang Y, 2009, ENVIRON TOXICOL, V24, P446, DOI 10.1002/tox.20447; Zamanakou M, 2007, IMMUNOL LETT, V111, P69, DOI 10.1016/j.imlet.2007.06.001; Zhou FL, 2007, LEUKEMIA RES, V31, P387, DOI 10.1016/j.leukres.2006.07.014	48	81	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15010	15015		10.1074/jbc.M110.103713	http://dx.doi.org/10.1074/jbc.M110.103713			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20233720	hybrid, Green Published			2022-12-27	WOS:000277399000022
J	Gutierrez, GJ; Tsuji, T; Cross, JV; Davis, RJ; Templeton, DJ; Jiang, W; Ronai, ZA				Gutierrez, Gustavo J.; Tsuji, Toshiya; Cross, Janet V.; Davis, Roger J.; Templeton, Dennis J.; Jiang, Wei; Ronai, Ze'ev A.			JNK-mediated Phosphorylation of Cdc25C Regulates Cell Cycle Entry and G(2)/M DNA Damage Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; SIGNAL-TRANSDUCTION; TUMOR-GROWTH; S-PHASE; APOPTOSIS; INHIBITION; ARREST; ENDOREDUPLICATION	c-Jun NH2-terminal Kinases (JNKs) play a central role in the cellular response to a wide variety of stress signals. After their activation, JNKs induce phosphorylation of substrates, which control proliferation, migration, survival, and differentiation. Recent studies suggest that JNKs may also play a role in cell cycle control, although the underlying mechanisms are largely unexplored. Here we show that JNK directly phosphorylates Cdc25C at serine 168 during G(2) phase of the cell cycle. Cdc25C phosphorylation by JNK negatively regulates its phosphatase activity and thereby Cdk1 activation, enabling a timely control of mitosis onset. Unrestrained phosphorylation by JNK, as obtained by a cell cycle-stabilized form of JNK or as seen in some human tumors, results in aberrant cell cycle progression. Additionally, UV irradiation-induced G(2)/M checkpoint requires inactivation of Cdc25C by JNK phosphorylation. JNK phosphorylation of Cdc25C as well as Cdc25A establishes a novel link between stress signaling and unperturbed cell cycle and checkpoint pathways.	[Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA; [Cross, Janet V.; Templeton, Dennis J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@burnham.org	Gutierrez, Gustavo/AAO-9957-2021; Cross, Janet V/F-8276-2011; Gutierrez, Gustavo/B-6771-2013; Templeton, Dennis J/F-7695-2011	Gutierrez, Gustavo/0000-0001-8652-972X; Gutierrez, Gustavo/0000-0003-4133-5002; RONAI, ZEEV/0000-0002-3859-0400; Jiang, Wei/0000-0002-2309-9571; Davis, Roger/0000-0002-0130-1652	National Institutes of Health [CA78419]; Sass Foundation; NATIONAL CANCER INSTITUTE [R01CA078419, R01CA138143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sass Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA78419 (NCI; to Z. A. R.).; Supported by a postdoctoral fellowship from the Sass Foundation.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Gonzalez ME, 2009, CELL SIGNAL, V21, P477, DOI 10.1016/j.cellsig.2008.11.007; Goss VL, 2003, CELL SIGNAL, V15, P709, DOI 10.1016/S0898-6568(03)00009-3; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Moon DO, 2009, EXP MOL MED, V41, P665, DOI 10.3858/emm.2009.41.9.073; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pimienta G, 2007, CELL CYCLE, V6, P1762, DOI 10.4161/cc.6.14.4434; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Potapova O, 2002, CANCER RES, V62, P3257; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sluss HK, 2006, MOL CELL, V23, P152, DOI 10.1016/j.molcel.2006.07.001; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuiki H, 2003, CANCER RES, V63, P250; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xia HHX, 2006, CANCER LETT, V241, P268, DOI 10.1016/j.canlet.2005.10.031; Yang SH, 2007, TOXICON, V49, P966, DOI 10.1016/j.toxicon.2007.01.005; Yang YM, 2003, CLIN CANCER RES, V9, P391	47	59	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14217	14228		10.1074/jbc.M110.121848	http://dx.doi.org/10.1074/jbc.M110.121848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220133	hybrid, Green Published			2022-12-27	WOS:000277299700018
J	Walz, HA; Shi, XR; Chouinard, M; Bue, CA; Navaroli, DM; Hayakawa, A; Zhou, QL; Nadler, J; Leonard, DM; Corvera, S				Walz, Helena A.; Shi, Xiarong; Chouinard, My; Bue, Catherine A.; Navaroli, Deanna M.; Hayakawa, Akira; Zhou, Qiong L.; Nadler, Jonathan; Leonard, Deborah M.; Corvera, Silvia			Isoform-specific Regulation of Akt Signaling by the Endosomal Protein WDFY2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYVE PROTEIN; PHOSPHOINOSITIDE 3-KINASES; ENDOCYTIC TRAFFICKING; PLASMA-MEMBRANE; MICE LACKING; APPL1; GROWTH; BINDS; BETA; TRANSDUCTION	Recent work has led to the identification of novel endocytic compartments with functional roles in both protein trafficking and growth factor signal transduction. The phosphatidylinositol 3-phosphate binding, FYVE domain-containing protein WDFY2 is localized to a distinct subset of early endosomes, which are localized close to the plasma membrane. Here, we find that the serine/threonine kinase Akt interacts with these endosomes in an isoform-specific manner. Using quantitative fluorescence microscopy we demonstrate specific co-localization of WDFY2 with endogenous Akt2, but not Akt1. Moreover, depletion of WDFY2 leads to impaired phosphorylation of Akt in response to insulin due to isoform specific reduction of Akt2, but not Akt1, protein levels, and to a marked reduction in the insulin-stimulated phosphorylation of numerous Akt substrates. This is accompanied by an impairment in insulin-stimulated glucose transport and, after prolonged silencing, a reduction in the level of expression of adipogenic genes. We propose that WDFY2-enriched endosomes serve as a scaffold that enables specificity of insulin signaling through Akt2.	[Walz, Helena A.; Shi, Xiarong; Chouinard, My; Bue, Catherine A.; Navaroli, Deanna M.; Hayakawa, Akira; Zhou, Qiong L.; Nadler, Jonathan; Leonard, Deborah M.; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01604 USA.	silvia.corvera@umassmed.edu	Jones, Helena/C-8847-2013	Jones, Helena/0000-0002-3948-161X	NIDDK/National Institutes of Health [5 P30 DK32520, DK60837]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK060837] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK/National Institutes of Health Grant 5 P30 DK32520 (to the imaging core services) and by Grant DK60837.	Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Driscoll PC, 2001, NAT STRUCT BIOL, V8, P287, DOI 10.1038/86144; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Evans DRH, 2004, BIOTECHNIQUES, V37, P840, DOI 10.2144/04375PT02; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fritzius T, 2008, EMBO J, V27, P1399, DOI 10.1038/emboj.2008.67; Fritzius T, 2007, FEBS J, V274, P1552, DOI 10.1111/j.1742-4658.2007.05702.x; Fritzius T, 2006, BIOCHEM J, V399, P9, DOI 10.1042/BJ20060511; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kittler JT, 2001, TRAFFIC, V2, P437, DOI 10.1034/j.1600-0854.2001.20702.x; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; von Zastrow M, 2001, BIOCHEM SOC T, V29, P500, DOI 10.1042/BST0290500; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	38	29	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14101	14108		10.1074/jbc.M110.110536	http://dx.doi.org/10.1074/jbc.M110.110536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20189988	Green Published, hybrid			2022-12-27	WOS:000277299700005
J	Kang, WH; Park, YH; Park, HM				Kang, Won-Hwa; Park, Yun-Hee; Park, Hee-Moon			The LAMMER Kinase Homolog, Lkh1, Regulates Tup Transcriptional Repressors through Phosphorylation in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TUP1-LIKE REPRESSORS; SR SPLICING FACTORS; FISSION YEAST; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NEURONAL DIFFERENTIATION; CYC8-TUP1 COREPRESSOR; OXIDATIVE-STRESS; BINDING PROTEIN	Disruption of the fission yeast LAMMER kinase, Lkh1, gene resulted in diverse phenotypes, including adhesive filamentous growth and oxidative stress sensitivity, but an exact cellular function had not been assigned to Lkh1. Through an in vitro pull down approach, a transcriptional repressor, Tup12, was identified as an Lkh1 binding partner. Interactions between Lkh1 and Tup11 or Tup12 were confirmed by in vitro and in vivo binding assays. Tup proteins were phosphorylated by Lkh1 in a LAMMER motif dependent manner. The LAMMER motif was also necessary for substrate recognition in vitro and cellular function in vivo. Transcriptional activity assays using promoters negatively regulated by Tup11 and Tup12 showed 6 or 2 times higher activity in the Delta lkh1 mutant than the wild type, respectively. Northern analysis revealed derepressed expression of the fbp1(+) mRNA in Delta lkh1 and in Delta tup11 Delta tup12 mutant cells under repressed conditions. Delta lkh1 and Delta tup11 Delta tup12 mutant cells showed flocculation, which was reversed by coexpression of Tup11 and 12 with Ssn6. Here, we presented a new aspect of the LAMMER kinase by demonstrating that the activities of global transcriptional repressors, Tup11 and Tup12, were positively regulated by Lkh1 mediated phosphorylation.	[Kang, Won-Hwa; Park, Yun-Hee; Park, Hee-Moon] Chungnam Natl Univ, Dept Microbiol, Sch Biosci & Biotechnol, Taejon 305764, South Korea	Chungnam National University	Park, HM (corresponding author), Chungnam Natl Univ, Dept Microbiol, Sch Biosci & Biotechnol, Gung Dong 220, Taejon 305764, South Korea.	hmpark@cnu.ac.kr	Heemoon, Park/F-5783-2013	Heemoon, Park/0000-0001-6780-9283	Korea Science and Engineering Foundation [R01-2004-000-10082-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Basic Research Program of the Korea Science and Engineering Foundation Grant R01-2004-000-10082-0.	ALFA C, 1993, EXPT FISSION YEAST L, P95; BALCIUNAS D, 1995, NUCLEIC ACIDS RES, V23, P4421, DOI 10.1093/nar/23.21.4421; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; BYRNE SM, 1993, J CELL SCI, V105, P1095; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Courey AJ, 2001, GENE DEV, V15, P2786; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fagerstrom-Billai F, 2005, MOL CELL BIOL, V25, P716, DOI 10.1128/MCB.25.2.716-727.2005; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Greenall A, 2002, MOL BIOL CELL, V13, P2977, DOI 10.1091/mbc.01-12-0568; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hengen PN, 1996, TRENDS BIOCHEM SCI, V21, P75, DOI 10.1016/0968-0004(96)80871-1; Hirota K, 2003, GENETICS, V165, P505; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Janoo RTK, 2001, GENETICS, V157, P1205; Kang WH, 2007, FEBS LETT, V581, P3473, DOI 10.1016/j.febslet.2007.06.053; Kim KH, 2001, BIOCHEM BIOPH RES CO, V289, P1237, DOI 10.1006/bbrc.2001.6128; Kobayashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P50, DOI 10.1016/j.bbrc.2008.01.033; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Kovacikova Michaela, 2006, Endocr Regul, V40, P21; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lee M, 2000, GENETICS, V155, P1535; LIPKE PN, 1984, J BACTERIOL, V159, P797, DOI 10.1128/JB.159.2.797-799.1984; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; MYERS MP, 1994, MOL CELL BIOL, V14, P6954, DOI 10.1128/MCB.14.10.6954; Nikolakaki E, 2002, BIOCHEMISTRY-US, V41, P2055, DOI 10.1021/bi011521h; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; PADMANABHA R, 1991, MOL GEN GENET, V229, P1; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Park YD, 2003, BIOCHEM BIOPH RES CO, V311, P1078, DOI 10.1016/j.bbrc.2003.10.110; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Redd MJ, 1997, J BIOL CHEM, V272, P11193; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROTH SY, 1995, CURR OPIN GENET DEV, V5, P168, DOI 10.1016/0959-437X(95)80004-2; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Savaldi-Goldstein S, 2003, PLANT CELL, V15, P926, DOI 10.1105/tpc.011056; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stettler S, 1996, J CELL SCI, V109, P1927; Tang ZH, 2003, EXP CELL RES, V283, P101, DOI 10.1016/S0014-4827(02)00022-8; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wan YQ, 2008, MOL CELL BIOCHEM, V307, P177, DOI 10.1007/s11010-007-9597-0; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200	62	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13797	13806		10.1074/jbc.M110.113555	http://dx.doi.org/10.1074/jbc.M110.113555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200159	Green Published, hybrid			2022-12-27	WOS:000276987700055
J	Gold, DA; Dunphy, WG				Gold, Daniel A.; Dunphy, William G.			Drf1-dependent Kinase Interacts with Claspin through a Conserved Protein Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DNA-REPLICATION CHECKPOINT; REPEATED PHOSPHOPEPTIDE MOTIFS; S-PHASE CHECKPOINT; CDC7 KINASE; REGULATED PROTEIN; DAMAGE CHECKPOINT; MAMMALIAN-CELLS; CHK1; PHOSPHORYLATION	The Dbf4/Drf1-dependent kinase (DDK) is required for the initiation of DNA replication in eukaryotes. Another protein, Claspin, mediates the activation of a cellular checkpoint response to stalled replication forks and is also a regulator of replication. In this study, we found that DDK phosphorylates Claspin in vitro and forms a nuclear complex containing Cdc7, Drf1, and Claspin in Xenopus egg extracts. In addition, purified Claspin and DDK are capable of a direct in vitro interaction. We identified a conserved binding site on Claspin required for its interaction with DDK. This site corresponds to the first of two sequence repeats in the Chk1-binding domain of Claspin. Furthermore, we have established that two amino acids in this motif, Asp861 and Gln866, are essential for the interaction between Claspin and DDK. We found that mutant forms of Claspin incapable of interacting with DDK are still able to associate with and activate Chk1 in response to DNA replication blockages. However, Claspin-depleted egg extracts that have been reconstituted with these mutants of Claspin undergo DNA replication more slowly. These findings suggest that the interaction of DDK with Claspin mediates a checkpoint-independent function of Claspin related to DNA replication.	[Gold, Daniel A.; Dunphy, William G.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA.	dunphy@caltech.edu			National Institutes of Health [GM043974, GM070891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043974, R01GM070891, R37GM043974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM043974 and GM070891 (to W.G.D.).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Roberts BT, 1999, P NATL ACAD SCI USA, V96, P2800, DOI 10.1073/pnas.96.6.2800; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	46	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12638	12646		10.1074/jbc.M109.077370	http://dx.doi.org/10.1074/jbc.M109.077370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20190277	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000276787800022
J	Landau, G; Bercovich, Z; Park, MH; Kahana, C				Landau, Guy; Bercovich, Zippi; Park, Myung Hee; Kahana, Chaim			The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; DEOXYHYPUSINE SYNTHASE; FACTOR 5A; HYPUSINE MODIFICATION; PROTEIN-SYNTHESIS; MESSENGER-RNA; INHIBITION; EIF5A; SPERMIDINE; ANTIZYME	Polyamines are essential cell constituents whose depletion results in growth cessation. Here we have investigated potential mechanisms of action of polyamines in supporting mammalian cell proliferation. We demonstrate that polyamines regulate translation both at the initiation and at the elongation steps. L-alpha-Difluoromethylornithine treatment resulting in polyamine depletion reduces protein synthesis via inhibition of translation initiation. N1-Guanyl-diaminoheptane (GC7), a spermidine analogue that inhibits eukaryotic initiation factor 5A (eIF5A) hypusination, also caused inhibition of translation initiation. In contrast, depletion of eIF5A by short hairpin RNA inhibits translation elongation as was recently demonstrated in yeast and Drosophila. These results suggest that in addition to competing with spermidine in the hypusination reaction, GC7 also competes with spermidine at yet undefined sites required for translation initiation. Finally, we show that either polyamine depletion or GC7 treatment induced eIF2 alpha phosphorylation and reduced phosphorylation of 4E-BP, thus setting the molecular basis for the observed inhibition of translation initiation.	[Landau, Guy; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel; [Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			M. D. Moross Institute for Cancer Research; Israel Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	M. D. Moross Institute for Cancer Research; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by a grant from the M. D. Moross Institute for Cancer Research at the Weizmann Institute and by the Israel Science Foundation.	BENNE R, 1978, J BIOL CHEM, V253, P3078; BITONTI AJ, 1985, BIOCHEM PHARMACOL, V34, P1773, DOI 10.1016/0006-2952(85)90648-3; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chen KY, 1997, BIOL SIGNAL, V6, P105; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Christian BE, 2010, BIOCHEM BIOPH RES CO, V391, P942, DOI 10.1016/j.bbrc.2009.11.169; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; GHODA L, 1990, J BIOL CHEM, V265, P11823; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Lee Y, 2002, MOL CELL BIOCHEM, V237, P69, DOI 10.1023/A:1016535217038; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; MARTIN TE, 1970, J BIOL CHEM, V245, P1504; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Mitchell JLA, 2002, BIOCHEM J, V366, P663, DOI 10.1042/BJ20011612; Mize GJ, 2001, RNA, V7, P374, DOI 10.1017/S1355838201001972; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; PARK MH, 1994, J BIOL CHEM, V269, P27827; Park MH, 1997, BIOL SIGNAL, V6, P115; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; Shimogori T, 1996, BIOCHEM BIOPH RES CO, V223, P544, DOI 10.1006/bbrc.1996.0931; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0	41	81	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12474	12481		10.1074/jbc.M110.106419	http://dx.doi.org/10.1074/jbc.M110.106419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181941	Green Published, hybrid			2022-12-27	WOS:000276787800003
J	Maruhashi, T; Kii, I; Saito, M; Kudo, A				Maruhashi, Takumi; Kii, Isao; Saito, Mitsuru; Kudo, Akira			Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; GROWTH-FACTOR-BETA; PROCOLLAGEN C-PROTEINASE; HUMAN-LUNG FIBROBLASTS; SMOOTH-MUSCLE-CELLS; CROSS-LINKS; EXTRACELLULAR-MATRIX; COLLAGEN; EXPRESSION; METALLOPROTEINASES	Intra- and intermolecular covalent cross-linking between collagen fibrils, catalyzed by lysyl oxidase (LOX), determines the mechanical properties of connective tissues; however, mechanisms that regulate the collagen cross-linking according to tissue specificity are not well understood. Here we show that periostin, a secretory protein in the dense connective tissues, promotes the activation of LOX. Previous studies showed that periostin null mice exhibit reduced collagen cross-linking in their femurs, periosteum, infarcted myocardium, and tendons. Presently, we showed that active LOX protein, formed by cleavage of its propeptide by bone morphogenetic protein-1 (BMP-1), was decreased in calvarial osteoblast cells derived from periostin null mice. Overexpression of periostin promoted the proteolytic cleavage of the propeptide, which increased the amount of active LOX protein. The results of co-immunoprecipitation and solid phase binding assays revealed that periostin interacted with BMP-1. Furthermore, this interaction probably resulted in enhanced deposition of BMP-1 on the extracellular matrix, suggesting that this enhanced deposition would lead to cleavage of the propeptide of LOX. Thus, we demonstrated that periostin supported BMP-1-mediated proteolytic activation of LOX on the extracellular matrix, which promoted collagen cross-linking.	Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Saito, Mitsuru] Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	Tokyo Institute of Technology; Jikei University	Kudo, A (corresponding author), 4259-B-33 Midori Ku, Yokohama, Kanagawa 2268501, Japan.	akudo@bio.titech.ac.jp	Kudo, Akira/C-7340-2015; KII, Isao/C-4117-2017	Kudo, Akira/0000-0001-6289-3391; KII, Isao/0000-0002-6153-6250; Maruhashi, Takumi/0000-0003-2944-1611	Ministry of Education, Science, Culture, and Sports of Japan; Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan (to I. K. and A. K.) and by grants from the Ground-based Research Program for Space Utilization promoted by the Japan Space Forum (to A. K.).	ACIL Y, 1995, J AM ACAD DERMATOL, V33, P522, DOI 10.1016/0190-9622(95)91404-8; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Gacheru SN, 1997, J CELL BIOCHEM, V65, P395, DOI 10.1002/(SICI)1097-4644(19970601)65:3<395::AID-JCB9>3.0.CO;2-N; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203; Kaler SG, 1998, PEDIATR DEVEL PATHOL, V1, P85, DOI 10.1007/s100249900011; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Medeck RJ, 2003, BIOCHEM J, V376, P361, DOI 10.1042/BJ20030894; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; Roy R, 1996, J CELL BIOCHEM, V62, P411, DOI 10.1002/(SICI)1097-4644(199609)62:3<411::AID-JCB11>3.0.CO;2-L; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Suzuki H, 2004, ANAT REC PART A, V281A, P1264, DOI 10.1002/ar.a.20080; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takayama I, 2009, J BIOCHEM, V146, P713, DOI 10.1093/jb/mvp117; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6	47	179	186	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13294	13303		10.1074/jbc.M109.088864	http://dx.doi.org/10.1074/jbc.M109.088864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181949	Green Published, hybrid			2022-12-27	WOS:000276787800084
J	Wang, HB; Mo, PL; Ren, SM; Yan, CH				Wang, Hongbo; Mo, Pingli; Ren, Shumei; Yan, Chunhong			Activating Transcription Factor 3 Activates p53 by Preventing E6-associated Protein from Binding to E6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; FACTOR ATF3; GENE; EXPRESSION; DEGRADATION; INHIBITION; APOPTOSIS; MDM2; ONCOPROTEIN; STABILITY	Genomic integration of human papillomavirus (HPV) DNA accounts for more than 90% of cervical cancers. High-risk genital HPVs encode E6 proteins that can interact with a cellular ubiquitin ligase E6-associated protein (E6AP) and target the tumor suppressor p53 for ubiquitin-mediated proteolysis. Currently, how this critical event is regulated is largely unknown. Here we report that activating transcription factor 3 (ATF3), a broad DNA damage sensor whose expression is frequently downregulated in cervical cancer, interacted with E6 and prevented p53 from ubiquitination and degradation mediated by the viral protein. Consistent with its role as a potent E6 antagonist, ATF3 expressed enforcedly in HPV-positive SiHa cells activated p53, leading to expression of p53-target genes (e. g. p21 and PUMA), cell cycle arrest and apoptotic cell death. The leucine zipper domain of ATF3 appears indispensable for these effects as an ATF3 mutant lacking this domain failed to interact with E6 and activate p53 in the cervical cancer cells. The prevention of p53 degradation was unlikely caused by binding of ATF3 to the tumor suppressor, but rather was a consequence of disruption of the E6-E6AP interaction by ATF3. These results indicate that ATF3 plays a key role in a mechanism defending against HPV-induced carcinogenesis, and could serve as a novel therapeutic target for HPV-positive cancers.	[Wang, Hongbo; Mo, Pingli; Ren, Shumei; Yan, Chunhong] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	Yan, CH (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	yanc@mail.amc.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Yan, Chunhong/0000-0002-3974-7991	Department of Defense [PC061106]; NATIONAL CANCER INSTITUTE [R01CA139107] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant PC061106 (to C. Y.).	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Camus S, 2003, FEBS LETT, V536, P220, DOI 10.1016/S0014-5793(03)00054-1; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Huibregtse JM, 1996, SEMIN CANCER BIOL, V7, P317, DOI 10.1006/scbi.1996.0041; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Ishiguro T, 1996, CANCER RES, V56, P875; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Liu YQ, 2008, FRONT BIOSCI-LANDMRK, V13, P121, DOI 10.2741/2664; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nakamura S, 2002, ONCOGENE, V21, P2605, DOI 10.1038/sj.onc.1205343; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tran N, 2007, HEAD NECK-J SCI SPEC, V29, P64, DOI 10.1002/hed.20460; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogt M, 2006, ONCOGENE, V25, P4009, DOI 10.1038/sj.onc.1209429; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; XU L, 1994, INT J CANCER, V59, P383, DOI 10.1002/ijc.2910590316; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2005, MOL CANCER THER, V4, P233; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Zhang XY, 2005, J BIOL CHEM, V280, P33165, DOI 10.1074/jbc.M505124200; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	58	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13201	13210		10.1074/jbc.M109.058669	http://dx.doi.org/10.1074/jbc.M109.058669			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167600	hybrid, Green Published			2022-12-27	WOS:000276787800075
J	Zhang, B; Hemann, CF; Hille, R				Zhang, Bo; Hemann, Craig F.; Hille, Russ			Kinetic and Spectroscopic Studies of the Molybdenum-Copper CO Dehydrogenase from Oligotropha carboxidovorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; ELECTRON-PARAMAGNETIC-RESONANCE; FLAVIN ADENINE-DINUCLEOTIDE; REDUCTIVE HALF-REACTION; XANTHINE-OXIDASE; PSEUDOMONAS-CARBOXYDOVORANS; ACTIVE-SITE; HYDROGENOPHAGA-PSEUDOFLAVA; MOLECULAR CHARACTERIZATION; SULFITE OXIDASE	Carbon monoxide dehydrogenase from the aerobic bacterium Oligotropha carboxidovorans catalyzes the oxidation of CO to CO2, yielding two electrons and two H+. The steady-state kinetics of the enzyme exhibit a pH optimum of 7.2 with a k(cat) of 93.3 s(-1) and K-m of 10.7 mu M at 25 degrees C. k(red) for the reductive half-reaction agrees well with k(cat) and exhibits a similar pH optimum, indicating that the rate-limiting step of overall turnover is likely in the reductive half-reaction. No dependence on CO concentration was observed in the rapid reaction kinetics, however, suggesting that CO initially binds rapidly to the enzyme, possibly at the Cu(I) of the active site, prior to undergoing oxidation. A Mo(V) species that exhibits strong coupling to the copper of the active center (I = 3/2) has been characterized by EPR. The signal is further split when [C-13] CO is used to generate it, demonstrating that substrate (or product) is a component of the signal-giving species. Finally, resonance Raman spectra of CODH reveal the presence of FAD, Fe/S clusters, and a [CuSMoO2] coordination in the active site, consistent with earlier x-ray absorption and crystallographic results.	[Zhang, Bo; Hemann, Craig F.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [075036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 075036.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY RC, 1978, BIOCHEM J, V171, P653, DOI 10.1042/bj1710653; BRAY RC, 1983, BIOCHEM J, V211, P687, DOI 10.1042/bj2110687; CYPIONKA H, 1983, J BACTERIOL, V156, P1178, DOI 10.1128/JB.156.3.1178-1187.1983; Dean J.A., 1972, LANGES HDB CHEM, V15; DILORIO, 1981, METHOD ENZYMOL, V76, P58; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Garton SD, 1997, J AM CHEM SOC, V119, P2590, DOI 10.1021/ja963931c; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Gourlay C, 2006, J AM CHEM SOC, V128, P2164, DOI 10.1021/ja056500f; Gremer L, 2000, J BIOL CHEM, V275, P1864, DOI 10.1074/jbc.275.3.1864; Hanzelmann P, 1998, EUR J BIOCHEM, V255, P755, DOI 10.1046/j.1432-1327.1998.2550755.x; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HILLE R, 1991, BIOCHEMISTRY-US, V30, P8522, DOI 10.1021/bi00099a004; Hofmann M, 2005, J BIOL INORG CHEM, V10, P490, DOI 10.1007/s00775-005-0661-5; Johnson MK, 2004, PROG INORG CHEM, V52, P213; Kang BS, 1999, J BACTERIOL, V181, P5581, DOI 10.1128/JB.181.18.5581-5590.1999; Kim JH, 1996, J BIOL CHEM, V271, P6771, DOI 10.1074/jbc.271.12.6771; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; MEYER O, 1984, J BIOL CHEM, V259, P5612; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; MEYER O, 1980, J BACTERIOL, V141, P74, DOI 10.1128/JB.141.1.74-80.1980; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; Moersdorf Gerhard, 1992, Biodegradation, V3, P61; OLSON JS, 1974, J BIOL CHEM, V249, P4363; PICK FM, 1969, BIOCHEM J, V114, P735, DOI 10.1042/bj1140735; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Siegbahn PEM, 2005, J COMPUT CHEM, V26, P888, DOI 10.1002/jcc.20230	36	52	52	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12571	12578		10.1074/jbc.M109.076851	http://dx.doi.org/10.1074/jbc.M109.076851			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178978	Green Published, hybrid			2022-12-27	WOS:000276787800014
J	Byla, P; Andersen, MH; Holtet, TL; Jacobsen, H; Munch, M; Gad, HH; Thogersen, HC; Hartmann, R				Byla, Povilas; Andersen, Mikkel H.; Holtet, Thor L.; Jacobsen, Helle; Munch, Mette; Gad, Hans Henrik; Thogersen, Hans Christian; Hartmann, Rune			Selection of a Novel and Highly Specific Tumor Necrosis Factor alpha (TNF alpha) Antagonist INSIGHT FROM THE CRYSTAL STRUCTURE OF THE ANTAGONIST-TNF alpha COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; LECTIN-LIKE DOMAIN; RHEUMATOID-ARTHRITIS; TETRANECTIN; BINDING; REFINEMENT; PROTEIN; CALCIUM; FORM	Inhibition of tumor necrosis factor alpha (TNF alpha) is a favorable way of treating several important diseases such as rheumatoid arthritis, Crohn disease, and psoriasis. Therefore, an extensive range of TNF alpha inhibitory proteins, most of them based upon an antibody scaffold, has been developed and used with variable success as therapeutics. We have developed a novel technology platform using C-type lectins as a vehicle for the creation of novel trimeric therapeutic proteins with increased avidity and unique properties as compared with current protein therapeutics. We chose human TNF alpha as a test target to validate this new technology because of the extensive experience available with protein-based TNF alpha antagonists. Here, we present a novel and highly specific TNF alpha antagonist developed using this technology. Furthermore, we have solved the three-dimensional structure of the antagonist-TNF alpha complex by x-ray crystallography, and this structure is presented here. The structure has given us a unique insight into how the selection procedure works at a molecular level. Surprisingly little change is observed in the C-type lectin-like domain structure outside of the randomized regions, whereas a substantial change is observed within the randomized loops. Thus, the overall integrity of the C-type lectin-like domain is maintained, whereas specificity and binding affinity are changed by the introduction of a number of specific contacts with TNF alpha.	[Byla, Povilas; Gad, Hans Henrik; Thogersen, Hans Christian; Hartmann, Rune] Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Byla, Povilas; Andersen, Mikkel H.; Holtet, Thor L.; Jacobsen, Helle; Munch, Mette; Thogersen, Hans Christian] Borean Pharma AS, DK-8000 Aarhus C, Denmark	Aarhus University	Thogersen, HC (corresponding author), Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	hct@mb.au.dk; rh@mb.au.dk		Hartmann, Rune/0000-0003-1159-066X; Gad, Hans Henrik/0000-0001-8449-1115	Novo Nordisk Foundation; The Danish Medical Research Council [22-04-0704]; The Carlsberg Foundation; Arne Hansen stipend	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); The Danish Medical Research Council(Danish Medical Research Council); The Carlsberg Foundation(Carlsberg Foundation); Arne Hansen stipend	This work was supported by a Novo Nordisk Foundation senior research grant and by grants from The Danish Medical Research Council (Grant 22-04-0704) and The Carlsberg Foundation and an Arne Hansen stipend (to R. H.).	Caterer NR, 2002, BIOL CHEM, V383, P1743, DOI 10.1515/BC.2002.195; DeLano W.L, PYMOL MOL GRAPHICS S; ECK MJ, 1988, J BIOL CHEM, V263, P12816; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graversen JH, 1998, J BIOL CHEM, V273, P29241, DOI 10.1074/jbc.273.44.29241; HOGAN MM, 2001, CURRENT PROTOCOLS IM, P183; Holtet TL, 1997, PROTEIN SCI, V6, P1511, DOI 10.1002/pro.5560060715; Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mogues T, 2004, J BIOMED BIOTECHNOL, P73, DOI 10.1155/S1110724304307096; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielbo S, 2004, BIOCHEMISTRY-US, V43, P8636, DOI 10.1021/bi049570s; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	19	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12096	12100		10.1074/jbc.M109.063305	http://dx.doi.org/10.1074/jbc.M109.063305			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20179326	Green Published, hybrid			2022-12-27	WOS:000276787100039
J	Durrnagel, S; Kuhn, A; Tsiairis, CD; Williamson, M; Kalbacher, H; Grimmelikhuijzen, CJP; Holstein, TW; Grunder, S				Duerrnagel, Stefan; Kuhn, Anne; Tsiairis, Charisios D.; Williamson, Michael; Kalbacher, Hubert; Grimmelikhuijzen, Cornelis J. P.; Holstein, Thomas W.; Gruender, Stefan			Three Homologous Subunits Form a High Affinity Peptide-gated Ion Channel in Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; HELISOMA-TRIVOLVIS; DEG/ENAC CHANNEL; SODIUM-CHANNEL; HELIX NEURONS; FMRFAMIDE; EXPRESSION; CLONING; SYSTEM; FAMILY	Recently, three ion channel subunits of the degenerin (DEG)/epithelial Na+ channel (ENaC) gene family have been cloned from the freshwater polyp Hydra magnipapillata, the Hydra Na+ channels (HyNaCs) 2-4. Two of them, HyNaC2 and HyNaC3, co-assemble to form an ion channel that is gated by the neuropeptides Hydra-RFamides I and II. The HyNaC2/3 channel is so far the only cloned ionotropic receptor from cnidarians and, together with the related ionotropic receptor FMRFamide-activated Na+ channel (FaNaC) from snails, the only known peptide-gated ionotropic receptor. The HyNaC2/3 channel has pore properties, like a low Na+ selectivity and a low amiloride affinity, that are different from other channels of the DEG/ENaC gene family, suggesting that a component of the native Hydra channel might still be lacking. Here, we report the cloning of a new ion channel subunit from Hydra, HyNaC5. The new subunit is closely related to HyNaC2 and -3 and co-localizes with HyNaC2 and -3 to the base of the tentacles. Coexpression in Xenopus oocytes of HyNaC5 with HyNaC2 and -3 largely increases current amplitude after peptide stimulation and affinity of the channel to Hydra-RFamides I and II. Moreover, the HyNaC2/3/5 channel has altered pore properties and amiloride affinity, more similarly to other DEG/ENaC channels. Collectively, our results suggest that the three homologous subunits HyNaC2,-3, and -5 form a peptide-gated ion channel in Hydra that could contribute to fast synaptic transmission.	[Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany; [Kuhn, Anne; Tsiairis, Charisios D.; Holstein, Thomas W.] Heidelberg Inst Zool, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany; [Williamson, Michael; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Ctr Funct & Comparat Insect Genom, DK-2100 Copenhagen, Denmark; [Kalbacher, Hubert] Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	RWTH Aachen University; University of Copenhagen; Eberhard Karls University of Tubingen	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019; Tsiairis, Charisios/A-9145-2018	Gründer, Stefan/0000-0002-7635-9883; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Tsiairis, Charisios/0000-0002-9788-9875; Holstein, Thomas/0000-0003-0480-4674	Deutsche Forschungsgemeinschaft [SFB 488, SFB 685]; Danish Research Agency; Heidelberg Cluster of Excellence CellNetworks	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Research Agency; Heidelberg Cluster of Excellence CellNetworks	This work was supported by the Deutsche Forschungsgemeinschaft SFB 488 (to T. W. H.), SFB 685 (to H. K.), the Danish Research Agency (to C. J. P. G.), and the Heidelberg Cluster of Excellence CellNetworks (to C. D. T.).	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Davey F, 2001, J NEUROCYTOL, V30, P877, DOI 10.1023/A:1020656915810; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Green KA, 1999, J PHYSIOL-LONDON, V519, P47, DOI 10.1111/j.1469-7793.1999.0047o.x; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Hansen GN, 2000, CELL TISSUE RES, V301, P245; HILLE B, 2001, ION CHANNELS EXCITAB, P471; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; LOOMIS WF, 1955, ANN NY ACAD SCI, V62, P211, DOI 10.1111/j.1749-6632.1955.tb35372.x; Martinez DE, 1997, DEV BIOL, V192, P523, DOI 10.1006/dbio.1997.8715; MEECH RW, 1995, J NEUROPHYSIOL, V74, P1662, DOI 10.1152/jn.1995.74.4.1662; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmer LG, 1997, J GEN PHYSIOL, V109, P675, DOI 10.1085/jgp.109.6.675; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0	28	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11958	11965		10.1074/jbc.M109.059998	http://dx.doi.org/10.1074/jbc.M109.059998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159980	Green Published, hybrid			2022-12-27	WOS:000276787100024
J	Izumikawa, T; Kanagawa, N; Watamoto, Y; Okada, M; Saeki, M; Sakano, M; Sugahara, K; Sugihara, K; Asano, M; Kitagawa, H				Izumikawa, Tomomi; Kanagawa, Nao; Watamoto, Yukiko; Okada, Megumi; Saeki, Mika; Sakano, Masahiro; Sugahara, Kazuyuki; Sugihara, Kazushi; Asano, Masahide; Kitagawa, Hiroshi			Impairment of Embryonic Cell Division and Glycosaminoglycan Biosynthesis in Glucuronyltransferase-I-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B SECRETION; HEPATIC VLDL PRODUCTION; CASSETTE PROTEIN A1; TANGIER-DISEASE; CHOLESTERYL ESTERS; PLASMA-MEMBRANE; ABCA1; INSULIN; HDL; GOLGI	We have revealed that in Caenorhabditis elegans, non-sulfated chondroitin is required for normal cell division and cytokinesis at an early developmental stage, whereas heparan sulfate is essential for embryonic morphogenesis in the later stages of development. To clarify the roles of chondroitin sulfate and heparan sulfate in early embryogenesis in mammals, we generated glucuronyltransferase-I (GlcAT-I) knock-out mice by gene targeting. GlcAT-I is an enzyme required for the synthesis of both chondroitin sulfate and heparan sulfate. Here we report that mice with a deletion of GlcAT-I showed remarkable reduction of the synthesis of chondroitin sulfate and heparan sulfate and embryonic lethality before the 8-cell stage because of failed cytokinesis. In addition, treatment of wild-type 2-cell embryos with chondroitinase ABC had marked effects on cell division, although many heparitinase-treated embryos normally developed to blastocysts. Taken together, these results suggest that chondroitin sulfate in mammals, as with non-sulfated chondroitin in C. elegans, is indispensable for embryonic cell division.	[Izumikawa, Tomomi; Kanagawa, Nao; Watamoto, Yukiko; Okada, Megumi; Saeki, Mika; Sakano, Masahiro; Sugahara, Kazuyuki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan	Kobe Pharmaceutical University; Kanazawa University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Science and Technology (JST) Corporation; Science Research Promotion Fund of the Japan Private School Promotion Foundation; Naito Foundation; MEXT, Japan [16390026, 21390025]	Japan Science and Technology (JST) Corporation(Japan Science & Technology Agency (JST)); Science Research Promotion Fund of the Japan Private School Promotion Foundation; Naito Foundation(Naito Memorial Foundation); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology (JST) Corporation (to H. K.), the Science Research Promotion Fund of the Japan Private School Promotion Foundation, the Naito Foundation (to H. K.), and Grants-in-aid for Scientific Research-B 16390026 (to K. S.) and 21390025 (to H. K.) from MEXT, Japan.	Adiels M, 2007, DIABETOLOGIA, V50, P2356, DOI 10.1007/s00125-007-0790-1; Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Assmann G, 2001, METABOLIC MOL BASES, P2937; Attie AD, 2001, J LIPID RES, V42, P1717; Au CS, 2004, METABOLISM, V53, P228, DOI 10.1016/j.metabol.2003.09.011; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown AM, 2001, ARTERIOSCL THROM VAS, V21, P1656, DOI 10.1161/hq1001.096640; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Chung SY, 2010, J LIPID RES, V51, P729, DOI 10.1194/jlr.M900083; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Furbee JW, 2002, J LIPID RES, V43, P428; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Joyce CW, 2006, J BIOL CHEM, V281, P33053, DOI 10.1074/jbc.M604526200; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kolovou G, 2003, J CLIN PATHOL, V56, P937, DOI 10.1136/jcp.56.12.937; Kypreos KE, 2008, BIOCHEMISTRY-US, V47, P10491, DOI 10.1021/bi801249c; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; PARKS JS, 1982, J LIPID RES, V23, P410; Phung TL, 1997, J BIOL CHEM, V272, P30693, DOI 10.1074/jbc.272.49.30693; ROBENEK H, 1991, ARTERIOSCLER THROMB, V11, P1007, DOI 10.1161/01.ATV.11.4.1007; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Schaefer EJ, 2001, ATHEROSCLEROSIS, V159, P231, DOI 10.1016/S0021-9150(01)00688-8; SCHMITZ G, 1985, P NATL ACAD SCI USA, V82, P6305, DOI 10.1073/pnas.82.18.6305; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Sparks JD, 1996, BIOCHEM J, V313, P567, DOI 10.1042/bj3130567; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; WANG CS, 1987, BIOCHIM BIOPHYS ACTA, V920, P9, DOI 10.1016/0005-2760(87)90305-5; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; WILCOX RW, 1991, LIPIDS, V26, P283, DOI 10.1007/BF02537138; YAMADA N, 1986, J LIPID RES, V27, P910; Zha XH, 2003, J BIOL CHEM, V278, P10002, DOI 10.1074/jbc.C300024200; Zha XH, 2001, J BIOL CHEM, V276, P39476, DOI 10.1074/jbc.M105067200; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	45	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12190	12209		10.1074/jbc.M110.100941	http://dx.doi.org/10.1074/jbc.M110.100941			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164174	hybrid, Green Published			2022-12-27	WOS:000276787100049
J	Abu-Hayyeh, S; Martinez-Becerra, P; Kadir, SHSA; Selden, C; Romero, MR; Rees, M; Marschall, HU; Marin, JJG; Williamson, C				Abu-Hayyeh, Shadi; Martinez-Becerra, Pablo; Kadir, Siti H. Sheikh Abdul; Selden, Clare; Romero, Marta R.; Rees, Myrddin; Marschall, Hanns-Ulrich; Marin, Jose J. G.; Williamson, Catherine			Inhibition of Na+-Taurocholate Co-transporting Polypeptide-mediated Bile Acid Transport by Cholestatic Sulfated Progesterone Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT EXPORT PUMP; INTRAHEPATIC CHOLESTASIS; COTRANSPORTING POLYPEPTIDE; ABCB4 GENE; PREGNANCY; HEPATOCYTES; RAT; DEXAMETHASONE; POLYMORPHISM; VARIANTS	Sulfated progesterone metabolite (P4-S) levels are raised in normal pregnancy and elevated further in intrahepatic cholestasis of pregnancy (ICP), a bile acid-liver disorder of pregnancy. ICP can be complicated by preterm labor and intrauterine death. The impact of P4-S on bile acid uptake was studied using two experimental models of hepatic uptake of bile acids, namely cultured primary human hepatocytes (PHH) and Na+-taurocholate co-transporting polypeptide (NTCP)-expressing Xenopus laevis oocytes. Two P4-S compounds, allopregnanolone-sulfate (PM4-S) and epiallopregnanolone-sulfate (PM5-S), reduced [H-3] taurocholate (TC) uptake in a dose-dependent manner in PHH, with both Na+-dependent and-independent bile acid uptake systems significantly inhibited. PM5-S-mediated inhibition of TC uptake could be reversed by increasing the TC concentration against a fixed PM5-S dose indicating competitive inhibition. Experiments using NTCP-expressing Xenopus oocytes confirmed that PM4-S/PM5-S are capable of competitively inhibiting NTCP-mediated uptake of [H-3]TC. Total serum PM4-S + PM5-S levels were measured in non-pregnant and third trimester pregnant women using liquid chromatography-electrospray tandem mass spectrometry and were increased in pregnant women, at levels capable of inhibiting TC uptake. In conclusion, pregnancy levels of P4-S can inhibit Na+-dependent and-independent influx of taurocholate in PHH and cause competitive inhibition of NTCP-mediated uptake of taurocholate in Xenopus oocytes.	[Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Maternal & Fetal Dis Grp, Dept Surg & Canc, Inst Reprod & Dev Biol,Fac Med, London W12 0NN, England; [Martinez-Becerra, Pablo; Romero, Marta R.; Marin, Jose J. G.] Univ Salamanca, Lab Expt Hepatol & Drug Targeting, CIBERehd, Salamanca 37007, Spain; [Selden, Clare] Royal Free Campus Univ Coll London, Univ Coll Med Sch, Dept Med, Univ Coll London Ctr Hepatol, London NW3 2PF, England; [Rees, Myrddin] N Hampshire Hosp Natl Hlth Serv Trust, Basingstoke RG24 9NA, Hants, England; [Marschall, Hanns-Ulrich] Karolinska Inst, Dept Med, Karolinska Univ Hosp Huddinge, S-14186 Stockholm, Sweden	Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Salamanca; University of London; University College London; Karolinska Institutet; Karolinska University Hospital	Williamson, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Maternal & Fetal Dis Grp, Dept Surg & Canc, Inst Reprod & Dev Biol,Fac Med, Du Cane Rd, London W12 0NN, England.	catherine.williamson@imperial.ac.uk	Marschall, Hanns-Ulrich/K-8842-2017; Romero, Marta Rodriguez/B-1596-2017; Marin, Jose J. G./D-5017-2011; Sheikh Abdul Kadir, Siti Hamimah/ABA-7769-2021; IBSAL, Secretaría/H-3719-2011	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Romero, Marta Rodriguez/0000-0001-6729-0215; Marin, Jose J. G./0000-0003-1186-6849; Sheikh Abdul Kadir, Siti Hamimah/0000-0002-1671-4839; Selden, Angela/0000-0003-2648-443X; Williamson, Catherine/0000-0002-6226-7611	Action Medical Research Grant [SP4005]; Women for Women Charity; Biomedical Research Centre at Imperial College Hospitals NHS Trust; Junta de Castilla y Leon (Spain) [GR75/2008, SA033A08, SA03508, SA03608, SAN 673/SA07/08]; Ministerio de Ciencia y Tecnologia; Plan Nacional de Investigacion Cientifica; Desarrollo e Innovacion Tecnologica (Spain) [BFU2006-12577, BFU2007-30688-E/BFI]	Action Medical Research Grant; Women for Women Charity; Biomedical Research Centre at Imperial College Hospitals NHS Trust; Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Nacional de Investigacion Cientifica(Instituto de Salud Carlos IIIEuropean Commission); Desarrollo e Innovacion Tecnologica (Spain)	This work was supported in part by Action Medical Research Grant SP4005, Women for Women Charity, Biomedical Research Centre at Imperial College Hospitals NHS Trust, Junta de Castilla y Leon Grants GR75/2008, SA033A08, SA03508, SA03608, and SAN 673/SA07/08 (Spain), Ministerio de Ciencia y Tecnologia, Plan Nacional de Investigacion Cientifica, and Desarrollo e Innovacion Tecnologica Grants BFU2006-12577 and BFU2007-30688-E/BFI (Spain).	Arrese M, 2003, J HEPATOL, V38, P148, DOI 10.1016/S0168-8278(02)00379-3; Bacq Y, 1997, HEPATOLOGY, V26, P358, DOI 10.1002/hep.510260216; Briz O, 2002, MOL PHARMACOL, V61, P853, DOI 10.1124/mol.61.4.853; Castano G, 2006, CLIN SCI, V110, P459, DOI 10.1042/CS20050302; Crocenzi FA, 2003, AM J PHYSIOL-GASTR L, V285, pG449, DOI 10.1152/ajpgi.00508.2002; Diac M, 2006, J Obstet Gynaecol, V26, P110; Dixon PH, 2008, OBSTET MED, V1, P65, DOI 10.1258/om.2008.080010; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Eloranta JJ, 2006, MOL ENDOCRINOL, V20, P65, DOI 10.1210/me.2005-0159; GANGULY T, 1993, J PHARMACOL EXP THER, V267, P82; Geier A, 2003, BBA-BIOMEMBRANES, V1609, P87, DOI 10.1016/S0005-2736(02)00657-0; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; HIRVIOJA ML, 1992, BRIT J OBSTET GYNAEC, V99, P109, DOI 10.1111/j.1471-0528.1992.tb14465.x; Ho RH, 2004, J BIOL CHEM, V279, P7213, DOI 10.1074/jbc.M305782200; Kancheva R, 2007, J ENDOCRINOL, V195, P67, DOI 10.1677/JOE-06-0192; Kim RB, 1999, J PHARMACOL EXP THER, V291, P1204; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Marschall HU, 2001, J LIPID RES, V42, P735; Meier Y, 2008, WORLD J GASTROENTERO, V14, P38, DOI 10.3748/wjg.14.38; Meng LJ, 1997, J HEPATOL, V27, P346, DOI 10.1016/S0168-8278(97)80181-X; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Mullenbach R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e70; Pascual MJ, 2002, CLIN SCI, V102, P587, DOI 10.1042/CS20010258; Pauli-Magnus C, 2004, PHARMACOGENETICS, V14, P91, DOI 10.1097/00008571-200402000-00003; SANDKER GW, 1994, BIOCHEM PHARMACOL, V47, P2193, DOI 10.1016/0006-2952(94)90255-0; Selden C, 2007, J GENE MED, V9, P67, DOI 10.1002/jgm.1000; SJOVALL J, 1970, Annals of Clinical Research, V2, P321; SJOVALL K, 1970, Annals of Clinical Research, V2, P393; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Vallejo M, 2006, J HEPATOL, V44, P1150, DOI 10.1016/j.jhep.2005.09.017; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; Vicens M, 2007, BIOORGAN MED CHEM, V15, P2359, DOI 10.1016/j.bmc.2007.01.027; Wasmuth HE, 2007, GUT, V56, P265, DOI 10.1136/gut.2006.092742; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Yamamoto Y, 2006, J BIOL CHEM, V281, P16625, DOI 10.1074/jbc.M602723200; ZIMMERLI B, 1989, J PHARMACOL EXP THER, V250, P301	39	50	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16504	16512		10.1074/jbc.M109.072140	http://dx.doi.org/10.1074/jbc.M109.072140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20177056	Green Published, hybrid			2022-12-27	WOS:000277982600012
J	Wiens, CJ; Tong, YF; Esmail, MA; Oh, E; Gerdes, JM; Wang, JH; Tempel, W; Rattner, JB; Katsanis, N; Park, HW; Leroux, MR				Wiens, Cheryl J.; Tong, Yufeng; Esmail, Muneer A.; Oh, Edwin; Gerdes, Jantje M.; Wang, Jihong; Tempel, Wolfram; Rattner, Jerome B.; Katsanis, Nicholas; Park, Hee-Won; Leroux, Michel R.			Bardet-Biedl Syndrome-associated Small GTPase ARL6 (BBS3) Functions at or near the Ciliary Gate and Modulates Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSYLATION FACTOR 6; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; CHLAMYDOMONAS-REINHARDTII; ACTIVATING PROTEIN; FLAGELLA MUTANTS; BINDING PROTEINS; GENETIC-ANALYSIS; ARF FAMILY; CILIOGENESIS	The expansive family of metazoan ADP-ribosylation factor and ADP-ribosylation factor-like small GTPases is known to play essential roles in modulating membrane trafficking and cytoskeletal functions. Here, we present the crystal structure of ARL6, mutations in which cause Bardet-Biedl syndrome (BBS3), and reveal its unique ring-like localization at the distal end of basal bodies, in proximity to the so-called ciliary gate where vesicles carrying ciliary cargo fuse with the membrane. Overproduction of GDP- or GTP-locked variants of ARL6/BBS3 in vivo influences primary cilium length and abundance. ARL6/BBS3 also modulates Wnt signaling, a signal transduction pathway whose association with cilia in vertebrates is just emerging. Importantly, this signaling function is lost in ARL6 variants containing BBS-associated point mutations. By determining the structure of GTP-bound ARL6/BBS3, coupled with functional assays, we provide a mechanistic explanation for such pathogenic alterations, namely altered nucleotide binding. Our findings therefore establish a previously unknown role for ARL6/BBS3 in mammalian ciliary (dis)assembly and Wnt signaling and provide the first structural information for a BBS protein.	[Wiens, Cheryl J.; Esmail, Muneer A.; Leroux, Michel R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Tong, Yufeng; Wang, Jihong; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Gerdes, Jantje M.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Oh, Edwin; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27708 USA	Simon Fraser University; University of Toronto; Structural Genomics Consortium; University of Toronto; Johns Hopkins University; University of Calgary; Duke University	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca	Katsanis, Nicholas/E-1837-2012; Gerdes, Jantje Mareike/M-9868-2014; Tong, Yufeng/D-2785-2011	Gerdes, Jantje Mareike/0000-0001-6885-5441; Tong, Yufeng/0000-0001-7740-1812; Katsanis, Nicholas/0000-0002-2480-0171	National Institutes of Health; NICHD [R01HD04260]; NIDDK [R01DK072301, DK075972]; National Institute of Mental Health; Canadian Institutes of Health Research [MOP-82870]; Heart and Stroke Foundation of British Columbia; Yukon grant; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute,; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia; Yukon grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute,(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD04260 from NICHD (to N.K.) and R01DK072301 and DK075972 from NIDDK (to N.K.). This work was also supported by a Conte Center grant from the National Institute of Mental Health (to N.K.), Canadian Institutes of Health Research Grant MOP-82870 (to M. R. L.), Heart and Stroke Foundation of British Columbia and Yukon grant (to M. R. L.), Natural Sciences and Engineering Research Council of Canada grant (to J.B.R.), and in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from Canadian Institutes of Health Research, Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, Ontario Innovation Trust, Ontario Ministry for Research and Innovation, Merck, Novartis Research Foundation, Swedish Agency for Innovation Systems, Swedish Foundation for Strategic Research, and the Wellcome Trust.	Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Asleson CM, 1998, GENETICS, V148, P693; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BARSEL SE, 1988, GENETICS, V118, P637; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cuvillier A, 2000, J CELL SCI, V113, P2065; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Ding M, 1996, J BIOL CHEM, V271, P24005, DOI 10.1074/jbc.271.39.24005; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Huang HY, 2009, DEV DYNAM, V238, P232, DOI 10.1002/dvdy.21832; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Kobayashi T, 2009, BIOCHEM BIOPH RES CO, V381, P439, DOI 10.1016/j.bbrc.2009.02.087; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KUCHKA MR, 1987, GENETICS, V115, P685; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Leroux MR, 2007, CELL, V129, P1041, DOI 10.1016/j.cell.2007.05.049; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Luby-Phelps K, 2008, VISION RES, V48, P413, DOI 10.1016/j.visres.2007.08.022; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCVITTIE A, 1972, J GEN MICROBIOL, V71, P525, DOI 10.1099/00221287-71-3-525; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SCHOEPFER R, 1993, GENE, V124, P83, DOI 10.1016/0378-1119(93)90764-T; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tayeh MK, 2008, HUM MOL GENET, V17, P1956, DOI 10.1093/hmg/ddn093; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; WAGNER P, 1992, METHOD ENZYMOL, V219, P369; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; WEISS O, 1989, J BIOL CHEM, V264, P21066; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	100	72	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16218	16230		10.1074/jbc.M109.070953	http://dx.doi.org/10.1074/jbc.M109.070953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207729	Green Published, hybrid			2022-12-27	WOS:000277715900058
J	Platzer, B; Fiebiger, E				Platzer, Barbara; Fiebiger, Edda			The Signal Peptide of the IgE Receptor alpha-Chain Prevents Surface Expression of an Immunoreceptor Tyrosine-based Activation Motif-free Receptor Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; DENDRITIC CELLS; QUALITY-CONTROL; ALLERGY; PROTEIN; BETA; RECOGNITION	The high affinity receptor for IgE, Fc epsilon receptor I (Fc epsilon RI), is an activating immune receptor and key regulator of allergy. Antigen-mediated cross-linking of IgE-loaded Fc epsilon RI alpha-chains induces cell activation via immunoreceptor tyrosine-based activation motifs in associated signaling subunits, such as Fc epsilon RI gamma-chains. Here we show that the human Fc epsilon RI alpha-chain can efficiently reach the cell surface by itself as an IgE-binding receptor in the absence of associated signaling subunits when the endogenous signal peptide is swapped for that of murine major histocompatibility complex class-I H2-K-b. This single-chain isoform of Fc epsilon RI exited the endoplasmic reticulum (ER), trafficked to the Golgi and, subsequently, trafficked to the cell surface. Mutational analysis showed that the signal peptide regulates surface expression in concert with other described ER retention signals of Fc epsilon RI-alpha. Once the Fc epsilon RI alpha-chain reached the cell surface by itself, it formed a ligand-binding receptor that stabilized upon IgE contact. Independently of the Fc epsilon RI gamma-chain, this single-chain Fc epsilon RI was internalized after receptor cross-linking and trafficked into a LAMP-1-positive lysosomal compartment like multimeric Fc epsilon RI. These data suggest that the single-chain isoform is capable of shuttling IgE-antigen complexes into antigen loading compartments, which plays an important physiologic role in the initiation of immune responses toward allergens. We propose that, in addition to cytosolic and transmembrane ER retention signals, the Fc epsilon RI alpha-chain signal peptide contains a negative regulatory signal that prevents expression of an immunoreceptor tyrosine-based activation motif-free IgE receptor pool, which would fail to induce cell activation.	[Platzer, Barbara; Fiebiger, Edda] Childrens Hosp Boston, Div Gastroenterol & Nutr, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Fiebiger, E (corresponding author), 300 Longwood Ave,EN720, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu			National Institutes of Health [DK081256, R56AI075037, R01AI075037]; American Gastroenterological Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075037, R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081256 (to B. P.) and R56AI075037 and R01AI075037 (to E. F.). This work was also supported by a Research Scholar Award from the American Gastroenterological Association (to E. F.).	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Castro-Fernandez C, 2005, ENDOCR REV, V26, P479, DOI 10.1210/er.2004-0010; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Donnadieu E, 2003, IMMUNITY, V18, P665, DOI 10.1016/S1074-7613(03)00115-8; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Fattakhova GV, 2009, MOL IMMUNOL, V46, P793, DOI 10.1016/j.molimm.2008.09.002; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hartman ML, 2008, MOL IMMUNOL, V45, P2307, DOI 10.1016/j.molimm.2007.11.017; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Kinet JP, 1996, EUR RESPIR J, V9, pS116; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; MAURER D, 1995, J IMMUNOL, V154, P6285; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Piersma D, 2006, J CLIN ENDOCR METAB, V91, P1470, DOI 10.1210/jc.2005-2156; Schamel WWA, 2008, ADV EXP MED BIOL, V640, P64, DOI 10.1007/978-0-387-09789-3_6; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; von Bubnoff D, 2003, CLIN EXP DERMATOL, V28, P184, DOI 10.1046/j.1365-2230.2003.01209.x; Wollenberg A, 2000, CLIN EXP DERMATOL, V25, P530, DOI 10.1046/j.1365-2230.2000.00699.x	41	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15314	15323		10.1074/jbc.M110.104281	http://dx.doi.org/10.1074/jbc.M110.104281			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304923	hybrid, Green Published			2022-12-27	WOS:000277399000052
J	Sanchez-Alvarez, M; Montes, M; Sanchez-Hernandez, N; Hernandez-Munain, C; Sune, C				Sanchez-Alvarez, Miguel; Montes, Marta; Sanchez-Hernandez, Noemi; Hernandez-Munain, Cristina; Sune, Carlos			Differential Effects of Sumoylation on Transcription and Alternative Splicing by Transcription Elongation Regulator 1 (TCERG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; INHERITED DEMENTIA FTDP-17; C-TERMINAL DOMAIN; IN-VIVO; SUMO MODIFICATION; CA150 BIND; FF DOMAINS; PROTEIN; SPLICEOSOME	Modification of proteins by small ubiquitin-like modifier (SUMO) is emerging as an important control of transcription and RNA processing. The human factor TCERG1 (also known as CA150) participates in transcriptional elongation and alternative splicing of pre-mRNAs. Here, we report that SUMO family proteins modify TCERG1. Furthermore, TCERG1 binds to the E2 SUMO-conjugating enzyme Ubc9. Two lysines (Lys-503 and Lys-608) of TCERG1 are the major sumoylation sites. Sumoylation does not affect localization of TCERG1 to the splicing factor-rich nuclear speckles or the alternative splicing function of TCERG1. However, mutation of the SUMO acceptor lysine residues enhanced TCERG1 transcriptional activity, indicating that SUMO modification negatively regulates TCERG1 transcriptional activity. These results reveal a regulatory role for sumoylation in controlling the activity of a transcription factor that modulates RNA polymerase II elongation and mRNA alternative processing, which are discriminated differently by this post-translational modification.	[Sanchez-Alvarez, Miguel; Montes, Marta; Sanchez-Hernandez, Noemi; Sune, Carlos] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Granada 18100, Spain; [Sanchez-Alvarez, Miguel; Hernandez-Munain, Cristina] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Cell Biol & Immunol, Granada 18100, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Sune, C (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada 18100, Spain.	csune@ipb.csic.es	Montes, Marta/G-2751-2016; de Munain, Cristina Hernandez Lopez/S-4389-2018; Sánchez, Noemí/V-7150-2017; Montes, Marta/ABF-8298-2020; Suñé, Carlos/AAA-8198-2019; SÁNCHEZ-ÁLVAREZ, MIGUEL/AAA-4507-2019	Montes, Marta/0000-0003-1223-8385; de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458; Sánchez, Noemí/0000-0002-1697-2352; Montes, Marta/0000-0003-1223-8385; Suñé, Carlos/0000-0002-7991-0458; SÁNCHEZ-ÁLVAREZ, MIGUEL/0000-0001-5287-1420	Spanish Ministry of Science and Innovation [BFU2008-01599, BFU2008- 01651]; Fundacion para la Investigacion y la Prevencion del SIDA en Espana [36768]; Fundacion de Investigacion Medica Mutua Madrilena	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y la Prevencion del SIDA en Espana; Fundacion de Investigacion Medica Mutua Madrilena	This work was supported in part by Spanish Ministry of Science and Innovation Grant BFU2008-01599, Fundacion para la Investigacion y la Prevencion del SIDA en Espana Grant 36768 (to C. S.), Spanish Ministry of Science and Innovation Grant BFU2008- 01651, and Fundacion de Investigacion Medica Mutua Madrilena (to C.H.-M.).	Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Amelio AL, 2009, EMBO J, V28, P2733, DOI 10.1038/emboj.2009.216; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Delattre C, 2006, CELLULOSE, V13, P63, DOI 10.1007/s10570-005-9031-2; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Fernandez-Lloris R, 2006, FEBS LETT, V580, P1215, DOI 10.1016/j.febslet.2006.01.031; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; HARLOW E, 1999, USING ANTIBODIES LAB, P521; HARRISON MJ, 2010, NUCL ACIDS RES; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hirose Y, 2000, GENE DEV, V14, P1415; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kalbfuss B, 2001, J BIOL CHEM, V276, P42986, DOI 10.1074/jbc.M105113200; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kao HY, 1996, MOL CELL BIOL, V16, P960; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Mabon SA, 2005, PLOS BIOL, V3, P1893, DOI 10.1371/journal.pbio.0030374; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Nojima M, 2008, J MOL BIOL, V382, P275, DOI 10.1016/j.jmb.2008.07.017; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Shimada M, 1999, J BIOCHEM-TOKYO, V126, P1033, DOI 10.1093/oxfordjournals.jbchem.a022547; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Yan J, 2007, BIOCHEM BIOPH RES CO, V362, P132, DOI 10.1016/j.bbrc.2007.07.158; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	73	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15220	15233		10.1074/jbc.M109.063750	http://dx.doi.org/10.1074/jbc.M109.063750			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215116	hybrid, Green Published			2022-12-27	WOS:000277399000043
J	Haberland, M; Carrer, M; Mokalled, MH; Montgomery, RL; Olson, EN				Haberland, Michael; Carrer, Michele; Mokalled, Mayssa H.; Montgomery, Rusty L.; Olson, Eric N.			Redundant Control of Adipogenesis by Histone Deacetylases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; INHIBITORS; DIFFERENTIATION; HYPERTROPHY; ROLES	Adipocyte differentiation is a well defined process that is under the control of transcriptional activators and repressors. We show that histone deacetylase (HDAC) inhibitors efficiently block adipocyte differentiation in vitro. This effect is specific to adipogenesis, as another mesenchymal differentiation process, osteoblastogenesis, is enhanced upon HDAC inhibition. Through the systematic genetic deletion of HDAC genes in cultured mesenchymal precursor cells, we show that deletion of HDAC1 and HDAC2 leads to reduced lipid accumulation, revealing redundant and requisite roles of these class I HDACs in adipogenesis. These findings unveil a previously unrecognized role for HDACs in the control of adipogenesis.	[Haberland, Michael; Carrer, Michele; Mokalled, Mayssa H.; Montgomery, Rusty L.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.Olson@utsouthwestern.edu		Carrer, Michele/0000-0002-6464-9584	National Institutes of Health [5-R01-HL083371]; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083371, R01HL093039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5-R01-HL083371 (to E.N.O.). This work was also supported by the Donald W. Reynolds Center for Clinical Cardiovascular Research and the Robert A. Welch Foundation.	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Bakker A, 2003, METH MOLEC MED, V80, P19; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200	29	94	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14663	14670		10.1074/jbc.M109.081679	http://dx.doi.org/10.1074/jbc.M109.081679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20190228	Green Published, hybrid			2022-12-27	WOS:000277299700064
J	Jin, BF; Shen, HX; Lin, SB; Li, JL; Chen, ZR; Griffin, JD; Wu, LZ				Jin, Baofeng; Shen, Huangxuan; Lin, Shuibin; Li, Jian-Liang; Chen, Zirong; Griffin, James D.; Wu, Lizi			The Mastermind-like 1 (MAML1) Co-activator Regulates Constitutive NF-kappa B Signaling and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATORS; NOTCH RECEPTORS; EMBRYONIC LETHALITY; LIVER-REGENERATION; MICE LACKING; CROSS-TALK; APOPTOSIS; ALPHA; EXPRESSION; PATHWAY	Nuclear factor-kappa B (NF-kappa B)-based signaling regulates diverse biological processes, and its deregulation is associated with various disorders including autoimmune diseases and cancer. Identification of novel factors that modulate NF-kappa B function is therefore of significant importance. The Mastermind-like 1 (MAML1) transcriptional co-activator regulates transcriptional activity in the Notch pathway and is emerging as a co-activator of other pathways. In this study, we found that MAML1 regulates NF-kappa B signaling via two mechanisms. First, MAML1 coactivates the NF-kappa B subunit RelA (p65) in NF-kappa B-dependent transcription. Second, MAML1 causes degradation of the inhibitor of NF-kappa B (I kappa B alpha). Maml1-deficient mouse embryonic fibroblasts showed impaired tumor necrosis factor-alpha (TNF alpha)-induced NF-kappa B responses. Moreover, MAML1 expression level directly influences cellular sensitivity to TNF alpha-induced cytotoxicity. In vivo, mice deficient in the Maml1 gene exhibited spontaneous cell death in the liver, with a large increase in the number of apoptotic hepatic cells. These findings indicate that MAML1 is a novel modulator for NF-kappa B signaling and regulates cellular survival.	Univ Florida, Shands Canc Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Li, Jian-Liang] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA; [Griffin, James D.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Griffin, James D.] Harvard Univ, Sch Med, Boston, MA 02115 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wu, LZ (corresponding author), 2033 Mowry Rd, Gainesville, FL 32610 USA.	lzwu@ufl.edu	Li, Jian-Liang/AAE-9315-2019; chen, zirong/S-4042-2016; Li, J L/E-6100-2018	Li, Jian-Liang/0000-0002-6487-081X; chen, zirong/0000-0002-0589-4619; Li, J L/0000-0002-6487-081X	National Institutes of Health [R01 CA097148, R01 CA036167]; University of Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE [R01CA036167, R01CA097148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA097148. This work was also supported by the University of Florida Shands Cancer Center startup fund (to L. W.) and National Institutes of Health Grant R01 CA036167 (to J. D. G.).	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; CRESSMAN DE, 1993, ONCOGENE, V8, P2567; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Espinosa L, 2002, J CELL SCI, V115, P1295; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Plumpe J, 2000, AM J PHYSIOL-GASTR L, V278, pG173, DOI 10.1152/ajpgi.2000.278.1.G173; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2004, SEMIN CANCER BIOL, V14, P348, DOI 10.1016/j.semcancer.2004.04.014; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	36	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14356	14365		10.1074/jbc.M109.078865	http://dx.doi.org/10.1074/jbc.M109.078865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231278	Green Published, hybrid			2022-12-27	WOS:000277299700033
J	Richard, D; MacRaild, CA; Riglar, DT; Chan, JA; Foley, M; Baum, J; Ralph, SA; Norton, RS; Cowman, AF				Richard, Dave; MacRaild, Christopher A.; Riglar, David T.; Chan, Jo-Anne; Foley, Michael; Baum, Jake; Ralph, Stuart A.; Norton, Raymond S.; Cowman, Alan F.			Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and the Rhoptry Neck Protein Complex Defines a Key Step in the Erythrocyte Invasion Process of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; TOXOPLASMA-GONDII; MOVING JUNCTION; CHALLENGE INFECTION; VACCINE CANDIDATE; FINE-STRUCTURE; MEROZOITES; ANTIBODY; KNOWLESI; AMA1	Invasion of host cells by apicomplexan parasites, including Plasmodium falciparum and Toxoplasma gondii, is a multistep process. Central to invasion is the formation of a tight junction, an aperture in the host cell through which the parasite pulls itself before settling into a newly formed parasitophorous vacuole. Two protein groups, derived from different secretory organelles, the micronemal protein AMA1 and the rhoptry proteins RON2, RON4, and RON5, have been shown to form part of this structure, with antibodies targeting P. falciparum AMA1 known to inhibit invasion, probably via disruption of its association with the PfRON proteins. Inhibitory AMA1-binding peptides have also been described that block P. falciparum merozoite invasion of the erythrocyte. One of these, R1, blocks invasion some time after initial attachment to the erythrocyte and reorientation of the merozoite to its apical pole. Here we show that the R1 peptide binds the PfAMA1 hydrophobic trough and demonstrate that binding to this region prevents its interaction with the PfRON complex. We show that this defined association between PfAMA1 and the PfRON complex occurs after reorientation and engagement of the actomyosin motor and argue that it precedes rhoptry release. We propose that the formation of the AMA1-RON complex is essential for secretion of the rhoptry contents, which then allows the establishment of parasite infection within the parasitophorous vacuole.	[Richard, Dave; MacRaild, Christopher A.; Riglar, David T.; Chan, Jo-Anne; Baum, Jake; Norton, Raymond S.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Foley, Michael] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; La Trobe University; University of Melbourne	Norton, RS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	rnorton@wehi.edu.au; cowman@wehi.edu.au	; Ralph, Stuart/C-8590-2014	Foley, Michael/0000-0003-1349-4698; Norton, Raymond/0000-0001-8893-0584; Baum, Jake/0000-0002-0275-352X; MacRaild, Christopher/0000-0002-3694-3989; Riglar, David/0000-0002-5004-4373; Ralph, Stuart/0000-0003-0114-7808	National Health and Medical Research Council of Australia (NHMRC); Victorian State Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	This work was supported by the National Health and Medical Research Council of Australia (NHMRC). This work was supported by an NHMRC Institutes Infrastructure Support Scheme grant and a Victorian State Government Operational Infrastructure Support grant.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; AIKAWA M, 1981, J CELL BIOL, V91, P55, DOI 10.1083/jcb.91.1.55; AIKAWA M, 1977, B WORLD HEALTH ORGAN, V55, P139; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; BANNISTER LH, 1989, J PROTOZOOL, V36, P362, DOI 10.1111/j.1550-7408.1989.tb05527.x; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Gupta A, 2005, PROTEIN EXPRES PURIF, V41, P186, DOI 10.1016/j.pep.2005.01.005; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOWARD RF, 1990, EXP PARASITOL, V71, P330, DOI 10.1016/0014-4894(90)90038-E; HOWARD RF, 1984, AM J TROP MED HYG, V33, P1055, DOI 10.4269/ajtmh.1984.33.1055; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Morahan BJ, 2009, EXP PARASITOL, V122, P280, DOI 10.1016/j.exppara.2009.04.013; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; STEWART MJ, 1986, AM J TROP MED HYG, V35, P37, DOI 10.4269/ajtmh.1986.35.37; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x	46	181	190	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14815	14822		10.1074/jbc.M109.080770	http://dx.doi.org/10.1074/jbc.M109.080770			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228060	hybrid, Green Published			2022-12-27	WOS:000277299700078
J	Guevara, T; Yiallouros, I; Kappelhoff, R; Bissdorf, S; Stocker, W; Gomis-Ruth, FX				Guevara, Tibisay; Yiallouros, Irene; Kappelhoff, Reinhild; Bissdorf, Steffen; Stoecker, Walter; Xavier Gomis-Rueth, F.			Proenzyme Structure and Activation of Astacin Metallopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYSTEINE SWITCH; ACTIVE-SITE; 3-DIMENSIONAL STRUCTURE; ZINC-ENDOPEPTIDASE; CATALYTIC DOMAIN; SNAKE-VENOM; MECHANISM; FAMILY; COMPLEX	Proteolysis is regulated by inactive (latent) zymogens, with a prosegment preventing access of substrates to the active-site cleft of the enzyme. How latency is maintained often depends on the catalytic mechanism of the protease. For example, in several families of the metzincin metallopeptidases, a "cysteine switch" mechanism involves a conserved prosegment motif with a cysteine residue that coordinates the catalytic zinc ion. Another family of metzincins, the astacins, do not possess a cysteine switch, so latency is maintained by other means. We have solved the high resolution crystal structure of proastacin from the European crayfish, Astacus astacus. Its prosegment is the shortest structurally reported for a metallopeptidase, and it has a unique structure. It runs through the active-site cleft in reverse orientation to a genuine substrate. Moreover, a conserved aspartate, projected by a wide loop of the prosegment, coordinates the zinc ion instead of the catalytic solvent molecule found in the mature enzyme. Activation occurs through two-step limited proteolysis and entails major rearrangement of a flexible activation domain, which becomes rigid and creates the base of the substrate-binding cleft. Maturation also requires the newly formed N terminus to be precisely trimmed so that it can participate in a buried solvent-mediated hydrogen-bonding network, which includes an invariant active-site residue. We describe a novel mechanism for latency and activation, which shares some common features both with other metallopeptidases and with serine peptidases.	[Guevara, Tibisay; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, E-08028 Barcelona, Spain; [Yiallouros, Irene; Kappelhoff, Reinhild; Bissdorf, Steffen; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Johannes Gutenberg University of Mainz	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es	Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Guevara Puig, Tibisay/0000-0002-1366-8507	Deutsche Forschungsgemeinschaft [Sto185/3-3]; European Synchrotron Radiation Facility;  [Strep FP7-223101-AntiPathoGN];  [BIO2008-04080-E];  [BIO2009-10334];  [CSD2006-00015];  [PSE-010000-2009-8];  [2009SGR1036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Synchrotron Radiation Facility; ; ; ; ; ; 	This work was supported by grants from European, Spanish, and Catalan public agencies (Strep FP7-223101-AntiPathoGN, BIO2008-04080-E, BIO2009-10334, CSD2006-00015, PSE-010000-2009-8, and 2009SGR1036) and by Deutsche Forschungsgemeinschaft Grant Sto185/3-3. Funding for data collection was provided by the European Synchrotron Radiation Facility.	ABRAMOWITZ N, 1967, BIOCHEM BIOPH RES CO, V29, P862, DOI 10.1016/0006-291X(67)90299-9; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demidyuk IV, 2008, PROTEIN J, V27, P343, DOI 10.1007/s10930-008-9143-2; Demidyuk IV, 2010, J BIOL CHEM, V285, P2003, DOI 10.1074/jbc.M109.015396; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; HOLZER H, 1980, ANNU REV BIOCHEM, V49, P63, DOI 10.1146/annurev.bi.49.070180.000431; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; KAPPELHOFF R, 2002, I ZOOPHYSIOLOGY, P77; Khan AR, 1998, PROTEIN SCI, V7, P815; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nagase H, 1997, BIOL CHEM, V378, P151; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Reyda S, 1999, BIOCHEM J, V344, P851, DOI 10.1042/0264-6021:3440851; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; STOCKER W, 1995, METHOD ENZYMOL, V248, P305; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; STOCKER W, 1995, PROTEIN SCI, V4, P823; STOCKER W, 1991, COMP BIOCHEM PHYS B, V98, P501, DOI 10.1016/0305-0491(91)90244-8; STOCKER W, 2004, HDB PROTEOLYTIC ENZY, P595; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3; Yiallouros I, 2002, J MOL BIOL, V324, P237, DOI 10.1016/S0022-2836(02)01102-6	59	58	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13958	13965		10.1074/jbc.M109.097436	http://dx.doi.org/10.1074/jbc.M109.097436			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202938	hybrid, Green Published			2022-12-27	WOS:000276987700070
J	Kim, S; Leal, SS; Ben Halevy, D; Gomes, CM; Lev, S				Kim, SoHui; Leal, Sonia S.; Ben Halevy, Daniel; Gomes, Claudio M.; Lev, Sima			Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-ASSOCIATED PROTEIN; OXYSTEROL-BINDING PROTEIN; MOTOR-NEURON DISEASE; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; NEURITE OUTGROWTH; FFAT MOTIF; MEMBRANE; VAMP; MUTATION	The integral endoplasmic reticulum (ER)-membrane protein VAP-B interacts with various lipid-transfer/binding proteins containing an FFAT motif through its N-terminal MSP domain. A genetic mutation within its MSP domain, P56S, was identified in familial forms of motor neuron diseases. This mutation induces the formation of insoluble VAP-B(P56S) protein aggregates by an unknown mechanism. In this study, we defined the structural requirements for VAP-B oligomerization and demonstrated their contribution for VAP-B(P56S) aggregation and neurotoxicity. We show that the oligomerization of VAP-B is mainly mediated by its coiled-coil domain and that the GXXXG dimerization motif within the transmembrane domain mediates transmembrane domains self-association but is insufficient to drive VAP-B oligomerization. We further show that the oligomerization of the wild-type VAP-B is independent of its MSP domain. However, we found that the P56S mutation induces conformational changes within the MSP domain and facilitates its propensity to aggregate by exposing hydrophobic patches to the solvent. These conformational changes have no direct effect on FFAT binding. Rather, they enhance VAP-B(P56S) oligomerization driven by the combined contributions of the coiled-coil and the transmembrane domains, thereby preventing accessibility to FFAT-binding site, facilitating the production of VAP-B(P56S)-insoluble aggregates and consequently its neurotoxicity. These results shed light on the mechanism by which VAP-B(P56S) aggregates are formed and induce familial motor neuron diseases.	[Kim, SoHui; Ben Halevy, Daniel; Lev, Sima] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Weizmann Institute of Science; Universidade Nova de Lisboa	Lev, S (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	sima.lev@weizmann.ac.il	Leal, Sónia/F-1129-2015; Lev, Sima/AAP-7880-2020; Benhalevy, Daniel/AGG-5321-2022; Gomes, Cláudio M./A-8152-2008	Leal, Sónia/0000-0001-8445-0065; Lev, Sima/0000-0002-2108-3330; Benhalevy, Daniel/0000-0001-6998-1933; Gomes, Cláudio M./0000-0003-4662-6933	Federal German Ministry for Education and Research; Israel Science Foundation [548/08]; Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal	Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation(Israel Science Foundation); Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Minerva foundation with funding from the Federal German Ministry for Education and Research and by Israel Science Foundation Grant 548/08.; Recipient of a Postdoctoral fellowship from Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal.	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brosig B, 1998, PROTEIN SCI, V7, P1052; Brown RH, 2001, SEMIN NEUROL, V21, P131; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; de Pril R, 2006, NEUROBIOL AGING, V27, P515, DOI 10.1016/j.neurobiolaging.2005.04.016; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Leal SS, 2007, PROTEINS, V68, P606, DOI 10.1002/prot.21448; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Martin Stephen R, 2002, Methods Mol Biol, V173, P43; MCCLURE WO, 1966, BIOCHEMISTRY-US, V5, P1908, DOI 10.1021/bi00870a018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Thompson AJ, 2002, CURR MED CHEM, V9, P1751; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Ye CF, 2008, NEUROSCI LETT, V442, P63, DOI 10.1016/j.neulet.2008.05.119	55	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13839	13849		10.1074/jbc.M109.097345	http://dx.doi.org/10.1074/jbc.M109.097345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207736	Green Published, hybrid			2022-12-27	WOS:000276987700059
J	Lott, K; Bhardwaj, A; Mitrousis, G; Pante, N; Cingolani, G				Lott, Kaylen; Bhardwaj, Anshul; Mitrousis, Gregory; Pante, Nelly; Cingolani, Gino			The Importin beta Binding Domain Modulates the Avidity of Importin beta for the Nuclear Pore Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICEOSOMAL U-SNRNPS; STRUCTURAL BASIS; PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNAL; MAMMALIAN-CELLS; MOLECULAR-BASIS; IN-VIVO; EXPORT; RECEPTOR	Importin beta mediates active passage of cellular substrates through the nuclear pore complex (NPC). Adaptors such as importin alpha and snurportin associate with importin beta via an importin beta binding (IBB) domain. The intrinsic structural flexibility of importin beta allows its concerted interactions with IBB domains, phenylalanine-glycine nucleoporins, and the GTPase Ran during transport. In this paper, we provide evidence that the nature of the IBB domain modulates the affinity of the import complex for the NPC. In permeabilized cells, importin beta imports a cargo fused to the snurportin IBB (sIBB) with similar to 70% reduced energy requirement as compared with the classical importin alpha IBB. At the molecular level, this is explained by similar to 200-fold reduced affinity of importin beta for Nup62, when bound to the sIBB. Consistently, in vivo, the importin beta center dot sIBB complex has greatly reduced persistence inside the central channel of the NPC. We propose that by controlling the degree of strain in the tertiary structure of importin beta, the IBB domain modulates the affinity of the import complex for nucleoporins, thus dictating its persistence inside the NPC.	[Lott, Kaylen; Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lott, Kaylen; Mitrousis, Gregory] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Mitrousis, Gregory] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Pante, Nelly] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Boulder; University of British Columbia	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Pante, Nelly/GVR-8478-2022	Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [GM074846-01A1]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846-01A1 (to G. C.). This work was also supported by a grant from Natural Sciences and Engineering Research Council of Canada (to N.P.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kent HM, 1996, J STRUCT BIOL, V116, P326, DOI 10.1006/jsbi.1996.0049; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lyman SK, 2002, J CELL BIOL, V159, P55, DOI 10.1083/jcb.200204163; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Melchior F, 1998, METH MOL B, V88, P265; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nevo R, 2003, NAT STRUCT BIOL, V10, P553, DOI 10.1038/nsb940; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Pante Nelly, 2006, V322, P301; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.e02-06-0372; Rollenhagen C, 2006, CAN J PHYSIOL PHARM, V84, P367, DOI 10.1139/Y05-101; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zachariae U, 2006, STRUCTURE, V14, P1469, DOI 10.1016/j.str.2006.08.001; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	57	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13769	13780		10.1074/jbc.M109.095760	http://dx.doi.org/10.1074/jbc.M109.095760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197273	Green Published, hybrid			2022-12-27	WOS:000276987700052
J	Lye, MF; Fanning, AS; Su, Y; Anderson, JM; Lavie, A				Lye, Ming F.; Fanning, Alan S.; Su, Ying; Anderson, James M.; Lavie, Arnon			Insights into Regulated Ligand Binding Sites from the Structure of ZO-1 Src Homology 3-Guanylate Kinase Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; INTRAMOLECULAR INTERACTION; DISCS LARGE; PROTEIN; JUNCTIONS; MEMBRANE; OCCLUDIN; IDENTIFICATION; LOCALIZATION; CYTOSKELETON	Tight junctions are dynamic components of epithelial and endothelial cells that regulate the paracellular transport of ions, solutes, and immune cells. The assembly and permeability of these junctions is dependent on the zonula occludens (ZO) proteins, members of the membrane-associated guanylate kinase homolog (MAGUK) protein family, which are characterized by a core Src homology 3 (SH3)-GUK module that coordinates multiple protein-protein interactions. The structure of the ZO-1 SH3-GUK domain confirms that the interdependent folding of the SH3 and GUK domains is a conserved feature of MAGUKs, but differences in the orientation of the GUK domains in three different MAGUKs reveal interdomain flexibility of the core unit. Using pull-down assays, we show that an effector loop, the U6 region in ZO-1, forms a novel intramolecular interaction with the core module. This interaction is divalent cation-dependent and overlaps with the binding site for the regulatory molecule calmodulin on the GUK domain. These findings provide insight into the previously observed ability of the U6 region to regulate TJ assembly in vivo and the structural basis for the complex protein interactions of the MAGUK family.	[Lye, Ming F.; Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.; Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health (NIH) [R01DK061397]; NIH, NIDDK [T32DK07739]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, T32DK007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01DK061397 and NIH, NIDDK, Institutional Training Grant T32DK07739, "Training Program in Signal Transduction and Cellular Endocrinology."	Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1977, J MOL BIOL, V117, P999, DOI 10.1016/S0022-2836(77)80009-0; KISTNER U, 1995, FEBS LETT, V359, P159, DOI 10.1016/0014-5793(95)00030-D; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Muller SL, 2005, J BIOL CHEM, V280, P3747, DOI 10.1074/jbc.M411365200; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740	27	28	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13907	13917		10.1074/jbc.M109.093674	http://dx.doi.org/10.1074/jbc.M109.093674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200156	hybrid, Green Published			2022-12-27	WOS:000276987700065
J	Papandreou, MJ; Barbouche, R; Guieu, R; Rivera, S; Fantini, J; Khrestchatisky, M; Jones, IM; Fenouillet, E				Papandreou, Marie-Jeanne; Barbouche, Rym; Guieu, Regis; Rivera, Santiago; Fantini, Jacques; Khrestchatisky, Michel; Jones, Ian M.; Fenouillet, Emmanuel			Mapping of Domains on HIV Envelope Protein Mediating Association with Calnexin and Protein-disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP120; RECOMBINANT GP120; MEMBRANE-FUSION; V3 LOOP; BINDING; BONDS; GLYCOSYLATION; CONFORMATION; ENTRY	The cell catalysts calnexin (CNX) and protein-disulfide isomerase (PDI) cooperate in establishing the disulfide bonding of the HIV envelope (Env) glycoprotein. Following HIV binding to lymphocytes, cell-surface PDI also reduces Env to induce the fusogenic conformation. We sought to define the contact points between Env and these catalysts to illustrate their potential as therapeutic targets. In lysates of Env-expressing cells, 15% of the gp160 precursor, but not gp120, coprecipitated with CNX, whereas only 0.25% of gp160 and gp120 coprecipitated with PDI. Under in vitro conditions, which mimic the Env/PDI interaction during virus/cell contact, PDI readily associated with Env. The domains of Env interacting in cellulo with CNX or in vitro with PDI were then determined using anti-Env antibodies whose binding site was occluded by CNX or PDI. Antibodies against domains V1/V2, C2, and the C terminus of V3 did not bind CNX-associated Env, whereas those against C1, V1/V2, and the CD4-binding domain did not react with PDI-associated Env. In addition, a mixture of the latter antibodies interfered with PDI-mediated Env reduction. Thus, Env interacts with intracellular CNX and extracellular PDI via discrete, largely nonover-lapping, regions. The sites of interaction explain the mode of action of compounds that target these two catalysts and may enable the design of further new competitive agents.	[Papandreou, Marie-Jeanne; Barbouche, Rym; Rivera, Santiago; Khrestchatisky, Michel; Fenouillet, Emmanuel] Univ Aix Marseille 1, Fac Med Nord, CNRS, F-13015 Marseille, France; [Guieu, Regis] Hop La Timone, F-13005 Marseille, France; [Fantini, Jacques] Univ Aix Marseille 3, F-13013 Marseille, France; [Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; University of Reading	Barbouche, R (corresponding author), Univ Aix Marseille 1, Fac Med Nord, CNRS, Bd P Dramard, F-13015 Marseille, France.	rym.barbouche@univmed.fr; emmanuel.fenouillet@univmed.fr	Jones, Ian/AAF-4986-2019	Jones, Ian/0000-0002-7738-2516; Fantini, Jacques/0000-0001-8653-5521; Khrestchatisky, Michel/0000-0003-4797-8332	Agence Nationale de Recherche sur le Sida; United Kingdom Medical Research Council; MRC [G0200000] Funding Source: UKRI; Medical Research Council [G0200000] Funding Source: researchfish	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Agence Nationale de Recherche sur le Sida (to E.F., R.B., and I.M.J.) and the United Kingdom Medical Research Council (to I.M.J.).	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; AVRIL LE, 1993, FEBS LETT, V317, P167, DOI 10.1016/0014-5793(93)81515-2; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Billington J, 2007, J VIROL, V81, P4604, DOI 10.1128/JVI.02138-06; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; FENOUILLET E, 1993, J VIROL, V67, P150, DOI 10.1128/JVI.67.1.150-160.1993; FENOUILLET E, 1992, VIROLOGY, V187, P825, DOI 10.1016/0042-6822(92)90487-A; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FISCHER P, 1995, J VIROL, V69, P5791, DOI 10.1128/JVI.69.9.5791-5797.1995; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; JONES DH, 1995, VACCINE, V13, P991, DOI 10.1016/0264-410X(95)00019-W; JONES IM, 1991, NATURE, V352, P198, DOI 10.1038/352198b0; KIENY MP, 1988, PROTEIN ENG, V2, P219; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; MCKEATING JA, 1992, VIROLOGY, V190, P134, DOI 10.1016/0042-6822(92)91199-5; MOORE JP, 1993, J VIROL, V67, P6136, DOI 10.1128/JVI.67.10.6136-6151.1993; MOORE JP, 1990, AIDS, V4, P307, DOI 10.1097/00002030-199004000-00004; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; Nagradova N, 2007, CURR PROTEIN PEPT SC, V8, P273, DOI 10.2174/138920307780831866; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Papandreou MJ, 2002, MOL PHARMACOL, V61, P186, DOI 10.1124/mol.61.1.186; Papandreou MJ, 1996, FEBS LETT, V379, P171, DOI 10.1016/0014-5793(95)01505-1; Pfeiffer T, 1997, J GEN VIROL, V78, P1745, DOI 10.1099/0022-1317-78-7-1745; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; ROTH RA, 1981, BIOCHEMISTRY-US, V20, P6594, DOI 10.1021/bi00526a012; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Wanamaker CP, 2005, J BIOL CHEM, V280, P33800, DOI 10.1074/jbc.M501813200; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	50	14	15	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13788	13796		10.1074/jbc.M109.066670	http://dx.doi.org/10.1074/jbc.M109.066670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202930	Green Published, hybrid			2022-12-27	WOS:000276987700054
J	Ran, FL; Gadura, N; Michels, CA				Ran, Fulai; Gadura, Nidhi; Michels, Corinne A.			Hsp90 Cochaperone Aha1 Is a Negative Regulator of the Saccharomyces MAL Activator and Acts Early in the Chaperone Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; QUALITY-CONTROL; ATPASE ACTIVITY; MOLECULAR CHAPERONES; CLIENT PROTEIN; MIDDLE DOMAIN; CDC37; CHIP; IDENTIFICATION; EXPRESSION	Aha1 is a ubiquitous cochaperone of the Hsp90/Hsp70 chaperone machine. It binds the middle domain of Hsp90 and stimulates ATPase activity, suggesting a function late in the chaperone pathway. Saccharomyces Mal63 MAL activator is a DNA-binding transcription factor and Hsp90 client protein. This study utilizes several MAL activator mutants to investigate Aha1functioninvivo. Deletion of AHA1 enhances induced Mal63-dependent maltase activity levels 2-fold, whereas overproduction of Aha1 represses expression. Maltase expression in strains carrying constitutive and super-inducible mutant activators with alterations near the C terminus (particularly residues 433-463) is unaffected by either aha1 Delta or Aha1 overproduction. However, another constitutive activator with alterations outside of this C-terminal region is sensitive to Aha1 regulation. Previously, we showed that in the absence of inducer, Mal63 forms a stable intermediate complex with Hsp70, Hsp90, and Sti1, whereas noninducible mutant activators bind only with Hsp70 in an apparent early complex. Here, we find that triple Myc-tagged Aha1/Myc3 copurifies with all noninducible Mal63 mutant activators tested. Aha1/Myc3 association with inducible Mal63 is observed only in a sti1 Delta strain, in which Hsp90 binding and intermediate complex formation are defective. Constitutive and super-inducible mutant activators with C-terminal alterations do not bind Aha1 even in a sti1 Delta strain. Mal63 binding to Hsp90 and Hsp70 is enhanced 3-fold by loss of Aha1. These results suggest an interaction between Aha1 and residues near the C terminus of Mal63 thereby regulating Hsp90 association. A novel mechanism for the negative regulation of the MAL activator by Aha1 cochaperone is proposed.	[Ran, Fulai; Michels, Corinne A.] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Ran, Fulai; Michels, Corinne A.] CUNY, Grad Sch, Ph D Program Biochem, New York, NY 10016 USA; [Gadura, Nidhi] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Michels, CA (corresponding author), CUNY Queens Coll, Dept Biol, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	corinne.michels@qc.cuny.edu			National Institutes of Health [GM28216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28216 (to C. A. M.).	Abbas-Terki T, 2002, BIOL CHEM, V383, P1335, DOI 10.1515/BC.2002.152; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bali M, 2003, J BIOL CHEM, V278, P47441, DOI 10.1074/jbc.M309536200; Barnett JA, 2005, YEAST, V22, P835, DOI 10.1002/yea.1249; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; CHARRON MJ, 1987, GENETICS, V116, P23; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Danzi SE, 2003, CURR GENET, V44, P173, DOI 10.1007/s00294-003-0429-9; Danzi SE, 2000, CURR GENET, V38, P233, DOI 10.1007/s002940000161; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; DUBIN RA, 1985, J BACTERIOL, V164, P605, DOI 10.1128/JB.164.2.605-610.1985; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gibson AW, 1997, GENETICS, V146, P1287; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; McDowell CL, 2009, INT J BIOL MACROMOL, V45, P310, DOI 10.1016/j.ijbiomac.2009.06.012; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Ran F, 2008, GENETICS, V179, P331, DOI 10.1534/genetics.107.084921; Richter K, 2006, CELL, V127, P251, DOI 10.1016/j.cell.2006.10.004; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang X, 2004, GENETICS, V168, P747, DOI 10.1534/genetics.104.029611; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	60	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13850	13862		10.1074/jbc.M109.040600	http://dx.doi.org/10.1074/jbc.M109.040600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177068	hybrid, Green Published			2022-12-27	WOS:000276987700060
J	Piechota, J; Kolodziejczak, M; Juszczak, I; Sakamoto, W; Janska, H				Piechota, Janusz; Kolodziejczak, Marta; Juszczak, Ilona; Sakamoto, Wataru; Janska, Hanna			Identification and Characterization of High Molecular Weight Complexes Formed by Matrix AAA Proteases and Prohibitins in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; MEMBRANE-PROTEIN DEGRADATION; CRISTAE MORPHOGENESIS; SUBUNIT COMPOSITION; CELL-PROLIFERATION; PLANT-MITOCHONDRIA; GENE-EXPRESSION; CHAPERONE; DEPENDS	We identify and characterize two matrix (m)-AAA proteases (AtFtsH3 and AtFtsH10) present in the mitochondria of Arabidopsis thaliana. AtFtsH3 is the predominant protease in leaves of wild type plants. Both proteases assemble with prohibitins (PHBs) into high molecular weight complexes (similar to 2 MDa), similarly to their yeast counterparts. A smaller PHB complex (similar to 1 MDa), without the m-AAA proteases, was also detected. Unlike in yeast, stable prohibitin-independent high molecular weight assemblies of m-AAA proteases could not be identified in A. thaliana. AtFtsH3 and AtFtsH10 form at least two types of m-AAA-PHB complexes in wild type plants. The one type contains PHBs and AtFtsH3, and the second one is composed of PHBs and both AtFtsH3 and AtFtsH10. Complexes composed of PHBs and AtFtsH10 were found in an Arabidopsis mutant lacking AtFtsH3 (ftsh3). Thus, both AtFtsH3 and AtFtsH10 may form hetero- and homo-oligomeric complexes with prohibitins. The increased level of AtFtsH10 observed in ftsh3 suggests that functions of the homo- and hetero-oligomeric complexes containing AtFtsH3 can be at least partially substituted by AtFtsH10 homo-oligomers. The steady-state level of the AtFtsH10 transcripts did not change in ftsh3 compared with wild type plants, but we found that almost twice more of the AtFtsH10 transcripts were associated with polysomes in ftsh3. Based on this result, we assume that the AtFtsH10 protein is synthesized at a higher rate in the ftsh3 mutant. Our results provide the first data on the composition of m-AAA and PHB complexes in plant mitochondria and suggest that the abundance of m-AAA proteases is regulated not only at the transcriptional but also at the translational level.	[Piechota, Janusz; Kolodziejczak, Marta; Juszczak, Ilona; Janska, Hanna] Univ Wroclaw, Dept Biotechnol, PL-51148 Wroclaw, Poland; [Sakamoto, Wataru] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	University of Wroclaw; Okayama University	Janska, H (corresponding author), Univ Wroclaw, Dept Biotechnol, Przybyszewskiego 63-77 St, PL-51148 Wroclaw, Poland.	Hanna.Janska@ibmb.uni.wroc.pl	Sakamoto, Wataru/AAJ-9362-2020; SAKAMOTO, Wataru/B-2511-2011; Sakamoto, Wataru/J-5588-2015	Sakamoto, Wataru/0000-0001-9747-5042; SAKAMOTO, Wataru/0000-0001-9747-5042; Juszczak, Ilona/0000-0001-7592-8426; Janska, Hanna/0000-0002-6542-343X	Ministry of Science and Higher Education [N301 119 32/4116]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Grant N301 119 32/4116 from the Ministry of Science and Higher Education.	Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Janska H, 2005, PHYSIOL PLANTARUM, V123, P399, DOI 10.1111/j.1399-3054.2004.00439.x; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Kolodziejczak M, 2002, J BIOL CHEM, V277, P43792, DOI 10.1074/jbc.M203831200; Kolodziejczak M, 2007, PHYSIOL PLANTARUM, V129, P135, DOI 10.1111/j.1399-3054.2006.00835.x; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Urantowka A, 2005, PLANT MOL BIOL, V59, P239, DOI 10.1007/s11103-005-8766-3; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	32	54	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12512	12521		10.1074/jbc.M109.063644	http://dx.doi.org/10.1074/jbc.M109.063644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172857	hybrid, Green Published			2022-12-27	WOS:000276787800008
J	Miehe, S; Bieberstein, A; Arnould, I; Ihdene, O; Rutten, H; Strubing, C				Miehe, Susanne; Bieberstein, Andrea; Arnould, Isabelle; Ihdene, Orhia; Ruetten, Hartmut; Struebing, Carsten			The Phospholipid-binding Protein SESTD1 Is a Novel Regulator of the Transient Receptor Potential Channels TRPC4 and TRPC5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; STORE-OPERATED CHANNELS; SMOOTH-MUSCLE-CELLS; CALCIUM-ENTRY; SURFACE EXPRESSION; CATION CHANNELS; CA2+ CHANNEL; BRAIN; ACTIVATION; SIGNALS	TRPC4 and TRPC5 are two closely related members of the mammalian transient receptor potential cation channel family that have been implicated in important physiological functions, such as growth cone guidance and smooth muscle contraction. To further unravel the role of TRPC4 and TRPC5 in these processes in vivo, detailed information about the molecular composition of native channel complexes and their association with cellular signaling networks is needed. We therefore searched a human aortic cDNA library for novel TRPC4-interacting proteins using a modified yeast two-hybrid assay. This screen identified SESTD1, a previously uncharacterized protein containing a lipid-binding SEC14-like domain as well as spectrin-type cytoskeleton interaction domains. SESTD1 was found to associate with TRPC4 and TRPC5 via the channel's calmodulin-and inositol 1,4,5-trisphosphate receptor-binding domain. In functional studies, we demonstrate that SESTD1 binds several phospholipid species in vitro and is essential for efficient receptor-mediated activation of TRPC5. Notably, phospholipid binding to SESTD1 was Ca2+-dependent. Because TRPC4 and -5 conduct Ca2+, SESTD1-channel signaling may be bidirectional and also couple TRPC activity to lipid signaling through SESTD1. The modulation of TRPC channel function by specific lipid-binding proteins, such as SESTD1, adds another facet to the complex regulation of these channels complementary to the previously described effects of direct channel-phospholipid interaction.	[Miehe, Susanne; Bieberstein, Andrea; Ruetten, Hartmut; Struebing, Carsten] Sanofi Aventis Deutschland GmbH, Therapeut Dept Cardiovasc Dis, D-65926 Frankfurt, Germany; [Arnould, Isabelle; Ihdene, Orhia] Sanofi Aventis, Biol Sci, F-94403 Vitry Sur Seine, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Strubing, C (corresponding author), Sanofi Aventis Deutschland GmbH, Therapeut Dept Cardiovasc Dis, Ind Pk,Hoechst H824, D-65926 Frankfurt, Germany.	carsten.struebing@sanofi-aventis.com						Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bankaitis VA, 2005, ADV ENZYME REGUL, V45, P155, DOI 10.1016/j.advenzreg.2005.02.014; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; GRAZIANI A, 2010, BIOL CHEM, V285, P4213; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Griac P, 2006, BIOCHEM SOC T, V34, P377, DOI 10.1042/BST0340377; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Lee KP, 2005, MOL CELLS, V20, P435; Mery L, 2002, J CELL SCI, V115, P3497; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	39	39	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12426	12434		10.1074/jbc.M109.068304	http://dx.doi.org/10.1074/jbc.M109.068304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164195	hybrid, Green Published			2022-12-27	WOS:000276787100070
J	Wijeyewickrema, LC; Gardiner, EE; Gladigau, EL; Berndt, MC; Andrews, RK				Wijeyewickrema, Lakshmi C.; Gardiner, Elizabeth E.; Gladigau, Elsa L.; Berndt, Michael C.; Andrews, Robert K.			Nerve Growth Factor Inhibits Metalloproteinase-Disintegrins and Blocks Ectodomain Shedding of Platelet Glycoprotein VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); SNAKE-VENOM METALLOPROTEINASES; AMYLOID PRECURSOR PROTEIN; GAMMA-ESTERASE ACTIVITY; VON-WILLEBRAND-FACTOR; GPIB-IX-V; ALZHEIMERS-DISEASE; SUBUNIT INTERACTIONS; IB-ALPHA; IN-VITRO	Nerve growth factor (NGF) plays an important role in regulating mammalian neuronal/embryonic development, angiogenesis, and other physiological processes and has recently been investigated as a potential treatment for the neurodegenerative disorder, Alzheimer disease. In this study, we provide evidence that human NGF may also function as a metalloproteinase inhibitor, based on studies of NGF from snake venom. Originally, our aim was to isolate snake venom metalloproteinases targeting platelet receptors and/or ligands relevant to hemostasis and thrombosis, using Ni2+-agarose as a purification step based on the conserved metal ion-coordination motif in venom metalloproteinases. However, subsequent analysis of cobra (Naja kaouthia) venom led to the unexpected discovery that cobra venom NGF bound to Ni2+-agarose, eluting at similar to 15 mM imidazole, enabling a one-step purification. The identity of the purified protein was confirmed by mass spectrometry and N-terminal sequence analysis. Partial co-purification of NGF within metalloproteinase-enriched venom fractions led us to test whether NGF affected metalloproteinase activity. Venom NGF potently inhibited metalloproteinases isolated from the same or different venom and specifically bound to purified Nk metalloproteinase immobilized on agarose beads. Human NGF also interacted with human metalloproteinases because it blocked metalloproteinase-mediated shedding of the platelet collagen receptor, glycoprotein (GP) VI, and associated with recombinant ADAM10 by surface plasmon resonance. Together, these results suggest that NGF can function as a metalloproteinase inhibitor.	[Andrews, Robert K.] Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Monash University; Monash University	Andrews, RK (corresponding author), Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	rob.andrews@med.monash.edu.au	Wijeyewickrema, Lakshmi/A-9676-2015; Gardiner, Elizabeth/E-7774-2011; Gardiner, Elizabeth/P-8716-2019; Berndt, Michael C/D-5580-2012	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Gardiner, Elizabeth/0000-0001-9453-9688; Andrews, Robert Keith/0000-0001-9577-8082	National Health and Medical Research Council of Australia; Monash University	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University)	This work was supported by grants from the National Health and Medical Research Council of Australia and Monash University.	Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andrews RK, 2001, J BIOL CHEM, V276, P28092, DOI 10.1074/jbc.M011352200; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; ANDREWS RK, 2004, HDB PROTEOLYTIC ENZY, P696; Andrews RK, 2007, ARTERIOSCL THROM VAS, V27, P1511, DOI 10.1161/ATVBAHA.107.141390; Arthur JF, 2005, THROMB HAEMOSTASIS, V93, P716, DOI 10.1160/TH04-09-0584; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; Berndt MC, 2007, J THROMB HAEMOST, V5, P212, DOI 10.1111/j.1538-7836.2007.02484.x; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; COHEN S, 1959, J BIOL CHEM, V234, P1129; Cohen S, 2004, ANN NY ACAD SCI, V1038, P98, DOI 10.1196/annals.1315.017; Colciaghi F, 2004, NEUROLOGY, V62, P498, DOI 10.1212/01.WNL.0000106953.49802.9C; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DELUCA M, 1995, J BIOL CHEM, V270, P26734, DOI 10.1074/jbc.270.45.26734; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Gardiner EE, 2008, BLOOD, V111, P165, DOI 10.1182/blood-2007-04-086983; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Huang KF, 1998, BIOCHEM BIOPH RES CO, V248, P562, DOI 10.1006/bbrc.1998.9017; Kamiguti AS, 2005, TOXICON, V45, P1041, DOI 10.1016/j.toxicon.2005.02.026; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Laske C, 2008, J PSYCHIATR RES, V42, P746, DOI 10.1016/j.jpsychires.2007.07.017; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; PALMER TE, 1980, J BIOL CHEM, V255, P5170; RAO AG, 1984, J BIOL CHEM, V259, P73; Salehi A, 2004, J NEURAL TRANSM, V111, P323, DOI 10.1007/s00702-003-0091-x; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Villoslada P, 2004, PROG BRAIN RES, V146, P403; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wijeyewickrema LC, 2007, TOXICON, V50, P1064, DOI 10.1016/j.toxicon.2007.07.006; Wijeyewickrema LC, 2005, TOXICON, V45, P1051, DOI 10.1016/j.toxicon.2005.02.025	41	18	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11793	11799		10.1074/jbc.M110.100479	http://dx.doi.org/10.1074/jbc.M110.100479			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164177	Green Published, hybrid			2022-12-27	WOS:000276787100006
J	McNeish, J; Roach, M; Hambor, J; Mather, RJ; Weibley, L; Lazzaro, J; Gazard, J; Schwarz, J; Volkmann, R; Machacek, D; Stice, S; Zawadzke, L; O'Donnell, C; Hurst, R				McNeish, John; Roach, Marsha; Hambor, John; Mather, Robert J.; Weibley, Laura; Lazzaro, John; Gazard, Justin; Schwarz, Jacob; Volkmann, Robert; Machacek, David; Stice, Steve; Zawadzke, Laura; O'Donnell, Christopher; Hurst, Raymond			High-throughput Screening in Embryonic Stem Cell-derived Neurons Identifies Potentiators of alpha-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBJECT RECOGNITION TASK; AMPA RECEPTORS; POSITIVE MODULATION; IPS CELLS; HUMAN ES; DIFFERENTIATION; ACID; PROLIFERATION; HIPPOCAMPAL; EXPRESSION	Stem cell biology offers advantages to investigators seeking to identify new therapeutic molecules. Specifically, stem cells are genetically stable, scalable for molecular screening, and function in cellular assays for drug efficacy and safety. A key hurdle for drug discoverers of central nervous system disease is a lack of high quality neuronal cells. In the central nervous system, alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate (AMPA) subtype glutamate receptors mediate the vast majority of excitatory neurotransmissions. Embryonic stem (ES) cell protocols were developed to differentiate into neuronal sub-types that express AMPA receptors and were pharmacologically responsive to standard compounds for AMPA potentiation. Therefore, we hypothesized that stem cell-derived neurons should be predictive in high-throughput screens (HTSs). Here, we describe a murine ES cell-based HTS of a 2.4 x 10(6) compound library, the identification of novel chemical "hits" for AMPA potentiation, structure function relationship of compounds and receptors, and validation of chemical leads in secondary assays using human ES cell-derived neurons. This reporting of murine ES cell derivatives being formatted to deliver HTS of greater than 10(6) compounds for a specific drug target conclusively demonstrates a new application for stem cells in drug discovery. In the future new molecular entities may be screened directly in human ES or induced pluripotent stem cell derivatives.	[McNeish, John; Roach, Marsha; Hambor, John] Pfizer Global Res & Dev, Genetically Modified Models COE, Groton, CT 06340 USA; [Mather, Robert J.; Weibley, Laura; Lazzaro, John; Gazard, Justin; Zawadzke, Laura; Hurst, Raymond] Pfizer Global Res & Dev, Neurosci Biol, Groton, CT 06340 USA; [Schwarz, Jacob; Volkmann, Robert; O'Donnell, Christopher] Pfizer Global Res & Dev, Neurosci Chem, Groton, CT 06340 USA; [Machacek, David; Stice, Steve] ArunA Biomed, Athens, GA 30602 USA	Pfizer; Pfizer; Pfizer	McNeish, J (corresponding author), Pfizer Regenerat Med, 620 Mem Dr, Cambridge, MA 02139 USA.	john.d.mcneish@pfizer.com						Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Baumbarger PJ, 2001, J PHARMACOL EXP THER, V298, P86; Bertheleme N., 2008, Patent No. [WO 2008/113795 A1, 2008113795]; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bradley D. M., 2008, Patent No. [WO 2008/148832 A1, 2008148832]; Bradley D. M., 2008, Patent No. [WO 2008/148836 A1, 2008148836]; BRADLEY DM, 2007, Patent No. 2007107539; BRADLEY DM, 2008, Patent No. 2008110566; Cardullo F., 2008, [No title captured], Patent No. [WO 2008/053031 A1, 2008053031, 2008053031 A1]; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Desos P, 1996, J MED CHEM, V39, P197, DOI 10.1021/jm950323j; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; Francotte Pierre, 2006, Recent Pat CNS Drug Discov, V1, P239, DOI 10.2174/157488906778773661; Gillen K.J., 2008, Patent No. [WO 2008/003452 A1, 2008003452]; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Lang RJ, 2004, EUR J NEUROSCI, V20, P3209, DOI 10.1111/j.1460-9568.2004.03782.x; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Lebrun C, 2000, EUR J PHARMACOL, V401, P205, DOI 10.1016/S0014-2999(00)00429-5; LEVIN ED, 1988, NEUROSCI BIOBEHAV R, V12, P169, DOI 10.1016/S0149-7634(88)80008-3; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; Lynch G, 2004, CURR OPIN PHARMACOL, V4, P4, DOI 10.1016/j.coph.2003.09.009; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; Mackowiak M, 2002, NEUROPHARMACOLOGY, V43, P1, DOI 10.1016/S0028-3908(02)00066-7; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; McNeish JD, 2007, CURR OPIN PHARMACOL, V7, P515, DOI 10.1016/j.coph.2007.06.005; Miret JJ, 2005, J BIOMOL SCREEN, V10, P780, DOI 10.1177/1087057105279493; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; O'Neill MJ, 2007, IDRUGS, V10, P185; OLTON DS, 1987, PHYSIOL BEHAV, V40, P793, DOI 10.1016/0031-9384(87)90286-1; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Roach M L, 2002, Methods Mol Biol, V185, P1; Robas Nicola M, 2005, Methods Mol Biol, V306, P17; Rorick-Kehn LM, 2005, PSYCHOPHARMACOLOGY, V183, P226, DOI 10.1007/s00213-005-0169-2; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; ZIVKOVIC I, 1995, J PHARMACOL EXP THER, V272, P300	47	56	57	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17209	17217		10.1074/jbc.M109.098814	http://dx.doi.org/10.1074/jbc.M109.098814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20212047	Green Published, hybrid			2022-12-27	WOS:000277982600083
J	Walton, KL; Makanji, Y; Chen, J; Wilce, MC; Chan, KL; Robertson, DM; Harrison, CA				Walton, Kelly L.; Makanji, Yogeshwar; Chen, Justin; Wilce, Matthew C.; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.			Two Distinct Regions of Latency-associated Peptide Coordinate Stability of the Latent Transforming Growth Factor-beta 1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CAMURATI-ENGELMANN-DISEASE; DOMAIN-SPECIFIC MUTATIONS; MOLECULAR-WEIGHT COMPLEX; TGF-BETA; BINDING-PROTEIN; EXTRACELLULAR-MATRIX; OVARIAN FAILURE; HUMAN-PLATELETS; STRUCTURAL-CHARACTERIZATION	Transforming growth factor-beta 1 (TGF-beta 1) is secreted as part of an inactive complex consisting of the mature dimer, the TGF-beta 1 propeptide (latency-associated peptide (LAP)), and latent TGF-beta-binding proteins. Using in vitro mutagenesis, we identified the regions of LAP that govern the cooperative assembly and stability of the latent TGF-beta 1 complex. Initially, hydrophobic LAP residues (Ile(53), Leu(54), Leu(57), and Leu(59)), which form a contiguous epitope on one surface of an amphipathic alpha-helix, interact with mature TGF-beta 1 to form the small latent complex. TGF-beta 1 binding is predicted to alter LAP conformation, exposing ionic residues (Arg(45), Arg(50), Lys(56), and Arg(58)) on the other side of the alpha-helix, which form the binding site for latent TGF-beta-binding proteins. The stability of the resultant large latent complex is dependent upon covalent dimerization of LAP, which is facilitated by key residues (Phe(198), Asp(199), Val(200), Leu(208), Phe(217), and Leu(219)) at the dimer interface. Significantly, genetic mutations in LAP (e.g. R218H) that cause the rare bone disorder Camurati-Engelmann disease disrupted dimerization and reduced the stability of the latent TGF-beta 1 complex.	[Walton, Kelly L.; Makanji, Yogeshwar; Chen, Justin; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Chen, Justin; Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University	Harrison, CA (corresponding author), Prince Henrys Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	craig.harrison@princehenrys.org	Walton, Kelly/ABF-7282-2020; Chan, Karen/E-4041-2015	Walton, Kelly/0000-0003-0627-2958; Chan, Karen/0000-0001-9947-4713; Harrison, Craig/0000-0003-1059-3682	National Health and Medical Research Council of Australia [494804, 241000]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council of Australia Project 494804 (to C. A. H.) and Program Grant 241000 (to K. L. W. and D. M. R.) and by the Victorian Government's Operational Infrastructure Support Program.	Altmann CR, 2002, DEV BIOL, V248, P118, DOI 10.1006/dbio.2002.0716; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chen Y, 2005, J MOL BIOL, V345, P175, DOI 10.1016/j.jmb.2004.10.039; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; FROLIK CA, 1983, P NATL ACAD SCI-BIOL, V80, P3676, DOI 10.1073/pnas.80.12.3676; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Janssens K, 2003, J BIOL CHEM, V278, P7718, DOI 10.1074/jbc.M208857200; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Saito T, 2001, J BIOL CHEM, V276, P11469, DOI 10.1074/jbc.C000859200; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Thies RS, 2001, GROWTH FACTORS, V18, P251; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wu SL, 2007, BONE, V40, P1630, DOI 10.1016/j.bone.2007.02.025; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200; Zhao H, 2007, FERTIL STERIL, V88, P1474, DOI 10.1016/j.fertnstert.2007.01.021	61	71	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17029	17037		10.1074/jbc.M110.110288	http://dx.doi.org/10.1074/jbc.M110.110288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308061	Green Published, hybrid			2022-12-27	WOS:000277982600066
J	Chen, JQ; Li, Y; Pan, X; Lei, BK; Chang, C; Liu, ZX; Lu, H				Chen, Jian-Qiang; Li, Yang; Pan, Xian; Lei, Bing-Kun; Chang, Cheng; Liu, Zheng-Xun; Lu, Hong			The Fission Yeast Inhibitor of Growth (ING) Protein Png1p Functions in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4 ACETYLATION; DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; PHD FINGER; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; CELL-SEPARATION; REPAIR; ACETYLTRANSFERASE	In budding yeast and human cells, ING (inhibitor of growth) tumor suppressor proteins play important roles in response to DNA damage by modulating chromatin structure through collaborating with histone acetyltransferase or histone deacetylase complexes. However, the biological functions of ING family proteins in fission yeast are poorly defined. Here, we report that Png1p, a fission yeast ING homolog protein, is required for cell growth under normal and DNA-damaged conditions. Png1p was further confirmed to regulate histone H4acetylation through collaboration with the MYST family histone acetyltransferase 1 (Mst1). Additionally, both fission yeast PNG1 and MST1 can functionally complement their budding yeast correspondence homologs YNG2 and ESA1, respectively. These results suggest that ING proteins in fission yeast might also conserve function, similar to ING proteins in budding yeast and human cells. We also showed that decreased acetylation in Delta png1 cells resulted in genome-wide down-regulation of 756 open reading frames, including the central DNA repair gene RAD22. Overexpression of RAD22 partially rescued the png1 mutant phenotype under both normal and DNA-damaged conditions. Furthermore, decreased expression of RAD22 in Delta png1 cells was confirmed to be caused by decreased H4 acetylation at its promoter. Altogether, these results indicate that Png1p is required for histone H4 acetylation and functions upstream of RAD22 in the DNA damage response pathway.	[Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Lu, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	honglu0211@yahoo.com		Lei, Bingkun/0000-0002-2773-1669; /0000-0003-1726-3037	National Program on Key Basic Research [2009CB825601]; National Natural Science Foundation of China [30771145, 30671175]; Specialized Research Fund for the Doctoral Program of High Education (SRFDP) [20060246017]; Fudan University	National Program on Key Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of High Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fudan University	This work was supported by grants from the National Program on Key Basic Research Project (973 Program, 2009CB825601), the National Natural Science Foundation of China (30771145 and 30671175), the Specialized Research Fund for the Doctoral Program of High Education (SRFDP 20060246017), and the Innovation Fund of Fudan University.	Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CHLEBOWICZ E, 1979, MOL GEN GENET, V167, P279, DOI 10.1007/BF00267420; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Gomez EB, 2008, GENETICS, V179, P757, DOI 10.1534/genetics.107.085779; Gregan J, 2006, NAT PROTOC, V1, P2457, DOI 10.1038/nprot.2006.385; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim WJ, 2000, J BIOL CHEM, V275, P35607, DOI 10.1074/jbc.M007060200; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Minoda A, 2005, MOL BIOL CELL, V16, P316, DOI 10.1091/mbc.E04-06-0519; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nourani A, 2003, J BIOL CHEM, V278, P19171, DOI 10.1074/jbc.C300036200; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; OUSTRIN ML, 1995, BIOCHIMIE, V77, P279, DOI 10.1016/0300-9084(96)88137-5; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Saksouk N, 2008, CELL MOL LIFE SCI, V65, P1013, DOI 10.1007/s00018-008-7459-x; Shen L, 2003, FEBS LETT, V540, P86, DOI 10.1016/S0014-5793(03)00229-1; Shi XB, 2005, J CELL BIOCHEM, V96, P1127, DOI 10.1002/jcb.20625; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	45	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15786	15793		10.1074/jbc.M110.101832	http://dx.doi.org/10.1074/jbc.M110.101832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299455	hybrid, Green Published			2022-12-27	WOS:000277715900016
J	Sauliere-Nzeh, AN; Millot, C; Corbani, M; Mazeres, S; Lopez, A; Salome, L				Sauliere-Nzeh, Aude Ndong; Millot, Claire; Corbani, Maithe; Mazeres, Serge; Lopez, Andre; Salome, Laurence			Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANE; LIVING CELLS; LIPID RAFTS; FLUORESCENCE RECOVERY; SH-SY5Y CELLS; ENDOCYTOSIS; MECHANISMS; DESENSITIZATION; MICRODOMAINS	Techniques for analyzing the membrane diffusion of molecules are the most promising methods for investigating the compartmentalization of G-protein-coupled receptors, particularly as relevant to receptor signaling processes. Here, we report fluorescence recovery after photobleaching (FRAP) measurements performed at variable spot radius for human mu opioid (hMOP) receptors on SH-SY5Y neuroblastoma cells in the presence of ligands. Although an antagonist did not affect the behavior of the receptors compared with the basal state, two different agonists, DAMGO and morphine, caused markedly different changes to receptor diffusion. Like receptors in the absence of ligand, receptors bound to morphine exhibited diffusion confined to joined semipermeable domains, but with smaller domain size and diffusion coefficient. This effect was inhibited by pertussis toxin, strongly suggesting that this dynamic behavior is associated with early steps of signaling. In the presence of DAMGO, half of the receptors displayed free long-range diffusion and the other half were confined to smaller isolated domains. Hypertonic sucrose buffer suppressed this effect, which we attribute to receptor entry into clathrin-coated pits. It is likely that the observation of distinct receptor dynamics in the presence of DAMGO and morphine involves the agonist-selective phosphorylation of the receptor.	[Salome, Laurence] CNRS, IPBS, F-31077 Toulouse, France; Univ Toulouse, IPBS, UPS, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Salome, L (corresponding author), CNRS, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	laurence.salome@ipbs.fr		MAZERES, Serge/0000-0002-0263-634X; SALOME, Laurence/0000-0001-9667-4154	CNRS; MENESR	CNRS(Centre National de la Recherche Scientifique (CNRS)); MENESR	This work was supported by the CNRS and MENESR joint DRAB program.	Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; BELCHEVA MM, 1992, MOL PHARMACOL, V42, P445; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chidiac P, 1998, BIOCHEM PHARMACOL, V55, P549, DOI 10.1016/S0006-2952(97)00361-4; DAUMAS F, 2002, THESIS U P SABATIER; Destainville Nicolas, 2008, J Chem Biol, V1, P37, DOI 10.1007/s12154-008-0005-3; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Gaibelet G, 2008, MOL MEMBR BIOL, V25, P423, DOI 10.1080/09687680802203380; Hegener O, 2004, BIOCHEMISTRY-US, V43, P6190, DOI 10.1021/bi035928t; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Lopez A, 2009, CELL MOL LIFE SCI, V66, P2093, DOI 10.1007/s00018-009-0008-4; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; PRATHER PL, 1994, J PHARMACOL EXP THER, V270, P177; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	40	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14514	14520		10.1074/jbc.M109.076695	http://dx.doi.org/10.1074/jbc.M109.076695			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197280	Green Published, hybrid			2022-12-27	WOS:000277299700048
J	Voolstra, O; Beck, K; Oberegelsbacher, C; Pfannstiel, J; Huber, A				Voolstra, Olaf; Beck, Katherina; Oberegelsbacher, Claudia; Pfannstiel, Jens; Huber, Armin			Light-dependent Phosphorylation of the Drosophila Transient Receptor Potential Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; IN-VIVO; RETINAL DEGENERATION; POTASSIUM CHANNEL; TRP CHANNELS; GENE; MECHANISM; COMPLEX; DEACTIVATION; MAINTENANCE	The Drosophila phototransduction cascade terminates in the opening of an ion channel, designated transient receptor potential (TRP). TRP has been shown to become phosphorylated in vitro, suggesting regulation of the ion channel through post-translational modification. However, except for one phosphorylation site, Ser(982), which was analyzed by functional in vivo studies (Popescu, D. C., Ham, A. J., and Shieh, B. H. (2006) J. Neurosci. 26, 8570-8577), nothing is known about the role of TRP phosphorylation in vivo. Here, we report the identification of 21 TRP phosphorylation sites by a mass spectrometry approach. 20 phosphorylation sites are located in the C-terminal portion of the channel, and one site is located near the N terminus. All 21 phosphorylation sites were also identified in the inaC(P209) mutant, indicating that phosphorylation of TRP at these sites occurred independently from the eye-enriched protein kinase C. Relative quantification of phosphopeptides revealed that at least seven phosphorylation sites were predominantly phosphorylated in the light, whereas one site, Ser(936), was predominantly phosphorylated in the dark. We show that TRP phosphorylated at Ser(936) was located in the rhabomere. Light-dependent changes in the phosphorylation state of this site occurred within minutes. The dephosphorylation of TRP at Ser(936) required activation of the phototransduction cascade.	[Voolstra, Olaf] Univ Hohenheim, Dept Biosensor, Inst Physiol, D-70599 Stuttgart, Germany; [Pfannstiel, Jens; Huber, Armin] Univ Hohenheim, Life Sci Ctr, D-70599 Stuttgart, Germany	University Hohenheim; University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Dept Biosensor, Inst Physiol, Garbenstr 30, D-70599 Stuttgart, Germany.	voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	Deutsche Forschungsgemeinschaft [Hu 839/2-5]; German-Israeli Foundation [I 1001-96.13/2008]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft Grant Hu 839/2-5 and by German-Israeli Foundation for Scientific Research and Development Grant I 1001-96.13/2008.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hong YS, 2002, J BIOL CHEM, V277, P33884, DOI 10.1074/jbc.M204075200; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; KOMORI N, 1994, INSECT BIOCHEM MOLEC, V24, P607, DOI 10.1016/0965-1748(94)90097-3; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; Mecklenburg KL, 2010, J NEUROSCI, V30, P1238, DOI 10.1523/JNEUROSCI.4464-09.2010; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Minke B, 2006, ANNU REV PHYSIOL, V68, P649, DOI 10.1146/annurev.physiol.68.040204.100939; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Sadygov RG, 2006, ANAL CHEM, V78, P8207, DOI 10.1021/ac060923y; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	51	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14275	14284		10.1074/jbc.M110.102053	http://dx.doi.org/10.1074/jbc.M110.102053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215118	Green Published, hybrid			2022-12-27	WOS:000277299700024
J	Wang, XJ; Han, YX; Dang, Y; Fu, W; Zhou, T; Ptak, RG; Zheng, YH				Wang, Xiaojun; Han, Yanxing; Dang, Ying; Fu, William; Zhou, Tao; Ptak, Roger G.; Zheng, Yong-Hui			Moloney Leukemia Virus 10 (MOV10) Protein Inhibits Retrovirus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX RNA HELICASE; MESSENGER-RNAS; ANTIRETROVIRAL FACTOR; HIV-1 REPLICATION; ANTIVIRAL PROTEIN; STRESS GRANULES; HUMAN-CELLS; APOBEC3G; GENE; IDENTIFICATION	Moloney leukemia virus 10 (MOV10) protein is a superfamily-1 RNA helicase, and it is also a component of the RNA-induced silencing complex. Recent studies have shown that MOV10 plays an active role in the RNA interference pathway. Here, we report that MOV10 inhibits retrovirus replication. When it was overexpressed in viral producer cells, MOV10 was able to reduce the infectivity of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus, and murine leukemia virus. Conversely, when MOV10 expression was reduced by small interfering RNAs, HIV-1 infectivity was increased. Consistently, silencing of MOV10 expression in a human T cell line enhanced HIV-1 replication. Furthermore, we found that MOV10 interacts with HIV-1 nucleocapsid protein in an RNA-dependent manner and is packaged into virions. It blocks HIV-1 replication at a postentry step. In addition, we also found that HIV-1 could suppress MOV10 protein expression to counteract this cellular resistance. All of these results indicate that MOV10 has a broad antiretroviral activity that can target a wide range of retroviruses, and it could be actively involved in host defense against retroviral infection.	[Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Fu, William; Ptak, Roger G.] So Res Inst, Frederick, MD 21701 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Han, Yanxing/GRO-5138-2022; Zheng, Yong-Hui/AAP-4492-2021; Zhou, Tao/B-5757-2017	Zheng, Yong-Hui/0000-0002-1098-7385; Zhou, Tao/0000-0002-3648-9923; Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944, AI080225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063944, K02AI080225, R01AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 and AI080225 (to Y.-H.Z.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Han YX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002796; HARBERS K, 1982, NUCLEIC ACIDS RES, V10, P2521, DOI 10.1093/nar/10.8.2521; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindbo JA, 2005, ANNU REV PHYTOPATHOL, V43, P191, DOI 10.1146/annurev.phyto.43.040204.140228; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	36	89	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14346	14355		10.1074/jbc.M110.109314	http://dx.doi.org/10.1074/jbc.M110.109314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215113	Green Published, hybrid			2022-12-27	WOS:000277299700032
J	Zhang, ZY; Theler, D; Kaminska, KH; Hiller, M; de la Grange, P; Pudimat, R; Rafalska, I; Heinrich, B; Bujnicki, JM; Allain, FHT; Stamm, S				Zhang, Zhaiyi; Theler, Dominik; Kaminska, Katarzyna H.; Hiller, Michael; de la Grange, Pierre; Pudimat, Rainer; Rafalska, Ilona; Heinrich, Bettina; Bujnicki, Janusz M.; Allain, Frederic H.-T.; Stamm, Stefan			The YTH Domain Is a Novel RNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN; RECOGNITION; TRANSLATION; PREDICTION; SEQUENCES; SELECTION; DISPLAY; GENE	The YTH (YT521-B homology) domain was identified by sequence comparison and is found in 174 different proteins expressed in eukaryotes. It is characterized by 14 invariant residues within an alpha-helix/beta-sheet structure. Here we show that the YTH domain is a novel RNA binding domain that binds to a short, degenerated, single-stranded RNA sequence motif. The presence of the binding motif in alternative exons is necessary for YT521-B to directly influence splice site selection in vivo. Array analyses demonstrate that YT521-B predominantly regulates vertebrate-specific exons. An NMR titration experiment identified the binding surface for single-stranded RNA on the YTH domain. Structural analyses indicate that the YTH domain is related to the pseudouridine synthase and archaeosine transglycosylase (PUA) domain. Our data show that the YTH domain conveys RNA binding ability to a new class of proteins that are found in all eukaryotic organisms.	[Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Zhang, Zhaiyi; Rafalska, Ilona; Heinrich, Bettina] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Hiller, Michael; Pudimat, Rainer] Univ Freiburg, Bioinformat Grp, Inst Comp Sci, D-79110 Freiburg, Germany; [de la Grange, Pierre] Hop St Louis, Inst Univ Hematol, F-75010 Paris, France; [Theler, Dominik; Allain, Frederic H.-T.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Kaminska, Katarzyna H.; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, PL-02109 Warsaw, Poland; [Kaminska, Katarzyna H.; Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Bioinformat Lab, PL-61614 Poznan, Poland	University of Kentucky; University of Erlangen Nuremberg; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Stamm, S (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 Biomed & Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net	Kaminska, Katarzyna/C-8370-2011	Kaminska, Katarzyna/0000-0001-5726-6967	European Union; Deutsche Forschungsgemeinschaft; Swiss National Science Foundation National Center of Competence in Research Structural Biology	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation National Center of Competence in Research Structural Biology	This work was supported in part by the European Union (EURASNET) (to J. M. B., F.H.-T.A., and S. S.) and the Deutsche Forschungsgemeinschaft (to S. S.).; Supported by the Swiss National Science Foundation National Center of Competence in Research Structural Biology.	Arakaki T, 2006, ACTA CRYSTALLOGR F, V62, P175, DOI 10.1107/S1744309106005902; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Imai Y, 1998, MOL BRAIN RES, V53, P33, DOI 10.1016/S0169-328X(97)00262-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805; Lie YS, 1999, DEVELOPMENT, V126, P1129; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Rafalska I, 2004, HUM MOL GENET, V13, P1535, DOI 10.1093/hmg/ddh167; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; White EK, 2001, RNA, V7, P1855; Zuker M, 1994, Methods Mol Biol, V25, P267	30	161	170	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14701	14710		10.1074/jbc.M110.104711	http://dx.doi.org/10.1074/jbc.M110.104711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20167602	Green Published, hybrid			2022-12-27	WOS:000277299700068
J	Craig-Barnes, HA; Doumouras, BS; Palaniyar, N				Craig-Barnes, Hayley A.; Doumouras, Barbara S.; Palaniyar, Nades			Surfactant Protein D Interacts with alpha(2)-Macroglobulin and Increases Its Innate Immune Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; CYSTIC-FIBROSIS; BACTERIAL LIPOPOLYSACCHARIDES; HUMAN ALPHA-2-MACROGLOBULIN; BRONCHOALVEOLAR LAVAGE; LUNG COLLECTINS; RECOGNITION; ALPHA; FLUID; LOCALIZATION	Surfactant protein D (SP-D) is an innate immune collectin that recognizes microbes via its carbohydrate recognition domains, agglutinates bacteria, and forms immune complexes. During microbial infections, proteases, such as elastases, cleave the carbohydrate recognition domains and can inactivate the innate immune functions of SP-D. Host responses to counterbalance the reduction of SP-D-mediated innate immune response under these conditions are not clearly understood. We have unexpectedly identified that SP-D could interact with protein fractions containing ovomucin and ovomacroglobulin. Here, we show that SP-D interacts with human alpha(2)-macroglobulin (A2M), a protease inhibitor present in the lungs and serum. Using enzyme-linked immunosorbent assays, surface plasmon resonance, and carbohydrate competition assays, we show that SP-D interacts with A2M both in solid phase (K-D of 7.33 nM) and in solution via lectin-carbohydrate interactions under physiological calcium conditions. Bacterial agglutination assays further show that SP-D.A2M complexes increase the ability of SP-D to agglutinate bacteria. Western blot analyses show that SP-D, but not A2M, avidly binds bacteria. Interestingly, intact and activated A2M also protect SP-D against elastase-mediated degradation, and the cleaved A2M still interacts with SP-D and is able to enhance its agglutination abilities. We also found that SP-D and A2M can interact with each other in the airway-lining fluid. Therefore, we propose that SP-D utilizes a novel mechanism in which the collectin interacts with protease inhibitor A2M to decrease its degradation and to concurrently increase its innate immune function. These interactions particularly enhance bacterial agglutination and immune complex formation.	[Palaniyar, Nades] Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Palaniyar, N (corresponding author), Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	nades.palaniyar@sickkids.ca		Palaniyar, Nades/0000-0002-2170-8548	center for the study of the complex childhood diseases at the Hospital for Sick Children; Canadian Institutes of Health Research [MOP-84312]	center for the study of the complex childhood diseases at the Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	ProteON analyses were performed in the Analytical Laboratory for Bioactive Materials of the Canada Foundation for Innovation-funded center for the study of the complex childhood diseases at the Hospital for Sick Children.; This work was supported by Canadian Institutes of Health Research Grant MOP-84312 (to N.P.).	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Baker CS, 2000, RESPIRATION, V67, P533, DOI 10.1159/000067469; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Brinker KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1453, DOI 10.1152/ajplung.2001.281.6.L1453; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; ECCLESTON ED, 1985, J BIOL CHEM, V260, P169; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Haley KJ, 2002, AM J PHYSIOL-LUNG C, V282, pL573, DOI 10.1152/ajplung.00117.2001; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; HOWARD JB, 1983, ANN NY ACAD SCI, V421, P160, DOI 10.1111/j.1749-6632.1983.tb18106.x; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; LIM BL, 1994, J BIOL CHEM, V269, P11820; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mariencheck WI, 2003, AM J RESP CELL MOL, V28, P528, DOI 10.1165/rcmb.2002-0141OC; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; NIELSON DW, 1988, PEDIATR RES, V24, P322, DOI 10.1203/00006450-198809000-00009; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Russo TA, 2002, AM J PHYSIOL-LUNG C, V283, pL655, DOI 10.1152/ajplung.00071.2002; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2; von Bredow C, 2003, LUNG, V181, P79, DOI 10.1007/s00408-003-1008-z; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wang L, 2008, BIOCHEMISTRY-US, V47, P8103, DOI 10.1021/bi800626h; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; [No title captured]	47	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13461	13470		10.1074/jbc.M110.108837	http://dx.doi.org/10.1074/jbc.M110.108837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207732	Green Published, hybrid			2022-12-27	WOS:000276987700018
J	Francisco, AB; Singh, R; Li, SA; Vani, AK; Yang, L; Munroe, RJ; Diaferia, G; Cardano, M; Biunno, I; Qi, L; Schimenti, JC; Long, QM				Francisco, Adam B.; Singh, Rajni; Li, Shuai; Vani, Anish K.; Yang, Liu; Munroe, Robert J.; Diaferia, Giuseppe; Cardano, Marina; Biunno, Ida; Qi, Ling; Schimenti, John C.; Long, Qiaoming			Deficiency of Suppressor Enhancer Lin12 1 Like (SEL1L) in Mice Leads to Systemic Endoplasmic Reticulum Stress and Embryonic Lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; CELL-DEATH; SECRETORY PATHWAY; MESSENGER-RNA; ER; DEGRADATION; EXPRESSION; ALPHA-1-ANTITRYPSIN	Stress in the endoplasmic reticulum (ER) plays an important causal role in the pathogenesis of several chronic diseases such as Alzheimer, Parkinson, and diabetes mellitus. Insight into the genetic determinants responsible for ER homeostasis will greatly facilitate the development of therapeutic strategies for the treatment of these debilitating diseases. Suppressor enhancer Lin12 1 like (SEL1L) is an ER membrane protein and was thought to be involved in the quality control of secreted proteins. Here we show that the mice homozygous mutant for SEL1L were embryonic lethal. Electron microscopy studies revealed a severely dilated ER in the fetal liver of mutant embryos, indicative of alteration in ER homeostasis. Consistent with this, several ER stress responsive genes were significantly up-regulated in the mutant embryos. Mouse embryonic fibroblast cells deficient in SEL1L exhibited activated unfolded protein response at the basal state, impaired ER-associated protein degradation, and reduced protein secretion. Furthermore, markedly increased apoptosis was observed in the forebrain and dorsal root ganglions of mutant embryos. Taken together, our results demonstrate an essential role for SEL1L in protein quality control during mouse embryonic development.	[Francisco, Adam B.; Singh, Rajni; Li, Shuai; Vani, Anish K.; Long, Qiaoming] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14850 USA; [Yang, Liu; Qi, Ling] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA; [Munroe, Robert J.; Schimenti, John C.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA; [Diaferia, Giuseppe; Cardano, Marina] BioRep, I-20090 Milan, Italy; [Cardano, Marina] Univ Milan, Doctorate Sch Mol Med, I-20090 Milan, Italy; [Biunno, Ida] CNR, Inst Biomed Technol, I-20090 Milan, Italy	Cornell University; Cornell University; Cornell University; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Long, QM (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, 321 Morrison Hall,Tower Rd, Ithaca, NY 14850 USA.	ql39@cornell.edu	Diaferia, Giuseppe/AAN-5910-2020; Li, Shuai/ABD-5132-2021; Long, Qiaoming/L-5074-2017	Diaferia, Giuseppe/0000-0003-4022-8483; Li, Shuai/0000-0002-9574-9609; Long, Qiaoming/0000-0001-8243-589X; , IDA_2/0000-0002-1068-4763; Francisco, Adam B./0000-0001-8462-6569; Qi, Ling/0000-0001-8229-0184	College of Agricultural and Life Science, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	College of Agricultural and Life Science, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the College of Agricultural and Life Science, Cornell University (to Q. M. L.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Cattaneo M, 2004, GENE, V326, P149, DOI 10.1016/j.gene.2003.10.021; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oresic K, 2009, BIOSCIENCE REP, V29, P173, DOI 10.1042/BSR20080143; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Sommer T, 2002, DEV CELL, V3, P1, DOI 10.1016/S1534-5807(02)00210-1; Urano F, 2000, J CELL SCI, V113, P3697; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	56	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13694	13703		10.1074/jbc.M109.085340	http://dx.doi.org/10.1074/jbc.M109.085340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197277	hybrid, Green Published			2022-12-27	WOS:000276987700044
J	Milbradt, J; Webel, R; Auerochs, S; Sticht, H; Marschall, M				Milbradt, Jens; Webel, Rike; Auerochs, Sabrina; Sticht, Heinrich; Marschall, Manfred			Novel Mode of Phosphorylation-triggered Reorganization of the Nuclear Lamina during Nuclear Egress of Human Cytomegalovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PUL97; TO-TAIL POLYMERS; CELL-CYCLE; VIRAL-PROTEINS; CDC2 KINASE; WW-DOMAINS; IN-VITRO; INHIBITORS; INFECTION; PHASE	The nucleocytoplasmic egress of viral capsids is a rate-limiting step in the replication of the human cytomegalovirus (HCMV). As reported recently, an HCMV-specific nuclear egress complex is composed of viral and cellular proteins, in particular protein kinases with the capacity to induce destabilization of the nuclear lamina. Viral protein kinase pUL97 and cellular protein kinase C (PKC) play important roles by phosphorylating several types of nuclear lamins. Using pUL97 mutants, we show that the lamin-phosphorylating activity of pUL97 is associated with a reorganization of nuclear lamin A/C. Either pUL97 or PKC has the potential to induce distinct punctate lamina-depleted areas at the periphery of the nuclear envelope, which were detectable in transiently transfected and HCMV-infected cells. Using recombinant HCMV, which produces green fluorescent protein-labeled viral capsids, the direct transition of viral capsids through these areas could be visualized. This process was sensitive to an inhibitor of pUL97/PKC activity. The pUL97-mediated phosphorylation of lamin A/C at Ser(22) generated a novel binding motif for the peptidyl-prolyl cis/trans-isomerase Pin1. In HCMV-infected fibroblasts, the physiological localization of Pin1 was altered, leading to recruitment of Pin1 to viral replication centers and to the nuclear lamina. The local increase in Pin1 peptidyl-prolyl cis/trans-isomerase activity may promote conformational modulation of lamins. Thus, we postulate a novel phosphorylation-triggered mechanism for the reorganization of the nuclear lamina in HCMV-infected cells.	[Milbradt, Jens; Webel, Rike; Auerochs, Sabrina; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-95104 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Div Bioinformat, Inst Biochem, D-95104 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Marschall, M (corresponding author), Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Schlossgarten 4, D-95104 Erlangen, Germany.	manfred.marschall@viro.med.uni-erlangen.de		Sticht, Heinrich/0000-0001-5644-045X; Milbradt, Jens/0000-0003-2172-7471	Deutsche Forschungsgemeinschaft [SFB 796, MA 1289/4-1, MA 1289/6-1]; Argus Foundation (Berlin)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Argus Foundation (Berlin)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 796 (C3 and A2), MA 1289/4-1, and MA 1289/6-1 and by the Argus Foundation (Berlin).	Bain M, 2007, REV MED VIROL, V17, P423, DOI 10.1002/rmv.551; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; DREW WL, 1992, CLIN MICROBIOL REV, V5, P204, DOI 10.1128/CMR.5.2.204-210.1992; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Likhacheva E V, 2001, Membr Cell Biol, V14, P565; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Maul GG, 2008, MED MICROBIOL IMMUN, V197, P241, DOI 10.1007/s00430-008-0078-1; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Michel D, 1996, J VIROL, V70, P6340, DOI 10.1128/JVI.70.9.6340-6346.1996; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2002, SCIENCE, V297, P778, DOI 10.1126/science.1075102; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895	48	83	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13979	13989		10.1074/jbc.M109.063628	http://dx.doi.org/10.1074/jbc.M109.063628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202933	Green Published, hybrid			2022-12-27	WOS:000276987700072
J	Almeida-Souza, L; Goethals, S; de Winter, V; Dierick, I; Gallardo, R; Van Durme, J; Irobi, J; Gettemans, J; Rousseau, F; Schymkowitz, J; Timmerman, V; Janssens, S				Almeida-Souza, Leonardo; Goethals, Sofie; de Winter, Vicky; Dierick, Ines; Gallardo, Rodrigo; Van Durme, Joost; Irobi, Joy; Gettemans, Jan; Rousseau, Frederic; Schymkowitz, Joost; Timmerman, Vincent; Janssens, Sophie			Increased Monomerization of Mutant HSPB1 Leads to Protein Hyperactivity in Charcot-Marie-Tooth Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-CRYSTALLIN DOMAIN; A-CRYSTALLIN; SUBUNIT INTERACTIONS; CHAPERONE ACTIVITY; B-CRYSTALLIN; IN-VIVO; HSP27; MUTATION; DISSOCIATION	Small heat shock proteins are molecular chaperones capable of maintaining denatured proteins in a folding-competent state. We have previously shown that missense mutations in the small heat shock protein HSPB1 (HSP27) cause distal hereditary motor neuropathy and axonal Charcot-Marie-Tooth disease. Here we investigated the biochemical consequences of HSPB1 mutations that are known to cause peripheral neuropathy. In contrast to other chaperonopathies, our results revealed that particular HSPB1 mutations presented higher chaperone activity compared with wild type. Hyperactivation of HSPB1 was accompanied by a change from its wild-type dimeric state to a monomer without dissociation of the 24-meric state. Purification of protein complexes from wild-type and HSPB1 mutants showed that the hyperactive isoforms also presented enhanced binding to client proteins. Furthermore, we show that the wildtype HSPB1 protein undergoes monomerization during heat-shock activation, strongly suggesting that the monomer is the active form of the HSPB1 protein.	[Timmerman, Vincent] Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, CDE, B-2610 Antwerp, Belgium; [Gallardo, Rodrigo; Van Durme, Joost; Rousseau, Frederic; Schymkowitz, Joost] Vrije Univ Brussel, VIB Switch Lab, B-1050 Brussels, Belgium; [Gettemans, Jan] Univ Ghent, VIB Dept Med Prot Res, B-9000 Ghent, Belgium; [Gettemans, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Almeida-Souza, Leonardo; Goethals, Sofie; de Winter, Vicky; Dierick, Ines; Irobi, Joy; Timmerman, Vincent; Janssens, Sophie] Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Timmerman, V (corresponding author), Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, CDE, Univ Pl 1,Bldg 5, B-2610 Antwerp, Belgium.	vincent.timmerman@molgen.vib-ua.be; sophie.janssens@molgen.vib-ua.be	Timmerman, Vincent/O-7283-2019; Rousseau, Frederic/J-9044-2016; Janssens, Sophie/HHN-1756-2022; Almeida-Souza, Leonardo/C-3437-2011; Schymkowitz, Joost/AAV-3680-2021; Schymkowitz, Joost/K-7764-2016	Timmerman, Vincent/0000-0002-2162-0933; Rousseau, Frederic/0000-0002-9189-7399; Almeida-Souza, Leonardo/0000-0002-7169-1238; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth; Association Belge contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office [P6/43]; Institute for Science and Technology	University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth; Association Belge contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Institute for Science and Technology	This work was supported by the Methusalem program of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth, the "Association Belge contre les Maladies Neuromusculaires," and the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office.; Supported by a Ph.D. fellowship from the University of Antwerp.; Supported by a Ph.D. fellowship of the Institute for Science and Technology.; Postdoctoral researcher supported by the FWO-Flanders.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Borrelli MJ, 2002, CELL STRESS CHAPERON, V7, P281, DOI 10.1379/1466-1268(2002)007<0281:SPBAFH>2.0.CO;2; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cuesta R, 2000, GENE DEV, V14, P1460; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Guay J, 1997, J CELL SCI, V110, P357; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hilario E, 2006, ACTA CRYSTALLOGR F, V62, P446, DOI 10.1107/S174430910601219X; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Huot J, 1996, CANCER RES, V56, P273; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; LANDRY J, 1992, J BIOL CHEM, V267, P794; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P14627, DOI 10.1021/bi971700s; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perng MD, 2004, CURR BIOL, V14, pR625, DOI 10.1016/j.cub.2004.07.047; SALMON P, 2006, CURRENT PROTOCOLS NE; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	42	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12778	12786		10.1074/jbc.M109.082644	http://dx.doi.org/10.1074/jbc.M109.082644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178975	Green Published, hybrid			2022-12-27	WOS:000276787800036
J	Viana, AAB; Li, M; Schnell, DJ				Viana, Antonio A. B.; Li, Ming; Schnell, Danny J.			Determinants for Stop-transfer and Post-import Pathways for Protein Targeting to the Chloroplast Inner Envelope Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTION; PLASTIDS; TIC40; COMPONENTS; BACTERIAL; PEPTIDE; REGION; DOMAIN	The inner envelope membrane (IEM) of the chloroplast plays key roles in controlling metabolite transport between the organelle and cytoplasm and is a major site of lipid and membrane synthesis within the organelle. IEM biogenesis requires the import and integration of nucleus-encoded membrane proteins. Previous reports have led to the conclusion that membrane proteins are inserted into the IEM during protein import from the cytoplasm via a stop-transfer mechanism or are completely imported into the stroma and then inserted into the IEM in a post-import mechanism. In this study, we examined the determinants for each pathway by comparing the targeting of APG1 (albino or pale green mutant 1), an example of a stop-transfer substrate, and atTic40, an example of a post-import substrate. We show that the APG1 transmembrane domain is sufficient to direct stop-transfer insertion. The APG1 transmembrane domain also functions as a topology determinant. We also show that the ability of the post-import signals within atTic40 to target proteins to the IEM is dependent upon their context within the full protein sequence. In the incorrect context, the atTic40 signals can behave as stop-transfer signals or fail to target fusion proteins to the IEM. These data suggest that the post-import pathway signals are complex and have evolved to avoid stop-transfer insertion.	[Viana, Antonio A. B.; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Li, Ming] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Schnell, DJ (corresponding author), 710 N Pleasant St LGRT 914, Amherst, MA 01003 USA.	dschnell@biochem.umass.edu	Li, Ming/AAU-5026-2020; Viana, Antonio/F-5426-2011; Li, Ming/A-1493-2011	Li, Ming/0000-0002-1247-2377; Viana, Antonio/0000-0001-7011-1724; 	National Institutes of Health [GM-61893]; CAPES/Fulbright-Brazil fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES/Fulbright-Brazil fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-61893 (to D. J. S.). This work was also supported by a CAPES/Fulbright-Brazil fellowship (to A. A. B. V.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; BRINK S, 1995, J BIOL CHEM, V270, P20808, DOI 10.1074/jbc.270.35.20808; Chiu CC, 2008, PLANT J, V56, P793, DOI 10.1111/j.1365-313X.2008.03638.x; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; Firlej-Kwoka E, 2008, PLANT MOL BIOL, V68, P505, DOI 10.1007/s11103-008-9387-4; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jarvis P, 2004, CURR BIOL, V14, pR317, DOI 10.1016/j.cub.2004.03.054; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; KNIGHT JS, 1995, PLANT CELL, V7, P1421, DOI 10.1105/tpc.7.9.1421; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; LI HM, 1992, J BIOL CHEM, V267, P18999; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; SMITH MD, 2003, CURRENT PROTOCOLS CE; SOLL J, 1985, ARCH BIOCHEM BIOPHYS, V238, P290, DOI 10.1016/0003-9861(85)90167-5; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292	35	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12948	12960		10.1074/jbc.M110.109744	http://dx.doi.org/10.1074/jbc.M110.109744			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20194502	Green Published, hybrid			2022-12-27	WOS:000276787800053
J	Luscieti, S; Santambrogio, P; d'Estaintot, BL; Granier, T; Cozzi, A; Poli, M; Gallois, B; Finazzi, D; Cattaneo, A; Levi, S; Arosio, P				Luscieti, Sara; Santambrogio, Paolo; d'Estaintot, Beatrice Langlois; Granier, Thierry; Cozzi, Anna; Poli, Maura; Gallois, Bernard; Finazzi, Dario; Cattaneo, Angela; Levi, Sonia; Arosio, Paolo			Mutant Ferritin L-chains That Cause Neurodegeneration Act in a Dominant-negative Manner to Reduce Ferritin Iron Incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERFERRITINEMIA-CATARACT SYNDROME; LIGHT-POLYPEPTIDE GENE; H-CHAIN; HEREDITARY FERRITINOPATHY; ESCHERICHIA-COLI; CLINICAL-FEATURES; JAPANESE FAMILY; HELA-CELLS; MUTATION; NEUROFERRITINOPATHY	Nucleotide insertions that modify the C terminus of ferritin light chain (FTL) cause neurodegenerative movement disorders named neuroferritinopathies, which are inherited with dominant transmission. The disorders are characterized by abnormal brain iron accumulation. Here we describe the biochemical and crystallographic characterization of pathogenic FTL mutant p. Phe167SerfsX26 showing that it is a functional ferritin with an altered conformation of the C terminus. Moreover we analyze functional and stability properties of ferritin heteropolymers made of 20-23 H-chains and 1-4 L-chains with representative pathogenic mutations or the last 10-28 residues truncated. All the heteropolymers containing the pathogenic or truncated mutants had a strongly reduced capacity to incorporate iron, both when expressed in Escherichia coli, and in vitro when iron was supplied as Fe(III) in the presence of ascorbate. The mutations also reduced the physical stability of the heteropolymers. The data indicate that even a few mutated L-chains are sufficient to alter the permeability of 1-2 of the 6 hydrophobic channels and modify ferritin capacity to incorporate iron. The dominant-negative action of the mutations explains the dominant transmission of the disorder. The data support the hypothesis that hereditary ferritinopathies are due to alterations of ferritin functionality and provide new input on the mechanism of the function of isoferritins.	[Luscieti, Sara; Poli, Maura; Finazzi, Dario; Arosio, Paolo] Univ Brescia, Dipartimento Materno Infantile & Tecnol Biomed, I-25123 Brescia, Italy; [Santambrogio, Paolo; Cozzi, Anna; Levi, Sonia] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Cattaneo, Angela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [d'Estaintot, Beatrice Langlois; Granier, Thierry; Gallois, Bernard] Univ Bordeaux 1, UMR 5248, CNRS, F-33405 Talence, France; [Finazzi, Dario; Arosio, Paolo] AO Spedali Civili Brescia, Terzo Lab Anal Chim Clin, I-25123 Brescia, Italy; [Levi, Sonia] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University	Arosio, P (corresponding author), Univ Brescia, Dipartimento Materno Infantile & Tecnol Biomed, Viale Europa 11, I-25123 Brescia, Italy.	arosio@med.unibs.it	Luscieti, Sara/H-1324-2015; levi, sonia/A-3161-2015; finazzi, dario/GYV-1567-2022; Cozzi, Anna/AAN-3821-2020; arosio, paolo/E-6817-2010; arosio, paolo/S-3272-2019; Santambrogio, Paolo/AAN-3837-2020	Luscieti, Sara/0000-0002-3800-1303; levi, sonia/0000-0002-5092-0847; arosio, paolo/0000-0002-5343-8992; Santambrogio, Paolo/0000-0002-5481-2130; Finazzi, Dario/0000-0001-5176-2839	Telethon-Italia [GGP05141]; Fondazione [CARIPLO-2007]; European Community	Telethon-Italia(Fondazione Telethon); Fondazione(Fondazione CarifeFondazione Caritro); European Community(European Commission)	This work was supported in part by Telethon-Italia Grant GGP05141 (to S. L. and P. A.), Fondazione Grant CARIPLO-2007 (to S. L. and A. C.), and European Community Grant Euroiron1 (to P. A.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Baraibar MA, 2010, J BIOL CHEM, V285, P1950, DOI 10.1074/jbc.M109.042986; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; Brooks DG, 2002, INVEST OPHTH VIS SCI, V43, P1121; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Cozzi A, 2006, NEUROBIOL DIS, V23, P644, DOI 10.1016/j.nbd.2006.05.004; Cozzi A, 2010, NEUROBIOL DIS, V37, P77, DOI 10.1016/j.nbd.2009.09.009; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Gerardi G, 2005, BLOOD CELL MOL DIS, V35, P177, DOI 10.1016/j.bcmd.2005.06.002; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Infante AA, 2007, EXP CELL RES, V313, P1602, DOI 10.1016/j.yexcr.2007.02.021; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JAPPELLI R, 1992, J MOL BIOL, V227, P532, DOI 10.1016/0022-2836(92)90905-Y; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEVI S, 1994, J BIOL CHEM, V269, P30334; Levi S, 1998, BLOOD, V91, P4180, DOI 10.1182/blood.V91.11.4180.411k38_4180_4187; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; Santambrogio P, 1997, BIOCHEM J, V322, P461, DOI 10.1042/bj3220461; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294	48	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11948	11957		10.1074/jbc.M109.096404	http://dx.doi.org/10.1074/jbc.M109.096404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159981	Green Published, hybrid			2022-12-27	WOS:000276787100023
J	Yates, Z; Gunasekaran, K; Zhou, HX; Hu, ZH; Liu, Z; Ketchem, RR; Yan, BX				Yates, Zac; Gunasekaran, Kannan; Zhou, Hongxing; Hu, Zhonghua; Liu, Zhi; Ketchem, Randal R.; Yan, Boxu			Histidine Residue Mediates Radical-induced Hinge Cleavage of Human IgG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-FUNCTIONAL CALCULATIONS; COUPLED ELECTRON-TRANSFER; EPR CONTINUOUS-FLOW; COMPLEMENT ACTIVATION; SEGMENTAL FLEXIBILITY; EFFECTOR FUNCTION; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION; PROTEINS; PEPTIDES	Hydroxyl radicals induce hinge cleavage in a human IgG1 molecule via initial radical formation at the first hinge Cys(231) followed by electron transfer to the upper hinge residues. To enable engineering of a stable monoclonal antibody hinge, we investigated the role of the hinge His(229) residue using structure modeling and site-directed mutagenesis. Direct involvement of His(229) in the reaction mechanism is suggested by a 75-85% reduction of the hinge cleavage for variants in which His(229) was substituted with either Gln, Ser, or Ala. In contrast, mutation of Lys(227) to Gln, Ser, or Ala increased hinge cleavage. However, the H229S/K227S double mutant shows hinge cleavage levels similar to that of the single H229S variant, further revealing the importance of His(229). Examination of the hinge structure shows that His(229) is capable of forming hydrogen bonds with surrounding residues. These observations led us to hypothesize that the imidazole ring of His(229) may function to facilitate the cleavage by forming a transient radical center that is capable of extracting a proton from neighboring residues. The work presented here suggests the feasibility of engineering a new generation of monoclonal antibodies capable of resisting hinge cleavage to improve product stability and efficacy.	[Yates, Zac; Yan, Boxu] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA; [Gunasekaran, Kannan; Zhou, Hongxing; Hu, Zhonghua; Liu, Zhi; Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen	Yan, BX (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA.	yan.boxu@gene.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682				BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Coloma MJ, 1997, J IMMUNOL, V158, P733; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DEAN RT, 1989, FREE RADICAL RES COM, V7, P97, DOI 10.3109/10715768909087929; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Giese B, 2008, CURR OPIN CHEM BIOL, V12, P755, DOI 10.1016/j.cbpa.2008.08.026; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Hawkins CL, 1997, BBA-MOL BASIS DIS, V1360, P84, DOI 10.1016/S0925-4439(96)00069-5; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lassmann G, 2000, J PHYS CHEM A, V104, P9144, DOI 10.1021/jp001437w; Lassmann G, 1999, J PHYS CHEM A, V103, P1283, DOI 10.1021/jp9843454; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Michels DA, 2007, ANAL CHEM, V79, P5963, DOI 10.1021/ac0705521; Navaratnam S, 1998, J CHEM SOC FARADAY T, V94, P2577, DOI 10.1039/a803477j; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; RAO PS, 1975, J PHYS CHEM-US, V79, P1260, DOI 10.1021/j100580a006; Reece SY, 2007, J AM CHEM SOC, V129, P8500, DOI 10.1021/ja0704434; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; RODGERS MAJ, 1970, BIOCHEM BIOPH RES CO, V40, P622, DOI 10.1016/0006-291X(70)90949-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TAN LK, 1990, P NATL ACAD SCI USA, V87, P162, DOI 10.1073/pnas.87.1.162; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147	38	23	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18662	18671		10.1074/jbc.M110.108597	http://dx.doi.org/10.1074/jbc.M110.108597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20304919	hybrid, Green Published			2022-12-27	WOS:000278453900059
J	Amezcua-Romero, JC; Pantoja, O; Vera-Estrella, R				Amezcua-Romero, Julio C.; Pantoja, Omar; Vera-Estrella, Rosario			Ser(123) Is Essential for the Water Channel Activity of McPIP2;1 from Mesembryanthemum crystallinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE AQUAPORINS; DEPENDENT PROTEIN-KINASE; MAJOR INTRINSIC PROTEIN; PHYSIOLOGICAL FUNCTIONS; PHYSCOMITRELLA-PATENS; SOYBEAN NODULIN-26; PHOSPHORYLATION; GLYCEROL; PERMEABILITY; TRANSPORT	The increased expression of McPIP2;1 (MipC), a root-specific aquaporin (AQP) from Mesembryanthemum crystallinum, under salt stress has suggested a role for this AQP in the salt tolerance of the plant. However, whether McPIP2;1 transports water or another solute and how its activity is regulated are so far unknown. Therefore, wild type (wt) or mutated McPIP2;1 protein was expressed in Xenopus laevis oocytes. Then, the osmotic water permeability (P-f) of the oocytes membrane was assessed by hypotonic challenges. Selectivity of McPIP2;1 to water was determined by radiolabeled glycerol or urea uptake assays. Moreover, swelling and in vitro phosphorylation assays revealed that both water permeation and phosphorylation status of McPIP2;1 were significantly increased by the phosphorylation agonists okadaic acid (OA), phorbol myristate acetate (PMA), and 8-Br-cAMP, and markedly decreased by the inhibitory peptides PKI 14-22 and PKC 20-28, inhibitors of protein kinases A (PKA) and C (PKC), respectively. Substitution of Ser(123) or both, Ser123 and Ser(282), abolished the water channel activity of McPIP2;1 while substitution of Ser(282) only partially inhibited it (51.9% inhibition). Despite lacking Ser(123) and/or Ser(282), the McPIP2;1 mutant forms were still phosphorylated in vitro, which suggests that phosphorylation may have a dual role on this AQP. Our results indicate that McPIP2;1 water permeability depends completely on Ser(123) and is positively regulated by PKA- and PKC-mediated phosphorylation. Regulation of the phosphorylation status of McPIP2;1 may contribute to control water transport through root cells when the plant is subjected to high salinity conditions.	[Amezcua-Romero, Julio C.; Pantoja, Omar; Vera-Estrella, Rosario] Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Vera-Estrella, R (corresponding author), Apdo Postal 510-3,Col Miraval, Cuernavaca, Morelos, Mexico.	rosario@ibt.unam.mx	Pantoja, Omar/H-5981-2012	Pantoja, Omar/0000-0002-6538-9059	DGAPA [IN221308]; CONACYT [57685]	DGAPA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by DGAPA IN221308 and CONACYT 57685 (to R. V.-E.).	Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Daniels MJ, 2005, BIOCHEMISTRY-US, V44, P14443, DOI 10.1021/bi050565d; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustavsson S, 2005, PLANT PHYSIOL, V139, P287, DOI 10.1104/pp.105.063198; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HEI YJ, 1991, MOL PHARMACOL, V39, P233; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; JOHNSON KD, 1992, PLANT PHYSIOL, V100, P1787, DOI 10.1104/pp.100.4.1787; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Katsuhara M, 2008, PFLUG ARCH EUR J PHY, V456, P687, DOI 10.1007/s00424-007-0434-9; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kirch HH, 2000, PLANT PHYSIOL, V123, P111, DOI 10.1104/pp.123.1.111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; MIAO GH, 1992, J CELL BIOL, V118, P481, DOI 10.1083/jcb.118.2.481; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Vera-Estrella R., 2000, MOL BIOL PHYSL WATER, P339; Wallace IS, 2005, BIOCHEMISTRY-US, V44, P16826, DOI 10.1021/bi0511888; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035	50	10	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16739	16747		10.1074/jbc.M109.053850	http://dx.doi.org/10.1074/jbc.M109.053850			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20332086	Green Published, hybrid			2022-12-27	WOS:000277982600037
J	Pisterzi, LF; Jansma, DB; Georgiou, J; Woodside, MJ; Chou, JTC; Angers, S; Raicu, V; Wells, JW				Pisterzi, Luca F.; Jansma, David B.; Georgiou, John; Woodside, Michael J.; Chou, Judy Tai-Chieh; Angers, Stephane; Raicu, Valerica; Wells, James W.			Oligomeric Size of the M-2 Muscarinic Receptor in Live Cells as Determined by Quantitative Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HIGHER-ORDER OLIGOMERS; CHOLINERGIC-RECEPTOR; ACETYLCHOLINE-RECEPTOR; LIVING CELLS; SIGNALING COMPLEXES; CALCIUM-PHOSPHATE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MULTIPLE STATES	Fluorescence resonance energy transfer (FRET), measured by fluorescence intensity-based microscopy and fluorescence lifetime imaging, has been used to estimate the size of oligomers formed by the M-2 muscarinic cholinergic receptor. The approach is based on the relationship between the apparent FRET efficiency within an oligomer of specified size (n) and the pairwise FRET efficiency between a single donor and a single acceptor (E). The M-2 receptor was fused at the N terminus to enhanced green or yellow fluorescent protein and expressed in Chinese hamster ovary cells. Emission spectra were analyzed by spectral deconvolution, and apparent efficiencies were estimated by donor-dequenching and acceptor-sensitized emission at different ratios of enhanced yellow fluorescent protein-M-2 receptor to enhanced green fluorescent protein-M-2 receptor. The data were interpreted in terms of a model that considers all combinations of donor and acceptor within a specified oligomer to obtain fitted values of E as follows: n = 2, 0.495 +/- 0.019; n = 4, 0.202 +/- 0.010; n = 6, 0.128 +/- 0.006; n = 8, 0.093 +/- 0.005. The pairwise FRET efficiency determined independently by fluorescence lifetime imaging was 0.20-0.24, identifying the M-2 receptor as a tetramer. The strategy described here yields an explicit estimate of oligomeric size on the basis of fluorescence properties alone. Its broader application could resolve the general question of whether G protein-coupled receptors exist as dimers or larger oligomers. The size of an oligomer has functional implications, and such information can be expected to contribute to an understanding of the signaling process.	[Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Raicu, Valerica] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Pisterzi, Luca F.; Chou, Judy Tai-Chieh; Angers, Stephane; Wells, James W.] Univ Toronto, Leslie L Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Jansma, David B.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Georgiou, John] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodside, Michael J.] Hosp Sick Children, Imaging Facil, Toronto, ON M5G 1X8, Canada	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Raicu, V (corresponding author), Univ Wisconsin, Dept Phys, POB 413, Milwaukee, WI 53211 USA.	vraicu@uwm.edu; jwells@phm.utoronto.ca	Angers, Stephane/E-1432-2014; Georgiou, John/E-9873-2013; Georgiou, John/ABA-1687-2020	Angers, Stephane/0000-0001-7241-9044; Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384	Canadian Institutes of Health Research [MOP 43990, MOP 97978]; Heart and Stroke Foundation of Ontario [T5650, T6280]; University of Wisconsin-Milwaukee Research Growth Initiative; Wisconsin Institute for Biomedical and Health Technologies	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Wisconsin-Milwaukee Research Growth Initiative; Wisconsin Institute for Biomedical and Health Technologies	This work was supported in part by the Canadian Institutes of Health Research Grants MOP 43990 and MOP 97978 (to J. W. W.), the Heart and Stroke Foundation of Ontario Grants T5650 and T6280 (to J. W. W.), the University of Wisconsin-Milwaukee Research Growth Initiative (to V. R.), and the Wisconsin Institute for Biomedical and Health Technologies (to V. R.).	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BERRIE CP, 1979, BIOCHEM BIOPH RES CO, V87, P1000, DOI 10.1016/S0006-291X(79)80006-6; BIRDSALL NJM, 1977, ADV BEHAV BIOL, V24, P25; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Chowdhury EH, 2003, ANAL BIOCHEM, V314, P316, DOI 10.1016/S0003-2697(02)00648-6; Colozo AT, 2007, BIOCHEM PHARMACOL, V74, P236, DOI 10.1016/j.bcp.2007.04.009; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dinant C, 2008, J MICROSC-OXFORD, V231, P97, DOI 10.1111/j.1365-2818.2008.02020.x; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Gazi L, 2003, EUR J BIOCHEM, V270, P3928, DOI 10.1046/j.1432-1033.2003.03773.x; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Green MA, 1997, BIOCHEMISTRY-US, V36, P7380, DOI 10.1021/bi961940s; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Heim R, 1999, METHOD ENZYMOL, V302, P408, DOI 10.1016/S0076-6879(99)02036-4; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P445; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Ma DB, 2004, BIOTECHNOL LETT, V26, P1441, DOI 10.1023/B:BILE.0000045648.00893.c8; MATTERA R, 1985, J BIOL CHEM, V260, P7410; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Park P, 2001, EUR J PHARMACOL, V421, P11, DOI 10.1016/S0014-2999(01)00998-0; Park PSH, 2004, J NEUROCHEM, V90, P537, DOI 10.1111/j.1471-4159.2004.02536.x; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Pathak A, 2005, INT J OBESITY, V29, P176, DOI 10.1038/sj.ijo.0802751; PETERSON GL, 1984, PREP BIOCHEM, V14, P33, DOI 10.1080/10826068408070612; PISTERZI LF, 2009, BIOPHYS J, V96, pA169; Raicu V, 2005, BIOCHEM J, V385, P265, DOI 10.1042/BJ20040226; RAICU V, 2006, P SPIE IMAGING MANIP, V4; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; RASBAND WS, 1997, IMAGEJ VERSION 1 41K; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; SHIOZAKI K, 1992, BIOCHEMISTRY-US, V31, P10634, DOI 10.1021/bi00158a028; Skrabanek L, 2003, NUCLEIC ACIDS RES, V31, P3856, DOI 10.1093/nar/gkg552; Sum CS, 2001, BIOCHEM PHARMACOL, V62, P829; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; Weill C, 1999, J NEUROCHEM, V73, P791, DOI 10.1046/j.1471-4159.1999.0730791.x; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	73	60	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16723	16738		10.1074/jbc.M109.069443	http://dx.doi.org/10.1074/jbc.M109.069443			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304928	Green Published, hybrid			2022-12-27	WOS:000277982600036
J	Burke, JR; Deshong, AJ; Pelton, JG; Rubin, SM				Burke, Jason R.; Deshong, Alison J.; Pelton, Jeffrey G.; Rubin, Seth M.			Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; TUMOR-SUPPRESSOR; CELL-CYCLE; TRANSCRIPTION FACTOR; IMPROVED SENSITIVITY; GROWTH SUPPRESSION; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; STRUCTURAL BASIS; PRB	Inactivation of the retinoblastoma protein (Rb) through phosphorylation is an important step in promoting cell cycle progression, and hyperphosphorylated Rb is commonly found in tumors. Rb phosphorylation prevents its association with the E2F transcription factor; however, the molecular basis for complex inhibition has not been established. We identify here the key phosphorylation events and conformational changes that occur in Rb to inhibit the specific association between the E2F transactivation domain (E2F(TD)) and the Rb pocket domain. Calorimetry assays demonstrate that phosphorylation of Rb reduces the affinity of E2F(TD) binding similar to 250-fold and that phosphorylation at Ser(608)/Ser(612) and Thr(356)/Thr(373) is necessary and sufficient for this effect. An NMR assay identifies phosphorylation-driven conformational changes in Rb that directly inhibit E2F(TD) binding. We find that phosphorylation at Ser(608)/Ser(612) promotes an intramolecular association between a conserved sequence in the flexible pocket linker and the pocket domain of Rb that occludes the E2F(TD) binding site. We also find that phosphorylation of Thr(356)/Thr(373) inhibits E2F(TD) binding in a manner that requires the Rb N-terminal domain. Taken together, our results suggest two distinct mechanisms for how phosphorylation of Rb modulates association between E2F(TD) and the Rb pocket and describe for the first time a function for the structured N-terminal domain in Rb inactivation.	[Burke, Jason R.; Deshong, Alison J.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Pelton, Jeffrey G.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94706 USA	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley	Rubin, SM (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	srubin@ucsc.edu		Rubin, Seth/0000-0002-1670-4147; Burke, Jason/0000-0002-2572-8298	National Institutes of Health [CA132685, GM68933, SS10-RR20939]; NATIONAL CANCER INSTITUTE [R01CA132685] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132685 (to S. M. R.) and GM68933 (to support the Central California 900-MHz facility), and SS10-RR20939 (to support the University of California Santa Cruz mass spectrometry facility).	Adams P.D., 2001, BIOCHIM BIOPHYS ACTA, V1471, P123; Brown VD, 1999, MOL CELL BIOL, V19, P3246; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FATTAEY A, 1993, PHILOS T ROY SOC B, V340, P333, DOI 10.1098/rstb.1993.0075; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; HIEBERT SW, 1993, MOL CELL BIOL, V13, P3384, DOI 10.1128/MCB.13.6.3384; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Lents NH, 2006, CELL CYCLE, V5, P1699, DOI 10.4161/cc.5.15.3126; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Russo AA, 1997, METHOD ENZYMOL, V283, P3; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	37	96	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16286	16293		10.1074/jbc.M110.108167	http://dx.doi.org/10.1074/jbc.M110.108167			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223825	Green Published, hybrid			2022-12-27	WOS:000277715900065
J	Nakamura, T; Hayashi, T; Mimori-Kiyosue, Y; Sakaue, F; Matsuura, K; Iemura, S; Natsume, T; Akiyama, T				Nakamura, Tsutomu; Hayashi, Tomoatsu; Mimori-Kiyosue, Yuko; Sakaue, Fumika; Matsuura, Ken; Iemura, Shun-ichiro; Natsume, Toru; Akiyama, Tetsu			The PX-RICS-14-3-3 zeta/theta Complex Couples N-cadherin-beta-Catenin with Dynein-Dynactin to Mediate Its Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; MEMBRANE DYNAMICS; 14-3-3 PROTEINS; PX-RICS; TRANSPORT; GABARAP; EXIT; PHOSPHOINOSITIDES; IDENTIFICATION; LOCALIZATION	We have recently shown that beta-catenin-facilitated export of cadherins from the endoplasmic reticulum requires PX-RICS, a beta-catenin-interacting GTPase-activating protein for Cdc42. Here we show that PX-RICS interacts with isoforms of 14-3-3 and couples the N-cadherin-beta-catenin complex to the microtubule-based molecular motor dynein-dynactin. Similar to knockdown of PX-RICS, knockdown of either 14-3-3 zeta or -theta resulted in the disappearance of N-cadherin and beta-catenin from the cell-cell boundaries. Furthermore, we found that PX-RICS and 14-3-3 zeta/theta are present in a large multiprotein complex that contains dynein-dynactin components as well as N-cadherin and beta-catenin. Both RNAi- and dynamitin-mediated inhibition of dynein-dynactin function also led to the absence of N-cadherin and beta-catenin at the cell-cell contact sites. Our results suggest that the PX-RICS-14-3-3 zeta/theta complex links the N-cadherin-beta-catenin cargo with the dynein-dynactin motor and thereby mediates its endoplasmic reticulum export.	[Nakamura, Tsutomu; Hayashi, Tomoatsu; Sakaue, Fumika; Matsuura, Ken; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan; [Mimori-Kiyosue, Yuko] RIKEN Ctr Dev Biol, Opt Image Anal Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Iemura, Shun-ichiro; Natsume, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Nakamura, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	nakamura@iam.u-tokyo.ac.jp	Mimori-Kiyosue, Yuko/K-9158-2015; Natsume, Tohru/M-7627-2018	Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Natsume, Tohru/0000-0002-1510-2582; Sakaue, Fumika/0000-0003-1364-8730	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on Priority Areas, Cell Innovation, Genome Network Project, and in part by the Global Centers of Excellence (COE) Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; GALLIN WJ, 1983, P NATL ACAD SCI-BIOL, V80, P1038, DOI 10.1073/pnas.80.4.1038; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hayashi T, 2007, GENES CELLS, V12, P929, DOI 10.1111/j.1365-2443.2007.01101.x; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kurth T, 1999, DEV DYNAM, V215, P155, DOI 10.1002/(SICI)1097-0177(199906)215:2<155::AID-DVDY8>3.0.CO;2-S; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MUKHERJI S, 1995, J BIOL CHEM, V270, P14062, DOI 10.1074/jbc.270.23.14062; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; PEYRIERAS N, 1983, P NATL ACAD SCI-BIOL, V80, P6274, DOI 10.1073/pnas.80.20.6274; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	40	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16145	16154		10.1074/jbc.M109.081315	http://dx.doi.org/10.1074/jbc.M109.081315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308060	Green Published, hybrid			2022-12-27	WOS:000277715900052
J	Li, PP; Lu, M; Nguyen, MTA; Bae, EJ; Chapman, J; Feng, DR; Hawkins, M; Pessin, JE; Sears, DD; Nguyen, AK; Amidi, A; Watkins, SM; Nguyen, U; Olefsky, JM				Li, Pingping; Lu, Min; Nguyen, M. T. Audrey; Bae, Eun Ju; Chapman, Justin; Feng, Daorong; Hawkins, Meredith; Pessin, Jeffrey E.; Sears, Dorothy D.; Nguyen, Anh-Khoi; Amidi, Arezou; Watkins, Steven M.; Nguyen, UyenThao; Olefsky, Jerrold M.			Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; HEPATIC STEATOSIS; SKELETAL-MUSCLE; FATTY-ACIDS; ADIPOCYTE DEATH; GENE-EXPRESSION; FACTOR-ALPHA; CRUCIAL ROLE; T-CELLS	Obesity represents a state of chronic, low grade inflammation and is associated with infiltration of increased numbers of adipose tissue macrophages (ATMs). Diet-induced obesity leads to an increase in non-inflammatory M1-like ATMs displaying the CD11c surface marker. We assessed the function of CD11c-positive ATMs when insulin resistant high fat diet (HFD) mice become insulin-sensitive after switching from HFD to normal chow (NC). HFD mice rapidly become insulin-sensitive in all major insulin-target tissues, including muscle, liver, and adipose tissue, after the diet switch. In adipose tissue the CD11c-positive macrophages remain constant in number despite the presence of insulin sensitivity, but these macrophages now assume a new phenotype in which they no longer exhibit increased inflammatory pathway markers. Adipose tissue markers of apoptosis and necrosis were elevated on HFD and remain high after the HFD -> NC diet switch. Furthermore, ATM accumulation preceded detectable adipocyte necrosis at the early phase of HFD. Together, these results indicate that 1) CD11c-positive M1-like ATMs can exhibit phenotypic plasticity and that the polarization of these cells between inflammatory and non-inflammatory states is well correlated to the presence of absence of insulin resistance, and 2) adipocyte necrosis and apoptosis can be dissociated from ATM accumulation.	[Sears, Dorothy D.; Nguyen, Anh-Khoi; Amidi, Arezou] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Chapman, Justin] Pfizer Inc, San Diego, CA 92121 USA; [Feng, Daorong; Hawkins, Meredith; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Watkins, Steven M.; Nguyen, UyenThao] Lipom Technol Inc, W Sacramento, CA 95691 USA	University of California System; University of California San Diego; Pfizer; Yeshiva University; Albert Einstein College of Medicine	Olefsky, JM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019; Sears, Dorothy D/AHE-5524-2022	Li, Pingping/0000-0003-0679-270X; Sears, Dorothy D/0000-0002-9260-3540	National Institutes of Health [DK033651, DK074868, DK063491, DK020541, DK048321]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048321, R01DK033651, R37DK033651, P60DK020541, P30DK063491, P01DK074868, P30DK020541, R37DK048321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033651, DK074868, DK063491, DK020541, and DK048321 and Eunice Kennedy Shriver NICHD/National Institutes of Health Cooperative Agreement U54 HD 012303 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kusunoki M, 2003, METABOLISM, V52, P30, DOI 10.1053/meta.2003.50012; Lee JY, 2006, MOL CELLS, V21, P174; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lo CJ, 1999, J SURG RES, V82, P216, DOI 10.1006/jsre.1998.5524; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; MEYDANI SN, 1993, J CLIN INVEST, V92, P105, DOI 10.1172/JCI116537; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	50	176	185	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15333	15345		10.1074/jbc.M110.100263	http://dx.doi.org/10.1074/jbc.M110.100263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308074	Green Published, hybrid			2022-12-27	WOS:000277399000054
J	Mohan, SK; Rani, SG; Yu, C				Mohan, Sepuru K.; Rani, Sandhya G.; Yu, Chin			The Heterohexameric Complex Structure, a Component in the Non-classical Pathway for Fibroblast Growth Factor 1 (FGF1) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SHOCK IN-VITRO; BINDING-AFFINITY; MAMMALIAN-CELLS; SYNAPTOTAGMIN-I; RELEASE COMPLEX; PLASMA-MEMBRANE; TERMINAL DOMAIN; KEY COMPONENT; NMR	Fibroblast growth factors (FGFs) are key regulators of cell proliferation, tumor-induced angiogenesis, and migration. FGFs are essential for early embryonic development, organ formation, and angiogenesis. FGF1 also plays an important role in inflammation, wound healing, and restenosis. The biological effects of FGF1 are mediated through the activation of the four transmembrane phosphotyrosine kinase fibroblast growth factor receptors in the presence of heparin sulfate proteoglycans and, therefore, require the release of the protein into the extracellular space. FGF1 is exported through a non-classical release pathway involving the formation of a specific multiprotein complex. The protein constituents of this complex include FGF1, S100A13, and the p40 form of synaptotagmin 1 (Syt1). Because FGF1 plays an important role in tumor formation, it is clear that preventing the formation of the multiprotein complex would be an effective strategy to inhibit a wide range of cancers. To understand the molecular events in the FGF1 release pathway, we studied the FGF1-S100A13 tetrameric and FGF1-S100A13-C2A hexameric complex structures, which are both complexes possibly formed during the non-classical pathway of FGF1 release.	[Mohan, Sepuru K.; Rani, Sandhya G.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Science Council of Taiwan [NSC 98-2113-M-007-018-MYZ]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant NSC 98-2113-M-007-018-MYZ.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Arunkumar AI, 2002, PROTEIN SCI, V11, P1050, DOI 10.1110/ps.2270102; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhattacharya S, 2003, STRUCTURE, V11, P738, DOI 10.1016/S0969-2126(03)00132-1; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Carreira CM, 2001, GROWTH FACTORS, V18, P277, DOI 10.3109/08977190109029116; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS12, DOI 10.2337/diabetes.51.2007.S12; Goddard T. D., SPARKY 3; Graziani I, 2006, BIOCHEM BIOPH RES CO, V349, P192, DOI 10.1016/j.bbrc.2006.08.021; GRZESIEK S, 1993, J MAGN RESON SER B, V102, P103, DOI 10.1006/jmrb.1993.1069; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hayrabedyan S, 2005, J REPROD IMMUNOL, V67, P87, DOI 10.1016/j.jri.2005.07.001; Hubbard S. J., 1993, NACCESS; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Landriscina M, 2001, J BIOL CHEM, V276, P22544, DOI 10.1074/jbc.M100546200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Mohan SK, 2009, BIOCHEM BIOPH RES CO, V380, P514, DOI 10.1016/j.bbrc.2009.01.143; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rajalingam D, 2005, BIOCHEMISTRY-US, V44, P14431, DOI 10.1021/bi051387r; Rajalingam D, 2007, BIOCHEMISTRY-US, V46, P9225, DOI 10.1021/bi7002586; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Riek R, 2000, TRENDS BIOCHEM SCI, V25, P462, DOI 10.1016/S0968-0004(00)01665-0; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sivaraja V, 2006, BIOPHYS J, V91, P1832, DOI [10.1529/biophysj.105.079988, 10.1529/biophysj.106.079988]; Soldi R, 2007, EXP CELL RES, V313, P3308, DOI 10.1016/j.yexcr.2007.05.031; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Wang AJ, 1996, CURR OPIN BIOTECH, V7, P403, DOI 10.1016/S0958-1669(96)80115-7; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	57	19	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15464	15475		10.1074/jbc.M109.066357	http://dx.doi.org/10.1074/jbc.M109.066357			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220137	hybrid, Green Published			2022-12-27	WOS:000277399000066
J	Ito, I; Hanyu, A; Wayama, M; Goto, N; Katsuno, Y; Kawasaki, S; Nakajima, Y; Kajiro, M; Komatsu, Y; Fujimura, A; Hirota, R; Murayama, A; Kimura, K; Imamur, T; Yanagisawa, J				Ito, Ichiaki; Hanyu, Aki; Wayama, Mitsutoshi; Goto, Natsuka; Katsuno, Yoko; Kawasaki, Shohei; Nakajima, Yuka; Kajiro, Masashi; Komatsu, Yoko; Fujimura, Akiko; Hirota, Ryuichi; Murayama, Akiko; Kimura, Keiji; Imamur, Takeshi; Yanagisawa, Junn			Estrogen Inhibits Transforming Growth Factor beta Signaling by Promoting Smad2/3 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; PROTEASOME-DEPENDENT DEGRADATION; MAD-RELATED PROTEIN; TGF-BETA; TRANSCRIPTION FACTORS; RECEPTOR-ALPHA; BREAST-CANCER; REGULATED TRANSCRIPTION; NUCLEAR RECEPTORS; I RECEPTOR	Estrogen is a growth factor that stimulates cell proliferation. The effects of estrogen are mediated through the estrogen receptors, ER alpha and ER beta, which function as ligand-induced transcription factors and belong to the nuclear receptor superfamily. On the other hand, TGF-beta acts as a cell growth inhibitor, and its signaling is transduced by Smads. Although a number of studies have been made on the cross-talk between estrogen/ER alpha and TGF-beta/Smad signaling, whose molecular mechanisms remain to be determined. Here, we show that ER alpha inhibits TGF-beta signaling by decreasing Smad protein levels. ER alpha-mediated reductions in Smad levels did not require the DNA binding ability of ER alpha, implying that ER alpha opposes the effects of TGF-beta via a novel non-genomic mechanism. Our analysis revealed that ER alpha formed a protein complex with Smad and the ubiquitin ligase Smurf, and enhanced Smad ubiquitination and subsequent degradation in an estrogen-dependent manner. Our observations provide new insight into the molecular mechanisms governing the non-genomic functions of ER alpha	[Hanyu, Aki; Katsuno, Yoko; Imamur, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Ito, Ichiaki; Wayama, Mitsutoshi; Goto, Natsuka; Kawasaki, Shohei; Nakajima, Yuka; Kajiro, Masashi; Komatsu, Yoko; Fujimura, Akiko; Hirota, Ryuichi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan	Japanese Foundation for Cancer Research; University of Tsukuba; University of Tsukuba	Imamur, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp; junny@agbi.tsukuba.ac.jp	Hirota, Ryuichi/Q-3138-2016	Hirota, Ryuichi/0000-0003-3959-5892	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cherlet T, 2007, MOL CELL BIOCHEM, V306, P33, DOI 10.1007/s11010-007-9551-1; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; Malek D, 2006, EUR J PHARMACOL, V534, P39, DOI 10.1016/j.ejphar.2006.01.025; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Ren YS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-111; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	41	108	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14747	14755		10.1074/jbc.M109.093039	http://dx.doi.org/10.1074/jbc.M109.093039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207742	hybrid, Green Published			2022-12-27	WOS:000277299700072
J	Kondo, K; Obitsu, S; Ohta, S; Matsunami, K; Otsuka, H; Teshima, R				Kondo, Kazunari; Obitsu, Saemi; Ohta, Sayaka; Matsunami, Katsuyoshi; Otsuka, Hideaki; Teshima, Reiko			Poly(ADP-ribose) Polymerase (PARP)-1-independent Apoptosis-inducing Factor (AIF) Release and Cell Death Are Induced by Eleostearic Acid and Blocked by alpha-Tocopherol and MEK Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATED TRIENE SYSTEM; FOCAL CEREBRAL-ISCHEMIA; BCL-2 PROTEIN FAMILY; ERK ACTIVATION; NEURONAL DEATH; PAR POLYMER; BRAIN; SUPPRESSION; PROTECTION; TRANSIENT	Poly(ADP-ribose) polymerase-1 (PARP-1) is thought to be required for apoptosis-inducing factor (AIF) release from mitochondria in caspase-independent apoptosis. The mechanism by which AIF is released through PARP-1 remains unclear. Here, we provide evidence that PARP-1-independent AIF release and cell death are induced by a trienoic fatty acid, alpha-eleostearic acid (alpha-ESA). alpha-ESA induced the caspase-independent and AIF-initiated apoptotic death of neuronal cell lines, independently of PARP-1 activation. The cell death was inhibited by the MEK inhibitor U0126 and by knockdown of MEK using small interfering RNA. However, inhibitors for JNK, p38 inhibitors, calpain, phospholipase A(2), and phosphatidylinositol 3-kinase, did not block cell death. AIF was translocated to the nucleus after the induction of apoptosis by alpha-ESA in differentiated PC12 cells without activating caspase-3 and PARP-1. The alpha-ESA-mediated cell death was not inhibited by PARP inhibitor 3,4-dihydro- 5-[4-(1-piperidinyl) butoxyl]-1(2H)-isoquinoline and by knockdown of PARP-1 using small interfering RNA. Unlike N-methyl-N'-nitro-N-nitrosoguanidine treatment, histone-phosphorylated histone 2AX was not phosphorylated by alpha-ESA, which suggests no DNA damage. Overexpression of Bcl-2 did not inhibit the cell death. alpha-ESA caused a small quantity of superoxide production in the mitochondria, resulting in the reduction of mitochondrial membrane potential, both of which were blocked by a trace amount of alpha-tocopherol localized in the mitochondria. Our results demonstrate that alpha-ESA induces PARP-1-independent AIF release and cell death without activating Bax, cytochrome c, and caspase-3. MEK is also a key molecule, although the link between ERK, AIF release, and cell death remains unknown. Finding molecules that regulate AIF release may be an important therapeutic target for the treatment of neuronal injury.	[Kondo, Kazunari; Obitsu, Saemi; Ohta, Sayaka; Teshima, Reiko] Natl Inst Hlth Sci, Div Novel Food & Immunochem, Setagaya Ku, Tokyo 1588501, Japan; [Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacognosy, Minami Ku, Hiroshima 7348553, Japan	National Institute of Health Sciences - Japan; Hiroshima University	Kondo, K (corresponding author), Natl Inst Hlth Sci, Div Novel Food & Immunochem, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	kondo@nihs.go.jp	kondo, kazunari/AGE-0558-2022; Matsunami, Katsuyoshi/AHC-4234-2022	kondo, kazunari/0000-0002-2662-4626; Matsunami, Katsuyoshi/0000-0002-8034-0253	Ministry of Health, Labor, and Welfare of Japan; Japan Health Sciences Foundation; Grant-in-aid for Scientific Research [20590132]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Grant-in-aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan, the Japan Health Sciences Foundation, and Grant-in-aid for Scientific Research 20590132 (to K. K.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chen J, 1998, J NEUROSCI, V18, P4914; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; EGUCHI Y, 1992, NUCLEIC ACIDS RES, V20, P4187, DOI 10.1093/nar/20.16.4187; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hara C, 2006, BRAIN CELL BIOL, V35, P229, DOI 10.1007/s11068-008-9021-z; Igarashi M, 2000, CANCER LETT, V148, P173, DOI 10.1016/S0304-3835(99)00332-8; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Maeda H, 2005, J AM CHEM SOC, V127, P68, DOI 10.1021/ja047018k; Maeda H, 2007, CHEM-EUR J, V13, P1946, DOI 10.1002/chem.200600522; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x; Okuno S, 1998, J BIOL CHEM, V273, P34272, DOI 10.1074/jbc.273.51.34272; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109; Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; YANG J, 1997, SCIENCE, V275, P1132; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	44	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13079	13091		10.1074/jbc.M109.044206	http://dx.doi.org/10.1074/jbc.M109.044206			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177052	Green Published, hybrid			2022-12-27	WOS:000276787800065
J	Novikova, M; Kazakov, T; Vondenhoff, GH; Semenova, E; Rozenski, J; Metlytskaya, A; Zukher, I; Tikhonov, A; Van Aerschot, A; Severinov, K				Novikova, Maria; Kazakov, Teymur; Vondenhoff, Gaston H.; Semenova, Ekaterina; Rozenski, Jef; Metlytskaya, Anastasija; Zukher, Inna; Tikhonov, Anton; Van Aerschot, Arthur; Severinov, Konstantin			MccE Provides Resistance to Protein Synthesis Inhibitor Microcin C by Acetylating the Processed Form of the Antibiotic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; MATURATION; C51; GENES; H22	The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. McC is excreted from producing cells by the MccC transporter. The residual McC that remains in the producing cell can be processed by cellular amino-peptidases with the release of a non-hydrolyzable aspartyl-adenylate, a strong inhibitor of aspartyl-tRNA synthetase. Accumulation of processed McC inside producing cells should therefore lead to translation inhibition and cessation of growth. Here, we show that a product of another gene of the McC biosynthetic cluster, mccE, acetylates processed McC and converts it into a non-toxic compound. MccE also makes Escherichia coli resistant to albomycin, a Trojan horse inhibitor unrelated to McC that, upon processing, gives rise to a serine coupled to a thioxylofuranosyl pyrimidine, an inhibitor of seryl-tRNA synthetase. We speculate that MccE and related cellular acetyltransferases of the Rim family may detoxify various aminoacyl-nucleotides, either exogenous or those generated inside the cell.	[Kazakov, Teymur; Vondenhoff, Gaston H.; Semenova, Ekaterina; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Novikova, Maria; Kazakov, Teymur; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Vondenhoff, Gaston H.; Rozenski, Jef; Van Aerschot, Arthur] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Metlytskaya, Anastasija; Zukher, Inna; Tikhonov, Anton; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; KU Leuven; Rutgers State University New Brunswick; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Novikova, Mariia/AAL-1120-2020; Severinov, Konstantin/C-8545-2016	Rozenski, Jef/0000-0001-9624-5536; Van Aerschot, Arthur/0000-0003-3528-8588	National Institutes of Health; NIAID [U54 AI057158]; Russian Academy of Sciences; Rutgers University Technology Commercialization Fund; Russian Foundation for Basic Research [06-04-48865, 09-04-13825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Russian Academy of Sciences(Russian Academy of Sciences); Rutgers University Technology Commercialization Fund; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, North Eastern Biodefense Center Grant U54 AI057158.This work was also supported by the Burroughs Wellcome Career Award, a Russian Academy of Sciences Presidium program in Molecular and Cellular Biology new groups grant, a Rutgers University Technology Commercialization Fund Grant (to K.S.), and Russian Foundation for Basic Research Grants 06-04-48865 (to A.M.) and 09-04-13825 (to K.S.).	BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; BENZ G, 1982, ANGEW CHEM INT EDIT, V21, P527, DOI 10.1002/anie.198205271; BODE R, 1993, ARCH MICROBIOL, V160, P397; BRAUN V, 1983, J BACTERIOL, V156, P308, DOI 10.1128/JB.156.1.308-315.1983; Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; Finking R, 2003, CHEMBIOCHEM, V4, P903, DOI 10.1002/cbic.200300666; Fomenko D, 2001, RES MICROBIOL, V152, P469, DOI 10.1016/S0923-2508(01)01220-7; Fomenko DE, 2003, ANTIMICROB AGENTS CH, V47, P2868, DOI 10.1128/AAC.47.9.2868-2874.2003; GONZALEZPASTOR JE, 1994, NATURE, V369, P281, DOI 10.1038/369281a0; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Kazakov T, 2007, J BACTERIOL, V189, P2114, DOI 10.1128/JB.01609-06; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Moreno F, 2002, BIOCHIMIE, V84, P521, DOI 10.1016/S0300-9084(02)01452-9; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Zeng Y, 2009, ANTIMICROB AGENTS CH, V53, P4619, DOI 10.1128/AAC.00782-09	25	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12662	12669		10.1074/jbc.M109.080192	http://dx.doi.org/10.1074/jbc.M109.080192			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159968	Green Published, hybrid			2022-12-27	WOS:000276787800025
J	Borikova, AL; Dibble, CF; Sciaky, N; Welch, CM; Abell, AN; Bencharit, S; Johnson, GL				Borikova, Asya L.; Dibble, Christopher F.; Sciaky, Noah; Welch, Christopher M.; Abell, Amy N.; Bencharit, Sompop; Johnson, Gary L.			Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; INTEGRITY; GTPASES; FASUDIL; PATHWAY; CCM1	Cerebral cavernous malformations (CCM) are vascular lesions causing seizures and stroke. Mutations causing inactivation of one of three genes, ccm1, -2, or -3, are sufficient to induce vascular endothelial cell defects resulting in CCM. Herein, we show that loss of expression of the CCM1, -2, or -3 proteins causes a marked increase in expression of the GTPase RhoA. Live cell imaging with a RhoA-specific biosensor demonstrates increased RhoA activity with loss of CCM1, -2, or -3, with an especially pronounced RhoA activation in both the cytosol and the nucleus with loss of CCM1 expression. Increased RhoA activation was associated with Rho kinase-dependent phosphorylation of myosin light chain 2. Functionally, loss of CCM1, -2, or -3 inhibited endothelial cell vessel-like tube formation and extracellular matrix invasion, each of which is rescued by chemical inhibition or short hairpin RNA knockdown of Rho kinase. The findings, for the first time, define a signaling network for CCM1, -2, and -3 in CCM pathology, whereby loss of CCM1, -2, or -3 protein expression results in increased RhoA activity, with the activation of Rho kinase responsible for endothelial cell dysregulation. The results define Rho kinase as a therapeutic target to rescue endothelial cells from loss of CCM protein function.	[Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Borikova, Asya L.; Dibble, Christopher F.; Sciaky, Noah; Welch, Christopher M.; Abell, Amy N.; Johnson, Gary L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bencharit, Sompop] Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Campus Box 7365, Chapel Hill, NC 27599 USA.	glj@med.unc.edu	Bencharit, Sompop/AAO-8563-2020		National Institutes of Health [GM068820, GM068820-S1, HL092338, T32GM80079, HL094020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092338, F30HL108598, F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM068820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068820 (to G. L. J.), GM068820-S1 and HL092338 (to S. B.), T32GM80079 (to C. F. D. and C. M. W.), and HL094020 (to C. M. W.).	Awad IA, 2005, SURG NEUROL, V63, P317, DOI 10.1016/j.surneu.2004.12.032; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Inan SY, 2008, BRIT J PHARMACOL, V155, P44, DOI 10.1038/bjp.2008.225; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Suzuki Y, 2008, NEUROL MED-CHIR, V48, P241, DOI 10.2176/nmc.48.241; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	19	99	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11760	11764		10.1074/jbc.C109.097220	http://dx.doi.org/10.1074/jbc.C109.097220			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20181950	Green Published, hybrid			2022-12-27	WOS:000276787100002
J	Qu, ZX; Fu, J; Yan, PR; Hu, J; Cheng, SY; Xiao, GT				Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Hu, Jing; Cheng, Shi-Yuan; Xiao, Gutian			Epigenetic Repression of PDZ-LIM Domain-containing Protein 2 IMPLICATIONS FOR THE BIOLOGY AND TREATMENT OF BREAST CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA METHYLATION; INDEPENDENT GROWTH; KINASE NIK; DEGRADATION; ACTIVATION; AUTOPHAGY; TAX; DEREGULATION; TERMINATION	The NF-kappa B transcription factor plays a pivotal role in breast cancer progression and therapy resistance. However, the mechanisms by which the tightly regulated NF-kappa B becomes constitutively activated during breast cancer pathogenesis remain obscure. Here, we report that PDZ-LIM domain-containing protein 2 (PDLIM2), an essential terminator of NF-kappa B activation, is repressed in both estrogen receptor-positive and estrogen receptor-negative breast cancer cells, suggesting one important mechanism for the constitutive activation of NF-kappa B. Indeed, PDLIM2 reexpression inhibited constitutive NF-kappa B activation and expression of NF-kappa B-targeted genes in those breast cancer cells. Importantly, PDLIM2, but not its mutants defective in NF-kappa B termination, could suppress in vitro anchorage-independent growth and in vivo tumor formation of those malignant breast cells. In addition, we have shown that PDLIM2 repression involves promoter methylation. Accordingly, treatment of the breast cancer cells with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine reverses the methylation of the PDLIM2 promoter, restored PDLIM2 expression, and suppressed tumorigenicities of human breast cancer cells both in vitro and in vivo. These studies thus provide important mechanistic insights into breast cancer pathogenesis. These studies also suggest a tumor suppression function of PDLIM2 and a therapeutic strategy for breast cancer.	[Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Hu, Jing; Cheng, Shi-Yuan; Xiao, Gutian] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Xiao, Gutian] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GT (corresponding author), Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	xiaog2@upmc.edu	Hu, Jing/M-3130-2014; fu, jing/G-6084-2012; Yan, Pengrong/H-1150-2012; Fu, Jing/C-7921-2016	Fu, Jing/0000-0002-3894-722X; Yan, Pengrong/0000-0003-0021-6461	NCI/National Institutes of Health [R01 CA116616, R01 CA102011, R01 CA130966]; American Cancer Society [RSG-06-066-01-MGO, RSG-CSM-107144]; Pennsylvania Department of Health; Hillman Innovative Research Scholar; Hillman Innovative Cancer Research Award; NATIONAL CANCER INSTITUTE [R01CA130966, R01CA116616, R01CA102011] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Pennsylvania Department of Health; Hillman Innovative Research Scholar; Hillman Innovative Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by NCI/National Institutes of Health Grants R01 CA116616, R01 CA102011, and R01 CA130966. This work was also supported by American Cancer Society Grants RSG-06-066-01-MGO and RSG-CSM-107144, grants from the Pennsylvania Department of Health, and a Hillman Innovative Research Scholar and a Hillman Innovative Cancer Research Award (to G. X. and S. Y. C.).	Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cvijic ME, 2003, J IMMUNOL METHODS, V278, P293, DOI 10.1016/S0022-1759(03)00191-1; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lo PK, 2008, PHARMACOGENOMICS, V9, P1879, DOI 10.2217/14622416.9.12.1879; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Pratt MAC, 2009, ONCOGENE, V28, P2710, DOI 10.1038/onc.2009.131; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Samlowski WE, 2005, J CLIN ONCOL, V23, P3897, DOI 10.1200/JCO.2005.06.118; Sun SC, 2003, CANCER METAST REV, V22, P405, DOI 10.1023/A:1023733231406; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yan PR, 2009, NEOPLASIA, V11, P1036, DOI 10.1593/neo.09752; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660	28	46	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11786	11792		10.1074/jbc.M109.086561	http://dx.doi.org/10.1074/jbc.M109.086561			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20185823	Green Published, hybrid			2022-12-27	WOS:000276787100005
J	Toffalini, F; Hellberg, C; Demoulin, JB				Toffalini, Federica; Hellberg, Carina; Demoulin, Jean-Baptiste			Critical Role of the Platelet-derived Growth Factor Receptor (PDGFR) beta Transmembrane Domain in the TEL-PDGFR beta Cytosolic Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; WW-LIKE DOMAIN; TYROSINE KINASE; R FUSION; ERYTHROPOIETIN RECEPTOR; PRODUCTIVE INTERACTION; STRUCTURAL BASIS; ACTIVATION; JUXTAMEMBRANE; GENE	The fusion of TEL with platelet-derived growth factor receptor (PDGFR) beta (TP beta) is found in a subset of patients with atypical myeloid neoplasms associated with eosinophilia and is the archetype of a larger group of hybrid receptors that are produced by rearrangements of PDGFR genes. TP beta is activated by oligomerization mediated by the pointed domain of TEL/ETV6, leading to constitutive activation of the PDGFR beta kinase domain. The receptor transmembrane (TM) domain is retained in TP beta and in most of the described PDGFR beta hybrids. Deletion of the TM domain (Delta TM-TP beta) strongly impaired the ability of TP beta to sustain growth factor-independent cell proliferation. We confirmed that TP beta resides in the cytosol, indicating that the PDGFR beta TM domain does not act as a transmembrane domain in the context of the hybrid receptor but has a completely different function. The Delta TM-TP beta protein was expressed at a lower level because of increased degradation. It could form oligomers, was phosphorylated at a slightly higher level, co-immunoprecipitated with the p85 adaptor protein, but showed a much reduced capacity to activate STAT5 and ERK1/2 in Ba/F3 cells, compared with TP beta. Inanin vitro kinase assay, Delta TM-TP beta was more active than TP beta and less sensitive to imatinib, a PDGFR inhibitor. In conclusion, we show that the TM domain is required for TP beta-mediated signaling and proliferation, suggesting that the activation of the PDGFR beta kinase domain is not enough for cell transformation.	[Demoulin, Jean-Baptiste] Catholic Univ Louvain, de Duve Inst, Unite MEXP UCL 74 30, BE-1200 Brussels, Belgium; [Hellberg, Carina] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Universite Catholique Louvain; Ludwig Institute for Cancer Research	Demoulin, JB (corresponding author), Catholic Univ Louvain, de Duve Inst, Unite MEXP UCL 74 30, Ave Hippocrate 75, BE-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Demoulin, Jean-Baptiste/E-5847-2010	Demoulin, Jean-Baptiste/0000-0002-8016-6689	Bekales Foundation; Salus Sanguinis Foundation, Belgium	Bekales Foundation; Salus Sanguinis Foundation, Belgium	This work was supported by grants from the Bekales Foundation, from Action de Recherche Concertee (Communaute Francaise de Belgique), and from the Salus Sanguinis Foundation, Belgium.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Cain JA, 2007, BLOOD, V109, P3906, DOI 10.1182/blood-2006-07-036335; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Classen JF, 2009, ARTHRITIS RHEUM-US, V60, P1137, DOI 10.1002/art.24381; Demoulin JB, 2000, FEBS LETT, V482, P200, DOI 10.1016/S0014-5793(00)02059-7; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Demoulin JB, 2006, GROWTH FACTORS, V24, P184, DOI 10.1080/08977190600696430; Dobbin E, 2009, EXP HEMATOL, V37, P111, DOI 10.1016/j.exphem.2008.09.012; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; GULLICK WJ, 1992, EMBO J, V11, P43, DOI 10.1002/j.1460-2075.1992.tb05025.x; Hellberg C, 2009, MOL BIOL CELL, V20, P2856, DOI 10.1091/mbc.E08-12-1228; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Irusta PM, 2002, J BIOL CHEM, V277, P38627, DOI 10.1074/jbc.M204890200; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; MEDVES S, 2010, LEUKEMIA IN PRESS; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakao M, 1996, LEUKEMIA, V10, P1911; Nappi VM, 2002, J BIOL CHEM, V277, P47149, DOI 10.1074/jbc.M209582200; OATES J, 2009, BIOCHIM BIOPHYS ACTA, V1798, P605; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sjoblom T, 1999, ONCOGENE, V18, P7055, DOI 10.1038/sj.onc.1203190; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Sternberg DW, 2001, BLOOD, V98, P3390, DOI 10.1182/blood.V98.12.3390; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902; Valgeirsdottir S, 1998, ONCOGENE, V16, P505, DOI 10.1038/sj.onc.1201555; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	49	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12268	12278		10.1074/jbc.M109.076638	http://dx.doi.org/10.1074/jbc.M109.076638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164181	Green Published, hybrid			2022-12-27	WOS:000276787100056
J	Weatherill, DB; Dyer, J; Sossin, WS				Weatherill, Daniel B.; Dyer, John; Sossin, Wayne S.			Ribosomal Protein S6 Kinase Is a Critical Downstream Effector of the Target of Rapamycin Complex 1 for Long-term Facilitation in Aplysia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT TRANSLATION; MESSENGER-RNA TRANSLATION; INITIATION-FACTOR 4E; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; SENSITIVE MANNER; NERVOUS-SYSTEM; RHEB BINDS; PHOSPHORYLATION	Long-term facilitation (LTF) in Aplysia is a leading cellular model for elucidating the biochemical mechanisms of synaptic plasticity underlying learning. In Aplysia, LTF requires translational control downstream of the target of rapamycin (TOR) complex 1 (TORC1). The major known downstream targets of TORC1 are 4E binding protein (4E-BP) and S6 kinase (S6K). By removing the site within these regulators required for their interaction with TORC1, we have generated dominant negative proteins that disrupt specific pathways downstream of TORC1. Expression of dominant negative S6K, but not dominant negative 4E-BP, in Aplysia sensory neurons (SNs) blocked 24-h LTF. TORC1 is directly activated by the small GTP-binding protein, Ras homologue enriched in brain (Rheb). To determine the effects of TORC1 activation on translation in Aplysia neurons, we have examined the effects of expressing a constitutively active form of the Aplysia orthologue of Rheb, ApRheb (ApRheb(Q63L)). Expression of ApRheb(Q63L) increased 4E-BP phosphorylation and the level of general, cap-dependent translation within the SN cell soma in a rapamycin-sensitive manner. This increase in cap-dependent translation was blocked neither by dominant negative 4E-BP nor dominant negative S6K. Thus, we demonstrate that S6K is an important downstream target of TORC1 in Aplysia and that it is necessary for 24-h LTF, but not for TORC1-mediated increases in somatic cap-dependent translation.	[Weatherill, Daniel B.; Dyer, John; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Rm BT 110,3801 Univ St, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca			Canadian Institutes of Health Research [MOP 15121]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP 15121 (to W. S. S.).; Recipient of a studentship from the Fonds de la Recherche en Sante du Quebec (FRSQ).	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Carroll M, 2006, MOL CELL BIOL, V26, P8586, DOI 10.1128/MCB.00955-06; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu JY, 2006, J NEUROSCI, V26, P1026, DOI 10.1523/JNEUROSCI.4258-05.2006; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manseau F, 2001, J NEUROSCI, V21, P1247; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MOSER BK, 1992, AM STAT, V46, P19, DOI 10.2307/2684403; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PAINTER SD, 1989, J COMP NEUROL, V287, P515, DOI 10.1002/cne.902870409; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shama Silvian, 1995, Gene Expression, V4, P241; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; STANTON PK, 1984, J NEUROSCI, V4, P3080; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yanow SK, 1998, J NEUROCHEM, V70, P572; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zimmerman DW, 2004, BRIT J MATH STAT PSY, V57, P173, DOI 10.1348/000711004849222	62	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12255	12267		10.1074/jbc.M109.071142	http://dx.doi.org/10.1074/jbc.M109.071142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177060	hybrid, Green Published			2022-12-27	WOS:000276787100055
J	Yu, QJ; Schaub, P; Ghisla, S; Al-Babili, S; Krieger-Liszkay, A; Beyer, P				Yu, Qiuju; Schaub, Patrick; Ghisla, Sandro; Al-Babili, Salim; Krieger-Liszkay, Anja; Beyer, Peter			The Lycopene Cyclase CrtY from Pantoea ananatis (Formerly Erwinia uredovora) Catalyzes an FAD(red)-dependent Non-redox Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASE; IN-VITRO CHARACTERIZATION; BETA-CAROTENE; RETINAL BIOSYNTHESIS; NEOXANTHIN SYNTHASE; FAD SYNTHETASE; FLAVIN; IDENTIFICATION; PATHWAY; MECHANISM	The cyclization of lycopene generates provitamin A carotenoids such as beta-carotene and paves the way toward the formation of cyclic xanthophylls playing distinct roles in photosynthesis and as precursors for regulatory molecules in plants and animals. The biochemistry of lycopene cyclization has been enigmatic, as the previously proposed acid-base catalysis conflicted with the possibility of redox catalysis as predicted by the presence of a dinucleotide binding site. We show that reduced FAD is the essential lycopene cyclase (CrtY) cofactor. Using flavin analogs, mass spectrometry, and mutagenesis, evidence was obtained based on which a catalytic mechanism relying on cryptic (net) electron transfer can be refuted. The role of reduced FAD is proposed to reside in the stabilization of a transition state carrying a (partial) positive charge or of a positively charged intermediate via a charge transfer interaction, acid-base catalysis serving as the underlying catalytic principle. Lycopene cyclase, thus, ranks among the novel class of non-redox flavoproteins, such as isopentenyl diphosphate: dimethylallyl diphosphate isomerase type 2 (IDI-2) that requires the reduced form of the cofactor.	[Yu, Qiuju; Schaub, Patrick; Al-Babili, Salim; Beyer, Peter] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Krieger-Liszkay, Anja] CEA, Inst Biol & Technol Saclay, CNRS, Serv Bioenerget Biol Struct & Mecanisme,URA 2096, F-91191 Gif Sur Yvette, France	University of Freiburg; University of Konstanz; CEA; Centre National de la Recherche Scientifique (CNRS)	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de	Schaub, Patrick/C-8358-2018	Krieger-Liszkay, Anja/0000-0001-7141-4129; Al-Babili, Salim/0000-0003-4823-2882	The German-Israel Foundation; German Federal and State Governments [EXC 294]	The German-Israel Foundation; German Federal and State Governments	This work was supported by The German-Israel Foundation and by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Al-Babili S, 2000, FEBS LETT, V485, P168, DOI 10.1016/S0014-5793(00)02193-1; Arigoni D, 1999, P NATL ACAD SCI USA, V96, P1309, DOI 10.1073/pnas.96.4.1309; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; BEYER P, 1991, J BIOL CHEM, V266, P17072; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Bouvier F, 1997, ARCH BIOCHEM BIOPHYS, V346, P53, DOI 10.1006/abbi.1997.0278; BOUVIER F, 1994, PLANT J, V6, P45, DOI 10.1046/j.1365-313X.1994.6010045.x; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; BRITTON G, 1977, FEBS LETT, V79, P281, DOI 10.1016/0014-5793(77)80803-X; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.1105/tpc.8.9.1613; D'Ambrosio C, 2004, PLANT SCI, V166, P207, DOI 10.1016/j.plantsci.2003.09.015; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; ECKSTEIN JW, 1993, BIOCHEMISTRY-US, V32, P404, DOI 10.1021/bi00053a004; Edge R, 1999, ADV PHOTOSYNTH, V8, P223; Edmondson D, 1999, METH MOL B, V131, P157; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Estrada AF, 2009, FUNGAL GENET BIOL, V46, P803, DOI 10.1016/j.fgb.2009.06.011; Faller P, 2005, ADV PHOTO RESPIRAT, V22, P347; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; HALL LH, 1987, BIOCHEMISTRY-US, V26, P7401, DOI 10.1021/bi00397a031; Hornero-Mendez D, 2002, FEBS LETT, V515, P133, DOI 10.1016/S0014-5793(02)02453-5; Husain M, 1978, Methods Enzymol, V53, P429; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; KUSHWAHA SC, 1969, J BIOL CHEM, V244, P3635; Laupitz R, 2004, EUR J BIOCHEM, V271, P2658, DOI 10.1111/j.1432-1033.2004.04194.x; Lee JK, 2007, J BACTERIOL, V189, P8556, DOI 10.1128/JB.01050-07; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; MCCORMICK DB, 1967, EUR J BIOCHEM, V2, P387, DOI 10.1111/j.1432-1033.1967.tb00150.x; Morstadt L, 2002, PLANTA, V215, P134, DOI 10.1007/s00425-001-0724-y; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Prado-Cabrero A, 2007, EUKARYOT CELL, V6, P650, DOI 10.1128/EC.00392-06; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Rosati C, 2000, PLANT J, V24, P413, DOI 10.1046/j.1365-313x.2000.00880.x; Rothman SC, 2008, J AM CHEM SOC, V130, P4906, DOI 10.1021/ja7108954; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; Schnurr G, 1996, BIOCHEM J, V315, P869, DOI 10.1042/bj3150869; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3594, DOI 10.1021/bi00635a015; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3586, DOI 10.1021/bi00635a014; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Thibodeaux CJ, 2008, BIOCHEMISTRY-US, V47, P2547, DOI 10.1021/bi701467g; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; UNDEN G, 2008, ECOSAL MODULE 3 2 2; Unno H, 2009, J BIOL CHEM, V284, P9160, DOI 10.1074/jbc.M808438200; Unversucht S, 2005, ADV SYNTH CATAL, V347, P1163, DOI 10.1002/adsc.200505029; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	65	42	47	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12109	12120		10.1074/jbc.M109.091843	http://dx.doi.org/10.1074/jbc.M109.091843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178989	hybrid, Green Published			2022-12-27	WOS:000276787100041
J	Kohlwein, SD				Kohlwein, Sepp D.			Triacylglycerol Homeostasis: Insights from Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID-SYNTHESIS; NEUTRAL LIPIDS; METABOLISM; PROTEINS; DROPLET; STORAGE	The endemic increase in lipid-associated disorders such as obesity and type 2 diabetes mellitus has placed triacylglycerol metabolism and its associated organelle, lipid droplets, in the spotlight of biomedical research. Key enzymes of triacylglycerol metabolism are structurally and functionally conserved between yeast and mammalian cells, and studies in yeast have contributed significantly to the understanding of their biological function(s). Based on these similarities, studies performed in yeast may provide further significant mechanistic insight into the molecular basis of triacylglycerol homeostasis and its important physiological roles in healthy and diseased cells.	Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Kohlwein, SD (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	sepp.kohlwein@uni-graz.at		Kohlwein, Sepp Dieter/0000-0002-1030-0598	Austrian Science Fund (FWF) [F3005, W009]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Fund (FWF; Project SFB Lipotox F3005 and Ph.D. Program W009 Molecular Enzymology) and the Austrian Federal Ministry for Science and Research (Project GOLD (Genomics of Lipid-associated Disorders)) in the framework of the Austrian Genomics Program (GEN-AU). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Daum G, 2007, BIOCHIMIE, V89, P243, DOI 10.1016/j.biochi.2006.06.018; DAUM G, 2007, NOVART FDN SYMP, V162, P196; Daum Gunther, 2007, Novartis Found Symp, V286, P142; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kamisaka Y, 2006, BIOSCI BIOTECH BIOCH, V70, P646, DOI 10.1271/bbb.70.646; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kohlwein SD, 2007, CURR HYPERTENS REP, V9, P455, DOI 10.1007/s11906-007-0084-5; Kohlwein SD, 2010, BBA-MOL CELL BIOL L, V1801, P222, DOI 10.1016/j.bbalip.2009.12.016; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	51	101	107	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15663	15667		10.1074/jbc.R110.118356	http://dx.doi.org/10.1074/jbc.R110.118356			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20231294	Green Published, hybrid			2022-12-27	WOS:000277715900001
J	Pan, BY; Dou, SX; Yang, Y; Xu, YN; Bugnard, E; Ding, XY; Zhang, LY; Wang, PY; Li, M; Xi, XG				Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Bugnard, Elisabeth; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming; Xi, Xu Guang			Mutual Inhibition of RecQ Molecules in DNA Unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; COLI REP HELICASE; C VIRUS HELICASE; CRYSTAL-STRUCTURES; PCRA HELICASE; MECHANISM; TRANSLOCATION; UVRD; MONOMER; SEPARATION	Helicases make conformational changes and mechanical movements through hydrolysis of NTP to unwind duplex DNA (or RNA). Most helicases require a single-stranded overhang for loading onto the duplex DNA substrates. Some helicases have been observed to exhibit an enhanced unwinding efficiency with increasing length of the single-stranded DNA tail both by preventing reannealing of the unwound DNA and by compensating for premature dissociation of the leading monomers. Here we report a previously unknown mutual inhibition of neighboring monomers in DNA unwinding by the monomeric Escherichia coli RecQ helicase. With single molecule fluorescence resonance energy transfer microscopy, we observed that the unwinding initiation of RecQ at saturating concentrations was more delayed for a long rather than a short tailed DNA. In stopped-flow kinetic studies under both single and multiple turnover conditions, the unwinding efficiency decreased with increasing enzyme concentration for long tailed substrates. In addition, preincubation of RecQ and DNA in the presence of 5'-adenylyl-beta,gamma-imidodiphosphate was observed to alleviate the inhibition. We propose that the mutual inhibition effect results from a forced closure of cleft between the two RecA-like domains of a leading monomer by a trailing one, hence the forward movements of both monomers are stalled by prohibition of ATP binding to the leading one. This effect represents direct evidence for the relative movements of the two RecA-like domains of RecQ in DNA unwinding. It may occur for all superfamily I and II helicases possessing two RecA-like domains.	[Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China; [Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Xu, Ya-Nan] Renmin Univ, Dept Phys, Beijing 100872, Peoples R China; [Bugnard, Elisabeth; Xi, Xu Guang] Ctr Univ Orsay, Sect Rech, Inst Curie, CNRS,UMR 3348, F-91405 Orsay, France; [Bugnard, Elisabeth] Univ Paris 11, Fac Pharm, F-92296 Chatenay Malabry, France	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS; Renmin University of China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Dou, SX (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China.	sxdou@aphy.iphy.ac.cn; xgxi@curie.u-psud.fr	Xi, Xu Guang/AAK-4511-2020; ruc, phy/E-4170-2012; Yang, Ye/C-8397-2011; 石, 源/D-5929-2012; 王, 鹏业/A-9811-2012	Wang, Peng-Ye/0000-0002-9765-0610; Dou, Shuo-Xing/0000-0002-7201-2081	National Natural Science Foundation of China [10834014, 10674173, 30770517, 30870590]; 973 Project [2009CB930704, 2006CB910302]; Institut Curie and the Centre National de la Recherche Scientifique (CNRS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Institut Curie and the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by National Natural Science Foundation of China Grants 10834014, 10674173, 30770517, and 30870590, 973 Project Grants 2009CB930704 and 2006CB910302, and grants from the Institut Curie and the Centre National de la Recherche Scientifique (CNRS) (to X. G. X.).	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Bennett RJ, 2004, CRIT REV BIOCHEM MOL, V39, P79, DOI 10.1080/10409230490460756; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	27	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15884	15893		10.1074/jbc.M110.104299	http://dx.doi.org/10.1074/jbc.M110.104299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233727	Green Published, hybrid			2022-12-27	WOS:000277715900026
J	Cura, AJ; Carruthers, A				Cura, Anthony J.; Carruthers, Anthony			Acute Modulation of Sugar Transport in Brain Capillary Endothelial Cell Cultures during Activation of the Metabolic Stress Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT1 GLUCOSE-TRANSPORTER; ELECTRON-MICROSCOPIC IMMUNOGOLD; PROTEIN-KINASE; UP-REGULATION; MESSENGER-RNA; CHRONIC HYPOGLYCEMIA; SKELETAL-MUSCLE; BARRIER; ATP; STIMULATION	GLUT1-catalyzed equilibrative sugar transport across the mammalian blood-brain barrier is stimulated during acute and chronic metabolic stress; however, the mechanism of acute transport regulation is unknown. We have examined acute sugar transport regulation in the murine brain microvasculature endothelial cell line bEnd.3. Acute cellular metabolic stress was induced by glucose depletion, by potassium cyanide, or by carbonyl cyanide p-trifluoromethoxyphenylhydrazone, which reduce or deplete intracellular ATP within 15 min. This results in a 1.7-7-fold increase in V-max for zero-trans 3-O-methylglucose uptake (sugar uptake into sugar-free cells) and a 3-10-fold increase in V-max for equilibrium exchange transport (intracellular [sugar] = extracellular [sugar]). GLUT1, GLUT8, and GLUT9 mRNAs are detected in bEnd.3 cells where GLUT1 mRNA levels are 33-fold greater than levels of GLUT8 or GLUT9 mRNA. Neither GLUT1 mRNA nor total protein levels are affected by acute metabolic stress. Cell surface biotinylation reveals that plasma membrane GLUT1 levels are increased 2-3-fold by metabolic depletion, although cell surface Na+, K+-ATPase levels remain unaffected by ATP depletion. Treatment with the AMP-activated kinase agonist, AICAR, increases V-max for net 3-O-methylglucose uptake by 2-fold. Glucose depletion and treatment with potassium cyanide, carbonyl cyanide p-trifluoromethoxyphenylhydrazone, and AICAR also increase AMP-dependent kinase phosphorylation in bEnd.3 cells. These results suggest that metabolic stress rapidly stimulates blood-brain barrier endothelial cell sugar transport by acute up-regulation of plasma membrane GLUT1 levels, possibly involving AMP-activated kinase activity.	[Cura, Anthony J.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044888, R56DK036081, R01DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Barnes K, 2002, J CELL SCI, V115, P2433; Barros LF, 2001, PFLUG ARCH EUR J PHY, V442, P614; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; BOADO RJ, 1995, NEUROSCI LETT, V197, P179, DOI 10.1016/0304-3940(95)11930-U; Boado RJ, 1999, NEUROSCI RES, V34, P217, DOI 10.1016/S0168-0102(99)00056-5; CARRUTHERS A, 1986, J BIOL CHEM, V261, P1028; COOMBER BL, 1985, MICROVASC RES, V30, P99, DOI 10.1016/0026-2862(85)90042-1; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; CORNFORD EM, 1993, J CEREBR BLOOD F MET, V13, P841, DOI 10.1038/jcbfm.1993.106; Cornford EM, 2000, AM J PHYSIOL-HEART C, V279, pH1346, DOI 10.1152/ajpheart.2000.279.3.H1346; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; GORGA FR, 1979, BIOCHEM BIOPH RES CO, V91, P955, DOI 10.1016/0006-291X(79)91972-7; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; HAWORTH RA, 1986, CIRC RES, V58, P157, DOI 10.1161/01.RES.58.1.157; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; HEBERT DN, 1986, J BIOL CHEM, V261, P93; KALARIA RN, 1988, ANN NEUROL, V24, P757, DOI 10.1002/ana.410240610; KUMAGAI AK, 1994, BBA-BIOMEMBRANES, V1193, P24, DOI 10.1016/0005-2736(94)90328-X; KUMAGAI AK, 1995, DIABETES, V44, P1399, DOI 10.2337/diabetes.44.12.1399; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 2001, BLOOD CELL MOL DIS, V27, P139, DOI 10.1006/bcmd.2000.0359; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; MCCALL AL, 1986, AM J PHYSIOL, V251, pE442, DOI 10.1152/ajpendo.1986.251.4.E442; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; SIMONS TJB, 1983, J PHYSIOL-LONDON, V338, P477, DOI 10.1113/jphysiol.1983.sp014685; Simpson IA, 2001, J BIOL CHEM, V276, P12725, DOI 10.1074/jbc.M010897200; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Souza-Menezes J, 2007, CELL PHYSIOL BIOCHEM, V20, P455, DOI 10.1159/000107529; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C	46	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15430	15439		10.1074/jbc.M110.110593	http://dx.doi.org/10.1074/jbc.M110.110593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231288	Green Published, hybrid			2022-12-27	WOS:000277399000063
J	Kim, S; Saeki, Y; Fukunaga, K; Suzuki, A; Takagi, K; Yamane, T; Tanaka, K; Mizushima, T; Kato, K				Kim, Sangwoo; Saeki, Yasushi; Fukunaga, Keisuke; Suzuki, Atsuo; Takagi, Kenji; Yamane, Takashi; Tanaka, Keiji; Mizushima, Tsunehiro; Kato, Koichi			Crystal Structure of Yeast Rpn14, a Chaperone of the 19 S Regulatory Particle of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY PATHWAY; 20S PROTEASOME; COMPLEX; SUBCOMPLEX; ATPASE; SIGNAL	The ubiquitin-proteasome pathway is a major proteolytic system in eukaryotic cells and regulates various cellular processes. The 26 S proteasome, the central enzyme of this pathway, consists of a proteolytic core particle and two 19 S regulatory particles (RPs) composed of ATPase (Rpt) and non-ATPase (Rpn) subunits. Growing evidence indicates that proteasome assembly is assisted by a variety of chaperones. In particular, it has been reported recently that Nas2, Nas6, Rpn14, and Hsm3 bind specific Rpt subunits, thereby contributing to the formation of 19 S RP. Rpn14 transiently binds to the C-terminal domain of the Rpt6 subunit (Rpt6-C) during maturation of the ATPase ring of 19 S RP. In this study, we determined the crystal structure of yeast Rpn14 at 2.0 angstrom resolution, which revealed that this chaperone consists of a unique N-terminal domain with unknown function and a C-terminal domain assuming a canonical seven-bladed beta-propeller fold. The Rpt6-binding site on Rpn14 was predicted based on structural comparison with the complex formed between Nas6 and Rpt3-C. The top face of Rpn14 exhibits a highly acidic surface area, whereas the putative interacting surface of Rpt6-C is basic. By inspection of structural data along with genetic and biochemical data, we determined the specific residues of Rpn14 and Rpt6 for complementary charge interactions that are required for 19 S RP assembly.	[Kim, Sangwoo; Takagi, Kenji; Mizushima, Tsunehiro; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Saeki, Yasushi; Fukunaga, Keisuke; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Suzuki, Atsuo; Yamane, Takashi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Nagoya City University; Tokyo Metropolitan Institute of Medical Science; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp	Kim, Sangwoo/F-8043-2013; Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Kato, Koichi/0000-0001-7187-9612; Mizushima, Tsunehiro/0000-0002-6631-2889	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. M. and K. K.) and the Targeted Proteins Research Program of MEXT (to T. M., K. T., and K. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Leggett David S., 2005, V301, P57; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	39	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15159	15166		10.1074/jbc.M110.104042	http://dx.doi.org/10.1074/jbc.M110.104042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236927	Green Published, hybrid			2022-12-27	WOS:000277399000037
J	Palmitessa, A; Benovic, JL				Palmitessa, Aimee; Benovic, Jeffrey L.			Arrestin and the Multi-PDZ Domain-containing Protein MPZ-1 Interact with Phosphatase and Tensin Homolog (PTEN) and Regulate Caenorhabditis elegans Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; AGE-1 PI3 KINASE; C-ELEGANS; LIFE-SPAN; DAUER FORMATION; BETA-ARRESTINS; FAMILY-MEMBER; DAF-16; INSULIN/IGF-1; DIAPAUSE	Arrestins are multifunctional adaptor proteins best known for their role in regulating G protein-coupled receptor signaling. Arrestins also regulate other types of receptors, including the insulin-like growth factor receptor (IGF-1R), although the mechanism by which this occurs is not well understood. In Caenorhabditis elegans, the IGF-1R ortholog DAF-2 regulates dauer formation, stress resistance, metabolism, and lifespan through a conserved signaling cascade. To further elucidate the role of arrestin in IGF-1R signaling, we employed an in vivo approach to investigate the role of ARR-1, the sole arrestin ortholog in C. elegans, on longevity. Here, we report that ARR-1 functions to positively regulate DAF-2 signaling in C. elegans. arr-1 mutant animals exhibit increased longevity and enhanced nuclear localization of DAF-16, an indication of decreased DAF-2 signaling, whereas animals overexpressing ARR-1 have decreased longevity. Genetic and biochemical analysis reveal that ARR-1 functions to regulate DAF-2 signaling via direct interaction with MPZ-1, a multi-PDZ domain-containing protein, via a C-terminal PDZ binding domain in ARR-1. Interestingly, ARR-1 and MPZ-1 are found in a complex with the phosphatase and tensin homolog (PTEN) ortholog DAF-18, which normally serves as a suppressor of DAF-2 signaling, suggesting that these three proteins work together to regulate DAF-2 signaling. Our results suggest that the ARR-1-MPZ-1-DAF-18 complex functions to regulate DAF-2 signaling in vivo and provide insight into a novel mechanism by which arrestin is able to regulate IGF-1R signaling and longevity.	[Palmitessa, Aimee; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu			National Institutes of Health [R37 GM047417]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM047417 (to J. L. B.).	Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Barki-Harrington L, 2008, PHYSIOLOGY, V23, P17, DOI 10.1152/physiol.00042.2007; BASERGA R, 1995, CANCER RES, V55, P249; BRENNER S, 1974, GENETICS, V77, P71; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; DORMAN JB, 1995, GENETICS, V141, P1399; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Philipp S, 1997, FEBS LETT, V413, P243, DOI 10.1016/S0014-5793(97)00877-6; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044	46	18	23	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15187	15200		10.1074/jbc.M110.104612	http://dx.doi.org/10.1074/jbc.M110.104612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20207731	Green Published, hybrid			2022-12-27	WOS:000277399000040
J	Rambhadran, A; Gonzalez, J; Jayaraman, V				Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi			Subunit Arrangement in N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING DOMAIN; CONFORMATIONAL-CHANGES; AMPA RECEPTORS; ACTIVATION; MECHANISM; AGONIST; DESENSITIZATION; CLONING; DISEASE	N-Methyl-D-aspartate (NMDA) receptors, the main mediators of excitatory synaptic transmission, are heterotetrameric receptors. Typically, glycine binding NR1 subunits co-assemble with glutamate binding NR2 subunits to form a functional receptor. Here we have used luminescence resonance energy transfer (LRET) investigations to establish the specific configuration in which these subunits assemble to form the functional tetramer and show that the dimer of dimers structure is formed by the NR1 subunits assembling diagonally to each other. The distances measured by LRET are consistent with the NMDA structure predicted based on cross-linking investigations and on the structure of the full-length alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid (AMPA) receptor structure (1). Additionally, the LRET distances between the NR1 and NR2A subunits within a dimer measured in the desensitized state of the receptor are longer than the distances in the previously published crystal structure of the isolated ligand binding domain of NR1-NR2A. Because the dimer interface in the isolated ligand binding domain crystallizes in the open channel structure, the longer LRET distances would be consistent with the decoupling of the dimer interface in the desensitized state. This is similar to what has been previously observed for the AMPA subtype of the ionotropic glutamate receptors, suggesting a similar mechanism for desensitization in the two subtypes of the glutamate receptor.	[Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Ctr Membrane Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102]; American Heart Association [0855081F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102, F31GM082023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102 (to V. J.). This work was also supported by American Heart Association Grant 0855081F.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012	23	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15296	15301		10.1074/jbc.M109.085035	http://dx.doi.org/10.1074/jbc.M109.085035			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304927	Green Published, hybrid			2022-12-27	WOS:000277399000050
J	Tarrago, L; Laugier, E; Zaffagnini, M; Marchand, CH; Le Marechal, P; Lemaire, SD; Rey, P				Tarrago, Lionel; Laugier, Edith; Zaffagnini, Mirko; Marchand, Christophe H.; Le Marechal, Pierre; Lemaire, Stephane D.; Rey, Pascal			Plant Thioredoxin CDSP32 Regenerates 1-Cys Methionine Sulfoxide Reductase B Activity through the Direct Reduction of Sulfenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; ESCHERICHIA-COLI; OXIDATIVE STRESS; REVERSIBLE INACTIVATION; PLASTIDIAL THIOREDOXINS; HYDROGEN-PEROXIDE; REDOX; GLUTAREDOXINS; PEROXIREDOXIN; CHLOROPLAST	Thioredoxins (Trxs) are ubiquitous enzymes catalyzing the reduction of disulfide bonds, thanks to a CXXC active site. Among their substrates, 2-Cys methionine sulfoxide reductases B (2-Cys MSRBs) reduce the R diastereoisomer of methionine sulfoxide (MetSO) and possess two redox-active Cys as follows: a catalytic Cys reducing MetSO and a resolving one, involved in disulfide bridge formation. The other MSRB type, 1-Cys MSRBs, possesses only the catalytic Cys, and their regeneration mechanisms by Trxs remain unclear. The plant plastidial Trx CDSP32 is able to provide 1-Cys MSRB with electrons. CDSP32 includes two Trx modules with one potential active site (219)CGPC(222) and three extra Cys. Here, we investigated the redox properties of recombinant Arabidopsis CDSP32 and delineated the biochemical mechanisms of MSRB regeneration by CDSP32. Free thiol titration and 4-acetamido-4'-maleimidyl-distilbene-2,2'-disulfonic acid alkylation assays indicated that the Trx possesses only two redox-active Cys, very likely the Cys(219) and Cys(222). Protein electrophoresis analyses coupled to mass spectrometry revealed that CDSP32 forms a heterodimeric complex with MSRB1 via reduction of the sulfenic acid formed on MSRB1 catalytic Cys after MetSO reduction. MSR activity assays using variable CDSP32 amounts revealed that MSRB1 reduction proceeds with a 1: 1 stoichiometry, and redox titrations indicated that CDSP32 and MSRB1 possess midpoints potentials of -337 and -328 mV at pH 7.9, respectively, indicating that regeneration of MSRB1 activity by the Trx through sulfenic acid reduction is thermodynamically feasible in physiological conditions.	[Tarrago, Lionel; Laugier, Edith; Rey, Pascal] Univ Aix Marseille 2, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol,Lab Ecophysiol Mo, F-13108 St Paul Les Durance, France; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, Inst Biotechnol Plantes, Unite Mixte Rech 8618, F-91405 Orsay, France; [Marchand, Christophe H.; Le Marechal, Pierre] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Unite Mixte Rech 8619, F-91405 Orsay, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rey, P (corresponding author), Univ Aix Marseille 2, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol,Lab Ecophysiol Mo, Batiment 158, F-13108 St Paul Les Durance, France.	pascal.rey@cea.fr	MARCHAND, Christophe H/B-5854-2008; Tarrago, Lionel/CAH-1308-2022; Tarrago, Lionel/N-3534-2016; REY, Pascal/E-5794-2019; Lemaire, Stéphane D/A-3530-2008	MARCHAND, Christophe H/0000-0002-0729-3841; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; REY, Pascal/0000-0001-6512-1418; Lemaire, Stéphane D/0000-0001-6442-0547; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche (Genoplante) [GNP05010G]; Region Provence-Alpes-Cote d'Azur;  [ANR-08-BLAN-0153]	Agence Nationale de la Recherche (Genoplante)(French National Research Agency (ANR)); Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); 	This work was supported by Agence Nationale de la Recherche (Genoplante) Grants GNP05010G ( to E. L. and P. R.) and ANR-08-BLAN-0153 ( to M.Z., C. H. M., P. L. M., and S. D. L.) and by Region Provence-Alpes-Cote d'Azur ( to L. T.).	Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Balmer Y, 2001, FEBS LETT, V492, P58, DOI 10.1016/S0014-5793(01)02229-3; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Broin M, 2000, FEBS LETT, V467, P245, DOI 10.1016/S0014-5793(00)01165-0; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Eymery F, 1999, PLANT PHYSIOL BIOCH, V37, P305, DOI 10.1016/S0981-9428(99)80029-1; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Preger V, 2009, PLANT PHYSIOL, V150, P606, DOI 10.1104/pp.109.139170; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Rey P, 1998, PLANT J, V13, P97, DOI 10.1046/j.1365-313X.1998.00015.x; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, PHOTOSYNTH RES, V74, P259, DOI 10.1023/A:1021218932260; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	58	60	65	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14964	14972		10.1074/jbc.M110.108373	http://dx.doi.org/10.1074/jbc.M110.108373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236937	hybrid, Green Published			2022-12-27	WOS:000277399000017
J	Xu, T; Shively, CA; Jin, R; Eckwahl, MJ; Dobry, CJ; Song, QX; Kumar, A				Xu, Tao; Shively, Christian A.; Jin, Rui; Eckwahl, Matthew J.; Dobry, Craig J.; Song, Qingxuan; Kumar, Anuj			A Profile of Differentially Abundant Proteins at the Yeast Cell Periphery during Pseudohyphal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREVISIAE FILAMENTOUS-GROWTH; HAPLOID INVASIVE GROWTH; SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; TRANSCRIPTION FACTOR; FLUORESCENT PROTEIN; GENE-EXPRESSION; KINASE PATHWAY; MAP KINASE; FLO11	Yeast filamentous growth is a stress response to conditions of nitrogen deprivation, wherein yeast colonies form pseudohyphal filaments of elongated and connected cells. As proteins mediating adhesion and transport are required for this growth transition, we expect that the protein complement at the yeast cell periphery plays a critical and tightly regulated role in pseudohyphal filamentation. To identify proteins differentially abundant at the yeast cell periphery during pseudohyphal growth, we generated quantitative proteomic profiles of plasma membrane protein preparations under conditions of vegetative growth and filamentation. By isobaric tags for relative and absolute quantification chemistry and two-dimensional liquid chromatography-tandem mass spectrometry, we profiled 2463 peptides and 356 proteins, identifying 11 differentially abundant proteins that localize to the yeast cell periphery. This protein set includes Ylr414cp, herein renamed Pun1p, a previously uncharacterized protein localized to the plasma membrane compartment of Can1. Pun1p abundance is doubled under conditions of nitrogen stress, and deletion of PUN1 abolishes filamentous growth in haploids and diploids; pun1 Delta mutants are noninvasive, lack surface-spread filamentation, grow slowly, and exhibit impaired cell adhesion. Conversely, overexpression of PUN1 results in exaggerated cell elongation under conditions of nitrogen stress. PUN1 contributes to yeast nitrogen signaling, as pun1 Delta mutants misregulate amino acid biosynthetic genes during nitrogen stress. By chromatin immunoprecipitation and reverse transcription-PCR, we find that the filamentous growth factor Mss11p directly binds the PUN1 promoter and regulates its transcription. In total, this study provides the first profile of differential protein abundance during pseudohyphal growth, identifying a previously uncharacterized membrane compartment of Can1 protein required for wild-type nitrogen signaling and filamentous growth.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kumar, A (corresponding author), Life Sci Inst 6026, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	anujk@umich.edu		Kumar, Anuj/0000-0002-8923-297X	National Institutes of Health [1R21A1084539-01]; American Cancer Society [RSG-06-179-01-MBC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21A1084539-01 (to A. K.). This work was also supported by Grant RSG-06-179-01-MBC from the American Cancer Society.	Abdullah U, 2009, EUKARYOT CELL, V8, P1362, DOI 10.1128/EC.00015-09; Ahn SH, 1999, MOL BIOL CELL, V10, P3301, DOI 10.1091/mbc.10.10.3301; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; Birkaya B, 2009, EUKARYOT CELL, V8, P1118, DOI 10.1128/EC.00006-09; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1984, MOL CELL BIOL, V4, P49, DOI 10.1128/MCB.4.1.49; Chandarlapaty S, 1998, MOL CELL BIOL, V18, P2884, DOI 10.1128/MCB.18.5.2884; Chang A, 2002, METHOD ENZYMOL, V351, P339; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Edgington NP, 1999, MOL CELL BIOL, V19, P1369; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Erdman S, 2001, GENETICS, V159, P919; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Gagiano M, 2003, MOL MICROBIOL, V47, P119, DOI 10.1046/j.1365-2958.2003.03247.x; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gingras AC, 2005, J PHYSIOL-LONDON, V563, P11, DOI 10.1113/jphysiol.2004.080440; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P339, DOI 10.1016/0304-4165(66)90388-6; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Juan Hsueh-Fen, 2007, V382, P405, DOI 10.1007/978-1-59745-304-2_25; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kim TS, 2004, MOL CELL BIOL, V24, P9542, DOI 10.1128/MCB.24.21.9542-9556.2004; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Li WS, 1997, GENETICS, V145, P63; Liu HP, 1996, GENETICS, V144, P967; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Lorenz MC, 1998, GENETICS, V150, P1443; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ma J, 2008, AUTOPHAGY, V4, P792, DOI 10.4161/auto.6308; Ma J, 2007, GENETICS, V177, P205, DOI 10.1534/genetics.107.076596; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Miled C, 2001, MOL CELL BIOL, V21, P3714, DOI 10.1128/MCB.21.11.3714-3724.2001; Mir SS, 2009, MOL CELL BIOL, V29, P187, DOI 10.1128/MCB.02271-07; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; van Dyk D, 2005, GENETICS, V169, P91, DOI 10.1534/genetics.104.033704; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Vyas VK, 2003, MOL CELL BIOL, V23, P1341, DOI 10.1128/MCB.23.4.1341-1348.2003; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	76	30	32	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15476	15488		10.1074/jbc.M110.114926	http://dx.doi.org/10.1074/jbc.M110.114926			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228058	Green Published, hybrid			2022-12-27	WOS:000277399000067
J	Gagnon, KB; Delpire, E				Gagnon, Kenneth B.; Delpire, Eric			Multiple Pathways for Protein Phosphatase 1 (PP1) Regulation of Na-K-2Cl Cotransporter (NKCC1) Function THE N-TERMINAL TAIL OF THE Na-K-2Cl COTRANSPORTER SERVES AS A REGULATORY SCAFFOLD FOR Ste20-RELATED PROLINE/ALANINE-RICH KINASE (SPAK) AND PP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; MEDULLARY COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER; MOLECULAR-CLONING; PHOSPHORYLATION; KINASES; CALYCULIN; MODULATION; ACTIVATION; EXPRESSION	The Na-K-2Cl cotransporter (NKCC1) participates in epithelial transport and in cell volume maintenance by mediating the movement of ions and water across plasma membranes. Functional studies have previously demonstrated that NKCC1 activity is stimulated by protein phosphatase 1 (PP1) inhibitors. In this study, we utilized both in vivo (heterologous cRNA expression in Xenopus laevis oocytes) and in vitro (P-32-phosphorylation assays with glutathione S-transferase fusion proteins) experiments to determine whether PP1 exerts its inhibitory effect directly on the cotransporter, or indirectly by affecting the activating kinase. We found that PP1 reduced NKCC1 activity in oocytes under both isotonic and hypertonic conditions to the same level as in water-injected controls. Interestingly, mutation of key residues in the PP1 binding motif located in the N-terminal tail of NKCC1 significantly reduced the inhibitory effect of PP1. In vitro experiments performed with recombinant PP1, SPAK (Ste20-related proline/alanine-rich kinase, which activates NKCC1), and the N terminus of NKCC1 fused to glutathione S-transferase demonstrated that PP1 dephosphorylated both the kinase and the cotransporter in a time-dependent manner. More importantly, PP1 dephosphorylation of SPAK was significantly greater when protein-protein interaction between the kinase and the N-terminal tail of NKCC1 was present in the reaction, indicating the necessity of scaffolding the phosphatase and kinase in proximity to one another. Taken together, our data are consistent with PP1 inhibiting NKCC1 activity directly by dephosphorylating the cotransporter and indirectly by dephosphorylating SPAK.	[Gagnon, Kenneth B.; Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37221 USA	Vanderbilt University	Delpire, E (corresponding author), T-4202 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu		Gagnon, Kenneth/0000-0001-7602-6379	National Institutes of Health [GM074771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074771 (to E. D.).	Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Fagerholm AE, 2010, MAR DRUGS, V8, P122, DOI 10.3390/md80100122; GAGNON KB, 2010, FASEB J, V24; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gagnon KBE, 2007, AM J PHYSIOL-CELL PH, V292, pC1809, DOI 10.1152/ajpcell.00580.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1997, J BIOL CHEM, V272, P15069, DOI 10.1074/jbc.272.24.15069; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; ODonnell ME, 1995, AM J PHYSIOL-CELL PH, V269, pC1513, DOI 10.1152/ajpcell.1995.269.6.C1513; PALFREY HC, 1993, PFLUG ARCH EUR J PHY, V425, P321, DOI 10.1007/BF00374182; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	27	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14115	14121		10.1074/jbc.M110.112672	http://dx.doi.org/10.1074/jbc.M110.112672			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223824	Green Published, hybrid			2022-12-27	WOS:000277299700007
J	Alvaro-Benito, M; Polo, A; Gonzalez, B; Fernandez-Lobato, M; Sanz-Aparicio, J				Alvaro-Benito, Miguel; Polo, Aitana; Gonzalez, Beatriz; Fernandez-Lobato, Maria; Sanz-Aparicio, Julia			Structural and Kinetic Analysis of Schwanniomyces occidentalis Invertase Reveals a New Oligomerization Pattern and the Role of Its Supplementary Domain in Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; BETA-FRUCTOSIDASE; ALPHA-AMYLASE; PROTEIN; EXPRESSION; PURIFICATION; YEAST; GLYCOSYLATION; ENZYMES	Schwanniomyces occidentalis invertase is an extracellular enzyme that hydrolizes sucrose and releases beta-fructose from various oligosaccharides and essential storage fructan polymers such as inulin. We report here the three-dimensional structure of Sw. occidentalis invertase at 2.9 angstrom resolution and its complex with fructose at 1.9 angstrom resolution. The monomer presents a bimodular arrangement common to other GH32 enzymes, with an N-terminal 5-fold beta-propeller catalytic domain and a C-terminal beta-sandwich domain for which the function has been unknown until now. However, the dimeric nature of Sw. occidentalis invertase reveals a unique active site cleft shaped by both subunits that may be representative of other yeast enzymes reported to be multimeric. Binding of the tetrasaccharide nystose and the polymer inulin was explored by docking analysis, which suggested that medium size and long substrates are recognized by residues from both subunits. The identified residues were mutated, and the enzymatic activity of the mutants against sucrose, nystose, and inulin were investigated by kinetic analysis. The replacements that showed the largest effect on catalytic efficiency were Q228V, a residue putatively involved in nystose and inulin binding, and S281I, involved in a polar link at the dimer interface. Moreover, a significant decrease in catalytic efficiency against inulin was observed in the mutants Q435A and Y462A, both located in the beta-sandwich domain of the second monomer. This highlights the essential function that oligomerization plays in substrate specificity and assigns, for the first time, a direct catalytic role to the supplementary domain of a GH32 enzyme.	[Polo, Aitana; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Madrid 28006, Spain; [Alvaro-Benito, Miguel; Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Serrano 119, Madrid 28006, Spain.	xjulia@iqfr.csic.es	Gonzalez, Beatriz/M-1219-2014; Lobato, Maria Fernandez/F-1338-2016; Alvaro-Benito, Miguel/AAC-9704-2022; Sanz-Aparicio, Julia/F-6201-2013	Gonzalez, Beatriz/0000-0002-0710-0202; Lobato, Maria Fernandez/0000-0003-0778-7443; Alvaro-Benito, Miguel/0000-0002-6019-3567; Sanz-Aparicio, Julia/0000-0002-6849-8621	Ministerio de Educacion y Ciencia, Spain [BIO2007-67708-C04-04, BIO2007-67708-C04-03, BIO2004-67708-C04-04, BIO2004-67708-C04-03]; Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; Spanish Comunidad de Madrid Program	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; Spanish Comunidad de Madrid Program	This work was supported by Grants BIO2007-67708-C04-04, BIO2007-67708-C04-03, BIO2004-67708-C04-04, and BIO2004-67708-C04-03 from the Ministerio de Educacion y Ciencia, Spain, and by an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa.; Supported by the Spanish Comunidad de Madrid Program.	ABARCA D, 1989, FEBS LETT, V255, P455, DOI 10.1016/0014-5793(89)81144-5; ABARCA D, 1991, FEBS LETT, V279, P41, DOI 10.1016/0014-5793(91)80245-X; Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Andre I, 1996, MACROMOLECULES, V29, P4626, DOI 10.1021/ma951799f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Burke D., 2000, METHODS YEAST GENETI; Coutinho PM, 1999, ROY SOC CH, P3; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEIBEL MR, 1988, PREP BIOCHEM, V18, P77, DOI 10.1080/00327488808062514; DeLano W.L, PYMOL MOL GRAPHICS S; DOHMEN RJ, 1990, GENE, V95, P111, DOI 10.1016/0378-1119(90)90421-M; Ghazi I, 2007, J BIOTECHNOL, V128, P204, DOI 10.1016/j.jbiotec.2006.09.017; Holm L, 1998, CURR OPIN STRUC BIOL, V8, P372, DOI 10.1016/S0959-440X(98)80072-9; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEIN RD, 1989, PREP BIOCHEM, V19, P293, DOI 10.1080/10826068908544919; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, CRYSTALLOGRAPHIC COM, V5, P39; Matrai J, 2008, PROTEINS, V71, P552, DOI 10.1002/prot.21700; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; OKUYAMA K, 1993, B CHEM SOC JPN, V66, P374, DOI 10.1246/bcsj.66.374; Polo A, 2009, ACTA CRYSTALLOGR F, V65, P1162, DOI 10.1107/S1744309109039384; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; REDDY AV, 1990, BIOCHEMISTRY-US, V29, P2482, DOI 10.1021/bi00462a007; Sangeetha PT, 2005, PROCESS BIOCHEM, V40, P1085, DOI 10.1016/j.procbio.2004.03.009; Schmidt A, 1999, BIOCHEMISTRY-US, V38, P2403, DOI 10.1021/bi982108l; TAMMI M, 1987, J BIOL CHEM, V262, P4395; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Wang TT, 1999, CRIT REV BIOTECHNOL, V19, P113, DOI 10.1080/0738-859991229215; WILLIAMS RS, 1985, J BIOL CHEM, V260, P3334; Yanez E, 1998, BIOCHEM J, V329, P65, DOI 10.1042/bj3290065; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	45	63	65	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13930	13941		10.1074/jbc.M109.095430	http://dx.doi.org/10.1074/jbc.M109.095430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181943	Green Published, hybrid			2022-12-27	WOS:000276987700067
J	Bairwa, NK; Zzaman, S; Mohanty, BK; Bastia, D				Bairwa, Narendra K.; Zzaman, Shamsu; Mohanty, Bidyut K.; Bastia, Deepak			Replication Fork Arrest and rDNA Silencing Are Two Independent and Separable Functions of the Replication Terminator Protein Fob1 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL DNA REPEATS; YEAST; RECOMBINATION; COMPLEX; POLYMERASES; REQUIREMENT; PROGRESSION; EXPANSION; HELICASE; BARRIER	The replication terminator protein Fob1 of Saccharomyces cerevisiae is multifunctional, and it not only promotes polar replication fork arrest at the tandem Ter sites located in the intergenic spacer region of rDNA but also loads the NAD-dependent histone deacetylase Sir2 at Ter sites via a protein complex called RENT (regulator of nucleolar silencing and telophase exit). Sir2 is a component of the RENT complex, and its loading not only silences intrachromatid recombination in rDNA but also RNA polymerase II-catalyzed transcription. Here, we present three lines of evidence showing that the two aforementioned activities of Fob1 are independent of each other as well as functionally separable. First, a Fob1 ortholog of Saccharomyces bayanus expressed in a fob1 Delta strain of S. cerevisiae restored polar fork arrest at Ter but not rDNA silencing. Second, a mutant form (I407T) of S. cerevisiae Fob1 retained normal fork arresting activity but was partially defective in rDNA silencing. We further show that the silencing defect of S. bayanus Fob1 and the I407T mutant of S. cerevisiae Fob1 were caused by the failure of the proteins to interact with two members of the S. cerevisiae RENT complex, namely S. cerevisiae Sir2 and S. cerevisiae Net1. Third, deletions of the intra-S phase checkpoint proteins Tof1 and Csm3 abolished fork arrest by Fob1 at Ter without causing loss of silencing. Taken together, the data support the conclusion that unlike some other functions of Fob1, rDNA silencing at Ter is independent of fork arrest.	[Bairwa, Narendra K.; Zzaman, Shamsu; Mohanty, Bidyut K.; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Mohanty, BK (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	mohanty@musc.edu; bastia@musc.edu			NIGMS [GM049264]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM049264 from the NIGMS, National Institutes of Health (to D.B.).	BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chen XW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001562; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Garcia SN, 2002, GENETICS, V162, P721; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; James P, 1996, GENETICS, V144, P1425; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kobayashi T, 2001, MOL CELL BIOL, V21, P136, DOI 10.1128/MCB.21.1.136-147.2001; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Mohanty BK, 2004, J BIOL CHEM, V279, P1932, DOI 10.1074/jbc.M309078200; PETES TD, 1979, P NATL ACAD SCI USA, V76, P410, DOI 10.1073/pnas.76.1.410; Serizawa N, 2004, GENES CELLS, V9, P305, DOI 10.1111/j.1356-9597.2004.00729.x; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000	38	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12612	12619		10.1074/jbc.M109.082388	http://dx.doi.org/10.1074/jbc.M109.082388			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20179323	Green Published, hybrid			2022-12-27	WOS:000276787800019
J	Lebbink, JHG; Fish, A; Reumer, A; Natrajan, G; Winterwerp, HHK; Sixma, TK				Lebbink, Joyce H. G.; Fish, Alexander; Reumer, Annet; Natrajan, Ganesh; Winterwerp, Herrie H. K.; Sixma, Titia K.			Magnesium Coordination Controls the Molecular Switch Function of DNA Mismatch Repair Protein MutS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEINS; ESCHERICHIA-COLI; ATPASE ACTIVITY; GDP/GTP EXCHANGE; FLUORESCENCE POLARIZATION; RECOGNITION COMPLEX; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE	The DNA mismatch repair protein MutS acts as a molecular switch. It toggles between ADP and ATP states and is regulated by mismatched DNA. This is analogous to G-protein switches and the regulation of their "on" and "off" states by guanine exchange factors. Although GDP release in monomeric GTPases is accelerated by guanine exchange factor-induced removal of magnesium from the catalytic site, we found that release of ADP from MutS is not influenced by the metal ion in this manner. Rather, ADP release is induced by the binding of mismatched DNA at the opposite end of the protein, a long-range allosteric response resembling the mechanism of activation of heterotrimeric GTPases. Magnesium influences switching in MutS by inducing faster and tighter ATP binding, allowing rapid downstream responses. MutS mutants with decreased affinity for the metal ion are impaired in fast switching and in vivo mismatch repair. Thus, the G-proteins and MutS conceptually employ the same efficient use of the high energy cofactor: slow hydrolysis in the absence of a signal and fast conversion to the active state when required.	[Lebbink, Joyce H. G.] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Lebbink, Joyce H. G.] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands; [Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Netherlands Cancer Institute	Lebbink, JHG (corresponding author), Erasmus MC, Dept Cell Biol & Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.lebbink@erasmusmc.nl; t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632	European Community [223545]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen [VENI 700.53.407]; Koningin Wilhelmina Fonds [04-3084]; Center for Biomedical Genetics	European Community(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen; Koningin Wilhelmina Fonds; Center for Biomedical Genetics	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant 223545 "mismatch2model," the Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (VENI 700.53.407 to J. H. G. L.), the Koningin Wilhelmina Fonds (Project 04-3084), and the Center for Biomedical Genetics. Author's Choice-Final version full access.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bjornson KP, 2003, J BIOL CHEM, V278, P34667, DOI 10.1074/jbc.M305513200; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENG G, 1995, BIOTECHNIQUES, V19, P956; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; JOHN J, 1993, J BIOL CHEM, V268, P923; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Lebbink JHG, 2005, STRUCTURE, V13, P498, DOI 10.1016/j.str.2005.03.003; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Muradov KG, 2000, BIOCHEMISTRY-US, V39, P3937, DOI 10.1021/bi992156l; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shim KS, 2006, DNA REPAIR, V5, P704, DOI 10.1016/j.dnarep.2006.03.004; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STEWART FM, 1994, GENETICS, V137, P1139; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; 1994, ACTA CRYSTALLOGR, V50, P760	74	41	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13131	13141		10.1074/jbc.M109.066001	http://dx.doi.org/10.1074/jbc.M109.066001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167596	Green Published, hybrid			2022-12-27	WOS:000276787800069
J	Lee, J; Padhye, A; Sharma, A; Song, GS; Miao, J; Mo, YY; Wang, L; Kemper, JK				Lee, Jiyoung; Padhye, Amruta; Sharma, Abhilasha; Song, Guisheng; Miao, Ji; Mo, Yin-Yuan; Wang, Li; Kemper, Jongsook Kim			A Pathway Involving Farnesoid X Receptor and Small Heterodimer Partner Positively Regulates Hepatic Sirtuin 1 Levels via MicroRNA-34a Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID; METABOLIC DISEASE; LIPID-METABOLISM; FXR; SHP; P53; PGC-1-ALPHA; ACTIVATION; PROTECTS; GLUCOSE	Sirtuin 1 (SIRT1) is a NAD-dependent deacetylase that is critically involved in diverse cellular processes including metabolic disease, cancer, and possibly aging. Despite extensive studies on SIRT1 function, how SIRT1 levels are regulated remains relatively unknown. Here, we report that the nuclear bile acid receptor farnesoid X receptor (FXR) inhibits microRNA-34a (miR34a) in the liver, which results in a positive regulation of SIRT1 levels. Activation of FXR by the synthetic agonist GW4064 decreases hepatic miR-34a levels in normal mice, and consistently, hepatic miR-34a levels are elevated in FXR-null mice. FXR induces expression of small heterodimer partner (SHP), an orphan nuclear receptor and transcriptional corepressor, which in turn results in repression of p53, a key activator of the miR34a gene, by inhibiting p53 occupancy at the promoter. MiR-34a decreased SIRT1 levels by binding to the 3'-untranslated region of SIRT1 mRNA, and adenovirus-mediated overexpression of miR-34a substantially decreased SIRT1 protein levels in mouse liver. Remarkably, miR-34a levels were elevated, and SIRT1 protein levels were reduced in diet-induced obese mice, and FXR activation in these mice reversed the miR-34a and SIRT1 levels, indicating an intriguing link among FXR activation, decreased miR-34a, and subsequently, increased SIRT1 levels. Our study demonstrates an unexpected role of the FXR/SHP pathway in controlling SIRT1 levels via miR-34a inhibition and that elevated miR-34a levels in obese mice contribute to decreased SIRT1 levels. Manipulation of this regulatory network may be useful for treating diseases of aging, such as metabolic disease and cancer.	[Lee, Jiyoung; Padhye, Amruta; Sharma, Abhilasha; Miao, Ji; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Mo, Yin-Yuan] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA	University of Illinois System; University of Illinois Urbana-Champaign; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Southern Illinois University System; Southern Illinois University	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	Mo, Yin-Yuan/R-8255-2019; Padhye, Amruta/ABB-3858-2020; song, guisheng/E-4913-2011; Miao, Ji/F-9398-2015	Padhye, Amruta/0000-0002-1524-5612; Miao, Ji/0000-0003-0869-4492	National Institutes of Health [DK062777, DK080032]; American Diabetes Association Basic Science Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440, R01DK062777, R01DK080032, R56DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Science Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062777 and DK080032. This work was also supported by an American Diabetes Association Basic Science Award (to J.K.K.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	40	185	191	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12604	12611		10.1074/jbc.M109.094524	http://dx.doi.org/10.1074/jbc.M109.094524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185821	Green Published, hybrid			2022-12-27	WOS:000276787800018
J	Molinari, P; Vezzi, V; Sbraccia, M; Gro, C; Riitano, D; Ambrosio, C; Casella, I; Costa, T				Molinari, Paola; Vezzi, Vanessa; Sbraccia, Maria; Gro, Cristina; Riitano, Daniela; Ambrosio, Caterina; Casella, Ida; Costa, Tommaso			Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTOR; RESONANCE ENERGY-TRANSFER; BETA-ARRESTIN; LIVING CELLS; FUNCTIONAL SELECTIVITY; REDUCES TOLERANCE; BIASED AGONISM; IN-VIVO; INTERNALIZATION	The addictive potential of opioids may be related to their differential ability to induce G protein signaling and endocytosis. We compared the ability of 20 ligands (sampled from the main chemical classes of opioids) to promote the association of mu and delta receptors with G protein or beta-arrestin 2. Receptor-arrestin binding was monitored by bioluminescence resonance energy transfer (BRET) in intact cells, where pertussis toxin experiments indicated that the interaction was minimally affected by receptor signaling. To assess receptor-G protein coupling without competition from arrestins, we employed a cell-free BRET assay using membranes isolated from cells expressing luminescent receptors and fluorescent G beta(1). In this system, the agonist-induced enhancement of BRET (indicating shortening of distance between the two proteins) was G alpha-mediated (as shown by sensitivity to pertussis toxin and guanine nucleotides) and yielded data consistent with the known pharmacology of the ligands. We found marked differences of efficacy for G protein and arrestin, with a pattern suggesting more restrictive structural requirements for arrestin efficacy. The analysis of such differences identified a subset of structures showing a marked discrepancy between efficacies for G protein and arrestin. Addictive opiates like morphine and oxymorphone exhibited large differences both at delta and mu receptors. Thus, they were effective agonists for G protein coupling but acted as competitive enkephalins antagonists (delta) or partial agonists (mu) for arrestin. This arrestin-selective antagonism resulted in inhibition of short and long term events mediated by arrestin, such as rapid receptor internalization and down-regulation.	[Molinari, Paola; Vezzi, Vanessa; Sbraccia, Maria; Gro, Cristina; Riitano, Daniela; Ambrosio, Caterina; Casella, Ida; Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Costa, T (corresponding author), Ist Super Sanita, Dip Farmaco, Viale Regina Elena 299, I-00161 Rome, Italy.	tomcosta@iss.it	Vezzi, Vanessa/H-7084-2018; costa, tommaso/AAD-3714-2019; ambrosio, caterina/M-7952-2017	Vezzi, Vanessa/0000-0002-7649-345X; costa, tommaso/0000-0002-8729-3357; Casella, Ida/0000-0002-3358-4976; ambrosio, caterina/0000-0002-0807-9003; molinari, paola/0000-0002-8454-0121	FIRB Internationalization Program [RBIN04CKYN_001]	FIRB Internationalization Program	This work was supported in part by FIRB Internationalization Program Grant RBIN04CKYN_001.	Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Bradbury FA, 2009, J NEUROCHEM, V109, P1526, DOI 10.1111/j.1471-4159.2009.06082.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Hack SP, 2005, J NEUROSCI, V25, P3192, DOI 10.1523/JNEUROSCI.4585-04.2005; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kenakin TP, 2008, BRIT J PHARMACOL, V153, P432, DOI 10.1038/sj.bjp.0707407; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Marie N, 2003, J BIOL CHEM, V278, P22795, DOI 10.1074/jbc.M300084200; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Molinari P, 2003, J BIOL CHEM, V278, P15778, DOI 10.1074/jbc.M300731200; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Morinville A, 2003, J NEUROSCI, V23, P4888; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Przewlocka B, 2002, NEUROSCI LETT, V325, P107, DOI 10.1016/S0304-3940(02)00246-X; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VACHON L, 1987, MOL PHARMACOL, V31, P159; VACHON L, 1987, BIOCHEM PHARMACOL, V36, P2889, DOI 10.1016/0006-2952(87)90199-7; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	47	88	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12522	12535		10.1074/jbc.M109.059410	http://dx.doi.org/10.1074/jbc.M109.059410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20189994	hybrid, Green Published			2022-12-27	WOS:000276787800009
J	Tovey, SC; Dedos, SG; Rahman, T; Taylor, EJA; Pantazaka, E; Taylor, CW				Tovey, Stephen C.; Dedos, Skarlatos G.; Rahman, Taufiq; Taylor, Emily J. A.; Pantazaka, Evangelia; Taylor, Colin W.			Regulation of Inositol 1,4,5-Trisphosphate Receptors by cAMP Independent of cAMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; TRISPHOSPHATE RECEPTOR; INTRACELLULAR CA2+; FUNCTIONAL-CHARACTERIZATION; SIGNALING COMPLEX; IP3 RECEPTORS; ACINAR-CELLS; PHOSPHORYLATION; RELEASE; CALCIUM	In HEK cells stably expressing type 1 receptors for parathyroid hormone (PTH), PTH causes a sensitization of inositol 1,4,5-trisphosphate receptors (IP3R) to IP3 that is entirely mediated by cAMP and requires cAMP to pass directly from type 6 adenylyl cyclase (AC6) to IP(3)R2. Using DT40 cells expressing single subtypes of mammalian IP3R, we demonstrate that high concentrations of cAMP similarly sensitize all IP3R isoforms to IP3 by a mechanism that does not require cAMP-dependent protein kinase (PKA). IP3 binding to IP(3)R2 is unaffected by cAMP, and sensitization is not mediated by the site through which ATP potentiates responses to IP3. In single channel recordings from excised nuclear patches of cells expressing IP(3)R2, cAMP alone had no effect, but it increased the open probability of IP(3)R2 activated by a submaximal concentration of IP3 alone or in combination with a maximally effective concentration of ATP. These results establish that cAMP itself increases the sensitivity of all IP3R subtypes to IP3. For IP(3)R2, this sensitization results from cAMP binding to a novel site that increases the efficacy of IP3. Using stably expressed short hairpin RNA to reduce expression of the G-protein, G alpha(s), we demonstrate that attenuation of AC activity by loss of G alpha(s) more substantially reduces sensitization of IP3R by PTH than does comparable direct inhibition of AC. This suggests that G alpha(s) may also specifically associate with each AC.IP3R complex. We conclude that all three subtypes of IP3R are regulated by cAMP independent of PKA. In HEK cells, where IP(3)R2 selectively associates with AC6, G alpha s also associates with the AC.IP3R signaling junction.	[Tovey, Stephen C.; Dedos, Skarlatos G.; Rahman, Taufiq; Taylor, Emily J. A.; Pantazaka, Evangelia; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	rahman, taufiq/E-9806-2013; rahman, taufiq/GON-8210-2022; Dedos, Skarlatos G./A-5345-2008; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; rahman, taufiq/0000-0003-3830-5160; Dedos, Skarlatos G./0000-0002-0432-338X; Taylor, Emily/0000-0001-7974-1538; Taylor, Colin/0000-0001-7771-1044; PANTAZAKA, EVANGELIA/0000-0001-6737-8428	Wellcome Trust [085295]; Medical Research Council, UK [G0700843]; Biotechnology and Biological Sciences Research Council, UK [BB/E004660/1]; Biotechnology and Biological Sciences Research Council [BB/E004660/1] Funding Source: researchfish; Medical Research Council [G0700843] Funding Source: researchfish; BBSRC [BB/E004660/1] Funding Source: UKRI; MRC [G0700843] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by The Wellcome Trust (Grant 085295), the Medical Research Council, UK (Grant G0700843), and the Biotechnology and Biological Sciences Research Council, UK (Grant BB/E004660/1).	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Collado-Hilly M, 2009, BIOL CELL, V101, P469, DOI 10.1042/BC20080184; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Dyer JL, 2003, BIOCHEM BIOPH RES CO, V302, P121, DOI 10.1016/S0006-291X(03)00120-7; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Nerou EP, 2001, BIOCHEM J, V355, P59, DOI 10.1042/bj3550059; QUINTON TM, 1992, BIOCHEM BIOPH RES CO, V184, P893, DOI 10.1016/0006-291X(92)90675-B; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Short AD, 2000, J BIOL CHEM, V275, P1807, DOI 10.1074/jbc.275.3.1807; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sun Y, 2008, BIOCHEM J, V416, P243, DOI 10.1042/BJ20080861; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Tovey SC, 2003, BRIT J PHARMACOL, V138, P81, DOI 10.1038/sj.bjp.0705011; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495	47	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12979	12989		10.1074/jbc.M109.096016	http://dx.doi.org/10.1074/jbc.M109.096016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20189985	hybrid, Green Published			2022-12-27	WOS:000276787800056
J	Lee, AJ; Wu, XF; Cheng, HY; Zhou, XF; Cheng, XH; Sun, SC				Lee, Andrew Joon; Wu, Xuefeng; Cheng, Hanyin; Zhou, Xiaofei; Cheng, Xuhong; Sun, Shao-Cong			CARMA1 Regulation of Regulatory T Cell Development Involves Modulation of Interleukin-2 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME CYLD; C-REL; RECEPTOR; LINEAGE; PHOSPHORYLATION; ENTEROPATHY; COMMITMENT; ACTIVATION; EXPRESSION	T cell receptor-stimulated NF-kappa B activation requires CARMA1 and is negatively regulated by the deubiquitinase CYLD. Recent studies suggest that CARMA1 regulates regulatory T cell (Treg) development, although the role of NF-kappa B in this event is incompletely understood. We show that CYLD deficiency causes constitutive NF-kappa B activation in thymocytes, which is associated with enhanced frequency of Treg cells. The NF-kappa B activation in CYLD-deficient thymocytes is independent of CARMA1, because the NF-kappa B activation was also detected in CYLD/CARMA1 double knock-out thymocytes. Interestingly, although loss of CYLD causes NF-kappa B activation in the CARMA1-deficient thymocytes, the CYLD deficiency fails to rescue the defect of CARMA1 knock-out mice in Treg development. Furthermore, inhibition of canonical NF-kappa B by an I kappa B alpha transgene only partially inhibits Treg development. We demonstrate that CARMA1 regulates IL-2 receptor signaling and controls the IL-2-stimulated maturation of Treg precursors to mature Tregs. These results suggest that the role of CARMA1 in Treg regulation involves both NF-kappa B activation and IL-2 receptor signaling.	[Lee, Andrew Joon; Wu, Xuefeng; Cheng, Hanyin; Zhou, Xiaofei; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sun, Shao-Cong] Univ Texas, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Lee, Andrew Joon] Penn State Univ, Coll Med, MD PhD Program, Hershey, PA 17033 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Lee, Andrew/GVU-2817-2022; Wu, Xuefeng/F-5003-2011; zhou, xiaofei/A-9844-2013		National Institutes of Health [AI064639, GM084459, GM084459S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008445, R01GM084459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064639, GM084459, and GM084459S1.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhou P, 2005, J IMMUNOL, V174, P3447, DOI 10.4049/jimmunol.174.6.3447	36	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15696	15703		10.1074/jbc.M109.095190	http://dx.doi.org/10.1074/jbc.M109.095190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233721	Green Published, hybrid			2022-12-27	WOS:000277715900004
J	Wei, G; Pazgier, M; de Leeuw, E; Rajabi, M; Li, J; Zou, GZ; Jung, G; Yuan, WR; Lu, WY; Lehrer, RI; Lu, WY				Wei, Gang; Pazgier, Marzena; de Leeuw, Erik; Rajabi, Mohsen; Li, Jing; Zou, Guozhang; Jung, Grace; Yuan, Weirong; Lu, Wei-Yue; Lehrer, Robert I.; Lu, Wuyuan			Trp-26 Imparts Functional Versatility to Human alpha-Defensin HNP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED SALT BRIDGE; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; MOUSE CRYPTDIN-4; ANTIBACTERIAL ACTIVITY; BACTERICIDAL ACTIVITY; MAMMALIAN DEFENSINS; SERINE PROTEINASES; CHEMICAL LIGATION; INNATE IMMUNITY	We performed a comprehensive alanine scan of human alpha-defensin HNP1 and tested the ability of the resulting analogs to kill Staphylococcus aureus, inhibit anthrax lethal factor, and bind human immunodeficiency virus-1 gp120. By far, the most deleterious mutation for all of these functions was W26A. The activities lost by W26A-HNP1 were restored progressively by replacing W26 with non-coded, straight-chain aliphatic amino acids of increasing chain length. The hydrophobicity of residue 26 also correlated with the ability of the analogs to bind immobilized wild type HNP1 and to undergo further self-association. Thus, the hydrophobicity of residue 26 is not only a key determinant of the direct interactions of HNP1 with target molecules, but it also governs the ability of this peptide to form dimers and more complex quaternary structures at micromolar concentrations. Although all defensin peptides are cationic, their amphipathicity is at least as important as their positive charge in enabling them to participate in innate host defense.	[Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Wei, Gang; Pazgier, Marzena; de Leeuw, Erik; Rajabi, Mohsen; Li, Jing; Zou, Guozhang; Yuan, Weirong; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Maryland; University of Maryland Baltimore; Fudan University	Lehrer, RI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	rlehrer@mednet.ucla.edu; wlu@ihv.umaryland.edu	Wei, Gang/AAH-7377-2019; Pazgier, Marzena/B-7295-2012; Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Wei, Gang/0000-0002-9600-0982; Lu, Wuyuan/0000-0003-1318-9968	National Institutes of Health [AI072732, AI061482]; National Natural Science Foundation of China [30701060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).; Supported in part by National Natural Science Foundation of China Grant 30701060.	Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kouno T, 2008, BIOCHEMISTRY-US, V47, P10611, DOI 10.1021/bi800957n; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Qasim MA, 2003, BIOCHEMISTRY-US, V42, P6460, DOI 10.1021/bi027186u; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Semple CAM, 2006, BIOCHEM SOC T, V34, P257, DOI 10.1042/BST0340257; Siebert HC, 2009, CARBOHYD RES, V344, P1515, DOI 10.1016/j.carres.2009.06.002; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	79	46	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16275	16285		10.1074/jbc.M110.102749	http://dx.doi.org/10.1074/jbc.M110.102749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20220136	hybrid, Green Published			2022-12-27	WOS:000277715900064
J	Zhou, Z; Li, XG; Deng, CW; Ney, PA; Huang, SM; Bungert, J				Zhou, Zhuo; Li, Xingguo; Deng, Changwang; Ney, Paul A.; Huang, Suming; Bungert, Joerg			USF and NF-E2 Cooperate to Regulate the Recruitment and Activity of RNA Polymerase II in the beta-Globin Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; HYPERSENSITIVE SITE 2; UPSTREAM STIMULATORY FACTOR; CONTROL REGION FUNCTION; LOOP-HELIX PROTEINS; ERYTHROID-CELLS; IN-VIVO; DOWNSTREAM PROMOTER; CHROMATIN DOMAIN; BARRIER-ELEMENT	The human beta-globin gene is expressed at high levels in erythroid cells and regulated by proximal and distal cis-acting DNA elements, including promoter, enhancer, and a locus control region (LCR). Transcription complexes are recruited not only to the globin gene promoters but also to the LCR. Previous studies have implicated the ubiquitously expressed transcription factor USF and the tissue-restricted activator NF-E2 in the recruitment of transcription complexes to the beta-globin gene locus. Here we demonstrate that although USF is required for the efficient association of RNA polymerase II (Pol II) with immobilized LCR templates, USF and NF-E2 together regulate the association of Pol II with the adult beta-globin gene promoter. Recruitment of Pol II to the LCR occurs in undifferentiated murine erythroleukemia cells, but phosphorylation of LCR-associated Pol II at serine 5 of the C-terminal domain is mediated by erythroid differentiation and requires the activity of NF-E2. Furthermore, we provide evidence showing that USF interacts with NF-E2 in erythroid cells. The data provide mechanistic insight into how ubiquitous and tissue-restricted transcription factors cooperate to regulate the recruitment and activity of transcription complexes in a tissue-specific chromatin domain.	[Bungert, Joerg] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Powell Gene Therapy Ctr,Ctr Epigenet, Gainesville, FL 32610 USA; [Zhou, Zhuo; Li, Xingguo; Deng, Changwang; Huang, Suming; Bungert, Joerg] Univ Florida, Genet Inst, Gainesville, FL 32610 USA; [Ney, Paul A.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; St Jude Children's Research Hospital	Bungert, J (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Powell Gene Therapy Ctr,Ctr Epigenet, 1600 Archer Rd,POB 100245, Gainesville, FL 32610 USA.	jbungert@ufl.edu	Li, Xingguo/T-9582-2019	Li, Xingguo/0000-0002-2801-7555; Li, Xing-Guo/0000-0003-1952-3445	National Institutes of Health [DK052356, HL091929]; American Heart Association [AHAGRNT2260915]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052356 (to J.B.) and HL091929 (to S. H.). This work was also supported by American Heart Association Grant AHAGRNT2260915 (to J.B.).	Amrolia PJ, 1997, P NATL ACAD SCI USA, V94, P10051, DOI 10.1073/pnas.94.19.10051; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; BUNGERT J, 1992, J MOL BIOL, V223, P885, DOI 10.1016/0022-2836(92)90250-N; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Elnitski L, 1997, J BIOL CHEM, V272, P369; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Gallagher PG, 2009, BLOOD, V113, P1547, DOI 10.1182/blood-2008-06-164954; Gong QH, 1996, MOL CELL BIOL, V16, P6055; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kang SHL, 2002, NUCLEIC ACIDS RES, V30; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Levings PP, 2006, FEBS J, V273, P746, DOI 10.1111/j.1742-4658.2005.05107.x; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Liang S, 2008, J CELL BIOCHEM, V105, P9, DOI 10.1002/jcb.21820; Liang SY, 2009, MOL CELL BIOL, V29, P5900, DOI 10.1128/MCB.00419-09; Lin IJ, 2009, J BIOL CHEM, V284, P20130, DOI 10.1074/jbc.M109.001461; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Loyd MR, 2003, BLOOD, V102, P4223, DOI 10.1182/blood-2003-02-0574; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Nagai T, 1998, J BIOL CHEM, V273, P5358, DOI 10.1074/jbc.273.9.5358; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005	70	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15894	15905		10.1074/jbc.M109.098376	http://dx.doi.org/10.1074/jbc.M109.098376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236933	Green Published, hybrid			2022-12-27	WOS:000277715900027
J	Foster, KG; Fingar, DC				Foster, Kathryn G.; Fingar, Diane C.			Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RICH AKT SUBSTRATE; P70 S6 KINASE; 40 KDA PRAS40; PROTEIN-KINASE; AMINO-ACIDS; MOTIF PHOSPHORYLATION; TSC1-TSC2 COMPLEX; CYCLE PROGRESSION; RAG GTPASES; TOS MOTIF	The mammalian target of rapamycin (mTOR) protein kinase responds to diverse environmental cues to control a plethora of cellular processes. mTOR forms the catalytic core of at least two distinct signaling complexes known as mTOR complexes 1 and 2. Differing sensitivities to the mTOR inhibitor rapamycin, unique partner proteins, distinct substrates, and unique cellular functions distinguish the complexes. Here, we review recent progress in our understanding of the regulation and function of mTOR signaling networks in cellular physiology.	[Foster, Kathryn G.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fingar, DC (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dfingar@umich.edu			National Institutes of Health [R01-DK 078135]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK 078135 (to D.C.F. and K.G.F.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rosner M, 2009, HUM MOL GENET, V18, P3298, DOI 10.1093/hmg/ddp271; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schleich S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006305; SHARP ZD, 2010, J GERONTO A IN PRESS; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Villalonga P, 2009, J BIOL CHEM, V284, P35287, DOI 10.1074/jbc.M109.050120; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299	99	402	424	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14071	14077		10.1074/jbc.R109.094003	http://dx.doi.org/10.1074/jbc.R109.094003			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231296	Green Published, hybrid			2022-12-27	WOS:000277299700001
J	Shakoury-Elizeh, M; Protchenko, O; Berger, A; Cox, J; Gable, K; Dunn, TM; Prinz, WA; Bard, M; Philpott, CC				Shakoury-Elizeh, Minoo; Protchenko, Olga; Berger, Alvin; Cox, James; Gable, Kenneth; Dunn, Teresa M.; Prinz, William A.; Bard, Martin; Philpott, Caroline C.			Metabolic Response to Iron Deficiency in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-BINDING PROTEIN; SQUALENE EPOXIDASE; FERRIC REDUCTASE; LIPID PARTICLES; BUDDING YEAST; RESISTANCE; STORAGE; BIOSYNTHESIS; DEPRIVATION; ERGOSTEROL	Iron is an essential cofactor for enzymes involved in numerous cellular processes, yet little is known about the impact of iron deficiency on cellular metabolism or iron proteins. Previous studies have focused on changes in transcript and proteins levels in iron-deficient cells, yet these changes may not reflect changes in transport activity or flux through a metabolic pathway. We analyzed the metabolomes and transcriptomes of yeast grown in iron-rich and iron-poor media to determine which bio-synthetic processes are altered when iron availability falls. Iron deficiency led to changes in glucose metabolism, amino acid biosynthesis, and lipid biosynthesis that were due to deficiencies in specific iron-dependent enzymes. Iron-sulfur proteins exhibited loss of iron cofactors, yet amino acid synthesis was maintained. Ergosterol and sphingolipid biosynthetic pathways had blocks at points where heme and diiron enzymes function, whereas Ole1, the essential fatty acid desaturase, was resistant to iron depletion. Iron-deficient cells exhibited depletion of most iron enzyme activities, but loss of activity during iron deficiency did not consistently disrupt metabolism. Amino acid homeostasis was robust, but iron deficiency impaired lipid synthesis, altering the properties and functions of cellular membranes.	[Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Prinz, William A.] NIDDK, Lab Cell Biol & Biochem, NIH, Bethesda, MD 20892 USA; [Berger, Alvin] Metabolon Inc, Durham, NC 27713 USA; [Cox, James] Univ Utah, Metabol Core Res Facil, Salt Lake City, UT 84132 USA; [Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Metabolon; Utah System of Higher Education; University of Utah; Uniformed Services University of the Health Sciences - USA; Indiana University System; Indiana University-Purdue University Indianapolis	Philpott, CC (corresponding author), Bldg 10,Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Berger, Alvin/AAE-5353-2022; Protchenko, Olga/AAU-9237-2021	Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health, NIDDK [P30 DK072437]; NIH [GM62104]; Center of Excellence in Molecular Hematology; United States Public Health Service, NINDS, NIH [NS47717]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105, ZIADK054507, ZIADK060004] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Public Health Service, NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIDDK (to M. S.-E., O.P., W. A. P., and C. C. P.), by NIH Grant NIDDK P30 DK072437 (to J.C.), and by NIH Grant GM62104 (to M. B.). This work was also supported by the Center of Excellence in Molecular Hematology and by United States Public Health Service Grant NS47717 awarded by NINDS, NIH (to T. M. D.).	Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; BERTELLO LE, 1995, BIOCHEM J, V310, P255, DOI 10.1042/bj3100255; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DAUM G, 1998, YEAST, V1471, P1510; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; HUNG CY, 1995, BIOCHEM J, V307, P107, DOI 10.1042/bj3070107; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kennedy MA, 2001, BBA-GENE STRUCT EXPR, V1517, P177, DOI 10.1016/S0167-4781(00)00246-3; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEES ND, 2003, LIPID METABOLISM MEM, P213; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, MOL CELLULAR BIOL YE, P283; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; MBAYA B, 1989, LIPIDS, V24, P1020, DOI 10.1007/BF02544072; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stehling O., 2007, METHOD MOL BIOL, P325; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	50	118	124	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14823	14833		10.1074/jbc.M109.091710	http://dx.doi.org/10.1074/jbc.M109.091710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231268	Green Published, hybrid			2022-12-27	WOS:000277299700079
J	Gohil, VM; Nilsson, R; Belcher-Timme, CA; Luo, B; Root, DE; Mootha, VK				Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Luo, Biao; Root, David E.; Mootha, Vamsi K.			Mitochondrial and Nuclear Genomic Responses to Loss of LRPPRC Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; CYCLOOXYGENASE-2 EXPRESSION; INTEGRATIVE GENOMICS; OXIDASE DEFICIENCY; GENE-EXPRESSION; COMPLEX; DYSFUNCTION; LRP130; CELL; RNA	Rapid advances in genotyping and sequencing technology have dramatically accelerated the discovery of genes underlying human disease. Elucidating the function of such genes and understanding their role in pathogenesis, however, remain challenging. Here, we introduce a genomic strategy to characterize such genes functionally, and we apply it to LRPPRC, a poorly studied gene that is mutated in Leigh syndrome, French-Canadian type (LSFC). We utilize RNA interference to engineer an allelic series of cellular models in which LRPPRC has been stably silenced to different levels of knockdown efficiency. We then combine genome-wide expression profiling with gene set enrichment analysis to identify cellular responses that correlate with the loss of LRPPRC. Using this strategy, we discovered a specific role for LRPPRC in the expression of all mitochondrial DNA-encoded mRNAs, but not the rRNAs, providing mechanistic insights into the enzymatic defects observed in the disease. Our analysis shows that nuclear genes encoding mitochondrial proteins are not collectively affected by the loss of LRPPRC. We do observe altered expression of genes related to hexose metabolism, prostaglandin synthesis, and glycosphingolipid biology that may either play an adaptive role in cell survival or contribute to pathogenesis. The combination of genetic perturbation, genomic profiling, and pathway analysis represents a generic strategy for understanding disease pathogenesis.	[Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Luo, Biao; Root, David E.; Mootha, Vamsi K.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-806, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Nilsson, Roland/AAJ-3519-2021	Gohil, Vishal/0000-0002-9920-2563; Nilsson, Roland/0000-0002-6020-7498	National Institutes of Health [R01DK081457]; United Mitochondrial Disease Foundation; Broad Institute Scientific Planning and Allocation of Resources Committee; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Broad Institute Scientific Planning and Allocation of Resources Committee; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081457 (to V. K. M.). This work was also supported by grants from the United Mitochondrial Disease Foundation (to V. M. G.), the Broad Institute Scientific Planning and Allocation of Resources Committee, and the American Diabetes Association.	Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Lee N, 2001, AM J HUM GENET, V68, P397, DOI 10.1086/318197; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MERANTE F, 1993, AM J HUM GENET, V53, P481; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	25	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13742	13747		10.1074/jbc.M109.098400	http://dx.doi.org/10.1074/jbc.M109.098400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20220140	hybrid, Green Published			2022-12-27	WOS:000276987700049
J	Myeni, SK; Zhou, DG				Myeni, Sebenzile K.; Zhou, Daoguo			The C Terminus of SipC Binds and Bundles F-actin to Promote Salmonella Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELLS; TYPHIMURIUM ENTRY; PROTEIN DELIVERY; NUCLEATION; CYTOSKELETON; DIMERIZATION; COMPLEX; FIMBRIN; VILLIN	Salmonella enterica serovar Typhimurium invade non-phagocytic cells by injecting bacterial effector proteins to exploit the host actin cytoskeleton network. SipC is such a Salmonella effector known to nucleate actin, bundle F-actin, and translocate type III effectors. The molecular mechanism of how SipC bundles F-actin and SipC domains responsible for these activities are not well characterized. We successfully separated these activities through a series of genetic deletion/insertions in SipC. We found that the C terminus (amino acids 200-409) of SipC bundled actin filaments using in vitro biochemical assays. We further demonstrated that amino acid residues 221-260 and 381-409 of full-length SipC were indispensable for its actin binding and bundling activities. Furthermore, Salmonella mutant strains lacking the actin bundling activity were less invasive into HeLa cells. These studies indicate that the C terminus of SipC bundles F-actin to promote Salmonella invasion.	[Myeni, Sebenzile K.; Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, DG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	zhoud@purdue.edu						Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; HUECK CJ, 1995, MOL MICROBIOL, V18, P479, DOI 10.1111/j.1365-2958.1995.mmi_18030479.x; Jepson MA, 2001, CELL MICROBIOL, V3, P417, DOI 10.1046/j.1462-5822.2001.00124.x; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TSUKITA S, 1988, CELL MOTIL CYTOSKEL, V10, P451, DOI 10.1002/cm.970100402; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	31	52	55	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13357	13363		10.1074/jbc.M109.094045	http://dx.doi.org/10.1074/jbc.M109.094045			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212042	Green Published, hybrid			2022-12-27	WOS:000276987700006
J	Xia, GQ; Maier, L; Sanchez-Carballo, P; Li, M; Otto, M; Holst, O; Peschel, A				Xia, Guoqing; Maier, Lisa; Sanchez-Carballo, Patricia; Li, Min; Otto, Michael; Holst, Otto; Peschel, Andreas			Glycosylation of Wall Teichoic Acid in Staphylococcus aureus by TarM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLRIBITOL LINKAGES; BACTERIOPHAGE-RESISTANT MUTANTS; IN-VITRO RECONSTITUTION; BACILLUS-SUBTILIS 168; CELL-WALL; LISTERIA-MONOCYTOGENES; ENZYMATIC SYNTHESIS; STREPTOCOCCUS-PNEUMONIAE; NASAL COLONIZATION; GLYCEROL PHOSPHATE	Wall teichoic acid (WTA) glycopolymers are major constituents of cell envelopes in Staphylococcus aureus and related Gram-positive bacteria with important roles in cell wall maintenance, susceptibility to antimicrobial molecules, biofilm formation, and host interaction. Most S. aureus strains express polyribitol phosphate WTA substituted with D-alanine and N-acetylglucosamine (GlcNAc). WTA sugar modifications are highly variable and have been implicated in bacteriophage susceptibility and immunogenicity, but the pathway and enzymes of staphylococcal WTA glycosylation have remained unknown. Revisiting the structure of S. aureus RN4220 WTA by NMR analysis revealed the presence of canonical polyribitol phosphate WTA bearing only alpha-linked GlcNAc substituents. A RN4220 transposon mutant resistant to WTA-dependent phages was identified and shown to produce altered WTA, which exhibited faster electrophoretic migration and lacked completely the WTA alpha-GlcNAc residues. Disruption of a gene of unknown function, renamed tarM, was responsible for this phenotype. Recombinant TarM was capable of glycosylating WTA in vitro in a UDP-GlcNAc-dependent manner, thereby confirming its WTA GlcNAc-transferase activity. Deletion of the last seven amino acids from the C terminus abolished the activity of TarM. tarM-related genes were found in the genomes of several WTA-producing bacteria, suggesting that TarM-mediated WTA glycosylation is a general pathway in Gram-positive bacteria. Our study represents a basis for dissecting the biosynthesis and function of glycosylated WTA in S. aureus and other bacteria.	[Xia, Guoqing; Maier, Lisa; Peschel, Andreas] Univ Tubingen, Div Cellular & Mol Microbiol, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Sanchez-Carballo, Patricia; Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany; [Li, Min; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Forschungszentrum Borstel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peschel, A (corresponding author), Univ Tubingen, Div Cellular & Mol Microbiol, Interfac Inst Microbiol & Infect Med, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Xia, Guoqing/C-2365-2015; Maier, Lisa/ABH-1893-2021	Xia, Guoqing/0000-0003-4492-9156; Maier, Lisa/0000-0002-6473-4762; Sanchez Carballo, Patricia M./0000-0003-1061-7023; Otto, Michael/0000-0002-2222-4115	German Research Foundation [SFB34, SFB766, GKR685]; German Ministry of Education and Technology; National Institutes of Health [AI000904-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000904, ZIAAI000904] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by German Research Foundation Grants TR-SFB34, SFB766, and GKR685 and by the German Ministry of Education and Technology (SkinStaph) (to A. P.) and also in part by the National Institutes of Health Intramural Research Program of NIAIDZIA AI000904-08 (to M. L. and M. O.).	Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; CHATTERJEE AN, 1969, J BACTERIOL, V100, P846, DOI 10.1128/JB.100.2.846-853.1969; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Debabov DV, 1996, J BACTERIOL, V178, P3869, DOI 10.1128/jb.178.13.3869-3876.1996; ENDL J, 1983, ARCH MICROBIOL, V135, P215, DOI 10.1007/BF00414483; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1966, BIOCHIM BIOPHYS ACTA, V124, P415, DOI 10.1016/0304-4165(66)90211-X; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; Jenni R, 1998, ARCH MICROBIOL, V170, P171, DOI 10.1007/s002030050630; JUERGENS WG, 1963, J EXP MED, V117, P925, DOI 10.1084/jem.117.6.925; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lei XH, 2001, J BACTERIOL, V183, P1133, DOI 10.1128/JB.183.4.1133-1139.2001; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; LOWRY OH, 1954, J BIOL CHEM, V207, P39; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Meredith TC, 2008, J BACTERIOL, V190, P3046, DOI 10.1128/JB.01880-07; NATHENSON SG, 1962, J BIOL CHEM, V237, P3839; NATHENSON SG, 1963, J BIOL CHEM, V238, P3161; NATHENSON SG, 1966, J BIOL CHEM, V241, P651; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005; Pantucek R, 2004, ARCH VIROL, V149, P1689, DOI 10.1007/s00705-004-0335-6; PARK JT, 1974, ANN NY ACAD SCI, V236, P54, DOI 10.1111/j.1749-6632.1974.tb41481.x; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; POLLACK JH, 1994, J BACTERIOL, V176, P7252, DOI 10.1128/JB.176.23.7252-7259.1994; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; SANDERSON AR, 1962, J BIOL CHEM, V237, P3603; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SHAW DRD, 1970, J BIOL CHEM, V245, P5101; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; STROMINGER JL, 1959, J BIOL CHEM, V234, P3263; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; TORII M, 1964, J EXP MED, V120, P13, DOI 10.1084/jem.120.1.13; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Vinogradov E, 2006, CARBOHYD RES, V341, P738, DOI 10.1016/j.carres.2006.01.012; Vollmer W, 2001, MOL MICROBIOL, V39, P1610, DOI 10.1046/j.1365-2958.2001.02349.x; Wann ER, 1999, FEMS MICROBIOL LETT, V170, P97; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, INT J MED MICROBIOL, V298, P505, DOI 10.1016/j.ijmm.2007.11.006; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377	58	100	103	8	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13405	13415		10.1074/jbc.M109.096172	http://dx.doi.org/10.1074/jbc.M109.096172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185825	Green Published, hybrid			2022-12-27	WOS:000276987700012
J	Zhang, LL; Xie, P; Wang, JZ; Yang, QW; Fang, CQ; Zhou, S; Li, JC				Zhang, Lili; Xie, Peng; Wang, Jingzhou; Yang, Qingwu; Fang, Chuanqin; Zhou, Shuang; Li, Jingcheng			Impaired Peroxisome Proliferator-activated Receptor-gamma Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; GENE-EXPRESSION; MIGRATION; PHOSPHORYLATION; INSULIN; ROSIGLITAZONE; GROWTH; INHIBITION; NUCLEAR; ALPHA	The phenotypic modulation of vascular smooth muscle cells (VSMCs) plays a pivotal role in hypertension-induced vascular changes including vascular remodeling. The precise mechanisms underlying VSMC phenotypic modulation remain elusive. Here we test the role of peroxisome proliferator-activated receptor (PPAR)-gamma in the VSMC phenotypic modulation during hypertension. Both spontaneously hypertensive rat (SHR) aortas and SHR-derived VSMCs exhibited reduced PPAR-gamma expression and excessive VSMC phenotypic modulation identified by reduced contractile proteins, alpha-smooth muscle actin (alpha-SMA) and smooth muscle 22 alpha (SM22 alpha), and enhanced proliferation and migration. PPAR-gamma overexpression rescued the expression of alpha-SMA and SM22 alpha, and inhibited the proliferation and migration in SHR-derived VSMCs. In contrast, PPAR-gamma silencing exerted the opposite effect. Activating PPAR-gamma using rosiglitazone in vivo up-regulated aortic alpha-SMA and SM22 alpha expression and attenuated aortic remodeling in SHRs. Increased activation of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling was observed in SHR-derived VSMCs. PI3K inhibitor LY294002 rescued the impaired expression of contractile proteins, and inhibited proliferation and migration in VSMCs from SHRs, whereas constitutively active PI3K mutant had the opposite effect. Overexpression or silencing of PPAR-gamma inhibited or excited PI3K/Akt activity, respectively. LY294002 counteracted the PPAR-gamma silencing induced proliferation and migration in SHR-derived VSMCs, whereas active PI3K mutant had the opposite effect. In contrast, reduced proliferation and migration by PPAR-gamma overexpression were reversed by the active PI3K mutant, and further inhibited by LY294002. We conclude that PPAR-gamma inhibits VSMC phenotypic modulation through inhibiting PI3K/Akt signaling. Impaired PPAR-gamma expression is responsible for VSMC phenotypic modulation during hypertension. These findings highlight an attractive therapeutic target for hypertension-related vascular disorders.	[Zhang, Lili; Wang, Jingzhou; Yang, Qingwu; Fang, Chuanqin; Li, Jingcheng] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China; [Xie, Peng] Chongqing Univ Med Sci, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; [Zhou, Shuang] Second Mil Med Univ, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China	Army Medical University; Chongqing Medical University; Naval Medical University	Li, JC (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China.	lijingcheng11@gmail.com			National Natural Science Foundation of China [30800444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30800444.	Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bruemmer D, 2003, AM J MED, V115, P87, DOI 10.1016/j.amjmed.2003.09.014; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Choi D, 2004, DIABETES CARE, V27, P2654, DOI 10.2337/diacare.27.11.2654; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gensch C, 2007, ATHEROSCLEROSIS, V192, P67, DOI 10.1016/j.atherosclerosis.2006.06.026; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; Hattori Y, 2000, BIOCHEM BIOPH RES CO, V273, P1144, DOI 10.1006/bbrc.2000.3084; Hayashi K, 2009, J MECH BEHAV BIOMED, V2, P3, DOI 10.1016/j.jmbbm.2008.05.002; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Lee SJ, 2009, INT IMMUNOPHARMACOL, V9, P837, DOI 10.1016/j.intimp.2009.03.010; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Mitra AK, 2009, J CELL MOL MED, V13, P177, DOI 10.1111/j.1582-4934.2008.00311.x; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nakagawa M, 2007, BIOL PHARM BULL, V30, P1754, DOI 10.1248/bpb.30.1754; Ogawa D, 2006, CIRC RES, V98, pE50, DOI 10.1161/01.RES.0000218271.93076.c3; OGIHARA T, 1995, AM J HYPERTENS, V8, P316, DOI 10.1016/0895-7061(95)96214-5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Sidhu JS, 2004, ARTERIOSCL THROM VAS, V24, P930, DOI 10.1161/01.ATV.0000124890.40436.77; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wang ZB, 2005, NEUROSCI LETT, V373, P38, DOI 10.1010/j.neulet.2004.09.068; Xiong C, 2005, LIFE SCI, V77, P3037, DOI 10.1016/j.lfs.2005.02.032; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704	40	43	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13666	13677		10.1074/jbc.M109.087718	http://dx.doi.org/10.1074/jbc.M109.087718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212046	Green Published, hybrid			2022-12-27	WOS:000276987700041
J	Zheng, YX; Brash, AR				Zheng, Yuxiang; Brash, Alan R.			Formation of a Cyclopropyl Epoxide via a Leukotriene A Synthase-related Pathway in an Anaerobic Reaction of Soybean Lipoxygenase-1 with 15S-Hydroperoxyeicosatetraenoic Acid EVIDENCE THAT OXYGEN ACCESS IS A DETERMINANT OF SECONDARY REACTIONS WITH FATTY ACID HYDROPEROXIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; LINOLEIC-ACID; PORCINE LEUKOCYTES; RETICULOCYTE LIPOXYGENASE; LIQUID-CHROMATOGRAPHY; MAST-CELLS; ENZYME; TRANSFORMATION; HYDROPEROXIDE; BIOSYNTHESIS	The further conversion of an arachidonic acid hydroperoxide to a leukotriene A (LTA) type epoxide by specific lipoxygenase (LOX) enzymes constitutes a key step in inflammatory mediator biosynthesis. Whereas mammalian 5-LOX transforms its primary product (5S-hydroperoxyeicosatetraenoic acid; 5S-HPETE) almost exclusively to LTA(4), the model enzyme, soybean LOX-1, normally produces no detectable leukotrienes and instead further oxygenates its primary product 15S-HPETE to 5,15- and 8,15-dihydroperoxides. Mammalian 15-LOX-1 displays both types of activity. We reasoned that availability of molecular oxygen within the LOX active site favors oxygenation, whereas lack of O-2 promotes LTA epoxide synthesis. To test this, we reacted 15S-HPETE with soybean LOX-1 under anaerobic conditions and identified the products by high pressure liquid chromatography, UV, mass spectrometry, and NMR. Among the products, we identified a pair of 8,15-dihydroxy diastereomers with all-trans-conjugated trienes that incorporated O-18 from H-2 O-18 at C-8, indicative of the formation of 14,15-LTA(4). A pair of 5,15-dihydroxy diastereomers containing two trans, trans-conjugated dienes (6E, 8E, 11E, 13E) and that incorporated O-18 from H-2 O-18 at C-5 was deduced to arise from hydrolysis of a novel epoxide containing a cyclopropyl ring, 14,15-epoxy-[9,10,11-cyclopropyl]-eicosa-5Z, 7E, 13E-trienoic acid. Also identified was the delta-lactone of the 5,15-diol, a derivative that exhibited no O-18 incorporation due to its formation by intramolecular reaction of the carboxyl anion with the proposed epoxide intermediate. Our results support a model in which access to molecular oxygen within the active site directs the outcome from competing pathways in the secondary reactions of lipoxygenases.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Zheng, YX (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [AR-051968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR-051968 (to A. R. B.).	Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; BRYANT RW, 1985, J BIOL CHEM, V260, P3548; CHRISTIE WW, 1989, J CHROMATOGR, V469, P261, DOI 10.1016/S0021-9673(01)96461-1; COREY EJ, 1980, J AM CHEM SOC, V102, P1435, DOI 10.1021/ja00524a044; COREY EJ, 1989, J AM CHEM SOC, V111, P1452, DOI 10.1021/ja00186a046; COREY EJ, 1983, TETRAHEDRON LETT, V24, P4921, DOI 10.1016/S0040-4039(01)99811-9; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; DEGROOT JJM, 1973, BIOCHIM BIOPHYS ACTA, V326, P279, DOI 10.1016/0005-2760(73)90254-3; DEGROOT JJM, 1975, FEBS LETT, V56, P50, DOI 10.1016/0014-5793(75)80109-8; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Fukushige H, 2005, J AGR FOOD CHEM, V53, P5691, DOI 10.1021/jf047958o; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao XQ, 2008, PLANTA, V227, P491, DOI 10.1007/s00425-007-0634-8; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; GARSSEN GJ, 1976, EUR J BIOCHEM, V62, P33, DOI 10.1111/j.1432-1033.1976.tb10094.x; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GARSSEN GJ, 1972, BIOCHEM J, V130, P435, DOI 10.1042/bj1300435; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; HAMBERG M, 1983, BIOCHIM BIOPHYS ACTA, V752, P353, DOI 10.1016/0005-2760(83)90134-0; HAMBERG M, 1983, BIOCHIM BIOPHYS ACTA, V752, P191, DOI 10.1016/0005-2760(83)90112-1; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; MAAS RL, 1982, J BIOL CHEM, V257, P7056; MAAS RL, 1981, P NATL ACAD SCI-BIOL, V78, P5523, DOI 10.1073/pnas.78.9.5523; MAAS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2884, DOI 10.1073/pnas.80.10.2884; MAAS RL, 1985, J BIOL CHEM, V260, P4217; MOUSSEBOIS C, 1966, J CHEM SOC C, P260, DOI 10.1039/j39660000260; POWELL WS, 1982, METHOD ENZYMOL, V86, P530; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; SHIMIZU T, 1986, P NATL ACAD SCI USA, V83, P4175, DOI 10.1073/pnas.83.12.4175; SOK DE, 1983, BIOCHEM BIOPH RES CO, V110, P273, DOI 10.1016/0006-291X(83)91291-3; VANOS CPA, 1981, BIOCHIM BIOPHYS ACTA, V663, P177, DOI 10.1016/0005-2760(81)90204-6; Vliegenthart J. F. G., 1982, FREE RADICAL BIO MED, P29; YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100	45	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13427	13436		10.1074/jbc.M109.084632	http://dx.doi.org/10.1074/jbc.M109.084632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194505	hybrid, Green Published			2022-12-27	WOS:000276987700014
J	Premkumar, L; Bobkov, AA; Patel, M; Jaroszewski, L; Bankston, LA; Stec, B; Vuori, K; Cote, JF; Liddington, RC				Premkumar, Lakshmanane; Bobkov, Andrey A.; Patel, Manishha; Jaroszewski, Lukasz; Bankston, Laurie A.; Stec, Boguslaw; Vuori, Kristiina; Cote, Jean-Francois; Liddington, Robert C.			Structural Basis of Membrane Targeting by the Dock180 Family of Rho Family Guanine Exchange Factors (Rho-GEFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; NUCLEOTIDE-EXCHANGE; C2 DOMAIN; CELL-MIGRATION; MYOBLAST CITY; CRKII/DOCK180/RAC PATHWAY; APOPTOTIC CELLS; CDC42 ACTIVATOR; BINDING; PROTEIN	The Dock180 family of atypical Rho family guanine nucleotide exchange factors (Rho-GEFs) regulate a variety of processes involving cellular or subcellular polarization, including cell migration and phagocytosis. Each contains a Dock homology region-1 (DHR-1) domain that is required to localize its GEF activity to a specific membrane compartment where levels of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) are up-regulated by the local activity of PtdIns 3-kinase. Here we define the structural and energetic bases of phosphoinositide specificity by the DHR-1 domain of Dock1 (a GEF for Rac1), and show that DHR-1 utilizes a C2 domain scaffold and surface loops to create a basic pocket on its upper surface for recognition of the PtdIns(3,4,5)P-3 head group. The pocket has many of the characteristics of those observed in pleckstrin homology domains. We show that point mutations in the pocket that abolish phospholipid binding in vitro ablate the ability of Dock1 to induce cell polarization, and propose a model that brings together recent mechanistic and structural studies to rationalize the central role of DHR-1 in dynamic membrane targeting of the Rho-GEF activity of Dock180.	[Stec, Boguslaw; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Bobkov, Andrey A.; Jaroszewski, Lukasz; Vuori, Kristiina] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Patel, Manishha; Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Liddington, RC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@burnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health NIGMS Cell Migration Consortium [U54 GM06346]; Canadian Institute of Health Research; IRCM Training Program in Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); IRCM Training Program in Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Cell Migration Consortium Grant U54 GM06346 (to R. C. L.) and the Canadian Institute of Health Research (to J.-F.C.).; Supported by a Canadian Institute of Health Research award from the IRCM Training Program in Cancer Research.; Holds a Canadian Institute of Health Research New Investigator award.	Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadmel B, 2008, J PROTEOME RES, V7, P5295, DOI 10.1021/pr800540h; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kanai A, 2008, IUBMB LIFE, V60, P467, DOI 10.1002/iub.67; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Meller N, 2008, BIOCHEM J, V409, P525, DOI 10.1042/BJ20071263; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Omi N, 2008, EXP EYE RES, V86, P828, DOI 10.1016/j.exer.2008.02.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468	86	44	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13211	13222		10.1074/jbc.M110.102517	http://dx.doi.org/10.1074/jbc.M110.102517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167601	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000276787800076
J	Zhou, MX; Zhu, F; Dong, SL; Pritchard, DG; Wu, H				Zhou, Meixian; Zhu, Fan; Dong, Shengli; Pritchard, David G.; Wu, Hui			A Novel Glucosyltransferase Is Required for Glycosylation of a Serine-rich Adhesin and Biofilm Formation by Streptococcus parasanguinis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIAE-ASSOCIATED ADHESIN; BINDING-PROTEIN GSPB; ACCESSORY SEC SYSTEM; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; HUMAN PLATELETS; SANGUIS FW213; FAP1; GLYCOPROTEIN; GLYCOSYLTRANSFERASES	Fap1-like serine-rich glycoproteins are conserved in streptococci, staphylococci, and lactobacilli, and are required for bacterial biofilm formation and pathogenesis. Glycosylation of Fap1 is mediated by a gene cluster flanking the fap1 locus. The key enzymes responsible for the first step of Fap1 glycosylation are glycosyltransferases Gtf1 and Gtf2. They form a functional enzyme complex that catalyzes the transfer of N-acetylglucosamine (GlcNAc) residues to the Fap1 polypeptide. However, until now nothing was known about the subsequent step in Fap1 glycosylation. Here, we show that the second step in Fap1 glycosylation is catalyzed by nucleotide-sugar synthetase-like (Nss) protein. The nss gene located upstream of fap1 is also highly conserved in streptococci and lactobacilli. Nss-deficient mutants failed to catalyze the second step of Fap1 glycosylation in vivo in Streptococcus parasanguinis and in a recombinant Fap1 glycosylation system. Nss catalyzed the direct transfer of the glucosyl residue to the GlcNAc-modified Fap1 substrate in vitro, demonstrating that Nss is a glucosyltransferase. Thus we renamed Nss as glucosyltransferase 3 (Gtf3). A gtf3 mutant exhibited a biofilm defect. Taken together, we conclude that this new glucosyltransferase mediates the second step of Fap1 glycosylation and is required for biofilm formation.	[Wu, Hui] Univ Alabama, Dept Pediat Dent, Sch Dent, Birmingham, AL 35244 USA; [Dong, Shengli; Pritchard, David G.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35244 USA; [Wu, Hui] Univ Alabama, Dept Microbiol, Birmingham, AL 35244 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), Univ Alabama, Dept Pediat Dent, Sch Dent, 802 SDB, Birmingham, AL 35244 USA.	hwu@uab.edu			National Institutes of Health [R01 DE011000]; NIDCR [DE017954]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE011000 and DE017954 from the NIDCR (to H.W.).	Banerjee A, 2002, J EXP MED, V196, P147, DOI 10.1084/jem.20012022; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; ELDER BL, 1986, INFECT IMMUN, V54, P421, DOI 10.1128/IAI.54.2.421-427.1986; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; HAMADEH RM, 1995, INFECT IMMUN, V63, P4900, DOI 10.1128/IAI.63.12.4900-4906.1995; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Leipold MD, 2007, J BIOL CHEM, V282, P26786, DOI 10.1074/jbc.M704131200; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Mendez C, 2001, TRENDS BIOTECHNOL, V19, P449, DOI 10.1016/S0167-7799(01)01765-6; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Oberthur M, 2005, J AM CHEM SOC, V127, P10747, DOI 10.1021/ja052945s; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orihuela CJ, 2009, J INFECT DIS, V200, P1180, DOI 10.1086/605649; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Truman AW, 2009, CHEM BIOL, V16, P676, DOI 10.1016/j.chembiol.2009.04.013; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	52	39	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12140	12148		10.1074/jbc.M109.066928	http://dx.doi.org/10.1074/jbc.M109.066928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164186	hybrid, Green Published			2022-12-27	WOS:000276787100044
J	Field, JR; Henry, LK; Blakely, RD				Field, Julie R.; Henry, L. Keith; Blakely, Randy D.			Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; SUBSTITUTED-CYSTEINE ACCESSIBILITY; HIGH-AFFINITY RECOGNITION; DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTER; SUBSTRATE RECOGNITION; SCANNING MUTAGENESIS; MOLECULAR-MECHANISM; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE	The plasma membrane serotonin (5-HT) transporter (SERT, SLC6A4) clears 5-HT after release at nerve termini and is targeted by both antidepressant medications and psychostimulants (e. g. MDMA, cocaine). Homology modeling of human SERT (hSERT), based on high resolution structures of the microbial SLC6 family member LeuT(Aa), along with biochemical studies of wild type and mutant transporters, predicts transmembrane (TM) domains 1, 3, 6, and 8 comprise the 5-HT-binding pocket. We utilized the substituted cysteine accessibility method along with surface and site-specific biotinylation to probe TM6 for aqueous accessibility and differential interactions with 5-HT and psychostimulants. Our results are consistent with TM6 being composed of an aqueous-accessible, alpha-helical extracellular domain (TM6a) that is separated by a central, unwound section from a cytoplasmically localized domain (TM6b) with limited aqueous accessibility. The substitution G338C appears to lock hSERT in an outward-facing conformation that, although accessible to aminoethylmethanethio-sulfonate-biotin, 5-HT, and citalopram, is incapable of inward 5-HT transport. Transport of 5-HT by G338C can be partially restored by the TM1 mutation Y95F. With regard to methanethiosulfonate (MTS) inactivation of uptake, TM6a Cys mutants demonstrate Na+-dependent [2-(trimethylammonium)ethyl]MTS sensitivity. Studies with the centrally located substitution S336C reveal features of acommonbinding pocket for 5-HT and 3,4-methylenedioxymethamphetamine (MDMA). Interestingly, the substitution I333C reveals an MDMA-induced conformation not observed with 5-HT. In the context of prior studies on TM1, our findings document shared and unique features of TM6 contributing to hSERT aqueous accessibility, ligand recognition, and conformational dynamics.	[Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA; [Field, Julie R.; Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37232 USA; [Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of North Dakota Grand Forks	Blakely, RD (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA.	randy.blakely@vanderbilt.edu			National Institutes of Health [DA07390, DA022378, DA23337]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023337, R01DA007390, K01DA022378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA07390 (to R. D. B.), DA022378 (to L. K. H.), and DA23337 (to J.R.F.).	Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Cooper J.R., 2003, BIOCH BASIS NEUROPHA, Veighth, P271; Dodd JR, 2005, J BIOL CHEM, V280, P32649, DOI 10.1074/jbc.M506723200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gu HH, 1996, J BIOL CHEM, V271, P6911, DOI 10.1074/jbc.271.12.6911; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lill H, 1998, METHOD ENZYMOL, V296, P425; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Melikian HE, 1996, MOL PHARMACOL, V50, P266; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Prasad HC, 2009, PHILOS T R SOC B, V364, P163, DOI 10.1098/rstb.2008.0143; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; SAIER MH, 2002, TRANSMEMBRANE TRANSP, P1; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2000, J NEUROCHEM, V74, P1317; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TATE CG, 1994, J BIOL CHEM, V269, P26303; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200	58	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11270	11280		10.1074/jbc.M109.093658	http://dx.doi.org/10.1074/jbc.M109.093658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159976	hybrid, Green Published			2022-12-27	WOS:000276286200033
J	Kock, K; Koenen, A; Giese, B; Fraunholz, M; May, K; Siegmund, W; Hammer, E; Volker, U; Jedlitschky, G; Kroemer, HK; Grube, M				Koeck, Kathleen; Koenen, Anna; Giese, Bernd; Fraunholz, Martin; May, Karen; Siegmund, Werner; Hammer, Elke; Voelker, Uwe; Jedlitschky, Gabriele; Kroemer, Heyo K.; Grube, Markus			Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; BREAST-CANCER; HUMAN PLACENTA; PHOSPHORYLATION SITES; DOPAMINE TRANSPORTER; STEROID-HORMONES; DOWN-REGULATION; CACO-2 CELLS; HUMAN HEART; CLATHRIN	Members of the organic anion transporting polypeptide (OATP) family are involved in various pharmacological, pathophysiological, and physiological processes, such as hepatic drug uptake, progress of cancer, or transport of hormones. Although variability in expression and function of OATPs has been investigated in detail, data concerning regulation are rather limited. Here, we report a novel mechanism for rapid regulation of OATP2B1 mediated by protein kinase C (PKC) resulting in significant changes of transport activity. PKC activation by the phorbol ester (phorbol 12-myristate 13-acetate, PMA) resulted in increased phosphorylation of OATP2B1 as well as reduced OATP2B1 transport activity with a decrease in V-max of E1S uptake (288 +/- 21 (control) versus 165 +/- 16 pmol/min/mg of protein (PMA)). This effect was sensitive to the PKC inhibitor bisindolylmaleimide I (BIM-I). Confocal microscopy, fluorescence-based internalization assay, and live-cell imaging using green fluorescent protein-tagged OATP2B1 revealed that transport inhibition was due to internalization of the transporter. Furthermore, colocalization with LAMP-2 and chloroquine-sensitive degradation of OATP2B1 suggest that the internalized protein is targeted to a lysosomal degradation pathway. With regard to the underlying mechanism inhibition of caveolin/lipid raft-mediated endocytosis failed to prevent OATP2B1 internalization, whereas inhibition of clathrin-mediated processes blocked OATP2B1 sequestration. However, small interfering RNA-mediated clathrin knock-down affected general trafficking of OATP2B1 and resulted in intracellular accumulation in the absence of PMA. In conclusion, our data demonstrate that OATP2B1 function is regulated by PKC-mediated, clathrin-dependent internalization and followed by lysosomal degradation. Furthermore, internalization could be shown in an ex vivo placenta perfusion. Our findings represent a new, rapid mechanism in regulation of human OATPs.	[Koeck, Kathleen; Koenen, Anna; May, Karen; Siegmund, Werner; Jedlitschky, Gabriele; Kroemer, Heyo K.; Grube, Markus] Ernst Moritz Arndt Univ Greifswald, Res Ctr Pharmacol & Expt Therapeut, Dept Pharmacol, D-17487 Greifswald, Germany; [Giese, Bernd; Fraunholz, Martin] Ernst Moritz Arndt Univ Greifswald, Competence Ctr Funct Gen, D-17487 Greifswald, Germany; [Hammer, Elke; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Kroemer, HK (corresponding author), Friedrich Loeffler Str 23D, D-17487 Greifswald, Germany.	kroemer@uni-greifswald.de		Hammer, Elke/0000-0002-1507-0402; Volker, Uwe/0000-0002-5689-3448; Fraunholz, Martin/0000-0002-4581-6244	Deutsche Forschungsgemeinschaft [GR 3375/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GR 3375/1-1.	Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Alzamora R, 2008, STEROIDS, V73, P885, DOI 10.1016/j.steroids.2008.01.001; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Assender JW, 2007, J CLIN PATHOL, V60, P1216, DOI 10.1136/jcp.2006.041616; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Crocenzi FA, 2008, HEPATOLOGY, V48, P1885, DOI 10.1002/hep.22532; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Deng JW, 2008, PHARMACOGENET GENOM, V18, P424, DOI 10.1097/FPC.0b013e3282fb02a3; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Grube M, 2006, CIRCULATION, V113, P1114, DOI 10.1161/CIRCULATIONAHA.105.586107; Grube M, 2007, DRUG METAB DISPOS, V35, P30, DOI 10.1124/dmd.106.011411; Grube M, 2006, CLIN PHARMACOL THER, V80, P607, DOI 10.1016/j.clpt.2006.09.010; Grube M, 2006, MOL PHARMACOL, V70, P1735, DOI 10.1124/mol.106.026450; Guo GL, 2001, J PHARMACOL EXP THER, V299, P551; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iwai M, 2004, PHARMACOGENETICS, V14, P749, DOI 10.1097/00008571-200411000-00006; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LIE SO, 1973, BIOCHEM PHARMACOL, V22, P3109, DOI 10.1016/0006-2952(73)90197-4; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010; Niessen J, 2009, DRUG METAB DISPOS, V37, P1129, DOI 10.1124/dmd.108.024570; Nozawa T, 2004, J PHARMACOL EXP THER, V308, P438, DOI 10.1124/jpet.103.060194; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; Rost D, 2005, EUR J CLIN INVEST, V35, P635, DOI 10.1111/j.1365-2362.2005.01556.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P780, DOI 10.1073/pnas.77.2.780; Sai Y, 2006, DRUG METAB DISPOS, V34, P1423, DOI 10.1124/dmd.106.009530; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Satoh H, 2005, DRUG METAB DISPOS, V33, P518, DOI 10.1124/dmd.104.002337; Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; St-Pierre MV, 2002, J CLIN ENDOCR METAB, V87, P1856, DOI 10.1210/jc.87.4.1856; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Sun AQ, 2008, PHARM RES-DORDR, V25, P463, DOI 10.1007/s11095-007-9399-9; Tachibana-Iimori Rieko, 2004, Drug Metab Pharmacokinet, V19, P375, DOI 10.2133/dmpk.19.375; Tamai I, 2001, PHARMACEUT RES, V18, P1262, DOI 10.1023/A:1013077609227; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaidyanathan S, 2008, J CLIN PHARMACOL, V48, P1323, DOI 10.1177/0091270008323258; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P1145, DOI 10.1210/jcem-63-5-1145; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200	63	73	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11336	11347		10.1074/jbc.M109.056457	http://dx.doi.org/10.1074/jbc.M109.056457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159975	Green Published, hybrid			2022-12-27	WOS:000276286200040
J	Denda-Nagai, K; Aida, S; Saba, K; Suzuki, K; Moriyama, S; Oo-puthinan, S; Tsuiji, M; Morikawa, A; Kumamoto, Y; Sugiura, D; Kudo, A; Akimoto, Y; Kawakami, H; Bovin, NV; Irimura, T				Denda-Nagai, Kaori; Aida, Satoshi; Saba, Kengo; Suzuki, Kiwamu; Moriyama, Saya; Oo-puthinan, Sarawut; Tsuiji, Makoto; Morikawa, Akiko; Kumamoto, Yosuke; Sugiura, Daisuke; Kudo, Akihiko; Akimoto, Yoshihiro; Kawakami, Hayato; Bovin, Nicolai V.; Irimura, Tatsuro			Distribution and Function of Macrophage Galactose-type C-type Lectin 2 (MGL2/CD301b) EFFICIENT UPTAKE AND PRESENTATION OF GLYCOSYLATED ANTIGENS BY DENDRITIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGALACTOSAMINE-SPECIFIC LECTIN; IN-VIVO; MOLECULAR-CLONING; CROSS-PRESENTATION; EXPRESSION; MONOCYTES; DISTINCT; MUC1; DIFFERENTIATION; INTERNALIZATION	Dendritic cells (DCs) express cell surface lectins that are potentially involved in the recognition, uptake, and presentation of glycosylated foreign substances. A unique calcium-type (C-type) lectin, the macrophage galactose (Gal)-type C-type lectin (MGL/CD301) expressed on DCs, is thought to participate in the recognition of molecules from both altered self and pathogens due to its monosaccharide specificity for Gal and N-acetylgalactosamine (GalNAc). Although mice have two MGL genes, Mgl1 and Mgl2, their distinct roles have not been previously explored. The present report characterizes the properties of MGL2 by examining its distribution and its role in antigen presentation by DCs. We generated an MGL2-specific monoclonal antibody and examined MGL2 expression in tissues by immunohistochemistry and in isolated cells by flow cytometry. The cells reactive with this antibody were shown to be a portion of MGL1-expressing cells, mostly conventional DCs. Internalization of soluble polyacrylamide polymers (PAA) with a-GalNAc residues (GalNAc-PAA) by bone marrow-derived DCs (BM-DCs) was mediated by MGL2, as revealed by a comparison of Mgl1(-/-) and Mgl2(-/-) BM-DCs with wild-type BM-DCs. Biotinylated GalNAc-PAA conjugated to streptavidin (SAv) was more efficiently presented to SAv-primed T cells by BM-DCs than beta-N-acetylglucosamine-PAA conjugated to SAv or SAv alone as shown by thymidine uptake and cytokine production. This is the first report that demonstrates the involvement of GalNAc residues in antigen uptake and presentation by DCs that lead to CD4(+) T cell activation.	[Irimura, Tatsuro] Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tsuiji, Makoto] Hoshi Univ, Dept Microbiol, Sch Pharm & Pharmaceut Sci, Tokyo 1428501, Japan; [Kudo, Akihiko; Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Div Microscop Anat, Mitaka, Tokyo 1818611, Japan; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	University of Tokyo; Hoshi University; Kyorin University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Irimura, T (corresponding author), Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp	Tsuiji, Makoto/G-1411-2010; Bovin, Nicolai/P-2948-2017; Kudo, Akihiko/ACZ-3340-2022	Tsuiji, Makoto/0000-0002-5607-4880; Bovin, Nicolai/0000-0001-8669-4477; Kudo, Akihiko/0000-0002-2630-5991; Kumamoto, Yosuke/0000-0001-9369-4934; Denda-Nagai, Kaori/0000-0001-8325-3289; Sugiura, Daisuke/0000-0002-3865-3889	Ministry of Education, Science, Sports, and Culture of Japan; Research Association for Biotechnology; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Association for Biotechnology; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, the Research Association for Biotechnology, and the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bovin NV, 1998, GLYCOCONJUGATE J, V15, P431, DOI 10.1023/A:1006963717646; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Clark G, 2005, CELL IMMUNOL, V236, P21, DOI 10.1016/j.cellimm.2005.08.005; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Denda-Nagai K, 2000, GLYCOCONJUGATE J, V17, P649, DOI 10.1023/A:1011039013134; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Imai Y, 1995, IMMUNOLOGY, V86, P591; KIMURA T, 1995, J BIOL CHEM, V270, P16056, DOI 10.1074/jbc.270.27.16056; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; Monti P, 2004, J IMMUNOL, V172, P7341, DOI 10.4049/jimmunol.172.12.7341; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Onami TM, 2002, MOL CELL BIOL, V22, P5173, DOI 10.1128/MCB.22.14.5173-5181.2002; Oo-Puthinan S, 2008, BBA-GEN SUBJECTS, V1780, P89, DOI 10.1016/j.bbagen.2007.10.017; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rughetti A, 2005, J IMMUNOL, V174, P7764, DOI 10.4049/jimmunol.174.12.7764; Saba K, 2009, AM J PATHOL, V174, P144, DOI 10.2353/ajpath.2009.080235; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Suzuki N, 1996, J IMMUNOL, V156, P128; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2007, EUR J IMMUNOL, V37, P2075, DOI 10.1002/eji.200636838; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; YAMAMOTO K, 1994, BIOCHEMISTRY-US, V33, P8159, DOI 10.1021/bi00192a021	48	51	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19193	19204		10.1074/jbc.M110.113613	http://dx.doi.org/10.1074/jbc.M110.113613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20304916	Green Published, hybrid			2022-12-27	WOS:000278727800029
J	Heras, B; Totsika, M; Jarrott, R; Shouldice, SR; Guncar, G; Achard, MES; Wells, TJ; Argente, MP; McEwan, AG; Schembri, MA				Heras, Begona; Totsika, Makrina; Jarrott, Russell; Shouldice, Stephen R.; Guncar, Gregor; Achard, Maud E. S.; Wells, Timothy J.; Argente, M. Pilar; McEwan, Alastair G.; Schembri, Mark A.			Structural and Functional Characterization of Three DsbA Paralogues from Salmonella enterica Serovar Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; UROPATHOGENIC ESCHERICHIA-COLI; FORMATION IN-VIVO; NEISSERIA-MENINGITIDIS; FORMATION INVIVO; ARYLSULFATE SULFOTRANSFERASE; OXIDOREDUCTASE DSBA; CRYSTAL-STRUCTURE; SECRETION SYSTEM; NUCLEIC-ACIDS	In prototypic Escherichia coli K-12 the introduction of disulfide bonds into folding proteins is mediated by the Dsb family of enzymes, primarily through the actions of the highly oxidizing protein EcDsbA. Homologues of the Dsb catalysts are found in most bacteria. Interestingly, pathogens have developed distinct Dsb machineries that play a pivotal role in the biogenesis of virulence factors, hence contributing to their pathogenicity. Salmonella enterica serovar (sv.) Typhimurium encodes an extended number of sulfhydryl oxidases, namely SeDsbA, SeDsbL, and SeSrgA. Here we report a comprehensive analysis of the sv. Typhimurium thiol oxidative system through the structural and functional characterization of the three Salmonella DsbA paralogues. The three proteins share low sequence identity, which results in several unique three-dimensional characteristics, principally in areas involved in substrate binding and disulfide catalysis. Furthermore, the Salmonella DsbA-like proteins also have different redox properties. Whereas functional characterization revealed some degree of redundancy, the properties of SeDsbA, SeDsbL, and SeSrgA and their expression pattern in sv. Typhimurium indicate a diverse role for these enzymes in virulence.	[Heras, Begona; Jarrott, Russell; Shouldice, Stephen R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Totsika, Makrina; Achard, Maud E. S.; Wells, Timothy J.; Argente, M. Pilar; McEwan, Alastair G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Guncar, Gregor] Jozef Stefan Inst, Ljubljana 1000, Slovenia	University of Queensland; University of Queensland; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Heras, B (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80, Brisbane, Qld 4072, Australia.	b.heras@imb.uq.edu.au	Heras, Begona/H-8686-2014; Schembri, Mark A/C-7262-2009; Totsika, Makrina/A-8993-2011; Wells, Timothy/AAG-3311-2021; Wells, Timothy/M-2025-2016	Heras, Begona/0000-0003-3469-7988; Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Guncar, Gregor/0000-0003-4500-6951; Wells, Timothy/0000-0001-7766-5404; Jarrott, Russell/0000-0003-4326-1203; McEwan, Alastair/0000-0002-2419-1003	Australian Research Council; Australian National Health and Medical Research Council; University of Queensland; Australian Synchrotron	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Australian Synchrotron	This work was supported in part by the Australian Research Council (to B. H., M. A. S., and A. G. M.), the Australian National Health and Medical Research Council (to B. H., M. A. S., and A. G. M.), and the University of Queensland (Postdoctoral Fellowship, to S. R. S.).; We thank Professor Jenny Martin for support and advice. We acknowledge use of the Australian Synchrotron and the support of PX1 3BM1 beamline scientists Julian Adams and Tom Caradoc-Davies. We thank Karl Byriel and Gordon King for support and access to the University of Queensland (UQ) ROCX Diffraction facility. We thank David Low for providing the anti-PefA polyclonal serum.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W.L., 2002, DELANO SCI; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jarrott R, 2010, ACTA CRYSTALLOGR F, V66, P601, DOI 10.1107/S1744309110011942; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kankwatira AM, 2004, TROP DOCT, V34, P198, DOI 10.1177/004947550403400404; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Turcot I, 2001, CAN J MICROBIOL, V47, P711, DOI 10.1139/cjm-47-8-711; Vivian JP, 2008, J BIOL CHEM, V283, P32452, DOI 10.1074/jbc.M803990200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yun HJ, 2001, MICROBIOL IMMUNOL, V45, P673, DOI 10.1111/j.1348-0421.2001.tb01301.x; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	50	41	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18423	18432		10.1074/jbc.M110.101360	http://dx.doi.org/10.1074/jbc.M110.101360			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20233716	hybrid, Green Published			2022-12-27	WOS:000278453900036
J	Lin, YF; Xu, XS; Cape, A; Li, SH; Li, XJ				Lin, Yung-Feng; Xu, Xingshun; Cape, Austin; Li, Shihua; Li, Xiao-Jiang			Huntingtin-associated Protein-1 Deficiency in Orexin-producing Neurons Impairs Neuronal Process Extension and Leads to Abnormal Behavior in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; JOUBERT-SYNDROME; FEEDING-BEHAVIOR; AXONAL-TRANSPORT; HYPOCRETIN; SLEEP; BRAIN; HAP1; AHI1; INTERACTS	Huntingtin-associated protein-1 (Hap1) is a neuronal protein that associates with huntingtin, the Huntington disease protein. Although Hap1 and huntingtin are known to be involved in intracellular trafficking, whether and how the impairment of Hap1-associated trafficking leads to neurological pathology and symptoms remain to be seen. As Hap1 is enriched in neuronal cells in the brain, addressing this issue is important in defining the role of defective intracellular trafficking in the selective neuropathology associated with Hap1 dysfunction. Here, we find that Hap1 is abundantly expressed in orexin (hypocretin)-producing neurons (orexin neurons), which are distinctly distributed in the hypothalamus and play an important role in the regulation of feeding and behavior. We created conditional Hap1 knock-out mice to selectively deplete Hap1 in orexin neurons via the Cre-loxP system. These mice show process fragmentation of orexin neurons and reductions in food intake, body weight, and locomotor activity. Sucrose density gradient fractionation reveals that loss of Hap1 in the mouse brain also reduces the distribution of trafficking protein complexes and cargo proteins in the fractions that are enriched in synaptosomes. These results suggest that Hap1 is critical for the transport of multiple proteins to the nerve terminals to maintain the integrity of neuronal processes and that selective disruption of the processes of orexin neurons can cause abnormal feeding and locomotor activity.	[Lin, Yung-Feng; Xu, Xingshun; Cape, Austin; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu	Xu, Xingshun/AAF-8183-2020; Lin, Yung-Feng/H-3289-2019	Xu, Xingshun/0000-0003-0205-6342	National Institutes of Health [NS036232, NS045016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS036232 (to X.-J.L.) and NS045016 (to S. L.).	Akimoto-Takano S, 2005, NEUROENDOCRINOLOGY, V82, P256, DOI 10.1159/000092754; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Kirouac GJ, 2005, BRAIN RES, V1059, P179, DOI 10.1016/j.brainres.2005.08.035; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kotz CM, 2005, AM J PHYSIOL-REG I, V289, pR359, DOI 10.1152/ajpregu.00717.2004; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Peyron C, 1998, J NEUROSCI, V18, P9996; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sawai N, 2010, NEUROSCI LETT, V468, P51, DOI 10.1016/j.neulet.2009.10.061; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Uldry M, 2004, EMBO J, V23, P531, DOI 10.1038/sj.emboj.7600072; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamamoto Y, 2000, MOL BRAIN RES, V78, P108, DOI 10.1016/S0169-328X(00)00080-2; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003	41	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15941	15949		10.1074/jbc.M110.107318	http://dx.doi.org/10.1074/jbc.M110.107318			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304926	hybrid, Green Published			2022-12-27	WOS:000277715900031
J	Svensson, SL; Pasupuleti, M; Walse, B; Malmsten, M; Morgelin, M; Sjogren, C; Olin, AI; Collin, M; Schmidtchen, A; Palmer, R; Egesten, A				Svensson, Sara L.; Pasupuleti, Mukesh; Walse, Bjorn; Malmsten, Martin; Morgelin, Matthias; Sjogren, Camilla; Olin, Anders I.; Collin, Mattias; Schmidtchen, Artur; Palmer, Ruth; Egesten, Arne			Midkine and Pleiotrophin Have Bactericidal Properties PRESERVED ANTIBACTERIAL ACTIVITY IN A FAMILY OF HEPARIN-BINDING GROWTH FACTORS DURING EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; EPITHELIAL-CELLS; EXPRESSION; GENE; PROTEIN; CHEMOKINES; CYTOKINE; IMMUNITY; PURIFICATION	Antibacterial peptides of the innate immune system combat pathogenic microbes, but often have additional roles in promoting inflammation and as growth factors during tissue repair. Midkine (MK) and pleiotrophin (PTN) are the only two members of a family of heparin-binding growth factors. They show restricted expression during embryogenesis and are up-regulated in neoplasia. In addition, MK shows constitutive and inflammation-dependent expression in some non-transformed tissues of the adult. In the present study, we show that both MK and PTN display strong antibacterial activity, present at physiological salt concentrations. Electron microscopy of bacteria and experiments using artificial lipid bilayers suggest that MK and PTN exert their antibacterial action via a membrane disruption mechanism. The predicted structure of PTN, employing the previously solved MK structure as a template, indicates that both molecules consist of two domains, each containing three antiparallel beta-sheets. The antibacterial activity was mapped to the unordered C-terminal tails of both molecules and the last beta-sheets of the N-terminals. Analysis of the highly conserved MK and PTN orthologues from the amphibian Xenopus laevis and the fish Danio rerio suggests that they also harbor antibacterial activity in the corresponding domains. In support of an evolutionary conserved function it was found that the more distant orthologue, insect Miple2 from Drosophila melanogaster, also displays strong antibacterial activity. Taken together, the findings suggest that MK and PTN, in addition to their earlier described activities, may have previously unrealized important roles as innate antibiotics.	[Svensson, Sara L.; Olin, Anders I.; Egesten, Arne] Lund Univ, Univ Hosp, Sect Resp Med & Allergol, SE-22185 Lund, Sweden; [Pasupuleti, Mukesh; Schmidtchen, Artur] Lund Univ, Univ Hosp, Dermatol Sect, SE-22185 Lund, Sweden; [Morgelin, Matthias; Olin, Anders I.; Collin, Mattias] Lund Univ, Univ Hosp, Sect Infect Med, Dept Clin Sci Lund, SE-22185 Lund, Sweden; [Walse, Bjorn] SARom AB, SE-22007 Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Sjogren, Camilla; Palmer, Ruth] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Uppsala University; Umea University	Egesten, A (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	arne.egesten@med.lu.se	Nordin, Sara/G-5361-2011; Collin, Mattias/C-6398-2009; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAF-4066-2020	Collin, Mattias/0000-0002-6166-7410; Pasupuleti, Mukesh/0000-0001-6337-6257; Walse, Bjorn/0000-0003-1513-9040	Swedish Research Council [20674]; Swedish Heart and Lung Foundation [20080246]; Medical Faculty at Lund University; Swedish Government Funds for Clinical Research; Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty at Lund University; Swedish Government Funds for Clinical Research; Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund	This work was supported by grants from the Swedish Research Council (Project 20674), the Swedish Heart and Lung Foundation (Project 20080246), the Medical Faculty at Lund University, Swedish Government Funds for Clinical Research (ALF), and the Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Englund C, 2006, DEV GENES EVOL, V216, P10, DOI 10.1007/s00427-005-0025-8; FABRI L, 1993, J CHROMATOGR, V646, P213, DOI 10.1016/S0021-9673(99)87023-X; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Keates S, 2007, J IMMUNOL, V178, P8013, DOI 10.4049/jimmunol.178.12.8013; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; KOJIMA S, 1995, BIOCHEM BIOPH RES CO, V206, P468, DOI 10.1006/bbrc.1995.1066; Krishnakumari V, 2008, PEPTIDES, V29, P7, DOI 10.1016/j.peptides.2007.10.015; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P208, DOI 10.1002/ibd.21011; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Lucas S, 2010, PEDIATR INT, V52, P75, DOI 10.1111/j.1442-200X.2009.02885.x; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; MURPHY CJ, 1993, J CELL PHYSIOL, V155, P408, DOI 10.1002/jcp.1041550223; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; SEKIGUCHI K, 1995, J BIOCHEM-TOKYO, V118, P94, DOI 10.1093/oxfordjournals.jbchem.a124898; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; TSUTSUI J, 1993, CANCER RES, V53, P1281; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Yan WK, 2010, PROTEIN EXPRES PURIF, V70, P270, DOI 10.1016/j.pep.2009.10.015; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yoshida Y, 2008, INTERNAL MED, V47, P83, DOI 10.2169/internalmedicine.47.0260; You ZB, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-6; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	59	39	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16105	16115		10.1074/jbc.M109.081232	http://dx.doi.org/10.1074/jbc.M109.081232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308059	Green Published, hybrid			2022-12-27	WOS:000277715900048
J	Miwa, N; Ogawa, M; Shinmyo, Y; Hiraoka, Y; Takamatsu, K; Kawamura, S				Miwa, Naofumi; Ogawa, Motoyuki; Shinmyo, Yukiko; Hiraoka, Yoshiki; Takamatsu, Ken; Kawamura, Satoru			Dicalcin Inhibits Fertilization through Its Binding to a Glycoprotein in the Egg Envelope in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; ZONA-PELLUCIDA; SPERM BINDING; VITELLINE ENVELOPE; MOUSE SPERM; PROTEIN; IDENTIFICATION; OOCYTES; P26OLF; CLONING	Fertilization comprises oligosaccharide-mediated sperm-egg interactions, including sperm binding to an extracellular egg envelope, sperm penetration through the envelope, and fusion with an egg plasma membrane. We show that Xenopus dicalcin, an S100-like Ca2+-binding protein, present in the extracellular egg envelope (vitelline envelope (VE)), is a suppressive mediator of sperm-egg interaction. Preincubation with specific antibody greatly increased the efficiency of in vitro fertilization, whereas prior application of exogenous dicalcin substantially inhibited fertilization as well as sperm binding to an egg and in vitro sperm penetration through the VE protein layer. Dicalcin showed binding to protein cores of gp41 and gp37, constituents of VE, in a Ca2+-dependent manner and increased in vivo reactivity of VE with a lectin, Ricinus communis agglutinin I, which was accounted for by increased binding ability of gp41 to the lectin and greater exposure of gp41 to an external environment. Our findings strongly suggest that dicalcin regulates the distribution of oligosaccharides within the VE through its binding to the protein core of gp41, probably by modulating configuration of oligosaccharides on gp41 and the three-dimensional structure of VE framework, and thereby plays a pivotal role in sperm-egg interactions during fertilization.	Toho Univ, Sch Med, Dept Physiol, Ohta Ku, Tokyo 1438540, Japan; [Ogawa, Motoyuki] Kitasato Univ, Sch Med, Dept Med Educ, Kanagawa 2288555, Japan; [Shinmyo, Yukiko; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hiraoka, Yoshiki] Keio Univ, Sch Med, Dept Anat, Shinjyuku Ku, Tokyo 1600016, Japan	Kitasato University; Osaka University; Keio University		nmiwa@med.toho-u.ac.jp			Japan Society for the Promotion of Science; Toho University School of Medicine; Grants-in-Aid for Scientific Research [22590213] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University School of Medicine(Toho University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (to N. M. and S. K.) and by the Project Research of Toho University School of Medicine (to N. M.).	Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; BERTRAND E, 1995, HUM REPROD, V10, P1189, DOI 10.1093/oxfordjournals.humrep.a136116; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; David G, 1997, J PHYSIOL-LONDON, V504, P83, DOI 10.1111/j.1469-7793.1997.083bf.x; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kubo H, 1997, DEV GROWTH DIFFER, V39, P405; LARABELL CA, 1988, CELL TISSUE RES, V251, P129, DOI 10.1007/BF00215457; LINDSAY LL, 1989, DEV BIOL, V135, P202, DOI 10.1016/0012-1606(89)90170-X; LINDSAY LL, 1988, J EXP ZOOL, V245, P286, DOI 10.1002/jez.1402450309; Litscher ES, 2007, HISTOL HISTOPATHOL, V22, P337, DOI 10.14670/HH-22.337; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Miwa N, 1998, BIOCHEM BIOPH RES CO, V251, P860, DOI 10.1006/bbrc.1998.9571; Miwa N, 2001, EUR J BIOCHEM, V268, P6029, DOI 10.1046/j.0014-2956.2001.02511.x; Miwa N, 2000, J BIOL CHEM, V275, P27245; Miwa N, 2007, DNA SEQUENCE, V18, P400, DOI 10.1080/10425170701241470; Mori E, 1997, BIOCHEM BIOPH RES CO, V238, P95, DOI 10.1006/bbrc.1997.7249; OIKAWA T, 1973, NATURE, V241, P256, DOI 10.1038/241256a0; Pramanik A, 2001, SPRINGER SERIES CHEM, V65, P101; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICHTER HP, 1980, CELL BIOL INT REP, V4, P985, DOI 10.1016/0309-1651(80)90171-X; Talevi R, 1997, HUM REPROD, V12, P2773, DOI 10.1093/humrep/12.12.2773; Tian JD, 1997, J CELL BIOL, V136, P1099, DOI 10.1083/jcb.136.5.1099; Uebi T, 2007, FEBS J, V274, P4863, DOI 10.1111/j.1742-4658.2007.06007.x; Vo LH, 2003, BIOL REPROD, V69, P1822, DOI 10.1095/biolreprod.103.015370; Vo LH, 2000, BIOL REPROD, V62, P766, DOI 10.1095/biolreprod62.3.766; WOLF DP, 1976, BIOCHEMISTRY-US, V15, P3671, DOI 10.1021/bi00662a005; Yanagimachi R., 1994, P189	36	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15627	15636		10.1074/jbc.M109.079483	http://dx.doi.org/10.1074/jbc.M109.079483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299459	hybrid, Green Published			2022-12-27	WOS:000277399000081
J	Jansma, AL; Kirkpatrick, JP; Hsu, AR; Handel, TM; Nietlispach, D				Jansma, Ariane L.; Kirkpatrick, John P.; Hsu, Andro R.; Handel, Tracy M.; Nietlispach, Daniel			NMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-3; GLYCOSAMINOGLYCAN-BINDING-SITE; IN-VIVO ACTIVITY; CHEMICAL-EXCHANGE; CC-CHEMOKINE; ROTATIONAL DIFFUSION; RELAXATION DATA; IDENTIFICATION; INFLAMMATION; SYSTEM	Chemokines have two essential interactions in vivo, with G protein-coupled receptors, which activate intracellular signaling pathways, and with glycosaminoglycans (GAGs), which are involved in cell surface localization and transport. Although it has been shown that chemokines bind and activate their respective G protein-coupled receptors as monomers, many chemokines oligomerize upon GAG binding, and the ability to oligomerize and bind GAGs is required for in vivo function. In this study, we investigated the structure, dynamics, and oligomerization behavior of cutaneous T-cell-attracting chemokine (CTACK, also known as CCL27) by NMR. N-15 relaxation and translational self-diffusion rates indicate that CCL27 oligomerizes, but in contrast to many other chemokines that form relatively discrete oligomers, CCL27 transitions between monomer, dimer, and tetramer species over a relatively narrow concentration range. A three-dimensional structure determination was pursued under conditions where CCL27 is primarily dimeric, revealing the standard motif for a chemokine monomer. Analysis of chemical shift perturbations of H-1-N-15 HSQC spectra, relaxation-dispersion experiments, and filtered nuclear Over-hauser effects suggest that CCL27 does not adopt a discrete CXC or CC dimer motif. Instead, CCL27 has uncommon oligomerization behavior, where several equilibria involving relatively low affinity interactions between different interfaces seem to be simultaneously at work. However, interaction with heparin avidly promotes oligomerization under conditions where CCL27 is monomeric by itself. We hypothesize that the plasticity in the oligomerization state may enable CCL27 to adopt different oligomeric structures, depending on the nature of the GAG binding partner, thereby providing a mechanism for increased diversity and specificity in GAG-binding and GAG-related functions.	Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Jansma, Ariane L.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kirkpatrick, John P.; Nietlispach, Daniel] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Cambridge		thandel@ucsd.edu; dn206@bioc.cam.ac.uk		Nietlispach, Daniel/0000-0003-4364-9291	National Institutes of Health [RO1-AI37113, RO1-GM081763, GM08326]; Biotechnology and Biological Sciences and Research Council (BBSRC); BBSRC [BB/G011915/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011915/1, BB/E013228/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM081763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences and Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AI37113 and RO1-GM081763 (to T. M. H.) and NIH Molecular Biophysics Training Grant GM08326 (to A. L. J.). The NMR facility of the Biochemistry Department in Cambridge is supported by the Biotechnology and Biological Sciences and Research Council (BBSRC).	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baysal C, 2001, PROTEINS, V43, P150, DOI 10.1002/1097-0134(20010501)43:2<150::AID-PROT1027>3.0.CO;2-M; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Carrasco B, 1999, BIOPHYS J, V76, P3044, DOI 10.1016/S0006-3495(99)77457-6; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Colobran R, 2007, CLIN EXP IMMUNOL, V148, P208, DOI 10.1111/j.1365-2249.2007.03344.x; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Ghose R, 1998, J MAGN RESON, V134, P308, DOI 10.1006/jmre.1998.1499; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Hwang TL, 1997, J AM CHEM SOC, V119, P6203, DOI 10.1021/ja970160j; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Jabeen T, 2008, ACTA CRYSTALLOGR D, V64, P611, DOI 10.1107/S0907444908007026; Jansma A, 2009, METHOD ENZYMOL, V461, P31, DOI 10.1016/S0076-6879(09)05402-0; Jin HJ, 2005, BIOCHEM BIOPH RES CO, V338, P987, DOI 10.1016/j.bbrc.2005.10.062; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kroenke CD, 1998, J AM CHEM SOC, V120, P7905, DOI 10.1021/ja980832l; Kuloglu ES, 2002, J BIOL CHEM, V277, P17863, DOI 10.1074/jbc.M200402200; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Volkman BF, 2009, METHOD ENZYMOL, V461, P51, DOI 10.1016/S0076-6879(09)05403-2; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200	65	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14424	14437		10.1074/jbc.M109.091108	http://dx.doi.org/10.1074/jbc.M109.091108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20200157	Green Published, hybrid			2022-12-27	WOS:000277299700039
J	Kim, MJ; Park, IJ; Yun, H; Kang, I; Choe, W; Kim, SS; Ha, J				Kim, Min-Jung; Park, In-Ja; Yun, Hee; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun			AMP-activated Protein Kinase Antagonizes Pro-apoptotic Extracellular Signal-regulated Kinase Activation by Inducing Dual-specificity Protein Phosphatases in Response to Glucose Deprivation in HCT116 Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASES; CARDIAC FIBROBLASTS; CELL PROLIFERATION; GENOTOXIC STRESS; GROWTH; P53; EXPRESSION; MITOGEN; PATHWAY; ERK	Mitogen-activated protein kinase (MAPK) pathways are involved in the regulation of cellular responses, including cell proliferation, differentiation, cell growth, and apoptosis. Because these responses are tightly related to cellular energy level, AMP-activated protein kinase (AMPK), which plays an essential role in energy homeostasis, has emerged as another key regulator. In the present study, we demonstrate a novel signal network between AMPK and MAPK in HCT116 human colon carcinoma. Glucose deprivation activated AMPK and three MAPK subfamilies, extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK. Under these conditions, inhibition of endogenous AMPK by expressing a dominant-negative form significantly potentiated ERK activation, indicating that glucose deprivation-induced AMPK is specifically antagonizing ERK activity in HCT116 cells. Moreover, we provide novel evidence that AMPK activity is critical for p53-dependent expression of dual-specificity phosphatase (DUSP) 1 & 2, which are negative regulators of ERK. Notably, ERK exhibits pro-apoptotic effects in HCT116 cells under glucose deprivation. Collectively, our data suggest that AMPK protects HCT116 cancer cells from glucose deprivation, in part, via inducing DUSPs, which suppresses pro-apoptotic ERK, further implying that a signal network between AMPK and ERK is a critical regulatory point in coupling the energy status of the cell to the regulation of cell survival.	[Ha, Joohun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, Seoul 130701, South Korea; Kyung Hee Univ, Sch Med, Inst Biomed Sci, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Ha, J (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, 1 Hoegidong, Seoul 130701, South Korea.	hajh@khu.ac.kr	Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668	Korean government (MEST) [20090080996, 20090091345]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Korea Science and Engineering Foundation (KOSEF) grants funded by the Korean government (MEST) (20090080996 and 20090091345).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Fukuda T, 2007, J NEUROENDOCRINOL, V19, P621, DOI 10.1111/j.1365-2826.2007.01570.x; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Longnus SL, 2005, DIABETOLOGIA, V48, P2591, DOI 10.1007/s00125-005-0016-3; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sasaki K, 2004, MOL BIOL CELL, V15, P1387, DOI 10.1091/mbc.E03-06-0367; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	46	40	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14617	14627		10.1074/jbc.M109.085456	http://dx.doi.org/10.1074/jbc.M109.085456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220132	hybrid, Green Published			2022-12-27	WOS:000277299700059
J	Mao, DQ; Hinds, PW				Mao, Daqin; Hinds, Philip W.			p35 Is Required for CDK5 Activation in Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; ONCOGENE-INDUCED SENESCENCE; RETINOBLASTOMA PROTEIN; TUMOR-CELLS; DNA-DAMAGE; P53; EXPRESSION; ARREST; RAS; ROLES	The retinoblastoma tumor suppressor gene (RB-1) is a key regulator of cellular senescence. Expression of the retinoblastoma protein (pRB) in human tumor cells that lack it results in senescence-like changes. The induction of the senescent phenotype by pRB requires the postmitotic kinase CDK5, the best known function of which is in neuronal development and postmitotic neuronal activities. Activation of CDK5 in neurons depends on its activators p35 and p39; however, little is known about how CDK5 is activated in non-neuronal senescent cells. Here we report that p35 is required for the activation ofCDK5in the process of cellular senescence. We demonstrate that: (i) p35 is expressed in osteosarcoma cells, (ii) p35 is required for CDK5 activation induced by pRB during senescence, (iii) p35 is required for the senescent morphological changes in which CDK5 is known to be involved as well as for expression of the senescence secretome, and (iv) p35 is up-regulated in senescing cells. Taken together, these results suggest that p35 is at least one of the activators of CDK5 that is mobilized in the process of cellular senescence, which may provide insight into cancer cell proliferation and future cancer therapeutics.	[Mao, Daqin; Hinds, Philip W.] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Mao, Daqin] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Hinds, PW (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St 5609, Boston, MA 02111 USA.	phinds@tuftsmedicalcenter.org			National Institutes of Health [CA104322, AG020208]; NATIONAL CANCER INSTITUTE [R01CA104322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104322 and AG020208 (to P. W. H.).	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, CANCER RES, V59, P3761; Chen F, 2004, CANCER RES, V64, P5425, DOI 10.1158/0008-5472.CAN-04-0806; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stein GH, 1999, MOL CELL BIOL, V19, P2109; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; te Poele RH, 2002, CANCER RES, V62, P1876; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4	51	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14671	14680		10.1074/jbc.M109.066118	http://dx.doi.org/10.1074/jbc.M109.066118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20181942	Green Published, hybrid			2022-12-27	WOS:000277299700065
J	Biyashev, D; Veliceasa, D; Kwiatek, A; Sutanto, MM; Cohen, RN; Volpert, OV				Biyashev, Dauren; Veliceasa, Dorina; Kwiatek, Angela; Sutanto, Maria M.; Cohen, Ronald N.; Volpert, Olga V.			Natural Angiogenesis Inhibitor Signals through Erk5 Activation of Peroxisome Proliferator-activated Receptor gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; APOPTOSIS; CELLS; REQUIREMENT; INVOLVEMENT; SUPPRESSION; BMK1/ERK5; P38-ALPHA	Erk-5, a member of the MAPK superfamily, has a catalytic domain similar to Erk1/2 and a unique C-terminal domain enabling binding with transcription factors. Aberrant vascularization in the Erk5-null mice suggested a link to angiogenesis. Ectopic expression of constitutively active Erk5 blocks endothelial cell morphogenesis and causes HIF1-alpha destabilization/degradation. However the mechanisms by which endogenous Erk5 regulates angiogenesis remain unknown. We show that Erk5 and its activating kinase MEK5 are the upstream mediators of the anti-angiogenic signal by the natural angiogenesis inhibitor, pigment epithelial-derived factor (PEDF). We demonstrate that Erk5 phosphorylation allows activation of PPAR alpha transcription factor by displacement of SMRT co-repressor. PPAR alpha, in turn is critical for NF kappa B activation, PEDF-dependent apoptosis, and anti-angiogenesis. The dominant negative MEK5 mutant and Erk5 shRNA diminished PEDF-dependent apoptosis, inhibition of the endothelial cell chemotaxis, and angiogenesis. This is the first evidence of Erk5-dependent transduction of signals by endogenous angiogenesis inhibitors.	[Biyashev, Dauren; Veliceasa, Dorina; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Biyashev, Dauren; Veliceasa, Dorina; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, RH Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kwiatek, Angela] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Cohen, Ronald N.] Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA; [Sutanto, Maria M.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago	Volpert, OV (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	olgavolp@northwestern.edu			National Institutes of Health [NIH R01 HL68033, NIH R01 HL077471, NIDDK R01DK078125]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077471, R01HL068033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH R01 HL68033, HL077471 (to O. V. V.), and NIDDK R01DK078125 (to R. N. C.).	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; AURORA AB, 2010, BLOOD IN PRESS; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Chung JH, 2008, AGEING RES REV, V7, P126, DOI 10.1016/j.arr.2008.01.001; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Griffin MD, 2007, ARCH BIOCHEM BIOPHYS, V460, P218, DOI 10.1016/j.abb.2007.01.034; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, MOL IMMUNOL, V45, P898, DOI 10.1016/j.molimm.2007.08.004; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407; Liu CJ, 2003, BIOCHEM BIOPH RES CO, V312, P780, DOI 10.1016/j.bbrc.2003.10.186; Mirochnik Y, 2008, CURR DRUG TARGETS, V9, P851, DOI 10.2174/138945008785909347; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; PASSANITI A, 1992, LAB INVEST, V67, P519; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Veliceasa D, 2008, PPAR RES, V2008, DOI 10.1155/2008/945275; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474	34	21	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13517	13524		10.1074/jbc.M110.117374	http://dx.doi.org/10.1074/jbc.M110.117374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185831	hybrid, Green Published			2022-12-27	WOS:000276987700024
J	Dickinson, GD; Churchill, GC; Brailoiu, E; Patel, S				Dickinson, George D.; Churchill, Grant C.; Brailoiu, Eugen; Patel, Sandip			Deviant Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Ca2+ Signaling upon Lysosome Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-MOBILIZING MESSENGER; CALCIUM; NAADP; STORES; RELEASE; MEGANEURITES; INHIBITORS; ORGANELLES; BETA	Accumulating evidence suggests that the endolysosomal system is a novel intracellular Ca2+ pool mobilized by the second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). Although lysosomes in neurons are known to proliferate in numerous neurodegenerative diseases and during the normal course of aging, little is known concerning the effect of lysosomal proliferation on Ca2+ homeostasis. Here, we induce proliferation of lysosomes in primary cultures of rat hippocampal neurons and PC12 cells through chronic treatment with the cathepsin inhibitor, Z-Phe-Ala-diazomethylketone. We demonstrate that lysosome proliferation increases the size of the lysosomal Ca2+ pool and enhances Ca2+ signals in response to direct cellular delivery of NAADP and glutamate, an identified NAADP-producing agonist. Our data suggest that deregulated lysosomal Ca2+ signaling through NAADP may contribute to neuronal dysfunction and highlight the usefulness of lysosomal hydrolase inhibition in probing NAADP action.	[Dickinson, George D.; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of London; University College London; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Dickinson, George/H-6609-2016; Dickinson, George/D-1461-2009; Patel, Sandip/O-9591-2015	Dickinson, George/0000-0001-7711-0388; Dickinson, George/0000-0001-7711-0388; Patel, Sandip/0000-0001-7247-2013	Alzheimer's Research Trust, Research into Ageing; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/D012694/1]; BBSRC [BB/D012694/1, BB/G008523/1, BB/G013721/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish	Alzheimer's Research Trust, Research into Ageing; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Alzheimer's Research Trust, Research into Ageing, and the Biotechnology and Biological Sciences Research Council (Grant BB/G013721/1 to S. P. and Grant BB/D012694/1 to G. C. C.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Bednarski E, 1997, J NEUROSCI, V17, P4006; BERG TO, 1994, EUR J BIOCHEM, V221, P595, DOI 10.1111/j.1432-1033.1994.tb18771.x; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bi XN, 1999, EXP NEUROL, V158, P312, DOI 10.1006/exnr.1999.7087; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2003, BIOCHEM J, V373, P313, DOI 10.1042/BJ20030472; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Holtzman E, 1989, LYSOSOMES; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; IVY GO, 1992, ANN NY ACAD SCI, V674, P89, DOI 10.1111/j.1749-6632.1992.tb27479.x; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lynch G, 2003, NEUROCHEM RES, V28, P1725, DOI 10.1023/A:1026069223763; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Saftig Paul, 2005, P37; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yong AP, 1999, EXP NEUROL, V157, P150, DOI 10.1006/exnr.1999.7038	41	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13321	13325		10.1074/jbc.C110.112573	http://dx.doi.org/10.1074/jbc.C110.112573			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20231291	Green Published, hybrid			2022-12-27	WOS:000276987700002
J	Hu, TH; Li, CX; Cao, Z; Van Raay, TJ; Smith, JG; Willert, K; Solnica-Krezel, L; Coffey, RJ				Hu, Tianhui; Li, Cunxi; Cao, Zheng; Van Raay, Terence J.; Smith, Jason G.; Willert, Karl; Solnica-Krezel, Lila; Coffey, Robert J.			Myristoylated Naked2 Antagonizes Wnt-beta-Catenin Activity by Degrading Dishevelled-1 at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-ALPHA; SUBCELLULAR-LOCALIZATION; EXOCYTIC VESICLES; CELL POLARITY; MDCK CELLS; PROTEIN; DEGRADATION; ZEBRAFISH; PATHWAYS; POSTERIORIZATION	In Drosophila, naked cuticle is an inducible antagonist of the Wnt-beta-catenin pathway, likely acting at the level of Dishevelled (Dsh/Dvl), an essential component of this pathway. The mechanism by which naked cuticle and its two vertebrate orthologs, Naked1 (NKD1) and Naked2 (NKD2), inhibit Dvl function is unknown. NKD2 is myristoylated, a co-translational modification that leads to its plasma membrane localization. In contrast, myristoylation-deficient G2A NKD2 is cytoplasmic. Herein we show that the ability of Nkd2/NKD2 to antagonize Wnt-beta-catenin activity during zebrafish embryonic development and in mammalian HEK293cells is myristoylation-dependent. NKD2 and Dvl-1 interact and co-localize at the lateral membrane of polarized epithelial cells. In reciprocal overexpression and siRNA knockdown experiments, NKD2 and Dvl-1 destabilize each other via enhanced polyubiquitylation; this effect is also dependent upon Naked2 myristoylation. Cell fractionation and ubiquitylation assays indicate that endogenous NKD2 interacts with a slower migrating, ubiquitylated form of Dvl-1 in plasma membrane fractions. These results provide a mechanism by which NKD2 antagonizes Wnt signaling: myristoylated NKD2 interacts with Dvl-1 at the plasma membrane, and this interaction leads to their mutual ubiquitin-mediated proteasomal degradation.	[Hu, Tianhui; Li, Cunxi; Cao, Zheng; Van Raay, Terence J.; Smith, Jason G.; Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med & Cell & Dev Biol, Nashville, TN 37232 USA; [Van Raay, Terence J.; Solnica-Krezel, Lila] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Hu, Tianhui] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Hu, Tianhui] Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen 361005, Peoples R China	Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Xiamen University; Xiamen University	Coffey, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med & Cell & Dev Biol, 10415-E MRB 4,2213 Garland Ave, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu	Van Raay, Terry/AAA-7342-2021; Hu, T/G-3381-2010	Van Raay, Terence/0000-0003-0196-1041	National Institutes of Health [5R01CA046413, 5P50CA095103, 5T32HL007751]; Ministry of Science and Technology [2009CB522200, 2006AA02A303]; Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University [2009102]; NATIONAL CANCER INSTITUTE [U01CA084239, R01CA046413, P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA046413 and 5P50CA095103 ( to R.J.C.) and 5T32HL007751. This work was also supported by Project Grant 985 from Xiamen University, Ministry of Science and Technology Grants 2009CB522200 and 2006AA02A303, and Research Grant 2009102 from the Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University ( to T. H.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chung EK, 2005, EXP CELL RES, V309, P149, DOI 10.1016/j.yexcr.2005.05.012; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Ding W, 2008, P NATL ACAD SCI USA, V105, P13433, DOI 10.1073/pnas.0806298105; Erter CE, 2001, DEVELOPMENT, V128, P3571; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nusse R, 1997, COLD SPRING HARB SYM, V62, P185; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Polakis P, 2000, GENE DEV, V14, P1837; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	40	40	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13561	13568		10.1074/jbc.M109.075945	http://dx.doi.org/10.1074/jbc.M109.075945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177058	Green Published, hybrid			2022-12-27	WOS:000276987700029
J	Widau, RC; Jin, YJ; Dixon, SA; Wadzinski, BE; Gallagher, PJ				Widau, Ryan C.; Jin, Yijun; Dixon, Shelley A.; Wadzinski, Brian E.; Gallagher, Patricia J.			Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-associated Protein Kinase (DAPK) in Ceramide-induced Anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+ RELEASE; INDUCED APOPTOSIS; PHOSPHORYLATION; ACTIVATION; SUBUNIT; IDENTIFICATION; INHIBITORS; COMPLEX	The tumor suppressor, death-associated protein kinase (DAPK), is a Ca2+/calmodulin-regulated Ser/Thr kinase with an important role in regulating cytoskeletal dynamics. Autophosphorylation within the calmodulin-binding domain at Ser-308 inhibits DAPK catalytic activity. Dephosphorylation of Ser-308 by a previously unknown phosphatase enhances kinase activity and proteasome-mediated degradation of DAPK. In these studies, we identified two holoenzyme forms of protein phosphatase 2A (PP2A), AB alpha C and AB delta C, as DAPK-interacting proteins. These phosphatase holoenzymes dephosphorylate DAPK at Ser-308 in vitro and in vivo resulting in enhanced kinase activity of DAPK. The enzymatic activity of PP2A also negatively regulates DAPK levels by enhancing proteasome-mediated degradation of the kinase. Overexpression of wild type DAPK induces cell rounding and detachment in HEK293 cells; however, this effect is not observed following expression of an inactive DAPK S308E mutant. Finally, activation of DAPK by PP2A was found to be required for ceramide-induced anoikis. Together, our results provide a mechanism by which PP2A and DAPK activities control cell adhesion and anoikis.	[Widau, Ryan C.; Dixon, Shelley A.; Gallagher, Patricia J.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Jin, Yijun] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Wadzinski, Brian E.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Vanderbilt University	Gallagher, PJ (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pgallag@iupui.edu			National Institutes of Health [DK62810, HLB54118, GM051366, DK070787, T32 CA111198]; DeVault Endowment Cancer Training Fellowship; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787, R01DK062810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051366, R56GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DeVault Endowment Cancer Training Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62810 and HLB54118 (to P. J. G.) and GM051366 and DK070787 (to B. E. W.). This work was also supported by a DeVault Endowment Cancer Training Fellowship.; Supported by National Institutes of Health Training Grant T32 CA111198.	Adams Deanna G., 2007, V365, P101; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Bialik S, 2004, CELL DEATH DIFFER, V11, P631, DOI 10.1038/sj.cdd.4401386; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; COHEN P, 1989, J BIOL CHEM, V264, P21435; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Jin YJ, 2001, J BIOL CHEM, V276, P39667, DOI 10.1074/jbc.M101886200; Kuo JC, 2006, J CELL BIOL, V172, P619, DOI 10.1083/jcb.200505138; Lin Y, 2007, J BIOL CHEM, V282, P16792, DOI 10.1074/jbc.M611559200; Lin Y, 2009, MOL CELL BIOCHEM, V328, P101, DOI 10.1007/s11010-009-0079-4; Liu Z, 2008, J NEUROCHEM, V106, P2463, DOI 10.1111/j.1471-4159.2008.05562.x; Liu Z, 2007, J CELL PHYSIOL, V213, P151, DOI 10.1002/jcp.21106; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Pelled D, 2002, J BIOL CHEM, V277, P1957, DOI 10.1074/jbc.M104677200; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Swingle Mark, 2007, V365, P23; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Yamamoto M, 2002, EUR J BIOCHEM, V269, P139, DOI 10.1046/j.0014-2956.2002.00029.x; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang LG, 2007, J BIOL CHEM, V282, P11795, DOI 10.1074/jbc.M610430200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229	43	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13827	13838		10.1074/jbc.M109.085076	http://dx.doi.org/10.1074/jbc.M109.085076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20220139	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000276987700058
J	Pozzi, A; Popescu, V; Yang, SL; Mei, SJ; Shi, MJ; Puolitaival, SM; Caprioli, RM; Capdevila, JH				Pozzi, Ambra; Popescu, Vlad; Yang, Shilin; Mei, Shaojun; Shi, Mingjian; Puolitaival, Satu M.; Caprioli, Richard M.; Capdevila, Jorge H.			The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor alpha Are Arachidonic Acid Epoxygenase-mediated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOLUBLE EPOXIDE HYDROLASE; EPOXYEICOSATRIENOIC ACIDS; PPAR-ALPHA; SPECIES-DIFFERENCES; CARCINOMA-CELLS; DOWN-REGULATION; LUNG-CANCER; IN-VIVO; ANGIOGENESIS	Prevalence and mortality make cancer a health challenge in need of effective and better tolerated therapeutic approaches, with tumor angiogenesis identified as a promising target for drug development. The epoxygenase products, the epoxyeicosatrienoic acids, are pro-angiogenic, and down-regulation of their biosynthesis by peroxisomal proliferator-activated receptor alpha (PPAR alpha) ligands reduces tumor angiogenesis and growth. Endothelial cells lacking a Cyp2c44 epoxygenase, a PPAR alpha target, show reduced proliferative and tubulogenic activities that are reversed by the enzyme's metabolites. In a mouse xenograft model of tumorigenesis, disruption of the host Cyp2c44 gene causes marked reductions in tumor volume, mass, and vascularization. The relevance of these studies to human cancer is indicated by the demonstration that: (a) activation of human PPAR alpha down-regulates endothelial cell CYP2C9 epoxygenase expression and blunts proliferation and tubulogenesis, (b) in a PPAR alpha-humanized mouse model, activation of the receptor inhibits tumor angiogenesis and growth, and (c) the CYP2C9 epoxygenase is expressed in the vasculature of human tumors. The identification of anti-angiogenic/anti-tumorigenic properties of PPAR alpha points to a role for the receptor and its epoxygenase regulatory target in the pathophysiology of cancer, and for its ligands as candidates for the development of a new generation of safer and better tolerated anti-cancer drugs.	[Pozzi, Ambra; Popescu, Vlad; Yang, Shilin; Mei, Shaojun; Shi, Mingjian; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Puolitaival, Satu M.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Caprioli, Richard M.; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Puolitaival, Satu M.; Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Ctr Mass Spectrometry Res, Nashville, TN 37232 USA; [Pozzi, Ambra] Vet Affairs Hosp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Capdevila, JH (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Med Ctr N S 3223, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu		Shi, Mingjian/0000-0003-1569-9822	National Institutes of Health [DK 5P01-038226, GM 5R01-037922, DK R01-065123]; Department of Veterans Affairs; Vanderbilt University Cancer Center [CA-68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R01GM037922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt University Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 5P01-038226 and GM 5R01-037922 (to J. H. C.), DK R01-065123 (to A. P.), and GM5R01-58008 (to R. M. C.). This work was also supported by a Department of Veterans Affairs Merit Award (to A. P.). Mass Spectrometric analyses were done with support from the Vanderbilt University Cancer Center Grant CA-68485.	Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen XW, 2005, INT J CANCER, V116, P52, DOI 10.1002/ijc.20997; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Chung EK, 2008, CLIN GENITOURIN CANC, V6, pS22, DOI 10.3816/CGC.2008.s.004; Corton JC, 1998, MOL PHARMACOL, V54, P463, DOI 10.1124/mol.54.3.463; Dellavalle RP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003697.pub2; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601, DOI 10.1097/FJC.0b013e318159cbe3; Golembesky AK, 2008, CARCINOGENESIS, V29, P1944, DOI 10.1093/carcin/bgn154; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Hardesty WM, 2008, ANAL BIOANAL CHEM, V391, P899, DOI 10.1007/s00216-008-1972-5; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kuhn H, 2007, CURR MED CHEM, V14, P3157, DOI 10.2174/092986707782793907; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Nie DT, 2000, BLOOD, V95, P2304, DOI 10.1182/blood.V95.7.2304.007k23_2304_2311; Obhrai JS, 2008, KIDNEY INT, V74, P685, DOI 10.1038/ki.2008.288; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Pozzi A, 2005, J BIOL CHEM, V280, P27138, DOI 10.1074/jbc.M501730200; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Pozzi A, 2008, PPAR RES, V2008, DOI 10.1155/2008/906542; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; ROBERTS WC, 1989, CARDIOLOGY, V76, P169, DOI 10.1159/000174488; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Savas U, 1999, MOL PHARMACOL, V56, P851, DOI 10.1124/mol.56.5.851; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Sivanandam VG, 2008, J GENE MED, V10, P1083, DOI 10.1002/jgm.1244; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Steinhoff M, 2008, J AM ACAD DERMATOL, V58, pS88, DOI 10.1016/j.jaad.2007.07.012; Strakova N, 2005, NEOPLASMA, V52, P126; Tenenbaum A, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-18; Tsubouchi Y, 2000, BIOCHEM BIOPH RES CO, V270, P400, DOI 10.1006/bbrc.2000.2436; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Wu CW, 2009, ONCOL REP, V22, P451, DOI 10.3892/or_00000456; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206; Yang SL, 2009, ARCH BIOCHEM BIOPHYS, V489, P82, DOI 10.1016/j.abb.2009.05.006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	58	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12840	12850		10.1074/jbc.M109.081554	http://dx.doi.org/10.1074/jbc.M109.081554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178979	Green Published, hybrid			2022-12-27	WOS:000276787800042
J	Crozet, P; Jammes, F; Valot, B; Ambard-Bretteville, F; Nessler, S; Hodges, M; Vidal, J; Thomas, M				Crozet, Pierre; Jammes, Fabien; Valot, Benoit; Ambard-Bretteville, Francoise; Nessler, Sylvie; Hodges, Michael; Vidal, Jean; Thomas, Martine			Cross-phosphorylation between Arabidopsis thaliana Sucrose Nonfermenting 1-related Protein Kinase 1 (AtSnRK1) and Its Activating Kinase (AtSnAK) Determines Their Catalytic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM KINASE; YEAST SNF1; IN-VITRO; ENERGY; SNRK1; EXPRESSION; REGULATORS; REDUCTASE; BETA; LOOP	Arabidopsis thaliana sucrose nonfermenting 1-related protein kinase 1 complexes belong to the SNF1/AMPK/SnRK1 protein kinase family that shares an ancestral function as central regulators of metabolism. In A. thaliana, the products of AtSnAK1 and AtSnAK2, orthologous to yeast genes, have been shown to autophosphorylate and to phosphorylate/activate the AtSnRK1.1 catalytic subunit on Thr(175). The phosphorylation of these kinases has been investigated by site-directed mutagenesis and tandem mass spectrometry. The autophosphorylation site of AtSnAK2 was identified as Thr(154), and it was shown to be required for AtSnAK catalytic activity. Interestingly, activated AtSnRK1 exerted a negative feedback phosphorylation on AtSnAK2 at Ser(261) (Ser(260) of AtSnAK1) that was dependent on AtSnAK autophosphorylation. The dynamics of these reciprocal phosphorylation events on the different kinases was established, and structural modeling allowed clarification of the topography of the AtSnAK phosphorylation sites. A mechanism is proposed to explain the observed changes in the enzymatic properties of each kinase triggered by these phosphorylation events.	[Crozet, Pierre; Jammes, Fabien; Ambard-Bretteville, Francoise; Hodges, Michael; Vidal, Jean; Thomas, Martine] Univ Paris 11, Lab Signalisat & Regulat Metab, Inst Biol Plantes, CNRS,UMR 8618, F-91405 Orsay, France; [Valot, Benoit] Univ Paris 11, UMR Genet Vegetale INRA, CNRS, INA PG, F-91190 Gif Sur Yvette, France; [Nessler, Sylvie] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thomas, M (corresponding author), Univ Paris 11, Lab Signalisat & Regulat Metab, Inst Biol Plantes, CNRS,UMR 8618, Batiment 630, F-91405 Orsay, France.	martine.thomas@u-psud.fr	Hodges, Michael/A-8883-2008; Valot, Benoit BV/G-3521-2018; Crozet, Pierre/M-4306-2013; Jammes, Fabien/AAB-6235-2020; Nessler, Sylvie/R-4296-2016	Crozet, Pierre/0000-0001-5113-2407; Nessler, Sylvie/0000-0003-4973-9941	French Ministere de l'Enseignement Superieur et de la Recherche (MENRT)	French Ministere de l'Enseignement Superieur et de la Recherche (MENRT)	Supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche (MENRT).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Cai XJ, 2009, MOL PHARMACOL, V75, P626, DOI 10.1124/mol.108.050278; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hey S, 2007, J BIOL CHEM, V282, P10472, DOI 10.1074/jbc.M611244200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; LAEMMLI UK, 1970, NATURE, V227, P685; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031	24	54	59	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12071	12077		10.1074/jbc.M109.079194	http://dx.doi.org/10.1074/jbc.M109.079194			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164192	hybrid, Green Published			2022-12-27	WOS:000276787100036
J	Lin, JJ; Hemenway, CS				Lin, Jeffrey J.; Hemenway, Charles S.			Hsp90 Directly Modulates the Spatial Distribution of AF9/MLLT3 and Affects Target Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MLL FUSION PARTNER; TRANSCRIPTIONAL ELONGATION; CHROMOSOMAL TRANSLOCATION; NUCLEAR IMPORT; LEUKEMIA; INTERACTS; CHAPERONE; CHROMATIN; COMPLEXES; BINDING	AF9/MLLT3 contributes to the regulation of the gene encoding the epithelial sodium channel alpha, ENaC alpha, in renal tubular cells. Specifically, increases in AF9 protein lead to a reduction in ENaC alpha expression and changes in AF9 activity appear to be an important component of aldosterone signaling in the kidney. Whereas AF9 is found in the nucleus where it interacts with the histone H3 lysine 79 methyltransferase, Dot1, AF9 is also present in the cytoplasm. Data presented in this report indicate that the heat shock protein Hsp90 directly and specifically interacts with AF9 as part of an Hsp90-Hsp70-p60/Hop chaperone complex. Experimental manipulation of Hsp90 function by the inhibitor novobiocin, but not 17-AAG, results in redistribution of AF9 from a primarily nuclear to cytoplasmic location. Knockdown of Hsp90 with siRNA mimics the effect elicited by novobiocin. As expected, a shift in AF9 from the nucleus to the cytoplasm in response to Hsp90 interference leads to increased ENaC alpha expression. This is accompanied by a decrease in AF9 occupancy at the ENaC alpha promoter. Our data suggest that the interaction of Hsp90, Hsp70, and p60/Hop with AF9 is necessary for the proper subnuclear localization and activity of AF9. AF9 is among a growing number of nuclear proteins recognized to rely on the Hsp90 complex for nuclear targeting.	[Hemenway, Charles S.] Loyola Univ Chicago, Stritch Sch Med, Dept Pediat, Maywood, IL 60153 USA; [Hemenway, Charles S.] Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA; Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA	Loyola University Chicago; Loyola University Chicago; Tulane University	Hemenway, CS (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	chemenway@lumc.edu			National Institutes of Health [CA098459]; Cardinal Bernardin Cancer Center; NATIONAL CANCER INSTITUTE [R01CA098459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardinal Bernardin Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA098459. This work was also supported by funds from the Cardinal Bernardin Cancer Center.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; BLATCH GL, 2007, NETWORKING CHAPERONE, V55; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; DiMartino JF, 2000, BLOOD, V96, P3887, DOI 10.1182/blood.V96.12.3887.h8003887_3887_3893; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; ISSACS JS, 2003, CANCER CELL, V3, P23; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Longshaw VM, 2009, EUR J CELL BIOL, V88, P153, DOI 10.1016/j.ejcb.2008.09.003; Ma YS, 2000, BBA-PROTEIN STRUCT M, V1476, P300, DOI 10.1016/S0167-4838(99)00250-2; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Selkirk James K., 1994, Applied and Theoretical Electrophoresis, V4, P89; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Zeng Y, 2003, BLOOD, V101, P4485, DOI 10.1182/blood-2002-10-3108; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11966	11973		10.1074/jbc.M110.101642	http://dx.doi.org/10.1074/jbc.M110.101642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159978	Green Published, hybrid			2022-12-27	WOS:000276787100025
J	Xu, HX; Zhang, Z; Li, M; Zhang, RW				Xu, Hongxia; Zhang, Zhuo; Li, Mao; Zhang, Ruiwen			MDM2 Promotes Proteasomal Degradation of p21(Waf1) via a Conformation Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; RESONANCE ENERGY-TRANSFER; REG-GAMMA-PROTEASOME; CELL-CYCLE; HUMAN MALIGNANCIES; ONCOPROTEIN MDM2; LIGASE ACTIVITY; 20S PROTEASOME; CANCER-THERAPY; C-TERMINUS	MDM2 plays a major role in cancer development and progression via both p53-dependent and -independent functions. One of its p53-independent functions is the induction of the ubiquitin-independent proteasomal degradation of p21(Waf1). The present study was designed to characterize the mechanism(s) by which MDM2 induces p21(Waf1) degradation. We first determined the regions of MDM2 required for p21(Waf1) degradation using pulldown assays and Western blotting and then examined the mechanisms using limited proteolysis and fluorescence resonance energy transfer assays. We found that the MDM2-p21(Waf1) interaction depended on the central domain of MDM2 and that nuclear localization of both proteins was necessary for p21(Waf1) degradation. Specifically, amino acids 226-250 of MDM2 were required for p21(Waf1) binding and degradation, and amino acids 251-260 were necessary for p21(Waf1) degradation. The latter region induced a conformation change in p21(Waf1), increasing its interaction with the C8 subunit of the proteasome, leading to its degradation. When MDM2 lacked either segment (aa 226-250 or aa 251-260), its capacity to promote p21(Waf1) degradation and cell cycle progression was significantly reduced. In summary, the present study elucidated a previously unknown mechanism by which MDM2 promotes the degradation of an intact protein (p21(Waf1)) through an ubiquitin-independent proteasomal degradation pathway. Because MDM2 also increases the degradation of other proteins in a ubiquitin-independent manner, this mechanism may underlie part of its tumorigenic properties.	[Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Ctr Comprehens Canc, Div Clin Pharmacol, Birmingham, AL 35294 USA; [Xu, Hongxia] Third Mil Med Univ, Coll Prevent Med, Chongqing 400038, Peoples R China	University of Alabama System; University of Alabama Birmingham; Army Medical University	Zhang, RW (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Ctr Comprehens Canc, Div Clin Pharmacol, 1825 Univ Blvd,Shelby Bldg,Rm 603, Birmingham, AL 35294 USA.	ruiwen.zhang@ccc.uab.edu	Xu, Hongxia/AAN-8608-2021	xu, hongxia/0000-0001-5215-734X	NCI, National Institutes of Health [R01CA112029, R01CA121211]; Department of Defense Prostate Cancer Research [W81XWH-04-1-0845]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Grants R01CA112029 and R01CA121211 (to R.Z.).; Supported in part by a post-doctoral fellowship from the Department of Defense Prostate Cancer Research Program (Grant W81XWH-04-1-0845). 3 Present address: Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294.	BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BARTEK J, 1991, ONCOGENE, V6, P1699; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Gerards WLH, 1998, J MOL BIOL, V275, P113, DOI 10.1006/jmbi.1997.1429; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Onel K, 2004, MOL CANCER RES, V2, P1; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Romero P, 1998, Pac Symp Biocomput, P437; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Schon O, 2004, J MOL BIOL, V336, P197, DOI 10.1016/j.jmb.2003.11.051; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25	44	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18407	18414		10.1074/jbc.M109.059568	http://dx.doi.org/10.1074/jbc.M109.059568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20308078	Green Published, hybrid			2022-12-27	WOS:000278453900034
J	Hong, BS; Allali-Hassani, A; Tempel, W; Finerty, PJ; MacKenzie, F; Dimov, S; Vedadi, M; Park, HW				Hong, Bum Soo; Allali-Hassani, Abdellah; Tempel, Wolfram; Finerty, Patrick J., Jr.; MacKenzie, Farrell; Dimov, Svetoslav; Vedadi, Masoud; Park, Hee-Won			Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3 SINGLE AMINO ACID NEAR THE ACTIVE SITE INFLUENCES INHIBITOR SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-METABOLISM; CHOLINE/ETHANOLAMINE KINASE; PROTEIN; CANCER; SEQUENCE; ALPHA; PHOSPHORYLCHOLINE; EXPRESSION; REVEALS; CELLS	Human choline kinase (ChoK) catalyzes the first reaction in phosphatidylcholine biosynthesis and exists as ChoK alpha (alpha 1 and alpha 2) and ChoK beta isoforms. Recent studies suggest that ChoK is implicated in tumorigenesis and emerging as an attractive target for anticancer chemotherapy. To extend our understanding of the molecular mechanism of ChoK inhibition, we have determined the high resolution x-ray structures of the ChoK alpha 1 and ChoK beta isoforms in complex with hemi-cholinium-3 (HC-3), a known inhibitor of ChoK. In both structures, HC-3 bound at the conserved hydrophobic groove on the C-terminal lobe. One of the HC-3 oxazinium rings complexed with ChoK alpha 1 occupied the choline-binding pocket, providing a structural explanation for its inhibitory action. Interestingly, the HC-3 molecule co-crystallized with ChoK beta was phosphorylated in the choline binding site. This phosphorylation, albeit occurring at a very slow rate, was confirmed experimentally by mass spectroscopy and radioactive assays. Detailed kinetic studies revealed that HC-3 is a much more potent inhibitor for ChoK alpha isoforms (alpha 1 and alpha 2) compared with ChoK beta. Mutational studies based on the structures of both inhibitor-bound ChoK complexes demonstrated that Leu-401 of ChoK alpha 2 (equivalent to Leu-419 of ChoK alpha 1), or the corresponding residue Phe-352 of ChoK beta, which is one of the hydrophobic residues neighboring the active site, influences the plasticity of the HC-3-binding groove, thereby playing a key role in HC-3 sensitivity and phosphorylation.	[Hong, Bum Soo; Allali-Hassani, Abdellah; Tempel, Wolfram; Finerty, Patrick J., Jr.; MacKenzie, Farrell; Dimov, Svetoslav; Vedadi, Masoud; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, MaRS S Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	mvedadi@uhnres.utoronto.ca; heewon.park@utoronto.ca			Structural Genomics Consortium; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Use of the Advanced Photon Source was supported by the U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Allali-Hassani A, 2004, BIOCHEM J, V384, P577, DOI 10.1042/BJ20041082; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1393, P179, DOI 10.1016/S0005-2760(98)00062-9; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; BROSTROM MA, 1973, J BIOL CHEM, V248, P2364; Campos J, 2000, BIOORG MED CHEM LETT, V10, P767, DOI 10.1016/S0960-894X(00)00080-9; Conejo-Garcia A, 2005, EUR J MED CHEM, V40, P315, DOI 10.1016/j.ejmech.2004.09.016; Conejo-Garcia A, 2004, J MED CHEM, V47, P5433, DOI 10.1021/jm0496537; Conejo-Garcia A, 2003, EUR J MED CHEM, V38, P109, DOI 10.1016/S0223-5234(02)00004-1; CUADRADO A, 1993, ONCOGENE, V8, P2959; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EXTON JH, 1990, J BIOL CHEM, V265, P1; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAMZA M, 1983, BIOCHEM PHARMACOL, V32, P1893, DOI 10.1016/0006-2952(83)90055-2; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; JIMENEZ B, 1995, J CELL BIOCHEM, V57, P141, DOI 10.1002/jcb.240570114; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Lacal JC, 1999, EUR J CANCER, V35, pS133, DOI 10.1016/S0959-8049(99)80913-7; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; MACARA IG, 1989, MOL CELL BIOL, V9, P325, DOI 10.1128/MCB.9.1.325; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Milanese L, 2006, CHEMMEDCHEM, V1, P1216, DOI 10.1002/cmdc.200600158; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; RATNAM S, 1995, ARCH BIOCHEM BIOPHYS, V323, P313, DOI 10.1006/abbi.1995.9959; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; SHEFF KY, 1990, J PHARMACOL EXP THER, V255, P357; Srivani P, 2009, J MOL GRAPH MODEL, V27, P676, DOI 10.1016/j.jmgm.2008.10.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	47	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16330	16340		10.1074/jbc.M109.039024	http://dx.doi.org/10.1074/jbc.M109.039024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299452	hybrid, Green Published			2022-12-27	WOS:000277715900069
J	Jiang, RT; Martz, A; Gonin, S; Taly, A; de Carvalho, LP; Grutter, T				Jiang, Ruotian; Martz, Adeline; Gonin, Sophie; Taly, Antoine; de Carvalho, Lia Prado; Grutter, Thomas			A Putative Extracellular Salt Bridge at the Subunit Interface Contributes to the Ion Channel Function of the ATP-gated P2X2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND TRANSMEMBRANE DOMAIN; P2X(2) RECEPTOR; BINDING-SITE; POLAR RESIDUES; TASTE-BUDS; IDENTIFICATION; MUTAGENESIS; AGONISTS; NEURONS; MOTIONS	The recent crystal structure of the ATP-gated P2X4 receptor revealed a static view of its architecture, but the molecular mechanisms underlying the P2X channels activation are still unknown. By using a P2X2 model based on the x-ray structure, we sought salt bridges formed between charged residues located in a region that directly connects putative ATP-binding sites to the ion channel. To reveal their significance for ion channel activation, we made systematic charge exchanges and measured the effects on ATP sensitivity. We found that charge reversals at the interfacial residues Glu(63) and Arg(274) produced gain-of-function phenotypes that were cancelled upon paired charge swapping. These results suggest that a putative intersubunit salt bridge formed between Glu(63) and Arg(274) contributes to the ion channel function. Engineered cysteines E63C and R274C formed redox-dependent cross-links in the absence of ATP. By contrast, the presence of ATP reduced the rate of disulfide bond formation, indicating that ATP binding might trigger relative movement of adjacent subunits at the level of Glu(63) and Arg(274), allowing the transmembrane helices to open the channel.	[Jiang, Ruotian; Martz, Adeline; Gonin, Sophie; Taly, Antoine; de Carvalho, Lia Prado; Grutter, Thomas] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophysicochim Recepteurs Canaux,UMR 7199, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grutter, T (corresponding author), Univ Strasbourg, Fac Pharm, CNRS, Lab Biophysicochim Recepteurs Canaux,UMR 7199, 74 Route Rhin,BP 24, F-67401 Illkirch Graffenstaden, France.	grutter@unistra.fr	Jiang, Ruotian/S-3594-2018; Taly, Antoine/B-3339-2008	Taly, Antoine/0000-0001-5109-0091; Grutter, Thomas/0000-0002-4351-9203; Jiang, Ruotian/0000-0001-5322-6802	Agence National de la Recherche [06-0050-01]; CNRS; China Scholarship Council; NATIONAL EYE INSTITUTE [R01EY011708, R01EY017123] Funding Source: NIH RePORTER	Agence National de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Agence National de la Recherche Grant 06-0050-01 and CNRS ( Programme d'Incitation a la Mobilite).; Recipient of a fellowship from the China Scholarship Council.; Recipient of a fellowship from CNRS.	Adriouch S, 2009, PURINERG SIGNAL, V5, P151, DOI 10.1007/s11302-009-9134-6; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Faiman GA, 1996, PROTEIN ENG, V9, P315, DOI 10.1093/protein/9.3.315; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2003, J NEUROSCI, V23, P7426; Le Novere N, 1999, NUCLEIC ACIDS RES, V27, P340, DOI 10.1093/nar/27.1.340; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006	40	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15805	15815		10.1074/jbc.M110.101980	http://dx.doi.org/10.1074/jbc.M110.101980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308075	Green Published, hybrid			2022-12-27	WOS:000277715900018
J	Shim, M; Foley, J; Anna, C; Mishina, Y; Eling, T				Shim, Minsub; Foley, Julie; Anna, Colleen; Mishina, Yuji; Eling, Thomas			Embryonic Expression of Cyclooxygenase-2 Causes Malformations in Axial Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRAL COLUMN; BREAST-CANCER; CELLS; MICE; P53; APOPTOSIS; PHOSPHORYLATION; CHONDROGENESIS; ACCUMULATION; SCLEROTOME	Cyclooxygenases (COXs) have important functions in various physiological and pathological processes. COX-2 expression is highly induced by a variety of stimuli and is observed during certain periods of embryonic development. In this report, the direct effect of COX-2 expression on embryonic development is examined in a novel COX-2 transgenic mouse model that ubiquitously expresses human COX-2 from the early stages of embryonic development. COX-2 transgenic fetuses exhibit severe skeletal malformations and die shortly after birth. Skeletal malformations are localized along the entire vertebral column and rib cage and are linked to defective formation of cartilage anlagen. The cartilage anlagen of axial skeleton fail to properly develop in transgenic embryos because of impaired precartilaginous sclerotomal condensation, which results from the reduction of cell number in the sclerotome. Despite the ubiquitous expression of COX-2, the number of apoptotic cells is highly increased in the sclerotome of transgenic embryos but not in other tissues, suggesting that it is a tissue-specific response. Therefore, the loss of sclerotomal cells due to an increased apoptosis is probably responsible for axial skeletal malformations in transgenic fetuses. In addition, the sclerotomal accumulation of p53 protein is observed in transgenic embryos, suggesting that COX-2 may induce apoptosis via the up-regulation of p53. Our results demonstrate that the aberrant COX-2 signaling during embryonic development is teratogenic and suggest a possible association of COX-2 with fetal malformations of unknown etiology.	[Shim, Minsub; Anna, Colleen; Eling, Thomas] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Foley, Julie] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Michigan System; University of Michigan	Eling, T (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	eling@niehs.nih.gov			National Institutes of Health; NIEHS; Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES010016, ZIAES050144, ZIGES102505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health, NIEHS, Intramural Research Program.	Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Christ B, 2000, ANAT EMBRYOL, V202, P179, DOI 10.1007/s004290000114; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Fukuda N, 2006, ONCOGENE, V25, P3509, DOI 10.1038/sj.onc.1209393; Hermanova M, 2008, EUR J GASTROEN HEPAT, V20, P732, DOI 10.1097/MEG.0b013e3282f945fb; Kaplan Kevin M, 2005, Spine J, V5, P564, DOI 10.1016/j.spinee.2004.10.044; Legan M, 2006, WORLD J GASTROENTERO, V12, P3425, DOI 10.3748/wjg.v12.i21.3425; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; MONTARRAS D, 1991, NEW BIOL, V3, P592; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Parman T, 2002, FASEB J, V16, P1001, DOI 10.1096/fj.01-0140com; Peters H, 1999, DEVELOPMENT, V126, P5399; RANDALL CL, 1991, ALCOHOL CLIN EXP RES, V15, P673, DOI 10.1111/j.1530-0277.1991.tb00577.x; RANDALL CL, 1991, TERATOLOGY, V44, P521, DOI 10.1002/tera.1420440506; Ristimaki A, 2002, CANCER RES, V62, P632; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Slater D, 1999, J MOL ENDOCRINOL, V22, P125, DOI 10.1677/jme.0.0220125; Stanfield KM, 2003, BIRTH DEFECTS RES A, V67, P54, DOI 10.1002/bdra.10032; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Tyl RW, 2007, BIRTH DEFECTS RES B, V80, P451, DOI 10.1002/bdrb.20134; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Xu Z, 2006, CANCER RES, V66, P6657, DOI 10.1158/0008-5472.CAN-05-3624; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16206	16217		10.1074/jbc.M109.078576	http://dx.doi.org/10.1074/jbc.M109.078576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236942	Green Published, hybrid			2022-12-27	WOS:000277715900057
J	Patel, SA; Simon, MC				Patel, Shetal A.; Simon, M. Celeste			Functional Analysis of the Cdk7.Cyclin H.Mat1 Complex in Mouse Embryonic Stem Cells and Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-ACTIVATING KINASE; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR TFIIH; RING FINGER PROTEIN; C-TERMINAL DOMAIN; CATALYTIC SUBUNIT; GENERAL TRANSCRIPTION; REGULATORY CIRCUITRY; CHEMICAL GENETICS; DROSOPHILA EMBRYO	The trimeric Cdk7.cyclin H.Mat1 complex functions in cell cycle regulation, as the Cdk-activating kinase, and in transcription, as a module of the general transcription factor TFIIH. As a component of TFIIH, Cdk7 phosphorylates serines 5 and 7 of the carboxyl-terminal domain of RNA polymerase II and can also directly phosphorylate transcription factors to regulate gene expression. Here we have investigated the function of the Cdk7.cyclin H.Mat1 complex in murine embryonic stem (ES) cells and preimplantation embryos to determine whether it regulates the unique cell cycle structure and transcriptional network of pluripotent cells. We demonstrate that depletion of cyclin H leads to differentiation of ES cells independent of changes in cell cycle progression. In contrast, we observed that developmental genes are acutely up-regulated after cyclin H down-regulation, likely perturbing normal ES self-renewal pathways. We further demonstrate that Spt5, a known phosphorylation target of Cdk7, similarly regulates ES pluripotency and gene expression. Consistent with its function in ES cells, cyclin H depletion from mouse embryos also leads to defects in the expansion of the inner cell mass of blastocysts, a transient pluripotent stem cell population in vivo. Our findings indicate that cyclin H has an essential function in promoting the self-renewal of the pluripotent stem cells of blastocyst stage embryos. Collectively, these studies demonstrate a critical and novel role for cyclin H in maintaining ES cell identity and suggest that cyclin H has important functions in early embryonic development.	[Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Patel, Shetal A.; Simon, M. Celeste] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Howard Hughes Med Inst, 451 BRB II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		medical scientist training grant; Developmental Biology Training Grant [2-T32-HD-007516-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER	medical scientist training grant; Developmental Biology Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by a medical scientist training grant and Developmental Biology Training Grant 2-T32-HD-007516-11.	Aguilar-Fuentes J, 2006, J CELL SCI, V119, P3866, DOI 10.1242/jcs.03150; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BROWN AJ, 1994, MOL BIOL CELL, V5, P921, DOI 10.1091/mbc.5.8.921; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Helenius K, 2009, MOL CELL BIOL, V29, P315, DOI 10.1128/MCB.00347-08; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Korsisaari N, 2002, J CELL SCI, V115, P4275, DOI 10.1242/jcs.00121; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PINES J, 2001, CURRENT PROTOCOLS CE, V8; POON RYC, 1994, J CELL SCI, V107, P2789; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sano M, 2007, CELL METAB, V5, P129, DOI 10.1016/j.cmet.2007.01.003; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638	63	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15587	15598		10.1074/jbc.M109.081687	http://dx.doi.org/10.1074/jbc.M109.081687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231280	Green Published, hybrid			2022-12-27	WOS:000277399000077
J	Andreu, JM; Schaffner-Barbero, C; Huecas, S; Alonso, D; Lopez-Rodriguez, ML; Ruiz-Avila, LB; Nunez-Ramirez, R; Llorca, O; Martin-Galiano, AJ				Andreu, Jose M.; Schaffner-Barbero, Claudia; Huecas, Sonia; Alonso, Dulce; Lopez-Rodriguez, Maria L.; Ruiz-Avila, Laura B.; Nunez-Ramirez, Rafael; Llorca, Oscar; Martin-Galiano, Antonio J.			The Antibacterial Cell Division Inhibitor PC190723 Is an FtsZ Polymer-stabilizing Agent That Induces Filament Assembly and Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; ESCHERICHIA-COLI; PROTEIN FTSZ; STRUCTURAL INSIGHTS; IN-VITRO; Z-RING; MICROTUBULE; PROTOFILAMENTS; GTP; DYNAMICS	Cell division protein FtsZ can form single-stranded filaments with a cooperative behavior by self-switching assembly. Subsequent condensation and bending of FtsZ filaments are important for the formation and constriction of the cytokinetic ring. PC190723 is an effective bactericidal cell division inhibitor that targets FtsZ in the pathogen Staphylococcus aureus and Bacillus subtilis and does not affect Escherichia coli cells, which apparently binds to a zone equivalent to the binding site of the antitumor drug taxol in tubulin (Haydon, D. J., Stokes, N. R., Ure, R., Galbraith, G., Bennett, J. M., Brown, D. R., Baker, P. J., Barynin, V. V., Rice, D. W., Sedelnikova, S. E., Heal, J. R., Sheridan, J. M., Aiwale, S. T., Chauhan, P. K., Srivastava, A., Taneja, A., Collins, I., Errington, J., and Czaplewski, L. G. (2008) Science 312, 16731675). We have found that the benzamide derivative PC190723 is an FtsZ polymer-stabilizing agent. PC190723 induced nucleated assembly of Bs-FtsZ into single-stranded coiled protofilaments and polymorphic condensates, including bundles, coils, and toroids, whose formation could be modulated with different solution conditions. Under conditions for reversible assembly of Bs-FtsZ, PC190723 binding reduced the GTPase activity and induced the formation of straight bundles and ribbons, which was also observed with Sa-FtsZ but not with nonsusceptible Ec-FtsZ. The fragment 2,6-difluoro-3-methoxybenzamide also induced Bs-FtsZ bundling. We propose that polymer stabilization by PC190723 suppresses in vivo FtsZ polymer dynamics and bacterial division. The biochemical action of PC190723 on FtsZ parallels that of the microtubule-stabilizing agent taxol on the eukaryotic structural homologue tubulin. Both taxol and PC190723 stabilize polymers against disassembly by preferential binding to each assembled protein. It is yet to be investigated whether both ligands target structurally related assembly switches.	[Andreu, Jose M.; Schaffner-Barbero, Claudia; Huecas, Sonia; Ruiz-Avila, Laura B.; Nunez-Ramirez, Rafael; Llorca, Oscar; Martin-Galiano, Antonio J.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Alonso, Dulce; Lopez-Rodriguez, Maria L.] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid	Andreu, JM (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	j.m.andreu@cib.csic.es	Llorca, Oscar/P-2784-2019; Huecas, Sonia/P-2542-2019; Physics, Biophym IEM-CSIC Macromolecular/C-7939-2011; Huecas, Sonia/K-1754-2014; Lopez-Rodriguez, Maria L/S-6342-2016; Llorca, Oscar/K-1144-2014	Llorca, Oscar/0000-0001-5705-0699; Huecas, Sonia/0000-0002-6419-441X; Huecas, Sonia/0000-0002-6419-441X; Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Llorca, Oscar/0000-0001-5705-0699; Andreu, Jose M/0000-0001-8064-6933; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Nunez, Rafael/0000-0002-2949-8709	Ministerio de Ciencia (MCINN) [BFU2008-00013, SAF2007-67008, S-SAL-249-2006, SAF2008-00451]; Comunidad Autonoma de Madrid [S-BIO-0214-2006]; Red Tematica de Investigacion Cooperativa en Cancer [RD06-0020-1001]; Human Frontiers Science Program [RGP39-2008]; Formacion de Personal Investigation; Consejo Superior de Investigaciones Cientificas i3p; Juan de la Cierva	Ministerio de Ciencia (MCINN); Comunidad Autonoma de Madrid(Comunidad de Madrid); Red Tematica de Investigacion Cooperativa en Cancer; Human Frontiers Science Program(Human Frontier Science Program); Formacion de Personal Investigation; Consejo Superior de Investigaciones Cientificas i3p; Juan de la Cierva(Instituto de Salud Carlos III)	This work was supported by Grants Ministerio de Ciencia (MCINN) BFU2008-00013 (to J. M. A.), Comunidad Autonoma de Madrid S-BIO-0214-2006 (to J. M. A. and O. L.), MCINN SAF2007-67008 (to M. L. L.-R.), S-SAL-249-2006 (to M. L. L.-R.), SAF2008-00451 (to O. L.), Red Tematica de Investigacion Cooperativa en Cancer RD06-0020-1001 (to O. L.), Human Frontiers Science Program RGP39-2008 (to O. L.) and contracts Formacion de Personal Investigation (to C. S.-B.), Consejo Superior de Investigaciones Cientificas i3p (to S. H.), and Juan de la Cierva (to A. J. M.-G.).	Abal M, 2001, CELL MOTIL CYTOSKEL, V49, P1, DOI 10.1002/cm.1016; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P534, DOI 10.1021/bi00532a019; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Beuria TK, 2009, BIOCHEM J, V423, P61, DOI 10.1042/BJ20090817; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; Dajkovic A, 2006, J MOL MICROB BIOTECH, V11, P140, DOI 10.1159/000094050; Diaz JF, 2009, TOP CURR CHEM, V286, P121, DOI 10.1007/128_2008_12; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nova E, 2007, ARCH BIOCHEM BIOPHYS, V465, P315, DOI 10.1016/j.abb.2007.06.032; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	51	128	131	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14239	14246		10.1074/jbc.M109.094722	http://dx.doi.org/10.1074/jbc.M109.094722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212044	Green Published, hybrid			2022-12-27	WOS:000277299700020
J	Budzynski, E; Gross, AK; McAlear, SD; Peachey, NS; Shukla, M; He, F; Edwards, M; Won, J; Hicks, WL; Wensel, TG; Naggert, JK; Nishina, PM				Budzynski, Ewa; Gross, Alecia K.; McAlear, Suzanne D.; Peachey, Neal S.; Shukla, Meera; He, Feng; Edwards, Malia; Won, Jungyeon; Hicks, Wanda L.; Wensel, Theodore G.; Naggert, Jurgen K.; Nishina, Patsy M.			Mutations of the Opsin Gene (Y102H and I307N) Lead to Light-induced Degeneration of Photoreceptors and Constitutive Activation of Phototransduction in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; RHODOPSIN MUTATION; TRANSGENIC MICE; MUTANT OPSIN; MOUSE MODEL; IN-VIVO; ROD PHOTOTRANSDUCTION; DARK-ADAPTATION; INDUCED DAMAGE; GENERATION	Mutations in the Rhodopsin (Rho) gene can lead to autosomal dominant retinitis pigmentosa (RP) in humans. Transgenic mouse models with mutations in Rho have been developed to study the disease. However, it is difficult to know the source of the photoreceptor (PR) degeneration in these transgenic models because overexpression of wild type (WT) Rho alone can lead to PR degeneration. Here, we report two chemically mutagenized mouse models carrying point mutations in Rho (Tvrm1 with an Y102H mutation and Tvrm4 with an I307N mutation). Both mutants express normal levels of rhodopsin that localize to the PR outer segments and do not exhibit PR degeneration when raised in ambient mouse room lighting; however, severe PR degeneration is observed after short exposures to bright light. Both mutations also cause a delay in recovery following bleaching. This defect might be due to a slower rate of chromophore binding by the mutant opsins compared with the WT form, and an increased rate of transducin activation by the unbound mutant opsins, which leads to a constitutive activation of the phototransduction cascade as revealed by in vitro biochemical assays. The mutant-free opsins produced by the respective mutant Rho genes appear to be more toxic to PRs, as Tvrm1 and Tvrm4 mutants lacking the 11-cis chromophore degenerate faster than mice expressing WT opsin that also lack the chromophore. Because of their phenotypic similarity to humans with B1 Rho mutations, these mutants will be important tools in examining mechanisms underlying Rho-induced RP and for testing therapeutic strategies.	[Budzynski, Ewa; Edwards, Malia; Won, Jungyeon; Hicks, Wanda L.; Naggert, Jurgen K.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Gross, Alecia K.; McAlear, Suzanne D.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Peachey, Neal S.; Shukla, Meera] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [He, Feng; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wensel, Theodore G.] Baylor Coll Med, Dept Neurosci & Ophthalmol, Houston, TX 77030 USA	Jackson Laboratory; University of Alabama System; University of Alabama Birmingham; Cleveland Clinic Foundation; Case Western Reserve University; Baylor College of Medicine; Baylor College of Medicine	Nishina, PM (corresponding author), 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org	Peachey, Neal/G-5533-2010; Gross, Alecia K./AAJ-1792-2021	Peachey, Neal/0000-0002-4419-7226; Gross, Alecia K./0000-0003-1857-6633; Wensel, Theodore/0000-0003-3518-9352	NCI [CA-34196]; Maine Institute of Human Genetics Health; Foundation Fighting Blindness; National Institutes of Health [EY016510, EY07981]; Research to Prevent Blindness; Prevent Blindness Ohio; Medical Research Service Department of Veterans Affairs; Hope for Vision; EyeSight Foundation of Alabama; Karl Kirchgessner Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019311, R01EY007981, R01EY016501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maine Institute of Human Genetics Health; Foundation Fighting Blindness(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Prevent Blindness Ohio; Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); Hope for Vision; EyeSight Foundation of Alabama; Karl Kirchgessner Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-34196 from the NCI, grants from the Maine Institute of Human Genetics & Health (to P. M. N.), Foundation Fighting Blindness (to P. M. N.), National Institutes of Health Grant EY016510 (to P. M. N.), Research to Prevent Blindness (to N. S. P.), Prevent Blindness Ohio (to M. S.), the Medical Research Service Department of Veterans Affairs (to N. S. P.), Hope for Vision (to N. S. P.), EyeSight Foundation of Alabama (to A. K. G.), the Karl Kirchgessner Foundation (to A. K. G.), and National Institutes of Health Grant EY07981 (to T. G. W.).	BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Goto Y, 1996, J OPT SOC AM A, V13, P577, DOI 10.1364/JOSAA.13.000577; Groenendijk G W, 1980, Methods Enzymol, V67, P203; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2002, DOI 10.1021/bi020612r; Gu D, 2007, INVEST OPHTH VIS SCI, V48, P4907, DOI 10.1167/iovs.07-0428; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hawes N L, 1999, Mol Vis, V5, P22; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Justice MJ, 1997, METHODS, V13, P423, DOI 10.1006/meth.1997.0548; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Lamb T D, 1996, Aust N Z J Ophthalmol, V24, P105, DOI 10.1111/j.1442-9071.1996.tb01562.x; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Naash MI, 1996, J NEUROSCI, V16, P7853; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pang JJ, 2005, MOL VIS, V11, P152; Pepperberg DR, 1996, J OPT SOC AM A, V13, P586, DOI 10.1364/JOSAA.13.000586; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Pinto LH, 2005, VISUAL NEUROSCI, V22, P619, DOI 10.1017/S0952523805225117; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717	51	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14521	14533		10.1074/jbc.M110.112409	http://dx.doi.org/10.1074/jbc.M110.112409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207741	hybrid, Green Published			2022-12-27	WOS:000277299700049
J	Aleksandrov, A; Simonson, T				Aleksandrov, Alexey; Simonson, Thomas			Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; INDUCED FIT MECHANISM; LIGAND-BINDING; C-SRC; STI-571 INHIBITION; STRUCTURAL BASIS; SURFACE-AREA; BCR-ABL; RESISTANCE; DOMAIN	mechanism, involving their phosphorylation and switching between inactive and active conformations. The cancer drug imatinib binds tightly to several homologous kinases, including Abl, but weakly to others, including Src. Imatinib specifically targets the inactive, so-called "DFG-out" conformation of Abl, which differs from the preferred, "DFG-in" conformation of Src in the orientation of a conserved Asp-Phe-Gly (DFG) activation loop. However, recent x-ray structures showed that Src can also adopt the DFG-out conformation and uses it to bind imatinib. The Src/Abl-binding free energy difference can thus be decomposed into two contributions. Contribution i measures the different protein-imatinib interactions when either kinase is in its DFG-out conformation. Contribution ii depends on the ability of imatinib to select or induce this conformation, i. e. on the relative stabilities of the DFG-out and DFG-in conformations of each kinase. Neither contribution has been measured experimentally. We use molecular dynamics simulations to show that contribution i is very small, 0.2 +/- 0.6 kcal/mol; imatinib interactions are very similar in the two kinases, including long range electrostatic interactions with the imatinib positive charge. Contribution ii, deduced using the experimental binding free energy difference, is much larger, 4.4 +/- 0.9 kcal/mol. Thus, conformational selection, easy in Abl, difficult in Src, underpins imatinib specificity. Contribution ii has a simple interpretation; it closely approximates the stability difference between the DFG-out and DFG- in conformations of apo-Src. Additional calculations show that conformational selection also governs the relative binding of imatinib to the kinases c-Kit and Lck. These results should help clarify the current framework for engineering kinase signaling.	[Aleksandrov, Alexey; Simonson, Thomas] Ecole Polytech, CNRS, Dept Biol, Lab Biochim,UMR7654, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Simonson, T (corresponding author), Ecole Polytech, CNRS, Dept Biol, Lab Biochim,UMR7654, F-91128 Palaiseau, France.	thomas.simonson@polytechnique.fr		Simonson, Thomas/0000-0002-5117-7338; Aleksandrov, Alexey/0000-0002-8150-3931	French Agence Nationale pour la Recherche	French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the French Agence Nationale pour la Recherche.	ALEKSANDROV A, 2010, J COMP CHEM IN PRESS; Aleksandrov A, 2010, J MOL RECOGNIT, V23, P117, DOI 10.1002/jmr.980; Archontis G, 2001, J MOL BIOL, V306, P307, DOI 10.1006/jmbi.2000.4285; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2006, P NATL ACAD SCI USA, V103, P9244, DOI 10.1073/pnas.0600001103; Banavali NK, 2005, STRUCTURE, V13, P1715, DOI 10.1016/j.str.2005.09.005; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carlsson J, 2006, J PHYS CHEM B, V110, P12034, DOI 10.1021/jp056929t; Chen JP, 2007, BIOINFORMATICS, V23, P563, DOI 10.1093/bioinformatics/btl666; Chipot C, 2005, J COMPUT AID MOL DES, V19, P765, DOI 10.1007/s10822-005-9021-3; Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Fernandez A, 2007, CANCER RES, V67, P4028, DOI 10.1158/0008-5472.CAN-07-0345; Froloff N, 1997, PROTEIN SCI, V6, P1293, DOI 10.1002/pro.5560060617; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunenberger PH, 1999, BIOCHEMISTRY-US, V38, P2358, DOI 10.1021/bi982064g; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Jencks WP, 1986, CATALYSIS CHEM ENZYM; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JonesHertzog DK, 1997, J MED CHEM, V40, P1539, DOI 10.1021/jm960684e; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J CHEM PHYS, V89, P3742, DOI 10.1063/1.454895; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kinnings SL, 2009, J CHEM INF MODEL, V49, P318, DOI 10.1021/ci800289y; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levy RM, 2003, J AM CHEM SOC, V125, P9523, DOI 10.1021/ja029833a; Liu SY, 2006, PROTEINS, V64, P68, DOI 10.1002/prot.20954; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; McCammon JA, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P41, DOI 10.1016/B978-044451719-7/50046-9; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearlman DA, 2005, J MED CHEM, V48, P7796, DOI 10.1021/jm050306m; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Setny P, 2005, PROTEINS, V58, P511, DOI 10.1002/prot.20350; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Son MY, 2008, REPRODUCTION, V136, P423, DOI 10.1530/REP-08-0080; STOTE RH, 1991, J CHIM PHYS PCB, V88, P2419, DOI 10.1051/jcp/1991882419; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Verkhivker GM, 2006, BIOINFORMATICS, V22, P1846, DOI 10.1093/bioinformatics/btl199; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang W, 2001, J AM CHEM SOC, V123, P3986, DOI 10.1021/ja003164o; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Wong CF, 2001, J MED CHEM, V44, P1530, DOI 10.1021/jm000443d; Wong S, 2008, PROTEINS, V71, P153, DOI 10.1002/prot.21666; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zhou RH, 2001, J PHYS CHEM B, V105, P10388, DOI 10.1021/jp011480z	80	65	66	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13807	13815		10.1074/jbc.M110.109660	http://dx.doi.org/10.1074/jbc.M110.109660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200154	Green Published, hybrid			2022-12-27	WOS:000276987700056
J	Visschedyk, DD; Perieteanu, AA; Turgeon, ZJ; Fieldhouse, RJ; Dawson, JF; Merrill, AR				Visschedyk, Danielle D.; Perieteanu, Alexandru A.; Turgeon, Zachari J.; Fieldhouse, Robert J.; Dawson, John F.; Merrill, A. Rod			Photox, a Novel Actin-targeting Mono-ADP-ribosyltransferase from Photorhabdus luminescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; CLOSTRIDIUM-BOTULINUM; RIBOSYLATING TOXIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PROTEIN; VIRULENCE; MECHANISM; EXOENZYME; CLASSIFICATION	Photorhabdus luminescens is a pathogenic bacterium that produces many toxic proteins. The mono-ADP-ribosyltransferases (mARTs) are an enzyme class produced by numerous pathogenic bacteria and participate in disease in plants and animals, including humans. Herein we report a novel mART from P. luminescens called Photox. This 46-kDa toxin shows high homology to other actin-targeting mARTs in hallmark catalytic regions and a similar core catalytic fold. Furthermore, Photox shows in vivo cytotoxic activity against yeast, with protection occurring when catalytic residues are substituted with alanine. In vitro, enzymatic activity (k(cat), 1680 +/- 75 min(-1)) is higher than that of the related iota toxin, and diminishes by nearly 14,000-fold following substitution of the catalytic Glu (E355A). This toxin specifically ADP-ribosylates monomeric alpha-skeletal actin and nonmuscle beta- and alpha-actin at Arg(177), inhibiting regular polymerization of actin filaments. These results indicate that Photox is indeed an ADP-ribosyltransferase, making it the newest member of the actin-targeting mART family.	[Visschedyk, Danielle D.; Perieteanu, Alexandru A.; Turgeon, Zachari J.; Fieldhouse, Robert J.; Dawson, John F.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014; Dawson, John/HDM-6702-2022	Turgeon, Zachari/0000-0002-0883-8292	Ontario Graduate Scholarship; National Sciences and Engineering Research Council of Canada (NSERC) [250118]; Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes of Health Research; Human Frontier Science Program	Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program)	Supported by pre-doctoral fellowships from Ontario Graduate Scholarship and National Sciences and Engineering Research Council of Canada (NSERC).; Supported by a summer studentship from the Canadian Cystic Fibrosis Foundation (CCFF) and a NSERC fellowship.; Supported by pre-doctoral fellowships from OGS and NSERC.; Supported by NSERC Grant 250118.; Supported by grants from CCFF, Canadian Institutes of Health Research, and Human Frontier Science Program.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ehlers RU, 2001, APPL MICROBIOL BIOT, V56, P623, DOI 10.1007/s002530100711; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fehr D, 2007, J BIOL CHEM, V282, P28843, DOI 10.1074/jbc.M704797200; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; McGuffin LJ, 2004, NUCLEIC ACIDS RES, V32, pD196, DOI 10.1093/nar/gkh043; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018	50	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13525	13534		10.1074/jbc.M109.077339	http://dx.doi.org/10.1074/jbc.M109.077339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181945	Green Published, hybrid			2022-12-27	WOS:000276987700025
J	Zhu, QS; Kao, L; Azimov, R; Newman, D; Liu, WX; Pushkin, A; Abuladze, N; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Newman, Debra; Liu, Weixin; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira			Topological Location and Structural Importance of the NBCe1-A Residues Mutated in Proximal Renal Tubular Acidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COTRANSPORTER NBCE1-A; OCULAR ABNORMALITIES; FUNCTIONAL-ANALYSIS; TRANSPORT; MUTATIONS; MUTAGENESIS; PNBC1; HCO3	NBCe1-A electrogenically cotransports Na+ and HCO3- across the basolateral membrane of renal proximal tubule cells. Eight missense mutations and 3 nonsense mutations in NBCe1-A cause severe proximal renal tubular acidosis (pRTA). In this study, the topologic properties and structural importance of the 8 endogenous residues mutated in pRTA and the in situ topology of NBCe1-A were examined by the substituted cysteine accessibility method. Of the 55 analyzed individually introduced cysteines, 8 were labeled with both membrane permeant (biotin maleimide (BM)) and impermeant (2-((5(6)-tetra-methylrhodamine)carboxylamino)ethyl methanethiosulfonate (MTS-TAMRA)) sulfhydryl reagents, 4 with only BM, and 3 with only MTS-TAMRA. The location of the labeled and unlabeled introduced cysteines clearly indicates that the transmembrane region of NBCe1-A contains 14 transmembrane segments (TMs). In this in situ based NBCe1-A topology, residues mutated in pRTA (pRTA residues) are assigned as: Ser(427), TM1; Thr(485) and Gly(486), TM3; Arg(510) and Leu(522), TM4; Ala(799), TM10; and Arg(881), TM12. Substitution of pRTA residues with cysteines impaired the membrane trafficking of R510C and R881C, the remaining membrane-processed constructs had various impaired transport function. Surprisingly, none of the membrane-processed constructs was accessible to labeling with BM and MTS-TAMRA, nor were they functionally sensitive to the inhibition by (2-aminoethyl) methanethiosulfonate. Functional analysis of Thr(485) with different amino acid substitutions indicated it resides in a unique region important for NBCe1-A function. Our findings demonstrate that the pRTA residues in NBCe1-A are buried in the protein complex/lipid bilayer where they perform important structural roles.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Newman, Debra; Liu, Weixin; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, 10833 Le Conte Ave,Rm 7 155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563.	Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KURTZ I, 1987, J CLIN INVEST, V80, P928, DOI 10.1172/JCI113184; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; LIN S, 2009, J AM SOC NEPHROL, V20, pA33; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Suzuki M, 2008, PFLUG ARCH EUR J PHY, V455, P583, DOI 10.1007/s00424-007-0319-y; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	24	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13416	13426		10.1074/jbc.M109.093286	http://dx.doi.org/10.1074/jbc.M109.093286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197274	Green Published, hybrid			2022-12-27	WOS:000276987700013
J	Guo, XM; Williams, JG; Schug, TT; Li, XL				Guo, Xiumei; Williams, Jason G.; Schug, Thaddeus T.; Li, Xiaoling			DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE DYRK1A; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTORS; DEACETYLASE ACTIVITY; DUAL-SPECIFICITY; DNA-DAMAGE; STRESS; FAMILY; REGULATOR; P53	DYRK1A (the dual specificity tyrosine phosphorylation-regulated kinase 1A) plays an important role in body growth and brain physiology. Overexpression of this kinase has been associated with the development of Down syndrome in both human and animal models, whereas single copy loss-of-function of DYRK1A leads to increased apoptosis and decreased brain size. Although more than a dozen of DYRK1A targets have been identified, the molecular basis of its involvement in neuronal development remains unclear. Here we show that DYRK1A and another pro-survival member of the DYRK family, DYRK3, promote cell survival through phosphorylation and activation of SIRT1, an NAD(+)-dependent protein deacetylase that is essential in a variety of physiological processes including stress response and energy metabolism. DYRK1A and DYRK3 directly phosphorylate SIRT1 at Thr(522), promoting deacetylation of p53. A SIRT1 phosphorylation mimetic (SIRT1 T522D) displays elevated deacetylase activity, thus inhibiting cell apoptosis. Conversely, a SIRT1 dephosphorylation mimetic (SIRT1 T522V) fails to mediate DYRK-induced deacetylation of p53 and cell survival. We show that knockdown of endogenous DYRK1A and DYRK3 leads to hypophosphorylation of SIRT1, sensitizing cells to DNA damage-induced cell death. We also provide evidence that phosphorylation of Thr(522) activates SIRT1 by promoting product release, thereby increasing its enzymatic turnover. Taken together, our findings provide a novel mechanism by which two anti-apoptotic DYRK members promote cell survival through direct modification of SIRT1. These findings may have important implications in understanding the molecular mechanisms of tumorigenesis, Down syndrome, and aging.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)		lix3@niehs.nih.gov	Li, Xiaoling/A-2994-2015	Li, Xiaoling/0000-0001-5920-7784	National Institutes of Health [Z01 ES102205]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102205, ZICES102488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01 ES102205 ( to X. L.).	Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chang HS, 2007, INT J CANCER, V120, P2377, DOI 10.1002/ijc.22573; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Guarente L, 2000, GENE DEV, V14, P1021; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	45	166	177	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13223	13232		10.1074/jbc.M110.102574	http://dx.doi.org/10.1074/jbc.M110.102574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167603	hybrid, Green Published			2022-12-27	WOS:000276787800077
J	Mendillo, ML; Putnam, CD; Mo, AO; Jamison, JW; Li, S; Woods, VL; Kolodner, RD				Mendillo, Marc L.; Putnam, Christopher D.; Mo, Ashley O.; Jamison, Jonathan W.; Li, Sheng; Woods, Virgil L., Jr.; Kolodner, Richard D.			Probing DNA- and ATP-mediated Conformational Changes in the MutS Family of Mispair Recognition Proteins Using Deuterium Exchange Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; MISMATCH-REPAIR; DOMINANT MUTATIONS; CRYSTAL-STRUCTURE; BINDING; COMPLEX; MSH6; HYDROLYSIS; GENE	We have performed deuterium exchange mass spectrometry (DXMS) to probe the conformational changes that the bacterial MutS homodimer and the homologous eukaryotic heterodimer Msh2-Msh6 undergo when binding to ATP or DNA. The DXMS data support the view that high affinity binding to mispair-containing DNA and low affinity binding to fully base-paired DNA both involve forming rings by MutS protein family dimers around the DNA; however, mispair binding protects additional regions from deuterium exchange. DXMS also reveals two distinct conformations upon binding one or two ATP molecules and that binding of two ATP molecules propagates conformational changes to other regions of the protein complexes. The regions showing major changes in deuterium exchange upon ATP binding tend to occur in regions distinct from those involved in DNA binding, suggesting that although communication occurs between DNA and nucleotide binding, sliding clamps formed by binding both ATP and mispairs could result from the simultaneous action of two independent conformational changes.	[Putnam, Christopher D.; Mo, Ashley O.; Jamison, Jonathan W.; Li, Sheng; Woods, Virgil L., Jr.; Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Dept Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Mendillo, Marc L.; Putnam, Christopher D.; Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif San Diego, San Diego Sch Med, Dept Med, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020	Putnam, Christopher/0000-0002-6145-1265; Mendillo, Marc/0000-0001-8128-0128	National Institutes of Health [GM50006, CA92584, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer Program [CA099835, CA118595]; University of California Industry [UC10591]; BiogenIDEC corporate; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA118595, P01CA092584, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982, P01AI068730, R01AI072106, R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020501, R01GM066170, R01GM020501, R01GM050006, R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer Program; University of California Industry; BiogenIDEC corporate; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA92584 (to R. D. K.), AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.), and Grants CA099835 and CA118595 from Innovative Technologies for the Molecular Analysis of Cancer Program (to V. L. W.). This work was also supported by Discovery Grant UC10591 from the University of California Industry-University Cooperative Research Program, BiogenIDEC corporate sponsor (to V. L. W.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Biswas I, 2001, J MOL BIOL, V305, P805, DOI 10.1006/jmbi.2000.4367; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; DeLano WL, 2002, PYMOL USERS MANUAL; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER SW, 1994, METHOD ENZYMOL, V232, P26; FENG G, 1995, BIOTECHNIQUES, V19, P956; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564	50	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13170	13182		10.1074/jbc.M110.108894	http://dx.doi.org/10.1074/jbc.M110.108894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181951	hybrid, Green Published			2022-12-27	WOS:000276787800072
J	Ushiki-Kaku, Y; Endo, R; Iwamaru, Y; Shimizu, Y; Imamura, M; Masujin, K; Yamamoto, T; Hattori, S; Itohara, S; Irie, S; Yokoyama, T				Ushiki-Kaku, Yuko; Endo, Ryo; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Imamura, Morikazu; Masujin, Kentaro; Yamamoto, Takuji; Hattori, Shunji; Itohara, Shigeyoshi; Irie, Shinkichi; Yokoyama, Takashi			Tracing Conformational Transition of Abnormal Prion Proteins during Interspecies Transmission by Using Novel Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; STRAIN VARIATION; MINK ENCEPHALOPATHY; MONOCLONAL-ANTIBODY; MOLECULAR ANALYSIS; BSE; PRP; TISSUE; CONVERSION	Conformational differences in abnormal prion proteins (PrPSc) have been postulated to produce different prion phenotypes. During the interspecies transmission of prions, the conformation of PrPSc may change with passage; however, little is known about the mechanism of PrPSc transition. In this study, novel PrPSc-specific monoclonal antibodies (mAbs) were developed that could detect the PrPSc of mouse but not that of sheep. By using these mAbs, we attempted to examine PrPSc accumulated in mice inoculated with sheep scrapie serially up to five passages. The presence of PrPSc in the mice was confirmed at all passages; however, mAb-bound PrPSc conformer was detected only from the third passage onward. The generated mAb enabled tracing of a particular conformer during adaptation in sheep-to-mice transmission of prion, suggesting that the conformational transition of PrPSc was caused by propagation of this conformer. Such mAbs capable of discriminating conformational differences may allow us to address questions concerning PrPSc conformation and strain diversity.	[Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Ushiki-Kaku, Yuko; Yamamoto, Takuji; Hattori, Shunji; Irie, Shinkichi] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Endo, Ryo; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Imamura, Morikazu; Masujin, Kentaro; Yokoyama, Takashi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	RIKEN; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yokoyama, T (corresponding author), 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	tyoko@affrc.go.jp	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Baron TGM, 2001, J VIROL, V75, P107, DOI 10.1128/JVI.75.1.107-114.2001; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; KIMBERLIN RH, 1991, CURR T VET, V55, P137; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Masujin K, 2007, MICROBIOL IMMUNOL, V51, P1039, DOI 10.1111/j.1348-0421.2007.tb03988.x; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; OSTERMAN DG, 1985, J CELL BIOCHEM, V29, P57, DOI 10.1002/jcb.240290202; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1991, CURR TOP MICROBIOL, P233; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Shimada K, 2005, MICROBIOL IMMUNOL, V49, P801, DOI 10.1111/j.1348-0421.2005.tb03660.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172, DOI 10.1128/CDLI.2.2.172-176.1995; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200	35	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11931	11936		10.1074/jbc.M109.058859	http://dx.doi.org/10.1074/jbc.M109.058859			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177064	hybrid, Green Published			2022-12-27	WOS:000276787100021
J	Guo, JH; Cheng, P; Liu, Y				Guo, Jinhu; Cheng, Ping; Liu, Yi			Functional Significance of FRH in Regulating the Phosphorylation and Stability of Neurospora Circadian Clock Protein FRQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDBACK LOOPS; FREQUENCY; MULTIPLE; LIGHT; DEGRADATION; COMPLEX; EXOSOME; KINASE; TRANSCRIPTION; MECHANISM	FREQUENCY (FRQ) is the central component of the Neurospora circadian clock. All FRQ proteins form the FFC complex with FRH (FRQ-interacting RNA helicase) that acts as the negative element in the circadian negative feedback loop by repressing frq mRNA levels. To understand the function of the FRQ-FRH interaction, we mapped and identified the minimal FRQ region that is required for FRQ-FRH interaction. We demonstrated that the FRQ-FRH complex formation is required for the interaction between FRQ and the White Collar Complex (WCC) and clock function. On the other hand, in the FRQ-FRH complex, FRQ is also required for the FRH-WCC interaction. Disruption of FRQ-FRH interaction or down-regulation of FRH results in hypophosphorylation, rapid degradation of FRQ, as well as low levels of WHITE COLLAR-1 and WHITE COLLAR-2. Furthermore, we showed that the rapid FRQ degradation in the absence of FRH is independent of FWD-1, the ubiquitin E3 ligase of FRQ under normal conditions, thus uncovering an alternative pathway for FRQ degradation.	[Guo, Jinhu; Cheng, Ping; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu			National Institutes of Health [GM068496, GM062591]; The Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068496 and GM062591 (to Y.L.). This work was also supported by The Welch Foundation (to Y.L.).	ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; ARPAIA G, 1993, PLANT PHYSIOL, V102, P1299, DOI 10.1104/pp.102.4.1299; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dunlap JC, 1999, GENES CELLS, V4, P1, DOI 10.1046/j.1365-2443.1999.00239.x; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, BIOCHEM SOC T, V33, P953, DOI 10.1042/BST0330953; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	34	44	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11508	11515		10.1074/jbc.M109.071688	http://dx.doi.org/10.1074/jbc.M109.071688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159972	hybrid, Green Published			2022-12-27	WOS:000276286200057
J	Takabayashi, T; Xie, MJ; Takeuchi, S; Kawasaki, M; Yagi, H; Okamoto, M; Tariqur, RM; Malik, F; Kuroda, K; Kubota, C; Fujieda, S; Nagano, T; Sato, M				Takabayashi, Tetsuji; Xie, Min-Jue; Takeuchi, Seiji; Kawasaki, Motomi; Yagi, Hideshi; Okamoto, Masayuki; Tariqur, Rahman M.; Malik, Fawzia; Kuroda, Kazuki; Kubota, Chikara; Fujieda, Shigeharu; Nagano, Takashi; Sato, Makoto			LL5 beta Directs the Translocation of Filamin A and SHIP2 to Sites of Phosphatidylinositol 3,4,5-Triphosphate (PtdIns(3,4,5)P-3) Accumulation, and PtdIns(3,4,5)P-3 Localization Is Mutually Modified by Co-recruited SHIP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; PROTEIN; BINDING; LAMELLIPODIA; ASSOCIATION; MIGRATION; MEMBRANE; ADAPTER	Phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P-3) accumulates at the leading edge of migrating cells and works, at least partially, as both a compass to indicate directionality and a hub for subsequent intracellular events. However, how PtdIns(3,4,5)P-3 regulates the migratory machinery has not been fully elucidated. Here, we demonstrate a novel mechanism for efficient lamellipodium formation that depends on PtdIns(3,4,5)P-3 and the reciprocal regulation of PtdIns(3,4,5)P-3 itself. LL5 beta, whose subcellular localization is directed by membrane PtdIns(3,4,5)P-3, recruits the actin-cross-linking protein Filamin A to the plasma membrane, where PtdIns(3,4,5)P-3 accumulates, with the Filamin A-binding Src homology 2 domain-containing inositol polyphosphate 5-phosphatase 2 (SHIP2). A large and dynamic lamellipodium was formed in the presence of Filamin A and LL5 beta by the application of epidermal growth factor. Conversely, depletion of either Filamin A or LL5 beta or the overexpression of either an F-actin-cross-linking mutant of Filamin A or a mutant of LL5 beta without its PtdIns(3,4,5)P-3-interacting region inhibited such events in COS-7 cells. Because F-actin initially polymerizes near the plasma membrane, it is likely that membrane-recruited Filamin A efficiently cross-links newly polymerized F-actin, leading to enhanced lamellipodium formation at the site of PtdIns(3,4,5)P-3 accumulation. Moreover, we demonstrate that co-recruited SHIP2 dephosphorylates PtdIns(3,4,5)P-3 at the same location.	[Takabayashi, Tetsuji; Xie, Min-Jue; Takeuchi, Seiji; Kawasaki, Motomi; Yagi, Hideshi; Okamoto, Masayuki; Tariqur, Rahman M.; Malik, Fawzia; Kuroda, Kazuki; Kubota, Chikara; Nagano, Takashi; Sato, Makoto] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 9101193, Japan; [Takabayashi, Tetsuji; Okamoto, Masayuki; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan; [Kubota, Chikara] Univ Fukui, Fac Med Sci, Dept Surg, Div Orthoped Surg & Rehabil Med, Fukui 9101193, Japan; [Xie, Min-Jue; Takeuchi, Seiji; Yagi, Hideshi; Kuroda, Kazuki; Sato, Makoto] Univ Fukui, Res & Educ Program Life Sci, Fukui 9101193, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Sato, M (corresponding author), 23 Matsuokashimoaizuki, Fukui 9101193, Japan.	makosato@u-fukui.ac.jp	Rahman, Mohammad Tariqur/G-1728-2011	Rahman, Mohammad Tariqur/0000-0003-3600-3265; Yagi, Hideshi/0000-0002-8506-8965	21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program); University of Fukui; Toray Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Fukui; Toray Science Foundation(Toray Industries, Inc.); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the 21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program), the Project Allocation Fund of the University of Fukui, the Toray Science Foundation, and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Kagawa S, 2008, ENDOCRINOLOGY, V149, P642, DOI 10.1210/en.2007-0820; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LEVI L, 1993, BIOCHIM BIOPHYS ACTA, V1216, P342, DOI 10.1016/0167-4781(93)90171-9; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Navolanic PM, 2003, INT J ONCOL, V22, P237; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	27	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16155	16165		10.1074/jbc.M109.081901	http://dx.doi.org/10.1074/jbc.M109.081901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236936	Green Published, hybrid			2022-12-27	WOS:000277715900053
J	Van Antwerpen, P; Slomianny, MC; Boudjeltia, KZ; Delporte, C; Faid, V; Calay, D; Rousseau, A; Moguilevsky, N; Raes, M; Vanhamme, L; Furtmuller, PG; Obinger, C; Vanhaeverbeek, M; Neve, J; Michalski, JC				Van Antwerpen, Pierre; Slomianny, Marie-Christine; Boudjeltia, Karim Zouaoui; Delporte, Cedric; Faid, Valegh; Calay, Damien; Rousseau, Alexandre; Moguilevsky, Nicole; Raes, Martine; Vanhamme, Luc; Furtmueller, Paul G.; Obinger, Christian; Vanhaeverbeek, Michel; Neve, Jean; Michalski, Jean-Claude			Glycosylation Pattern of Mature Dimeric Leukocyte and Recombinant Monomeric Myeloperoxidase GLYCOSYLATION IS REQUIRED FOR OPTIMAL ENZYMATIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; PROTEINS; BINDING; SYSTEM; ROLES	The involvement of myeloperoxidase (MPO) in various inflammatory conditions has been the scope of many recent studies. Besides its well studied catalytic activity, the role of its overall structure and glycosylation pattern in biological function is barely known. Here, the N-glycan composition of native dimeric human MPO purified from neutrophils and of monomeric MPO recombinantly expressed in Chinese hamster ovary cells has been investigated. Analyses showed the presence of five N-glycans at positions 323, 355, 391, 483, 729 in both proteins. Site by site analysis demonstrated a well conserved micro-and macro-heterogeneity and more complex-type N-glycans for the recombinant form. Comparison of biological functionality of glycosylated and deglycosylated recombinant MPO suggests that glycosylation is required for optimal enzymatic activity. Data are discussed with regard to biosynthesis and the three-dimensional structure of MPO.	[Van Antwerpen, Pierre; Delporte, Cedric; Neve, Jean] Univ Libre Bruxelles, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Van Antwerpen, Pierre; Delporte, Cedric; Neve, Jean] Univ Libre Bruxelles, Analyt Platform Inst Pharm, B-1050 Brussels, Belgium; [Van Antwerpen, Pierre] Univ Libre Bruxelles, Inst Pharm, B-1050 Brussels, Belgium; [Slomianny, Marie-Christine; Faid, Valegh; Michalski, Jean-Claude] Univ Lille 1, CNRS, UMR 8576, USTL, F-59655 Villeneuve Dascq, France; [Boudjeltia, Karim Zouaoui; Rousseau, Alexandre; Vanhaeverbeek, Michel] Univ Libre Bruxelles, CHU Charleroi, Expt Med Lab, Montignies le Tilleul, Belgium; [Calay, Damien; Raes, Martine] Univ Namur, Res Unit Biochem & Cellular Biol, Namur, Belgium; [Moguilevsky, Nicole] Univ Namur, Technol Transfer Off, Namur, Belgium; [Vanhamme, Luc] Univ Libre Bruxelles, Fac Sci, IBMM, Mol Parasitol Lab, Gosselies, Belgium; [Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Appl Life Sci, BOKU, Div Biochem, Dept Chem, Vienna, Austria	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite Libre de Bruxelles; University of Namur; University of Namur; Universite Libre de Bruxelles; University of Natural Resources & Life Sciences, Vienna	Van Antwerpen, P (corresponding author), Univ Libre Bruxelles, Lab Pharmaceut Chem, Campus Plaine,CP 205-5, B-1050 Brussels, Belgium.	pvantwer@ulb.ac.be	Delporte, Cedric/C-2228-2013; Obinger, Christian/AAV-3173-2021; Furtmüller, Paul G./Y-5819-2018	Delporte, Cedric/0000-0001-7453-7028; Furtmüller, Paul G./0000-0002-1199-2469; Van Antwerpen, Pierre/0000-0002-4934-8863; Obinger, Christian/0000-0002-7133-3430	Belgian Fund for Scientific Research (FRS-FNRS) [2006/V 3/5/244-IB/BT-13924, 34553.08]; Dept. of International Relationship	Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Dept. of International Relationship	This work was supported by Grants from the Belgian Fund for Scientific Research (FRS-FNRS), number 2006/V 3/5/244-IB/BT-13924 and number 34553.08, and a grant from the Dept. of International Relationship (ULB).	BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Boudjeltia KZ, 2006, BIOCHEM CELL BIOL, V84, P805, DOI 10.1139/O06-061; Bragonzi A, 2000, BBA-GEN SUBJECTS, V1474, P273, DOI 10.1016/S0304-4165(00)00023-4; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; GEYER R, 1994, METHOD ENZYMOL, V230, P86; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HEWSON WD, 1979, J BIOL CHEM, V254, P3175; JOHNSON KR, 1987, NUCLEIC ACIDS RES, V15, P2013, DOI 10.1093/nar/15.5.2013; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kooter IM, 1997, J BIOL INORG CHEM, V2, P191, DOI 10.1007/s007750050124; Kooter IM, 1997, J AM CHEM SOC, V119, P11542, DOI 10.1021/ja9725460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Maruyama Y, 2004, J NEPHROL, V17, pS72; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Moguilevsky N, 2004, BIOCHEM BIOPH RES CO, V323, P1223, DOI 10.1016/j.bbrc.2004.08.220; Morelle W, 2005, CURR PHARM DESIGN, V11, P2615, DOI 10.2174/1381612054546897; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Slomianny MC, 2006, PROTEOMICS, V6, P2365, DOI 10.1002/pmic.200500546; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Van Antwerpen P, 2005, BIOCHEM BIOPH RES CO, V337, P82, DOI 10.1016/j.bbrc.2005.09.013; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; Boudjeltia KZ, 2007, EUR UROL, V51, P262, DOI 10.1016/j.eururo.2006.08.040	35	50	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16351	16359		10.1074/jbc.M109.089748	http://dx.doi.org/10.1074/jbc.M109.089748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332087	Green Published, hybrid			2022-12-27	WOS:000277715900071
J	Berry, DC; Soltanian, H; Noy, N				Berry, Daniel C.; Soltanian, Hooman; Noy, Noa			Repression of Cellular Retinoic Acid-binding Protein II during Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; ACTIVATED RECEPTOR; C/EBP-ALPHA; ADIPOGENESIS; CAMP; GENE; GROWTH; CELLS; SUPPRESSION; BETA/DELTA	In preadipocytes, retinoic acid (RA) regulates gene expression by activating the nuclear RA receptor (RAR) and its cognate intracellular lipid-binding protein CRABP-II. It was previously reported that RA inhibits adipocyte differentiation but only when administered early during the differentiation program. The data presented here indicate that the diminished ability of RA to activate RAR following induction of differentiation stems from down-regulation of CRABP-II. The observations show that expression of CRABP-II in preadipocytes is repressed by all three components of the classical hormonal mixture that induces adipocyte differentiation, i.e. isobutylmethylxanthine, insulin, and dexamethasone. Isobutylmethylxanthine-dependent activation of protein kinase A triggered the phosphorylation of the transcription factor cAMP-response element-binding protein, which induced the expression of the cAMP-response element-binding protein family repressor cAMP-response element modulator. In turn, cAMP-response element modulator was found to associate with a cognate response element in the CRABP-II promoter and to repress CRABP-II expression. The data further show that CRABP-II is a direct target gene for the glucocorticoid receptor and that it is subjected to dexamethasone-induced glucocorticoid receptor-mediated repression during adipogenesis. Finally, the observations demonstrate that permanent repression of CRABP-II in mature adipocytes is exerted by the master regulator of adipocyte differentiation CCAAT/enhancer-binding protein alpha and is directly mediated through CCAAT/enhancer-binding protein alpha-response elements in the CRABP-II promoter. Taken together, the observations emphasize the important role of CRABP-II in regulating the transcriptional activity of RA through RAR, and they demonstrate that repression of this gene is critical for allowing adipogenesis to proceed.	[Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Soltanian, Hooman] Case Med Ctr, Dept Plast Surg, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, W333 10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health [DK060684, DK073195T32]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319, R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK060684 (to N.N.); Supported by National Institutes of Health Grant DK073195T32.	Bakker AHF, 2004, OBES RES, V12, P488, DOI 10.1038/oby.2004.55; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Detry C, 2008, BONE, V42, P422, DOI 10.1016/j.bone.2007.10.016; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Manor D, 2003, CANCER RES, V63, P4426; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; Soliera AR, 2008, BLOOD, V112, P1942, DOI 10.1182/blood-2007-09-114975; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	36	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15324	15332		10.1074/jbc.M110.110635	http://dx.doi.org/10.1074/jbc.M110.110635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228061	Green Published, hybrid			2022-12-27	WOS:000277399000053
J	Gandhi, PS; Chen, ZW; Di Cera, E				Gandhi, Prafull S.; Chen, Zhiwei; Di Cera, Enrico			Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR; SUBSTRATE RECOGNITION; ALPHA-THROMBIN; SITE GEOMETRY; COMPLEX; BINDING; CLEAVAGE; PEPTIDE; FIBRINOGEN; RESIDUES	Abundant structural information exists on how thrombin recognizes ligands at the active site or at exosites separate from the active site region, but remarkably little is known about how thrombin recognizes substrates that bridge both the active site and exosite I. The case of the protease-activated receptor PAR1 is particularly relevant in view of the plethora of biological effects associated with its activation by thrombin. Here, we present the 1.8 angstrom resolution structure of thrombin S195A in complex with a 30-residue long uncleaved extracellular fragment of PAR1 that documents for the first time a productive binding mode bridging the active site and exosite I. The structure reveals two unexpected features of the thrombin-PAR1 interaction. The acidic P3 residue of PAR1, Asp(39), does not hinder binding to the active site and actually makes favorable interactions with Gly(219) of thrombin. The tethered ligand domain shows a considerable degree of disorder even when bound to thrombin. The results fill a significant gap in our understanding of the molecular mechanisms of recognition by thrombin in ways that are relevant to other physiological substrates.	[Gandhi, Prafull S.; Chen, Zhiwei; Di Cera, Enrico] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu			National Institutes of Health [HL49413, HL58141, HL73813, HL95315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, R44HL095315, R01HL073813, R01HL058141, R29HL049413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141 HL73813, and HL95315 (to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTUNIK HD, 1989, J MOL BIOL, V210, P813, DOI 10.1016/0022-2836(89)90110-1; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Cleary DB, 2002, ARCH BIOCHEM BIOPHYS, V403, P179, DOI 10.1016/S0003-9861(02)00220-5; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Isetti G, 2007, BIOCHEMISTRY-US, V46, P2444, DOI 10.1021/bi0622120; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Myles T, 2001, EUR J BIOCHEM, V268, P70, DOI 10.1046/j.1432-1327.2001.01844.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pechik I, 2006, BIOCHEMISTRY-US, V45, P3588, DOI 10.1021/bi0525369; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; RICHARDSON MA, 1992, NATURE, V360, P261, DOI 10.1038/360261a0; Rose T, 2002, J BIOL CHEM, V277, P18875, DOI 10.1074/jbc.M110977200; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; Yang LK, 2006, P NATL ACAD SCI USA, V103, P879, DOI 10.1073/pnas.0507700103; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200	62	51	52	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15393	15398		10.1074/jbc.M110.115337	http://dx.doi.org/10.1074/jbc.M110.115337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236938	hybrid, Green Published			2022-12-27	WOS:000277399000059
J	Lopez, H; Zhang, LQ; George, NM; Liu, XQ; Pang, XM; Evans, JJD; Targy, NM; Luo, X				Lopez, Hernando; Zhang, Liqiang; George, Nicholas M.; Liu, Xiaoqiong; Pang, Xiaming; Evans, Jacquelynn J. D.; Targy, Natalie M.; Luo, Xu			Perturbation of the Bcl-2 Network and an Induced Noxa/Bcl-xL Interaction Trigger Mitochondrial Dysfunction after DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; CELL-DEATH; MEMBRANE PERMEABILIZATION; FAMILY-MEMBERS; CYTOCHROME-C; APOPTOTIC RESPONSES; BH3 DOMAINS; BAX; ACTIVATION; MCL-1	How most apoptotic stimuli trigger mitochondrial dysfunction remains to be resolved. We screened the entire Bcl-2 network for its involvement in DNA damage-induced apoptosis in HeLa cells. Although the anti-apoptotic member Bcl-xL served as a major suppressor, apoptosis initiated only when both Mcl-1 and Bcl-xL were eliminated. The pro-apoptotic members Bak, Bad, Bim, and Noxa were required for apoptosis induced by DNA damaging agents camptothecin and UV. We, therefore, used a His-tagged Bcl-xL expression system to capture the relevant BH3-only proteins that bind to Bcl-xL in response to DNA damage. Surprisingly, unlike Bad and Bim, which bound Bcl-xL constitutively, Noxa became "Mcl-1-free" and interacted with Bcl-xL after DNA damage but not after death receptor engagement. Similar observations were also made in A431 cells. Importantly, this induced interaction caused cytochrome c release and apoptosis and was directly inhibited by Mcl-1, a protein eliminated or inactivated after DNA damage. These results suggest that the loss/inactivation of Mcl-1 in conjunction with an induced Noxa/Bcl-xL interaction may serve as a trigger for mitochondrial dysfunction during DNA damage-induced apoptosis.	[Lopez, Hernando; Zhang, Liqiang; George, Nicholas M.; Liu, Xiaoqiong; Pang, Xiaming; Evans, Jacquelynn J. D.; Targy, Natalie M.; Luo, Xu] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Luo, X (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Zhang, Liqiang/B-6889-2011; Lopez, Hernando/AAY-7655-2020	Lopez, Hernando/0000-0001-6618-1092	National Institutes of Health [GM76237, GM76237-04S1]; Nebraska Center for Cellular Signaling; Eppley Institute; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Center for Cellular Signaling; Eppley Institute; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76237 and GM76237-04S1. This work was also supported by a pilot grant from the Nebraska Center for Cellular Signaling ( to X. L.).; Supported by a student fellowship from the Nebraska Center for Cellular Signaling.; Supported by the Eppley Institute and a graduate fellowship from the University of Nebraska Medical Center.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bouillet P, 2002, J CELL SCI, V115, P1567; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	42	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15016	15026		10.1074/jbc.M109.086231	http://dx.doi.org/10.1074/jbc.M109.086231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223826	Green Published, hybrid			2022-12-27	WOS:000277399000023
J	Doyle, S; Pyndiah, S; De Gois, S; Erickson, JD				Doyle, Sukhjeevan; Pyndiah, Slovenie; De Gois, Stephanie; Erickson, Jeffrey D.			Excitation-Transcription Coupling via Calcium/Calmodulin-dependent Protein Kinase/ERK1/2 Signaling Mediates the Coordinate Induction of VGLUT2 and Narp Triggered by a Prolonged Increase in Glutamatergic Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; VESICULAR ACETYLCHOLINE TRANSPORTER; RAT CEREBRAL-CORTEX; GYRUS IN-VIVO; NEUROTROPHIC FACTOR; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; QUANTAL SIZE; HOMEOSTATIC PLASTICITY; ELECTROCONVULSIVE SEIZURE	Homeostatic scaling of glutamatergic and GABAergic transmission is triggered by prolonged alterations in synaptic neuronal activity . We have previously described a presynaptic mechanism for synaptic homeostasis and plasticity that involves scaling the level of vesicular glutamate (VGLUT1) and gamma-aminobutyric acid (GABA) (VGAT) transporter biosynthesis. These molecular determinants of vesicle filling and quantal size are regulated by neuronal activity in an opposite manner and bi-directionally. Here, we report that a striking induction of VGLUT2 mRNA and synaptic protein is triggered by a prolonged increase in glutamatergic synaptic activity in mature neocortical neuronal networks in vitro together with two determinants of inhibitory synaptic strength, the neuronal activity-regulated pentraxin (Narp), and glutamate decarboxylase(GAD65). Activity-dependent induction of VGLUT2 and Narp exhibits a similar intermediate-early gene response that is blocked by actinomycin D and tetrodotoxin, by inhibitors of ionotropic glutamate receptors and L-type voltage-gated calcium channels, and is dependent on downstream signaling via calmodulin, calcium/calmodulin-dependent protein kinase(CaMK) and extracellular signal-regulated kinase 1/2 (ERK1/2). The co-induction of VGLUT2 and Narp triggered by prolonged gamma-aminobutyric acid type A receptor blockade is independent of brain-derived nerve growth factor and TrkB receptor signaling. VGLUT2 protein induction occurs on a subset of cortically derived synaptic vesicles in excitatory synapses on somata and dendritic processes of multipolar GABAergic interneurons, recognized sites for the clustering of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate receptors by Narp. We propose that VGLUT2 and Narp induction by excitation transcription coupling leads to increased glutamatergic transmission at synapses on GABAergic inhibitory feedback neurons as part of a coordinated program of Ca2+-signal transcription involved in mechanisms of homeostatic plasticity after prolonged hyperactivity.	[Doyle, Sukhjeevan; Pyndiah, Slovenie; De Gois, Stephanie; Erickson, Jeffrey D.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Erickson, JD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA.	jerick@lsuhsc.edu			National Institutes of Health [NS36936]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36936. This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (NARSAD Southwest Florida Investigator) and a Research Enhancement Fund by Louisiana State University Health Sciences Center (to J. D. E.).	AGOSTON DV, 1991, J NEUROSCI RES, V28, P140, DOI 10.1002/jnr.490280115; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Choe ES, 2002, NEUROSCIENCE, V114, P557, DOI 10.1016/S0306-4522(02)00318-4; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Han EB, 2009, P NATL ACAD SCI USA, V106, P10817, DOI 10.1073/pnas.0903603106; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; HEAULME M, 1986, BRAIN RES, V384, P224, DOI 10.1016/0006-8993(86)91158-3; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Herzog E, 2006, J NEUROCHEM, V99, P1011, DOI 10.1111/j.1471-4159.2006.04144.x; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kirmse K, 2008, J PHYSIOL-LONDON, V586, P5665, DOI 10.1113/jphysiol.2008.161943; Kurt S, 2006, HEARING RES, V212, P224, DOI 10.1016/j.heares.2005.12.002; Liguz-Lecznar M, 2007, INT J DEV NEUROSCI, V25, P107, DOI 10.1016/j.ijdevneu.2006.12.005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mao XH, 2004, EXP CELL RES, V292, P304, DOI 10.1016/j.yexcr.2003.09.012; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mi RF, 2002, J NEUROSCI, V22, P7606; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Minelli A, 2003, DEV BRAIN RES, V140, P309, DOI 10.1016/S0165-3806(02)00617-X; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NIBUYA M, 1995, J NEUROSCI, V15, P7539; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Reti IM, 2008, NEUROSCIENCE, V151, P352, DOI 10.1016/j.neuroscience.2007.10.040; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sakata-Haga H, 2001, BRAIN RES, V902, P143, DOI 10.1016/S0006-8993(01)02290-9; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schallier A, 2009, NEUROCHEM INT, V55, P41, DOI 10.1016/j.neuint.2008.12.019; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Sulzer D, 2000, NEURON, V28, P5; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tsuda M, 1996, NEUROCHEM INT, V29, P443, DOI 10.1016/0197-0186(96)00014-9; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Ueno S, 1997, J NEUROSCI, V17, P625; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Wallen-Mackenzie A, 2009, J NEUROSCI, V29, P2238, DOI 10.1523/JNEUROSCI.5851-08.2009; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	102	31	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14366	14376		10.1074/jbc.M109.080069	http://dx.doi.org/10.1074/jbc.M109.080069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212045	hybrid, Green Published			2022-12-27	WOS:000277299700034
J	Gustot, A; Smriti; Ruysschaert, JM; Mchaourab, H; Govaerts, C				Gustot, Adelin; Smriti; Ruysschaert, Jean-Marie; Mchaourab, Hassane; Govaerts, Cedric			Lipid Composition Regulates the Orientation of Transmembrane Helices in HorA, an ABC Multidrug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INTEGRAL MEMBRANE-PROTEINS; BIOLOGICAL-MEMBRANES; ALTERNATING ACCESS; EXCHANGE; BINDING; TOPOLOGY; SPECTRA; MODEL; MSBA	ATP-binding cassette (ABC) transporters constitute a large class of molecular pumps whose central role in chemotherapy resistance has highlighted their clinical relevance. We investigated whether the lipid composition of the membrane affects the function and structure of HorA, a bacterial ABC multidrug transporter. When the transporter was reconstituted in a bilayer where phosphatidylethanolamine (PE), the main lipid of the bacterial membrane, was replaced with phosphatidylcholine (PC), ATP hydrolysis and substrate transport became uncoupled. Although ATPase activity was maintained, HorA lost its ability to extrude the prototypical substrate Hoechst33342. Attenuated Total Reflection-Fourier Transform Infrared spectroscopy (ATR-FTIR) revealed that, although the secondary structure of the protein was unaffected, the orientation of the transmembrane helices (TM) was modified by the change in lipid composition. The orientation of the backbone carbonyls indicated that the helices opened wider in PE versus PC-containing liposomes, with 10 degrees difference. This was supported by hydrogen/deuterium exchange studies showing increased protection of the backbone from the solvent in PC-containing liposomes. Electron Paramagnetic Resonance was used to further probe the structural change. In the PC-containing liposomes we observed increased mobility of the spin label in TM4, along with increased exposure to molecular oxygen, used as a hydrophobic quencher. This indicates that the lipid change induced modification of the orientation of TM4, exposing Cys-180 to the lipid phase. The lipid composition of the bilayer thus modulates the structure of HorA, and in turn its ability to extrude its substrates.	[Gustot, Adelin; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, B-1050 Brussels, Belgium; [Smriti; Mchaourab, Hassane] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Universite Libre de Bruxelles; Vanderbilt University	Govaerts, C (corresponding author), Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, CP206-2,Blvd Triomphe, B-1050 Brussels, Belgium.	cgovaert@ulb.ac.be	Mishra, Smriti/D-4034-2009	Mishra, Smriti/0000-0002-6765-5007	National Institutes of Health [GMR01-077659]; Actions de Recherche Concertees de la Communaute Francaise, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Actions de Recherche Concertees de la Communaute Francaise, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMR01-077659. This work was also supported by the Actions de Recherche Concertees de la Communaute Francaise, Belgium.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bechinger B, 1999, BIOPHYS J, V76, P552, DOI 10.1016/S0006-3495(99)77223-1; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Botelho AV, 2002, BIOCHEMISTRY-US, V41, P6354, DOI 10.1021/bi011995g; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deJongh HHJ, 1997, BIOCHEMISTRY-US, V36, P13603, DOI 10.1021/bi971337p; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Fringeli U P, 1981, Mol Biol Biochem Biophys, V31, P270; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lensink MF, 2010, J BIOL CHEM, V285, P10519, DOI 10.1074/jbc.M109.068890; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Pilot JD, 2001, BIOCHEMISTRY-US, V40, P8188, DOI 10.1021/bi0103258; Raussens V, 2004, APPL SPECTROSC, V58, P68, DOI 10.1366/000370204322729496; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Vigano C, 2000, BIOPOLYMERS, V55, P373, DOI 10.1002/1097-0282(2000)55:5<373::AID-BIP1011>3.0.CO;2-U; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARREN GB, 1974, BIOCHEMISTRY-US, V13, P5501, DOI 10.1021/bi00724a008; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	29	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14144	14151		10.1074/jbc.M109.079673	http://dx.doi.org/10.1074/jbc.M109.079673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223819	hybrid, Green Published			2022-12-27	WOS:000277299700010
J	Yu, WH; Li, RF; Gui, B; Shang, YF				Yu, Wenhua; Li, Ruifang; Gui, Bin; Shang, Yongfeng			sZIP, an Alternative Splice Variant of ZIP, Antagonizes Transcription Repression and Growth Inhibition by ZIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; BREAST-CANCER; ANDROGEN RECEPTOR; EGFR; PROTEIN; ESTROGEN; MECHANISMS; CROSSTALK; INVASION; SUBUNIT	Recently, we reported a novel transcriptional repressor, ZIP (for zinc finger and G-patch domain-containing), which recruits the Mi-2/NuRD (nucleosome remodeling and deacetylase) complex and represses the expression of epidermal growth factor receptor (EGFR). In doing so, ZIP inhibits cell proliferation and suppresses breast carcinogenesis. Here, we report the cloning and the characterization of an alternatively spliced isoform of ZIP, sZIP. sZIP is an N-terminal truncated form of ZIP, lacking the zinc finger but retaining part of the G-patch domain and C-terminal coiled-coil domain of ZIP. We showed that sZIP could interact with the NuRD complex but lost its DNA-binding capacity. We demonstrated that sZIP antagonizes the transcription repression by ZIP by competing for the binding of the NuRD complex and that sZIP alleviates the growth inhibitory effect of ZIP on hepatocarcinoma cells through attenuating the transcriptional repression of EGFR. Our data provide a finely tuned mechanism for EGFR regulation and add another player for transcription repression.	[Yu, Wenhua; Li, Ruifang; Gui, Bin; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Minist Educ,Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Minist Educ,Key Lab Carcinogenesis & Translat Res, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn			National Natural Science Foundation of China [30830032, 30921062, 30600319]; Ministry of Science and Technology of China [2005CB522404, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y. S.) and 30600319 (to W. Y.) from the National Natural Science Foundation of China and 973 Program Grants 2005CB522404 and 2007CB914503 (to Y. S.) from the Ministry of Science and Technology of China.	Barrett-Lee PJ, 2005, ENDOCR-RELAT CANCER, V12, pS125, DOI 10.1677/erc.1.01024; Bonaccorsi L, 2004, INT J CANCER, V112, P78, DOI 10.1002/ijc.20362; Bonaccorsi L, 2007, J MOL ENDOCRINOL, V38, P51, DOI 10.1677/jme.1.02155; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Gilmore JL, 2006, BIOCHEM J, V396, P79, DOI 10.1042/BJ20051687; Italiano A, 2009, INT J CANCER, V125, P2479, DOI 10.1002/ijc.24610; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Liang J, 2009, EMBO REP, V10, P51, DOI 10.1038/embor.2008.223; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moutinho C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-10; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	30	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14301	14307		10.1074/jbc.M110.107508	http://dx.doi.org/10.1074/jbc.M110.107508			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233718	Green Published, hybrid			2022-12-27	WOS:000277299700027
J	Dimitrova, YN; Li, JO; Lee, YT; Rios-Esteves, J; Friedman, DB; Choi, HJ; Weis, WI; Wang, CY; Chazin, WJ				Dimitrova, Yoana N.; Li, Jiong; Lee, Young-Tae; Rios-Esteves, Jessica; Friedman, David B.; Choi, Hee-Jung; Weis, William I.; Wang, Cun-Yu; Chazin, Walter J.			Direct Ubiquitination of beta-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; PROTEIN; BINDING; DEGRADATION; PATHWAY; LIGASE; COMPLEX; P53; RECOGNITION	beta-Catenin is a key component of the Wnt signaling pathway that functions as a transcriptional co-activator of Wnt target genes. Upon UV-induced DNA damage, beta-catenin is recruited for polyubiquitination and subsequent proteasomal degradation by a unique, p53-induced SCF-like complex (SCF(TBL1)), comprised of Siah-1, Siah-1-interacting protein (SIP), Skp1, transducin beta-like 1 (TBL1), and adenomatous polyposis coli (APC). Given the complexity of the various factors involved and the novelty of ubiquitination of the non-phosphorylated beta-catenin substrate, we have investigated Siah-1-mediated ubiquitination of beta-catenin in vitro and in cells. Overexpression and purification protocols were developed for each of the SCF(TBL1) proteins, enabling a systematic analysis of beta-catenin ubiquitination using an in vitro ubiquitination assay. This study revealed that Siah-1 alone was able to polyubiquitinate beta-catenin. In addition, TBL1 was shown to play a role in protecting beta-catenin from Siah-1 ubiquitination in vitro and from Siah-1-targeted proteasomal degradation in cells. Siah-1 and TBL1 were found to bind to the same armadillo repeat domain of beta-catenin, suggesting that polyubiquitination of beta-catenin is regulated by competition between Siah-1 and TBL1 during Wnt signaling.	[Dimitrova, Yoana N.; Lee, Young-Tae; Rios-Esteves, Jessica; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Dimitrova, Yoana N.; Lee, Young-Tae; Rios-Esteves, Jessica; Friedman, David B.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Friedman, David B.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Li, Jiong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Los Angeles; Stanford University; Stanford University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dimitrova, Yoana/0000-0003-1547-5781; Lee, Young-Tae/0000-0002-3522-9361; Choi, Hee-Jung/0000-0002-1167-1526	National Institutes of Health [R01 GM75156, R01 GM2112, R37DE13848, R01DE15964, R01DE16513, T35 HL007717, P30 CA68485, P50 ES0026]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, R37DE013848, R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Operating Grants (R01 GM75156 and R01 GM2112 to W. J. C.; R37DE13848, R01DE15964, and R01DE16513 to C.-Y. W.), Training Grant T35 HL007717, and grants to support access to facilities (P30 CA68485 and P50 ES0026).	Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chang PJ, 2008, DEVELOPMENT, V135, P3021, DOI 10.1242/dev.021923; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; EKLOF SK, 2001, EMBO J, V20, P6203; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Goddard T. D., 2006, SPARKY 3; Gwak J, 2009, BIOCHEM BIOPH RES CO, V387, P444, DOI 10.1016/j.bbrc.2009.07.027; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jang KL, 2005, P NATL ACAD SCI USA, V102, P18431, DOI 10.1073/pnas.0504054102; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Winer IS, 2006, J BIOL CHEM, V281, P26181, DOI 10.1074/jbc.M604217200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	49	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13507	13516		10.1074/jbc.M109.049411	http://dx.doi.org/10.1074/jbc.M109.049411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181957	hybrid, Green Published			2022-12-27	WOS:000276987700023
J	Gustafson, B; Smith, U				Gustafson, Birgit; Smith, Ulf			Activation of Canonical Wingless-type MMTV Integration Site Family (Wnt) Signaling in Mature Adipocytes Increases beta-Catenin Levels and Leads to Cell Dedifferentiation and Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MESENCHYMAL STEM-CELLS; TNF-ALPHA; RECEPTOR-GAMMA; PPAR-GAMMA; GENE-EXPRESSION; BONE MASS; DIFFERENTIATION; ADIPOGENESIS; PATHWAY	Canonical Wnt ligands are secreted by several cell types in the adipose tissue. We examined if mature adipocytes can also be target cells and found that canonical Wnt activation by Wnt3a induced a marked dedifferentiation of both 3T3-L1 and human adipocytes. Typical adipogenic markers were reduced while undifferentiated cell markers like Pref-1/Dlk1, Wnt10b, and Gata2 were increased. The cells also became insulin-resistant with impaired upstream insulin signaling and reduced glucose uptake. Wnt3a stabilized beta-catenin in the absence of the LRP6 receptor and with maintained axin and Dickkopf-1 protein expression. PPAR gamma was repressed and PPAR gamma ligands could not restore the adipogenic markers or reduce the beta-catenin levels. The dedifferentiated adipocytes expressed the myofibroblast marker alpha-smooth muscle actin and were also susceptible to osteogenic transdifferentiation. These results identify a novel pathway in mature adipose cells that is critical for maintaining the normal adipocyte phenotype and insulin sensitivity.	[Gustafson, Birgit; Smith, Ulf] Gothenburg Univ, Lundberg Lab Diabet Res, Ctr Excellence Metab & Cardiovasc Res, Dept Mol & Clin Med,Sahlgrenska Acad, S-41345 Gothenburg, Sweden	University of Gothenburg	Smith, U (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med, Vita Straket 12 L, S-41345 Gothenburg, Sweden.	ulf.smith@medic.gu.se			Swedish Research Council; Swedish Diabetes Association; Novo Nordisk Foundation; Swedish Foundation for Strategic Research; Torsten and Ragnar Sorderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Sorderberg Foundation	This work was supported by the Swedish Research Council, the Swedish Diabetes Association, the Novo Nordisk Foundation, the Swedish Foundation for Strategic Research, and the Torsten and Ragnar Sorderberg Foundation.	Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hammarstedt A, 2007, BIOCHEM BIOPH RES CO, V357, P700, DOI 10.1016/j.bbrc.2007.03.202; Hirobe T, 2010, J DERMATOL SCI, V57, P123, DOI 10.1016/j.jdermsci.2009.11.006; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	49	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14031	14041		10.1074/jbc.M110.102855	http://dx.doi.org/10.1074/jbc.M110.102855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20179324	hybrid, Green Published			2022-12-27	WOS:000276987700076
J	Soltoff, SP; Hedden, L				Soltoff, Stephen P.; Hedden, Lee			Isoproterenol and cAMP Block ERK Phosphorylation and Enhance [Ca2+](i) Increases and Oxygen Consumption by Muscarinic Receptor Stimulation in Rat Parotid and Submandibular Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; SALIVARY SECRETION; K+-ATPASE; GLAND; CARBACHOL; PATHWAYS; EPAC; LINE; MECHANISMS	Salivary glands are innervated by sympathetic and parasympathetic neurons, which release neurotransmitters that promote fluid secretion and exocytosis when they bind to muscarinic and beta-adrenergic receptors, respectively. Signaling pathways downstream of these receptors are mainly distinct, but there is cross-talk that affects receptor-dependent events. Here we report that the beta-adrenergic ligand isoproterenol blocks increases in extracellular signal-related kinase (ERK) phosphorylation, a protein kinase C-dependent event promoted by the muscarinic receptor ligand carbachol in freshly dispersed rat parotid acinar cells. The inhibitory action of isoproterenol was reproduced by cAMP stimuli (forskolin) and mimetics (dibutyryl-cAMP, 8-(4-chlorophenylthio)-cAMP), including one highly selective for protein kinase A (N-6-benzoyl-cAMP). In contrast, Epac (exchange proteins directly activated by cAMP)selective activators did not mimic the blockade of ERK by isoproterenol, suggesting that inhibition involved protein kinase A. Isoproterenol also blocked ERK downstream of phorbol 12-myristate 13-acetate and the P2X(7) and epidermal growth factor receptors. Isoproterenol and forskolin blocked MEK phosphorylation, reduced RAF phosphorylation on a stimulatory site (Ser-338), and increased RAF phosphorylation on an inhibitory site (Ser-259). Inhibitory effects on ERK were also observed in freshly dispersed rat submandibular acinar cells but not in three immortalized/cancer salivary cell lines (Par-C10, HSY, HSG), indicating significant differences between native cells and cell lines. Notably, in native parotid cells isoproterenol enhanced the carbachol-promoted increases in [Ca2+](i) and oxygen consumption, events that initiate and accompany, respectively, the stimulation of fluid secretion by muscarinic ligands. Thus, isoproterenol produces opposite effects on prominent events downstream of the muscarinic receptor second messengers diacylglycerol (decrease in ERK phosphorylation) and inositol trisphosphate (increase in [Ca2+](i) and fluid secretion).	[Soltoff, Stephen P.; Hedden, Lee] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, 330 Brookline Ave,EC CLS 406, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health (NIDCR) [DE-10877]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE-10877 (NIDCR).	Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BOBYOCK E, 1989, J DENT RES, V68, P1489, DOI 10.1177/00220345890680110401; Bockman CS, 2001, J PHARMACOL EXP THER, V297, P718; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Bradford MD, 1998, EUR J MORPHOL, V36, P176; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Budd DC, 1999, MOL PHARMACOL, V56, P813; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; DAI YS, 1991, AM J PHYSIOL, V261, pC1063, DOI 10.1152/ajpcell.1991.261.6.C1063; Dang H, 2008, DIFFERENTIATION, V76, P546, DOI 10.1111/j.1432-0436.2007.00251.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FULLER CM, 1984, J PHYSIOL-LONDON, V356, P335, DOI 10.1113/jphysiol.1984.sp015468; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Handra-Luca A, 2003, AM J PATHOL, V163, P957, DOI 10.1016/S0002-9440(10)63455-4; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; LANIYONU A, 1990, EUR J PHARM-MOLEC PH, V188, P171, DOI 10.1016/0922-4106(90)90052-Y; LARSSON O, 1989, ACTA PHYSIOL SCAND, V137, P231, DOI 10.1111/j.1748-1716.1989.tb08743.x; LEE KM, 1993, J BIOL CHEM, V268, P9945; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MARTIN SC, 1994, AM J PHYSIOL, V267, pC255, DOI 10.1152/ajpcell.1994.267.1.C255; MAZARIEGOS MR, 1984, J DENT RES, V63, P1102, DOI 10.1177/00220345840630090101; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MURAKAMI M, 1990, J PHYSIOL-LONDON, V426, P127, DOI 10.1113/jphysiol.1990.sp018130; Nagy K, 2007, ACTA PHYSIOL HUNG, V94, P301, DOI 10.1556/APhysiol.94.2007.4.2; PAULAIS M, 1992, J BIOL CHEM, V267, P21558; Pisitkun T, 2008, AM J PHYSIOL-RENAL, V295, pF1030, DOI 10.1152/ajprenal.90339.2008; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Ryberg AT, 2008, ARCH ORAL BIOL, V53, P66, DOI 10.1016/j.archoralbio.2007.07.012; SCHNEYER CA, 1989, CELL TISSUE RES, V256, P361; SCHNEYER CA, 1962, AM J PHYSIOL, V203, P232, DOI 10.1152/ajplegacy.1962.203.2.232; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Soltoff SP, 2004, J BIOL CHEM, V279, P10910, DOI 10.1074/jbc.M305396200; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Tanimura A, 1999, AM J PHYSIOL-CELL PH, V276, pC1282, DOI 10.1152/ajpcell.1999.276.6.C1282; Ten Hagen KG, 2002, PHYSIOL GENOMICS, V8, P107, DOI 10.1152/physiolgenomics.00039.2001; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; WATSON EL, 1993, AM J PHYSIOL, V265, pC1061; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yamada K, 2006, PATHOBIOLOGY, V73, P1, DOI 10.1159/000093086; Yeh CK, 2005, AM J PHYSIOL-CELL PH, V288, pC1357, DOI 10.1152/ajpcell.00370.2004; Yoshimura K, 2000, J PHYSIOL-LONDON, V522, P403, DOI 10.1111/j.1469-7793.2000.t01-1-00403.x	56	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13337	13348		10.1074/jbc.M110.112094	http://dx.doi.org/10.1074/jbc.M110.112094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207737	hybrid, Green Published			2022-12-27	WOS:000276987700004
J	Yan, W; Cao, QJ; Arenas, RB; Bentley, B; Shao, R				Yan, Wei; Cao, Qing Jackie; Arenas, Richard B.; Bentley, Brooke; Shao, Rong			GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; E-CADHERIN EXPRESSION; LUMINAL CELL FATE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; DNA-BINDING; TUMOR PROGRESSION; TH2 DEVELOPMENT; MAMMARY-GLAND; FACTOR SNAIL	GATA3, a transcription factor that regulates T lymphocyte differentiation and maturation, is exclusively expressed in early stage well differentiated breast cancers but not in advanced invasive cancers. However, little is understood regarding its activity and the mechanisms underlying this differential expression in cancers. Here, we employed GATA3-positive, non-invasive (MCF-7) and GATA3-negative, invasive (MDA-MB-231) breast cancer cells to define its role in the transformation between these two distinct phenotypes. Ectopic expression of GATA3 in MDA-MB-231 cells led to a cuboidal-like epithelial phenotype and reduced cell invasive activity. These cells also increased E-cadherin expression but decreased levels of vimentin, N-cadherin, and MMP-9. Further, MDA-MB-231 cells expressing GATA3 grew smaller primary tumors without metastasis compared with larger metastatic tumors derived from control MDA-MB-231 cells in xenografted mice. GATA3 was found to induce E-cadherin expression through binding GATA-like motifs located in the E-cadherin promoter. Blockade of GATA3 using small interfering RNA gene knockdown in MCF-7 cells triggered fibroblastic transformation and cell invasion, resulting in distant metastasis. Studies of human breast cancer showed that GATA3 expression correlated with elevated E-cadherin levels, ER expression, and long disease-free survival. These data suggest that GATA3 drives invasive breast cancer cells to undergo the reversal of epithelial-mesenchymal transition, leading to the suppression of cancer metastasis.	[Yan, Wei; Bentley, Brooke; Shao, Rong] Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Cao, Qing Jackie] Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA; [Arenas, Richard B.] Baystate Med Ctr, Dept Surg, Springfield, MA 01199 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Shao, Rong] Univ Massachusetts, Program Mol & Cellular Biol, Morrill Sci Ctr, Amherst, MA 01003 USA	University of Massachusetts System; Baystate Medical Center; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA.	rong.shao@bhs.org			National Institutes of Health, NCI [R01 CA120659]; United States Department of Defense [W81XWH-06-01-0563]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA120659 (to R. S.). This work was also supported in part by United States Department of Defense Grant W81XWH-06-01-0563.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bertucci F, 1999, ONCOGENE, V18, P3905, DOI 10.1038/sj.onc.1202731; Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981; Birchmeier C, 1996, ACTA ANAT, V156, P217; Boyer B, 1996, ACTA ANAT, V156, P227; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hoch RV, 1999, INT J CANCER, V84, P122; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Nass SJ, 2000, CANCER RES, V60, P4346; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Parikh P, 2005, J AM COLL SURGEONS, V200, P705, DOI 10.1016/j.jamcollsurg.2004.12.025; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Putz E, 1999, CANCER RES, V59, P241; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Saito T, 2004, ONCOGENE, V23, P8629, DOI 10.1038/sj.onc.1207960; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Voduc D, 2008, CANCER EPIDEM BIOMAR, V17, P365, DOI 10.1158/1055-9965.EPI-06-1090; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang GP, 1999, NUCLEIC ACIDS RES, V27, P1517, DOI 10.1093/nar/27.6.1517; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	50	147	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14042	14051		10.1074/jbc.M110.105262	http://dx.doi.org/10.1074/jbc.M110.105262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189993	hybrid, Green Published			2022-12-27	WOS:000276987700077
J	Qiu, JM; Xiao, JF; Han, CF; Li, N; Shen, X; Jiang, HL; Cao, XT				Qiu, Jianming; Xiao, Jianfeng; Han, Chaofeng; Li, Nan; Shen, Xu; Jiang, Hualiang; Cao, Xuetao			Potentiation of Tumor Necrosis Factor-alpha-induced Tumor Cell Apoptosis by a Small Molecule Inhibitor for Anti-apoptotic Protein hPEBP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; TRAIL-INDUCED APOPTOSIS; BREAST-CANCER CELLS; NF-KAPPA-B; SIGNAL-TRANSDUCTION; TNF SUPERFAMILY; DRUG DISCOVERY; IN-VITRO; ACTIVATION; PATHWAYS	hPEBP4 (human phosphatidylethanolamine-binding protein 4) has been identified to be able to potentiate the resistance of breast, prostate, and ovarian cancers, with the preferential expression of hPEBP4, to tumor necrosis factor-alpha (TNF-alpha) or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, suggesting that inhibitors targeting the anti-apoptotic protein hPEBP4 may be useful to increase the sensitivity of hPEBP4-expressing cancer cells to TNF-alpha or TRAIL-induced apoptosis. By structure-based virtual screening and following surface plasmon resonance-based binding assay, seven small compounds were found to potently bind with hPEBP4. The hit compounds were further functionally screened for their ability to inhibit cancer cell growth, and one small compound, IOI-42, was identified to be able to promote TNF-alpha-mediated growth inhibition of MCF-7 breast cancer cells. IOI-42 could potentiate TNF-alpha-induced apoptosis of MCF-7 cells by inhibiting hPEBP4 and could suppress anchorage-independent cell growth of MCF-7 cells. We further demonstrated that IOI-42 could reduce the endogenous association of hPEBP4 with Raf-1/MEK1 and enhance the activation of ERK1/2 and JNK while inhibiting Akt activation. Furthermore, IOI-42 also promoted TRAIL-induced cell apoptosis of prostate cancer cells. Taken together, our data suggest that IOI-42, as the first chemical inhibitor of anti-apoptotic protein hPEBP4, may serve as a potential anti-tumor drug by sensitizing tumor cells to apoptotic inducers.	[Xiao, Jianfeng; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Qiu, Jianming; Han, Chaofeng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Qiu, Jianming; Han, Chaofeng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Qiu, Jianming; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Naval Medical University; Naval Medical University; Zhejiang University	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; caoxt@immunol.org			National High Biotechnology Development Program of China [2009ZX09503-003, 2009AA02Z101, 2006AA02A305]; National Natural Science Foundation of China [30721091, 30772504]; National Key Basic Research Program of China [2010CB911903]; Shanghai Committee of Science and Technology [09QH1402800, 09SG35]	National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by grants from the National High Biotechnology Development Program of China (2009ZX09503-003, 2009AA02Z101, and 2006AA02A305), the National Natural Science Foundation of China (30721091 and 30772504), the National Key Basic Research Program of China (2010CB911903), and the Shanghai Committee of Science and Technology (09QH1402800 and 09SG35).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann D, 1999, J MED CHEM, V42, P4422, DOI 10.1021/jm991090p; Jana S, 2007, CURR MED CHEM, V14, P2369, DOI 10.2174/092986707781745569; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Li P, 2006, INT J MOL MED, V18, P505; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi RX, 2004, ONCOGENE, V23, P7712, DOI 10.1038/sj.onc.1208046; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Zhang YY, 2007, INT J MOL MED, V19, P55; Zheng SX, 2005, J CHEM INF MODEL, V45, P856, DOI 10.1021/ci050031j	38	25	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12241	12247		10.1074/jbc.M110.111898	http://dx.doi.org/10.1074/jbc.M110.111898			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177075	Green Published, hybrid			2022-12-27	WOS:000276787100053
J	Holm, AK; Blank, LM; Oldiges, M; Schmid, A; Solem, C; Jensen, PR; Vemuri, GN				Holm, Anders K.; Blank, Lars M.; Oldiges, Marco; Schmid, Andreas; Solem, Christian; Jensen, Peter R.; Vemuri, Goutham N.			Metabolic and Transcriptional Response to Cofactor Perturbations in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH AVAILABILITY; NETWORK; FLUX; CLONING; ARCA	Metabolic cofactors such as NADH and ATP play important roles in a large number of cellular reactions, and it is of great interest to dissect the role of these cofactors in different aspects of metabolism. Toward this goal, we overexpressed NADH oxidase and the soluble F1-ATPase in Escherichia coli to lower the level of NADH and ATP, respectively. We used a global interaction network, comprising of protein interactions, transcriptional regulation, and metabolic networks, to integrate data from transcription profiles, metabolic fluxes, and the metabolite levels. We identified high-scoring networks for the two strains. The results revealed a smaller, but denser network for perturbations of ATP level, compared with that of NADH level. The action of many global transcription factors such as ArcA, Fnr, CRP, and IHF commonly involved both NADH and ATP, whereas others responded to either ATP or NADH. Overexpressing NADH oxidase invokes response in widespread aspects of metabolism involving the redox cofactors (NADH and NADPH), whereas ATPase has a more focused response to restore ATP level by enhancing proton translocation mechanisms and repressing biosynthesis. Interestingly, NADPH played a key role in restoring redox homeostasis through the concerted activity of isocitrate dehydrogenase and UdhA transhydrogenase. We present a reconciled network of regulation that illustrates the overlapping and distinct aspects of metabolism controlled by NADH and ATP. Our study contributes to the general understanding of redox and energy metabolism and should help in developing metabolic engineering strategies in E. coli.	[Holm, Anders K.; Solem, Christian; Jensen, Peter R.] Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark; [Blank, Lars M.; Schmid, Andreas] TU Dortmund, Lab Chem Biotechnol, D-44227 Dortmund, Germany; [Oldiges, Marco] Forschungszentrum Julich, Inst Biotechnol, D-52425 Julich, Germany; [Vemuri, Goutham N.] Chalmers Univ Technol, Dept Chem & Biol Engn, Syst Biol Div, S-41296 Gothenburg, Sweden	Technical University of Denmark; Dortmund University of Technology; Helmholtz Association; Research Center Julich; Chalmers University of Technology	Jensen, PR (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	prj@bio.dtu.dk	jensen, Peter Ruhdal/AAC-4891-2019; Schmid, Andreas/L-5886-2017; Blank, Lars M./A-6761-2012	Schmid, Andreas/0000-0002-6684-9088; Jensen, Peter Ruhdal/0000-0003-2080-2070; Blank, Lars M./0000-0003-0961-4976; Oldiges, Marco/0000-0003-0704-5597; Hansen, Anders Cai Holm/0000-0001-7706-2304; Solem, Christian/0000-0002-3898-280X				Akinterinwa O, 2008, CURR OPIN BIOTECH, V19, P461, DOI 10.1016/j.copbio.2008.08.002; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Vemuri GN, 2006, BIOTECHNOL BIOENG, V94, P538, DOI 10.1002/bit.20853; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005; WORKMAN C, 2002, GENOME BIOL, V0003; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882	35	98	101	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17498	17506		10.1074/jbc.M109.095570	http://dx.doi.org/10.1074/jbc.M109.095570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20299454	hybrid, Green Published			2022-12-27	WOS:000278133400028
J	Vuppalanchi, D; Coleman, J; Yoo, S; Merianda, TT; Yadhati, AG; Hossain, J; Blesch, A; Willis, DE; Twiss, JL				Vuppalanchi, Deepika; Coleman, Jennifer; Yoo, Soonmoon; Merianda, Tanuja T.; Yadhati, Akshay G.; Hossain, Jobayer; Blesch, Armin; Willis, Dianna E.; Twiss, Jeffery L.			Conserved 3 '-Untranslated Region Sequences Direct Subcellular Localization of Chaperone Protein mRNAs in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; HIPPOCAMPAL-NEURONS; TRANSLATIONAL CONTROL; C-JUN; BINDING PROTEINS; NOGO RECEPTOR; AXON GROWTH; NANOS RNA; TRANSPORT; CYTOSKELETAL	mRNA localization provides polarized cells with a locally renewable source of proteins. In neurons, mRNA translation can occur at millimeters to centimeters from the cell body, giving the dendritic and axonal processes a means to autonomously respond to their environment. Despite that hundreds of mRNAs have been detected in neuronal processes, there are no reliable means to predict mRNA localization elements. Here, we have asked what RNA elements are needed for localization of transcripts encoding endoplasmic reticulum chaperone proteins in neurons. The 3'-untranslated regions (UTRs) of calreticulin and Grp78/BiP mRNAs show no homology to one another, but each shows extensive regions of high sequence identity to their 3'UTRs in mammalian orthologs. These conserved regions are sufficient for subcellular localization of reporter mRNAs in neurons. The 3'UTR of calreticulin has two conserved regions, and either of these is sufficient for axonal and dendritic targeting. However, only nucleotides 1315-1412 show ligand responsiveness to neurotrophin 3 (NT3) and myelin-associated glycoprotein (MAG). This NT3- and MAG-dependent axonal mRNA transport requires activation of JNK, both for calreticulin mRNA and for other mRNAs whose axonal levels are commonly regulated by NT3 and MAG.	[Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Vuppalanchi, Deepika; Coleman, Jennifer; Yoo, Soonmoon; Merianda, Tanuja T.; Yadhati, Akshay G.; Hossain, Jobayer] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Willis, Dianna E.] Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Blesch, Armin] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Drexel University; University of Delaware; Nemours Alfred I. duPont Hospital for Children; University of California System; University of California San Diego	Twiss, JL (corresponding author), Drexel Univ, Dept Biol, 3141 Chestnut St,Stratton Hall 118, Philadelphia, PA 19104 USA.	jeff.twiss@drexel.edu		Blesch, Armin/0000-0003-1133-1174; Yoo, Soonmoon/0000-0002-1645-6809	National Institutes of Health [R01-NS049041, R01-NS041596, K99-NR010797]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049041, R01NS041596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K99NR010797, R00NR010797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS049041 and R01-NS041596 (to J. L. T.) and K99-NR010797 (to D. E. W.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Bassell GJ, 1998, J NEUROSCI, V18, P251; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Goslin K., 1998, CULTURING NERVE CELL, P339; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MOHR E, 1992, EUR J NEUROSCI, V4, P870, DOI 10.1111/j.1460-9568.1992.tb00197.x; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; OCHS S, 1972, SCIENCE, V176, P252, DOI 10.1126/science.176.4032.252; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Smith DS, 1997, J NEUROSCI, V17, P646; Sotelo-Silveira J, 2008, J NEUROCHEM, V104, P545, DOI 10.1111/j.1471-4159.2007.04999.x; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; TIEDGE H, 1993, J NEUROSCI, V13, P4214; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Twiss JL, 2000, NEUROBIOL DIS, V7, P416, DOI 10.1006/nbdi.2000.0293; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Vuppalanchi D, 2009, RESULTS PROBL CELL D, V48, P193, DOI 10.1007/400_2009_16; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; WENSLEY CH, 1995, J NEUROSCI, V15, P4827; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	58	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18025	18038		10.1074/jbc.M109.061333	http://dx.doi.org/10.1074/jbc.M109.061333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20308067	Green Published, hybrid			2022-12-27	WOS:000278133400078
J	Goh, ETH; Pardo, OE; Michael, N; Niewiarowski, A; Totty, N; Volkova, D; Tsaneva, IR; Seckl, MJ; Gout, I				Goh, Eddy T. H.; Pardo, Olivier E.; Michael, Nicholas; Niewiarowski, Andrew; Totty, Nick; Volkova, Dariya; Tsaneva, Irina R.; Seckl, Michael J.; Gout, Ivan			Involvement of Heterogeneous Ribonucleoprotein F in the Regulation of Cell Proliferation via the Mammalian Target of Rapamycin/S6 Kinase 2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; PROTEIN-KINASE; HNRNP-H; SUBCELLULAR-LOCALIZATION; MESSENGER-RNA; PHOSPHORYLATION; ACTIVATION; BINDING; MTOR; IDENTIFICATION	The S6 kinases (S6Ks) have been linked to a number of cellular processes, including translation, insulin metabolism, cell survival, and RNA splicing. Signaling via the phosphotidylinositol 3-kinase and mammalian target of rapamycin (mTOR) pathways is critical in regulating the activity and subcellular localization of S6Ks. To date, nuclear functions of both S6K isoforms, S6K1 and S6K2, are not well understood. To better understand S6K nuclear roles, we employed affinity purification of S6Ks from nuclear preparations followed by mass spectrometry analysis for the identification of novel binding partners. In this study, we report that in contrast to S6K1, the S6K2 isoform specifically associates with a number of RNA-binding proteins, including heterogeneous ribonucleoproteins (hnRNPs). We focused on studying the mechanism and physiological relevance of the S6K2 interaction with hnRNP F/H. Interestingly, the S6K2-hnRNP F/H interaction was not affected by mitogenic stimulation, whereas mTOR binding to hnRNP F/H was induced by serum stimulation. In addition, we define a new role of hnRNP F in driving cell proliferation, which could be partially attenuated by rapamycin treatment. S6K2-driven cell proliferation, on the other hand, could be blocked by small interfering RNA-mediated down-regulation of hnRNP F. These results demonstrate that the specific interaction between mTOR and S6K2 with hnRNPs is implicated in the regulation of cell proliferation.	[Goh, Eddy T. H.; Niewiarowski, Andrew; Tsaneva, Irina R.; Gout, Ivan] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England; [Michael, Nicholas; Totty, Nick] Canc Res UK, London WC2A 3PX, England; [Pardo, Olivier E.; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; [Volkova, Dariya; Gout, Ivan] Inst Mol Biol & Genet, UA-143 Kiev, Ukraine	University of London; University College London; Cancer Research UK; Imperial College London; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Gout, I (corresponding author), UCL, Res Dept Struct & Mol Biol, Gower St, London WC1E 6BT, England.	i.gout@ucl.ac.uk	Pardo, Oliver/AEM-2071-2022	Pardo, Oliver/0000-0003-2223-1435				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Balcazar N, 2009, J BIOL CHEM, V284, P7832, DOI 10.1074/jbc.M807458200; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chou MY, 1999, MOL CELL BIOL, V19, P69; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Cruz R, 2005, J LEUKOCYTE BIOL, V78, P1378, DOI 10.1189/jlb.0405225; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Filonenko VV, 2004, EXP ONCOL, V26, P294; Fogel BL, 2000, J BIOL CHEM, V275, P32371, DOI 10.1074/jbc.M005000200; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacquenet S, 2001, J BIOL CHEM, V276, P40464, DOI 10.1074/jbc.M104070200; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; Oberg D, 2005, J VIROL, V79, P9254, DOI 10.1128/JVI.79.14.9254-9269.2005; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; Rossi R, 2007, FEBS LETT, V581, P4058, DOI 10.1016/j.febslet.2007.07.047; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yoshida T, 1999, GENES CELLS, V4, P707, DOI 10.1046/j.1365-2443.1999.00295.x; Yoshida T, 1999, FEBS LETT, V457, P251, DOI 10.1016/S0014-5793(99)01048-0; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	57	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17065	17076		10.1074/jbc.M109.078782	http://dx.doi.org/10.1074/jbc.M109.078782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308064	hybrid, Green Published			2022-12-27	WOS:000277982600070
J	Huang, H; Weiner, BE; Zhang, HJ; Fuller, BE; Gao, Y; Wile, BM; Zhao, K; Arnett, DR; Chazin, WJ; Fanning, E				Huang, Hao; Weiner, Brian E.; Zhang, Haijiang; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Zhao, Kun; Arnett, Diana R.; Chazin, Walter J.; Fanning, Ellen			Structure of a DNA Polymerase alpha-Primase Domain That Docks on the SV40 Helicase and Activates the Viral Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; LARGE T-ANTIGEN; C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; PRIMER SYNTHESIS; ORIGIN DNA; B-SUBUNIT; COMPLEX; INITIATION; REPLISOME	DNA polymerase alpha-primase (pol-prim) plays a central role in DNA replication in higher eukaryotes, initiating synthesis on both leading and lagging strand single-stranded DNA templates. Pol-prim consists of a primase heterodimer that synthesizes RNA primers, a DNA polymerase that extends them, and a fourth subunit, p68 (also termed B-subunit), that is thought to regulate the complex. Although significant knowledge about single-subunit primases of prokaryotes has accumulated, the functions and regulation of pol-prim remain poorly understood. In the SV40 replication model, the p68 subunit is required for primosome activity and binds directly to the hexameric viral helicase T antigen, suggesting a functional link between T antigen-p68 interaction and primosome activity. To explore this link, we first mapped the interacting regions of the two proteins and discovered a previously unrecognized N-terminal globular domain of p68 (p68N) that physically interacts with the T antigen helicase domain. NMR spectroscopy was used to determine the solution structure of p68N and map its interface with the T antigen helicase domain. Structure-guided mutagenesis of p68 residues in the interface diminished T antigen-p68 interaction, confirming the interaction site. SV40 primosome activity of corresponding pol-prim mutants decreased in proportion to the reduction in p68N-T antigen affinity, confirming that p68-T antigen interaction is vital for primosome function. A model is presented for how this interaction regulates SV40 primosome activity, and the implications of our findings are discussed in regard to the molecular mechanisms of eukaryotic DNA replication initiation.	[Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Huang, Hao; Zhang, Haijiang; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu; ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, GM65484, P30 CA068485, P30 ES00267]; Alexander von Humboldt-Foundation; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E. F.), GM65484 (to W. J. C.), P30 CA068485 (to the Vanderbilt-Ingram Cancer Center), and P30 ES00267 (to the Vanderbilt Center in Molecular Toxicology). This work was also supported by a grant from Alexander von Humboldt-Foundation (to E. F.).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Case DA, 2006, AMBER; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P533; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gai DH, 2004, J BIOL CHEM, V279, P38952, DOI 10.1074/jbc.M406160200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; MOAREFI IF, 1993, J VIROL, V67, P4992, DOI 10.1128/JVI.67.8.4992-5002.1993; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	68	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17112	17122		10.1074/jbc.M110.116830	http://dx.doi.org/10.1074/jbc.M110.116830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20234039	hybrid, Green Published			2022-12-27	WOS:000277982600074
J	Castilho, A; Strasser, R; Stadlmann, J; Grass, J; Jez, J; Gattinger, P; Kunert, R; Quendler, H; Pabst, M; Leonard, R; Altmann, F; Steinkellner, H				Castilho, Alexandra; Strasser, Richard; Stadlmann, Johannes; Grass, Josephine; Jez, Jakub; Gattinger, Pia; Kunert, Renate; Quendler, Heribert; Pabst, Martin; Leonard, Renaud; Altmann, Friedrich; Steinkellner, Herta			In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; SIALIC ACID TRANSPORTER; N-ACETYLNEURAMINIC ACID; LC-ESI-MS; ARABIDOPSIS-THALIANA; ANTIINFLAMMATORY ACTIVITY; VIRAL VECTORS; FC GLYCANS; EXPRESSION; GLYCOSYLATION	Many therapeutic proteins are glycosylated and require terminal sialylation to attain full biological activity. Current manufacturing methods based on mammalian cell culture allow only limited control of this important posttranslational modification, which may lead to the generation of products with low efficacy. Here we report in vivo protein sialylation in plants, which have been shown to be well suited for the efficient generation of complex mammalian glycoproteins. This was achieved by the introduction of an entire mammalian biosynthetic pathway in Nicotiana benthamiana, comprising the coordinated expression of the genes for (i) biosynthesis, (ii) activation, (iii) transport, and (iv) transfer of Neu5Ac to terminal galactose. We show the transient overexpression and functional integrity of six mammalian proteins that act at various stages of the biosynthetic pathway and demonstrate their correct subcellular localization. Co-expression of these genes with a therapeutic glycoprotein, a human monoclonal antibody, resulted in quantitative sialylation of the Fc domain. Sialylation was at great uniformity when glycosylation mutants that lack plant-specific N-glycan residues were used as expression hosts. Finally, we demonstrate efficient neutralization activity of the sialylated monoclonal antibody, indicating full functional integrity of the reporter protein. We report for the first time the incorporation of the entire biosynthetic pathway for protein sialylation in a multicellular organism naturally lacking sialylated glycoconjugates. Besides the biotechnological impact of the achievement, this work may serve as a general model for the manipulation of complex traits into plants.	[Castilho, Alexandra; Strasser, Richard; Jez, Jakub; Gattinger, Pia; Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Stadlmann, Johannes; Grass, Josephine; Pabst, Martin; Leonard, Renaud; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Kunert, Renate] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; [Quendler, Heribert] Polymun Sci GmbH, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	herta.steinkellner@boku.ac.at	Pabst, Martin/GOH-1766-2022; Kunert, Renate E/B-9185-2018; Castilho, Alexandra/AAC-8927-2020; Stadlmann, Johannes/AAC-3157-2021; Strasser, Richard/AAD-2916-2020; Steinkellner, Herta/N-4267-2016	Pabst, Martin/0000-0001-9897-0723; Kunert, Renate E/0000-0002-3397-3621; Castilho, Alexandra/0000-0003-4114-7861; Stadlmann, Johannes/0000-0001-5693-6690; Steinkellner, Herta/0000-0003-4823-1505; Strasser, Richard/0000-0001-8764-6530; Leonard, Renaud/0000-0001-5023-1032; Altmann, Friedrich/0000-0002-0112-7877; Jez, Jakub/0000-0002-6481-4383; Gattinger, Pia/0000-0001-6724-8543	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) [LS 154]; Austrian Science Fund (FWF) [P18-314, L575-B13, P19092]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) (Grant LS 154) and Austrian Science Fund (FWF) (Grants P18-314, L575-B13, and P19092 to R. S.).	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bakker H, 2008, CARBOHYD RES, V343, P2148, DOI 10.1016/j.carres.2008.01.010; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bork K, 2009, J PHARM SCI-US, V98, P3499, DOI 10.1002/jps.21684; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Choi BK, 2008, GLYCOCONJUGATE J, V25, P581, DOI 10.1007/s10719-008-9123-y; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Fleischer S, 1974, Methods Enzymol, V31, P6; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Misaki R, 2006, BIOCHEM BIOPH RES CO, V339, P1184, DOI 10.1016/j.bbrc.2005.11.130; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schuster Manfred, 2007, Biotechnology Journal, V2, P700, DOI 10.1002/biot.200600255; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Takashima S, 2006, J BIOCHEM, V139, P279, DOI 10.1093/jb/mvj029; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759	34	153	168	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15923	15930		10.1074/jbc.M109.088401	http://dx.doi.org/10.1074/jbc.M109.088401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20305285	Green Published, hybrid			2022-12-27	WOS:000277715900029
J	Guo, LW; Hajipour, AR; Ruoho, AE				Guo, Lian-Wang; Hajipour, Abdol R.; Ruoho, Arnold E.			Complementary Interactions of the Rod PDE6 Inhibitory Subunit with the Catalytic Subunits and Transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHODIESTERASE GAMMA-SUBUNIT; CGMP-BINDING-SITES; CYCLIC-GMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; PHOTORECEPTOR PHOSPHODIESTERASE; G-PROTEIN; RETINAL RODS; VISUAL TRANSDUCTION; CRYSTAL-STRUCTURE; TERMINAL REGION	Activation of the cyclic GMP phosphodiesterase (PDE6) by transducin is the central event of visual signal transduction. How the PDE6 inhibitory gamma-subunit (P gamma) interacts with the catalytic subunits (P alpha beta) and the transducin alpha-subunit (alpha(t)) in this process is not entirely clear. Here we have investigated this issue, taking advantage of site-specific label transfer from throughout the full-length P gamma molecule to both alpha(t) and P alpha beta. The interaction profiling and pull-down experiments revealed that the P gamma C-terminal domain accounted for the major interaction with alpha(t) bound with guanosine 5'-3-O-(thio)triphosphate (alpha(t)GTP gamma S) in comparison with the central region, whereas an opposite pattern was observed for the P gamma-P alpha beta interaction. This complementary feature was further exhibited when both alpha(t)GTP gamma S and P alpha beta were present and competing for P gamma interaction, with the P gamma C-terminal domain favoring alpha(nu), whereas the central region demonstrated a preference for P alpha beta. Furthermore, alpha(t)GTP gamma S co-immunoprecipitated with PDE6 and vice versa in a P gamma-dependent manner. Either P alpha beta or alpha(t)GTP gamma S could be pulled down by the Btn-P gamma molecules on streptavidin beads that were saturated by the other partner, indicating simultaneous binding of these two partners to P gamma. These data together indicate that complementary P gamma interactions with its two targets facilitate the alpha(t)center dot PDE6 "transducisome" formation. Thus, our study provides new insights into the molecular mechanisms of PDE6 activation.	[Guo, Lian-Wang; Hajipour, Abdol R.; Ruoho, Arnold E.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Coll Chem, Pharmaceut Lab, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Guo, LW (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	lianwangguo@wisc.edu			National Institutes of Health [GM33138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33138 (to A. E. R. and L.-W.G.).	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CATTY P, 1992, J BIOL CHEM, V267, P19489; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; CLERC A, 1992, J BIOL CHEM, V267, P19948; CLERC A, 1992, J BIOL CHEM, V267, P6620; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; COTE RH, 2006, PHOTORECEPTOR PHOSPH, P165; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Granovsky Alexey E., 1998, Cell Biochemistry and Biophysics, V28, P115, DOI 10.1007/BF02737808; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; NAVON SE, 1988, J BIOL CHEM, V263, P489; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Tsang SH, 2006, J NEUROSCI, V26, P4472, DOI 10.1523/JNEUROSCI.4775-05.2006; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200	46	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15209	15219		10.1074/jbc.M109.086116	http://dx.doi.org/10.1074/jbc.M109.086116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231289	Green Published, hybrid			2022-12-27	WOS:000277399000042
J	Rajasekar, K; Muntaha, ST; Tame, JRH; Kommareddy, S; Morris, G; Wharton, CW; Thomas, CM; White, SA; Hyde, EI; Scott, DJ				Rajasekar, Karthik; Muntaha, Sidra Tul; Tame, Jeremy R. H.; Kommareddy, Sireesha; Morris, Gordon; Wharton, Christopher W.; Thomas, Christopher M.; White, Scott A.; Hyde, Eva I.; Scott, David J.			Order and Disorder in the Domain Organization of the Plasmid Partition Protein KorB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; PROMISCUOUS INCP PLASMIDS; RAY SOLUTION SCATTERING; CENTRAL CONTROL REGION; PARB HOMOLOG KORB; X-RAY; BIOLOGICAL MACROMOLECULES; GLOBAL REGULATOR; BINDING-SITES	The plasmid partition protein KorB has a dual role: it is essential for the correct segregation of the low copy number broad host range RK2 plasmid while also being an important regulator of transcription. KorB belongs to the ParB family of proteins, and partitioning in RK2 has been studied as a simplified model of bacterial chromosome segregation. Structural information on full-length ParB proteins is limited, mainly due to the inability to grow crystals suitable for diffraction studies. We show, using CD and NMR, that KorB has regions of significant intrinsic disorder and hence it adopts a multiplicity of conformations in solution. The biophysical data are consistent with bioinformatic predictions based on the amino acid sequence that the N-terminal region and also the region between the central DNA-binding domain and the C-terminal dimerization domain are intrinsically disordered. We have used small angle x-ray scattering data to determine the ensemble of solution conformations for KorB and selected deletion mutants, based on models of the known domain structures. This conformational range of KorB is likely to be biologically required for DNA partitioning and for binding to a diverse set of partner proteins.	[Wharton, Christopher W.; Thomas, Christopher M.; White, Scott A.; Hyde, Eva I.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Tsurumi Ku, Kanagawa 2300045, Japan; [Morris, Gordon; Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of Birmingham; Yokohama City University; University of Nottingham	Hyde, EI (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	e.i.hyde@bham.ac.uk; dj.scott@nottingham.ac.uk	Hyde, Eva/GPC-8431-2022	Scott, David/0000-0002-6726-2078; White, Scott/0000-0002-0202-6154; Rajasekar, Karthik/0000-0002-8146-6560; Morris, Gordon/0000-0003-2588-6349; Hyde, Eva/0000-0003-3440-2799	Deutsches Elektronen-Synchrotron, Hamburg; Henry Wellcome Building NMR Centre; Higher Education Funding Council for England; Wellcome Trust	Deutsches Elektronen-Synchrotron, Hamburg; Henry Wellcome Building NMR Centre; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust(Wellcome TrustEuropean Commission)	D. J. S. and E. I. H. are grateful for Beamtime awards at Deutsches Elektronen-Synchrotron, Hamburg, and we are grateful to Peter Konarov of European Molecular Biology Laboratory, Hamburg, for help with data collection. We also thank Sara Whittaker and Christian Ludwig of the Henry Wellcome Building NMR Centre for support. NMR spectra were collected at the Henry Wellcome Building NMR Centre at the University of Birmingham, funded by the Higher Education Funding Council for England and the Wellcome Trust.	Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; BERNADO P, 2010, EUR BIOPHYS J, DOI DOI 10.1007/S00249-00009-00549-00243; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharyya A, 2001, J MOL BIOL, V310, P51, DOI 10.1006/jmbi.2001.4729; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bingle LEH, 2005, J MOL BIOL, V349, P302, DOI 10.1016/j.jmb.2005.03.062; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Chiu CM, 2008, PLASMID, V59, P163, DOI 10.1016/j.plasmid.2008.02.001; Delbruck H, 2002, J BIOL CHEM, V277, P4191, DOI 10.1074/jbc.M110103200; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jagura-Burdzy G, 1999, MOL MICROBIOL, V32, P519, DOI 10.1046/j.1365-2958.1999.01365.x; Jagura-Burdzy G, 1999, J BACTERIOL, V181, P2807, DOI 10.1128/JB.181.9.2807-2815.1999; Jagura-Burdzy G, 1997, J MOL BIOL, V265, P507, DOI 10.1006/jmbi.1996.0747; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kostelidou K, 2000, J MOL BIOL, V295, P411, DOI 10.1006/jmbi.1999.3359; Kostelidou K, 1999, J MOL BIOL, V289, P211, DOI 10.1006/jmbi.1999.2761; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lukaszewicz M, 2002, NUCLEIC ACIDS RES, V30, P1046, DOI 10.1093/nar/30.4.1046; Lund O, 2002, CASP5 C; Macartney DP, 1997, MICROBIOL-UK, V143, P2167, DOI 10.1099/00221287-143-7-2167; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, J BIOL CHEM, V282, P10456, DOI 10.1074/jbc.M610603200; Scott DJ, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617-00001; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams DR, 1998, MICROBIOL-UK, V144, P3369, DOI 10.1099/00221287-144-12-3369; WILLIAMS DR, 1993, NUCLEIC ACIDS RES, V21, P1141, DOI 10.1093/nar/21.5.1141; Zatyka M, 2001, J BACTERIOL, V183, P1022, DOI 10.1128/JB.183.3.1022-1031.2001; ZATYKA M, 1994, MICROBIOL-SGM, V140, P2981, DOI 10.1099/13500872-140-11-2981	45	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15440	15449		10.1074/jbc.M109.096099	http://dx.doi.org/10.1074/jbc.M109.096099			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20200158	Green Published, hybrid			2022-12-27	WOS:000277399000064
J	Tubio, MR; Fernandez, N; Fitzsimons, CP; Copsel, S; Santiago, S; Shayo, C; Davio, C; Monczor, F				Rosario Tubio, Maria; Fernandez, Natalia; Fitzsimons, Carlos Patricio; Copsel, Sabrina; Santiago, Sergio; Shayo, Carina; Davio, Carlos; Monczor, Federico			Expression of a G Protein-coupled Receptor (GPCR) Leads to Attenuation of Signaling by Other GPCRs EXPERIMENTAL EVIDENCE FOR A SPONTANEOUS GPCR CONSTITUTIVE INACTIVE FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX MODEL; GTP-BINDING PROTEINS; BREAST-CANCER CELLS; INVERSE AGONIST; OCCUPANCY MODEL; HISTAMINE-H-2-RECEPTOR GENE; MOLECULAR-CLONING; TISSUE EXPRESSION; HISTAMINE-H2-RECEPTOR; ACTIVATION	The idea of G protein-coupled receptors (GPCRs) coupling to G protein solely in their active form was abolished when it was found that certain ligands induce a G protein-coupled but inactive receptor form. This receptor form interferes with signaling of other receptors by sequestering G protein. However, the spontaneous existence of this receptor species has never been established. The aim of the present work was to evaluate the existence of the spontaneous conformation of the receptor inactively coupled to G protein able to interfere with the response of other GPCRs. According to the law of mass action, receptor overexpression should lead to increased amounts of all spontaneously occurring species. Based on this, we generated Chinese hamster ovary (CHO-K1)-derived cell lines expressing various amounts of the human histamine H2 receptor. In these systems, the signaling of other endogenously and transiently expressed GPCRs was attenuated proportionally to human H2 receptor expression levels. G protein transfection specifically reverted this attenuation, strongly suggesting hijacking of the G protein from a common pool. Similar attenuation effects were observed when the beta(2)-adrenergic receptor was overexpressed, suggesting that this is a more general phenomenon. Moreover, in human mammary MDA-MB-231 cells, a consistent increase in the response of other GPCRs was observed when endogenous expression of beta(2)-adrenergic receptor was knocked down using specific small interfering RNAs. Our findings show that GPCRs may interact with the signaling of other receptors by modulating the availability of the G protein and suggest the existence of GPCR spontaneous coupling to G proteins in an inactive form.	[Rosario Tubio, Maria; Fernandez, Natalia; Copsel, Sabrina; Santiago, Sergio; Davio, Carlos; Monczor, Federico] Univ Buenos Aires, Fac Farm & Bioquim, Lab Farmacol Receptores, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina; [Fitzsimons, Carlos Patricio] Leiden Univ, Dept Med Pharmacol, Leiden Amsterdam Ctr Drug Res, NL-2300 Leiden, Netherlands; [Shayo, Carina] Inst Biol & Med Expt, Lab Farmacol & Patol Mol, RA-1428 Buenos Aires, DF, Argentina; [Fernandez, Natalia; Copsel, Sabrina; Shayo, Carina; Davio, Carlos; Monczor, Federico] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	University of Buenos Aires; Leiden University; Leiden University - Excl LUMC; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Monczor, F (corresponding author), Junin 956 PP, RA-1113 Buenos Aires, DF, Argentina.	monczorf@ffyb.uba.ar	Copsel, Sabrina/I-2245-2019	Copsel, Sabrina/0000-0001-5465-9052; Fitzsimons, Carlos P./0000-0002-1556-2650	Agencia Nacional de Promocion Cientifica y Tecnologia [PICT 06-192, PICT 05-38318]; Universidad de Buenos Aires [UBACyT B808]	Agencia Nacional de Promocion Cientifica y Tecnologia(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grants PICT 06-192, PICT 05-38318 from the Agencia Nacional de Promocion Cientifica y Tecnologia, and UBACyT B808 from the Universidad de Buenos Aires.	Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; BATZRI S, 1986, PHARMACOLOGY, V32, P241, DOI 10.1159/000138176; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Cilluffo MC, 1998, INVEST OPHTH VIS SCI, V39, P1429; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; DASSO LLT, 1992, MOL PHARMACOL, V42, P453; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; Fitzsimons CP, 2004, J BIOL CHEM, V279, P34431, DOI 10.1074/jbc.M400738200; GANTZ I, 1991, BIOCHEM BIOPH RES CO, V178, P1386, DOI 10.1016/0006-291X(91)91047-G; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; George SE, 1997, J NEUROCHEM, V69, P1278; Hasseldine ARG, 2003, BRIT J PHARMACOL, V138, P1358, DOI 10.1038/sj.bjp.0705191; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Li SY, 2005, INT J ONCOL, V27, P1329; Matsuda N, 2004, J PHARMACOL EXP THER, V309, P786, DOI 10.1124/jpet.103.063065; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Monczor F, 2006, BIOCHEM PHARMACOL, V71, P1219, DOI 10.1016/j.bcp.2005.12.037; Monczor F, 2003, MOL PHARMACOL, V64, P512, DOI 10.1124/mol.64.2.512; Nakamura M, 2007, J MOL ENDOCRINOL, V39, P375, DOI 10.1677/JME-07-0036; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; Rising TJ, 1985, FRONTIERS HISTAMINE, P61; RUAT M, 1991, BIOCHEM BIOPH RES CO, V179, P1470, DOI 10.1016/0006-291X(91)91738-X; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; Shapira M, 2000, CELL MOL NEUROBIOL, V20, P291, DOI 10.1023/A:1007058008477; Shayo C, 2001, MOL PHARMACOL, V60, P1049, DOI 10.1124/mol.60.5.1049; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; Stickle D, 1996, BBA-MOL CELL RES, V1310, P242, DOI 10.1016/0167-4889(95)00147-6; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; TRAIFFORT E, 1995, BIOCHEM BIOPH RES CO, V211, P570, DOI 10.1006/bbrc.1995.1851; Weiss JM, 1996, J THEOR BIOL, V178, P169, DOI 10.1006/jtbi.1996.0015; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Weiss JM, 1996, J THEOR BIOL, V181, P381, DOI 10.1006/jtbi.1996.0139; WIELAND T, 1992, N-S ARCH PHARMACOL, V346, P475	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14990	14998		10.1074/jbc.M109.099689	http://dx.doi.org/10.1074/jbc.M109.099689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299453	Green Published, hybrid			2022-12-27	WOS:000277399000020
J	Rose, T; Pillet, AH; Lavergne, V; Tamarit, B; Lenormand, P; Rousselle, JC; Namane, A; Theze, J				Rose, Thierry; Pillet, Anne-Helene; Lavergne, Vincent; Tamarit, Blanche; Lenormand, Pascal; Rousselle, Jean-Claude; Namane, Abdelkader; Theze, Jacques			RETRACTED: Interleukin-7 Compartmentalizes Its Receptor Signaling Complex to Initiate CD4 T Lymphocyte Response (Retracted article. See vol. 294, pg. 1436, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PLASMA-MEMBRANE; ERM PROTEINS; IL-7; CYTOSKELETON; CLONING; EXPRESSION; BINDING; CELLS; IDENTIFICATION; ASSOCIATION	Interleukin (IL)-7 is a central cytokine that controls homeostasis of the CD4 T lymphocyte pool. Here we show on human primary cells that IL-7 binds to preassembled receptors made up of proprietary chain IL-7R alpha and the common chain gamma c shared with IL-2, -4, -9, -15, and -21 receptors. Upon IL-7 binding, both chains are driven in cholesterol-and sphingomyelin-rich rafts where associated signaling proteins Jak1, Jak3, STAT1, -3, and -5 are found to be phosphorylated. Meanwhile the IL-7 center dot IL-7R complex interacts with the cytoskeleton that halts its diffusion as measured by single molecule fluorescence autocorrelated spectroscopy monitored by microimaging. Comparative immunoprecipitations of IL-7R alpha signaling complex from non-stimulated and IL-7-stimulated cells confirmed recruitment of proteins such as STATs, but many others were also identified by mass spectrometry from two-dimensional gels. Among recruited proteins, two-thirds are involved in cytoskeleton and raft formation. Thus, early events leading to IL-7 signal transduction involve its receptor compartmentalization into membrane nanodomains and cytoskeleton recruitment.	[Lenormand, Pascal; Rousselle, Jean-Claude; Namane, Abdelkader] Plate Forme Prote, F-75724 Paris 15, France; [Theze, Jacques] Inst Pasteur, Unite Immunogenet Cellulaire, Dept Infect & Epidemiol, Dept Immunol, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris		rose@pasteur.fr	Namane, Abdelkader/O-1857-2013	Namane, Abdelkader/0000-0001-7180-7619; ROSE, Thierry/0000-0001-8863-0207	Institut Pasteur	Institut Pasteur(European Commission)	This work was supported in part by the Institut Pasteur.	Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Eckenberg R, 2000, J EXP MED, V191, P529, DOI 10.1084/jem.191.3.529; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lee SK, 2005, IMMUNOL REV, V208, P169, DOI 10.1111/j.0105-2896.2005.00339.x; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Lopez-Perez M, 2006, INT J BIOCHEM CELL B, V38, P1716, DOI 10.1016/j.biocel.2006.04.001; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pillet AH, 2008, EUR CYTOKINE NETW, V19, P49, DOI 10.1684/ecn.2008.0120; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rose T, 2003, J BIOL CHEM, V278, P22868, DOI 10.1074/jbc.M301757200; Rose T, 2009, J IMMUNOL, V182, P7389, DOI 10.4049/jimmunol.0900190; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; THUILLIER L, 1994, CELL IMMUNOL, V156, P322, DOI 10.1006/cimm.1994.1178; Zoubiane GS, 2004, J CELL SCI, V117, P271, DOI 10.1242/jcs.00855	43	33	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14898	14908		10.1074/jbc.M110.104232	http://dx.doi.org/10.1074/jbc.M110.104232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20167604	hybrid, Green Published			2022-12-27	WOS:000277399000011
J	Sakasai, R; Teraoka, H; Takagi, M; Tibbetts, RS				Sakasai, Ryo; Teraoka, Hirobumi; Takagi, Masatoshi; Tibbetts, Randal S.			Transcription-dependent Activation of Ataxia Telangiectasia Mutated Prevents DNA-dependent Protein Kinase-mediated Cell Death in Response to Topoisomerase I Poison	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; HELA-CELLS; DAMAGE; REPAIR; REPLICATION; PHOSPHORYLATION; 53BP1; ATM; DOWNSTREAM	Camptothecin (CPT) is a topoisomerase I inhibitor, derivatives of which are being used for cancer chemotherapy. CPT-induced DNA double-strand breaks (DSBs) are considered a major cause of its tumoricidal activity, and it has been shown that CPT induces DNA damage signaling through the phosphatidylinositol 3-kinase-related kinases, including ATM (ataxia telangiectasia mutated), ATR (ATM and Rad3-related), and DNA-PK (DNA-dependent protein kinase). In addition, CPT causes DNA strand breaks mediated by transcription, although the downstream signaling events are less well characterized. In this study, we show that CPT-induced activation of ATM requires transcription. Mechanistically, transcription inhibition suppressed CPT-dependent activation of ATM and blocked recruitment of the DNA damage mediator p53-binding protein 1 (53BP1) to DNA damage sites, whereas ATM inhibition abrogated CPT-induced G(1)/S and S phase checkpoints. Functional inactivation of ATM resulted in DNA replication-dependent hyperactivation of DNA-PK in CPT-treated cells and dramatic CPT hypersensitivity. On the other hand, simultaneous inhibition of ATM and DNA-PK partially restored CPT resistance, suggesting that activation of DNA-PK is proapoptotic in the absence of ATM. Correspondingly, comet assay and cell cycle synchronization experiments suggested that transcription collapse occurring as the result of CPT treatment are converted to frank double-strand breaks when ATM-deficient cells bypass the G(1)/S checkpoint. Thus, ATM suppresses DNA-PK-dependent cell death in response to topoisomerase poisons, a finding with potential clinical implications.	[Sakasai, Ryo; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo 1010062, Japan; [Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo 1138519, Japan; [Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Wisconsin System; University of Wisconsin Madison	Sakasai, R (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka 8128582, Japan.	sakasai@surg2.med.kyushu-u.ac.jp	Takagi, Masatoshi/F-3713-2011	Takagi, Masatoshi/0000-0002-7580-9184; Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437	National Institutes of Health [CA124722]; American Cancer Society; Greater Milwaukee Foundation; Japan Society for the Promotion of Science for Exploratory Research [20659047]; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; Japan Society for the Promotion of Science for Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722. This work was also supported by a grant from the American Cancer Society, a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation, and by Grant-in-aid 20659047 from Japan Society for the Promotion of Science for Exploratory Research (to H. T.).	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cobb LJ, 2006, CANCER RES, V66, P10878, DOI 10.1158/0008-5472.CAN-06-0585; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Gurley KE, 2009, EMBO REP, V10, P87, DOI 10.1038/embor.2008.214; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MIMORI T, 1986, J BIOL CHEM, V261, P375; Nakamura H, 2002, J RADIAT RES, V43, P167, DOI 10.1269/jrr.43.167; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sakasai R, 2010, DNA REPAIR, V9, P76, DOI 10.1016/j.dnarep.2009.10.008; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200	32	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15201	15208		10.1074/jbc.M110.101808	http://dx.doi.org/10.1074/jbc.M110.101808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304914	Green Published, hybrid			2022-12-27	WOS:000277399000041
J	Susaki, E; Kaneko-Oshikawa, C; Miyata, K; Tabata, M; Yamada, T; Oike, Y; Katagiri, H; Nakayama, KI				Susaki, Etsuo; Kaneko-Oshikawa, Chie; Miyata, Keishi; Tabata, Mitsuhisa; Yamada, Tetsuya; Oike, Yuichi; Katagiri, Hideki; Nakayama, Keiichi I.			Increased E4 Activity in Mice Leads to Ubiquitin-containing Aggregates and Degeneration of Hypothalamic Neurons Resulting in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; UNCOUPLING PROTEIN EXPRESSION; INCLUSION-BODY FORMATION; MUTANT ALPHA-SYNUCLEIN; PROTEASOME SYSTEM; PARAVENTRICULAR NUCLEUS; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; FOOD-INTAKE	Obesity has become a serious worldwide public health problem. Although neural degeneration in specific brain regions has been suggested to contribute to obesity phenotype in humans, a causal relationship between these two conditions has not been demonstrated experimentally. We now show that E4B (also known as UFD2a), a mammalian ubiquitin chain elongation factor (E4), induces the formation of intracellular aggregates positive for ubiquitin and the adaptor protein p62 when overexpressed in cultured cells or the brain. Mice transgenic for E4B manifested neural degeneration in association with aggregate formation, and they exhibited functional impairment specifically in a subset of hypothalamic neurons that regulate food intake and energy expenditure, resulting in development of hyperphagic obesity and related metabolic abnormalities. The neural pathology of E4B transgenic mice was similar to that of human neurodegenerative diseases associated with the formation of intracellular ubiquitin-positive deposits, indicating the existence of a link between such diseases and obesity and related metabolic disorders. Our findings thus provide experimental evidence for a role of hypothalamic neurodegeneration in obesity, and the E4B transgenic mouse should prove to be a useful animal model for studies of the relationship between neurodegenerative diseases and obesity.	[Susaki, Etsuo; Kaneko-Oshikawa, Chie; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Susaki, Etsuo; Kaneko-Oshikawa, Chie; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Miyata, Keishi; Tabata, Mitsuhisa; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Adv Therapeut Metab Dis,Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kumamoto University; Tohoku University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859; Susaki, Etsuo/0000-0001-5621-7311	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Takeda Science Foundation.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Baran K, 2002, DIABETES, V51, P152, DOI 10.2337/diabetes.51.1.152; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Ishii T, 1996, BIOCHEM BIOPH RES CO, V226, P456, DOI 10.1006/bbrc.1996.1377; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Masaki T, 2003, ENDOCRINOLOGY, V144, P2741, DOI 10.1210/en.2003-0031; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang CF, 2000, NEUROREPORT, V11, P3251, DOI 10.1097/00001756-200009280-00040; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wigley WC, 1999, J CELL BIOL, V145, P481; Wirth MM, 2001, PEPTIDES, V22, P129, DOI 10.1016/S0196-9781(00)00367-3; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	76	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15538	15547		10.1074/jbc.M110.105841	http://dx.doi.org/10.1074/jbc.M110.105841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20190229	Green Published, hybrid			2022-12-27	WOS:000277399000072
J	Groger, N; Frohlich, H; Maier, H; Olbrich, A; Kostin, S; Braun, T; Boettger, T				Groeger, Nicole; Froehlich, Henning; Maier, Hannes; Olbrich, Andrea; Kostin, Sawa; Braun, Thomas; Boettger, Thomas			SLC4A11 Prevents Osmotic Imbalance Leading to Corneal Endothelial Dystrophy, Deafness, and Polyuria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUAPORIN-1 WATER CHANNELS; DESCENDING THIN LIMBS; NULL MICE; MUTATIONS; TRANSPORTERS; MECHANISM; KIDNEY; FLUID; BORON; GENE	Maintenance of ion concentration gradients is essential for the function of many organs, including the kidney, the cornea, and the inner ear. Ion concentrations and fluid content in the cornea are regulated by endothelial cells that separate the collagenous avascular corneal stroma from the anterior eye chamber. Failure to maintain correct ion concentrations leads to swelling and destruction of the cornea. In the inner ear, the stria vascularis is responsible for generating proper ion concentrations in the endolymph, which is essential for hearing. Mutations of SLC4A11 in humans lead to syndromes associated with corneal dystrophy and perceptive deafness. The molecular mechanisms underlying these symptoms are poorly understood, impeding therapeutic interventions. The ion transporter SLC4A11 mediates sodium-dependent transport of borate as well as flux of sodium and hydroxyl ions in vitro. Here, we show that SLC4A11 is expressed in the endothelial cells of the cornea where it prevents severe morphological changes of the cornea caused by increased sodium chloride concentrations in the stroma. In the inner ear, SLC4A11 is located in fibrocytes underlying the stria vascularis. Loss of SLC4A11 leads to morphological changes in the fibrocytes and deafness. Wedemonstrate that SLC4A11 is essential for the generation of the endocochlear potential but not for regulation of potassium concentrations in the endolymph. In the kidney, SLC4A11 is expressed in the thin descending limb of Henle loop. SLC4A11 is essential for urinary concentration, suggesting that SLC4A11 participates in the countercurrent multiplication that concentrates urine in the kidney medulla.	[Boettger, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Maier, Hannes] Hannover Med Sch, Dept Expt Otol, D-30625 Hannover, Germany; [Olbrich, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37077 Gottingen, Germany	Max Planck Society; Hannover Medical School; University of Gottingen		thomas.braun@mpi-bn.mpg.de; thomas.boettger@mpi-bn.mpg.de	Hannes, Maier/AAE-5070-2020; Boettger, Thomas/E-3406-2012; Hannes, Maier/A-9457-2012; Braun, Thomas/B-2310-2008	Hannes, Maier/0000-0001-8457-5327; Boettger, Thomas/0000-0003-4280-8449; Hannes, Maier/0000-0001-8457-5327; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Deutsche Forschungsgemeinschaft [BO1970/1]	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society and by Deutsche Forschungsgemeinschaft Grant BO1970/1.	Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Diecke FPJ, 2007, BBA-BIOMEMBRANES, V1768, P2043, DOI 10.1016/j.bbamem.2007.05.020; Dordas C, 2001, BIOL TRACE ELEM RES, V81, P127, DOI 10.1385/BTER:81:2:127; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fischbarg J, 2006, J MEMBRANE BIOL, V210, P117, DOI 10.1007/s00232-005-0850-8; Fritz E, 2007, MICROSC MICROANAL, V13, P233, DOI 10.1017/S1431927607070420; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; HARBOYAN G, 1971, ARCH OPHTHALMOL-CHIC, V85, P27, DOI 10.1001/archopht.1971.00990050029005; Hemadevi B, 2008, ARCH OPHTHALMOL-CHIC, V126, P700, DOI 10.1001/archopht.126.5.700; JAMISON RL, 1973, AM J PHYSIOL, V224, P180, DOI 10.1152/ajplegacy.1973.224.1.180; KUHN W, 1959, HELV CHIM ACTA, V42, P628, DOI 10.1002/hlca.19590420303; Lee T, 2007, MOL HUM REPROD, V13, P771, DOI 10.1093/molehr/gam069; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Morris RG, 2005, AM J PHYSIOL-RENAL, V289, pF194, DOI 10.1152/ajprenal.00121.2004; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, AM J PHYSIOL-RENAL, V268, pF1023, DOI 10.1152/ajprenal.1995.268.6.F1023; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Skarnes WC, 2005, P NATL ACAD SCI USA, V102, P13001, DOI 10.1073/pnas.0506279102; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; WIRZ H, 1951, HELV PHYSIOL PHARM A, V9, P196; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	35	54	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14467	14474		10.1074/jbc.M109.094680	http://dx.doi.org/10.1074/jbc.M109.094680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20185830	Green Published, hybrid			2022-12-27	WOS:000277299700043
J	Kim, JI; Cali, I; Surewicz, K; Kong, QZ; Raymond, GJ; Atarashi, R; Race, B; Qing, LT; Gambetti, P; Caughey, B; Surewicz, WK				Kim, Jae-Il; Cali, Ignazio; Surewicz, Krystyna; Kong, Qingzhong; Raymond, Gregory J.; Atarashi, Ryuichiro; Race, Brent; Qing, Liuting; Gambetti, Pierluigi; Caughey, Byron; Surewicz, Witold K.			Mammalian Prions Generated from Bacterially Expressed Prion Protein in the Absence of Any Mammalian Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SCRAPIE; DISEASE; STRAINS; ANIMALS; HUMANS; MICE	Transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative diseases that are associated with the conformational conversion of a normal prion protein, PrPC, to a misfolded aggregated form, PrPSc. The protein-only hypothesis asserts that PrPSc itself represents the infectious TSE agent. Although this model is supported by rapidly growing experimental data, unequivocal proof has been elusive. The protein misfolding cyclic amplification reactions have been recently shown to propagate prions using brain-derived or recombinant prion protein, but only in the presence of additional cofactors such as nucleic acids and lipids. Here, using a protein misfolding cyclic amplification variation, we show that prions causing transmissible spongiform encephalopathy in wild-type hamsters can be generated solely from highly purified, bacterially expressed recombinant hamster prion protein without any mammalian or synthetic cofactors (other than buffer salts and detergent). These findings provide strong support for the protein-only hypothesis of TSE diseases, as well as argue that cofactors such as nucleic acids, other polyanions, or lipids are nonobligatory for prion protein conversion to the infectious form.	[Kim, Jae-Il; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cali, Ignazio; Kong, Qingzhong; Qing, Liuting; Gambetti, Pierluigi] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Raymond, Gregory J.; Atarashi, Ryuichiro; Race, Brent; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	cali, ignazio/AAS-1127-2020	cali, ignazio/0000-0001-5770-3848	National Institutes of Health [NS44158, AG14359]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44158 (to W. K. S.) and AG14359 (to P. G., W. K. S., and Q. K.) and by the Intramural Research Program of the NIAID.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; HILMERT H, 1984, BIOSCIENCE REP, V4, P165, DOI 10.1007/BF01120313; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RUBENSTEIN R, 1994, ARCH VIROL, V139, P301, DOI 10.1007/BF01310793; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	29	167	169	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14083	14087		10.1074/jbc.C110.113464	http://dx.doi.org/10.1074/jbc.C110.113464			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20304915	Green Published, hybrid			2022-12-27	WOS:000277299700003
J	Ryu, H; Al-Ani, G; Deckert, K; Kirkpatrick, D; Gygi, SP; Dasso, M; Azuma, Y				Ryu, Hyunju; Al-Ani, Gada; Deckert, Katelyn; Kirkpatrick, Donald; Gygi, Steven P.; Dasso, Mary; Azuma, Yoshiaki			PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; ACTIVE CENTROMERES; ENZYME; INTERACTS; CENPB; YEAST; BUB3	PIASy is a small ubiquitin-related modifier (SUMO) ligase that modifies chromosomal proteins in mitotic Xenopus egg extracts and plays an essential role in mitotic chromosome segregation. We have isolated a novel SUMO-2/3-modified mitotic chromosomal protein and identified it as poly(ADP-ribose) polymerase 1 (PARP1). PARP1 was robustly conjugated to SUMO-2/ 3 on mitotic chromosomes but not on interphase chromatin. PIASy promotes SUMOylation of PARP1 both in egg extracts and in vitro reconstituted SUMOylation assays. Through tandem mass spectrometry analysis of mitotically SUMOylated PARP1, we identified a residue within the BRCA1 C-terminal domain of PARP1 (lysine 482) as its primary SUMOylation site. Mutation of this residue significantly reduced PARP1 SUMOylation in egg extracts and enhanced the accumulation of species derived from modification of secondary lysine residues in assays using purified components. SUMOylation of PARP1 did not alter in vitro PARP1 enzyme activity, poly-ADP-ribosylation (PARylation), nor did inhibition of SUMOylation of PARP1 alter the accumulation of PARP1 on mitotic chromosomes, suggesting that SUMOylation regulates neither the intrinsic activity of PARP1 nor its localization. However, loss of SUMOylation increased PARP1-dependent PARylation on isolated chromosomes, indicating SUMOylation controls the capacity of PARP1 to modify other chromatin-associated proteins.	[Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Kirkpatrick, Donald; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dasso, Mary] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20852 USA	University of Kansas; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Azuma, Y (corresponding author), 1200 Sunnyside Ave,Haworth Hall,Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu		Kirkpatrick, Donald/0000-0003-3091-2804; Dasso, Mary/0000-0002-5410-1371	National Institutes of Health [P20 RR015563, GM80278, GM67945]; Department of Molecular Biosciences at University of Kansas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001902] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278, R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Molecular Biosciences at University of Kansas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 (National Center for Research Resources COBRE-Center for Cancer Experimental Therapeutics) and GM80278 and GM67945 (NIGMS to S. P. G.). This work was also supported in part by a start-up grant from Department of Molecular Biosciences at University of Kansas.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Earle E, 2000, HUM MOL GENET, V9, P187, DOI 10.1093/hmg/9.2.187; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Masson M, 1997, GENE, V190, P287, DOI 10.1016/S0378-1119(97)00015-2; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	36	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14415	14423		10.1074/jbc.M109.074583	http://dx.doi.org/10.1074/jbc.M109.074583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228053	Green Published, hybrid			2022-12-27	WOS:000277299700038
J	Shimotsuma, M; Okamura, E; Matsuzaki, H; Fukamizu, A; Tanimoto, K				Shimotsuma, Motoshi; Okamura, Eiichi; Matsuzaki, Hitomi; Fukamizu, Akiyoshi; Tanimoto, Keiji			DNase I Hypersensitivity and epsilon-Globin Transcriptional Enhancement Are Separable in Locus Control Region (LCR) HS1 Mutant Human beta-Globin YAC Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ARTIFICIAL CHROMOSOME; DOMINANT CONTROL REGION; ERYTHROID-DIFFERENTIATION; DEVELOPMENTAL REGULATION; GENE-TRANSCRIPTION; ERYTHROLEUKEMIA-CELLS; FACTOR GATA-1; EXPRESSION; SITES; DELETION	Expression of the five beta-like globin genes (epsilon, G gamma, A gamma, delta, beta) in the human beta-globin locus depends on enhancement by the locus control region, which consists of five DNase I hypersensitive sites (5'HS1 through 5'HS5). We report here a novel enhancer activity in 5'HS1 that appears to be potent in transfected K562 cells. Deletion analyses identified a core activating element that bound to GATA-1, and a two-nucleotide mutation that disrupted GATA-1 binding in vitro abrogated 5'HS1 enhancer activity in transfection experiments. To determine the in vivo role of this GATA site, we generated multiple lines of human beta-globin YAC transgenic mice bearing the same two-nucleotide mutation. In the mutant mice, epsilon-, but not gamma-globin, gene expression in primitive erythroid cells was severely attenuated, while adult beta-globin gene expression in definitive erythroid cells was unaffected. Interestingly, DNaseI hypersensitivity near the 5'HS1 mutant sequence was eliminated in definitive erythroid cells, whereas it was only mildly affected in primitive erythroid cells. We therefore conclude that, although the GATA site in 5'HS1 is critical for efficient epsilon-globin gene expression, hypersensitive site formation per se is independent of 5'HS1 function, if any, in definitive erythroid cells.	[Shimotsuma, Motoshi; Okamura, Eiichi; Matsuzaki, Hitomi; Fukamizu, Akiyoshi; Tanimoto, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba	Tanimoto, K (corresponding author), Tennoudai 1-1-1, Tsukuba, Ibaraki 3058577, Japan.	keiji@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014; fukamizu, akiyoshi/J-5350-2012	fukamizu, akiyoshi/0000-0002-8786-6020; Matsuzaki, Hitomi/0000-0002-8890-5933; Tanimoto, Keiji/0000-0003-1971-6546; Okamura, Eiichi/0000-0002-1713-9290	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Scientific Research (A) and for Young Scientists (S).	Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Bender MA, 2001, BLOOD, V98, P2022, DOI 10.1182/blood.V98.7.2022; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Bungert J, 1999, MOL CELL BIOL, V19, P3062; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Emery DW, 1998, BLOOD CELL MOL DIS, V24, P322, DOI 10.1006/bcmd.1998.0200; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; Fang XD, 2005, MOL CELL BIOL, V25, P7033, DOI 10.1128/MCB.25.16.7033-7041.2005; Fedosyuk H, 2007, BLOOD CELL MOL DIS, V39, P44, DOI 10.1016/j.bcmd.2007.02.006; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GAENSLER KML, 1991, GENOMICS, V10, P976, DOI 10.1016/0888-7543(91)90188-K; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; GROSVELD F, 1990, ANN NY ACAD SCI, V612, P152; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; KULOZIK AE, 1991, J CLIN INVEST, V87, P2142, DOI 10.1172/JCI115246; LEONARD M, 1993, BLOOD, V82, P1071; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; MOON AM, 1991, BLOOD, V77, P2272; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ren SC, 1996, NUCLEIC ACIDS RES, V24, P342, DOI 10.1093/nar/24.2.342; Shimotsuma M, 2007, MOL CELL BIOL, V27, P5664, DOI 10.1128/MCB.00602-07; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P3130, DOI 10.1093/nar/27.15.3130; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14495	14503		10.1074/jbc.M110.116525	http://dx.doi.org/10.1074/jbc.M110.116525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231293	hybrid, Green Published			2022-12-27	WOS:000277299700046
J	Sena, CBC; Fukuda, T; Miyanagi, K; Matsumoto, S; Kobayashi, K; Murakami, Y; Maeda, Y; Kinoshita, T; Morita, YS				Sena, Chubert B. C.; Fukuda, Takeshi; Miyanagi, Kana; Matsumoto, Sohkichi; Kobayashi, Kazuo; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh; Morita, Yasu S.			Controlled Expression of Branch-forming Mannosyltransferase Is Critical for Mycobacterial Lipoarabinomannan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED STRUCTURAL VARIANTS; PHOSPHATIDYLINOSITOL MANNOSIDES; CORYNEBACTERIUM-GLUTAMICUM; CONSERVED GENE; CELL-WALL; TUBERCULOSIS; SMEGMATIS; IDENTIFICATION; LIPOMANNAN; PHLEI	Lipomannan (LM) and lipoarabinomannan (LAM) are phosphatidylinositol-anchored glycans present in the mycobacterial cell wall. In Mycobacterium smegmatis, the mannan core of LM/LAM constitutes a linear chain of 20-25 alpha 1,6-mannoses elaborated by 8-9 alpha 1,2-monomannose side branches. At least two alpha 1,6-mannosyltransferases mediate the linear mannose chain elongation, and one branching alpha 1,2-mannosyltransferase (encoded by MSMEG_4247) transfers monomannose branches. An MSMEG_4247 deletion mutant accumulates branchless LAM and interestingly fails to accumulate LM, suggesting an unexpected role of mannose branching for LM synthesis or maintenance. To understand the roles of MSMEG_4247-mediated branching more clearly, we analyzed the MSMEG_4247 deletion mutant in detail. Our study showed that the deletion mutant restored the synthesis of wild-type LM and LAM upon the expression of MSMEG_4247 at wild-type levels. In striking contrast, overexpression of MSMEG_4247 resulted in the accumulation of dwarfed LM/LAM, although monomannose branching was restored. The dwarfed LAM carried a mannan chain less than half the length of wild-type LAM and was elaborated by an arabinan that was about 4 times smaller. Induced overexpression of an elongating alpha 1,6-mannosyltransferase competed with the overexpressed branching enzyme, alleviating the dwarfing effect of the branching enzyme. In wild-type cells, LM and LAM decreased in quantity in the stationary phase, and the expression levels of branching and elongating mannosyltransferases were reduced in concert, presumably to avoid producing abnormal LM/LAM. These data suggest that the coordinated expressions of branching and elongating mannosyltransferases are critical for mannan backbone elongation.	[Morita, Yasu S.] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; [Sena, Chubert B. C.; Fukuda, Takeshi; Miyanagi, Kana; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh; Morita, Yasu S.] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 5458585, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo 1628640, Japan	Osaka University; Osaka University; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID)	Morita, YS (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ymorita@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009	Matsumoto, Sohkichi/0000-0002-6106-7538; Morita, Yasu/0000-0002-4514-9242; Sena, Chubert/0000-0002-2328-9885	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology; International Human Frontier Science Program; Japan Society for the Promotion of Science [KAKENHI 20590441]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology; International Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by grants from the Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases), Ministry of Education, Culture, Sports, Science, and Technology, Japan Health Sciences Foundation, and the United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.; Supported by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology.; Supported by grants from the International Human Frontier Science Program and Japan Society for the Promotion of Science (KAKENHI 20590441).	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; BRENNAN P, 1968, J BIOL CHEM, V243, P2975; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; Gilleron M, 1997, J BIOL CHEM, V272, P117; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Khoo KH, 1996, J BIOL CHEM, V271, P28682, DOI 10.1074/jbc.271.45.28682; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; LEE YC, 1964, J BIOL CHEM, V239, P1316; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; Sauton B, 1912, CR HEBD ACAD SCI, V155, P860; SCHNEIDER P, 1993, ANAL BIOCHEM, V210, P106, DOI 10.1006/abio.1993.1158; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x	34	32	32	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13326	13336		10.1074/jbc.M109.077297	http://dx.doi.org/10.1074/jbc.M109.077297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215111	hybrid, Green Published			2022-12-27	WOS:000276987700003
J	White, CN; Liu, CC; Garcia, A; Hamilton, EJ; Chia, KKM; Figtree, GA; Rasmussen, HH				White, Caroline N.; Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.			Activation of cAMP-dependent Signaling Induces Oxidative Modification of the Cardiac Na+-K+ Pump and Inhibits Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CFTR CL-CHANNELS; MEDIATED ACTIVATION; NADPH OXIDASE; PHOSPHORYLATION; PHOSPHOLEMMAN; HEART; STIMULATION; DOPAMINE; MYOCYTES	Cellular signaling can inhibit the membrane Na+-K+ pump via protein kinase C (PKC)-dependent activation of NADPH oxidase and a downstream oxidative modification, glutathionylation, of the beta(1) subunit of the pump alpha/beta heterodimer. It is firmly established that cAMP-dependent signaling also regulates the pump, and we have now examined the hypothesis that such regulation can be mediated by glutathionylation. Exposure of rabbit cardiac myocytes to the adenylyl cyclase activator forskolin increased the co-immunoprecipitation of NADPH oxidase subunits p47(phox) and p22(phox), required for its activation, and increased superoxide-sensitive fluorescence. Forskolin also increased glutathionylation of the Na+-K+ pump beta(1) subunit and decreased its co-immunoprecipitation with the alpha(1) subunit, findings similar to those already established for PKC-dependent signaling. The decrease in co-immunoprecipitation indicates a decrease in the alpha(1)/beta(1) subunit interaction known to be critical for pump function. In agreement with this, forskolin decreased ouabain-sensitive electrogenic Na+-K+ pump current (arising from the 3:2 Na+:K+ exchange ratio) of voltage-clamped, internally perfused myocytes. The decrease was abolished by the inclusion of superoxide dismutase, the inhibitory peptide for the epsilon-isoform of PKC or inhibitory peptide for NADPH oxidase in patch pipette solutions that perfuse the intracellular compartment. Pump inhibition was also abolished by inhibitors of protein kinase A and phospholipase C. We conclude that cAMP- and PKC-dependent inhibition of the cardiac Na+-K+ pump occurs via a shared downstream oxidative signaling pathway involving NADPH oxidase activation and glutathionylation of the pump beta(1) subunit.	[White, Caroline N.; Garcia, Alvaro; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [White, Caroline N.; Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.] Univ Sydney, Kolling Inst, N Shore Heart Res Grp, Sydney, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Hamilton, Elisha/F-8187-2010; Garcia, Alvaro/E-6573-2015	Hamilton, Elisha/0000-0002-1892-352X; Rasmussen, Helge/0000-0003-2409-4083; Garcia, Alvaro/0000-0002-1159-4567	North Shore Heart Research Foundation; National Health and Medical Research Council; Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship; Sydney Medical Foundation	North Shore Heart Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship; Sydney Medical Foundation	The work was supported by grants from the North Shore Heart Research Foundation and the National Health and Medical Research Council.; Supported by a Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship and the University of Sydney Medical Foundation.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Buhagiar KA, 2001, AM J PHYSIOL-CELL PH, V281, pC1059, DOI 10.1152/ajpcell.2001.281.3.C1059; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Erlenkamp S, 2002, PFLUG ARCH EUR J PHY, V444, P251, DOI 10.1007/s00424-002-0802-4; Feschenko MS, 2000, J BIOL CHEM, V275, P34693, DOI 10.1074/jbc.M005869200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; GAO J, 1992, J PHYSIOL-LONDON, V449, P689, DOI 10.1113/jphysiol.1992.sp019109; Gao J, 1998, PFLUG ARCH EUR J PHY, V435, P479, DOI 10.1007/s004240050542; GARCIA A, 2008, 12 INT ATPASE C AARH; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gomes P, 2004, EUR J PHARMACOL, V488, P51, DOI 10.1016/j.ejphar.2004.02.011; Gomes P, 2002, AM J PHYSIOL-RENAL, V282, pF1084, DOI 10.1152/ajprenal.00318.2001; Hansen PS, 2000, AM J PHYSIOL-CELL PH, V278, pC546, DOI 10.1152/ajpcell.2000.278.3.C546; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HOOL LC, 1995, AM J PHYSIOL-CELL PH, V268, pC366, DOI 10.1152/ajpcell.1995.268.2.C366; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; Kockskamper J, 2000, J PHYSIOL-LONDON, V523, P561, DOI 10.1111/j.1469-7793.2000.t01-2-00561.x; Kockskamper J, 2001, PFLUG ARCH EUR J PHY, V441, P807, DOI 10.1007/s004240000485; Mihailidou AS, 1998, AM J PHYSIOL-CELL PH, V274, pC175, DOI 10.1152/ajpcell.1998.274.1.C175; Murdoch CE, 2006, CURR OPIN PHARMACOL, V6, P148, DOI 10.1016/j.coph.2005.10.008; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Park JW, 1997, J BIOL CHEM, V272, P11035; Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; William M, 2005, J PHYSIOL-LONDON, V565, P815, DOI 10.1113/jphysiol.2005.086447; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580; *ZAM SEV HEART FAI, 1990, LANCET, V336, P1	43	45	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13712	13720		10.1074/jbc.M109.090225	http://dx.doi.org/10.1074/jbc.M109.090225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194511	hybrid, Green Published			2022-12-27	WOS:000276987700046
J	Veyron-Churlet, R; Zanella-Cleon, I; Cohen-Gonsaud, M; Molle, V; Kremer, L				Veyron-Churlet, Romain; Zanella-Cleon, Isabelle; Cohen-Gonsaud, Martin; Molle, Virginie; Kremer, Laurent			Phosphorylation of the Mycobacterium tuberculosis beta-Ketoacyl-Acyl Carrier Protein Reductase MabA Regulates Mycolic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; SYNTHASE-III MTFABH; CELL-DIVISION; BIOCHEMICAL-CHARACTERIZATION; SERINE/THREONINE KINASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; FAS-II; PKNA; IDENTIFICATION	Mycolic acids are key cell wall components for the survival, pathogenicity, and antibiotic resistance of the human tubercle bacillus. Although it was thought that Mycobacterium tuberculosis tightly regulates their production to adapt to prevailing environmental conditions, the molecular mechanisms governing mycolic acid biosynthesis remained extremely obscure. Meromycolic acids, the direct precursors of mycolic acids, are synthesized by a type II fatty acid synthase from acyl carrier protein-bound substrates that are extended iteratively, with a reductive cycle in each round of extension, the second step of which is catalyzed by the essential beta-ketoacyl-acyl carrier protein reductase, MabA. In this study, we investigated whether post-translational modifications of MabA might represent a strategy employed by M. tuberculosis to regulate mycolic acid biosynthesis. Indeed, we show here that MabA was efficiently phosphorylated in vitro by several M. tuberculosis Ser/Thr protein kinases, including PknB, as well as in vivo in mycobacteria. Mass spectrometric analyses using LC-ESI/MS/MS and site-directed mutagenesis identified three phosphothreonines, with Thr(191) being the primary phosphor-acceptor. A MabA_T191D mutant, designed to mimic constitutive phosphorylation, exhibited markedly decreased ketoacyl reductase activity compared with the wild-type protein, as well as impaired binding of the NADPH cofactor, as demonstrated by fluorescence spectroscopy. The hypothesis that phosphorylation of Thr(191) alters the enzymatic activity of MabA, and subsequently mycolic acid biosynthesis, was further supported by the fact that constitutive overexpression of the mabA_T191D allele in Mycobacterium bovis BCG strongly impaired mycobacterial growth. Importantly, conditional expression of the phosphomimetic MabA_T191D led to a significant inhibition of de novo biosynthesis of mycolic acids. This study provides the first information on the molecular mechanism(s) involved in mycolic acid regulation through Ser/Thr protein kinase-dependent phosphorylation of a type II fatty acid synthase enzyme.	[Zanella-Cleon, Isabelle; Molle, Virginie] Univ Lyon 1, CNRS, IBCP UMR 5086, Biosci IFR128, F-69367 Lyon 07, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 1, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Cohen-Gonsaud, Martin] INSERM, U554, F-34090 Montpellier, France; [Cohen-Gonsaud, Martin] Univ Montpellier I & II, Ctr Biochim Struct, UMR 5048, CNRS, F-34093 Montpellier, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Molle, V (corresponding author), Univ Lyon 1, CNRS, IBCP UMR 5086, Biosci IFR128, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; laurent.kremer@univ-montp2.fr	Veyron-Churlet, Romain/J-4254-2019; Kremer, Laurent/M-4935-2017; MOLLE, Virginie/D-4050-2019	Veyron-Churlet, Romain/0000-0001-6902-5917; Kremer, Laurent/0000-0002-6604-4458; MOLLE, Virginie/0000-0002-6573-3411; Cohen-Gonsaud, Martin/0000-0002-0150-9912	National Research Agency [ANR-06-MIME-027-01, ANR-JC07_203251]	National Research Agency(French National Research Agency (ANR))	This work was supported by National Research Agency Grants ANR-06- MIME-027-01 (to V. M. and L. K.) and ANR-JC07_203251 (to M. C.-G.).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bloch K, 1975, Methods Enzymol, V35, P84, DOI 10.1016/0076-6879(75)35141-0; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2005, PROTEINS, V60, P392, DOI 10.1002/prot.20494; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2008, BIOCHEM J, V410, P309, DOI 10.1042/BJ20071384; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann UCT, 2001, CHEM-BIOL INTERACT, V130, P699, DOI 10.1016/S0009-2797(00)00301-X; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Zimhony O, 2004, J BACTERIOL, V186, P4051, DOI 10.1128/JB.186.13.4051-4055.2004	59	60	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12714	12725		10.1074/jbc.M110.105189	http://dx.doi.org/10.1074/jbc.M110.105189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178986	Green Published, hybrid			2022-12-27	WOS:000276787800030
J	Wright, TM; Rathmell, WK				Wright, Tricia M.; Rathmell, W. Kimryn			Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; TYROSINE KINASE ROR2; HIF-ALPHA; UBIQUITIN LIGASE; VHL; GENE; COMPLEX; FAMILY; EXPRESSION; MUTATIONS	Ror2 is an orphan receptor tyrosine kinase with expression normally restricted to early stages of development. However, emerging evidence has placed aberrantly expressed Ror2, leading to an invasive phenotype, in several cancers including renal cell carcinoma (RCC). Although Ror2 is currently identified as up-regulated in an assortment of cancers, neither the regulatory role or mechanism of action have been delineated. Wesought to place Ror2 in the most commonly mutated pathway of RCC, the loss of the tumor suppressor von Hippel-Lindau (VHL), which causes hypoxia-inducible factor (HIF)-1 alpha and -2 alpha stabilization and the transcriptional activation of a broad repertoire of response genes. We found that Ror2 was indeed associated with the pVHL loss in RCC as well as with VHL somatic mutations tightly coordinated with the induction of RCC. Additionally, knockdown and rescue analysis of HIF expression suggests that Ror2 is dependent on pathologic stabilization of either HIF-1 alpha or HIF-2 alpha. Subsequent evaluation of the ROR2 promoter suggests that HIF-2 alpha and its dimerization partner, aryl hydrocarbon nuclear transferase localize to the ROR2 promoter via a cryptic transcriptional element. This data substantiates a unique regulation pattern for Ror2 in the VHL-HIF axis that has the potential to be applied to other cancer etiologies.	[Wright, Tricia M.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet Curriculum Genet & Mol Biol, 450 W Dr,CB 7295, Chapel Hill, NC 27599 USA.	rathmell@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		National Institutes of Health [F31CA132543, R01 CA121781]; NCI; Doris Duke Charitable Fund; NATIONAL CANCER INSTITUTE [R01CA121781, F31CA132543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Charitable Fund(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NRSA Program Grants F31CA132543 (to T. M. W.) and R01 CA121781 (to W. K. R.) from the NCI and a grant from the Doris Duke Charitable Fund (to W. K. R.).	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hacker KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003801; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YD, 2003, MOL CANCER RES, V1, P453; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kubo T, 2009, CARCINOGENESIS, V30, P1857, DOI 10.1093/carcin/bgp206; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; SHUIN T, 1994, CANCER RES, V54, P2852; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884	37	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12916	12924		10.1074/jbc.M109.073924	http://dx.doi.org/10.1074/jbc.M109.073924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185829	Green Published, hybrid			2022-12-27	WOS:000276787800050
J	Huo, JX; Xu, SL; Lam, KP				Huo, Jianxin; Xu, Shengli; Lam, Kong-Peng			Fas Apoptosis Inhibitory Molecule Regulates T Cell Receptor-mediated Apoptosis of Thymocytes by Modulating Akt Activation and Nur77 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN STEROID-RECEPTOR; NEGATIVE SELECTION; SIGNAL-TRANSDUCTION; IMMATURE THYMOCYTES; DEATH; FAIM; COMPLEX; ANTIGEN; REQUIREMENT; LYMPHOCYTES	Fas apoptosis inhibitory molecule (FAIM) has been demonstrated to confer resistance to Fas-induced apoptosis of lymphocytes and hepatocytes in vitro and in vivo. Here, we show that FAIM is up-regulated in thymocytes upon T cell receptor (TCR) engagement and that faim(-/-) thymocytes are highly susceptible to TCR-mediated apoptosis with increased activation of caspase-8 and -9. Furthermore, injection of anti-CD3 antibodies leads to augmented depletion of CD4(+)CD8(+)T cells in the thymus of faim(-/-) mice compared with wild-type control, suggesting that FAIM plays a role in thymocyte apoptosis. Cross-linking of the TCR on faim(-/-) thymocytes leads to an elevated protein level of the orphan nuclear receptor Nur77, which plays a role in thymocyte apoptosis. Interestingly, in the absence of FAIM, there are reduced ubiquitination and degradation of the Nur77 protein. Faim(-/-) thymocytes also exhibit a defective TCR-induced activation of Akt whose activity we now show is required for Nur77 ubiquitination. Further analyses utilizing FAIM-deficient primary thymocytes and FAIM-overexpressing DO-11.10 T cells indicate that FAIM acts upstream of Akt during TCR signaling and influences the localization of Akt to lipid rafts, hence affecting its activation. Taken together, our study defined a TCR-induced FAIM/Akt/Nur77 signaling axis that is critical for modulating the apoptosis of developing thymocytes.	[Huo, Jianxin; Xu, Shengli; Lam, Kong-Peng] Agcy Sci Technol & Res, Bioproc Technol Inst, Immunol Grp, Singapore 138668, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Lam, KP (corresponding author), 20 Biopolis Way,06-01 Ctr, Singapore 138668, Singapore.	lam_kong_peng@bti.a-star.edu.sg	HUO, JIANXIN/GXH-0232-2022; Lam, Kong-Peng/G-5374-2012	HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of the Agency for Science, Technology and Research, Singapore.	Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; CALNAN BJ, 1995, IMMUNITY, V3, P273; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Huo J, 2009, CELL DEATH DIFFER, V16, P1062, DOI 10.1038/cdd.2009.26; Jiang D, 1999, CELL DEATH DIFFER, V6, P402, DOI 10.1038/sj.cdd.4400513; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; Moulian N, 1998, SEMIN IMMUNOL, V10, P449, DOI 10.1006/smim.1998.0155; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; SHI YF, 1991, J IMMUNOL, V146, P3340; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Sohn SJ, 2003, CURR OPIN IMMUNOL, V15, P209, DOI 10.1016/S0952-7915(03)00004-9; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhong XM, 2001, MOL IMMUNOL, V38, P65, DOI 10.1016/S0161-5890(01)00035-9	41	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11827	11835		10.1074/jbc.M109.072744	http://dx.doi.org/10.1074/jbc.M109.072744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178987	hybrid, Green Published			2022-12-27	WOS:000276787100010
J	Henry, RI; Cobbold, SA; Allen, RJW; Khan, A; Hayward, R; Lehane, AM; Bray, PG; Howitt, SM; Biagini, GA; Saliba, KJ; Kirk, K				Henry, Roselani I.; Cobbold, Simon A.; Allen, Richard J. W.; Khan, Asif; Hayward, Rhys; Lehane, Adele M.; Bray, Patrick G.; Howitt, Susan M.; Biagini, Giancarlo A.; Saliba, Kevin J.; Kirk, Kiaran			An Acid-loading Chloride Transport Pathway in the Intraerythrocytic Malaria Parasite, Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; INTRACELLULAR PH; HUMAN ERYTHROCYTES; H+-ATPASE; FLUORESCENT INDICATOR; ACIDIFICATION; CHLOROQUINE; EXCHANGERS; EXTRUSION; LACTATE	The intraerythrocytic malaria parasite exerts tight control over its ionic composition. In this study, a combination of fluorescent ion indicators and Cl-36(-) flux measurements was used to investigate the transport of Cl- and the Cl--dependent transport of "H+-equivalents" in mature (trophozoite stage) parasites, isolated from their host erythrocytes. Removal of extracellular Cl-, resulting in an outward [Cl-] gradient, gave rise to a cytosolic alkalinization (i.e. a net efflux of H+-equivalents). This was reversed on restoration of extracellular Cl-. The flux of H+-equivalents was inhibited by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and, when measured in ATP-depleted parasites, showed a pronounced dependence on the pH of the parasite cytosol; the flux was low at cytosolic pH values < 7.2 but increased steeply with cytosolic pH at values > 7.2. Cl-36(-) influx measurements revealed the presence of a Cl- uptake mechanism with characteristics similar to those of the Cl--dependent H+-equivalent flux. The intracellular concentration of Cl- in the parasite was estimated to be similar to 48 mM in situ. The data are consistent with the intraerythrocytic parasite having in its plasma membrane a 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid-sensitive transporter that, under physiological conditions, imports Cl- together with H+-equivalents, resulting in an intracellular Cl- concentration well above that which would occur if Cl- ions were distributed passively in accordance with the parasite's large, inwardly negative membrane potential.	[Henry, Roselani I.; Cobbold, Simon A.; Allen, Richard J. W.; Khan, Asif; Hayward, Rhys; Lehane, Adele M.; Howitt, Susan M.; Saliba, Kevin J.; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Bray, Patrick G.; Biagini, Giancarlo A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Saliba, Kevin J.] Australian Natl Univ, Sch Med, Canberra, ACT 0200, Australia	Australian National University; Liverpool School of Tropical Medicine; University of Liverpool; Australian National University	Kirk, K (corresponding author), Australian Natl Univ, Res Sch Biol, RN Robertson Bldg,Bldg 46, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	Howitt, Susan M/C-9308-2009; Allen, Richard/B-4752-2008; Biagini, Giancarlo A/F-3449-2011; Saliba, Kevin J/C-9166-2009; Lehane, Adele M/B-4127-2012; Kirk, Kiaran/C-8299-2009	Howitt, Susan M/0000-0002-2192-2317; Biagini, Giancarlo A/0000-0001-6356-6595; Saliba, Kevin J/0000-0003-3345-8440; Lehane, Adele M/0000-0002-0050-9101; Kirk, Kiaran/0000-0002-5613-2622; Cobbold, Simon/0000-0002-9927-8998; Henry, Roselani/0000-0001-7448-7358	Australian National Health and Medical Research Council; Australian Research Council; Leverhulme Trust	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leverhulme Trust(Leverhulme Trust)	This work was supported by grants from the Australian National Health and Medical Research Council (to K. K.), the Australian Research Council (to K. K. and K. J. S.), and the Leverhulme Trust (to G. A. B.).	Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; CHAO AC, 1990, J MEMBRANE BIOL, V113, P193, DOI 10.1007/BF01870071; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Eladari D, 1998, AM J PHYSIOL-RENAL, V275, pF334, DOI 10.1152/ajprenal.1998.275.3.F334; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; GRAF J, 1988, RENAL PHYSIOL BIOCH, V11, P202; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; KANAANI J, 1991, J CELL PHYSIOL, V149, P469, DOI 10.1002/jcp.1041490316; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Kummerow D, 2000, J MEMBRANE BIOL, V176, P207, DOI 10.1007/s002320001089; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; MASON MJ, 1989, AM J PHYSIOL, V256, pC428, DOI 10.1152/ajpcell.1989.256.2.C428; MERCK E, 1974, CLIN LAB 11 EDITION, P528; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Spillman NJ, 2008, MOL BIOCHEM PARASIT, V162, P96, DOI 10.1016/j.molbiopara.2008.07.001; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wunsch S, 1997, Behring Inst Mitt, P44	29	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18615	18626		10.1074/jbc.M110.120980	http://dx.doi.org/10.1074/jbc.M110.120980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20332090	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000278453900055
J	Krejsa, CM; Franklin, CC; White, CC; Ledbetter, JA; Schieven, GL; Kavanagh, TJ				Krejsa, Cecile M.; Franklin, Christopher C.; White, Collin C.; Ledbetter, Jeffrey A.; Schieven, Gary L.; Kavanagh, Terrance J.			Rapid Activation of Glutamate Cysteine Ligase following Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; APOPTOTIC CELL-DEATH; HAMSTER V79 CELLS; MODIFIER SUBUNIT; RAT-KIDNEY; GLUTATHIONE BIOSYNTHESIS; CATALYTIC SUBUNIT; HEAVY SUBUNIT; LIGHT SUBUNIT; MICE	Glutamate cysteine ligase (GCL) catalyzes the rate-limiting step in the formation of the cellular antioxidant glutathione (GSH). The GCL holoenzyme consists of two separately coded proteins, a catalytic subunit (GCLC) and a modifier subunit (GCLM). Both GCLC and GLCM are controlled transcriptionally by a variety of cellular stimuli, including oxidative stress. This study addresses post-translational control of GCL activity, which increased rapidly in human lymphocytes following oxidative stress. Activation of GCL occurred within minutes of treatment and without any change in GCL protein levels and coincided with an increase in the proportion of GCLC in the holoenzyme form. Likewise, GCLM shifted from the monomeric form to holoenzyme and higher molecular weight species. Normal rat tissues also showed a distribution of monomeric and higher molecular weight forms. Neither GCL activation, nor the formation of holoenzyme, required a covalent intermolecular disulfide bridge between GCLC and GCLM. However, in immunoprecipitation studies, a neutralizing epitope associated with enzymatic activity was protected following cellular oxidative stress. Thus, the N-terminal portion of GCLC may undergo a change that stabilizes the GCL holoenzyme. Our results suggest that a dynamic equilibrium exists between low and high activity forms of GCL and is altered by transient oxidative stress. This provides a mechanism for the rapid post-translational activation of GCL and maintenance of cellular GSH homeostasis.	[Krejsa, Cecile M.; White, Collin C.; Kavanagh, Terrance J.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Ledbetter, Jeffrey A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Franklin, Christopher C.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Schieven, Gary L.] Bristol Myers Squibb Co, Res & Dev, Immunol Drug Discovery, Princeton, NJ 08543 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb	Kavanagh, TJ (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Box 354695, Seattle, WA 98195 USA.	tjkav@u.washington.edu			National Institutes of Health [R01ES10849, P01AG01751, P42ES04696, P30ES07033, T32ES07032, R01CA90473]; Bristol-Myers Squibb Pharmaceutical Research Institute; NATIONAL CANCER INSTITUTE [R01CA090473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032, R01ES010849, P30ES007033, P42ES004696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb Pharmaceutical Research Institute(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES10849 (to T. J. K.), P01AG01751 (to T. J. K.), P42ES04696 (to T. J. K.), P30ES07033 (to T. J. K.), T32ES07032 (to C. M. K.), and R01CA90473 (to C. C. F.). This work was also supported by the Bristol-Myers Squibb Pharmaceutical Research Institute.	Backos DS, 2010, TOXICOL APPL PHARM, V243, P35, DOI 10.1016/j.taap.2009.11.010; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Botta D, 2004, FREE RADICAL BIO MED, V37, P632, DOI 10.1016/j.freeradbiomed.2004.05.027; Botta D, 2008, DRUG METAB REV, V40, P465, DOI [10.1080/03602530802186587, 10.1080/03602530802186587 ]; Chang LS, 1996, J PROTEIN CHEM, V15, P321, DOI 10.1007/BF01887121; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; FORMAN HJ, 1995, BIOTHIOLS HLTH DIS, P189; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; GIPP JJ, 1995, BIOCHEM BIOPH RES CO, V206, P584, DOI 10.1006/bbrc.1995.1083; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; HAMEL DM, 1991, TOXICOL METHOD, V1, P273; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Krzywanski DM, 2004, ARCH BIOCHEM BIOPHYS, V423, P116, DOI 10.1016/j.abb.2003.11.004; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Ochi T, 1995, ARCH TOXICOL, V70, P96, DOI 10.1007/BF02733669; Ochi T, 1996, TOXICOLOGY, V112, P45, DOI 10.1016/0300-483X(96)03348-3; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; SEELIG GF, 1984, J BIOL CHEM, V259, P9345; SEELIG GF, 1984, J BIOL CHEM, V259, P3534; SEITZ J, 1991, ELECTROPHORESIS, V12, P1051, DOI 10.1002/elps.1150121210; Siitonen T, 1999, ANN ONCOL, V10, P1361, DOI 10.1023/A:1008382912096; SONG JY, 1995, HISTOCHEM J, V27, P914; Sun WM, 1996, BIOCHEM J, V320, P321, DOI 10.1042/bj3200321; Thompson SA, 1999, TOXICOL LETT, V110, P1, DOI 10.1016/S0378-4274(99)00133-2; Toroser D, 2006, BBA-GEN SUBJECTS, V1760, P233, DOI 10.1016/j.bbagen.2005.10.010; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; Tu ZH, 1998, ARCH BIOCHEM BIOPHYS, V354, P247, DOI 10.1006/abbi.1998.0676; WHITE CC, 1999, CURRENT PROTOCOLS TO; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Yang Y, 2007, BIOCHEM PHARMACOL, V74, P372, DOI 10.1016/j.bcp.2007.02.003	39	70	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16116	16124		10.1074/jbc.M110.116210	http://dx.doi.org/10.1074/jbc.M110.116210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332089	Green Published, hybrid			2022-12-27	WOS:000277715900049
J	Kumar, A; Hou, X; Lee, C; Li, Y; Maminishkis, A; Tang, ZS; Zhang, F; Langer, HF; Arjunan, P; Dong, LJ; Wu, ZJ; Zhu, LY; Wang, LC; Min, W; Colosi, P; Chavakis, T; Li, X				Kumar, Anil; Hou, Xu; Lee, Chunsik; Li, Yang; Maminishkis, Arvydas; Tang, Zhongshu; Zhang, Fan; Langer, Harald F.; Arjunan, Pachiappan; Dong, Lijin; Wu, Zhijian; Zhu, Linda Y.; Wang, Lianchun; Min, Wang; Colosi, Peter; Chavakis, Triantafyllos; Li, Xuri			Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3 beta Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PDGF-D; RETINAL NEOVASCULARIZATION; INTRAVITREAL INJECTION; FACTOR VEGF; MACULAR DEGENERATION; PEGAPTANIB SODIUM; INHIBITION; EXPRESSION; SURVIVAL	Platelet-derived growth factor-DD (PDGF-DD) is a recently discovered member of the PDGF family. The role of PDGF-DD in pathological angiogenesis and the underlying cellular and molecular mechanisms remain largely unexplored. In this study, using different animal models, we showed that PDGF-DD expression was up-regulated during pathological angiogenesis, and inhibition of PDGF-DD suppressed both choroidal and retinal neovascularization. We also demonstrated a novel mechanism mediating the function of PDGF-DD. PDGF-DD induced glycogen synthase kinase-3 beta (GSK3 beta) Ser(9) phosphorylation and Tyr(216) dephosphorylation in vitro and in vivo, leading to increased cell survival. Consistently, GSK3 beta activity was required for the antiangiogenic effect of PDGF-DD targeting. Moreover, PDGF-DD regulated the expression of GSK3 beta and many other genes important for angiogenesis and apoptosis. Thus, we identified PDGF-DD as an important target gene for antiangiogenic therapy due to its pleiotropic effects on vascular and non-vascular cells. PDGF-DD inhibition may offer new therapeutic options to treat neovascular diseases.	[Kumar, Anil; Hou, Xu; Lee, Chunsik; Li, Yang; Maminishkis, Arvydas; Tang, Zhongshu; Zhang, Fan; Arjunan, Pachiappan; Dong, Lijin; Wu, Zhijian; Zhu, Linda Y.; Colosi, Peter; Li, Xuri] NEI, NIH, Rockville, MD 20852 USA; [Langer, Harald F.; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hou, Xu] Fourth Mil Med Univ, Xijing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Min, Wang] Yale Univ, Dept Pathol Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Langer, Harald F.] Univ Tubingen, Dept Cardiovasc Med, D-72076 Tubingen, Germany	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Air Force Military Medical University; University System of Georgia; University of Georgia; Yale University; Eberhard Karls University of Tubingen	Li, X (corresponding author), NEI, NIH, 5635 Fishers Lane, Rockville, MD 20852 USA.	lixur@nei.nih.gov	Chavakis, Triantafyllos/ABE-8845-2020; wu, zhi/GXH-3041-2022; Kumar, Anil/K-8504-2012; Arjunan, Pachiappan/AAG-3297-2021	Maminishkis, Arvydas/0000-0003-3345-3375	NEI; American Health Assistance Foundation; NATIONAL CANCER INSTITUTE [ZIABC010664] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000419, ZICEY000458, ZIAEY000447, ZIAEY000443] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NEI. This work was also supported by the Macular Degeneration Research program of the American Health Assistance Foundation.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Au PYB, 2005, ONCOGENE, V24, P3196, DOI 10.1038/sj.onc.1208516; Avci B, 2009, INVEST OPHTH VIS SCI, V50, P3438, DOI 10.1167/iovs.08-2871; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; BETSHOLTZ C, 1984, CELL, V39, P447, DOI 10.1016/0092-8674(84)90452-5; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Chang YZ, 2006, ARTERIOSCL THROM VAS, V26, P501, DOI 10.1161/01.ATV.0000201070.71787.b8; Chang YZ, 2004, AM J PHYSIOL-HEART C, V287, pH2201, DOI 10.1152/ajpheart.00520.2004; Choi SE, 2007, J VASC RES, V44, P365, DOI 10.1159/000102321; D'Antoni ML, 2008, AM J PHYSIOL-LUNG C, V294, pL764, DOI 10.1152/ajplung.00436.2007; Davies MH, 2008, INVEST OPHTH VIS SCI, V49, P4195, DOI 10.1167/iovs.07-1491; DeNiro M, 2009, EXP EYE RES, V89, P700, DOI 10.1016/j.exer.2009.06.013; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fischer JW, 2001, ARTERIOSCL THROM VAS, V21, P777, DOI 10.1161/01.ATV.21.5.777; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Funa K, 2003, ACTA BIOCHIM POL, V50, P647; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hernandez-Pastor LJ, 2008, AM J HEALTH-SYST PH, V65, P1805, DOI 10.2146/ajhp070342; Hinton DR, 1998, ARCH OPHTHALMOL-CHIC, V116, P203; Inan UU, 2007, INVEST OPHTH VIS SCI, V48, P1773, DOI 10.1167/iovs.06-0828; Julien S, 2008, MOL VIS, V14, P1358; Karvinen H, 2009, EUR J CLIN INVEST, V39, P320, DOI 10.1111/j.1365-2362.2009.02095.x; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; Klyve P, 1996, ACTA OPHTHALMOL SCAN, V74, P26; Kojima T, 2007, AM J PATHOL, V170, P764, DOI 10.2353/ajpath.2007.060487; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; KVANTA A, 1995, CURR EYE RES, V14, P1015, DOI 10.3109/02713689508998523; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liu G, 2008, HUM PATHOL, V39, P393, DOI 10.1016/j.humpath.2007.07.008; Loberg RD, 2002, J BIOL CHEM, V277, P41667, DOI 10.1074/jbc.M206405200; Lu J, 2009, CIRC RES, V104, P619, DOI 10.1161/CIRCRESAHA.108.190116; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Manzano RPA, 2006, RETINA-J RET VIT DIS, V26, P257, DOI 10.1097/00006982-200603000-00001; Mendes CT, 2009, EUR ARCH PSY CLIN N, V259, P16, DOI 10.1007/s00406-008-0828-5; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Molander C, 2000, EXP CELL RES, V258, P65, DOI 10.1006/excr.2000.4917; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ray S, 2005, J BIOL CHEM, V280, P8494, DOI 10.1074/jbc.M413570200; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Rodrigues EB, 2009, PROG RETIN EYE RES, V28, P117, DOI 10.1016/j.preteyeres.2008.11.005; Rosenmuller T, 2001, J CELL PHYSIOL, V188, P369, DOI 10.1002/jcp.1126; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Semkova I, 2006, FASEB J, V20, P1689, DOI 10.1096/fj.05-5653fje; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Silva RLE, 2006, J CELL PHYSIOL, V208, P161, DOI 10.1002/jcp.20645; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Stahl A, 2009, GRAEF ARCH CLIN EXP, V247, P767, DOI 10.1007/s00417-009-1058-x; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Takahashi-Yanaga F, 2009, J PHARMACOL SCI, V109, P179, DOI 10.1254/jphs.08R28FM; Tuuminen R, 2009, ARTERIOSCL THROM VAS, V29, P691, DOI 10.1161/ATVBAHA.108.178558; Uutela M, 2001, CIRCULATION, V103, P2242; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; van Wijngaarden P, 2008, CLIN EXP OPTOM, V91, P427, DOI 10.1111/j.1444-0938.2008.00305.x; Wagsater D, 2009, ATHEROSCLEROSIS, V202, P415, DOI 10.1016/j.atherosclerosis.2008.04.050; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Williams AJ, 2006, AM J OPHTHALMOL, V142, P683, DOI 10.1016/j.ajo.2006.04.032; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhu Wen-Hui, 2002, Angiogenesis, V5, P81, DOI 10.1023/A:1021509004829	80	27	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15500	15510		10.1074/jbc.M110.113787	http://dx.doi.org/10.1074/jbc.M110.113787			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231273	Green Published, hybrid			2022-12-27	WOS:000277399000069
J	Mitsuishi, Y; Hasegawa, H; Matsuo, A; Araki, W; Suzuki, T; Tagami, S; Okochi, M; Takeda, M; Roepman, R; Nishimura, M				Mitsuishi, Yachiyo; Hasegawa, Hiroshi; Matsuo, Akinori; Araki, Wataru; Suzuki, Toshiharu; Tagami, Shinji; Okochi, Masayasu; Takeda, Masatoshi; Roepman, Ronald; Nishimura, Masaki			Human CRB2 Inhibits gamma-Secretase Cleavage of Amyloid Precursor Protein by Binding to the Presenilin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; ALZHEIMERS-DISEASE; APH-1 INTERACTS; BETA-PEPTIDE; N-CADHERIN; TNF-ALPHA; A-BETA; NICASTRIN; MODULATION; NOTCH	Drosophila Crumbs has been reported to attenuate Notch signaling by inhibition of gamma-secretase cleavage at the wing margins. gamma-Secretase is an intramembrane protease that is responsible for the generation of amyloid-beta (A beta) peptides from the beta-amyloid precursor protein (APP). Here, we re-examined gamma-secretase inhibition by human CRB2, which is the most abundant Crumbs ortholog in the brain. Transfected CRB2 inhibited proteolytic production of A beta and APP intracellular domains from APP C-terminal fragments in HEK293 and SH-SY5Y cells. Conversely, knockdown of endogenous CRB2 increased gamma-secretase cleavage products in SH-SY5Y cells. CRB2 inhibition of gamma-cleavage was also detected in cell-free assays. CRB2 interacted with the gamma-secretase complex, but was not a competitive substrate for gamma-cleavage. The transmembrane domain of CRB2 was indispensable for inhibition of A beta generation and mediated CRB2 binding with the gamma-secretase complex. In addition, the cytoplasmic domain appeared to play a supportive role in gamma-secretase inhibition, whereas mutational disruption of the two protein-binding motifs involved in the formation of cell adhesion complexes did not affect gamma-secretase inhibition. Co-overexpression of presenilin-1 or APH-1 abrogated gamma-secretase inhibition probably through prevention of the incorporation of CRB2 into the gamma-secretase complex. Our results suggest that CRB2 functions as an inhibitory binding protein that is involved in the formation of a mature but inactive pool of the gamma-secretase complex.	[Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan; [Araki, Wataru] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Kodaira, Tokyo 1878502, Japan; [Suzuki, Toshiharu] Hokkaido Univ, Neurosci Lab, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Tagami, Shinji; Okochi, Masayasu; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Div Psychiat & Behav Prote, Dept Postgenom & Dis, Suita, Osaka 5650871, Japan; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Shiga University of Medical Science; National Center for Neurology & Psychiatry - Japan; Hokkaido University; Osaka University; Radboud University Nijmegen	Nishimura, M (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan.	mnishimu@belle.shiga-med.ac.jp	Roepman, Ronald/B-1339-2014; Suzuki, Toshiharu/B-5342-2013; Araki, Wataru/G-7913-2014	Roepman, Ronald/0000-0002-5178-8163; Araki, Wataru/0000-0001-8467-6937; Okochi, Masayasu/0000-0002-2318-7651	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation [05-26]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported in part by a grant-in-aid for scientific research on Priority Area-Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M.N.), and a grant from the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (05-26) ( to M. T., M.O., S. T., and M.N.).	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Berezovska O, 2001, J BIOL CHEM, V276, P30018, DOI 10.1074/jbc.M008268200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lleo A, 2005, J BIOL CHEM, V280, P27303, DOI 10.1074/jbc.M413969200; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Pardossi-Piquard R, 2007, BIOCHEMISTRY-US, V46, P13704, DOI 10.1021/bi701347w; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Takeda K, 2004, EUR J NEUROSCI, V19, P258, DOI 10.1111/j.0953-816X.2003.03135.x; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; van den Hurk JAJM, 2005, MOL VIS, V11, P263; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	47	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14920	14931		10.1074/jbc.M109.038760	http://dx.doi.org/10.1074/jbc.M109.038760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299451	Green Published, hybrid			2022-12-27	WOS:000277399000013
J	Turm, H; Maoz, M; Katz, V; Yin, YJ; Offermanns, S; Bar-Shavit, R				Turm, Hagit; Maoz, Myriam; Katz, Vered; Yin, Yong-Jun; Offermanns, Steffan; Bar-Shavit, Rachel			Protease-activated Receptor-1 (PAR1) Acts via a Novel G alpha(13)-Dishevelled Axis to Stabilize beta-Catenin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DISHEVELLED GENE; HETEROTRIMERIC G-PROTEINS; WNT SIGNALING PATHWAY; COLORECTAL-CANCER; ENDOTHELIAL-CELLS; HUMAN COUNTERPART; PROSTATE-CANCER; UP-REGULATION; DIX DOMAIN; G12 FAMILY	We have previously shown a novel link between hPar-1 (human protease-activated receptor-1) and beta-catenin stabilization. Although it is well recognized that Wnt signaling leads to beta-catenin accumulation, the role of PAR1 in the process is unknown. We provide here evidence that PAR1 induces beta-catenin stabilization independent of Wnt, Fz (Frizzled), and the co-receptor LRP5/6 (low density lipoprotein-related protein 5/6) and identify selective mediators of the PAR1-beta-catenin axis. Immunohistological analyses of hPar1-transgenic (TG) mouse mammary tissues show the expression of both G alpha(12) and G alpha(13) compared with age-matched control counterparts. However, only G alpha(13) was found to be actively involved in PAR1-induced beta-catenin stabilization. Indeed, a dominant negative form of G alpha(13) inhibited both PAR1-induced Matrigel invasion and Lef/Tcf (lymphoid enhancer factor/T cell factor) transcription activity. PAR1-G alpha(13) association is followed by the recruitment of DVL (Dishevelled), an upstream Wnt signaling protein via the DIX domain. Small interfering RNA-Dvl silencing leads to a reduction in PAR1-induced Matrigel invasion, inhibition of Lef/Tcf transcription activity, and decreased beta-catenin accumulation. It is of note that PAR1 also promotes the binding of beta-arrestin-2 to DVL, suggesting a role for beta-arrestin-2 in PAR1-induced DVL phosphorylation dynamics. Although infection of small interfering RNA-LRP5/6 or the use of the Wnt antagonists, SFRP2 (soluble Frizzled-related protein 2) or SFRP5 potently reduced Wnt3A-mediated beta-catenin accumulation, no effect was observed on PAR1-induced beta-catenin stabilization. Collectively, our data show that PAR1 mediates beta-catenin stabilization independent of Wnt. We propose here a novel cascade of PAR1-induced G alpha(13)-DVL axis in cancer and beta-catenin stabilization.	[Turm, Hagit; Maoz, Myriam; Katz, Vered; Yin, Yong-Jun; Bar-Shavit, Rachel] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, IL-91120 Jerusalem, Israel; [Offermanns, Steffan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Max Planck Society	Bar-Shavit, R (corresponding author), Hadassah Univ Hosp, Dept Oncol, POB 12000, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Israel Science Foundation; Fritz-Thyssen Stiftung	Israel Science Foundation(Israel Science Foundation); Fritz-Thyssen Stiftung	This work was supported by grants from the Israel Science Foundation (to R.B.-S.) and the Fritz-Thyssen Stiftung (to R.B.-S. and S.O.).	ALBINI A, 1987, CANCER RES, V47, P3239; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Eshleman JR, 1996, ONCOGENE, V12, P1425; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Greco TL, 1996, MAMM GENOME, V7, P475, DOI 10.1007/s003359900144; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; ISHII K, 1994, J BIOL CHEM, V269, P1125; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kaplan DD, 2001, J BIOL CHEM, V276, P44037, DOI 10.1074/jbc.M106121200; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Nialbon C. C., 2005, SCI STKE, V2005, ppe35; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Okino K, 2003, ONCOL REP, V10, P1219; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Polakis P, 2000, GENE DEV, V14, P1837; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; van de Wetering M, 2001, CANCER RES, V61, P278; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	70	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15137	15148		10.1074/jbc.M109.072843	http://dx.doi.org/10.1074/jbc.M109.072843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223821	hybrid, Green Published			2022-12-27	WOS:000277399000035
J	Wang, YB; Weiss, LM; Orlofsky, A				Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos			Coordinate Control of Host Centrosome Position, Organelle Distribution, and Migratory Response by Toxoplasma gondii via Host mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; ADENOMATOUS POLYPOSIS-COLI; MICROTUBULE STABILIZATION; GSK3-BETA PHOSPHORYLATION; CELL-MIGRATION; KINASE-B; RICTOR; AKT; POLARIZATION; ASSOCIATION	The invasion of host cells by Toxoplasma gondii is accompanied by a reorganization of host cell structure, in which the host centrosome and Golgi apparatus are localized to the vacuole, and mitochondria, microtubules, and endolysosomes are recruited to the vacuole perimeter. The mechanism and functional significance of this process have not been well defined. Here, we report that the centrosome-vacuole association was abolished in mammalian target of rapamycin complex 2 (mTORC2)-deficient cells, which also displayed a disordered distribution of perivacuolar host mitochondria and lysosomes. Infection of fibroblasts led to stable, mTORC2-dependent activation of Akt, and Akt inhibition mimicked the effect of mTORC2 ablation on centrosome, mitochondria, and lysosome localization. Mobilization of the centrosome by Akt inhibition was abrogated by inhibitors of glycogen synthase kinase 3 (GSK3), implying that the centrosome is constrained to the vacuole through an mTORC2-Akt-GSK3 pathway. Infected cells were incapable of migration in a wounded monolayer model, and this effect was associated with the inability of centrosomes to reorient in the direction of migration. Both migration and centrosome reorientation were fully restored upon ablation of mTORC2. These findings provide the first linkage of host signals to parasite-mediated host cell reorganization and demonstrate migratory suppression as a novel functional consequence of this process that is associated with mTORC2-mediated centrosome constraint.	[Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Weiss, Louis M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Orlofsky, A (corresponding author), Albert Einstein Coll Med, Dept Pathol, G704,1300 Morris Pk Ave, Bronx, NY 10461 USA.	amos.orlofsky@einstein.yu.edu	Wang, Yubao/L-3912-2014		National Institutes of Health [AI-55358, AI-39454]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055358, R01AI039454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55358 (to A. O.) and AI-39454 (to L. M. W.).	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Martin AM, 2007, J EUKARYOT MICROBIOL, V54, P25, DOI 10.1111/j.1550-7408.2006.00230.x; Nakaar V, 2003, J CELL SCI, V116, P2311, DOI 10.1242/jcs.00382; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sinai AP, 1997, J CELL SCI, V110, P2117; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	48	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15611	15618		10.1074/jbc.M109.095778	http://dx.doi.org/10.1074/jbc.M109.095778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236941	hybrid, Green Published			2022-12-27	WOS:000277399000079
J	Lampl, N; Budai-Hadrian, O; Davydov, O; Joss, TV; Harrop, SJ; Curmi, PMG; Roberts, TH; Fluhr, R				Lampl, Nardy; Budai-Hadrian, Ofra; Davydov, Olga; Joss, Tom V.; Harrop, Stephen J.; Curmi, Paul M. G.; Roberts, Thomas H.; Fluhr, Robert			Arabidopsis AtSerpin1, Crystal Structure and in Vivo Interaction with Its Target Protease RESPONSIVE TO DESICCATION-21 (RD21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; VACUOLAR PROCESSING ENZYME; PROTEINASE-INHIBITORS SERPINS; SEED STORAGE PROTEINS; CYSTEINE PROTEASES; REACTIVE CENTERS; GRAIN; ACTIVATION; EXPRESSION; MECHANISM	In animals, protease inhibitors of the serpin family are associated with many physiological processes, including blood coagulation and innate immunity. Serpins feature a reactive center loop (RCL), which displays a protease target sequence as a bait. RCL cleavage results in an irreversible, covalent serpin-protease complex. AtSerpin1 is an Arabidopsis protease inhibitor that is expressed ubiquitously throughout the plant. The x-ray crystal structure of recombinant AtSerpin1 in its native stressed conformation was determined at 2.2 A. The electrostatic surface potential below the RCL was found to be highly positive, whereas the breach region critical for RCL insertion is an unusually open structure. AtSerpin1 accumulates in plants as a full-length and a cleaved form. Fractionation of seedling extracts by nonreducing SDS-PAGE revealed the presence of an additional slower migrating complex that was absent when leaves were treated with the specific cysteine protease inhibitor L-trans-epoxysuccinyl-L-leucylamido (4-guanidino) butane. Significantly, RESPONSIVE TO DESICCATION-21 (RD21) was the major protease labeled with the L-trans-epoxysuccinyl-L-leucylamido (4-guanidino) butane derivative DCG-04 in wild type extracts but not in extracts of mutant plants constitutively overexpressing AtSerpin1, indicating competition. Fractionation by nonreducing SDS-PAGE followed by immunoblotting with RD21-specific antibody revealed that the protease accumulated both as a free enzyme and in a complex with AtSerpin1. Importantly, both RD21 and AtSerpin1 knock-out mutants lacked the serpin-protease complex. The results establish that the major Arabidopsis plant serpin interacts with RD21. This is the first report of the structure and in vivo interaction of a plant serpin with its target protease.	[Lampl, Nardy; Budai-Hadrian, Ofra; Davydov, Olga; Fluhr, Robert] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Joss, Tom V.; Roberts, Thomas H.] Macquarie Univ N Ryde, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia	Weizmann Institute of Science; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney	Fluhr, R (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	robert.fluhr@weizmann.ac.il	Roberts, Thomas H/H-2071-2012; Curmi, Paul/G-7185-2011	Roberts, Thomas H/0000-0003-3831-3240; Curmi, Paul/0000-0001-5762-7638	Israel Science Foundation, Macquarie University [1306/06]; Australian Research Council	Israel Science Foundation, Macquarie University(Israel Science Foundation); Australian Research Council(Australian Research Council)	This work was supported by Grant 1306/06 (to R. F.) by the Israel Science Foundation, Macquarie University funding (to T. H. R.), and Australian Research Council funding (to P. M. G. C.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn JW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-52; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass E, 2002, J BIOL CHEM, V277, P30921, DOI 10.1074/jbc.M112250200; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fu YP, 2007, J PLANT RES, V120, P465, DOI 10.1007/s10265-007-0080-5; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hejgaard J, 2001, FEBS LETT, V488, P149, DOI 10.1016/S0014-5793(00)02425-X; Hejgaard J, 2002, PHYSIOL PLANTARUM, V116, P155, DOI 10.1034/j.1399-3054.2002.1160204.x; Hejgaard J, 2007, MOL CELLULAR ASPECTS, P279; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Patston PA, 2004, METHODS, V32, P93, DOI 10.1016/S1046-2023(03)00201-9; Petersen ML, 2005, J EXP BOT, V56, P3111, DOI 10.1093/jxb/eri308; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Roberts TH, 2003, J EXP BOT, V54, P2251, DOI 10.1093/jxb/erg248; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Rojo E, 2003, P NATL ACAD SCI USA, V100, P7389, DOI 10.1073/pnas.1230987100; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Simonovic I, 2000, BBA-PROTEIN STRUCT M, V1481, P97, DOI 10.1016/S0167-4838(00)00115-1; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; WOLTERING EJ, 2008, J BIOL CHEM, V283, P774; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yamada T, 2000, PLANT CELL PHYSIOL, V41, P185, DOI 10.1093/pcp/41.2.185; Yoo BC, 2000, J BIOL CHEM, V275, P35122, DOI 10.1074/jbc.M006060200; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; ZHOU J, 1993, J BIOL CHEM, V268, P10863	72	62	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13550	13560		10.1074/jbc.M109.095075	http://dx.doi.org/10.1074/jbc.M109.095075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181955	Green Published, hybrid			2022-12-27	WOS:000276987700028
J	Li, YF; Hao, B				Li, Yunfeng; Hao, Bing			Structural Basis of Dimerization-dependent Ubiquitination by the SCFFbx4 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX; CYCLIN D1; SCF; ACTIVATION; INSIGHTS; COMPLEX; BINDING; FORM; RECOGNITION; ORIENTATION	The F-box proteins are the substrate recognition subunits of the SCF (Skp1-Cul1-Rbx1-F-box protein) ubiquitin ligase complexes that control the stability of numerous regulators in eukaryotic cells. Here we show that dimerization of the F-box protein Fbx4 is essential for SCFFbx4 (the superscript denotes the F-box protein) ubiquitination activity toward the telomere regulator Pin2 (also known as TRF1). The crystal structure of Fbx4 in complex with an adaptor protein Skp1 reveals an anti-parallel dimer configuration in which the linker domain of Fbx4 interacts with the C-terminal substrate-binding domain of the other protomer, whereas the C-terminal domain of the protein adopts a compact alpha/beta fold distinct from those of known F-box proteins. Biochemical studies indicate that both the N-terminal domain and a loop connecting the linker and C-terminal domain of Fbx4 are critical for the dimerization and activation of the protein. Our findings provide a framework for understanding the role of F-box dimerization in the SCF-mediated ubiquitination reaction.			Hao, B (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	bhao@uchc.edu		Li, Yunfeng/0000-0001-6501-9093	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbash O, 2008, CELL CYCLE, V7, P2983, DOI 10.4161/cc.7.19.6775; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	50	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13896	13906		10.1074/jbc.M110.111518	http://dx.doi.org/10.1074/jbc.M110.111518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181953	Green Published, hybrid			2022-12-27	WOS:000276987700064
J	Chai, S; Li, MH; Branigan, D; Xiong, ZG; Simon, RP				Chai, Sunghee; Li, Minghua; Branigan, Deborah; Xiong, Zhi-Gang; Simon, Roger P.			Activation of Acid-sensing Ion Channel 1a (ASIC1a) by Surface Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; ENDOPLASMIC-RETICULUM; CORTICAL-NEURONS; SODIUM-CHANNELS; REDOX REAGENTS; PROTEIN PICK1; NMDA RECEPTOR; NA+ CHANNEL; MODULATION; BRAIN	Acid-sensing ion channels (ASICs) are voltage-independent Na+ channels activated by extracellular protons. ASIC1a is expressed in neurons in mammalian brain and is implicated in long term potentiation of synaptic transmission that contributes to learning and memory. In ischemic brain injury, however, activation of this Ca2+-permeable channel plays a critical role in acidosis-mediated, glutamate-independent, Ca2+ toxicity. We report here the identification of insulin as a regulator of ASIC1a surface expression. In modeled ischemia using Chinese hamster ovary cells, serum depletion caused a significant increase in ASIC1a surface expression that resulted in the potentiation of ASIC1a activity. Among the components of serum, insulin was identified as the key factor that maintains a low level of ASIC1a on the plasma membrane. Neurons subjected to insulin depletion increased surface expression of ASIC1a with resultant potentiation of ASIC1a currents. Intracellularly, ASIC1a is predominantly localized to the endoplasmic reticulum in Chinese hamster ovary cells, and this intracellular localization is also observed in neurons. Under conditions of serum or insulin depletion, the intracellular ASIC1a is translocated to the cell surface, increasing the surface expression level. These results reveal an important trafficking mechanism of ASIC1a that is relevant to both the normal physiology and the pathological activity of this channel.	[Chai, Sunghee; Li, Minghua; Branigan, Deborah; Xiong, Zhi-Gang; Simon, Roger P.] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Chai, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97232 USA.	chaisu@ohsu.edu			National Institutes of Health [R01NS050610, R01NS047506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047506, R01NS050610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS050610 (to R. P. S.) and R01NS047506 (to Z. G. X.).	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; NEDERGAARD M, 1991, AM J PHYSIOL, V260, P581; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	38	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13002	13011		10.1074/jbc.M109.086041	http://dx.doi.org/10.1074/jbc.M109.086041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185828	hybrid, Green Published			2022-12-27	WOS:000276787800058
J	Mandriota, SJ; Buser, R; Lesne, L; Stouder, C; Favaudon, V; Maechler, P; Bena, F; Clement, V; Ruegg, C; Montesano, R; Sappino, AP				Mandriota, Stefano J.; Buser, Raphaele; Lesne, Laurence; Stouder, Christelle; Favaudon, Vincent; Maechler, Pierre; Bena, FredeRique; Clement, Virginie; Rueegg, Curzio; Montesano, Roberto; Sappino, Andre-Pascal			Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MUTATIONS; GENE; LINE; IMMORTALIZATION; HETEROZYGOSITY; SECRETION	Carriers of mutations in the cell cycle checkpoint protein kinase ataxia telangiectasia mutated (ATM), which represent 1-2% of the general population, have an increased risk of breast cancer. However, experimental evidence that ATM deficiency contributes to human breast carcinogenesis is lacking. We report here that in MCF-10A and MCF-12A cells, which are well established normal human mammary gland epithelial cell models, partial or almost complete stable ATM silencing or pharmacological inhibition resulted in cellular transformation, genomic instability, and formation of dysplastic lesions in NOD/SCID mice. These effects did not require the activity of exogenous DNA-damaging agents and were preceded by an unsuspected and striking increase in cell proliferation also observed in primary human mammary gland epithelial cells. Increased proliferation correlated with a dramatic, transient, and proteasome dependent reduction of p21(WAF1/CIP1) and p27(KIP1) protein levels, whereas little or no effect was observed on p(21WAF1/CIP1) or p27(KIP1) mRNAs. p21(WAF1/CIP1) silencing also increased MCF-10A cell proliferation, thus identifying p21(WAF1/CIP1) down-regulation as a mediator of the proliferative effect of ATM inhibition. Our findings provide the first experimental evidence that ATMis a human breast tumor suppressor. In addition, they mirror the sensitivity of ATM tumor suppressor function and unveil a new mechanism by which ATM might prevent human breast tumorigenesis, namely a direct inhibitory effect on the basal proliferation of normal mammary epithelial cells.	Univ Geneva, Ctr Oncol, CH-1206 Geneva, Switzerland; [Stouder, Christelle; Bena, FredeRique] Univ Geneva, Dept Genet Med & Dev, CH-1206 Geneva, Switzerland; [Maechler, Pierre; Montesano, Roberto] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Clement, Virginie] Univ Hosp Geneva, Dept Clin Neurosci & Neurosurg, CH-1205 Geneva, Switzerland; [Rueegg, Curzio] Ctr Pluridisciplinaire Oncol, Div Expt Oncol, CH-1066 Epalinges, Switzerland; [Favaudon, Vincent] Inst Curie, INSERM, F-91405 Orsay, France	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie		stefano.mandriota@unige.ch	Montesano, Roberto/AAV-3192-2020	Maechler, Pierre/0000-0002-2005-1433	Ligue Genevoise Contre le Cancer; Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques; Fondation Gustave et Simone Prevot; Fondation Ritva Meier; Swiss National Science Foundation [310030-120584, 3100A0-113832/1, 3100A0-118079]; Medic Foundation	Ligue Genevoise Contre le Cancer; Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques; Fondation Gustave et Simone Prevot; Fondation Ritva Meier; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medic Foundation	This work was supported by grants from the Ligue Genevoise Contre le Cancer, from the Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques, from the Fondation Gustave et Simone Prevot, and from the Fondation Ritva Meier (to S. J. M. and/or A. P. S.); from the Swiss National Science Foundation (Grant 310030-120584 to P. M.), Grant 3100A0-113832/1 (to R. M.), and Grant 3100A0-118079 (to C. R.)); and from the Medic Foundation (to C. R.).	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; FAVAUDON V, 1983, BIOCHIMIE, V65, P593; Forsyth NR, 2004, NEOPLASIA, V6, P258, DOI 10.1593/neo.04103; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall J, 2005, CANCER LETT, V227, P105, DOI 10.1016/j.canlet.2004.12.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jones A, 2008, J PATHOL, V214, P533, DOI 10.1002/path.2320; Khanna KK, 2004, J MAMMARY GLAND BIOL, V9, P247, DOI 10.1023/B:JOMG.0000048772.92326.a1; KOJIS TL, 1991, CANCER GENET CYTOGEN, V56, P143, DOI 10.1016/0165-4608(91)90164-P; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Maillet P, 2002, J MED GENET, V39, P751, DOI 10.1136/jmg.39.10.751; Mao X, 2005, CANCER GENET CYTOGEN, V160, P141, DOI 10.1016/j.cancergencyto.2004.12.018; Montesano R, 2005, J CELL SCI, V118, P3487, DOI 10.1242/jcs.02467; Montesano R, 2009, AM J PHYSIOL-RENAL, V296, pF446, DOI 10.1152/ajprenal.90415.2008; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soukupova J, 2008, ONCOL REP, V19, P1505; SOULE HD, 1990, CANCER RES, V50, P6075; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; TAIT L, 1990, CANCER RES, V50, P6087; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weil MM, 2001, ONCOGENE, V20, P4409, DOI 10.1038/sj.onc.1204589; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	39	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13092	13106		10.1074/jbc.M109.078360	http://dx.doi.org/10.1074/jbc.M109.078360			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177072	Green Published, hybrid			2022-12-27	WOS:000276787800066
J	Ren, JQ; Wang, YQ; Liang, YH; Zhang, YQ; Bao, SL; Xu, ZH				Ren, Jinqi; Wang, Yaqing; Liang, Yuheng; Zhang, Yongqing; Bao, Shilai; Xu, Zhiheng			Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; FISSION YEAST; HUMAN HOMOLOG; PRMT5; NUCLEOPHOSMIN; COMPLEX; SKB1; IDENTIFICATION; METHYLOSOME; ACTIVATION	Modulation of ribosomal assembly is a fine tuning mechanism for cell number and organ size control. Many ribosomal proteins undergo post-translational modification, but their exact roles remain elusive. Here, we report that ribosomal protein s10 (RPS10) is a novel substrate of an oncoprotein, protein-arginine methyltransferase 5 (PRMT5). We show that PRMT5 interacts with RPS10 and catalyzes its methylation at the Arg(158) and Arg(160) residues. The methylation of RPS10 at Arg(158) and Arg(160) plays a role in the proper assembly of ribosomes, protein synthesis, and optimal cell proliferation. The RPS10-R158K/R160K mutant is not efficiently assembled into ribosomes and is unstable and prone to degradation by the proteasomal pathway. In nucleoli, RPS10 interacts with nucleophosmin/B23 and is predominantly concentrated in the granular component region, which is required for ribosome assembly. The RPS10 methylation mutant interacts weakly with nucleophosmin/B23 and fails to concentrate in the granular component region. Our results suggest that PRMT5 is likely to regulate cell proliferation through the methylation of ribosome proteins, and thus reveal a novel mechanism for PRMT5 in tumorigenesis.	[Ren, Jinqi; Wang, Yaqing; Liang, Yuheng; Zhang, Yongqing; Bao, Shilai; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xu, ZH (corresponding author), 1 W Beichen Rd, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Ren, Jinqi/D-5545-2015	Ren, Jinqi/0000-0001-7461-0491; Xu, Zhiheng/0000-0002-4809-2851	Ministry of Science and Technology of China [2007CB947202, 2006CB500701, 2006AA02Z173, 2006AA02Z140, 2009DFA32450]; National Science Foundation of China [30970580, 30725007, 30670663, 30870527, 30670479]; Chinese Academy of Sciences [KSCX1-YW-R-62/84]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the Ministry of Science and Technology of China "973" program (2007CB947202/2006CB500701), "863" program (2006AA02Z173/Z140), and 2009DFA32450; the National Science Foundation of China (30970580/30725007/30670663/30870527/30670479); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bao SL, 2001, J BIOL CHEM, V276, P14549, DOI 10.1074/jbc.C100096200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Castro ME, 2008, CARCINOGENESIS, V29, P1343, DOI 10.1093/carcin/bgm302; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hasegawa H, 1999, LUPUS, V8, P439, DOI 10.1177/096120339900800605; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; SCOLNIK P, 1979, EUR J BIOCHEM, V101, P93, DOI 10.1111/j.1432-1033.1979.tb04220.x; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shin HS, 2009, BIOCHEM BIOPH RES CO, V385, P273, DOI 10.1016/j.bbrc.2009.05.055; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zieve GW, 2003, AUTOIMMUN REV, V2, P235, DOI 10.1016/S1568-9972(03)00018-1	50	98	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12695	12705		10.1074/jbc.M110.103911	http://dx.doi.org/10.1074/jbc.M110.103911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159986	Green Published, hybrid			2022-12-27	WOS:000276787800028
J	Herman, BD; Votruba, I; Holy, A; Sluis-Cremer, N; Balzarini, J				Herman, Brian D.; Votruba, Ivan; Holy, Antonin; Sluis-Cremer, Nicolas; Balzarini, Jan			The Acyclic 2,4-Diaminopyrimidine Nucleoside Phosphonate Acts as a Purine Mimetic in HIV-1 Reverse Transcriptase DNA Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL ACTIVITY; IN-VITRO; KINETIC-ANALYSIS; MECHANISM; DERIVATIVES; POLYMERASE; RESISTANCE; CIDOFOVIR; MUTATION; ANALOGS	The acyclic pyrimidine nucleoside phosphonate (ANP) phosphonylmethoxyethoxydiaminopyrimidine (PMEO-DA-Pym) differs from other ANPs in that the aliphatic alkyloxy linker is bound to the C-6 of the 2,4-diaminopyrimidine base through an ether bond, instead of the traditional alkyl linkage to the N-1 or N-9 of the pyrimidine or purine base. In this study, we have analyzed the molecular interactions between PMEO-DA-Pym-diphosphate (PMEO-DAPym-pp) and the active sites of wild-type (WT) and drug-resistant HIV-1 reverse transcriptase (RT). Pre-steady-state kinetic analyses revealed that PMEO-DAPym-pp is a good substrate for WT HIV-1 RT: its catalytic efficiency of incorporation (k(pol)/K-d) is only 2- to 3-fold less than that of the corresponding prototype purine nucleotide analogs PMEA-pp or (R) PMPA-pp. HIV-1 RT recognizes PMEO-DAPym-pp as a purine base instead of a pyrimidine base and incorporates it opposite to thymine (in DNA) or uracil (in RNA). Molecular modeling demonstrates that PMEO-DAPym-pp fits into the active site of HIV-1 RT without significant perturbation of key amino acid residues and mimics an open incomplete purine ring that allows the canonical Watson-Crick base pairing to be maintained. PMEO-DAPym-pp is incorporated more efficiently than (R) PMPA-pp by mutant K65R HIV-1 RT and is not as efficiently excised as (R) PMPA by HIV-1RT containing thymidine analog mutations. Overall, the data revealed that PMEO-DAPym represents the prototype compound of a novel class of pyrimidine acyclic nucleoside phosphonates that are recognized as a purine nucleotide and should form the rational basis for the design and development of novel purine nucleo(s)(t)ide mimetics as potential antiviral or antimetabolic agents.	[Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Herman, Brian D.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA; [Votruba, Ivan; Holy, Antonin] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CZ-16610 Prague, Czech Republic	KU Leuven; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be			National Institutes of Health [R01 AI081571]; KU Leuven [GOA Krediet 05/19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Leuven(KU Leuven); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI081571 (to N.S.-C.). This work was also supported by KU Leuven Grant GOA Krediet 05/19 (to J.B.).	Balzarini J, 2002, ANTIMICROB AGENTS CH, V46, P2185, DOI 10.1128/AAC.46.7.2185-2193.2002; BALZARINI J, 1993, ANTIMICROB AGENTS CH, V37, P332, DOI 10.1128/AAC.37.2.332; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P4961, DOI 10.1073/pnas.88.11.4961; Balzarini J, 2007, J ANTIMICROB CHEMOTH, V59, P80, DOI 10.1093/jac/dkl454; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Cherrington JM, 1996, ANTIMICROB AGENTS CH, V40, P2212, DOI 10.1128/AAC.40.9.2212; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; DECLERCQ E, 1987, ANTIVIR RES, V8, P261; DECLERCQ E, 1986, NATURE, V323, P464, DOI 10.1038/323464a0; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; GU ZX, 1995, ANTIMICROB AGENTS CH, V39, P1888, DOI 10.1128/AAC.39.8.1888; Hockova D, 2003, J MED CHEM, V46, P5064, DOI 10.1021/jm030932o; Holy A, 2002, J MED CHEM, V45, P1918, DOI 10.1021/jm011095y; HOLY A, 1990, ANTIVIR RES, V13, P295, DOI 10.1016/0166-3542(90)90014-X; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Magee WC, 2008, ANTIMICROB AGENTS CH, V52, P586, DOI 10.1128/AAC.01172-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MUL YM, 1989, NUCLEIC ACIDS RES, V17, P8917, DOI 10.1093/nar/17.22.8917; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; PAUWELS R, 1988, ANTIMICROB AGENTS CH, V32, P1025, DOI 10.1128/AAC.32.7.1025; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Xiong XF, 1997, ANTIMICROB AGENTS CH, V41, P594, DOI 10.1128/AAC.41.3.594; Xiong XF, 1996, BIOCHEM PHARMACOL, V51, P1563, DOI 10.1016/0006-2952(96)00100-1; Ying C, 2005, ANTIMICROB AGENTS CH, V49, P1177, DOI 10.1128/AAC.49.3.1177-1180.2005; ZINNEN S, 1994, J BIOL CHEM, V269, P24195	29	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12101	12108		10.1074/jbc.M109.096529	http://dx.doi.org/10.1074/jbc.M109.096529			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164190	Green Published, hybrid			2022-12-27	WOS:000276787100040
J	Oberst, A; Pop, C; Tremblay, AG; Blais, V; Denault, JB; Salvesen, GS; Green, DR				Oberst, Andrew; Pop, Cristina; Tremblay, Alexandre G.; Blais, Veronique; Denault, Jean-Bernard; Salvesen, Guy S.; Green, Douglas R.			Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERCHAIN PROTEOLYSIS; SPECIFICITY; MECHANISM; DEATH; MODEL	Caspase-8 is a cysteine protease activated by membrane-bound receptors at the cytosolic face of the cell membrane, initiating the extrinsic pathway of apoptosis. Caspase-8 activation relies on recruitment of inactive monomeric zymogens to activated receptor complexes, where they produce a fully active enzyme composed of two catalytic domains. Although in vitro studies using drug-mediated affinity systems or kosmotropic salts to drive dimerization have indicated that uncleaved caspase-8 can be readily activated by dimerization alone, in vivo results using mouse models have reached the opposite conclusion. Furthermore, in addition to interdomain autoprocessing, caspase-8 can be cleaved by activated executioner caspases, and reports of whether this cleavage event can lead to activation of caspase-8 have been conflicting. Here, we address these questions by carrying out studies of the activation characteristics of caspase-8 mutants bearing prohibitive mutations at the interdomain cleavage sites both in vitro and in cell lines lacking endogenous caspase-8, and we find that elimination of these cleavage sites precludes caspase-8 activation by prodomain-driven dimerization. We then further explore the consequences of interdomain cleavage of caspase-8 by adapting the tobacco etch virus protease to create a system in which both the cleavage and the dimerization of caspase-8 can be independently controlled in living cells. We find that unlike the executioner caspases, which are readily activated by interdomain cleavage alone, neither dimerization nor cleavage of caspase-8 alone is sufficient to activate caspase-8 or induce apoptosis and that only the coordinated dimerization and cleavage of the zymogen produce efficient activation in vitro and apoptosis in cellular systems.	[Pop, Cristina; Salvesen, Guy S.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tremblay, Alexandre G.; Blais, Veronique; Denault, Jean-Bernard] Univ Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital; University of Sherbrooke	Salvesen, GS (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@burnham.org; green@stjude.org	Green, Douglas R/N-8083-2018; Denault, Jean-Bernard/AAC-5945-2019	Green, Douglas R/0000-0002-7332-1417; 	National Institutes of Health [AI47891, AI44828, CA69381]; Canadian Institutes of Health Research; Cancer Research Society; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047891, R01AI044828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI47891 (to D. R. G.), AI44828 (to D. R. G.), and CA69381 (to D. R. G. and G. S. S.). This work was also supported in part by Canadian Institutes of Health Research and Cancer Research Society operating grants (to J.-B. D.).	Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Denault JB, 2003, CURR PROTOC PROTEIN; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Denault Jean-Bernard, 2008, V414, P191; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Spencer DM, 1996, CURR BIOL, V6, P839, DOI 10.1016/S0960-9822(02)00607-3; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340	40	147	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16632	16642		10.1074/jbc.M109.095083	http://dx.doi.org/10.1074/jbc.M109.095083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308068	Green Published, hybrid			2022-12-27	WOS:000277982600027
J	Guo, NX; Baglole, CJ; O'Loughlin, CW; Feldon, SE; Phipps, RP				Guo, Naxin; Baglole, Carolyn J.; O'Loughlin, Charles W.; Feldon, Steven E.; Phipps, Richard P.			Mast Cell-derived Prostaglandin D-2 Controls Hyaluronan Synthesis in Human Orbital Fibroblasts via DP1 Activation IMPLICATIONS FOR THYROID EYE DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAVES OPHTHALMOPATHY; THYROTROPIN RECEPTOR; GROWTH-FACTOR; ALLERGIC INFLAMMATION; TISSUE-INJURY; D SYNTHASE; EXPRESSION; CRTH2; GAMMA; LYMPHOCYTES	Thyroid eye disease (TED) is a debilitating disorder characterized by the accumulation of adipocytes and hyaluronan (HA). Production of HA by fibroblasts leads to remarkable increases in tissue volume and to the anterior displacement of the eyes. Prostaglandin D-2 (PGD(2)), mainly produced by mast cells, promotes orbital fibroblast adipogenesis. The mechanism by which PGD(2) influences orbital fibroblasts and their synthesis of HA is poorly understood. We report here that mast cell-derived PGD(2) is a key factor that promotes HA biosynthesis by orbital fibroblasts. Primary orbital fibroblasts from TED patients were isolated and used to test the effects of PGD(2), prostaglandin J(2), as well as prostaglandin D receptor (DP) agonists and antagonists on HA synthesis. The expression of HA synthase (HAS), hyaluronidase, DP1, and DP2 mRNA levels was assessed by PCR. Small interfering RNAs against HAS1 or HAS2 were used to assess the importance of HAS isoforms on HA production. Treatment of human orbital fibroblasts with PGD(2) and PGJ(2) increased HA synthesis and HAS mRNA. HAS2 was the dominant isoform responsible for HA production by PGD(2). The effect of PGD(2) on HA production was mimicked by the selective DP1 agonist BW245C. The DP1 antagonist MK-0524 completely blocked PGD(2)-induced HA synthesis. Human mast cells (HMC-1) produced PGD(2). Co-culture of HMC-1 cells with orbital fibroblasts induced HA production and inhibition of mast cell-derived PGD(2) prevented HA synthesis. Mast cell-derived PGD(2) increased HA production via activation of DP1. Selectively targeting the production of PGD(2) and/or activation of DP1 may prevent pathological changes associated with TED.	[Baglole, Carolyn J.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14642 USA; [Guo, Naxin; O'Loughlin, Charles W.; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Dept Ophthalmol, Sch Med & Dent, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Phipps, Richard P.] Univ Rochester, Lung Biol & Dis Program, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Dept Environm Med, Sch Med & Dent, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu		Feldon, Steven/0000-0003-0603-9312	Research to Prevent Blindness Foundation Grant [EY017123, EY011708]; Parker B. Francis Fellowship; American Thoracic Society; NATIONAL EYE INSTITUTE [R01EY017123, R01EY011708] Funding Source: NIH RePORTER	Research to Prevent Blindness Foundation Grant(Research to Prevent Blindness (RPB)); Parker B. Francis Fellowship; American Thoracic Society; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by EY017123 and EY011708 and a Research to Prevent Blindness Foundation Grant.; Supported by a Parker B. Francis Fellowship and an American Thoracic Society Research Grant.	Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Bartalena L, 2009, NEW ENGL J MED, V360, P994, DOI 10.1056/NEJMcp0806317; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Borrello MA, 1996, CELL IMMUNOL, V173, P198, DOI 10.1006/cimm.1996.0268; Boschi A, 2005, BRIT J OPHTHALMOL, V89, P724, DOI 10.1136/bjo.2004.050807; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2009, BRIT J BIOMED SCI, V66, P28; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Costagliola S, 2000, J CLIN INVEST, V105, P803, DOI 10.1172/JCI7665; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gianoukakis AG, 2007, ENDOCRINOLOGY, V148, P54, DOI 10.1210/en.2006-0736; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; HUFNAGEL TJ, 1984, OPHTHALMOLOGY, V91, P1411; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kahaly G, 1998, THYROID, V8, P429, DOI 10.1089/thy.1998.8.429; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Khoo TK, 2008, THYROID, V18, P1291, DOI 10.1089/thy.2008.0255; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Lauer SA, 2008, OPHTHAL PLAST RECONS, V24, P257, DOI 10.1097/IOP.0b013e318177ebac; Leblanc Y, 2009, BIOORG MED CHEM LETT, V19, P2125, DOI 10.1016/j.bmcl.2009.03.010; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lehmann GM, 2008, PPAR RES, V2008, DOI 10.1155/2008/895901; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Many MC, 1999, J IMMUNOL, V162, P4966; Margulis A, 2009, J IMMUNOL, V183, P1739, DOI 10.4049/jimmunol.0803951; Marzoll A, 2009, J CELL MOL MED, V13, P3713, DOI 10.1111/j.1582-4934.2009.00736.x; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Royer JF, 2008, EUR J CLIN INVEST, V38, P663, DOI 10.1111/j.1365-2362.2008.01989.x; Schwartz JI, 2009, AM J THER, V16, P215, DOI 10.1097/MJT.0b013e31818f9c68; Smith TJ, 1999, ENDOCRINOLOGY, V140, P3518, DOI 10.1210/en.140.8.3518; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; SMITH TJ, 1991, J CLIN ENDOCR METAB, V72, P1169, DOI 10.1210/jcem-72-5-1169; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427, DOI 10.2174/15680266106061427; van Steensel L, 2009, INVEST OPHTH VIS SCI, V50, P3091, DOI 10.1167/iovs.08-2443; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Weinberg E, 2009, J CELL BIOCHEM, V108, P207, DOI 10.1002/jcb.22242; Xue L, 2009, CLIN EXP IMMUNOL, V156, P126, DOI 10.1111/j.1365-2249.2008.03871.x; Yamada M, 2002, AUTOIMMUNITY, V35, P403, DOI 10.1080/0891693021000026319; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x	71	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15794	15804		10.1074/jbc.M109.074534	http://dx.doi.org/10.1074/jbc.M109.074534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308056	Green Published, hybrid			2022-12-27	WOS:000277715900017
J	Popp, D; Narita, A; Maeda, K; Fujisawa, T; Ghoshdastider, U; Iwasa, M; Maeda, Y; Robinson, RC				Popp, David; Narita, Akihiro; Maeda, Kayo; Fujisawa, Tetsuro; Ghoshdastider, Umesh; Iwasa, Mitsusada; Maeda, Yuichiro; Robinson, Robert C.			Filament Structure, Organization, and Dynamics in MreB Sheets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SHAPE; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; BINDING PROTEINS; ACTIN-FILAMENTS; POLYMERIZATION; BACTERIA; ROLES; FLUORESCENCE	In vivo fluorescence microscopy studies of bacterial cells have shown that the bacterial shape-determining protein and actin homolog, MreB, forms cable-like structures that spiral around the periphery of the cell. The molecular structure of these cables has yet to be established. Here we show by electron microscopy that Thermatoga maritime MreB forms complex, several mu m long multilayered sheets consisting of diagonally interwoven filaments in the presence of either ATP or GTP. This architecture, in agreement with recent rheological measurements on MreB cables, may have superior mechanical properties and could be an important feature for maintaining bacterial cell shape. MreB polymers within the sheets appear to be single-stranded helical filaments rather than the linear protofilaments found in the MreB crystal structure. Sheet assembly occurs over a wide range of pH, ionic strength, and temperature. Polymerization kinetics are consistent with a cooperative assembly mechanism requiring only two steps: monomer activation followed by elongation. Steady-state TIRF microscopy studies of MreB suggest filament treadmilling while high pressure small angle x-ray scattering measurements indicate that the stability of MreB polymers is similar to that of F-actin filaments. In the presence of ADP or GDP, long, thin cables formed in which MreB was arranged in parallel as linear protofilaments. This suggests that the bacterial cell may exploit various nucleotides to generate different filament structures within cables for specific MreB-based functions.	[Popp, David; Narita, Akihiro; Maeda, Kayo; Iwasa, Mitsusada; Maeda, Yuichiro] RIKEN Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Narita, Akihiro; Maeda, Kayo; Ghoshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Maeda, Kayo; Ghoshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fujisawa, Tetsuro] Gifu Univ, Grad Sch Engn, Dept Biomol Sci, Gifu 5011193, Japan	Japan Science & Technology Agency (JST); RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nagoya University; Nagoya University; Gifu University	Popp, D (corresponding author), RIKEN Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011; Fujisawa, Tetsuro/AAA-5202-2019; Ghoshdastider, Umesh/O-5327-2015	Robinson, Robert/0000-0001-6367-6903; Ghoshdastider, Umesh/0000-0003-4471-9394	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore ( to R. C. R.).	Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Divakaruni AV, 2005, P NATL ACAD SCI USA, V102, P18602, DOI 10.1073/pnas.0507937102; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; FUJIMORI H, 2000, JAMSTECR, V42, P105; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Ikeuchi Y, 2002, EUR J BIOCHEM, V269, P364, DOI 10.1046/j.0014-2956.2001.02664.x; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Jewett MC, 2009, J BACTERIOL, V191, P1083, DOI 10.1128/JB.00852-08; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; KRULWICH TA, 1985, J BACTERIOL, V162, P768, DOI 10.1128/JB.162.2.768-772.1985; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Nishikawa Y, 2001, NUCL INSTRUM METH A, V467, P1384, DOI 10.1016/S0168-9002(01)00738-0; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; UPCHURCH RG, 1980, J BACTERIOL, V143, P274, DOI 10.1128/JB.143.1.274-284.1980; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884	34	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15858	15865		10.1074/jbc.M109.095901	http://dx.doi.org/10.1074/jbc.M109.095901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223832	Green Published, hybrid			2022-12-27	WOS:000277715900023
J	Kihira, Y; Hermanstyne, TO; Misonou, H				Kihira, Yoshitaka; Hermanstyne, Tracey O.; Misonou, Hiroaki			Formation of Heteromeric Kv2 Channels in Mammalian Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC POTASSIUM CHANNELS; K+ CHANNEL; DELAYED RECTIFIER; RAT-BRAIN; ALPHA-SUBUNITS; MODULATION; LOCALIZATIONS; PHOSPHORYLATION; IDENTIFICATION; DETERMINANTS	The formation of heteromeric tetramers is a common feature of voltage-gated potassium (Kv) channels. This results in the generation of a variety of tetrameric Kv channels that exhibit distinct biophysical and biochemical characteristics. Kv2 delayed rectifier channels are, however, unique exceptions. It has been previously shown that mammalian Kv2.1 and Kv2.2 are localized in distinct domains of neuronal membranes and are not capable of forming heteromeric channels with each other (Hwang, P. M., Glatt, C. E., Bredt, D. S., Yellen, G., and Snyder, S. H. (1992) Neuron 8, 473-481). In this study, we report a novel form of rat Kv2.2, Kv2.2(long), which has not been previously recognized. Our data indicate that Kv2.2(long) is the predominant form of Kv2.2 expressed in cortical pyramidal neurons. In contrast to the previous findings, we also found that rat Kv2.1 and Kv2.2(long) are colocalized in the somata and proximal dendrites of cortical pyramidal neurons and are capable of forming functional heteromeric delayed rectifier channels. Our results suggest that the delayed rectifier currents, which regulate action potential firing, are encoded by heteromeric Kv2 channels in cortical neurons.	[Kihira, Yoshitaka; Hermanstyne, Tracey O.; Misonou, Hiroaki] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Hermanstyne, Tracey O.; Misonou, Hiroaki] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Misonou, H (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.	hmisono@umaryland.edu		Misono, Hiroaki/0000-0001-5892-1804	American Heart Association; National Institutes of Health [U24NS050606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association. The University of California Davis/National Institutes of Health NeuroMab Facility is supported by National Institutes of Health Grant U24NS050606.	Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blaine JT, 1998, J NEUROSCI, V18, P9585; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HWANG PM, 1993, J NEUROSCI, V13, P1569; HWANG PM, 1993, NEUROSCIENCE, V55, P613, DOI 10.1016/0306-4522(93)90427-H; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Johnston J, 2008, J PHYSIOL-LONDON, V586, P3493, DOI 10.1113/jphysiol.2008.153734; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Malin SA, 2002, J NEUROSCI, V22, P10094; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1999, J NEUROSCI, V19, P1728; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Trimmer JS, 2001, POTASSIUM CHANNELS IN CARDIOVASCULAR BIOLOGY, P163; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Wray D, 2004, EUR BIOPHYS J BIOPHY, V33, P194, DOI 10.1007/s00249-003-0363-2; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	39	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15048	15055		10.1074/jbc.M109.074260	http://dx.doi.org/10.1074/jbc.M109.074260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202934	Green Published, hybrid			2022-12-27	WOS:000277399000026
J	Li, MX; Zhong, ZY; Zhu, JW; Xiang, DB; Dai, N; Cao, XJ; Qing, Y; Yang, ZZ; Xie, JY; Li, ZP; Baugh, L; Wang, G; Wang, D				Li, Mengxia; Zhong, Zhaoyang; Zhu, Jianwu; Xiang, Debing; Dai, Nan; Cao, Xiaojing; Qing, Yi; Yang, Zhenzhou; Xie, Jiayin; Li, Zengpeng; Baugh, Laura; Wang, Ge; Wang, Dong			Identification and Characterization of Mitochondrial Targeting Sequence of Human Apurinic/Apyrimidinic Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; IMPORT RECEPTORS TOM20; PREPROTEIN TRANSLOCASE; MAMMALIAN-CELLS; REPAIR PROTEIN; DNA-REPAIR; APE1/REF-1; LOCALIZATION; APE/REF-1; REF-1	Dually targeted mitochondrial proteins usually possess an unconventional mitochondrial targeting sequence (MTS), which makes them difficult to predict by current bioinformatics approaches. Human apurinic/apyrimidinic endonuclease (APE1) plays a central role in the cellular response to oxidative stress. It is a dually targeted protein preferentially residing in the nucleus with conditional distribution in the mitochondria. However, the mitochondrial translocation mechanism of APE1 is not well characterized because it harbors an unconventional MTS that is difficult to predict by bioinformatics analysis. Two experimental approaches were combined in this study to identify the MTS of APE1. First, the interactions between the peptides from APE1 and the three purified translocase receptors of the outer mitochondrial membrane (Tom) were evaluated using a peptide array screen. Consequently, the intracellular distribution of green fluorescent protein-tagged, truncated, or mutated APE1 proteins was traced by tag detection. The results demonstrated that the only MTS of APE1 is harbored within residues 289-318 in the C terminus, which is normally masked by the intact N-terminal structure. As a dually targeted mitochondrial protein, APE1 possesses a special distribution pattern of different subcellular targeting signals, the identification of which sheds light on future prediction of MTSs.	[Wang, Dong] Third Mil Med Univ, Ctr Canc, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China; [Xiang, Debing; Li, Zengpeng] Third Mil Med Univ, Daping Hosp, Dept Pathol Res, Inst Surg, Chongqing 400042, Peoples R China; [Baugh, Laura] Univ Dallas, Dept Biol, Irving, TX 75062 USA	Army Medical University; Army Medical University	Wang, D (corresponding author), Third Mil Med Univ, Ctr Canc, Inst Surg Res, Daping Hosp, 10 Changjiang Zhi Rd, Chongqing 400042, Peoples R China.	dongwang64@hotmail.com	Xiang, Debing/AAZ-7727-2020		National Natural Science Foundation of China [30670628]; Natural Science Research Foundation of the Third Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research Foundation of the Third Military Medical University	This work was supported by National Natural Science Foundation of China Grant 30670628 (to D. W.) and by the Natural Science Research Foundation of the Third Military Medical University ( to Z.Z.).	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Li MX, 2008, FREE RADICAL BIO MED, V45, P592, DOI 10.1016/j.freeradbiomed.2008.05.007; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919	29	62	70	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14871	14881		10.1074/jbc.M109.069591	http://dx.doi.org/10.1074/jbc.M109.069591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231292	Green Published, hybrid			2022-12-27	WOS:000277399000008
J	Moriguchi, T; Kezuka, Y; Nonaka, T; Ebizuka, Y; Fujii, I				Moriguchi, Tomomi; Kezuka, Yuichiro; Nonaka, Takamasa; Ebizuka, Yutaka; Fujii, Isao			Hidden Function of Catalytic Domain in 6-Methylsalicylic Acid Synthase for Product Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I POLYKETIDE SYNTHASE; PENICILLIUM-PATULUM; ASPERGILLUS-TERREUS; DIRECTED MUTAGENESIS; GENE-CLUSTER; BIOSYNTHESIS; IDENTIFICATION; THIOESTERASE; SITE; ATX	Functional investigation of the proposed dehydratase domain of ATX, a 6-methylsalicylic acid synthase from Aspergillus terreus, revealed that the domain is not involved in dehydration of the beta-hydroxytriketide intermediate tethered on the acyl carrier protein but catalyzes thioester hydrolysis to release the product from the acyl carrier protein. Thus, we renamed this domain the thioester hydrolase (TH) domain. The intermediate bound to the TH domain of mutant H972A formed in the presence of NADPH was released as 6-methylsalicylic acid by both the intact ATX and by THID (a 541-amino acid region containing TH domain and its downstream) protein, in trans. Furthermore, THID showed a catalytic activity to hydrolyze a model substrate, 6-methylsalicylic acid-N-acetylcysteamine. The TH domain is the first example of a product-releasing domain that is located in the middle of a multidomain iterative type I polyketide synthase. Moreover, it is functionally different from serine protease-type thioesterase domains of iterative type I polyketide synthases.	[Kezuka, Yuichiro; Nonaka, Takamasa; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Iwate Medical University; University of Tokyo	Fujii, I (corresponding author), Iwate Med Univ, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ifujii@iwate-med.ac.jp		Kezuka, Yuichiro/0000-0003-4039-3825	Japan Society for the Promotion of Science [19310139]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research B 19310139 from the Japan Society for the Promotion of Science (to I. F.) and by a Grant-in-aid for Scientific Research on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to I. F.).	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bailey AM, 2007, CHEM COMMUN, P4053, DOI 10.1039/b708614h; BECK J, 1990, EUR J BIOCHEM, V192, P487, DOI 10.1111/j.1432-1033.1990.tb19252.x; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; DIMROTH P, 1970, EUR J BIOCHEM, V13, P98, DOI 10.1111/j.1432-1033.1970.tb00904.x; DIMROTH P, 1976, EUR J BIOCHEM, V68, P591, DOI 10.1111/j.1432-1033.1976.tb10847.x; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Fujii I, 1996, MOL GEN GENET, V253, P1, DOI 10.1007/s004380050289; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Kealey JT, 1998, P NATL ACAD SCI USA, V95, P505, DOI 10.1073/pnas.95.2.505; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Moriguch T, 2008, CHEMBIOCHEM, V9, P1207, DOI 10.1002/cbic.200700691; Moriguchi T, 2006, CHEMBIOCHEM, V7, P1869, DOI 10.1002/cbic.200600235; PAZIRANDEH M, 1991, J BIOL CHEM, V266, P20946; Richardson MT, 1999, METAB ENG, V1, P180, DOI 10.1006/mben.1999.0113; SCOTT AI, 1976, BIOORG CHEM, V3, P238; Shoolingin-Jordan P. M., 1999, COMPREHENSIVE NATURA, P345; SINGH N, 1984, J BIOL CHEM, V259, P3605; SPENCER JB, 1992, BIOCHEM J, V288, P839, DOI 10.1042/bj2880839; SPENCER JB, 1992, BIOCHEMISTRY-US, V31, P9107, DOI 10.1021/bi00152a055; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	35	29	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15637	15643		10.1074/jbc.M110.107391	http://dx.doi.org/10.1074/jbc.M110.107391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304931	Green Published, hybrid			2022-12-27	WOS:000277399000082
J	Ash, MR; Guilfoyle, A; Clarke, RJ; Guss, M; Maher, MJ; Jormakka, M				Ash, Miriam-Rose; Guilfoyle, Amy; Clarke, Ronald J.; Guss, Mitchell; Maher, Megan J.; Jormakka, Mika			Potassium-activated GTPase Reaction in the G Protein-coupled Ferrous Iron Transporter B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SALMONELLA-TYPHIMURIUM; ABC TRANSPORTER; G-DOMAIN; DIMERIZATION; GDP; COMPLEX; FEOB; SUBUNIT	FeoB is a prokaryotic membrane protein responsible for the import of ferrous iron (Fe2+). A defining feature of FeoB is that it includes an N-terminal 30-kDa soluble domain with GTPase activity, which is required for iron transport. However, the low intrinsic GTP hydrolysis rate of this domain appears to be too slow for FeoB either to function as a channel or to possess an active Fe2+ membrane transport mechanism. Here, we present crystal structures of the soluble domain of FeoB from Streptococcus thermophilus in complex with GDP and with the GTP analogue derivative 2'-(or -3')-O-(N-methylanthraniloyl)-beta,gamma-imidoguanosine 5'-triphosphate (mant-GMPPNP). Unlike recent structures of the G protein domain, the mant-GMPPNP-bound structure shows clearly resolved, active conformations of the critical Switch motifs. Importantly, biochemical analyses demonstrate that the GTPase activity of FeoB is activated by K+, which leads to a 20-fold acceleration in its hydrolysis rate. Analysis of the structure identified a conserved asparagine residue likely to be involved in K+ coordination, and mutation of this residue abolished K+-dependent activation. We suggest that this, together with a second asparagine residue that we show is critical for the structure of the Switch I loop, allows the prediction of K+-dependent activation in G proteins. In addition, the accelerated hydrolysis rate opens up the possibility that FeoB might indeed function as an active transporter.	[Guilfoyle, Amy; Maher, Megan J.; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW 2042, Australia; [Ash, Miriam-Rose; Guss, Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Jormakka, Mika] Univ Sydney, Fac Med, Cent Clin Sch, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Sydney	Jormakka, M (corresponding author), Centenary Inst, Struct Biol Program, Locked Bag 6, Sydney, NSW 2042, Australia.	m.jormakka@centenary.org.au	Guss, Jules Mitchell/N-1387-2019; Maher, Megan/B-2239-2012; Clarke, Ronald J/L-5259-2016	Guss, Jules Mitchell/0000-0003-4259-6079; Clarke, Ronald J/0000-0002-0950-8017; Maher, Megan/0000-0003-0848-9640; Ash, Miriam-Rose/0000-0002-0573-9854	National Health and Medical Research Council [570784, 632703]; Australian Government; University of Sydney	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); University of Sydney(University of Sydney)	This work was supported by National Health and Medical Research Council Grants 570784 and 632703 and in part by the Australian Government's Major National Research Facilities program and the University of Sydney.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cachero TG, 1998, CELL, V93, P1077, DOI 10.1016/S0092-8674(00)81212-X; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Guilfoyle A, 2009, EMBO J, V28, P2677, DOI 10.1038/emboj.2009.208; Hattori M, 2009, STRUCTURE, V17, P1345, DOI 10.1016/j.str.2009.08.007; JOHN J, 1993, J BIOL CHEM, V268, P923; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEURY J, 1981, EUR J BIOCHEM, V119, P165, DOI 10.1111/j.1432-1033.1981.tb05589.x; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; MORBACH S, 1993, J BIOL CHEM, V268, P18617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petermann N, 2010, FEBS LETT, V584, P733, DOI 10.1016/j.febslet.2009.12.045; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Schaafsma D, 2008, CELL SIGNAL, V20, P1705, DOI 10.1016/j.cellsig.2008.04.012; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000	43	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14594	14602		10.1074/jbc.M110.111914	http://dx.doi.org/10.1074/jbc.M110.111914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220129	hybrid, Green Published			2022-12-27	WOS:000277299700056
J	Bishop, JR; Foley, E; Lawrence, R; Esko, JD				Bishop, Joseph R.; Foley, Erin; Lawrence, Roger; Esko, Jeffrey D.			Insulin-dependent Diabetes Mellitus in Mice Does Not Alter Liver Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSAMINYL N-DEACETYLASE; GLOMERULAR BASEMENT-MEMBRANE; LDL RECEPTOR; TRANSMEMBRANE DOMAIN; KNOCKOUT MICE; RATS; GLYCOSAMINOGLYCANS; METABOLISM; LIPOPROTEINS; ASSOCIATION	Diabetes-associated hyperlipidemia is generally attributed to reduced clearance of plasma lipoproteins, especially remnant lipoproteins enriched in cholesterol and triglycerides. Hepatic clearance of remnants occurs via low density lipoprotein receptors and the heparan sulfate proteoglycan, syndecan-1. Previous studies have suggested alterations in heparan sulfate proteoglycan metabolism in rat and mouse diabetic models, consistent with the idea that diabetic dyslipidemia might be caused by alterations in proteoglycan expression in the liver. In this study we analyzed the content and composition of liver heparan sulfate in streptozotocin-induced insulin-deficient diabetic mice that displayed fasting hypertriglyceridemia and delayed clearance of dietary triglyceride-rich lipoproteins. No differences between normal and diabetic littermates in liver heparan sulfate content, sulfation, syndecan-1 protein levels, or affinity for heparin-binding ligands, such as apolipoprotein E or fibroblast growth factor-2, were noted. Decreased incorporation of [S-35] sulfate in insulin-deficient mice in vivo was observed, but the decrease was due to increased plasma inorganic sulfate, which reduced the efficiency of labeling of liver heparan sulfate. These results show that hyperlipidemia in insulin-deficient mice is not due to changes in hepatic heparan sulfate composition.	[Bishop, Joseph R.; Foley, Erin; Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Foley, Erin] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [GM33063]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by National Institutes of Health Grant GM33063 (to J.D.E.). This work was also supported by an American Heart Association scientist development grant (to J.R.B.).	ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BARON H, 1976, DIABETES, V25, P509, DOI 10.2337/diabetes.25.6.509; Blazquez-Medela AM, 2010, CURR DIABETES REV, V6, P68, DOI 10.2174/157339910790909422; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; COHEN MP, 1981, J LAB CLIN MED, V98, P715; COHEN MP, 1984, DIABETES, V33, P8, DOI 10.2337/diabetes.33.1.8; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; EBARA T, 1994, METABOLISM, V43, P299, DOI 10.1016/0026-0495(94)90096-5; ESKO JD, 1986, J BIOL CHEM, V261, P5725; FAN MY, 1992, DIABETES METAB, V18, P98; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Goldberg Ronald B., 2003, Cardiology Clinics, V21, P399, DOI 10.1016/S0733-8651(03)00074-2; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Haffner SM, 1998, ENDOCR REV, V19, P583, DOI 10.1210/er.19.5.583; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; KJELLEN L, 1983, DIABETES, V32, P337, DOI 10.2337/diabetes.32.4.337; KOFOEDENEVOLDSEN A, 1992, KIDNEY INT, V41, P763, DOI 10.1038/ki.1992.119; KOFOEDENEVOLDSEN A, 1991, DIABETES, V40, P1449, DOI 10.2337/diabetes.40.11.1449; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEVY E, 1985, BIOCHIM BIOPHYS ACTA, V834, P376, DOI 10.1016/0005-2760(85)90011-6; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; MIETTINEN HM, 1994, J CELL SCI, V107, P1571; Olsson U, 2001, DIABETES, V50, P2126, DOI 10.2337/diabetes.50.9.2126; Oturai P, 1999, EXP CLIN ENDOCR DIAB, V107, P453, DOI 10.1055/s-0029-1212137; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SPIRO MJ, 1987, DIABETOLOGIA, V30, P259, DOI 10.1007/BF00270425; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; UNGER E, 1991, J BIOL CHEM, V266, P8671; van den Born J, 2006, J BIOL CHEM, V281, P29606, DOI 10.1074/jbc.M601552200; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116	36	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14658	14662		10.1074/jbc.M110.112391	http://dx.doi.org/10.1074/jbc.M110.112391			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236939	hybrid, Green Published			2022-12-27	WOS:000277299700063
J	Han, GS; Carman, GM				Han, Gil-Soo; Carman, George M.			Characterization of the Human LPIN1-encoded Phosphatidate Phosphatase Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHY FLD MUTATION; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PHOSPHATIDYLCHOLINE BREAKDOWN; SUBCELLULAR-LOCALIZATION; PARTIAL-PURIFICATION; ACID PHOSPHATASE; LIPID-METABOLISM	The human LPIN1 gene encodes the protein lipin 1, which possesses phosphatidate (PA) phosphatase (3-sn-phosphatidate phosphohydrolase; EC 3.1.3.4) activity (Han, G.-S., Wu, W.-I., and Carman, G. M. (2006) J. Biol. Chem. 281, 9210-9218). In this work, we characterized human lipin 1 alpha, beta, and gamma isoforms that were expressed in Escherichia coli and purified to near homogeneity. PA phosphatase activities of the alpha, beta, and gamma isoforms were dependent on Mg2+ or Mn2+ ions at pH 7.5 at 37 degrees C. The activities were inhibited by concentrations of Mg2+ and Mn2+ above their optimums and by Ca2+, Zn2+, N-ethylmaleimide, propranolol, and the sphingoid bases sphingosine and sphinganine. The activities were thermally labile at temperatures above 40 degrees C. The alpha, beta, and gamma activities followed saturation kinetics with respect to the molar concentration of PA (K-m values of 0.35, 0.24, and 0.11 mM, respectively) but followed positive cooperative (Hill number similar to 2) kinetics with respect to the surface concentration of PA (K-m values of 4.2, 4.5, and 4.3 mol %, respectively) in Triton X-100/PA-mixed micelles. The turnover numbers (k(cat)) for the alpha, beta, and gamma isoforms were 68.8 +/- 3.5, 42.8 +/- 2.5, and 5.7 +/- 0.2 s(-1), respectively, whereas their energy of activation values were 14.2, 15.5, and 18.5 kcal/mol, respectively. The isoform activities were dependent on PA as a substrate and required at least one unsaturated fatty acyl moiety for maximum activity.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-28140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.).	BHAT BG, 1995, BIOCHEMISTRY-US, V34, P11237, DOI 10.1021/bi00035a033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; BUTTERWITH SC, 1984, BIOCHEM J, V220, P825, DOI 10.1042/bj2200825; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Dennis EA, 1983, ENZYMES, P307; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; EXTON JH, 1990, J BIOL CHEM, V265, P1; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSAKA K, 1975, J BIOCHEM-TOKYO, V77, P501, DOI 10.1093/oxfordjournals.jbchem.a130751; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; Noguchi K, 2001, BIOCHEM BIOPH RES CO, V281, P1313, DOI 10.1006/bbrc.2001.4498; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Siess EA, 2005, BIOL CHEM, V386, P1197, DOI 10.1515/BC.2005.137; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tanyi JL, 2003, CANCER RES, V63, P1073; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WU WI, 1993, J BIOL CHEM, V268, P13830; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	65	103	110	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14628	14638		10.1074/jbc.M110.117747	http://dx.doi.org/10.1074/jbc.M110.117747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231281	hybrid, Green Published			2022-12-27	WOS:000277299700060
J	Kashyap, V; Gudas, LJ				Kashyap, Vasundhra; Gudas, Lorraine J.			Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATORS; HISTONE DEACETYLASE COMPLEX; POLYCOMB TARGET GENES; DNA METHYLATION; CO-REPRESSOR; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; HORMONE-RECEPTORS; SIGNALING PATHWAY; CPG ISLANDS	Retinoic acid (RA), a vitamin A metabolite, regulates transcription by binding to RA receptor (RAR) and retinoid X receptor (RXR) heterodimers. This transcriptional response is determined by receptor interactions with transcriptional regulators and chromatin modifying proteins. We compared transcriptional responses of three RA target genes (Hoxa1, Cyp26a1, RAR beta(2)) in primary embryo fibroblasts (mouse embryonic fibroblasts), immortalized fibroblasts (Balb/c3T3), and F9 teratocarcinoma stem cells. Hoxa1 and Cyp26a1 transcripts are not expressed, but RAR beta(2) transcripts are induced by RA in mouse embryonic fibroblasts and Balb/c3T3 cells. Retinoid receptors (RAR gamma, RXR alpha), coactivators (pCIP (NCOA3, SRC3)), and p300 and RNA polymerase II are recruited only to the RAR beta(2) RA response element (RARE) in Balb/c3T3, whereas these proteins are recruited to RAREs of all three genes by RA in F9 cells. In F9, RA reduces polycomb (PcG) protein Suz12 and the associated H3K27me3 repressive epigenetic modification at the RAREs of all three genes. In contrast, in Balb/c3T3 cells cultured in the +/-RA, Suz12 is not associated with the Hoxa1, RAR beta(2), and Cyp26a1 RAREs, whereas low levels of the H3K27me3 mark are seen at these RAREs. Thus, Suz12 is not required for gene repression in the absence of RA. Even though the Hoxa1 RARE and proximal promoter show high levels of H3K9, K14 acetylation in Balb/c3T3, the Hoxa1 gene is not transcriptionally activated by RA. In Balb/c3T3, CpG islands are methylated in the Cyp26a1 promoter region but not in the Hoxa1 promoter or in these promoters in F9 cells. We have delineated the complex mechanisms that control RA-mediated transcription in fibroblasts versus stem cells.	[Kashyap, Vasundhra; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu	Kashyap, Vasundhra/H-8970-2019		National Institutes of Health [R01CA043796]; Department of Defense [W81XWH-08-1-0317]; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043796 ( to L. J. G.).; Supported by Department of Defense Predoctoral Award W81XWH-08-1-0317.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bovenzi V, 1999, ANTI-CANCER DRUG, V10, P471, DOI 10.1097/00001813-199906000-00007; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Cho JH, 2001, ENDOCRINOLOGY, V142, P3389, DOI 10.1210/en.142.8.3389; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Glass CK, 2000, GENE DEV, V14, P121; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Herman JG, 2000, CURR TOP MICROBIOL, V249, P35; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Ivanova T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-4; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kastner P, 1997, DEVELOPMENT, V124, P313; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; Means AL, 1996, CELL GROWTH DIFFER, V7, P989; Missaghian E, 2009, J ENDOCRINOL, V202, P99, DOI 10.1677/JOE-08-0353; MONK M, 1987, DEVELOPMENT, V99, P371; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; SCHRODER EW, 1982, P NATL ACAD SCI-BIOL, V79, P1549, DOI 10.1073/pnas.79.5.1549; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Thompson JR, 1998, DEV DYNAM, V211, P97, DOI 10.1002/(SICI)1097-0177(199801)211:1<97::AID-AJA9>3.3.CO;2-M; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; Wei LN, 2003, ANNU REV PHARMACOL, V43, P47, DOI 10.1146/annurev.pharmtox.43.100901.140301; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yin H, 2000, BLOOD, V95, P111, DOI 10.1182/blood.V95.1.111.001k20_111_119; Zhuang Y, 2003, MOL CANCER RES, V1, P619	88	64	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14534	14548		10.1074/jbc.M110.115345	http://dx.doi.org/10.1074/jbc.M110.115345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231276	Green Published, hybrid			2022-12-27	WOS:000277299700050
J	Schults, MA; Timmermans, L; Godschalk, RW; Theys, J; Wouters, BG; van Schooten, FJ; Chiu, RK				Schults, Marten A.; Timmermans, Leen; Godschalk, Roger W.; Theys, Jan; Wouters, Bradly G.; van Schooten, Frederik J.; Chiu, Roland K.			Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; ARNT TRANSCRIPTION FACTOR; ENDOTHELIAL GROWTH-FACTOR; CARBONIC-ANHYDRASES; SIGNALING PATHWAYS; FACTOR 1-ALPHA; CROSS-TALK; ENOLASE 1; FACTOR-I; EXPRESSION	The hypoxia-inducible factor 1 (HIF-1) pathway is induced in many tumors and associated with poorer outcome. The hypoxia-responsive transcription factor HIF-1 alpha dimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT), which is also an important binding partner for the aryl hydrocarbon receptor (AhR). AhR is an important mediator in the metabolic activation and detoxification of carcinogens, such as the environmental pollutant benzo[a] pyrene (BaP). We hypothesized that HIF-1 alpha activation attenuates BaP-induced AhR-mediated gene expression, which may lead to increased genetic instability and malignant progression. Human lung carcinoma cells (A549) were simultaneously stimulated with CoCl2, which leads to HIF-1 alpha stabilization and varying concentrations of BaP. Both quantitative PCR and immunoblot analysis indicated that induction of the hypoxia response pathway significantly reduced the levels of AhR downstream targets CYP1A1 and CYP1B1 and AhR protein binding to ARNT. We further demonstrate that the BaP-induced hypoxanthine-guanine phosphoribosyltransferase mutation frequency and gamma-H2AX foci were markedly amplified when the HIF-1 pathway was induced. BaP-DNA adducts were only marginally increased, and transient strand breaks were diminished by HIF-1 induction, indicating changes in DNA repair. These data indicate that concurrent exposure of tumor cells to hypoxia and exogenous genotoxins can enhance genetic instability.	[Schults, Marten A.; Timmermans, Leen; Godschalk, Roger W.; van Schooten, Frederik J.; Chiu, Roland K.] Maastricht Univ, Dept Hlth Risk Anal & Toxicol, NUTRIM Res Inst, NL-6200 MD Maastricht, Netherlands; [Theys, Jan] Maastricht Univ, Dept Radiat Oncol MAASTRO, NL-6200 MD Maastricht, Netherlands; [Wouters, Bradly G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5S 1A1, Canada	Maastricht University; Maastricht University; University of Toronto	Chiu, RK (corresponding author), Maastricht Univ, Dept Hlth Risk Anal & Toxicol, NUTRIM Res Inst, POB 616, NL-6200 MD Maastricht, Netherlands.	r.chiu@grat.unimaas.nl	Theys, Jan/K-6685-2015; Wouters, Bradly/T-1525-2017; Theys, Jan/AAI-9211-2021	Wouters, Bradly/0000-0002-8187-592X; Theys, Jan/0000-0002-9718-8251	Province of Limburg, The Netherlands; European Network of Excellence (NoE) [FOOD-CT-2005-513943]	Province of Limburg, The Netherlands(Netherlands Government); European Network of Excellence (NoE)	This work was supported by the Province of Limburg, The Netherlands, and the European Network of Excellence (NoE) "Environmental Cancer, Nutrition and Individual Susceptibility" (ECNIS) Sixth Framework Program (FP6, FOOD-CT-2005-513943).	Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gassmann M, 1997, KIDNEY INT, V51, P567, DOI 10.1038/ki.1997.81; Godschalk RWL, 1998, CARCINOGENESIS, V19, P819, DOI 10.1093/carcin/19.5.819; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jiang BH, 1997, CANCER RES, V57, P5328; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Langie SAS, 2007, DNA REPAIR, V6, P852, DOI 10.1016/j.dnarep.2007.02.012; Lee K, 2006, CHEM RES TOXICOL, V19, P1284, DOI 10.1021/tx060068d; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Nie MH, 2001, ENVIRON TOXICOL PHAR, V10, P17, DOI 10.1016/S1382-6689(01)00065-5; Papp-Szabo E, 2005, INT J CANCER, V116, P679, DOI 10.1002/ijc.21088; Pollenz RS, 1999, MOL PHARMACOL, V56, P1127, DOI 10.1124/mol.56.6.1127; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Ravi R, 2000, GENE DEV, V14, P34; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Reynolds TY, 1996, CANCER RES, V56, P5754; See KY, 2000, MUTAT RES-REV MUTAT, V463, P215, DOI 10.1016/S1383-5742(00)00047-8; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shimada T, 2003, TOXICOL APPL PHARM, V187, P1, DOI 10.1016/S0041-008X(02)00035-2; Takacova M, 2009, BIOCHEM J, V419, P419, DOI 10.1042/BJ20080952; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Wykoff CC, 2000, CANCER RES, V60, P7075; Yuan JL, 2000, CANCER RES, V60, P4372; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhong H, 1999, CANCER RES, V59, P5830; Zundel W, 2000, GENE DEV, V14, P391	40	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14558	14564		10.1074/jbc.M109.076323	http://dx.doi.org/10.1074/jbc.M109.076323			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228066	Green Published, hybrid			2022-12-27	WOS:000277299700052
J	Wang, YK; Zhao, GY; Li, Y; Chen, XL; Xie, BB; Su, HN; Lv, YH; He, HL; Liu, H; Hu, J; Zhou, BC; Zhang, YZ				Wang, Yu-Kai; Zhao, Guo-Yan; Li, Yang; Chen, Xiu-Lan; Xie, Bin-Bin; Su, Hai-Nan; Lv, Yao-Hui; He, Hai-Lun; Liu, Hong; Hu, Jun; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Mechanistic Insight into the Function of the C-terminal PKD Domain of the Collagenolytic Serine Protease Deseasin MCP-01 from Deep Sea Pseudoalteromonas sp SM9913 BINDING OF THE PKD DOMAIN TO COLLAGEN RESULTS IN COLLAGEN SWELLING BUT DOES NOT UNWIND THE COLLAGEN TRIPLE HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; GELATINASE-A; GENE; CONFORMATION; DEGRADATION; EXPRESSION; CHITINASE; BACTERIUM	Deseasin MCP-01 is a bacterial collagenolytic serine protease. Its catalytic domain alone can degrade collagen, and its C-terminal PKD domain is a collagen-binding domain (CBD) that can improve the collagenolytic efficiency of the catalytic domain by an unknown mechanism. Here, scanning electron microscopy (SEM), atomic force microscopy (AFM), zeta potential, and circular dichroism spectroscopy were used to clarify the functional mechanism of the PKD domain in MCP-01 collagenolysis. The PKD domain observably swelled insoluble collagen. Its collagen-swelling ability and its improvement to the collagenolysis of the catalytic domain are both temperature-dependent. SEM observation showed the PKD domain swelled collagen fascicles with an increase of their diameter from 5.3 mu m to 8.8 mu m after 1 h of treatment, and the fibrils forming the fascicles were dispersed. AFM observation directly showed that the PKD domain bound collagen, swelled the microfibrils, and exposed the monomers. The PKD mutant W36A neither bound collagen nor disturbed its structure. Zeta potential results demonstrated that PKD treatment increased the net positive charges of the collagen surface. PKD treatment caused no change in the content or the thermostability of the collagen triple helix. Furthermore, the PKD-treated collagen could not be degraded by gelatinase. Therefore, though the triple helix monomers were exposed, the PKD domain could not unwind the collagen triple helix. Our study reveals the functional mechanism of the PKD domain of the collagenolytic serine protease MCP-01 in collagen degradation, which is distinct from that of the CBDs of mammalian matrix metalloproteases.	[Wang, Yu-Kai; Zhao, Guo-Yan; Li, Yang; Chen, Xiu-Lan; Xie, Bin-Bin; Su, Hai-Nan; He, Hai-Lun; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lv, Yao-Hui; Liu, Hong] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Hu, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China	Shandong University; Shandong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Hong/AAR-8837-2020; Liu, Hong/D-7288-2019	Liu, Hong/0000-0003-1640-9620	National Natural Science Foundation of China [30770040, 50925205]; Hi-Tech Research and Development program of China [2007AA091903]; COMRA Program [DYXM-115-02-2-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); COMRA Program	This work was supported by National Natural Science Foundation of China (30770040 and 50925205), Hi-Tech Research and Development program of China (2007AA091903), and COMRA Program (DYXM-115-02-2-6).	Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; KADLER K, 1994, PROTEIN PROFILE, V1, P519; Kadler KE, 1996, BIOCHEM J, V316, P1; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miyamoto K, 2002, J BACTERIOL, V184, P1865, DOI 10.1128/JB.184.7.1865-1872.2002; Monaco S, 2006, PROTEIN SCI, V15, P2805, DOI 10.1110/ps.062430706; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Oda K, 1996, J BIOCHEM, V120, P564; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Poenitzsch VZ, 2006, MICROSC MICROANAL, V12, P221, DOI 10.1017/S1431927606060314; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Usha R, 2002, J APPL POLYM SCI, V84, P975, DOI 10.1002/app.10262; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	33	35	37	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14285	14291		10.1074/jbc.M109.087023	http://dx.doi.org/10.1074/jbc.M109.087023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207733	Green Published, hybrid			2022-12-27	WOS:000277299700025
J	Byeon, IJL; Dao, KK; Jung, JW; Keen, J; Leiros, I; Doskeland, SO; Martinez, A; Gronenborn, AM				Byeon, In-Ja L.; Dao, Khanh K.; Jung, Jinwon; Keen, Jeffrey; Leiros, Ingar; Doskeland, Stein O.; Martinez, Aurora; Gronenborn, Angela M.			Allosteric Communication between cAMP Binding Sites in the RI Subunit of Protein Kinase A Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; PHYSIOLOGICAL CONDITIONS; DEPENDENT ACTIVATION; CYCLIC-NUCLEOTIDES; CATALYTIC SUBUNITS; ALPHA SUBUNIT; PKA; MECHANISM; HOLOENZYME; MUTATIONS	The activation of protein kinase A involves the synergistic binding of cAMP to two cAMP binding sites on the inhibitory R subunit, causing release of the C subunit, which subsequently can carry out catalysis. We used NMR to structurally characterize in solution the RI alpha-(98-381) subunit, a construct comprising both cyclic nucleotide binding (CNB) domains, in the presence and absence of cAMP, and map the effects of cAMP binding at single residue resolution. Several conformationally disordered regions in free RI alpha become structured upon cAMP binding, including the interdomain alpha C:A and alpha C':A helices that connect CNB domains A and B and are primary recognition sites for the C subunit. NMR titration experiments with cAMP, B site-selective 2-Cl-8-hexylamino-cAMP, and A site-selective N-6-monobutyryl-cAMP revealed that cyclic nucleotide binding to either the B or A site affected the interdomain helices. The NMR resonances of this interdomain region exhibited chemical shift changes upon ligand binding to a single site, either site B or A, with additional changes occurring upon binding to both sites. Such distinct, stepwise conformational changes in this region reflect the synergistic interplay between the two sites and may underlie the positive cooperativity of cAMP activation of the kinase. Furthermore, nucleotide binding to the A site also affected residues within the B domain. The present NMR study provides the first structural evidence of unidirectional allosteric communication between the sites. Trp(262), which lines the CNB A site but resides in the sequence of domain B, is an important structural determinant for intersite communication.	[Dao, Khanh K.; Keen, Jeffrey; Doskeland, Stein O.; Martinez, Aurora] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Byeon, In-Ja L.; Jung, Jinwon; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Leiros, Ingar] Univ Tromso, Dept Chem, Norwegian Struct Biol Ctr Norstruct, N-9037 Tromso, Norway	University of Bergen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UiT The Arctic University of Tromso	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no; amg100@pitt.edu	Leiros, Ingar/AAM-2940-2020; Martinez, Aurora/M-3088-2019; Jung, Jinwon/F-6038-2010	Martinez, Aurora/0000-0003-1643-6506; Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525; Leiros, Ingar/0000-0001-9333-4541; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway (RCN), Helse-Vest; Norwegian Cancer Society; Commonwealth of Pennsylvania [SAP 4100026429]; RCN	Research Council of Norway (RCN), Helse-Vest(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Commonwealth of Pennsylvania; RCN	This work was supported by grants from The Research Council of Norway (RCN), Helse-Vest, and the Norwegian Cancer Society (to A. M. and S. O. D.) and Commonwealth of Pennsylvania Grant SAP 4100026429 (to A. M. G.). NorStruct is supported by a grant from the National Program in Functional Genomics of the RCN.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BUILDER SE, 1980, J BIOL CHEM, V255, P3514; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; Christensen A.E., 2003, HDB CELL SIGNALING, P549; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; GOSSE ME, 1994, BIOCHEM J, V297, P79, DOI 10.1042/bj2970079; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hahnefeld C, 2005, BIOL CHEM, V386, P623, DOI 10.1515/BC.2005.073; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HOUGE G, 1990, J BIOL CHEM, V265, P19507; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; OGREID D, 1982, FEBS LETT, V150, P161, DOI 10.1016/0014-5793(82)81326-4; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; RINGHEIM GE, 1990, J BIOL CHEM, V265, P19472; ROSEN OM, 1975, J BIOL CHEM, V250, P7788; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022	46	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14062	14070		10.1074/jbc.M110.106666	http://dx.doi.org/10.1074/jbc.M110.106666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197278	Green Published, hybrid			2022-12-27	WOS:000276987700079
J	Chevalier, C; Al Bazzal, A; Vidic, J; Fevrier, V; Bourdieu, C; Bouguyon, E; Le Goffic, R; Vautherot, JF; Bernard, J; Moudjou, M; Noinville, S; Chich, JF; Da Costa, B; Rezaei, H; Delmas, B				Chevalier, Christophe; Al Bazzal, Ali; Vidic, Jasmina; Fevrier, Vincent; Bourdieu, Christiane; Bouguyon, Edwige; Le Goffic, Ronan; Vautherot, Jean-Francois; Bernard, Julie; Moudjou, Mohammed; Noinville, Sylvie; Chich, Jean-Francois; Da Costa, Bruno; Rezaei, Human; Delmas, Bernard			PB1-F2 Influenza A Virus Protein Adopts a beta-Sheet Conformation and Forms Amyloid Fibers in Membrane Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; MITOCHONDRIAL PROTEIN; MISFOLDING DISEASES; ALZHEIMERS-DISEASE; UNFOLDED PROTEINS; THIOFLAVINE-T; PEPTIDES; BINDING; DOMAIN; GENE	The influenza A virus PB1-F2 protein, encoded by an alternative reading frame in the PB1 polymerase gene, displays a high sequence polymorphism and is reported to contribute to viral pathogenesis in a sequence-specific manner. To gain insights into the functions of PB1-F2, the molecular structure of several PB1-F2 variants produced in Escherichia coli was investigated in different environments. Circular dichroism spectroscopy shows that all variants have a random coil secondary structure in aqueous solution. When incubated in trifluoroethanol polar solvent, all PB1-F2 variants adopt an alpha-helix-rich structure, whereas incubated in acetonitrile, a solvent of medium polarity mimicking the membrane environment, they display beta-sheet secondary structures. Incubated with asolectin liposomes and SDS micelles, PB1-F2 variants also acquire a beta-sheet structure. Dynamic light scattering revealed that the presence of beta-sheets is correlated with an oligomerization/aggregation of PB1-F2. Electron microscopy showed that PB1-F2 forms amorphous aggregates in acetonitrile. In contrast, at low concentrations of SDS, PB1-F2 variants exhibited various abilities to form fibers that were evidenced as amyloid fibers in a thioflavin T assay. Using a recombinant virus and its PB1-F2 knock-out mutant, we show that PB1-F2 also forms amyloid structures in infected cells. Functional membrane permeabilization assays revealed that the PB1-F2 variants can perforate membranes at nanomolar concentrations but with activities found to be sequence-dependent and not obviously correlated with their differential ability to form amyloid fibers. All of these observations suggest that PB1-F2 could be involved in physiological processes through different pathways, permeabilization of cellular membranes, and amyloid fiber formation.	[Chevalier, Christophe; Al Bazzal, Ali; Vidic, Jasmina; Fevrier, Vincent; Bourdieu, Christiane; Bouguyon, Edwige; Le Goffic, Ronan; Bernard, Julie; Moudjou, Mohammed; Noinville, Sylvie; Chich, Jean-Francois; Da Costa, Bruno; Rezaei, Human; Delmas, Bernard] INRA, Ctr Rech Jouy En Josas, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France; [Vautherot, Jean-Francois] INRA, Unite Infectiol Anim & Sante Publ, UR1282, Ctr Tours, F-37380 Nouzilly, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Chevalier, C (corresponding author), INRA Jouy En Josas, Ctr Rech, Equipe Virus Influenza, Unite VIM, Batiment 440, F-78350 Jouy En Josas, France.	christophe.chevalier@jouy.inra.fr	LE GOFFIC, Ronan/B-7649-2008; Chevalier, Christophe/AAW-5560-2020; LE GOFFIC, Ronan/M-3099-2019; Vidic, Jasmina/AFP-6747-2022; Noinville, Sylvie/S-8318-2019; Chevalier, Christophe/AAK-4461-2020; Chevalier, Christophe/C-2575-2009; Noinville, Sylvie/B-1086-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Vidic, Jasmina/0000-0002-8549-8199; Noinville, Sylvie/0000-0002-8320-9488; Chevalier, Christophe/0000-0003-3231-9027; 				BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chang DK, 1997, J VIROL, V71, P6593, DOI 10.1128/JVI.71.9.6593-6602.1997; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Freire E, 2008, PROTEINS, V70, P450, DOI 10.1002/prot.21580; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Henklein P, 2005, J PEPT SCI, V11, P481, DOI 10.1002/psc.641; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; KAMLET MJ, 1977, J AM CHEM SOC, V99, P6027, DOI 10.1021/ja00460a031; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Lashuel HA., 2005, SCI AGING KNOWLEDGE; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Najbar LV, 1997, BIOCHEMISTRY-US, V36, P11525, DOI 10.1021/bi970730s; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Pancucharova H, 2006, ACTA VIROL, V50, P269; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Roder R, 2008, J PEPT SCI, V14, P954, DOI 10.1002/psc.1031; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zell R, 2006, EMERG INFECT DIS, V12, P1607, DOI 10.3201/eid1210.060511; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	56	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13233	13243		10.1074/jbc.M109.067710	http://dx.doi.org/10.1074/jbc.M109.067710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172856	Green Published, hybrid			2022-12-27	WOS:000276787800078
J	Guo, SL; Vanderford, NL; Stein, R				Guo, Shuangli; Vanderford, Nathan L.; Stein, Roland			Phosphorylation within the MafA N Terminus Regulates C-terminal Dimerization and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZIP TRANSCRIPTION FACTOR; PANCREATIC BETA-CELLS; LEUCINE-ZIPPER; IN-VIVO; INSULIN-SECRETION; SEGMENTATION GENE; CRYSTAL-STRUCTURE; BASIC DOMAIN; DIFFERENTIATION; EXPRESSION	Phosphorylation regulates transcription factor activity by influencing dimerization, cellular localization, activation potential, and/or DNA binding. Nevertheless, precisely how this post-translation modification mediates these processes is poorly understood. Here, we examined the role of phosphorylation on the DNA-binding properties of MafA and MafB, closely related transcriptional activators of the basic-leucine zipper (b-Zip) family associated with cell differentiation and oncogenesis. Many common phosphorylation sites were identified by mass spectrometry. However, dephosphorylation only precluded the detection of MafA dimers and consequently dramatically reduced DNA-binding ability. Analysis of MafA/B chimeras revealed that sensitivity to the phosphorylation status of MafA was imparted by sequences spanning the C-terminal dimerization region (amino acids (aa) 279-359), whereas the homologous MafB region (aa 257-323) conveyed phosphorylation-independent DNA binding. Mutational analysis showed that formation of MafA dimers capable of DNA binding required phosphorylation within the distinct N-terminal transactivation domain (aa 1-72) and not the C-terminal b-Zip region. These results demonstrate a novel relationship between the phosphoamino acid-rich transactivation and b-Zip domains in controlling MafA DNA-binding activity.	[Guo, Shuangli; Vanderford, Nathan L.; Stein, Roland] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	roland.stein@vanderbilt.edu			National Institutes of Health [P01 DK42502]; Diabetes and Endocrinology [5T32 DK007061-34]; Juvenile Diabetes Foundation Postdoctoral Training [3-2009-555]; Vanderbilt University Diabetes Research [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007061, P01DK042502, P60DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology; Juvenile Diabetes Foundation Postdoctoral Training; Vanderbilt University Diabetes Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK42502 (to R. S.). This work was also supported by Postdoctoral Research Training Grant in Diabetes and Endocrinology 5T32 DK007061-34 (to N. L. V.), Juvenile Diabetes Foundation Postdoctoral Training Grant 3-2009-555 (to S. G.), and the Vanderbilt University Diabetes Research and Training Center Molecular Biology Core Laboratory (Public Health Service Grant P60 DK20593).	Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2008, J ENDOCRINOL, V198, P271, DOI 10.1677/JOE-08-0063; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Benkhelifa S, 1998, ONCOGENE, V17, P247, DOI 10.1038/sj.onc.1201898; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Ferdous A, 2008, MOL BIOSYST, V4, P1116, DOI 10.1039/b809291e; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kurokawa H, 2009, MOL CELL BIOL, V29, P6232, DOI 10.1128/MCB.00708-09; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matsuoka T, 2001, J BIOL CHEM, V276, P22071, DOI 10.1074/jbc.M010321200; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsushima-Hibiya Y, 1998, BIOCHEM BIOPH RES CO, V245, P412, DOI 10.1006/bbrc.1998.8447; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Muniappan Latha, 2007, BMC Physiology, V7, P11, DOI 10.1186/1472-6793-7-11; Murakami YI, 2007, AM J SURG PATHOL, V31, P1695, DOI 10.1097/PAS.0b013e318054dbcf; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Nishizawa M, 2003, ONCOGENE, V22, P7882, DOI 10.1038/sj.onc.1206526; Nomura S, 2006, BIOCHEM BIOPH RES CO, V349, P136, DOI 10.1016/j.bbrc.2006.08.032; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; Sehgal PB, 2000, CELL SIGNAL, V12, P525, DOI 10.1016/S0898-6568(00)00098-X; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Song YD, 2007, BIOCHEM BIOPH RES CO, V354, P334, DOI 10.1016/j.bbrc.2006.12.216; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	53	20	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12655	12661		10.1074/jbc.M110.105759	http://dx.doi.org/10.1074/jbc.M110.105759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20208071	Green Published, hybrid			2022-12-27	WOS:000276787800024
J	Hoshino, T; Matsuda, M; Yamashita, Y; Takehara, M; Fukuya, M; Mineda, K; Maji, D; Ihn, H; Adachi, H; Sobue, G; Funasaka, Y; Mizushima, T				Hoshino, Tatsuya; Matsuda, Minoru; Yamashita, Yasuhiro; Takehara, Masaya; Fukuya, Masayo; Mineda, Kazutaka; Maji, Daisuke; Ihn, Hironobu; Adachi, Hiroaki; Sobue, Gen; Funasaka, Yoko; Mizushima, Tohru			Suppression of Melanin Production by Expression of HSP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INDUCED GASTRIC-LESIONS; HUMAN SKIN PIGMENTATION; CELL-LINE; IN-VITRO; ULTRAVIOLET-RADIATION; GENETIC-EVIDENCE; EXCISION-REPAIR; INDUCED COLITIS; PROTECTIVE ROLE	Skin hyperpigmentation disorders due to abnormal melanin production induced by ultraviolet (UV) irradiation are both a clinical and cosmetic problem. UV irradiation stimulates melanin production in melanocytes by increasing intracellular cAMP. Expression of heat shock proteins (HSPs), especially HSP70, is induced by various stressors, including UV irradiation, to provide cellular resistance to such stressors. In this study we examined the effect of expression of HSP70 on melanin production both in vitro and in vivo. 3-Isobutyl-1-methylxanthine (IBMX), a cAMP-elevating agent, stimulated melanin production in cultured mouse melanoma cells, and this stimulation was suppressed in cells overexpressing HSP70. IBMX-dependent transcriptional activation of the tyrosinase gene was also suppressed in HSP70-overexpressing cells. Expression of microphthalmia-associated transcription factor (MITF), which positively regulates transcription of the tyrosinase gene, was up-regulated by IBMX; however, this up-regulation was not suppressed in HSP70-overexpressing cells. On the other hand, immunoprecipitation and immunostaining analyses revealed a physical interaction between and co-localization of MITF and HSP70, respectively. Furthermore, the transcription of tyrosinase gene in nuclear extract was inhibited by HSP70. In vivo, UV irradiation of wild-type mice increased the amount of melanin in the basal layer of the epidermis, and this increase was suppressed in transgenic mice expressing HSP70. This study provides the first evidence of an inhibitory effect of HSP70 on melanin production both in vitro and in vivo. This effect seems to be mediated by modulation of MITF activity through a direct interaction between HSP70 and MITF.	[Hoshino, Tatsuya; Matsuda, Minoru; Yamashita, Yasuhiro; Takehara, Masaya; Fukuya, Masayo; Ihn, Hironobu; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Mineda, Kazutaka; Maji, Daisuke] Saishunkan Pharmaceut Co Ltd, Kumamoto 8612201, Japan; [Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Funasaka, Yoko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kumamoto University; Nagoya University; Kobe University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020	Adachi, Hiroaki/0000-0002-9302-4663	Ministry of Health, Labour, and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labour, and Welfare of Japan as well as the Japan Science and Technology Agency and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Allanson M, 2004, J INVEST DERMATOL, V122, P1030, DOI 10.1111/j.0022-202X.2004.22421.x; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ito T, 2005, BRIT J DERMATOL, V152, P623, DOI 10.1111/j.1365-2133.2005.06453.x; Jonak C., 2006, International Journal of Cosmetic Science, V28, P233, DOI 10.1111/j.1467-2494.2006.00327.x; Kim DS, 2007, ARCH PHARM RES, V30, P581, DOI 10.1007/BF02977652; Kim DS, 2005, CELL SIGNAL, V17, P1023, DOI 10.1016/j.cellsig.2004.11.020; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; Kimura K, 2007, J BIOL CHEM, V282, P5910, DOI 10.1074/jbc.M609025200; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lei TC, 2002, ANAL BIOCHEM, V305, P260, DOI 10.1006/abio.2002.5665; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; MAYTIN EV, 1994, J INVEST DERMATOL, V103, P547, DOI 10.1111/1523-1747.ep12396274; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; Murakami M, 2007, MOL CELL BIOCHEM, V303, P251, DOI 10.1007/s11010-007-9474-x; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Park HY, 2006, BIOCHEM J, V395, P571, DOI 10.1042/BJ20051388; Park KC, 2000, ARCH DERMATOL RES, V292, P482, DOI 10.1007/s004030000173; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Rattan SIS, 1998, BIOCHEM MOL BIOL INT, V45, P753; Shorrocks J, 2008, J INVEST DERMATOL, V128, P685, DOI 10.1038/sj.jid.5701037; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Takehara M, 2008, BIOCHEM J, V413, P535, DOI 10.1042/BJ20070484; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, J INVEST DERMATOL, V105, P160, DOI 10.1111/1523-1747.ep12317003; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; YAMASHITA Y, 2010, EXP DERMATO IN PRESS; Yang JY, 2006, ACTA PHARMACOL SIN, V27, P1467, DOI 10.1111/j.1745-7254.2006.00435.x; Zou Y, 1998, J BIOL CHEM, V273, P12887, DOI 10.1074/jbc.273.21.12887	62	36	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13254	13263		10.1074/jbc.M110.103051	http://dx.doi.org/10.1074/jbc.M110.103051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177067	Green Published, hybrid			2022-12-27	WOS:000276787800080
J	Wei, Z; Liu, CD; Wu, X; Xu, NN; Zhou, B; Liang, C; Zhu, G				Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang			Characterization and Structure Determination of the Cdt1 Binding Domain of Human Minichromosome Maintenance (Mcm) 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DNA-REPLICATION; PROTEIN STRUCTURES; CHEMICAL-SHIFT; NMR; COMPLEXES; INITIATION; CEREVISIAE; RESTRAINTS; DATABASE	The minichromosome maintenance (Mcm) 2-7 complex is the replicative helicase in eukaryotic species, and it plays essential roles in the initiation and elongation phases of DNA replication. During late M and early G1, the Mcm 2-7 complex is loaded on to chromatin to form prereplicative complex in a Cdt1-dependent manner. However, the detailed molecular mechanism of this loading process is still elusive. In this study, we demonstrate that the previously uncharacterized Cterminal domain of human Mcm6 is the Cdt1 binding domain (CBD) and present its high resolution NMR structure. The structure of CBD exhibits a typical "winged helix" fold that is generally involved in protein-nucleic acid interaction. Nevertheless, the CBD failed to interact with DNA in our studies, indicating that it is specific for proteinprotein interaction. The CBD-Cdt1 interaction involves the helix-turn-helix motif of CBD. The results reported here provide insight into the molecular mechanism of Mcm2-7 chromatin loading and prereplicative complex assembly.	[Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Wei, Zhun; Liu, Changdong] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Wei, Zhun; Liu, Changdong] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang] Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; East China Normal University; East China Normal University; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk; gzhu@ust.hk	WEI, ZHUN/AAT-9380-2020	Zhou, Bo/0000-0002-7856-029X; LIU, Changdong/0000-0001-7356-9765	Hong Kong Research Grants Council [HKUST6436/06M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by a grant from the Hong Kong Research Grants Council (Grant HKUST6436/06M to G. Z. and C. L.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brunger A.T., 2001, CRYSTALLOGRAPHY NMR; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Goddard T. D, 2007, SPARKY 3; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai Hisao, 1999, Frontiers in Bioscience, V4, pd834, DOI 10.2741/Masai; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Neuwald AF, 1999, GENOME RES, V9, P27; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Teer JK, 2008, J BIOL CHEM, V283, P6817, DOI 10.1074/jbc.M708767200; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L; 2006, J AM CHEM SOC, V128, P7566	46	38	39	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12469	12473		10.1074/jbc.C109.094599	http://dx.doi.org/10.1074/jbc.C109.094599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20202939	Green Published, hybrid			2022-12-27	WOS:000276787800002
J	Swift, S; Xu, J; Trivedi, V; Austin, KM; Tressel, SL; Zhang, L; Covic, L; Kuliopulos, A				Swift, Steven; Xu, Jian; Trivedi, Vishal; Austin, Karyn M.; Tressel, Sarah L.; Zhang, Lei; Covic, Lidija; Kuliopulos, Athan			A Novel Protease-activated Receptor-1 Interactor, Bicaudal D1, Regulates G Protein Signaling and Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN RECEPTOR; BETA-ARRESTINS; DOWN-REGULATION; PAR1; TERMINATION; KINASE; DYNEIN; DESENSITIZATION; INHIBITION; MECHANISM	Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor that plays critical roles in cancer, angiogenesis, inflammation, and thrombosis. Proteolytic cleavage of the extracellular domain of PAR1 generates a tethered ligand that activates PAR1 in an unusual intramolecular mode. The signal emanating from the irreversibly cleaved PAR1 is terminated by G protein uncoupling and internalization; however, the mechanisms of PAR1 signal shut off still remain unclear. Using a yeast two-hybrid screen, we identified Bicaudal D1 (BicD1) as a direct interactor with the C-terminal cytoplasmic domain of PAR1. BICD was originally identified as an essential developmental gene associated with mRNA and Golgi-endoplasmic reticulum transport. We discovered a novel function of BicD1 in the modulation of G protein signaling, cell proliferation, and endocytosis downstream of PAR1. BicD1 and its C-terminal CC3 domain inhibited PAR1 signaling to G(q)-phospholipase C-beta through coiled-coil interactions with the cytoplasmic 8th helix of PAR1. Unexpectedly, BicD1 was also found to be a potent suppressor of PAR1-driven proliferation of breast carcinoma cells. The growth-suppressing effects of BicD1 required the ability to interact with the 8th helix of PAR1. Silencing of BicD1 expression impaired endocytosis of PAR1, and BicD1 co-localized with PAR1 and tubulin, implicating BicD1 as an important adapter protein involved in the transport of PAR1 from the plasma membrane to endosomal vesicles. Together, these findings provide a link between PAR1 signal termination and internalization through the non-G protein effector, BicD1.	[Kuliopulos, Athan] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Box 7510,750 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		Swift, Steven/0000-0002-3840-4401	National Institutes of Health [F32 HL10296, T32 CA65441, R01-HL64701, R01-CA122992, R01-HL57905]; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA122992, T32CA065441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057905, R01HL064701, F32HL010296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 HL10296 (to S. S.), T32 CA65441 (to L.Z.), and R01-HL64701, R01-CA122992, and R01-HL57905 (to A. K.). This work was also supported by the Susan G. Komen Breast Cancer Foundation (A. K.).	Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Houalla T, 2005, MECH DEVELOP, V122, P97, DOI 10.1016/j.mod.2004.08.005; ISHII K, 1994, J BIOL CHEM, V269, P1125; Kamath L, 2001, CANCER RES, V61, P5933; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Luttrell LM, 2002, J CELL SCI, V115, P455; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rothwell SW, 1997, THROMB HAEMOSTASIS, V78, P910; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VanObberghenSchilling E, 1995, ANN NY ACAD SCI, V766, P431, DOI 10.1111/j.1749-6632.1995.tb26692.x; VOURETCRAVIARI V, 1992, MOL BIOL CELL, V3, P95, DOI 10.1091/mbc.3.1.95; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; Zain J, 2000, BLOOD, V95, P3133	40	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11402	11410		10.1074/jbc.M110.105403	http://dx.doi.org/10.1074/jbc.M110.105403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164183	Green Published, hybrid			2022-12-27	WOS:000276286200046
J	Abbassi, F; Lequin, O; Piesse, C; Goasdoue, N; Foulon, T; Nicolas, P; Ladram, A				Abbassi, Feten; Lequin, Olivier; Piesse, Christophe; Goasdoue, Nicole; Foulon, Thierry; Nicolas, Pierre; Ladram, Ali			Temporin-SHf, a New Type of Phe-rich and Hydrophobic Ultrashort Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; THERMOTROPIC PHASE-BEHAVIOR; PHOSPHOLIPID-MEMBRANES; BIOLOGICAL-ACTIVITY; AROMATIC RESIDUES; MOLECULAR-CLONING; NMR-SPECTROSCOPY; SKIN SECRETIONS; DERMASEPTIN B2; LIPID-BILAYERS	Because issues of cost and bioavailability have hampered the development of gene-encoded antimicrobial peptides to combat infectious diseases, short linear peptides with high microbial cell selectivity have been recently considered as antibiotic substitutes. A new type of short antimicrobial peptide, designated temporin-SHf, was isolated and cloned from the skin of the frog Pelophylax saharica. Temporin-SHf has a highly hydrophobic sequence (FFFLSRIFa) and possesses the highest percentage of Phe residues of any known peptide or protein. Moreover, it is the smallest natural linear antimicrobial peptide found to date, with only eight residues. Despite its small size and hydrophobicity, temporin-SHf has broad-spectrum microbicidal activity against Gram-positive and Gram-negative bacteria and yeasts, with no hemolytic activity. CD and NMR spectroscopy combined with restrained molecular dynamics calculations showed that the peptide adopts a well defined non-amphipathic alpha-helical structure from residue 3 to 8, when bound to zwitterionic dodecyl phosphocholine or anionic SDS micelles. Relaxation enhancement caused by paramagnetic probes showed that the peptide adopts nearly parallel orientations to the micelle surface and that the helical structure is stabilized by a compact hydrophobic core on one face that penetrates into the micelle interior. Differential scanning calorimetry on multilamellar vesicles combined with membrane permeabilization assays on bacterial cells indicated that temporin-SHf disrupts the acyl chain packing of anionic lipid bilayers, thereby triggering local cracks and microbial membrane disintegration through a detergent-like effect probably via the carpet mechanism. The short length, compositional simplicity, and broad-spectrum activity of temporin-SHf make it an attractive candidate to develop new antibiotic agents.	[Ladram, Ali] Univ Paris 06, Biogenese Signaux Peptid ER3, F-75005 Paris, France; [Lequin, Olivier; Goasdoue, Nicole] Univ Paris 06, CNRS, Unite Mixte Rech 7203, Lab Biomol, F-75005 Paris, France; [Piesse, Christophe] Univ Paris 06, IFR Plate Forme Ingn Prot & Synth Peptid 83, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Ladram, A (corresponding author), Univ Paris 06, ER3, Batiment A,5 Eme Etage,Case Courier 29,7 Quai St, F-75005 Paris, France.	ali.ladram@upmc.fr	Nicolas, Pierre/C-7908-2009	LEQUIN, Olivier/0000-0001-5307-3068	Universite Pierre et Marie Curie	Universite Pierre et Marie Curie	This work was supported by grants from the Universite Pierre et Marie Curie. The nucleotide sequence(s) reported in this paper has been submitted to the GenBank (TM)/EBI Data Bank with accession number(s) FN557009, FN557010, FN557011, FN557012, and FN557013.	Abbassi F, 2008, PEPTIDES, V29, P1526, DOI 10.1016/j.peptides.2008.05.008; Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Amiche M, 1999, FEBS LETT, V456, P352, DOI 10.1016/S0014-5793(99)00964-3; Amiche M, 2008, PEPTIDES, V29, P2074, DOI 10.1016/j.peptides.2008.06.017; Banerjee R, 2002, FEBS LETT, V523, P152, DOI 10.1016/S0014-5793(02)02974-5; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; Conlon JM, 2008, PEPTIDES, V29, P1815, DOI 10.1016/j.peptides.2008.05.029; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HARWIG SSL, 1995, FEBS LETT, V362, P65, DOI 10.1016/0014-5793(95)00210-Z; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Marenah L, 2006, J ENDOCRINOL, V188, P1, DOI 10.1677/joe.1.06293; MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3; MOR A, 1994, J BIOL CHEM, V269, P1934; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SIMMACO M, 1994, J BIOL CHEM, V269, P11956; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; Thrippleton MJ, 2003, ANGEW CHEM INT EDIT, V42, P3938, DOI 10.1002/anie.200351947; van Kan EJM, 2003, BBA-BIOMEMBRANES, V1615, P84, DOI 10.1016/S0005-2736(03)00233-5; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Woody R. W., 1992, ADV BIOPHYS CHEM, V2, P37; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	51	64	70	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16880	16892		10.1074/jbc.M109.097204	http://dx.doi.org/10.1074/jbc.M109.097204			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308076	Green Published, hybrid			2022-12-27	WOS:000277982600052
J	Spanaki, C; Zaganas, I; Kleopa, KA; Plaitakis, A				Spanaki, Cleanthe; Zaganas, Ioannis; Kleopa, Kleopas A.; Plaitakis, Andreas			Human GLUD2 Glutamate Dehydrogenase Is Expressed in Neural and Testicular Supporting Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC GLUD2; SERTOLI-CELLS; NEUROLOGICAL DISORDERS; HUMAN-LIVER; EVOLUTION; MITOCHONDRIA; METABOLISM; ASTROCYTES; MECHANISMS; GENE	Mammalian glutamate dehydrogenase (GDH) is an allosterically regulated enzyme that is expressed widely. Its activity is potently inhibited by GTP and thought to be controlled by the need of the cell for ATP. In addition to this housekeeping human (h) GDH1, humans have acquired (via a duplication event) a highly homologous isoenzyme (hGDH2) that is resistant to GTP. Although transcripts of GLUD2, the gene encoding hGDH2, have been detected in human neural and testicular tissues, data on the endogenous protein are lacking. Here, we developed an antibody specific for hGDH2 and used it to study human tissues. Western blot analyses revealed, to our surprise, that endogenous hGDH2 is more densely expressed in testis than in brain. At the subcellular level, hGDH2 localized to mitochondria. Study of testicular tissue using immunocytochemical and immunofluorescence methods revealed that the Sertoli cells were strongly labeled by our anti-hGDH2 antibody. In human cerebral cortex, a robust labeling of astrocytes was detected, with neurons showing faint hGDH2 immunoreactivity. Astrocytes and Sertoli cells are known to support neurons and germ cells, respectively, providing them with lactate that largely derives from the tricarboxylic acid cycle via conversion of glutamate to alpha-ketoglutarate (GDH reaction). As hGDH2 is not subject to GTP control, the enzyme is able to metabolize glutamate even when the tricarboxylic acid cycle generates GTP amounts sufficient to inactivate the housekeeping hGDH1 protein. Hence, the selective expression of hGDH2 by astrocytes and Sertoli cells may provide a significant biological advantage by facilitating metabolic recycling processes essential to the supportive role of these cells.	Univ Crete, Dept Neurol, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece; [Kleopa, Kleopas A.] Cyprus Inst Neurol & Genet, Neurosci Lab, CY-1683 Nicosia, Cyprus; [Kleopa, Kleopas A.] Cyprus Inst Neurol & Genet, Neurol Clin, CY-1683 Nicosia, Cyprus	University of Crete		plaitak@med.uoc.gr	Zaganas, Ioannis/AAE-5441-2020	Zaganas, Ioannis/0000-0002-0774-5772; Kleopa, Kleopas/0000-0002-4103-8094	Association for Research and Treatment of Neurologic Disorders of Crete; Cyprus Research Promotion Foundation	Association for Research and Treatment of Neurologic Disorders of Crete; Cyprus Research Promotion Foundation	This work was supported by grants from the Association for Research and Treatment of Neurologic Disorders of Crete (EY ZHN) and by the Cyprus Research Promotion Foundation (to K.A.K.).	AUMULLER G, 1988, ANAT EMBRYOL, V178, P129, DOI 10.1007/BF02463646; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Choi SY, 1999, J NEUROCHEM, V72, P2162, DOI 10.1046/j.1471-4159.1999.0722162.x; CLARK JB, 1970, J BIOL CHEM, V245, P4724; ERECINSKA M, 1990, J NEUROCHEM, V54, P1335, DOI 10.1111/j.1471-4159.1990.tb01967.x; Fawcett D W, 1973, Adv Biosci, V10, P83; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; GRISWOLD MD, 1977, MOL CELL ENDOCRINOL, V7, P151, DOI 10.1016/0303-7207(77)90064-8; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; HUSSAIN MM, 1989, J BIOL CHEM, V264, P20730; Hutson SM, 1998, J NEUROCHEM, V71, P863; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; Kanavouras K, 2007, J NEUROSCI RES, V85, P1101, DOI 10.1002/jnr.21197; Kanavouras K, 2009, J NEUROCHEM, V109, P167, DOI 10.1111/j.1471-4159.2009.05914.x; Lee WK, 2000, J CELL BIOCHEM, V76, P244; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; McKenna MC, 1996, DEV NEUROSCI-BASEL, V18, P380, DOI 10.1159/000111431; Morand JPF, 2005, J BIOL CHEM, V280, P17626, DOI 10.1074/jbc.M413343200; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2003, NEUROCHEM INT, V43, P401, DOI 10.1016/S0197-0186(03)00028-7; PLAITAKIS A, 1984, ANN NEUROL, V15, P144, DOI 10.1002/ana.410150206; Plaitakis A, 2010, EUR J HUM GENET, V18, P336, DOI 10.1038/ejhg.2009.179; Rosso L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000150; Sharpe Richard M., 1994, P1363; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; SMITH EL, 1979, P AM PHILOS SOC, V123, P73; SONNEWALD U, 1993, J NEUROCHEM, V61, P1179, DOI 10.1111/j.1471-4159.1993.tb03641.x; Waagepetersen HS, 2000, J NEUROCHEM, V75, P471, DOI 10.1046/j.1471-4159.2000.0750471.x; Zaganas I, 2002, J BIOL CHEM, V277, P26422, DOI 10.1074/jbc.M200022200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001	34	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16748	16756		10.1074/jbc.M109.092999	http://dx.doi.org/10.1074/jbc.M109.092999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20194501	hybrid, Green Published			2022-12-27	WOS:000277982600038
J	Chelico, L; Prochnow, C; Erie, DA; Chen, XS; Goodman, MF				Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F.			Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; CYTIDINE DEAMINASE; VIF PROTEIN; FUNCTIONAL IMPLICATIONS; CRYSTAL-STRUCTURE; TYPE-1 VIF; WILD-TYPE; 7SL RNA; DNA; DOMAIN	APOBEC3G (Apo3G) is a single-stranded DNA-dependent deoxycytidine deaminase, which, in the absence of the human immunodeficiency virus (HIV) viral infectivity factor, is encapsulated into HIV virions. Subsequently, Apo3G triggers viral inactivation by processively deaminating C -> U, with 3'-> 5' polarity, on nascent minus-strand cDNA. Apo3G has a catalytically inactive N-terminal CD1 domain and an active C-terminal CD2 domain. Apo3G exists as monomers, dimers, tetramers, and higher order oligomers whose distributions depend on DNA substrate and salt. Here we use multiangle light scattering and atomic force microscopy to identify oligomerization states of Apo3G. A double mutant (F126A/W127A), designed to disrupt dimerization at the predicted CD1-CD1 dimer interface, predominantly converts Apo3G to a monomer that binds single-stranded DNA, Alu RNA, and catalyzes processive C -> U deaminations with 3'-> 5' deamination polarity, similar to native Apo3G. The CD1 domain is essential for both processivity and polarity. We propose a structure-based model to explain the scanning and catalytic behavior of Apo3G.	[Chelico, Linda; Prochnow, Courtney; Chen, Xiaojiang S.; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Chen, Xiaojiang S.; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Erie, Dorothy A.] Univ N Carolina, Appl & Mat Sci Curriculum, Chapel Hill, NC 27599 USA	University of Southern California; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Goodman, MF (corresponding author), 1050 Childs Way, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		Chelico, Linda/0000-0003-4673-8978	National Institutes of Health [ESO13192, R37GM21422, GM080294, GM079480, GM087986]; California HIV/AIDS Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM087986, R37GM021422, R01GM080294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ESO13192 and R37GM21422 (to M. F. G.), GM080294 and GM079480 (to D. A. E.), and GM087986 (to X. S. C.). This work was also supported by a California HIV/AIDS Research Program grant (to X. S. C.).	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith JL, 2009, TRENDS PHARMACOL SCI, V30, P638, DOI 10.1016/j.tips.2009.09.006; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang X, 2009, BIOPHYS J, V96, P1884, DOI 10.1016/j.bpj.2008.12.3890	51	95	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16195	16205		10.1074/jbc.M110.107987	http://dx.doi.org/10.1074/jbc.M110.107987			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20212048	Green Published, hybrid			2022-12-27	WOS:000277715900056
J	Liechti, LA; Berneche, S; Bargeton, B; Iwaszkiewicz, J; Roy, S; Michielin, O; Kellenberger, S				Liechti, Luz Angelica; Berneche, Simon; Bargeton, Benoite; Iwaszkiewicz, Justyna; Roy, Sophie; Michielin, Olivier; Kellenberger, Stephan			A Combined Computational and Functional Approach Identifies New Residues Involved in pH-dependent Gating of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; ACID; BRAIN; H+; DESENSITIZATION; ION-CHANNEL-1; ARCHITECTURE; CONTRIBUTES; SENSITIVITY; ISCHEMIA	Acid-sensing ion channels (ASICs) are key receptors for extracellular protons. These neuronal nonvoltage-gated Na+ channels are involved in learning, the expression of fear, neuro-degeneration after ischemia, and pain sensation. We have applied a systematic approach to identify potential pH sensors in ASIC1a and to elucidate the mechanisms by which pH variations govern ASIC gating. We first calculated the pK(a) value of all extracellular His, Glu, and Asp residues using a Poisson-Boltzmann continuum approach, based on the ASIC three-dimensional structure, to identify candidate pH-sensing residues. The role of these residues was then assessed by site-directed mutagenesis and chemical modification, combined with functional analysis. The localization of putative pH-sensing residues suggests that pH changes control ASIC gating by protonation/deprotonation of many residues per subunit in different channel domains. Analysis of the function of residues in the palm domain close to the central vertical axis of the channel allowed for prediction of conformational changes of this region during gating. Our study provides a basis for the intrinsic ASIC pH dependence and describes an approach that can also be applied to the investigation of the mechanisms of the pH dependence of other proteins.	[Liechti, Luz Angelica; Bargeton, Benoite; Roy, Sophie; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Berneche, Simon; Iwaszkiewicz, Justyna; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch	Michielin, Olivier/ABE-7924-2020; Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094; Iwaszkiewicz, Justyna/0000-0003-3494-589X; Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [31003A0- 117717, 3232B0- 103172, 3200B0- 103173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31003A0- 117717 from the Swiss National Science Foundation (to S. K.) and by SCORE Grants 3232B0- 103172 and 3200B0- 103173 from the Swiss National Science Foundation (to O. M.).	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v; Sanchez R, 2000, METH MOL B, V143, P97; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	46	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16315	16329		10.1074/jbc.M109.092015	http://dx.doi.org/10.1074/jbc.M109.092015			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299463	Green Published, hybrid			2022-12-27	WOS:000277715900068
J	Layer, JH; Miller, SG; Weil, PA				Layer, Justin H.; Miller, Scott G.; Weil, P. Anthony			Direct Transactivator-Transcription Factor IID (TFIID) Contacts Drive Yeast Ribosomal Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR-SPECIFIC RECRUITMENT; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING; COMPLEX; COACTIVATOR; PROMOTER; MEDIATOR; GENOME	Transcription factor IID (TFIID) plays a key role in regulating eukaryotic gene expression by directly binding promoters and enhancer-bound transactivator proteins. However, the precise mechanisms and outcomes of transactivator-TFIID interaction remain unclear. Transcription of yeast ribosomal protein genes requires TFIID and the DNA-binding transactivator Rap1. We have previously shown that Rap1 directly binds to the TFIID complex through interaction with its TATA-binding protein-associated factor (Taf) subunits Taf4, -5, and -12. Here, we identify and characterize the Rap1 binding domains (RBDs) of Taf4 and Taf5. These RBDs are essential for viability but dispensable for Taf-Taf interactions and TFIID stability. Cells expressing altered Rap1 binding domains exhibit conditional growth, synthetic phenotypes when expressed in combination or with altered Rap1, and are selectively defective in ribosomal protein gene transcription. Taf4 and Taf5 proteins with altered RBDs bind Rap1 with reduced affinity. We propose that collectively the Taf4, Taf5, and Taf12 subunits of TFIID represent the physical and functional targets for Rap1 interaction and, furthermore, that these interactions drive ribosomal protein gene transcription.	[Layer, Justin H.; Miller, Scott G.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [GM52461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM052461, R01GM052461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52461.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Durso RJ, 2001, MOL CELL BIOL, V21, P7331, DOI 10.1128/MCB.21.21.7331-7344.2001; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Klein J, 2003, J BIOL CHEM, V278, P6779, DOI 10.1074/jbc.M212514200; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Mischerikow N, 2009, J PROTEOME RES, V8, P5020, DOI 10.1021/pr900449e; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; TSANG JSH, 1990, NUCLEIC ACIDS RES, V18, P7331, DOI 10.1093/nar/18.24.7331; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	59	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15489	15499		10.1074/jbc.M110.104810	http://dx.doi.org/10.1074/jbc.M110.104810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20189987	Green Published, hybrid			2022-12-27	WOS:000277399000068
J	Effantin, G; Maurizi, MR; Steven, AC				Effantin, Gregory; Maurizi, Michael R.; Steven, Alasdair C.			Binding of the ClpA Unfoldase Opens the Axial Gate of ClpP Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASES; AAA PLUS PROTEINS; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; COMPLEX-FORMATION; HSP100 CHAPERONE; SERINE PROTEASES; 20S PROTEASOMES; N-TERMINUS; PROTEOLYSIS	ClpP is a serine protease whose active sites are sequestered in a cavity enclosed between two heptameric rings of subunits. The ability of ClpP to process folded protein substrates depends on its being partnered by an AAA+ ATPase/unfoldase, ClpA or ClpX. In active complexes, substrates are unfolded and fed along an axial channel to the degradation chamber inside ClpP. We have used cryoelectron microscopy at similar to 11-angstrom resolution to investigate the three-dimensional structure of ClpP complexed with either one or two end-mounted ClpA hexamers. In the absence of ClpA, the apical region of ClpP is sealed; however, it opens on ClpA binding, creating an access channel. This region is occupied by the N-terminal loops (residues 1-17) of ClpP, which tend to be poorly visible in crystal structures, indicative of conformational variability. Nevertheless, we were able to model the closed-to-open transition that accompanies ClpA binding in terms of movements of these loops; in particular, "up" conformations of the loops correlate with the open state. The main part of ClpP, the barrel formed by 14 copies of residues 18-193, is essentially unchanged by the interaction with ClpA. Using difference mapping, we localized the binding site for ClpA to a peripheral pocket between adjacent ClpP subunits. Based on these observations, we propose that access to the ClpP degradation chamber is controlled allosterically by hinged movements of its N-terminal loops, which the symmetry-mismatched binding of ClpA suffices to induce.	[Steven, Alasdair C.] NIAMS, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA; [Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Steven, AC (corresponding author), NIAMS, Struct Biol Res Lab, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov			NIAMS; NCI of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Programs of NIAMS and NCI of the National Institutes of Health.	Adams P, 2009, J BIOL CHEM, V284, P22012, DOI 10.1074/jbc.M109.031807; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Choi KH, 2005, BIOCHEMISTRY-US, V44, P13921, DOI 10.1021/bi0505060; EFFANTIN G, 2010, STRUCTURE IN PRESS; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11031, DOI 10.1021/bi8010169; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	45	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14834	14840		10.1074/jbc.M109.090498	http://dx.doi.org/10.1074/jbc.M109.090498			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236930	Green Published, hybrid			2022-12-27	WOS:000277299700080
J	Karlsen, JR; Borregaard, N; Cowland, JB				Karlsen, Joachim R.; Borregaard, Niels; Cowland, Jack B.			Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-alpha Is Controlled by I kappa B-zeta but neither by C/EBP-beta nor C/EBP-delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE PROTEIN EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTION; IDENTIFICATION; BINDING; NGAL; RECEPTOR; PATTERN; TARGET	Neutrophil gelatinase-associated lipocalin (NGAL) is a siderophore-binding antimicrobial protein that is up-regulated in epithelial tissues during inflammation. We demonstrated previously that the gene encoding NGAL (LCN2) is strongly up-regulated by interleukin (IL)-1 beta in an NF-kappa B-dependent manner but not by tumor necrosis factor (TNF)-alpha, another potent activator of NF-kappa B. This is due to an IL-1 beta-specific synthesis of the NF-kappa B-binding co-factor I kappa B-zeta, which is essential for NGAL induction. We demonstrate here that NGAL is strongly induced by stimulation with TNF-alpha in the presence of IL-17, a pro-inflammatory cytokine produced by the newly discovered subset of CD4(+) T helper cells, TH-17. In contrast to the murine NGAL orthologue, 24p3/lipocalin 2, we found no requirement for C/EBP-beta or C/EBP-delta for NGAL induction by IL-17 and TNF-alpha as neither small interfering RNAs against the two C/EBP mRNAs nor mutation of the C/EBP sites in the LCN2 promoter abolished IL-17- and TNF-alpha-induced up-regulation of NGAL. NGAL induction is governed solely by NF-kappa B and its co-factor I kappa B-zeta. This was demonstrated by a pronounced reduction in the amount of NGAL mRNA and NGAL protein synthesized in cells treated with small interfering RNA against I kappa B-zeta and a total lack of activation of an LCN2 promoter construct with a mutated NF-kappa B site. As IL-17 stimulation stabilizes the I kappa B-zeta transcript, we propose a model where TNF-alpha induces activation and binding of NF-kappa B to the promoters of both NFKBIZ and LCN2 genes but induce only transcription of I kappa B-zeta. Co-stimulation with IL-17 leads to accumulation of I kappa B-zeta mRNA and I kappa B-zeta protein, which can bind to NF-kappa B on the LCN2 promoter and thus induce NGAL expression.	[Karlsen, Joachim R.; Borregaard, Niels; Cowland, Jack B.] Univ Copenhagen, Rigshosp, Granulocyte Res Lab, Dept Hematol 93 2 2, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Cowland, JB (corresponding author), Univ Copenhagen, Rigshosp, Granulocyte Res Lab, Dept Hematol 93 2 2, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark.	jcowland@rh.dk		Cowland, Jack Bernard/0000-0002-7429-5388	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; A.P. Moller Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A.P. Moller Foundation	This work was supported by grants from the Danish Medical Research Council, the Novo Nordisk Foundation, the Lundbeck Foundation, and the A.P. Moller Foundation for the Advancement of Medical Science.	Agrawal A, 2003, MOL IMMUNOL, V40, P373, DOI 10.1016/S0161-5890(03)00148-2; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hu HM, 1998, J IMMUNOL, V160, P2334; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kjeldsen L, 1996, J IMMUNOL METHODS, V198, P155, DOI 10.1016/S0022-1759(96)00153-6; KJELDSEN L, 1994, BLOOD, V83, P799; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200	34	110	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14088	14100		10.1074/jbc.M109.017129	http://dx.doi.org/10.1074/jbc.M109.017129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220144	hybrid, Green Published			2022-12-27	WOS:000277299700004
J	Luckner, SR; Liu, NN; Ende, CWA; Tonge, PJ; Kisker, C				Luckner, Sylvia R.; Liu, Nina; Ende, Christopher W. Am; Tonge, Peter J.; Kisker, Caroline			A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDENCE TIME; ACP REDUCTASE; DRUG-TARGET; TRICLOSAN; AFFINITY; BIOSYNTHESIS; FABL; GENE	InhA, the enoyl-ACP reductase in Mycobacterium tuberculosis is an attractive target for the development of novel drugs against tuberculosis, a disease that kills more than two million people each year. InhA is the target of the current first line drug isoniazid for the treatment of tuberculosis infections. Compounds that directly target InhA and do not require activation by the mycobacterial catalase-peroxidase KatG are promising candidates for treating infections caused by isoniazid-resistant strains. Previously we reported the synthesis of several diphenyl ethers with nanomolar affinity for InhA. However, these compounds are rapid reversible inhibitors of the enzyme, and based on the knowledge that long drug target residence times are an important factor for in vivo drug activity, we set out to generate a slow onset inhibitor of InhA using structure-based drug design. 2-(o-Tolyloxy)-5-hexylphenol (PT70) is a slow, tight binding inhibitor of InhA with a K-1 value of 22 pM. PT70 binds preferentially to the InhA center dot NAD(+) complex and has a residence time of 24 min on the target, which is 14,000 times longer than that of the rapid reversible inhibitor from which it is derived. The 1.8 angstrom crystal structure of the ternary complex between InhA, NAD(+), and PT70 reveals the molecular details of enzyme-inhibitor recognition and supports the hypothesis that slow onset inhibition is coupled to ordering of an active site loop, which leads to the closure of the substrate-binding pocket.	[Liu, Nina; Ende, Christopher W. Am; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	tonge@sunysb.edu; caroline.kisker@virchow.uni-wuerzburg.de	Liu, Nina/G-2837-2013; Kisker, Caroline/T-1724-2019; Tonge, Peter J/A-7443-2009	Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [AI44639]; Deutsche Forschungsgemeinschaft [SFB 630]; Forschungszentrum [FZ82]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044639, R01AI044639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44639 (to P. J. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 630 and Forschungszentrum Grant FZ82 (to C. K.).	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; COPELAND RA, 2005, EVALUATION ENZYME IN, P141; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ende CWA, 2008, BIOORG MED CHEM LETT, V18, P3029, DOI 10.1016/j.bmcl.2008.04.038; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; Rafi SB, 2006, J MED CHEM, V49, P4574, DOI 10.1021/jm060222t; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sivaraman S, 2004, J MED CHEM, V47, P509, DOI 10.1021/jm030182i; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; *WHO, 2007, WHO REP; WILLIAMS JW, 1979, BIOCHEMISTRY-US, V18, P2567, DOI 10.1021/bi00579a021; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	34	138	145	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14330	14337		10.1074/jbc.M109.090373	http://dx.doi.org/10.1074/jbc.M109.090373			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20200152	Green Published, hybrid			2022-12-27	WOS:000277299700030
J	Nho, RS; Kahm, J				Nho, Richard Seonghun; Kahm, Judy			beta 1-Integrin-Collagen Interaction Suppresses FoxO3a by the Coordination of Akt and PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHR; COLLAGEN MATRIX CONTRACTION; PROTEIN-KINASE B; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; SIGNALING PATHWAY; IN-VITRO; EPITHELIAL-CELLS; DOWN-REGULATION; CYCLIN-D	When cells attach to the extracellular matrix (ECM) a proliferation permissive signal is engaged. The mechanism involves activation of the integrin/PI3K/Akt signal pathway. FoxO3a is a transcriptional activator and inhibits cell proliferation via up-regulating the expression of the cell cycle inhibitor p27. Furthermore, it is known that activated Akt can suppress FoxO3a function. However, it is not known whether integrin interaction with the ECM regulates FoxO3a function. We examined whether the beta 1-integrin-mediated signaling pathway promotes fibroblast proliferation via FoxO3a suppression. We found that when fibroblasts are attached to collagen, PTEN protein expression and activity are inhibited due to promotion of PTEN degradation. This decrease in PTEN function permits FoxO3a suppression via the PI3K/Akt pathway. In contrast, the inhibition of PI3K/Akt or reconstitution of PTEN restores FoxO3a expression on collagen. Furthermore, we found that the serine/threonine phosphatase PP2A also regulates FoxO3a. PP2A expression/activity is low when fibroblasts are attached to collagen, and PP2A overexpression augments FoxO3a levels. Thus the mechanism involves a coordinated decrease in PTEN and PP2A phosphatase activity and increase in PI3K/Akt activity. We show that beta 1-integrin-ECM interaction decreases FoxO3a protein levels via caspase-3-mediated cleavage. Our novel finding indicates that during fibroblast interaction with ECM, activation of beta 1-integrin/PI3K/Akt by inhibiting PTEN in combination with low PP2A phosphatase activity synergistically inhibits FoxO3a, promoting fibroblast proliferation.	[Nho, Richard Seonghun; Kahm, Judy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			American Heart Association; American Lung Association	American Heart Association(American Heart Association); American Lung Association	This work was supported by Scientist Development and Pulmonary Fibrosis Research grants from the American Heart Association and the American Lung Association (to R. S. N.).	Aoshiba K, 1997, AM J PHYSIOL-LUNG C, V272, pL28, DOI 10.1152/ajplung.1997.272.1.L28; Behzad H, 2007, CYTOKINE, V38, P74, DOI 10.1016/j.cyto.2007.05.004; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Choe G, 2003, CANCER RES, V63, P2742; Depraetere H, 1997, THROMB HAEMOSTASIS, V77, P981; Diao LR, 2007, CELL RES, V17, P291, DOI 10.1038/cr.2007.24; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Liu XP, 1997, EXP EYE RES, V65, P117, DOI 10.1006/exer.1997.0317; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Upadhyay J, 2003, J UROLOGY, V169, P750, DOI 10.1016/S0022-5347(05)64007-4; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xia H, 2008, J BIOL CHEM, V283, P20350, DOI 10.1074/jbc.M707489200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang WS, 2008, NAT CELL BIOL, V10, P125, DOI 10.1038/ncb0208-125; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhao YM, 2008, EUR J HAEMATOL, V81, P83, DOI 10.1111/j.1600-0609.2008.01077.x; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	37	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14195	14209		10.1074/jbc.M109.052845	http://dx.doi.org/10.1074/jbc.M109.052845			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223831	Green Published, hybrid			2022-12-27	WOS:000277299700016
J	Compton, SA; Ozgur, S; Griffith, JD				Compton, Sarah A.; Ozgur, Sezgin; Griffith, Jack D.			Ring-shaped Rad51 Paralog Protein Complexes Bind Holliday Junctions and Replication Forks as Visualized by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; XRCC3; CELLS; MICE; IDENTIFICATION	In mammals, there are five Rad51 paralogs that form two distinct complexes in vivo. One complex is composed of Rad51B-Rad51C-Rad51D-Xrcc2 (BCDX2) and the other Rad51C-Xrcc3 (CX3). We co-expressed and purified human BCDX2 and CX3 protein complexes from insect cells and investigated their binding preferences and structure using transmission electron microscopy (TEM). We visualized the binding of BCDX2 and CX3 to DNA templates containing replication forks and Holliday junctions, intermediates observed during DNA replication and recombination, respectively. We show that both complexes bind with exceptionally high specificity to the DNA junctions with little binding observed elsewhere on the DNAs. Further analysis of the structure of free or DNA-bound BCDX2 and CX3 complexes revealed a multimeric ring structure whose subunits are arranged into a flat disc around a central channel. This work provides the first EM visualization of BCDX2 and CX3 binding to Holliday junctions and forked DNAs and suggests the complexes form ring-shaped structures.	[Compton, Sarah A.; Ozgur, Sezgin; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Compton, SA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295,Mason Farm Rd, Chapel Hill, NC 27599 USA.	compton@med.unc.edu			National Institutes of Health [GM077900, GM31819, ES013773]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077900, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship Grant GM077900 (to S. A. C.) and Grants GM31819 and ES013773 (to J. D. G.).	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Braybrooke JP, 2003, J BIOL CHEM, V278, P48357, DOI 10.1074/jbc.M308838200; Cousineau I, 2005, CANCER RES, V65, P11384, DOI 10.1158/0008-5472.CAN-05-2156; Deans B, 2003, CANCER RES, V63, P8181; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Jang YK, 1996, MOL GEN GENET, V251, P167; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; Kurumizaka H, 2002, J BIOL CHEM, V277, P14315, DOI 10.1074/jbc.M105719200; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Pittman DL, 2000, GENESIS, V26, P167, DOI 10.1002/(SICI)1526-968X(200003)26:3<167::AID-GENE1>3.0.CO;2-M; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Shu ZG, 1999, MOL CELL BIOL, V19, P8686; Stansel RM, 2001, EMBO J, V20, P5532; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Thacker J, 2004, DNA REPAIR, V3, P1081, DOI 10.1016/j.dnarep.2004.04.012; Yokoyama H, 2004, NUCLEIC ACIDS RES, V32, P2556, DOI 10.1093/nar/gkh578; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Yuan SSF, 1999, CANCER RES, V59, P3547	34	25	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13349	13356		10.1074/jbc.M109.074286	http://dx.doi.org/10.1074/jbc.M109.074286			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207730	hybrid, Green Published			2022-12-27	WOS:000276987700005
J	Mak, SK; McCormack, AL; Manning-Bog, AB; Cuervo, AM; Di Monte, DA				Mak, Sally K.; McCormack, Alison L.; Manning-Bog, Amy B.; Cuervo, Ana Maria; Di Monte, Donato A.			Lysosomal Degradation of alpha-Synuclein in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; RAT-LIVER LYSOSOMES; OXIDATIVE STRESS; PARKINSONS-DISEASE; HERBICIDE PARAQUAT; SELECTIVE UPTAKE; DEGENERATION; CLEARANCE; PROTEINS; NEURODEGENERATION	Pathologic accumulation of alpha-synuclein is a feature of human parkinsonism and other neurodegenerative diseases. This accumulation may be counteracted by mechanisms of protein degradation that have been investigated in vitro but remain to be elucidated in animal models. In this study, lysosomal clearance of alpha-synuclein in vivo was indicated by the detection of alpha-synuclein in the lumen of lysosomes isolated from the mouse midbrain. When neuronal alpha-synuclein expression was enhanced as a result of toxic injury (i.e. treatment of mice with the herbicide paraquat) or transgenic protein overexpression, the intralysosomal content of alpha-synuclein was also significantly increased. This effect was paralleled by a marked elevation of the lysosome-associated membrane protein type 2A (LAMP-2A) and the lysosomal heat shock cognate protein of 70 kDa (hsc70), two essential components of chaperone-mediated autophagy (CMA). Immunofluorescence microscopy revealed an increase in punctate (lysosomal) LAMP-2A staining that co-localized with alpha-synuclein within nigral dopaminergic neurons of paraquat-treated and alpha-synuclein-overexpressing animals. The data provide in vivo evidence of lysosomal degradation of alpha-synuclein under normal conditions and, quite importantly, under conditions of enhanced protein burden. In the latter, increased lysosomal clearance of alpha-synuclein was mediated, at least in part, by CMA induction. It is conceivable that these neuronal mechanisms of protein clearance play an important role in neurodegenerative processes characterized by abnormal alpha-synuclein buildup.	[Mak, Sally K.] Parkinsons Inst, Sunnyvale, CA 94085 USA; [McCormack, Alison L.; Manning-Bog, Amy B.; Di Monte, Donato A.] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Bronx, NY 10461 USA	SRI International; Yeshiva University; Albert Einstein College of Medicine	Di Monte, DA (corresponding author), 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	donato.dimonte@sri.com		Di Monte, Donato/0000-0002-8296-836X; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [ES12077]; Backus Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Backus Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES12077, the Backus Foundation, and the Parkinson's Disease Foundation.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; OHSUMI Y, 1983, J BIOCHEM, V93, P547; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	32	258	261	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13621	13629		10.1074/jbc.M109.074617	http://dx.doi.org/10.1074/jbc.M109.074617			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200163	Green Published, hybrid			2022-12-27	WOS:000276987700036
J	Caccamo, A; Majumder, S; Richardson, A; Strong, R; Oddo, S				Caccamo, Antonella; Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore			Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-beta, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TRIPLE-TRANSGENIC MODEL; P70 S6 KINASE; ALZHEIMERS-DISEASE; A-BETA; LIFE-SPAN; SIGNALING PATHWAY; PROTEIN-TAU; GLYCOPROTEIN COMPLEX; INDUCED APOPTOSIS	Accumulation of amyloid-beta (A beta) and Tau is an invariant feature of Alzheimer disease (AD). The upstream role of A beta accumulation in the disease pathogenesis is widely accepted, and there is strong evidence showing that A beta accumulation causes cognitive impairments. However, the molecular mechanisms linking A beta to cognitive decline remain to be elucidated. Here we show that the buildup of A beta increases the mammalian target of rapamycin (mTOR) signaling, whereas decreasing mTOR signaling reduces A beta levels, thereby highlighting an interrelation between mTOR signaling and A beta. The mTOR pathway plays a central role in controlling protein homeostasis and hence, neuronal functions; indeed mTOR signaling regulates different forms of learning and memory. Using an animal model of AD, we show that pharmacologically restoring mTOR signaling with rapamycin rescues cognitive deficits and ameliorates A beta and Tau pathology by increasing autophagy. Indeed, we further show that autophagy induction is necessary for the rapamycin mediated reduction in A beta levels. The results presented here provide a molecular basis for the A beta-induced cognitive deficits and, moreover, show that rapamycin, an FDA approved drug, improves learning and memory and reduces A beta and Tau pathology.	[Caccamo, Antonella; Majumder, Smita; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78245 USA; [Caccamo, Antonella; Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78245 USA; [Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu		Oddo, Salvatore/0000-0001-7304-7430	NIA [AG29729-4]; San Antonio Nathan Shock Aging Center [1P30-AG-13319]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [R00AG029729, K99AG029729, P30AG013319] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); San Antonio Nathan Shock Aging Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG29729-4 from the NIA (to S. O.), San Antonio Nathan Shock Aging Center Grant 1P30-AG-13319, and a grant from the Department of Veterans Affairs Enhancement Award Program.	An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Cao RF, 2009, J NEUROSCI, V29, P12372, DOI 10.1523/JNEUROSCI.3486-09.2009; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ferri KF, 2000, CELL DEATH DIFFER, V7, P1137, DOI 10.1038/sj.cdd.4400748; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; Ito S, 2006, NEUROSCI RES, V56, P294, DOI 10.1016/j.neures.2006.07.009; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Ling DJ, 2009, AUTOPHAGY, V5, P738, DOI 10.4161/auto.5.5.8626; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lopes JP, 2009, CURR ALZHEIMER RES, V6, P205, DOI 10.2174/156720509788486590; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	76	631	677	0	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13107	13120		10.1074/jbc.M110.100420	http://dx.doi.org/10.1074/jbc.M110.100420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178983	hybrid, Green Published			2022-12-27	WOS:000276787800067
J	Chen, SH; Albuquerque, CP; Liang, J; Suhandynata, RT; Zhou, HL				Chen, Sheng-hong; Albuquerque, Claudio P.; Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin			A Proteome-wide Analysis of Kinase-Substrate Network in the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHECKPOINT KINASE; IN-VIVO; RAD53 PHOSPHORYLATION; REPLICATION FORKS; GENOME STABILITY; C-TERMINUS; ATM; YEAST; PATHWAYS	The DNA damage checkpoint, consisting of an evolutionarily conserved protein kinase cascade, controls the DNA damage response in eukaryotes. Knowledge of the in vivo substrates of the checkpoint kinases is essential toward understanding their functions. Here we used quantitative mass spectrometry to identify 53 new and 34 previously known targets of Mec1/Tel1, Rad53, and Dun1 in Saccharomyces cerevisiae. Analysis of replication protein A (RPA)-associated proteins reveals extensive physical interactions between RPA-associated proteins and Mec1/Tel1-specific substrates. Among them, multiple subunits of the chromatin remodeling complexes including ISW1, ISW2, INO80, SWR1, RSC, and SWI/SNF are identified and they undergo DNA damage-induced phosphorylation by Mec1 and Tel1. Taken together, this study greatly expands the existing knowledge of the targets of DNA damage checkpoint kinases and provides insights into the role of RPA-associated chromatins in mediating Mec1 and Tel1 substrate phosphorylation in vivo.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), CMM E, Rm 2070,9500 Gilman Dr, La Jolla, CA 92093 USA.	huzhou@ucsd.edu	Chen, Sheng-hong/AAU-4018-2021	Chen, Sheng-hong/0000-0002-7722-2221; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [GM080463]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080463 and the Ludwig Institute for Cancer Research.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COLE GM, 1989, MOL CELL BIOL, V9, P3314, DOI 10.1128/MCB.9.8.3314; Craven RJ, 2002, GENETICS, V161, P493; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	96	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12803	12812		10.1074/jbc.M110.106989	http://dx.doi.org/10.1074/jbc.M110.106989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20190278	Green Published, hybrid			2022-12-27	WOS:000276787800038
J	Meloni, A; Fiorillo, E; Corda, D; Incani, F; Serra, ML; Contini, A; Cao, A; Rosatelli, MC				Meloni, Allesandra; Fiorillo, Edoardo; Corda, Denise; Incani, Federica; Serra, Maria Luisa; Contini, Antonella; Cao, Antonio; Rosatelli, Maria Cristina			DAXX Is a New AIRE-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; CREB-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVITY; PHD FINGER; IMMUNOLOGICAL-TOLERANCE; FUNCTIONAL DOMAINS; GENE-EXPRESSION; CHROMATIN; APOPTOSIS; COMPLEX	The AIRE protein plays a remarkable role as a regulator of central tolerance by controlling the promiscuous expression of tissue-specific antigens in thymic medullary epithelial cells. Defects in the AIRE gene cause the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, a rare disease frequent in Iranian Jews, Finns, and Sardinian population. To this day, the precise function of the AIRE protein in regulating transcription and its interacting proteins has yet to be entirely clarified. The knowledge of novel AIRE interactors and their precise role will improve our knowledge of its biological activity and address some of the foremost autoimmunity-related questions. In this study, we have used a yeast two-hybrid system to identify AIRE-interacting proteins. This approach led us to the discovery of a new AIRE-interacting protein called DAXX. The protein is known to be a multifunctional adaptor with functions both in apoptosis and in transcription regulation pathways. The interaction between AIRE and DAXX has been validated by in vivo coimmunoprecipitation analysis and colocalization study in mammalian cells. The interaction has been further confirmed by showing in transactivation assays that DAXX exerts a strong repressive role on the transcriptional activity of AIRE.	[Fiorillo, Edoardo; Corda, Denise; Incani, Federica; Serra, Maria Luisa; Contini, Antonella; Rosatelli, Maria Cristina] Univ Cagliari, Dept Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Meloni, Allesandra; Cao, Antonio] Univ Cagliari, CNR, Ist Neurogenet & Neurofarmacol, I-09121 Cagliari, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Rosatelli, MC (corresponding author), Univ Cagliari, Dept Sci Biomed & Biotecnol, Via Jenner S-N, I-09121 Cagliari, Italy.	rosatelli@unica.it	Fiorillo, Edoardo/AAY-3804-2020	incani, federica/0000-0003-2699-8035; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190	EURAPS [2006-2008]; Sardinian Regional Government	EURAPS; Sardinian Regional Government(Regione Sardegna)	This work was supported in part by grants from the Community Sixth Framework Programme, Project "EURAPS"-Autoimmune Polyendocrine Syndrome Type I, 2006-2008.; Supported by "Master and Back" fellowship from the Sardinian Regional Government.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gu HD, 2009, J VIROL, V83, P4376, DOI 10.1128/JVI.02515-08; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x; Ilmarinen T, 2008, MOL IMMUNOL, V45, P1847, DOI 10.1016/j.molimm.2007.10.045; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Meloni A, 2002, J CLIN ENDOCR METAB, V87, P841, DOI 10.1210/jc.87.2.841; Meloni A, 2008, MOL IMMUNOL, V45, P805, DOI 10.1016/j.molimm.2007.06.156; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Muromoto R, 2004, BIOCHEM BIOPH RES CO, V316, P827, DOI 10.1016/j.bbrc.2004.02.126; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Perheentupa J, 2002, ENDOCRIN METAB CLIN, V31, P295, DOI 10.1016/S0889-8529(01)00013-5; Perheentupa J, 1999, ANN MED INTERNE, V150, P313; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ramsey C, 2002, HUM MOL GENET, V11, P3299, DOI 10.1093/hmg/11.26.3299; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tao YX, 2006, MOL IMMUNOL, V43, P335, DOI 10.1016/j.molimm.2005.02.018; Tonooka A, 2009, BIOCHEM BIOPH RES CO, V379, P765, DOI 10.1016/j.bbrc.2008.12.123; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	59	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13012	13021		10.1074/jbc.M109.037747	http://dx.doi.org/10.1074/jbc.M109.037747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185822	Green Published, hybrid			2022-12-27	WOS:000276787800059
J	Nishida, M; Watanabe, K; Sato, Y; Nakaya, M; Kitajima, N; Ide, T; Inoue, R; Kurose, H				Nishida, Motohiro; Watanabe, Kenta; Sato, Yoji; Nakaya, Michio; Kitajima, Naoyuki; Ide, Tomomi; Inoue, Ryuji; Kurose, Hitoshi			Phosphorylation of TRPC6 Channels at Thr(69) Is Required for Anti-hypertrophic Effects of Phosphodiesterase 5 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; INDUCED CARDIAC-HYPERTROPHY; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-G; CATION CHANNELS; HEART-FAILURE; B-LYMPHOCYTES; CA2+ RELEASE; ACTIVATION; CELLS	Activation of Ca2+ signaling induced by receptor stimulation and mechanical stress plays a critical role in the development of cardiac hypertrophy. A canonical transient receptor potential protein subfamily member, TRPC6, which is activated by diacylglycerol and mechanical stretch, works as an upstream regulator of the Ca2+ signaling pathway. Although activation of protein kinase G (PKG) inhibits TRPC6 channel activity and cardiac hypertrophy, respectively, it is unclear whether PKG suppresses cardiac hypertrophy through inhibition of TRPC6. Here, we show that inhibition of cGMP-selective PDE5 (phosphodiesterase 5) suppresses endothelin-1-,diacylglycerol analog-, and mechanical stretch-induced hypertrophy through inhibition of Ca2+ influx in rat neonatal cardiomyocytes. Inhibition of PDE5 suppressed the increase in frequency of Ca2+ spikes induced by agonists or mechanical stretch. However, PDE5 inhibition did not suppress the hypertrophic responses induced by high KCl or the activation of protein kinase C, suggesting that PDE5 inhibition suppresses Ca2+ influx itself or molecule(s) upstream of Ca2+ influx. PKG activated by PDE5 inhibition phosphorylated TRPC6 proteins at Thr(69) and prevented TRPC6-mediated Ca2+ influx. Substitution of Ala for Thr(69) in TRPC6 abolished the anti-hypertrophic effects of PDE5 inhibition. In addition, chronic PDE5 inhibition by oral sildenafil treatment actually induced TRPC6 phosphorylation in mouse hearts. Knockdown of RGS2 (regulator of G protein signaling 2) and RGS4, both of which are activated by PKG to reduce G alpha(q)-mediated signaling, did not affect the suppression of receptor-activated Ca2+ influx by PDE5 inhibition. These results suggest that phosphorylation and functional suppression of TRPC6 underlie prevention of pathological hypertrophy by PDE5 inhibition.	[Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan; [Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Jyonan Ku, Fukuoka 8140180, Japan	Kyushu University; Kyushu University; National Institute of Health Sciences - Japan; Fukuoka University	Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp		Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; grant-in-aid for scientific research on Innovative Areas; grant-in-aid for scientific research on Priority Areas; Naito Foundation; Nakatomi Foundation; Sapporo Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grant-in-aid for scientific research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant-in-aid for scientific research on Priority Areas; Naito Foundation(Naito Memorial Foundation); Nakatomi Foundation; Sapporo Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nishida, M. Nakaya, and H. Kurose), a grant-in-aid for scientific research on Innovative Areas (to M. Nishida), a grant-in-aid for scientific research on Priority Areas (H. Kurose), and grants from the Naito Foundation, the Nakatomi Foundation, the Sapporo Bioscience Foundation (M. Nishida), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. Nakaya).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hsu S, 2009, CARDIOVASC RES, V81, P301, DOI 10.1093/cvr/cvn324; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Large WA, 2002, J CARDIOVASC ELECTR, V13, P493, DOI 10.1046/j.1540-8167.2002.00493.x; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Liao XD, 2003, BIOCHEM BIOPH RES CO, V310, P405, DOI 10.1016/j.bbrc.2003.09.023; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	46	77	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13244	13253		10.1074/jbc.M109.074104	http://dx.doi.org/10.1074/jbc.M109.074104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177073	Green Published, hybrid			2022-12-27	WOS:000276787800079
J	Gruber, A; Cornaciu, I; Lass, A; Schweiger, M; Poeschl, M; Eder, C; Kumari, M; Schoiswohl, G; Wolinski, H; Kohlwein, SD; Zechner, R; Zimmermann, R; Oberer, M				Gruber, Astrid; Cornaciu, Irina; Lass, Achim; Schweiger, Martina; Poeschl, Margret; Eder, Christina; Kumari, Manju; Schoiswohl, Gabriele; Wolinski, Heimo; Kohlwein, Sepp D.; Zechner, Rudolf; Zimmermann, Robert; Oberer, Monika			The N-terminal Region of Comparative Gene Identification-58 (CGI-58) Is Important for Lipid Droplet Binding and Activation of Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; PROTEIN TRAFFICKING; 3T3-L1 ADIPOCYTES; LAMELLAR GRANULES; STORAGE DISEASE; PERILIPIN; LIPOLYSIS; HYDROLASE; CELLS; MOBILIZATION	In mammals, excess energy is stored in the form of triacylglycerol primarily in lipid droplets of white adipose tissue. The first step of lipolysis (i.e. the mobilization of fat stores) is catalyzed by adipose triglyceride lipase (ATGL). The enzymatic activity of ATGL is strongly enhanced by CGI-58 (comparative gene identification-58), and the loss of either ATGL or CGI-58 function causes systemic triglyceride accumulation in humans and mice. However, the mechanism by which CGI-58 stimulates ATGL activity is unknown. To gain insight into CGI-58 function using structural features of the protein, we generated a three-dimensional homology model based on sequence similarity with other proteins. Interestingly, the model of CGI-58 revealed that the N terminus forms an extension of the otherwise compact structure of the protein. This N-terminal region (amino acids 1-30) harbors a lipophilic tryptophan-rich stretch, which affects the localization of the protein. H-1 NMR experiments revealed strong interaction between the N-terminal peptide and dodecylphosphocholine micelles as a lipid droplet-mimicking system. A role for this N-terminal region of CGI-58 in lipid droplet binding was further strengthened by localization studies in cultured cells. Although wild-type CGI-58 localizes to the lipid droplet, the N-terminally truncated fragments of CGI-58 are dispersed in the cytoplasm. Moreover, CGI-58 lacking the N-terminal extension loses the ability to stimulate ATGL, implying that the ability of CGI-58 to activate ATGL is linked to correct localization. In summary, our study shows that the N-terminal, Trp-rich region of CGI-58 is essential for correct localization and ATGL-activating function of CGI-58.	[Gruber, Astrid; Cornaciu, Irina; Lass, Achim; Schweiger, Martina; Poeschl, Margret; Eder, Christina; Kumari, Manju; Schoiswohl, Gabriele; Wolinski, Heimo; Kohlwein, Sepp D.; Zechner, Rudolf; Zimmermann, Robert; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Oberer, M (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	m.oberer@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Zechner, Rudolf/0000-0001-5483-1182; Paar, Margret/0000-0001-5494-8890; Oberer, Monika/0000-0003-2525-9513; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Schweiger, Martina/0000-0002-3419-1007; Schoiswohl, Gabriele/0000-0002-7346-2834; Zimmermann, Robert/0000-0002-7354-870X; Wolinski, Heimo/0000-0002-1583-6092	GEN-AU Genome Research in Austria; Austrian Federal Ministry of Science and Research; Austrian Science Fund [FWF W901-B05]; Austrian Science Fund (FWF) [F 3002, F 3005, W 901, Z 136, P 22170] Funding Source: researchfish	GEN-AU Genome Research in Austria; Austrian Federal Ministry of Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from "GOLD: Genomics of Lipid-Associated Disorders," which is part of the Austrian Genome Project "GEN-AU Genome Research in Austria" and is funded by the Austrian Federal Ministry of Science and Research and DK Molecular Enzymology, which is funded by Austrian Science Fund Grant FWF W901-B05.	Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2009, BBA-MOL CELL BIOL L, V1791, P519, DOI 10.1016/j.bbalip.2008.10.012; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zou JY, 2000, STRUCTURE, V8, P111, DOI 10.1016/S0969-2126(00)00087-3; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	40	83	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12289	12298		10.1074/jbc.M109.064469	http://dx.doi.org/10.1074/jbc.M109.064469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164531	Green Published, hybrid			2022-12-27	WOS:000276787100058
J	Lu, QW; Hinken, AC; Patrick, SE; Solaro, RJ; Kobayashi, T				Lu, Qun-Wei; Hinken, Aaron C.; Patrick, Stacey E.; Solaro, R. John; Kobayashi, Tomoyoshi			Phosphorylation of Cardiac Troponin I at Protein Kinase C Site Threonine 144 Depresses Cooperative Activation of Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORDERED PHOSPHORYLATION; MYOCARDIAL-FUNCTION; CROSSBRIDGE CYCLE; FORCE DEVELOPMENT; CALCIUM-BINDING; ATPASE ACTIVITY; HEART-FAILURE; MUSCLE-FIBERS; CA2+ AFFINITY; CROSS-BRIDGE	There is evidence for PKC-dependent multisite phosphorylation of cardiac troponin I (cTnI) at Ser-23 and Ser-24 (also PKA sites) in the cardiac-specific N-terminal extension and at Thr-144, a unique residue in the inhibitory region. The functional effect of these phosphorylations in combination is of interest in view of data indicating intramolecular interaction between the N-terminal extension and the inhibitory region of cTnI. To determine the role of PKC-dependent phosphorylation of cTnI on sarcomeric function, we measured contractile regulation at multiple levels of complexity. Ca2+ binding to thin filaments reconstituted with either cTnI(wild-type) or pseudo-phosphorylated cTnI(S23D/S24D), cTnI(T144E), and cTnI(S23D/S24D/T144E) was determined. Compared with controls regulated by cTnI(wild-type), thin filaments with cTnI(S23D/S24D) and cTnI(S23D/S24D/T144E) exhibited decreased Ca2+ sensitivity. In contrast, there was no significant difference between Ca2+ binding to thin filaments with cTnI(wild-type) and with cTnI(T144E). Studies of the pCa-force relations in skinned papillary fibers regulated by these forms of cTnI yielded similar results. However, in both the Ca2+ binding measurements and the skinned fiber tension measurements, the presence of cTnI(S23D/S24D/T144E) induced a much lower Hill coefficient than either wild type, S23D/S24D, or T144E. These data highlight the importance of thin filament-based cooperative mechanisms in cardiac regulation, with implications for mechanisms of control of function in normal and pathological hearts.	[Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Cardiovasc Res Ctr, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kobayashi, T (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave M-C 901, Chicago, IL 60612 USA.	tkoba@uic.edu			National Institutes of Health [R01HL082923, R01HL022231, P01HL062426, T32HL07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, P01HL062426, R01HL022231, R01HL082923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL082923, R01HL022231, P01HL062426, and T32HL07692.	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dohet C, 1995, FEBS LETT, V377, P131, DOI 10.1016/0014-5793(95)01319-9; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hanft LM, 2008, CARDIOVASC RES, V77, P627, DOI 10.1093/cvr/cvm099; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hunlich M, 2005, J MOL CELL CARDIOL, V38, P119, DOI 10.1016/j.yjmcc.2004.10.005; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2005, J MOL CELL CARDIOL, V38, P213, DOI 10.1016/j.yjmcc.2004.10.014; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; ONISHI H, 1995, P NATL ACAD SCI USA, V92, P704, DOI 10.1073/pnas.92.3.704; PAN BS, 1987, J BIOL CHEM, V262, P7839; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Phan TT, 2009, J AM COLL CARDIOL, V54, P402, DOI 10.1016/j.jacc.2009.05.012; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Rarick HM, 1996, J BIOL CHEM, V271, P27039, DOI 10.1074/jbc.271.43.27039; Regnier M, 2004, BIOPHYS J, V87, P1815, DOI 10.1529/biophysj.103.039123; Reiffert SU, 1996, FEBS LETT, V384, P43, DOI 10.1016/0014-5793(96)00274-8; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Sleep J, 2005, J PHYSIOL-LONDON, V563, P671, DOI 10.1113/jphysiol.2004.078873; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Steffen W, 2004, P NATL ACAD SCI USA, V101, P12904, DOI 10.1073/pnas.0400227101; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zabrouskov V, 2008, MOL CELL PROTEOMICS, V7, P1838, DOI 10.1074/mcp.M700524-MCP200; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	55	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11810	11817		10.1074/jbc.M109.055657	http://dx.doi.org/10.1074/jbc.M109.055657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164197	Green Published, hybrid			2022-12-27	WOS:000276787100008
J	Meena, N; Kaur, H; Mondal, AK				Meena, Netrapal; Kaur, Harsimran; Mondal, Alok K.			Interactions among HAMP Domain Repeats Act as an Osmosensing Molecular Switch in Group III Hybrid Histidine Kinases from Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; SEVERE OSMOTIC-STRESS; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; DEBARYOMYCES-HANSENII; HYPHAL DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; PROTEIN INTERACTIONS; YEAST OSMOSENSOR; DRUG-SENSITIVITY	The members of group III hybrid histidine kinases (HHK) are ubiquitous in fungi. Group III HHK have been implicated to function as osmosensors in the high osmolarity glycerol (HOG) pathway that is essential for fungal survival under high osmolarity stress. Recent literature suggests that group III HHK are also involved in conidia formation, virulence in several filamentous fungi, and are an excellent molecular target for antifungal agents. Thus, group III HHK constitute a very important group of sensor kinases. Structurally, group III HHK are distinct from Sln1p, the osmosensing HHK that regulates the HOG pathway in Saccharomyces cerevisiae. Group III HHK lack any transmembrane domain and typically contain HAMP domain repeats at the N terminus. Until now, it is not clear how group III HHK function as an osmosensor to regulate the HOG pathway. To investigate this, we undertook molecular characterization of DhNIK1, an ortholog from osmotolerant yeast Debaryomyces hansenii. We show here that DhNIK1 could complement sln1 mutation in S. cerevisiae thereby confirming its role as a bona fide osmosensor. We further investigated the role of HAMP domains by deleting them systematically. Our results clearly indicate that the HAMP4 domain is crucial for osmosensing by DhNik1p. Most importantly, we also show that the alternative interaction among the HAMP domains regulates the activity of DhNik1p like an "on-off switch" and thus provides, for the first time, an insight into the molecular mechanism of osmosensing by this group of HHKs.	[Meena, Netrapal; Kaur, Harsimran; Mondal, Alok K.] Inst Microbial Technol, Sector 39A, Council Sci & Ind Res, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mondal, AK (corresponding author), Inst Microbial Technol, Sector 39A, Council Sci & Ind Res, Chandigarh 160036, India.	alok@imtech.res.in		Meena, Netra/0000-0003-1898-4530	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by a grant from Department of Biotechnology, India.	Aggarwal M, 2006, EUKARYOT CELL, V5, P262, DOI 10.1128/EC.5.2.262-271.2006; Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Alex LA, 1996, P NATL ACAD SCI USA, V93, P3416, DOI 10.1073/pnas.93.8.3416; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chapeland-Leclerc F, 2007, EUKARYOT CELL, V6, P1782, DOI 10.1128/EC.00155-07; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; De Nadal E, 2007, TRENDS CELL BIOL, V17, P571, DOI 10.1016/j.tcb.2007.10.001; Dongo A, 2009, APPL ENVIRON MICROB, V75, P127, DOI 10.1128/AEM.00993-08; Germino FJ, 1999, METHOD ENZYMOL, V303, P422; Golemis EA, 1997, YEAST 2 HYBRID SYSTE, P43; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Miller TK, 2002, FUNGAL GENET BIOL, V35, P147, DOI 10.1006/fgbi.2001.1306; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Nagahashi S, 1998, MICROBIOL-UK, V144, P425, DOI 10.1099/00221287-144-2-425; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Oshima Michiyo, 2006, Journal of General Plant Pathology, V72, P65, DOI 10.1007/s10327-005-0247-7; Ostrander DB, 1999, J BACTERIOL, V181, P2527, DOI 10.1128/JB.181.8.2527-2534.1999; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; Schumacher MM, 1997, CURR MICROBIOL, V34, P340, DOI 10.1007/s002849900193; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Srikantha T, 1998, MICROBIOL-SGM, V144, P2715, DOI 10.1099/00221287-144-10-2715; Stephens DJ, 2000, TRAFFIC, V1, P763, DOI 10.1034/j.1600-0854.2000.011003.x; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4	48	54	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12121	12132		10.1074/jbc.M109.075721	http://dx.doi.org/10.1074/jbc.M109.075721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164185	Green Published, hybrid			2022-12-27	WOS:000276787100042
J	Cui, M; Tang, XN; Christian, WV; Yoon, Y; Tieu, K				Cui, Mei; Tang, Xiangna; Christian, Whitney V.; Yoon, Yisang; Tieu, Kim			Perturbations in Mitochondrial Dynamics Induced by Human Mutant PINK1 Can Be Rescued by the Mitochondrial Division Inhibitor mdivi-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; UBIQUITIN LIGASE; INDEPENDENT UBIQUITINATION; RECESSIVE PARKINSONISM; OXIDATIVE STRESS; MAMMALIAN-CELLS; DISEASE; MUTATIONS; PROTEIN; DEGRADATION	Mutations in the mitochondrial encoded protein PTEN-induced putative kinase 1 (PINK1) cause autosomal recessive Parkinson disease (PD). In mammalian cells, mutant PINK1 has been reported to promote fission or inhibit fusion in mitochondria; however, the mechanism by which this process occurs remains elusive. Using an ecdysone-inducible expression system in mammalian dopaminergic neuronal cells, we report here that human mutant PINK1 (L347P and W437X) mediates an overall fission effect by increasing the ratio of mitochondrial fission over fusion proteins, leading to excessive dysfunctional fragmented mitochondria. Knocking down endogenous Pink1 produces similar effects. In contrast, overexpressing human wild type PINK1 produces a pro-fusion effect by increasing the ratio of mitochondrial fusion/fission proteins without resulting in functionally compromised mitochondria. Parkin knockdown blocks the imbalance in fission/fusion proteins. Furthermore, overexpressing parkin and ubiquitin increases degradation of the mitochondrial fission hFis1 protein, suggesting PINK1 and parkin maintain proper mitochondrial function and integrity via the fission/fusion machinery. Through genetic manipulations and treatment with the small molecule mitochondrial division inhibitor (mdivi-1), which inhibits DLP1/Drp1, both structural and functional mitochondrial defects induced by mutant PINK1 were attenuated, highlighting a potential novel therapeutic avenue for Parkinson disease.	[Tieu, Kim] Univ Rochester, Sch Med, Dept Neurol, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Christian, Whitney V.; Tieu, Kim] Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY 14642 USA; [Yoon, Yisang] Univ Rochester, Sch Med, Dept Anesthesiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Tieu, K (corresponding author), Univ Rochester, Sch Med, Dept Neurol, Ctr Translat Neuromed, 575 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	kim_tieu@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020; Tieu, Kim/F-5426-2012; Tieu, Kim/AAG-7336-2019	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [ES014899, ES17470, DK078618, DK061991, P30 ES01247, T32 ES07026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK078618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, T32ES007026, R01ES014899, R21ES017470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES014899 and ES17470 (to K.T.), DK078618 and DK061991 (to Y.Y.), and P30 ES01247 and T32 ES07026.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Criscuolo C, 2006, MOVEMENT DISORD, V21, P1265, DOI 10.1002/mds.20933; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Halterman MW, 2009, J NEUROSCI METH, V177, P348, DOI 10.1016/j.jneumeth.2008.10.023; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mopert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Prasad KN, 1998, MOL GENET METAB, V65, P1, DOI 10.1006/mgme.1998.2726; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rohe CF, 2004, ANN NEUROL, V56, P427, DOI 10.1002/ana.20247; Rojo M, 2002, J CELL SCI, V115, P1663; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	52	145	149	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11740	11752		10.1074/jbc.M109.066662	http://dx.doi.org/10.1074/jbc.M109.066662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164189	hybrid, Green Published			2022-12-27	WOS:000276286200077
J	Gurgul-Convey, E; Lenzen, S				Gurgul-Convey, Ewa; Lenzen, Sigurd			Protection against Cytokine Toxicity through Endoplasmic Reticulum and Mitochondrial Stress Prevention by Prostacyclin Synthase Overexpression in Insulin-producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PANCREATIC BETA-CELLS; FACTOR-KAPPA-B; TUMOR-NECROSIS-FACTOR; BERAPROST SODIUM; RINM5F CELLS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; PROINFLAMMATORY CYTOKINES; ENDOGENOUS PROSTACYCLIN	Proinflammatory cytokines play a crucial role in the pathogenesis of type 1 diabetes mellitus. One of the cytokine-regulated pathways mediating inflammation in this autoimmune disease is the arachidonic acid metabolism pathway, comprising both the induction of cyclooxygenases and the production of different prostaglandins. Cytokine toxicity is mediated in many cell types, including pancreatic beta cells through this pathway. Interestingly, some cell types have been shown to be insensitive to such toxicity, and this correlated with a high expression of prostacyclin synthase (PGIS). Using insulin-producing RINm5F cells as a model for pancreatic beta cells, PGIS was overexpressed and exhibited a large protective effect against cytokine toxicity. This protective effect of PGIS against cytokine toxicity correlated with a decreased activation of the transcription factor NF kappa B and the inducible NO synthase promoter as well as a reduced inducible NO synthase protein expression and nitrite production. A reduction in the cytokine-stimulated endoplasmic reticulum and mitochondrial stress was also found in the PGIS-overexpressing cells. Moreover, cytokine-induced caspase-3 activation and reduction of glucose oxidation and cell proliferation were suppressed. Thus, PGIS overexpression apparently protects insulin-producing cells against cytokine toxicity via suppression of endoplasmic reticulum and mitochondrial stress-mediated cell death pathways.	[Gurgul-Convey, Ewa; Lenzen, Sigurd] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Hannover Medical School	Gurgul-Convey, E (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	Gurgul-Convey.Ewa@mh-hannover.de		Gurgul-Convey, Ewa/0000-0002-9269-266X	European Union [LSHM-CT-2006-036903]; German Foundation Das Zuckerkranke Kind	European Union(European Commission); German Foundation Das Zuckerkranke Kind	This work was supported by European Union Grant STREP SaveBeta LSHM-CT-2006-036903 in Framework Programme 6 of the European Community) (to S. L.) and by a grant from the German Foundation Das Zuckerkranke Kind (to E. G.- C.).	Arita S, 1999, PANCREAS, V19, P289, DOI 10.1097/00006676-199910000-00010; Arita S, 2001, PANCREAS, V23, P62, DOI 10.1097/00006676-200107000-00009; Arita S, 1998, TRANSPLANT P, V30, P366, DOI 10.1016/S0041-1345(97)01310-9; Arita S, 1997, TRANSPLANT P, V29, P1977, DOI 10.1016/S0041-1345(97)00190-5; Azevedo-Martins AK, 2003, DIABETES, V52, P93, DOI 10.2337/diabetes.52.1.93; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chambers KT, 2007, AM J PHYSIOL-ENDOC M, V292, pE1052, DOI 10.1152/ajpendo.00274.2006; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EIZIRIK DL, 1991, ENDOCRINOLOGY, V128, P1611, DOI 10.1210/endo-128-3-1611; EIZIRIK DL, 1988, ACTA ENDOCRINOL-COP, V119, P321, DOI 10.1530/acta.0.1190321; EIZIRIK DL, 1991, AUTOIMMUNITY, V10, P107, DOI 10.3109/08916939109004814; Eizirik DL, 1996, HORM METAB RES, V28, P302, DOI 10.1055/s-2007-979799; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; EIZIRIK DL, 1994, DIABETES METAB, V20, P116; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Elsner M, 2002, DIABETOLOGIA, V45, P1542, DOI 10.1007/s00125-002-0955-x; Flodstrom M, 1996, FEBS LETT, V385, P4, DOI 10.1016/0014-5793(96)00337-7; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Hatae T, 2001, J BIOL CHEM, V276, P46260, DOI 10.1074/jbc.M107180200; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Jobin C, 1998, IMMUNOLOGY, V95, P537; Kunugiza Y, 2006, GENE THER, V13, P1143, DOI 10.1038/sj.gt.3302767; Kwon G, 1998, DIABETES, V47, P583, DOI 10.2337/diabetes.47.4.583; LENZEN S, 1980, BIOCHEM J, V186, P135, DOI 10.1042/bj1860135; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Lortz S, 2000, DIABETES, V49, P1123, DOI 10.2337/diabetes.49.7.1123; Lortz S, 2005, DIABETOLOGIA, V48, P1541, DOI 10.1007/s00125-005-1822-3; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Maggi LB, 2000, DIABETES, V49, P346, DOI 10.2337/diabetes.49.3.346; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; MARNETT LJ, 1982, DRUG METAB REV, V13, P235, DOI 10.3109/03602538209029998; Marnett LJ, 2000, E SCHERING RES FDN W, V31, P65; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Pakrasi PL, 2007, LIFE SCI, V80, P1503, DOI 10.1016/j.lfs.2007.01.044; Pakrasi PL, 2008, PROSTAG LEUKOTR ESS, V79, P27, DOI 10.1016/j.plefa.2008.07.006; PAOLISSO G, 1995, DIABETES CARE, V18, P200, DOI 10.2337/diacare.18.2.200; PAOLISSO G, 1995, EUR J CLIN PHARMACOL, V48, P333; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Sandler S, 1992, Lakartidningen, V89, P1777; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; SCHEEREN T, 1994, J CRIT CARE, V9, P175, DOI 10.1016/0883-9441(94)90014-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Siegle I, 2000, J HISTOCHEM CYTOCHEM, V48, P631, DOI 10.1177/002215540004800507; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Souza KLA, 2008, J ENDOCRINOL, V197, P139, DOI 10.1677/JOE-07-0638; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Suarez-Pinzon WL, 2001, J AUTOIMMUN, V16, P449, DOI 10.1006/jaut.2001.0507; Tabatabaie T, 2003, DIABETES, V52, P1994, DOI 10.2337/diabetes.52.8.1994; Tiedge M, 1999, DIABETOLOGIA, V42, P849, DOI 10.1007/s001250051237; Tonnesen MF, 2009, ENDOCRINOLOGY, V150, P4094, DOI 10.1210/en.2009-0029; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Weber SM, 2004, AM J PHYSIOL-ENDOC M, V287, pE1171, DOI 10.1152/ajpendo.00331.2004; Weber SM, 2003, AM J PHYSIOL-ENDOC M, V284, pE883, DOI 10.1152/ajpendo.00515.2002; Wu KK, 2005, BIOCHEM BIOPH RES CO, V338, P45, DOI 10.1016/j.bbrc.2005.08.021; Yang ZD, 2005, AM J TRANSPLANT, V5, P475, DOI 10.1111/j.1600-6143.2005.00707.x; YEGEN C, 1994, PROSTAG LEUKOTR ESS, V51, P257, DOI 10.1016/0952-3278(94)90189-9	71	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11121	11128		10.1074/jbc.M109.054775	http://dx.doi.org/10.1074/jbc.M109.054775			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159982	hybrid, Green Published			2022-12-27	WOS:000276286200017
J	Kim, ED; Buckley, R; Learman, S; Richard, J; Parke, C; Worthylake, DK; Wojcik, EJ; Walker, RA; Kim, S				Kim, Elizabeth D.; Buckley, Rebecca; Learman, Sarah; Richard, Jessica; Parke, Courtney; Worthylake, David K.; Wojcik, Edward J.; Walker, Richard A.; Kim, Sunyoung			Allosteric Drug Discrimination Is Coupled to Mechanochemical Changes in the Kinesin-5 Motor Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE PROTEIN KSP; TRANSFORM INFRARED-SPECTROSCOPY; PRINCIPAL-COMPONENTS-ANALYSIS; TRITYL-L-CYSTEINE; SECONDARY STRUCTURE; SMALL-MOLECULE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL; BINDING REGION	Essential in mitosis, the human Kinesin-5 protein is a target for > 80 classes of allosteric compounds that bind to a surface exposed site formed by the L5 loop. Not established is why there are differing efficacies in drug inhibition. Here we compare the ligand-bound states of two L5-directed inhibitors against 15 Kinesin-5 mutants by ATPase assays and IR spectroscopy. Biochemical kinetics uncovers functional differences between individual residues at the N or C termini of the L5 loop. Infrared evaluation of solution structures and multivariate analysis of the vibrational spectra reveal that mutation and/or ligand binding not only can remodel the allosteric binding surface but also can transmit long range effects. Changes in L5-localized 310 helix and disordered content, regardless of substitution or drug potency, are experimentally detected. Principal component analysis couples these local structural events to two types of rearrangements in beta-sheet hydrogen bonding. These transformations in beta-sheet contacts are correlated with inhibitory drug response and are corroborated by wild type Kinesin-5 crystal structures. Despite considerable evolutionary divergence, our data directly support a theorized conserved element for long distance mechanochemical coupling in kinesin, myosin, and F-1-ATPase. These findings also suggest that these relatively rapid IR approaches can provide structural biomarkers for clinical determination of drug sensitivity and drug efficacy in nucleotide triphosphatases.	[Kim, Elizabeth D.; Buckley, Rebecca; Richard, Jessica; Parke, Courtney; Worthylake, David K.; Wojcik, Edward J.; Kim, Sunyoung] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Learman, Sarah; Walker, Richard A.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Virginia Polytechnic Institute & State University	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; OSER/Carilion Biomedical Institute; National Science Foundation; ASPIRES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066328, R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; OSER/Carilion Biomedical Institute; National Science Foundation(National Science Foundation (NSF)); ASPIRES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. J. W.). This work was also supported by grants from the Louisiana Board of Regents (to S. K. and to D. K. W.), the OSER/Carilion Biomedical Institute (to E. J. W. and S. K.), ASPIRES (to S. K., R. A. W., and E. J. W.), and the National Science Foundation (to R. A. W.).	Banci L, 2006, ACTA CRYSTALLOGR D, V62, P1208, DOI 10.1107/S0907444906029350; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2004, BIOCHEMISTRY-US, V43, P13072, DOI 10.1021/bi049264e; Brier S, 2006, RAPID COMMUN MASS SP, V20, P456, DOI 10.1002/rcm.2329; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Cox CD, 2005, BIOORG MED CHEM LETT, V15, P2041, DOI 10.1016/j.bmcl.2005.02.055; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fraley ME, 2006, BIOORG MED CHEM LETT, V16, P1775, DOI 10.1016/j.bmcl.2006.01.030; Garbaccio RM, 2006, BIOORG MED CHEM LETT, V16, P1780, DOI 10.1016/j.bmcl.2005.12.094; Garcia-Saez I, 2007, J BIOL CHEM, V282, P9740, DOI 10.1074/jbc.M608883200; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Hotha S, 2003, ANGEW CHEM INT EDIT, V42, P2379, DOI 10.1002/anie.200351173; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jun B, 2010, J BIOL CHEM, V285, P11073, DOI 10.1074/jbc.C110.103762; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Lin Z, 2004, AM J HUM GENET, V75, P850, DOI 10.1086/425587; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marshall CG, 2009, ARCH BIOCHEM BIOPHYS, V484, P1, DOI 10.1016/j.abb.2009.01.015; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sunder-Plassmann N, 2005, BIOORGAN MED CHEM, V13, P6094, DOI 10.1016/j.bmc.2005.06.027; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhang B, 2008, BIOCHEM BIOPH RES CO, V372, P565, DOI 10.1016/j.bbrc.2008.05.074	56	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18650	18661		10.1074/jbc.M109.092072	http://dx.doi.org/10.1074/jbc.M109.092072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20299460	Green Published, hybrid			2022-12-27	WOS:000278453900058
J	Hurst, DP; Grossfield, A; Lynch, DL; Feller, S; Romo, TD; Gawrisch, K; Pitman, MC; Reggio, PH				Hurst, Dow P.; Grossfield, Alan; Lynch, Diane L.; Feller, Scott; Romo, Tod D.; Gawrisch, Klaus; Pitman, Michael C.; Reggio, Patricia H.			A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; IONIC LOCK; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL MICRODOMAINS; METARHODOPSIN-II; PROTON UPTAKE; RHODOPSIN; ACTIVATION; CB2	Recent isothiocyanate covalent labeling studies have suggested that a classical cannabinoid, (-)-7'-isothiocyanato-11-hydroxy-1',1'dimethylheptyl-hexahydrocannabinol (AM841), enters the cannabinoid CB2 receptor via the lipid bilayer (Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D., Reggio, P. H., Janero, D. R., and Makriyannis, A. (2008) Chem. Biol. 15, 1207-1219). However, the sequence of steps involved in such a lipid pathway entry has not yet been elucidated. Here, we test the hypothesis that the endogenous cannabinoid sn-2-arachidonoylglycerol (2-AG) attains access to the CB2 receptor via the lipid bilayer. To this end, we have employed microsecond time scale all-atom molecular dynamics (MD) simulations of the interaction of 2-AG with CB2 via a palmitoyl-oleoyl-phosphatidylcholine lipid bilayer. Results suggest the following: 1) 2-AG first partitions out of bulk lipid at the transmembrane alpha-helix (TMH) 6/7 interface; 2) 2-AG then enters the CB2 receptor binding pocket by passing between TMH6 and TMH7; 3) the entrance of the 2-AG headgroup into the CB2 binding pocket is sufficient to trigger breaking of the intracellular TMH3/6 ionic lock and the movement of the TMH6 intracellular end away from TMH3; and 4) subsequent to protonation at D3.49/D6.30, further 2-AG entry into the ligand binding pocket results in both a W6.48 toggle switch change and a large influx of water. To our knowledge, this is the first demonstration via unbiased molecular dynamics that a ligand can access the binding pocket of a class A G protein-coupled receptor via the lipid bilayer and the first demonstration via molecular dynamics of G protein-coupled receptor activation triggered by a ligand binding event.	[Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Ctr Drug Discovery, Greensboro, NC 27402 USA; [Grossfield, Alan; Romo, Tod D.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Feller, Scott] Wabash Coll, Dept Chem, Crawfordsville, IN 47933 USA; [Gawrisch, Klaus] NIAAA, NIH, Bethesda, MD 20892 USA; [Pitman, Michael C.] IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	University of North Carolina; University of North Carolina Greensboro; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); International Business Machines (IBM)	Reggio, PH (corresponding author), Univ N Carolina, Dept Chem & Biochem, POB 26170, Greensboro, NC 27412 USA.	phreggio@uncg.edu		Grossfield, Alan/0000-0002-5877-2789	National Institutes of Health, NIDA [DA003934, DA021358]; NIAAA; National Science Foundation [MCB-0543124]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021358, R01DA003934] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA003934 and DA021358 (to P. H. R.) from NIDA and by grants from NIAAA, Intramural Research program (to K. G.). This work was also supported by National Science Foundation Grant MCB-0543124 (to S. F.).	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Benito C, 2003, J NEUROSCI, V23, P11136; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Fitch BG, 2003, J PARALLEL DISTR COM, V63, P759, DOI 10.1016/S0743-7315(03)00084-4; Fitch BG, 2006, LECT NOTES COMPUT SC, V3992, P846, DOI 10.1007/11758525_113; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Martinez-Mayorga K, 2006, J AM CHEM SOC, V128, P16502, DOI 10.1021/ja0671971; MAVROMOUSTAKOS T, 1991, PHARMACOL BIOCHEM BE, V40, P547, DOI 10.1016/0091-3057(91)90361-5; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Nebane NM, 2006, FEBS LETT, V580, P5392, DOI 10.1016/j.febslet.2006.09.001; Nebane NM, 2008, BIOCHEMISTRY-US, V47, P13811, DOI 10.1021/bi8007802; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pei Y, 2008, CHEM BIOL, V15, P1207, DOI 10.1016/j.chembiol.2008.10.011; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Pitman MC, 2005, J AM CHEM SOC, V127, P4576, DOI 10.1021/ja042715y; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reggio PH, 2006, AAPS J, V8, pE322; Rhee MH, 2000, FEBS LETT, V466, P300, DOI 10.1016/S0014-5793(00)01094-2; Romo TD, 2009, IEEE ENG MED BIO, P2332, DOI 10.1109/IEMBS.2009.5335065; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song ZH, 1999, MOL PHARMACOL, V56, P834; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Tian XY, 2005, J BIOL CHEM, V280, P29788, DOI 10.1074/jbc.M502925200; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Visiers I, 2002, INT J QUANTUM CHEM, V88, P65, DOI 10.1002/qua.10078; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Zhang RD, 2005, MOL PHARMACOL, V68, P69, DOI 10.1124/mol.104.007823	74	174	174	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17954	17964		10.1074/jbc.M109.041590	http://dx.doi.org/10.1074/jbc.M109.041590			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20220143	hybrid, Green Published			2022-12-27	WOS:000278133400071
J	Crouch, EC; Hirche, TO; Shao, BH; Boxio, R; Wartelle, J; Benabid, R; McDonald, B; Heinecke, J; Matalon, S; Belaaouaj, A				Crouch, Erika C.; Hirche, Tim O.; Shao, Baohai; Boxio, Rachel; Wartelle, Julien; Benabid, Rym; McDonald, Barbara; Heinecke, Jay; Matalon, Sadis; Belaaouaj, Azzaq			Myeloperoxidase-dependent Inactivation of Surfactant Protein D in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; D ENHANCES PHAGOCYTOSIS; RECOMBINANT SP-D; HYPOCHLOROUS ACID; HUMAN-NEUTROPHILS; HOST-DEFENSE; STRUCTURAL-CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; PULMONARY COLLECTINS; ALVEOLAR MACROPHAGES	Surfactant protein D (SP-D) plays diverse and important roles in innate immunity and pulmonary homeostasis. Neutrophils and myeloperoxidase (MPO) colocalized with SP-D in a murine bacterial pneumonia model of acute inflammation, suggesting that MPO-derived reactive species might alter the function of SP-D. Exposure of SP-D to the complete MPO-H2O2-halide system caused loss of SP-D-dependent aggregating activity. Hypochlorous acid (HOCl), the major oxidant generated by MPO, caused a similar loss of aggregating activity, which was accompanied by the generation of abnormal disulfide-cross-linked oligomers. A full-length SP-D mutant lacking N-terminal cysteine residues and truncation mutants lacking the N-terminal domains were resistant to the oxidant-induced alterations in disulfide bonding. Mass spectroscopy of HOCl-treated human SP-D demonstrated several modifications, but none involved key ligand binding residues. There was detectable oxidation of cysteine 15, but no HOCl-induced cysteine modifications were observed in the C-terminal lectin domain. Together, the findings localize abnormal disulfide cross-links to the N-terminal domain. MPO-deficient mice showed decreased cross-linking of SP-D and increased SP-D-dependent aggregating activity in the pneumonia model. Thus, MPO-derived oxidants can lead to modifications of SP-D structure with associated alterations in its characteristic aggregating activity.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Shao, Baohai; Heinecke, Jay] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35205 USA; [Hirche, Tim O.; Boxio, Rachel; Wartelle, Julien; Benabid, Rym; Belaaouaj, Azzaq] CHU Reims, INSERM Avenir EA 4303, IFR 53, F-51092 Reims, France	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crouch, EC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid, St Louis, MO 63110 USA.	crouch@path.wustl.edu	Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456; Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL-44015, HL-29594, 1U01ES015676, HL-086798, DK17047, K99HL-091055]; Conseil Regional Champagne-Ardenne; INSERM Avenir Program; University of Washington Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091055, R01HL044015, P01HL029594, R00HL091055, R01HL086798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conseil Regional Champagne-Ardenne(Region Grand-Est); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Washington Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-44015 and HL-29594 (to E. C. C.), 1U01ES015676 (to S. M.), HL-086798 and DK17047 (to J. H.), and K99HL-091055 (to B. S.). This work was also supported by grants from Conseil Regional Champagne-Ardenne, the INSERM Avenir Program (to R. B. and A. B.), FRM, and ANR (to A. B.), and the Mass Spectrometry Core (University of Washington Diabetes Endocrinology Research Center).	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; Clark H, 2002, IMMUNOBIOLOGY, V205, P619, DOI 10.1078/0171-2985-00159; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CROUCH E, 1993, AM J PATHOL, V142, P241; CROUCH E, 1992, AM J PHYSIOL, V263, pL60, DOI 10.1152/ajplung.1992.263.1.L60; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Crouch E C, 2000, Respir Res, V1, P93; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Davis IC, 2002, FREE RADICAL BIO MED, V33, P1703, DOI 10.1016/S0891-5849(02)01170-X; Drapeau G R, 1977, Methods Enzymol, V47, P189; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Haddad IY, 1996, AM J PHYSIOL-LUNG C, V270, pL281, DOI 10.1152/ajplung.1996.270.2.L281; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Hawgood S, 2001, ANNU REV PHYSIOL, V63, P495, DOI 10.1146/annurev.physiol.63.1.495; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hirche TO, 2005, J IMMUNOL, V174, P1557, DOI 10.4049/jimmunol.174.3.1557; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; King CC, 1997, J LEUKOCYTE BIOL, V61, P293, DOI 10.1002/jlb.61.3.293; Kishore U, 2001, Results Probl Cell Differ, V33, P225; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lessig J, 2005, CHEM PHYS LIPIDS, V135, P201, DOI 10.1016/j.chemphyslip.2005.02.015; Leth-Larsen R, 1999, BIOCHEM J, V343, P645, DOI 10.1042/0264-6021:3430645; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Matalon S, 2009, FASEB J, V23, P1415, DOI 10.1096/fj.08-120568; Naskalski JW, 2002, CLIN CHEM LAB MED, V40, P463, DOI 10.1515/CCLM.2002.080; NASKALSKI JW, 1994, ANN BIOL CLIN-PARIS, V52, P451; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Rothmann AB, 1997, EUR J BIOCHEM, V243, P630, DOI 10.1111/j.1432-1033.1997.t01-1-00630.x; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; Whiteman M, 2003, ARTHRITIS RHEUM-US, V48, P3140, DOI 10.1002/art.11284; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200; Zhu S, 1998, AM J PHYSIOL-LUNG C, V275, pL1031, DOI 10.1152/ajplung.1998.275.6.L1031	62	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16757	16770		10.1074/jbc.M109.097048	http://dx.doi.org/10.1074/jbc.M109.097048			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20228064	Green Published, hybrid			2022-12-27	WOS:000277982600039
J	Bekhouche, M; Kronenberg, D; Vadon-Le Goff, S; Bijakowski, C; Lim, NH; Font, B; Kessler, E; Colige, A; Nagase, H; Murphy, G; Hulmes, DJS; Moali, C				Bekhouche, Mourad; Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bijakowski, Cecile; Lim, Ngee Han; Font, Bernard; Kessler, Efrat; Colige, Alain; Nagase, Hideaki; Murphy, Gillian; Hulmes, David J. S.; Moali, Catherine			Role of the Netrin-like Domain of Procollagen C-Proteinase Enhancer-1 in the Control of Metalloproteinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; FRIZZLED-RELATED PROTEINS; ALPHA-CONVERTING-ENZYME; HUMAN TISSUE INHIBITOR; I PROCOLLAGEN; MATRIX-METALLOPROTEINASES; TERMINAL DOMAIN; SULFATED GLYCOSAMINOGLYCANS; PLASMINOGEN ACTIVATION; FIBRILLAR PROCOLLAGENS	The netrin-like (NTR) domain is a feature of several extracellular proteins, most notably the N-terminal domain of tissue inhibitors of metalloproteinases (TIMPs), where it functions as a strong inhibitor of matrix metalloproteinases and some other members of the metzincin superfamily. The presence of a C-terminal NTR domain in procollagen C-proteinase enhancers (PCPEs), proteins that stimulate the activity of astacin-like tolloid proteinases, raises the possibility that this might also have inhibitory activity. Here we show that both long and short forms of the PCPE-1 NTR domain, the latter beginning at the N-terminal cysteine known to be critical for TIMP activity, show no inhibition, at micromolar concentrations, of several members of the metzincin superfamily, including matrix metalloproteinase-2, bone morphogenetic protein-1 (a tolloid proteinase), and different ADAMTS (a disintegrin and a metalloproteinase with thrombospondin motifs) proteinases from the adamalysin family. In contrast, we report that the NTR domain within PCPE-1 leads to superstimulation of bone morphogenetic protein-1 activity in the presence of heparin and heparan sulfate. These observations point to a new mechanism whereby binding to cell surface-associated or extracellular heparin-like sulfated glycosaminoglycans might provide a means to accelerate procollagen processing in specific cellular and extracellular microenvironments.	[Bekhouche, Mourad; Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bijakowski, Cecile; Font, Bernard; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, Inst Biol & Chim Prot, CNRS, IFR128,UMR 5086, F-69367 Lyon 7, France; [Kronenberg, Daniel] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany; [Lim, Ngee Han; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Kessler, Efrat] Tel Aviv Univ, Chaim Sheba Med Ctr, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, IL-52621 Tel Hashomer, Israel; [Colige, Alain] Univ Liege, Lab Connect Tissues Biol, B-4000 Liege, Belgium; [Murphy, Gillian] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johannes Gutenberg University of Mainz; Imperial College London; University of Oxford; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Liege; CRUK Cambridge Institute; University of Cambridge	Hulmes, DJS (corresponding author), Univ Lyon, Inst Biol & Chim Prot, CNRS, IFR128,UMR 5086, 7 Passage Vercors, F-69367 Lyon 7, France.	d.hulmes@ibcp.fr	Bekhouche, Mourad/ABA-6557-2020; Bekhouche, Mourad/ABA-7355-2020; Kronenberg, Daniel/ABA-9255-2020; Bekhouche, Mourad/J-2230-2015; le goff, sandrine/AAE-1990-2019; Lim, Ngee Han/B-4226-2011	Bekhouche, Mourad/0000-0003-3786-2563; Kronenberg, Daniel/0000-0001-6807-7328; Bekhouche, Mourad/0000-0003-3786-2563; vadon-le goff, sandrine/0000-0002-4582-2273; Hulmes, David/0000-0002-0651-1317; MOALI, Catherine/0000-0003-2479-4290; Lim, Ngee Han/0000-0002-8520-7857	National Institutes of Health [AR40994]; La Ligue Contre le Cancer; Agence Nationale de la Recherche; Region Rhone-Alpes; Centre National de la Recherche Scientifique; Universite Claude Bernard Lyon 1; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994. This work was also supported by La Ligue Contre le Cancer, the Agence Nationale de la Recherche, the Region Rhone-Alpes, the Centre National de la Recherche Scientifique, and the Universite Claude Bernard Lyon 1.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunner G, 1998, EXP CELL RES, V239, P301, DOI 10.1006/excr.1997.3877; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; EDELBERG JM, 1991, BIOCHEMISTRY-US, V30, P10999, DOI 10.1021/bi00109a027; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GALLOWAY WA, 1983, BIOCHEM J, V209, P741, DOI 10.1042/bj2090741; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; RICARDBLUM S, 2006, FED EUR CONN TISS SO; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKADA Y, 1994, THROMB RES, V73, P301, DOI 10.1016/0049-3848(94)90026-4; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; WEISS T, 2008, FED EUR CONN TISS SO; Williamson RA, 2008, MOL BIOSYST, V4, P417, DOI 10.1039/b717901d; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	65	33	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15950	15959		10.1074/jbc.M109.086447	http://dx.doi.org/10.1074/jbc.M109.086447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207734	Green Published, hybrid			2022-12-27	WOS:000277715900032
J	Altimimi, HF; Fung, EH; Winkfein, RJ; Schnetkamp, PPM				Altimimi, Haider F.; Fung, Eric H.; Winkfein, Robert J.; Schnetkamp, Paul P. M.			Residues Contributing to the Na+-binding Pocket of the SLC24 Na+/Ca2+-K+ Exchanger NCKX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; RETINAL CONE PHOTORECEPTORS; ROD OUTER SEGMENTS; NA/CA-K EXCHANGER; MOLECULAR-CLONING; NA+-CA2+ EXCHANGER; CRYSTAL-STRUCTURE; GENE FAMILY; CA2+; TRANSPORT	Na+/Ca2+-K+ exchangers (NCKX; gene family SLC24) are plasma membrane Ca2+ transporters that mediate the extrusion of one Ca2+ ion and one K+ ion in exchange for four Na+ ions. NCKX is modeled to have two sets of five transmembrane segments separated by a large cytosolic loop; within each set of transmembrane segments are regions of internal symmetry termed alpha(1) and alpha(2) repeats. The central residues that are important for Ca2+ and K+ liganding and transport have been identified in NCKX2, and they comprise three central acidic residues, Glu(188) in alpha(1) and Asp(548) and Asp(575) in alpha(2), as well as Ser/Thr residues one-helical turn away from these residues. In this study, we have scanned through more than 100 single-residue substitutions of NCKX2 for shifts in Na+ affinity using a fluorescence assay to monitor changes in free Ca2+ in HEK293 cells treated with gramicidin to control intracellular Na+. We have identified 31 residues that, when substituted, result in shifts in Na+ affinity, either toward higher or lower K-m values when compared with wild type NCKX2 (K-m for Na+ 58 mM). These residues include the central acidic residues Glu(188), Asp(548), and Asp(575), and their neighboring residues in alpha(1) and alpha(2), in addition to a number of newly investigated residues in transmembrane segment 3. Our results relate the identification of residues important for Na+ transport in this study to those previously identified as important in the counter-transport of Ca2+ and K+, lending support to the alternating access model of transmembrane transport.	[Altimimi, Haider F.; Fung, Eric H.; Winkfein, Robert J.; Schnetkamp, Paul P. M.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary	Schnetkamp, PPM (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca	Altimimi, Haider/K-8658-2012	Altimimi, Haider/0000-0002-4516-141X	Canadian Institutes of Health Research [MOP 81327]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP 81327 from the Canadian Institutes of Health Research (to P. P. M. S.).	Altimimi HF, 2007, J BIOL CHEM, V282, P3720, DOI 10.1074/jbc.M609285200; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Dong H, 2006, AM J PHYSIOL-HEART C, V291, pH1226, DOI 10.1152/ajpheart.00196.2006; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; MOTULSKY H, 2004, FITTING MODELS BIOL, P134; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Paillart C, 2007, J GEN PHYSIOL, V129, P1, DOI 10.1085/jgp.200609652; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P198; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; Sharon D, 2002, INVEST OPHTH VIS SCI, V43, P1971; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15245	15255		10.1074/jbc.M109.090738	http://dx.doi.org/10.1074/jbc.M109.090738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231282	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000277399000045
J	Maiuri, T; Ho, J; Stambolic, V				Maiuri, Tamara; Ho, Jason; Stambolic, Vuk			Regulation of Adipocyte Differentiation by Distinct Subcellular Pools of Protein Kinase B (PKB/Akt)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; MITOTIC CLONAL EXPANSION; CELL-SURVIVAL; PEPTIDE INHIBITORS; AKT SUBSTRATE; PHOSPHORYLATION; ADIPOGENESIS; AKT/PKB; LOCALIZATION; ACTIVATION	The phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)/Akt-PTEN signal transduction pathway orchestrates a variety of fundamental cell processes and its deregulation is implicated in many human diseases. Although the importance of this pathway to many cellular functions is well established, the mechanisms by which it achieves context-specific physiological outcomes in response to a variety of stimuli, using a relatively limited pool of effectors, remain largely unknown. Spatial restriction of signaling events is one means by which cells coordinate specific responses using common molecules. To investigate the subcellular location-specific roles of the major PI3K effector PKB/Akt in various cell processes, we have developed a novel experimental system employing cellular compartment-directed PKB/Akt pseudosubstrate inhibitors. Subcellular location-restricted PKB/Akt inhibition in the 3T3L1 adipocyte differentiation model revealed that nuclear and plasma membrane, but not cytoplasmic, PKB/Akt activity is required for terminal adipocyte differentiation. Nuclear and plasma membrane pools of PKB/Akt were found to contribute to distinct stages of adipocyte differentiation, revealing that PKB/Akt activity impacts multiple points of this program. Our work establishes the use of localized pseudosubstrate PKB/Akt inhibitors as an effective method for the dissection of PKB/Akt signaling.	Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Stambolic, V (corresponding author), 610 Univ Ave,Rm 10-123, Toronto, ON M5G 2M9, Canada.	vuks@uhnres.utoronto.ca		Stambolic, Vuk/0000-0001-8853-3239; Maiuri, Tamara/0000-0002-6103-5835	Canadian Breast Cancer Foundation (Ontario branch)	Canadian Breast Cancer Foundation (Ontario branch)	This work was supported by funding from the Canadian Breast Cancer Foundation (Ontario branch) ( to V. S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alfaro-Lopez J, 1998, J MED CHEM, V41, P2252, DOI 10.1021/jm9707885; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geshi N, 2004, PLANTA, V218, P862, DOI 10.1007/s00425-003-1168-3; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; HARRIS TE, 1995, BIOCHEM SOC T, V23, pS187, DOI 10.1042/bst023187s; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yarmo MN, 2009, EXP CELL RES, V315, P411, DOI 10.1016/j.yexcr.2008.10.036; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]	50	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15038	15047		10.1074/jbc.M110.121434	http://dx.doi.org/10.1074/jbc.M110.121434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223817	Green Published, hybrid			2022-12-27	WOS:000277399000025
J	Nasie, I; Steiner-Mordoch, S; Gold, A; Schuldiner, S				Nasie, Iris; Steiner-Mordoch, Sonia; Gold, Ayala; Schuldiner, Shimon			Topologically Random Insertion of EmrE Supports a Pathway for Evolution of Inverted Repeats in Ion-coupled Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; X-RAY-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BIOLOGY; BACILLUS-SUBTILIS; PROTON RELEASE; CROSS-LINKING; MECHANISM; IDENTIFICATION; REVEALS	Inverted repeats in ion-coupled transporters have evolved independently in many unrelated families. It has been suggested that this inverted symmetry is an essential element of the mechanism that allows for the conformational transitions in transporters. We show here that small multidrug transporters offer a model for the evolution of such repeats. This family includes both homodimers and closely related heterodimers. In the former, the topology determinants, evidently identical in each protomer, are weak, and we show that for EmrE, an homodimer from Escherichia coli, the insertion into the membrane is random, and dimers are functional whether they insert into the cytoplasmic membrane with the N- and C-terminal domains facing the inside or the outside of the cell. Also, mutants designed to insert with biased topology are functional regardless of the topology. In the case of EbrAB, a heterodimer homologue supposed to interact antiparallel, we show that one of the subunits, EbrB, can also function as a homodimer, most likely in a parallel mode. In addition, the EmrE homodimer can be forced to an antiparallel topology by fusion of an additional transmembrane segment. The simplicity of the mechanism of coupling ion and substrate transport and the few requirements for substrate recognition provide the robustness necessary to tolerate such a unique and unprecedented ambiguity in the interaction of the subunits and in the dimer topology relative to the membrane. The results suggest that the small multidrug transporters are at an evolutionary junction and provide a model for the evolution of structure of transport proteins.	[Nasie, Iris; Steiner-Mordoch, Sonia; Gold, Ayala; Schuldiner, Shimon] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander A Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	National Institutes of Health [NS16708]; Israel Science Foundation [119/04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708. This work was also supported by Grant 119/04 from the Israel Science Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Godsey MH, 2002, J BIOL CHEM, V277, P40169, DOI 10.1074/jbc.R200018200; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAL N, 2009, S P NATL ACAD SCI US, V106, P9051; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	53	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15234	15244		10.1074/jbc.M110.108746	http://dx.doi.org/10.1074/jbc.M110.108746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308069	Green Published, hybrid			2022-12-27	WOS:000277399000044
J	Mantuano, E; Jo, M; Gonias, SL; Campana, WM				Mantuano, Elisabetta; Jo, Minji; Gonias, Steven L.; Campana, W. Marie			Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B PATHWAY; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; UROKINASE RECEPTOR; DEPENDENT PATHWAY; KINASE FUNCTIONS; BINDING; GTPASES; MOTILITY; FAMILY	LDL receptor-related protein (LRP1) is expressed by Schwann cells in vivo mainly after injury to the peripheral nervous system (PNS). Schwann cells in primary culture, which provide a model of Schwann cells in the injured PNS, also express abundant LRP1. Herein, we show that LRP1 gene-silencing or treatment with receptor-associated protein (RAP) promotes Schwann cell adhesion and inhibits cell migration on fibronectin. LRP1 gene-silencing also resulted in the formation of prominent focal adhesions and actin stress fibers. These changes, which were induced by loss of LRP1 expression or activity, were explained mechanistically by an increase in activated RhoA, coupled with a decrease in activated Rac1. Known LRP1 ligands, including matrix metalloprotease-9, tissue-type plasminogen activator, and alpha(2)-macroglobulin activated Rac1 in LRP1-expressing Schwann cells. An inhibitor of Rac1 activation promoted Schwann cell adhesion. Conversely, in cells in which LRP1 was silenced, a Rho kinase inhibitor promoted migration and inhibited adhesion. These results demonstrate that direct binding of ligands to LRP1 controls activation of small Rho family GTPases. The effects of LRP1 gene-silencing and RAP implicate autocrine pathways involving endogenously produced LRP1 ligands. Regulation of Schwann cell migration by LRP1 may be important in PNS injury.	[Mantuano, Elisabetta; Campana, W. Marie] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Mantuano, Elisabetta; Jo, Minji; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Campana, WM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@ucsd.edu	Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261	National Institutes of Health [R01 NS57456, R01 NS54671]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671, R01NS057456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS57456 and R01 NS54671.	Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; BOTTENSTEIN JE, 1980, EXP CELL RES, V129, P361, DOI 10.1016/0014-4827(80)90504-2; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Carstanjen D, 2005, TRANSFUSION, V45, P1192, DOI 10.1111/j.1537-2995.2005.00172.x; Chan JR, 2007, J CELL BIOL, V177, P953, DOI 10.1083/jcb.200705105; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feltri ML, 2008, GLIA, V56, P1508, DOI 10.1002/glia.20752; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Ide C, 1996, NEUROSCI RES, V25, P101; Inoue G, 2010, GLIA, V58, P399, DOI 10.1002/glia.20931; Jessen KR, 1999, ADV EXP MED BIOL, V468, P3; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Krause S, 2008, J PERIPHER NERV SYST, V13, P188, DOI 10.1111/j.1529-8027.2008.00177.x; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rebeck GW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pe28; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Webb DJ, 2000, J CELL SCI, V113, P123; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Wiggan ON, 2006, CELL SIGNAL, V18, P1501, DOI 10.1016/j.cellsig.2005.12.002; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Zhang XH, 2007, AM J PATHOL, V171, P1281, DOI 10.2353/ajpath.2007.070472	51	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14259	14266		10.1074/jbc.M109.085126	http://dx.doi.org/10.1074/jbc.M109.085126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197276	Green Published, hybrid			2022-12-27	WOS:000277299700022
J	Hsu, YC; Liao, WC; Kao, CY; Chiu, IM				Hsu, Yi-Chao; Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming			Regulation of FGF1 Gene Promoter through Transcription Factor RFX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM/PROGENITOR CELLS; STEM-CELLS; GROWTH-FACTOR; HEPARAN-SULFATE; SELF-RENEWAL; 1B PROMOTER; FACTOR-X; ADULT; EXPRESSION; PROTEIN	Fibroblast growth factor 1 (FGF1) has been suggested to have an important role in cell growth, proliferation, and neurogenesis. Human FGF1 gene 1B promoter (-540 to +31)-driven green fluorescence (F1BGFP) has been shown to monitor endogenous FGF1 expression. F1BGFP could also be used to isolate neural stem/progenitor cells from embryonic, neonatal, and adult mouse brains or to isolate glioblastoma stem cells (GBM-SCs) from human glioblastoma tissues. Here, we present evidence that transcription factor RFX1 could bind the 18-bp cis-elements (-484 to -467) of the F1B promoter, modulate F1BGFP expression and endogenous FGF1 expression, and further regulate the maintenance of GBM-SCs. These observations were substantiated by using yeast one-hybrid assay, electrophoretic mobility shift assay, chromatin immunoprecipitation assay, gain-and loss-of-function assays, and neurosphere assays. Overexpression of RFX1 was shown to down-regulate FGF-1B mRNA expression and neurosphere formation in human glioblastoma cells, whereas RNA interference knockdown of RFX1 demonstrated the opposite effects. Our findings provide insight into FGF1 gene regulation and suggest that the roles of FGF1 and RFX1 in the maintenance of GBM-SCs. RFX1 may negatively regulate the self-renewal of GBM-SCs through modulating FGF-1B and FGF1 expression levels by binding the 18-bp cis-elements of the F1B promoter.	[Hsu, Yi-Chao; Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Div Regenerat Med, Zhunan 35053, Miaoli County, Taiwan; [Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Inst Biotechnol, Hsinchu 30013, Taiwan; [Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Chiu, Ing-Ming] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Chiu, Ing-Ming] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Chiu, Ing-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 250, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Tsing Hua University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Chung Hsing University	Chiu, IM (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Div Regenerat Med, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	ingming@nhri.org.tw	Chiu, Ing-Ming/B-1534-2008; Hsu, Yi-Chao/AAK-7478-2021		National Science Council, Taiwan; National Health Research Institutes, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council, Taiwan, and the National Health Research Institutes, Taiwan.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Blake M, 1996, J VIROL, V70, P6060, DOI 10.1128/JVI.70.9.6060-6066.1996; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Chiu IM, 2000, ONCOGENE, V19, P6229, DOI 10.1038/sj.onc.1204021; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Chotani MA, 2000, J BIOL CHEM, V275, P30432, DOI 10.1074/jbc.M003545200; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Durand B, 2000, GENE, V246, P285, DOI 10.1016/S0378-1119(00)00093-7; ECKENSTEIN FP, 1994, PROG BRAIN RES, V103, P55; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Feng CZ, 2009, BIOCHEM BIOPH RES CO, V386, P715, DOI 10.1016/j.bbrc.2009.06.111; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galli Rosselia, 2008, V438, P67, DOI 10.1007/978-1-59745-133-8_7; Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x; Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Iwama A, 1999, MOL CELL BIOL, V19, P3940; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Katan-Khaykovich Y, 1998, J BIOL CHEM, V273, P24504, DOI 10.1074/jbc.273.38.24504; Katan-Khaykovich Y, 2001, EUR J BIOCHEM, V268, P3108, DOI 10.1046/j.1432-1327.2001.02211.x; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010; Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Ma BF, 2006, NEUROREPORT, V17, P377, DOI 10.1097/01.wnr.0000204981.36995.db; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; MYERS RL, 1995, ONCOGENE, V11, P785; MYERS RL, 1995, J BIOL CHEM, V270, P8257, DOI 10.1074/jbc.270.14.8257; MYERS RL, 1993, ONCOGENE, V8, P341; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Park JH, 2007, NEUROSCI LETT, V421, P185, DOI 10.1016/j.neulet.2007.02.069; PAYSON RA, 1993, NUCLEIC ACIDS RES, V21, P489, DOI 10.1093/nar/21.3.489; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Poltavtseva R. A., 2003, Ontogenez, V34, P211; Ray SK, 1997, J BIOL CHEM, V272, P7546, DOI 10.1074/jbc.272.11.7546; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Senti G, 2008, MOL BIOL CELL, V19, P5517, DOI 10.1091/mbc.E08-04-0416; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Ueba T, 1999, J BIOL CHEM, V274, P10382, DOI 10.1074/jbc.274.15.10382; Wang KR, 2007, J BIOL CHEM, V282, P26167, DOI 10.1074/jbc.M703448200; Weiss S, 1996, J NEUROSCI, V16, P7599; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	70	24	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13885	13895		10.1074/jbc.M109.081463	http://dx.doi.org/10.1074/jbc.M109.081463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189986	Green Published, hybrid			2022-12-27	WOS:000276987700063
J	Li, M; Wang, H; Huang, T; Wang, JY; Ding, Y; Li, ZF; Zhang, JK; Li, L				Li, Meng; Wang, He; Huang, Tao; Wang, Jiyong; Ding, Yu; Li, Zhenfei; Zhang, Jinkuo; Li, Lin			TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMO-LIKE-KINASE; MAP-KINASE; KAPPA-B; BETA-CATENIN; NEURAL INDUCTION; PROTEIN-KINASES; PATHWAY; ACTIVATION; TRANSCRIPTION; IL-1	The TAK1-NLK cascade is a mitogen-activated protein kinase-related pathway that plays an inhibitory role in canonical Wnt/beta-catenin signaling through regulating the LEF1/TCF family transcriptional factors. TAB2 (TAK1-binding protein 2) is a putative TAK1 interacting protein that is involved in the regulation of TAK1. Here, we found that TAB2 could directly interact with NLK and function as a scaffold protein to facilitate the interaction between TAK1 and NLK. Knocking down TAB2 using small interfering RNA abolished the interaction of TAK1 with NLK in mammalian cells. The intermediate region (residues 292-417) of TAB2 was mapped for its binding to NLK. TAB2-Delta M, a TAB2 mutant lacking this region, showed a lower affinity for NLK and became defective in its scaffolding function. In addition, TAB2, but not TAB2-Delta M, mediated TAK1-dependent activation of NLK and LEF1 polyubiquitylation, resulting in the inhibition of canonical Wnt signaling. Moreover, Wnt3a stimulation led to an increase in the interaction of TAB2 with NLK and the formation of a TAK1.TAB2.NLK complex, suggesting that this TAK1-TAB2-NLK pathway may constitute a negative feedback mechanism for canonical Wnt signaling.	[Li, Meng; Wang, He; Huang, Tao; Wang, Jiyong; Ding, Yu; Li, Zhenfei; Zhang, Jinkuo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Li, Zhenfei/AAU-1097-2020; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Ding, Yu/A-2949-2013; LI, LI/GVS-5344-2022	Li, Zhenfei/0000-0001-6520-431X; 	Ministry of Science and Technology of China [2010CB912100, 2007CB914500]; Natural Science Foundation of China [30821065, 30930052, 90813024, 30600305]; Science and Technology Commission of Shanghai Municipality	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2010CB912100 and 2007CB914500, by Natural Science Foundation of China Grants 30821065, 30930052, and 90813024 (to L. L.) and 30600305 (to J. W.), and by Science and Technology Commission of Shanghai Municipality grants.	Behrens J, 2000, J CELL SCI, V113, P911; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masui O, 2002, INT J MOL MED, V9, P489; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Munoz-Sanjuan I, 2002, DEVELOPMENT, V129, P5529, DOI 10.1242/dev.00097; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	52	25	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13397	13404		10.1074/jbc.M109.083246	http://dx.doi.org/10.1074/jbc.M109.083246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194509	hybrid, Green Published			2022-12-27	WOS:000276987700011
J	Li, ZY; Zhang, GY; Liu, JL; Stojanovic, A; Ruan, CG; Lowell, CA; Du, XP				Li, Zhenyu; Zhang, Guoying; Liu, Junling; Stojanovic, Aleksandra; Ruan, Changgeng; Lowell, Clifford A.; Du, Xiaoping			An Important Role of the Src Family Kinase Lyn in Stimulating Platelet Granule Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RECEPTOR-GAMMA-CHAIN; SIGNALING PATHWAY; GLYCOPROTEIN-VI; NITRIC-OXIDE; THROMBOXANE A(2); GUANYLYL CYCLASE; ACTIVATION; COLLAGEN; AGGREGATION	The Src family kinases (SFKs) have been proposed to play stimulatory and inhibitory roles in platelet activation. The mechanisms for these apparently contradictory roles are unclear. Here we show that SFK, mainly Lyn, is important in stimulating a common signaling pathway leading to secretion of platelet granules. Lyn knock-out or an isoform-nonselective SFK inhibitor, PP2, inhibited platelet secretion of both dense and alpha granules and the secretion-dependent platelet aggregation induced by thrombin, collagen, and thromboxane A(2). The inhibitory effect of Lyn knock-out on platelet aggregation was reversed by supplementing granule content ADP, indicating that the primary role of Lyn is to stimulate granule secretion. Inhibitory effect of PP2 on platelet aggregation induced by thrombin and thromboxane A(2) were also reversed by supplementing ADP. Furthermore, PP2 treatment or Lyn knock-out diminished agonist-induced Akt activation and cyclic GMP production. The inhibitory effect of PP2 or Lyn knock-out on platelet response can be corrected by supplementing cyclic GMP. These data indicate that Lyn stimulates platelet secretion by activating the phosphoinositide 3-kinase-Akt-nitric oxide (NO)-cyclic GMP pathway and also provide an explanation why Lyn can both stimulate and inhibit platelet activation.	[Li, Zhenyu; Zhang, Guoying] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Li, Zhenyu; Zhang, Guoying; Liu, Junling; Stojanovic, Aleksandra; Du, Xiaoping] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Li, Zhenyu; Ruan, Changgeng; Du, Xiaoping] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Dept Mol & Cell Biol, Shanghai 200025, Peoples R China; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Soochow University - China; Shanghai Jiao Tong University; University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, 741 S Limestone St,BBSRB Bldg,Rm B251, Lexington, KY 40536 USA.	zhenyuli08@uky.edu			National Institutes of Health (NIH); NHLBI [HL68819, HL62350, 080264]; NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease [P20 RR021954-01A1]; American Heart Association (AHA) National Scientist Development [0430095N]; AHA Midwes [0855698G]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068819, R01HL062350] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association (AHA) National Scientist Development(American Heart Association); AHA Midwes(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH), NHLBI, Grants HL68819, HL62350, and 080264 (to X.D.) and by NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant P20 RR021954-01A1. This work was also supported by American Heart Association (AHA) National Scientist Development Grant 0430095N and AHA Midwest Affiliate Grand-in-aid 0855698G (to Z. L.).	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; CHIANG TM, 1976, J LAB CLIN MED, V88, P215; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Du XP, 2007, CURR OPIN HEMATOL, V14, P262, DOI 10.1097/MOH.0b013e3280dce51a; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Locke D, 2003, J BIOL CHEM, V278, P15441, DOI 10.1074/jbc.M212338200; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Nanamori M, 2007, J IMMUNOL, V178, P416, DOI 10.4049/jimmunol.178.1.416; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Randriamboavonjy V, 2004, J EXP MED, V199, P347, DOI 10.1084/jem.20030694; Reed GL, 2000, BLOOD, V96, P3334; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; RETTORI V, 1993, P NATL ACAD SCI USA, V90, P10130, DOI 10.1073/pnas.90.21.10130; Riba R, 2008, J THROMB HAEMOST, V6, P2121, DOI 10.1111/j.1538-7836.2008.03179.x; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wildemann B, 1999, J NEUROBIOL, V39, P337, DOI 10.1002/(SICI)1097-4695(19990605)39:3<337::AID-NEU1>3.0.CO;2-9; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514	57	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12559	12570		10.1074/jbc.M109.098756	http://dx.doi.org/10.1074/jbc.M109.098756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20189992	Green Published, hybrid			2022-12-27	WOS:000276787800013
J	Romanenko, VG; Catalan, MA; Brown, DA; Putzier, I; Hartzell, HC; Marmorstein, AD; Gonzalez-Begne, M; Rock, JR; Harfe, BD; Melvin, JE				Romanenko, Victor G.; Catalan, Marcelo A.; Brown, David A.; Putzier, Ilva; Hartzell, H. Criss; Marmorstein, Alan D.; Gonzalez-Begne, Mireya; Rock, Jason R.; Harfe, Brian D.; Melvin, James E.			Tmem16A Encodes the Ca2+-activated Cl- Channel in Mouse Submandibular Salivary Gland Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNEL; REGULATED ANION CHANNELS; FLUID SECRETION; PROTEIN-KINASE; DUCT CELLS; FAMILY; BESTROPHIN; CONDUCTANCE; EXPRESSION; VOLUME	Activation of an apical Ca2+-dependent Cl- channel (CaCC) is the rate-limiting step for fluid secretion in many exocrine tissues. Here, we compared the properties of native CaCC in mouse submandibular salivary gland acinar cells to the Ca2+-gated Cl- currents generated by Tmem16A and Best2, members from two distinct families of Ca2+-activated Cl-channels found in salivary glands. Heterologous expression of Tmem16A and Best2 transcripts in HEK293 cells produced Ca2+-activated Cl-currents with time and voltage dependence and inhibitor sensitivity that resembled the Ca2+-activated Cl- current found in native salivary acinar cells. Best2(-/-) and Tmem16A(-/-) mice were used to further characterize the role of these channels in the exocrine salivary gland. The amplitude and the biophysical footprint of the Ca2+-activated Cl- current in submandibular gland acinar cells from Best2-deficient mice were the same as in wild type cells. Consistent with this observation, the fluid secretion rate in Best2 null mice was comparable with that in wild type mice. In contrast, submandibular gland acinar cells from Tmem16A(-/-) mice lacked a Ca2+-activated Cl-current and a Ca2+-mobilizing agonist failed to stimulate Cl-efflux, requirements for fluid secretion. Furthermore, saliva secretion was abolished by the CaCC inhibitor niflumic acid in wild type and Best2(-/-) mice. Our results demonstrate that both Tmem16A and Best2 generate Ca2+-activated Cl-current in vitro with similar properties to those expressed in native cells, yet only Tmem16A appears to be a critical component of the acinar Ca2+-activated Cl- channel complex that is essential for saliva production by the submandibular gland.	[Melvin, James E.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Gonzalez-Begne, Mireya] Univ Rochester, Ctr Oral Biol, Rochester, NY 14642 USA; [Putzier, Ilva; Hartzell, H. Criss; Melvin, James E.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA; [Marmorstein, Alan D.] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85711 USA; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA	University of Rochester; University of Rochester; Emory University; University of Arizona; University of Arizona; State University System of Florida; University of Florida	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu	Catalan, Marcelo/ABE-7044-2021; Catalan, Marcelo/AAW-3848-2020	Catalan, Marcelo/0000-0003-3544-2821	National Institutes of Health [DE09692, DE08921, GM060448, EY13160]; Macular Vision Research Foundation; NIDCR [DE07202]; NATIONAL EYE INSTITUTE [R01EY014852, R56EY013160, R01EY013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921, ZIADE000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE008921, T32DE007202, R01DE009692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE09692 and DE08921 (to J. E. M.), GM060448 (to H. C. H.), and EY13160 (to A. D. M.). This work was also supported by the Macular Vision Research Foundation (to A. D. M.) and an unrestricted grant to the Department of Ophthalmology and Vision Science at the University of Arizona from Research to Prevent Blindness (to A. D. M.).; Supported by National Institutes of Health Training Grant DE07202 from NIDCR (to J. E. M.)	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Brown DA, 2007, BBA-MOL CELL RES, V1773, P166, DOI 10.1016/j.bbamcr.2006.09.020; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Catalan MA, 2010, J PHYSIOL-LONDON, V588, P713, DOI 10.1113/jphysiol.2009.183541; COOK DIV, 1994, SECRETION MAJOR SALI, P1061; Droogmans G, 1999, BRIT J PHARMACOL, V128, P35, DOI 10.1038/sj.bjp.0702770; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; Duta V, 2006, J MEMBRANE BIOL, V213, P165, DOI 10.1007/s00232-006-0062-x; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; HANCOCK AA, 1988, TRENDS PHARMACOL SCI, V9, P29, DOI 10.1016/0165-6147(88)90239-8; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; HILLE B, 1992, IONIC CHANNELS EXCIT, P344; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Ishikawa T, 1996, J MEMBRANE BIOL, V153, P147, DOI 10.1007/s002329900118; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nakamoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC810, DOI 10.1152/ajpcell.00511.2007; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Rock JR, 2008, DEV DYNAM, V237, P2566, DOI 10.1002/dvdy.21676; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Srivastava A, 2008, J MEMBRANE BIOL, V222, P43, DOI 10.1007/s00232-008-9098-4; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Suzuki M, 2006, CELL MOL LIFE SCI, V63, P12, DOI 10.1007/s00018-005-5336-4; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zeng WZ, 1997, J BIOL CHEM, V272, P32956, DOI 10.1074/jbc.272.52.32956; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	56	148	152	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12990	13001		10.1074/jbc.M109.068544	http://dx.doi.org/10.1074/jbc.M109.068544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177062	Green Published, hybrid			2022-12-27	WOS:000276787800057
J	Porro, A; Haber, M; Diolaiti, D; Iraci, N; Henderson, M; Gherardi, S; Valli, E; Munoz, MA; Xue, CY; Flemming, C; Schwab, M; Wong, JH; Marshall, GM; Della Valle, G; Norris, MD; Perini, G				Porro, Antonio; Haber, Michelle; Diolaiti, Daniel; Iraci, Nunzio; Henderson, Michelle; Gherardi, Samuele; Valli, Emanuele; Munoz, Marcia A.; Xue, Chengyuan; Flemming, Claudia; Schwab, Manfred; Wong, Jason H.; Marshall, Glenn M.; Della Valle, Giuliano; Norris, Murray D.; Perini, Giovanni			Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; N-MYC; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; STEM-CELLS; TARGET GENES; IN-VIVO; C-MYC; EXPRESSION; PROTEIN	Increased expression of specific ATP-binding cassette (ABC) transporters is known to mediate the efflux of chemotherapeutic agents from cancer cells. Therefore, establishing how ABC transporter genes are controlled at their transcription level may help provide insight into the role of these multifaceted transporters in the malignant phenotype. We have investigated ABC transporter gene expression in a large neuroblastoma data set of 251 tumor samples. Clustering analysis demonstrated a strong association between differential ABC gene expression patterns in tumor samples and amplification of the MYCN oncogene, suggesting a correlation with MYCN function. Using expression profiling and chromatin immunoprecipitation studies, we show that MYCN oncoprotein coordinately regulates transcription of specificABCtransporter genes, by acting as either an activator or a repressor. Finally, we extend these notions to c-MYC showing that it can also regulate the same set of ABC transporter genes in other tumor cells through similar dynamics. Overall our findings provide insight into MYC-driven molecular mechanisms that contribute to coordinate transcriptional regulation of a large set of ABC transporter genes, thus affecting global drug efflux.	[Norris, Murray D.] UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia; [Porro, Antonio; Diolaiti, Daniel; Iraci, Nunzio; Gherardi, Samuele; Valli, Emanuele; Della Valle, Giuliano; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Schwab, Manfred] German Canc Res Ctr, Div Tumor Genet, D-69120 Heidelberg, Germany; [Wong, Jason H.] Univ New S Wales, Canc Res Ctr, Sydney, NSW 2052, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of Bologna; Helmholtz Association; German Cancer Research Center (DKFZ); University of New South Wales Sydney	Norris, MD (corresponding author), UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, POB 81, Randwick, NSW 2031, Australia.	mnorris@ccia.unsw.edu.au; giovanni.perini@unibo.it	Wong, Jason/A-9466-2008; diolaiti, daniel/A-7168-2012; Porro, Antonio/E-4363-2013; Valli, Emanuele/ABD-7213-2020; henderson, Michelle/G-6657-2012; Iraci, Nunzio/M-7451-2016	Wong, Jason/0000-0003-2953-7728; Valli, Emanuele/0000-0002-0928-8624; Iraci, Nunzio/0000-0003-2146-9329; Haber, Michelle/0000-0003-2036-8817; Norris, Murray/0000-0002-0632-4589; Porro, Antonio/0000-0003-2131-7771; Munoz, Marcia/0000-0001-7603-0351	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Dean M, 2001, J LIPID RES, V42, P1007; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Hendig D, 2009, MOL CELL BIOCHEM, V328, P85, DOI 10.1007/s11010-009-0077-6; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Lutz W, 1996, ONCOGENE, V13, P803; Mack JT, 2006, BIOMED PHARMACOTHER, V60, P587, DOI 10.1016/j.biopha.2006.07.090; Malynn BA, 2000, GENE DEV, V14, P1390; Manohar CF, 2004, ONCOGENE, V23, P753, DOI 10.1038/sj.onc.1207151; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nishimura S, 2007, HUM PATHOL, V38, P134, DOI 10.1016/j.humpath.2006.06.026; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Oevermann L, 2009, INT J CANCER, V124, P2303, DOI 10.1002/ijc.24207; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Porro A., 2007, EPIGENOME NETWORK EX; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Soichi O, 2007, NEUROSURGERY, V60, P707, DOI 10.1227/01.NEU.0000255395.15657.06; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tsuda H, 2005, CLIN CANCER RES, V11, P6880, DOI 10.1158/1078-0432.CCR-05-0751; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	49	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19532	19543		10.1074/jbc.M109.078584	http://dx.doi.org/10.1074/jbc.M109.078584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20233711	Green Published, hybrid			2022-12-27	WOS:000278727800063
J	Gupta, V; Kalaiarasan, P; Faheem, M; Singh, N; Iqbal, MA; Bamezai, RNK				Gupta, Vibhor; Kalaiarasan, Ponnusamy; Faheem, Mohammad; Singh, Nishant; Iqbal, Mohammad Askandar; Bamezai, Rameshwar N. K.			Dominant Negative Mutations Affect Oligomerization of Human Pyruvate Kinase M-2 Isozyme and Promote Cellular Growth and Polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL EXTENSION CE; BLOOM-SYNDROME CELLS; NUCLEAR TRANSLOCATION; ALLOSTERIC REGULATION; TUMOR-MARKER; M2; PROTEIN; BINDING; CANCER; GENE	This study was designed to understand the mechanism and functional implication of the two heterozygous mutations (H391Y and K422R) of human pyruvate kinase M2 isozyme (PKM2) observed earlier in a Bloom syndrome background. The co-expression of homotetrameric wild type and mutant PKM2 in the cellular milieu resulting in the interaction between the two at the monomer level was substantiated further by in vitro experiments. The cross-monomer interaction significantly altered the oligomeric state of PKM2 by favoring dimerization and heterotetramerization. In silico study provided an added support in showing that hetero-oligomerization was energetically favorable. The hetero-oligomeric populations of PKM2 showed altered activity and affinity, and their expression resulted in an increased growth rate of Escherichia coli as well as mammalian cells, along with an increased rate of polyploidy. These features are known to be essential to tumor progression. This study provides insight in understanding the modulated role of large oligomeric multifunctional proteins such as PKM2 by affecting cellular behavior, which is an essential observation to understand tumor sustenance and progression and to design therapeutic intervention in future.	[Gupta, Vibhor; Kalaiarasan, Ponnusamy; Faheem, Mohammad; Singh, Nishant; Iqbal, Mohammad Askandar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Shri Mata Vaishno Devi Univ, Katra Jammu 182320, Jammu & Kashmir, India.	bamezai@hotmail.com	Singh, Nishant/T-9054-2019	Singh, Nishant/0000-0002-8466-8862; Iqbal, Mohammad Askandar/0000-0003-3485-3530	University Grants Commission, Government of India; Council of Scientific and Industrial Research	University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by University Grants Commission, Government of India, for providing funds (to R. N. K. B.), and a Council of Scientific and Industrial Research fellowship (to V. G.).	Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Asou H, 2003, GENE CHROMOSOME CANC, V36, P167, DOI 10.1002/gcc.10161; Bagewadi B, 2004, J VIROL, V78, P11890, DOI 10.1128/JVI.78.21.11890-11903.2004; BAMEZAI R, 1987, HUM GENET, V75, P356, DOI 10.1007/BF00284107; BAMEZAI R, 1986, EXP CELL RES, V164, P163, DOI 10.1016/0014-4827(86)90463-5; Bamezai R., 1996, Indian Journal of Experimental Biology, V34, P298; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Dridi W, 2003, CANCER GENET CYTOGEN, V143, P39, DOI 10.1016/S0165-4608(02)00837-3; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Feiden Sandra, 2007, Reproduction, V134, P81, DOI 10.1530/REP-06-0250; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Grasberger H, 2005, MOL ENDOCRINOL, V19, P1779, DOI 10.1210/me.2004-0426; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; Hassan NMM, 2008, CANCER LETT, V270, P108, DOI 10.1016/j.canlet.2008.04.052; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huqun, 2003, CANCER SCI, V94, P718, DOI 10.1111/j.1349-7006.2003.tb01508.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; MASTERS M, 1971, NATURE-NEW BIOL, V232, P137, DOI 10.1038/newbio232137a0; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; MAZUREK S, 2010, INT J BIOCH IN PRESS; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Reddy BSN, 2000, INT J DERMATOL, V39, P760, DOI 10.1046/j.1365-4362.2000.00047.x; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; Shindyalov IN, 2001, NUCLEIC ACIDS RES, V29, P228, DOI 10.1093/nar/29.1.228; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Vertessy BG, 1999, BIOCHEM BIOPH RES CO, V254, P430, DOI 10.1006/bbrc.1998.9957; Wang H, 2002, DIABETES, V51, P2861, DOI 10.2337/diabetes.51.9.2861; Wenstrup RJ, 1996, CONNECT TISSUE RES, V35, P249, DOI 10.3109/03008209609029198; Wijnhoven SWP, 2007, CANCER RES, V67, P4648, DOI 10.1158/0008-5472.CAN-06-4681; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	53	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16864	16873		10.1074/jbc.M109.065029	http://dx.doi.org/10.1074/jbc.M109.065029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304929	Green Published, hybrid			2022-12-27	WOS:000277982600050
J	Pagliai, FA; Gardner, CL; Pande, SG; Lorca, GL				Pagliai, Fernando A.; Gardner, Christopher L.; Pande, Santosh G.; Lorca, Graciela L.			LVIS553 Transcriptional Regulator Specifically Recognizes Novobiocin as an Effector Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; LACTIC-ACID BACTERIA; PROMOTE PROTEIN STABILITY; ESCHERICHIA-COLI; DNA-BINDING; MARR FAMILY; BACILLUS-SUBTILIS; DEINOCOCCUS-RADIODURANS; MULTIDRUG TRANSPORTER; NEGATIVE REGULATOR	In this study we aimed to identify small molecules with high affinity involved in the allosteric regulation of LVIS553, a MarR member from Lactobacillus brevis ATCC367. Using high throughput screening, novobiocin was found to specifically bind LVIS553 with a K-D = 33.8 +/- 2.9 mu M consistent with a biologically relevant ligand. Structure guided site-directed mutagenesis identified Lys(9) as a key residue in novobiocin recognition. The results found in vitro were correlated in vivo. An increased tolerance to the antibiotic was observed when LVIS553 and the downstream putative transport protein LVIS552 were either expressed in a low copy plasmid in L. brevis or as a single copy chromosomal insertion in Bacillus subtilis. We provide evidence that LVIS553 is involved in the specific regulation of a new mechanism of tolerance to novobiocin.	[Pagliai, Fernando A.; Gardner, Christopher L.; Pande, Santosh G.; Lorca, Graciela L.] Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Inst Food & Agr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Inst Food & Agr Sci, Gainesville, FL 32610 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019	Gardner, Christopher/0000-0001-6416-8476; Pagliai, Fernando A./0000-0002-0434-4594	NIAID [R03AI078001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078001] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI078001 from the NIAID.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Coq AMCL, 2008, PLASMID, V60, P212, DOI 10.1016/j.plasmid.2008.08.002; Dangel V, 2008, ARCH MICROBIOL, V190, P509, DOI 10.1007/s00203-008-0396-0; Eustaquio AS, 2005, MICROBIOL-SGM, V151, P1949, DOI 10.1099/mic.0.27669-0; GOMBERT ME, 1984, ANTIMICROB AGENTS CH, V26, P933, DOI 10.1128/AAC.26.6.933; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; HOOPER DC, 1982, ANTIMICROB AGENTS CH, V22, P662, DOI 10.1128/AAC.22.4.662; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; Kim JY, 2009, J BACTERIOL, V191, P3273, DOI 10.1128/JB.00151-09; Kumaraswami M, 2009, NUCLEIC ACIDS RES, V37, P1211, DOI 10.1093/nar/gkn1046; Lorca GL, 2007, BBA-BIOMEMBRANES, V1768, P1342, DOI 10.1016/j.bbamem.2007.02.007; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lorca Graciela L., 2009, P115; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Middleton R, 2004, PLASMID, V51, P238, DOI 10.1016/j.plasmid.2004.01.006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nobeli I, 2006, BIOESSAYS, V28, P534, DOI 10.1002/bies.20414; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Perez-Rueda E, 2004, COMPUT BIOL CHEM, V28, P341, DOI 10.1016/j.compbiolchem.2004.09.004; PETITGLATRON MF, 1992, J GEN MICROBIOL, V138, P1089, DOI 10.1099/00221287-138-6-1089; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; SIMPSON WJ, 1992, LETT APPL MICROBIOL, V14, P13, DOI 10.1111/j.1472-765X.1992.tb00636.x; Suzuki K, 2005, APPL ENVIRON MICROB, V71, P5089, DOI 10.1128/AEM.71.9.5089-5097.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wilkinson SP, 2004, J BIOL CHEM, V279, P51442, DOI 10.1074/jbc.M405586200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilkinson SP, 2005, J MOL BIOL, V350, P617, DOI 10.1016/j.jmb.2005.05.027; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yu LL, 2009, BIOCHEMISTRY-US, V48, P2099, DOI 10.1021/bi801662s; Zianni Michael, 2006, J Biomol Tech, V17, P103	43	17	17	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16921	16930		10.1074/jbc.M110.111138	http://dx.doi.org/10.1074/jbc.M110.111138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308066	Green Published, hybrid			2022-12-27	WOS:000277982600055
J	Brandao, TAS; Hengge, AC; Johnson, SJ				Brandao, Tiago A. S.; Hengge, Alvan C.; Johnson, Sean J.			Insights into the Reaction of Protein-tyrosine Phosphatase 1B CRYSTAL STRUCTURES FOR TRANSITION STATE ANALOGS OF BOTH CATALYTIC STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ACID CATALYSIS; ACTIVE-SITE; PHOSPHORYL TRANSFER; INSULIN-RECEPTOR; PTP1B INHIBITOR; MOLECULAR-BASIS; YERSINIA; INTERMEDIATE; MECHANISM; VANADATE	Catalysis by protein-tyrosine phosphatase 1B (PTP1B) occurs through a two-step mechanism involving a phosphocysteine intermediate. We have solved crystal structures for the transition state analogs for both steps. Together with previously reported crystal structures of apo-PTP1B, the Michaelis complex of an inactive mutant, the phosphoenzyme intermediate, and the product complex, a full picture of all catalytic steps can now be depicted. The transition state analog for the first catalytic step comprises a ternary complex between the catalytic cysteine of PTP1B, vanadate, and the peptide DADEYL, a fragment of a physiological substrate. The equatorial vanadate oxygen atoms bind to the P-loop, and the apical positions are occupied by the peptide tyrosine oxygen and by the PTP1B cysteine sulfur atom. The vanadate assumes a trigonal bipyramidal geometry in both transition state analog structures, with very similar apical O-O distances, denoting similar transition states for both phosphoryl transfer steps. Detailed interactions between the flanking peptide and the enzyme are discussed.	[Brandao, Tiago A. S.; Hengge, Alvan C.; Johnson, Sean J.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Hengge, AC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	alvan.hengge@usu.edu; sean.johnson@usu.edu	Hengge, Alvan C/C-8667-2011; Johnson, Sean/G-8191-2012; Brandao, Tiago/N-6623-2017	Hengge, Alvan C/0000-0002-5696-2087; Johnson, Sean/0000-0001-7992-2494; Brandao, Tiago/0000-0002-7783-3014	National Institutes of Health [GM47297]; Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047297, R29GM047297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47297 (to A. C. H.).; Recipient of a fellowship from Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ala PJ, 2006, J BIOL CHEM, V281, P32784, DOI 10.1074/jbc.M606873200; Alhambra C, 1998, J AM CHEM SOC, V120, P3858, DOI 10.1021/ja972578n; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen HS, 2000, J BIOL CHEM, V275, P7101, DOI 10.1074/jbc.275.10.7101; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Asthagiri D, 2002, J AM CHEM SOC, V124, P10225, DOI 10.1021/ja020046n; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Baxter NJ, 2006, P NATL ACAD SCI USA, V103, P14732, DOI 10.1073/pnas.0604448103; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Brandao TAS, 2007, J ORG CHEM, V72, P3800, DOI 10.1021/jo070090r; Brandao TAS, 2009, J AM CHEM SOC, V131, P778, DOI 10.1021/ja807418b; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Deng H, 2002, BIOCHEMISTRY-US, V41, P5865, DOI 10.1021/bi016097z; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; DRUECKHAMMER DG, 1989, J ORG CHEM, V54, P70, DOI 10.1021/jo00262a021; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2006, ACTA CRYSTALLOGR D, V62, P1435, DOI 10.1107/S0907444906037784; Fauman EB, 1996, J BIOL CHEM, V271, P18780, DOI 10.1074/jbc.271.31.18780; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Guo XL, 2002, J BIOL CHEM, V277, P41014, DOI 10.1074/jbc.M207347200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; Hengge AC, 2002, ACCOUNTS CHEM RES, V35, P105, DOI 10.1021/ar000143q; HENGGE AC, 1994, J AM CHEM SOC, V116, P11256, DOI 10.1021/ja00104a007; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Hengge AC, 1997, BIOCHEMISTRY-US, V36, P7928, DOI 10.1021/bi970364c; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; Humphry T, 2004, J AM CHEM SOC, V126, P11864, DOI 10.1021/ja047110g; Humphry T, 2008, J AM CHEM SOC, V130, P17858, DOI 10.1021/ja8059864; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; JONES JP, 1991, BIOCHEMISTRY-US, V30, P3634, DOI 10.1021/bi00229a007; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Kirby AJ, 2005, J AM CHEM SOC, V127, P7033, DOI 10.1021/ja0502876; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; Li SQ, 2005, STRUCTURE, V13, P1643, DOI 10.1016/j.str.2005.07.019; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELANDER L, 1987, REACTION RATES ISOTO, P1; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; NOURELDEEN AF, 1985, J BIOL CHEM, V260, P6836; Orth ES, 2008, J AM CHEM SOC, V130, P2436, DOI 10.1021/ja710693x; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Phan J, 2003, BIOCHEMISTRY-US, V42, P13113, DOI 10.1021/bi030156m; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; *RIG CORP, 2006, CRYSTALCLEAR INT PRO; Rye CS, 2005, CURR MED CHEM, V12, P3127, DOI 10.2174/092986705774933452; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; Shen K, 2001, J BIOL CHEM, V276, P47311, DOI 10.1074/jbc.M106568200; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; WOLFENDEN R, 1978, TRANSITION STATES BI, P555; Zalatan JG, 2007, J AM CHEM SOC, V129, P9789, DOI 10.1021/ja072196+; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhao Y, 1996, BIOCHEMISTRY-US, V35, P11797, DOI 10.1021/bi960471r	79	102	105	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15874	15883		10.1074/jbc.M109.066951	http://dx.doi.org/10.1074/jbc.M109.066951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236928	hybrid, Green Published			2022-12-27	WOS:000277715900025
J	Majtan, T; Liu, L; Carpenter, JF; Kraus, JP				Majtan, Tomas; Liu, Lu; Carpenter, John F.; Kraus, Jan P.			Rescue of Cystathionine beta-Synthase (CBS) Mutants with Chemical Chaperones PURIFICATION AND CHARACTERIZATION OF EIGHT CBS MUTANT ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; REACTION-MECHANISM; REDOX REGULATION; LIGAND SWITCH; ACTIVE CORE; PROTEIN; HEME; MUTATIONS; HOMOCYSTINURIA; DISORDERS	Missense mutations represent the most common cause of many genetic diseases including cystathionine beta-synthase (CBS) deficiency. Many of these mutations result in misfolded proteins, which lack biological function. The presence of chemical chaperones can sometimes alleviate or even restore protein folding and activity of mutant proteins. We present the purification and characterization of eight CBS mutants expressed in the presence of chemical chaperones such as ethanol, dimethyl sulfoxide, or trimethylamine-N-oxide. Preliminary screening in Escherichia coli crude extracts showed that their presence during protein expression had a significant impact on the amount of recovered CBS protein, formation of tetramers, and catalytic activity. Subsequently, we purified eight CBS mutants to homogeneity (P49L, P78R, A114V, R125Q, E176K, P422L, I435T, and S466L). The tetrameric mutant enzymes fully saturated with heme had the same or higher specific activities than wild type CBS. Thermal stability measurements demonstrated that the purified mutants are equally or more thermostable than wild type CBS. The response to S-adenosyl-L-methionine stimulation or thermal activation varied. The lack of response of R125Q and E176K to both stimuli indicated that their specific conformations were unable to reach the activated state. Increased levels of molecular chaperones in crude extracts, particularly DnaJ, indicated a rather indirect effect of the chemical chaperones on folding of CBS mutants. In conclusion, the chemical chaperones present in the expression medium were able to fully restore the activity of eight CBS mutants by improving their protein folding. This finding could have direct implications for the development of a therapeutical approach to pyridoxine unresponsive homocystinuria.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Majtan, Tomas; Kraus, Jan P.] Univ Colorado Denver, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO 80045 USA; [Majtan, Tomas] Slovak Acad Sci, Inst Mol Biol, Dept Genom & Biotechnol, Bratislava 84551, Slovakia; [Liu, Lu; Carpenter, John F.] Univ Colorado Denver, Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Slovak Academy of Sciences; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kraus, JP (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, 12800 E 19th Ave, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Majtan, Tomas/AAE-8426-2021	Majtan, Tomas/0000-0002-2751-2124	National Institutes of Health [HL065217-06A2]; American Heart Association [09GRNT2110159, 0920079G]; Jerome Lejeune Foundation; Margie McGlynn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jerome Lejeune Foundation; Margie McGlynn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065217-06A2 (to J. P. K.). This work was also supported by American Heart Association Grant-in-Aid 09GRNT2110159, a grant from the Jerome Lejeune Foundation (to J. P. K.), and a generous gift from Margie McGlynn.; Recipient of Postdoctoral Fellowship 0920079G from the American Heart Association.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; Frank N, 2006, BIOCHEMISTRY-US, V45, P11021, DOI 10.1021/bi060737m; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; KRAUS JP, 1983, ARCH BIOCHEM BIOPHYS, V222, P44, DOI 10.1016/0003-9861(83)90500-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nascimento C, 2008, PROTEIN J, V27, P392, DOI 10.1007/s10930-008-9149-9; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Sideras K, 2009, ADV CLIN CHEM, V47, P1, DOI 10.1016/S0065-2423(09)47001-X; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Staretz-Chacham O, 2009, PEDIATRICS, V123, P1191, DOI 10.1542/peds.2008-0635; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9	38	54	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15866	15873		10.1074/jbc.M110.107722	http://dx.doi.org/10.1074/jbc.M110.107722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308073	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000277715900024
J	Berwick, DC; Diss, JKJ; Budhram-Mahadeo, VS; Latchman, DS				Berwick, Daniel C.; Diss, James K. J.; Budhram-Mahadeo, Vishwanie S.; Latchman, David S.			A Simple Technique for the Prediction of Interacting Proteins Reveals a Direct Brn-3a-Androgen Receptor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRN-3A TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; FUNCTIONAL INTERACTION; NEURITE OUTGROWTH; ESTROGEN-RECEPTOR; NEURONAL CELLS; IN-VIVO; ACTIVATION; EXPRESSION; PROMOTER	The formation of multiprotein complexes constitutes a key step in determining the function of any translated gene product. Thus, the elucidation of interacting partners for a protein of interest is of fundamental importance to cell biology. Here we describe a simple methodology for the prediction of novel interactors. We have applied this to the developmental transcription factor Brn-3a to predict and verify a novel interaction between Brn-3a and the androgen receptor (AR). We demonstrate that these transcription factors form complexes within the nucleus of ND7 neuroblastoma cells, while in vitro pull-down assays show direct association. As a functional consequence of the Brn-3a-AR interaction, the factors bind cooperatively to multiple elements within the promoter of the voltage-gated sodium channel, Nav1.7, leading to a synergistic increase in its expression. Thus, these data define AR as a direct Brn-3a interactor and verify a simple interacting protein prediction methodology that is likely to be useful for many other proteins.	[Berwick, Daniel C.; Diss, James K. J.; Budhram-Mahadeo, Vishwanie S.; Latchman, David S.] UCL, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; [Latchman, David S.] Univ London, London WC1E 7HX, England	University of London; University College London; University of London	Berwick, DC (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	daniel.berwick@live.pharmacy.ac.uk	Berwick, Dan/J-2378-2012; Diss, James K/C-5994-2008; Berwick, Dan/AAJ-7779-2021	Berwick, Dan/0000-0002-7144-7841; Diss, James K/0000-0003-4988-257X; Berwick, Dan/0000-0002-7144-7841	Biotechnology and Biological Science Research Center; Prostate UK; BBSRC [BB/D521314/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521314/1] Funding Source: researchfish	Biotechnology and Biological Science Research Center(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Science Research Center and Prostate UK.	Arndt HD, 2006, ANGEW CHEM INT EDIT, V45, P4552, DOI 10.1002/anie.200600285; Asthana S, 2004, GENOME RES, V14, P1170, DOI 10.1101/gr.2203804; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Berwick DC, 2009, BRAIN RES, V1256, P8, DOI 10.1016/j.brainres.2008.12.009; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Budhram-Mahadeo V, 1998, MOL CELL BIOL, V18, P1029, DOI 10.1128/MCB.18.2.1029; BUDHRAMMAHADEO V, 1995, J BIOL CHEM, V270, P2853, DOI 10.1074/jbc.270.6.2853; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Calissano M, 2005, MOL BRAIN RES, V141, P10, DOI 10.1016/j.molbrainres.2005.07.013; Calissano M, 2003, ONCOGENE, V22, P5408, DOI 10.1038/sj.onc.1206635; Chan HM, 2001, J CELL SCI, V114, P2363; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dennis JH, 2002, BIOCHEM BIOPH RES CO, V294, P487, DOI 10.1016/S0006-291X(02)00500-4; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Diss JKJ, 2008, MOL CELL NEUROSCI, V37, P537, DOI 10.1016/j.mcn.2007.12.002; Diss JKJ, 2006, PROSTATE CANCER P D, V9, P83, DOI 10.1038/sj.pcan.4500837; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Farooqui-Kabir SR, 2004, CELL DEATH DIFFER, V11, P1242, DOI 10.1038/sj.cdd.4401478; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hudson CD, 2008, CELL DEATH DIFFER, V15, P1266, DOI 10.1038/cdd.2008.45; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Kawaguchi A, 2007, NEUROCHEM RES, V32, P1469, DOI 10.1007/s11064-007-9334-9; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164; Koentges G, 2008, NATURE, V451, P658, DOI 10.1038/451658a; LAKIN ND, 1995, J BIOL CHEM, V270, P15858, DOI 10.1074/jbc.270.26.15858; Latchman DS, 1998, INT J BIOCHEM CELL B, V30, P1153, DOI 10.1016/S1357-2725(98)00090-9; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Luo H, 2008, HISTOCHEM CELL BIOL, V129, P525, DOI 10.1007/s00418-008-0380-4; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Perez-Sanchez C, 2002, NUCLEIC ACIDS RES, V30, P4872, DOI 10.1093/nar/gkf610; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith MD, 1997, J BIOL CHEM, V272, P21325, DOI 10.1074/jbc.272.34.21325; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Smith MD, 2001, MOL CELL NEUROSCI, V17, P460, DOI 10.1006/mcne.2000.0927; Smith MD, 1997, MOL CELL BIOL, V17, P345, DOI 10.1128/MCB.17.1.345; Smith MD, 1998, NUCLEIC ACIDS RES, V26, P4100, DOI 10.1093/nar/26.18.4100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Theil T, 1995, J BIOL CHEM, V270, P30958, DOI 10.1074/jbc.270.52.30958; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yu HY, 2006, BIOINFORMATICS, V22, P823, DOI 10.1093/bioinformatics/btl014	54	8	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15286	15295		10.1074/jbc.M109.071456	http://dx.doi.org/10.1074/jbc.M109.071456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228055	Green Published, hybrid			2022-12-27	WOS:000277399000049
J	Herrera, M; Garvin, JL				Herrera, Marcela; Garvin, Jeffrey L.			Angiotensin II Stimulates Thick Ascending Limb NO Production via AT(2) Receptors and Akt1-dependent Nitric-oxide Synthase 3 (NOS3) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-SENSITIVE RATS; TYPE-2 RECEPTOR; NACL ABSORPTION; ANG-II; CHLORIDE ABSORPTION; INDUCED INHIBITION; ENDOTHELIAL-CELLS; ENOS ACTIVATION; L-ARGININE; PHOSPHORYLATION	Angiotensin II (Ang II) acutely stimulates thick ascending limb (TAL) NO via an unknown mechanism. In endothelial cells, activation of Ang II type 2 receptor (AT(2)) stimulates NO. Akt1 activates NOS3 by direct phosphorylation. We hypothesized that Ang II stimulates TAL NO production via AT(2)-mediated Akt1 activation, which phosphorylates NOS3 at serine 1177. We measured NO production by fluorescence microscopy. In isolated TALs, Ang II (100 nM) increased NO production by 1.1 +/- 0.2 fluorescence units/min (p < 0.01). Ang II increased cGMP accumulation by 4.9 +/- 1.3 fmol/mu g (p < 0.01). Upon adding the AT(2) antagonist PD123319 (1 mu M), Ang II failed to stimulate NO (0.1 +/- 0.1 fluorescence units/min; p < 0.001 versus Ang II); adding the AT(1) antagonist losartan (1 mu M) resulted in Ang II stimulating NO by 0.9 +/- 0.1 fluorescence units/min. Akt inhibitor (5 mu M) blocked Ang II-stimulated NO (-0.1 +/- 0.2 fluorescence units/min versus inhibitor alone). Phospho-Akt1 increased by 72% after 5 min (p < 0.006), returning to basal after 10 min. Phospho-Akt2 did not change after 5 min but increased by 115 and 163% after 10 and 15 min (p < 0.02). Phospho-Akt3 did not change. An AT(2) agonist increased pAkt1 by 78% (p < 0.02), PI3K inhibition blocked this effect. In TALs transduced with dominant negative Akt1, Ang II failed to stimulate NO(0.1 +/- 0.2 fluorescence units/min versus 1.2 +/- 0.2 for controls; p < 0.001). Ang II increased phospho-NOS3 at serine 1177 by 130% (p < 0.01) and 150% after 5 and 10 min (p < 0.02). Ang II increased phospho-NOS3 at serine 633 by 50% after 5 min (p < 0.01). Akt inhibition prevented NOS3 phosphorylation. We concluded that Ang II enhances TAL NO production via activation of AT(2) and Akt1-dependent phosphorylation of NOS3 at serines 1177 and 633.	[Herrera, Marcela; Garvin, Jeffrey L.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Herrera, M (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, E&R 7018,2799 W Grand Blvd, Detroit, MI 48202 USA.	mherrer1@hfhs.org			NHLBI, National Institutes of Health [PO1HL-28982, PO1HL-90550, RO1HL-70985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090550, P01HL028982, R01HL070985] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grants PO1HL-28982, PO1HL-90550, and RO1HL-70985 ( to J.L.G.).	Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047, DOI 10.1152/ajpcell.1998.274.4.C1047; Batenburg WW, 2004, CIRCULATION, V109, P2296, DOI 10.1161/01.CIR.0000128696.12245.57; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Cervenka L, 1998, AM J PHYSIOL-RENAL, V274, pF940, DOI 10.1152/ajprenal.1998.274.5.F940; Dickhout JG, 2002, CIRC RES, V91, P487, DOI 10.1161/01.RES.0000035243.66189.92; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia NH, 1999, HYPERTENSION, V34, P508, DOI 10.1161/01.HYP.34.3.508; GARVIN J L, 1988, American Journal of Physiology, V255, pF57; HALL JE, 1977, AM J PHYSIOL, V232, pF538, DOI 10.1152/ajprenal.1977.232.6.F538; HARRIS PJ, 1985, AM J PHYSIOL, V248, pF621, DOI 10.1152/ajprenal.1985.248.5.F621; HARRIS PJ, 1984, CLIN SCI, V66, P541, DOI 10.1042/cs0660541; Helle F, 2009, AM J PHYSIOL-RENAL, V296, pF78, DOI 10.1152/ajprenal.90518.2008; Herrera M, 2006, AM J PHYSIOL-RENAL, V290, pF1279, DOI 10.1152/ajprenal.00465.2005; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hiyoshi H, 2005, HYPERTENSION, V45, P967, DOI 10.1161/01.HYP.0000164571.77710.19; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Ikenaga H, 1996, AM J PHYSIOL-RENAL, V271, pF365, DOI 10.1152/ajprenal.1996.271.2.F365; KOST CK, 1993, HYPERTENSION, V21, P420, DOI 10.1161/01.HYP.21.4.420; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Lerolle N, 2004, AM J PHYSIOL-RENAL, V287, pF404, DOI 10.1152/ajprenal.00265.2003; Liu RS, 2004, HYPERTENSION, V43, P649, DOI 10.1161/01.HYP.0000116222.57000.85; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Majid DSA, 2005, AM J PHYSIOL-RENAL, V288, pF412, DOI 10.1152/ajprenal.00294.2004; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF274, DOI 10.1152/ajprenal.00382.2003; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF281, DOI 10.1152/ajprenal.00383.2003; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2002, HYPERTENSION, V39, P591, DOI 10.1161/hy0202.103287; Ortiz PA, 2002, AM J PHYSIOL-RENAL, V283, pF957, DOI 10.1152/ajprenal.00102.2002; Ortiz PA, 2001, AM J PHYSIOL-RENAL, V281, pF819, DOI 10.1152/ajprenal.0075.2001; Padia SH, 2006, HYPERTENSION, V47, P537, DOI 10.1161/01.HYP.0000196950.48596.21; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Plato CF, 2001, AM J PHYSIOL-RENAL, V281, pF679, DOI 10.1152/ajprenal.2001.281.4.F679; Plato CF, 1999, AM J PHYSIOL-RENAL, V276, pF159, DOI 10.1152/ajprenal.1999.276.1.F159; Pollock JS, 2006, HYPERTENSION, V47, P19, DOI 10.1161/01.HYP.0000196276.29211.6f; Ramseyer VD, 2009, HYPERTENSION, V53, P313, DOI 10.1161/HYPERTENSIONAHA.108.124107; ROMAN RJ, 1991, HYPERTENSION, V17, P1018, DOI 10.1161/01.HYP.17.6.1018; Saito S, 1996, Hypertens Res, V19, P201, DOI 10.1291/hypres.19.201; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Silva GB, 2009, AM J PHYSIOL-RENAL, V297, pF646, DOI 10.1152/ajprenal.00270.2009; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Szentivanyi M, 2002, AM J PHYSIOL-REG I, V283, pR266, DOI 10.1152/ajpregu.00461.2001; Welch WJ, 2001, KIDNEY INT, V59, P1257, DOI 10.1046/j.1523-1755.2001.0590041257.x; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27; Zhang Z, 2005, AM J PHYSIOL-HEART C, V288, pH29, DOI 10.1152/ajpheart.00623.2004	54	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14932	14940		10.1074/jbc.M110.109041	http://dx.doi.org/10.1074/jbc.M110.109041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299462	Green Published, hybrid			2022-12-27	WOS:000277399000014
J	Loesch, M; Zhi, HY; Hou, SW; Qi, XM; Li, RS; Basir, Z; Iftner, T; Cuenda, A; Chen, G				Loesch, Mathew; Zhi, Hui-Ying; Hou, Song-Wang; Qi, Xiao-Mei; Li, Rong-Shan; Basir, Zainab; Iftner, Thomas; Cuenda, Ana; Chen, Guan			p38 gamma MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D-RECEPTOR; BREAST-CANCER CELLS; TRANSCRIPTION FACTORS; RAS TRANSFORMATION; ESTROGEN-RECEPTOR; SB 203580; IN-VITRO; P38; EXPRESSION	Mitogen-activated protein kinases (MAPKs) regulate gene expression through transcription factors. However, the precise mechanisms in this critical signal event are largely unknown. Here, we show that the transcription factor c-Jun is activated by p38 gamma MAPK, and the activated c-Jun then recruits p38 gamma as a cofactor into the matrix metalloproteinase 9 (MMP9) promoter to induce its trans-activation and cell invasion. This signaling event was initiated by hyperexpressed p38 gamma that led to increased c-Jun synthesis, MMP9 transcription, and MMP9-dependent invasion through p38 gamma interacting with c-Jun. p38 gamma requires phosphorylation and its C terminus to bind c-Jun, whereas both c-Jun and p38 gamma are required for the trans-activation of MMP9. The active p38 gamma/c-Jun/MMP9 pathway also exists in human colon cancer, and there is a coupling of increased p38 gamma and MMP9 expression in the primary tissues. These results reveal a new paradigm in which a MAPK acts both as an activator and a cofactor of a transcription factor to regulate gene expression leading to an invasive response.	[Loesch, Mathew; Zhi, Hui-Ying; Hou, Song-Wang; Qi, Xiao-Mei; Chen, Guan] Milwaukee Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Li, Rong-Shan; Basir, Zainab] Milwaukee Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Chen, Guan] Milwaukee Med Coll Wisconsin, Res Serv, Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Iftner, Thomas] Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, Sect Expt Virol, D-72076 Tubingen, Germany; [Cuenda, Ana] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Chen, G (corresponding author), Milwaukee Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	gchen@mcw.edu	Iftner, Thomas/ABF-9029-2020		National Institutes of Health [2R01 CA91576]; Department of Veterans Affairs; Breast Cancer Show House (Cancer Center, Medical College of Wisconsin); NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Breast Cancer Show House (Cancer Center, Medical College of Wisconsin); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 2R01 CA91576. This work was also supported by the Department of Veterans Affairs (Merit Review) and the Breast Cancer Show House (Cancer Center, Medical College of Wisconsin).	Adiseshaiah P, 2008, BIOCHEM BIOPH RES CO, V371, P304, DOI 10.1016/j.bbrc.2008.04.063; Allgayer H, 1999, BRIT J CANCER, V80, P1884, DOI 10.1038/sj.bjc.6690616; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Baumgartner M, 2008, MOL CELL BIOL, V28, P642, DOI 10.1128/MCB.01024-07; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Canning MT, 2001, EXP CELL RES, V267, P88, DOI 10.1006/excr.2001.5243; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; GALANG CK, 1994, ONCOGENE, V9, P2913; Goruppi S, 2007, MOL CELL BIOL, V27, P993, DOI 10.1128/MCB.00996-06; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hall-Jackson CA, 1999, ONCOGENE, V18, P2047, DOI 10.1038/sj.onc.1202603; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Illemann M, 2006, MOL CANCER RES, V4, P293, DOI 10.1158/1541-7786.MCR-06-0003; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Lubbe WJ, 2006, CLIN CANCER RES, V12, P1876, DOI 10.1158/1078-0432.CCR-05-2686; MAGRISSO IJ, 1993, LAB INVEST, V69, P674; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rylski M, 2009, MOL CELL NEUROSCI, V40, P98, DOI 10.1016/j.mcn.2008.09.005; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; Simon C, 1998, CANCER RES, V58, P1135; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	51	71	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15149	15158		10.1074/jbc.M110.105429	http://dx.doi.org/10.1074/jbc.M110.105429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231272	Green Published, hybrid			2022-12-27	WOS:000277399000036
J	Skals, M; Jensen, UB; Ousingsawat, J; Kunzelmann, K; Leipziger, J; Praetorius, HA				Skals, Marianne; Jensen, Uffe B.; Ousingsawat, Jiraporn; Kunzelmann, Karl; Leipziger, Jens; Praetorius, Helle A.			Escherichia coli alpha-Hemolysin Triggers Shrinkage of Erythrocytes via K(Ca)3.1 and TMEM16A Channels with Subsequent Phosphatidylserine Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; RECEPTOR ACTIVATION; SHEEP ERYTHROCYTES; GARDOS-CHANNEL; OUTER-LEAFLET; DEATH; APOPTOSIS; MEMBRANE; MACROPHAGES; MORPHOLOGY	alpha-Hemolysin from Escherichia coli (HlyA) readily lyse erythrocytes from various species. We have recently demonstrated that this pore-forming toxin provokes distinct shrinkage and crenation before it finally leads to swelling and lysis of erythrocytes. The present study documents the underlying mechanism for this severe volume reduction. We show that HlyA-induced shrinkage and crenation of human erythrocytes occur subsequent to a significant rise in [Ca2+](i). The Ca2+-activated K+ channel K(Ca)3.1 (or Gardos channel) is essential for the initial shrinkage, because both clotrimazole and TRAM-34 prevent the shrinkage and potentiate hemolysis produced by HlyA. Notably, the recently described Ca2+-activated Cl- channel TMEM16A contributes substantially to HlyA-induced cell volume reduction. Erythrocytes isolated from TMEM16A(-/-) mice showed significantly attenuated crenation and increased lysis compared with controls. Additionally, we found that HlyA leads to acute exposure of phosphatidylserine in the outer leaflet of the plasma membrane. This exposure was considerably reduced by K(Ca)3.1 antagonists. In conclusion, this study shows that HlyA triggers acute erythrocyte shrinkage, which depends on Ca2+-activated efflux of K+ via K(Ca)3.1 and Cl- via TMEM16A, with subsequent phosphatidylserine exposure. This mechanism might potentially allow HlyA-damaged erythrocytes to be removed from the bloodstream by macrophages and thereby reduce the risk of intravascular hemolysis.	[Skals, Marianne; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Jensen, Uffe B.] Aarhus Univ, Inst Human Genet, DK-8000 Aarhus C, Denmark; [Jensen, Uffe B.] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Ousingsawat, Jiraporn; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany	Aarhus University; Aarhus University; Aarhus University; University of Regensburg	Praetorius, HA (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 1180, DK-8000 Aarhus C, Denmark.	hp@fi.au.dk	Jensen, Uffe Birk/ABA-8306-2021; Jensen, Uffe Birk/E-6066-2017	Jensen, Uffe Birk/0000-0002-6205-6355; Jensen, Uffe Birk/0000-0002-6205-6355; Leipziger, Jens/0000-0002-6719-7034; Kunzelmann, Karl/0000-0002-4583-7037; Praetorius, Helle/0000-0002-0970-5061	Danish Medical Research Council; Danish National Research Foundation; German Research Foundation [SFB699 A6/A7, KU 756/8-2]; Danish National Research Foundation (Danmarks Grundforskningsfond)	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); German Research Foundation(German Research Foundation (DFG)); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond)	This work was supported by the Danish Medical Research Council, the Danish National Research Foundation, and German Research Foundation Grants SFB699 A6/A7 and KU 756/8-2. The Water and Salt Research Center at the Aarhus University is established and supported by the Danish National Research Foundation (Danmarks Grundforskningsfond).	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; BORGERS M, 1983, J HISTOCHEM CYTOCHEM, V31, P1109, DOI 10.1177/31.9.6411806; Bracci R, 2002, ACTA PAEDIATR, V91, P130, DOI 10.1080/080352502320764328; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; CONNOR J, 1989, P NATL ACAD SCI USA, V86, P3184, DOI 10.1073/pnas.86.9.3184; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Foller M, 2007, CELL PHYSIOL BIOCHEM, V20, P1051, DOI 10.1159/000110715; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; HOFFMAN JF, 1974, J PHYSIOL-LONDON, V239, P519, DOI 10.1113/jphysiol.1974.sp010581; HUBER SM, 2008, ACTA PHYSL, V192, P54; HUNTER MJ, 1977, J PHYSIOL-LONDON, V268, P35, DOI 10.1113/jphysiol.1977.sp011845; JAY AWL, 1975, BIOPHYS J, V15, P205, DOI 10.1016/S0006-3495(75)85812-7; JORGENSEN SE, 1983, TOXICON, V21, P717, DOI 10.1016/0041-0101(83)90277-5; JORGENSEN SE, 1980, INFECT IMMUN, V27, P988, DOI 10.1128/IAI.27.3.988-994.1980; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KNAUF PA, 1977, J GEN PHYSIOL, V69, P363, DOI 10.1085/jgp.69.3.363; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang KS, 2002, CELL PHYSIOL BIOCHEM, V12, P365, DOI 10.1159/000067907; Lang PA, 2004, CELL MICROBIOL, V6, P391, DOI 10.1111/j.1462-5822.2004.00369.x; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lew VL, 2005, BLOOD, V105, P361, DOI 10.1182/blood-2004-01-0125; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MCMANUS M, 1993, AM J PHYSIOL, V265, pC562, DOI 10.1152/ajpcell.1993.265.2.C562; Menestrina G, 1996, J MEMBRANE BIOL, V149, P113, DOI 10.1007/s002329900012; Myssina S, 2004, CELL PHYSIOL BIOCHEM, V14, P241, DOI 10.1159/000080333; Piagnerelli M., 2007, Transfusion Alternatives in Transfusion Medicine, V9, P143, DOI 10.1111/j.1778-428X.2007.00072.x; Piagnerelli M, 2007, J CLIN PATHOL, V60, P549, DOI 10.1136/jcp.2006.037523; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; SARKADI B, 1976, J MEMBRANE BIOL, V26, P357, DOI 10.1007/BF01868883; SHORT EC, 1971, INFECT IMMUN, V3, P678, DOI 10.1128/IAI.3.5.678-687.1971; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Sluyter R, 2007, BIOCHEM BIOPH RES CO, V355, P169, DOI 10.1016/j.bbrc.2007.01.124; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V17, P29, DOI 10.1159/000091457; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; WHITE JG, 1974, AM J PATHOL, V77, P135	42	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15557	15565		10.1074/jbc.M109.082578	http://dx.doi.org/10.1074/jbc.M109.082578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231275	hybrid, Green Published			2022-12-27	WOS:000277399000074
J	Chichili, GR; Westmuckett, AD; Rodgers, W				Chichili, Gurunadh R.; Westmuckett, Andrew D.; Rodgers, William			T Cell Signal Regulation by the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; GPI-ANCHORED PROTEINS; ENRICHED MEMBRANE DOMAINS; RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE MICROSCOPY; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; LIPID RAFTS; IMMUNE SYNAPSE; LIVE CELLS	T cells form an immunological synapse (IS) that sustains and regulates signals for cell stimulation. Enriched in the IS is the Src family kinase Lck. Conversely, the membrane phosphatase CD45, which activates Src family kinases, is excluded, and this is necessary to avoid quenching of T cell receptor phosphosignals. Data suggest that this arrangement occurs by an enrichment of cholesterol-dependent rafts in the IS. However, the role of rafts in structuring the IS remains unclear. To address this question, we used fluorescence resonance energy transfer (FRET) to interrogate the nanoscopic structure of the IS. The FRET probes consisted of membrane-anchored fluorescent proteins with distinct affinities for rafts. Both the raft and nonraft probes exhibited clustering in the IS. However, co-clustering of raft donor-acceptor pairs was 10-fold greater than co-clustering of raft-nonraft pairs. We measured the effect of disrupting rafts in the IS on CD45 localization and Lck regulation by treating stimulated T cells with filipin. The filipin specifically disrupted co-clustering of the raft FRET pairs in the IS and allowed targeting of CD45 to the IS and dephosphorylation of the regulatory tyrosine of Lck. Clustering of the raft probes was also sensitive to latrunctulin B, which disrupts actin filaments. Strikingly, enriching the cortical cytoskeleton using jasplakinolide maintained raft probe co-clustering, CD45 exclusion, and Lck regulation in the IS following the addition of filipin. These data show the actin cytoskeleton maintains a membrane raft environment in the IS that promotes Lck regulation by excluding CD45.	[Chichili, Gurunadh R.; Westmuckett, Andrew D.; Rodgers, William] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			National Institutes of Health [R01 GM070001]; Oklahoma Center for the Advancement of Science and Technology [HR08-084]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM070001 (to W. R.). This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR08-084 (to W. R.).	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gordy C, 2004, J IMMUNOL, V172, P2030, DOI 10.4049/jimmunol.172.4.2030; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	69	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14737	14746		10.1074/jbc.M109.097311	http://dx.doi.org/10.1074/jbc.M109.097311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194498	Green Published, hybrid			2022-12-27	WOS:000277299700071
J	Le Marchand, SJ; Piston, DW				Le Marchand, Sylvain J.; Piston, David W.			Glucose Suppression of Glucagon Secretion METABOLIC AND CALCIUM RESPONSES FROM alpha-CELLS IN INTACT MOUSE PANCREATIC ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC CA2+ CONCENTRATION; BETA-CELLS; DELTA-CELLS; B-CELLS; INSULIN-SECRETION; A-CELLS; FLUORESCENT PROTEIN; CARDIAC MYOCYTES; IDENTIFIED ALPHA; GENE-EXPRESSION	Glucagon is released from alpha-cells present in intact pancreatic islets at glucose concentrations below 4 mM, whereas higher glucose levels inhibit its secretion. The mechanisms underlying the suppression of alpha-cell secretory activity are poorly understood, but two general types of models have been proposed as follows: direct inhibition by glucose or paracrine inhibition from non-alpha-cells within the islet of Langerhans. To identify alpha-cells for analysis, we utilized transgenic mice expressing fluorescent proteins targeted specifically to these cells. Measurements of glucagon secretion from pure populations of flow-sorted alpha-cells show that contrary to its effect on intact islets, glucose does stimulate glucagon secretion from isolated alpha-cells. This observation argues against a direct inhibition of glucagon secretion by glucose and supports the paracrine inhibition model. Imaging of cellular metabolism by two-photon excitation of NAD(P) H autofluorescence indicates that glucose is metabolized in alpha-cells and that glucokinase is the likely rate-limiting step in this process. Imaging calcium dynamics of alpha-cells in intact islets reveals that inhibiting concentrations of glucose increase the intracellular calcium concentration and the frequency of alpha-cell calcium oscillations. Application of candidate paracrine inhibitors leads to reduced glucagon secretion but did not decrease the alpha-cell calcium activity. Taken together, the data suggest that suppression occurs downstream from alpha-cell calcium signaling, presumably at the level of vesicle trafficking or exocytotic machinery.	[Le Marchand, Sylvain J.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 702 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health [DK53434, GM72048, RR25649]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053434, P30DK020593, P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53434, GM72048, and RR25649.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; BARLOW CH, 1976, SCIENCE, V193, P909, DOI 10.1126/science.181843; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; Cejvan K, 2003, DIABETES, V52, P1176, DOI 10.2337/diabetes.52.5.1176; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; COORE HG, 1964, BIOCHEM J, V91, P56, DOI 10.1042/bj0910056; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; FLETCHER DJ, 1983, ENDOCRINOLOGY, V113, P1791, DOI 10.1210/endo-113-5-1791; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GILON P, 1992, J BIOL CHEM, V267, P20713; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; GORUS FK, 1984, J BIOL CHEM, V259, P1196; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Heimberg H, 1996, P NATL ACAD SCI USA, V93, P7036, DOI 10.1073/pnas.93.14.7036; HEIMBERG H, 1995, J BIOL CHEM, V270, P8971, DOI 10.1074/jbc.270.15.8971; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HOENIG M, 1986, ENDOCRINOLOGY, V119, P2502, DOI 10.1210/endo-119-6-2502; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Magnuson MA, 2004, FRONT DIABETES, V16, P1; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matsuda M, 2002, METABOLISM, V51, P1111, DOI 10.1053/meta.2002.34700; MEDA P, 1986, DIABETES, V35, P232, DOI 10.2337/diabetes.35.2.232; Mercan D, 1999, BIOCHEM BIOPH RES CO, V262, P346, DOI 10.1006/bbrc.1999.1219; MICHAELS RL, 1981, SCIENCE, V214, P801, DOI 10.1126/science.6117129; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; OSTENSON CG, 1979, DIABETOLOGIA, V17, P325, DOI 10.1007/BF01235889; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P817, DOI 10.1210/endo-117-3-817; Piston DW, 1999, METHOD ENZYMOL, V307, P351; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, BIOPHYS J, V90, P2641, DOI 10.1529/biophysj.105.069906; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SANDISON DR, 1995, APPL OPTICS, V34, P3576, DOI 10.1364/AO.34.003576; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; UNGER RH, 1971, NEW ENGL J MED, V285, P443; UNGER RH, 1981, DIABETOLOGIA, V20, P1; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; WEIR GC, 1984, METABOLISM, V33, P447, DOI 10.1016/0026-0495(84)90146-X; WEIR GC, 1986, HORM RES, V24, P62, DOI 10.1159/000180540; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	82	99	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14389	14398		10.1074/jbc.M109.069195	http://dx.doi.org/10.1074/jbc.M109.069195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231269	Green Published, hybrid			2022-12-27	WOS:000277299700036
J	McCormick, WD; Atkinson-Dell, R; Campion, KL; Mun, HC; Conigrave, AD; Ward, DT				McCormick, Wanda D.; Atkinson-Dell, Rebecca; Campion, Katherine L.; Mun, Hee-Chang; Conigrave, Arthur D.; Ward, Donald T.			Increased Receptor Stimulation Elicits Differential Calcium-sensing Receptor(T888) Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BOVINE PARATHYROID CELLS; EXTRACELLULAR CA2+-SENSING RECEPTOR; TRANSFECTED HEK293 CELLS; N-LINKED GLYCOSYLATION; L-AMINO-ACIDS; CA2+ OSCILLATIONS; CA-0(2+)-SENSING RECEPTOR; HORMONE-SECRETION; PHOSPHORYLATION	The calcium-sensing receptor (CaR) elicits oscillatory Ca-i(2+) mobilization associated with dynamic, inhibitory protein kinase C-mediated phosphorylation of CaRT888. While modest CaR stimulation elicits Ca-i(2+) oscillations, greater stimulation either increases oscillation frequency or elicits sustained responses by an unknown mechanism. Here, moderate CaR stimulation (2.5 mM Ca-o(2+), 10 min) increased CaRT888 phosphorylation (160 kDa mature receptor) 5-fold in CaR stably transfected HEK-293 cells, whereas 3-5 mM Ca-o(2+) treatments were without apparent effect. Treatment with 2 mM Ca-o(2+) caused sustained CaRT888 phosphorylation (>= 20 min) and oscillatory Ca-i(2+) mobilization. However, 5 mM Ca-o(2+) increased CaRT888 phosphorylation only briefly while eliciting sustained Ca-i(2+) mobilization, suggesting that greater CaR activation induces rapid CaRT888 dephosphorylation, thus permitting sustained Ca-i(2+) responses. Indeed, 5 mM Ca-o(2+) stimulated protein phosphatase 2A activity and induced CaRT888 dephosphorylation following acute phorbol ester pretreatment, the latter effect being mimicked by CaR-positive allosteric modulators (NPS-R467 and L-Phe). Finally, the phosphatase inhibitor calyculin-A reversed CaR-induced inhibition of parathyroid hormone secretion from bovine parathyroid slices and normal human parathyroid cells, demonstrating the physiological importance of phosphorylation status on parathyroid function. Therefore, high Ca-o(2+)-stimulated protein kinase C acts in concert with high Ca-o(2+)- induced phosphatase activity to generate and maintain CaR-induced Ca-i(2+) oscillations via the dynamic phosphorylation and dephosphorylation of CaRT888.	[Ward, Donald T.] Univ Manchester, Fac Life Sci, Core Technol Facil, Manchester M13 9NT, Lancs, England; [Mun, Hee-Chang; Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Manchester; University of Sydney	Ward, DT (corresponding author), Univ Manchester, Fac Life Sci, Core Technol Facil, Floor 2,46 Grafton St, Manchester M13 9NT, Lancs, England.	d.ward@manchester.ac.uk	Centeno, Patricia Pacios/O-8368-2016; Atkinson-Dell, Rebecca/A-4353-2016	Conigrave, Arthur/0000-0002-7232-3891; McCormick, Wanda/0000-0002-6287-7321; Ward, Donald/0000-0003-1342-9458	United Kingdom Biotechnology and Biological Sciences Research Council; Kidney Research UK [IN4/2008]; National Health and Medical Research Council (Australia); Biotechnology and Biological Sciences Research Council [BBS/B/04986] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kidney Research UK(Kidney Research UK (KRUK)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a United Kingdom Biotechnology and Biological Sciences Research Council studentship (to W. M.) and by a grant from Kidney Research UK (IN4/2008).; Supported by a project grant from the National Health and Medical Research Council (Australia).	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; CLARKE BL, 1993, ENDOCRINOLOGY, V132, P1168, DOI 10.1210/en.132.3.1168; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2004, J BIOL CHEM, V279, P38151, DOI 10.1074/jbc.M406373200; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Galitzer H, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-17; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Kim CH, 2005, J BIOL CHEM, V280, P25409, DOI 10.1074/jbc.M502644200; KOBAYASHI N, 1988, P NATL ACAD SCI USA, V85, P4857, DOI 10.1073/pnas.85.13.4857; MEMBRENO L, 1989, ENDOCRINOLOGY, V124, P789, DOI 10.1210/endo-124-2-789; MORRISSEY JJ, 1988, AM J PHYSIOL, V254, pE63, DOI 10.1152/ajpendo.1988.254.1.E63; Mun HC, 2009, J CLIN ENDOCR METAB, V94, P3567, DOI 10.1210/jc.2008-2714; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; NEMETH EF, 1986, J BIOL CHEM, V261, P2668; NYGREN P, 1988, BIOCHIM BIOPHYS ACTA, V968, P253, DOI 10.1016/0167-4889(88)90014-6; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P163, DOI 10.1113/jphysiol.1993.sp019765; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Young SH, 2002, J BIOL CHEM, V277, P46871, DOI 10.1074/jbc.M207083200; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001	35	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14170	14177		10.1074/jbc.M109.071084	http://dx.doi.org/10.1074/jbc.M109.071084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233724	Green Published, hybrid			2022-12-27	WOS:000277299700013
J	Zoudilova, M; Min, J; Richards, HL; Carter, D; Huang, T; Defea, KA				Zoudilova, Maria; Min, Jungah; Richards, Heddie L.; Carter, David; Huang, Timothy; Defea, Kathryn A.			beta-Arrestins Scaffold Cofilin with Chronophin to Direct Localized Actin Filament Severing and Membrane Protrusions Downstream of Protease-activated Receptor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL INFLAMMATION; CANCER-CELLS; CHEMOTAXIS; BETA-ARRESTIN-1; STIMULATION; MIGRATION; PATHWAY; EGF; POLYMERIZATION; PHOSPHATASE	Protease-activated receptor-2 (PAR-2) mediates pro-inflammatory signals in a number of organs, including enhancing leukocyte recruitment to sites of injury and infection. At the cellular level, PAR-2 promotes activation of the actin filament-severing protein cofilin, which is crucial for the reorganization of the actin cytoskeleton and chemotaxis. These responses require the scaffolding functions of beta-arrestins; however, the mechanism by which beta-arrestins spatially regulate cofilin activity and the role of this pathway in primary cells has not been investigated. Here, using size-exclusion chromatography and co-immunoprecipitation, we demonstrate that PAR-2 promotes the formation of a complex containing beta-arrestins, cofilin, and chronophin (CIN) in primary leukocytes and cultured cells. Both association of cofilin with CIN and cell migration are inhibited in leukocytes from beta-arrestin-2(-/-) mice. We show that, in response to PAR-2 activation, beta-arrestins scaffold cofilin with its upstream activator CIN, to facilitate the localized generation of free actin barbed ends, leading to membrane protrusion. These studies suggest that a major role of beta-arrestins in chemotaxis is to spatially regulate cofilin activity to facilitate the formation of a leading edge, and that this pathway may be important for PAR-2-stimulated immune cell migration.	[Richards, Heddie L.; Defea, Kathryn A.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Zoudilova, Maria; Min, Jungah; Defea, Kathryn A.] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Carter, David] Univ Calif Riverside, Integrat Inst Genome Biol, Riverside, CA 92521 USA; [Huang, Timothy] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Scripps Research Institute	Defea, KA (corresponding author), Univ Calif Riverside, Div Biomed Sci, B605 Stat Rd, Riverside, CA 92521 USA.	kathryn.defea@ucr.edu		DeFea, Kathryn/0000-0001-6056-907X	National Institutes of Health [R01GM066151, 1R21HL092388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM066151 and 1R21HL092388.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chan AY, 1998, J CELL SCI, V111, P199; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KUMAR P, 2007, AM J PHYSL CELL PHYS; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUZAKI F, 1988, J BIOL CHEM, V263, P11564; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	42	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14318	14329		10.1074/jbc.M109.055806	http://dx.doi.org/10.1074/jbc.M109.055806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207744	Green Published, hybrid			2022-12-27	WOS:000277299700029
J	Batulan, Z; Haddad, GA; Blunck, R				Batulan, Zarah; Haddad, Georges A.; Blunck, Rikard			An Intersubunit Interaction between S4-S5 Linker and S6 Is Responsible for the Slow Off-gating Component in Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; OPEN-STATE; PACEMAKER CHANNELS; CHARGE MOVEMENT; ACTIVATION GATE; VOLTAGE SENSOR; ION CONDUCTION; WILD-TYPE; CURRENTS; INACTIVATION	Voltage-gated ion channels are controlled by the membrane potential, which is sensed by peripheral, positively charged voltage sensors. The movement of the charged residues in the voltage sensor may be detected as gating currents. In Shaker K+ channels, the gating currents are asymmetric; although the on-gating currents are fast, the off-gating currents contain a slow component. This slow component is caused by a stabilization of the activated state of the voltage sensor and has been suggested to be linked to ion permeation or C-type inactivation. The molecular determinants responsible for the stabilization, however, remain unknown. Here, we identified an interaction between Arg-394, Glu-395, and Leu-398 on the C termini of the S4-S5 linker and Tyr-485 on the S6 of the neighboring subunit, which is responsible for the development of the slow off-gating component. Mutation of residues involved in this intersubunit interaction modulated the strength of the associated interaction. Impairment of the interaction still led to pore opening but did not exhibit slow gating kinetics. Development of this interaction occurs under physiological ion conduction and is correlated with pore opening. We, thus, suggest that the above residues stabilize the channel in the open state.	[Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Blunck, Rikard/AAM-3078-2020; Blunck, Rikard/L-4226-2013	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research [MOP-81351]; Canada Research Chairs [202965]; Canada Foundation for Innovation [202965]; Groupe d'Etude des Proteines Membranaires scholarship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Groupe d'Etude des Proteines Membranaires scholarship	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-81351), Canada Research Chairs (202965), and the Canada Foundation for Innovation (202965).; Supported by a Groupe d'Etude des Proteines Membranaires scholarship.	ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; BEZANILLA F, 1974, SCIENCE, V183, P753, DOI 10.1126/science.183.4126.753; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chen FSP, 1997, J GEN PHYSIOL, V110, P87, DOI 10.1085/jgp.110.2.87; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Coquiere D, 2009, P NATL ACAD SCI USA, V106, P10449, DOI 10.1073/pnas.0811663106; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Ding SH, 2003, BIOPHYS J, V84, P295, DOI 10.1016/S0006-3495(03)74850-4; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Imbrici P, 2006, EUR J NEUROSCI, V24, P3073, DOI 10.1111/j.1460-9568.2006.05186.x; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Okumura A, 2007, FEBS LETT, V581, P5255, DOI 10.1016/j.febslet.2007.10.015; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Sigg D, 1999, BIOPHYS J, V76, P782, DOI 10.1016/S0006-3495(99)77243-7; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1992, BIOPHYS J, V62, P34, DOI 10.1016/S0006-3495(92)81770-8; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Umezawa Y, 1999, BIOORGAN MED CHEM, V7, P2021, DOI 10.1016/S0968-0896(99)00123-6; Varga Z, 2002, J GEN PHYSIOL, V119, P467, DOI 10.1085/jgp.20028520; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	48	69	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14005	14019		10.1074/jbc.M109.097717	http://dx.doi.org/10.1074/jbc.M109.097717			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202932	hybrid, Green Published			2022-12-27	WOS:000276987700074
J	Carrera, S; de Verdier, PJ; Khan, Z; Zhao, B; Mahale, A; Bowman, KJ; Zainol, M; Jones, GDD; Lee, SW; Aaronson, SA; Macip, S				Carrera, Samantha; de Verdier, Petra J.; Khan, Zahid; Zhao, Bo; Mahale, Alka; Bowman, Karen J.; Zainol, Muri; Jones, George D. D.; Lee, Sam W.; Aaronson, Stuart A.; Macip, Salvador			Protection of Cells in Physiological Oxygen Tensions against DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCED APOPTOSIS; REPLICATIVE LIFE-SPAN; TUMOR-SUPPRESSOR P53; ACTIVATION; FIBROBLASTS; PROTEIN; STRESS; EXPRESSION; CARCINOMA; RADIATION	Oxygen availability has important effects on cell physiology. Although hyperoxic and hypoxic stresses have been well characterized, little is known about cellular functions in the oxygen levels commonly found in vivo. Here, we show that p53-dependent apoptosis in response to different DNA-damaging agents was reduced when normal and cancer cells were cultured at physiological oxygen tensions instead of the usual atmospheric levels. Different from what has been described in hypoxia, this was neither determined by decreases in p53 induction or its transactivation activity, nor by differences in the intracellular accumulation of reactive oxygen species. At these physiological oxygen levels, we found a constitutive activation of the ERK1/2 MAPK in all the models studied. Inhibition of this signaling pathway reversed the protective effect in some but not all cell lines. We conclude that a stress-independent constitutive activation of prosurvival pathways, including but probably not limited to MAPK, can protect cells in physiological oxygen tensions against genotoxic stress. Our results underscore the need of considering the impact of oxygen levels present in the tissue microenvironment when studying cell sensitivity to treatments such as chemotherapy and radiotherapy.	[Carrera, Samantha; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [de Verdier, Petra J.] Karolinska Inst, Dept Mol Med & Surg, Urol Lab, S-17176 Stockholm, Sweden; [Khan, Zahid; Zhao, Bo; Mahale, Alka; Aaronson, Stuart A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Bowman, Karen J.; Zainol, Muri; Jones, George D. D.] Univ Leicester, Radiat & Oxidat Stress Grp, Dept Canc Studies & Mol Med, Leicester LE1 7RH, Leics, England; [Lee, Sam W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Cutaneous Biol Res Ctr, Boston, MA 02129 USA	University of Leicester; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; University of Leicester; Harvard University; Harvard Medical School; Massachusetts General Hospital	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	sm460@le.ac.uk	Macip, Salvador/S-6358-2019; Macip, Salvador/P-4233-2019; Macip, Salvador/K-5985-2014	Macip, Salvador/0000-0003-1963-8840; Zainol, Murizal/0000-0001-7372-0672; Jones, George/0000-0002-9543-2206	National Institutes of Health [CA80058, CA85214, CA78356, CA82211]; Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA085214, R01CA078356, R01CA082211, R01CA085681, R01CA149477, P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported, in whole or in part, by National Institutes of Health Grants CA80058 and CA85214 (to S. A. A.) and CA78356 and CA82211 (to S. W. L.). This work was also supported by the Medical Research Council (New Blood Lectureship Research support funding).	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Cuisnier O, 2003, INT J ONCOL, V23, P1033; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; HALL EJ, 2005, RADIOBIOLOGY RADIOLO, P89; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Jeong HJ, 2005, J NEUROIMMUNOL, V163, P84, DOI 10.1016/j.jneuroim.2005.02.019; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Mahale AM, 2008, CANCER RES, V68, P1417, DOI 10.1158/0008-5472.CAN-07-3021; Matsuda N, 2000, PHOTOCHEM PHOTOBIOL, V72, P334, DOI 10.1562/0031-8655(2000)072<0334:DAOEAJ>2.0.CO;2; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Renton A, 2003, CARCINOGENESIS, V24, P1177, DOI 10.1093/carcin/bgg044; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; SAITO H, 1995, EXP CELL RES, V217, P272, DOI 10.1006/excr.1995.1087; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; SCHROY PC, 1995, CANCER, V76, P201, DOI 10.1002/1097-0142(19950715)76:2<201::AID-CNCR2820760207>3.0.CO;2-T; STEFANELLI C, 1995, BIOCHEM BIOPH RES CO, V212, P300, DOI 10.1006/bbrc.1995.1970; Steurer J, 1997, RESPIRATION, V64, P200; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Zhang QZ, 2004, J CELL PHYSIOL, V199, P89, DOI 10.1002/jcp.10452	34	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13658	13665		10.1074/jbc.M109.062562	http://dx.doi.org/10.1074/jbc.M109.062562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20228054	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000276987700040
J	Weinman, EJ; Biswas, R; Steplock, D; Douglass, TS; Cunningham, R; Shenolikar, S				Weinman, Edward J.; Biswas, Rajatsubhra; Steplock, Deborah; Douglass, Tia S.; Cunningham, Rochelle; Shenolikar, Shirish			Sodium-Hydrogen Exchanger Regulatory Factor 1 (NHERF-1) Transduces Signals That Mediate Dopamine Inhibition of Sodium-Phosphate Co-transport in Mouse Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PROXIMAL TUBULE; PARATHYROID-HORMONE; FACTOR-I; RECEPTOR INTERACTS; ADAPTER PROTEINS; NA+/H+ EXCHANGE; NAPI-IIA; CELLS; PHOSPHORYLATION; INTERNALIZATION	Dopamine inhibited phosphate transport in isolated renal brush border membrane vesicles and in cultured renal proximal tubule cells from wild-type but not from NHERF-1 null mice. Co-immunoprecipitation experiments established that NHERF-1 associated with D1-like receptors. In wild-type mice, dopamine stimulated cAMP accumulation and protein kinase C (PKC) activity in renal proximal tubule cells, an effect that was abolished by SCH-23390, a D1-like receptor antagonist. In NHERF-1 null kidney tissue; however, dopamine failed to stimulate either cAMP accumulation or PKC activity. Infection of proximal tubule cells from NHERF-1 null mice with adenovirus-green fluorescent protein-NHERF-1 restored the ability of dopamine to stimulate cAMP and PKC. Finally, in P-32-labeled wild-type proximal tubule cells and in opossum kidney cells, dopamine increased NHERF-1 phosphorylation at serine 77 of the PDZ I domain of NHERF-1, a site previously shown to attenuate binding of cellular targets including the Npt2a (sodium-dependent phosphate transporter 2a). Together, these studies establish that NHERF-1 plays a key role in dopamine signaling and is also a downstream target of D1-like receptors in the mouse kidney. These studies suggest a novel role for the PDZ adapter protein NHERF-1 in coordinating dopamine signals that inhibit renal phosphate transport.	[Weinman, Edward J.; Biswas, Rajatsubhra; Steplock, Deborah; Douglass, Tia S.; Cunningham, Rochelle] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.; Cunningham, Rochelle] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, UMH, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Department of Veterans Affairs; Kidney Foundation of Maryland; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Kidney Foundation of Maryland; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E. J. W.). This work was also supported by funds from the Department of Veterans Affairs (to E. J. W.) and the Kidney Foundation of Maryland (to R. C.).; Recipient of a Harold Amos Faculty Development Award from the Robert Wood Johnson Foundation.	Bacic D, 2005, AM J PHYSIOL-RENAL, V288, pF740, DOI 10.1152/ajprenal.00380.2004; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Gomes P, 2002, AM J PHYSIOL-RENAL, V282, pF1084, DOI 10.1152/ajprenal.00318.2001; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Lederer ED, 1998, J AM SOC NEPHROL, V9, P975; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Pedrosa R, 2004, CELL PHYSIOL BIOCHEM, V14, P91, DOI 10.1159/000076930; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang XY, 2008, PEDIATR NEPHROL, V23, P2131, DOI 10.1007/s00467-008-0901-3; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	27	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13454	13460		10.1074/jbc.M109.094359	http://dx.doi.org/10.1074/jbc.M109.094359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200151	Green Published, hybrid			2022-12-27	WOS:000276987700017
J	Abrass, CK; Hansen, KM				Abrass, Christine K.; Hansen, Kim M.			Insulin-like Growth Factor-binding Protein-5-induced Laminin gamma 1 Transcription Requires Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; RAT MESANGIAL CELLS; ANDROGEN RECEPTOR; DEPENDENT ACTIVATION; EXPRESSION; IGFBP-5; DOMAINS; GTPASES; RHO; PHOSPHORYLATION	Insulin-like growth factor-binding protein-5 (IGFBP-5) has IGF-1-independent intranuclear effects that are poorly defined. Treatment of cells with IGFBP-5 induces migration, prevents apoptosis, and leads to increased laminin subunit transcription. Similarly, filamin A (FLNa), an actin-binding protein that participates in cell attachment, plays important additional roles in signal transduction and modulation of transcriptional responses. In this report, we show that IGFBP-5 leads to dephosphorylation of FLNa with subsequent FLNa cleavage. Following cleavage, there is enhanced recruitment of Smad3/4 to a C-terminal FLNa fragment with nuclear translocation and subsequent binding to the promoter region of the laminin gamma 1 (lamc1) gene. FLNa knockdown prevents IGFBP-5-mediated increases in lamc1 transcription. These data indicate that IGFBP-5 induces formation of a FLNa-based nuclear shuttle that recruits transcription factors and regulates transcription of IGFBP-5 target genes. These studies provide new insights into the mechanisms whereby IGFBP-5 and FLNa exert intranuclear effects.	[Abrass, Christine K.; Hansen, Kim M.] Univ Washington, Dept Med, Allergy & Inflammat Program, Sch Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Abrass, CK (corresponding author), UW Med S Lake Union, 815 Mercer St, Seattle, WA 98109 USA.	cabrass@u.washington.edu			National Institutes of Health [R01 DK 49771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 49771 (to C. K. A.).	ABRASS CK, 1994, KIDNEY INT, V46, P613, DOI 10.1038/ki.1994.313; Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; ABRASS CK, 1995, KIDNEY INT, V47, P25, DOI 10.1038/ki.1995.3; Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Andress DL, 1998, AM J PHYSIOL-ENDOC M, V274, pE744, DOI 10.1152/ajpendo.1998.274.4.E744; Anilkumar G, 2003, CANCER RES, V63, P2645; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Berfield AK, 2006, AM J PHYSIOL-CELL PH, V291, pC589, DOI 10.1152/ajpcell.00623.2005; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; BOOTH BA, 1995, GROWTH REGULAT, V5, P1; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; Coughlin MF, 2006, BIOPHYS J, V90, P2199, DOI 10.1529/biophysj.105.061267; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Goda N, 2008, EXP CELL RES, V314, P2352, DOI 10.1016/j.yexcr.2008.05.008; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hastie LE, 1998, J CELL BIOCHEM, V68, P511, DOI 10.1002/(SICI)1097-4644(19980315)68:4<511::AID-JCB10>3.0.CO;2-C; He HJ, 2003, J BIOL CHEM, V278, P27096, DOI 10.1074/jbc.M301003200; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; HOCK RS, 1990, BIOCHEMISTRY-US, V29, P9441, DOI 10.1021/bi00492a019; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawata Y, 2002, J BIOL CHEM, V277, P11375, DOI 10.1074/jbc.M111284200; Khazenzon NM, 2003, MOL CANCER THER, V2, P985; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; KREISBERG JI, 1983, KIDNEY INT, V23, P439, DOI 10.1038/ki.1983.40; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Parker A, 1996, J BIOL CHEM, V271, P13523, DOI 10.1074/jbc.271.23.13523; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Ravid D, 2008, EXP CELL RES, V314, P2762, DOI 10.1016/j.yexcr.2008.06.004; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Shand JH, 2003, J BIOL CHEM, V278, P17859, DOI 10.1074/jbc.M300526200; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sprenger CCT, 2008, NEOPLASIA, V10, P1350, DOI 10.1593/neo.08746; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Uribe R, 2009, MOL BIOL REP, V36, P121, DOI 10.1007/s11033-007-9159-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vainionpaa N, 2007, LAB INVEST, V87, P780, DOI 10.1038/labinvest.3700592; Wang Q, 1996, J CELL BIOCHEM, V62, P383, DOI 10.1002/(SICI)1097-4644(199609)62:3<383::AID-JCB8>3.0.CO;2-N; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	68	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12925	12934		10.1074/jbc.M109.061754	http://dx.doi.org/10.1074/jbc.M109.061754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167606	Green Published, hybrid			2022-12-27	WOS:000276787800051
J	Barko, S; Bugyi, B; Carlier, MF; Gombos, R; Matusek, T; Mihaly, J; Nyitrai, M				Barko, Szilvia; Bugyi, Beata; Carlier, Marie-France; Gombos, Rita; Matusek, Tamas; Mihaly, Jozsef; Nyitrai, Miklos			Characterization of the Biochemical Properties and Biological Function of the Formin Homology Domains of Drosophila DAAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-FILAMENT ELONGATION; RABBIT SKELETAL-MUSCLE; BARBED END ELONGATION; CAPPING PROTEIN; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MAMMALIAN FORMINS; BUNDLING ACTIVITY; ARP2/3 COMPLEX	We characterized the properties of Drosophila melanogaster DAAM-FH2 and DAAM-FH1-FH2 fragments and their interactions with actin and profilin by using various biophysical methods and in vivo experiments. The results show that although the DAAM-FH2 fragment does not have any conspicuous effect on actin assembly in vivo, in cells expressing the DAAM-FH1-FH2 fragment, a profilin-dependent increase in the formation of actin structures is observed. The trachea-specific expression of DAAM-FH1-FH2 also induces phenotypic effects, leading to the collapse of the tracheal tube and lethality in the larval stages. In vitro, both DAAM fragments catalyze actin nucleation but severely decrease both the elongation and depolymerization rate of the filaments. Profilin acts as a molecular switch in DAAM function. DAAM-FH1-FH2, remaining bound to barbed ends, drives processive assembly of profilin-actin, whereas DAAM-FH2 forms an abortive complex with barbed ends that does not support profilin-actin assembly. Both DAAM fragments also bind to the sides of the actin filaments and induce actin bundling. These observations show that the D. melanogaster DAAM formin represents an extreme class of barbed end regulators gated by profilin.	[Barko, Szilvia; Bugyi, Beata; Nyitrai, Miklos] Univ Pecs, Fac Med, Dept Biophys, H-7624 Pecs, Hungary; [Bugyi, Beata; Carlier, Marie-France] CNRS, Lab Enzymol & Biochem Struct, F-91198 Gif Sur Yvette, France; [Gombos, Rita; Matusek, Tamas; Mihaly, Jozsef] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6726 Szeged, Hungary	University of Pecs; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Nyitrai, M (corresponding author), Univ Pecs, Fac Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	miklos.nyitrai@aok.pte.hu		Nyitrai, Miklos/0000-0002-6229-4337; Mihaly, Jozsef/0000-0003-3399-2424	Hungarian Science Foundation [K60968, K77840]; Hungarian National Office for Research and Technology [GVOP-3.2.1-2004-04-0190/3.0, GVOP-3.2.1-2004-04-0228/3.0]; Science, Please! Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; European Molecular Biology Organization [ALTF 626-2006]; La Ligue Nationale Contre le Cancer; ANR-PCV [2006-2009]; European STREP	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office for Research and Technology(National Office for Research and Technology); Science, Please! Research Team on Innovation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ANR-PCV(French National Research Agency (ANR)); European STREP(European Commission)	This work was supported by grants from the Hungarian Science Foundation (OTKA Grants K60968 and K77840 (to M. N.)) and from the Hungarian National Office for Research and Technology (Grants GVOP-3.2.1-2004-04-0190/3.0 and GVOP-3.2.1-2004-04-0228/3.0). This work was also supported by "Science, Please! Research Team on Innovation" Grant SROP-4.2.2/08/1/2008-0011.; Supported by European Molecular Biology Organization "Long-Term Fellowship" ALTF 626-2006 and by La Ligue Contre le Cancer" Allocation Post-doctorale pour Jeune Chercheur Confirme."; Supported in part by La Ligue Nationale Contre le Cancer, ANR-PCV 2006-2009, and the European STREP "BIOMICS."	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Franch-Marro X, 2006, DEVELOPMENT, V133, P785, DOI 10.1242/dev.02260; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kida Y, 2004, DEV BRAIN RES, V153, P143, DOI 10.1016/j.devbrainres.2004.07.014; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kupi T, 2009, BIOPHYS J, V96, P2901, DOI 10.1016/j.bpj.2008.11.058; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Le Clainche C., 2004, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1207s24, DOI 10.1002/0471143030.CB1207S24]; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Nakaya MA, 2004, GENE EXPR PATTERNS, V5, P97, DOI 10.1016/j.modgep.2004.06.001; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; WEGNER A, 1983, P NATL ACAD SCI-BIOL, V80, P4922, DOI 10.1073/pnas.80.16.4922; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	71	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13154	13169		10.1074/jbc.M109.093914	http://dx.doi.org/10.1074/jbc.M109.093914			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177055	Green Published, hybrid			2022-12-27	WOS:000276787800071
J	Nieves, EC; Manchanda, N				Nieves, Evelyn C.; Manchanda, Naveen			A Cleavage-resistant Urokinase Plasminogen Activator Receptor Exhibits Dysregulated Cell-surface Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; VITRONECTIN-BINDING; ENDOCYTIC RECEPTOR; THYROID-CELLS; UPAR; MIGRATION; COMPLEXES; EXPRESSION; PROTEIN; INTERNALIZATION	Urokinase plasminogen activator receptor (u-PAR) binds urokinase plasminogen activator (u-PA) and participates in plasminogen activation in addition to modulating several cellular processes such as adhesion, proliferation, and migration. u-PAR is susceptible to proteolysis by its cognate ligand and several other proteases. To elucidate the biological significance of receptor cleavage by u-PA, we engineered and expressed a two-chain urokinase plasminogen activator (tcu-PA) cleavageresistant u-PAR (cr-u-PAR). This mutated receptor was similar to wild-type u-PAR in binding u-PA and initiating plasminogen activation. However, cr-u-PAR exhibited accelerated internalization and resurfacing due to direct association with the endocytic receptor alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein in the absence of the enzyme inhibitor complex of tcu-PA and plasminogen activator inhibitor-1 (tcu-PA.PAI-1). cr-u-PAR-expressing cells had enhanced migration compared with wild-type u-PAR-expressing cells, and cr-u-PAR was less sensitive to chymotrypsin cleavage as compared with wt u-PAR. Our studies suggest that these mutations in the linker region result in a rearrangement within the cr-u-PAR structure that makes it resemble its ligand-bound form. This constitutively active variant may mimic highly glycosylated cleavage-resistant u-PAR expressed in certain highly malignant cancer-cells.	[Nieves, Evelyn C.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Manchanda, Naveen] Univ Illinois, Dept Internal Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nieves, EC (corresponding author), 1500 E Med Ctr Dr,6420 Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.	ecnieves@gmail.com						ANDREASEN PA, 1994, FEBS LETT, V338, P239, DOI 10.1016/0014-5793(94)80276-9; ANDREW SM, 2001, CURR PROTOC IMMU MAY, pCH16; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BLASI F, 1986, J CELL BIOCHEM, V32, P179, DOI 10.1002/jcb.240320303; BLASI F, 1990, CELL DIFFER DEV, V32, P247, DOI 10.1016/0922-3371(90)90037-W; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; FIORE MM, 1992, BLOOD, V80, P3127; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; GRIFFITH MJ, 1985, J CLIN INVEST, V75, P4, DOI 10.1172/JCI111694; Henic E, 2006, GYNECOL ONCOL, V101, P28, DOI 10.1016/j.ygyno.2005.09.038; Hoyer-Hansen G, 1997, FEBS LETT, V420, P79, DOI 10.1016/S0014-5793(97)01491-9; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; HoyerHansen G, 1997, EUR J BIOCHEM, V243, P21, DOI 10.1111/j.1432-1033.1997.0021a.x; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; KETTNER C, 1979, BIOCHIM BIOPHYS ACTA, V569, P31, DOI 10.1016/0005-2744(79)90078-0; LI H, 1994, J BIOL CHEM, V269, P8153; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MANCHANDA N, 1991, J BIOL CHEM, V266, P14580; Mannari C, 2008, INT J IMMUNOPATH PH, V21, P651, DOI 10.1177/039463200802100319; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; MOLLER LB, 1993, J BIOL CHEM, V268, P11152; Montuori N, 1999, FEBS LETT, V460, P32, DOI 10.1016/S0014-5793(99)01314-9; Montuori N, 2000, FEBS LETT, V476, P166, DOI 10.1016/S0014-5793(00)01713-0; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; Ragno P, 1998, CANCER RES, V58, P1315; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; SCHWARTZ BS, 1988, BLOOD, V71, P734; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596	59	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12595	12603		10.1074/jbc.M109.008581	http://dx.doi.org/10.1074/jbc.M109.008581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177061	Green Published, hybrid			2022-12-27	WOS:000276787800017
J	Savas, JN; Ma, B; Deinhardt, K; Culver, BP; Restituito, S; Wu, LG; Belasco, JG; Chao, MV; Tanese, N				Savas, Jeffrey N.; Ma, Bin; Deinhardt, Katrin; Culver, Brady P.; Restituito, Sophie; Wu, Ligang; Belasco, Joel G.; Chao, Moses V.; Tanese, Naoko			A Role for Huntington Disease Protein in Dendritic RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; P-BODIES; RIBONUCLEOPROTEIN-PARTICLES; TRANSLATION; TRANSPORT; LOCALIZATION; DEGRADATION; TRAFFICKING; EXPRESSION	Regulated transport and local translation of mRNA in neurons are critical for modulating synaptic strength, maintaining proper neural circuitry, and establishing long term memory. Neuronal RNA granules are ribonucleoprotein particles that serve to transport mRNA along microtubules and control local protein synthesis in response to synaptic activity. Studies suggest that neuronal RNA granules share similar structures and functions with somatic P-bodies. We recently reported that the Huntington disease protein huntingtin (Htt) associates with Argonaute (Ago) and localizes to cytoplasmic P-bodies, which serve as sites of mRNA storage, degradation, and small RNA-mediated gene silencing. Here we report that wild-type Htt associates with Ago2 and components of neuronal granules and co-traffics with mRNA in dendrites. Htt was found to co-localize with RNA containing the 3'-untranslated region sequence of known dendritically targeted mRNAs. Knockdown of Htt in neurons caused altered localization of mRNA. When tethered to a reporter construct, Htt down-regulated reporter gene expression in a manner dependent on Ago2, suggesting that Htt may function to repress translation of mRNAs during transport in neuronal granules.	[Belasco, Joel G.; Tanese, Naoko] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA; [Deinhardt, Katrin; Chao, Moses V.] NYU, Dept Cell Biol, Sch Med, Mol Neurobiol Program, New York, NY 10016 USA; [Deinhardt, Katrin; Belasco, Joel G.; Chao, Moses V.] NYU, Kimmel Ctr, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Restituito, Sophie] NYU, Dept Biochem, Sch Med, New York, NY 10016 USA; [Savas, Jeffrey N.; Tanese, Naoko] Natl Inst Hlth Grad Partnership Program Struct Bi, New York, NY 10016 USA	New York University; New York University; New York University; New York University; National Institutes of Health (NIH) - USA	Tanese, N (corresponding author), NYU, Dept Microbiol, Sch Med, 550 1st Ave, New York, NY 10016 USA.	tanesn01@med.nyu.edu		Tanese, Naoko/0000-0002-1946-3211; Deinhardt, Katrin/0000-0002-6473-5298; Chao, Moses/0000-0002-6969-3744	National Institutes of Health [NS061917]; Hereditary Disease Foundation; CHDI Foundation, Inc; NIH [S10 RR017970]; Vilcek Endowment Fellowship Award; Human Frontier Science Program; Alzheimer's Association [NIRG-06-25401]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; CHDI Foundation, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Endowment Fellowship Award; Human Frontier Science Program(Human Frontier Science Program); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS061917 (to N. T.). This work was also supported by the Hereditary Disease Foundation (to N. T.) and CHDI Foundation, Inc. (to N. T. and M. V. C.). Purchase of the confocal microscope was through a Shared Instrumentation Grant from NIH (Grant S10 RR017970).; Supported in part by the Vilcek Endowment Fellowship Award. Current address: Dept. of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.; Supported by the Human Frontier Science Program.; Supported by the Alzheimer's Association (Grant NIRG-06-25401).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Hillebrand Jens, 2007, ScientificWorldJournal, V7, P178; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim M, 1999, NEUROSCIENCE, V89, P1159, DOI 10.1016/S0306-4522(98)00400-X; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Thonberg H, 2004, BIOCHEM BIOPH RES CO, V318, P927, DOI 10.1016/j.bbrc.2004.04.119; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Zabel C, 2002, MOL CELL PROTEOMICS, V1, P366, DOI 10.1074/mcp.M200016-MCP200; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	56	56	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13142	13153		10.1074/jbc.M110.114561	http://dx.doi.org/10.1074/jbc.M110.114561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185826	hybrid, Green Published			2022-12-27	WOS:000276787800070
J	Pioszak, AA; Harikumar, KG; Parker, NR; Miller, LJ; Xu, HE				Pioszak, Augen A.; Harikumar, Kaleeckal G.; Parker, Naomi R.; Miller, Laurence J.; Xu, H. Eric			Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; SECRETIN RECEPTOR; BINDING DOMAIN; MOLECULAR RECOGNITION; OLIGOMERIC COMPLEXES; EXTRACELLULAR DOMAIN; GPCR OLIGOMERIZATION; CRYSTAL-STRUCTURE; PTH RECEPTOR; LIVING CELLS	The parathyroid hormone receptor (PTH1R) is a class B G protein-coupled receptor that is activated by parathyroid hormone (PTH) and PTH-related protein (PTHrP). Little is known about the oligomeric state of the receptor and its regulation by hormone. The crystal structure of the ligand-free PTH1R extracellular domain (ECD) reveals an unexpected dimer in which the C-terminal segment of both ECD protomers forms an alpha-helix that mimics PTH/PTHrP by occupying the peptide binding groove of the opposing protomer. ECD-mediated oligomerization of intact PTH1R was confirmed in living cells by bioluminescence and fluorescence resonance energy transfer experiments. As predicted by the structure, PTH binding disrupted receptor oligomerization. A receptor rendered monomeric by mutations in the ECD retained wild-type PTH binding and cAMP signaling ability. Our results are consistent with the hypothesis that PTH1R forms constitutive dimers that are dissociated by ligand binding and that monomeric PTH1R is capable of activating G protein.	[Pioszak, Augen A.; Parker, Naomi R.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144; Harikumar, Kaleeckal/0000-0003-0411-5334	National Institutes of Health [GM087413, DK46577]; Jay and Betty Van Andel Foundation; Fiterman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Fiterman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM087413 (to H.E.X.) and DK46577 (to L.J.M.). This work was also supported in part by the Jay and Betty Van Andel Foundation (to H.E.X.) and the Fiterman Foundation (to L.J.M.).	Angers S, 2001, LIFE SCI, V68, P2243, DOI 10.1016/S0024-3205(01)01012-8; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Carter PH, 1999, J BIOL CHEM, V274, P31955, DOI 10.1074/jbc.274.45.31955; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; DeLano W.L, PYMOL MOL GRAPHICS S; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Jin L, 2000, J BIOL CHEM, V275, P27238; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pellegrini M, 1998, BIOCHEMISTRY-US, V37, P12737, DOI 10.1021/bi981265h; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	61	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12435	12444		10.1074/jbc.M109.093138	http://dx.doi.org/10.1074/jbc.M109.093138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172855	Green Published, hybrid			2022-12-27	WOS:000276787100071
J	Shen, WY; Li, JQ; Dauk, M; Huang, Y; Periappuram, C; Wei, YD; Zou, JT				Shen, Wenyun; Li, John Qiang; Dauk, Melanie; Huang, Yi; Periappuram, Cyril; Wei, Yangdou; Zou, Jitao			Metabolic and Transcriptional Responses of Glycerolipid Pathways to a Perturbation of Glycerol 3-Phosphate Metabolism in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN ISOFORMS; WILD-TYPE ARABIDOPSIS; FATTY-ACID SYNTHESIS; LIPID-SYNTHESIS; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEFICIENT; MUTANT; PLANT; BIOSYNTHESIS; MEMBRANE	Glycerolipid synthesis in plants involves two major metabolic pathways compartmentalized in the chloroplasts and cytosol, respectively. Although these two parallel pathways are regulated with considerable flexibility, the factors mediating this process remain unclear. To investigate the influence of glycerol 3-phosphate (Gly-3-P) on the interactions of the glycerolipid pathways, we generated transgenic Arabidopsis lines with a feedback-resistant Gly-3-P dehydrogenase gene (gpsA(FR)) from Escherichia coli. gpsA(FR) was detected in the cytosol, but augmented Gly-3-P levels were observed in the cytosol as well as in chloroplasts. Glycerolipid composition and fatty acid positional distribution analyses revealed an altered fatty acid flux that affected not only the molar ratios of glycerolipid species but also their fatty acid composition. To decipher this complex pathway, a transgenic line was subjected to lipidomic analysis and a global gene-expression survey. The results revealed that changes in Gly-3-P metabolism caused altered expression of a broad array of genes. When viewed from the perspective of glycerolipid metabolism, coherent networks emerged, revealing that many enzymatic components of the glycerolipid pathways operate in a modular manner under the influence of Gly-3-P. Transcript levels of the enzymes involved in the prokaryotic pathway were mostly induced, whereas genes of the eukaryotic pathway enzymes were largely suppressed. Hence, the gene-expression changes were consistent with the detected biochemical phenotype. Our results suggest that Gly-3-P modulates the balance of the two glycerolipid pathways in Arabidopsis by influencing both metabolic flux and gene transcription.	[Shen, Wenyun; Li, John Qiang; Dauk, Melanie; Huang, Yi; Periappuram, Cyril; Zou, Jitao] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; [Li, John Qiang; Wei, Yangdou] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada	National Research Council Canada; University of Saskatchewan	Zou, JT (corresponding author), 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	Jitao.Zou@nrc-cnrc.gc.ca			Saskatchewan Canola Development commission; National Research Council Canada-Genomic and Health Initiatives; Genome Prairie; Genome Canada; National Research Council Canada [50160]	Saskatchewan Canola Development commission; National Research Council Canada-Genomic and Health Initiatives; Genome Prairie; Genome Canada(Genome Canada); National Research Council Canada	This work was supported in part by the Saskatchewan Canola Development commission, the National Research Council Canada-Genomic and Health Initiatives, Genome Prairie, and Genome Canada. This research is National Research Council Canada Publication 50160.	Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BELL RM, 1975, J BIOL CHEM, V250, P7153; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaventure G, 2002, PLANT PHYSIOL, V128, P223, DOI 10.1104/pp.010397; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKMAN JA, 1990, PHYTOCHEMISTRY, V29, P1447, DOI 10.1016/0031-9422(90)80098-2; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; BROWSE J, 1986, PLANT PHYSIOL, V81, P859, DOI 10.1104/pp.81.3.859; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FLIEGE R, 1978, BIOCHIM BIOPHYS ACTA, V502, P232, DOI 10.1016/0005-2728(78)90045-2; FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629; Frentzen Margrit, 1993, P195; GARDINER SE, 1982, PLANT PHYSIOL, V70, P1316, DOI 10.1104/pp.70.5.1316; GARDINER SE, 1983, BIOCHEM J, V210, P949, DOI 10.1042/bj2100949; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GHOSH S, 1988, ARCH BIOCHEM BIOPHYS, V262, P508, DOI 10.1016/0003-9861(88)90402-X; GUERRA DJ, 1986, PLANT PHYSIOL, V82, P448, DOI 10.1104/pp.82.2.448; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Heinz E., 1977, Lipids and lipid polymers in higher plants., P102; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; JOHNSON G, 1989, PLANT PHYSIOL, V91, P924, DOI 10.1104/pp.91.3.924; Kachroo A, 2004, P NATL ACAD SCI USA, V101, P5152, DOI 10.1073/pnas.0401315101; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; MCKEE JWA, 1979, ARCH BIOCHEM BIOPHYS, V197, P322, DOI 10.1016/0003-9861(79)90252-2; Millenaar FF, 2000, PLANT J, V23, P623, DOI 10.1046/j.1365-313x.2000.00832.x; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Quettier AL, 2008, PLANT PHYSIOL, V148, P519, DOI 10.1104/pp.108.123703; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; ROUGHAN PG, 1979, BIOCHEM J, V184, P193, DOI 10.1042/bj1840193; SAUER A, 1983, Z NATURFORSCH C, V38, P399; SCHMIDT H, 1993, BIOCHEM J, V289, P777, DOI 10.1042/bj2890777; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; SIEBERTZ HP, 1977, Z NATURFORSCH C, V32, P193; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Wei YD, 2004, J BIOL CHEM, V279, P429, DOI 10.1074/jbc.M308363200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WU JR, 1994, PLANT PHYSIOL, V106, P143, DOI 10.1104/pp.106.1.143	52	25	34	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22955	22963		10.1074/jbc.M109.097758	http://dx.doi.org/10.1074/jbc.M109.097758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20304913	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279999900030
J	Di, AK; Kawamura, T; Gao, XP; Tang, HY; Berdyshev, E; Vogel, SM; Zhao, YY; Sharma, T; Bachmaier, K; Xu, JS; Malik, AB				Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Tang, Haiyang; Berdyshev, Evgeny; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.			A Novel Function of Sphingosine Kinase 1 Suppression of JNK Activity in Preventing Inflammation and Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; LUNG VASCULAR-PERMEABILITY; TOLL-LIKE RECEPTOR; ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-MECHANISMS; ADHESION MOLECULES; SIGNALING PATHWAYS; BETA(2) INTEGRINS	The mechanism underlying the protective effect of sphingosine kinase 1 (SphK1) in inflammatory injury is not clear. We demonstrated using SphK1-null mice (SphK1(-/-)) the crucial role of SphK1 in suppressing lipopolysaccharide-induced neutrophil oxidant production and sequestration in lungs and mitigating lung inflammatory injury. This effect of SphK1 was independent of the production of sphingosine 1-phosphate, the product of SphK1 activity. The anti-inflammatory effect of SphK1 in the lipopolysaccharide model was mediated through SphK1 interaction with JNK. SphK1 stabilization of JNK in turn inhibited JNK binding to the JNK-interacting protein 3 (JIP3) and thus abrogated the activation of NADPH oxidase and oxidant generation and resultant NF-kappa B activation. Therefore, SphK1-mediated down-regulation of JNK activity serves to dampen inflammation and tissue injury.	[Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Tang, Haiyang; Xu, Jingsong] Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60612 USA; [Berdyshev, Evgeny] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Di, AK (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, E403 MSB,835 S Wolcott Ave, Chicago, IL 60612 USA.	ankedi@uic.edu	Bachmaier, Kurt/B-6331-2014; Bachmaier, Kurt/AHC-5491-2022; TANG, HAIYANG/J-4006-2013	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128; ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [P01 HL77806]; Parker B. Francis Fellowship in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL77806. This work was also supported by a Parker B. Francis Fellowship in Pulmonary Research.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beaven MA, 2007, IMMUNITY, V26, P271, DOI 10.1016/j.immuni.2007.03.002; Bhattacharya J, 2004, AM J RESP CRIT CARE, V170, P928, DOI 10.1164/rccm.2408008; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Chen CC, 2004, MOL PHARMACOL, V66, P683; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; French KJ, 2003, CANCER RES, V63, P5962; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hordijk PL, 2003, CELL BIOCHEM BIOPHYS, V38, P305, DOI 10.1385/CBB:38:3:305; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Kawasumi M, 2002, NEUROSIGNALS, V11, P236, DOI 10.1159/000067424; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Malik AB, 1996, PHARMACOL REV, V48, P213; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Olivera A, 2008, PROSTAG OTH LIPID M, V86, P1, DOI 10.1016/j.prostaglandins.2008.02.005; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; SMITH CW, 1993, SEMIN HEMATOL, V30, P45; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TATE RM, 1983, AM REV RESPIR DIS, V128, P552, DOI 10.1164/arrd.1983.128.3.552; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407	52	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15848	15857		10.1074/jbc.M109.075549	http://dx.doi.org/10.1074/jbc.M109.075549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299461	Green Published, hybrid			2022-12-27	WOS:000277715900022
J	Rajagopalan, M; Dziedzic, R; Al Zayer, M; Stankowska, D; Ouimet, MC; Bastedo, DP; Marczynski, GT; Madiraju, MV				Rajagopalan, Malini; Dziedzic, Renata; Al Zayer, Maha; Stankowska, Dorota; Ouimet, Marie-Claude; Bastedo, D. Patrick; Marczynski, Gregory T.; Madiraju, Murty V.			Mycobacterium tuberculosis Origin of Replication and the Promoter for Immunodominant Secreted Antigen 85B Are the Targets of MtrA, the Essential Response Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; MCE1 OPERON; IN-VITRO; BINDING; 2-COMPONENT; DNAA; INITIATION; CHROMOSOME; EXPRESSION	Efficient proliferation of Mycobacterium tuberculosis (Mtb) inside macrophage requires that the essential response regulator MtrA be optimally phosphorylated. However, the genomic targets of MtrA have not been identified. We show by chromatin immunoprecipitation and DNase I footprinting that the chromosomal origin of replication, oriC, and the promoter for the major secreted immunodominant antigen Ag85B, encoded by fbpB, are MtrA targets. DNase I footprinting analysis revealed that MtrA recognizes two direct repeats of GTCACAgcg-like sequences and that MtrA similar to P, the phosphorylated form of MtrA, binds preferentially to these targets. The oriC contains several MtrA motifs, and replacement of all motifs or of a single select motif with TATATA compromises the ability of oriC plasmids to maintain stable autonomous replication in wild type and MtrA-overproducing strains, indicating that the integrity of the MtrA motif is necessary for oriC replication. The expression of the fbpB gene is found to be down-regulated in Mtb cells upon infection when these cells overproduce wild type MtrA but not when they overproduce a nonphosphorylated MtrA, indicating that MtrA similar to P regulates fbpB expression. We propose that MtrA is a regulator of oriC replication and that the ability of MtrA to affect apparently unrelated targets, i.e. oriC and fbpB, reflects its main role as a coordinator between the proliferative and pathogenic functions of Mtb.	[Rajagopalan, Malini; Dziedzic, Renata; Al Zayer, Maha; Stankowska, Dorota; Madiraju, Murty V.] Univ Texas Hlth Sci Ctr, Tyler, TX 75708 USA; [Ouimet, Marie-Claude; Bastedo, D. Patrick; Marczynski, Gregory T.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); McGill University	Madiraju, MV (corresponding author), Univ Texas Hlth Sci Ctr, Tyler, TX 75708 USA.	murty.madiraju@uthct.edu			National Institutes of Health [AI 084734, AI 73966, AI 48417]; Canadian Institutes for Health Research [MT-13453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073966, R01AI048417, R01AI084734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 084734 and AI 73966 ( to M. V. M.) and AI 48417 ( to M. R.). This work was also supported by Canadian Institutes for Health Research Operating Grant MT-13453 ( to M.-C. O.,D. P. B., and G. T. M.).	ABOUZEID C, 1991, INFECT IMMUN, V59, P2712, DOI 10.1128/IAI.59.8.2712-2718.1991; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CONTENT J, 1991, INFECT IMMUN, V59, P3205, DOI 10.1128/IAI.59.9.3205-3212.1991; Dasgupta S, 2004, PLASMID, V52, P151, DOI 10.1016/j.plasmid.2004.08.001; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; Farhana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002087; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; GOREN MB, 1972, BACTERIOL REV, V36, P33, DOI 10.1128/MMBR.36.1.33-64.1972; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Kana BD, 2004, TUBERCULOSIS, V84, P63, DOI 10.1016/j.tube.2003.08.006; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; Mustafa AS, 2000, INFECT IMMUN, V68, P3933, DOI 10.1128/IAI.68.7.3933-3940.2000; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pai SR, 2000, MICROB PATHOGENESIS, V28, P335, DOI 10.1006/mpat.2000.0353; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; RAJAGOPALAN M, 1995, J BACTERIOL, V177, P6527, DOI 10.1128/jb.177.22.6527-6535.1995; Rajagopalan M, 2005, BIOCHEM BIOPH RES CO, V331, P1171, DOI 10.1016/j.bbrc.2005.03.239; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Siam R, 2000, EMBO J, V19, P1138, DOI 10.1093/emboj/19.5.1138; Siam R, 2003, J BACTERIOL, V185, P5563, DOI 10.1128/JB.185.18.5563-5572.2003; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sola-Landa A, 2008, NUCLEIC ACIDS RES, V36, P1358, DOI 10.1093/nar/gkm1150; Via LE, 1996, J BACTERIOL, V178, P3314, DOI 10.1128/jb.178.11.3314-3321.1996; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wilkinson RJ, 2001, MOL MICROBIOL, V39, P813, DOI 10.1046/j.1365-2958.2001.02280.x; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P898, DOI 10.1006/bbrc.2000.4202; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zundel CJ, 1998, FEBS LETT, V441, P242, DOI 10.1016/S0014-5793(98)01556-7; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	45	61	63	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15816	15827		10.1074/jbc.M109.040097	http://dx.doi.org/10.1074/jbc.M109.040097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223818	Green Published, hybrid			2022-12-27	WOS:000277715900019
J	Joly, N; Buck, M				Joly, Nicolas; Buck, Martin			Engineered Interfaces of an AAA(+) ATPase Reveal a New Nucleotide-dependent Coordination Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; ENHANCER-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; RNA-POLYMERASE; PORE LOOPS; TRANSCRIPTION; ACTIVATOR; BONE	Homohexameric ring AAA(+) ATPases are found in all kingdoms of life and are involved in all cellular processes. To accommodate the large spectrum of substrates, the conserved AAA(+) core has become specialized through the insertion of specific substrate-binding motifs. Given their critical roles in cellular function, understanding the nucleotide-driven mechanisms of action is of wide importance. For one type of member AAA(+) protein (phage shock protein F, PspF), we identified and established the functional significance of strategically placed arginine and glutamate residues that form interacting pairs in response to nucleotide binding. We show that these interactions are critical for "cis" and "trans" subunit communication, which support coordination between subunits for nucleotide-dependent substrate remodeling. Using an allele-specific suppression approach for ATPase and substrate remodeling, we demonstrate that the targeted residues directly interact and are unlikely to make any other pairwise critical interactions. We then propose a mechanistic rationale by which the nucleotide-bound state of adjacent subunits can be sensed without direct involvement of R-finger residues. As the structural AAA(+) core is conserved, we propose that the functional networks established here could serve as a template to identify similar residue pairs in other AAA(+) proteins.	[Joly, Nicolas; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England	Imperial College London	Joly, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	n.joly@imperial.ac.uk; m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	Biotechnology and Biological Sciences Research Council [BB/G001278/1]; BBSRC [BB/G001278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521922/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BB/G001278/1.	Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Burrows PC, 2009, MOL MICROBIOL, V73, P519, DOI 10.1111/j.1365-2958.2009.06744.x; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Greenleaf WB, 2008, J VIROL, V82, P6017, DOI 10.1128/JVI.00387-08; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2008, J BIOL CHEM, V283, P13725, DOI 10.1074/jbc.M800801200; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2008, BIOCHEM SOC T, V36, P68, DOI 10.1042/BST0360068; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2005, HUM GENET, V118, P508, DOI 10.1007/s00439-005-0075-z; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	40	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15178	15186		10.1074/jbc.M110.103150	http://dx.doi.org/10.1074/jbc.M110.103150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20197281	Green Published, hybrid			2022-12-27	WOS:000277399000039
J	Brakemann, T; Weber, G; Andresen, M; Groenhof, G; Stiel, AC; Trowitzsch, S; Eggeling, C; Grubmuller, H; Hell, SW; Wahl, MC; Jakobs, S				Brakemann, Tanja; Weber, Gert; Andresen, Martin; Groenhof, Gerrit; Stiel, Andre C.; Trowitzsch, Simon; Eggeling, Christian; Grubmueller, Helmut; Hell, Stefan W.; Wahl, Markus C.; Jakobs, Stefan			Molecular Basis of the Light-driven Switching of the Photochromic Fluorescent Protein Padron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MECHANISM	Reversibly switchable fluorescent proteins can be repeatedly photoswitched between a fluorescent and a nonfluorescent state by irradiation with the light of two different wavelengths. The molecular basis of the switching process remains a controversial topic. Padron0.9 is a reversibly switchable fluorescent protein with "positive" switching characteristics, exhibiting excellent spectroscopic properties. Its chromophore is formed by the amino acids Cys-Tyr-Gly. We obtained high resolution x-ray structures of Padron0.9 in both the fluorescent and the nonfluorescent states and used the structural information for molecular dynamics simulations. We found that in Padron0.9 the chromophore undergoes a cis-trans isomerization upon photoswitching. The molecular dynamics simulations clarified the protonation states of the amino acid residues within the chromophore pocket that influence the protonation state of the chromophore. We conclude that a light driven cis-trans isomerization of the chromophore appears to be the fundamental switching mechanism in all photochromic fluorescent proteins known to date. Distinct absorption cross-sections for the switching wavelengths in the fluorescent and the nonfluorescent state are not essential for efficient photochromism in fluorescent proteins, although they may facilitate the switching process.	[Brakemann, Tanja; Andresen, Martin; Stiel, Andre C.; Eggeling, Christian; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Weber, Gert; Trowitzsch, Simon; Wahl, Markus C.] Max Planck Inst Biophys Chem, Dept Cellular Biochem Xray Crystallog, D-37077 Gottingen, Germany; [Groenhof, Gerrit; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Free University of Berlin	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.	sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012; Stiel, Andre/B-1644-2014; Wahl, Markus C./D-6365-2017; Trowitzsch, Simon/O-4957-2016; Weber, Gert/I-1800-2013	Jakobs, Stefan/0000-0002-8028-3121; Stiel, Andre/0000-0001-8675-6797; Wahl, Markus C./0000-0002-2811-5307; Trowitzsch, Simon/0000-0001-9143-766X; Weber, Gert/0000-0003-3624-1060; Groenhof, Gerrit/0000-0001-8148-5334	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (to S. W. H.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Fron E, 2007, J AM CHEM SOC, V129, P4870, DOI 10.1021/ja069365v; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Klingen AR, 2006, PHOTOCH PHOTOBIO SCI, V5, P588, DOI 10.1039/b515479k; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Moors SLC, 2008, J CHEM THEORY COMPUT, V4, P1012, DOI 10.1021/ct8000359; Nienhaus GU, 2009, CHEMPHYSCHEM, V10, P1369, DOI 10.1002/cphc.200800839; Oelgemoller M, 2002, J CHEM SOC PERK T 2, P1760, DOI 10.1039/b203167a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; Schafer LV, 2007, ANGEW CHEM INT EDIT, V46, P530, DOI 10.1002/anie.200602315; Schuttrigkeit TA, 2006, CHEM PHYS, V323, P149, DOI 10.1016/j.chemphys.2005.09.039; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199	28	52	54	0	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14603	14609		10.1074/jbc.M109.086314	http://dx.doi.org/10.1074/jbc.M109.086314			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236929	hybrid, Green Published			2022-12-27	WOS:000277299700057
J	Schmidt, DR; Holmstrom, SR; Tacer, KF; Bookout, AL; Kliewer, SA; Mangelsdorf, DJ				Schmidt, Daniel R.; Holmstrom, Sam R.; Tacer, Klementina Fon; Bookout, Angie L.; Kliewer, Steven A.; Mangelsdorf, David J.			Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FEEDBACK-REGULATION; LITHOCHOLIC ACID; X-RECEPTOR; LIVER; ACTIVATION; CANCER; HOMEOSTASIS; ENZYMES	Bile acids are required for proper absorption of dietary lipids, including fat-soluble vitamins. Here, we show that the dietary vitamins A and D inhibit bile acid synthesis by repressing hepatic expression of the rate-limiting enzyme CYP7A1. Receptors for vitamin A and D induced expression of Fgf15, an intestine-derived hormone that acts on liver to inhibit Cyp7a1. These effects were mediated through distinct cis-acting response elements in the promoter and intron of Fgf15. Interestingly, transactivation of both response elements appears to be required to maintain basal Fgf15 expression levels in vivo. Furthermore, whereas induction of Fgf15 by vitamin D is mediated through its receptor, the induction of Fgf15 by vitamin A is mediated through the retinoid X receptor/farnesoid X receptor heterodimer and is independent of bile acids, suggesting that this heterodimer functions as a distinct dietary vitamin A sensor. Notably, vitamin A treatment reversed the effects of the bile acid sequestrant cholestyramine on Fgf15, Shp, and Cyp7a1 expression, suggesting a potential therapeutic benefit of vitamin A under conditions of bile acid malabsorption. These results reveal an unexpected link between the intake of fat-soluble vitamins A and D and bile acid metabolism, which may have evolved as a means for these dietary vitamins to regulate their own absorption.	[Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Holmstrom, Sam R.; Tacer, Klementina Fon; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas		steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796	National Institutes of Health [U19DK62434, GM07062, CA114109]; Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-1558]; NATIONAL CANCER INSTITUTE [R01CA114109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U19DK62434 (to D. J. M.), GM07062 (to D. R. S. and A. L. B.), and CA114109 (to S. A. K.). This work was also supported by the Howard Hughes Medical Institute and Robert A. Welch Foundation Grants I-1275 (to D. J. M.) and I-1558 (to S. A. K.).	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Crestani M, 1998, J LIPID RES, V39, P2192; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Gilardi F, 2007, PHARMACOL THERAPEUT, V116, P449, DOI 10.1016/j.pharmthera.2007.08.003; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haussler MR, 1997, J ENDOCRINOL, V154, pS57; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hofmann AF, 2009, CLIN GASTROENTEROL H, V7, P1151, DOI 10.1016/j.cgh.2009.07.026; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mangelsdorf DJ, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P863; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; Nehring JA, 2007, P NATL ACAD SCI USA, V104, P10006, DOI 10.1073/pnas.0703512104; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; ROSS AC, 1993, J NUTR, V123, P346, DOI 10.1093/jn/123.suppl_2.346; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Walters JRF, 2009, CLIN GASTROENTEROL H, V7, P1189, DOI 10.1016/j.cgh.2009.04.024; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S	38	149	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14486	14494		10.1074/jbc.M110.116004	http://dx.doi.org/10.1074/jbc.M110.116004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233723	Green Published, hybrid			2022-12-27	WOS:000277299700045
J	Yan, WS; Chen, XB				Yan, Wensheng; Chen, Xinbin			Characterization of Functional Domains Necessary for Mutant p53 Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; WILD-TYPE P53; GENE-EXPRESSION; P53-MEDIATED APOPTOSIS; FAMILY PROTEINS; TERMINAL DOMAIN; TARGET GENES; ACTIVATION; CELLS; IDENTIFICATION	Tumor cells, including SW480 carcinoma cells that carry a mutant p53, are addicted to the mutant for their survival and resistance to growth suppression by chemotherapeutic agents. Here, we investigated whether various classes of p53 mutants share a common property and functional domains necessary for mutant p53 gain of function. To test this, we generated SW480 cell lines in which endogenous mutant R273H/P309S can be inducibly or stably knocked down, whereas a small interfering RNA-resistant mutant p53 along with a mutated functional domain can be inducibly or stably expressed. We found that both contact-site (R248W and R273H) and conformation (G245S and R249S) mutants are able to maintain the transformed phenotypes of SW480 cells conferred by endogenous mutant p53. We also found that activation domains 1-2 and the proline-rich domain are required for mutant p53 gain of function. Interestingly, we showed that the C-terminal basic domain, which is required for wild-type p53 activity, is an inhibitory domain for mutant p53. Furthermore, we showed that deletion of the basic domain enhances, whereas a mutation in activation domains 1-2 and deletion of the proline-rich domain abolish mutant p53 to regulate Gro1 and Id2, both of which are regulated by and mediate endogenous mutant p53 gain of function. These results indicate that both conformation and contact-site mutants share a property for cell transformation, and the domains critical for wild-type p53 tumor suppression are also required for mutant p53 tumor promotion. Thus, the inhibitory basic domain and the common property for p53 mutants can be explored for targeting tumors with mutant p53.	[Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Comparat Canc Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Canc Ctr, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA121137 (to X. C.).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gaidarenko O, 2009, ONCOGENE, V28, P4397, DOI 10.1038/onc.2009.290; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnson TM, 2006, CELL DEATH DIFFER, V13, P902, DOI 10.1038/sj.cdd.4401902; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LIN JY, 1995, ONCOGENE, V10, P2387; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Nister M, 2005, ONCOGENE, V24, P3563, DOI 10.1038/sj.onc.1208354; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yap DBS, 2004, CANCER RES, V64, P4749, DOI 10.1158/0008-5472.CAN-1305-2; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	39	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14229	14238		10.1074/jbc.M109.097253	http://dx.doi.org/10.1074/jbc.M109.097253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212049	Green Published, hybrid			2022-12-27	WOS:000277299700019
J	Krol, E; Mentzel, T; Chinchilla, D; Boller, T; Felix, G; Kemmerling, B; Postel, S; Arents, M; Jeworutzki, E; Al-Rasheid, KAS; Becker, D; Hedrich, R				Krol, Elzbieta; Mentzel, Tobias; Chinchilla, Delphine; Boller, Thomas; Felix, Georg; Kemmerling, Birgit; Postel, Sandra; Arents, Michael; Jeworutzki, Elena; Al-Rasheid, Khaled A. S.; Becker, Dirk; Hedrich, Rainer			Perception of the Arabidopsis Danger Signal Peptide 1 Involves the Pattern Recognition Receptor AtPEPR1 and Its Close Homologue AtPEPR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE CELL-DEATH; DEFENSE RESPONSES; INNATE IMMUNITY; ABSCISIC-ACID; CALCIUM; CHANNEL; REGULATOR; ELICITORS; TRANSPORT; PATHWAYS	Plasma membrane-borne pattern recognition receptors, which recognize microbe-associated molecular patterns and endogenous damage-associated molecular patterns, provide the first line of defense in innate immunity. In plants, leucine-rich repeat receptor kinases fulfill this role, as exemplified by FLS2 and EFR, the receptors for the microbe-associated molecular patterns flagellin and elongation factor Tu. Here we examined the perception of the damage-associated molecular pattern peptide 1 (AtPep1), an endogenous peptide of Arabidopsis identified earlier and shown to be perceived by the leucine-rich repeat protein kinase PEPR1. Using seedling growth inhibition, elicitation of an oxidative burst and induction of ethylene biosynthesis, we show that wild type plants and the pepr1 and pepr2 mutants, affected in PEPR1 and in its homologue PEPR2, are sensitive to AtPep1, but that the double mutant pepr1/pepr2 is completely insensitive. As a central body of our study, we provide electrophysiological evidence that at the level of the plasma membrane, AtPep1 triggers a receptor-dependent transient depolarization through activation of plasma membrane anion channels, and that this effect is absent in the double mutant pepr1/pepr2. The double mutant also fails to respond to AtPep2 and AtPep3, two distant homologues of AtPep1 on the basis of homology screening, implying that the PEPR1 and PEPR2 are responsible for their perception too. Our findings provide a basic framework to study the biological role of AtPep1-related danger signals and their cognate receptors.	[Becker, Dirk] Univ Wurzburg, Julius von Sachs Inst Biosci Mol Plant Physi & Bi, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Mentzel, Tobias; Chinchilla, Delphine; Boller, Thomas] Univ Basel, Inst Bot, Zuerich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Felix, Georg; Kemmerling, Birgit; Postel, Sandra] Univ Tubingen, Zentrum Mol Biol Pflanzen Plant Biochem, D-72076 Tubingen, Germany; [Al-Rasheid, Khaled A. S.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Krol, Elzbieta] UMCS Lublin, Dept Biophys, Inst Biol, PL-20033 Lublin, Poland	University of Wurzburg; University of Basel; Eberhard Karls University of Tubingen; King Saud University; Maria Curie-Sklodowska University	Becker, D (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biosci Mol Plant Physi & Bi, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany.	dbecker@botanik.uni-wuerzburg.de	Becker, Dirk/F-7826-2010; Hedrich, Rainer/G-8771-2011; AL-Rasheid, Khaled/C-2486-2008; Boller, Thomas/G-3500-2012	Hedrich, Rainer/0000-0003-3224-1362; AL-Rasheid, Khaled/0000-0002-3404-3397; Boller, Thomas/0000-0001-6768-7503; Becker, Dirk/0000-0003-0723-4160	Polish Ministry of Education [N N301 464534]; Swiss National Science Foundation; German Research Foundation Graduierten Kolleg [1342, SFB567]; Alexander von Humboldt Foundation	Polish Ministry of Education; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation Graduierten Kolleg(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work supported in part by Polish Ministry of Education Grant N N301 464534, the Swiss National Science Foundation, and German Research Foundation Graduierten Kolleg 1342 "Lipid Signalling" and SFB567.; Supported by the Alexander von Humboldt Foundation.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Genger RK, 2008, MOL PLANT MICROBE IN, V21, P1285, DOI 10.1094/MPMI-21-10-1285; Hedrich R, 2006, PLANTA, V224, P725, DOI 10.1007/s00425-006-0341-x; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Pearce G, 2001, NATURE, V411, P817, DOI 10.1038/35081107; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	34	250	262	3	78	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13471	13479		10.1074/jbc.M109.097394	http://dx.doi.org/10.1074/jbc.M109.097394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200150	hybrid, Green Published			2022-12-27	WOS:000276987700019
J	Miralem, T; Gibbs, PEM; Revert, F; Saus, J; Maines, MD				Miralem, Tihomir; Gibbs, Peter E. M.; Revert, Fernando; Saus, Juan; Maines, Mahin D.			Human Biliverdin Reductase Suppresses Goodpasture Antigen-binding Protein (GPBP) Kinase Activity THE REDUCTASE REGULATES TUMOR NECROSIS FACTOR-alpha-NF-kappa B-DEPENDENT GPBP EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; IV COLLAGEN; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BILIRUBIN; IDENTIFICATION; PHOSPHORYLATION; ACTIVATION; INDUCTION	The Ser/Thr/Tyr kinase activity of human biliverdin reductase (hBVR) and the expression of Goodpasture antigen-binding protein (GPBP), a nonconventional Ser/Thr kinase for the type IV collagen of basement membrane, are regulated by tumor necrosis factor (TNF-alpha). The pro-inflammatory cytokine stimulates kinase activity of hBVR and activates NF-kappa B, a transcriptional regulator of GPBP mRNA. Increased GPBP activity is associated with several autoimmune conditions, including Goodpasture syndrome. Here we show that in HEK293A cells hBVR binds to GPBP and down-regulates its TNF-alpha-stimulated kinase activity; this was not due to a decrease in GPBP expression. Findings with small interfering RNA to hBVR and to the p65 regulatory subunit of NF-kappa B show the hBVRrole in the initial stimulation of GPBP expression by TNF-alpha activated NF-kappa B; hBVR was not a factor in mediating GPBP mRNA stability. The interacting domain was mapped to the (CX10C)-C-281 motif in the C-terminal 24 residues of hBVR. A 7-residue peptide, KKRILHC281, corresponding to the core of the consensus D(delta)-Box motif in the interacting domain, was as effective as the intact 296-residue hBVR polypeptide in inhibiting GPBP kinase activity. GPBP neither regulated hBVR expression nor TNF-alpha dependent NF-kappa B expression. Collectively, our data reveal that hBVR is a regulator of the TNF-alpha GPBP-collagen type IV signaling cascade and uncover a novel biological interaction that may be of relevance in autoimmune pathogenesis.	[Miralem, Tihomir; Gibbs, Peter E. M.; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Revert, Fernando; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain	University of Rochester; Prince Felipe Research Center; University of Valencia	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu	REVERT, FERNANDO/ABF-8171-2021; Miralem, Tihomir/F-7576-2013	REVERT, FERNANDO/0000-0002-7304-5846; Saus, Juan/0000-0003-2082-1597; Miralem, Tihomir/0000-0001-7705-0442	National Institutes of Health [ES04066, ES12187]; SAF [2006-12520-C02-01]; Ministerio de Educacion y Ciencia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066, R01ES012187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SAF; Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES04066 and ES12187 (to M.D.M.). This work was also supported by SAF 2006-12520-C02-01 from the Plan Nacional I + D of the Ministerio de Educacion y Ciencia and Prometeo/2009/065 from Generalitat Valenciana, of Spain (to J.S.).	BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; C J, 2008, AM J PHYSIOL-LUNG C, V295, pL624; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; HUBBARD SR, 1991, SCIENCE, V254, P1776; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hunter T, 1998, Harvey Lect, V94, P81; Immenschuh S, 2005, CELL MOL BIOL, V51, P471, DOI 10.1170/T652; Jacobs JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P8, DOI 10.1006/abbi.1999.1416; Juan SH, 2005, BIOCHEM PHARMACOL, V69, P41, DOI 10.1016/j.bcp.2004.09.015; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasza A, 2005, J BIOL CHEM, V280, P1149, DOI 10.1074/jbc.M411161200; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mancuso C, 2006, REDOX REP, V11, P207, DOI 10.1179/135100006X154978; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Naidu S, 2008, J IMMUNOL, V181, P4113, DOI 10.4049/jimmunol.181.6.4113; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; QUINONES S, 1992, J BIOL CHEM, V267, P19780; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SAUS J, 1998, ENCY IMMUNOLOGY, P1005; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2	51	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12551	12558		10.1074/jbc.M109.032771	http://dx.doi.org/10.1074/jbc.M109.032771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177069	hybrid, Green Published			2022-12-27	WOS:000276787800012
J	Barreteau, H; Bouhss, A; Gerard, F; Duche, D; Boussaid, B; Blanot, D; Lloubes, R; Mengin-Lecreulx, D; Touze, T				Barreteau, Helene; Bouhss, Ahmed; Gerard, Fabien; Duche, Denis; Boussaid, Boubekeur; Blanot, Didier; Lloubes, Roland; Mengin-Lecreulx, Dominique; Touze, Thierry			Deciphering the Catalytic Domain of Colicin M, a Peptidoglycan Lipid II-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IMMUNITY PROTEIN; BIOSYNTHESIS; ACQUISITION; EXPRESSION; INHIBITOR; MECHANISM; BINDING; GENES; CELLS	Colicin M inhibits Escherichia coli peptidoglycan synthesis through cleavage of its lipid-linked precursors. It has a compact structure, whereas other related toxins are organized in three independent domains, each devoted to a particular function: translocation through the outer membrane, receptor binding, and toxicity, from the N to the C termini, respectively. To establish whether colicin M displays such an organization despite its structural characteristics, protein dissection experiments were performed, which allowed us to delineate an independent toxicity domain encompassing exactly the C-terminal region conserved among colicin M-like proteins and covering about half of colicin M( residues 124-271). Surprisingly, the in vitro activity of the isolated domain was 45-fold higher than that of the full-length protein, suggesting a mechanism by which the toxicity of this domain is revealed following primary protein maturation. In vivo, the isolated toxicity domain appeared as toxic as the full-length protein under conditions where the reception and translocation steps were by-passed. Contrary to the full-length colicin M, the isolated domain did not require the presence of the periplasmic FkpA protein to be toxic under these conditions, demonstrating that FkpA is involved in the maturation process. Mutational analysis further identified five residues that are essential for cytotoxicity as well as in vitro lipid II-degrading activity: Asp-229, His-235, Asp-226, Tyr-228, and Arg-236. Most of these residues are surface-exposed and located relatively close to each other, hence suggesting they belong to the colicin M active site.	[Touze, Thierry] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Lab Enveloppes Bacteriennes & Antibiot,UMR 8619, F-91405 Orsay, France; [Duche, Denis; Lloubes, Roland] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Touze, T (corresponding author), Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Lab Enveloppes Bacteriennes & Antibiot,UMR 8619, Batiment 430, F-91405 Orsay, France.	thierry.touze@u-psud.fr	Touzé, Thierry/GLT-1308-2022	MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Duche, Denis/0000-0002-4208-6661; LLOUBES, Roland/0000-0002-9520-1053; Touze, Thierry/0000-0002-2176-6537	Agence Nationale de la Recherche [ANR-07-MIME-020]; CNRS [UMR 8619]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche (PEPGLYCOL project, ANR-07-MIME-020) and the CNRS (UMR 8619).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1973, BIOCHIM BIOPHYS ACTA, V323, P87, DOI 10.1016/0005-2736(73)90433-1; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chavan M, 2005, J MOL EVOL, V60, P546, DOI 10.1007/s00239-004-0263-9; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; EICKHELMERICH K, 1989, J BACTERIOL, V171, P5117, DOI 10.1128/jb.171.9.5117-5126.1989; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; FEHRST A, 1977, ENZYME STRUCTURE MEC; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; JOHNSON KA, 1990, ENZYMES, V19, P159; Kageyama M, 1996, J BACTERIOL, V178, P103, DOI 10.1128/jb.178.1.103-110.1996; KOCK J, 1987, J BACTERIOL, V169, P3358; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Mavrodi DV, 2002, APPL ENVIRON MICROB, V68, P5170, DOI 10.1128/AEM.68.10.5170-5176.2002; MILLER JH, 1972, COLD SPRING HARBOR L, P431; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; OLSCHLAGER T, 1987, J BACTERIOL, V169, P4765, DOI 10.1128/jb.169.10.4765-4769.1987; OLSCHLAGER T, 1984, MOL GEN GENET, V196, P482, DOI 10.1007/BF00436196; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Press WH, 1986, NUMERICAL RECIPES AR, P521; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; SCHALLER K, 1982, J BACTERIOL, V152, P994; SHIMIZU K, 1979, MOL GEN GENET, V168, P37, DOI 10.1007/BF00267931; TOUZE T, 2008, UNDECAPRENYL PHOSPHA; van Dam V, 2007, MOL MICROBIOL, V64, P1105, DOI 10.1111/j.1365-2958.2007.05722.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	41	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12378	12389		10.1074/jbc.M109.093583	http://dx.doi.org/10.1074/jbc.M109.093583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159977	Green Published, hybrid			2022-12-27	WOS:000276787100066
J	Phillips, NB; Wan, ZI; Whittaker, L; Hu, SQ; Huang, K; Hua, QX; Whittaker, J; Ismail-Beigi, F; Weiss, MA				Phillips, Nelson B.; Wan, Zhu-Ii; Whittaker, Linda; Hu, Shi-Quan; Huang, Kun; Hua, Qing-xin; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Weiss, Michael A.			Supramolecular Protein Engineering DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING SITES; RECEPTOR-BINDING; CRYSTAL-STRUCTURE; ANALOGS; GLARGINE; RECOGNITION; INTERFACE; THERAPY	Bottom-up control of supramolecular protein assembly can provide a therapeutic nanobiotechnology. We demonstrate that the pharmacological properties of insulin can be enhanced by design of "zinc staples" between hexamers. Paired (i, i+4) His substitutions were introduced at an alpha-helical surface. The crystal structure contains both classical axial zinc ions and novel zinc ions at hexamer-hexamer interfaces. Although soluble at pH 4, the combined electrostatic effects of the substitutions and bridging zinc ions cause isoelectric precipitation at neutral pH. Following subcutaneous injection in a diabetic rat, the analog effected glycemic control with a time course similar to that of long acting formulation Lantus (R). Relative to Lantus, however, the analog discriminates at least 30-fold more stringently between the insulin receptor and mitogenic insulin-like growth factor receptor. Because aberrant mitogenic signaling may be associated with elevated cancer risk, such enhanced specificity may improve safety. Zinc stapling provides a general strategy to modify the pharmacokinetic and biological properties of a subcutaneous protein depot.	[Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Hu, Shi-Quan; Huang, Kun; Hua, Qing-xin; Whittaker, Jonathan] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		National Institutes of Health [DK069764]; American Diabetes Association; Dietrich Diabetes Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074176, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Dietrich Diabetes Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069764 (to M. A. W.). This work was also supported by grants from the American Diabetes Association (to N. B. P. and M. A. W.) and Dietrich Diabetes Research Institute (to N. B. P. and F. I.-B.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology. M. A. W. is a founding shareholder of Thermalin Diabetes, Inc. (Cleveland, OH).	Albrecht M, 2007, NATURWISSENSCHAFTEN, V94, P951, DOI 10.1007/s00114-007-0282-7; Asuri P, 2006, CURR OPIN BIOTECH, V17, P562, DOI 10.1016/j.copbio.2006.09.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baxter MA, 2008, ACTA DIABETOL, V45, P253, DOI 10.1007/s00592-008-0052-9; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, Pharm Biotechnol, V10, P343; BRANGE J, 1987, GALENICS INSULIN, P18; Campbell RK, 2001, CLIN THER, V23, P1938, DOI 10.1016/S0149-2918(01)80148-X; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Le Roith D, 2007, DIABETES-METAB RES, V23, P593, DOI 10.1002/dmrr.776; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Mayer Doris, 2008, Archives of Physiology and Biochemistry, V114, P38, DOI [10.1080/13813450801900645, 10.1080/13813450801900645 ]; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Raskin P, 2007, ENDOCRIN METAB CLIN, V36, P21, DOI 10.1016/S0889-8529(07)80005-3; REGAN L, 1993, ANNU REV BIOPH BIOM, V22, P257, DOI 10.1146/annurev.bb.22.060193.001353; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Schneider S, 2004, ARZNEIMITTELFORSCH, V54, P842; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Zhao M, 2009, J BIOL CHEM, V284, P32178, DOI 10.1074/jbc.M109.028399	33	25	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11755	11759		10.1074/jbc.C110.105825	http://dx.doi.org/10.1074/jbc.C110.105825			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20181952	Green Published, hybrid			2022-12-27	WOS:000276787100001
J	Wu, M; Kang, MM; Schoene, NW; Cheng, WH				Wu, Min; Kang, Mandy M.; Schoene, Norberta W.; Cheng, Wen-Hsing			Selenium Compounds Activate Early Barriers of Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; PROSTATE-CANCER; OXIDATIVE STRESS; GENOMIC INSTABILITY; VITAMIN-E; DEPENDENT PHOSPHORYLATION; TRIGGERS SENESCENCE; INDUCED APOPTOSIS; LUNG-CANCER; IN-VITRO	Selenium chemoprevention by apoptosis has been well studied, but it is not clear whether selenium can activate early barriers of tumorigenesis, namely senescence and DNA damage response. To test this hypothesis, we treated normal and cancerous cells with a gradient concentration of sodium selenite, methylseleninic acid and methylselenocysteine for 48 h, followed by a recovery of 1-7 days. Here we show that selenium compounds at doses of <= LD50 can induce cellular senescence, as evidenced by the expression of senescence-associated beta-galactosidase and 5-bromo-2-deoxyuridine incorporation, in normal but not cancerous cells. In response to clastogens, the ataxia telangiectasia mutated (ATM) protein is rapidly activated, which in turn initiates a cascade of DNA damage response. We found that the ATM pathway is activated by the selenium compounds, and the kinase activity is required for the selenium-induced senescence response. Pretreatment of the MRC-5 non-cancerous cells with the antioxidant N-acetylcysteine or 2,2,6,6-tetramethylpiperidine-1-oxyl suppresses the selenium-induced ATM activation and senescence. Taken together, the results suggest a novel role of selenium in the activation of early tumorigenesis barriers specific in non-cancerous cells, whereby selenium induces an ATM-dependent senescence response that depends on reactive oxygen species.	[Wu, Min; Kang, Mandy M.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Schoene, Norberta W.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, 3107B Skinner Bldg, College Pk, MD 20742 USA.	whcheng@umd.edu			General Research Board, the University of Maryland at College Park; United States Department of Agriculture Agricultural Research Service [1235-51530-052-00D]	General Research Board, the University of Maryland at College Park; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by an award from the General Research Board, the University of Maryland at College Park (to W.-H. C.), and United States Department of Agriculture Agricultural Research Service Project 1235-51530-052-00D (to N.W.S.). Downloaded from www.jbc.org at ISI, Thomson Scientific, on April 19, 2010	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Camphausen K, 2004, MOL CANCER THER, V3, P409; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Cheng WH, 2008, MOL BIOL CELL, V19, P3923, DOI 10.1091/mbc.E07-07-0698; Cheng WH, 2009, ENVIRON MOL MUTAGEN, V50, P349, DOI 10.1002/em.20489; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu HB, 2006, MOL CANCER THER, V5, P1873, DOI 10.1158/1535-7163.MCT-06-0063; HURST R, 2009, JAMA-J AM MED ASSOC, V301, P1877; Hurst R, 2009, JAMA-J AM MED ASSOC, V301, P1876, DOI 10.1001/jama.2009.626; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Li GX, 2007, INT J CANCER, V120, P2034, DOI 10.1002/ijc.22480; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Marshall JR, 2006, CANCER EPIDEM BIOMAR, V15, P1479, DOI 10.1158/1055-9965.EPI-05-0585; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ravizza R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-92; Rayman MP, 2009, JAMA-J AM MED ASSOC, V301, P1876, DOI 10.1001/jama.2009.625; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Shen CL, 2001, CANCER EPIDEM BIOMAR, V10, P385; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Spallholz JE, 2001, NUTR CANCER, V40, P34, DOI 10.1207/S15327914NC401_8; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; te Poele RH, 2002, CANCER RES, V62, P1876; Thompson IM, 2007, J UROLOGY, V178, pS9, DOI 10.1016/j.juro.2007.03.138; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; von Kobbe C, 2004, FASEB J, V18, P1970, DOI 10.1096/fj.04-1895fje; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Waters DJ, 2005, CARCINOGENESIS, V26, P1256, DOI 10.1093/carcin/bgi077; Zhao R, 2006, MOL CANCER THER, V5, P3275, DOI 10.1158/1535-7163.MCT-06-0400; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	51	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12055	12062		10.1074/jbc.M109.088781	http://dx.doi.org/10.1074/jbc.M109.088781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20157118	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000276787100034
J	Derbyshire, ER; Deng, S; Marletta, MA				Derbyshire, Emily R.; Deng, Sarah; Marletta, Michael A.			Incorporation of Tyrosine and Glutamine Residues into the Soluble Guanylate Cyclase Heme Distal Pocket Alters NO and O-2 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; NITRIC-OXIDE; CARBON-MONOXIDE; LIGAND-BINDING; TRUNCATED HEMOGLOBINS; BACILLUS-SUBTILIS; OXYGEN; DOMAIN; ACTIVATION; SENSOR	Nitric oxide (NO) is the physiologically relevant activator of the mammalian hemoprotein soluble guanylate cyclase (sGC). The heme cofactor of alpha 1 beta 1 sGC has a high affinity for NO but has never been observed to form a complex with oxygen. Introduction of a key tyrosine residue in the sGC heme binding domain beta 1(1-385) is sufficient to produce an oxygen-binding protein, but this mutation in the full-length enzyme did not alter oxygen affinity. To evaluate ligand binding specificity in full-length sGC we mutated several conserved distal heme pocket residues (beta 1 Val-5, Phe-74, Ile-145, and Ile-149) to introduce a hydrogen bond donor in proximity to the heme ligand. We found that the NO coordination state, NO dissociation, and enzyme activation were significantly affected by the presence of a tyrosine in the distal heme pocket; however, the stability of the reduced porphyrin and the proteins affinity for oxygen were unaltered. Recently, an atypical sGC from Drosophila, Gyc-88E, was shown to form a stable complex with oxygen. Sequence analysis of this protein identified two residues in the predicted heme pocket (tyrosine and glutamine) that may function to stabilize oxygen binding in the atypical cyclase. The introduction of these residues into the rat beta 1 distal heme pocket (Ile-145 -> Tyr and Ile-149 -> Gln) resulted in an sGC construct that oxidized via an intermediate with an absorbance maximum at 417 nm. This absorbance maximum is consistent with globin Fe-II-O-2 complexes and is likely the first observation of a FeII-O-2 complex in the full-length alpha 1 beta 1 protein. Additionally, these data suggest that atypical sGCs stabilize O-2 binding by a hydrogen bonding network involving tyrosine and glutamine.	[Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, Berkeley, CA 94720 USA; [Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; [Deng, Sarah] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Derbyshire, Emily R.; Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Marletta, MA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, 570 Stanley Hall, Berkeley, CA 94720 USA.	marletta@berkeley.edu			National Institutes of Health [GM077365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077365 (to M. A. M.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Boon EM, 2006, J BIOL CHEM, V281, P21892, DOI 10.1074/jbc.M600557200; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Das TK, 2004, J BIOL CHEM, V279, P10433, DOI 10.1074/jbc.M309590200; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Huang SH, 2007, BIOCHEMISTRY-US, V46, P15115, DOI 10.1021/bi701771r; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Li ZQ, 2005, BIOCHEMISTRY-US, V44, P939, DOI 10.1021/bi0489208; Makino R, 2003, J BIOL CHEM, V278, P11130, DOI 10.1074/jbc.M209026200; Marti MA, 2007, PROTEINS, V68, P480, DOI 10.1002/prot.21454; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Mishra S, 2010, J AM CHEM SOC, V132, P2968, DOI 10.1021/ja9078144; Morton DB, 2004, J BIOL CHEM, V279, P50651, DOI 10.1074/jbc.C400461200; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; SANDERS KM, 1992, JPN J PHARMACOL, V58, pP220; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Vermeersch P, 2007, CIRCULATION, V116, P936, DOI 10.1161/CIRCULATIONAHA.106.677245; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Warner T D, 1994, Adv Pharmacol, V26, P171, DOI 10.1016/S1054-3589(08)60054-X; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	45	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17471	17478		10.1074/jbc.M109.098269	http://dx.doi.org/10.1074/jbc.M109.098269			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20231286	Green Published, hybrid			2022-12-27	WOS:000278133400025
J	Ohashi, M; Eagle, RA; Trowsdale, J				Ohashi, Maki; Eagle, Robert A.; Trowsdale, John			Post-translational Modification of the NKG2D Ligand RAET1G Leads to Cell Surface Expression of a Glycosylphosphatidylinositol-linked Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; NK CYTOTOXICITY; TUMOR-CELLS; AMINO-ACID; RECEPTOR; STRESS; BINDING; MICA; MOLECULES; PROTEINS	NKG2D is an important activating receptor on lymphocytes. In human, it interacts with two groups of ligands: the major histocompatibility complex class I chain-related A/B (MICA/B) family and the UL-16 binding protein (ULBP) family, also known as retinoic acid early transcript (RAET1). MIC proteins are membrane-anchored, but all of the ULBP/RAET1 proteins, except for RAET1E and RAET1G, are glycosylphosphatidylinositol (GPI)-anchored. To address the reason for these differences we studied the association of RAET1G with the membrane. Using epitope-tagged RAET1G protein in conjunction with antibodies to different parts of the molecule and in pulse-chase experiments, we showed that the C terminus of the protein was cleaved soon after protein synthesis. Endoglycosidase H and peptide N-glycosidase treatment and cell surface immunoprecipitation indicated that most of the protein stayed in the endoplasmic reticulum, but some of the cleaved form was modified in the Golgi and transported to the cell surface. We examined the possibility of GPI anchoring of the protein in three ways: (i) Phosphatidylinositol (PI)-specific phospholipase C released the PI-linked form of the protein. (ii) The surface expression pattern of RAET1G decreased in cells defective in GPI anchoring through mutant GPI-amidase. (iii) Site-directed mutagenesis, to disrupt residues predicted to facilitate GPI-anchoring, resulted in diminished surface expression of RAET1G. Thus, a form of RAET1G is GPI-anchored, in line with most other ULBP/RAET1 family proteins. The cytoplasmic tail and transmembrane domains appear to result from gene duplication and frameshift mutation. Together with our previous results, our data suggest that RAET1G is regulated post-translationally to produce a GPI-anchored isoform.	[Ohashi, Maki; Eagle, Robert A.; Trowsdale, John] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Eagle, Robert A.] CALTECH, Pasadena, CA 91125 USA; [Trowsdale, John] Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England	University of Cambridge; California Institute of Technology; University of Cambridge	Ohashi, M (corresponding author), Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	mo325@cam.ac.uk; jt233@cam.ac.uk	Eagle, Robert/A-2679-2011	Eagle, Robert/0000-0003-0304-6111	Cancer Research United Kingdom; MRC [G9800943, G0401569] Funding Source: UKRI; Medical Research Council [G0401569, G9800943] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from Cancer Research United Kingdom.	Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bohme U, 2002, J CELL SCI, V115, P805; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Cao W, 2008, INT IMMUNOL, V20, P981, DOI 10.1093/intimm/dxn057; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Eagle RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004503; Ebihara T, 2007, INT IMMUNOL, V19, P1145, DOI 10.1093/intimm/dxm073; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; KODUKULA K, 1993, J CELL BIOL, V120, P657, DOI 10.1083/jcb.120.3.657; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Ohishi K, 2003, J BIOL CHEM, V278, P13959, DOI 10.1074/jbc.M300586200; Pende D, 2002, CANCER RES, V62, P6178; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wittenbrink M, 2009, EUR J IMMUNOL, V39, P1642, DOI 10.1002/eji.200839074	31	11	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16408	16415		10.1074/jbc.M109.077636	http://dx.doi.org/10.1074/jbc.M109.077636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304922	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000277982600002
J	Pletneva, NV; Pletnev, VZ; Lukyanov, KA; Gurskaya, NG; Goryacheva, EA; Martynov, VI; Wlodawer, A; Dauter, Z; Pletnev, S				Pletneva, Nadya V.; Pletnev, Vladimir Z.; Lukyanov, Konstantin A.; Gurskaya, Nadya G.; Goryacheva, Ekaterina A.; Martynov, Vladimir I.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Sergei			Structural Evidence for a Dehydrated Intermediate in Green Fluorescent Protein Chromophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GFP; MECHANISM; CYCLIZATION; EXCITATION; EXTENSION; VARIANTS; PROGRAM	The acGFPL is the first-identified member of a novel, colorless and non-fluorescent group of green fluorescent protein (GFP)-like proteins. Its mutant aceGFP, with Gly replacing the invariant catalytic Glu-222, demonstrates a relatively fast maturation rate and bright green fluorescence (lambda(ex) = 480 nm, lambda(em) = 505 nm). The reverse G222E single mutation in aceGFP results in the immature, colorless variant aceGFP-G222E, which undergoes irreversible photoconversion to a green fluorescent state under UV light exposure. Here we present a high resolution crystallographic study of aceGFP and aceGFP-G222E in the immature and UV-photoconverted states. A unique and striking feature of the colorless aceGFP-G222E structure is the chromophore in the trapped intermediate state, where cyclization of the protein backbone has occurred, but Tyr-66 still stays in the native, non-oxidized form, with C-alpha and C-beta atoms in the sp(3) hybridization. This experimentally observed immature aceGFP-G222E structure, characterized by the non-coplanar arrangement of the imidazolone and phenolic rings, has been attributed to one of the intermediate states in the GFP chromophore biosynthesis. The UV irradiation (lambda = 250-300 nm) of aceGFP-G222E drives the chromophore maturation further to a green fluorescent state, characterized by the conventional coplanar bicyclic structure with the oxidized double Tyr-66 C-alpha = C-beta bond and the conjugated system of pi-electrons. Structure-based site-directed mutagenesis has revealed a critical role of the proximal Tyr-220 in the observed effects. In particular, an alternative reaction pathway via Tyr-220 rather than conventional wild type Glu-222 has been proposed for aceGFP maturation.	[Pletnev, Sergei] SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletneva, Nadya V.; Pletnev, Vladimir Z.; Lukyanov, Konstantin A.; Gurskaya, Nadya G.; Goryacheva, Ekaterina A.; Martynov, Vladimir I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Dauter, Zbigniew; Pletnev, Sergei] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, NIH, Argonne, IL 60439 USA; [Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, 9700 S Cass Ave, Argonne, IL 60439 USA.	pletnevs@mail.nih.gov	Pletnev, Vladimir/Q-6151-2016; Pletneva, Nadya/F-7839-2014; Lukyanov, Konstantin A/D-4030-2013; Martynov, Vladimir I./S-3483-2016; Gurskaya, Nadya G/Q-1750-2016	Lukyanov, Konstantin A/0000-0001-9845-2088; Martynov, Vladimir I./0000-0003-4923-6842; Gurskaya, Nadya G/0000-0002-8028-8176; Pletneva, Nadya/0000-0001-9681-4022	National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health, NCI [HHSN261200800001E]; Russian Foundation for Basic Research [09-04-00212, 08-04-01702-a]; Russian Academy of Sciences; Russian Federation [MD-2780.2009.4]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD002780] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, and with federal funds from the National Institutes of Health, NCI, under Contract HHSN261200800001E. This project also was supported in part by the Russian Foundation for Basic Research (Grants 09-04-00212 and 08-04-01702-a), Molecular and Cell Biology Program Russian Academy of Sciences, and by Grant MD-2780.2009.4 from the President of the Russian Federation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2006, J AM CHEM SOC, V128, P4685, DOI 10.1021/ja056635l; Barondeau DP, 2006, J AM CHEM SOC, V128, P3166, DOI 10.1021/ja0552693; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Barondeau DP, 2005, BIOCHEMISTRY-US, V44, P1960, DOI 10.1021/bi0479205; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DeLano W.L, PYMOL MOL GRAPHICS S; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Henderson JN, 2009, J AM CHEM SOC, V131, P4176, DOI 10.1021/ja808851n; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Shu X, 2007, PROTEIN SCI, V16, P2703, DOI 10.1110/ps.073112007; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1	36	21	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15978	15984		10.1074/jbc.M109.092320	http://dx.doi.org/10.1074/jbc.M109.092320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20220148	Green Published, hybrid			2022-12-27	WOS:000277715900035
J	Valliere-Douglass, JF; Eakin, CM; Wallace, A; Ketchem, RR; Wang, W; Treuheit, MJ; Balland, A				Valliere-Douglass, John F.; Eakin, Catherine M.; Wallace, Alison; Ketchem, Randal R.; Wang, Wesley; Treuheit, Michael J.; Balland, Alain			Glutamine-linked and Non-consensus Asparagine-linked Oligosaccharides Present in Human Recombinant Antibodies Define Novel Protein Glycosylation Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXY AMINO-ACID; POSTTRANSLATIONAL N-GLYCOSYLATION; X-SER/THR SEQUON; MASS-SPECTROMETRY; STRUCTURAL REQUIREMENTS; ACTIVE-SITE; HUMAN-IGG; OLIGOSACCHARYLTRANSFERASE; PEPTIDES; GLYCOPROTEIN	We report the presence of oligosaccharide structures on a glutamine residue present in the V-L domain sequence of a recombinant human IgG2 molecule. Residue Gln-106, present in the QGT sequence following the rule of an asparagine-linked consensus motif, was modified with biantennary fucosylated oligosaccharide structures. In addition to the glycosylated glutamine, analysis of a lectin-enriched antibody population showed that 4 asparagine residues: heavy chain Asn-162, Asn-360, and light chain Asn-164, both of which are present in the IgG1 and IgG2 constant domain sequences, and Asn-35, which was present in CDRL1, were also modified with oligosaccharide structures at low levels. The primary sequences around these modified residues do not adhere to the N-linked consensus sequon, NX(S/T). Modeling of these residues from known antibody crystal structures and sequence homology comparison indicates that non-consensus glycosylation occurs on Asn residues in the context of a reverse consensus motif (S/T) XN located on highly flexile turns within 3 residues of a conformational change. Taken together our results indicate that protein glycosylation is governed by more diversified requirements than previously appreciated.	[Valliere-Douglass, John F.; Eakin, Catherine M.; Wallace, Alison; Wang, Wesley; Treuheit, Michael J.; Balland, Alain] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA; [Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen	Balland, A (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA.	ballanda@amgen.com	Valliere-Douglass, John F/F-1618-2013; Ketchem, Randal/AAB-4372-2020; Ketchem, Randal R/K-2258-2017	Ketchem, Randal/0000-0002-7821-2682; Ketchem, Randal R/0000-0002-7821-2682				Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Fan JQ, 1997, J BIOL CHEM, V272, P27058, DOI 10.1074/jbc.272.43.27058; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; GLABE CG, 1980, J BIOL CHEM, V255, P9236; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kabat EA, 1991, SEQUENCES PROTEINS I; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Marshall R D, 1974, Biochem Soc Symp, P17; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mimura Y, 2007, J IMMUNOL METHODS, V326, P116, DOI 10.1016/j.jim.2007.07.014; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; Valliere-Douglass JF, 2009, GLYCOBIOLOGY, V19, P144, DOI 10.1093/glycob/cwn116; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241	40	62	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16012	16022		10.1074/jbc.M109.096412	http://dx.doi.org/10.1074/jbc.M109.096412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233717	hybrid, Green Published			2022-12-27	WOS:000277715900039
J	Lee, SB; Park, JH; Woster, PM; Casero, RA; Park, MH				Lee, Seung Bum; Park, Jong Hwan; Woster, Patrick M.; Casero, Robert A., Jr.; Park, Myung Hee			Suppression of Exogenous Gene Expression by Spermidine/Spermine N-1-Acetyltransferase 1 (SSAT1) Cotransfection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCES CELL-MIGRATION; POLYAMINE CATABOLISM; LUNG-CARCINOMA; ANALOGS; METABOLISM; INDUCTION; SPERMIDINE/SPERMINE-N-1-ACETYLTRANSFERASE-2; UBIQUITINATION; IDENTIFICATION; ACETYLATION	Spermidine/spermine N-1-acetyltransferase 1 (SSAT1), which catalyzes the N-1-acetylation of spermidine and spermine to form acetyl derivatives, is a rate-limiting enzyme in polyamine catabolism. We now report a novel activity of transiently transfected SSAT1 in suppressing the exogenous expression of other proteins, i.e. green fluorescent protein (GFP) or GFP-eIF5A. Spermidine/spermine N-1-acetyltransferase 2 (SSAT2) or inactive SSAT1 mutant enzymes (R101A or R101K) were without effect. The loss of exogenous gene expression is not due to accelerated protein degradation, because various inhibitors of proteases, lysosome, or autophagy did not mitigate the effects. This SSAT1 effect cannot be attributed to the depletion of overall cellular polyamines or accumulation of N-1-acetylspermidine (N-1-AcSpd) because of the following: (i) addition of putrescine, spermidine, spermine, or N-1-AcSpd did not restore the expression of GFP or GFP-eIF5A; (ii) depletion of cellular polyamines with alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, did not inhibit exogenous gene expression; and (iii) N-1, N-11-bis(ethyl)norspermine caused a drastic depletion of cellular polyamines through induction of endogenous SSAT1 but did not block exogenous gene expression. SSAT1 transient transfection did not affect stable expression of GFP, and stably expressed SSAT1 did not affect exogenous expression of GFP, suggesting that only transiently (episomally) expressed SSAT1 blocks exogenous (episomal) expression of other proteins. SSAT1 may regulate exogenous gene expression by blocking steps involved in transcription/translation from an episomal vector by targeting non-polyamine substrate(s) critical for this pathway.	[Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Woster, Patrick M.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Wayne State University; Johns Hopkins University; Johns Hopkins Medicine	Park, MH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bldg 30,Rm 211, Bethesda, MD 20892 USA.	mhpark@nih.gov	Woster, Patrick M/A-5604-2010	Woster, Patrick M/0000-0002-9471-1916; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [CA51085]; NIDCR; NATIONAL CANCER INSTITUTE [R01CA051085, R01CA149095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA51085 (extramural) and the NIDCR Intramural Research Program.	Babbar N, 2007, BIOCHEM SOC T, V35, P300, DOI 10.1042/BST0350300; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Bras APM, 2001, DRUG METAB DISPOS, V29, P676; CASERO RA, 1990, BIOCHEM J, V270, P615, DOI 10.1042/bj2700615; CASERO RA, 1989, CANCER RES, V49, P3829; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; COLEMAN CS, 1995, BIOCHEMISTRY-US, V34, P13423, DOI 10.1021/bi00041a020; Coleman CS, 2004, BIOCHEM J, V384, P139, DOI 10.1042/BJ20040790; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Gabrielson EW, 1999, CLIN CANCER RES, V5, P1638; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; LIBBY PR, 1989, CANCER RES, V49, P6226; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; McCloskey DE, 2003, J BIOL CHEM, V278, P13881, DOI 10.1074/jbc.M205689200; Murray-Stewart T, 2003, BIOCHEM J, V373, P629, DOI 10.1042/BJ20021895; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Pegg AE, 2003, BIOCHEM SOC T, V31, P356, DOI 10.1042/BST0310356; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200	32	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15548	15556		10.1074/jbc.M109.092007	http://dx.doi.org/10.1074/jbc.M109.092007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20212040	Green Published, hybrid			2022-12-27	WOS:000277399000073
J	Lynagh, T; Lynch, JW				Lynagh, Timothy; Lynch, Joseph W.			An Improved Ivermectin-activated Chloride Channel Receptor for Inhibiting Electrical Activity in Defined Neuronal Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; MAMMALIAN NEURONS; GABA(A) RECEPTOR; CAENORHABDITIS-ELEGANS; ALLATOSTATIN RECEPTOR; GINKGOLIDE BINDING; P-GLYCOPROTEIN; SUBUNIT; GLUTAMATE; MICE	The ability to silence the electrical activity of defined neuronal populations in vivo is dramatically advancing our understanding of brain function. This technology may eventually be useful clinically for treating a variety of neuropathological disorders caused by excessive neuronal activity. Several neuronal silencing methods have been developed, with the bacterial light-activated halorhodopsin and the invertebrate allatostatin-activated G protein-coupled receptor proving the most successful to date. However, both techniques may be difficult to implement clinically due to their requirement for surgically implanted stimulus delivery methods and their use of nonhuman receptors. A third silencing method, an invertebrate glutamate-gated chloride channel receptor (GluClR) activated by ivermectin, solves the stimulus delivery problem as ivermectin is a safe, well tolerated drug that reaches the brain following systemic administration. However, the limitations of this method include poor functional expression, possibly due to the requirement to coexpress two different subunits in individual neurons, and the nonhuman origin of GluClR. Here, we describe the development of a modified human alpha 1 glycine receptor as an improved ivermectin-gated silencing receptor. The crucial development was the identification of a mutation, A288G, which increased ivermectin sensitivity almost 100-fold, rendering it similar to that of GluClR. Glycine sensitivity was eliminated via the F207A mutation. Its large unitary conductance, homomeric expression, and human origin may render the F207A/A288G alpha 1 glycine receptor an improved silencing receptor for neuroscientific and clinical purposes. As all known highly ivermectin-sensitive GluClRs contain an endogenous glycine residue at the corresponding location, this residue appears essential for exquisite ivermectin sensitivity.	[Lynagh, Timothy] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynagh, T (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Lynagh, Timothy/0000-0003-4888-4098				Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Chen XB, 2009, NEUROPHARMACOLOGY, V56, P318, DOI 10.1016/j.neuropharm.2008.07.001; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cotreau MM, 2003, J CLIN PHARMACOL, V43, P1108, DOI 10.1177/0091270003257456; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; FRANKE C, 1986, J COMP PHYSIOL A, V159, P591, DOI 10.1007/BF00612033; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Griffin J, 2005, J VET PHARMACOL THER, V28, P257, DOI 10.1111/j.1365-2885.2005.00655.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Keck T, 2009, REV NEUROSCIENCE, V20, P13; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lee VK, 2009, COMPARATIVE MED, V59, P227; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lespine A, 2007, EUR J PHARM SCI, V30, P84, DOI 10.1016/j.ejps.2006.10.004; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; McKellar QA, 1996, J VET PHARMACOL THER, V19, P331, DOI 10.1111/j.1365-2885.1996.tb00062.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Siva N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2755; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vafa B, 1999, J NEUROCHEM, V73, P2158; Wehr M, 2009, J NEUROPHYSIOL, V102, P2554, DOI 10.1152/jn.00480.2009; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yamakura T, 1999, J BIOL CHEM, V274, P23006, DOI 10.1074/jbc.274.33.23006; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	47	60	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14890	14897		10.1074/jbc.M110.107789	http://dx.doi.org/10.1074/jbc.M110.107789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308070	hybrid, Green Published			2022-12-27	WOS:000277399000010
J	Muratoglu, SC; Mikhailenko, I; Newton, C; Migliorini, M; Strickland, DK				Muratoglu, Selen Catania; Mikhailenko, Irina; Newton, Christopher; Migliorini, Mary; Strickland, Dudley K.			Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Forms a Signaling Complex with Platelet-derived Growth Factor Receptor-beta in Endosomes and Regulates Activation of the MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 DISTINCT PHASES; TYROSINE PHOSPHORYLATION; PDGF RECEPTOR; INTIMAL HYPERPLASIA; CORECEPTOR FUNCTION; PORCINE ARTERIES; PHOSPHOLIPASE-C; DEFICIENT MICE; IN-VIVO; B GENE	In addition to its endocytic function, the low density lipoprotein receptor-related protein 1 (LRP1) also contributes to cell signaling events. In the current study, the potential of LRP1 to modulate the platelet-derived growth factor (PDGF) signaling pathway was investigated. PDGF is a key regulator of cell migration and proliferation and mediates the tyrosine phosphorylation of LRP1 within its cytoplasmic domain. In WI-38 fibroblasts, PDGF-mediated LRP1 tyrosine phosphorylation occurred at 37 C but not at 4 C, where endocytosis is minimized. Furthermore, blockade of endocytosis with the dynamin inhibitor, dynasore, also prevented PDGF-mediated LRP1 tyrosine phosphorylation. Immunofluorescence studies revealed co-localization of LRP1 with the PDGF receptor after PDGF treatment within endosomal compartments, whereas surface biotinylation experiments confirmed that phosphorylated LRP1 primarily originates from intracellular compartments. Together, the data reveal the association of these two receptors in endosomal compartments where they form a signaling complex. To study the contribution of LRP1 to PDGF signaling, we used mouse embryonic fibroblasts genetically deficient in LRP1 and identified phenotypic changes in these cell lines in response to PDGF stimulation by performing phospho-site profiling. Of 38 phosphorylated proteins analyzed, 8 were significantly different in LRP1 deficient fibroblasts and were restored when LRP1 was expressed back in these cells. Importantly, the results revealed that LRP1 expression is necessary for PDGF-mediated activation of ERK. Overall, the studies reveal that LRP1 associates with the PDGF receptor in endosomal compartments and modulates its signaling properties affecting the MAPK and Akt/phosphatidylinositol 3-kinase pathways.	[Muratoglu, Selen Catania; Mikhailenko, Irina; Newton, Christopher; Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,R219, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu		Muratoglu Catania, Selen/0000-0002-1804-4875	National Institutes of Health [PO1 HL54710, PO1 HL50784]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054710, R01HL050784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants PO1 HL54710 and HL50784 (both to D. K. S.).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Balciunaite E, 2000, CURR BIOL, V10, P261, DOI 10.1016/S0960-9822(00)00358-4; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; FRACKELTON AR, 1984, J BIOL CHEM, V259, P7909; Giese NA, 1999, ARTERIOSCL THROM VAS, V19, P900, DOI 10.1161/01.ATV.19.4.900; Hart CE, 1999, CIRCULATION, V99, P564, DOI 10.1161/01.CIR.99.4.564; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Jain RK, 2008, PLOS MED, V5, P20, DOI 10.1371/journal.pmed.0050024; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Levitzki A, 2004, CYTOKINE GROWTH F R, V15, P229, DOI 10.1016/j.cytogfr.2004.03.010; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; NABEL EG, 1993, J CLIN INVEST, V91, P1822, DOI 10.1172/JCI116394; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; POMPILI VJ, 1995, ARTERIOSCL THROM VAS, V15, P2254, DOI 10.1161/01.ATV.15.12.2254; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200	47	67	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14308	14317		10.1074/jbc.M109.046672	http://dx.doi.org/10.1074/jbc.M109.046672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220145	Green Published, hybrid			2022-12-27	WOS:000277299700028
J	Baima, ET; Guzova, JA; Mathialagan, S; Nagiec, EE; Hardy, MM; Song, LR; Bonar, SL; Weinberg, RA; Selness, SR; Woodard, SS; Chrencik, J; Hood, WF; Schindler, JF; Kishore, N; Mbalaviele, G				Baima, Eric T.; Guzova, Julia A.; Mathialagan, Sumathy; Nagiec, Eva E.; Hardy, Medora M.; Song, Lily R.; Bonar, Sheri L.; Weinberg, Robin A.; Selness, Shaun R.; Woodard, Scott S.; Chrencik, Jill; Hood, William F.; Schindler, John F.; Kishore, Nandini; Mbalaviele, Gabriel			Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-kappa B Essential Modulator Binding Domain Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE LIVER DEGENERATION; KINASE IKK INHIBITOR; SELECTIVE-INHIBITION; IN-VIVO; BLOCKS OSTEOCLASTOGENESIS; MURINE COLITIS; NEMO; ACTIVATION; BETA; PHOSPHORYLATION	The classical nuclear factor kappa B (NF-kappa B) signaling pathway is under the control of the I kappa B kinase (IKK) complex, which consists of IKK-1, IKK-2, and NF-kappa B essential modulator (NEMO). This complex is responsible for the regulation of cell proliferation, survival, and differentiation. Dysregulation of this pathway is associated with several human diseases, and as such, its inhibition offers an exciting opportunity for therapeutic intervention. NEMO-binding domain (NBD) peptides inhibit the binding of recombinant NEMO to IKK-2 in vitro. However, direct evidence of disruption of this binding by NBD peptides in biological systems has not been provided. Using a cell system, we expanded on previous observations to show that NBD peptides inhibit inflammation-induced but not basal cytokine production. We report that these peptides cause the release of IKK-2 from an IKK complex and disrupt NEMO-IKK2 interactions in cells. We demonstrate that by interfering with NEMO-IKK-2 interactions, NBD peptides inhibit IKK-2 phosphorylation, without affecting signaling intermediates upstream of the IKK complex of the NF-kappa B pathway. Furthermore, in a cell-free system of IKK complex activation by TRAF6 (TNF receptor-associated factor 6), we show that these peptides inhibit the ability of this complex to phosphorylate downstream substrates, such as p65 and inhibitor of kappa B alpha (I kappa B alpha). Thus, consistent with the notion that NEMO regulates IKK-2 catalytic activity by serving as a scaffold, appropriately positioning IKK-2 for activation by upstream kinase(s), our findings provide novel insights into the molecular mechanisms by which NBD peptides exert their anti-inflammatory effects in cells.	[Baima, Eric T.; Guzova, Julia A.; Mathialagan, Sumathy; Nagiec, Eva E.; Hardy, Medora M.; Song, Lily R.; Bonar, Sheri L.; Weinberg, Robin A.; Selness, Shaun R.; Woodard, Scott S.; Chrencik, Jill; Hood, William F.; Schindler, John F.; Kishore, Nandini; Mbalaviele, Gabriel] Pfizer Inc, Dept Inflammat, Chesterfield, MO 63017 USA	Pfizer	Mbalaviele, G (corresponding author), Washington Univ, Sch Med, Div Bone & Mineral Dis, 660 S Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA.	mbalaviele@yahoo.com						Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3656, DOI 10.1016/j.bmcl.2008.04.042; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Drew D, 2007, BIOCHEMISTRY-US, V46, P12482, DOI 10.1021/bi701137a; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Lo YC, 2008, BIOCHEMISTRY-US, V47, P3109, DOI 10.1021/bi702312c; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Sommers CD, 2009, J PHARMACOL EXP THER, V330, P377, DOI 10.1124/jpet.108.147538; Strnad J, 2006, J MOL RECOGNIT, V19, P227, DOI 10.1002/jmr.766; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	33	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13498	13506		10.1074/jbc.M109.099895	http://dx.doi.org/10.1074/jbc.M109.099895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20167598	Green Published, hybrid			2022-12-27	WOS:000276987700022
J	Bie, JH; Zhao, B; Song, JM; Ghosh, S				Bie, Jinghua; Zhao, Bin; Song, Jingmei; Ghosh, Shobha			Improved Insulin Sensitivity in High Fat- and High Cholesterol-fed Ldlr(-/-) Mice with Macrophage-specific Transgenic Expression of Cholesteryl Ester Hydrolase ROLE OF MACROPHAGE INFLAMMATION AND INFILTRATION INTO ADIPOSE TISSUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HIGH-DENSITY-LIPOPROTEIN; NF-KAPPA-B; IN-VIVO; ABCA1-DEFICIENT MACROPHAGES; CARDIOVASCULAR-DISEASE; RESISTANCE; CELLS; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS	Cellular cholesterol balance induces changes in the inflammatory status of macrophages, and low grade chronic inflammation is increasingly being recognized as one of the key steps in the development of atherosclerosis as well as insulin resistance. Cholesteryl ester hydrolase (CEH) catalyzes the hydrolysis of intracellular stored cholesteryl esters (CEs) and thereby enhances free cholesterol efflux and reduces cellular CE content. We have earlier reported reduced atherosclerosis and lesion necrosis in macrophage-specific CEH transgenic mice on a Ldlr(-/-) background. In the present study, we tested the hypothesis that reduced intracellular accumulation of CE in macrophages from CEH transgenic mice will attenuate expression of proinflammatory mediators, thereby reducing infiltration into adipose tissue, alleviating inflammation, and resulting in improved insulin sensitivity. Western diet fed Ldlr(-/-) CEH transgenic mice showed improved insulin sensitivity as assessed by glucose and insulin tolerance tests. Macrophages from CEH transgenic mice expressed significantly lower levels of proinflammatory cytokines (interleukin-1 beta and interleukin-6) and chemokine (MCP-1; monocyte chemoattractant protein). Attenuation of NF-kappa B- and AP-1-driven gene expression was determined to be the underlying mechanism. Infiltration of macrophages into the adipose tissue that increases inflammation and impairs insulin signaling was also significantly reduced in Ldlr(-/-) CEH transgenic mice. In the OP-9 adipocyte peritoneal macrophage co-culture system, macrophages from CEH transgenic mice had a significantly reduced effect on insulin signaling as measured by Akt phosphorylation compared with nontransgenic macrophages. Taken together, these studies demonstrate that macrophage-specific overexpression of CEH decreases expression of proinflammatory mediators and attenuates macrophage infiltration into the adipose tissue, resulting in decreased circulating cytokines and improved insulin sensitivity.	[Ghosh, Shobha] Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Ghosh, S (corresponding author), Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	shobha@vcu.edu			NHLBI [HL-069946]; American Diabetes Association [7-08-RA-51]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069946] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL-069946 from NHLBI. This work was also supported by Research Award 7-08-RA-51 from the American Diabetes Association (to S. G.).	Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; BESEDOVSKY HO, 1990, ANN NY ACAD SCI, V594, P214; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Brown JM, 2004, J BIOL CHEM, V279, P26735, DOI 10.1074/jbc.M401766200; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Fazio S, 2001, AM J CARDIOL, V88, p12E; Ferreira V, 2007, ATHEROSCLEROSIS, V192, P283, DOI 10.1016/j.atherosclerosis.2006.07.018; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Nam JS, 2008, DIABETES RES CLIN PR, V81, P25, DOI 10.1016/j.diabres.2008.01.032; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Persson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-70; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Taishi P, 2008, BRAIN RES, V1226, P89, DOI 10.1016/j.brainres.2008.05.067; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	31	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13630	13637		10.1074/jbc.M109.069781	http://dx.doi.org/10.1074/jbc.M109.069781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189995	hybrid, Green Published			2022-12-27	WOS:000276987700037
J	Kim, Y; Kim, BS; Park, YJ; Choi, WC; Hwang, J; Kang, BS; Oh, TK; Choi, SH; Kim, MH				Kim, Yoonjeong; Kim, Byoung Sik; Park, Yu Jin; Choi, Won-Chan; Hwang, Jungwon; Kang, Beom Sik; Oh, Tae-Kwang; Choi, Sang Ho; Kim, Myung Hee			Crystal Structure of SmcR, a Quorum-sensing Master Regulator of Vibrio vulnificus, Provides Insight into Its Regulation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; EXPRESSION; LUXR; ELASTASE; GENE; TRAR; IDENTIFICATION; DIMERIZATION; RECOGNITION; RESISTANCE	Quorum sensing has been implicated as an important global regulatory system controlling the expression of numerous virulence factors in bacterial pathogens. SmcR, a homologue of Vibrio harveyi LuxR, has been proposed as a quorum-sensing master regulator of Vibrio vulnificus, an opportunistic human pathogen. Previous studies demonstrated that SmcR is essential for the survival and pathogenesis of V. vulnificus, indicating that inhibiting SmcR is an attractive approach to combat infections by the bacteria. Here, we determined the crystal structure of SmcR at 2.1 angstrom resolution. The protein structure reveals a typical TetR superfamily fold consisting of an N-terminal DNA binding domain and a C-terminal dimerization domain. In vivo and in vitro functional analysis of the dimerization domain suggested that dimerization of SmcR is vital for its biological regulatory function. The N-terminal DNA recognition and binding residues were assigned based on the protein structure and the results of in vivo and in vitro mutagenesis experiments. Furthermore, protein-DNA interaction experiments suggested that SmcR may have a sophisticated mechanism that enables the protein to recognize each of its many target operators with different affinities.	[Kim, Byoung Sik; Park, Yu Jin; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Kim, Yoonjeong; Choi, Won-Chan; Hwang, Jungwon; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Yoonjeong; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Hwang, Jungwon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon 305333, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Korea Advanced Institute of Science & Technology (KAIST)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr; mhk8n@kribb.re.kr	Kim, Byoungsik/AAE-6239-2021	Choi, Sang Ho/0000-0003-3865-1039; Kim, Byoung Sik/0000-0001-9820-6071	Ministry of Education, Science, and Technology, Republic of Korea [R0A-2007-000-200390]	Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the 21st Century Frontier Microbial Genomics and Applications Center Program (to M. H. K.) and from the National Research Laboratory Program (R0A-2007-000-200390 to S. H. C.) funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kim MH, 2008, J BIOL CHEM, V283, P31981, DOI 10.1074/jbc.M804092200; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; MILLER JH, 1976, EXPT MOL GENETICS, P352; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	38	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14020	14030		10.1074/jbc.M109.100248	http://dx.doi.org/10.1074/jbc.M109.100248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20178981	Green Published, hybrid			2022-12-27	WOS:000276987700075
J	Kozlov, G; Safaee, N; Rosenauer, A; Gehring, K				Kozlov, Guennadi; Safaee, Nozhat; Rosenauer, Angelika; Gehring, Kalle			Structural Basis of Binding of P-body-associated Proteins GW182 and Ataxin-2 by the Mlle Domain of Poly(A)-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; C-TERMINAL DOMAIN; TRANSLATIONAL REPRESSION; POLY(A) NUCLEASE; UBIQUITIN LIGASE; MAMMALIAN-CELLS; GENE-EXPRESSION; DECAY; PABC; RECOGNITION	Poly(A)-binding protein (PABPC1) is involved in multiple aspects of mRNA processing and translation. It is a component of RNA stress granules and binds the RNA-induced silencing complex to promote degradation of silenced mRNAs. Here, we report the crystal structures of the C-terminal Mlle (or PABC) domain in complex with peptides from GW182 (TNRC6C) and Ataxin-2. The structures reveal overlapping binding sites but with unexpected diversity in the peptide conformation and residues involved in binding. The mutagenesis and binding studies show low to submicromolar binding affinity with overlapping but distinct specificity determinants. These results rationalize the role of the Mlle domain of PABPC1 in microRNA-mediated mRNA deadenylation and suggest a more general function in the assembly of cytoplasmic RNA granules.	[Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data acquisition at the Macromolecular Diffraction Facility at the Cornell High Energy Synchrotron Source (Cornell High Energy Synchrotron Source) was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Award RR-01646.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Huynh DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006235; Katzenellenbogen RA, 2007, J VIROL, V81, P3786, DOI 10.1128/JVI.02007-06; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Konig J, 2009, EMBO J, V28, P1855, DOI 10.1038/emboj.2009.145; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Siddiqui N, 2007, J BIOL CHEM, V282, P25067, DOI 10.1074/jbc.M701256200; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	54	65	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13599	13606		10.1074/jbc.M109.089540	http://dx.doi.org/10.1074/jbc.M109.089540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181956	Green Published, hybrid			2022-12-27	WOS:000276987700033
J	Suzuki, A; Sanda, N; Miyawaki, Y; Fujimori, Y; Yamada, T; Takagi, A; Murate, T; Saito, H; Kojima, T				Suzuki, Atsuo; Sanda, Naomi; Miyawaki, Yuhri; Fujimori, Yuta; Yamada, Takayuki; Takagi, Akira; Murate, Takashi; Saito, Hidehiko; Kojima, Tetsuhito			Down-regulation of PROS1 Gene Expression by 17 beta-Estradiol via Estrogen Receptor alpha (ER alpha)-Sp1 Interaction Recruiting Receptor-interacting Protein 140 and the Corepressor-HDAC3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT PROTEIN; BREAST-CANCER CELLS; C4B-BINDING PROTEIN; S DEFICIENCY; TRANSCRIPTION FACTORS; SP1; BINDING; PLASMA; BIOSYNTHESIS; ORGANIZATION	Pregnant women show a low level of protein S (PS) in plasma, which is known to be a risk for deep venous thrombosis. 17 beta-Estradiol (E-2), an estrogen that increases in concentration in the late stages of pregnancy, regulates the expression of various genes via the estrogen receptor (ER). Here, we investigated the molecular mechanisms behind the reduction in PS levels caused by E-2 in HepG2-ER alpha cells, which stably express ER alpha, and also the genomic ER signaling pathway, which modulates the ligand-dependent repression of the PS alpha gene (PROS1). We observed that E-2 repressed the production of mRNA and antigen of PS. A luciferase reporter assay revealed that E-2 down-regulated PROS1 promoter activity and that this E-2-dependent repression disappeared upon the deletion or mutation of two adjacent GC-rich motifs in the promoter. An electrophoretic mobility shift assay and DNA pulldown assay revealed that the GC-rich motifs were associated with Sp1, Sp3, and ER alpha. In a chromatin immunoprecipitation assay, we found ER alpha-Sp protein-promoter interaction involved in the E-2-dependent repression of PROS1 transcription. Furthermore, we demonstrated that E-2 treatment recruited RIP140 and the NCoR-SMRT-HDAC3 complex to the PROS1 promoter, which hypoacetylated chromatin. Taken together, this suggested that E-2 might repress PROS1 transcription depending upon ER alpha-Sp1 recruiting transcriptional repressors in HepG2-ER alpha cells and, consequently, that high levels of E-2 leading to reduced levels of plasma PS would be a risk for deep venous thrombosis in pregnant women.	[Takagi, Akira; Murate, Takashi; Kojima, Tetsuhito] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Suzuki, Atsuo; Miyawaki, Yuhri; Fujimori, Yuta; Yamada, Takayuki; Takagi, Akira; Murate, Takashi; Kojima, Tetsuhito] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4618673, Japan; [Sanda, Naomi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi 4668550, Japan; [Saito, Hidehiko] Nagoya Cent Hosp, Nagoya, Aichi 4530801, Japan	Nagoya University; Nagoya University; Nagoya University	Kojima, T (corresponding author), Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, 1-1-20,Daiko Minami, Nagoya, Aichi 4618673, Japan.	kojima@met.nagoya-u.ac.jp	Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065	Ministry of Education, Culture, Sports, Science, and Technology [19590553]; Ministry of Health and Welfare; Kitamura Memorial Foundation, Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Kitamura Memorial Foundation, Japan	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (19590553), the Ministry of Health and Welfare (Health Sciences Research Grant, Research on Specific Disease), and the Kitamura Memorial Foundation, Japan.	Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; COMP PC, 1986, BLOOD, V68, P881; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DANGELO A, 1988, J CLIN INVEST, V81, P1445, DOI 10.1172/JCI113475; De Wolf CJF, 2005, J THROMB HAEMOST, V3, P410, DOI 10.1111/j.1538-7836.2005.01138.x; de Wolf CJF, 2006, J BIOL CHEM, V281, P17635, DOI 10.1074/jbc.M603094200; Delfino F, 1999, MOL CELL ENDOCRINOL, V157, P1, DOI 10.1016/S0303-7207(99)00127-6; EDENBRANDT CM, 1990, BIOCHEMISTRY-US, V29, P7861, DOI 10.1021/bi00486a012; ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677; FAIR DS, 1986, BLOOD, V67, P64; FAIR DS, 1986, BLOOD, V67, P1168; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Furuhata A, 2009, LEUKEMIA, V23, P1270, DOI 10.1038/leu.2009.13; Gandrille S, 2000, THROMB HAEMOSTASIS, V84, P918; GRIFFIN JH, 1992, BLOOD, V79, P3203; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Guenther MG, 2000, GENE DEV, V14, P1048; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Higgins KJ, 2008, MOL ENDOCRINOL, V22, P388, DOI 10.1210/me.2007-0319; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Jepsen K, 2002, J CELL SCI, V115, P689; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levin CS, 2005, EUR J NUCL MED MOL I, V32, pS325, DOI 10.1007/s00259-005-1973-y; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; MAILLARD C, 1992, ENDOCRINOLOGY, V130, P1599, DOI 10.1210/en.130.3.1599; Makris M, 2000, BLOOD, V95, P1935, DOI 10.1182/blood.V95.6.1935; MALM J, 1994, BIOCHEM J, V302, P845, DOI 10.1042/bj3020845; MALM J, 1988, BRIT J HAEMATOL, V68, P437, DOI 10.1111/j.1365-2141.1988.tb04232.x; OGURA M, 1987, BLOOD, V70, P301; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Sanda N, 2007, BRIT J HAEMATOL, V138, P663, DOI 10.1111/j.1365-2141.2007.06668.x; SCHMIDEL DK, 1990, BIOCHEMISTRY-US, V29, P7845, DOI 10.1021/bi00486a010; SCHWARZ HP, 1984, BLOOD, V64, P1297; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Tans G, 2000, THROMB HAEMOSTASIS, V84, P15, DOI 10.1055/s-0037-1613960; Tatewaki H, 2003, THROMB HAEMOSTASIS, V90, P1029, DOI 10.1160/TH03-07-0443; VANAMSTEL HKP, 1990, BIOCHEMISTRY-US, V29, P7853, DOI 10.1021/bi00486a011; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; White JH, 2004, VITAM HORM, V68, P123	53	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13444	13453		10.1074/jbc.M109.062430	http://dx.doi.org/10.1074/jbc.M109.062430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200160	hybrid, Green Published			2022-12-27	WOS:000276987700016
J	Yin, H; Gui, Y; Du, GW; Frohman, MA; Zheng, XL				Yin, Hao; Gui, Yu; Du, Guangwei; Frohman, Michael A.; Zheng, Xi-Long			Dependence of Phospholipase D1 Multi-monoubiquitination on Its Enzymatic Activity and Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; UBIQUITIN ISOPEPTIDASE; D DEFINES; ENDOCYTOSIS; ACTIVATION; GOLGI; TRANSLOCATION; DEGRADATION; PROTEASOME	Phospholipase D(PLD) is an important lipase in many cellular processes, including vesicular trafficking, cell survival, and cell migration. In the present study, we show that PLD1, but not PLD2, is posttranslationally modified by multi-monoubiquitination. Intriguingly, suppression of lipase activity either by mutation of the HKD motif (PLD1 H896R, K898R, or D903A) or the phosphatidylinositol 4,5-bisphosphate binding motif (PLD1 R691G,R695G) or through use of PLD-selective inhibitors impaired the ubiquitination of PLD1, although stimulation of lipase activity by phorbol 12-myristate 13-acetate did not enhance its ubiquitination. A palmitoylation-deficient mutant PLD1 allele, which exhibits altered patterns of vesicular trafficking, had significantly lower levels of monoubiquitination. In addition, the expression of ubiquitin-fused PLD1 induced aberrantly enlarged vesicles partially co-localized with the Golgi complex but not with early endosomes. The altered localization was reduced by the K898R mutation, suggesting a role of multi-monoubiquitination in PLD1 subcellular localization. Surprisingly, the degradation of PLD1, but not of PLD1 K898R or PLD2, was blocked by inhibitors of proteasomes but not by inhibitors of lysosomes or other proteases, suggesting a role of the ubiquitination in proteasomal degradation of PLD1. In summary, our studies show that PLD1, but not PLD2, is multi-monoubiquitinated. The ubiquitination modification might represent a novel regulatory mechanism in PLD1 functioning, particularly in the context of subcellular trafficking between different membrane compartments.	[Yin, Hao] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB T2N 4N1, Canada; [Du, Guangwei] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zheng, XL (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	xlzheng@ucalgary.ca		Zheng, Xi-Long/0000-0002-0889-1827; Du, Guangwei/0000-0003-4193-6975	Canadian Institutes of Health Research; Pfizer Canada Inc	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada Inc	This work was supported by the Canadian Institutes of Health Research and Pfizer Canada Inc. ( to X.-L. Z.).	Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Su WJ, 2006, CELL SIGNAL, V18, P469, DOI 10.1016/j.cellsig.2005.05.027; Sugars JM, 1999, J BIOL CHEM, V274, P30023, DOI 10.1074/jbc.274.42.30023; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; Xie Z, 2001, J BIOL CHEM, V276, P9383, DOI 10.1074/jbc.M009425200	29	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13580	13588		10.1074/jbc.M109.046359	http://dx.doi.org/10.1074/jbc.M109.046359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189990	Green Published, hybrid			2022-12-27	WOS:000276987700031
J	Irimia, JM; Meyer, CM; Peper, CL; Zhai, LM; Bock, CB; Previs, SF; McGuinness, OP; DePaoli-Roach, A; Roach, PJ				Irimia, Jose M.; Meyer, Catalina M.; Peper, Caron L.; Zhai, Lanmin; Bock, Cheryl B.; Previs, Stephen F.; McGuinness, Owen P.; DePaoli-Roach, Anna; Roach, Peter J.			Impaired Glucose Tolerance and Predisposition to the Fasted State in Liver Glycogen Synthase Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID-METABOLISM; MUSCLE GLYCOGEN; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; MIXED MEAL; STORAGE; LACKING; CARBOHYDRATE; HOMEOSTASIS	Conversion to glycogen is a major fate of ingested glucose in the body. A rate-limiting enzyme in the synthesis of glycogen is glycogen synthase encoded by two genes, GYS1, expressed in muscle and other tissues, and GYS2, primarily expressed in liver (liver glycogen synthase). Defects in GYS2 cause the inherited monogenic disease glycogen storage disease 0. We have generated mice with a liver-specific disruption of the Gys2 gene (liver glycogen synthase knock-out (LGSKO) mice), using Lox-P/Cre technology. Conditional mice carrying floxed Gys2 were crossed with mice expressing Cre recombinase under the albumin promoter. The resulting LGSKO mice are viable, develop liver glycogen synthase deficiency, and have a 95% reduction in fed liver glycogen content. They have mild hypoglycemia but dispose glucose less well in a glucose tolerance test. Fed, LGSKO mice also have a reduced capacity for exhaustive exercise compared with mice carrying floxed alleles, but the difference disappears after an overnight fast. Upon fasting, LGSKO mice reach within 4 h decreased blood glucose levels attained by control floxed mice only after 24 h of food deprivation. The LGSKO mice maintain this low blood glucose for at least 24 h. Basal gluconeogenesis is increased in LGSKO mice, and insulin suppression of endogenous glucose production is impaired as assessed by euglycemic-hyperinsulinemic clamp. This observation correlates with an increase in the liver gluconeogenic enzyme phosphoenolpyruvate carboxykinase expression and activity. This mouse model mimics the pathophysiology of glycogen storage disease 0 patients and highlights the importance of liver glycogen stores in whole body glucose homeostasis.	[DePaoli-Roach, Anna; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Ctr Diabet Res, Indianapolis, IN 46202 USA; [Bock, Cheryl B.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Previs, Stephen F.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [McGuinness, Owen P.] Vanderbilt Univ, Sch Med, Metab Pathophysiol Core Mouse Metab Phenotyping, Nashville, TN 37232 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Duke University; Case Western Reserve University; Vanderbilt University	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221, DK59637, DK082376]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637, R25DK082376, R01DK027221, R56DK027221, R37DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 (to P. J. R.), DK59637 (to the Vanderbilt Mouse Metabolic Phenotyping Center), and DK082376 (to the Case Western Reserve University Mouse Metabolic Phenotyping Center).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ANTWI D, 1988, AM J PHYSIOL, V254, pE720, DOI 10.1152/ajpendo.1988.254.6.E720; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BALLET F, 1990, PHARMACOL THERAPEUT, V47, P281, DOI 10.1016/0163-7258(90)90091-F; BHAVNANI BR, 1983, CAN J BIOCHEM CELL B, V61, P191, DOI 10.1139/o83-027; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CALDER PC, 1992, INT J BIOCHEM, V24, P71, DOI 10.1016/0020-711X(92)90231-O; Capaldo B, 1999, DIABETES, V48, P958, DOI 10.2337/diabetes.48.5.958; CHEN C, 1992, HORM METAB RES, V24, P161, DOI 10.1055/s-2007-1003285; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fueger PT, 2005, J PHYSIOL-LONDON, V562, P925, DOI 10.1113/jphysiol.2004.076158; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; LUDVIK B, 1995, J CLIN INVEST, V95, P2232, DOI 10.1172/JCI117913; Marliss E B, 1974, Horm Metab Res, VSuppl 4, P93; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Ozen H, 2007, WORLD J GASTROENTERO, V13, P2541; Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890; Parker GE, 2006, BIOCHEM J, V395, P137, DOI 10.1042/BJ20051456; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2005, BIOCHEM BIOPH RES CO, V331, P491, DOI 10.1016/j.bbrc.2005.03.206; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	47	55	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12851	12861		10.1074/jbc.M110.106534	http://dx.doi.org/10.1074/jbc.M110.106534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178984	hybrid, Green Published			2022-12-27	WOS:000276787800043
J	Kaysser, L; Eitel, K; Tanino, T; Siebenberg, S; Matsuda, A; Ichikawa, S; Gust, B				Kaysser, Leonard; Eitel, Kornelia; Tanino, Tetsuya; Siebenberg, Stefanie; Matsuda, Akira; Ichikawa, Satoshi; Gust, Bertolt			A New Arylsulfate Sulfotransferase Involved in Liponucleoside Antibiotic Biosynthesis in Streptomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOFURANOSYL NUCLEOSIDE MOIETY; HUMAN INTESTINAL BACTERIUM; ASTA GENE; PEPTIDOGLYCAN SYNTHESIS; ESCHERICHIA-COLI; EUBACTERIUM A-44; CELL-WALL; LIPOSIDOMYCINS; ANALOGS; CLONING	Sulfotransferases are involved in a variety of physiological processes and typically use 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as the sulfate donor substrate. In contrast, microbial arylsulfate sulfotransferases (ASSTs) are PAPS-independent and utilize arylsulfates as sulfate donors. Yet, their genuine acceptor substrates are unknown. In this study we demonstrate that Cpz4 from Streptomyces sp. MK730-62F2 is an ASST-type sulfotransferase responsible for the formation of sulfated liponucleoside antibiotics. Gene deletion mutants showed that cpz4 is required for the production of sulfated caprazamycin derivatives. Cloning, overproduction, and purification of Cpz4 resulted in a 58-kDa soluble protein. The enzyme catalyzed the transfer of a sulfate group from p-nitrophenol sulfate (K-m 48.1 mu M, k(cat) 0.14 s(-1)) and methyl umbelliferone sulfate (K-m 34.5 mu M, k(cat) 0.15 s(-1)) onto phenol (K-m 25.9 and 29.7 mM, respectively). The Cpz4 reaction proceeds by a ping pong bi-bi mechanism. Several structural analogs of intermediates of the caprazamycin biosynthetic pathway were synthesized and tested as substrates of Cpz4. Des-N-methyl-acyl-caprazol was converted with highest efficiency 100 times faster than phenol. The fatty acyl side chain and the uridyl moiety seem to be important for substrate recognition by Cpz4. Liponucleosides, partially purified from various mutant strains, were readily sulfated by Cpz4 using p-nitrophenol sulfate. No product formation could be observed with PAPS as the donor substrate. Sequence homology of Cpz4 to the previously examined ASSTs is low. However, numerous orthologs are encoded in microbial genomes and represent interesting subjects for future investigations.	[Gust, Bertolt] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Tanino, Tetsuya; Matsuda, Akira; Ichikawa, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0650812, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hokkaido University	Gust, B (corresponding author), Univ Tubingen, Inst Pharmazeut, Auf Morgenstelle 8, D-72076 Tubingen, Germany.	bertolt.gust@uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019; Ichikawa, Satoshi S/F-6915-2012; Matsuda, Akira/D-5477-2012	Kaysser, Leonard/0000-0002-3943-993X; 	European Commission [IP005224]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Grant IP005224 (ActinoGEN).	Baek MC, 1996, MICROBIOL IMMUNOL, V40, P531, DOI 10.1111/j.1348-0421.1996.tb01105.x; BURNS GRJ, 1977, BIOCHEM J, V167, P223, DOI 10.1042/bj1670223; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; Cronan GE, 2004, J BACTERIOL, V186, P4168, DOI 10.1128/JB.186.13.4168-4176.2004; Dini C, 2001, BIOORG MED CHEM LETT, V11, P533, DOI 10.1016/S0960-894X(00)00714-9; Dini C, 2001, BIOORG MED CHEM LETT, V11, P529, DOI 10.1016/S0960-894X(00)00715-0; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; HARADA K, 1994, TOXICON, V32, P73, DOI 10.1016/0041-0101(94)90023-X; Hirano S, 2008, BIOORGAN MED CHEM, V16, P5123, DOI 10.1016/j.bmc.2008.03.020; Hirano S, 2008, J ORG CHEM, V73, P569, DOI 10.1021/jo702264e; Hirano S, 2007, TETRAHEDRON, V63, P2798, DOI 10.1016/j.tet.2007.01.055; Hirano S, 2008, BIOORGAN MED CHEM, V16, P428, DOI 10.1016/j.bmc.2007.09.022; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; IWAMOTO T, 1994, J ANTIBIOT, V47, P1084; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kang JW, 2001, BIOL PHARM BULL, V24, P570, DOI 10.1248/bpb.24.570; Kang JW, 2001, ARCH PHARM RES, V24, P316, DOI 10.1007/BF02975099; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim B, 2007, BIOL PHARM BULL, V30, P11, DOI 10.1248/bpb.30.11; KIM DH, 1991, J BIOCHEM-TOKYO, V109, P45; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; KIMURA K, 1989, AGR BIOL CHEM TOKYO, V53, P1811, DOI 10.1080/00021369.1989.10869560; KIMURA K, 2002, Patent No. 6455694; KONISHIIMAMURA L, 1994, BIOL PHARM BULL, V17, P1018; Kwon AR, 2001, BIOCHEM BIOPH RES CO, V285, P526, DOI 10.1006/bbrc.2001.5185; Kwon AR, 1999, PROTEIN EXPRES PURIF, V17, P366, DOI 10.1006/prep.1999.1129; Lamb SS, 2006, CHEM BIOL, V13, P171, DOI 10.1016/j.chembiol.2005.12.003; Malojcic G, 2008, P NATL ACAD SCI USA, V105, P19217, DOI 10.1073/pnas.0806997105; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNEIDER H, 1993, J ORG CHEM, V58, P683, DOI 10.1021/jo00055a022; Shi R, 2007, J BIOL CHEM, V282, P13073, DOI 10.1074/jbc.M611912200; TAKEUCHI T, 2002, Patent No. 6780616; UBUKATA M, 1992, J ORG CHEM, V57, P6392, DOI 10.1021/jo00050a009	41	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12684	12694		10.1074/jbc.M109.094490	http://dx.doi.org/10.1074/jbc.M109.094490			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157116	Green Published, hybrid			2022-12-27	WOS:000276787800027
J	Moynihan, PJ; Clarke, AJ				Moynihan, Patrick J.; Clarke, Anthony J.			O-Acetylation of Peptidoglycan in Gram-negative Bacteria IDENTIFICATION AND CHARACTERIZATION OF PEPTIDOGLYCAN O-ACETYLTRANSFERASE IN NEISSERIA GONORRHOEAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; NEISSERIA-GONORRHOEAE; GONOCOCCAL PEPTIDOGLYCAN; LYTIC TRANSGLYCOSYLASES; ACETYLPEPTIDOGLYCAN ESTERASE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; LYSOZYME SENSITIVITY; PROTEUS-MIRABILIS; CRYSTAL-STRUCTURE	The ape2 gene encoding a hypothetical O-acetylpeptidoglycan esterase was amplified from genomic DNA of Neisseria gonorrhoeae FA1090 and cloned to encode either the full-length protein or a truncated version lacking its hypothetical signal sequence. Expression trials revealed that production of the full-length version possessing either an N-terminal or C-terminal His(6) tag was toxic to Escherichia coli transformants and that the host rapidly degraded the small amount of protein that was produced. An N-terminally truncated protein could be produced in sufficient yields for purification only if it possessed an N-terminal His(6) tag. This form of the protein was isolated and purified to apparent homogeneity, and its enzymatic properties were characterized. Whereas the protein could bind to insoluble peptidoglycan, it did not function as an esterase. Phenotypic characterization of E. coli transformants producing various forms of the protein revealed that it functions instead to O-acetylate peptidoglycan within the periplasm, and it was thus renamed peptidoglycan O-acetyltransferase B. This activity was found to be dependent upon a second protein, which functions to translocate acetate from the cytoplasm to the periplasm, demonstrating that the O-acetylation of peptidoglycan in N. gonorrhoeae, and other Gram-negative bacteria, requires a two component system.	[Moynihan, Patrick J.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	aclarke@uoguelph.ca	Moynihan, Patrick J/I-3393-2013	Moynihan, Patrick J/0000-0003-4182-6223	Canadian Institutes for Health Research [MOP81223]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP81223 (to A.J.C.).	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; BLACK WJ, 1984, INFECT IMMUN, V45, P453, DOI 10.1128/IAI.45.2.453-457.1984; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; BLUNDELL JK, 1980, FEMS MICROBIOL LETT, V9, P259, DOI 10.1111/j.1574-6968.1980.tb05648.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Clarke AJ, 2000, GLYCOMICROBIOLOGY, P187; Clarke J. H, 1996, GREAT MIGHTY WALK; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DEUTSCHER MP, 1974, J BACTERIOL, V118, P633, DOI 10.1128/JB.118.2.633-639.1974; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; DUPONT C, 1991, J BACTERIOL, V173, P4618, DOI 10.1128/jb.173.15.4618-4624.1991; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOLMQUIST M, 2000, CURR OPIN STRUC BIOL, V9, P209; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; HOYLE BD, 1984, CAN J MICROBIOL, V30, P204, DOI 10.1139/m84-031; Kajimura J, 2006, J BACTERIOL, V188, P7542, DOI 10.1128/JB.00783-06; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; LAEMMLI UK, 1970, NATURE, V227, P685; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Pagotto FJ, 2000, GENE, V244, P13, DOI 10.1016/S0378-1119(99)00557-0; Payie KG, 1996, MICROB DRUG RESIST, V2, P135, DOI 10.1089/mdr.1996.2.135; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; ROSENTHAL RS, 1982, INFECT IMMUN, V37, P826, DOI 10.1128/IAI.37.2.826-829.1982; ROSENTHAL RS, 1983, INFECT IMMUN, V40, P903, DOI 10.1128/IAI.40.3.903-911.1983; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; SNOWDEN MA, 1989, J GEN MICROBIOL, V135, P3015; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang M, 2007, BIOCHEM BIOPH RES CO, V363, P1050, DOI 10.1016/j.bbrc.2007.08.153; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	42	53	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13264	13273		10.1074/jbc.M110.107086	http://dx.doi.org/10.1074/jbc.M110.107086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178982	Green Published, hybrid			2022-12-27	WOS:000276787800081
J	Major, B; Kardos, J; Kekesi, KA; Lorincz, Z; Zavodszky, P; Gal, P				Major, Balazs; Kardos, Jozsef; Kekesi, Katalin Adrienna; Lorincz, Zsolt; Zavodszky, Peter; Gal, Peter			Calcium-dependent Conformational Flexibility of a CUB Domain Controls Activation of the Complement Serine Protease C1r	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; ENERGY CONTENT; PROTEINS; REVEALS; REGION; RECOGNITION; COMPLEXES; MECHANISM; INSIGHTS	C1, the first component of the complement system, is a Ca2+-dependent heteropentamer complex of C1q and two modular serine proteases, C1r and C1s. Current functional models assume significant flexibility of the subcomponents. Noncatalytic modules in C1r have been proposed to provide the flexibility required for function. Using a recombinant CUB2-CCP1 domain pair and the individual CCP1 module, we showed that binding of Ca2+ induces the folding of the CUB2 domain and stabilizes its structure. In the presence of Ca2+, CUB2 shows a compact, folded structure, whereas in the absence of Ca2+, it has a flexible, disordered conformation. CCP1 module is Ca2+-in-sensitive. Isothermal titration calorimetry revealed that CUB2 binds a single Ca2+ with a relatively high K-D (430 mu M). In blood, the CUB2 domain of C1r is only partially (74%) saturated by Ca2+, therefore the disordered, Ca2+-free form could provide the flexibility required for C1 activation. In accordance with this assumption, the effect of Ca2+ on the autoactivation of native, isolated C1r zymogen was proved. In the case of infection-inflammation when the local Ca2+ concentration decreases, this property of CUB2 domain could serve as subtle means to trigger the activation of the classical pathway of complement. The CUB2 domain of C1r is a novel example for globular protein domains with marginal stability, high conformational flexibility, and proteolytic sensitivity. The physical nature of the behavior of this domain is similar to that of intrinsically unstructured proteins, providing a further example of functionally relevant ligand-induced reorganization of a polypeptide chain.	[Major, Balazs; Kardos, Jozsef; Lorincz, Zsolt; Zavodszky, Peter; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Lab Proteom, H-1117 Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Inst Biol, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University	Kardos, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Karolina Ut 29-31, H-1113 Budapest, Hungary.	kardos@elte.hu; gal@enzim.hu	Kékesi, Katalin Adrienna A/H-3484-2017; Gal, Peter/B-5886-2011; Kardos, József/J-1035-2017	Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Kardos, József/0000-0002-2135-2932	Hungarian Scientific Research Fund [68464, 81950, NK77978]; National Development Agency [KMOP-1.1.2-07/1-2008-0003];  [NKFP_07_1-MASPOK07]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; 	This work was supported by Hungarian Scientific Research Fund Grants 68464, 81950, and NK77978, Anyos Jedlik Grant NKFP_07_1-MASPOK07, and National Development Agency Grant KMOP-1.1.2-07/1-2008-0003.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61; ARLAUD GJ, 1986, BIOCHEMISTRY-US, V25, P5177, DOI 10.1021/bi00366a029; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Dobo J, 2006, J BIOL CHEM, V281, P38781, DOI 10.1074/jbc.M605151200; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; FINN BE, 1995, STRUCTURE, V3, P7, DOI 10.1016/S0969-2126(01)00130-7; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; GAL P, 1989, COMPLEMENT INFLAMMAT, V6, P433; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MONKOVIC DD, 1992, BIOCHEM BIOPH RES CO, V189, P233, DOI 10.1016/0006-291X(92)91549-6; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SCHUMAKER VN, 1989, BEHRING I MITT, V84, P102; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	40	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11863	11869		10.1074/jbc.M109.098541	http://dx.doi.org/10.1074/jbc.M109.098541			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178990	Green Published, hybrid			2022-12-27	WOS:000276787100014
J	Loukili, N; Rosenblatt-Velin, N; Rolli, J; Levrand, S; Feihl, F; Waeber, B; Pacher, P; Liaudet, L				Loukili, Noureddine; Rosenblatt-Velin, Nathalie; Rolli, Joelle; Levrand, Sandra; Feihl, Francois; Waeber, Bernard; Pacher, Pal; Liaudet, Lucas			Oxidants Positively or Negatively Regulate Nuclear Factor kappa B in a Context-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN PHOSPHATASE 2A; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; KINASE; ACTIVATION; INHIBITION; PEROXYNITRITE; PHOSPHORYLATION	Redox-based mechanisms play critical roles in the regulation of multiple cellular functions. NF-kappa B, a master regulator of inflammation, is an inducible transcription factor generally considered to be redox-sensitive, but the modes of interactions between oxidant stress and NF-kappa B are incompletely defined. Here, we show that oxidants can either amplify or suppress NF-kappa B activation in vitro by interfering both with positive and negative signals in the NF-kappa B pathway. NF-kappa B activation was evaluated in lung A549 epithelial cells stimulated with tumor necrosis factor alpha (TNF alpha), either alone or in combination with various oxidant species, including hydrogen peroxide or peroxynitrite. Exposure to oxidants after TNF alpha stimulation produced a robust and long lasting hyperactivation of NF-kappa B by preventing resynthesis of the NF-kappa B inhibitor I kappa B, thereby abrogating the major negative feedback loop of NF-kappa B. This effect was related to continuous activation of inhibitor of kappa B kinase (IKK), due to persistent IKK phosphorylation consecutive to oxidant-mediated inactivation of protein phosphatase 2A. In contrast, exposure to oxidants before TNF alpha stimulation impaired IKK phosphorylation and activation, leading to complete prevention of NF-kappa B activation. Comparable effects were obtained when interleukin-1 beta was used instead of TNF alpha as the NF-kappa B activator. This study demonstrates that the influence of oxidants on NF-kappa B is entirely context-dependent, and that the final outcome (activation versus inhibition) depends on a balanced inhibition of protein phosphatase 2A and IKK by oxidant species. Our findings provide a new conceptual framework to understand the role of oxidant stress during inflammatory processes.	[Loukili, Noureddine; Rolli, Joelle; Levrand, Sandra; Liaudet, Lucas] BH 08 621 Univ Hosp, Dept Intens Care Med, Div Pathophysiol, CH-1011 Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas] Univ Med Ctr, Dept Med, CH-1011 Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas] Fac Biol & Med, CH-1011 Lausanne, Switzerland; [Pacher, Pal] NIH, Lab Physiol Studies, NIAA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Liaudet, L (corresponding author), BH 08 621 Univ Hosp, Dept Intens Care Med, Div Pathophysiol, CH-1011 Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Liaudet, Lucas/E-1322-2017; Pacher, Pal/B-6378-2008	Liaudet, Lucas/0000-0003-2670-4930; Rosenblatt, Nathalie/0000-0003-2011-2862; Pacher, Pal/0000-0001-7036-8108	Swiss National Fund for Scientific Research [PP00B-68882/1, 320000-118174/1]; NIAAA, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Swiss National Fund for Scientific Research Grants PP00B-68882/1 and 320000-118174/1 (to L. L.). This work was also supported by the Intramural Research Program of the NIAAA, National Institutes of Health (to P. P.).	Barisic S, 2008, CELL DEATH DIFFER, V15, P1681, DOI 10.1038/cdd.2008.98; Bjelakovic G, 2007, JNCI-J NATL CANCER I, V99, P742, DOI 10.1093/jnci/djk211; Byun MS, 2002, EXP MOL MED, V34, P332, DOI 10.1038/emm.2002.47; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Levrand S, 2005, J BIOL CHEM, V280, P34878, DOI 10.1074/jbc.M501977200; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanchez-Alcazar JA, 2003, BIOCHEM J, V370, P609, DOI 10.1042/BJ20021623; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200	31	61	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15746	15752		10.1074/jbc.M110.103259	http://dx.doi.org/10.1074/jbc.M110.103259			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299457	Green Published, hybrid			2022-12-27	WOS:000277715900010
J	Chen, P; Dendorfer, A; Finol-Urdaneta, RK; Terlau, H; Olivera, BM				Chen, Ping; Dendorfer, Andreas; Finol-Urdaneta, Rocio K.; Terlau, Heinrich; Olivera, Baldomero M.			Biochemical Characterization of kappa M-RIIIJ, a Kv1.2 Channel Blocker EVALUATION OF CARDIOPROTECTIVE EFFECTS OF kappa M-CONOTOXINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNELS; POTASSIUM CHANNELS; SODIUM-CHANNELS; PEPTIDE TOXINS; INFARCT SIZE; SNAIL VENOM; REPERFUSION; INHIBITOR; SUBUNIT; IDENTIFICATION	Conus snail (Conus) venoms are a valuable source of pharmacologically active compounds; some of the peptide toxin families from the snail venoms are known to interact with potassium channels. We report the purification, synthesis, and characterization of kappa M-conotoxin RIIIJ from the venom of a fish-hunting species, Conus radiatus. This conopeptide, like a previously characterized peptide in the same family, kappa M-RIIIK, inhibits the homotetrameric human Kv1.2 channels. When tested in Xenopus oocytes, kappa M-RIIIJ has an order of magnitude higher affinity (IC50 = 33 nM) to Kv1.2 than kappa M-RIIIK (IC50 = 352 nM). Chimeras of RIIIK and RIIIJ tested on the human Kv1.2 channels revealed that Lys-9 from kappa M-RIIIJ is a determinant of its higher potency against hKv1.2. However, when compared in a model of ischemia/reperfusion, kappa M-RIIIK (100 mu g/kg of body weight), administered just before reperfusion, significantly reduces the infarct size in rat hearts in vivo without influencing hemodynamics, providing a potential compound for cardioprotective therapeutics. In contrast, kappa M-RIIIJ does not exert any detectable cardioprotective effect. kappa M-RIIIJ shows more potency for Kv1.2-Kv1.5 and Kv1.2-Kv1.6 heterodimers than kappa M-RIIIK, whereas the affinity of kappa M-RIIIK to Kv1.2-Kv1.7 heterodimeric channels is higher (IC50 = 680 nM) than that of kappa M-RIIIJ (IC50 = 3.15 mu M). Thus, the cardioprotection seems to correlate to antagonism to heteromultimeric channels, involving the Kv1.2 alpha-subunit rather than antagonism to Kv1.2 homotetramers. Furthermore, kappa M-RIIIK and kappa M-RIIIJ provide a valuable set of probes for understanding the underlying mechanism of cardioprotection.	[Finol-Urdaneta, Rocio K.; Terlau, Heinrich] Univ Kiel, Inst Physiol, D-24098 Kiel, Germany; [Chen, Ping; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Dendorfer, Andreas; Terlau, Heinrich] Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; [Finol-Urdaneta, Rocio K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Finol-Urdaneta, Rocio K.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Kiel; Utah System of Higher Education; University of Utah; University of Kiel; Schleswig Holstein University Hospital; University of Calgary; University of Calgary	Terlau, H (corresponding author), Univ Kiel, Inst Physiol, Olshausenstr 40, D-24098 Kiel, Germany.	h.terlau@physiologie.uni-kiel.de	Finol-Urdaneta, Rocio K./AAH-6447-2019	Finol-Urdaneta, Rocio K./0000-0003-2157-4532; Terlau, Heinrich/0000-0002-2206-1221	National Institutes of Health [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48677 ( to B.M.O.).	Al-Sabi A, 2004, BIOCHEMISTRY-US, V43, P8625, DOI 10.1021/bi0495681; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Dixon JE, 1996, EUR J NEUROSCI, V8, P183, DOI 10.1111/j.1460-9568.1996.tb01179.x; Ferber M, 2004, TOXICON, V43, P915, DOI 10.1016/j.toxicon.2003.12.010; Ferber M, 2003, J BIOL CHEM, V278, P2177, DOI 10.1074/jbc.M205953200; Finol-Urdaneta RK, 2006, J GEN PHYSIOL, V128, P133, DOI 10.1085/jgp.200609498; Gulbis JM, 2002, NOVART FDN SYMP, V245, P127; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KAPLAN SH, 1995, CARDIOVASC RES, V29, P231, DOI 10.1016/S0008-6363(96)88575-0; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Koch ED, 2004, BIOPHYS J, V86, P191, DOI 10.1016/S0006-3495(04)74096-5; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lubbers NL, 2005, J CARDIOVASC PHARM, V46, P141, DOI 10.1097/01.fjc.0000167015.84715.27; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Qiu MH, 2003, J NEUROCHEM, V87, P1509, DOI 10.1046/j.1471-4159.2003.02110.x; Rockel D, 1995, MANUAL LIVING CONIDA; SCHLUTER KD, 1991, AM J PHYSIOL, V261, pH416, DOI 10.1152/ajpheart.1991.261.2.H416; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verdier L, 2005, J BIOL CHEM, V280, P21246, DOI 10.1074/jbc.M502376200; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; Zhang SJ, 2003, J CARDIOVASC PHARM, V42, P764, DOI 10.1097/00005344-200312000-00011	34	34	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14882	14889		10.1074/jbc.M109.068486	http://dx.doi.org/10.1074/jbc.M109.068486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220134	Green Published, hybrid			2022-12-27	WOS:000277399000009
J	Meyer, MB; Goetsch, PD; Pike, JW				Meyer, Mark B.; Goetsch, Paul D.; Pike, J. Wesley			A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1 alpha,25-Dihydroxyvitamin D-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; LIGAND GENE-EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; NUCLEAR RECEPTOR; DNA-BINDING; PARATHYROID-HORMONE; CO-REPRESSOR; ACTIVATION; ELEMENTS; INACTIVATION	CYP24A1 expression is up-regulated by 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) via a vitamin D receptor (VDR)/retinoid X receptor (RXR) heterodimer that binds to two vitamin D response elements (VDREs) located near the proximal promoter. Interestingly, although 1,25(OH)(2)D-3 induced VDR/RXR binding to the VDRE-containing proximal promoter, the VDR/RXR heterodimer also localized to a cluster of at least four potential enhancers located in intergenic regions 50-69 kb downstream of the human CYP24A1 gene and 35-45 kb downstream of the mouse Cyp24a1 gene as revealed by ChIP-chip and ChIP-seq analyses. To address whether this downstream region and potential VDREs located within mediated CYP24A1 induction, we constructed recombinant wild-type and mutant bacterial artificial chromosome clones that spanned mouse and human loci and contained luciferase reporters inserted into their 3'-untranslated regions. The activity of these clones in stably transfected cells revealed that both the proximal and the putative downstream elements contributed to CYP24A1 up-regulation by 1,25(OH)(2)D-3. Further analysis using transfected enhancer fragments led to the identification of contributing regulatory elements in several of these downstream regions. Additional studies of coregulator recruitment using ChIP-chip analysis revealed both similarities and differences between the region located proximal to and those located downstream of the promoter. Recruitment of these coregulators was likely responsible for the increase in RNA polymerase II and histone H4 acetylation, which was also observed in response to 1,25(OH)(2)D-3 at the enhancer sites across the locus. We conclude that a more complex mechanism is responsible for the striking CYP24A1 up-regulation induced by the vitamin D hormone in target cells.	[Meyer, Mark B.; Goetsch, Paul D.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281, R01DK073995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-072281 (to J. W. P.).	Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DeLuca HF, 1998, NUTR REV, V56, pS4; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kuan Pei Fen, 2008, Pac Symp Biocomput, P515; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Miele Adriana, 2008, V464, P105; Murayama A, 1999, ENDOCRINOLOGY, V140, P2224, DOI 10.1210/en.140.5.2224; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nerenz RD, 2008, MOL ENDOCRINOL, V22, P1044, DOI 10.1210/me.2007-0380; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; OHYAMA Y, 1993, BIOCHEMISTRY-US, V32, P76, DOI 10.1021/bi00052a011; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pike JW, 2007, J BONE MINER RES, V22, pV16, DOI [10.1359/jbmr.07s207, 10.1359/JBMR.07S207]; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; TANAKA Y, 1984, AM J PHYSIOL, V246, pE168, DOI 10.1152/ajpendo.1984.246.2.E168; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong Y, 2009, J BIOL CHEM, V284, P11059, DOI 10.1074/jbc.M806561200; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	55	105	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15599	15610		10.1074/jbc.M110.119958	http://dx.doi.org/10.1074/jbc.M110.119958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236932	hybrid, Green Published			2022-12-27	WOS:000277399000078
J	Qiu, WM; Hu, YH; Andersen, TE; Jafari, A; Li, N; Chen, W; Kassem, M				Qiu, Weimin; Hu, Yuhui; Andersen, Tom E.; Jafari, Abbas; Li, Na; Chen, Wei; Kassem, Moustapha			Tumor Necrosis Factor Receptor Superfamily Member 19 (TNFRSF19) Regulates Differentiation Fate of Human Mesenchymal (Stromal) Stem Cells through Canonical Wnt Signaling and C/EBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; TNF RECEPTOR; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; OSTEOCLAST DIFFERENTIATION; MISSENSE MUTATIONS; FAMILY-MEMBER; MASS; LRP5	Mechanisms controlling human multipotent mesenchymal (stromal) stem cell (hMSC) differentiation into osteoblasts or adipocytes are poorly understood. We have previously demonstrated that Wnt signaling in hMSC enhanced osteoblast differentiation and inhibited adipogenesis by comparing two hMSC cell lines overexpressing mutated forms of the Wnt co-receptor LRP5:T253I (hMSC-LRP5(T253)) and T244M (hMSC-LRP5(T244)) conducting high and low level of Wnt signaling, respectively. To explore the underlying molecular mechanisms, we compared gene expression profiles of hMSC-LRP5(T253) and hMSC-LRP5(T244) treated with Wnt3a using whole genome expression microarrays and found that TNFRSF19 is differentially up-regulated between the two cells lines. Bioinformatic analysis and dual luciferase assay of its promoter revealed that TNFRSF19 transcript 2 (TNFRSF19.2) is a target of canonical Wnt signaling. Knocking down TNFRSF19 in hMSC-LRP5(T253) cells decreased Wnt3a-induced osteoblast differentiation marker alkaline phosphate activity and its overexpression in hMSC-LRP5(T244) cells increased alkaline phosphate activity. In addition, TNFRSF19 was negatively regulated by adipogenic transcription factor CCAAT/enhancer-binding proteins (C/EBP). Knocking down TNFRSF19 in hMSC-LRP5(T253) cells or its overexpression in hMSC-LRP5(T244) cells significantly increased or decreased adipogenesis, respectively. In conclusion, we revealed a novel function of TNFRSF19 as a factor mediating differentiation signals that determine the hMSC differentiating fate into osteoblasts or adipocytes.	[Qiu, Weimin; Andersen, Tom E.; Jafari, Abbas; Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol & Metab, Lab Mol Endocrinol KMEB, DK-5000 Odense C, Denmark; [Hu, Yuhui; Li, Na; Chen, Wei] Berlin Insitute Med Syst Biol, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Kassem, Moustapha] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 11451, Saudi Arabia	University of Southern Denmark; Odense University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; King Saud University	Kassem, M (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, Lab Mol Endocrinol KMEB, JB Winslows Vej 25,1, DK-5000 Odense C, Denmark.	mkassem@health.sdu.dk	Jafari Kermani, Abbas/I-5074-2015; Jafari, Abbas/AAF-6256-2019; Chen, Wei/C-1273-2011; Kassem, Moustapha/J-7688-2013; Kassem, Moustapha/O-3819-2019	Jafari Kermani, Abbas/0000-0003-2443-6231; Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Chen, Wei/0000-0003-3263-1627; Li, Na/0000-0001-6163-1648	Danish Medical Research Council; Danish Stem Cell Center; Novo Nordisk Foundation; local government of the region of Southern Denmark	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Stem Cell Center; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); local government of the region of Southern Denmark	This work was supported in part by grants from the Danish Medical Research Council, the Danish Stem Cell Center, the Novo Nordisk Foundation, and a grant from the local government of the region of Southern Denmark.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Albagha OME, 2002, HUM MOL GENET, V11, P2289, DOI 10.1093/hmg/11.19.2289; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BARON R, 2009, IBMS BONEKEY, V6, P86; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hisaoka T, 2003, DEV BRAIN RES, V143, P105, DOI 10.1016/S0165-3806(03)00101-9; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marie PJ, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/64807; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mullin BH, 2008, OSTEOPOROSIS INT, V19, P961, DOI 10.1007/s00198-007-0517-7; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Spotila LD, 2003, CALCIFIED TISSUE INT, V73, P140, DOI 10.1007/s00223-002-2079-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tasker PN, 2004, OSTEOPOROSIS INT, V15, P903, DOI 10.1007/s00198-004-1617-2; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yang TL, 2007, ANN HUM GENET, V71, P152, DOI 10.1111/j.1469-1809.2006.00313.x; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	55	53	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14438	14449		10.1074/jbc.M109.052001	http://dx.doi.org/10.1074/jbc.M109.052001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223822	Green Published, hybrid			2022-12-27	WOS:000277299700040
J	Shaw, FL; Elliott, KA; Kinch, LN; Fuell, C; Phillips, MA; Michael, AJ				Shaw, Frances L.; Elliott, Katherine A.; Kinch, Lisa N.; Fuell, Christine; Phillips, Margaret A.; Michael, Anthony J.			Evolution and Multifarious Horizontal Transfer of an Alternative Biosynthetic Pathway for the Alternative Polyamine sym-Homospermidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; ORNITHINE-DECARBOXYLASE; ESCHERICHIA-COLI; DEOXYHYPUSINE SYNTHASE; CRYSTAL-STRUCTURE; GLUTATHIONYLSPERMIDINE METABOLISM; SUBSTRATE-SPECIFICITY; DISTRIBUTION PROFILES; LYSINE BIOSYNTHESIS; STRUCTURAL BASIS	Polyamines are small flexible organic polycations found in almost all cells. They likely existed in the last universal common ancestor of all extant life, and yet relatively little is understood about their biological function, especially in bacteria and archaea. Unlike eukaryotes, where the predominant polyamine is spermidine, bacteria may contain instead an alternative polyamine, sym-homospermidine. We demonstrate that homospermidine synthase (HSS) has evolved vertically, primarily in the alpha-Proteobacteria, but enzymatically active, diverse HSS orthologues have spread by horizontal gene transfer to other bacteria, bacteriophage, archaea, eukaryotes, and viruses. By expressing diverse HSS orthologues in Escherichia coli, we demonstrate in vivo the production of co-products diaminopropane and N-1-aminobutylcadaverine, in addition to sym-homospermidine. We show that sym-homospermidine is required for normal growth of the alpha-proteobacterium Rhizobium leguminosarum. However, sym-homospermidine can be replaced, for growth restoration, by the structural analogues spermidine and sym-norspermidine, suggesting that the symmetrical or unsymmetrical form and carbon backbone length are not critical for polyamine function in growth. We found that the HSS enzyme evolved from the alternative spermidine biosynthetic pathway enzyme carboxyspermidine dehydrogenase. The structure of HSS is related to lysine metabolic enzymes, and HSS and carboxyspermidine dehydrogenase evolved from the aspartate family of pathways. Finally, we show that other bacterial phyla such as Cyanobacteria and some alpha-Proteobacteria synthesize sym-homospermidine by an HSS-independent pathway, very probably based on deoxyhypusine synthase orthologues, similar to the alternative homospermidine synthase found in some plants. Thus, bacteria can contain alternative biosynthetic pathways for both spermidine and sym-norspermidine and distinct alternative pathways for sym-homospermidine.	[Shaw, Frances L.; Elliott, Katherine A.; Fuell, Christine; Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Kinch, Lisa N.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Phillips, Margaret A.; Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michael, AJ (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	anthony.michael@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [RO1 AI34432]; Biotechnology and Biological Sciences Research Council UK; Institute Development Fellowship [BB/E024467/1]; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Development Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI34432 (to M. A. P.). This work was also supported by a Biotechnology and Biological Sciences Research Council UK Competitive Strategic Grant and an Institute Development Fellowship (BB/E024467/1) (to A.J.M.).	Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BACCHI CJ, 1993, ACTA TROP, V54, P225, DOI 10.1016/0001-706X(93)90095-S; Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; BEY P, 1978, J MED CHEM, V21, P50, DOI 10.1021/jm00199a009; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; BOTTCHER F, 1994, CAN J CHEM, V72, P80, DOI 10.1139/v94-013; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; CACCIAPUOTI G, 1986, EUR J BIOCHEM, V161, P263, DOI 10.1111/j.1432-1033.1986.tb10442.x; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2001, J BIOL CHEM, V276, P21235, DOI 10.1074/jbc.M010643200; Chin KJ, 2001, INT J SYST EVOL MICR, V51, P1965, DOI 10.1099/00207713-51-6-1965; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; DeLano W.L, PYMOL MOL GRAPHICS S; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; Foerstner KU, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003976; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; FUJIHARA S, 1995, J BIOL CHEM, V270, P9932, DOI 10.1074/jbc.270.17.9932; FUKUCHI J, 1994, J BIOL CHEM, V269, P22581; GILLIN FD, 1984, J PROTOZOOL, V31, P161, DOI 10.1111/j.1550-7408.1984.tb04308.x; GuevaraOlvera L, 1997, MICROBIOL-UK, V143, P2237, DOI 10.1099/00221287-143-7-2237; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; HAMANA K, 1983, BIOCHEM BIOPH RES CO, V112, P606, DOI 10.1016/0006-291X(83)91507-3; HAMANA K, 1984, J BIOCHEM-TOKYO, V95, P1105, DOI 10.1093/oxfordjournals.jbchem.a134698; Hamana K., 1998, MICROBIOL CULT COLL, V14, P1; Hamana K, 2008, J GEN APPL MICROBIOL, V54, P229, DOI 10.2323/jgam.54.229; Heydari M, 2004, APPL ENVIRON MICROB, V70, P937, DOI 10.1128/AEM.70.2.937-942.2004; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P255, DOI 10.2323/jgam.50.255; Hosoya R., 2006, MICROBIOL CULT; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Jin Y, 2002, MOL MICROBIOL, V46, P801, DOI 10.1046/j.1365-2958.2002.03201.x; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kaiser A, 1999, PLANT J, V19, P195, DOI 10.1046/j.1365-313X.1999.00509.x; KALLIO A, 1981, BIOCHEM J, V200, P69, DOI 10.1042/bj2000069; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li F, 1996, MOL BIOCHEM PARASIT, V78, P227, DOI 10.1016/S0166-6851(96)02630-8; Lindemose S, 2005, NUCLEIC ACIDS RES, V33, P1790, DOI 10.1093/nar/gki319; Lu ZCJ, 2004, J BIOL CHEM, V279, P265, DOI 10.1074/jbc.M308793200; MOMANY C, 1995, PROTEIN SCI, V4, P849; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; NORGAARD E, 1983, FEMS MICROBIOL LETT, V20, P159; O'Kelly CJ, 2003, PROTIST, V154, P281; Ober D, 2003, PHYTOCHEMISTRY, V62, P339, DOI 10.1016/S0031-9422(02)00553-8; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; OSHIMA T, 1987, J BIOL CHEM, V262, P11979; PAULIN L, 1983, FEMS MICROBIOL LETT, V19, P299, DOI 10.1111/j.1574-6968.1983.tb00561.x; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHERER P, 1983, J BACTERIOL, V154, P1315, DOI 10.1128/JB.154.3.1315-1322.1983; SCHWARTZ B, 1995, BIOCHEM J, V312, P83, DOI 10.1042/bj3120083; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; SMITH K, 1995, BIOCHEM J, V312, P465, DOI 10.1042/bj3120465; TABOR CW, 1987, J BIOL CHEM, V262, P16037; Tait GH, 1979, BIOCHEM SOC T, V7, P199, DOI 10.1042/bst0070199; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Tholl D, 1996, EUR J BIOCHEM, V240, P373, DOI 10.1111/j.1432-1033.1996.0373h.x; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Urano K, 2005, FEBS LETT, V579, P1557, DOI 10.1016/j.febslet.2005.01.048; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Whitaker JW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r36; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOLFF EC, 1990, J BIOL CHEM, V265, P4793; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; Yamada T, 2010, VIROLOGY, V398, P135, DOI 10.1016/j.virol.2009.11.043; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021; YAMAMOTO S, 1989, FEMS MICROBIOL LETT, V61, P225, DOI 10.1016/0378-1097(89)90201-2; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V114, P45, DOI 10.1093/oxfordjournals.jbchem.a124137	82	43	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14711	14723		10.1074/jbc.M110.107219	http://dx.doi.org/10.1074/jbc.M110.107219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194510	Green Published, hybrid			2022-12-27	WOS:000277299700069
J	Malhotra, R; D'Souza, KM; Staron, ML; Birukov, KG; Bodi, I; Akhter, SA				Malhotra, Ricky; D'Souza, Karen M.; Staron, Michelle L.; Birukov, Konstantin G.; Bodi, Ilona; Akhter, Shahab A.			G alpha(q)-mediated Activation of GRK2 by Mechanical Stretch in Cardiac Myocytes THE ROLE OF PROTEIN KINASE C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENERGIC-RECEPTOR KINASE; RENIN-ANGIOTENSIN SYSTEM; FAILING HUMAN HEART; IN-VITRO; CONTRACTILE FUNCTION; BETA-ADRENOCEPTORS; GENE-EXPRESSION; FAILURE; HYPERTROPHY; ALPHA	G protein-coupled receptor kinase-2 (GRK2) is a critical regulator of beta-adrenergic receptor (beta-AR) signaling and cardiac function. We studied the effects of mechanical stretch, a potent stimulus for cardiac myocyte hypertrophy, on GRK2 activity and beta-AR signaling. To eliminate neurohormonal influences, neonatal rat ventricular myocytes were subjected to cyclical equi-biaxial stretch. A hypertrophic response was confirmed by "fetal" gene up-regulation. GRK2 activity in cardiac myocytes was increased 4.2-fold at 48 h of stretch versus unstretched controls. Adenylyl cyclase activity was blunted in sarcolemmal membranes after stretch, demonstrating beta-AR desensitization. The hypertrophic response to mechanical stretch is mediated primarily through the G alpha(q)-coupled angiotensin II AT(1) receptor leading to activation of protein kinase C(PKC). PKC is known to phosphorylate GRK2 at the N-terminal serine 29 residue, leading to kinase activation. Overexpression of a mini-gene that inhibits receptor-G alpha(q) coupling blunted stretch-induced hypertrophy and GRK2 activation. Short hairpin RNA-mediated knockdown of PKC alpha also significantly attenuated stretch-induced GRK2 activation. Overexpression of a GRK2 mutant (S29A) in cardiac myocytes inhibited phosphorylation of GRK2 by PKC, abolished stretch-induced GRK2 activation, and restored adenylyl cyclase activity. Cardiac-specific activation of PKC alpha in transgenic mice led to impaired beta-agonist-stimulated ventricular function, blunted cyclase activity, and increased GRK2 phosphorylation and activity. Phosphorylation of GRK2 by PKC appears to be the primary mechanism of increased GRK2 activity and impaired beta-AR signaling after mechanical stretch. Cross-talk between hypertrophic signaling at the level of PKC and beta-AR signaling regulated by GRK2 may be an important mechanism in the transition from compensatory ventricular hypertrophy to heart failure.	[Malhotra, Ricky; D'Souza, Karen M.; Staron, Michelle L.; Akhter, Shahab A.] Univ Chicago, Med Ctr, Dept Surg, Sect Cardiac & Thorac Surg, Chicago, IL 60637 USA; [Birukov, Konstantin G.] Univ Chicago, Med Ctr, Dept Surg, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Bodi, Ilona] Univ Cincinnati, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45267 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of Cincinnati	Akhter, SA (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Sect Cardiac & Thorac Surg, 5841 S Maryland Ave,MC 5040, Chicago, IL 60637 USA.	sakhter@surgery.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		National Institutes of Health [HL081472, HL058064, HL087823]; Thoracic Surgery Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087823, K08HL081472, P01HL058064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Surgery Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL081472 (to S. A. A.) and HL058064 and HL087823 (to K. G. B.). This work was also supported by the Thoracic Surgery Foundation for Research and Education (to S. A. A.).	Akhter SA, 2006, AM J PHYSIOL-HEART C, V290, pH1427, DOI 10.1152/ajpheart.00908.2005; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; BOHM M, 1995, CIRCULATION, V92, P3006, DOI 10.1161/01.CIR.92.10.3006; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; BRODDE OE, 1993, PHARMACOL THERAPEUT, V60, P405, DOI 10.1016/0163-7258(93)90030-H; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; CHUANG TT, 1995, J BIOL CHEM, V270, P18660, DOI 10.1074/jbc.270.31.18660; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P371, DOI 10.1016/j.yjmcc.2007.05.021; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Iaccarino G, 2001, HYPERTENSION, V38, P255, DOI 10.1161/01.HYP.38.2.255; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; MORAVEC CS, 1995, J MOL CELL CARDIOL, V27, P2101, DOI 10.1016/S0022-2828(95)91191-X; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oyama N, 2006, CIRC J, V70, P362, DOI 10.1253/circj.70.362; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Sethi R, 2004, MOL CELL BIOCHEM, V263, P11, DOI 10.1023/B:MCBI.0000041844.24424.35; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	44	29	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13748	13760		10.1074/jbc.M110.109272	http://dx.doi.org/10.1074/jbc.M110.109272			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194499	Green Published, hybrid			2022-12-27	WOS:000276987700050
J	Mazars, R; Gonzalez-De-Peredo, A; Cayrol, C; Lavigne, AC; Vogel, JL; Ortega, N; Lacroix, C; Gautier, V; Huet, G; Ray, A; Monsarrat, B; Kristie, TM; Girard, JP				Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Vogel, Jodi L.; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Kristie, Thomas M.; Girard, Jean-Philippe			The THAP-Zinc Finger Protein THAP1 Associates with Coactivator HCF-1 and O-GlcNAc Transferase A LINK BETWEEN DYT6 AND DYT3 DYSTONIAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED DYSTONIA-PARKINSONISM; CELL-PROLIFERATION; TORSION DYSTONIA; GENE; EXPRESSION; PROMOTERS; MODULE; DOMAIN; VP16	THAP1 is a sequence-specific DNA binding factor that regulates cell proliferation through modulation of target genes such as the cell cycle-specific gene RRM1. Mutations in the THAP1 DNA binding domain, an atypical zinc finger (THAP-zf), have recently been found to cause DYT6 dystonia, a neurological disease characterized by twisting movements and abnormal postures. In this study, we report that THAP1 shares sequence characteristics, in vivo expression patterns and protein partners with THAP3, another THAP-zf protein. Proteomic analyses identified HCF-1, a potent transcriptional coactivator and cell cycle regulator, and O-GlcNAc transferase (OGT), the enzyme that catalyzes the addition of O-GlcNAc, as major cellular partners of THAP3. THAP3 interacts with HCF-1 through a consensus HCF-1-binding motif (HBM), a motif that is also present in THAP1. Accordingly, THAP1 was found to bind HCF-1 in vitro and to associate with HCF-1 and OGT in vivo. THAP1 and THAP3 belong to a large family of HCF-1 binding factors since seven other members of the human THAP-zf protein family were identified, which harbor evolutionary conserved HBMs and bind to HCF-1. Chromatin immunoprecipitation (ChIP) assays and RNA interference experiments showed that endogenous THAP1 mediates the recruitment of HCF-1 to the RRM1 promoter during endothelial cell proliferation and that HCF-1 is essential for transcriptional activation of RRM1. Together, our findings suggest HCF-1 is an important cofactor for THAP1. Interestingly, our results also provide an unexpected link between DYT6 and DYT3 (X-linked dystonia-parkinsonism) dystonias because the gene encoding the THAP1/DYT6 protein partner OGT maps within the DYT3 critical region on Xq13.1.	[Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Girard, Jean-Philippe] CNRS, IPBS, F-31077 Toulouse, France; [Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Girard, Jean-Philippe] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Vogel, Jodi L.; Kristie, Thomas M.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Girard, JP (corresponding author), CNRS, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	CAYROL, Corinne/C-2106-2011; GIRARD, Jean-Philippe/F-5229-2010; Ortega, Nathalie/C-3382-2019; Lavigne, Anne-Claire/O-8805-2015	CAYROL, Corinne/0000-0002-7813-4397; GIRARD, Jean-Philippe/0000-0002-9154-1691; Gonzalez de Peredo, Anne/0000-0001-6152-6311	Ligue Nationale contre le Cancer; INCA; ANR; National Institutes of Health, Laboratory of Viral Diseases, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000711] Funding Source: NIH RePORTER	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); National Institutes of Health, Laboratory of Viral Diseases, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants from Ligue Nationale contre le Cancer (Equipe labellise e Ligue 2009), INCA, and ANR-Programme Blanc "Regulome." This work was also supported, in part, by the Intramural Research Program of the National Institutes of Health, Laboratory of Viral Diseases, NIAID.	Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bressman SB, 2009, LANCET NEUROL, V8, P441, DOI 10.1016/S1474-4422(09)70081-X; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Djarmati A, 2009, LANCET NEUROL, V8, P447, DOI 10.1016/S1474-4422(09)70083-3; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Lefebvre T, 2001, BIOCHEM J, V360, P179, DOI 10.1042/0264-6021:3600179; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Tamiya G, 2009, LANCET NEUROL, V8, P416, DOI 10.1016/S1474-4422(09)70087-0; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	27	76	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13364	13371		10.1074/jbc.M109.072579	http://dx.doi.org/10.1074/jbc.M109.072579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200153	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000276987700007
J	Muylaert, I; Elias, P				Muylaert, Isabella; Elias, Per			Contributions of Nucleotide Excision Repair, DNA Polymerase eta, and Homologous Recombination to Replication of UV-irradiated Herpes Simplex Virus Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; ORIGIN-BINDING-PROTEIN; DAMAGE RESPONSE; TRANSLESION SYNTHESIS; PROCESSIVITY FACTOR; CRYSTAL-STRUCTURE; CELLULAR-DNA; RECONSTITUTION; LOCALIZATION; GENOME	The effects of UV irradiation on herpes simplex virus type 1 (HSV-1) gene expression and DNA replication were examined in cell lines containing mutations inactivating the XPA gene product required for nucleotide-excision repair, the DNA polymerase eta responsible for translesion synthesis, or the Cockayne syndrome A and B (CSA and CSB) gene products required for transcription-coupled nucleotide excision repair. In the absence of XPA and CSA and CSB gene products, virus replication was reduced 10(6)-, 400-, and 100-fold, respectively. In DNA polymerase eta mutant cells HSV-1 plaque efficiency was reduced 10(4)-fold. Furthermore, DNA polymerase eta was strictly required for virus replication at low multiplicities of infection but dispensable at high multiplicities of infection. Knock down of Rad 51, Rad 52, and Rad 54 levels by RNA interference reduced replication of UV-irradiated HSV-1 150-, 100-, and 50-fold, respectively. We find that transcription-coupled repair efficiently supports expression of immediate early and early genes from UV-irradiated HSV-1 DNA. In contrast, the progression of the replication fork appears to be impaired, causing a severe reduction of late gene expression. Since the HSV-1 replisome does not make use of proliferating cell nuclear antigen, we attribute the replication defect to an inability to perform proliferating cell nuclear antigen-dependent translesion synthesis by polymerase switching at the fork. Instead, DNA polymerase eta may act during postreplication gap filling. Homologous recombination, finally, might restore the physical and genetic integrity of the virus chromosome.	[Muylaert, Isabella; Elias, Per] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, S-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, Box 440, S-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se			Swedish Cancer Foundation; Swedish Research Council; Sahlgrenska University Hospital Lakarutbildningsavtal	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital Lakarutbildningsavtal	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, and the Sahlgrenska University Hospital Lakarutbildningsavtal.	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; Cavanaugh NA, 2009, BIOCHEMISTRY-US, V48, P3554, DOI 10.1021/bi8022202; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; COMPTON T, 1984, J VIROL, V49, P594, DOI 10.1128/JVI.49.2.594-597.1984; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gregory DA, 2008, VIROLOGY, V373, P124, DOI 10.1016/j.virol.2007.12.005; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang CY, 2009, J VIROL, V83, P7573, DOI 10.1128/JVI.00193-09; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Knipe DM, 2007, FIELDS VIROLOGY, P2501; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Le Gac NT, 1998, J BIOL CHEM, V273, P13801, DOI 10.1074/jbc.273.22.13801; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Makhov AM, 2009, J MOL BIOL, V386, P273, DOI 10.1016/j.jmb.2008.12.059; Masutani C, 2000, COLD SPRING HARB SYM, V65, P71, DOI 10.1101/sqb.2000.65.71; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; OLIVO PD, 1989, J VIROL, V63, P196, DOI 10.1128/JVI.63.1.196-204.1989; Olsson M, 2009, J BIOL CHEM, V284, P16246, DOI 10.1074/jbc.M807551200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SARISKY RT, 1994, J VIROL, V68, P34, DOI 10.1128/JVI.68.1.34-47.1994; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; Song LP, 2004, J BIOL CHEM, V279, P18535, DOI 10.1074/jbc.M309848200; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; TAIN W, 2009, J VIROL, V83, P7194; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Wilkinson DE, 2004, J VIROL, V78, P4783, DOI 10.1128/JVI.78.9.4783-4796.2004; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; YAO XD, 1999, THESIS U GOTHENBURG; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	53	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13761	13768		10.1074/jbc.M110.107920	http://dx.doi.org/10.1074/jbc.M110.107920			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215648	hybrid, Green Published			2022-12-27	WOS:000276987700051
J	Furuita, K; Jee, J; Fukada, H; Mishima, M; Kojima, C				Furuita, Kyoko; Jee, JunGoo; Fukada, Harumi; Mishima, Masaki; Kojima, Chojiro			Electrostatic Interaction between Oxysterol-binding Protein and VAMP-associated Protein A Revealed by NMR and Mutagenesis Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPICALLY ENRICHED PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; CELLULAR LIPID-METABOLISM; TORSION ANGLE DYNAMICS; OSBP-RELATED PROTEINS; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; VESICLE TRANSPORT; ENERGY CONTENT; FFAT MOTIF	Oxysterol-binding protein (OSBP), a cytosolic receptor of cholesterol and oxysterols, is recruited to the endoplasmic reticulum by binding to the cytoplasmic major sperm protein (MSP) domain of integral endoplasmic reticulum protein VAMP-associated protein-A (VAP-A), a process essential for the stimulation of sphingomyelin synthesis by 25-hydroxycholesterol. To delineate the interaction mechanism between VAP-A and OSBP, we determined the complex structure between the VAP-A MSP domain (VAP-A(MSP)) and the OSBP fragment containing a VAP-A binding motif FFAT (OSBPF) by NMR. This solution structure explained that five of six conserved residues in the FFAT motif are required for the stable complex formation, and three of five, including three critical intermolecular electrostatic interactions, were not explained before. By combining NMR relaxation and titration, isothermal titration calorimetry, and mutagenesis experiments with structural information, we further elucidated the detailed roles of the FFAT motif and underlying motions of VAP-A(MSP), OSBPF, and the complex. Our results show that OSBPF is disordered in the free state, and VAP-A(MSP) and OSBPF form a final complex by means of intermediates, where electrostatic interactions through acidic residues, including an acid patch preceding the FFAT motif, probably play a collective role. Additionally, we report that the mutation that causes the familial motor neuron disease decreases the stability of the MSP domain.	[Furuita, Kyoko; Jee, JunGoo; Mishima, Masaki; Kojima, Chojiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Jee, JunGoo] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Fukada, Harumi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; [Mishima, Masaki] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Tokyo 1920397, Japan	Nara Institute of Science & Technology; Tokyo Metropolitan University; Osaka Metropolitan University; Tokyo Metropolitan University	Kojima, C (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kojima@protein.osaka-u.ac.jp	Kojima, Chojiro/AFV-4592-2022	Kojima, Chojiro/0000-0003-2723-8249; Furuita, Kyoko/0000-0002-9272-0026	Ministry of Education, Culture, Sports and Technology (Japan)	Ministry of Education, Culture, Sports and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports and Technology (Japan) through Target Proteins Research Program, Global Centers of Excellence Program, and grants-in-aid for scientific research.	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Furuita K, 2006, J BIOMOL NMR, V36, P69, DOI 10.1007/s10858-006-9057-2; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Lapierre LA, 1999, J CELL SCI, V112, P3723; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PALMER AG, 1991, CHEM PHYS LETT, V185, P41, DOI 10.1016/0009-2614(91)80136-L; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarr DEK, 2005, TRENDS PARASITOL, V21, P224, DOI 10.1016/j.pt.2005.03.009; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002	55	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12961	12970		10.1074/jbc.M109.082602	http://dx.doi.org/10.1074/jbc.M109.082602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178991	Green Published, hybrid			2022-12-27	WOS:000276787800054
J	Kenoth, R; Simanshu, DK; Kamlekar, RK; Pike, HM; Molotkovsky, JG; Benson, LM; Bergen, HR; Prendergast, FG; Malinina, L; Venyaminov, SY; Patel, DJ; Brown, RE				Kenoth, Roopa; Simanshu, Dhirendra K.; Kamlekar, Ravi Kanth; Pike, Helen M.; Molotkovsky, Julian G.; Benson, Linda M.; Bergen, H. Robert, III; Prendergast, Franklyn G.; Malinina, Lucy; Venyaminov, Sergei Y.; Patel, Dinshaw J.; Brown, Rhoderick E.			Structural Determination and Tryptophan Fluorescence of Heterokaryon Incompatibility C2 Protein (HET-C2), a Fungal Glycolipid Transfer Protein (GLTP), Provide Novel Insights into Glycolipid Specificity and Membrane Interaction by the GLTP Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; EXTINCTION COEFFICIENTS; CRYSTAL-STRUCTURES; FILAMENTOUS FUNGI; BINDING PROTEINS; BILAYER VESICLES; CELL-DEATH; RECOGNITION; GLYCOSPHINGOLIPIDS	HET-C2 is a fungal protein that transfers glycosphingolipids between membranes and has limited sequence homology with human glycolipid transfer protein (GLTP). The human GLTP fold is unique among lipid binding/transfer proteins, defining the GLTP superfamily. Herein, GLTP fold formation by HET-C2, its glycolipid transfer specificity, and the functional role(s) of its two Trp residues have been investigated. X-ray diffraction (1.9 angstrom) revealed a GLTP fold with all key sugar headgroup recognition residues (Asp(66), Asn(70), Lys(73), Trp(109), and His(147)) conserved and properly oriented for glycolipid binding. Far-UV CD showed secondary structure dominated by alpha-helices and a cooperative thermal unfolding transition of 49 degrees C, features consistent with a GLTP fold. Environmentally induced optical activity of Trp/Tyr/Phe (2: 4: 12) detected by near-UV CD was unaffected by membranes containing glycolipid but was slightly altered by membranes lacking glycolipid. Trp fluorescence was maximal at similar to 355 nm and accessible to aqueous quenchers, indicating free exposure to the aqueous milieu and consistent with surface localization of the two Trps. Interaction with membranes lacking glycolipid triggered significant decreases in Trp emission intensity but lesser than decreases induced by membranes containing glycolipid. Binding of glycolipid (confirmed by electro-spray injection mass spectrometry) resulted in a blue-shifted emission wavelength maximum (similar to 6 nm) permitting determination of binding affinities. The unique positioning of Trp(208) at the HET-C2 C terminus revealed membrane-induced conformational changes that precede glycolipid uptake, whereas key differences in residues of the sugar headgroup recognition center accounted for altered glycolipid specificity and suggested evolutionary adaptation for the simpler glycosphingolipid compositions of filamentous fungi.	[Prendergast, Franklyn G.; Venyaminov, Sergei Y.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN 55905 USA; [Malinina, Lucy] Ctr Invest Cooperat Biociencias, Derio 48160, Spain; [Kenoth, Roopa; Kamlekar, Ravi Kanth; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Mayo Clinic; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Mayo Clinic; University of Minnesota System	Venyaminov, SY (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	venyaminov.sergei@mayo.edu; pateld@mskcc.org; reb@umn.edu	Malinina, Lucy/B-8161-2013; Kenoth, Roopa/F-3942-2010; Kamlekar, Ravikanth/B-9447-2009; Simanshu, Dhirendra/B-3361-2008; Kenoth, Roopa/ABH-5650-2020	Kenoth, Roopa/0000-0003-1992-3465; Kamlekar, Ravikanth/0000-0003-1627-122X; Simanshu, Dhirendra/0000-0002-9717-4618; Brown, Rhoderick/0000-0002-7337-3604; Malinina, Lucy/0000-0001-7973-1831	National Institutes of Health [GM45928, GM34847, CA121493]; Russian Foundation for Basic Research [09-04-00313]; Abby Rockefeller Mauze Trust; Dewitt Wallace, Maloris, Mayo, and Hormel Foundations; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928, R01GM034847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Abby Rockefeller Mauze Trust; Dewitt Wallace, Maloris, Mayo, and Hormel Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants GM45928 and GM34847 and National Institutes of Health, NCI, Grant CA121493. This work was also supported by Russian Foundation for Basic Research Grant 09-04-00313, the Abby Rockefeller Mauze Trust, and the Dewitt Wallace, Maloris, Mayo, and Hormel Foundations.	ABE A, 1989, BIOCHIM BIOPHYS ACTA, V985, P38, DOI 10.1016/0005-2736(89)90100-4; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Aoki K, 2004, BIOCHEM J, V378, P461, DOI 10.1042/BJ20031307; BASHFORD CL, 1979, BIOPHYS J, V25, P63, DOI 10.1016/S0006-3495(79)85278-9; BLOJ B, 1981, J BIOL CHEM, V256, P5988; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Hoh F, 2005, ACTA CRYSTALLOGR D, V61, P397, DOI 10.1107/S0907444905000417; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; Mattjus P, 2002, BIOCHEMISTRY-US, V41, P266, DOI 10.1021/bi015718l; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2000, BIOCHEMISTRY-US, V39, P1067, DOI 10.1021/bi991810u; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIHALYI E, 1968, J CHEM ENG DATA, V13, P179, DOI 10.1021/je60037a011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neumann S, 2008, ADV ENZYME REGUL, V48, P137, DOI 10.1016/j.advenzreg.2007.11.009; Nylund M, 2005, BBA-BIOMEMBRANES, V1669, P87, DOI 10.1016/j.bbamem.2004.12.014; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paoletti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000283; Park C, 2005, J LIPID RES, V46, P759, DOI 10.1194/jlr.M400457-JLR200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VENYAMINOV SY, 1994, ANAL BIOCHEM, V222, P176, DOI 10.1006/abio.1994.1470; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; West G, 2006, BBA-BIOMEMBRANES, V1758, P1732, DOI 10.1016/j.bbamem.2006.06.020; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200	65	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13066	13078		10.1074/jbc.M109.093203	http://dx.doi.org/10.1074/jbc.M109.093203			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164530	Green Published, hybrid			2022-12-27	WOS:000276787800064
J	Ni, YG; Condra, JH; Orsatti, L; Shen, X; Di Marco, S; Pandit, S; Bottomley, MJ; Ruggeri, L; Cummings, RT; Cubbon, RM; Santoro, JC; Ehrhardt, A; Lewis, D; Fisher, TS; Ha, S; Njimoluh, L; Wood, DD; Hammond, HA; Wisniewski, D; Volpari, C; Noto, A; Lo Surdo, P; Hubbard, B; Carfi, A; Sitlani, A				Ni, Yan G.; Condra, Jon H.; Orsatti, Laura; Shen, Xun; Di Marco, Stefania; Pandit, Shilpa; Bottomley, Matthew J.; Ruggeri, Lionello; Cummings, Richard T.; Cubbon, Rose M.; Santoro, Joseph C.; Ehrhardt, Anka; Lewis, Dale; Fisher, Timothy S.; Ha, Sookhee; Njimoluh, Leila; Wood, Dana D.; Hammond, Holly A.; Wisniewski, Douglas; Volpari, Cinzia; Noto, Alessia; Lo Surdo, Paola; Hubbard, Brian; Carfi, Andrea; Sitlani, Ayesha			A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL-CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA; NONHUMAN-PRIMATES; RECEPTOR; MUTATIONS; MICE; MUTANTS; DISEASE; GENE	PCSK9 binds to the low density lipoprotein receptor (LDLR) and leads to LDLR degradation and inhibition of plasma LDL cholesterol clearance. Consequently, the role of PCSK9 in modulating circulating LDL makes it a promising therapeutic target for treating hypercholesterolemia and coronary heart disease. Although the C-terminal domain of PCSK9 is not involved in LDLR binding, the location of several naturally occurring mutations within this region suggests that it has an important role for PCSK9 function. Using a phage display library, we identified an anti-PCSK9 Fab (fragment antigen binding), 1G08, with subnanomolar affinity for PCSK9. In an assay measuring LDL uptake in HEK293 and HepG2 cells, 1G08 Fab reduced 50% the PCSK9-dependent inhibitory effects on LDL uptake. Importantly, we found that 1G08 did not affect the PCSK9-LDLR interaction but inhibited the internalization of PCSK9 in these cells. Furthermore, proteolysis and site-directed mutagenesis studies demonstrated that 1G08 Fab binds a region of beta-strands encompassing Arg-549, Arg-580, Arg-582, Glu-607, Lys-609, and Glu-612 in the PCSK9 C-terminal domain. Consistent with these results, 1G08 fails to bind PCSK9 Delta C, a truncated form of PCSK9 lacking the C-terminal domain. Additional studiesrevealed that lack of the C-terminal domain compromised the ability of PCSK9 to internalize into cells, and to inhibit LDL uptake. Together, the present study demonstrate that the PCSK9 C-terminal domain contribute to its inhibition of LDLR function mainly through its role in the cellular uptake of PCSK9 and LDLR complex. 1G08 Fab represents a useful new tool for delineating the mechanism of PCSK9 uptake and LDLR degradation.	[Ni, Yan G.; Shen, Xun; Pandit, Shilpa; Cummings, Richard T.; Cubbon, Rose M.; Santoro, Joseph C.; Fisher, Timothy S.; Njimoluh, Leila; Hubbard, Brian; Sitlani, Ayesha] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; [Wisniewski, Douglas] Merck Res Labs, Dept Infect Dis, Rahway, NJ 07065 USA; [Lewis, Dale] Merck Res Labs, Dept Vitro Sci, Rahway, NJ 07065 USA; [Ehrhardt, Anka; Ha, Sookhee] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; [Condra, Jon H.; Wood, Dana D.; Hammond, Holly A.] Merck Res Labs, Dept Biol, West Point, PA 19486 USA; [Orsatti, Laura; Di Marco, Stefania; Bottomley, Matthew J.; Ruggeri, Lionello; Volpari, Cinzia; Noto, Alessia; Lo Surdo, Paola; Carfi, Andrea] IRBM P Angeletti & Merck Res Labs, Dept Biochem & Mol Biol, I-00040 Rome, Italy	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Ni, YG (corresponding author), 126 E Lincoln Ave, Rahway, NJ 07065 USA.	yan_ni@merck.com; andrea.carfi@novartis.com; ayesha_sitlani@merck.com	Fisher, Timothy S/D-8517-2011; Wisniewski, Douglas/AAT-9198-2021	Fisher, Timothy S/0000-0002-8909-313X; 				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rauchenberger R, 2003, J BIOL CHEM, V278, P38194, DOI 10.1074/jbc.M303164200; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	30	87	100	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12882	12891		10.1074/jbc.M110.113035	http://dx.doi.org/10.1074/jbc.M110.113035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172854	hybrid, Green Published			2022-12-27	WOS:000276787800046
J	Shepherd, M; Barynin, V; Lu, CY; Bernhardt, PV; Wu, GH; Yeh, SR; Egawa, T; Sedelnikova, SE; Rice, DW; Wilson, JL; Poole, RK				Shepherd, Mark; Barynin, Vladimir; Lu, Changyuan; Bernhardt, Paul V.; Wu, Guanghui; Yeh, Syun-Ru; Egawa, Tsuyoshi; Sedelnikova, Svetlana E.; Rice, David W.; Wilson, Jayne Louise; Poole, Robert K.			The Single-domain Globin from the Pathogenic Bacterium Campylobacter jejuni NOVEL D-HELIX CONFORMATION, PROXIMAL HYDROGEN BONDING THAT INFLUENCES LIGAND BINDING, AND PEROXIDASE-LIKE REDOX PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; VITREOSCILLA HEMOGLOBIN VHB; TRUNCATED HEMOGLOBIN; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; NITROSATIVE STRESS; NITRIC-OXIDE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; FLAVOHEMOGLOBIN	The food-borne pathogen Campylobacter jejuni possesses a single-domain globin (Cgb) whose role in detoxifying nitric oxide has been unequivocally demonstrated through genetic and molecular approaches. The x-ray structure of cyanide-bound Cgb has been solved to a resolution of 1.35 angstrom. The overall fold is a classic three-on-three alpha-helical globin fold, similar to that of myoglobin and Vgb from Vitreoscilla stercoraria. However, the D region (defined according to the standard globin fold nomenclature) of Cgb adopts a highly ordered alpha-helical conformation unlike any previously characterized members of this globin family, and the GlnE7 residue has an unexpected role in modulating the interaction between the ligand and the TyrB10 residue. The proximal hydrogen bonding network in Cgb demonstrates that the heme cofactor is ligated by an imidazolate, a characteristic of peroxidase-like proteins. Mutation of either proximal hydrogen-bonding residue (GluH23 or TyrG5) results in the loss of the high frequency nu(Fe-His) stretching mode (251 cm(-1)), indicating that both residues are important for maintaining the anionic character of the proximal histidine ligand. Cyanide binding kinetics for these proximal mutants demonstrate for the first time that proximal hydrogen bonding in globins can modulate ligand binding kinetics at the distal site. A low redox midpoint for the ferrous/ferric couple (-134 mV versus normal hydrogen electrode at pH 7) is consistent with the peroxidase-like character of the Cgb active site. These data provide a new insight into the mechanism via which Campylobacter may survive host-derived nitrosative stress.	[Shepherd, Mark; Barynin, Vladimir; Sedelnikova, Svetlana E.; Rice, David W.; Wilson, Jayne Louise; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Lu, Changyuan; Yeh, Syun-Ru; Egawa, Tsuyoshi] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Bernhardt, Paul V.] Univ Queensland, Dept Chem, Brisbane, Qld 4072, Australia; [Wu, Guanghui] Vet Labs Agcy, Dept Food & Environm Safety, Addlestone KT15 3NB, Surrey, England	University of Sheffield; Yeshiva University; Albert Einstein College of Medicine; University of Queensland; Veterinary Laboratories Agency	Shepherd, M (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	m.shepherd@sheffield.ac.uk	Wu, Guanghui/A-3757-2016; Bernhardt, Paul V/J-8008-2013	Wu, Guanghui/0000-0002-9374-3190; Bernhardt, Paul V/0000-0001-6839-1763; Yeh, Syun-Ru/0000-0002-9858-386X; Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BB/EO10504/1]; BBSRC [BB/E010504/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010504/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/EO10504/1 (to R. K. P.).	Arcovito A, 2007, P NATL ACAD SCI USA, V104, P6211, DOI 10.1073/pnas.0608411104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; Bolognesi M, 1999, J MOL BIOL, V291, P637, DOI 10.1006/jmbi.1999.2975; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; Dou Y, 1996, BIOCHEMISTRY-US, V35, P7107, DOI 10.1021/bi9600299; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; ERMLER U, 1995, PROTEINS, V21, P351, DOI 10.1002/prot.340210408; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; Iovine NM, 2008, INFECT IMMUN, V76, P986, DOI 10.1128/IAI.01063-07; JAKOB W, 1992, ARCH BIOCHEM BIOPHYS, V292, P29, DOI 10.1016/0003-9861(92)90046-Y; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHI M, 1994, BIOCHEM BIOPH RES CO, V202, P535, DOI 10.1006/bbrc.1994.1961; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Kaur R, 2008, FEBS LETT, V582, P3494, DOI 10.1016/j.febslet.2008.09.018; KEILIN D, 1953, NATURE, V172, P390, DOI 10.1038/172390a0; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2004, BIOCHEM BIOPH RES CO, V316, P1101, DOI 10.1016/j.bbrc.2004.02.154; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Monk CE, 2008, J BIOL CHEM, V283, P28413, DOI 10.1074/jbc.M801016200; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Rayner BS, 2004, BIOCHEM J, V381, P365, DOI 10.1042/BJ20031924; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Tari C, 1998, BIOTECHNOL BIOENG, V59, P673, DOI 10.1002/(SICI)1097-0290(19980920)59:6&lt;673::AID-BIT3&gt;3.0.CO;2-C; Tarricone C, 1997, PROTEINS, V27, P154, DOI 10.1002/(SICI)1097-0134(199701)27:1<154::AID-PROT15>3.0.CO;2-M; Tarricone C, 1997, STRUCTURE, V5, P497, DOI 10.1016/S0969-2126(97)00206-2; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; Verma S, 2005, BIOCHEM BIOPH RES CO, V326, P290, DOI 10.1016/j.bbrc.2004.11.025; Wainwright LM, 2005, MICROBIOL-SGM, V151, P4079, DOI 10.1099/mic.0.28266-0; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; YAMADA H, 1975, ARCH BIOCHEM BIOPHYS, V169, P344, DOI 10.1016/0003-9861(75)90350-1	48	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12747	12754		10.1074/jbc.M109.084509	http://dx.doi.org/10.1074/jbc.M109.084509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164176	hybrid, Green Published			2022-12-27	WOS:000276787800033
J	Berger, A; Munk, C; Schweizer, M; Cichutek, K; Schule, S; Flory, E				Berger, Andre; Muenk, Carsten; Schweizer, Matthias; Cichutek, Klaus; Schuele, Silke; Flory, Egbert			Interaction of Vpx and Apolipoprotein B mRNA-editing Catalytic Polypeptide 3 Family Member A (APOBEC3A) Correlates with Efficient Lentivirus Infection of Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-2 VPX; CELL-CYCLE ARREST; CD4(+) T-CELLS; NUCLEAR IMPORT; PREINTEGRATION COMPLEX; REVERSE TRANSCRIPTION; PAPILLOMAVIRUS DNA; UBIQUITIN LIGASE; PROTEINS; HIV-1	The accessory protein Vpx is encoded by lentiviruses of the human immunodeficiency virus type 2 (HIV-2) and the simian immunodeficiency SIVsm/SIVmac lineage. It is packaged into virions and is indispensable in early steps of monocyte infection. HIV-1, which does not encode Vpx, is not able to infect human monocytes, but Vpx enables infection with HIV-1. The underlying mechanism is not completely understood. In this work, we focus on Vpx-mediated intracellular postentry events as counteraction of host cell proteins. We found that Vpx binds to apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A; A3A), a member of the family of cytidine deaminases, present in monocytes. This interaction led to a reduction of the steady-state protein level of A3A. A single-point mutation in Vpx (H82A) abrogated binding to A3A and single-round infection of monocytes by HIV-1. Taken together, our data indicate that lentiviral Vpx counteracts A3A in human monocytes.	[Berger, Andre; Schweizer, Matthias; Cichutek, Klaus; Schuele, Silke; Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Muenk, Carsten] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Paul Ehrlich Institute; Heinrich Heine University Dusseldorf	Flory, E (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	floeg@pei.de			Ansmann Foundation for AIDS Research; European Comission [LSHB-CT-2006-018933]; German Research Foundation [SPP1230]	Ansmann Foundation for AIDS Research; European Comission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG))	Supported by the Ansmann Foundation for AIDS Research.; Supported by the CliniGene Network of Excellence funded by the European Comission FP6 Research Programme under Contract LSHB-CT-2006-018933 and by German Research Foundation Grant SPP1230.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Belshan M, 2003, VIROLOGY, V311, P7, DOI 10.1016/S0042-6822(03)00093-X; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; DEWHURST S, 1990, NATURE, V345, P636, DOI 10.1038/345636a0; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Fritz JV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-87; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; HORTON R, 1994, VIROLOGY, V199, P453, DOI 10.1006/viro.1994.1144; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; KAPPES JC, 1993, VIROLOGY, V193, P222, DOI 10.1006/viro.1993.1118; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Kurg R, 2009, VIROLOGY, V386, P353, DOI 10.1016/j.virol.2009.01.025; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muhlebach MD, 2005, MOL THER, V12, P1206, DOI 10.1016/j.ymthe.2005.06.483; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Pancio HA, 2000, J VIROL, V74, P6162, DOI 10.1128/JVI.74.13.6162-6167.2000; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Schule S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007098; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sleigh R, 1998, VIROLOGY, V245, P338, DOI 10.1006/viro.1998.9159; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wolfrum N, 2007, VIROLOGY, V364, P330, DOI 10.1016/j.virol.2007.03.008	43	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12248	12254		10.1074/jbc.M109.090977	http://dx.doi.org/10.1074/jbc.M109.090977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178977	Green Published, hybrid			2022-12-27	WOS:000276787100054
J	Kang, LS; Bondensgaard, K; Li, TK; Hartmann, R; Hjorth, SA				Kang, Lishan; Bondensgaard, Kent; Li, Tengkun; Hartmann, Rune; Hjorth, Siv A.			Rational Design of Interleukin-21 Antagonist through Selective Elimination of the gamma C Binding Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; STRUCTURAL BASIS; IL-21 RECEPTOR; T-CELLS; CHAIN; AFFINITY; COMPLEX; REQUIREMENTS; BIOLOGY; GROWTH	The cytokine interleukin (IL)-21 exerts pleiotropic effects acting through innate as well as adaptive immune responses. The activities of IL-21 are mediated through binding to its cognate receptor complex composed of the IL-21 receptor private chain (IL-21R alpha) and thecommon gamma-chain (gamma C), the latter being shared by IL-2, IL-4, IL-7, IL-9, and IL-15. The binding energy of the IL-21 ternary complex is predominantly provided by the high affinity interaction between IL-21 and IL-21R alpha, whereas the interaction between IL-21 and gamma C, albeit essential for signaling, is rather weak. The design of IL-21 analogues, which have lost most or all affinity toward the signaling gamma C chain, while simultaneously maintaining a tight interaction with the private chain, would in theory represent candidates for IL-21 antagonists. We predicted the IL-21 residues, which compose the gamma C binding epitope using homology modeling and alignment with the related cytokines, IL-2 and IL-4. Next we systematically analyzed the predicted binding epitope by a mutagenesis study. Indeed two mutants, which have significantly impaired gamma C affinity with undiminished IL-21R alpha affinity, were successfully identified. Functional studies confirmed that these two novel hIL-21 double mutants do act as hIL-21 antagonists.	[Kang, Lishan] Novo Nordisk China R&D, Beijing 102206, Peoples R China; [Bondensgaard, Kent; Hjorth, Siv A.] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Hartmann, Rune] Aarhus Univ, Struct Biol Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Novo Nordisk; Novo Nordisk; Aarhus University	Kang, LS (corresponding author), Novo Nordisk China R&D, 29 Life Sci Pk Rd, Beijing 102206, Peoples R China.	LshK@novonordisk.com		Hjorth, Siv Annegrethe/0000-0002-6470-650X; Hartmann, Rune/0000-0003-1159-066X				Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DUSCHL A, 1995, EUR J BIOCHEM, V228, P305; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; KRUSE N, 1992, EMBO J, V11, P3237, DOI 10.1002/j.1460-2075.1992.tb05401.x; KRUSE N, 1993, EMBO J, V12, P5121, DOI 10.1002/j.1460-2075.1993.tb06207.x; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Letzelter F, 1998, EUR J BIOCHEM, V257, P11, DOI 10.1046/j.1432-1327.1998.2570011.x; MULLER T, 1994, J MOL BIOL, V237, P423, DOI 10.1006/jmbi.1994.1245; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; PRESNELL SR, 2007, Patent No. 7186805; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x	24	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12223	12231		10.1074/jbc.M110.101444	http://dx.doi.org/10.1074/jbc.M110.101444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167599	hybrid, Green Published			2022-12-27	WOS:000276787100051
J	Santiago, MF; Alcami, P; Striedinger, KM; Spray, DC; Scemes, E				Santiago, Marcelo F.; Alcami, Pepe; Striedinger, Katharine M.; Spray, David C.; Scemes, Eliana			The Carboxyl-terminal Domain of Connexin43 Is a Negative Modulator of Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL PROGENITOR CELLS; GAP-JUNCTION BLOCKAGE; NTERA2/CLONE D1 CELLS; NERVOUS-SYSTEM; NEOCORTICAL DEVELOPMENT; ASTROCYTE PROGENITORS; CORTICAL DEVELOPMENT; TEMPORAL EXPRESSION; P2Y(1) RECEPTORS; IN-VITRO	Connexin43 (Cx43) is widely expressed in embryonic brain, and its expression becomes restricted mainly to astrocytes as the central nervous system matures. Recent studies have indicated that Cx43 plays important, nonchannel, roles during central nervous system development by affecting neuronal cell migration. Here, we evaluated the effects of Cx43 on neuronal differentiation. For that we used an in vitro model of neural cell development (neurospheres) to evaluate, through immunocytochemistry, electrophysiology, and molecular biology, the degree of neuronal maturation from neurospheres derived from wild-type (WT) and Cx43-null mice. Our results indicate that Cx43 is a negative modulator of neuronal differentiation. The percent neurospheres containing differentiated neurons and the number of cells displaying inward currents were significantly higher in Cx43-null than in WT littermate neurospheres. Knockdown of Cx43 with small interfering RNA increased the number of WT neurospheres generating differentiated neurons. Blockade of gap junctional communication with carbenoxolone did not induce neuronal differentiation in WT neurospheres. Transfection of Cx43-null neurospheres with Cx43 mutants revealed that Cx43 carboxyl terminus prevents neuronal maturation. In agreement with these in vitro data, in situ analysis of embryonic day 16 brains revealed increased beta-III-tubulin expression in germinal zones of Cx43-null compared with that of WT littermates. These results indicate that Cx43, and specifically its carboxyl terminus, is crucial for signaling mechanisms preventing premature neuronal differentiation during embryonic brain development.	Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA; [Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil; [Alcami, Pepe] Ecole Normale Super, Dept Biol, F-75005 Paris, France; [Striedinger, Katharine M.] Accuray Inc, Sunnyvale, CA 94089 USA	Yeshiva University; Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Scemes, E (corresponding author), Kennedy Ctr, 1410 Pelham Pkwy,Rm 203, Bronx, NY 10461 USA.	scemes@aecom.yu.edu	Santiago, Marcelo Felippe/AAZ-3553-2020; Alcami, Pepe/T-2242-2018; Santiago, Marcelo F/H-3943-2011; Scemes, Eliana/K-6257-2019	Santiago, Marcelo Felippe/0000-0003-2428-9606; Alcami, Pepe/0000-0003-0023-7377; Santiago, Marcelo F/0000-0003-2428-9606; Scemes, Eliana/0000-0002-6650-3976; Spray, David/0000-0001-8368-5073	NINDS/National Institutes of Health [NS052245, NS041282]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041282, R01NS052245] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants NS052245 (to E. S.) and NS041282 (to D. C. S.).	Agresti C, 2005, GLIA, V50, P132, DOI 10.1002/glia.20160; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bani-Yaghoub M, 1999, DEV GENET, V24, P69, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M; Bani-Yaghoub M, 1999, EXP NEUROL, V156, P16, DOI 10.1006/exnr.1998.6950; BaniYaghoub M, 1997, J NEUROSCI RES, V49, P19, DOI 10.1002/(SICI)1097-4547(19970701)49:1<19::AID-JNR3>3.0.CO;2-G; Belliveau DJ, 2006, J BIOL CHEM, V281, P20920, DOI 10.1074/jbc.M600026200; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bittman K, 1997, J NEUROSCI, V17, P7037; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; CONNORS BW, 1983, J NEUROSCI, V3, P773; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Duval N, 2002, J CELL SCI, V115, P3241; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304; GOODMAN CS, 1979, NATURE, V280, P208, DOI 10.1038/280208a0; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Iacobas DA, 2007, GENOMICS, V89, P113, DOI 10.1016/j.ygeno.2006.09.007; INGRAHAM CA, 1989, MOL CHEM NEUROPATHOL, V10, P1, DOI 10.1007/BF02969481; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kreuzberg MM, 2008, MOL CELL NEUROSCI, V37, P119, DOI 10.1016/j.mcn.2007.09.003; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MIENVILLE JM, 1994, DEV BRAIN RES, V77, P89, DOI 10.1016/0165-3806(94)90216-X; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; PEINADO A, 1993, CEREB CORTEX, V3, P488, DOI 10.1093/cercor/3.5.488; ROZENTAL R, 1995, DEV BIOL, V167, P350, DOI 10.1006/dbio.1995.1029; Rozental R, 1998, J NEUROSCI, V18, P1753; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Scemes E, 2003, J NEUROSCI, V23, P11444; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Scemes Eliana, 2009, P107, DOI 10.1007/978-0-387-79492-1_5; Shamekh R, 2006, EXP BRAIN RES, V170, P277, DOI 10.1007/s00221-005-0212-x; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Striedinger K, 2008, J NEUROIMMUNOL, V196, P116, DOI 10.1016/j.jneuroim.2008.03.014; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	49	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11836	11845		10.1074/jbc.M109.058750	http://dx.doi.org/10.1074/jbc.M109.058750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164188	Green Published, hybrid			2022-12-27	WOS:000276787100011
J	Soto, T; Villar-Tajadura, MA; Madrid, M; Vicente, J; Gacto, M; Perez, P; Cansado, J				Soto, Teresa; Antonia Villar-Tajadura, Maria; Madrid, Marisa; Vicente, Jero; Gacto, Mariano; Perez, Pilar; Cansado, Jose			Rga4 Modulates the Activity of the Fission Yeast Cell Integrity MAPK Pathway by Acting as a Rho2 GTPase-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; REGULATES MORPHOGENESIS; NUCLEOTIDE EXCHANGE; S-POMBE; KINASE; LOCALIZATION; STRESS; POLARITY; CDC42P; FAMILY	Rho GTPase-activating proteins ( GAPs) are responsible for the inactivation of Rho GTPases, which are involved in the regulation of critical biological responses in eukaryotic cells, ranging from cell cycle control to cellular morphogenesis. The genome of fission yeast Schizosaccharomyces pombe contains six genes coding for putative Rho GTPases, whereas nine genes code for predicted Rho GAPs (Rga1 to Rga9). One of them, Rga4, has been recently described as a Cdc42 GAP, involved in the control of cell diameter and symmetry in fission yeast. In this work we show that Rga4 is also a Rho2 GAP that negatively modulates the activity of the cell integrity pathway and its main effector, MAPK Pmk1. The DYRK-type protein kinase Pom1, which regulates both the localization and phosphorylation state of Rga4, is also a negative regulator of the Pmk1 pathway, but this control is not dependent upon the Rga4 role as a Rho2-GAP. Hence, two subsets of Rga4 negatively regulate Cdc42 and Rho2 functions in a specific and unrelated way. Finally, we show that Rga7, another Rho2 GAP, down-regulates the Pmk1 pathway in addition to Rga4. These results reinforce the notion of the existence of complex mechanisms determining the selectivity of Rho GAPs toward Rho GTPases and their functions.	[Soto, Teresa; Madrid, Marisa; Vicente, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Antonia Villar-Tajadura, Maria; Perez, Pilar] Univ Salamanca, CSIC, Dept Microbiol & Genet, Inst Microbiol Bioquim, Salamanca 30007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Gacto, M (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain.	maga@um.es; jcansado@um.es	Perez, Pilar/B-4948-2010; Madrid, Marisa/K-7755-2014; Madrid, Marisa/AAV-2154-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Pino, Teresa Soto/AAC-6096-2020	Perez, Pilar/0000-0003-3557-2247; Madrid, Marisa/0000-0002-7970-2587; Madrid, Marisa/0000-0002-7970-2587; Vicente-Soler, Jerónima/0000-0001-8759-6545; Cansado, Jose/0000-0002-2342-8152; Pino, Teresa Soto/0000-0003-2965-318X	Ministerio de Cienicia e Innovacion [BFU2007-60675, BFU2008-01653]; Junta de Castilla y Leon, Spain [GR231]; Fundacion Seneca (Region de Murcia), Spain [08725/PI/08]	Ministerio de Cienicia e Innovacion; Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Fundacion Seneca (Region de Murcia), Spain(Fundacion Seneca)	This work was supported by Grants BFU2007-60675 from Ministerio de Cienicia e Innovacion and GR231 from Junta de Castilla y Leon, Spain (to P. P.) and Grants BFU2008-01653 from Ministerio de Cienicia e Innovacion and 08725/PI/08 from Fundacion Seneca (Region de Murcia), Spain (to J.C.).	Alfa C., 1993, EXPT FISSION YEAST; Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Calonge TM, 2003, MOL MICROBIOL, V47, P507, DOI 10.1046/j.1365-2958.2003.03312.x; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Hirata D, 1998, J CELL SCI, V111, P149; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; Nakano K, 2001, GENES CELLS, V6, P1031, DOI 10.1046/j.1365-2443.2001.00485.x; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Schmidt A, 2002, MOL MICROBIOL, V45, P1433, DOI 10.1046/j.1365-2958.2002.03110.x; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toda T, 1996, MOL CELL BIOL, V16, P6752; Yang PR, 2003, J BIOL CHEM, V278, P48821, DOI 10.1074/jbc.M306819200; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11516	11525		10.1074/jbc.M109.071027	http://dx.doi.org/10.1074/jbc.M109.071027			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164182	hybrid, Green Published			2022-12-27	WOS:000276286200058
J	Vonlaufen, N; Naguleswaran, A; Coppens, I; Sullivan, WJ				Vonlaufen, Nathalie; Naguleswaran, Arunasalam; Coppens, Isabelle; Sullivan, William J., Jr.			MYST Family Lysine Acetyltransferase Facilitates Ataxia Telangiectasia Mutated (ATM) Kinase-mediated DNA Damage Response in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASES; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES ATM; PROTOZOAN; ACETYLATION; TIP60; PROTEIN; EXPRESSION; GENE; STABILITY	The MYST family of lysine acetyltransferases (KATs) function in a wide variety of cellular operations, including gene regulation and the DNA damage response. Here we report the characterization of the second MYST family KAT in the protozoan parasite Toxoplasma gondii (TgMYST-B). Toxoplasma causes birth defects and is an opportunistic pathogen in the immuno-compromised, the latter due to its ability to convert into a latent cyst (bradyzoite). We demonstrate that TgMYST-B can gain access to the parasite nucleus and acetylate histones. Overexpression of recombinant, tagged TgMYST-B reduces growth rate in vitro and confers protection from a DNA-alkylating agent. Expression of mutant TgMYST-B produced no growth defect and failed to protect against DNA damage. We demonstrate that cells overexpressing TgMYST-B have increased levels of ataxia telangiectasia mutated (ATM) kinase and phosphorylated H2AX and that TgMYST-B localizes to the ATM kinase gene. Pharmacological inhibitors of ATM kinase or KATs reverse the slow growth phenotype seen in parasites overexpressing TgMYST-B. These studies are the first to show that a MYST KAT contributes to ATM kinase gene expression, further illuminating the mechanism of how ATM kinase is up-regulated to respond to DNA damage.	[Vonlaufen, Nathalie; Naguleswaran, Arunasalam; Sullivan, William J., Jr.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sullivan, WJ (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS A-525, Indianapolis, IN 46202 USA.	wjsulliv@iupui.edu			National Institutes of Health, NIAID [R21AI083732]; American Heart Association [0725725Z]; Swiss National Foundation [PBBSA-115870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083732] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Award R21AI083732 (to W. J. S.). This work was also supported by American Heart Association Grant 0725725Z (to A. N.) and Swiss National Foundation Grant PBBSA-115870 (to N. V.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhatti MM, 2006, EUKARYOT CELL, V5, P62, DOI 10.1128/EC.5.1.62-76.2006; Bhatti MM, 2005, J BIOL CHEM, V280, P5902, DOI 10.1074/jbc.M410656200; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; CAPPAI R, 1992, MOL BIOCHEM PARASIT, V54, P117, DOI 10.1016/0166-6851(92)90103-Q; Costa JM, 2000, J CLIN MICROBIOL, V38, P2929, DOI 10.1128/JCM.38.8.2929-2932.2000; Dalmasso MC, 2009, J MOL BIOL, V392, P33, DOI 10.1016/j.jmb.2009.07.017; Decker PV, 2008, GENETICS, V178, P1209, DOI 10.1534/genetics.107.080135; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Escargueil AE, 2008, MUTAT RES-REV MUTAT, V658, P259, DOI 10.1016/j.mrrev.2008.01.004; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Ran QT, 2000, GENE, V258, P141, DOI 10.1016/S0378-1119(00)00410-8; Rios-Doria J, 2009, CANCER BIOL THER, V8, P422, DOI 10.4161/cbt.8.5.7592; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sullivan WJ, 2006, CELL MICROBIOL, V8, P1850, DOI 10.1111/j.1462-5822.2006.00818.x; Sullivan WJ, 2005, ANTIMICROB AGENTS CH, V49, P2172, DOI 10.1128/AAC.49.6.2172-2179.2005; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2007, MOL CELL BIOCHEM, V303, P1, DOI 10.1007/s11010-007-9449-y	32	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11154	11161		10.1074/jbc.M109.066134	http://dx.doi.org/10.1074/jbc.M109.066134			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159970	Green Published, hybrid			2022-12-27	WOS:000276286200020
J	Cao, AQ; Li, H; Zhou, Y; Wu, MH; Liu, JW				Cao, Aiqin; Li, Hai; Zhou, Yue; Wu, Minhao; Liu, Jingwen			Long Chain Acyl-CoA Synthetase-3 Is a Molecular Target for Peroxisome Proliferator-activated Receptor delta in HepG2 Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; 3T3-L1 ADIPOCYTES; LIPID-METABOLISM; ADIPOSE-TISSUE; EXPRESSION; GENE; DROPLETS; AGONIST; DIET	ACSL3 is a member of the long chain acyl-CoA synthetase (ACSL) family that plays key roles in fatty acid metabolism in various tissues in an isozyme-specific manner. Our previous studies showed that ACSL3 was transcriptionally up-regulated by the cytokine oncostatin M (OSM) in HepG2 cells, accompanied by reduced cellular triglyceride content and enhanced beta-oxidation. In this study, we investigated the molecular mechanism underlying the OSM-induced activation of ACSL3 gene transcription in HepG2 cells. We showed that OSM treatment resulted in a coordinated elevation of mRNA levels of ACSL3 and peroxisome proliferator-activated receptor delta (PPAR delta). The effect of OSM on ACSL3 mRNA expression was inhibited by cellular depletion of PPAR delta. By utilizing a PPAR delta agonist, L165041, we demonstrated that activation of PPAR delta led to increases in ACSL3 promoter activity, mRNA level, and protein level in HepG2 cells. Analysis of the ACSL3 promoter sequence identified two imperfect PPAR-responsive elements (PPRE) located in the ACSL3 promoter region -944 to -915, relative to the transcription start site. The up-regulation of ACSL3 promoter activity by PPAR delta was abolished by deletion of this PPRE-containing region or mutation to disrupt the binding sites. Direct interactions of PPAR delta with ACSL3-PPRE sequences were demonstrated by gel mobility shift and chromatin immunoprecipitation assays. Finally, we provided in vivo evidence showing that activation of PPAR delta by L165041 in hamsters increased ACSL3 mRNA and protein levels in the liver. These new findings define ACSL3 as a novel molecular target of PPAR delta in HepG2 cells and provide a regulatory mechanism for ACSL3 transcription in liver tissue.	[Cao, Aiqin; Li, Hai; Zhou, Yue; Wu, Minhao; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Wu, Minhao] Stanford Univ, Div Endocrinol, Dept Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Liu, JW (corresponding author), 3801 Miranda Ave, Palo Alto, CA 94304 USA.	jingwen.liu@va.gov			Department of Veterans Affairs (Office of Research and Development, Medical Research Service); National Center for Complementary and Alterative Medicine [1RO1 AT002543-01A1, 1R21AT003195-01A2]; NATIONAL CANCER INSTITUTE [R01CA127250] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); National Center for Complementary and Alterative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	The work was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and National Center for Complementary and Alterative Medicine Grants 1RO1 AT002543-01A1 and 1R21AT003195-01A2.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi KC, 2007, BIOCHEM BIOPH RES CO, V357, P62, DOI 10.1016/j.bbrc.2007.03.114; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197, DOI 10.1093/oxfordjournals.jbchem.a123737; Fujino T, 1997, J BIOCHEM-TOKYO, V122, P212; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Minekura H, 2001, GENE, V278, P185, DOI 10.1016/S0378-1119(01)00714-4; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; SCATENA R, 2008, B PPAR RES; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu MH, 2009, LIPIDS, V44, P989, DOI 10.1007/s11745-009-3341-3; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429	30	28	29	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16664	16674		10.1074/jbc.M110.112805	http://dx.doi.org/10.1074/jbc.M110.112805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308079	Green Published, hybrid			2022-12-27	WOS:000277982600030
J	Radichev, IA; Remacle, AG; Shiryaev, SA; Purves, AN; Johnson, SL; Pellecchia, M; Strongin, AY				Radichev, Ilian A.; Remacle, Albert G.; Shiryaev, Sergey A.; Purves, Angela N.; Johnson, Sherida L.; Pellecchia, Maurizio; Strongin, Alex Y.			Biochemical Characterization of the Cellular Glycosylphosphatidylinositol-linked Membrane Type-6 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-1-PROTEINASE INHIBITOR; PERICELLULAR PROTEOLYSIS; IV COLLAGENASE; CADHERIN SUPERFAMILY; TISSUE INHIBITORS; CATALYTIC DOMAIN; CANCER-CELLS; ACTIVATION; MT1-MMP; SURFACE	Ubiquitously expressed membrane type-1 matrix metalloproteinase (MT1-MMP), an archetype member of the MMP family, binds tissue inhibitor of metalloproteinases-2 (TIMP-2), activates matrix metalloproteinase-2 (MMP-2), and stimulates cell migration in various cell types. In contrast with MT1MMP, the structurally similar MT6-MMP associates with the lipid raft compartment of the plasma membrane using a GPI anchor. As a result, MT6-MMP is functionally distinct from MT1-MMP. MT6-MMP is insufficiently characterized as yet. In addition, a number of its biochemical features are both conflicting and controversial. To reassess the biochemical features of MT6-MMP, we have expressed theMT6-MMPconstruct tagged with a FLAG tag in breast carcinoma MCF-7 and fibrosarcoma HT1080 cells. Wethen used phosphatidylinositol-specific phospholipase C to release MT6-MMP from the cell surface and characterized the solubilized MT6-MMP fractions. We now are confident that cellular MT6-MMP partially exists in its complex with TIMP-2. Both TIMP-1 and TIMP-2 are capable of inhibiting the proteolytic activity of MT6-MMP. MT6-MMP does not stimulate cell migration. MT6-MMP, however, generates a significant level of gelatinolysis of the fluorescein isothiocyanate-labeled gelatin and exhibits an intrinsic, albeit low, ability to activate MMP-2. As a result, it is exceedingly difficult to record the activation of MMP-2 by cellular MT6-MMP. Because of its lipid raft localization, cellular MT6-MMP is inefficiently internalized. MT6-MMP is predominantly localized in the cell-to-cell junctions. Because MT6-MMP has been suggested to play a role in disease, including cancer and autoimmune multiple sclerosis, the identity of its physiologically relevant cleavage targets remains to be determined.	[Radichev, Ilian A.; Remacle, Albert G.; Shiryaev, Sergey A.; Purves, Angela N.; Johnson, Sherida L.; Pellecchia, Maurizio; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@burnham.org	Pellecchia, Maurizio/Y-7072-2018; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	Agrawal A, 2010, CHEMMEDCHEM, V5, P195, DOI 10.1002/cmdc.200900516; Angst BD, 2001, J CELL SCI, V114, P629; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BOOHER RN, 1987, J MED CHEM, V30, P580, DOI 10.1021/jm00386a023; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; HSIEH P, 1980, J CELL BIOL, V87, P14, DOI 10.1083/jcb.87.1.14; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Li W, 2004, CANCER RES, V64, P8657, DOI 10.1158/0008-5472.CAN-04-3019; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nie J, 2003, CANCER RES, V63, P6758; Nie J, 2007, J BIOL CHEM, V282, P6438, DOI 10.1074/jbc.M607337200; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Radichev IA, 2009, BIOCHEM J, V420, P37, DOI 10.1042/BJ20090082; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; SIRES UI, 1994, BIOCHEM BIOPH RES CO, V204, P613, DOI 10.1006/bbrc.1994.2503; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Velasco G, 2000, CANCER RES, V60, P877; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; ZHANG Z, 1994, BBA-GEN SUBJECTS, V1199, P224, DOI 10.1016/0304-4165(94)90119-8; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	52	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16076	16086		10.1074/jbc.M110.107094	http://dx.doi.org/10.1074/jbc.M110.107094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308072	Green Published, hybrid			2022-12-27	WOS:000277715900045
J	Yoneda, K; Demitsu, T; Nakai, K; Moriue, T; Ogawa, W; Igarashi, J; Kosaka, H; Kubota, Y				Yoneda, Kozo; Demitsu, Toshio; Nakai, Kozo; Moriue, Tetsuya; Ogawa, Wataru; Igarashi, Junsuke; Kosaka, Hiroaki; Kubota, Yasuo			Activation of Vascular Endothelial Growth Factor Receptor 2 in a Cellular Model of Loricrin Keratoderma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SYMMETRIC ERYTHROKERATODERMA; PHOSPHOINOSITIDE 3-KINASE; VOHWINKELS-KERATODERMA; 3T3-L1 ADIPOCYTES; MUTANT LORICRIN; MOLECULAR-BASIS; SKIN DISEASES; FACTOR VEGF; MUTATION; GENE	Loricrin is a major constituent of the epidermal cornified cell envelope. Recently, heterozygous loricrin gene mutations have been identified in two dominantly inherited skin diseases, Vohwinkel syndrome with ichthyosis and progressive symmetric erythrokeratoderma, collectively termed loricrin keratoderma. We generated stable HaCaT cell lines that express wildtype (WT) loricrin and a mutant form found in Vohwinkel syndrome with ichthyosis, using an ecdysone-inducible promoter system. The cells expressing the mutant loricrin grew more rapidly than those expressing WT loricrin after induction for 5 days. Confocal immunofluorescence microscopy revealed that phospho-Akt occurred in the nucleolus where the mutant loricrin was also located. The level of activity of Akt kinase was about nine times higher in cells with the mutant than in those with WT loricrin. ERK1/2, the epidermal growth factor receptor, vascular endothelial growth factor (VEGF) receptor 2 and Stat3 were all phosphorylated in cells with the mutant loricrin. The docking proteins, Gab1 and c-Cbl, were also tyrosine-phosphorylated in these cells. Furthermore, chromatin immunoprecipitation assays showed that Stat3 protein bound to the VEGF promoter in cells with the mutant. Thus, this study suggests that VEGF release and the subsequent activation of VEGF receptor 2 link loricrin gene mutations to rapid cell proliferation in a cellular model of loricrin keratoderma.	[Yoneda, Kozo; Nakai, Kozo; Moriue, Tetsuya; Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Kagawa 7610793, Japan; [Igarashi, Junsuke; Kosaka, Hiroaki] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa 7610793, Japan; [Demitsu, Toshio] Jichi Med Univ, Omiya Med Ctr, Dept Dermatol, Saitama 3308503, Japan; [Ogawa, Wataru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan	Kagawa University; Kagawa University; Jichi Medical University; Kobe University	Yoneda, K (corresponding author), Kagawa Univ, Fac Med, Dept Dermatol, Kagawa 7610793, Japan.	kyoneda@med.kagawa-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020		Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan	Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan	This work was supported by grants from the Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan.	Armstrong DKB, 1998, J INVEST DERMATOL, V111, P702, DOI 10.1046/j.1523-1747.1998.00343.x; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Cascio S, 2009, J CELL PHYSIOL, V221, P189, DOI 10.1002/jcp.21843; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Gedicke MM, 2006, BRIT J DERMATOL, V154, P167, DOI 10.1111/j.1365-2133.2005.06995.x; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Ishida-Yamamoto A, 1998, HISTOL HISTOPATHOL, V13, P819, DOI 10.14670/HH-13.819; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; Ishida-Yamamoto A, 2003, J DERMATOL SCI, V31, P3, DOI 10.1016/S0923-1811(02)00143-3; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V115, P1088, DOI 10.1046/j.1523-1747.2000.00163.x; IshidaYamamoto A, 1997, AM J HUM GENET, V61, P581, DOI 10.1086/515518; Kalinin A, 2001, J CELL SCI, V114, P3069; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Korge BP, 1997, J INVEST DERMATOL, V109, P604, DOI 10.1111/1523-1747.ep12337534; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Marchand-Adam S, 2005, AM J RESP CELL MOL, V32, P470, DOI 10.1165/rcmb.2004-0205OC; Matsumoto K, 2001, BRIT J DERMATOL, V145, P657, DOI 10.1046/j.1365-2133.2001.04412.x; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; O'Driscoll J, 2002, CLIN EXP DERMATOL, V27, P243, DOI 10.1046/j.1365-2230.2002.01031.x; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Piossek C, 1999, J BIOL CHEM, V274, P5612, DOI 10.1074/jbc.274.9.5612; Saez E, 2000, P NATL ACAD SCI USA, V97, P14512, DOI 10.1073/pnas.260499497; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Song S, 2008, BRIT J DERMATOL, V159, P714, DOI 10.1111/j.1365-2133.2008.08657.x; Suga Y, 2000, J CELL BIOL, V151, P401, DOI 10.1083/jcb.151.2.401; Suzuki A, 2003, CANCER RES, V63, P674; Takahashi H, 1999, J DERMATOL SCI, V19, P44, DOI 10.1016/S0923-1811(98)00049-8; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; YONEDA K, 1990, J INVEST DERMATOL, V94, P724, DOI 10.1111/1523-1747.ep12876298; Yoneda K, 2004, J BIOL CHEM, V279, P7296, DOI 10.1074/jbc.M307242200; YONEDA K, 1992, J BIOL CHEM, V267, P18060; YONEDA K, 1993, P NATL ACAD SCI USA, V90, P10754, DOI 10.1073/pnas.90.22.10754; Yoneda Kozo, 1992, Journal of Dermatology (Tokyo), V19, P761; Yoneda Kozo, 2004, Journal of Dermatological Science, V34, P124; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	40	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16184	16194		10.1074/jbc.M109.056424	http://dx.doi.org/10.1074/jbc.M109.056424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236940	Green Published, hybrid			2022-12-27	WOS:000277715900055
J	Cheng, ZJ; Singh, RD; Holicky, EL; Wheatley, CL; Marks, DL; Pagano, RE				Cheng, Zhi-Jie; Singh, Raman Deep; Holicky, Eileen L.; Wheatley, Christine L.; Marks, David L.; Pagano, Richard E.			Co-regulation of Caveolar and Cdc42-dependent Fluid Phase Endocytosis by Phosphocaveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; TYROSINE PHOSPHORYLATION; SRC KINASE; CELLS; MEMBRANE; DYNAMIN; INTERNALIZATION; ACTIVATION; PROTEIN; GLYCOSPHINGOLIPIDS	Several clathrin-independent endocytosis mechanisms have been identified that can be distinguished by specific requirements for certain proteins, such as caveolin-1 (Cav1) and the Rho GTPases, RhoA and Cdc42, as well as by specific cargo. Some endocytic pathways may be co-regulated such that disruption of one pathway leads to the up-regulation of another; however, the underlying mechanisms for this are unclear. Cav1 has been reported to function as a guanine nucleotide dissociation inhibitor (GDI), which inhibits Cdc42 activation. We tested the hypothesis that Cav1 can regulate Cdc42-dependent, fluid phase endocytosis. We demonstrate that Cav1 overexpression decreases fluid phase endocytosis, whereas silencing of Cav1 enhances this pathway. Enhancement of Cav1 phosphorylation using a phosphatase inhibitor reduces Cdc42-regulated pinocytosis while stimulating caveolar endocytosis. Fluid phase endocytosis was inhibited by expression of a putative phosphomimetic mutant, Cav1-Y14E, but not by the phospho-deficient mutant, Cav1-Y14F. Overexpression of Cav2, or a Cav1 mutant in which the GDI region was altered to the corresponding sequence in Cav2, did not suppress fluid phase endocytosis. These results suggest that the Cav1 expression level and phosphorylation state regulates fluid phase endocytosis via the interaction between the Cav1 GDI region and Cdc42. These data define a novel molecular mechanism for co-regulation of two distinct clathrin-independent endocytic pathways.	Mayo Clin, Coll Med, Thorac Dis Res Unit, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Pagano, RE (corresponding author), Stabile 8,200 1st St SW, Rochester, MN 55905 USA.	pagano.richard@mayo.edu	Takhter, Ramandeep/AAG-8977-2019	Takhter, Ramandeep/0000-0002-1441-2722	National Institutes of Health [GM22942]; USPHS; NIDDK, National Institutes of Health [F32-DK068985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK068985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022942, R37GM022942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM22942 from USPHS (to R. E. P.).; Supported by National Research Service Award F32-DK068985 from NIDDK, National Institutes of Health. Present address: Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711.	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peng FF, 2007, J AM SOC NEPHROL, V18, P189, DOI 10.1681/ASN.2006050498; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873	38	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15119	15125		10.1074/jbc.M109.069427	http://dx.doi.org/10.1074/jbc.M109.069427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228056	hybrid, Green Published			2022-12-27	WOS:000277399000033
J	Kilili, GK; Kyriakis, JM				Kilili, Geoffrey K.; Kyriakis, John M.			Mammalian Ste20-like Kinase (Mst2) Indirectly Supports Raf-1/ERK Pathway Activity via Maintenance of Protein Phosphatase-2A Catalytic Subunit Levels and Consequent Suppression of Inhibitory Raf-1 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-PROLIFERATION; B-RAF; APOPTOSIS; HIPPO; 2A; ACTIVATION; GROWTH; EXPRESSION; DROSOPHILA	Many tumor suppressor proteins act to blunt the effects of mitogenic signaling pathways. Loss of function mutations in the merlin tumor suppressor underlie neurofibromatosis type 2 (NF2), a familial autosomal dominant cancer syndrome. Studies of Drosophila suggest that Hippo (hpo) is required for inhibition of cell proliferation mediated by dMer, the orthologue of human merlin. Mammalian sterile 20-like kinase-2 (Mst2) is a mammalian Hpo orthologue, and numerous studies implicate Mst2 as a tumor suppressor. Mst2 is negatively regulated by the proto-oncoprotein Raf-1 in a manner independent of the kinase activity of Raf-1. We sought to determine whether, in mammalian cells, merlin could positively regulate Mst2. We also sought to determine whether Mst2, in addition to being negatively regulated by Raf-1, might itself reciprocally regulate Raf-1. In contrast to findings from Drosophila, we find no evidence that mammalian merlin positively regulates mammalian Mst2. Instead, surprisingly, RNA interference silencing of Mst2 leads to elevated inhibitory phosphorylation of Raf-1 at Ser-259 and impaired Raf-1 kinase activity. Consequent to this, ERK pathway activation and cell proliferation are attenuated. Phosphatase-2A (PP2A) dephosphorylates Raf-1 Ser-259 in response to mitogens. Interestingly RNA interference silencing of Mst2 triggers a striking proteasome-dependent decrease in the levels of the catalytic subunit of PP2A (PP2A-C). A similar effect is achieved upon silencing of large tumor suppressor (LATS)-1 and LATS2, direct substrates of Mst2. Our studies reveal a more complex role for Mst2 than previously thought. The Mst2 -> LATS1/2 pathway, by maintaining PP2A-C levels, may, in some situations, positively affect mitogenic signaling.	[Kyriakis, John M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Kyriakis, JM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	jkyriakis@tuftsmedicalcenter.org			National Institutes of Health [CA112399]; Tufts Medical Center; NATIONAL CANCER INSTITUTE [R01CA112399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112399 (to J. M. K.).; We thank Philip Tsichlis (Tufts Medical Center) for the akt2/3<SUP>-/-</SUP>; akt-1<SUP>flox/flox</SUP> cells, Andrea McClatchey (Massachusetts General Hospital) for merlin-expressing recombinant adenovirus, and Joseph Avruch (Massachusetts General Hospital) for the phospho-specific Mst2 antibody. We thank Michael Mendelsohn (Tufts Medical Center) for the Cre recombinase adenovirus and for continued support.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KING BL, 1992, AM J PATHOL, V140, P23; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lepont P, 2008, MUTAT RES-FUND MOL M, V637, P142, DOI 10.1016/j.mrfmmm.2007.07.015; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scoles DR, 2008, BBA-REV CANCER, V1785, P32, DOI 10.1016/j.bbcan.2007.10.001; Sun CX, 2002, HUM MOL GENET, V11, P3167, DOI 10.1093/hmg/11.25.3167; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	54	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15076	15087		10.1074/jbc.M109.078915	http://dx.doi.org/10.1074/jbc.M109.078915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20212043	hybrid, Green Published			2022-12-27	WOS:000277399000029
J	Torres-Altoro, MI; Kuntz, CP; Nichols, DE; Barker, EL				Torres-Altoro, Melissa I.; Kuntz, Charles P.; Nichols, David E.; Barker, Eric L.			Structural Analysis of the Extracellular Entrance to the Serotonin Transporter Permeation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITES; TRANSMEMBRANE DOMAIN; EXTERNAL LOOP; SUBSTRATE; DOPAMINE; RESIDUES; COCAINE; LEUT	Neurotransmitter transporters are responsible for removal of biogenic amine neurotransmitters after release into the synapse. These transporters are the targets for many clinically relevant drugs, such as antidepressants and psychostimulants. A high resolution crystal structure for the monoamine transporters has yet to be solved. We have developed a homology model for the serotonin transporter (SERT) based on the crystal structure of the leucine transporter (LeuT(Aa)) from Aquifex aeolicus. The objective of the present studies is to identify the structural determinants forming the entrance to the substrate permeation pathway based on predictions from the SERT homology model. Using the substituted cysteine accessibility method, we identified residues predicted to reside at the entrance to the substrate permeation pathway that were reactive with methanethiosulfonate (MTS) reagents. Of these residues, Gln(332) in transmembrane helix(TMH) VI was protected against MTS inactivation in the presence of serotonin. Surprisingly, the reactivity of Gln(332) to MTS reagents was enhanced in the presence of cocaine. Bifunctional MTS cross-linkers also were used to examine the distances between helices predicted to form the entrance into the substrate and ion permeation pathway. Our studies suggest that substrate and ligand binding may induce conformational shifts in TMHI and/or VI, providing new opportunities to refine existing homology models of SERT and related monoamine transporters.	[Torres-Altoro, Melissa I.; Kuntz, Charles P.; Nichols, David E.; Barker, Eric L.] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Barker, EL (corresponding author), 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	barkerel@purdue.edu		Torres-Altoro, Melissa/0000-0002-2574-2356	National Institutes of Health [DA018682]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA018682 (to E. L. B. and D. E. N.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ravna AW, 2006, BIOORG MED CHEM LETT, V16, P5594, DOI 10.1016/j.bmcl.2006.08.028; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres-Altoro MI, 2008, PROTEIN SCI, V17, P1761, DOI 10.1110/ps.036749.108; WANG JB, 1995, J NEUROCHEM, V64, P1416; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231	32	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15369	15379		10.1074/jbc.M109.088138	http://dx.doi.org/10.1074/jbc.M109.088138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304925	Green Published, hybrid			2022-12-27	WOS:000277399000057
J	Zhang, Y; Liu, R; Ni, M; Gill, P; Lee, AS				Zhang, Yi; Liu, Ren; Ni, Min; Gill, Parkash; Lee, Amy S.			Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; DRUG-RESISTANCE; ER CHAPERONE; STRESS; ACTIVATION; RECEPTOR; BINDING; EXPRESSION	The recent discovery that GRP78/BiP, a typical endoplasmic reticulum (ER) lumenal chaperone, can be expressed on the cell surface, interacting with an increasing repertoire of surface proteins and acting as receptor in signaling pathways, represents a paradigm shift in its biological function. However, the mechanism of GRP78 trafficking from the ER to the cell surface is not well understood. Using a combination of cellular, biochemical, and mutational approaches, we tested multiple hypotheses. Here we report that ER stress actively promotes GRP78 localization on the cell surface, whereas ectopic expression of GRP78 is also able to cause cell surface relocation in the absence of ER stress. Moreover, deletion of the C-terminal ER retention motif in GRP78 alters its cell surface presentation in a dose-dependent manner; however, mutation of the putative O-linked glycosylation site Thr(648) of human GRP78 is without effect. We also identified the exposure of multiple domains of GRP78 on the cell surface and determined that binding of extracellular GRP78 to the cell surface is unlikely. Anew topology model for cell surface GRP78 is presented.	[Zhang, Yi; Ni, Min; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Liu, Ren; Gill, Parkash] Univ So Calif, Keck Sch Med, Dept Pathol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607, CA111700]; NATIONAL CANCER INSTITUTE [R01CA027607, R01CA111700, R37CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027607 and CA111700 (to A. S. L.).	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Jakobsen CG, 2007, CANCER RES, V67, P9507, DOI 10.1158/0008-5472.CAN-06-4686; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2009, CANCER BIOL THER, V8, P2103, DOI 10.4161/cbt.8.22.10140; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liu C, 2003, AM J PATHOL, V163, P1859, DOI 10.1016/S0002-9440(10)63545-6; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Matsumoto A, 2000, CANCER RES, V60, P3921; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]	41	225	243	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15065	15075		10.1074/jbc.M109.087445	http://dx.doi.org/10.1074/jbc.M109.087445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20208072	Green Published, hybrid			2022-12-27	WOS:000277399000028
J	Gordon, PM; Fisher, DE				Gordon, Peter M.; Fisher, David E.			Role for the Proapoptotic Factor BIM in Mediating Imatinib-induced Apoptosis in a c-KIT-dependent Gastrointestinal Stromal Tumor Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY; MESSENGER-RNA; PROTEIN BIM; SURVIVAL; PHOSPHORYLATION; INACTIVATION; INHIBITION; MECHANISMS; PROMOTES; CANCER	The c-KIT receptor tyrosine kinase is constitutively activated and oncogenic in the majority of gastrointestinal stromal tumors. The identification of selective inhibitors of c-KIT, such as imatinib, has provided a novel therapeutic approach in the treatment of this chemotherapy refractory tumor. However, despite the clinical importance of these findings and the potential it provides as a model system for understanding targeted therapy, this approach has not yielded curative outcomes in most patients, and the biochemical pathways connecting c-KIT inhibition to cell death are not completely understood. Here, we show that inhibition of c-KIT with imatinib in gastrointestinal stromal tumors (GISTs) triggered the up-regulation of the proapoptotic protein BIM via both transcriptional and post-translational mechanisms. The inhibition of c-KIT by imatinib increased levels of the dephosphorylated and deubiquitinated form of BIM as well as triggered the accumulation of the transcription factor FOXO3a on the BIM promoter to activate transcription of BIM mRNA. Furthermore, using RNA interference directed against BIM, we demonstrated that BIM knockdown attenuated the effects of imatinib, suggesting that BIM functionally contributes to imatinib-induced apoptosis in GIST. The identification and characterization of the pathways that mediate imatinib-induced cell death in GIST provide for a better understanding of targeted therapy and may facilitate the development of new therapeutic approaches to further exploit these pathways.	[Gordon, Peter M.; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Gordon, Peter M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Gordon, Peter M.] Childrens Hosp Boston, Boston, MA 02115 USA; [Gordon, Peter M.; Fisher, David E.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 55 Fruit St, Boston, MA 02114 USA.	dfisher3@partners.org			National Institutes of Health [AR043369-14]; Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR043369-14. This work was also supported by the Melanoma Research Alliance (to D. E. F.).	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Bauer S, 2010, CANCER RES, V70, P150, DOI 10.1158/0008-5472.CAN-09-1449; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Duensing A, 2004, CANCER INVEST, V22, P106, DOI 10.1081/CNV-120027585; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Liu Y, 2008, CANCER RES, V68, P9015, DOI 10.1158/0008-5472.CAN-08-1935; Liu Y, 2007, CANCER RES, V67, P2685, DOI 10.1158/0008-5472.CAN-06-3497; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Miselli F, 2008, TRANSL ONCOL, V1, P177, DOI 10.1593/tlo.08157; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quek R, 2009, HEMATOL ONCOL CLIN N, V23, P69, DOI 10.1016/j.hoc.2008.11.006; Sambol EB, 2006, CANCER RES, V66, P5858, DOI 10.1158/0008-5472.CAN-05-2933; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0	36	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14109	14114		10.1074/jbc.M109.078592	http://dx.doi.org/10.1074/jbc.M109.078592			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231287	Green Published, hybrid			2022-12-27	WOS:000277299700006
J	Legleiter, J; Mitchell, E; Lotz, GP; Sapp, E; Ng, C; DiFiglia, M; Thompson, LM; Muchowski, PJ				Legleiter, Justin; Mitchell, Emily; Lotz, Gregor P.; Sapp, Ellen; Ng, Cheping; DiFiglia, Marian; Thompson, Leslie M.; Muchowski, Paul J.			Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; NEURONAL INTRANUCLEAR INCLUSIONS; AMYLOID-LIKE FIBRILS; AGGREGATION NUCLEATION; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; DISEASE PATHOLOGY; PROTEIN CONTEXT; SHEET FORMATION; MOUSE MODEL	Huntington disease (HD) is caused by an expansion of more than 35-40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein, resulting in accumulation of inclusion bodies containing fibrillar deposits of mutant htt fragments. Intriguingly, polyQ length is directly proportional to the propensity for htt to form fibrils and the severity of HD and is inversely correlated with age of onset. Although the structural basis for htt toxicity is unclear, the formation, abundance, and/or persistence of toxic conformers mediating neuronal dysfunction and degeneration in HD must also depend on polyQ length. Here we used atomic force microscopy to demonstrate mutant htt fragments and synthetic polyQ peptides form oligomers in a polyQ length-dependent manner. By time-lapse atomic force microscopy, oligomers form before fibrils, are transient in nature, and are occasionally direct precursors to fibrils. However, the vast majority of fibrils appear to form by monomer addition coinciding with the disappearance of oligomers. Thus, oligomers must undergo a major structural transition preceding fibril formation. In an immortalized striatal cell line and in brain homogenates from a mouse model of HD, a mutant htt fragment formed oligomers in a polyQ length-dependent manner that were similar in size to those formed in vitro, although these structures accumulated over time in vivo. Finally, using immunoelectron microscopy, we detected oligomeric-like structures in human HD brains. These results demonstrate that oligomer formation by a mutant htt fragment is strongly polyQ length-dependent in vitro and in vivo, consistent with a causative role for these structures, or subsets of these structures, in HD pathogenesis.	[Legleiter, Justin; Lotz, Gregor P.; Ng, Cheping; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Legleiter, Justin; Lotz, Gregor P.; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif Irvine, Taube Koret Ctr Huntingtons Dis Res, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Sapp, Ellen; DiFiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02114 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019	Sontag, Emily/0000-0003-3068-6253; Lotz, Gregor/0000-0002-0231-5503; Legleiter, Justin/0000-0002-5262-1867	National Institutes of Health [R01NS054753, R01NS047237]; Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054753, R01NS047237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054753 and R01NS047237.; Supported by a post-doctoral fellowship from the Hereditary Disease Foundation. Present address: The C. Eugene Bennett Dept. of Chemistry, WV University, Morgantown, WV 26505.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; CUMMINGS DM, 2008, SOC NEUR ABSTR, V34; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Miller J, 2009, STRUCTURE, V17, P1151, DOI 10.1016/j.str.2009.08.004; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Starling AJ, 2005, J NEUROSCI RES, V82, P377, DOI 10.1002/jnr.20651; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wong SLA, 2008, FASEB J, V22, P3348, DOI 10.1096/fj.07-103887; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	58	148	149	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14777	14790		10.1074/jbc.M109.093708	http://dx.doi.org/10.1074/jbc.M109.093708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220138	Green Published, hybrid			2022-12-27	WOS:000277299700075
J	Tallant, C; Garcia-Castellanos, R; Baumann, U; Gomis-Ruth, FX				Tallant, Cynthia; Garcia-Castellanos, Raquel; Baumann, Ulrich; Xavier Gomis-Rueth, F.			On the Relevance of the Met-turn Methionine in Metzincins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INTEGRITY; FAMILY; METALLOPROTEASE; SERRALYSINS; GELATINASE; EXPRESSION; PROTEINS; ASTACINS; ULILYSIN; SEQUENCE	The metzincins are a clan of metallopeptidases consisting of families that share a series of structural elements. Among them is the Met-turn, a tight 1,4-turn found directly below the zinc-binding site, which is structurally and spatially conserved and invariantly shows a methionine at position 3 in all metzincins identified. The reason for this conservation has been a matter of debate since its discovery. We have studied this structural element in Methanosarcina acetivorans ulilysin, the structural prototype of the pappalysin family, by generating 10 mutants that replaced methionine with proteogenic amino acids. We compared recombinant overexpression yields, autolytic and tryptic activation, proteolytic activity, thermal stability, and three-dimensional structure with those of the wild type. All forms were soluble and could be purified, although with varying yields, and three variants underwent autolysis, could be activated by trypsin, and displayed significant proteolytic activity. All variants were analyzed for the thermal stability of their zymogens. None of the mutants analyzed proved more stable or active than the wild type. Both bulky and small side chains, as well as hydrophilic ones, showed diminished thermal stability. Two mutants, leucine and cysteine, crystallized and showed three-dimensional structures that were indistinguishable from the wild type. These studies reveal that the Met-turn acts as a plug that snugly inserts laterally into a core structure created by the protein segment engaged in zinc binding and thus contributes to its structural integrity, which is indispensable for function. Replacement of the methionine with residues that deviate in size, side-chain conformation, and chemical properties impairs the plug-core interaction and prejudices molecular stability and activity.	[Tallant, Cynthia; Garcia-Castellanos, Raquel; Baumann, Ulrich; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es	Baumann, Ulrich/B-1220-2013	Tallant, Cynthia/0000-0001-5645-435X; Garcia-Castellanos, Raquel/0000-0001-6225-5373; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	Swiss National Science Foundation; ESRF; European Union;  [SAB2002-0102];  [BIO2009-10336];  [BIO2008-04080-E];  [2009SGR1036];  [PSE-010000-2009-8];  [CSD2006-00015]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ESRF; European Union(European Commission); ; ; ; ; ; 	This work was supported by grants and fellowships from European, Catalan, and Spanish public agencies: SAB2002-0102, BIO2009-10336, BIO2008-04080-E, 2009SGR1036, PSE-010000-2009-8, CSD2006-00015, FP7 Strep Project 223101 "AntiPathoGN." This work was also supported by the Swiss National Science Foundation. Funding for x-ray diffraction data collection at European Synchrotron Radiation Facility (ESRF) synchrotron was provided by ESRF and the European Union.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chun YJ, 1998, ARCH PHARM RES, V21, P305, DOI 10.1007/BF02975292; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans P. R., 1993, DATA COLLECTION PROC, P114; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Garcia-Castellanos R, 2007, ARCH BIOCHEM BIOPHYS, V457, P57, DOI 10.1016/j.abb.2006.10.004; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurisu G, 1997, J BIOCHEM, V121, P304; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oberholzer AE, 2009, BIOL CHEM, V390, P875, DOI 10.1515/BC.2009.100; Perez L, 2007, BIOCHEM CELL BIOL, V85, P141, DOI 10.1139/O06-179; Pieper M, 1997, J PROTEIN CHEM, V16, P637, DOI 10.1023/A:1026327125333; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHEEF ED, 2003, STRUCTURAL BIOINFORM, P15; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2007, BIOL CHEM, V388, P1243, DOI 10.1515/BC.2007.143; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Walasek Paula, 2005, BMC Biochem, V6, P21, DOI 10.1186/1471-2091-6-21; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zappacosta F, 1996, PROTEIN SCI, V5, P802, DOI 10.1002/pro.5560050502	33	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13951	13957		10.1074/jbc.M109.083378	http://dx.doi.org/10.1074/jbc.M109.083378			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202937	Green Published, hybrid			2022-12-27	WOS:000276987700069
J	Han, Y; Huang, C; Sun, XX; Xiang, BG; Wang, M; Yeh, ETH; Chen, YY; Li, H; Shi, GY; Cang, H; Sun, YP; Wang, J; Wang, W; Gao, F; Yi, J				Han, Yan; Huang, Chao; Sun, Xuxu; Xiang, Binggang; Wang, Ming; Yeh, Edward T. H.; Chen, Yuying; Li, Hui; Shi, Guiying; Cang, Hui; Sun, Yueping; Wang, Jian; Wang, Wei; Gao, Fei; Yi, Jing			SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; NF-KAPPA-B; PROTEIN SUMOYLATION; TYROSINE KINASES; CEREBRAL-ISCHEMIA; BODY FORMATION; CANCER; ACTIVATION; SENP3; ND10	Small ubiquitin-like modifier (SUMO) 2/3 is known to conjugate to substrates in response to a variety of cellular stresses. However, whether and how SUMO2/3-specific proteases are involved in de-conjugation under cell stress is unclear. Here, we show that low doses of hydrogen peroxide (H2O2) induce an increase of the SENP3 protein, which removes SUMO2/3 from promyelocytic leukemia (PML). Low dose H2O2 causes SENP3 to co-localize with PML bodies and reduces the number of PML bodies in a SENP3-dependent manner. Furthermore, de-conjugation of SUMO2/3 from PML is responsible for the accelerated cell proliferation caused by low dose H2O2. Knocking down PML promotes basal cell proliferation as expected. This can be reversed by reconstitution with wild-type PML but not its mutant lacking SUMOylation, indicating that only the SUMOylated PML can play an inhibitory role for cell proliferation. Thus, SENP3 appears to be a key mediator in mild oxidative stress-induced cell proliferation via regulation of the SUMOylation status of PML. Furthermore, SENP3 is over-accumulated in a variety of primary human cancers including colon adenocarcinoma in which PML is hypo-SUMOylated. These results reveal an important role of SENP3 and the SUMOylation status of PML in the regulation of cell proliferation under oxidative stress.	[Han, Yan; Huang, Chao; Sun, Xuxu; Xiang, Binggang; Wang, Ming; Chen, Yuying; Li, Hui; Shi, Guiying; Cang, Hui; Sun, Yueping; Gao, Fei; Yi, Jing] Shanghai Jiao Tong Univ, Sch Med, Dept Cell Biol,Inst Med Sci, Key Lab Educ Minist Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Wang, Jian; Wang, Wei] Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Ren Ji Hosp, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Yi, J (corresponding author), 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	yijing@shsmu.edu.cn	Xiang, Binggang/N-6494-2013	huang, chao/0000-0002-4913-921X; Wang, Jian/0000-0002-5335-8845	National Natural Science Foundation of China [30971437]; Ministry of Science and Technology of China [2006CB910104]; Shanghai Municipal Science and Technology Commission [08JC1413800]; Shanghai Municipal Education Commission [J50201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the National Natural Science Foundation of China (30971437), the Ministry of Science and Technology of China (2006CB910104), Shanghai Municipal Science and Technology Commission (08JC1413800), and Shanghai Municipal Education Commission (J50201).	Beech SJ, 2005, EXP CELL RES, V307, P109, DOI 10.1016/j.yexcr.2005.03.012; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; BIANCHINI L, 1993, J BIOL CHEM, V268, P3357; Boddy MN, 1996, ONCOGENE, V13, P971; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Ding XJ, 2008, ONCOL REP, V20, P1041, DOI 10.3892/or_00000107; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Galaris D, 2008, CANCER LETT, V266, P21, DOI 10.1016/j.canlet.2008.02.038; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kamei H, 1997, EXP CELL RES, V237, P207, DOI 10.1006/excr.1997.3790; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kuo ML, 2008, CELL CYCLE, V7, P3378, DOI 10.4161/cc.7.21.6930; Laviano A, 2007, CURR OPIN CLIN NUTR, V10, P449, DOI 10.1097/MCO.0b013e328122db94; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; MESSINA MJ, 1991, FREE RADICAL BIO MED, V10, P175, DOI 10.1016/0891-5849(91)90072-B; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Natarajan R, 2002, FREE RADICAL BIO MED, V33, P962, DOI 10.1016/S0891-5849(02)00990-5; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Wang RY, 2009, ANAT REC, V292, P777, DOI 10.1002/ar.20904; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	55	81	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12906	12915		10.1074/jbc.M109.071431	http://dx.doi.org/10.1074/jbc.M109.071431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181954	Green Published, hybrid			2022-12-27	WOS:000276787800049
J	Li, YJ; Xu, FFL; Lu, J; Saunders, WS; Prochownik, EV				Li, Youjun; Xu, Fengfeng L.; Lu, Jie; Saunders, William S.; Prochownik, Edward V.			Widespread Genomic Instability Mediated by a Pathway Involving Glycoprotein Ib alpha and Aurora B Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; C-MYC TARGET; DNA-DAMAGE; CHROMOSOME SEGREGATION; PROMOTES TUMORIGENESIS; ENDOPLASMIC-RETICULUM; CELL-DIVISION; IN-VITRO; CYTOKINESIS; REPAIR	c-Myc (Myc) oncoprotein induction of genomic instability (GI) contributes to its initial transforming function and subsequent tumor cell evolution. We describe here a pathway by which Myc, via its target protein glycoprotein Ib alpha (GpIb alpha), mediates GI. Proteomic profiling revealed that the serine/threonine kinase Aurora B is down-regulated by GpIb alpha in p53-deficient primary human fibroblasts. The phenotypes of Aurora B deficiency are strikingly reminiscent of Myc or GpIb alpha overexpression and include double-stranded DNA breaks, altered nuclear size and morphology, chromatin bridges, cleavage furrow regression, and tetraploidy. During mitosis, GpIb alpha and Aurora B redistribute to the cleavage furrow along with other cleavage furrow proteins. GpIb alpha overexpression at levels comparable with those seen in some tumor cells causes the dispersal of these proteins but not Aurora B, resulting in furrow regression and cytokinesis failure. Aurora B normalization redirects the mislocalized furrow proteins to their proper location, corrects the cleavage furrow abnormalities, and restores genomic stability. Aurora B thus appears necessary for a previously unrecognized function in guiding and positioning a number of key proteins, including GpIb alpha to the cleavage furrow. These findings underscore the importance of maintaining a delicate balance among cleavage furrow-associated proteins during mitosis. Suppression of Aurora B via GpIb alpha provides a unifying and mechanistic explanation for several types of Myc-mediated GI.	Univ Pittsburgh, Hematol Oncol Sect, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15201 USA; [Xu, Fengfeng L.; Saunders, William S.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15201 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15201 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Hematol Oncol Sect, Res Ctr, Rm 5124,530 45th St, Pittsburgh, PA 15201 USA.	prochownikev@upmc.edu			National Institutes of Health [RO1 CA105033, ROI DE 016086]; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA105033 (to E. V. P.) and ROI DE 016086 (to W. S. S.).	Acilan C, 2007, GENE CHROMOSOME CANC, V46, P522, DOI 10.1002/gcc.20425; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eilers M, 1999, MOL CELLS, V9, P1; Engels WR, 2007, CELL CYCLE, V6, P131, DOI 10.4161/cc.6.2.3758; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kuo LJ, 2008, IN VIVO, V22, P305; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Li YJ, 2009, J BIOL CHEM, V284, P1410, DOI 10.1074/jbc.M806222200; Lopez J A, 1997, Curr Opin Hematol, V4, P323; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mendoza M, 2008, BIOCHEM SOC T, V36, P387, DOI 10.1042/BST0360387; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Natarajan AT, 2008, MUTAT RES-GEN TOX EN, V657, P3, DOI 10.1016/j.mrgentox.2008.08.017; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsuno T, 2007, J NEURO-ONCOL, V83, P249, DOI 10.1007/s11060-007-9335-1; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Zhou ZQ, 2001, TRENDS CELL BIOL, V11, pS10, DOI 10.1016/S0962-8924(01)02121-3	75	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13183	13192		10.1074/jbc.M109.084913	http://dx.doi.org/10.1074/jbc.M109.084913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157117	Green Published, hybrid			2022-12-27	WOS:000276787800073
J	Sobczak, K; Michlewski, G; de Mezer, M; Kierzek, E; Krol, J; Olejniczak, M; Kierzek, R; Krzyzosiak, WJ				Sobczak, Krzysztof; Michlewski, Gracjan; de Mezer, Mateusz; Kierzek, Elzbieta; Krol, Jacek; Olejniczak, Marta; Kierzek, Ryszard; Krzyzosiak, Wlodzimierz J.			Structural Diversity of Triplet Repeat RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO TRANSLATION; TRINUCLEOTIDE REPEATS; G-QUADRUPLEX; CAG REPEATS; MYOTONIC-DYSTROPHY; MESSENGER-RNA; CUG REPEATS; FORM; DNA; GENE	Tandem repeats of various trinucleotide motifs are present in the human transcriptome, but the functions of these regular sequences, which likely depend on the structures they form, are still poorly understood. To gain new insight into the structural and functional properties of triplet repeats in RNA, we have performed a biochemical structural analysis of the complete set of triplet repeat transcripts, each composed of a single sequence repeated 17 times. We show that these transcripts fall into four structural classes. The repeated CAA, UUG, AAG, CUU, CCU, CCA, and UAA motifs did not form any higher order structure under any analyzed conditions. The CAU, CUA, UUA, AUG, and UAG repeats are ordered according to their increasing tendency to form semistable hairpins. The repeated CGA, CGU, and all CNG motifs form fairly stable hairpins, whereas AGG and UGG repeats fold into stable G-quadruplexes. The triplet a repeats that formed the most stable structures were characterized further by biophysical methods. UV-monitored structure melting revealed that CGG and CCG repeats form, respectively, the most and least stable hairpins of all CNG repeats. Circular dichroism spectra showed that the AGG and UGG repeat quadruplexes are formed by parallel RNA strands. Furthermore, we demonstrated that the different susceptibility of various triplet repeat transcripts to serum nucleases can be explained by the sequence and structural features of the tested RNAs. The results of this study provide a comprehensive structural foundation for the functional analysis of triplet repeats in transcripts.	[Sobczak, Krzysztof; Michlewski, Gracjan; de Mezer, Mateusz; Krol, Jacek; Olejniczak, Marta; Krzyzosiak, Wlodzimierz J.] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, PL-61704 Poznan, Poland; [Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Lab RNA Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Krzyzosiak, WJ (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Noskowskiego 12-14 St, PL-61704 Poznan, Poland.	wlodkrzy@ibch.poznan.pl	Olejniczak, Marta/W-2610-2018; de Mezer, Mateusz/B-2060-2012; Olejniczak, Marta/AAU-5704-2020; Michlewski, Gracjan/J-1264-2019; de Mezer, Mateusz/GQP-6125-2022	Olejniczak, Marta/0000-0001-8471-6302; Olejniczak, Marta/0000-0001-8471-6302; Michlewski, Gracjan/0000-0002-7409-9619; de Mezer, Mateusz/0000-0003-4718-9747; Sobczak, Krzysztof/0000-0001-8352-9812; Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X	European Union [LSHB-CT-2004- 005276]; Ministry of Science and Higher Education [PBZ-MNil-2/1/2005, N301-112-32/3910, N302 278937, N N301 284837]; Operational Programme "Innovative economy" [POIG.01.03.01-00-098/08]	European Union(European Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Operational Programme "Innovative economy"	This work was supported by grants from the Sixth Research Framework Programme of the European Union, Project RIGHT (Grant LSHB-CT-2004- 005276) and the Ministry of Science and Higher Education, Grants PBZ-MNil-2/1/2005, N301-112-32/3910, N302 278937, and N N301 284837, and Operational Programme "Innovative economy" Grant POIG.01.03.01-00-098/08.	Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GIEGE R, 2001, RNA, P71; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Krzyzosiak W.J., 2006, GENETIC INSTABILITIE, P705; KRZYZOSIAK WJ, 1988, BIOCHEMISTRY-US, V27, P5771, DOI 10.1021/bi00415a056; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lee MM, 2009, J AM CHEM SOC, V131, P17464, DOI 10.1021/ja906877y; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Matsugami A, 2001, J MOL BIOL, V313, P255, DOI 10.1006/jmbi.2001.5047; MATSUGAMI A, 2008, NUCL ACIDS S SER, V52, P179; MATSUGAMI A, 2002, NUCLEIC ACIDS RES, V2, P49; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Napierala M, 2005, NUCLEIC ACIDS RES, V33, P451, DOI 10.1093/nar/gki186; Nishikawa F, 2009, OLIGONUCLEOTIDES, V19, P179, DOI 10.1089/oli.2008.0167; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Qiu L, 1998, MOL GEN GENET, V258, P352, DOI 10.1007/s004380050741; Rozanska M, 2007, HUM MUTAT, V28, P451, DOI 10.1002/humu.20466; SHIDA T, 1997, NUCL ACIDS S SER, V37, P129; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Vieregg J, 2007, J AM CHEM SOC, V129, P14966, DOI 10.1021/ja074809o; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	61	90	91	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12755	12764		10.1074/jbc.M109.078790	http://dx.doi.org/10.1074/jbc.M109.078790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159983	Green Published, hybrid			2022-12-27	WOS:000276787800034
J	Mora-Montes, HM; Bates, S; Netea, MG; Castillo, L; Brand, A; Buurman, ET; Diaz-Jimenez, DF; Kullberg, BJ; Brown, AJP; Odds, FC; Gow, NAR				Mora-Montes, Hector M.; Bates, Steven; Netea, Mihai G.; Castillo, Luis; Brand, Alexandra; Buurman, Ed T.; Diaz-Jimenez, Diana F.; Kullberg, Bart Jan; Brown, Alistair J. P.; Odds, Frank C.; Gow, Neil A. R.			A Multifunctional Mannosyltransferase Family in Candida albicans Determines Cell Wall Mannan Structure and Host-Fungus Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN MANNOSYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; MANNOSYLPHOSPHATE TRANSFER; ANTIFUNGAL RESISTANCE; IMMUNE RECOGNITION; MOLECULAR ANALYSIS; SEROTYPE-B; VIRULENCE; GLYCOSYLATION	The cellwall proteins of fungi are modified by N- and O-linked mannosylation and phosphomannosylation, resulting in changes to the physical and immunological properties of the cell. Glycosylation of cell wall proteins involves the activities of families of endoplasmic reticulum and Golgi-located glycosyl transferases whose activities are difficult to infer through bioinformatics. The Candida albicans MNT1/KRE2 mannosyl transferase family is represented by five members. We showed previously that Mnt1 and Mnt2 are involved in O-linked mannosylation and are required for virulence. Here, the role of C. albicans MNT3, MNT4, and MNT5 was determined by generating single andmultiple MnT Delta null mutants and by functional complementation experiments in Saccharomyces cerevisiae. CaMnt3, CaMnt4, and CaMnt5 did not participate in O-linked mannosylation, but CaMnt3 and CaMnt5 had redundant activities in phosphomannosylation and were responsible for attachment of approximately half of the phosphomannan attached to N-linked mannans. CaMnt4 and CaMnt5 participated in N-mannan branching. Deletion of CaMNT3, CaMNT4, and CaMNT5 affected the growth rate and virulence of C. albicans, affected the recognition of the yeast by human monocytes and cytokine stimulation, and led to increased cell wall chitin content and exposure of beta-glucan at the cell wall surface. Therefore, the MNT1/KRE2 gene family participates in three types of protein mannosylation in C. albicans, and these modifications play vital roles in fungal cell wall structure and cell surface recognition by the innate immune system.	[Mora-Montes, Hector M.; Bates, Steven; Castillo, Luis; Brand, Alexandra; Buurman, Ed T.; Brown, Alistair J. P.; Odds, Frank C.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Netea, Mihai G.; Kullberg, Bart Jan] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Diaz-Jimenez, Diana F.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato 6000, Mexico	University of Aberdeen; Radboud University Nijmegen; Universidad de Guanajuato	Gow, NAR (corresponding author), Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	n.gow@abdn.ac.uk	GOW, Neil/AAS-5323-2021; Kullberg, BJ/C-8520-2013; Netea, Mihai/N-5155-2014; Montes, Hector Manuel Mora/H-1729-2014; Brown, Alistair J.P./B-6627-2014; Brand, Alexandra/P-7493-2018	GOW, Neil/0000-0002-2776-5850; Kullberg, BJ/0000-0002-6813-8167; Montes, Hector Manuel Mora/0000-0001-6973-0595; Brown, Alistair JP/0000-0003-1406-4251; Bates, Steven/0000-0003-0489-5705; Brand, Alexandra/0000-0002-7381-131X	Wellcome Trust [080088]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 080088 (to N.A.R.G., A.J.P.B., and F.C.O.).	Bai C, 2006, EUKARYOT CELL, V5, P238, DOI 10.1128/EC.5.2.238-247.2006; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Buurman ET, 1998, P NATL ACAD SCI USA, V95, P7670, DOI 10.1073/pnas.95.13.7670; Calderone Richard A., 1993, Trends in Microbiology, V1, P55, DOI 10.1016/0966-842X(93)90033-N; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; de Nobel H, 2000, TRENDS MICROBIOL, V8, P344, DOI 10.1016/S0966-842X(00)01805-9; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; FONZI WA, 1993, GENETICS, V134, P717; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakayama K, 1998, BBA-GEN SUBJECTS, V1425, P255, DOI 10.1016/S0304-4165(98)00078-6; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; SHIBATA N, 1992, INFECT IMMUN, V60, P4100, DOI 10.1128/IAI.60.10.4100-4110.1992; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Southard SB, 1999, J BACTERIOL, V181, P7439, DOI 10.1128/JB.181.24.7439-7448.1999; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Thomson LM, 2000, J BIOL CHEM, V275, P18933, DOI 10.1074/jbc.M909699199; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; Trinel PA, 1997, FEBS LETT, V416, P203, DOI 10.1016/S0014-5793(97)01205-2; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Wang YY, 1998, INFECT IMMUN, V66, P1384, DOI 10.1128/IAI.66.4.1384-1391.1998; Warit S, 2000, MOL MICROBIOL, V36, P1156, DOI 10.1046/j.1365-2958.2000.01944.x; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M	46	88	94	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12087	12095		10.1074/jbc.M109.081513	http://dx.doi.org/10.1074/jbc.M109.081513			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164191	Green Published, hybrid			2022-12-27	WOS:000276787100038
J	Higashi, T; Ikeda, T; Murakami, T; Shirakawa, R; Kawato, M; Okawa, K; Furuse, M; Kimura, T; Kita, T; Horiuchi, H				Higashi, Tomohito; Ikeda, Tomoyuki; Murakami, Takaaki; Shirakawa, Ryutaro; Kawato, Mitsunori; Okawa, Katsuya; Furuse, Mikio; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori			Flightless-I (Fli-I) Regulates the Actin Assembly Activity of Diaphanous-related Formins (DRFs) Daam1 and mDia1 in Cooperation with Active Rho GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; EMBRYONIC-DEVELOPMENT; BINDING PROTEIN; GELSOLIN-LIKE; MECHANISM; NUCLEATION; PROFILIN; DOMAINS	Eukaryotic cells dynamically reorganize the actin cytoskeleton to regulate various cellular activities, such as cell shape change, cell motility, cytokinesis, and vesicular transport. Diaphanous-related formins (DRFs), such as Daam1 and mDia1, play central roles in actin dynamics through assembling linear actin filaments. It has been reported that the GTP-bound active Rho binds directly to DRFs and partially unleashes the intramolecular autoinhibition of DRFs. However, whether proteins other than Rho involve the regulation of the actin assembly activity of DRFs has been unclear. Here, we show that Flightless-I (Fli-I), a gelsolin family protein essential for early development, binds directly to Daam1 and mDia1. Fli-I enhances the intrinsic actin assembly activity of Daam1 and mDia1 in vitro and is required for Daam1-induced actin assembly in living cells. Furthermore, Fli-I promotes the GTP-bound active Rho-mediated relief of the autoinhibition of Daam1 and mDia1. Thus, Fli-I is a novel positive regulator of Rho-induced linear actin assembly mediated by DRFs.	[Higashi, Tomohito; Ikeda, Tomoyuki; Murakami, Takaaki; Shirakawa, Ryutaro; Kawato, Mitsunori; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Cell Biol, Kobe, Hyogo 6500017, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068501, Japan; [Shirakawa, Ryutaro; Horiuchi, Hisanori] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Sendai, Miyagi 9808575, Japan	Kyoto University; Kobe University; Kyoto University; Tohoku University	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@idac.tohoku.ac.jp	Higashi, Tomohito/AHE-7942-2022	Furuse, Mikio/0000-0003-2847-8156; Higashi, Tomohito/0000-0001-5616-1477	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20013201]; Takeda Science Foundation; Novartis Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [22501009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research Grant 20013201 (to H. H.), the Takeda Science Foundation (to H. H.), Novartis Foundation (Japan) for the Promotion of Science (to H. H.), and Global COE Program "Center for Frontier Medicine" from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Afshar K, 2000, DEVELOPMENT, V127, P1887; Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Deng H, 2007, GENETICS, V177, P847, DOI 10.1534/genetics.107.078964; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; PERRIMON N, 1989, GENETICS, V121, P313; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Straub KL, 1996, J CELL SCI, V109, P263; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	34	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16231	16238		10.1074/jbc.M109.079236	http://dx.doi.org/10.1074/jbc.M109.079236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223827	Green Published, hybrid			2022-12-27	WOS:000277715900059
J	Liu, RM; Choi, J; Wu, JH; Pravia, KAG; Lewis, KM; Brand, JD; Mochel, NSR; Krzywanski, DM; Lambeth, JD; Hagood, JS; Forman, HJ; Thannickal, VJ; Postlethwait, EM				Liu, Rui-Ming; Choi, Jinah; Wu, Jian-He; Pravia, Kimberly A. Gaston; Lewis, Karen M.; Brand, Jeffrey D.; Mochel, N. S. Reyes; Krzywanski, David M.; Lambeth, J. David; Hagood, James S.; Forman, Henry Jay; Thannickal, Victor J.; Postlethwait, Edward M.			Oxidative Modification of Nuclear Mitogen-activated Protein Kinase Phosphatase 1 Is Involved in Transforming Growth Factor beta 1-induced Expression of Plasminogen Activator Inhibitor 1 in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; NADPH OXIDASE; MAP KINASE; UP-REGULATION; NAD(P)H OXIDASE; CROSS-TALK; KAPPA-B; NOX4; P38; APOPTOSIS	Transforming growth factor beta(TGF-beta) stimulates reactive oxygen species (ROS) production in various cell types, which mediates many of the effects of TGF-beta. The molecular mechanisms whereby TGF-beta increases ROS production and ROS modulate the signaling processes of TGF-beta, however, remain poorly defined. In this study, we show that TGF-beta 1 stimulates NADPH oxidase 4 (Nox4) expression and ROS generation in the nucleus of murine embryo fibroblasts (NIH3T3 cells). This is associated with an increase in protein thiol modification and inactivation of MAPK phosphatase 1 (MKP-1), a nuclear phosphatase. Furthermore, knockdown of MKP-1 using small interfering RNA enhances TGF-beta 1-induced phosphorylation of JNK and p38 as well as the expression of plasminogen activator inhibitor 1 (PAI-1), a TGF-beta-responsive gene involved in the pathogenesis of many diseases. Knockdown of Nox4 with Nox4 small interfering RNA, on the other hand, reduces TGF-beta 1-stimulated ROS production, p38 phosphorylation, and PAI-1 expression. TGF-beta also increased the nuclear level of Nox4 protein as well as PAI-1 expression in human lung fibroblasts (CCL-210 cells), suggesting that TGF-beta may induce PAI-1 expression by a similar mechanism in human lung fibroblasts. In summary, in this study we have identified nuclear MAPK phosphatase MKP-1 as a novel molecular target of ROS in TGF-beta signaling pathways. Our data suggest that increased generation of ROS by Nox4 mediates TGF-beta 1-induced PAI-1 gene expression at least in part through oxidative modification and inhibition of MKP-1 leading to a sustained activation of JNK and p38 MAPKs.	[Liu, Rui-Ming; Wu, Jian-He; Pravia, Kimberly A. Gaston; Lewis, Karen M.; Brand, Jeffrey D.; Postlethwait, Edward M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Krzywanski, David M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Hagood, James S.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Choi, Jinah; Mochel, N. S. Reyes; Forman, Henry Jay] Univ Calif, Dept Nat Sci, Merced, CA 95343 USA; [Lambeth, J. David] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Merced; Emory University	Liu, RM (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA.	rliu@uab.edu		Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [ES011831, HL088141, HL54696, ES05511, HL067967, CA105116]; American Lung Association; University of California at Merced; NATIONAL CANCER INSTITUTE [R01CA105116, R56CA105116] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088141, R01HL054696, R01HL067967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES005511, R01ES005511, R01ES011831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; University of California at Merced(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES011831 and HL088141 (to R.-M. L.); HL54696 (to E. M. P.); ES05511 (to H. J. F.); HL067967 (to V. J. T.); and CA105116 (to J. D. L.). This work was also supported by funds from the American Lung Association (to R.-M. L.) and start-up funds from University of California at Merced (to J. C.).	Albright CD, 2003, J CELL BIOCHEM, V89, P254, DOI 10.1002/jcb.10498; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu RM, 2004, AM J PHYSIOL-LUNG C, V286, pL121, DOI 10.1152/ajplung.00231.2003; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Mishra OP, 2004, NEUROSCIENCE, V129, P665, DOI 10.1016/j.neuroscience.2004.09.005; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sturrock A, 2007, AM J PHYSIOL-LUNG C, V292, pL1543, DOI 10.1152/ajplung.00430.2006; THANNICKAL VJ, 1993, AM J PHYSIOL, V265, pL622, DOI 10.1152/ajplung.1993.265.6.L622; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vayalil PK, 2005, AM J PHYSIOL-LUNG C, V289, pL937, DOI 10.1152/ajplung.00150.2005; Vayalil PK, 2007, AM J PHYSIOL-LUNG C, V293, pL1281, DOI 10.1152/ajplung.00128.2007; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	44	92	93	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16239	16247		10.1074/jbc.M110.111732	http://dx.doi.org/10.1074/jbc.M110.111732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20228065	Green Published, hybrid			2022-12-27	WOS:000277715900060
J	Radhakrishnan, Y; Busby, WH; Shen, XC; Maile, LA; Clemmons, DR				Radhakrishnan, Yashwanth; Busby, Walker H., Jr.; Shen, Xinchun; Maile, Laura A.; Clemmons, David R.			Insulin-like Growth Factor-I-stimulated Insulin Receptor Substrate-1 Negatively Regulates Src Homology 2 Domain-containing Protein-tyrosine Phosphatase Substrate-1 Function in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; IRS-1 PTB DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; HIGH GLUCOSE; SERINE PHOSPHORYLATION; SKELETAL-MUSCLE; DOWN-REGULATION; ANGIOTENSIN-II; RAT ADIPOCYTES	Vascular smooth muscle cells maintained in normal (5.6 mM) glucose respond to insulin-like growth factor-I (IGF-I) with increased protein synthesis but do not proliferate. In contrast, hyperglycemia alters responsiveness to IGF-I, resulting in increased SHPS-1 phosphorylation and assembly of a signaling complex that enhances MAPK and phosphatidylinositol 3-kinase pathways. Hyperglycemia also reduces the basal IRS-1 concentration and IGF-I-stimulated IRS-1-linked signaling. To determine if failure to down-regulate IRS-1 alters vascular smooth muscle cell (VSMC) responses to IGF-I, we over-expressed IRS-1 in VSMCs maintained in high glucose. These cultures showed reduced SHPS-1 phosphorylation, transfer of SHP-2 to SHPS-1, and impaired Shc and MAPK phosphorylation and cell proliferation in response to IGF-I. In vitro studies demonstrated that SHPS-1 was a substrate for type I IGF receptor (IGF-IR) and that IRS-1 competitively inhibited SHPS-1 phosphorylation. Exposure of VSMC cultures to a peptide that inhibited IRS-1/IGF-IR interaction showed that IRS-1 binding to IGF-IR impairs SHPS-1 phosphorylation in vivo. IRS-1 also sequestered SHP-2. Expression of an IRS-1 mutant (Y1179F/Y1229F) reduced IRS-1/SHP-2 association, and exposure of cells expressing the mutant to the inhibitory peptide enhanced SHPS-1 phosphorylation and SHP-2 transfer. This result was confirmed by expressing an IRS-1 mutant that had both impaired binding to IGF-IR and to SHP-2 IGF-I increased SHPS-1 phosphorylation, SHP-2 association with SHPS-1, Shc MAPK phosphorylation, and proliferation in cells expressing the mutant. We conclude that IRS-1 is an important factor for maintaining VSMCs in the non-proliferative state and that its down-regulation is a component of the VSMC response to hyperglycemic stress that results in an enhanced response to IGF-I.	[Clemmons, David R.] Univ N Carolina, Div Endocrinol, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, Sch Med, Dept Med, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	endo@med.unc.edu			National Institutes of Health [HL56580, AG02331]; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56580 and AG02331.	Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Bifulco G, 2002, J BIOL CHEM, V277, P24306, DOI 10.1074/jbc.M202962200; BLAKESLEY VA, 1995, J BIOL CHEM, V270, P2764, DOI 10.1074/jbc.270.6.2764; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Buren J, 2003, EUR J ENDOCRINOL, V148, P157, DOI 10.1530/eje.0.1480157; Carvalho E, 2000, MOL CELL BIOCHEM, V206, P7, DOI 10.1023/A:1007009723616; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Chu A, 2006, AM J PHYSIOL-CELL PH, V291, pC1014, DOI 10.1152/ajpcell.00191.2006; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Guvakova MA, 1997, CANCER RES, V57, P2606; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kawabe J, 2000, J HYPERTENS, V18, P1457, DOI 10.1097/00004872-200018100-00014; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Lima MHM, 2002, ENDOCRINE, V18, P1, DOI 10.1385/ENDO:18:1:01; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2003, MOL BIOL CELL, V14, P3519, DOI 10.1091/mbc.E03-04-0239; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2008, MOL ENDOCRINOL, V22, P1226, DOI 10.1210/me.2007-0552; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Mitsuhashi H, 2008, J NEUROCHEM, V105, P101, DOI 10.1111/j.1471-4159.2007.05121.x; Motley ED, 2001, CELL MOL BIOL, V47, P1059; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ochi F, 1997, BIOCHEM BIOPH RES CO, V239, P483, DOI 10.1006/bbrc.1997.7489; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Renstrom F, 2005, ENDOCRINOLOGY, V146, P3044, DOI 10.1210/en.2004-1675; Renstrom F, 2007, METABOLISM, V56, P190, DOI 10.1016/j.metabol.2006.09.012; Rice KM, 1999, BIOCHEM BIOPH RES CO, V255, P614, DOI 10.1006/bbrc.1999.0238; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Sadagurski M, 2007, J CELL PHYSIOL, V213, P519, DOI 10.1002/jcp.21131; SEGATTO O, 1993, ONCOGENE, V8, P2105; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WHITE MF, 1994, J BIOL CHEM, V269, P1; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; YONEZAWA K, 1994, J BIOL CHEM, V269, P4634; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang H, 2000, J BIOL CHEM, V275, P22558, DOI 10.1074/jbc.M000412200; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	74	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15682	15695		10.1074/jbc.M109.092270	http://dx.doi.org/10.1074/jbc.M109.092270			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207740	Green Published, hybrid			2022-12-27	WOS:000277715900003
J	Aziz, A; Hess, JF; Budamagunta, MS; Voss, JC; FitzGerald, PG				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; Voss, John C.; FitzGerald, Paul G.			Site-directed Spin Labeling and Electron Paramagnetic Resonance Determination of Vimentin Head Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; IN-VITRO; MOLECULAR ARCHITECTURE; CROSS-LINKING; KINASE-A; PHOSPHORYLATION; PROTEIN; DESMIN; IDENTIFICATION; SEQUENCE	Intermediate filament (IF) proteins have been predicted to have a conserved tripartite domain structure consisting of a largely alpha-helical central rod domain, flanked by head and tail domains. However, crystal structures have not been reported for any IF or IF protein. Although progress has been made in determining central rod domain structure, no structural data have been reported for either the head or tail domains. We used site-directed spin labeling and electron paramagnetic resonance to analyze 45 different spin labeled mutants spanning the head domain of vimentin. The data, combined with results from a previous study, provide strong evidence that the polypeptide backbones of the head domains form a symmetric dimer of closely apposed backbones that fold back onto the rod domain, imparting an asymmetry to the dimer. By following the behavior of spin labels during the process of in vitro assembly, we show that head domain structure is dynamic, changing as a result of filament assembly. Finally, because the vimentin head domain is the major site of the phosphorylation that induces disassembly at mitosis, we studied the effects of phosphorylation on head domain structure and demonstrate that phosphorylation drives specific head domain regions apart. These data provide the first evidence-based model of IF head domain structure.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	FitzGerald, PG (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Voss, John/0000-0001-9279-209X	National Institutes of Health [EY017575, P30 EY012576, AG029246]; National Institutes of Health National Center for Research Resources [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017575 (to P. G. F.) and P30 EY012576 and AG029246 (to J.C.V.). This work was also supported in part by Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Institutes of Health National Center for Research Resources.	ALBERS K, 1992, INT REV CYTOL, V134, P243, DOI 10.1016/S0074-7696(08)62030-6; ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; Aziz A, 2009, J BIOL CHEM, V284, P7330, DOI 10.1074/jbc.M809029200; Chomiki N, 2001, EUR J BIOCHEM, V268, P903, DOI 10.1046/j.1432-1327.2001.01946.x; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; DELACOURTE A, 1982, BIOCHIM BIOPHYS ACTA, V709, P99, DOI 10.1016/0167-4838(82)90426-5; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7; GEISLER N, 1989, EUR J BIOCHEM, V183, P441, DOI 10.1111/j.1432-1033.1989.tb14947.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Hess JF, 2005, J BIOL CHEM, V280, P2141, DOI 10.1074/jbc.M412254200; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; HOFMANN I, 1992, J CELL SCI, V101, P687; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PARRY D, 1985, CELLULAR MOL BIOL IN, P175; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; PARRY DAD, 1985, INT J BIOL MACROMOL, V7, P203, DOI 10.1016/0141-8130(85)90003-0; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Pittenger JT, 2008, BIOCHEMISTRY-US, V47, P10863, DOI 10.1021/bi801137m; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; RAATS JMH, 1990, J CELL BIOL, V111, P1971, DOI 10.1083/jcb.111.5.1971; RAATS JMH, 1992, PROG NUCLEIC ACID RE, V43, P67, DOI 10.1016/S0079-6603(08)61044-2; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Shoeman RL, 2002, EXP CELL RES, V279, P344, DOI 10.1006/excr.2002.5618; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; TRAUB P, 1993, J MOL BIOL, V230, P837, DOI 10.1006/jmbi.1993.1205; TRAUB P, 1984, J CELL SCI, V65, P1; TRAUB P, 1992, J CELL SCI, V101, P363; TRAUB P, 1983, J CELL SCI, V63, P43	52	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15278	15285		10.1074/jbc.M109.075598	http://dx.doi.org/10.1074/jbc.M109.075598			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231271	Green Published, hybrid			2022-12-27	WOS:000277399000048
J	Moullintraffort, L; Bruneaux, M; Nazabal, A; Allegro, D; Giudice, E; Zal, F; Peyrot, V; Barbier, P; Thomas, D; Garnier, C				Moullintraffort, Laura; Bruneaux, Matthieu; Nazabal, Alexis; Allegro, Diane; Giudice, Emmanuel; Zal, Franck; Peyrot, Vincent; Barbier, Pascale; Thomas, Daniel; Garnier, Cyrille			Biochemical and Biophysical Characterization of the Mg2+-induced 90-kDa Heat Shock Protein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; STRUCTURAL-ANALYSIS; SUBSTRATE-BINDING; ATP HYDROLYSIS; RECONSTRUCTION; DISTINCT; SYSTEMS; STATES	The 90-kDa heat shock protein (Hsp90) is involved in the regulation and activation of numerous client proteins essential for diverse functions such as cell growth and differentiation. Although the function of cytosolic Hsp90 is dependent on a battery of cochaperone proteins regulating both its ATPase activity and its interaction with client proteins, little is known about the real Hsp90 molecular mechanism. Besides its highly flexible dimeric state, Hsp90 is able to self-oligomerize in the presence of divalent cations or under heat shock. In addition to dimers, oligomers exhibit a chaperone activity. In this work, we focused on Mg2+-induced oligomers that we named Type I, Type II, and Type III in increasing molecular mass order. After stabilization of these quaternary structures, we optimized a purification protocol. Combining analytical ultracentrifugation, size exclusion chromatography coupled to multiangle laser light scattering, and high mass matrix-assisted laser desorption/ionization time of flight mass spectrometry, we determined biochemical and biophysical characteristics of each Hsp90 oligomer. We demonstrate that Type I oligomer is a tetramer, and Type II is an hexamer, whereas Type III is a dodecamer. These even-numbered structures demonstrate that the building brick for oligomerization is the dimer up to the Type II, whereas Type III probably results from the association of two Type II. Moreover, the Type II oligomer structure, studied by negative stain transmission electron microscopy tomography, exhibits a "nest-like" shape that forms a "cozy chaperoning chamber" where the client protein folding/protection could occur.	[Moullintraffort, Laura; Giudice, Emmanuel; Thomas, Daniel; Garnier, Cyrille] Univ Rennes 1, CNRS, UMR 6026, F-35042 Rennes, France; [Bruneaux, Matthieu; Zal, Franck] Univ Paris 06, Equipe Ecophysiol Invertebres Marins Milieux Extr, CNRS, UMR 7144,Stn Biol Roscoff, F-29682 Roscoff, France; [Nazabal, Alexis; Barbier, Pascale] INSERM, CRO2, UMR 911, CH-8952 Zurich, Switzerland; [Allegro, Diane; Peyrot, Vincent] Univ Mediterranee, Fac Pharm, INSERM, CRO2,UMR 911, F-13385 Marseille 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Garnier, C (corresponding author), Univ Rennes 1, CNRS, UMR 6026, Campus Beaulieu Batiment 13,263 Ave Gen Leclerc, F-35042 Rennes, France.	cyrille.garnier@univ-rennes1.fr	peyrot, vincent/B-6365-2015; THOMAS, Danniel/AAJ-5033-2020; Giudice, Emmanuel/AFT-2595-2022; Barbier, Pascale/AAE-1781-2019	THOMAS, Danniel/0000-0002-9650-0434; Bruneaux, Matthieu/0000-0001-6997-192X; GARNIER, Cyrille/0000-0002-5715-8218; Le Breton, Laura/0000-0002-5599-3244; GIUDICE, Emmanuel/0000-0001-7209-7890	Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest; Region Bretagne Ph. D. grant	Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest; Region Bretagne Ph. D. grant	This work was supported by a grant from the Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest (to C. G.) and a Region Bretagne Ph. D. grant (to L. M.) and research grant (to D. T.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aherne Wynne, 2003, Methods Mol Med, V85, P149; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Bruneaux M, 2008, CURR PROTEIN PEPT SC, V9, P150, DOI 10.2174/138920308783955270; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Garnier C, 2001, EUR J BIOCHEM, V268, P2402, DOI 10.1046/j.1432-1327.2001.02121.x; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; HICKEY E, 1986, GENE, V43, P147, DOI 10.1016/0378-1119(86)90018-1; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Laue T.M., 1992, COMPUTER AIDED INTER; Le Bras G, 2007, J MED CHEM, V50, P6189, DOI 10.1021/jm0707774; LEMAIRE M, 1980, ANAL BIOCHEM, V106, P12, DOI 10.1016/0003-2697(80)90112-8; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; MINTON AP, 1994, MODERN ANAL ULTRACEN; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; RADANYI C, 1989, J BIOL CHEM, V264, P2568; Radanyi C, 2009, CANCER LETT, V274, P88, DOI 10.1016/j.canlet.2008.09.001; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; Zhao C, 2004, CELL SIGNAL, V16, P313, DOI 10.1016/j.cellsig.2003.08.005	45	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15100	15110		10.1074/jbc.M109.094698	http://dx.doi.org/10.1074/jbc.M109.094698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228408	Green Published, hybrid			2022-12-27	WOS:000277399000031
J	Saini, V; Marchese, A; Majetschak, M				Saini, Vikas; Marchese, Adriano; Majetschak, Matthias			CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOGENOUS UBIQUITIN; FACTOR-I; PROTEIN; INJURY; AGONIST; APOPTOSIS; AMD3100; LIGAND; ASSOCIATION; ANTAGONIST	Ubiquitin is one of the most highly conserved proteins in eukaryotes and plays major biological roles as a post-translational protein modifier. Ubiquitin is also a natural constituent of plasma, and several lines of evidence suggest that extracellular ubiquitin is an immune modulator with anti-inflammatory properties. In addition, ubiquitin treatment has been shown to limit inflammation and reduce organ injury in various disease models and species in vivo. However, its mechanism of action is unknown. Here we show that extracellular ubiquitin is a natural CXC chemokine receptor 4 (CXCR4 and CD184) agonist. Extracellular ubiquitin promotes intracellular Ca2+ flux and reduces cAMP levels through a G protein-coupled receptor that signals via a G alpha(i/o) protein in THP1 cells. Toll-like receptor 4 stimulation reduces ubiquitin-binding sites, which enabled identification of four G alpha(i/o) PCRs as ubiquitin receptor candidates. Overexpression of candidate genes in HEK293 cells, gene silencing in THP1 cells, competition binding, and signaling studies with the CXCR4 agonist stromal cell-derived factor-1 alpha (chemokine (CXC motif) ligand 12) and inhibitor AMD3100 identify CXCR4 as a functional ubiquitin receptor. Our finding uncovers a fundamentally new aspect of the role of ubiquitin in biology, has implications for the understanding of CXCR4-mediated events, and is expected to facilitate development of new therapeutic avenues for a variety of diseases.	Loyola Univ, Chicago Stritch Sch Med, Burn & Shock Trauma Inst, Dept Surg, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu			Deutsche Forschungsgemeinschaft [MA 2474/2-2]; National Institutes of Health [GM075159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 2474/2-2 (to M. M.). This work was also supported in part by National Institutes of Health Grant GM075159 (to A. M.). The therapeutic use of ubiquitin has been patented (United States Patent 7,262,162), and M. M. is an inventor. Based on the results of this work, Loyola University Chicago has filed a provisional patent application (serial number 61/222,267). The authors are the inventors. None of the authors has received any income related to the patent or patent application.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Akarsu E, 2001, NEPHRON, V88, P280, DOI 10.1159/000046005; ASSEMAN C, 1994, J IMMUNOL METHODS, V173, P93, DOI 10.1016/0022-1759(94)90286-0; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chen WJ, 1998, MOL PHARMACOL, V53, P177, DOI 10.1124/mol.53.2.177; Daino H, 2000, BLOOD, V95, P2577; Di Salvo J, 2000, EUR J PHARMACOL, V409, P143, DOI 10.1016/S0014-2999(00)00846-3; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 1999, J IMMUNOL, V163, P2368; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Jaremko L, 2009, BIOPOLYMERS, V91, P423, DOI 10.1002/bip.21160; KAGAN WA, 1977, BLOOD, V50, P275; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Majetschak M, 2006, IMMUNOL CELL BIOL, V84, P59, DOI 10.1111/j.1440-1711.2005.01399.x; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; PANCRE V, 1991, EUR J IMMUNOL, V21, P2735, DOI 10.1002/eji.1830211113; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Singh M, 2010, CARDIOVASC RES, V86, P20, DOI 10.1093/cvr/cvp402; Takada K, 1997, CLIN CHEM, V43, P1188; Takagi M, 1999, ALCOHOL CLIN EXP RES, V23, p76S, DOI 10.1111/j.1530-0277.1999.tb04539.x; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011	50	125	133	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15566	15576		10.1074/jbc.M110.103408	http://dx.doi.org/10.1074/jbc.M110.103408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228059	hybrid, Green Published			2022-12-27	WOS:000277399000075
J	Shor, B; Wu, J; Shakey, Q; Toral-Barza, L; Shi, C; Follettie, M; Yu, K				Shor, Boris; Wu, Jiang; Shakey, Quazi; Toral-Barza, Lourdes; Shi, Celine; Follettie, Max; Yu, Ker			Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; NUCLEAR-LOCALIZATION; SIGNALING PATHWAYS; RAPAMYCIN; PROTEIN; REPRESSION; ACTIVATION; MECHANISMS; INHIBITORS; REVEALS	The mammalian target of rapamycin (mTOR) regulates growth via promoting translation and transcription. Here, employing an mTOR active-site inhibitor WYE-125132 (WYE-132), we have performed quantitative phospho-proteomics and identified a Ser-75-containing phosphopeptide from Maf1, a known repressor of RNA polymerase III (Pol III) transcription. Treatment of cancer cells with WYE-132 or the rapamycin analog CCI-779 led to a rapid loss of the phosphorylation at Ser-75, whereas this effect was not seen in cells treated with cytotoxic agents or unrelated inhibitors. WYE-132-induced Maf1 dephosphorylation correlated with its accumulation in the nucleus and a marked decline in the cellular levels of pre-tRNAs. Depletion of cellular Maf1 via small interfering RNA increased basal pre-tRNA and rendered tRNA synthesis refractory to mTOR inhibitors. Maf1 mutant proteins carrying S75A alone or with S60A, T64A, and S68A (Maf1-S75A, Maf1-4A) progressively enhanced basal repression of tRNA in actively proliferating cells and attenuated amino acid-induced tRNA transcription. Gene alignment revealed conservation of all four Ser/Thr sites in high eukaryotes, further supporting a critical role of these residues in Maf1 function. Interestingly, mTOR inhibition led to an increase in the occupancy of Maf1 on a set of Pol III-dependent genes, with concomitant reduction in the binding of Pol III and Brf1. Unexpectedly, mTORC1 itself was also enriched at the same set of Pol III templates, but this association was not influenced by mTOR inhibitor treatment. Our results highlight a new and unique mode of regulation of Pol III transcription by mTOR and suggest that normalization of Pol III activity may contribute to the therapeutic efficacy of mTOR inhibitors.	[Shor, Boris; Toral-Barza, Lourdes; Shi, Celine; Yu, Ker] Wyeth Res, Discovery Oncol, Pearl River, NY 10965 USA; [Wu, Jiang; Shakey, Quazi; Follettie, Max] Wyeth Res, Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Shor, B (corresponding author), Wyeth Res, Discovery Oncol, 401 N Middletown Rd, Pearl River, NY 10965 USA.	shorb@wyeth.com; yuker2b@gmail.com						Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Clarke EM, 1996, J BIOL CHEM, V271, P22189, DOI 10.1074/jbc.271.36.22189; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIG JR, 1977, MOL GEN GENET, V158, P117; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; Saxena A, 2005, MOL CELL BIOL, V25, P9406, DOI 10.1128/MCB.25.21.9406-9418.2005; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179; WHITE RJ, 1990, EMBO J, V9, P3713, DOI 10.1002/j.1460-2075.1990.tb07584.x; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; YU K, 2010, J CANC RES, V70, P621; Yu K, 2008, CANCER BIOL THER, V7, P307; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; Zask A, 2008, J MED CHEM, V51, P1319, DOI 10.1021/jm7012858; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	50	126	129	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15380	15392		10.1074/jbc.M109.071639	http://dx.doi.org/10.1074/jbc.M109.071639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20233713	Green Published, hybrid			2022-12-27	WOS:000277399000058
J	Ziegeler, G; Ming, J; Koseki, JC; Sevinc, S; Chen, T; Ergun, S; Qin, XB; Aktas, BH				Ziegeler, Gudrun; Ming, Jie; Koseki, Jana C.; Sevinc, Sema; Chen, Ting; Ergun, Suleyman; Qin, Xuebin; Aktas, Bertal H.			Embryonic Lethal Abnormal Vision-like HuR-dependent mRNA Stability Regulates Post-transcriptional Expression of Cyclin-dependent Kinase Inhibitor p27Kip1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; GROWTH-FACTOR; ELAV PROTEIN; RICH ELEMENT; S-PHASE; P27(KIP1); P27; TRANSLATION; CARCINOMAS	The cyclin-dependent kinase inhibitor p27(Kip1) plays a critical role in regulating entry into and exit from the cell cycle. Posttranscriptional regulation of p27(Kip1) expression is of significant interest. The embryonic lethal abnormal vision (ELAV)-like RNA-binding protein HuR is thought be important for the translation of p27(Kip1), however, different reports attributed diametrically opposite roles to HuR. We report here an alternative mechanism wherein HuR regulates stability of the p27(Kip1) mRNA. Specifically, human and mouse p27(Kip1) mRNAs interact with HuR protein through multiple U-rich elements in both 5' and 3' untranslated regions (UTR). These interactions, which occur in vitro and in vivo, stabilize p27(Kip1) mRNA and play a critical role in its accumulation. Deleting HuR binding sites or knocking down HuR expression destabilizes p27(Kip1) mRNA and reduces its accumulation. We also identified a CT repeat in the 5' UTR of full-length p27(Kip1) mRNA isoforms that interact with a similar to 41-kDa protein and represses p27(Kip1) expression. This CT-rich element and diffuse elements in the 3' UTR regulate post-transcriptional expression of p27(Kip1) at the level of translation. This is the first demonstration that HuR-dependent mRNA stability and HuR-independent mRNA translation plays a critical role in the regulation of post-transcriptional p27(Kip1) expression.	[Ziegeler, Gudrun; Ming, Jie; Koseki, Jana C.; Sevinc, Sema; Chen, Ting; Ergun, Suleyman; Qin, Xuebin; Aktas, Bertal H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ming, Jie] Tongji Med Sch HUST, Union Hosp, Breast & Thyroid Res Ctr, Wuhan 430022, Peoples R China; [Qin, Xuebin; Aktas, Bertal H.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital	Aktas, BH (corresponding author), Lab Translat Res, 1 Kendall Sq,Bldg 600,3rd Floor, Cambridge, MA 02139 USA.	huseyin_Aktas@hms.harvard.edu	Chen, Ting/A-2124-2012	Chen, Ting/0000-0003-1725-7956				Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Atasoy U, 1998, J CELL SCI, V111, P3145; Ayrault O, 2009, MOL CANCER RES, V7, P33, DOI 10.1158/1541-7786.MCR-08-0369; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Elledge SJ, 1996, TRENDS CELL BIOL, V6, P388, DOI 10.1016/0962-8924(96)10030-1; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRANA X, 1995, ONCOGENE, V11, P211; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; LEE WH, 1995, ANN NY ACAD SCI, V752, P432, DOI 10.1111/j.1749-6632.1995.tb17453.x; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Rodolico V, 2005, ORAL ONCOL, V41, P268, DOI 10.1016/j.oraloncology.2004.08.014; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sgambato A, 2000, CANCER-AM CANCER SOC, V89, P2247, DOI 10.1002/1097-0142(20001201)89:11<2247::AID-CNCR13>3.0.CO;2-5; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Tan P, 1997, CANCER RES, V57, P1259; Woenckhaus C, 2005, HISTOL HISTOPATHOL, V20, P501, DOI 10.14670/HH-20.501; Zafon C, 2008, ENDOCR PATHOL, V19, P184, DOI 10.1007/s12022-008-9037-z; Zhao ZQ, 2000, NUCLEIC ACIDS RES, V28, P2695, DOI 10.1093/nar/28.14.2695	35	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15408	15419		10.1074/jbc.M110.113365	http://dx.doi.org/10.1074/jbc.M110.113365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20332085	Green Published, hybrid			2022-12-27	WOS:000277399000061
J	Alger, HM; Brown, JM; Sawyer, JK; Kelley, KL; Shah, R; Wilson, MD; Willingham, MC; Rudel, LL				Alger, Heather M.; Brown, J. Mark; Sawyer, Janet K.; Kelley, Kathryn L.; Shah, Ramesh; Wilson, Martha D.; Willingham, Mark C.; Rudel, Lawrence L.			Inhibition of Acyl-Coenzyme A: Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; LOW-DENSITY-LIPOPROTEIN; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; TRIACYLGLYCEROL-HYDROLASE; ATHEROSCLEROSIS; MICE; ESTER; POPULATION; ABSORPTION	Acyl-CoA: cholesterol O-acyl transferase 2 (ACAT2) promotes cholesterol absorption by the intestine and the secretion of cholesteryl ester-enriched very low density lipoproteins by the liver. Paradoxically, mice lacking ACAT2 also exhibit mild hypertriglyceridemia. The present study addresses the unexpected role of ACAT2 in regulation of hepatic triglyceride (TG) metabolism. Mouse models of either complete genetic deficiency or pharmacological inhibition of ACAT2 were fed low fat diets containing various amounts of cholesterol to induce hepatic steatosis. Mice genetically lacking ACAT2 in both the intestine and the liver were dramatically protected against hepatic neutral lipid ( TG and cholesteryl ester) accumulation, with the greatest differences occurring in situations where dietary cholesterol was elevated. Further studies demonstrated that liver-specific depletion of ACAT2 with antisense oligonucleotides prevents dietary cholesterol-associated hepatic steatosis both in an inbred mouse model of non-alcoholic fatty liver disease (SJL/J) and in a humanized hyperlipidemic mouse model (LDLr-/-, apoB(100/100)). All mouse models of diminished ACAT2 function showed lowered hepatic triglyceride concentrations and higher plasma triglycerides secondary to increased hepatic secretion of TG into nascent very low density lipoproteins. This work demonstrates that inhibition of hepatic ACAT2 can prevent dietary cholesterol-driven hepatic steatosis in mice. These data provide the first evidence to suggest that ACAT2-specific inhibitors may hold unexpected therapeutic potential to treat both atherosclerosis and non-alcoholic fatty liver disease.	[Alger, Heather M.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Brown, J. Mark; Sawyer, Janet K.; Kelley, Kathryn L.; Shah, Ramesh; Wilson, Martha D.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Willingham, Mark C.] Wake Forest Univ, Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Rudel, LL (corresponding author), Wake Forest Univ, Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lrudel@wfubmc.edu	Alger, Heather/AAK-1019-2020	Alger, Heather/0000-0003-1795-9675	National Institutes of Health [HL-49373]; Amgen; Glaxo-Smith Kline; National Institutes of Health NHLBI Pathway to Independence [1K99-HL096166]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL096166, K99HL096166, P01HL049373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); Glaxo-Smith Kline(GlaxoSmithKline); National Institutes of Health NHLBI Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-49373 (to L. L. R.). L. L. R. has ongoing collaborations with Amgen and Glaxo-Smith Kline. He participates in a speaker's bureau for Merck-Schering Plough.; Supported by National Institutes of Health NHLBI Pathway to Independence Grant 1K99-HL096166.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alam M, 2006, J LIPID RES, V47, P375, DOI 10.1194/jlr.M500344-JLR200; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; DAVIS RA, 1982, J BIOL CHEM, V257, P2634; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; DEMEL RA, 1985, J BIOL CHEM, V260, P9589; Dolinsky VW, 2004, CELL MOL LIFE SCI, V61, P1633, DOI 10.1007/s00018-004-3426-3; Fan JG, 2008, J DIGEST DIS, V9, P63, DOI 10.1111/j.1751-2980.2008.00323.x; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; NISHINA PM, 1993, LIPIDS, V28, P599, DOI 10.1007/BF02536053; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; VANHARKEN DR, 1969, J BIOL CHEM, V244, P2278; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; WILSON MD, 1994, J LIPID RES, V35, P943	32	59	61	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14267	14274		10.1074/jbc.M110.118422	http://dx.doi.org/10.1074/jbc.M110.118422			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231283	Green Published, hybrid			2022-12-27	WOS:000277299700023
J	Goranovic, D; Kosec, G; Mrak, P; Fujs, S; Horvat, J; Kuscer, E; Kopitar, G; Petkovic, H				Goranovic, Dusan; Kosec, Gregor; Mrak, Peter; Fujs, Stefan; Horvat, Jaka; Kuscer, Enej; Kopitar, Gregor; Petkovic, Hrvoje			Origin of the Allyl Group in FK506 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; GENE-CLUSTER; STREPTOMYCES-COELICOLOR; RAPAMYCIN BIOSYNTHESIS; ERYTHROMYCIN ANALOGS; POLYKETIDE; GENOME; METHIONINE; DOMAIN; UNIT	FK506 (tacrolimus) is a secondary metabolite with a potent immunosuppressive activity, currently registered for use as immunosuppressant after organ transplantation. FK506 and FK520 are biogenetically related natural products that are synthesized by combined polyketide synthase/nonribosomal peptide synthetase systems. The entire gene cluster for biosynthesis of FK520 from Streptomyces hygroscopicus var. ascomyceticus has been cloned and sequenced. On the other hand, the FK506 gene cluster from Streptomyces sp. MA6548 (ATCC55098) was sequenced only partially, and it was reasonable to expect that additional genes would be required for the provision of substrate supply. Here we report the identification of a previously unknown region of the FK506 gene cluster from Streptomyces tsukubaensis NRRL 18488 containing genes encoding the provision of unusual building blocks for FK506 biosynthesis as well as a regulatory gene. Among others, we identified a group of genes encoding biosynthesis of the extender unit that forms the allyl group at carbon 21 of FK506. Interestingly, we have identified a small independent diketide synthase system involved in the biosynthesis of the allyl group. Inactivation of one of these genes, encoding an unusual ketosynthase domain, resulted in an FK506 nonproducing strain, and the production was restored when a synthetic analog of the allylmalonyl-CoA extender unit was added to the cultivation medium. Based on our results, we propose a biosynthetic pathway for the provision of an unusual five-carbon extender unit, which is carried out by a novel diketide synthase complex.	[Petkovic, Hrvoje] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Chair Biotechnol, SI-1000 Ljubljana, Slovenia; [Goranovic, Dusan; Kosec, Gregor; Fujs, Stefan; Horvat, Jaka; Kuscer, Enej; Petkovic, Hrvoje] Acies Bio Doo, SI-1000 Ljubljana, Slovenia; [Mrak, Peter; Kopitar, Gregor] Lek Pharmaceut Dd, SI-1526 Ljubljana, Slovenia	University of Ljubljana; Novartis	Petkovic, H (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Chair Biotechnol, Jamnikarjeva 101, SI-1000 Ljubljana, Slovenia.	hrvoje.petkovic@bf.uni-lj.si			Government of Slovenia Ministry of Higher Education, Science and Technology [Z4-1054]; Ministry of the Economy [J4-9331, L4-7117]; Public Agency of the Republic of Slovenia; Foreign Investments Agency; European Social Fund [102/2008]	Government of Slovenia Ministry of Higher Education, Science and Technology; Ministry of the Economy; Public Agency of the Republic of Slovenia; Foreign Investments Agency; European Social Fund(European Social Fund (ESF))	This work was supported by Government of Slovenia Ministry of Higher Education, Science and Technology Postdoctoral Fellowship Z4-1054 (to S. F.) and Grants J4-9331 and L4-7117 (to H. P.) funds from the Ministry of the Economy and the Public Agency of the Republic of Slovenia for Entrepreneurship and Foreign Investments Agency and European Social Fund Contract 102/2008 (to G. K.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chuck JA, 1997, CHEM BIOL, V4, P757, DOI 10.1016/S1074-5521(97)90314-8; Easton JB, 2004, EXPERT OPIN THER TAR, V8, P551, DOI 10.1517/14728222.8.6.551; Fang A, 1995, FOLIA MICROBIOL, V40, P607, DOI 10.1007/BF02818516; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Frykman S, 2001, BIOTECHNOL BIOENG, V76, P303, DOI 10.1002/bit.10086; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Graziani EI, 2009, NAT PROD REP, V26, P602, DOI 10.1039/b804602f; Gregory MA, 2006, ORG BIOMOL CHEM, V4, P3565, DOI 10.1039/b608813a; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Husain S, 2002, CLIN INFECT DIS, V35, P53, DOI 10.1086/340867; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Kato Y, 2002, J AM CHEM SOC, V124, P5268, DOI 10.1021/ja0127483; Kieser T, 2000, PRACTICAL STREPTOMYC, P161; KOLLING R, 1985, J BACTERIOL, V164, P310; KUMAR P, 2007, Patent No. 1751272; Li YL, 2005, J BACTERIOL, V187, P3795, DOI 10.1128/JB.187.11.3795-3799.2005; Lowden PAS, 2001, ANGEW CHEM INT EDIT, V40, P777, DOI 10.1002/1521-3773(20010216)40:4<777::AID-ANIE7770>3.3.CO;2-0; Mamaeva DV, 2005, ACTA CRYSTALLOGR F, V61, P546, DOI 10.1107/S1744309105015447; Mandoli A, 2004, TETRAHEDRON-ASYMMETR, V15, P3233, DOI 10.1016/j.tetasy.2004.08.015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDaniel R, 2005, CHEM REV, V105, P543, DOI 10.1021/cr0301189; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Motamedi H, 1996, J BACTERIOL, V178, P5243, DOI 10.1128/jb.178.17.5243-5248.1996; Motamedi H, 1998, EUR J BIOCHEM, V256, P528, DOI 10.1046/j.1432-1327.1998.2560528.x; Motamedi H, 1997, EUR J BIOCHEM, V244, P74, DOI 10.1111/j.1432-1033.1997.00074.x; PAIVA NL, 1991, J NAT PROD, V54, P167, DOI 10.1021/np50073a015; Podust LM, 2004, PROTEIN SCI, V13, P255, DOI 10.1110/ps.03384804; Sambrook J., 2001, MOL CLONING LAB MANU; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; SHAFIEE A, 1993, Patent No. 5264355; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stassi DL, 1998, P NATL ACAD SCI USA, V95, P7305, DOI 10.1073/pnas.95.13.7305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Yuan J, 2008, J CHROMATOGR B, V868, P34, DOI 10.1016/j.jchromb.2008.04.028; Zhang WW, 2001, J BACTERIOL, V183, P2071, DOI 10.1128/JB.183.6.2071-2080.2001	41	61	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14292	14300		10.1074/jbc.M109.059600	http://dx.doi.org/10.1074/jbc.M109.059600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194504	Green Published, hybrid			2022-12-27	WOS:000277299700026
J	Kim, MS; Yoon, SK; Bollig, F; Kitagaki, J; Hur, W; Whye, NJ; Wu, YP; Rivera, MN; Park, JY; Kim, HS; Malik, K; Bell, DW; Englert, C; Perantoni, AO; Lee, SB				Kim, Myoung Shin; Yoon, Seung Kew; Bollig, Frank; Kitagaki, Jirouta; Hur, Wonhee; Whye, Nathan J.; Wu, Yun-Ping; Rivera, Miguel N.; Park, Jik Young; Kim, Ho-Shik; Malik, Karim; Bell, Daphne W.; Englert, Christoph; Perantoni, Alan O.; Lee, Sean Bong			A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CTNNB1 MUTATIONS; SUPPRESSOR; IDENTIFICATION; INHIBITION; IDAX	Mammalian kidney development requires the functions of the Wilms tumor gene WT1 and the WNT/beta-catenin signaling pathway. Recent studies have shown that WT1 negatively regulates WNT/beta-catenin signaling, but the molecular mechanisms by which WT1 inhibits WNT/beta-catenin signaling are not completely understood. In this study, we identified a gene, CXXC5, which we have renamed WID (WT1-induced Inhibitor of Dishevelled), as a novel WT1 transcriptional target that negatively regulates WNT/beta-catenin signaling. WT1 activates WID transcription through the upstream enhancer region. In the developing kidney, Wid and Wt1 are coexpressed in podocytes of maturing nephrons. Structure-function analysis demonstrated that WID interacts with Dishevelled via its C-terminal CXXC zinc finger and Dishevelled binding domains and potently inhibits WNT/beta-catenin signaling in vitro and in vivo. WID is evolutionarily conserved, and ablation of wid in zebrafish embryos with antisense morpholino oligonucleotides perturbs embryonic kidney development. Taken together, our results demonstrate that the WT1 negatively regulates WNT/beta-catenin pathway via its target gene WID and further suggest a role for WID in nephrogenesis.	[Kim, Myoung Shin; Whye, Nathan J.; Wu, Yun-Ping; Park, Jik Young; Kim, Ho-Shik; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Yoon, Seung Kew; Hur, Wonhee] Catholic Univ Korea, Dept Internal Med, World Hlth Org,Catholic Res Inst Med Sci, Collaborating Ctr Viral Hepatitis, Seoul 137701, South Korea; [Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Kitagaki, Jirouta; Perantoni, Alan O.] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21702 USA; [Rivera, Miguel N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Malik, Karim] Univ Bristol, Canc & Leukaemia Childhood Sargent Unit, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of Korea; World Health Organization; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lee, SB (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10,9D11, Bethesda, MD 20892 USA.	seanL@mail.nih.gov		Lee, Sean/0000-0001-6211-3498; Malik, Karim/0000-0002-8965-200X; Englert, Christoph/0000-0002-5931-3189	National Institutes of Health, NIDDK; National Human Genome Research Institute; NCI; Deutsche Forschungsgemeinschaft; 21st Century Frontier Functional Human Genome Project in Korea [FG06-11-11]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 21st Century Frontier Functional Human Genome Project in Korea; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program, NIDDK (to S. B. L.), National Human Genome Research Institute (to D. W. B.), and NCI (to A.O.P.). This work was also supported by the Deutsche Forschungsgemeinschaft (to C. E.) and Grant FG06-11-11 of the 21st Century Frontier Functional Human Genome Project in Korea (to S.K.Y.).	Abdulkadyrov K. M., 2004, Voprosy Onkologii (St. Petersburg), V50, P668; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Han M, 2007, GENE CHROMOSOME CANC, V46, P909, DOI 10.1002/gcc.20476; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Katoh M, 2004, INT J ONCOL, V25, P1193; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; Kim MKH, 2009, P NATL ACAD SCI USA, V106, P11154, DOI 10.1073/pnas.0901591106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Maiti S, 2000, CANCER RES, V60, P6288; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Menke AL, 2003, J PATHOL, V200, P667, DOI 10.1002/path.1390; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nusse R, 2007, SCIENCE, V316, P988, DOI 10.1126/science.1143337; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zhang TF, 2003, ANTICANCER RES, V23, P3575	36	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14585	14593		10.1074/jbc.M109.094334	http://dx.doi.org/10.1074/jbc.M109.094334			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220130	Green Published, hybrid			2022-12-27	WOS:000277299700055
J	Eltit, JM; Yang, TZ; Li, HL; Molinski, TF; Pessah, IN; Allen, PD; Lopez, JR				Eltit, Jose M.; Yang, Tianzhong; Li, Hongli; Molinski, Tadeusz F.; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.			RyR1-mediated Ca2+ Leak and Ca2+ Entry Determine Resting Intracellular Ca2+ in Skeletal Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR PROTEIN; CA-2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA; SARCOPLASMIC-RETICULUM; MUSCLE FIBERS; CALCIUM; RYR1; MOUSE; EXPRESSION; MODULATION	The control of resting free Ca2+ in skeletal muscle is thought to be a balance of channels, pumps, and exchangers in both the sarcolemma and sarcoplasmic reticulum. We explored these mechanisms using pharmacologic and molecular perturbations of genetically engineered (dyspedic) muscle cells that constitutively lack expression of the skeletal muscle sarcoplasmic reticulum Ca2+ release channels, RyR1 and RyR3. We demonstrate here that expression of RyR1 is responsible for more than half of total resting Ca2+ concentration ([Ca2+](rest)) measured in wild type cells. The elevated [Ca2+](rest) in RyR1-expressing cells is not a result of active gating of the RyR1 channel but instead is accounted for by the RyR1 ryanodine-insensitive Ca2+ leak conformation. In addition, we demonstrate that basal sarcolemmal Ca2+ influx is also governed by RyR1 expression and contributes in the regulation of [Ca2+](rest) in skeletal myotubes.	[Eltit, Jose M.; Yang, Tianzhong; Li, Hongli; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Univ Chile, Fac Med, Programa Biol Mol & Celular, Inst Ciencias Biomed, Santiago 7, Chile; [Molinski, Tadeusz F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA	Harvard University; Brigham & Women's Hospital; Universidad de Chile; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Allen, PD (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.		Pessah, Isaac N/K-7985-2017; Molinski, Tadeusz F/P-2125-2018	Pessah, Isaac N/0000-0002-8149-588X; 	National Institutes of Health [2R01AR43140, 5P01 AR052354]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01AR43140 and 5P01 AR052354 (to P.D.A. and I.N.P.).	BUCK E, 1992, J BIOL CHEM, V267, P23560; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Fessenden JD, 2001, P NATL ACAD SCI USA, V98, P2865, DOI 10.1073/pnas.041608898; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Lee EH, 2004, AM J PHYSIOL-CELL PH, V286, pC179, DOI 10.1152/ajpcell.00176.2003; Lopez JR, 2005, AM J PHYSIOL-CELL PH, V288, pC606, DOI 10.1152/ajpcell.00297.2004; LOPEZ JR, 1987, MUSCLE NERVE, V10, P77, DOI 10.1002/mus.880100114; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; MACK MM, 1994, J BIOL CHEM, V269, P23236; Masuno MN, 2006, J MED CHEM, V49, P4497, DOI 10.1021/jm050708u; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Moore RA, 1998, J CELL BIOL, V140, P843, DOI 10.1083/jcb.140.4.843; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Quattrini A, 2001, J NEUROIMMUNOL, V114, P213, DOI 10.1016/S0165-5728(00)00452-5; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ward CW, 2000, J PHYSIOL-LONDON, V525, P91, DOI 10.1111/j.1469-7793.2000.t01-2-00091.x; Ward CW, 2001, BIOPHYS J, V81, P3216, DOI 10.1016/S0006-3495(01)75957-7; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhou JS, 2006, AM J PHYSIOL-CELL PH, V290, pC539, DOI 10.1152/ajpcell.00592.2004	25	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13781	13787		10.1074/jbc.M110.107300	http://dx.doi.org/10.1074/jbc.M110.107300			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207743	Green Published, hybrid			2022-12-27	WOS:000276987700053
J	Hyvarinen, J; Hassinen, IE; Sormunen, R; Maki, JM; Kivirikko, KI; Koivunen, P; Myllyharju, J				Hyvarinen, Jaana; Hassinen, Ilmo E.; Sormunen, Raija; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna			Hearts of Hypoxia-inducible Factor Prolyl 4-Hydroxylase-2 Hypomorphic Mice Show Protection against Acute Ischemia-Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; PROLINE HYDROXYLATION; MYOCARDIAL-ISCHEMIA; OXYGEN HOMEOSTASIS; FACTOR-ALPHA; HIF-ALPHA; FACTOR-I; HIF-1-ALPHA; CARDIOPROTECTION; GENE	Hypoxia-inducible factor (HIF) has a pivotal role in oxygen homeostasis and cardioprotection mediated by ischemic preconditioning. Its stability is regulated by HIF prolyl 4-hydroxylases (HIF-P4Hs), the inhibition of which is regarded as a promising strategy for treating diseases such as anemia and ischemia. We generated a viable Hif-p4h-2 hypomorph mouse line (Hif-p4h-2(gt/gt)) that expresses decreased amounts of wild-type Hif-p4h-2 mRNA: 8% in the heart; 15% in the skeletal muscle; 34-47% in the kidney, spleen, lung, and bladder; 60% in the brain; and 85% in the liver. These mice have no polycythemia and show no signs of the dilated cardiomyopathy or hyperactive angiogenesis observed in mice with broad spectrum conditional Hif-p4h-2 inactivation. We focused here on the effects of chronic Hif-p4h-2 deficiency in the heart. Hif-1 and Hif-2 were stabilized, and the mRNA levels of glucose transporter-1, several enzymes of glycolysis, pyruvate dehydrogenase kinase 1, angiopoietin-2, and adrenomedullin were increased in the Hif-p4h-2(gt/gt) hearts. When isolated Hif-p4h-2(gt/gt) hearts were subjected to ischemia-reperfusion, the recovery of mechanical function and coronary flow rate was significantly better than in wild type, while cumulative release of lactate dehydrogenase reflecting the infarct size was reduced. The preischemic amount of lactate was increased, and the ischemic versus preischemic [CrP]/[Cr] and [ATP] remained at higher levels in Hif-p4h-2(gt/gt) hearts, indicating enhanced glycolysis and an improved cellular energy state. Our data suggest that chronic stabilization of Hif-1 alpha and Hif-2 alpha by genetic knockdown of Hif-p4h-2 promotes cardioprotection by induction of many genes involved in glucose metabolism, cardiac function, and blood pressure.	[Hyvarinen, Jaana; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Hassinen, Ilmo E.; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi			Academy of Finland [200471, 202469, 120156]; S. Juselius Foundation; FibroGen Inc.	Academy of Finland(Academy of Finland); S. Juselius Foundation; FibroGen Inc.	This work was supported by Health Science Council Grants 200471 and 202469 (to J. M.) and 120156 (to P. K.) from the Academy of Finland and by funds from the S. Juselius Foundation and FibroGen Inc. (to J. M.).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; BERGMEYER HU, 1970, METHODEN ENZYMATISCH, P533; BERNT E, 1970, METHODEN ENZYMATISCH, P1724; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Czibik G, 2009, CARDIOVASC RES, V82, P107, DOI 10.1093/cvr/cvp035; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Lamprecht W., 1970, METHODEN ENZYMATISCH, P2024; LAMPRECHT W, 1970, METHODEN ENZYMATISCH, P1729; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; NOLL F, 1970, METHODEN ENZYMATISCH, P1433; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Opie LH, 2002, J MOL CELL CARDIOL, V34, P1077, DOI 10.1006/jmcc.2002.2066; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Voss AK, 1998, DEV DYNAM, V212, P258; WURST W, 2000, GENE TARGETING PRACT, P234; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	52	83	89	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13646	13657		10.1074/jbc.M109.084855	http://dx.doi.org/10.1074/jbc.M109.084855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185832	Green Published, hybrid			2022-12-27	WOS:000276987700039
J	Zhang, J; Li, HF; Herrup, K				Zhang, Jie; Li, Huifang; Herrup, Karl			Cdk5 Nuclear Localization Is p27-dependent in Nerve Cells IMPLICATIONS FOR CELL CYCLE SUPPRESSION AND CASPASE-3 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PREVENTS NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; EXPORT SIGNALS; DEATH; PHOSPHORYLATION; CRM1; P25; NEURODEGENERATION	Initiation of a cell cycle in an adult neuron leads to cell death, placing great importance on the mechanisms that normally suppress the neuronal cell cycle. We have previously shown that the cyclin-dependent kinase Cdk5 is an important part of this process, but only when it is present in the nucleus. We report here that Cdk5 nuclear localization relies on its binding to the cyclin-dependent kinase inhibitor p27. Cdk5 has no intrinsic nuclear localization signal; in the absence of p27, two weak nuclear export signals that bind CRM1 cause it to shuttle to the cytoplasm. When a neuron is subjected to stress, such as exposure to beta-amyloid, the Cdk5-p27 interaction is lost, reducing Cdk5 levels in the nucleus and depriving the neuron of a major cell cycle suppression mechanism. Caspase-3 is activated within hours, but death is not immediate; elevated levels of cytoplasmic Cdk5 appear to retard neuronal death by a mechanism that may involve Bcl2. These data suggest a model in which Cdk5 exerts a double protective function in neurons: chronically suppressing the cell cycle when located in the nucleus and transiently delaying cell death in the cytoplasm.	[Zhang, Jie; Li, Huifang; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Herrup, K (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	herrup@biology.rutgers.edu	Zhang, Jie/A-5426-2010; Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	National Institutes of Health [R01NS020591]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS020591.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Busser J, 1998, J NEUROSCI, V18, P2801; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FEDDERSEN RM, 1995, MOL CELL NEUROSCI, V6, P153, DOI 10.1006/mcne.1995.1014; Feddersen RM, 1997, MOL CELL NEUROSCI, V9, P42, DOI 10.1006/mcne.1997.0601; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	41	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14052	14061		10.1074/jbc.M109.068262	http://dx.doi.org/10.1074/jbc.M109.068262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189989	Green Published, hybrid			2022-12-27	WOS:000276987700078
J	Omi, R; Kurokawa, S; Mihara, H; Hayashi, H; Goto, M; Miyahara, I; Kurihara, T; Hirotsu, K; Esaki, N				Omi, Rie; Kurokawa, Suguru; Mihara, Hisaaki; Hayashi, Hideyuki; Goto, Masaru; Miyahara, Ikuko; Kurihara, Tatsuo; Hirotsu, Ken; Esaki, Nobuyoshi			Reaction Mechanism and Molecular Basis for Selenium/Sulfur Discrimination of Selenocysteine Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE ACTIVITY; ESCHERICHIA-COLI COUNTERPART; NIFS-LIKE PROTEIN; CRYSTAL-STRUCTURE; SULFUR TRANSFER; GENE CLONING; TRANSFER-RNA; MOUSE-LIVER; BETA-LYASE; BIOSYNTHESIS	Selenocysteine lyase (SCL) catalyzes the pyridoxal 5'-phosphate-dependent removal of selenium from L-selenocysteine to yield L-alanine. The enzyme is proposed to function in the recycling of the micronutrient selenium from degraded selenoproteins containing selenocysteine residue as an essential component. The enzyme exhibits strict substrate specificity toward L-selenocysteine and no activity to its cognate L-cysteine. However, it remains unclear how the enzyme distinguishes between selenocysteine and cysteine. Here, we present mechanistic studies of selenocysteine lyase from rat. ESI-MS analysis of wild-type and C375A mutant SCL revealed that the catalytic reaction proceeds via the formation of an enzyme-bound selenopersulfide intermediate on the catalytically essential Cys-375 residue. UV-visible spectrum analysis and the crystal structure of SCL complexed with L-cysteine demonstrated that the enzyme reversibly forms a nonproductive adduct with L-cysteine. Cys-375 on the flexible loop directed L-selenocysteine, but not L-cysteine, to the correct position and orientation in the active site to initiate the catalytic reaction. These findings provide, for the first time, the basis for understanding how trace amounts of a selenium-containing substrate is distinguished from excessive amounts of its cognate sulfur-containing compound in a biological system.	[Mihara, Hisaaki] Ritsumeikan Univ, Dept Biotechnol, Inst Sci & Engn, Coll Life Sci, Shiga 5258577, Japan; [Omi, Rie; Kurokawa, Suguru; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Goto, Masaru; Miyahara, Ikuko; Hirotsu, Ken] Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan; [Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan	Ritsumeikan University; Kyoto University; Osaka Metropolitan University; Osaka Medical College	Mihara, H (corresponding author), Ritsumeikan Univ, Dept Biotechnol, Inst Sci & Engn, Coll Life Sci, Shiga 5258577, Japan.	mihara@fc.ritsumei.ac.jp; hirotsu@spring8.or.jp; esakin@SCL.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19370040]; Japan Society for the Promotion of Science [21780094]; National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas (B) 19370040 (to N. E.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Grant-in-aid for Encouragement of Young Scientists 21780094 (to H. M.) from the Japan Society for the Promotion of Science, by the National Project on Protein Structural and Functional Analyses, and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21st Century COE on Kyoto University Alliance for Chemistry) (to N. E.).	ALLEN FH, 1999, INT TABLES CRYSTALLO, VC, P782; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHOCAT P, 1985, J BACTERIOL, V163, P669, DOI 10.1128/JB.163.2.669-676.1985; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; COMBS GF, 1984, ANNU REV NUTR, V4, P257, DOI 10.1146/annurev.nu.04.070184.001353; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Delano W. L., 2001, PYMOL MOL GRAPHICS S; ESAKI N, 1981, BIOCHEMISTRY-US, V20, P4492, DOI 10.1021/bi00518a039; ESAKI N, 1982, J BIOL CHEM, V257, P4386; ESAKI N, 1987, METHOD ENZYMOL, V143, P415; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hatfield D. L., 2001, SELENIUM ITS MOL BIO; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kim IY, 1997, P NATL ACAD SCI USA, V94, P418, DOI 10.1073/pnas.94.2.418; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2000, J BIOL CHEM, V275, P6195, DOI 10.1074/jbc.275.9.6195; Mihara H, 2002, METHOD ENZYMOL, V347, P198; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Momany C, 2004, BIOCHEMISTRY-US, V43, P1193, DOI 10.1021/bi035744e; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; SCHWARZ K, 1965, FED PROC, V24, P58; Small-Howard AL, 2005, BIOCHEM SOC T, V33, P1493, DOI 10.1042/BST0331493; Smith AD, 2005, FEBS LETT, V579, P5236, DOI 10.1016/j.febslet.2005.08.046; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tormay P, 1998, EUR J BIOCHEM, V254, P655, DOI 10.1046/j.1432-1327.1998.2540655.x; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	48	27	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12133	12139		10.1074/jbc.M109.084475	http://dx.doi.org/10.1074/jbc.M109.084475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164179	Green Published, hybrid			2022-12-27	WOS:000276787100043
J	Tay, YD; Wu, L				Tay, Ye Dee; Wu, Leonard			Overlapping Roles for Yen1 and Mus81 in Cellular Holliday Junction Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; IN-VIVO; ENDONUCLEASE; RESOLVASE; RECOMBINATION; CROSSOVERS; RESOLUTION; YEAST; REPLICATION	Eukaryotic Holliday junction (HJ) resolvases have attracted much attention recently with the identification of at least three distinct proteins that can cleave model HJs in vitro. However, the specificDNAstructure(s) that these proteins act upon in the cell is unknown. Here, we describe a system in budding yeast to directly and quantitatively monitor in vivo HJ resolution. We found that Yen1 acts redundantly with Mus81, but not Slx1, to resolve a model HJ in vivo. This functional overlap specifically extends to the repair/bypass of lesions that impede the progression of replication forks but not to the repair of double-strand breaks induced by ionizing radiation. Together, these results suggest a direct role for Yen1 in the response to DNA damage and implicate overlapping HJ resolution functions of Yen1 with Mus81 during replication fork repair.	[Tay, Ye Dee; Wu, Leonard] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Wu, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	leonard.wu@imm.ox.ac.uk		TAY, YE DEE/0000-0002-7031-7789	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; de los Santos T, 2003, GENETICS, V164, P81; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Rouse J, 2009, BIOCHEM SOC T, V37, P495, DOI 10.1042/BST0370495; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105	24	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11427	11432		10.1074/jbc.M110.108399	http://dx.doi.org/10.1074/jbc.M110.108399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20178992	Green Published, hybrid			2022-12-27	WOS:000276286200049
J	Monfregola, J; Napolitano, G; D'Urso, M; Lappalainen, P; Ursini, MV				Monfregola, Jlenia; Napolitano, Gennaro; D'Urso, Michele; Lappalainen, Pekka; Ursini, Matilde Valeria			Functional Characterization of Wiskott-Aldrich Syndrome Protein and Scar Homolog (WASH), a Bi-modular Nucleation-promoting Factor Able to Interact with Biogenesis of Lysosome-related Organelle Subunit 2 (BLOS2) and gamma-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; CYTOSKELETAL DYNAMICS; N-WASP; ACTIN; ACTIVATION; PALLIDIN; DOMAINS	The Arp2/3 complex is essential for actin filament nucleation in a variety of cellular processes. The activation of the Arp2/3 complex is mediated by nucleation-promoting factors, such as the Wiskott-Aldrich syndrome family proteins, which share a WCA (WH2 domain, central region, acidic region) catalytic module at the C-terminal region, required for Arp2/3 activation, but diverge at the N-terminal region, required for binding to specific activators. Here, we report the characterization of WASH, a new member of the WAS family that has nucleation-promoting factor activity and recently has been demonstrated to play a role in endosomal sorting. We found that overexpression of the WASH-WCA domain induced disruption of the actin cytoskeleton, whereas overexpression of full-length WASH in mammalian cells did not affect stress fiber organization. Furthermore, our analysis has revealed that nerve growth factor treatment of PC12 cells overexpressing full-length WASH leads to disruption of the actin cytoskeleton. We have also found that WASH interacts through its N-terminal region with BLOS2, a centrosomal protein belonging to the BLOC-1 complex that functions as a scaffolding factor in the biogenesis of lysosome-related organelles. In addition to BLOS2, WASH also interacts with centrosomal gamma-tubulin and with pallidin, an additional component of the BLOC-1 complex. Collectively, our data propose that WASH is a bimodular protein in which the C terminus is involved in Arp2/3-mediated actin nucleation, whereas the N-terminal portion is required for its regulation and localization in the cells. Moreover, our data suggest that WASH is also a component of the BLOC-1 complex that is associated with the centrosomes.	[Monfregola, Jlenia; Napolitano, Gennaro; D'Urso, Michele; Ursini, Matilde Valeria] Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Helsinki	Ursini, MV (corresponding author), Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy.	ursini@igb.cnr.it	Monfregola, Jlenia/AAW-9055-2021; Napolitano, Gennaro/O-5377-2016	Napolitano, Gennaro/0000-0002-8615-4654; Lappalainen, Pekka/0000-0001-6227-0354	Telethon [GGP08125]; Istituto Banco di Napoli Fondazione	Telethon(Fondazione Telethon); Istituto Banco di Napoli Fondazione	This work was supported by Telethon Grant GGP08125 (to M.V.U.) and Istituto Banco di Napoli Fondazione.	Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Callebaut I, 1998, FEBS LETT, V441, P181, DOI 10.1016/S0014-5793(98)01541-5; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Gianfrancesco F, 2001, CYTOGENET CELL GENET, V94, P98, DOI 10.1159/000048796; Goldberg DJ, 2000, J NEUROSCI RES, V60, P458, DOI 10.1002/(SICI)1097-4547(20000515)60:4<458::AID-JNR4>3.3.CO;2-Q; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Monfregola J, 2005, J CELL PHYSIOL, V204, P839, DOI 10.1002/jcp.20332; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pommereit D, 2007, J CELL SCI, V120, P2694, DOI 10.1242/jcs.03475; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Wang ZQ, 2004, J MOL BIOL, V343, P71, DOI 10.1016/j.jmb.2004.08.034	31	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16951	16957		10.1074/jbc.M109.078501	http://dx.doi.org/10.1074/jbc.M109.078501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308062	Green Published, hybrid			2022-12-27	WOS:000277982600058
J	Suhaiman, L; De Blas, GA; Obeid, LM; Darszon, A; Mayorga, LS; Belmonte, SA				Suhaiman, Laila; De Blas, Gerardo A.; Obeid, Lina M.; Darszon, Alberto; Mayorga, Luis S.; Belmonte, Silvia A.			Sphingosine 1-Phosphate and Sphingosine Kinase Are Involved in a Novel Signaling Pathway Leading to Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERMATOGENIC CELLS; PROTEIN-KINASE; SPERM CAPACITATION; PLASMA-MEMBRANE; EXTRACELLULAR RELEASE; MOLECULAR-CLONING; PERTUSSIS TOXIN; RAB3A TRIGGERS; MAST-CELLS; EGG ZP3	Regulated secretion is a central issue for the specific function of many cells; for instance, mammalian sperm acrosomal exocytosis is essential for egg fertilization. Sphingosine 1-phosphate is a bioactive sphingolipid that regulates crucial physiological processes. Here we report that this lipid triggers acrosomal exocytosis in human sperm by a mechanism involving a G(i)-coupled receptor. Real-time imaging showed a remarkable increase of cytosolic calcium upon activation with sphingosine 1-phosphate and pharmacological experiments indicate that the process requires extracellular calcium influx through voltage and store-operated calcium channels and efflux from intracellular stores through inositol 1,4,5-trisphosphate-sensitive calcium channels. Sphingosine 1-phosphate-induced exocytosis requires phospholipase C and protein kinase C activation. We investigated possible sources of the lipid. Western blot indicates that sphingosine kinase 1 is present in spermatozoa. Indirect immunofluorescence showed that phorbol ester, a potent protein kinase C activator that can also trigger acrosomal exocytosis, redistributes sphingosine kinase 1 to the acrosomal region. Functional assays showed that phorbol ester-induced exocytosis depends on the activation of sphingosine kinase 1. Furthermore, incorporation of P-32 to sphingosine demonstrates that cells treated with the phorbol ester increase their sphingosine kinase activity that yields sphingosine 1-phosphate. We present here the first evidence indicating that human spermatozoa produce sphingosine 1-phosphate when challenged with an exocytic stimulus. These observations point to a new role of sphingosine 1-phosphate in a signaling cascade that facilitates acrosome reaction providing some clues about novel lipid molecules involved in exocytosis.	[Suhaiman, Laila; Mayorga, Luis S.; Belmonte, Silvia A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol,Consejo Nacl Invest Cient, RA-5500 Mendoza, Argentina; [De Blas, Gerardo A.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62250, Morelos, Mexico; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Universidad Nacional Autonoma de Mexico; Medical University of South Carolina; Medical University of South Carolina	Belmonte, SA (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol,Consejo Nacl Invest Cient, CC56, RA-5500 Mendoza, Argentina.	sbelmont@fcm.uncu.edu.ar	Belmonte, Silvia Alejandra Alejandra/AAW-5131-2021	Darszon, Alberto/0000-0002-2502-0505; Mayorga, Luis S/0000-0002-5995-0671; obeid, lina/0000-0002-0734-0847	Florencio Fiorini Foundation (Argentina); Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Florencio Fiorini Foundation (Argentina); Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Florencio Fiorini Foundation (Argentina) and Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo) (to S. A. B.), grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) (to Claudia Tomes and L. S. M.) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) (to L. S. M.).	Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Bohring C, 1999, ELECTROPHORESIS, V20, P971, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<971::AID-ELPS971>3.0.CO;2-6; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Breitbart H, 1999, REV REPROD, V4, P151; Breitbart H, 2003, CELL MOL BIOL, V49, P321; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Delgado-Buenrostro NL, 2005, MOL REPROD DEV, V70, P198, DOI 10.1002/mrd.20192; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; ENDO Y, 1987, DEV BIOL, V119, P210, DOI 10.1016/0012-1606(87)90222-3; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; French KJ, 2003, CANCER RES, V63, P5962; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Gonzalez-Martinez MT, 2001, DEV BIOL, V236, P220, DOI 10.1006/dbio.2001.0323; Gupta Satish K, 2007, Soc Reprod Fertil Suppl, V63, P203; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Babak AK, 2006, J NEUROPHYSIOL, V96, P2688, DOI 10.1152/jn.00118.2006; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; KATADA T, 1984, J BIOL CHEM, V259, P3568; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kirkman-Brown JC, 2003, DEV BIOL, V259, P71, DOI 10.1016/S0012-1606(03)00137-4; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kopf G.S., 1988, Progress in Clinical and Biological Research, V267, P357; KUROSE H, 1983, J BIOL CHEM, V258, P4870; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Matsumoto K, 2005, J HISTOCHEM CYTOCHEM, V53, P243, DOI 10.1369/jhc.4B6507.2005; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; Melaine N, 2006, INT J ANDROL, V29, P392, DOI 10.1111/j.1365-2605.2005.00616.x; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Murase T, 1996, BIOCHEM J, V320, P1017, DOI 10.1042/bj3201017; Muratori M, 2009, INT J ANDROL, V32, P25, DOI 10.1111/j.1365-2605.2008.00875.x; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; O'Toole CMB, 1996, MOL HUM REPROD, V2, P921, DOI 10.1093/molehr/2.12.921; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; POWIS G, 1994, CANCER METAST REV, V13, P91, DOI 10.1007/BF00690420; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Raggers RJ, 1999, J CELL SCI, V112, P415; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Serrano-Sanchez M, 2008, ENDOCRINOLOGY, V149, P4669, DOI 10.1210/en.2008-1756; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Taylor Caroline J., 2006, Angiogenesis, V9, P39, DOI 10.1007/s10456-006-9028-y; Trevino CL, 2006, J CELL PHYSIOL, V206, P449, DOI 10.1002/jcp.20487; Way AL, 2002, J ANDROL, V23, P352; WEST RE, 1985, J BIOL CHEM, V260, P4428; Yanagimachi R., 1994, P189; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084	78	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16302	16314		10.1074/jbc.M109.072439	http://dx.doi.org/10.1074/jbc.M109.072439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236935	hybrid, Green Published			2022-12-27	WOS:000277715900067
J	Unal, H; Jagannathan, R; Bhat, MB; Karnik, SS				Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhat, Manjunatha B.; Karnik, Sadashiva S.			Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; AT(1) RECEPTOR; CONSTITUTIVE ACTIVATION; ALPHA(1)-ADRENERGIC RECEPTOR; CONTACT POINTS; BINDING; IDENTIFICATION; ANTAGONISTS	The orientation of the second extracellular loop (ECL2) is divergent in G-protein coupled receptor (GPCR) structures determined. This discovery provoked the question, is the ECL2 conformation differentially regulated in the GPCRs that respond to diffusible ligands? We have determined the conformation of the ECL2 of the angiotensin II type 1 receptor by reporter-cysteine accessibility mapping in different receptor states (i.e. empty, agonist-bound and antagonist-bound). We introduced cysteines at each position of ECL2 of an N-terminal epitope-tagged receptor surrogate lacking all non-essential cysteines and then measured reaction of these with a cysteine-reactive biotin probe. The ability of biotinylated mutant receptors to react with a steptavidin-HRP-conjugated antibody was used as the basis for examining differences in accessibility. Two segments of ECL2 were accessible in the empty receptor, indicating an open conformation of ECL2. These segments were inaccessible in the ligand-bound states of the receptor. Using the accessibility constraint, we performed molecular dynamics simulation to predict ECL2 conformation in different states of the receptor. Analysis suggested that a lid conformation similar to that of ECL2 in rhodopsin was induced upon binding both agonist and antagonist, but exposing different accessible segments delimited by the highly conserved disulfide bond. Our study reveals the ability of ECL2 to interact with diffusing ligands and to adopt a ligand-specific lid conformation, thus, slowing down dissociation of ligands when bound. Distinct conformations induced by the bound agonist and the antagonist around the conserved disulfide bond suggest an important role for this disulfide bond in producing different functional states of the receptor.	[Unal, Hamiyet; Jagannathan, Rajaganapathi; Karnik, Sadashiva S.] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Bhat, Manjunatha B.] Cleveland Clin Fdn, Lerner Res Inst, Ctr Anesthesiol Res, Cleveland, OH 44195 USA; [Unal, Hamiyet; Bhat, Manjunatha B.; Karnik, Sadashiva S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Karnik, SS (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [R01 HL57470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL57470 (to S. S. K.). This work was also supported by an assistantship from the Department of BGES, Cleveland State University.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Bourne HR, 2000, SCIENCE, V289, P733, DOI 10.1126/science.289.5480.733; BUMPUS FM, 1977, HYPERTENSION PHYSIOP, P183; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Feng YH, 2000, FEBS LETT, V484, P133, DOI 10.1016/S0014-5793(00)02141-4; GARCIA KC, 1992, SCIENCE, V257, P502, DOI 10.1126/science.1636085; GOGONEA C, 2006, J MOL MODEL, V12, P1610; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JI H, 1994, J BIOL CHEM, V269, P16533; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Liao YH, 2002, HYPERTENS RES, V25, P641; MARSHALL GR, 1974, RECENT ADV RENAL PHY, P215; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; NIKIFOROVICH GV, 1994, BIOCHEMISTRY-US, V33, P3591, DOI 10.1021/bi00178a016; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Nouet S, 1999, J MED CHEM, V42, P4572, DOI 10.1021/jm991050l; OHYAMA K, 1995, REGUL PEPTIDES, V57, P141, DOI 10.1016/0167-0115(95)00030-F; Ojima M, 1997, EUR J PHARMACOL, V319, P137, DOI 10.1016/S0014-2999(96)00837-0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMANEN J, 1994, ANGIOTENSIN 2 RECEPT, V2, P11; SCHAMBYE HT, 1994, P NATL ACAD SCI USA, V91, P7046, DOI 10.1073/pnas.91.15.7046; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang WZ, 2000, CHINESE MED J-PEKING, V113, P867; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhao MM, 1996, MOL PHARMACOL, V50, P1118; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	58	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16341	16350		10.1074/jbc.M109.094870	http://dx.doi.org/10.1074/jbc.M109.094870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299456	Green Published, hybrid			2022-12-27	WOS:000277715900070
J	Ma, JT; Benz, C; Grimaldi, R; Stockdale, C; Wyatt, P; Frearson, J; Hammarton, TC				Ma, Jiangtao; Benz, Corinna; Grimaldi, Raffaella; Stockdale, Christopher; Wyatt, Paul; Frearson, Julie; Hammarton, Tansy C.			Nuclear DBF-2-related Kinases Are Essential Regulators of Cytokinesis in Bloodstream Stage Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HUMAN AFRICAN TRYPANOSOMIASIS; MITOTIC EXIT NETWORK; NDR-PROTEIN-KINASE; CELL-CYCLE; TUMOR-SUPPRESSOR; RNA INTERFERENCE; INDUCIBLE EXPRESSION; SIGNALING PATHWAY; SLEEPING SICKNESS	Nuclear DBF-2-related (NDR) kinases are essential regulators of cell cycle progression, growth, and development in many organisms and are activated by the binding of an Mps One Binder (MOB) protein partner, autophosphorylation, and phosphorylation by an upstream STE20 family kinase. In the protozoan parasite, Trypanosoma brucei, the causative agent of human African trypanosomiasis, the NDR kinase, PK50, is expressed in proliferative life cycle stages and was shown to complement a yeast NDR kinase mutant cell line. However, the function of PK50 and a second NDR kinase, PK53, in T. brucei has not been determined to date, although trypanosome MOB1 is known to be essential for cytokinesis, suggesting the NDR kinases may also be involved in this process. Here, we show that specific depletion of PK50 or PK53 from bloodstream stage trypanosomes resulted in the rapid accumulation of cells with two nuclei and two kinetoplasts, indicating that cytokinesis was specifically inhibited. This led to a deregulation of the cell cycle and cell death and provides genetic validation of these kinases as potential novel drug targets for human African trypanosomiasis. Recombinant active PK50 and PK53 were produced and biochemically characterized. Both enzymes autophosphorylated, were able to trans-phosphorylate generic kinase substrates in vitro, and were active in the absence of phosphorylation by an upstream kinase. Additionally, both enzymes were active in the absence of MOB1 binding, which was also demonstrated to likely be a feature of the kinases in vivo. Biochemical characterization of recombinant PK50 and PK53 has revealed key kinetic differences between them, and the identification of in vitro peptide substrates in this study paves the way for high throughput inhibitor screening of these kinases.	[Hammarton, Tansy C.] Univ Glasgow, Div Infect & Immun, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Hammarton, Tansy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Grimaldi, Raffaella; Wyatt, Paul; Frearson, Julie] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Drug Discovery Unit,James Black Ctr, Dundee DD1 5EH, Scotland	University of Glasgow; University of Glasgow; University of Dundee	Hammarton, TC (corresponding author), Level 6 Glasgow Biomed Res Ctr,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	t.hammarton@bio.gla.ac.uk	Hammarton, Tansy/A-5632-2011; Benz, Corinna/AAD-8702-2021	Hammarton, Tansy/0000-0002-0799-6600; Benz, Corinna/0000-0003-4367-2758; Wyatt, Paul/0000-0002-0397-245X	Medical Research Council [G120/1001, G0900239]; Research Councils UK Academic Fellowship [GR/T28003/01]; Wellcome Trust [WT077705]; MRC [G0900239, G120/1001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK Academic Fellowship(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Career Development Fellowship G120/1001 (to T. C. H.), Medical Research Council New Investigator Research Grant G0900239 (to T. C. H.), Research Councils UK Academic Fellowship GR/T28003/01 (to T. C. H.), a Wellcome Trust Value in People award (to C. B.), and Wellcome Trust Strategic Award WT077705 (Drug Discovery for Tropical Disease Initiative).	Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; BURNHAM KP, 2002, MODEL SELECTION INFE, P362; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen YL, 2003, MOL BIOCHEM PARASIT, V126, P275, DOI 10.1016/S0166-6851(02)00276-1; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; Garcia-Salcedo JA, 2002, MOL MICROBIOL, V45, P307, DOI 10.1046/j.1365-2958.2002.03019.x; Geng W, 2000, GENETICS, V156, P1817; Gonzalez-Novo A, 2009, MOL MICROBIOL, V72, P1364, DOI 10.1111/j.1365-2958.2009.06729.x; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2005, MOL CELL BIOL, V25, P8259, DOI 10.1128/MCB.25.18.8259-8272.2005; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hirabayashi S, 2008, ONCOGENE, V27, P4281, DOI 10.1038/onc.2008.66; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Ross H, 2002, BIOCHEM J, V366, P977, DOI 10.1042/BJ20020786; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Segel I. H., 1993, ENZYME KINETICS BEHA, P274; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772, DOI 10.1128/MCB.5.7.1772; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Vieth M, 2004, BBA-PROTEINS PROTEOM, V1697, P243, DOI 10.1016/j.bbapap.2003.11.028; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	62	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15356	15368		10.1074/jbc.M109.074591	http://dx.doi.org/10.1074/jbc.M109.074591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231285	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000277399000056
J	Wagoner, KR; Czajkowski, C				Wagoner, Kelly R.; Czajkowski, Cynthia			Stoichiometry of Expressed alpha(4)beta(2)delta gamma-Aminobutyric Acid Type A Receptors Depends on the Ratio of Subunit cDNA Transfected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT GABA(A) RECEPTOR; DELTA-SUBUNIT; DENTATE GYRUS; ETHANOL SENSITIVITY; CA1 HIPPOCAMPUS; GRANULE CELLS; BINDING-SITE; ION-CHANNEL; INHIBITION; ARRANGEMENT	The gamma-aminobutyric acid type A receptor (GABA(A)R) is the target of many depressants, including benzodiazepines, anesthetics, and alcohol. Although the highly prevalent alpha beta gamma GABA(A)R subtype mediates the majority of fast synaptic inhibition in the brain, receptors containing delta subunits also play a key role, mediating tonic inhibition and the actions of endogenous neurosteroids and alcohol. However, the fundamental properties of delta-containing GABA(A)Rs, such as subunit stoichiometry, are not well established. To determine subunit stoichiometry of expressed delta-containing GABA(A)Rs, we inserted the alpha-bungarotoxin binding site tag in the alpha(4), beta(2), and delta subunit N termini. An enhanced green fluorescent protein tag was also inserted into the beta(2) subunit to shift its molecular weight, allowing us to separate subunits using SDS-PAGE. Tagged alpha(4)beta(2)delta GABA(A)Rs were expressed in HEK293T cells using various ratios of subunit cDNA, and receptor subunit stoichiometry was determined by quantitating fluorescent alpha-bungarotoxin bound to each subunit on Western blots of surface immunopurified tagged GABA(A)Rs. The results demonstrate that the subunit stoichiometry of alpha(4)beta(2)delta GABA(A)Rs is regulated by the ratio of subunit cDNAs transfected. Increasing the ratio of delta subunit cDNA transfected increased delta subunit incorporation into surface receptors with a concomitant decrease in beta(2) subunit incorporation. Because receptor subunit stoichiometry can directly influence GABA(A)R pharmacological and functional properties, considering how the transfection protocols used affect subunit stoichiometry is essential when studying heterologously expressed alpha(4)beta(2)delta GABA(A)Rs. Successful bungarotoxin binding site tagging of GABA(A)R subunits is a novel tool with which to accurately quantitate subunit stoichiometry and will be useful for monitoring GABA(A)R trafficking in live cells.	Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53711 USA; [Czajkowski, Cynthia] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), 601 Sci Dr, Madison, WI 53711 USA.	czajkowski@physiology.wisc.edu			National Institutes of Health [T32 GM008688, F31AA016898, NS34727]; Alcohol Beverage Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727, R56NS034727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA016898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcohol Beverage Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 GM008688 and F31AA016898 (to K. R. W.) and Grant NS34727 (to C. C.). This work was also supported by funds from the Alcohol Beverage Medical Research Foundation (to C. C.).	Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Boileau AJ, 2005, J NEUROSCI, V25, P11219, DOI 10.1523/JNEUROSCI.3751-05.2005; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 1998, MOL PHARMACOL, V53, P295, DOI 10.1124/mol.53.2.295; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2007, ALCOHOL, V41, P155, DOI 10.1016/j.alcohol.2007.03.006; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; BOTZOLAKIS EJ, 2007, SOC NEUR ANN M SAN D; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chang YC, 1996, J NEUROSCI, V16, P5415; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOU TC, 1974, MOL PHARMACOL, V10, P235; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; IM WB, 1995, J BIOL CHEM, V270, P26063, DOI 10.1074/jbc.270.44.26063; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Nelson KR, 2003, SOC WORK HEALTH CARE, V36, P63, DOI 10.1300/J010v36n03_04; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Shen H, 2009, BIOCHEM SOC T, V37, P1378, DOI 10.1042/BST0371378; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Smith SS, 2005, J PHYSIOL-LONDON, V564, P421, DOI 10.1113/jphysiol.2004.077297; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Tretter V, 1997, J NEUROSCI, V17, P2728; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x	47	30	31	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14187	14194		10.1074/jbc.M110.104257	http://dx.doi.org/10.1074/jbc.M110.104257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233712	Green Published, hybrid			2022-12-27	WOS:000277299700015
J	Eckenrode, EF; Yang, J; Velmurugan, GV; Foskett, JK; White, C				Eckenrode, Emily F.; Yang, Jun; Velmurugan, Gopal V.; Foskett, J. Kevin; White, Carl			Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL PROLIFERATION; OLIGOMERIZES BAK; CALCIUM-RELEASE; BCL-X(L); ER; TRANSDUCTION; INVOLVEMENT; ACTIVATION; PROTEINS; BINDING	Members of the Bcl-2 protein family play a central role in the regulation of apoptosis. An interaction between anti-apoptotic Bcl-x(L) and the endoplasmic reticulum (ER)-localized inositol trisphosphate receptor Ca2+ release channel (InsP(3)R) enables Bcl-x(L) to be fully efficacious as an anti-apoptotic mediator (White, C., Li, C., Yang, J., Petrenko, N. B., Madesh, M., Thompson, C. B., and Foskett, J. K. (2005) Nat. Cell Biol. 7, 1021-1028). Physiologically, Bcl-x(L) binds to the InsP(3)R to enhance its gating and Ca2+ signaling. Here we have discovered that structurally related proteins Bcl-2 and Mcl-1 function similarly. Bcl-2, Mcl-1 and Bcl-x(L) bind with comparable affinity to the carboxyl termini of all three mammalian InsP(3)R isoforms with important functional consequences. Stable expression of Bcl-2 or Mcl-1 lowered ER Ca2+ content and enhanced the rate of InsP(3)-mediated Ca2+ release in response to submaximal InsP(3) stimulation in permeabilized wild-type DT40 cells but not in cells lacking InsP(3)R. In addition, expression of either Bcl-2 or Mcl-1 enhanced spontaneous InsP(3)R-dependent Ca2+ oscillations and spiking in intact cells in the absence of agonist stimulation. Bcl-2- and Mcl-1-mediated protection from apoptosis induced by staurosporine or etoposide was enhanced in cells expressing InsP(3)R, demonstrating that their interactions with InsP(3)R enable Bcl-2 and Mcl-1 to be fully efficacious anti-apoptotic mediators. Our data suggest a molecular mechanism that is shared by several anti-apoptotic Bcl-2 proteins that provides apoptosis resistance by direct interactions at the ER with the InsP(3)R that impinges on cellular Ca2+ homeostasis.	[Eckenrode, Emily F.; Velmurugan, Gopal V.; White, Carl] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Yang, Jun; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Rosalind Franklin University Medical & Science; University of Pennsylvania; University of Pennsylvania	White, C (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	carl.white@rosalindfranklin.edu	Foskett, Kevin/R-2549-2019	White, Carl/0000-0002-0535-6968	National Institutes of Health [GM/DK56328]; Schweppe Foundation; Rosalind Franklin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; Rosalind Franklin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM/DK56328 (to J. K. F.) and funding from the Schweppe Foundation and Rosalind Franklin University (to C. W.).	Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Decaudin D, 1997, CANCER RES, V57, P62; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Korfali N, 2004, J BIOL CHEM, V279, P1030, DOI 10.1074/jbc.M306277200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Wei MC, 2000, GENE DEV, V14, P2060; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	31	132	139	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13678	13684		10.1074/jbc.M109.096040	http://dx.doi.org/10.1074/jbc.M109.096040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189983	hybrid, Green Published			2022-12-27	WOS:000276987700042
J	Wu, YY; Williams, M; Bernard, S; Driouich, A; Showalter, AM; Faik, A				Wu, Yingying; Williams, Matthew; Bernard, Sophie; Driouich, Azeddine; Showalter, Allan M.; Faik, Ahmed			Functional Identification of Two Nonredundant Arabidopsis alpha(1,2)Fucosyltransferases Specific to Arabinogalactan Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSE-DEFICIENT MUTANT; CELL WALL BIOSYNTHESIS; GOLGI-APPARATUS; XYLOGLUCAN OLIGOSACCHARIDES; GROWTH; GLYCOPROTEINS; GENES; POLYSACCHARIDE; TRANSFERASES; THALIANA	Virtually nothing is known about the mechanisms and enzymes responsible for the glycosylation of arabinogalactan proteins (AGPs). The glycosyltransferase 37 family contains plant-specific enzymes, which suggests involvement in plant-specific organs such as the cell wall. Our working hypothesis is that AtFUT4 and AtFUT6 genes encode alpha(1,2)fucosyltransferases (FUTs) for AGPs. Multiple lines of evidence support this hypothesis. First, overexpression of the two genes in tobacco BY2 cells, known to contain nonfucosylated AGPs, resulted in a staining of transgenic cells with eel lectin, which specifically binds to terminal alpha-linked fucose. Second, monosaccharide analysis by high pH anion exchange chromatography and electrospray ionization mass spectrometry indicated the presence of fucose in AGPs from transgenic cell lines but not in AGPs from wild type cells. Third, detergent extracts from microsomal membranes prepared from transgenic lines were able to fucosylate, in vitro, purified AGPs from BY2 wild type cells. Susceptibility of [C-14]fucosylated AGPs to alpha(1,2)fucosidase, and not to alpha(1,3/4)fucosidase, indicated that an alpha(1,2) linkage is formed. Furthermore, dearabinosylated AGPs were not substrate acceptors for these enzymes, indicating that arabinosyl residues represent the fucosylation sites on these molecules. Testing of several polysaccharides, oligosaccharides, and glycoproteins as potential substrate acceptors in the fucosyl transfer reactions indicated that the two enzymes are specific for AGPs but are not functionally redundant because they differentially fucosylate certain AGPs. AtFUT4 and AtFUT6 are the first enzymes to be characterized for AGP glycosylation and further our understanding of cell wall biosynthesis.	[Wu, Yingying; Williams, Matthew; Showalter, Allan M.; Faik, Ahmed] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Showalter, Allan M.; Faik, Ahmed] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Bernard, Sophie; Driouich, Azeddine] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, UFR Sci & Tech, UPRES EA 4358,IFRMP 23, F-76821 Mont St Aignan, France	University System of Ohio; Ohio University; University System of Ohio; Ohio University; Universite de Rouen Normandie	Faik, A (corresponding author), Ohio Univ, Dept Environm & Plant Biol, 512 Porter Hall, Athens, OH 45701 USA.	faik@ohio.edu	Faik, Ahmed/ABB-9120-2020		United States Department of Agriculture National Institute of Food and Agriculture [2008-35318-04563, 2008-35318-04572]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Research Initiative Competitive Grants 2008-35318-04563 and 2008-35318-04572 from the United States Department of Agriculture National Institute of Food and Agriculture.	AUGUR C, 1992, PLANT PHYSIOL, V99, P180, DOI 10.1104/pp.99.1.180; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Farrokhi N, 2006, PLANT BIOTECHNOL J, V4, P145, DOI 10.1111/j.1467-7652.2005.00169.x; GARDINER M, 1975, PLANT PHYSIOL, V55, P536, DOI 10.1104/pp.55.3.536; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; JOHNSON KD, 1987, PLANT PHYSIOL, V84, P1301, DOI 10.1104/pp.84.4.1301; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; LEVY S, 1991, PLANT J, V1, P195; MCDOUGALL GJ, 1990, PLANT PHYSIOL, V93, P1042, DOI 10.1104/pp.93.3.1042; Misawa H, 1996, PLANT PHYSIOL, V110, P665, DOI 10.1104/pp.110.2.665; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; OWENS RJ, 1981, BIOCHEM J, V195, P661, DOI 10.1042/bj1950661; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Shida K, 2009, GLYCOBIOLOGY, V19, P1018, DOI 10.1093/glycob/cwp083; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; WARNECK HM, 1997, PLANTA, V204, P78; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576	34	68	70	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13638	13645		10.1074/jbc.M110.102715	http://dx.doi.org/10.1074/jbc.M110.102715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194500	Green Published, hybrid			2022-12-27	WOS:000276987700038
J	Hara, K; Hashimoto, H; Murakumo, Y; Kobayashi, S; Kogame, T; Unzai, S; Akashi, S; Takeda, S; Shimizu, T; Sato, M				Hara, Kodai; Hashimoto, Hiroshi; Murakumo, Yoshiki; Kobayashi, Shunsuke; Kogame, Toshiaki; Unzai, Satoru; Akashi, Satoko; Takeda, Shunichi; Shimizu, Toshiyuki; Sato, Mamoru			Crystal Structure of Human REV7 in Complex with a Human REV3 Fragment and Structural Implication of the Interaction between DNA Polymerase zeta and REV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; YEAST REV1; MOLECULAR GRAPHICS; MULTIPLE ROLES; C-TERMINUS; Y-FAMILY; PROTEIN; DISRUPTION	DNA polymerase zeta (Pol zeta) is an error-prone DNA polymerase involved in translesion DNA synthesis. Pol zeta consists of two sub-units: the catalytic REV3, which belongs to B family DNA polymerase, and the noncatalytic REV7. REV7 also interacts with REV1 polymerase, which is an error-prone Y family DNA polymerase and is also involved in translesion DNA synthesis. Cells deficient in one of the three REV proteins and those deficient in all three proteins show similar phenotype, indicating the functional collaboration of the three REV proteins. REV7 interacts with both REV3 and REV1 polymerases, but the structure of REV7 or REV3, as well as the structural and functional basis of the REV1-REV7 and REV3-REV7 interactions, remains unknown. Here we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase (residues 1847-1898) and reveal the mechanism underlying REV7-REV3 interaction. The structure indicates that the interaction between REV7 and REV3 creates a structural interface for REV1 binding. Furthermore, we show that the REV7-mediated interactions are responsible for DNA damage tolerance. Our results highlight the function of REV7 as an adapter protein to recruit Pol zeta to a lesion site. REV7 is alternatively called MAD2B or MAD2L2 and also involved in various cellular functions such as signal transduction and cell cycle regulation. Our results will provide a general structural basis for understanding the REV7 interaction.	[Hara, Kodai; Hashimoto, Hiroshi; Unzai, Satoru; Akashi, Satoko; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murakumo, Yoshiki] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kobayashi, Shunsuke; Kogame, Toshiaki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Yokohama City University; Nagoya University; Kyoto University	Hashimoto, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp		Kogame, Toshiaki/0000-0002-0683-719X; hara, kodai/0000-0002-1586-6312; Hashimoto, Hiroshi/0000-0003-1503-6789; Akashi, Satoko/0000-0002-8978-6358	KAKENHI; Target Protein Research Programs; Yokohama Academic Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Target Protein Research Programs; Yokohama Academic Foundation	This work was supported by funding from KAKENHI, the Protein 3000 Project, and the Target Protein Research Programs (to H. H., T. S., and M. S.), and by a grant from the Yokohama Academic Foundation (to H. H.).	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; D'Souza S, 2006, MOL CELL BIOL, V26, P8173, DOI 10.1128/MCB.00202-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAWRENCE CW, 1979, GENETICS, V92, P397; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; LAWRENCE CW, 1982, MOL GEN GENET, V186, P1, DOI 10.1007/BF00422904; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2002, MUTAT RES-FUND MOL M, V510, P37, DOI 10.1016/S0027-5107(02)00250-6; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2004, ADV PROTEIN CHEM, V69, P205; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06	55	91	95	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12299	12307		10.1074/jbc.M109.092403	http://dx.doi.org/10.1074/jbc.M109.092403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164194	hybrid, Green Published			2022-12-27	WOS:000276787100059
J	Osakabe, A; Tachiwana, H; Matsunaga, T; Shiga, T; Nozawa, RS; Obuse, C; Kurumizaka, H				Osakabe, Akihisa; Tachiwana, Hiroaki; Matsunaga, Takaaki; Shiga, Tatsuya; Nozawa, Ryu-Suke; Obuse, Chikashi; Kurumizaka, Hitoshi			Nucleosome Formation Activity of Human Somatic Nuclear Autoantigenic Sperm Protein (sNASP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 VARIANTS; XENOPUS-LAEVIS OOCYTES; ASSEMBLY FACTOR-I; CENP-A; STRUCTURAL BASIS; CELL-CYCLE; MAMMALIAN-CELLS; BINDING PROTEIN; DNA-SYNTHESIS; CHROMATIN	NASP (nuclear autoantigenic sperm protein) is a member of the N1/N2 family, which is widely conserved among eukaryotes. Human NASP reportedly prefers to bind to histones H3.H4 and the linker histone H1, as compared with H2A.H2B, and is anticipated to function as an H3.H4 chaperone for nucleosome assembly. However, the direct nucleosome assembly activity of human NASP has not been reported so far. In humans, two spliced isoforms, somatic and testicular NASPs (sNASP and tNASP, respectively) were identified. In the present study we purified human sNASP and found that sNASP efficiently promoted the assembly of nucleosomes containing the conventional H3.1, H3.2, H3.3, or centromere-specific CENP-A. On the other hand, sNASP inefficiently promoted nucleosome assembly with H3T, a testis-specific H3 variant. Mutational analyses revealed that the Met-71 residue of H3T is responsible for this inefficient nucleosome formation by sNASP. Tetrasomes, composed of the H3.H4 tetramer and DNA without H2A.H2B, were efficiently formed by the sNASP-mediated nucleosome-assembly reaction. A deletion analysis of sNASP revealed that the central region, amino acid residues 26-325, of sNASP is responsible for nucleosome assembly in vitro. These experiments are the first demonstration that human NASP directly promotes nucleosome assembly and provide compelling evidence that sNASP is a bona fide histone chaperone for H3.H4.	[Nozawa, Ryu-Suke; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Kurumizaka, Hitoshi] Waseda Univ, Struct Biol Lab, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Hokkaido University; Waseda University	Kurumizaka, H (corresponding author), Waseda Res Inst Sci & Engn, Tokyo, Japan.	kurumizaka@waseda.jp	Tachiwana, Hiroaki/AHB-3091-2022; Obuse, Chikashi/F-5273-2011	Tachiwana, Hiroaki/0000-0001-9227-7653; Osakabe, Akihisa/0000-0002-2526-3398; Kurumizaka, Hitoshi/0000-0001-7412-3722	Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Japanese Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.; Supported by Japanese Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists (a JSPS Research Fellow).	Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Antczak AJ, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-26; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hu RJ, 1996, HUM MOL GENET, V5, P1743, DOI 10.1093/hmg/5.11.1743; ISHIMI Y, 1984, EUR J BIOCHEM, V142, P431, DOI 10.1111/j.1432-1033.1984.tb08305.x; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kamakaka RT, 1996, MOL CELL BIOL, V16, P810; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; KLEINSCHMIDT JA, 1982, CELL, V29, P799, DOI 10.1016/0092-8674(82)90442-1; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okuwaki M, 2005, MOL CELL BIOL, V25, P10639, DOI 10.1128/MCB.25.23.10639-10651.2005; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574	54	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11913	11921		10.1074/jbc.M109.083238	http://dx.doi.org/10.1074/jbc.M109.083238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167597	Green Published, hybrid			2022-12-27	WOS:000276787100019
J	Jinwal, UK; O'Leary, JC; Borysov, SI; Jones, JR; Li, QY; Koren, J; Abisambra, JF; Vestal, GD; Lawson, LY; Johnson, AG; Blair, LJ; Jin, Y; Miyata, Y; Gestwicki, JE; Dickey, CA				Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Miyata, Yoshinari; Gestwicki, Jason E.; Dickey, Chad A.			Hsc70 Rapidly Engages Tau after Microtubule Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; SHOCK-PROTEIN HSC70; ALZHEIMERS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASES; CONFORMATIONAL-CHANGE; HSP70; AGGREGATION; ASSOCIATION; EXPRESSION	The microtubule-associated protein Tau plays a crucial role in regulating the dynamic stability of microtubules during neuronal development and synaptic transmission. In a group of neurodegenerative diseases, such as Alzheimer disease and other tauopathies, conformational changes in Tau are associated with the initial stages of disease pathology. Folding of Tau into the MC1 conformation, where the amino acids at residues 7-9 interact with residues 312-342, is one of the earliest pathological alterations of Tau in Alzheimer disease. The mechanism of this conformational change in Tau and the subsequent effect on function and association to microtubules is largely unknown. Recent work by our group and others suggests that members of the Hsp70 family play a significant role in Tau regulation. Our new findings suggest that heat shock cognate (Hsc) 70 facilitates Tau-mediated microtubule polymerization. The association of Hsc70 with Tau was rapidly enhanced following treatment with microtubule-destabilizing agents. The fate of Tau released from the microtubule was found to be dependent on ATPase activity of Hsc70. Microtubule destabilization also rapidly increased the MC1 folded conformation of Tau. An in vitro assay suggests that Hsc70 facilitates formation of MC1 Tau. However, in a hyperphosphorylating environment, the formation of MC1 was abrogated, but Hsc70 binding to Tau was enhanced. Thus, under normal circumstances, MC1 formation may be a protective conformation facilitated by Hsc70. However, in a diseased environment, Hsc70 may preserve Tau in a more unstructured state, perhaps facilitating its pathogenicity.	[Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Gestwicki, Jason E.; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Gestwicki, Jason E.; Dickey, Chad A.] Univ S Florida, Johnnie B Byrd Sr Alzheimers Res Inst, Tampa, FL 33613 USA; [Miyata, Yoshinari] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, 4001 E Fletcher Ave,MDC 36, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Dickey, Chad A/H-4441-2011; Abisambra, Joe/AAP-3269-2020	Abisambra, Jose/0000-0001-6341-679X; Jones, Jeffrey/0000-0002-7570-2571; Blair, Laura/0000-0002-4981-5564; Lawson, Lisa/0000-0002-4436-5357; Koren, John/0000-0002-6017-1763	National Institutes of Health [NS059690, AG031291]; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291, K99AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059690 (to J. E. G.) and AG031291. This work was also supported by the Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP.	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Goedert M, 1999, NAT MED, V5, P454, DOI 10.1038/7454; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Khalilzadeh A, 2007, BIOCHEM PHARMACOL, V74, P407, DOI 10.1016/j.bcp.2007.05.006; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rasband MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000340; Ryu K, 2008, BIOCHEM BIOPH RES CO, V373, P74, DOI 10.1016/j.bbrc.2008.05.186; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Sevcik J, 2009, PROTEIN PEPTIDE LETT, V16, P61, DOI 10.2174/092986609787049349; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; TOHGI H, 1995, NEUROSCI LETT, V196, P89, DOI 10.1016/0304-3940(95)11854-P; Tortosa E, 2009, J ALZHEIMERS DIS, V17, P319, DOI 10.3233/JAD-2009-1049; Uboga NV, 2000, NEUROBIOL AGING, V21, P1, DOI 10.1016/S0197-4580(00)00091-9; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200	46	65	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16798	16805		10.1074/jbc.M110.113753	http://dx.doi.org/10.1074/jbc.M110.113753			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308058	hybrid, Green Published			2022-12-27	WOS:000277982600043
J	Staschke, KA; Dey, S; Zaborske, JM; Palam, LR; McClintick, JN; Pan, T; Edenberg, HJ; Wek, RC				Staschke, Kirk A.; Dey, Souvik; Zaborske, John M.; Palam, Lakshmi Reddy; McClintick, Jeanette N.; Pan, Tao; Edenberg, Howard J.; Wek, Ronald C.			Integration of General Amino Acid Control and Target of Rapamycin (TOR) Regulatory Pathways in Nitrogen Assimilation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GCN4; TRANSFER-RNA-BINDING; OPEN READING FRAMES; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSLATIONAL CONTROL; EXPRESSION; STRESS; ACTIVATION; IDENTIFICATION	Two important nutrient-sensing and regulatory pathways, the general amino acid control (GAAC) and the target of rapamycin (TOR), participate in the control of yeast growth and metabolism during changes in nutrient availability. Amino acid starvation activates the GAAC through Gcn2p phosphorylation of translation factor eIF2 and preferential translation of GCN4, a transcription activator. TOR senses nitrogen availability and regulates transcription factors such as Gln3p. We used microarray analyses to address the integration of the GAAC and TOR pathways in directing the yeast transcriptome during amino acid starvation and rapamycin treatment. We found that GAAC is a major effector of the TOR pathway, with Gcn4p and Gln3p each inducing a similar number of genes during rapamycin treatment. Although Gcn4p activates a common core of 57 genes, the GAAC directs significant variations in the transcriptome during different stresses. In addition to inducing amino acid biosynthetic genes, Gcn4p in conjunction with Gln3p activates genes required for the assimilation of secondary nitrogen sources such as gamma-aminobutyric acid (GABA). Gcn2p activation upon shifting to secondary nitrogen sources is suggested to occur by means of a dual mechanism. First, Gcn2p is induced by the release of TOR repression through a mechanism involving Sit4p protein phosphatase. Second, this eIF2 kinase is activated by select uncharged tRNAs, which were shown to accumulate during the shift to the GABA medium. This study highlights the mechanisms by which the GAAC and TOR pathways are integrated to recognize changing nitrogen availability and direct the transcriptome for optimal growth adaptation.	[Staschke, Kirk A.; Dey, Souvik; Palam, Lakshmi Reddy; McClintick, Jeanette N.; Edenberg, Howard J.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zaborske, John M.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015; Staschke, Kirk/HGC-5664-2022	Staschke, Kirk/0000-0001-8722-9585; Edenberg, Howard/0000-0003-0344-9690	National Institutes of Health [R01GM49164]; Indiana Genomics Initiative; Lilly Endowment, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Genomics Initiative; Lilly Endowment, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49164 (to R.C.W.).; We thank Li Jiang for technical assistance, Alan Hinnebusch, Gerhard Braus, and Stephen Zheng for providing reagents, and the Biochemistry Biotechnology Facility at Indiana University for DNA sequencing. We also thank Ron Jerome at the Center for Medical Genomics for processing of microarray chips. Microarray experiments were carried out at the Center for Medical Genomics at Indiana University School of Medicine, which is supported in part by the Indiana Genomics Initiative and the Lilly Endowment, Inc.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; ANDRE B, 1990, MOL GEN GENET, V220, P269; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bomeke K, 2006, MOL BIOL CELL, V17, P2952, DOI 10.1091/mbc.E05-10-0975; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUS GH, 2006, MOL BIOL CELL, V17, P2952; Burke D., 2000, METHODS YEAST GENETI, P171; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HARDY TA, 1993, J BIOL CHEM, V268, P23799; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Iraqui I, 1999, MOL CELL BIOL, V19, P3360; Irniger S, 2003, CURR GENET, V44, P8, DOI 10.1007/s00294-003-0422-3; Ishida C, 2006, MOL MICROBIOL, V59, P1790, DOI 10.1111/j.1365-2958.2006.05055.x; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SENTHESHANMUGANATHAN S, 1960, BIOCHEM J, V74, P568, DOI 10.1042/bj0740568; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shemer R, 2002, MOL CELL BIOL, V22, P5395, DOI 10.1128/MCB.22.15.5395-5404.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2004, TOP CURR GENET, V7, P171; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zar JH., 1999, BIOSTAT ANAL, V663rd; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	79	79	84	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16893	16911		10.1074/jbc.M110.121947	http://dx.doi.org/10.1074/jbc.M110.121947			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20233714	Green Published, hybrid			2022-12-27	WOS:000277982600053
J	Frondorf, K; Henkels, KM; Frohman, MA; Gomez-Cambronero, J				Frondorf, Kathleen; Henkels, Karen M.; Frohman, Michael A.; Gomez-Cambronero, Julian			Phosphatidic Acid Is a Leukocyte Chemoattractant That Acts through S6 Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PHOSPHOLIPASE-D ACTIVITY; MAMMALIAN TARGET; HUMAN NEUTROPHILS; CELL-MIGRATION; GM-CSF; MTOR; ACTIVATION; PATHWAY; PROTEIN	Phosphatidic acid (PA) is a pleiotropic lipid second messenger in mammalian cells. We report here that extracellular PA acts as a leukocyte chemoattractant, as membrane-soluble di-oleoyl-PA (DOPA) elicits actin polymerization and chemotaxis of human neutrophils and differentiated proleukemic HL-60 cells. We show that the mechanism for this involves the S6 kinase (S6K) signaling enzyme. Chemotaxis was inhibited >90% by the S6K inhibitors rapamycin and bisindolylmaleimide and by S6K1 silencing using double-stranded RNA. However, it was only moderately (similar to 30%) inhibited by mTOR siRNA, indicating the presence of an mTOR-independent mechanism for S6K. Exogenous PA led to robust time-and dose-dependent increases in S6K enzymatic activity and Thr(421)/Ser(424) phosphorylation, further supporting a PA/S6K connection. We also investigated whether intracellular PA production affects cell migration. Overexpression of phospholipase D2 (PLD2) and, to a lesser extent, PLD1, resulted in elevation of both S6K activity and chemokinesis, whereas PLD silencing was inhibitory. Because the lipase-inactive PLD2 mutants K444R and K758R neither activated S6K nor induced chemotaxis, intracellular PA is needed for this form of cell migration. Lastly, we demonstrated a connection between extracellular and intracellular PA. Using an enhanced green fluorescent protein-derived PA sensor (pEGFP-Spo20PABD), we showed that exogenous PA or PA generated in situ by bacterial (Streptomyces chromofuscus) PLD enters the cell and accumulates in vesicle-like cytoplasmic structures. In summary, we report the discovery of PA as a leukocyte chemoattractant via cell entry and activation of S6K to mediate the cytoskeletal actin polymerization and leukocyte chemotaxis required for the immune function of these cells.	[Frondorf, Kathleen; Henkels, Karen M.; Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA	University System of Ohio; Wright State University Dayton; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gomez-Cambronero, J (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653, 667131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 and Research challenge Grant 667131 ( Ohio Board of Regents) ( to J.G.-C.).	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Crouch MF, 1997, BIOCHEM BIOPH RES CO, V233, P193, DOI 10.1006/bbrc.1997.6419; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Di Fulvio M, 2007, J MOL BIOL, V367, P814, DOI 10.1016/j.jmb.2007.01.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Gomez-Cambronero J, 2003, FEBS LETT, V550, P94, DOI 10.1016/S0014-5793(03)00828-7; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kriebel PW, 2009, METHODS MOL BIOL, V571, P111, DOI 10.1007/978-1-60761-198-1_7; Kusner DJ, 2002, J BIOL CHEM, V277, P50683, DOI 10.1074/jbc.M209221200; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Shen L, 2004, CELL IMMUNOL, V230, P23, DOI 10.1016/j.cellimm.2004.08.004; Siddiqui RA, 1997, BBA-LIPID LIPID MET, V1349, P81, DOI 10.1016/S0005-2760(97)00085-4; Sliva D, 2000, BIOCHEM BIOPH RES CO, V268, P471, DOI 10.1006/bbrc.2000.2111; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Tanski WJ, 2005, J VASC SURG, V41, P91, DOI 10.1016/j.jvs.2004.08.058; Taylor RM, 2004, BBA-BIOMEMBRANES, V1663, P201, DOI 10.1016/j.bbamem.2004.03.009; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Uesugi Y, 2009, BBA-MOL CELL BIOL L, V1791, P962, DOI 10.1016/j.bbalip.2009.01.020; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; ZHOU D, 1995, J BIOL CHEM, V270, P25549, DOI 10.1074/jbc.270.43.25549	49	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15837	15847		10.1074/jbc.M109.070524	http://dx.doi.org/10.1074/jbc.M109.070524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304930	hybrid, Green Published			2022-12-27	WOS:000277715900021
J	Owens, RM; Gu, XL; Shin, MR; Springer, TA; Jin, MM				Owens, Roisin M.; Gu, Xiaoling; Shin, Miran; Springer, Timothy A.; Jin, Moonsoo M.			Engineering of Single Ig Superfamily Domain of Intercellular Adhesion Molecule 1 (ICAM-1) for Native Fold and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RHINOVIRUS; CRYSTAL-STRUCTURE; CELL-SURFACE; TRANSENDOTHELIAL MIGRATION; IMMUNOGLOBULIN SUPERFAMILY; DIRECTED EVOLUTION; COXSACKIEVIRUS A21; RECEPTOR MOLECULE; ANTIGEN-1 LFA-1; IN-VIVO	The immunoglobulin (Ig) superfamily is one of the largest families in the vertebrate genome, found most frequently in cell surface molecules. Intercellular adhesion molecule-1 (ICAM-1) contains five extracellular Ig superfamily domains (D1-D5) of which the first domain, D1, is the binding site for the integrin lymphocyte function-associated antigen-1 (LFA-1) and human rhinovirus. Despite the modular nature of many Ig superfamily domains with respect to domain folding and ligand recognition, D1 does not fold on its own due to the loss of its interaction with the second domain. The goal of this study was to engineer ICAM-1D1 by introducing mutations that would stabilize the Ig superfamily domain fold while retaining its ability to bind to LFA-1 and rhinovirus. First, with a directed evolution approach, we isolated mutations in D1 that showed binding to conformation-specific antibodies and the ligand binding domain of LFA-1 called the inserted, or I, domain. Then, with a rational design approach we introduced mutations that contributed to the stability of ICAM-1 D1 in solution. The mutations that restored native folding of D1 in isolation were those that would convert hydrogen bond networks in buried regions into hydrophobic contacts. Notably, for most mutations, identical or similar types of substitutions were found in ICAM-1 molecules of different species and other ICAM family members. The systematic approach demonstrated in this study to engineer a single Ig superfamily fold in ICAM-1 can be broadly applicable to the engineering of modular Ig superfamily domains in other cell surface molecules.	[Springer, Timothy A.; Jin, Moonsoo M.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Owens, Roisin M.; Gu, Xiaoling; Shin, Miran; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Cornell University	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu; mj227@cornell.edu	Owens, Roisin/O-4371-2019; Jin, Moonsoo/D-6128-2011	Owens, Roisin/0000-0001-7856-2108; 	National Institutes of Health [CA31798, AI079532]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA31798 and AI079532.	Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Blackford J, 1996, EUR J IMMUNOL, V26, P525, DOI 10.1002/eji.1830260304; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; GREVE JM, 1991, J VIROL, V65, P6015, DOI 10.1128/JVI.65.11.6015-6023.1991; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grunert HP, 1997, MED MICROBIOL IMMUN, V186, P1, DOI 10.1007/s004300050039; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117, DOI 10.1002/jlb.65.1.117; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Klickstein LB, 1996, J BIOL CHEM, V271, P23920, DOI 10.1074/jbc.271.39.23920; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MARTIN S, 1993, J VIROL, V67, P3561, DOI 10.1128/JVI.67.6.3561-3568.1993; MARTIN S, 1993, ANTIMICROB AGENTS CH, V37, P1278, DOI 10.1128/AAC.37.6.1278; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Owens RM, 2009, J RECEPT SIG TRANSD, V29, P195, DOI 10.1080/10799890903079919; Racaniello VR, 1996, P NATL ACAD SCI USA, V93, P11378, DOI 10.1073/pnas.93.21.11378; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; ROTHLEIN R, 1991, J IMMUNOL, V147, P3788; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Shafren DR, 1997, J VIROL, V71, P4736, DOI 10.1128/JVI.71.6.4736-4743.1997; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1992, J IMMUNOL, V148, P3271; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; TOMASSINI JE, 1986, J VIROL, V58, P290, DOI 10.1128/JVI.58.2.290-295.1986; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	50	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15906	15915		10.1074/jbc.M110.104349	http://dx.doi.org/10.1074/jbc.M110.104349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304924	Green Published, hybrid			2022-12-27	WOS:000277715900028
J	Takeda, A; Sarma, NJ; Abdul-Nabi, AM; Yaseen, NR				Takeda, Akiko; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Yaseen, Nabeel R.			Inhibition of CRM1-mediated Nuclear Export of Transcription Factors by Leukemogenic NUP98 Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PORE COMPLEX; ONCOGENE NUP98-HOXA9; NUCLEOPORIN NUP98; GENE; CRM1; BINDING; IMPORT	NUP98 is a nucleoporin that plays complex roles in the nucleocytoplasmic trafficking of macromolecules. Rearrangements of the NUP98 gene in human leukemia result in the expression of numerous fusion oncoproteins whose effect on nucleocytoplasmic trafficking is poorly understood. The present study was undertaken to determine the effects of leukemogenic NUP98 fusion proteins on CRM1-mediated nuclear export. NUP98-HOXA9, a prototypic NUP98 fusion, inhibited the nuclear export of two known CRM1 substrates: mutated cytoplasmic nucleophosmin and HIV-1 Rev. In vitro binding assays revealed that NUP98-HOXA9 binds CRM1 through the FG repeat motif in a Ran-GTP-dependent manner similar to but stronger than the interaction between CRM1 and its export substrates. Two NUP98 fusions, NUP98-HOXA9 and NUP98-DDX10, whose fusion partners are structurally and functionally unrelated, interacted with endogenous CRM1 in myeloid cells as shown by co-immunoprecipitation. These leukemogenic NUP98 fusion proteins interacted with CRM1, Ran, and the nucleoporin NUP214 in a manner fundamentally different from that of wildtype NUP98. NUP98-HOXA9 and NUP98-DDX10 formed characteristic aggregates within the nuclei of a myeloid cell line and primary human CD34+ cells and caused aberrant localization of CRM1 to these aggregates. These NUP98 fusions caused nuclear accumulation of two transcription factors, NFAT and NF kappa B, that are regulated by CRM1-mediated export. The nuclear entrapment of NFAT and NF kappa B correlated with enhanced transcription from promoters responsive to these transcription factors. Taken together, the results suggest a new mechanism by which NUP98 fusions dysregulate transcription and cause leukemia, namely, inhibition of CRM1-mediated nuclear export with aberrant nuclear retention of transcriptional regulators.	[Takeda, Akiko; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Yaseen, NR (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	nyaseen@path.wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	National Institutes of Health [R01 HL082549, K02 HL084179, T32 CA009547]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL082549 and K02 HL084179 ( to N. R. Y.) and T32 CA009547 ( to A. M. A.).	Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bibak N, 2004, ANAL BIOCHEM, V333, P57, DOI 10.1016/j.ab.2004.06.017; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Im SH, 2004, MOL CELLS, V18, P1; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	51	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16248	16257		10.1074/jbc.M109.048785	http://dx.doi.org/10.1074/jbc.M109.048785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233715	hybrid, Green Published			2022-12-27	WOS:000277715900061
J	Thorpe, CT; Streeter, I; Pinchbeck, GL; Goodship, AE; Clegg, PD; Birch, HL				Thorpe, Chavaunne T.; Streeter, Ian; Pinchbeck, Gina L.; Goodship, Allen E.; Clegg, Peter D.; Birch, Helen L.			Aspartic Acid Racemization and Collagen Degradation Markers Reveal an Accumulation of Damage in Tendon Collagen That Is Enhanced with Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; HUMAN INTERVERTEBRAL DISCS; AGE-RELATED ACCUMULATION; DIGITAL FLEXOR TENDON; EXTRACELLULAR-MATRIX; AGGRECAN TURNOVER; GLYCATION; EXERCISE; HYDROXYPROLINE; MICRODIALYSIS	Little is known about the rate at which protein turnover occurs in living tendon and whether the rate differs between tendons with different physiological roles. In this study, we have quantified the racemization of aspartic acid to calculate the age of the collagenous and non-collagenous components of the high strain injury-prone superficial digital flexor tendon (SDFT) and low strain rarely injured common digital extensor tendon (CDET) in a group of horses with a wide age range. In addition, the turnover of collagen was assessed indirectly by measuring the levels of collagen degradation markers (collagenase-generated neoepitope and cross-linked telopeptide of type I collagen). The fractional increase in D-Asp was similar (p = 0.7) in the SDFT (5.87 x 10(-4)/year) and CDET (5.82 x 10(-4)/year) tissue, and D/L-Asp ratios showed a good correlation with pentosidine levels. We calculated a mean (+/-S.E.) collagen half-life of 197.53 (+/-18.23) years for the SDFT, which increased significantly with horse age (p = 0.03) and was significantly (p < 0.001) higher than that for the CDET (34.03 (+/-3.39) years). Using similar calculations, the half-life of non-collagenous protein was 2.18 (+/-0.41) years in the SDFT and was significantly (p = 0.04) lower than the value of 3.51 (+/-0.51) years for the CDET. Collagen degradation markers were higher in the CDET and suggested an accumulation of partially degraded collagen within the matrix with aging in the SDFT. We propose that increased susceptibility to injury in older individuals results from an inability to remove partially degraded collagen from the matrix leading to reduced mechanical competence.	[Thorpe, Chavaunne T.; Streeter, Ian; Goodship, Allen E.; Birch, Helen L.] UCL, Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, London HA7 4LP, England; [Streeter, Ian] UCL, Dept Chem, London HA7 4LP, England; [Pinchbeck, Gina L.; Clegg, Peter D.] Univ Liverpool, Dept Comparat Mol Med, Leahurst HG4 7TE, Cheshire, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Liverpool	Thorpe, CT (corresponding author), UCL, Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, Stanmore Campus, London HA7 4LP, England.	rejacth@ucl.ac.uk	Thorpe, Chavaunne T/T-7289-2018	Thorpe, Chavaunne T/0000-0001-7051-3504; Birch, Helen/0000-0002-7966-9967; Clegg, Peter/0000-0003-0632-0032; Streeter, Ian/0000-0003-4024-3552	Horse Trust, UK [231748]; MRC [G0700869] Funding Source: UKRI; Medical Research Council [G0700869] Funding Source: researchfish	Horse Trust, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a welfare grant from The Horse Trust, UK (Registered Charity Number 231748).	BADA JL, 1984, METHOD ENZYMOL, V106, P98; BADA JL, 1973, NATURE, V245, P308, DOI 10.1038/245308a0; BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385; BANNISTER DW, 1970, ANALYST, V95, P596, DOI 10.1039/an9709500596; Becher C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-46; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; Birch HL, 2006, MATRIX BIOL, V25, pS74, DOI 10.1016/j.matbio.2006.08.204; Birch HL, 2008, MATRIX BIOL, V27, P182, DOI 10.1016/j.matbio.2007.10.004; Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; FANIBUNDA KB, 1986, J DENT, V14, P160, DOI 10.1016/0300-5712(86)90018-7; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; HELFMAN PM, 1976, NATURE, V262, P279, DOI 10.1038/262279b0; Ker RF, 2002, COMP BIOCHEM PHYS A, V133, P987, DOI 10.1016/S1095-6433(02)00171-X; Langberg H, 2001, J PHYSIOL-LONDON, V534, P297, DOI 10.1111/j.1469-7793.2001.00297.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Lin YL, 2005, J VET MED A, V52, P333, DOI 10.1111/j.1439-0442.2005.00742.x; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Reddy GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P174, DOI 10.1006/abbi.2001.2747; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Sivan SS, 2008, J BIOL CHEM, V283, P8796, DOI 10.1074/jbc.M709885200; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; Van Duin ACT, 1998, ORG GEOCHEM, V29, P1227, DOI 10.1016/S0146-6380(98)00098-9; Verzijl N, 2001, MATRIX BIOL, V20, P409, DOI 10.1016/S0945-053X(01)00158-5; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WILSON AM, 1994, J BIOMECH, V27, P899, DOI 10.1016/0021-9290(94)90262-3; WU JJ, 1991, J BIOL CHEM, V266, P5625; Yekkala R, 2007, J SEP SCI, V30, P118, DOI 10.1002/jssc.200600191	42	134	137	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15674	15681		10.1074/jbc.M109.077503	http://dx.doi.org/10.1074/jbc.M109.077503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308077	Green Published, hybrid			2022-12-27	WOS:000277715900013
J	Card, DAG; Sierant, ML; Davey, S				Card, Deborah A. Greer; Sierant, Megan L.; Davey, Scott			Rad9A Is Required for G(2) Decatenation Checkpoint and to Prevent Endoreduplication in Response to Topoisomerase II Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND BREAKS; CELL-CYCLE EVENTS; IONIZING-RADIATION; MAMMALIAN-CELLS; PROTEIN; DAMAGE; PHOSPHORYLATION; CHK2; ICRF-193; HRAD9	The Rad9A checkpoint protein interacts with and is required for proper localization of topoisomerase II-binding protein 1 (TopBP1) in response to DNA damage. Topoisomerase II (Topo II), another binding partner of TopBP1, decatenates sister chromatids that become intertwined during replication. Inhibition of Topo II by ICRF-193 (meso-4,4'-(3,2-butanediyl)-bis-(2,6-piperazinedione)), a catalytic inhibitor that does not induce DNA double-strand breaks, causes a mitotic delay known as the G(2) decatenation checkpoint. Here, we demonstrate that this checkpoint, dependent on ATR and BRCA1, also requires Rad9A. Analysis of different Rad9A phosphorylation mutants suggests that these modifications are required to prevent endoreduplication and to maintain decatenation checkpoint arrest. Furthermore, Rad9A Ser(272) is phosphorylated in response to Topo II inhibition. ICRF-193 treatment also causes phosphorylation of an effector kinase downstream of Rad9A in the DNA damage checkpoint pathway, Chk2, at Thr(68). Both of these sites are major targets of phosphorylation by the ATM kinase, although it has previously been shown that ATM is not required for the decatenation checkpoint. Examination of ataxia telangectasia (A-T) cells demonstrates that ATR does not compensate for ATM loss, suggesting that phosphorylation of Rad9A and Chk2 by ATM plays an additional role in response to Topo II inhibition than checkpoint function alone. Finally, we have shown that murine embryonic stem cells deficient for Rad9A have higher levels of catenated mitotic spreads than wild-type counterparts. Together, these results emphasize the importance of Rad9A in preserving genomic integrity in the presence of catenated chromosomes and all types of DNA aberrations.	[Card, Deborah A. Greer; Sierant, Megan L.; Davey, Scott] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Card, Deborah A. Greer; Davey, Scott] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Sierant, Megan L.; Davey, Scott] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Botterell Hall,Rm 364, Kingston, ON K7L 3N6, Canada.	sd13@queensu.ca			National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Breast Cancer Fellowship; Canadian Institute for Health Research; Canada Foundation for Innovation; Ontario Research Fund	National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Breast Cancer Fellowship; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund	This work was supported by the National Cancer Institute of Canada through funds from the Canadian Cancer Society, the Canadian Breast Cancer Fellowship (Ontario Chapter), and the Canadian Institute for Health Research (S. D.). Infrastructure used in the course of this work was purchased with funds from the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (S. D.).	Ahn JY, 2000, CANCER RES, V60, P5934; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Chabalier-Taste C, 2008, BBA-MOL CELL RES, V1783, P2223, DOI 10.1016/j.bbamcr.2008.08.006; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; CLARKE DJ, 1993, J CELL SCI, V105, P563; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Franchitto A, 2003, CANCER RES, V63, P3289; Greer DA, 2003, CANCER RES, V63, P4829; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Hajji N, 2003, MUTAT RES-FUND MOL M, V530, P35, DOI 10.1016/S0027-5107(03)00135-0; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Kaufmann WK, 1998, MUTAT RES-FUND MOL M, V400, P153, DOI 10.1016/S0027-5107(98)00041-4; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Marples B, 2003, RADIAT RES, V160, P38, DOI 10.1667/RR3013; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pastor N, 2002, MUTAT RES-GEN TOX EN, V516, P113, DOI 10.1016/S1383-5718(02)00029-3; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sierant ML, 2010, CELL CYCLE, V9, P548, DOI 10.4161/cc.9.3.10553; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 2001, J BIOL CHEM, V276, P41898, DOI 10.1074/jbc.M105152200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; TANABE K, 1991, CANCER RES, V51, P4903; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1	41	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15653	15661		10.1074/jbc.M109.096156	http://dx.doi.org/10.1074/jbc.M109.096156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20305300	Green Published, hybrid			2022-12-27	WOS:000277399000084
J	Nojima, J; Kanomata, K; Takada, Y; Fukuda, T; Kokabu, S; Ohte, S; Takada, T; Tsukui, T; Yamamoto, TS; Sasanuma, H; Yoneyama, K; Ueno, N; Okazaki, Y; Kamijo, R; Yoda, T; Katagiri, T				Nojima, Junya; Kanomata, Kazuhiro; Takada, Yumi; Fukuda, Toru; Kokabu, Shoichiro; Ohte, Satoshi; Takada, Takatora; Tsukui, Tohru; Yamamoto, Takamasa S.; Sasanuma, Hiroki; Yoneyama, Katsumi; Ueno, Naoto; Okazaki, Yasushi; Kamijo, Ryutaro; Yoda, Tetsuya; Katagiri, Takenobu			Dual Roles of Smad Proteins in the Conversion from Myoblasts to Osteoblastic Cells by Bone Morphogenetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; I RECEPTORS; DIFFERENTIATION; GENE; ACTIVATION; IDENTIFICATION; PROGENITORS; COOPERATION; INHIBITION	Bone morphogenetic proteins (BMPs) induce ectopic bone formation in muscle tissue in vivo and convert myoblasts such that they differentiate into osteoblastic cells in vitro. We report here that constitutively active Smad1 induced osteoblastic differentiation of C2C12 myoblasts in cooperation with Smad4 or Runx2. In floxed Smad4 mice-derived cells, Smad4 ablation partially suppressed BMP-4-induced osteoblast differentiation. In contrast, the BMP-4-induced inhibition of myogenesis was lost by Smad4 ablation and restored by Smad4 overexpression. A nuclear zinc finger protein, E4F1, was identified as a possible component of the Smad4 complex that suppresses myogenic differentiation in response to BMP signaling. In the presence of Smad4, E4F1 stimulated the expression of Ids. Taken together, these findings suggest that the Smad signaling pathway may play a dual role in the BMP-induced conversion of myoblasts to osteoblastic cells.	[Sasanuma, Hiroki; Yoneyama, Katsumi] Saitama Med Univ, Div Pathophysiol, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Tsukui, Tohru] Saitama Med Univ, Anim Expt Lab, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; Saitama Med Univ, Div Funct Genom & Syst Res, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Nojima, Junya; Kokabu, Shoichiro; Yoda, Tetsuya] Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Takada, Yumi; Takada, Takatora; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1425555, Japan; [Yamamoto, Takamasa S.; Ueno, Naoto] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Showa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)		katagiri@saitama-med.ac.jp		Ohte, Satoshi/0000-0002-5153-2176; Okazaki, Yasushi/0000-0003-3241-5502; Ueno, Naoto/0000-0002-8375-2317; Kokabu, Shoichiro/0000-0002-6663-4327	Ministry of Health, Labor and Welfare of Japan; Saitama Medical University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Sankyo Foundation of Life Science; Kawano Masanori Memorial Foundation for Promotion of Pediatrics; Novo Nordisk Award for Growth and Development; Japan Intractable Diseases Research Foundation; Takeda Science Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Saitama Medical University(Saitama Medical University); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); Novo Nordisk Award for Growth and Development(Novo Nordisk); Japan Intractable Diseases Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Health and Labor Sciences Research Grants for Research on Measures for Intractable Research from the Ministry of Health, Labor and Welfare of Japan (to T. K.), grant-in-aids from Saitama Medical University Internal Grants (to T. F. and T. K.), grant-in-aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. F. and T. K.), a grant-in-aid for "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Saitama Medical University Research Center for Genomic Medicine (to T. K.), a grant-in-aid from the Sankyo Foundation of Life Science (to T. K.), a grant-in-aid from the Kawano Masanori Memorial Foundation for Promotion of Pediatrics (to T. K.), a grant-in-aid from the Novo Nordisk Award for Growth and Development (to T. K.), a grant-in-aid from Japan Intractable Diseases Research Foundation (to T. F.), and a grant-in-aid from the Takeda Science Foundation (to T. K.).	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Clever JL, 2010, AM J PHYSIOL-CELL PH, V298, pC1087, DOI 10.1152/ajpcell.00388.2009; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hattori H, 2006, BIOCHEM BIOPH RES CO, V343, P1118, DOI 10.1016/j.bbrc.2006.03.061; He LW, 2005, ANAT EMBRYOL, V209, P401, DOI 10.1007/s00429-005-0454-1; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Katagiri Takenobu, 2008, P121; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rooney RJ, 1998, NUCLEIC ACIDS RES, V26, P1681, DOI 10.1093/nar/26.7.1681; SALMINEN A, 1991, J CELL BIOL, V115, P905, DOI 10.1083/jcb.115.4.905; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yoshida S, 1996, J CELL BIOL, V132, P181, DOI 10.1083/jcb.132.1.181; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	48	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15577	15586		10.1074/jbc.M109.028019	http://dx.doi.org/10.1074/jbc.M109.028019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231279	Green Published, hybrid			2022-12-27	WOS:000277399000076
J	Biterova, EI; Barycki, JJ				Biterova, Ekaterina I.; Barycki, Joseph J.			Structural Basis for Feedback and Pharmacological Inhibition of Saccharomyces cerevisiae Glutamate Cysteine Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GLUTATHIONE SYNTHESIS; KINETIC MECHANISM; INTRACELLULAR GLUTATHIONE; BUTHIONINE SULFOXIMINE; ARABIDOPSIS-THALIANA; BINDING DETERMINANTS; RAT; SUBUNIT; POTENT	Structural characterization of glutamate cysteine ligase (GCL), the enzyme that catalyzes the initial, rate-limiting step in glutathione biosynthesis, has revealed many of the molecular details of substrate recognition. To further delineate the mechanistic details of this critical enzyme, we have determined the structures of two inhibited forms of Saccharomyces cerevisiae GCL (ScGCL), which shares significant sequence identity with the human enzyme. In vivo, GCL activity is feedback regulated by glutathione. Examination of the structure of ScGCL-glutathione complex (2.5 angstrom; R = 19.9%, R-free = 25.1%) indicates that the inhibitor occupies both the glutamate-and the presumed cysteine-binding site and disrupts the previously observed Mg2+ coordination in the ATP-binding site. L-Buthionine-S-sulfoximine (BSO) is a mechanism-based inhibitor of GCL and has been used extensively to deplete glutathione in cell culture and in vivo model systems. Inspection of the ScGCL-BSO structure (2.2 angstrom; R = 18.1%, R-free = 23.9%) confirms that BSO is phosphorylated on the sulfoximine nitrogen to generate the inhibitory species and reveals contacts that likely contribute to transition state stabilization. Overall, these structures advance our understanding of the molecular regulation of this critical enzyme and provide additional details of the catalytic mechanism of the enzyme.	[Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	jbarycki2@unl.edu			National Institutes of Health [1R01 GM077289, RR07707]; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707, P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 GM077289 (to J. J. B.) and RR07707. This work was also supported by United States Department of Energy, Basic Energy Sciences, Office of Science Contract W-31-109-Eng-38.	Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128; Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; Biterova EI, 2009, J BIOL CHEM, V284, P32700, DOI 10.1074/jbc.M109.025114; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; CAMPBELL EB, 1991, ANAL BIOCHEM, V194, P268, DOI 10.1016/0003-2697(91)90229-M; Copley SD, 2002, GENOME BIOL, V3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Galant A, 2009, PLANT CELL, V21, P3450, DOI 10.1105/tpc.109.071183; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gogos A, 2002, STRUCTURE, V10, P1669, DOI 10.1016/S0969-2126(02)00906-1; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Herrera K, 2007, J BIOL CHEM, V282, P17157, DOI 10.1074/jbc.M700804200; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MARTENSSON J, 1991, P NATL ACAD SCI USA, V88, P9360, DOI 10.1073/pnas.88.20.9360; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Misra I, 1998, PROTEIN EXPRES PURIF, V13, P268, DOI 10.1006/prep.1998.0897; MULCAHY RT, 1994, CANCER CHEMOTH PHARM, V34, P67, DOI 10.1007/s002800050105; MULCAHY RT, 1995, CANCER RES, V55, P4771; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Rappa G, 2003, EUR J CANCER, V39, P120, DOI 10.1016/S0959-8049(02)00447-1; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; STRUMEYER DH, 1960, J BIOL CHEM, V235, pPC27; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Wild AC, 1999, BIOCHEM J, V338, P659, DOI 10.1042/0264-6021:3380659; YIP B, 1976, J BIOL CHEM, V251, P3563	48	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14459	14466		10.1074/jbc.M110.104802	http://dx.doi.org/10.1074/jbc.M110.104802			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220146	Green Published, hybrid			2022-12-27	WOS:000277299700042
J	Kondo, N; Miyauchi, K; Meng, FX; Iwamoto, A; Matsuda, Z				Kondo, Naoyuki; Miyauchi, Kosuke; Meng, Fanxia; Iwamoto, Aikichi; Matsuda, Zene			Conformational Changes of the HIV-1 Envelope Protein during Membrane Fusion Are Inhibited by the Replacement of Its Membrane-spanning Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; MEDIATED FUSION; 6-HELIX BUNDLE; GP41; LUCIFERASE; VIRION; CELLS	To help understand the dynamic nature of membrane fusion induced by the human immunodeficiency virus-1 (HIV-1) envelope protein, we developed a new cell-based real-time assay system employing a pair of novel reporter proteins. The reporter proteins consist of a pair of split Renilla luciferase (spRL) fused to split green fluorescent protein (spGFP). The spGFP modules were chosen not only to compensate weak self-association of spRL but also to provide visual reporter signals during membrane fusion. Use of this reporter together with a membrane permeable substrate for Renilla luciferase achieved a simple real-time monitoring of membrane fusion using live cells. We analyzed the HIV-1 envelope mutants whose membrane-spanning domains were replaced with that of glycophorin A or vesicular stomatitis virus G-protein. These mutants showed a slower kinetics of membrane fusion. The analysis of membrane fusion in the presence of fusion inhibitors, soluble CD4 and C34, revealed that these replacements prolonged the period during which the mutants were sensitive to the inhibitors, as compared with the wild type. These results suggest that the mutations within the membrane-spanning domains exerted an allosteric effect on the HIV-1 envelope protein, probably affecting the receptor-induced conformational changes of the ectodomain of the protein.	[Kondo, Naoyuki; Iwamoto, Aikichi; Matsuda, Zene] Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Iwamoto, Aikichi] Univ Tokyo, Div Infect Dis, Inst Med Sci,Adv Clin Res Ctr, Minato Ku, Tokyo 1088639, Japan; [Kondo, Naoyuki; Meng, Fanxia; Matsuda, Zene] Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100101, Peoples R China; [Miyauchi, Kosuke] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Matsuda, Z (corresponding author), Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	zmatsuda@ims.u-tokyo.ac.jp	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a contract grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases.	Blumenthal R, 2002, CHEM PHYS LIPIDS, V116, P39, DOI 10.1016/S0009-3084(02)00019-1; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Campbell RE, 2004, TRENDS BIOTECHNOL, V22, P208, DOI 10.1016/j.tibtech.2004.03.012; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; DIMITROV DS, 1992, VIROLOGY, V187, P398, DOI 10.1016/0042-6822(92)90441-Q; Gabrijel M, 2004, BIOCHEM BIOPH RES CO, V314, P717, DOI 10.1016/j.bbrc.2003.12.154; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Holland AU, 2004, VIROLOGY, V319, P343, DOI 10.1016/j.virol.2003.11.012; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017	22	73	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14681	14688		10.1074/jbc.M109.067090	http://dx.doi.org/10.1074/jbc.M109.067090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197275	hybrid, Green Published			2022-12-27	WOS:000277299700066
J	Mehboob, S; Song, YL; Witek, M; Long, F; Santarsiero, BD; Johnson, ME; Fung, LWM				Mehboob, Shahila; Song, Yuanli; Witek, Marta; Long, Fei; Santarsiero, Bernard D.; Johnson, Michael E.; Fung, Leslie W. -M.			Crystal Structure of the Nonerythroid alpha-Spectrin Tetramerization Site Reveals Differences between Erythroid and Nonerythroid Spectrin Tetramer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING BETA-SPECTRIN; II-SPECTRIN; MOLECULAR-DYNAMICS; MYELINATED AXONS; DIFFRACTION DATA; COILED COILS; REGION; REPEATS; ASSOCIATION; STABILITY	We have solved the crystal structure of a segment of nonerythroid alpha-spectrin (alpha II) consisting of the first 147 residues to a resolution of 2.3 angstrom. We find that the structure of this segment is generally similar to a corresponding segment from erythroid alpha-spectrin (alpha I) but exhibits unique differences with functional significance. Specific features include the following: (i) an irregular and frayed first helix (Helix C'); (ii) a helical conformation in the junction region connecting Helix C' with the first structural domain (D1); (iii) a long A(1)B(1) loop in D1; and (iv) specific inter-helix hydrogen bonds/salt bridges that stabilize D1. Our findings suggest that the hydrogen bond networks contribute to structural domain stability, and thus rigidity, in alpha II, and the lack of such hydrogen bond networks in alpha I leads to flexibility in alpha I. We have previously shown the junction region connecting Helix C' to D1 to be unstructured in alpha I (Park, S., Caffrey, M. S., Johnson, M. E., and Fung, L. W. (2003) J. Biol. Chem. 278, 21837-21844) and now find it to be helical in alpha II, an important difference for alpha-spectrin association with beta-spectrin in forming tetramers. Homology modeling and molecular dynamics simulation studies of the structure of the tetramerization site, a triple helical bundle of partial domain helices, show that mutations in alpha-spectrin will affect Helix C' structural flexibility and/or the junction region conformation and may alter the equilibrium between spectrin dimers and tetramers in cells. Mutations leading to reduced levels of functional tetramers in cells may potentially lead to abnormal neuronal functions.	[Mehboob, Shahila; Santarsiero, Bernard D.; Johnson, Michael E.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Song, Yuanli; Witek, Marta; Long, Fei; Fung, Leslie W. -M.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehboob, S (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave, Chicago, IL 60607 USA.	shahila@uic.edu; lfung@uic.edu	Christie, Shahila Mehboob/AAK-5648-2020; Santarsiero, Bernard D/N-9249-2018; Johnson, Michael E/F-5141-2013; Song, Yuanli/B-1798-2014	Santarsiero, Bernard D/0000-0002-9032-9699; Johnson, Michael E/0000-0002-8246-4081; 	National Institutes of Health [GM68621]; Multidisciplinary Oral Science Training Program [1T32DE018381]; American Heart Association [0350617Z]; NCRR [RR-15301]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multidisciplinary Oral Science Training Program; American Heart Association(American Heart Association); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68621 (to L. W.-M. F.) and 1T32DE018381 from Multidisciplinary Oral Science Training Program (to M. W.). This work was also supported by American Heart Association Grant 0350617Z (to L. W.-M. F.). This work is based upon research conducted at the Northeastern Collaborative Access Team beamline 24-ID-E of the Advanced Photon Source, supported by National Institutes of Health Grant RR-15301 from the NCRR.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Antoniou C, 2008, BIOCHEMISTRY-US, V47, P10765, DOI 10.1021/bi800840p; Begg GE, 1997, BIOCHEMISTRY-US, V36, P6977, DOI 10.1021/bi970186n; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bignone PA, 2003, BIOCHEM J, V374, P613, DOI 10.1042/BJ20030507; Bignone PA, 2007, J BIOL CHEM, V282, P888, DOI 10.1074/jbc.M605920200; Brown JH, 1996, PROTEINS, V26, P134; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; IPSARO JJ, 2010, BLOOD IN PRESS; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Lam VQ, 2009, BRIT J HAEMATOL, V147, P392, DOI 10.1111/j.1365-2141.2009.07876.x; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li AJ, 1995, PROTEIN ENG, V8, P1117, DOI 10.1093/protein/8.11.1117; Li QF, 2009, BIOCHEMISTRY-US, V48, P206, DOI 10.1021/bi8013032; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lusitani D, 1998, BIOCHEMISTRY-US, V37, P16546, DOI 10.1021/bi9811462; Mehboob S, 2003, BIOCHEMISTRY-US, V42, P14702, DOI 10.1021/bi0353833; Mehboob S, 2001, BIOCHEMISTRY-US, V40, P12457, DOI 10.1021/bi010984k; Mooers BHM, 2009, PROTEIN SCI, V18, P871, DOI 10.1002/pro.94; Oh Y, 2007, CELL MOL BIOL LETT, V12, P604, DOI 10.2478/s11658-007-0028-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; Park S, 2002, BLOOD, V100, P283, DOI 10.1182/blood.V100.1.283; Park S, 2001, CELL MOL BIOL LETT, V6, P571; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Silva PJ, 2008, PROTEINS, V70, P1588, DOI 10.1002/prot.21803; Song YL, 2009, PROTEIN SCI, V18, P1916, DOI 10.1002/pro.202; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Sumandea CA, 2005, MOL BRAIN RES, V136, P81, DOI 10.1016/j.molbrainres.2005.01.003; Susuki K, 2008, EXP BIOL MED, V233, P394, DOI 10.3181/0709-MR-243; Tatulian SA, 2008, COMPUT BIOL CHEM, V32, P370, DOI 10.1016/j.compbiolchem.2008.05.001; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W. F., 1987, GROMOS GRONINGEN MOL; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097	58	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14572	14584		10.1074/jbc.M109.080028	http://dx.doi.org/10.1074/jbc.M109.080028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228407	Green Published, hybrid			2022-12-27	WOS:000277299700054
J	Block, ER; Tolino, MA; Klarlund, JK				Block, Ethan R.; Tolino, Michael A.; Klarlund, Jes K.			Pyk2 Activation Triggers Epidermal Growth Factor Receptor Signaling and Cell Motility after Wounding Sheets of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE 2; FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; EGF RECEPTOR; C-SRC; BREAST-CANCER; FAMILY; PHOSPHORYLATION; TRANSACTIVATION; PROLIFERATION	Activation of the epidermal growth factor receptor (EGFR) is a key signaling event that promotes cells to move and cover wounds in many epithelia. We have previously shown that wounding activates the EGFR through activation of the Src family kinases (SFKs), which induce proteolytic shedding of epidermal growth factor-like ligands from the cell surface. A major goal in wound healing research is to identify early signals that promote motility, and here we examined the hypothesis that members of the focal adhesion kinase family are upstream activators of the SFKs after wounding. We found that focal adhesion kinase is not activated by wounding but that a different family member, Pyk2 (PTK2B/RAFTK/CAK beta), is activated rapidly and potently. Pyk2 interaction with c-Src is increased after wounding, as determined by co-immunoprecipitation experiments. Disruption of Pyk2 signaling either by small interfering RNA or by expression of a dominant negative mutant led to inhibition of wound-induced activation of the SFKs and the EGFR, and conversely, overexpression of wild-type Pyk2 stimulated SFK and EGFR kinase activities in cells. In wound healing studies, Pyk2 small interfering RNA or dominant negative inhibited cell migration. These results show that activation of Pyk2 is an early signal that promotes wound healing by stimulating the SFK/EGFR signaling pathway.	[Klarlund, Jes K.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Klarlund, JK (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Ophthalmol & Visual Sci Res Ctr, 203 Lothrop St, Pittsburgh, PA 15213 USA.	klarlundjk@upmc.edu			National Institutes of Health [EY013463, EY08098, T32 EY017271]; Research to Prevent Blindness; Eye and Ear Foundation (Pittsburgh, PA); NATIONAL EYE INSTITUTE [P30EY008098, R01EY013463, T32EY017271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation (Pittsburgh, PA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013463, EY08098, and T32 EY017271. This work was also supported by grants from Research to Prevent Blindness and the Eye and Ear Foundation (Pittsburgh, PA).	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Block ER, 2008, MOL BIOL CELL, V19, P4909, DOI 10.1091/mbc.E08-01-0097; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Burdick AD, 2006, CARCINOGENESIS, V27, P2331, DOI 10.1093/carcin/bgl083; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Amicis F, 2006, J CELL PHYSIOL, V209, P74, DOI 10.1002/jcp.20709; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kanno H, 2003, AM J PHYSIOL-CELL PH, V284, pC988, DOI 10.1152/ajpcell.00582.2001; Klepeis VE, 2001, J CELL SCI, V114, P4185; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; Kuwabara K, 2004, ENDOCRINOLOGY, V145, P3324, DOI 10.1210/en.2003-1433; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Menashi EB, 2009, CELL TISSUE RES, V337, P243, DOI 10.1007/s00441-009-0807-9; Montiel M, 2007, CELL SIGNAL, V19, P2138, DOI 10.1016/j.cellsig.2007.06.010; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Myhre GM, 2004, AM J PHYSIOL-GASTR L, V287, pG1213, DOI 10.1152/ajpgi.00149.2004; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Park SY, 2007, CELL SIGNAL, V19, P289, DOI 10.1016/j.cellsig.2006.07.005; Park SY, 2006, CELL SIGNAL, V18, P1063, DOI 10.1016/j.cellsig.2005.08.018; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Repertinger SK, 2004, J INVEST DERMATOL, V123, P982, DOI 10.1111/j.0022-202X.2004.23478.x; Roelle S, 2008, ONCOGENE, V27, P1737, DOI 10.1038/sj.onc.1210819; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sammak PJ, 1997, J CELL SCI, V110, P465; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schauwienold D, 2008, J BIOL CHEM, V283, P27748, DOI 10.1074/jbc.M801431200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Soe NN, 2009, J ATHEROSCLER THROMB, V16, P230, DOI 10.5551/jat.E422; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wilson SA, 2004, AM FAM PHYSICIAN, V70, P123; Xie JJ, 2008, MOL ENDOCRINOL, V22, P2322, DOI 10.1210/me.2008-0061; Xiong WC, 1998, J CELL SCI, V111, P1981; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P4277, DOI 10.1167/iovs.04-0119; Yamada T, 2000, CELL STRUCT FUNCT, V25, P351, DOI 10.1247/csf.25.351; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	72	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13372	13379		10.1074/jbc.M109.083089	http://dx.doi.org/10.1074/jbc.M109.083089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215112	hybrid, Green Published			2022-12-27	WOS:000276987700008
J	Garcia-Hoz, C; Sanchez-Fernandez, G; Diaz-Meco, MT; Moscat, J; Mayor, F; Ribas, C				Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Diaz-Meco, Maria Teresa; Moscat, Jorge; Mayor, Federico; Ribas, Catalina			G alpha(q) Acts as an Adaptor Protein in Protein Kinase C zeta (PKC zeta)-mediated ERK5 Activation by G Protein-coupled Receptors (GPCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NF-KAPPA-B; PKC-ZETA; CELL-PROLIFERATION; INDEPENDENT PATHWAY; GROWTH-FACTOR; DOMAIN; SRC; PHOSPHORYLATION; ISOFORMS	G(q)-coupled G protein-coupled receptors (GPCR) mediate the actions of a variety of messengers that are key regulators of different cellular functions. These receptors can regulate a highly interconnected network of biochemical routes that control the activity of several members of the mitogen-activated protein kinase (MAPK) family. The ERK5 MAPK has been shown to be activated by G(q)-coupled GPCR via unknown mechanisms. We find that the atypical protein kinase C (PKC zeta), previously reported to interact with the ERK5 activator MEK5 and to be involved in epidermal growth factor-mediated ERK5 stimulation, plays a crucial role in the activation of the ERK5 pathway by G(q)-coupled GPCR. Stimulation of ERK5 by G(q)-coupled GPCR is abolished upon pharmacological inhibition of PKC zeta as well as in embryonic fibroblasts obtained from PKC zeta-deficient mice. Both PKC zeta and MEK5 associate to G alpha(q) upon activation of GPCR, thus forming a ternary complex that seems essential for the activation of ERK5. These data put forward a novel function of G alpha(q) as a scaffold protein involved in the modulation of the ERK5 cascade by GPCR that could be relevant in G(q)-mediated physiological functions.	[Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Mayor, Federico; Ribas, Catalina] Univ Autonoma Madrid, Dept Biol Mol, Madrid 28049, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Mayor, Federico; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid 28049, Spain; [Diaz-Meco, Maria Teresa; Moscat, Jorge] Univ Cincinnati, Dept Genome Sci, Genome Res Inst, Cincinnati, OH 45221 USA	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University System of Ohio; University of Cincinnati	Mayor, F (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid 28049, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Mayor, Federico/N-7644-2016	Diaz-Meco, Maria/0000-0003-0147-0998; Garcia-Hoz, Carlota/0000-0001-8268-4159	Ministerio de Educacion y Ciencia [SAF2008-00552]; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Migration and Inflammation (MAIN) European Network [LSHG-CT-2003-502935]; Instituto de Salud Carlos III [PI080461]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Migration and Inflammation (MAIN) European Network; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from Ministerio de Educacion y Ciencia (Grant SAF2008-00552), Fundacion Ramon Areces, The Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III (Grant RD06-0014/0037), Comunidad de Madrid (Grant S-SAL-0159-2006), and the Migration and Inflammation (MAIN) European Network (Grant LSHG-CT-2003-502935) (to F. M.) and Instituto de Salud Carlos III (Grant PI080461) (to C. R.).	Cogolludo A, 2003, CIRC RES, V93, P656, DOI 10.1161/01.RES.0000095245.97945.FE; CRESPO P, 1994, J BIOL CHEM, V269, P21103; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; GUTKIND JS, 2000, SCI STKE, V40, P1; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Jimenez E, 2005, J CELL PHYSIOL, V204, P678, DOI 10.1002/jcp.20326; Kato M, 2005, IMMUNOLOGY, V116, P193, DOI 10.1111/j.1365-2567.2005.02210.x; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liggett SB, 2006, J CLIN INVEST, V116, P875, DOI 10.1172/JCI28234; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Mariggio S, 2006, CELL SIGNAL, V18, P2004, DOI 10.1016/j.cellsig.2006.03.004; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; May LT, 2008, INT J BIOCHEM CELL B, V40, P2013, DOI 10.1016/j.biocel.2008.04.001; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Muscella A, 2003, J CELL PHYSIOL, V197, P61, DOI 10.1002/jcp.10336; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V291, pH1602, DOI 10.1152/ajpheart.01363.2005; Parmentier JH, 2003, HYPERTENSION, V41, P794, DOI 10.1161/01.HYP.0000047873.76255.0B; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sumimoto H, 2007, SCI STKE, V401, pre6; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200	46	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13480	13489		10.1074/jbc.M109.098699	http://dx.doi.org/10.1074/jbc.M109.098699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200162	hybrid, Green Published			2022-12-27	WOS:000276987700020
J	Reich, S; Golbik, RP; Geissler, R; Behrens, SE				Reich, Stefan; Golbik, Ralph Peter; Geissler, Rene; Behrens, Sven-Erik			Mechanisms of Activity and Inhibition of the Hepatitis C Virus RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; DE-NOVO INITIATION; CRYSTAL-STRUCTURE; RIBONUCLEOTIDE INCORPORATION; NONNUCLEOSIDE POLYMERASE; FULL-LENGTH; NS5B; RNA-POLYMERASE-(3D(POL)); IDENTIFICATION; NUCLEOSIDE	The RNA-dependent RNA polymerase NS5B is a key enzyme of the replication of hepatitis C virus (HCV) and a major therapeutic target. Applying a novel continuous assay with highly purified protein and a fluorescent RNA-template we provide for the first time a comprehensive mechanistic description of the enzymatic reaction. Using fluorescence spectroscopy, the kinetics of NS5B was confirmed to consist of two half-reactions, namely substrate binding and turnover. Determining the binding constants of the substrates and the rate constants of individual reaction steps, NS5B was shown to bind the template single-stranded RNA with high affinity (nanomolar range) and in a stepwise process that reflects the substrate positioning. As demonstrated by CD, NTP(s) binding caused a tertiary structural change of the enzyme into an active conformation. The second half-reaction was dissected into a sequential polymerization and a subsequent, rate-limiting product release reaction. Taking advantage of these tools, we analyzed the mechanism of action of the NS5B inhibitor HCV-796, which was shown to interfere with the formation of double-stranded RNA by blocking the second half-reaction.	[Reich, Stefan; Golbik, Ralph Peter; Geissler, Rene; Behrens, Sven-Erik] Univ Halle Wittenberg, Fac Life Sci, Inst Biochem & Biotechnol, Dept Microbial Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Behrens, SE (corresponding author), Univ Halle Wittenberg, Fac Life Sci, Inst Biochem & Biotechnol, Dept Microbial Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	sven.behrens@biochemtech.uni-halle.de		Reich, Stefan/0000-0001-8822-2908	National Institutes of Health [RO1DK062847]; Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg [GRK 1026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK062847 (to R. G.). This work was also supported by Grant GRK 1026 of the Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Howe AYM, 2008, ANTIMICROB AGENTS CH, V52, P3327, DOI 10.1128/AAC.00238-08; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Le Pogam S, 2008, J ANTIMICROB CHEMOTH, V61, P1205, DOI 10.1093/jac/dkn085; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Makeyev EV, 2000, EMBO J, V19, P6275, DOI 10.1093/emboj/19.22.6275; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McHutchison JG, 2006, J HEPATOL, V44, P411, DOI 10.1016/j.jhep.2005.12.001; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Sun XL, 2000, BIOCHEM BIOPH RES CO, V268, P798, DOI 10.1006/bbrc.2000.2120; Vo NV, 2004, BIOCHEMISTRY-US, V43, P10579, DOI 10.1021/bi049773g; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	31	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13685	13693		10.1074/jbc.M109.082206	http://dx.doi.org/10.1074/jbc.M109.082206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194503	hybrid, Green Published			2022-12-27	WOS:000276987700043
J	Wang, HY; Leavitt, L; Ramaswamy, R; Rapraeger, AC				Wang, Haiyao; Leavitt, LuAnn; Ramaswamy, Ravishankar; Rapraeger, Alan C.			Interaction of Syndecan and alpha 6 beta 4 Integrin Cytoplasmic Domains REGULATION OF ErbB2-MEDIATED INTEGRIN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PHOSPHOINOSITIDE 3-OH KINASE; MAMMARY EPITHELIAL-CELLS; ALPHA(6)BETA(4) INTEGRIN; CARCINOMA INVASION; KERATINOCYTE MIGRATION; EXTRACELLULAR DOMAINS; LAMININ-5 LAMININ-332; BIOLOGICAL-ACTIVITY; BINDING DOMAIN	The alpha 6 beta 4 integrin is a laminin 332 (LN332) receptor central to the formation of hemidesmosomes in epithelial layers. However, the integrin becomes phosphorylated by keratinocytes responding to epidermal growth factor in skin wounds or by squamous cell carcinomas that overexpress/hyperactivate the tyrosine kinase ErbB2, epidermal growth factor receptor, or c-Met. We show here that the beta 4-dependent signaling in A431 human squamous carcinoma cells is dependent on the syndecan family of matrix receptors. Yeast two-hybrid analysis identifies an interaction within the distal third (amino acids 1473-1752) of the beta 4 cytoplasmic domain and the conserved C2 region of the syndecan cytoplasmic domain. Via its C2 region, Sdc1 forms a complex with the alpha 6 beta 4 integrin along with the receptor tyrosine kinase ErbB2 and the cytoplasmic kinase Fyn in A431 cells. Engagement of LN332 or clustering of the alpha 6 beta 4 integrin with integrin-specific antibodies causes phosphorylation of ErbB2, Fyn, and the beta 4 subunit as well as activation of phosphatidylinositol 3-kinase and Akt and their assimilation into this complex. This leads to phosphatidylinositol 3-kinase-dependent cell spreading and Akt-dependent protection from apoptosis. This is disrupted by RNA interference silencing of Sdc1 but can be rescued by mouse Sdc1 or Sdc4 but not by syndecan mutants lacking their C-terminal C2 region. This disruption does not prevent the phosphorylation of ErbB2 or Fyn but blocks the Fyn-mediated phosphorylation of the beta 4 tail. We propose that syndecans engage the distal region of the beta 4 cytoplasmic domain and bring it to the plasma membrane, where it can be acted upon by Src family kinases.	[Wang, Haiyao; Leavitt, LuAnn; Ramaswamy, Ravishankar; Rapraeger, Alan C.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53706 USA.	acraprae@wisc.edu	Ramaswamy, Ravishankar/I-2789-2019	Ramaswamy, Ravishankar/0000-0001-5253-9508	National Institutes of Health [R01-CA109010]; NATIONAL CANCER INSTITUTE [R01CA109010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA109010 (to A. C. R.).	Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; GAIETTA G, 1994, J CELL SCI, V107, P3339; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebakken CS, 2000, EXP CELL RES, V259, P315, DOI 10.1006/excr.2000.4981; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Ogawa T, 2004, J CELL BIOCHEM, V92, P701, DOI 10.1002/jcb.20112; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yamashita Y, 1999, J IMMUNOL, V162, P5940; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	66	55	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13569	13579		10.1074/jbc.M110.102137	http://dx.doi.org/10.1074/jbc.M110.102137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181947	hybrid, Green Published			2022-12-27	WOS:000276987700030
J	Li, Y; Hu, J; Hofer, K; Wong, AMS; Cooper, JD; Birnbaum, SG; Hammer, RE; Hofmann, SL				Li, Yi; Hu, Jie; Hoefer, Klemens; Wong, Andrew M. S.; Cooper, Jonathan D.; Birnbaum, Shari G.; Hammer, Robert E.; Hofmann, Sandra L.			DHHC5 Interacts with PDZ Domain 3 of Post-synaptic Density-95 (PSD-95) Protein and Plays a Role in Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITOYL TRANSFERASE; MENTAL-RETARDATION; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; ACYLATED PROTEINS; GABA(A) RECEPTORS; MAMMALIAN-CELLS; MOUSE MODEL; TRAFFICKING; HUNTINGTIN	A family of integral membrane proteins containing a signature DHHC motif has been shown to display protein S-acyltransferase activity, modifying cysteine residues in proteins with fatty acids. The physiological roles of these proteins have largely been unexplored. Here we report that mice homozygous for a hypomorphic allele of a previously uncharacterized member, DHHC5, are born at half the expected rate, and survivors show a marked deficit in contextual fear conditioning, an indicator of defective hippocampal-dependent learning. DHHC5 is highly enriched in a post-synaptic density preparation and co-immunoprecipitates with post-synaptic density protein-95 (PSD-95), an interaction that is mediated through binding of the carboxyl terminus of DHHC5 and the PDZ3 domain of PSD-95. Immunohistochemistry demonstrated that DHHC5 is expressed in the CA3 and dentate gyrus in the hippocampus. These findings point to a previously unsuspected role for DHHC5 in post-synaptic function affecting learning and memory.	[Li, Yi; Hu, Jie; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hoefer, Klemens; Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Pediat Storage Disorders Lab, Ctr Cellular Basis Behav,MRC,Inst Psychiat, Dept Neurosci,Ctr Neurodegenerat,James Black Ctr, London SE5 9NU, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; King's College London	Hofmann, SL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.hofmann@utsouthwestern.edu	Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health [NS36867, NS41930]; Robert A. Welch Foundation [I-1187]; Wellcome Trust [GR079491MA]; Erasmus Studentship; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036867, R37NS036867, R21NS041930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Erasmus Studentship; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36867 (to S. L. H.) and NS41930 (to J. D. C.). This work was also supported by Robert A. Welch Foundation Grant I-1187 (to S. L. H.), Wellcome Trust Grant GR079491MA (to J. D. C.), an Erasmus Studentship (to K. H.), the Batten Disease Support and Research Association (to J. D. C.), the Batten Disease Family Association (to J. D. C.), and the Natalie Fund (to J. D. C.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dalva MB, 2009, J CELL BIOL, V186, P7, DOI 10.1083/jcb.200906101; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hines RM, 2010, J BIOL CHEM, V285, P4621, DOI 10.1074/jbc.M109.069849; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Klemmer P, 2009, J PROTEOMICS, V72, P82, DOI 10.1016/j.jprot.2008.10.005; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Witzmann FA, 2005, PROTEOMICS, V5, P2177, DOI 10.1002/pmic.200401102; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	57	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13022	13031		10.1074/jbc.M109.079426	http://dx.doi.org/10.1074/jbc.M109.079426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178993	Green Published, hybrid			2022-12-27	WOS:000276787800060
J	Ishizuka, T; Fujimori, I; Kato, M; Noji-Sakikawa, C; Saito, M; Yoshigae, Y; Kubota, K; Kurihara, A; Izumi, T; Ikeda, T; Okazaki, O				Ishizuka, Tomoko; Fujimori, Izumi; Kato, Mitsunori; Noji-Sakikawa, Chisa; Saito, Motoko; Yoshigae, Yasushi; Kubota, Kazuishi; Kurihara, Atsushi; Izumi, Takashi; Ikeda, Toshihiko; Okazaki, Osamu			Human Carboxymethylenebutenolidase as a Bioactivating Hydrolase of Olmesartan Medoxomil in Liver and Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIENELACTONE HYDROLASE; CARBOXYLESTERASE ISOZYMES; HUMAN VALACYCLOVIRASE; CATALYTIC-PROPERTIES; PRODRUG; ACTIVATION; PROTEIN; IDENTIFICATION; HYDROLYSIS; STABILITY	Olmesartan medoxomil (OM) is a prodrug type angiotensin II type 1 receptor antagonist widely prescribed as an antihypertensive agent. Herein, we describe the identification and characterization of the OM bioactivating enzyme that hydrolyzes the prodrug and converts to its pharmacologically active metabolite olmesartan in human liver and intestine. The protein was purified from human liver cytosol by successive column chromatography and was identified by mass spectrometry to be a carboxymethylenebutenolidase (CMBL) homolog. Human CMBL, whose endogenous function has still not been reported, is a human homolog of Pseudomonas dienelactone hydrolase involved in the bacterial halocatechol degradation pathway. The ubiquitous expression of human CMBL gene transcript in various tissues was observed. The recombinant human CMBL expressed in mammalian cells was clearly shown to activate OM. By comparing the enzyme kinetics and chemical inhibition properties between the recombinant protein and human tissue preparations, CMBL was demonstrated to be the primary OM bioactivating enzyme in the liver and intestine. The recombinant CMBL also converted other prodrugs having the same ester structure as OM, faropenem medoxomil and lenampicillin, to their active metabolites. CMBL exhibited a unique sensitivity to chemical inhibitors, thus, being distinguishable from other known esterases. Site-directed mutagenesis on the putative active residue Cys(132) of the recombinant CMBL caused a drastic reduction of the OM-hydrolyzing activity. We report for the first time that CMBL serves as a key enzyme in the bioactivation of OM, hydrolyzing the ester bond of the prodrug type xenobiotics.	[Ishizuka, Tomoko; Kurihara, Atsushi; Izumi, Takashi; Okazaki, Osamu] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Fujimori, Izumi] Daiichi Sankyo Co Ltd, R&D Operat Dept, Tokyo 1408710, Japan; [Ikeda, Toshihiko] Yokohama Coll Pharm, Kanagawa 2450066, Japan; [Kato, Mitsunori; Noji-Sakikawa, Chisa; Kubota, Kazuishi] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Ishizuka, T (corresponding author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	ishizuka.tomoko.xx@daiichisankyo.co.jp						Beaumont K, 2003, CURR DRUG METAB, V4, P461, DOI 10.2174/1389200033489253; BEVERIDGE AJ, 1995, PROTEIN ENG, V8, P135, DOI 10.1093/protein/8.2.135; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; CHEAH E, 1993, PROTEINS, V16, P64, DOI 10.1002/prot.340160108; Chrysant SG, 2008, DRUG TODAY, V44, P443, DOI [10.1358/dot.2008.44.6.1223895, 10.1358/dot.2008.44.6.1219543]; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Easthope SE, 2002, DRUGS, V62, P1253, DOI 10.2165/00003495-200262080-00016; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; James RW, 2004, FREE RADICAL BIO MED, V37, P1986, DOI 10.1016/j.freeradbiomed.2004.08.012; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kubota K, 2003, PROTEOMICS, V3, P616, DOI 10.1002/pmic.200300410; Laeis Petra, 2001, Journal of Hypertension, V19, pS21; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Ma SF, 2005, DRUG METAB DISPOS, V33, P1911, DOI 10.1124/dmd.105.006163; NGAI KL, 1987, J BACTERIOL, V169, P699, DOI 10.1128/jb.169.2.699-703.1987; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PATHAK D, 1988, J MOL BIOL, V204, P435, DOI 10.1016/0022-2836(88)90587-6; PATHAK D, 1990, J MOL BIOL, V214, P497, DOI 10.1016/0022-2836(90)90196-S; PATHAK D, 1991, PROTEINS, V9, P267, DOI 10.1002/prot.340090405; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Redon Josep, 2009, J Renin Angiotensin Aldosterone Syst, V10, P147, DOI 10.1177/1470320309342735; Reyns T, 2008, J CHROMATOGR B, V861, P108, DOI 10.1016/j.jchromb.2007.11.007; SAARI WS, 1984, J MED CHEM, V27, P713, DOI 10.1021/jm00372a002; SAITO A, 1986, ANTIMICROB AGENTS CH, V29, P948, DOI 10.1128/AAC.29.5.948; SAKAMOTO F, 1984, CHEM PHARM BULL, V32, P2241; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Satoh Tetsuo, 2005, Toxicol Appl Pharmacol, V207, P11, DOI 10.1016/j.taap.2005.01.046; SCHMIDT E, 1980, BIOCHEM J, V192, P339, DOI 10.1042/bj1920339; Schurek KN, 2007, EXPERT REV ANTI-INFE, V5, P185, DOI 10.1586/14787210.5.2.185; Scott LJ, 2008, DRUGS, V68, P1239, DOI 10.2165/00003495-200868090-00005; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Testa B, 2004, BIOCHEM PHARMACOL, V68, P2097, DOI 10.1016/j.bcp.2004.07.005; TESTA B, 2003, HYDROLYSIS DRUG PROD, P1; Tougou K, 1998, DRUG METAB DISPOS, V26, P355	40	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11892	11902		10.1074/jbc.M109.072629	http://dx.doi.org/10.1074/jbc.M109.072629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177059	Green Published, hybrid			2022-12-27	WOS:000276787100017
J	Siskind, LJ; Mullen, TD; Rosales, KR; Clarke, CJ; Hernandez-Corbacho, MJ; Edinger, AL; Obeid, LM				Siskind, Leah J.; Mullen, Thomas D.; Rosales, Kimberly Romero; Clarke, Christopher J.; Hernandez-Corbacho, Maria Jose; Edinger, Aimee L.; Obeid, Lina M.			The BCL-2 Protein BAK Is Required for Long-chain Ceramide Generation during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; SPHINGOSINE KINASE-1; PROAPOPTOTIC BAX; MITOCHONDRIAL APOPTOSIS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; CANCER-CELLS; ER STRESS; ACTIVATION; RESISTANCE	The BCL-2 family members BAK and BAX are required for apoptosis and trigger mitochondrial outer membrane permeabilization (MOMP). Here we identify a MOMP-independent function of BAK as a required factor for long-chain ceramide production in response to pro-apoptotic stress. UV-C irradiation of wild-type (WT) cells increased long-chain ceramides; blocking ceramide generation prevented caspase activation and cell death, demonstrating that long-chain ceramides play a key role in UV-C-induced apoptosis. In contrast, UV-C irradiation did not increase long-chain ceramides in BAK and BAX double knock-out cells. Notably, this was not specific to the cell type (baby mouse kidney cells, hematopoietic) nor the apoptotic stimulus employed (UV-C, cisplatin, and growth factor withdrawal). Importantly, long-chain ceramide generation was dependent on the presence of BAK, but not BAX. However, ceramide generation was independent of the known downstream actions of BAK in apoptosis(MOMP or caspase activation), suggesting a novel role for BAK in apoptosis. Finally, enzymatic assays identified ceramide synthase as the mechanism by which BAK regulates ceramide metabolism. There was no change in CerS expression at the message or protein level, indicating regulation at the post-translational level. Moreover, CerS activity in BAK KO microsomes can be reactivated upon addition of BAK-containing microsomes. The data presented indicate that ceramide-induced apoptosis is dependent upon BAK and identify a novel role for BAK during apoptosis. By establishing a unique role for BAK in long-chain ceramide metabolism, these studies further demonstrate that the seemingly redundant proteins BAK and BAX have distinct mechanisms of action during apoptosis induction.	[Siskind, Leah J.; Mullen, Thomas D.; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Rosales, Kimberly Romero; Edinger, Aimee L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Clarke, Christopher J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of California System; University of California Irvine; Medical University of South Carolina	Siskind, LJ (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, 114 Doughty St,MSC 779, Charleston, SC 29425 USA.	siskind@musc.edu		Siskind, Leah/0000-0001-5026-5187; obeid, lina/0000-0002-0734-0847	NIEHS [1F30 ES016975-01]; NIA [F31 CA126494, K08 CA100526, R01 AG016583]; NCI [P01 CA097132]; Veterans Administration; American Cancer Society [IRG-97-219-11]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [F31CA126494, K08CA100526, P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F30 ES016975-01 (to T. D. M.) from NIEHS, F31 CA126494 (to K. R. R.), K08 CA100526 (to A. L. E.), and R01 AG016583 from NIA and P01 CA097132 from NCI (to L. M. O.). This work was also supported by a Veterans Administration Career Development Award-2 (to L. J. S.), pilot project funding from a Veterans Administration REAP (to L. J. S. and L. M. O.), and American Cancer Society Institutional Research Grant IRG-97-219-11 (sub-award to L. J. S.). The shared resources of the Hollings Cancer Center were supported in part by a Cancer Center Support Grant (P30 CA138313).	Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Charruyer A, 2007, BIOCHEM J, V405, P77, DOI 10.1042/BJ20061528; Chatterjee M, 2001, MOL CELL BIOCHEM, V219, P21, DOI 10.1023/A:1011083818452; Chmura SJ, 1997, CANCER RES, V57, P1270; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heath-Engel HM, 2006, CELL DEATH DIFFER, V13, P1277, DOI 10.1038/sj.cdd.4401961; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2006, CELL DEATH DIFFER, V13, P1272, DOI 10.1038/sj.cdd.4401953; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Muriel MP, 2000, J COMP NEUROL, V426, P297, DOI 10.1002/1096-9861(20001016)426:2<297::AID-CNE10>3.0.CO;2-O; Noda S, 2001, J NEURO-ONCOL, V52, P11, DOI 10.1023/A:1010624823158; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Sautin Y, 2000, THYROID, V10, P733, DOI 10.1089/thy.2000.10.733; Selzner M, 2001, CANCER RES, V61, P1233; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	46	89	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11818	11826		10.1074/jbc.M109.078121	http://dx.doi.org/10.1074/jbc.M109.078121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172858	Green Published, hybrid			2022-12-27	WOS:000276787100009
J	Brocker, C; Lassen, N; Estey, T; Pappa, A; Cantore, M; Orlova, VV; Chavakis, T; Kavanagh, KL; Oppermann, U; Vasiliou, V				Brocker, Chad; Lassen, Natalie; Estey, Tia; Pappa, Aglaia; Cantore, Miriam; Orlova, Valeria V.; Chavakis, Triantafyllos; Kavanagh, Kathryn L.; Oppermann, Udo; Vasiliou, Vasilis			Aldehyde Dehydrogenase 7A1 (ALDH7A1) Is a Novel Enzyme Involved in Cellular Defense against Hyperosmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIPECOLIC ACID METABOLISM; TURGOR-RESPONSIVE GENE; MOLECULAR-CLONING; TISSUE DISTRIBUTION; BACULOVIRUS EXPRESSION; SEABREAM ANTIQUITIN; LIPID-PEROXIDATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN LIVER	Mammalian ALDH7A1 is homologous to plant ALDH7B1, an enzyme that protects against various forms of stress, such as salinity, dehydration, and osmotic stress. It is known that mutations in the human ALDH7A1 gene cause pyridoxine-dependent and folic acid-responsive seizures. Herein, we show for the first time that human ALDH7A1 protects against hyperosmotic stress by generating osmolytes and metabolizing toxic aldehydes. Human ALDH7A1 expression in Chinese hamster ovary cells attenuated osmotic stress-induced apoptosis caused by increased extracellular concentrations of sucrose or sodium chloride. Purified recombinant ALDH7A1 efficiently metabolized a number of aldehyde substrates, including the osmolyte precursor, betaine aldehyde, lipid peroxidation-derived aldehydes, and the intermediate lysine degradation product, alpha-aminoadipic semialdehyde. The crystal structure for ALDH7A1 supports the enzyme's substrate specificities. Tissue distribution studies in mice showed the highest expression of ALDH7A1 protein in liver, kidney, and brain, followed by pancreas and testes. ALDH7A1 protein was found in the cytosol, nucleus, and mitochondria, making it unique among the aldehyde dehydrogenase enzymes. Analysis of human and mouse cDNA sequences revealed mitochondrial and cytosolic transcripts that are differentially expressed in a tissue-specific manner in mice. In conclusion, ALDH7A1 is a novel aldehyde dehydrogenase expressed in multiple subcellular compartments that protects against hyperosmotic stress by generating osmolytes and metabolizing toxic aldehydes.	[Brocker, Chad; Lassen, Natalie; Estey, Tia; Pappa, Aglaia; Cantore, Miriam; Vasiliou, Vasilis] Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, Aurora, CO 80045 USA; [Orlova, Valeria V.; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, Nuffield Dept Orthoped Surg Rheumatol & Musculosk, Botnar Res Ctr, Biomed Res Unit, Oxford OX3 7LD, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Oxford	Vasiliou, V (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, C238-P15,12700 E 19th Ave, Aurora, CO 80045 USA.	vasilis.vasiliou@ucdenver.edu	Pappa, Aglaia/E-8663-2011; Orlova, Valeria V/C-6065-2014; Pappa, Aglaia/P-4663-2019; Chavakis, Triantafyllos/ABE-8845-2020	Orlova, Valeria V/0000-0002-1169-2802; Pappa, Aglaia/0000-0003-0913-4315; Brocker, Chad/0000-0003-4262-3567; vasiliou, vasilis/0000-0003-2552-3118	National Institutes of Health [EY11490, EY17963]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Oxford BIHR Biomedical Research Unit; NATIONAL EYE INSTITUTE [R01EY011490, R29EY011490, R01EY017963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford BIHR Biomedical Research Unit; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11490 and EY17963. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was also supported by the Oxford BIHR Biomedical Research Unit. Portions of this work were presented at the 48th Annual Meeting of the Society of Toxicology, Baltimore, MD, March 2009 (50).	Akagawa M, 2002, EUR J BIOCHEM, V269, P5451, DOI 10.1046/j.1432-1033.2002.03243.x; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Andreucci M, 2009, CELL PROLIFERAT, V42, P554, DOI 10.1111/j.1365-2184.2009.00617.x; BROCKER C, 2009, TOXICOLOGIST, V108, P1556; Bunting KD, 1996, J BIOL CHEM, V271, P11884, DOI 10.1074/jbc.271.20.11884; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; CHANG YF, 1990, BIOCHIM BIOPHYS ACTA, V1038, P300, DOI 10.1016/0167-4838(90)90241-7; CHANG YF, 1976, BIOCHEM BIOPH RES CO, V69, P174, DOI 10.1016/S0006-291X(76)80288-4; CHANG YF, 1982, NEUROCHEM RES, V7, P577, DOI 10.1007/BF00965124; Chavakis T, 1998, BLOOD, V91, P2305, DOI 10.1182/blood.V91.7.2305.2305_2305_2312; Chern MK, 2000, BIOCHEM PHARMACOL, V60, P1629, DOI 10.1016/S0006-2952(00)00469-X; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTERBAUER H, 1989, FREE RADICAL BIO MED, V7, P197, DOI 10.1016/0891-5849(89)90015-4; Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; HUTZLER J, 1968, BIOCHIM BIOPHYS ACTA, V158, P62, DOI 10.1016/0304-4165(68)90072-X; IJlst L, 2000, BIOCHEM BIOPH RES CO, V270, P1101, DOI 10.1006/bbrc.2000.2575; Izaguirre G, 1997, COMP BIOCHEM PHYS B, V118, P59, DOI 10.1016/S0305-0491(97)00022-9; Jia SJ, 2007, FASEB J, V21, P3318, DOI 10.1096/fj.07-8172com; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026; Kultz D, 2001, COMP BIOCHEM PHYS A, V130, P421, DOI 10.1016/S1095-6433(01)00440-8; Lassen N, 2005, DRUG METAB DISPOS, V33, P649, DOI 10.1124/dmd.104.002964; Lassen N, 2006, FREE RADICAL BIO MED, V41, P1459, DOI 10.1016/j.freeradbiomed.2006.08.009; LEE P, 1994, GENOMICS, V21, P371, DOI 10.1006/geno.1994.1279; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Manzer R, 2003, DNA CELL BIOL, V22, P329, DOI 10.1089/104454903322216671; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NODA C, 1978, BIOCHIM BIOPHYS ACTA, V525, P307, DOI 10.1016/0005-2744(78)90225-5; Nosek TM, 1998, PFLUG ARCH EUR J PHY, V435, P394, DOI 10.1007/s004240050529; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2003, FREE RADICAL BIO MED, V34, P1178, DOI 10.1016/S0891-5849(03)00070-4; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Plecko B, 2007, HUM MUTAT, V28, P19, DOI 10.1002/humu.20433; RAO VV, 1990, BIOCHIM BIOPHYS ACTA, V1038, P295, DOI 10.1016/0167-4838(90)90240-G; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Schliess F, 2006, BIOL CHEM, V387, P1363, DOI 10.1515/BC.2006.171; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; Singh RP, 2003, CANCER EPIDEM BIOMAR, V12, P933; Skvorak AB, 1997, GENOMICS, V46, P191, DOI 10.1006/geno.1997.5026; Stewart BJ, 2009, BBA-MOL CELL BIOL L, V1791, P772, DOI 10.1016/j.bbalip.2009.04.004; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STROEHER VL, 1995, PLANT MOL BIOL, V27, P541, DOI 10.1007/BF00019320; Tang WK, 2008, FEBS LETT, V582, P3090, DOI 10.1016/j.febslet.2008.07.059; Tang WK, 2005, FEBS LETT, V579, P3759, DOI 10.1016/j.febslet.2005.05.070; TSAI CH, 1974, J BIOL CHEM, V249, P5790; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	65	138	143	2	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18452	18463		10.1074/jbc.M109.077925	http://dx.doi.org/10.1074/jbc.M109.077925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20207735	Green Published, hybrid			2022-12-27	WOS:000278453900039
J	Bachert, C; Linstedt, AD				Bachert, Collin; Linstedt, Adam D.			Dual Anchoring of the GRASP Membrane Tether Promotes trans Pairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAINS; GOLGI; STACKING; GM130; SECRETION	GRASP proteins share an N-terminal GRASP domain and mediate homotypic tethering of Golgi cisternae to form extended Golgi ribbons. The golgin GM130 is thought to bind the C-terminal side of the GRASP domain to recruit GRASP65 onto the Golgi whereas stable membrane association appears to also depend on anchoring of the N terminus by myristoylation. Here, we examine the nature of the GM130/GRASP65 interaction and test whether the dual membrane contacts of the GRASP domain have a role in tethering beyond membrane recruitment. GM130 was found to contain a C-terminal PDZ ligand that binds the putative groove of the second PDZ-like domain in GRASP65. To test tethering activity independent of targeting, we took advantage of a tethering assay carried out on the mitochondrial membrane in which the GRASP membrane attachment points were individually or simultaneously substituted with mitochondrially targeted transmembrane sequences. N-terminally anchored constructs tethered only if the C terminus was also anchored; and likewise, C-terminally anchored constructs tethered only if the N terminus was anchored. One explanation for the role of this dual anchoring is that it orients the GRASP domain to prevent cis interactions within the same membrane thereby favoring trans interactions between adjacent membranes. Indeed, singly anchored GRASP constructs, although nonfunctional in tethering, interacted with one another and also bound and inhibited dually anchored constructs. This work thus elucidates the GM130/GRASP65 interaction and supports a novel orientation-based model of membrane tether regulation in which dual membrane contact orients the tethering interaction interface to favor trans over cis interactions.	[Bachert, Collin; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [GM-56779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779, R01GM095549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A. D. L.).	Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	28	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16294	16301		10.1074/jbc.M110.116129	http://dx.doi.org/10.1074/jbc.M110.116129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20228057	Green Published, hybrid			2022-12-27	WOS:000277715900066
J	Sharma, A; Luke, CT; Dower, NA; Stone, JC; Lorenzo, PS				Sharma, Amrish; Luke, Courtney T.; Dower, Nancy A.; Stone, James C.; Lorenzo, Patricia S.			RasGRP1 Is Essential for Ras Activation by the Tumor Promoter 12-O-Tetradecanoylphorbol-13-acetate in Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL-BINDING MOTIFS; NUCLEOTIDE-RELEASING PROTEIN; MAP KINASE; SKIN TUMORIGENESIS; SIGNALING PATHWAY; CELL DEVELOPMENT; PHORBOL ESTERS; R-RAS; GOLGI	RasGRP1 is a guanine nucleotide exchange factor for Ras that binds with high affinity to diacylglycerol analogs like the phorbol esters. Recently, we demonstrated a role for RasGRP1 in skin carcinogenesis and suggested its participation in the action of tumor-promoting phorbol esters like 12-O-tetradecanoylphorbol-13-acetate (TPA) on Ras pathways in epidermal cells. Given the importance of Ras in carcinogenesis, we sought to discern whether RasGRP1 was a critical pathway in Ras activation, using a RasGRP1 knockout (KO) mouse model to examine the response of keratinocytes to TPA. In contrast to the effect seen in wild type keratinocytes, RasGTP levels were barely detected in RasGRP1 KO cells even after 60 min of exposure to phorbol esters. The lack of response was rescued by enforced expression of RasGRP1. Furthermore, small hairpin RNA-induced silencing of RasGRP1 abrogated the effect of TPA on Ras. Analysis of Ras isoforms showed that both H-Ras and N-Ras depended on RasGRP1 for activation by TPA, whereas activation of K-Ras could not be detected. Although RasGRP1 was dispensable for ERK activation in response to TPA, JNK activation was reduced in the KO keratinocytes. Notably, TPA-induced phosphorylation of JNK2, but not JNK1, was reduced by RasGRP1 depletion. These data identify RasGRP1 as a critical molecule in the activation of Ras by TPA in primary mouse keratinocytes and suggest JNK2 as one of the relevant downstream targets. Given the role of TPA as a skin tumor promoter, our findings provide additional support for a role for RasGRP1 in skin carcinogenesis.	[Sharma, Amrish; Luke, Courtney T.; Lorenzo, Patricia S.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Alberta; University of Alberta	Lorenzo, PS (corresponding author), 651 Ilalo St,Ste 222-K, Honolulu, HI 96813 USA.	plorenzo@crch.hawaii.edu						Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Chen NY, 2001, CANCER RES, V61, P3908; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Diez FR, 2009, AM J PATHOL, V175, P392, DOI 10.2353/ajpath.2009.090036; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Feith DJ, 2005, CANCER RES, V65, P572; Gross ND, 2007, CLIN CANCER RES, V13, P5910, DOI 10.1158/1078-0432.CCR-07-0352; HECKER E, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1890; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Lee SH, 2009, J IMMUNOL, V183, P7931, DOI 10.4049/jimmunol.0902012; Li J, 1999, J BIOL CHEM, V274, P4213, DOI 10.1074/jbc.274.7.4213; Li YS, 1996, MOL CELL BIOL, V16, P5947; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Luke CT, 2007, CANCER RES, V67, P10190, DOI 10.1158/0008-5472.CAN-07-2375; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Marks F, 1995, MUTAT RES-FUND MOL M, V333, P161, DOI 10.1016/0027-5107(95)00142-5; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; PUNNONEN K, 1992, J INVEST DERMATOL, V99, P221, DOI 10.1111/1523-1747.ep12650445; Rambaratsingh RA, 2003, J BIOL CHEM, V278, P52792, DOI 10.1074/jbc.M308240200; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; She QB, 2002, CANCER RES, V62, P1343; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Tuthill MC, 2006, MOL CANCER THER, V5, P602, DOI 10.1158/1535-7163.MCT-05-0317; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zhang JY, 2007, CANCER RES, V67, P3827, DOI 10.1158/0008-5472.CAN-06-4017; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	54	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15724	15730		10.1074/jbc.M109.100016	http://dx.doi.org/10.1074/jbc.M109.100016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308057	Green Published, hybrid			2022-12-27	WOS:000277715900007
J	Singleton, C; White, GF; Todd, JD; Marritt, SJ; Cheesman, MR; Johnston, AWB; Le Brun, NE				Singleton, Chloe; White, Gaye F.; Todd, Jonathan D.; Marritt, Sophie J.; Cheesman, Myles R.; Johnston, Andrew W. B.; Le Brun, Nick E.			Heme-responsive DNA Binding by the Global Iron Regulator Irr from Rhizobium leguminosarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMBIOTIC BACTERIUM RHIZOBIUM; FERRIC UPTAKE REGULATOR; BRADYRHIZOBIUM-JAPONICUM; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSOR; ALPHA-PROTEOBACTERIA; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN	Heme, a physiologically crucial form of iron, is a cofactor for a very wide range of proteins and enzymes. These include DNA regulatory proteins in which heme is a sensor to which an analyte molecule binds, effecting a change in the DNA binding affinity of the regulator. Given that heme, and more generally iron, must be carefully regulated, it is surprising that there are no examples yet in bacteria in which heme itself is sensed directly by a reversibly binding DNA regulatory protein. Here we show that the Rhizobium leguminosarum global iron regulatory protein Irr, which has many homologues within the alpha-proteobacteria and is a member of the Fur superfamily, binds heme, resulting in a dramatic decrease in affinity between the protein and its cognate, regulatory DNA operator sequence. Spectroscopic studies of wild-type and mutant Irr showed that the principal (but not only) heme-binding site is at a conserved HXH motif, whose substitution led to loss of DNA binding in vitro and of regulatory function in vivo. The R. leguminosarum Irr behaves very differently to the Irr of Bradyrhizobium japonicum, which is rapidly degraded in vivo by an unknown mechanism in conditions of elevated iron or heme, but whose DNA binding affinity in vitro does not respond to heme.	[White, Gaye F.; Todd, Jonathan D.; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Singleton, Chloe; White, Gaye F.; Marritt, Sophie J.; Cheesman, Myles R.; Le Brun, Nick E.] Univ E Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk; n.le-brun@uea.ac.uk	Johnston, Andrew W B/D-1859-2009; Todd, Jonathan/B-8967-2009	Todd, Jonathan/0000-0003-0777-9312; Le Brun, Nick/0000-0001-9780-4061	UK BBSRC [BB/E003400/1, BB/E013252/1, BB/C007808/1]; Wellcome Trust; BBSRC [BB/D001943/1, BB/E013252/1, BB/E003400/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C502822/1, BB/D001943/1, BB/E003400/1, BB/C007808/1, BB/E013252/1] Funding Source: researchfish	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK BBSRC through Grant BB/E003400/1 (to A. W. B. J. and N. E. L. B.), Grants BB/E013252/1 and BB/C007808/1 (to M. R. C.), and the Wellcome Trust through an award from the Joint Infrastructure Fund for equipment.	Allaway D, 2001, ENVIRON MICROBIOL, V3, P397, DOI 10.1046/j.1462-2920.2001.00205.x; An YJ, 2009, NUCLEIC ACIDS RES, V37, P3442, DOI 10.1093/nar/gkp198; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Carlton TM, 2007, ENVIRON MICROBIOL, V9, P2923, DOI 10.1111/j.1462-2920.2007.01402.x; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Chikira M., 1980, DALTON T, P526; D'Autreaux B, 2007, BIOCHEMISTRY-US, V46, P1329, DOI 10.1021/bi061636r; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; FALK JE, 1964, PORPHYRINS METALLOPO; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Martinez M, 2006, MICROBIOL-SGM, V152, P2591, DOI 10.1099/mic.0.28782-0; Ngok-Ngam P, 2009, J BACTERIOL, V191, P2083, DOI 10.1128/JB.01380-08; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Smith A, 1996, J PROTEIN CHEM, V15, P575, DOI 10.1007/BF01908539; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd JD, 2005, MOL GENET GENOMICS, V273, P197, DOI 10.1007/s00438-005-1127-8; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; Todd JD, 2006, MOL GENET GENOMICS, V275, P564, DOI 10.1007/s00438-006-0115-y; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; Wexler M, 2003, MICROBIOL-SGM, V149, P1357, DOI 10.1099/mic.0.26130-0; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yeoman KH, 2004, MICROBIOL-SGM, V150, P4065, DOI 10.1099/mic.0.27419-0; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	54	41	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16023	16031		10.1074/jbc.M109.067215	http://dx.doi.org/10.1074/jbc.M109.067215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233710	Green Published, hybrid			2022-12-27	WOS:000277715900040
J	Hager, LP				Hager, Lowell P.			A Lifetime of Playing with Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE COMPOUND; ELECTRON-PARAMAGNETIC-RESONANCE; METHYL-CHLORIDE TRANSFERASE; BIOLOGICAL CHLORINATION; ESCHERICHIA-COLI; PYRUVATE OXIDASE; ENANTIOSELECTIVE EPOXIDATION; ENZYMATIC CHLORINATION; DIRECTED EVOLUTION; CHLOROPEROXIDASE		Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hager, LP (corresponding author), Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA.	l-hager@illinois.edu						ALLAIN EJ, 1993, J AM CHEM SOC, V115, P4415, DOI 10.1021/ja00063a091; AXLEY MJ, 1986, J BIOL CHEM, V261, P5058; BECKWITH JR, 1963, J BIOL CHEM, V238, P3091; BECKWITH JR, 1963, J BIOL CHEM, V238, P3086; BECKWITH JR, 1961, J ORG CHEM, V26, P5206, DOI 10.1021/jo01070a515; BEISSNER RS, 1981, BIOCHEMISTRY-US, V20, P3724, DOI 10.1021/bi00516a009; BLANKE SR, 1990, J BIOL CHEM, V265, P12454; BLANKE SR, 1989, BIOTECHNOL LETT, V11, P769, DOI 10.1007/BF01026094; BROWN FS, 1967, J AM CHEM SOC, V89, P719, DOI 10.1021/ja00979a061; BROWN FS, 1966, FED PROC, V25, P586; Butler A, 2009, NATURE, V460, P848, DOI 10.1038/nature08303; CARROLL RB, 1974, P NATL ACAD SCI USA, V71, P3754, DOI 10.1073/pnas.71.9.3754; CHIANG R, 1976, J BIOL CHEM, V251, P6340; Clutterbuck PW, 1940, BIOCHEM J, V34, P664, DOI 10.1042/bj0340664; COLONNA S, 1992, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39920000357; COLVIN JT, 1983, BIOPHYS J, V41, P105, DOI 10.1016/S0006-3495(83)84412-9; CUNNINGHAM CC, 1971, J BIOL CHEM, V246, P1583; Debrunner PG, 1996, P NATL ACAD SCI USA, V93, P12791, DOI 10.1073/pnas.93.23.12791; DEXTER AF, 1995, J AM CHEM SOC, V117, P6412, DOI 10.1021/ja00128a053; DEXTER AF, 1995, J AM CHEM SOC, V117, P817, DOI 10.1021/ja00107a026; FANG GH, 1986, NUCLEIC ACIDS RES, V14, P8061, DOI 10.1093/nar/14.20.8061; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; GIACHERIO D, 1980, J BIOL CHEM, V255, P8963; GOUNARIS A, 1961, J BIOL CHEM, V236, P1013; GUNSALUS IC, 1953, MECHANISM ENZYME ACT, P545; HAGER L P, 1954, Fed Proc, V13, P734; Hager L.P., 1953, THESIS U ILLINOIS; HAGER LP, 1972, J AM CHEM SOC, V94, P4364, DOI 10.1021/ja00767a068; HAGER LP, 1966, J BIOL CHEM, V241, P1769; HAGER LP, 1957, J BIOL CHEM, V229, P251; HAGER LP, 1957, J AM CHEM SOC, V79, P5575, DOI 10.1021/ja01577a064; HAGER LP, 1953, J AM CHEM SOC, V75, P5767, DOI 10.1021/ja01118a533; HEWSON WD, 1979, J BIOL CHEM, V254, P3175; HOLLENBERG PF, 1974, J BIOL CHEM, V249, P5816; Hu SH, 1998, BIOCHEM BIOPH RES CO, V253, P544, DOI 10.1006/bbrc.1998.9721; Hu SH, 1999, J AM CHEM SOC, V121, P872, DOI 10.1021/ja983612g; KEDDERIS GL, 1980, J BIOL CHEM, V255, P174; KENIGSBERG P, 1987, ARCH BIOCHEM BIOPHYS, V254, P409, DOI 10.1016/0003-9861(87)90118-4; KREJCAREK GE, 1975, TETRAHEDRON LETT, P507; Lakner FJ, 1996, J ORG CHEM, V61, P3923, DOI 10.1021/jo960074m; Lakner FJ, 1997, TETRAHEDRON-ASYMMETR, V8, P3547, DOI 10.1016/S0957-4166(97)00467-9; Lakner FJ, 1997, J AM CHEM SOC, V119, P443, DOI 10.1021/ja962998x; LAKNER FJ, 1998, J MOL CATAL, V5, P1; Manoj KM, 2008, BIOCHEMISTRY-US, V47, P2997, DOI 10.1021/bi7022656; Manoj KM, 2006, ANAL BIOCHEM, V348, P84, DOI 10.1016/j.ab.2005.10.014; MANTHEY JA, 1985, J BIOL CHEM, V260, P9654; MANTHEY JA, 1981, J BIOL CHEM, V256, P1232; MCMILLAN JA, 1974, TETRAHEDRON LETT, P2039; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; MORRIS DR, 1966, J BIOL CHEM, V241, P3582; Ni XH, 1998, P NATL ACAD SCI USA, V95, P12866, DOI 10.1073/pnas.95.22.12866; Ni XH, 1999, P NATL ACAD SCI USA, V96, P3611, DOI 10.1073/pnas.96.7.3611; NUELL MJ, 1988, J BACTERIOL, V170, P1007, DOI 10.1128/jb.170.2.1007-1011.1988; PALCIC MM, 1980, BIOCHEM BIOPH RES CO, V94, P1123, DOI 10.1016/0006-291X(80)90535-5; Rai GP, 2001, ADV SYNTH CATAL, V343, P638, DOI 10.1002/1615-4169(200108)343:6/7<638::AID-ADSC638>3.0.CO;2-6; Rai GP, 2000, ISR J CHEM, V40, P63, DOI 10.1560/264G-UH9K-MEYU-9YHY; RECNY MA, 1985, J BIOL CHEM, V260, P4287; RECNY MA, 1982, J BIOL CHEM, V257, P2878; ROBERTS JE, 1981, J AM CHEM SOC, V103, P7654, DOI 10.1021/ja00415a044; ROBERTS JE, 1981, J BIOL CHEM, V256, P2118; RUTTER R, 1983, BIOCHEMISTRY-US, V22, P4769, DOI 10.1021/bi00289a024; RUTTER R, 1982, J BIOL CHEM, V257, P7958; Sachs F, 1903, BER DTSCH CHEM GES, V36, P3299, DOI 10.1002/cber.190303603113; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; SHAHANGIAN S, 1981, J BIOL CHEM, V256, P6034; SHAHANGIAN S, 1982, J BIOL CHEM, V257, P1529; SHAW PD, 1959, J BIOL CHEM, V234, P2560; SHAW PD, 1959, J AM CHEM SOC, V81, P6527, DOI 10.1021/ja01533a056; SHAW PD, 1959, J BIOL CHEM, V234, P2565; SHAW PD, 1959, J AM CHEM SOC, V81, P1011, DOI 10.1021/ja01513a069; SIUDA JF, 1975, J AM CHEM SOC, V97, P937, DOI 10.1021/ja00837a066; SPILLMAN T, 1979, J BIOL CHEM, V254, P3100; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; THEILER R, 1978, SCIENCE, V202, P1094, DOI 10.1126/science.202.4372.1094; WHITE RH, 1978, PHYTOCHEMISTRY, V17, P939, DOI 10.1016/S0031-9422(00)88650-1; WILLIAMS FR, 1966, ARCH BIOCHEM BIOPHYS, V116, P168, DOI 10.1016/0003-9861(66)90025-7; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563; Yi XW, 2003, J BIOL CHEM, V278, P13855, DOI 10.1074/jbc.M210906200; Yi XW, 1999, P NATL ACAD SCI USA, V96, P12412, DOI 10.1073/pnas.96.22.12412; ZAKS A, 1995, J AM CHEM SOC, V117, P10419, DOI 10.1021/ja00147a001; ZONG Q, 1995, BIOCHEMISTRY-US, V34, P12420, DOI 10.1021/bi00038a040	82	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14852	14860		10.1074/jbc.X110.121905	http://dx.doi.org/10.1074/jbc.X110.121905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215109	hybrid, Green Published			2022-12-27	WOS:000277399000003
J	Jiang, XN; Chen, S; Asara, JM; Balk, SP				Jiang, Xinnong; Chen, Sen; Asara, John M.; Balk, Steven P.			Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110 beta and p110 delta Catalytic Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TUMOR-SUPPRESSOR GENE; ONCOGENIC TRANSFORMATION; PHOSPHATIDYLINOSITOL 3'-KINASE; PTEN; P110-ALPHA; GROWTH; PI3K; METABOLISM; DELETION	Class IA phosphoinositide 3-kinase (PI3K) p110 catalytic subunits are activated upon Src homology 2 domain-mediated binding of their p85 regulatory subunits to tyrosine-phosphorylated pYXXM motifs in receptor tyrosine kinases (RTKs) or adaptor proteins. The PI3K pathway is activated by phosphate and tensin homolog (PTEN) loss in most prostate cancers (PCa), but the contribution of upstream RTKs that may be targeted therapeutically has not been assessed. Immunoblotting of p85-associated proteins in serum-starved PTEN-deficient LNCaP and C4-2 PCa cells showed a small set of discrete tyrosine-phosphorylated proteins, but these proteins were not recognized by an anti-pYXXM motif antibody and were not found in PTEN-deficient PC3 PCa cells. LC/MS/MS using label-free proteomics and immunoblotting showed that p85 was associated primarily with p110 beta and p110 delta. An interaction with ErbB3 was also detected but was independent of ErbB3 tyrosine phosphorylation and was not required for basal PI3K activity. Basal tyrosine phosphorylation of p110 beta and p110 delta could be blocked by c-Src inhibitors, but this did not suppress PI3K activity, which was similarly independent of Ras. Basal PI3K activity was mediated by p110 beta in PC3 cells and by both p110 beta and p110 delta in LNCaP cells, whereas p110 alpha was required for PI3K activation in response to RTK stimulation by heregulin-beta 1. These findings show that basal PI3K activity in PTEN-deficient PCa cells is RTK-independent and can be mediated by p110 beta and p110 delta. Increased p110 beta expression in PCa may be required for RTK-independent PI3K pathway activation in adult prostate epithelium with genetic or epigenetic PTEN down-regulation.	[Jiang, Xinnong; Asara, John M.; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Signal Transduct Div, Dept Med,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Balk, SP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	sbalk@bidmc.harvard.edu			National Institutes of Health [P50 CA90381, P01CA89021]; United States Department of Defense [PC073779]; NATIONAL CANCER INSTITUTE [P01CA089021, P30CA006516, P50CA090381, P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants Prostate SPORE P50 CA90381 and P01CA89021 ( to S. P. B.). This work was also supported by United States Department of Defense Grant PC073779 ( to S. P. B.).	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Cairns P, 1997, CANCER RES, V57, P4997; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hazeki O, 1998, LIFE SCI, V62, P1555, DOI 10.1016/S0024-3205(98)00106-4; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jia SD, 2009, CURR OPIN CELL BIOL, V21, P199, DOI 10.1016/j.ceb.2008.12.007; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; McMenamin ME, 1999, CANCER RES, V59, P4291; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rubin MA, 2000, HUM PATHOL, V31, P504, DOI 10.1053/hp.2000.6713; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vanaja DK, 2003, CANCER RES, V63, P3877; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Yang Xuemei, 2009, J Biomol Tech, V20, P272; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu Q, 2008, ONCOGENE, V27, P4569, DOI 10.1038/onc.2008.91	42	71	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14980	14989		10.1074/jbc.M109.085696	http://dx.doi.org/10.1074/jbc.M109.085696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231295	Green Published, hybrid			2022-12-27	WOS:000277399000019
J	Movitz, C; Brive, L; Hellstrand, K; Rabiet, MJ; Dahlgren, C				Movitz, Charlotta; Brive, Lars; Hellstrand, Kristoffer; Rabiet, Marie-Josephe; Dahlgren, Claes			The Annexin I Sequence Gln(9)-Ala(10)-Trp(11)-Phe(12) Is a Core Structure for Interaction with the Formyl Peptide Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NEUTROPHIL NADPH-OXIDASE; LIGAND-BINDING SITE; MET-LEU-PHE; CRYSTAL-STRUCTURE; ACTIVATES NEUTROPHILS; FPR FAMILY; MEMBRANE; IDENTIFICATION; RESOLUTION	The N-terminal part of the calcium-regulated and phospholipid-binding protein annexin AI contains peptide sequences with pro-and anti-inflammatory activities. We have earlier shown that a proinflammatory signal triggered by one of these peptides, Gln(9)-Lys(25), is mediated by FPR1, a member of the formyl peptide receptor family expressed in human neutrophils. To determine the core structure in Gln(9)-Lys(25), smaller peptides were generated, and their capacity to activate neutrophils was determined. A peptide spanning from amino acid Glu(14) to Lys(25) was inactive, whereas the activity was retained in the Gln(9)-Tyr(20) peptide. Removal of amino acids from the C and N terminus of Gln(9)-Tyr(20) revealed that the first amino acid (Gln(9)) was of the utmost importance for activity. The core structure that activated the neutrophil NADPH oxidase to release superoxide anions was Gln(9)-Ala(10)-Trp(11)-Phe(12). This peptide also inhibited the activity induced by N-formyl-Met-Leu-Phe and WKYMVM. A structural model of the peptide agonist-FPR1 complex suggests that the transmembrane part of the binding pocket of the receptor binds optimally to a tetrapeptide. According to the model and the results presented, the N-terminal amino acid glutamine in Gln(9)-Phe(12) is located close to the bottom of the binding cleft, leaving for steric reasons insufficient space to extend the peptide at the N terminus. The addition of amino acids at the C terminus will not affect binding. The model presented may be helpful in developing specific FPR1 ligands.	[Movitz, Charlotta; Hellstrand, Kristoffer] Univ Gothenburg, Dept Infect Med, SE-41346 Gothenburg, Sweden; [Brive, Lars] Univ Gothenburg, Dept Cell & Mol Biol, SE-41346 Gothenburg, Sweden; [Dahlgren, Claes] Univ Gothenburg, Dept Rheumatol & Inflammat Res, SE-41346 Gothenburg, Sweden; [Rabiet, Marie-Josephe] CEA, Inst Rech Technol & Sci Vivant, Lab Biochim & Biophys Syst Integres, F-38054 Grenoble 9, France	University of Gothenburg; University of Gothenburg; University of Gothenburg; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Movitz, C (corresponding author), Univ Gothenburg, Dept Infect Med, Guldhedsgatan, SE-41346 Gothenburg, Sweden.	charlotta.movitz@microbio.gu.se		Hellstrand, Kristoffer/0000-0002-6617-5976	Swedish Cancer Foundation (Cancer-fonden); Swedish Research Council; Wallenberg Foundation; Swedish Foundation for Strategic research; Torsten and Ragnar Soderberg Foundation; Anna-Lisa and Bror Bjornsson Foundation; Medical Faculty of Gothenburg; Swedish Government; King Gustaf V's 80-Years Foundation; Inga-Britt and Arne Lundberg Research Foundation	Swedish Cancer Foundation (Cancer-fonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Foundation(European Commission); Swedish Foundation for Strategic research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderberg Foundation; Anna-Lisa and Bror Bjornsson Foundation; Medical Faculty of Gothenburg; Swedish Government; King Gustaf V's 80-Years Foundation; Inga-Britt and Arne Lundberg Research Foundation	This work was supported by the Swedish Cancer Foundation (Cancer-fonden), the Swedish Research Council, the Wallenberg Foundation, the Swedish Foundation for Strategic research, the Torsten and Ragnar Soderberg Foundation, the Anna-Lisa and Bror Bjornsson Foundation, the Medical Faculty of Gothenburg, the Swedish Government under the ALF-agreement, King Gustaf V's 80-Years Foundation, and the Inga-Britt and Arne Lundberg Research Foundation.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Fu HM, 2004, IMMUNOLOGY, V112, P201, DOI 10.1111/j.1365-2567.2004.01884.x; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Heo J, 2007, CHEMBIOCHEM, V8, P1527, DOI 10.1002/cbic.200700188; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karlsson J, 2005, J LEUKOCYTE BIOL, V78, P762, DOI 10.1189/jlb.0305153; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Lin JC, 2003, BIOCHEMISTRY-US, V42, P293, DOI 10.1021/bi026766o; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Miettinen HM, 1997, J IMMUNOL, V159, P4045; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; Movitz C, 2000, BBA-BIOMEMBRANES, V1468, P231, DOI 10.1016/S0005-2736(00)00261-3; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; Perretti M, 2003, TRENDS PHARMACOL SCI, V24, P574, DOI 10.1016/j.tips.2003.09.010; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WENG XW, 1993, PROTEIN SCI, V2, P448; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	37	27	30	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14338	14345		10.1074/jbc.M109.080465	http://dx.doi.org/10.1074/jbc.M109.080465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220135	Green Published, hybrid			2022-12-27	WOS:000277299700031
J	Zotova, L; Aleschko, M; Sponder, G; Baumgartner, R; Reipert, S; Prinz, M; Schweyen, RJ; Nowikovsky, K				Zotova, Ludmila; Aleschko, Markus; Sponder, Gerhard; Baumgartner, Roland; Reipert, Siegfried; Prinz, Monika; Schweyen, Rudolf J.; Nowikovsky, Karin			Novel Components of an Active Mitochondrial K+/H+ Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; PROTEIN COMPLEXES; MAMMALIAN-CELLS; CANDIDATE GENE; LETM1; EXPRESSION; TRANSPORT; PHOSPHATE	Defects of the mitochondrial K+/H+ exchanger (KHE) result in increased matrix K+ content, swelling, and autophagic decay of the organelle. We have previously identified the yeast Mdm38 and its human homologue LETM1, the candidate gene for seizures in Wolf-Hirschhorn syndrome, as essential components of the KHE. In a genome-wide screen for multicopy suppressors of the pet(-) (reduced growth on nonfermentable substrate) phenotype of mdm38 Delta mutants, we now characterized the mitochondrial carriers PIC2 and MRS3 as moderate suppressors and MRS7 and YDL183c as strong suppressors. Like Mdm38p, Mrs7p and Ydl183cp are mitochondrial inner membrane proteins and constituents of similar to 500-kDa protein complexes. Triple mutant strains (mdm38 Delta mrs7 Delta ydl183c Delta) exhibit a remarkably stronger pet(-) phenotype than mdm38 Delta and a general growth reduction. They totally lack KHE activity, show a dramatic drop of mitochondrial membrane potential, and heavy fragmentation of mitochondria and vacuoles. Nigericin, an ionophore with KHE activity, fully restores growth of the triple mutant, indicating that loss of KHE activity is the underlying cause of its phenotype. Mdm38p or overexpression of Mrs7p, Ydl183cp, or LETM1 in the triple mutant rescues growth and KHE activity. ALETM1 human homologue, HCCR-1/LETMD1, described as an oncogene, partially suppresses the yeast triple mutant phenotype. Based on these results, we propose that Ydl183p and the Mdm38p homologues Mrs7p, LETM1, and HCCR-1 are involved in the formation of an active KHE system.	[Sponder, Gerhard; Schweyen, Rudolf J.; Nowikovsky, Karin] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, A-1030 Vienna, Austria; [Reipert, Siegfried] Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Sponder, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	gerhard.sponder@univie.ac.at; karin.nowikovsky@univie.ac.at	Reipert, Siegfried/A-4406-2014	Reipert, Siegfried/0000-0002-2043-3562; Nowikovsky, Karin/0000-0001-8435-8410; Baumgartner, Roland/0000-0003-1780-2424	Austrian Science Fund; SYSMO	Austrian Science Fund(Austrian Science Fund (FWF)); SYSMO	This work was supported by the Austrian Science Fund (to R. J. S.) and SYSMO (to R. J. S. and K. N.).	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Cho GW, 2006, GENE, V384, P18, DOI 10.1016/j.gene.2006.07.006; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cortes P, 2000, BBA-BIOENERGETICS, V1456, P67, DOI 10.1016/S0005-2728(99)00109-7; DAUM G, 1982, J BIOL CHEM, V257, P3075; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ha SA, 2008, INT J CANCER, V122, P501, DOI 10.1002/ijc.23146; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Lee WK, 2005, AM J PHYSIOL-CELL PH, V289, pC656, DOI 10.1152/ajpcell.00049.2005; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowikovsky K, 2009, METHOD ENZYMOL, V457, P305, DOI 10.1016/S0076-6879(09)05017-4; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; RASHEED BKA, 1984, EUR J BIOCHEM, V144, P643, DOI 10.1111/j.1432-1033.1984.tb08513.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHAMEL WW, 2008, CURR PROTOC CELL BIO, V6; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Volckaert G, 2003, YEAST, V20, P79, DOI 10.1002/yea.932; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WALDHERR M, 1993, CURR GENET, V24, P301, DOI 10.1007/BF00336780; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wojtczak L, 1996, BIOCHEM BIOPH RES CO, V223, P468, DOI 10.1006/bbrc.1996.0917; Zhang Y, 2007, FEBS LETT, V581, P2168, DOI 10.1016/j.febslet.2007.01.095; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	40	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14399	14414		10.1074/jbc.M109.059956	http://dx.doi.org/10.1074/jbc.M109.059956			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197279	Green Published, hybrid			2022-12-27	WOS:000277299700037
J	Aramini, JM; Tubbs, JL; Kanugula, S; Rossi, P; Ertekin, A; Maglaqui, M; Hamilton, K; Ciccosanti, CT; Jiang, M; Xiao, R; Soong, TT; Rost, B; Acton, TB; Everett, JK; Pegg, AE; Tainer, JA; Montelione, GT				Aramini, James M.; Tubbs, Julie L.; Kanugula, Sreenivas; Rossi, Paolo; Ertekin, Asli; Maglaqui, Melissa; Hamilton, Keith; Ciccosanti, Colleen T.; Jiang, Mei; Xiao, Rong; Soong, Ta-Tsen; Rost, Burkhard; Acton, Thomas B.; Everett, John K.; Pegg, Anthony E.; Tainer, John A.; Montelione, Gaetano T.			Structural Basis of O-6-Alkylguanine Recognition by a Bacterial Alkyltransferase-like DNA Repair Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TORSION ANGLE DYNAMICS; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; DAMAGE RECOGNITION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SOFTWARE SUITE; BINDING; VALIDATION	Alkyltransferase-like proteins (ATLs) are a novel class of DNA repair proteins related to O-6-alkylguanine-DNA alkyltransferases (AGTs) that tightly bind alkylated DNA and shunt the damaged DNA into the nucleotide excision repair pathway. Here, we present the first structure of a bacterial ATL, from Vibrio parahaemolyticus (vpAtl). We demonstrate that vpAtl adopts an AGT-like fold and that the protein is capable of tightly binding to O-6-methylguanine-containing DNA and disrupting its repair by human AGT, a hallmark of ATLs. Mutation of highly conserved residues Tyr(23) and Arg(37) demonstrate their critical roles in a conserved mechanism of ATL binding to alkylated DNA. NMR relaxation data reveal a role for conformational plasticity in the guanine-lesion recognition cavity. Our results provide further evidence for the conserved role of ATLs in this primordial mechanism of DNA repair.	[Aramini, James M.; Rossi, Paolo; Ertekin, Asli; Maglaqui, Melissa; Hamilton, Keith; Ciccosanti, Colleen T.; Jiang, Mei; Xiao, Rong; Acton, Thomas B.; Everett, John K.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, NE Struct Genom Consortium, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, NE Struct Genom Consortium, La Jolla, CA 92037 USA; [Kanugula, Sreenivas; Pegg, Anthony E.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Soong, Ta-Tsen; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, NE Struct Genom Consortium, Berkeley, CA 94720 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aramini, JM (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	jma@cabm.rutgers.edu; guy@cabm.rutgers.edu	Rost, Burkhard/A-1908-2016; Tainer, John/GWQ-4878-2022	Rost, Burkhard/0000-0003-0179-8424; Tainer, John/0000-0003-1659-2429; Montelione, Gaetano/0000-0002-9440-3059	NIGMS [U54-GM074958];  [CA097209];  [CA018137]; NATIONAL CANCER INSTITUTE [R01CA018137, R01CA097209, R37CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54-GM074958 (to G. T. M.) from NIGMS (Protein Structure Initiative) and Grants CA097209 (to J. A. T. and A. E. P.) and CA018137 (to S. K.).	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goodtzova K, 1998, BIOCHEMISTRY-US, V37, P12489, DOI 10.1021/bi9811718; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hashimoto H, 1999, J MOL BIOL, V292, P707, DOI 10.1006/jmbi.1999.3100; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; KANUGULA S, 1995, BIOCHEMISTRY-US, V34, P7113, DOI 10.1021/bi00021a024; Kanugula S, 2001, ENVIRON MOL MUTAGEN, V38, P235, DOI 10.1002/em.1077; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu JF, 2007, NAT BIOTECHNOL, V25, P850, DOI 10.1038/nbt0807-849; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Mazon G, 2009, DNA REPAIR, V8, P697, DOI 10.1016/j.dnarep.2009.01.022; MOORE MH, 1994, EMBO J, V13, P1495, DOI 10.1002/j.1460-2075.1994.tb06410.x; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pearson SJ, 2005, NUCLEIC ACIDS RES, V33, P3837, DOI 10.1093/nar/gki696; Pearson SJ, 2006, NUCLEIC ACIDS RES, V34, P2347, DOI 10.1093/nar/gkl270; PELTON JG, 1993, PROTEIN SCI, V2, P543; Reissner T, 2009, ANGEW CHEM INT EDIT, V48, P7293, DOI 10.1002/anie.200904042; Roberts A, 2006, MAGN RESON CHEM, V44, pS71, DOI 10.1002/mrc.1823; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Verbeek B, 2008, BRIT MED BULL, V85, P17, DOI 10.1093/bmb/ldm036; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393	39	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13736	13741		10.1074/jbc.M109.093591	http://dx.doi.org/10.1074/jbc.M109.093591			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212037	Green Published, hybrid			2022-12-27	WOS:000276987700048
J	Demuro, A; Parker, I; Stutzmann, GE				Demuro, Angelo; Parker, Ian; Stutzmann, Grace E.			Calcium Signaling and Amyloid Toxicity in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; IMPAIR SYNAPTIC PLASTICITY; D-ASPARTATE RECEPTORS; NF-KAPPA-B; A-BETA-P; BILAYER-MEMBRANES; CORTICAL-NEURONS; ION CHANNELS; CHOLINERGIC HYPOTHESIS; HIPPOCAMPAL-NEURONS	Intracellular Ca2+ signaling is fundamental to neuronal physiology and viability. Because of its ubiquitous roles, disruptions in Ca2+ homeostasis are implicated in diverse disease processes and have become a major focus of study in multifactorial neuro-degenerative diseases such as Alzheimer disease (AD). A hallmark of AD is the excessive production of beta-amyloid (A beta) and its massive accumulation in amyloid plaques. In this minireview, we highlight the pathogenic interactions between altered cellular Ca2+ signaling and A beta in its different aggregation states and how these elements coalesce to alter the course of the neurodegenerative disease. Ca2+ and A beta intersect at several functional levels and temporal stages of AD, thereby altering neurotransmitter receptor properties, disrupting membrane integrity, and initiating apoptotic signaling cascades. Notably, there are reciprocal interactions between Ca2+ pathways and amyloid pathology; altered Ca2+ signaling accelerates A beta formation, whereas A beta peptides, particularly in soluble oligomeric forms, induce Ca2+ disruptions. Adegenerative feed-forward cycle of toxic A beta generation and Ca2+ perturbations results, which in turn can spin off to accelerate more global neuropathological cascades, ultimately leading to synaptic breakdown, cell death, and devastating memory loss. Although no cause or cure is currently known, targeting Ca2+ dyshomeostasis as an underlying and integral component of AD pathology may result in novel and effective treatments for AD.	[Stutzmann, Grace E.] Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL 60064 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Parker, Ian] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of California System; University of California Irvine; University of California System; University of California Irvine	Stutzmann, GE (corresponding author), Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL 60064 USA.	grace.stutzmann@rosalindfranklin.edu			National Institutes of Health [GM48071, AG30205, P50-AG16573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048071, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030205, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM48071 (to I.P.), AG30205 (to G.E.S.), and P50-AG16573 (A.D.). This is the twelfth article in the "Thematic Minireview Series on the Molecular Basis of Alzheimer Disease." This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Avdulov NA, 1997, J NEUROCHEM, V68, P2086; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; CARETTE B, 1993, NEUROSCI LETT, V151, P111, DOI 10.1016/0304-3940(93)90059-T; Casley CS, 2009, BRAIN RES, V1260, P65, DOI 10.1016/j.brainres.2008.12.082; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Cribbs DH, 1997, J BIOL CHEM, V272, P7431, DOI 10.1074/jbc.272.11.7431; Decout A, 1998, BBA-BIOMEMBRANES, V1372, P102, DOI 10.1016/S0005-2736(98)00050-9; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; Demuro A, 2008, CELL CALCIUM, V43, P367, DOI 10.1016/j.ceca.2007.07.002; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; DURELL SR, 1994, BIOPHYS J, V67, P2137, DOI 10.1016/S0006-3495(94)80717-9; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Geerts H, 2006, J CLIN PHARMACOL, V46, p8S, DOI 10.1177/0091270006288734; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldman WP, 2001, NEUROLOGY, V56, P361, DOI 10.1212/WNL.56.3.361; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Inoue S, 2008, AMYLOID, V15, P223, DOI 10.1080/13506120802524858; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Korkotian E, 2007, CELL CALCIUM, V42, P41, DOI 10.1016/j.ceca.2006.11.006; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Mattson MP, 1997, APOPTOSIS, V2, P257, DOI 10.1023/A:1026433019210; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mingeot-Leclercq MP, 2002, CHEM PHYS LIPIDS, V120, P57, DOI 10.1016/S0009-3084(02)00108-1; Molinuevo Jose L, 2005, Am J Alzheimers Dis Other Demen, V20, P77, DOI 10.1177/153331750502000206; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; POLLARD HB, 1993, ANN NY ACAD SCI, V695, P165, DOI 10.1111/j.1749-6632.1993.tb23046.x; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schapansky J, 2007, EXP NEUROL, V208, P169, DOI 10.1016/j.expneurol.2007.04.009; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shaked GM, 2009, FEBS J, V276, P2736, DOI 10.1111/j.1742-4658.2009.06997.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shtifman A, 2010, NEUROBIOL AGING, V31, P2080, DOI 10.1016/j.neurobiolaging.2008.11.003; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P10, DOI 10.1159/000075332; VERDURAND M, 2010, NEUROBIOL A IN PRESS; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wevers A, 1999, EUR J NEUROSCI, V11, P2551, DOI 10.1046/j.1460-9568.1999.00676.x; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	100	290	300	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12463	12468		10.1074/jbc.R109.080895	http://dx.doi.org/10.1074/jbc.R109.080895			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20212036	Green Published, hybrid			2022-12-27	WOS:000276787800001
J	Crawford, J; Lamb, E; Wasmuth, J; Grujic, O; Grigg, ME; Boulanger, MJ				Crawford, Joanna; Lamb, Erika; Wasmuth, James; Grujic, Ognjen; Grigg, Michael E.; Boulanger, Martin J.			Structural and Functional Characterization of SporoSAG A SAG2-RELATED SURFACE ANTIGEN FROM TOXOPLASMA GONDII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII INFECTION; SURFACE-ANTIGEN; WATERBORNE TOXOPLASMOSIS; SWINE FARMS; PROTEIN; OUTBREAK; ENCEPHALITIS; SUPERFAMILY; ANTIBODIES; HUMANS	Toxoplasma gondii, the etiological agent of toxoplasmosis, utilizes stage-specific expression of antigenically distinct glycosylphosphatidylinositol-tethered surface coat proteins to promote and establish chronic infection. Of the three infective stages of T. gondii, sporozoites are encapsulated in highly infectious oocysts that have been linked to large scale outbreaks of toxoplasmosis. SporoSAG (surface antigen glycoprotein) is the dominant surface coat protein expressed on the surface of sporozoites. Using a bioinformatic approach, we show that SporoSAG clusters with the SAG2 subfamily of the SAG1-related superfamily (SRS) and is non-polymorphic among the 11 haplogroups of T. gondii strains. In contrast to the immunodominant SAG1 protein expressed on tachyzoites, SporoSAG is non-immunogenic during natural infection. We report the 1.60 angstrom resolution crystal structure of SporoSAG solved using cadmium single anomalous dispersion. SporoSAG crystallized as a monomer and displays unique features of the SRS beta-sandwich fold relative to SAG1 and BSR4. Intriguingly, the structural diversity is localized to the upper sheets of the beta-sandwich fold and may have important implications for multimerization and host cell ligand recognition. The structure of SporoSAG also reveals an unexpectedly acidic surface that contrasts with the previously determined SAG1 and BSR4 structures where a basic surface is predicted to play a role in binding negatively charged glycosaminoglycans. Our structural and functional characterization of SporoSAG provides a rationale for the evolutionary divergence of this key SRS family member.	[Lamb, Erika; Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Crawford, Joanna; Grujic, Ognjen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Wasmuth, James] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1L7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Victoria; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grigg, ME (corresponding author), NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, 4 Ctr Dr, Bethesda, MD 20892 USA.	griggm@niaid.nih.gov; mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889; Wasmuth, James/0000-0002-9516-212X	Canadian Institutes of Health Research (CIHR) [MOP82915]; National Institutes of Health through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Research Grant MOP82915 from the Canadian Institutes of Health Research (CIHR) (to M. J. B.). This work was also supported by the Intramural Research Program of the National Institutes of Health (to M. E. G.) through the NIAID.	Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENENSON MW, 1982, NEW ENGL J MED, V307, P666, DOI 10.1056/NEJM198209093071107; BESSIERES MH, 1992, PARASITOL RES, V78, P222, DOI 10.1007/BF00931730; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; DeLano W.L, PYMOL MOL GRAPHICS S; DRUMMOND AJ, 2006, GENEIOUS VERSION 2 5; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1995, J PARASITOL, V81, P723, DOI 10.2307/3283961; Dubey JP, 2002, J PARASITOL, V88, P802, DOI 10.1645/0022-3395(2002)088[0802:POTGAI]2.0.CO;2; DUBEY JP, 1981, AM J VET RES, V42, P1007; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Grimwood J, 1996, INT J PARASITOL, V26, P169, DOI 10.1016/0020-7519(95)00103-4; Grujic O, 2008, ACTA CRYSTALLOGR F, V64, P425, DOI 10.1107/S1744309108010920; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jones JL, 2003, EMERG INFECT DIS, V9, P1371, DOI 10.3201/eid0911.030098; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KHAN IA, 1988, J INFECT DIS, V157, P979, DOI 10.1093/infdis/157.5.979; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCCABE RE, 1983, EUR J CLIN MICROBIOL, V2, P95, DOI 10.1007/BF02001573; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304; PARTANEN P, 1984, J CLIN MICROBIOL, V20, P133, DOI 10.1128/JCM.20.1.133-135.1984; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prigione I, 2000, J IMMUNOL, V164, P3741, DOI 10.4049/jimmunol.164.7.3741; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Sharif M, 2009, TROP ANIM HEALTH PRO, V41, P183, DOI 10.1007/s11250-008-9173-y; SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0; SMITH KE, 1992, VET PARASITOL, V42, P199, DOI 10.1016/0304-4017(92)90062-E; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TEUTSCH SM, 1979, NEW ENGL J MED, V300, P695, DOI 10.1056/NEJM197903293001302; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	48	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12063	12070		10.1074/jbc.M109.054866	http://dx.doi.org/10.1074/jbc.M109.054866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164173	Green Published, hybrid			2022-12-27	WOS:000276787100035
J	Ippagunta, SK; Brand, DD; Luo, JW; Boyd, KL; Calabrese, C; Stienstra, R; Van de Veerdonk, FL; Netea, MG; Joosten, LAB; Lamkanfi, M; Kanneganti, TD				Ippagunta, Sirish K.; Brand, David D.; Luo, Jiwen; Boyd, Kelli L.; Calabrese, Christopher; Stienstra, Rinke; Van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Inflammasome-independent Role of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) in T Cell Priming Is Critical for Collagen-induced Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-1; AUTOIMMUNITY; ACTIVATION; IL-1-BETA; CARTILAGE; RELEASE; ENZYME; ALPHA; BETA; MICE	Rheumatoid arthritis is an autoimmune disease with 1% prevalence in the industrialized world. The contributions of the inflammasome components Nlrp3, ASC, and caspase-1 in the pathogenesis of collagen-induced arthritis have not been characterized. Here, we show that ASC(-/-) mice were protected from arthritis, whereas Nlrp3(-/-) and caspase-1(-/-) mice were susceptible to collagen-induced arthritis. Unlike Nlrp3(-/-) and caspase-1(-/-) mice, the production of collagen-specific antibodies was abolished in ASC(-/-) mice. This was due to a significantly reduced antigen-specific activation of lymphocytes by ASC(-/-) dendritic cells. Antigen-induced proliferation of purified ASC(-/-) T cells was restored upon incubation with wild type dendritic cells, but not when cultured with ASC(-/-) dendritic cells. Moreover, direct T cell receptor ligation with CD3 and CD28 antibodies induced a potent proliferation of ASC(-/-) T cells, indicating that ASC is specifically required in dendritic cells for antigen-induced T cell activation. Therefore, ASC fulfills a hitherto unrecognized inflammasome-independent role in dendritic cells that is crucial for T cell priming and the induction of antigen-specific cellular and humoral immunity and the onset of collagen-induced arthritis.	[Ippagunta, Sirish K.; Boyd, Kelli L.; Calabrese, Christopher; Kanneganti, Thirumala-Devi] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Brand, David D.; Luo, Jiwen] Univ Tennessee, Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; [Stienstra, Rinke; Van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Hosp, Dept Immunol, MS 351,570 St Jude Pl,Suite E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Joosten, Leo AB/H-3138-2015; Kanneganti, Thirumala-Devi/M-9435-2018; Netea, Mihai/N-5155-2014; Stienstra, Rinke/A-4763-2015; van de Veerdonk, Frank L/C-7256-2008	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Joosten, Leo AB/0000-0001-6166-9830; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Stienstra, Rinke/0000-0001-6729-7193; van de Veerdonk, Frank L/0000-0002-1121-4894; Ippagunta, Sirish Kumar/0000-0002-7449-0511; Brand, David/0000-0002-9260-7963	National Institutes of Health [AR056296]; American Lebanese and Syrian Associated Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant AR056296. This work was also supported by the American Lebanese and Syrian Associated Charities (to T.-D.K.).	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; HAQQI TM, 1990, J AUTOIMMUN, V3, P113, DOI 10.1016/0896-8411(90)90135-F; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; HOLMDAHL R, 1993, ANN MED, V25, P251, DOI 10.3109/07853899309147871; HOLMDAHL R, 1990, IMMUNOL REV, V118, P193, DOI 10.1111/j.1600-065X.1990.tb00817.x; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P1652, DOI 10.1021/bi00785a024; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344	25	73	76	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12454	12462		10.1074/jbc.M109.093252	http://dx.doi.org/10.1074/jbc.M109.093252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177071	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000276787100073
J	Wang, J; Peng, QS; Lin, Q; Childress, C; Carey, D; Yang, WN				Wang, Jian; Peng, Qisheng; Lin, Qiong; Childress, Chandra; Carey, David; Yang, Wannian			Calcium Activates Nedd4 E3 Ubiquitin Ligases by Releasing the C2 Domain-mediated Auto-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; INDUCIBLE KINASE ISOFORMS; GROWTH-FACTOR RECEPTOR; SODIUM-CHANNEL; INOSITOL 1,4,5-TRISPHOSPHATE; PROTEIN UBIQUITYLATION; ENDOPLASMIC-RETICULUM; FUNCTIONAL DIVERSITY; RNA INTERFERENCE; PHOSPHOLIPASE-C	Nedd4 E3 ligases are members of the HECT E3 ubiquitin ligase family and regulate ubiquitination-mediated protein degradation. In this report, we demonstrate that calcium releases the C2 domain-mediated auto-inhibition in both Nedd4-1 and Nedd4-2. Calcium disrupts binding of the C2 domain to the HECT domain. Consistent with this, calcium activates the E3 ubiquitin ligase activity of Nedd4. Elevation of intracellular calcium by ionomycin treatment, or activation of acetylcholine receptor or epidermal growth factor receptor by carbachol or epidermal growth factor stimulation induced activation of endogenous Nedd4 in vivo evaluated by assays of either Nedd4 E3 ligase activity or ubiquitination of Nedd4 substrate ENaC-beta. The activation effect of calcium on Nedd4 E3 ligase activity was dramatically enhanced by a membrane-rich fraction, suggesting that calcium-mediated membrane translocation through the C2 domain might be an activation mechanism of Nedd4 in vivo. Our studies have revealed an activation mechanism of Nedd4 E3 ubiquitin ligases and established a connection of intracellular calcium signaling to regulation of protein ubiquitination.	[Yang, Wannian] Geisinger Med Clin, Weis Ctr Res, Danville, PA 17822 USA; [Wang, Jian] Beijing Inst Biotechnol, Lab Mol Biol Med, Beijing 100850, Peoples R China; [Peng, Qisheng] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China	Geisinger Medical Center; Jilin University	Yang, WN (corresponding author), Geisinger Med Clin, Weis Ctr Res, 100 N Acad Ave, Danville, PA 17822 USA.	wyang1@geisinger.edu	Yang, Wannian/K-4836-2019	Lin, Qiong/0000-0002-4393-2495	American Cancer Society [ACS-RSG TBE-110602]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society Grant ACS-RSG TBE-110602 (to W. Y.).	Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Boehmer C, 2003, BIOCHEM BIOPH RES CO, V306, P156, DOI 10.1016/S0006-291X(03)00921-5; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Chen HM, 2001, EUR J HUM GENET, V9, P922, DOI 10.1038/sj.ejhg.5200747; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; LUO JH, 1993, J BIOL CHEM, V268, P23580; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; PRENTKI M, 1984, J BIOL CHEM, V259, P3777; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; QIAN NX, 1993, P NATL ACAD SCI USA, V90, P4077, DOI 10.1073/pnas.90.9.4077; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu LL, 2003, CANCER RES, V63, P4299; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	57	91	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12279	12288		10.1074/jbc.M109.086405	http://dx.doi.org/10.1074/jbc.M109.086405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172859	Green Published, hybrid			2022-12-27	WOS:000276787100057
J	Wang, K; Long, B; Zhou, J; Li, PF				Wang, Kun; Long, Bo; Zhou, Jing; Li, Pei-Feng			miR-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CASPASE RECRUITMENT DOMAIN; CARDIOMYOCYTE HYPERTROPHY; IN-VIVO; CALCINEURIN INHIBITION; OXIDATIVE MODIFICATION; OVERLOAD HYPERTROPHY; APOPTOSIS REPRESSOR; PRESSURE-OVERLOAD; DOWN-REGULATION	Myocardial hypertrophy is frequently associated with poor clinical outcomes including the development of cardiac systolic and diastolic dysfunction and ultimately heart failure. To prevent cardiac hypertrophy and heart failure, it is necessary to identify and characterize molecules that may regulate the hypertrophic program. Our present study reveals that nuclear factor of activated T cells c3 (NFATc3) and myocardin constitute a hypertrophic pathway that can be targeted by miR-9. Our results show that myocardin expression is elevated in response to hypertrophic stimulation with isoproterenol and aldosterone. In exploring the molecular mechanism by which myocardin expression is elevated, we identified that NFATc3 can bind to the promoter region of myocardin and transcriptionally activate its expression. Knockdown of myocardin can attenuate hypertrophic responses triggered by NFATc3, suggesting that myocardin can be a downstream mediator of NFATc3 in the hypertrophic cascades. MicroRNAs are a class of small noncoding RNAs that mediate post-transcriptional gene silencing. Our data reveal that miR-9 can suppress myocardin expression. However, the hypertrophic stimulation with isoproterenol and aldosterone leads to a decrease in the expression levels of miR-9. Administration of miR-9 could attenuate cardiac hypertrophy and ameliorate cardiac function. Taken together, our data demonstrate that NFATc3 can promote myocardin expression, whereas miR-9 is able to suppress myocardin expression, thereby regulating cardiac hypertrophy.	[Wang, Kun; Long, Bo; Zhou, Jing; Li, Pei-Feng] Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Div Cardiovasc Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/ABD-5663-2021; Long, Bo/AGX-8013-2022; Long, Bo/GQH-5131-2022; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407	National Natural Science Foundation of China [30730045, 30871243]; National Basic Research Program of China [2007CB512000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045 and 30871243 and by National Basic Research Program of China Program 973 Grant 2007CB512000.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DOLBER PC, 1994, AM J PHYSIOL-HEART C, V267, pH1279, DOI 10.1152/ajpheart.1994.267.4.H1279; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Olson EN, 1999, CIRC RES, V84, P623, DOI 10.1161/01.RES.84.6.623; Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Xia Y, 2000, J BIOL CHEM, V275, P1855, DOI 10.1074/jbc.275.3.1855; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	51	128	142	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11903	11912		10.1074/jbc.M109.098004	http://dx.doi.org/10.1074/jbc.M109.098004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177053	Green Published, hybrid			2022-12-27	WOS:000276787100018
J	Peng, Y; Lee, J; Zhu, CF; Sun, ZJ				Peng, Yue; Lee, Jane; Zhu, Chunfang; Sun, Zijie			A Novel Role for Protein Inhibitor of Activated STAT (PIAS) Proteins in Modulating the Activity of Zimp7, a Novel PIAS-like Protein, in Androgen Receptor-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; INTERACTING PROTEIN-3; GENE-EXPRESSION; NUCLEAR-BODIES; SUMO LIGASES; SP-RING; COACTIVATOR; COMPLEX; HZIMP10; FAMILY	The PIAS proteins ( protein inhibitor of activated STAT) were originally identified as inhibitors of the JAK-STAT pathway. Subsequently, their roles on transcriptional regulation have been identified in modulation of the androgen receptor (AR) and other nuclear hormone receptor-mediated actions. Zimp7, also named Zmiz2, is a novel PIAS-like protein and functions as a transcriptional co-activator. In this study, we demonstrate an interaction between Zimp7 and PIAS proteins with higher preference for PIAS3. A modified mammalian one-hybrid assay showed that the NH2-terminal proline-rich domain of Zimp7 and the region spanning amino acids 321-486 of PIAS3 were the primary interaction segments. The interaction between Zimp7 and PIAS3 proteins was further confirmed by in vitro protein pull-down and co-immunoprecipitation assays with both exogenous and endogenous proteins. Expression of exogenous PIAS3 further enhances Zimp7-mediated augmentation of AR transcription. Knockdown of the endogenous PIAS3 protein using a specific PIAS3 small hairpin RNA reduced the augmentation of Zimp7 on AR-mediated transcription. Co-localization of Zimp7 and PIAS3 proteins was observed in the nuclei of cells by immunostaining. Exogenous PIAS3 expression enhances the stability of the Zimp7 protein. Using chromatin immunoprecipitation assays, we showed that PIAS3 is involved in the AR- and Zimp7-formed protein complex(es) in the AR downstream target promoter to facilitate androgen-induced transcription. Finally, we further demonstrated that loss of Zimp7 significantly impaired PIAS3-mediated enhancement on AR activity in mouse Zimp7 null (zimp7(-/-)) embryonic fibroblasts. Taken together, these results demonstrate a novel interaction between PIAS and PIAS-like proteins and elucidate a novel regulatory mechanism for PIAS proteins in AR- mediated transcription.	[Sun, Zijie] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA.	zsun@stanford.edu			National Institutes of Health [CA70297]; NATIONAL CANCER INSTITUTE [R29CA070297, R01CA070297, R01CA087767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061002, R56DK061002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant CA70297.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; James P, 1996, GENETICS, V144, P1425; Jimenez-Lara AM, 2002, FEBS LETT, V526, P142, DOI 10.1016/S0014-5793(02)03154-X; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	37	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11465	11475		10.1074/jbc.M109.079327	http://dx.doi.org/10.1074/jbc.M109.079327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159969	hybrid, Green Published			2022-12-27	WOS:000276286200053
J	Tokesi, N; Lehotzky, A; Horvath, I; Szabo, B; Olah, J; Lau, P; Ovadi, J				Tokesi, Natalia; Lehotzky, Attila; Horvath, Istvan; Szabo, Balint; Olah, Judit; Lau, Pierre; Ovadi, Judit			TPPP/p25 Promotes Tubulin Acetylation by Inhibiting Histone Deacetylase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN TPPP/P25; OLIGODENDROCYTE DIFFERENTIATION; MICROTUBULE STABILITY; CELL MOTILITY; RAT-BRAIN; HDAC6; TAU; NEURONS	TPPP/p25 (tubulin polymerization-promoting protein/p25) is an unstructured protein that induces microtubule polymerization in vitro and is aligned along the microtubule network in transfected mammalian cells. In normal human brain, TPPP/p25 is expressed predominantly in oligodendrocytes, where its expression is proved to be crucial for their differentiation process. Here we demonstrated that the expression of TPPP/p25 in HeLa cells, in doxycycline-inducible CHO10 cells, and in the oligodendrocyte CG-4 cells promoted the acetylation of alpha-tubulin at residue Lys-40, whereas its down-regulation by specific small interfering RNA in CG-4 cells or by the withdrawal of doxycycline from CHO10 cells decreased the acetylation level of alpha-tubulin. Our results indicate that TPPP/p25 binds to HDAC6 (histone deacetylase 6), an enzyme responsible for tubulin deacetylation. Moreover, we demonstrated that the direct interaction of these two proteins resulted in the inhibition of the deacetylase activity of HDAC6. The measurement of HDAC6 activity showed that TPPP/p25 is able to induce almost complete (90%) inhibition at 3 mu M concentration. In addition, treatment of the cells with nocodazole, vinblastine, or cold exposure revealed that microtubule acetylation induced by trichostatin A, a well known HDAC6 inhibitor, does not cause microtubule stabilization. In contrast, the microtubule bundling activity of TPPP/p25 was able to protect the microtubules from depolymerization. Finally, we demonstrated that, similarly to other HDAC6 inhibitors, TPPP/p25 influences the microtubule dynamics by decreasing the growth velocity of the microtubule plus ends and also affects cell motility as demonstrated by time lapse video experiments. Thus, we suggest that TPPP/p25 is a multiple effector of the microtubule organization.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary; [Szabo, Balint] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Lau, Pierre] NINDS, Sect Dev Genet, NIH, Bethesda, MD 20892 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)		ovadi@enzim.hu	Horvath, Istvan/B-1889-2009	Horvath, Istvan/0000-0003-4262-1430; Olah, Judit/0000-0002-2470-8631; Attila, Lehotzky/0000-0001-5235-1812; Ovadi, Judit/0000-0002-3420-682X	FP6-2003-LIFESCIHEALTH-I: BioSim; Hungarian National Scientific Research Fund [OTKA T-067963, OTKA F-49795]; ELTE CellCom RET	FP6-2003-LIFESCIHEALTH-I: BioSim; Hungarian National Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ELTE CellCom RET	This work was supported by FP6-2003-LIFESCIHEALTH-I: BioSim and by Hungarian National Scientific Research Fund Grants OTKA T-067963 to (J. Ovadi) and OTKA F-49795 and ELTE CellCom RET (to B. S.).	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Kawada J, 2009, J BIOL CHEM, V284, P17102, DOI 10.1074/jbc.M809090200; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Nahhas F, 2007, MOL CELL BIOCHEM, V303, P221, DOI 10.1007/s11010-007-9478-6; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Ovadi J, 2009, BIOESSAYS, V31, P676, DOI 10.1002/bies.200900008; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Stepanova T, 2003, J NEUROSCI, V23, P2655; Suzuki K, 2007, NEUROSCIENCE, V147, P599, DOI 10.1016/j.neuroscience.2007.04.059; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; WEBSTER DR, 1989, J CELL SCI, V92, P57; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	51	75	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17896	17906		10.1074/jbc.M109.096578	http://dx.doi.org/10.1074/jbc.M109.096578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20308065	hybrid, Green Published			2022-12-27	WOS:000278133400066
J	Leonhardt, RM; Vigneron, N; Rahner, C; van den Eynde, BJ; Cresswell, P				Leonhardt, Ralf M.; Vigneron, Nathalie; Rahner, Christoph; van den Eynde, Benoit J.; Cresswell, Peter			Endoplasmic Reticulum Export, Subcellular Distribution, and Fibril Formation by Pmel17 Require an Intact N-terminal Domain Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII-DEPENDENT EXPORT; SPLICE VARIANT; PROTEIN GP100; REPEAT DOMAIN; ER EXPORT; MELANOMA; GOLGI; MELANOSOMES; CLEAVAGE; PATHWAY	Pmel17 is a melanocyte/melanoma-specific protein that sub-cellularly localizes to melanosomes, where it forms a fibrillar matrix that serves for the sequestration of potentially toxic reaction intermediates of melanin synthesis and deposition of the pigment. As a key factor in melanosomal biogenesis, understanding intracellular trafficking and processing of Pmel17 is of central importance to comprehend how these organelles are formed, how they mature, and how they function in the cell. Using a series of deletion and missense mutants of Pmel17, we are able to show that the integrity of the junction between the N-terminal region and the polycystic kidney disease-like domain is highly crucial for endoplasmic reticulum export, subcellular targeting, and fibril formation by Pmel17 and thus for establishing functional melanosomes.	[Leonhardt, Ralf M.; Vigneron, Nathalie; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Rahner, Christoph; Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Vigneron, Nathalie; van den Eynde, Benoit J.] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Vigneron, Nathalie; van den Eynde, Benoit J.] Catholic Univ Louvain, de Duve Inst, Cellular Genet Unit, B-1200 Brussels, Belgium	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Leonhardt, RM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S669-670, New Haven, CT 06519 USA.	ralf.leonhardt@yale.edu		Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [R37-AI23081]; Howard Hughes Medical Institute; Yale SPORE in Skin Cancer [5P50 CA121974]; Cancer Research Institute; European Union; Fonds National de la Recherche Scientifique, Belgium; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale SPORE in Skin Cancer; Cancer Research Institute; European Union(European Commission); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AI23081 (to P. C.). This work was also supported by the Howard Hughes Medical Institute and Yale SPORE in Skin Cancer Grant 5P50 CA121974 (to P. C.). Furthermore, support was provided by a Cancer Research Institute Fellowship (to R. M. L.) and a Marie Curie Outgoing International Fellowship from the European Union and the Fonds National de la Recherche Scientifique, Belgium (to N.V.).	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kuliawat R, 2009, EUR J CELL BIOL, V88, P653, DOI 10.1016/j.ejcb.2009.07.001; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Seliger B, 2001, CANCER RES, V61, P8647; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tanaka T, 2006, BIOPOLYMERS, V84, P161, DOI 10.1002/bip.20361; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Vigneron N, 2005, TISSUE ANTIGENS, V65, P156, DOI 10.1111/j.1399-0039.2005.00365.x; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Zheng Y, 2005, J MICROBIOL, V43, P529	41	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16166	16183		10.1074/jbc.M109.097725	http://dx.doi.org/10.1074/jbc.M109.097725			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20231267	hybrid, Green Published			2022-12-27	WOS:000277715900054
J	Staruschenko, A; Jeske, NA; Akopian, AN				Staruschenko, Alexander; Jeske, Nathaniel A.; Akopian, Armen N.			Contribution of TRPV1-TRPA1 Interaction to the Single Channel Properties of the TRPA1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; MUSTARD OIL RESPONSES; RECEPTOR POTENTIAL A1; SENSORY NEURONS; CAPSAICIN RECEPTOR; SUBUNIT STOICHIOMETRY; PLASMA-MEMBRANE; CATION CHANNEL; MICE LACKING; ION-CHANNEL	Several lines of evidence suggest that TRPA1 and TRPV1 mutually control the transduction of inflammation-induced noxious stimuli in sensory neurons. It was recently shown that certain TRPA1 properties are modulated by TRPV1. However, direct interaction between TRPA1 and TRPV1 as well as regulation of TRPA1 intrinsic characteristics by the TRPV1 channel have not been examined. To address these questions, we have studied a complex formation between TRPA1 and TRPV1 and characterized the influence of TRPV1 on single channel TRPA1-mediated currents. Co-immunoprecipitation analysis revealed direct interactions between TRPA1 and TRPV1 in an expression system as well as in sensory neurons. Data generated with total internal reflection fluorescence-based fluorescence resonance energy transfer indicate that a TRPA1-TRPV1 complex can be formed on the plasma membrane. The fluorescence resonance energy transfer interaction between TRPA1 and TRPV1 channels is as effective as for TRPV1 or TRPA1 homomers. Single channel analysis in a heterologous expression system and in sensory neurons of wild type and TRPV1 knockout mice demonstrated that co-expression of TRPV1 with TRPA1 results in outward rectification of single channel mustard oil (I-MO) current-voltage relationships (I-V) and substantial modulation of the open probability at negative holding potentials. TRPV1 also does not influence the characteristics of single channel IMO in Ca2+-free extracellular solution. However, association of TRPA1 with TRPV1 was not affected in Ca2+-free media. To assess a role of intracellular Ca2+ in TRPV1-dependent modulation of TRPA1 modulation, the TRPA1-mediated single channel WIN55,212-2-gated current (I-WIN) was recorded in inside-out configuration. Our data indicate that single channel properties of TRPA1 are regulated by TRPV1 independently of intracellular Ca2+. In summary, our results support the hypothesis that TRPV1 and TRPA1 form a complex and that TRPV1 influences intrinsic characteristics of the TRPA1 channel.	[Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin; Medical College of Wisconsin	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	akopian@uthscsa.edu		Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [DE017696, DE019311, NS061884]; American Heart Association [0730111N]; American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019311, R01DE017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE017696 and DE019311 (to A. N. A.) and NS061884 (to N. A. J.). This work was also supported by American Heart Association Grant 0730111N and a Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (to A. S.).	Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Ambudkar I. S., 2007, V179, P541; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Staruschenko AV, 2006, CELL RES, V16, P723, DOI 10.1038/sj.cr.7310084; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vennekens R, 2001, J PHYSIOL-LONDON, V530, P183, DOI 10.1111/j.1469-7793.2001.0183l.x; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	48	150	153	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15167	15177		10.1074/jbc.M110.106153	http://dx.doi.org/10.1074/jbc.M110.106153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231274	Green Published, hybrid			2022-12-27	WOS:000277399000038
J	Yao, JH; Py, BF; Zhu, H; Bao, JX; Yuan, JY				Yao, Jianhua; Py, Benedicte F.; Zhu, Hong; Bao, Jianxin; Yuan, Junying			Role of Protein Misfolding in DFNA9 Hearing Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-EAR; VESTIBULAR DYSFUNCTION; SENSORINEURAL DEAFNESS; COCHLEAR GENE; A DOMAIN; DISORDER; MOUSE; IDENTIFICATION; LOCALIZATION; MUTATIONS	Mutations in the COCH(coagulation factor Chomology) gene have been attributed to DFNA9 (deafness, autosomal-dominant 9), an autosomal-dominant non-syndromic hearing loss disorder. However, the mechanisms responsible for DFNA9 hearing loss remain unknown. Here, we demonstrate that mutant cochlin, the protein product of the COCH gene, forms a stable dimer that is sensitive to reducing agent. In contrast, wild-type (WT) cochlin may form only dimers transiently. Interestingly, the presence of mutant cochlin can stabilize WT cochlin in dimer conformation, providing a possible mechanism for the dominant nature of DFNA9 mutations. Furthermore, the expression of mutant cochlin eventually induces WT cochlin to form stable oligomers that are resistant to reducing agent. Finally, we show that mutant cochlin is cytotoxic in vitro and in vivo. Our study suggests a possible molecular mechanism underlying DFNA9 hearing loss and provides an in vitro model that may be used to explore protein-misfolding diseases in general.	[Yao, Jianhua; Py, Benedicte F.; Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bao, Jianxin] Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	junying_yuan@hms.harvard.edu	Py, Benedicte/M-6129-2014	Zhu, Hong/0000-0002-2575-4031; py, benedicte/0000-0001-6716-7807	National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award ( to J.Y.).	Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Ferrante RJ, 2009, BBA-MOL BASIS DIS, V1792, P506, DOI 10.1016/j.bbadis.2009.04.001; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Grabski R, 2003, HUM GENET, V113, P406, DOI 10.1007/s00439-003-0992-7; Iguchi F, 2004, ACTA OTO-LARYNGOL, V124, P43, DOI 10.1080/03655230310016816; Ikezono T, 2004, BIOCHEM BIOPH RES CO, V314, P440, DOI 10.1016/j.bbrc.2003.12.106; Ikezono T, 2001, BBA-MOL BASIS DIS, V1535, P258, DOI 10.1016/S0925-4439(00)00101-0; Khetarpal U, 2000, LARYNGOSCOPE, V110, P1379, DOI 10.1097/00005537-200008000-00030; KHETARPAL U, 1991, ARCH OTOLARYNGOL, V117, P1032; Lawlor P, 1999, J NEUROSCI, V19, P9445; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Lipinski MM, 2004, CURR OPIN PHARMACOL, V4, P85, DOI 10.1016/j.coph.2003.09.008; Makishima T, 2005, HUM GENET, V118, P29, DOI 10.1007/s00439-005-0001-4; Merchant SN, 2000, ADV OTO-RHINO-LARYNG, V56, P212; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Nagy I, 2008, FEBS LETT, V582, P4003, DOI 10.1016/j.febslet.2008.10.050; Nakagawa T, 2003, HEARING RES, V176, P122, DOI 10.1016/S0378-5955(02)00768-2; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Robertson NG, 2003, J MED GENET, V40, P479, DOI 10.1136/jmg.40.7.479; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Robertson NG, 2001, HUM MOL GENET, V10, P2493, DOI 10.1093/hmg/10.22.2493; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shen HY, 2007, HEARING RES, V226, P52, DOI 10.1016/j.heares.2006.12.011; Suko T, 2000, HEARING RES, V140, P137, DOI 10.1016/S0378-5955(99)00191-4; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	31	29	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14909	14919		10.1074/jbc.M110.106724	http://dx.doi.org/10.1074/jbc.M110.106724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228067	Green Published, hybrid			2022-12-27	WOS:000277399000012
J	Peterson, SB; Liu, J				Peterson, Sherket B.; Liu, Jian			Unraveling the Specificity of Heparanase Utilizing Synthetic Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEPARANASE; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; SULFATE GLYCOSAMINOGLYCANS; CAPSULAR POLYSACCHARIDE; CANCER METASTASIS; GROWTH-FACTOR; EXPRESSION; HEPARIN; CLONING	Heparanase is a promising anticancer target because of its involvement in cancer invasion and metastasis. Heparanase cleaves heparan sulfate (HS), a sulfated polysaccharide, and activates a series of HS-mediated cell proliferation and angiogenesis processes. Understanding the substrate specificity of heparanase will aid the discovery of heparanase inhibitors. Here, we sought to determine the specificity of heparanase using synthetic polysaccharide substrates. The substrates were prepared using purified HS biosynthetic enzymes. Using these substrates, we were able to dissect the structural moieties required for heparanase. Our data suggest that heparanase cleaves the linkage between a GlcA unit and an N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo group. In addition, heparanase cleaves the linkage of a GlcA unit and N-sulfo glucosamine unit with a 2-O-sulfated GlcA residue, not a 2-O-sulfated IdoA residue, in proximity. We also discovered that the polysaccharide with repeating disaccharide units of IdoA2S-GlcNS inhibits the activity of heparanase. Our findings advance the understanding of the substrate specificity of heparanase and identify a lead compound for developing polysaccharide-based heparanase inhibitors.	[Peterson, Sherket B.; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, 303 Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [R01AI050050, R01HL094463, R21AI074775]; American Heart Association, Mid-Atlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R21AI074775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM090647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Mid-Atlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI050050, R01HL094463, and R21AI074775. This work was also supported by Grant-in-aid 0855424E from the American Heart Association, Mid-Atlantic Affiliate.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; BAME KJ, 1993, J BIOL CHEM, V268, P19956; Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; BARNER M, 1987, BLOOD, V70, P551; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Davidson D, 2007, GYNECOL ONCOL, V104, P311, DOI 10.1016/j.ygyno.2006.08.045; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHAIMICHAELI R, 1992, BIOCHEMISTRY-US, V31, P2080, DOI 10.1021/bi00122a027; Koliopanos A, 2001, CANCER RES, V61, P4655; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lindahl U, 2005, J MED CHEM, V48, P349, DOI 10.1021/jm049812m; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; McDowell LM, 2006, J BIOL CHEM, V281, P6924, DOI 10.1074/jbc.M512932200; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; OGREN S, 1975, J BIOL CHEM, V250, P2690; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Quiros RM, 2006, CANCER-AM CANCER SOC, V106, P532, DOI 10.1002/cncr.21648; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Simizu S, 2004, CANCER SCI, V95, P553, DOI 10.1111/j.1349-7006.2004.tb02485.x; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Uno F, 2001, CANCER RES, V61, P7855; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Xiao Y, 2003, HEPATOL RES, V26, P192, DOI 10.1016/S1386-6346(03)00107-4	47	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14504	14513		10.1074/jbc.M110.104166	http://dx.doi.org/10.1074/jbc.M110.104166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20181948	Green Published, hybrid			2022-12-27	WOS:000277299700047
J	Ziebarth, TD; Gonzalez-Soltero, R; Makowska-Grzyska, MM; Nunez-Ramirez, R; Carazo, JM; Kaguni, LS				Ziebarth, Tawn D.; Gonzalez-Soltero, Rocio; Makowska-Grzyska, Magdalena M.; Nunez-Ramirez, Rafael; Carazo, Jose-Maria; Kaguni, Laurie S.			Dynamic Effects of Cofactors and DNA on the Oligomeric State of Human Mitochondrial DNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; SINGLE-STRANDED-DNA; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; PRIMASE-HELICASE; BACTERIOPHAGE-T7; HYDROLYSIS; MECHANISM; HEXAMER; DOMAIN	We examined the effects of cofactors and DNA on the stability, oligomeric state and conformation of the human mitochondrial DNA helicase. We demonstrate that low salt conditions result in protein aggregation that may cause dissociation of oligomeric structure. The low salt sensitivity of the mitochondrial DNA helicase is mitigated by the presence of magnesium, nucleotide, and increased temperature. Electron microscopic and glutaraldehyde cross-linking analyses provide the first evidence of a heptameric oligomer and its interconversion from a hexameric form. Limited proteolysis by trypsin shows that binding of nucleoside triphosphate produces a conformational change that is distinct from the conformation observed in the presence of nucleoside diphosphate. We find that single-stranded DNA binding occurs in the absence of cofactors and renders the mitochondrial DNA helicase more susceptible to proteolytic digestion. Our studies indicate that the human mitochondrial DNA helicase shares basic properties with the SF4 replicative helicases, but also identify common features with helicases outside the superfamily, including dynamic conformations similar to other AAA(+) ATPases.	[Ziebarth, Tawn D.; Makowska-Grzyska, Magdalena M.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 49924 USA; [Ziebarth, Tawn D.; Makowska-Grzyska, Magdalena M.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 49924 USA; [Gonzalez-Soltero, Rocio; Nunez-Ramirez, Rafael; Carazo, Jose-Maria] CSIC, Ctr Nacl Biotecnol, Unidad Biocomputac, E-28049 Madrid, Spain	Michigan State University; Michigan State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 49924 USA.	lskaguni@msu.edu	Garcia, Jose Maria Carazo/E-9234-2016; Gonzalez-Soltero, Rocio/Z-2702-2019; González-Soltero, Rocío/O-7686-2019; Physics, Biophym IEM-CSIC Macromolecular/C-7939-2011	Garcia, Jose Maria Carazo/0000-0003-0788-8447; Gonzalez-Soltero, Rocio/0000-0001-9799-0570; González-Soltero, Rocío/0000-0001-9799-0570; Nunez, Rafael/0000-0002-2949-8709	National Institutes of Health [GM45295]; MEC [CSD2006-00023, BIO2007-67150-C03-1]; CAM [S-GEN-0166-2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEC(European Commission); CAM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM45295 from the National Institutes of Health (to L. S. K.). This work was also supported by Grants CSD2006-00023 and BIO2007-67150-C03-1 from MEC and S-GEN-0166-2006 from CAM (to J.-M.C.).	ARAI K, 1981, J BIOL CHEM, V256, P5260; ARAI K, 1981, J BIOL CHEM, V256, P5247; Barcena M, 1998, J MOL BIOL, V283, P809, DOI 10.1006/jmbi.1998.2128; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; LIU CC, 1981, J BIOL CHEM, V256, P2813; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; MATSON SW, 1985, J BIOL CHEM, V260, P2281; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; PATEL SS, 1993, J BIOL CHEM, V268, P10668; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079	40	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14639	14647		10.1074/jbc.M109.099663	http://dx.doi.org/10.1074/jbc.M109.099663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212038	Green Published, hybrid			2022-12-27	WOS:000277299700061
J	Sevrioukova, IF; Poulos, TL; Churbanova, IY				Sevrioukova, Irina F.; Poulos, Thomas L.; Churbanova, Inna Y.			Crystal Structure of the Putidaredoxin Reductase.Putidaredoxin Electron Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450CAM MONOOXYGENASE; REDOX PARTNERS; ADRENODOXIN REDUCTASE; CYTOCHROME P450CAM; ASSOCIATIONS; COMPONENT; SYSTEM; ROLES	In the camphor monooxygenase system from Pseudomonas putida, the [2Fe-2S]-containing putidaredoxin (Pdx) shuttles electrons between the NADH-dependent putidaredoxin reductase (Pdr) and cytochrome P450(cam). The mechanism of the Pdr.Pdx redox couple has been investigated by a variety of techniques. One of the exceptions is x-ray crystallography as the native partners associate weakly and resist co-crystallization. Here, we present the 2.6-angstrom x-ray structure of a catalytically active complex between Pdr and Pdx C73S/C85S chemically cross-linked via the Lys(409Pdr)-Glu(72Pdx) pair. The 365 angstrom(2) Pdr-Pdx interface is predominantly hydrophobic with one central Arg(310Pdr)-Asp(38Pdx) salt bridge, likely assisting docking and orienting the partners optimally for electron transfer, and a few peripheral hydrogen bonds. A predicted 12-angstrom-long electron transfer route between FAD and [2Fe-2S] includes flavin flanking Trp(330Pdr) and the iron ligand Cys(39Pdx). The x-ray model agrees well with the experimental and theoretical results and suggests that the linked Pdx must undergo complex movements during turnover to accommodate P450(cam), which could limit the Pdx-to-P450(cam) electron transfer reaction.	[Sevrioukova, Irina F.; Poulos, Thomas L.; Churbanova, Inna Y.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem & Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	sevrioui@uci.edu			National Institutes of Health [GM67637, GM33688]; U. S. Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067637, R01GM033688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Dept. of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM67637 (to I. F. S.) and GM33688 (to T. L. P.). This work was based on research conducted at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Dept. of Energy under Contract DE-AC02-05CH11231.	Aoki M, 1998, BBA-PROTEIN STRUCT M, V1386, P168, DOI 10.1016/S0167-4838(98)00091-0; Aoki M, 1998, BBA-PROTEIN STRUCT M, V1386, P157, DOI 10.1016/S0167-4838(98)00094-6; Aoki M, 1998, BBA-PROTEIN STRUCT M, V1384, P180, DOI 10.1016/S0167-4838(98)00017-X; Aoki M, 1998, INORG CHIM ACTA, V272, P80, DOI 10.1016/S0020-1693(97)05946-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Churbanova IY, 2010, BIOCHEMISTRY-US, V49, P58, DOI 10.1021/bi901872s; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; DeLano W.L, PYMOL MOL GRAPHICS S; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; HINTZ MJ, 1982, J BIOL CHEM, V257, P4324; Holden M, 1997, J BIOL CHEM, V272, P21720, DOI 10.1074/jbc.272.35.21720; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Kurnikov I, 2000, HARLEM VERSION 1 0; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Purdy MM, 2004, BIOCHEMISTRY-US, V43, P271, DOI 10.1021/bi0356045; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P32, DOI 10.1016/0003-9861(88)90233-0; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P41, DOI 10.1016/0003-9861(88)90234-2; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Sevrioukova IF, 2001, BIOCHEMISTRY-US, V40, P10592, DOI 10.1021/bi010874d; Smith N, 2004, ACTA CRYSTALLOGR D, V60, P816, DOI 10.1107/S0907444904003348; Ziegler GA, 1999, J MOL BIOL, V289, P981, DOI 10.1006/jmbi.1999.2807	31	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13616	13620		10.1074/jbc.M110.104968	http://dx.doi.org/10.1074/jbc.M110.104968			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20179327	hybrid, Green Published			2022-12-27	WOS:000276987700035
J	Mierke, CT; Kollmannsberger, P; Zitterbart, DP; Diez, G; Koch, TM; Marg, S; Ziegler, WH; Goldmann, WH; Fabry, B				Mierke, Claudia T.; Kollmannsberger, Philip; Zitterbart, Daniel Paranhos; Diez, Gerold; Koch, Thorsten M.; Marg, Susanna; Ziegler, Wolfgang H.; Goldmann, Wolfgang H.; Fabry, Ben			Vinculin Facilitates Cell Invasion into Three-dimensional Collagen Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-CELLS; MIGRATION; ADHESION; LOCOMOTION; F9; PROTEOLYSIS; INTEGRINS; DYNAMICS; SURVIVAL; MOTILITY	The cytoskeletal protein vinculin contributes to the mechanical link of the contractile actomyosin cytoskeleton to the extracellular matrix (ECM) through integrin receptors. In addition, vinculin modulates the dynamics of cell adhesions and is associated with decreased cell motility on two-dimensional ECM substrates. The effect of vinculin on cell invasion through dense three-dimensional ECM gels is unknown. Here, we report how vinculin expression affects cell invasion into three-dimensional collagen matrices. Cell motility was investigated in vinculin knockout and vinculin expressing wild-type mouse embryonic fibroblasts. Vinculin knockout cells were 2-fold more motile on two-dimensional collagen-coated substrates compared with wild-type cells, but 3-fold less invasive in 2.4 mg/ml three-dimensional collagen matrices. Vinculin knockout cells were softer and remodeled their cytoskeleton more dynamically, which is consistent with their enhanced two-dimensional motility but does not explain their reduced three-dimensional invasiveness. Importantly, vinculin-expressing cells adhered more strongly to collagen and generated 3-fold higher traction forces compared with vinculin knockout cells. Moreover, vinculin-expressing cells were able to migrate into dense (5.8 mg/ml) three-dimensional collagen matrices that were impenetrable for vinculin knockout cells. These findings suggest that vinculin facilitates three-dimensional matrix invasion through up-regulation or enhanced transmission of traction forces that are needed to overcome the steric hindrance of ECMs.	[Goldmann, Wolfgang H.; Fabry, Ben] Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Biophys Grp, D-91052 Erlangen, Germany; [Marg, Susanna; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, Interdisziplinares Zentrum Klin Forsch Leipzig, D-404103 Leipzig, Germany	University of Erlangen Nuremberg; Leipzig University	Mierke, CT (corresponding author), Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Biophys Grp, Henkestr 91, D-91052 Erlangen, Germany.	claudia.mierke@t-online.de	Goldmann, Wolfgang H/H-5572-2013; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013; Kollmannsberger, Philip/D-7925-2011; Zitterbart, Daniel/N-7489-2013; Mierke, Claudia Tanja/L-5293-2018	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Kollmannsberger, Philip/0000-0002-8049-6186; Mierke, Claudia Tanja/0000-0002-6622-335X; Ziegler, Wolfgang H./0000-0003-4529-1916	National Institutes of Health [HL65960]; Deutsche Forschungsgemeinschaft [FA336/2-1, GO598/13-1]; Deutsche Krebshilfe [107384]; Deutscher Akademischer Austausch Dienst; Bavaria California Technology Center; Bayerisch-Franzo-Sisches Hochschulzentrum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Bavaria California Technology Center; Bayerisch-Franzo-Sisches Hochschulzentrum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL65960. This work was also supported by Deutsche Forschungsgemeinschaft Grants FA336/2-1 and GO598/13-1, the Cluster of Excellence "Engineering of Advanced Materials" Program, Deutsche Krebshilfe Grant 107384, Deutscher Akademischer Austausch Dienst, Bavaria California Technology Center, and Bayerisch-Franzo-Sisches Hochschulzentrum.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fabry B, 2003, RESP PHYSIOL NEUROBI, V137, P109, DOI 10.1016/S1569-9048(03)00141-1; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; GOLDMANN WH, 1995, EXP CELL RES, V221, P311, DOI 10.1006/excr.1995.1380; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McNulty AL, 2009, CLIN ORTHOP RELAT R, V467, P1557, DOI 10.1007/s11999-008-0596-6; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xu WM, 1998, J CELL SCI, V111, P1535; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	31	147	148	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13121	13130		10.1074/jbc.M109.087171	http://dx.doi.org/10.1074/jbc.M109.087171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181946	hybrid, Green Published			2022-12-27	WOS:000276787800068
J	Jennewein, C; von Knethen, A; Schmid, T; Brune, B				Jennewein, Carla; von Knethen, Andreas; Schmid, Tobias; Bruene, Bernhard			MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) mRNA Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; HALF-LIFE; KAPPA-B; EXPRESSION; INFLAMMATION; MACROPHAGES; NUCLEAR; ALPHA; TRANSLOCATION; STIMULATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) gained considerable interest as a therapeutic target during chronic inflammatory diseases. Remarkably, the pathogenesis of diseases such as multiple sclerosis or Alzheimer is associated with impaired PPAR gamma expression. Considering that regulation of PPAR gamma expression during inflammation is largely unknown, we were interested in elucidating underlying mechanisms. To this end, we initiated an inflammatory response by exposing primary human macrophages to lipopolysaccharide (LPS) and observed a rapid decline of PPAR gamma 1 expression. Because promoter activities were not affected by LPS, we focused on mRNA stability and noticed a decreased mRNA half-life. As RNA stability is often regulated via 3'-untranslated regions (UTRs), we analyzed the impact of the PPAR gamma-3'-UTR by reporter assays using specific constructs. LPS significantly reduced luciferase activity of the pGL3-PPAR gamma-3'-UTR, suggesting that PPAR gamma 1 mRNA is destabilized. Deletion or mutation of a potential microRNA-27a/b (miR-27a/b) binding site within the 3'-UTR restored luciferase activity. Moreover, inhibition of miR-27b, which was induced upon LPS exposure, partially reversed PPAR gamma 1 mRNA decay, whereas miR-27b overexpression decreased PPAR gamma 1 mRNA content. In addition, LPS further reduced this decay. The functional relevance of miR-27b-dependent PPAR gamma 1 decrease was proven by inhibition or overexpression of miR-27b, which affected LPS-induced expression of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF alpha) and interleukin (IL)-6. We provide evidence that LPS-induced miR-27b contributes to destabilization of PPAR gamma 1 mRNA. Understanding molecular mechanisms decreasing PPAR gamma might help to better appreciate inflammatory diseases.	[Jennewein, Carla; von Knethen, Andreas; Schmid, Tobias; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem I ZAFES, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Brune, B (corresponding author), Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bruene@pathobiochemie1.de	Jennewein, Carla/C-2199-2013	Schmid, Tobias/0000-0002-1952-5259	Deutsche Forschungsgemeinschaft [Br 999, FOG 784]; Sander Foundation; LOEWE	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sander Foundation; LOEWE	This work was supported by grants from Deutsche Forschungsgemeinschaft (Br 999, FOG 784, Excellence Cluster Cardiopulmonary System), Sander Foundation, and LOEWE (LiFF and OSF).	Drew PD, 2008, PPAR RES, V2008, DOI 10.1155/2008/627463; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dushkin MI, 2009, B EXP BIOL MED+, V147, P345, DOI 10.1007/s10517-009-0505-3; Elbrecht A, 1996, BIOCHEM BIOPH RES CO, V224, P431, DOI 10.1006/bbrc.1996.1044; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim D, 2001, MOL CELLS, V11, P267; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; Kobayashi M, 2005, ANN ALLERG ASTHMA IM, V95, P468, DOI 10.1016/S1081-1206(10)61173-8; Landreth G, 2007, CURR ALZHEIMER RES, V4, P159, DOI 10.2174/156720507780362092; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Von Knethen A, 2001, FASEB J, V15, P535, DOI 10.1096/fj.00-0187com; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhou M, 2008, AM J PHYSIOL-REG I, V294, pR84, DOI 10.1152/ajpregu.00340.2007	45	150	159	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11846	11853		10.1074/jbc.M109.066399	http://dx.doi.org/10.1074/jbc.M109.066399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164187	Green Published, hybrid			2022-12-27	WOS:000276787100012
J	Khan, MT; Joseph, SK				Khan, M. Tariq; Joseph, Suresh K.			Role of Inositol Trisphosphate Receptors in Autophagy in DT40 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; MAMMALIAN TARGET; ENDOPLASMIC-RETICULUM; CA2+ RELEASE; SIGNAL-TRANSDUCTION; PROMOTES AUTOPHAGY; EPITHELIAL-CELLS; CALCIUM SIGNALS; BECLIN 1; APOPTOSIS	Previous studies have shown that small interfering RNA knockdown and pharmacological inhibition of inositol 1,4,5-trisphosphate receptors (IP(3)Rs) stimulate autophagy. We have investigated autophagy in chicken DT40 cell lines containing targeted deletions of all three IP3R isoforms (triple knock-out (TKO) cells). Using gel shifts of microtubule-associated protein 1 light chain 3 as a marker of autophagy, we find that TKO cells have enhanced basal autophagic flux even under nutrient-replete conditions. Stable DT40 cell lines derived from TKO cells containing the functionally inactive D2550A IP3R mutant did not suppress autophagy in the same manner as wild-type receptors. This suggests that the channel function of the receptor is important in its regulatory role in autophagy. There were no marked differences in the phosphorylation state of AMP-activated protein kinase, Akt, or mammalian target of rapamycin between wild-type and TKO cells. The amount of immunoprecipitated complexes of Bcl-2-Beclin-1 and Beclin-1-Vps34 were also not different between the two cell lines. The major difference noted was a substantially decreased mTORC1 kinase activity in TKO cells based on decreased phosphorylation of S6 kinase and 4E-BP1. The discharge of intracellular stores with thapsigargin stimulated mTORC1 activity (measured as S6 kinase phosphorylation) to a greater extent in wild-type than in TKO cells. We suggest that basal autophagic flux may be negatively regulated by IP3R-dependent Ca2(+) signals acting to maintain an elevated mTORC1 activity in wild-type cells and that Ca2(+) regulation of this enzyme is defective in TKO cells. The protective effect of a higher autophagic flux in cells lacking IP(3)Rsmayplay a role in the delayed apoptotic response observed in these cells.	[Khan, M. Tariq; Joseph, Suresh K.] Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu						Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; CARDENAS C, 2008, J GEN PHYSIOL, V132, pA24; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Eskelinen EL, 2008, INT REV CEL MOL BIO, V266, P207, DOI 10.1016/S1937-6448(07)66005-5; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Guillemette J, 2005, CELL CALCIUM, V37, P97, DOI 10.1016/j.ceca.2004.03.005; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Joseph SK, 1999, BIOCHEM J, V342, P153, DOI 10.1042/0264-6021:3420153; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marchi S, 2008, BIOCHEM BIOPH RES CO, V375, P501, DOI 10.1016/j.bbrc.2008.07.153; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sekulic A, 2000, CANCER RES, V60, P3504; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625	63	77	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16912	16920		10.1074/jbc.M110.114207	http://dx.doi.org/10.1074/jbc.M110.114207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308071	Green Published, hybrid			2022-12-27	WOS:000277982600054
J	Ishino, K; Wakita, C; Shibata, T; Toyokuni, S; Machida, S; Matsuda, S; Matsuda, T; Uchida, K				Ishino, Kousuke; Wakita, Chika; Shibata, Takahiro; Toyokuni, Shinya; Machida, Sachiko; Matsuda, Shun; Matsuda, Tomonari; Uchida, Koji			Lipid Peroxidation Generates Body Odor Component trans-2-Nonenal Covalently Bound to Protein in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ALDEHYDE-MODIFIED PROTEINS; NONENZYMATICALLY GLYCOSYLATED PROTEINS; LIVER ENDOTHELIAL-CELLS; SCAVENGER RECEPTOR; FERRIC NITRILOTRIACETATE; OXIDATIVE INACTIVATION; RENAL CARCINOGEN; LDL RECEPTOR; MACROPHAGES	trans-2-Nonenal is an unsaturated aldehyde with an unpleasant greasy and grassy odor endogenously generated during the peroxidation of polyunsaturated fatty acids. 2-Nonenal covalently modified human serum albumin through a reaction in which the aldehyde preferentially reacted with the lysine residues. Modified proteins were immunogenic, and a specific monoclonal antibody (mAb) 27Q4 that cross-reacted with the protein covalently modified with 2-nonenal was raised from mouse. To verify the presence of the protein-bound 2-nonenal in vivo, the mAb 27Q4 against the 2-nonenal-modified keyhole limpet hemocyanin was raised. It was found that a novel 2-nonenal-lysine adduct, cis- and trans-N-epsilon-3-[(hept-1-enyl)-4-hexyl-pyridinium]lysine (HHP-lysine), constitutes an epitope of the antibody. The immunoreactive materials with mAb 27Q4 were detected in the kidney of rats exposed to ferric nitrilotriacetate, an iron chelate that induces free radical-mediated oxidative tissue damage. Using high performance liquid chromatography with on-line electrospray ionization tandem mass spectrometry, we also established a highly sensitive method for detection of the cis- and trans-HHP-lysine and confirmed that the 2-nonenal-lysine adducts were indeed formed during the lipid peroxidation-mediated modification of protein in vitro and in vivo. Furthermore, we examined the involvement of the scavenger receptor lectin-like oxidized low density lipoprotein receptor-1 in the recognition of 2-nonenal-modified proteins and established that the receptor recognized the HHP-lysine adducts as a ligand.	[Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan; [Machida, Sachiko] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Matsuda, Shun; Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Kyoto 5200811, Japan	Nagoya University; Nagoya University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Toyokuni, Shinya/ABE-7714-2021; Matsuda, Shun/A-4017-2011; Ishino, Kousuke/G-8473-2018; Shibata, Takahiro/I-6872-2014	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Matsuda, Shun/0000-0002-4181-2772; Ishino, Kousuke/0000-0002-6862-9898; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas (research in a proposed research area), from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. U.).	ALAIZ M, 1995, CHEM PHYS LIPIDS, V77, P217, DOI 10.1016/0009-3084(95)02470-4; AWAI M, 1979, AM J PATHOL, V95, P663; Baker A, 1998, CHEM RES TOXICOL, V11, P730, DOI 10.1021/tx970167e; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Duryee MJ, 2005, MOL PHARMACOL, V68, P1423, DOI 10.1124/mol.105.016121; Duryee MJ, 2003, BIOCHEM PHARMACOL, V66, P1045, DOI 10.1016/S0006-2952(03)00416-7; EBINA Y, 1986, J NATL CANCER I, V76, P107; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Hernandez-Hernandez A, 1999, FREE RADICAL BIO MED, V26, P1218, DOI 10.1016/S0891-5849(98)00306-2; HORIUCHI S, 1986, J BIOL CHEM, V261, P4962; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; LI JL, 1987, CANCER RES, V47, P1867; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; MARNETT LJ, 1980, CANCER RES, V40, P276; Matsunaga S, 2007, EXP CELL RES, V313, P1203, DOI 10.1016/j.yexcr.2007.01.007; OHYASHIKI T, 1995, J BIOCHEM-TOKYO, V118, P508, DOI 10.1093/oxfordjournals.jbchem.a124937; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Shi XH, 2001, J CELL SCI, V114, P1273; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEPHAN ZF, 1993, J LIPID RES, V34, P325; TAKATA K, 1988, J BIOL CHEM, V263, P14819; TAKATA K, 1989, BIOCHIM BIOPHYS ACTA, V986, P18, DOI 10.1016/0005-2736(89)90267-8; Thomas J.A., 1989, British Wildlife, V1, P2; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Toyokuni S, 1997, FREE RADICAL BIO MED, V22, P1019, DOI 10.1016/S0891-5849(96)00489-3; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009	38	55	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15302	15313		10.1074/jbc.M109.068023	http://dx.doi.org/10.1074/jbc.M109.068023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215107	hybrid, Green Published			2022-12-27	WOS:000277399000051
J	Masuda, M; Maruyama, T; Ohta, T; Ito, A; Hayashi, T; Tsukasaki, K; Kamihira, S; Yamaoka, S; Hoshino, H; Yoshida, T; Watanabe, T; Stanbridge, EJ; Murakami, Y				Masuda, Mari; Maruyama, Tomoko; Ohta, Tsutomu; Ito, Akihiko; Hayashi, Tomayoshi; Tsukasaki, Kunihiko; Kamihira, Shimeru; Yamaoka, Shoji; Hoshino, Hiroo; Yoshida, Teruhiko; Watanabe, Toshiki; Stanbridge, Eric J.; Murakami, Yoshinori			CADM1 Interacts with Tiam1 and Promotes Invasive Phenotype of Human T-cell Leukemia Virus Type I-transformed Cells and Adult T-cell Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE; TUMOR-SUPPRESSOR; IMMUNOGLOBULIN SUPERFAMILY; TSLC1; EXPRESSION; RHO; PROTEIN; GENE; RAC; HOMOLOGY	CADM1 encodes a multifunctional immunoglobulin-like cell adhesion molecule whose cytoplasmic domain contains a type II PSD95/Dlg/ZO-1 (PDZ)-binding motif (BM) for associating with other intracellular proteins. Although CADM1 lacks expression in T lymphocytes of healthy individuals, it is overexpressed in adult T-cell leukemia-lymphoma (ATL) cells. It has been suggested that the expression of CADM1 protein promotes infiltration of leukemic cells into various organs and tissues, which is one of the frequent clinical manifestations of ATL. Amino acid sequence alignment revealed that Tiam1 (T-lymphoma invasion and metastasis 1), a Rac-specific guanine nucleotide exchange factor, has a type II PDZ domain similar to those of membrane-associated guanylate kinase homologs (MAGUKs) that are known to bind to the PDZ-BM of CADM1. In this study, we demonstrated that the cytoplasmic domain of CADM1 directly interacted with the PDZ domain of Tiam1 and induced formation of lamellipodia through Rac activation in HTLV-I-transformed cell lines as well as ATL cell lines. Our results indicate that Tiam1 integrates signals from CADM1 to regulate the actin cytoskeleton through Rac activation, which may lead to tissue infiltration of leukemic cells in ATL patients.	[Masuda, Mari] Natl Canc Ctr, Res Inst, Div Chemotherapy, Tumor Suppress & Funct Genom Project,Chuo Ku, Tokyo 1040045, Japan; [Masuda, Mari; Ohta, Tsutomu; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Maruyama, Tomoko; Ito, Akihiko; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Mol Pathol, Tokyo 1088639, Japan; [Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tumor Cell Biol Lab, Tokyo 1088639, Japan; [Hayashi, Tomayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 8528523, Japan; [Tsukasaki, Kunihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med & Hematol, Nagasaki 8528523, Japan; [Kamihira, Shimeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528523, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138510, Japan; [Hoshino, Hiroo] Gunma Univ, Grad Sch Med, Dept Virol & Prevent Med, Maebashi, Gunma 3718511, Japan; [Stanbridge, Eric J.] Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; University of Tokyo; Nagasaki University; Nagasaki University; Nagasaki University; Tokyo Medical & Dental University (TMDU); Gunma University; University of California System; University of California Irvine	Masuda, M (corresponding author), Natl Canc Ctr, Res Inst, Div Chemotherapy, Tumor Suppress & Funct Genom Project,Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mamasuda@ncc.go.jp; ymurakam@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [17015048]; Ministry of Health, Labor, and Welfare, Japan; National Institute of Biomedical Innovation [05-10]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Grant-in-aid for Scientific Research on Priority Areas for Cancer 17015048 (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare, Japan (to Y. M.), and a Grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (Grant 05-10) (to Y. M.).	Arase N, 2005, INT IMMUNOL, V17, P1227, DOI 10.1093/intimm/dxh299; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Dewan MZ, 2008, J VIROL, V82, P11958, DOI 10.1128/JVI.01149-08; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ishioka K, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-71; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; TAJIMA K, 1990, INT J CANCER, V45, P237, DOI 10.1002/ijc.2910450206; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Yageta M, 2002, CANCER RES, V62, P5129; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Yasunaga JI, 2007, REV MED VIROL, V17, P301, DOI 10.1002/rmv.548; Yoshie O, 2005, LEUKEMIA LYMPHOMA, V46, P185, DOI 10.1080/10428190400007607	52	54	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15511	15522		10.1074/jbc.M109.076653	http://dx.doi.org/10.1074/jbc.M109.076653			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215110	Green Published, hybrid			2022-12-27	WOS:000277399000070
J	McNicholl, ET; Das, R; SilDas, S; Taylor, SS; Melacini, G				McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Taylor, Susan S.; Melacini, Giuseppe			Communication between Tandem cAMP Binding Domains in the Regulatory Subunit of Protein Kinase A-I alpha as Revealed by Domain-silencing Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE MUTATIONS; PKA; ACTIVATION; ANCIENT; STABILITY; MECHANISM; ALLOSTERY; DYNAMICS; MUTANT	Protein kinase A (PKA) is the main receptor for the universal cAMP second messenger. PKA is a tetramer with two catalytic (C) and two regulatory (R) subunits, each including two tandem cAMP binding domains, i.e. CBD-A and -B. Structural investigations of RI alpha have revealed that although CBD-A plays a pivotal role in the cAMP-dependent inhibition of C, the main function of CBD-B is to regulate the access of cAMP to site A. To further understand the mechanism underlying the cross-talk between CBD-A and -B, we report here the NMR investigation of a construct of R, RI alpha-(119-379), which unlike previous fragments characterized by NMR, spans in full both CBDs. Our NMR studies were also extended to two mutants, R209K and the corresponding R333K, which severely reduce the affinity of cAMP for CBD-A and -B, respectively. The comparative NMR analysis of wild-type RI alpha-(119-379) and of the two domain silencing mutations has led to the definition at an unprecedented level of detail of both intra- and interdomain allosteric networks, revealing several striking differences between the two CBDs. First, the two domains, although homologous in sequence and structure, exhibit remarkably different responses to the R/K mutations especially at the beta 2-3 allosteric "hot spot." Second, although the two CBDs are reciprocally coupled at the level of local unfolding of the hinge, the A-to-B and B-to-A pathways are dramatically asymmetrical at the level of global unfolding. Such an asymmetric interdomain cross-talk ensures efficiency and robustness in both the activation and de-activation of PKA.	[McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	McMaster University; McMaster University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Melacini, G (corresponding author), McMaster Univ, Dept Chem, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Das, Rahul/AAU-5123-2020	Das, Rahul/0000-0001-7841-8229	Canadian Institute of Health Research; National Institutes of Health [GM34921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institute of Health Research. This paper is dedicated to the memory of Captain George A. McNicholl.; Supported by National Institutes of Health Grant GM34921.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Anand G, 2007, BIOCHEMISTRY-US, V46, P9283, DOI 10.1021/bi700421h; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Englander J, 2006, BIOPOLYMERS, V84, P508, DOI 10.1002/bip.20546; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; Goddard T. D., 2006, SPARKY 3; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Scott JD, 2006, BIOCHEM SOC T, V34, P465, DOI 10.1042/BST0340465; Segui-Lines G, 2007, ANALYST, V132, P741, DOI 10.1039/b705469f; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022	37	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15523	15537		10.1074/jbc.M110.105783	http://dx.doi.org/10.1074/jbc.M110.105783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202931	hybrid, Green Published			2022-12-27	WOS:000277399000071
J	Parvatiyar, K; Barber, GN; Harhaj, EW				Parvatiyar, Kislay; Barber, Glen N.; Harhaj, Edward W.			TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; NEGATIVE FEEDBACK-REGULATION; TUMOR-SUPPRESSOR CYLD; EDITING ENZYME A20; RIG-I; IFN-BETA; ADAPTER PROTEIN; FACTOR ACTIVATION; INTERFERON	Induction of type I interferons by the transcription factor IRF3 is essential in the initiation of antiviral innate immunity. Activation of IRF3 requires C-terminal phosphorylation by the upstream kinases TBK1-IKKi, where IRF3 phosphorylation promotes dimerization, and subsequent nuclear translocation to the IFN beta promoter. Recent studies have described the ubiquitin-editing enzyme A20 as a negative regulator of IRF3 signaling by associating with TBK1-IKKi; however, the regulatory mechanism of A20 inhibition remains unclear. Here we describe the adaptor protein, TAX1BP1, as a key regulator of A20 function in terminating signaling to IRF3. Murine embryonic fibroblasts (MEFs) deficient in TAX1BP1 displayed increased amounts of IFN beta production upon viral challenge compared with WT MEFs. TAX1BP1 inhibited virus-mediated activation of IRF3 at the level of TBK1-IKKi. TAX1BP1 and A20 blocked antiviral signaling by disrupting Lys(63)-linked polyubiquitination of TBK1-IKKi independently of the A20 deubiquitination domain. Furthermore, TAX1BP1 was required for A20 effector function because A20 was defective for the targeting and inactivation of TBK1 and IKKi in Tax1bp1(-/-) MEFs. Additionally, we found the E3 ubiquitin ligase TRAF3 to play a critical role in promoting TBK1-IKKi ubiquitination. Collectively, our results demonstrate TBK1-IKKi to be novel substrates for A20 and further identify a novel mechanism whereby A20 and TAX1BP1 restrict antiviral signaling by disrupting a TRAF3-TBK1-IKKi signaling complex.	[Harhaj, Edward W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Barber, Glen N.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, 1550 NW 10 Ave, Miami, FL 33136 USA.	eharhaj@med.miami.edu			National Institutes of Health [RO1GM083143, P01CA128115]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM083143 and P01CA128115.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zheng LY, 2009, ORAL SURG ORAL MED O, V107, P661, DOI 10.1016/j.tripleo.2009.01.039; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	60	123	134	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14999	15009		10.1074/jbc.M110.109819	http://dx.doi.org/10.1074/jbc.M110.109819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304918	hybrid, Green Published			2022-12-27	WOS:000277399000021
J	Andreou, A; Gobel, C; Hamberg, M; Feussner, I				Andreou, Alexandra; Goebel, Cornelia; Hamberg, Mats; Feussner, Ivo			A Bisallylic Mini-lipoxygenase from Cyanobacterium Cyanothece sp That Has an Iron as Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; FATTY-ACID HYDROPEROXIDE; NOSTOC SP PCC-7120; POSITIONAL SPECIFICITY; MANGANESE LIPOXYGENASE; FUSION PROTEIN; 3-DIMENSIONAL STRUCTURE; SOYBEAN LIPOXYGENASE-1; LIQUID-CHROMATOGRAPHY; PRIMARY DETERMINANT	Lipoxygenases are enzymes that are found ubiquitously in higher animals and plants, but have only recently been identified in a number of bacteria. The genome of the diazotrophic unicellular cyanobacterium Cyanothece sp. harbors two genes with homology to lipoxygenases. Here we describe the isolation of one gene, formerly named csplox2. It was cloned, and the protein was expressed in Escherichia coli and purified. The purified enzyme belongs to the group of prokaryotic mini lipoxygenases, because it had a molecular mass of 65 kDa. Interestingly, it catalyzed the conversion of linoleic acid, the only endogenously found polyunsaturated fatty acid, primarily to the bisallylic hydroperoxide 11R-hydroperoxyoctadecadienoic acid. This product had previously only been described for the manganese lipoxygenase from the take all fungus, Gaeumannomyces graminis. By contrast, CspLOX2 was shown to be an iron lipoxygenase. In addition, CspLOX2 formed a mixture of typical conjugated lipoxygenase products, e. g. 9R- and 13S-hydroperoxide. The conversion of linoleic acid took place with a maximum reaction rate of 31 s(-1). Incubation of the enzyme with [(11S)-H-2] linoleic acid led to the formation of hydroperoxides that had lost the deuterium label, thus suggesting that CspLOX2 catalyzes antarafacial oxygenation as opposed to the mechanism of manganese lipoxygenase. CspLOX2 could also oxidize diarachidonylglycerophosphatidylcholine with similar specificity as the free fatty acid, indicating that binding of the substrate takes place with a "tail-first" orientation. We conclude that CspLOX2 is a novel iron mini-lipoxygenase that catalyzes the formation of bisallylic hydroperoxide as the major product.	Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden	University of Gottingen; Karolinska Institutet		ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Hamberg, Mats/0000-0002-8910-7810	IRTG [1422]; International M.Sc./Ph.D. Program Molecular Biology (Goettingen)	IRTG; International M.Sc./Ph.D. Program Molecular Biology (Goettingen)	This work was supported by IRTG 1422 Metal Sites in Biomolecules: Structures, Regulation, and Mechanisms.; Supported by the International M.Sc./Ph.D. Program Molecular Biology (Goettingen) and by IRTG 1422 Metal Sites in Biomolecules: Structures, Regulation, and Mechanisms.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 2000, LIPIDS, V35, P947, DOI 10.1007/s11745-000-0604-0; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Feussner I, 1997, J BIOL CHEM, V272, P21635, DOI 10.1074/jbc.272.34.21635; Gao BL, 2010, BBA-MOL CELL BIOL L, V1801, P58, DOI 10.1016/j.bbalip.2009.09.004; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GARDNER HW, 1989, BIOCHIM BIOPHYS ACTA, V1001, P274, DOI 10.1016/0005-2760(89)90111-2; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1992, LIPIDS, V27, P487, DOI 10.1007/BF02536128; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kitaguchi H, 2005, J AM CHEM SOC, V127, P6605, DOI 10.1021/ja044345j; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, MOL NUTR FOOD RES, V49, P1014, DOI 10.1002/mnfr.200500131; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1995, J LIPID MEDIAT CELL, V12, P157, DOI 10.1016/0929-7855(95)00016-J; Lang I, 2008, BIOCHEM J, V410, P347, DOI 10.1042/BJ20071277; Lang I, 2007, PHYTOCHEMISTRY, V68, P1120, DOI 10.1016/j.phytochem.2007.02.028; Liavonchanka A, 2009, J BIOL CHEM, V284, P8005, DOI 10.1074/jbc.M809060200; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2006, ANAL BIOCHEM, V354, P111, DOI 10.1016/j.ab.2006.04.010; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Oliw EH, 2004, LIPIDS, V39, P319, DOI 10.1007/s11745-004-1235-1; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Palmieri-Thiers C, 2009, BBA-MOL CELL BIOL L, V1791, P339, DOI 10.1016/j.bbalip.2009.02.012; Prigge ST, 1996, PROTEINS, V24, P275; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shureiqi I, 2001, CANCER RES, V61, P6307; Skrzypczak-Jankun E, 2001, J AM CHEM SOC, V123, P10814, DOI 10.1021/ja011759t; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200; Tallman KA, 2001, J AM CHEM SOC, V123, P11827, DOI 10.1021/ja0169724; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	57	41	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14178	14186		10.1074/jbc.M109.094771	http://dx.doi.org/10.1074/jbc.M109.094771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223828	hybrid, Green Published			2022-12-27	WOS:000277299700014
J	Noam, Y; Zha, QQ; Phan, L; Wu, RL; Chetkovich, DM; Wadman, WJ; Baram, TZ				Noam, Yoav; Zha, Qinqin; Phan, Lise; Wu, Rui-Lin; Chetkovich, Dane M.; Wadman, Wytse J.; Baram, Tallie Z.			Trafficking and Surface Expression of Hyperpolarization-activated Cyclic Nucleotide-gated Channels in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALAMOCORTICAL RELAY NEURONS; N-LINKED GLYCOSYLATION; HCN CHANNELS; I-H; PYRAMIDAL NEURONS; PACEMAKER CHANNELS; EXCITABILITY; HETEROMERIZATION; LOCALIZATION; MODULATION	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels mediate the hyperpolarization-activated current I-h and thus play important roles in the regulation of brain excitability. The subcellular distribution pattern of the HCN channels influences the effects that they exert on the properties and activity of neurons. However, little is known about the mechanisms that control HCN channel trafficking to subcellular compartments or that regulate their surface expression. Here we studied the dynamics of HCN channel trafficking in hippocampal neurons using dissociated cultures coupled with time lapse imaging of fluorophore-fused HCN channels. HCN1-green fluorescence protein (HCN1-GFP) channels resided in vesicle-like organelles that moved in distinct patterns along neuronal dendrites, and these properties were isoform-specific. HCN1 trafficking required intact actin and tubulin and was rapidly inhibited by activation of either NMDA or AMPA-type ionotropic glutamate receptors in a calcium-dependent manner. Glutamate-induced inhibition of the movement of HCN1-GFP-expressing puncta was associated with increased surface expression of both native and transfected HCN1 channels, and this surface expression was accompanied by augmented I-h. Taken together, the results reveal the highly dynamic nature of HCN1 channel trafficking in hippocampal neurons and provide a novel potential mechanism for rapid regulation of I-h, and hence of neuronal properties, via alterations of HCN1 trafficking and surface expression.	[Noam, Yoav; Zha, Qinqin; Phan, Lise; Wu, Rui-Lin; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Chetkovich, Dane M.] Northwestern Univ, Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Wadman, Wytse J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Northwestern University; University of Amsterdam	Baram, TZ (corresponding author), Univ Calif Irvine, Dept Pediat, ZOT 4475, Irvine, CA 92697 USA.	tallie@uci.edu	Baram, Tallie Z/J-6447-2014; Chetkovich, Dane/AAV-5457-2021		National Institutes of Health [R37 NS35439, K02NS05595, R01NS059934]; Dutch Epilepsy Fund [NEF 08-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035439, R21NS052595, K08NS041956, R01NS059934, R21NS065391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Epilepsy Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS35439 (to T.Z.B. and Y.N.) and K02NS05595 and R01NS059934 (to D. M. C.). This work was also supported by Dutch Epilepsy Fund Grant NEF 08-02 (to W.J.W. and Y.N.).	Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Budde T, 2008, PFLUG ARCH EUR J PHY, V456, P1061, DOI 10.1007/s00424-008-0482-9; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; de Wit J, 2009, J NEUROSCI, V29, P23, DOI 10.1523/JNEUROSCI.3931-08.2009; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Moroni A, 2001, J BIOL CHEM, V276, P29233, DOI 10.1074/jbc.M100830200; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Murphy DD, 1998, J NEUROSCI, V18, P2550; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	50	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14724	14736		10.1074/jbc.M109.070391	http://dx.doi.org/10.1074/jbc.M109.070391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215108	Green Published, hybrid			2022-12-27	WOS:000277299700070
J	Radaev, S; Zou, ZC; Huang, T; Lafer, EM; Hinck, AP; Sun, PD				Radaev, Sergei; Zou, Zhongcheng; Huang, Tao; Lafer, Eileen M.; Hinck, Andrew P.; Sun, Peter D.			Ternary Complex of Transforming Growth Factor-beta 1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA-ISOFORMS; CRYSTAL-STRUCTURE; SIGNALING COMPLEXES; BINDING-SPECIFICITY; STRUCTURAL BASIS; CLEFT-PALATE; AFFINITY; MICE; MECHANISMS; SOFTWARE	Transforming growth factor (TGF)-beta 1, -beta 2, and -beta 3 are 25-kDa homodimeric polypeptides that play crucial nonover-lapping roles in embryogenesis, tissue development, carcinogenesis, and immune regulation. Here we report the 3.0-angstrom resolution crystal structure of the ternary complex between human TGF-beta 1 and the extracellular domains of its type I and type II receptors, T beta RI and T beta RII. The TGF-beta 1 ternary complex structure is similar to previously reported TGF-beta 3 complex except with a 10 degrees rotation in T beta RI docking orientation. Quantitative binding studies showed distinct kinetics between the receptors and the isoforms of TGF-beta. T beta RI showed significant binding to TGF-beta 2 and TGF-beta 3 but not TGF-beta 1, and the binding to all three isoforms of TGF-beta was enhanced considerably in the presence of T beta RII. The preference of TGF-beta 2 to T beta RI suggests a variation in its receptor recruitment in vivo. Although TGF-beta 1 and TGF-beta 3 bind and assemble their ternary complexes in a similar manner, their structural differences together with differences in the affinities and kinetics of their receptor binding may underlie their unique biological activities. Structural comparisons revealed that the receptor-ligand pairing in the TGF-beta superfamily is dictated by unique insertions, deletions, and disulfide bonds rather than amino acid conservation at the interface. The binding mode of T beta RII on TGF-beta is unique to TGF-beta s, whereas that of type II receptor for bone morphogenetic protein on bone morphogenetic protein appears common to all other cytokines in the superfamily. Further, extensive hydrogen bonds and salt bridges are present at the high affinity cytokine-receptor interfaces, whereas hydrophobic interactions dominate the low affinity receptor-ligand interfaces.	[Radaev, Sergei; Zou, Zhongcheng; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Huang, Tao; Lafer, Eileen M.; Hinck, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Health San Antonio	Sun, PD (corresponding author), 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov		Hinck, Andrew/0000-0003-3320-8054; Lafer, Eileen/0000-0002-0493-6522	National Institutes of Health [GM58670]; NIAID; Robert A. Welch Foundation [AQ1431]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58670 (to A. P. H.). This work was also supported by NIAID intramural research funding and by Robert A. Welch Foundation Grant AQ1431 (to A. P. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerletti A, 2000, J DRUG TARGET, V8, P435, DOI 10.3109/10611860008997919; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hinck AP, 2000, J BIOMOL NMR, V18, P369, DOI 10.1023/A:1026775321886; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moustakas A, 2001, J CELL SCI, V114, P4359; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Taya Y, 1999, DEVELOPMENT, V126, P3869; WANG QH, 1992, J APPL PHYS, V71, P1014, DOI 10.1063/1.350437; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	50	109	119	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14806	14814		10.1074/jbc.M109.079921	http://dx.doi.org/10.1074/jbc.M109.079921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207738	Green Published, hybrid			2022-12-27	WOS:000277299700077
J	Wiltshire, TD; Lovejoy, CA; Wang, T; Xia, F; O'Connor, MJ; Cortez, D				Wiltshire, Timothy D.; Lovejoy, Courtney A.; Wang, Tong; Xia, Fen; O'Connor, Mark J.; Cortez, David			Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-RESPONSE; HOMOLOGOUS RECOMBINATION; RAD51 PROTEIN; BRCA1; COMPLEX; MDC1; ENZYME; 53BP1; PHOSPHORYLATION; DETERMINANTS	DNA damage repair and checkpoint responses prevent genome instability and provide a barrier to the development of cancer. Inherited mutations in DNA damage response (DDR) genes such as those that encode the homologous recombination (HR) proteins BRCA1 and BRCA2 cause cancer predisposition syndromes. PARP inhibitors are an exciting new class of targeted therapy for treating patients with HR repair-defective tumors. In this study, we use an RNAi screen to identify genes that when silenced cause synthetic lethality with the PARP inhibitor AZD2281. This screen identified the deubiquitylating enzyme USP11 as a participant in HR repair of DNA double-strand breaks. Silencing USP11 with siRNA leads to spontaneous DDR activation in otherwise undamaged cells and hypersensitivity to PARP inhibition, ionizing radiation, and other genotoxic stress agents. Moreover, we demonstrate that HR repair is defective in USP11-silenced cells. Finally, the recruitment of a subset of double-strand break repair proteins including RAD51 and 53BP1 to repair foci is misregulated in the absence of USP11 catalytic activity. Thus, our synthetic lethal approach identified USP11 as a component of the HR double-strand break repair pathway.	[Wiltshire, Timothy D.; Lovejoy, Courtney A.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Xia, Fen; O'Connor, Mark J.] Vanderbilt Univ, Dept Radiat Oncol, Sch Med, Nashville, TN 37232 USA; [O'Connor, Mark J.] KuDOS Pharmaceut Ltd, Cambridge CB4 OPE, England	Vanderbilt University; Vanderbilt University; AstraZeneca	Cortez, D (corresponding author), 613 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Xia, Fen/G-3708-2013		NCI, National Institutes of Health [R21CA132010, R01CA136933]; Vanderbilt Center for Molecular Toxicology [P30 ES000267]; Vanderbilt-Ingram Cancer Center [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, R21CA132010, R01CA136933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Center for Molecular Toxicology; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants (R21CA132010 and R01CA136933) and a Susan G. Komen for the Cure grant (to D. C.). Support for research facilities was provided by the Vanderbilt Center for Molecular Toxicology (Grant P30 ES000267) and the Vanderbilt-Ingram Cancer Center (Grant P30 CA068485).	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; SAFFHILL R, 1985, CHROMOSOMA, V92, P218, DOI 10.1007/BF00348697; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	50	95	105	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14565	14571		10.1074/jbc.M110.104745	http://dx.doi.org/10.1074/jbc.M110.104745			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233726	Green Published, hybrid			2022-12-27	WOS:000277299700053
J	Griggs, AM; Hahne, K; Hrycyna, CA				Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.			Functional Oligomerization of the Saccharomyces cerevisiae Isoprenylcysteine Carboxyl Methyltransferase, Ste14p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL MEMBRANE-PROTEINS; C-TERMINAL METHYLATION; GXXXG MOTIF; A-FACTOR; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; COUPLED RECEPTORS; KINETIC MECHANISM; ESCHERICHIA-COLI; GLYCOPHORIN-A	The isoprenylcysteine carboxyl methyltransferase (Icmt) from Saccharomyces cerevisiae, also designated Ste14p, is a 26-kDa integral membrane protein that contains six transmembrane spanning segments. This protein is localized to the endoplasmic reticulum membrane where it performs the methylation step of the CAAX post-translational processing pathway. Sequence analysis reveals a putative GXXXG dimerization motif located in transmembrane 1 of Ste14p, but it is not known whether Ste14p forms or functions as a dimer or higher order oligomer. We determined that Ste14p predominantly formed a homodimer in the presence of the cross-linking agent, bis-sulfosuccinimidyl suberate. Wild-type untagged Ste14p also co-immunoprecipitated and co-purified with N-terminal-tagged His(10)-myc(3)-Ste14p (His-Ste14p). Furthermore, enzymatically inactive His-Ste14p variants L81F and E213Q both exerted a dominant-negative effect on methyltransferase activity when co-expressed and co-purified with untagged wild-type Ste14p. Together, these data, although indirect, suggest that Ste14p forms and functions as a homodimer or perhaps a higher oligomeric species.	[Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hrycyna, CA (corresponding author), 560 Oval Dr, W Lafayette, IN 47907 USA.	hrycyna@purdue.edu						Ambroziak P., 2001, ENZYMES, P155; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P492; Anderson JL, 2006, ENZYMES, V24, P245, DOI 10.1016/S1874-6047(06)80011-9; Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Anderson JL, 2005, J BIOL CHEM, V280, P7336, DOI 10.1074/jbc.M410292200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Filizola M, 2002, BIOPOLYMERS, V66, P317, DOI 10.1002/bip.10311; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gerber D, 2001, J BIOL CHEM, V276, P31229, DOI 10.1074/jbc.M101889200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; HRYCYNA CA, 1993, PHARMACOL THERAPEUT, V59, P281, DOI 10.1016/0163-7258(93)90071-K; HRYCYNA CA, 1995, METHOD ENZYMOL, V250, P251; HRYCYNA CA, 1990, MOL CELL BIOL, V10, P5071, DOI 10.1128/MCB.10.10.5071; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARR RS, 1990, J BIOL CHEM, V265, P20057; Mcclain MS, 2003, J BIOL CHEM, V278, P12101, DOI 10.1074/jbc.M212595200; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Romano JD, 1998, MOL BIOL CELL, V9, P2231, DOI 10.1091/mbc.9.8.2231; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SAPPERSTEIN S, 1994, MOL CELL BIOL, V14, P1438, DOI 10.1128/MCB.14.2.1438; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; SHI YQ, 1992, J BIOL CHEM, V267, P9547; STEPHENSON RC, 1992, J BIOL CHEM, V267, P13314; STEPHENSON RC, 1990, J BIOL CHEM, V265, P16248; Ugolini S, 2002, PLASMID, V47, P94, DOI 10.1006/plas.2001.1557; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Whittington DA, 2001, P NATL ACAD SCI USA, V98, P9545, DOI 10.1073/pnas.161301298; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	48	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13380	13387		10.1074/jbc.M109.061366	http://dx.doi.org/10.1074/jbc.M109.061366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202940	hybrid, Green Published			2022-12-27	WOS:000276987700009
J	Bista, P; Zeng, WK; Ryan, S; Bailly, V; Browning, JL; Lukashev, ME				Bista, Pradeep; Zeng, Weike; Ryan, Sarah; Bailly, Veronique; Browning, Jeffrey L.; Lukashev, Matvey E.			TRAF3 Controls Activation of the Canonical and Alternative NF kappa B by the Lymphotoxin Beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CELLS IN-VIVO; DENDRITIC CELLS; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; NF-KAPPA-B2 P100; GENE-EXPRESSION; FACTOR-BINDING; IKK-ALPHA; KINASE	Components of lymphotoxin beta receptor (LTBR)-associated signaling complexes, including TRAF2, TRAF3, NIK, IKK1, and IKK2 have been shown to participate in the coupling of LTBR to NF kappa B. Here, we report that TRAF3 functions as a negative regulator of LTBR signaling via both canonical and non-canonical NF kappa B pathways by two distinct mechanisms. Analysis of NF kappa B signaling in cell lines with functionally intact NF kappa B pathway but lacking LTBR-mediated induction of NF kappa B target genes revealed an inverse association of cellular TRAF3 levels with LTBR-specific defect in canonical NF kappa B activation. Increased expression of TRAF3 correlated with its increased recruitment to LTBR-induced signaling complexes, decreased recruitment of TRAF2, and attenuated phosphorylation of I kappa B alpha and RelA. In contrast, activation of NF kappa B by TNF did not depend on TRAF3 levels. siRNA-mediated depletion of TRAF3 promoted recruitment of TRAF2 and IKK1 to activated LTBR, enabling LTBR-inducible canonical NF kappa B signaling and NF kappa B target gene expression. TRAF3 knock-down also increased mRNA and protein expression of several non-canonical NF kappa B components, including NF kappa B2/p100, RelB, and NIK, accompanied by processing of NF kappa B2/p100 into p52. These effects of TRAF3 depletion did not require LTBR signaling and were consistent with autonomous activation of the non-canonical NF kappa B pathway. Our data illustrate the function of TRAF3 as a dual-mode repressor of LTBR signaling that controls activation of canonical NF kappa B, and de-repression of the intrinsic activity of non-canonical NF kappa B. Modulation of cellular TRAF3 levels may thus contribute to regulation of NF kappa B-dependent gene expression by LTBR by affecting the balance of LTBR-dependent activation of canonical and non-canonical NF kappa B pathways.	Biogen Idec Inc, Dept Immunol, Cambridge, MA 02142 USA; [Bailly, Veronique] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA 02142 USA	Biogen; Biogen		matvey.lukashev@biogenidec.com		Browning, Jeffrey/0000-0001-9168-5233				Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Chung JY, 2002, J CELL SCI, V115, P679; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Kuai J, 2003, J BIOL CHEM, V278, P14363, DOI 10.1074/jbc.M208672200; Li QT, 2000, GENE DEV, V14, P1729; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Moore CR, 2005, J IMMUNOL, V175, P3780, DOI 10.4049/jimmunol.175.6.3780; Moore F, 2007, J IMMUNOL, V178, P1301, DOI 10.4049/jimmunol.178.3.1301; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	52	56	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12971	12978		10.1074/jbc.M109.076091	http://dx.doi.org/10.1074/jbc.M109.076091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185819	Green Published, hybrid			2022-12-27	WOS:000276787800055
J	Han, KJ; Yang, Y; Xu, LG; Shu, HB				Han, Ke-Jun; Yang, Yan; Xu, Liang-Guo; Shu, Hong-Bing			Analysis of a TIR-less Splice Variant of TRIF Reveals an Unexpected Mechanism of TLR3-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; REGULATORY FACTOR-3 ACTIVATION; TOLL-LIKE-RECEPTORS; CUTTING EDGE; BETA; PATHWAY; KINASE; TANK; IDENTIFICATION	Recognition of viral RNA by Toll-like receptor 3 (TLR3) triggers activation of the transcription factors NF-kappa B and IRF3 and induction of type I interferons. TRIF is a Toll-interleukin 1 receptor (TIR) domain-containing adapter protein critically involved in TLR3-mediated signaling. It has been shown that TRIF interacts with TLR3 through their respective TIR domains. In this study, we identified a splice variant of TRIF lacking the TIR domain, which is designated as TRIS. Overexpression of TRIS activates NF-kappa B, interferon-stimulated response element (ISRE), and the interferon-beta promoter, whereas knockdown of TRIS inhibited TLR3-mediated signaling, suggesting that TRIS is involved in TLR3-mediated signaling. Furthermore, we identified an N-terminal TBK1-binding motif of TRIS or TRIF that was important for its interaction with TBK1 and ability to activate ISRE. Activation of ISRE by TRIS also needs its dimerization or oligomerization mediated by its C-terminal RIP homotypic interaction motif. Finally, we demonstrated that TRIS was associated with TRIF upon TLR3 activation by poly(I-C). These findings reveal an unexpected mechanism of TLR3-mediated signaling.	[Yang, Yan; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Han, Ke-Jun; Xu, Liang-Guo] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	Wuhan University; National Jewish Health	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn		Xu, Liangguo/0000-0003-1991-2889	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; 111 Project [B06018]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by Chinese 973 Program Grants 2006CB504301 and 2010CB911802, National Natural Science Foundation of China Grants 30630019 and 30921001, and the 111 Project B06018.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	29	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12543	12550		10.1074/jbc.M109.072231	http://dx.doi.org/10.1074/jbc.M109.072231			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20200155	Green Published, hybrid			2022-12-27	WOS:000276787800011
J	de Zoete, MR; Keestra, AM; Wagenaar, JA; van Putten, JPM				de Zoete, Marcel R.; Keestra, A. Marijke; Wagenaar, Jaap A.; van Putten, Jos P. M.			Reconstitution of a Functional Toll-like Receptor 5 Binding Site in Campylobacter jejuni Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; CARBOHYDRATE MODIFICATIONS; SALMONELLA FLAGELLIN; SIGNAL-TRANSDUCTION; ACTIVATION; TOLL-LIKE-RECEPTOR-5; GENE; IDENTIFICATION	Bacterial flagellin is important for intestinal immune homeostasis. Flagellins from most species activate Toll-like receptor 5 (TLR5). The principal bacterial food-borne pathogen Campylobacter jejuni escapes TLR5 recognition, probably due to an alternate flagellin subunit structure. We investigated the molecular basis of TLR5 evasion by aiming to reconstitute TLR5 stimulating activity in live C. jejuni. Both native glycosylated C. jejuni flagellins (FlaA and FlaB) and recombinant proteins purified from Escherichia coli failed to activate NF-kappa B in HEK293 cells expressing TLR5. Introduction of multiple defined regions from Salmonella flagellin into C. jejuni FlaA via a recombinatorial approach revealed three regions critical for the activation of human and mouse TLR5, including a beta-hairpin structure not previously implicated in TLR5 recognition. Surprisingly, this domain was not required for the activation of chicken TLR5, indicating a selective requirement for the beta-hairpin in the recognition of mammalian TLR5. Expression of the active chimeric protein in C. jejuni resulted in secreted glycosylated flagellin that induced a potent TLR5 response. Overall, our results reveal a novel structural requirement for TLR5 recognition of bacterial flagellin and exclude flagellin glycosylation as an additional mechanism of bacterial evasion of the TLR5 response.	[de Zoete, Marcel R.; Keestra, A. Marijke; Wagenaar, Jaap A.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3508 TD Utrecht, Netherlands; [Wagenaar, Jaap A.; van Putten, Jos P. M.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis Utrecht Lely, NL-8200 AB Lelystad, Netherlands	Utrecht University	van Putten, JPM (corresponding author), Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	j.vanputten@uu.nl	Keestra-Gounder, A. Marijke/H-4394-2012; de Zoete, Marcel/C-1164-2011; de Zoete, Marcel R/O-3012-2014; de Zoete, Marcel/ABA-7918-2021	Keestra-Gounder, A. Marijke/0000-0002-2231-652X; de Zoete, Marcel/0000-0002-6561-5810; van Putten, Jos/0000-0002-4126-8172	Dutch Ministry of Agriculture, Nature, and Food Quality	Dutch Ministry of Agriculture, Nature, and Food Quality	The work was supported by the Dutch Ministry of Agriculture, Nature, and Food Quality.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Johanesen PA, 2006, INFECT IMMUN, V74, P3437, DOI 10.1128/IAI.01740-05; Karlyshev AV, 2002, MICROBIOL-SGM, V148, P473, DOI 10.1099/00221287-148-2-473; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Logan SM, 2002, MOL MICROBIOL, V46, P587, DOI 10.1046/j.1365-2958.2002.03185.x; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Meinersmann RJ, 2000, MICROBIOL-UK, V146, P2283, DOI 10.1099/00221287-146-9-2283; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Murthy KGK, 2004, J BIOL CHEM, V279, P5667, DOI 10.1074/jbc.M307759200; Neish AS, 2007, AM J PHYSIOL-GASTR L, V292, pG462, DOI 10.1152/ajpgi.00274.2006; NUIJTEN PJM, 1991, INFECT IMMUN, V59, P1100, DOI 10.1128/IAI.59.3.1100-1105.1991; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; SKOUNTZOU I, 2009, VACCINE IN PRESS; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; van Alphen LB, 2008, MICROBIOL-SGM, V154, P3385, DOI 10.1099/mic.0.2008/019919-0; Van Asten FJAM, 2000, FEMS MICROBIOL LETT, V185, P175, DOI 10.1111/j.1574-6968.2000.tb09058.x; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; WASSENAAR TM, 1993, GENE, V132, P131, DOI 10.1016/0378-1119(93)90525-8; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Way SS, 2004, CELL MICROBIOL, V6, P235, DOI 10.1046/j.1462-5822.2004.00360.x; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	56	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12149	12158		10.1074/jbc.M109.070227	http://dx.doi.org/10.1074/jbc.M109.070227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164175	Green Published, hybrid			2022-12-27	WOS:000276787100045
J	Hu, GQ; Wang, XB; Saunders, DN; Henderson, M; Russell, AJ; Herring, BP; Zhou, JL				Hu, Guoqing; Wang, Xiaobo; Saunders, Darren N.; Henderson, Michelle; Russell, Amanda J.; Herring, B. Paul; Zhou, Jiliang			Modulation of Myocardin Function by the Ubiquitin E3 Ligase UBR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; SERUM RESPONSE FACTOR; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; PHENOTYPIC MODULATION; INDUCED ACTIVATION; BINDING-PROTEIN; SMOOTH; EXPRESSION	Fully differentiated mature smooth muscle cells (SMCs) are characterized by the presence of a unique repertoire of smooth muscle-specific proteins. Although previous studies have shown myocardin to be a critical transcription factor for stimulating expression of smooth muscle-specific genes, the mechanisms regulating myocardin activity are still poorly understood. We used a yeast two-hybrid screen with myocardin as bait to search for factors that may regulate the transcriptional activity of the myocardin. From this screen we identified a HECT domain-containing protein UBR5 (ubiquitin protein ligase E3 component n-recognin 5) as a myocardin-binding protein. Previous studies have shown that HECT domain-containing proteins are ubiquitin E3 ligases that play an important role in protein degradation. UBR5 has, however, also been shown to regulate transcription independent of its E3 ligase activity. In the current study we demonstrated that UBR5 localized in the nuclei of SMCs and forms a complex with myocardin in vivo and in vitro. We also show that UBR5 specifically enhanced trans-activation of smooth muscle-specific promoters by the myocardin family of proteins. In addition, UBR5 significantly augmented the ability of myocardin to induce expression of endogenous SMC marker genes independent on its E3 ligase function. Conversely, depletion of endogenous UBR5 by small interfering RNA in fibroblast cells attenuated myocardin-induced smooth muscle-specific gene expression, and UBR5 knockdown in SMCs resulted in down-regulation of smooth muscle-specific genes. Furthermore, we found that UBR5 can attenuate myocardin protein degradation resulting in increased myocardin protein expression without affecting myocardin mRNA expression. The effects of UBR5 on myocardin requires only the HECT and UBR1 domains of UBR5. This study reveals an unexpected role for the ubiquitin E3 ligase UBR5 as an activator of smooth muscle differentiation through its ability to stabilize myocardin protein.	[Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Saunders, Darren N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada; [Saunders, Darren N.] British Columbia Canc Res Ctr, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada; [Henderson, Michelle; Russell, Amanda J.] Childrens Canc Inst Australia Med Res, Expt Therapeut Program, Randwick, NSW 2031, Australia; [Herring, B. Paul] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Albany Medical College; University of British Columbia; British Columbia Cancer Agency; Children's Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Zhou, JL (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/S-2476-2019; henderson, Michelle/G-6657-2012; Saunders, Darren/B-7677-2008; Wang, Xiaobo/J-4312-2014	Wang, Xiaobo/0000-0001-6044-914X; Saunders, Darren/0000-0003-0924-0513	National Institutes of Health [DK61130]; Albany Medical College; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany Medical College; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61130 (to B. P. H.) and a Albany Medical College start up grant and a Scientist Development Grant from the American Heart Association (to J. Z.).	Aikawa M, 1995, J Atheroscler Thromb, V2, P14; BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Doherty TM, 2003, FASEB J, V17, P592, DOI 10.1096/fj.02-0913hyp; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; MAJESKY MW, 1992, CIRC RES, V71, P759, DOI 10.1161/01.RES.71.4.759; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mori Y, 2002, CANCER RES, V62, P3641; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PENN A, 1990, MUTAT RES, V239, P149, DOI 10.1016/0165-1110(90)90003-T; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2008, J BIOL CHEM, V283, P35383, DOI 10.1074/jbc.M805489200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	37	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11800	11809		10.1074/jbc.M109.079384	http://dx.doi.org/10.1074/jbc.M109.079384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167605	Green Published, hybrid			2022-12-27	WOS:000276787100007
J	Liu, C; van Dyk, D; Xu, P; Choe, V; Pan, HH; Peng, JM; Andrews, B; Rao, H				Liu, Chang; van Dyk, Dewald; Xu, Ping; Choe, Vitnary; Pan, Haihui; Peng, Junmin; Andrews, Brenda; Rao, Hai			Ubiquitin Chain Elongation Enzyme Ufd2 Regulates a Subset of Doa10 Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; LIGASE; RETICULUM; MEMBRANE; MULTIUBIQUITYLATION; MUTATIONS; MECHANISM; PROTEINS; REVEALS; PATHWAY	Ufd2 is the founding member of E4 enzymes that are specifically involved in ubiquitin chain elongation but whose roles in proteolysis remain scarce. Here, using a genome-wide screen, we identified one cellular target of yeast Ufd2 as the membrane protein Pex29. The ubiquitin chains assembled on Pex29 in vivo by Ufd2 mainly contain Lys-48 linkages. We found that the ubiquitin-protein E3 ligase for overexpressed Pex29 is Doa10, which is known to be involved in protein quality control. Interestingly, not all Doa10 substrates are regulated by Ufd2, suggesting that E4 involvement is not specific to a particular E3, but may depend on the spatial arrangement of the E3-substrate interaction. Cells lacking UFD2 elicit an unfolded protein response, expanding the physiological function of Ufd2. Our results lead to novel insights into the biological role of Ufd2 and further underscore the significance of Ufd2 in proteolysis.	[Liu, Chang; Choe, Vitnary; Pan, Haihui; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [van Dyk, Dewald; Andrews, Brenda] Univ Toronto, Dept Mol & Med Genet, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Xu, Ping; Peng, Junmin] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of Texas System; University of Texas Health San Antonio; University of Toronto; Emory University	Rao, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	raoh@uthscsa.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM 078085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 078085 (to H. R.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	35	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10265	10272		10.1074/jbc.M110.110551	http://dx.doi.org/10.1074/jbc.M110.110551			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20159987	Green Published, hybrid			2022-12-27	WOS:000276264600010
J	Saha, T; Rih, JK; Roy, R; Ballal, R; Rosen, EM				Saha, Tapas; Rih, Jeong Keun; Roy, Rabindra; Ballal, Rahul; Rosen, Eliot M.			Transcriptional Regulation of the Base Excision Repair Pathway by BRCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; IONIZING IRRADIATION; MAMMALIAN-CELLS; GENE-EXPRESSION; OVARIAN-CANCER; DIFFERENTIATION; INHIBITION; STRESS	Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a subset of breast cancers, although the major tumor suppressor function of this gene remains unclear. Previously, we showed that BRCA1 induces antioxidant-response gene expression and protects cells against oxidative stress. We now report that BRCA1 stimulates the base excision repair pathway, a major mechanism for the repair of oxidized DNA, by stimulating the activity of key base excision repair (BER) enzymes, including 8-oxoguanine DNA glycosylase (OGG1), the DNA glycosylase NTH1, and the apurinic endonuclease redox factor 1/apurinic endonuclease 1 (REF1/APE1), in human breast carcinoma cells. The increase in BER enzyme activity appears to be due, primarily, to an increase in enzyme expression. The ability of BRCA1 to stimulate the expression of the three BER enzymes and to enhance NTH1 promoter activity was dependent upon the octamer-binding transcription factor OCT1. Finally, we found that OGG1, NTH1, and REF1/APE1 each contribute to the BRCA1 protection against oxidative stress due to hydrogen peroxide and that hydrogen peroxide stimulates the expression of BRCA1 and the three BER enzymes. These findings identify a novel mechanism through which BRCA1 may regulate the repair of oxidative DNA damage.	[Saha, Tapas; Rih, Jeong Keun; Roy, Rabindra; Ballal, Rahul; Rosen, Eliot M.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW,Box 571469, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health, USPHS [RO1-CA80000, RO1-CA104546, R01-CA82599]; Susan G. Komen Breast Cancer Foundation [PDF0403044]; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA092306, R01CA082599, R01CA080000] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA80000, RO1-CA104546, and R01-CA82599 from USPHS (to E. M. R.). This work was also supported by Grant PDF0403044 from the Susan G. Komen Breast Cancer Foundation (to E. M. R. and J. K. R.).	Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; ALLEY MC, 1988, CANCER RES, V48, P589; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chaudhry MA, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-15; Chen YM, 1996, CANCER RES, V56, P3168; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Fan SJ, 2001, ONCOGENE, V20, P8215, DOI 10.1038/sj.onc.1205033; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686; Goto M, 2009, CARCINOGENESIS, V30, P1345, DOI 10.1093/carcin/bgp108; Gudas JM, 1996, CELL GROWTH DIFFER, V7, P717; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jeng YM, 2007, ONCOGENE, V26, P6160, DOI 10.1038/sj.onc.1210451; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Litman R, 2008, ANTI-CANCER AGENT ME, V8, P426, DOI 10.2174/187152008784220285; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitra S, 1997, MOL CELLS, V7, P305; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nyaga SG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-297; Rajan JV, 1997, DEV BIOL, V184, P385, DOI 10.1006/dbio.1997.8526; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; Staff S, 2003, CANCER RES, V63, P4978; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; Trzeciak AR, 2004, CARCINOGENESIS, V25, P1359, DOI 10.1093/carcin/bgh144; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Vaughn JP, 1996, CELL GROWTH DIFFER, V7, P711; Vijg J, 2001, ANN NY ACAD SCI, V928, P85; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Weberpals JI, 2008, J CLIN ONCOL, V26, P3259, DOI 10.1200/JCO.2007.11.3902; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Windhofer F, 2007, INT J RADIAT ONCOL, V68, P1462, DOI 10.1016/j.ijrobp.2007.04.038; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yacoub A, 1997, CANCER RES, V57, P5457	53	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19092	19105		10.1074/jbc.M110.104430	http://dx.doi.org/10.1074/jbc.M110.104430			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20185827	Green Published, hybrid			2022-12-27	WOS:000278727800019
J	Nishida, M; Suda, R; Nagamatsu, Y; Tanabe, S; Onohara, N; Nakaya, M; Kanaho, Y; Shibata, T; Uchida, K; Sumimoto, H; Sato, Y; Kurose, H				Nishida, Motohiro; Suda, Reiko; Nagamatsu, Yuichi; Tanabe, Shihori; Onohara, Naoya; Nakaya, Michio; Kanaho, Yasunori; Shibata, Takahiro; Uchida, Koji; Sumimoto, Hideki; Sato, Yoji; Kurose, Hitoshi			Pertussis Toxin Up-regulates Angiotensin Type 1 Receptors through Toll-like Receptor 4-mediated Rac Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; SIGNAL-TRANSDUCTION; VENTRICULAR MYOCYTES; DEPENDENT ACTIVATION; CARDIAC FIBROBLASTS; DOWN-REGULATION; PROTEIN-KINASE; MESSENGER-RNA	Pertussis toxin (PTX) is recognized as a specific tool that uncouples receptors from G(i) and Go through ADP-ribosylation. During the study analyzing the effects of PTX on Ang II type 1 receptor (AT1R) function in cardiac fibroblasts, we found that PTX increases the number of AT1Rs and enhances AT1R-mediated response. Microarray analysis revealed that PTX increases the induction of interleukin (IL)-1 beta among cytokines. Inhibition of IL-1 beta suppressed the enhancement of AT1R-mediated response by PTX. PTX increased the expression of IL-1 beta and AT1R through NF-kappa B, and a small GTP-binding protein, Rac, mediated PTX-induced NF-kappa B activation through NADPH oxidase-dependent production of reactive oxygen species. PTX induced biphasic increases in Rac activity, and the Rac activation in a late but not an early phase was suppressed by IL-1 beta siRNA, suggesting that IL-1 beta-induced Rac activation contributes to the amplification of Rac-dependent signaling induced by PTX. Furthermore, inhibition of TLR4 (Toll-like receptor 4) abolished PTX-induced Rac activation and enhancement of AT1R function. However, ADP-ribosylation of G(i)/G(o) by PTX was not affected by inhibition of TLR4. Thus, PTX binds to two receptors; one is TLR4, which activates Rac, and another is the binding site that is required for ADP-ribosylation of G(i)/G(o).	[Nishida, Motohiro; Suda, Reiko; Nagamatsu, Yuichi; Onohara, Naoya; Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan; [Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 8128582, Japan; [Tanabe, Shihori; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Kyushu University; Kyushu University; National Institute of Health Sciences - Japan; University of Tsukuba; University of Tsukuba; Nagoya University	Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp	Tanabe, Shihori/AAH-6584-2019; Shibata, Takahiro/I-6872-2014	Tanabe, Shihori/0000-0003-3706-0616; Uchida, Koji/0000-0003-3894-5299; Nishida, Motohiro/0000-0002-2587-5458; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nakatomi Foundation; Sapporo Bioscience Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation; Sapporo Bioscience Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nishida, M. Nakaya, and H. K.); a grant-in-aid for scientific research on Innovative Areas (to M. Nishida); a grant-in-aid for scientific research on Priority Areas (to H. K.); and grants from the Nakatomi Foundation, Sapporo Bioscience Foundation, and Naito Foundation (to M. Nishida).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bai H, 2004, CHINESE MED J-PEKING, V117, P88; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chiloeches A, 1999, J BIOL CHEM, V274, P19762, DOI 10.1074/jbc.274.28.19762; Cowling RT, 2005, AM J PHYSIOL-HEART C, V289, pH1176, DOI 10.1152/ajpheart.00088.2005; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Ichiki T, 2001, ARTERIOSCL THROM VAS, V21, P1896, DOI 10.1161/hq1201.099430; Ichiki T, 2001, HYPERTENSION, V37, P535, DOI 10.1161/01.HYP.37.2.535; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255; Ju HS, 1998, CIRCULATION, V97, P892, DOI 10.1161/01.CIR.97.9.892; Kaiser P, 2004, ANIM GENET, V35, P169, DOI 10.1111/j.1365-2052.2004.01121.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KATADA T, 1982, J BIOL CHEM, V257, P7210; KUROSE H, 1993, MOL PHARMACOL, V43, P444; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LANDO Z, 1980, NATURE, V287, P551, DOI 10.1038/287551a0; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Li H, 2001, BIOCHEM BIOPH RES CO, V283, P1077, DOI 10.1006/bbrc.2001.4910; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Melien O, 2000, J CELL PHYSIOL, V184, P27, DOI 10.1002/(SICI)1097-4652(200007)184:1<27::AID-JCP3>3.0.CO;2-Q; MONKS BG, 1994, MOL IMMUNOL, V31, P139, DOI 10.1016/0161-5890(94)90086-8; Nagamatsu Y, 2006, J PHARMACOL SCI, V101, P144, DOI 10.1254/jphs.FP0051036; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Peng JF, 2002, CIRC RES, V91, P1119, DOI 10.1161/01.RES.0000047090.08299.D5; Pracyk JB, 1998, J CLIN INVEST, V102, P929, DOI 10.1172/JCI2552; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sakata Y, 1998, CIRCULATION, V97, P1488; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; TAMURA M, 1983, J BIOL CHEM, V258, P6756; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; VILLARREAL FJ, 1993, CIRCULATION, V88, P2849, DOI 10.1161/01.CIR.88.6.2849; Wang ZY, 2006, EXP HEMATOL, V34, P1115, DOI 10.1016/j.exphem.2006.04.025; Yamani MH, 2004, AM J TRANSPLANT, V4, P1097, DOI 10.1111/j.1600-6143.2004.00463.x; Zocchi MR, 2005, J IMMUNOL, V174, P6054, DOI 10.4049/jimmunol.174.10.6054	61	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15268	15277		10.1074/jbc.M109.076232	http://dx.doi.org/10.1074/jbc.M109.076232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231290	Green Published, hybrid			2022-12-27	WOS:000277399000047
J	Noda, Y; Yoda, K				Noda, Yoichi; Yoda, Koji			Svp26 Facilitates Endoplasmic Reticulum to Golgi Transport of a Set of Mannosyltransferases in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST GOLGI; MEMBRANE-PROTEIN; ALKALINE-PHOSPHATASE; CARGO BINDING; COPII; COMPLEX; COAT; VESICLES; ER; GLYCOSYLTRANSFERASES	Svp26 is a polytopic integral membrane protein found in the ER and early Golgi compartment. In the Delta svp26 cell, the Golgi mannosyltransferase Ktr3 remains in the ER. Here, we report that two other Golgi mannosyltransferases, Mnn2 and Mnn5 are also mislocalized and found in the ER in the absence of Svp26 and that localization of other mannosyltransferases including Mnn1 are not affected. Mnn2 and Mnn5 bind to Svp26 in vivo as Ktr3 does. Using an in vitro budding assay, the incorporation of Ktr3 and Mnn2 in the COPII vesicles is greatly stimulated by the presence of Svp26. As Svp26 itself is an efficient cargo, Svp26 is likely to support selective incorporation of a set of mannosyltransferases into COPII vesicles by working as their adaptor protein. The domain switching between Svp26-dependent Mnn2 or Ktr3 and Svp26-independent Mnn1 suggests that the lumenal domain of mannosyltransferases, but not the cytoplasmic or transmembrane domain, is responsible for recognition by Svp26.	[Noda, Yoichi; Yoda, Koji] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science; RIKEN Institute of Japan; Noda Institute of Scientific Research	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Institute of Japan; Noda Institute of Scientific Research(Noda Institute for Scientific Research)	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to Y. N. and K. Y.), a grant from the RIKEN Institute of Japan (to K. Y.), and a grant from the Noda Institute of Scientific Research (to Y. N. and K. Y.).	Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bue CA, 2006, MOL BIOL CELL, V17, P4780, DOI 10.1091/mbc.E06-05-0455; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; GRAHAM TR, 1994, J CELL BIOL, V127, P667, DOI 10.1083/jcb.127.3.667; Hashimoto H, 1997, BIOCHEM BIOPH RES CO, V241, P682, DOI 10.1006/bbrc.1997.7888; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Pelham HRB, 1998, TRENDS CELL BIOL, V8, P45, DOI 10.1016/S0962-8924(97)01185-9; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	32	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15420	15429		10.1074/jbc.M109.086272	http://dx.doi.org/10.1074/jbc.M109.086272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236934	hybrid, Green Published			2022-12-27	WOS:000277399000062
J	Wu, JC; Lei, GH; Mei, M; Tang, Y; Li, HL				Wu, Jianchun; Lei, Guohua; Mei, Mei; Tang, Yi; Li, Honglin			A Novel C53/LZAP-interacting Protein Regulates Stability of C53/LZAP and DDRGK Domain-containing Protein 1 (DDRGK1) and Modulates NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CHECKPOINT; INITIATION; DELETION; 6Q	C53/LZAP (also named as Cdk5rap3) is a putative tumor suppressor that plays important roles in multiple cell signaling pathways, including DNA damage response and NF-kappa B signaling. Yet how its function is regulated remains largely unclear. Here we report the isolation and characterization of two novel C53/LZAP-interacting proteins, RCAD (Regulator of C53/LZAP and DDRGK1) and DDRGK1 (DDRGK domain-containing protein 1). Our co-immunoprecipitation assays confirmed their interactions, while gel filtration assay indicated that C53/LZAP and RCAD may form a large protein complex. Intriguingly, we found that RCAD knockdown led to dramatic reduction of C53/LZAP and DDRGK1 proteins. We also found that C53/LZAP and DDRGK1 became more susceptible to the proteasome-mediated degradation in RCAD knockdown cells, whereas their ubiquitination was significantly attenuated by RCAD overexpression. In addition, we found that RCAD, like C53/LZAP, also plays an important role in regulation of NF-kappa B signaling and cell invasion. Taken together, our findings strongly suggest that RCAD is a novel regulator of C53/LZAP tumor suppressor and NF-kappa B signaling.	[Wu, Jianchun; Lei, Guohua; Mei, Mei; Tang, Yi; Li, Honglin] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Childrens Mem Res Ctr, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine	Li, HL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Childrens Mem Res Ctr, 2430 N Halsted St, Chicago, IL 60614 USA.	h-li2@northwestern.edu	Wu, Jianchun/AAX-3533-2020	Wu, Jianchun/0000-0002-8473-9368	National Institutes of Health [R01 GM081776]; Children's Memorial Research Center; Clarke family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Memorial Research Center; Clarke family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM081776 (to H. L.), the Children's Memorial Research Center, and the Clarke family.	ABRAN D, 1992, EXP EYE RES, V54, P737, DOI 10.1016/0014-4835(92)90029-R; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Li BCY, 2003, DIAGN MOL PATHOL, V12, P193, DOI 10.1097/00019606-200312000-00003; Lu T, 2008, PROSTATE CANCER P D, V11, P357, DOI 10.1038/pcan.2008.4; NEZIRI D, 2009, BIOCHIM BIOPHYS ACTA, V1800, P430; Saito S, 2006, ONCOL REP, V16, P949; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sun M, 2006, DNA CELL BIOL, V25, P597, DOI 10.1089/dna.2006.25.597; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; van Gils W, 2008, MELANOMA RES, V18, P10, DOI 10.1097/CMR.0b013e3282f1d4d9; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; YORKE MA, 1985, CELL TISSUE RES, V241, P629	18	73	80	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15126	15136		10.1074/jbc.M110.110619	http://dx.doi.org/10.1074/jbc.M110.110619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228063	hybrid, Green Published			2022-12-27	WOS:000277399000034
J	Oh, SJ; Santy, LC				Oh, Seung Ja; Santy, Lorraine C.			Differential Effects of Cytohesins 2 and 3 on beta 1 Integrin Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; ACTIN CYTOSKELETON; INTEGRIN BETA-1; GROWTH-FACTOR; SEC7 FAMILY; ARF; PROTEIN; ACTIVATION; MEMBRANE; TRANSLOCATION	ADP-ribosylation actor 6 (ARF6) regulates the endocytosis and recycling of a variety of proteins and also promotes peripheral actin rearrangements and cell motility. ARF6 is activated by a large number of guanine nucleotide exchange factors, which likely regulate ARF6 at different locations and during different processes. In this study we investigate the roles of the cytohesin ADP-ribosylation factor (ARF)-guanine nucleotide exchange factors during the recycling of integrin beta 1. Intriguingly, we find that knockdown and overexpression of ARNO/cytohesin 2 and GRP1/cytohesin 3 have opposing effects on cell adhesion and spreading on fibronectin and on cell migration. We find that ARNO/cytohesin 2 is required for integrin beta 1 recycling, whereas GRP1/cytohesin 3 is dispensable for this process. This is the first demonstration of unique roles for these proteins.	[Oh, Seung Ja; Santy, Lorraine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Santy, LC (corresponding author), 408 S Frear, University Pk, PA 16802 USA.	lcsanty@psu.edu	Oh, Seung Ja/ABC-6168-2021	Oh, Seung Ja/0000-0002-4572-0656; Santy, Lorraine/0000-0002-4795-0738	American Heart Association [SDG 0730229N]; Pennsylvania State University	American Heart Association(American Heart Association); Pennsylvania State University	This work was supported by American Heart Association Grant SDG 0730229N (to L. C. S.) and by funds from The Pennsylvania State University.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Clodi M, 1998, ENDOCRINOLOGY, V139, P4984, DOI 10.1210/en.139.12.4984; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Turner CE, 2001, CURR BIOL, V11, pR875, DOI 10.1016/S0960-9822(01)00521-8; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139	39	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14610	14616		10.1074/jbc.M109.043935	http://dx.doi.org/10.1074/jbc.M109.043935			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223830	Green Published, hybrid			2022-12-27	WOS:000277299700058
J	Sierra, MI; Wright, MH; Nash, PD				Sierra, Maria I.; Wright, Michelle H.; Nash, Piers D.			AMSH Interacts with ESCRT-0 to Regulate the Stability and Trafficking of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; UBIQUITIN ISOPEPTIDASE; DOWN-REGULATION; SH3 DOMAIN; FLUORESCENCE COMPLEMENTATION; MEMBRANE TRAFFICKING; SIGNAL-TRANSDUCTION; PROGENITOR CELLS; STRUCTURAL BASIS; CHEMOKINE SDF-1	Reversible ubiquitination is essential for the endocytic sorting and down-regulation of G protein-coupled receptors, such as the chemokine receptor CXCR4. The deubiquitinating enzyme AMSH has been implicated in the endocytic sorting of both G protein-coupled receptors and receptor-tyrosine kinases. Herein, we examine the role of AMSH in the regulation of CXCR4 stability and trafficking and characterize protein-protein interactions critical for this function. Loss of AMSH catalytic activity or depletion by RNAi results in increased steady-state levels of CXCR4 under basal conditions. Analysis of truncation and point mutation of AMSH reveal the importance of an RXXK motif for CXCR4 degradation. The RXXK motif of AMSH interacts with the SH3 domains of the STAM and Grb2 families of adaptor proteins with high affinity. Cells expressing a catalytically inactive mutant of AMSH show basal hyperubiquitination, but not increased degradation, of the ESCRT-0 components STAM1 and Hrs. This is dependent on the RXXK motif of AMSH. Ubiquitination of endocytic machinery modulates their activity, suggesting that AMSH may directly regulate endocytic adaptor protein function. This is reflected in CXCR4 trafficking and provides a mechanism by which AMSH specifies the fate of endocytosed receptors. Taken together, these studies implicate AMSH as a key modulator of receptor fate determination through its action on components of the endocytic machinery.	[Sierra, Maria I.; Wright, Michelle H.; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), 929 E 57th St,W432, Chicago, IL 60637 USA.	pdnash@uchicago.edu			Leukemia Research Foundation; Edward Mallinckrodt, Jr. Foundation; Concern Foundation; National Institutes of Health [T32HL07237, F31AI073227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI073227] Funding Source: NIH RePORTER	Leukemia Research Foundation; Edward Mallinckrodt, Jr. Foundation; Concern Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This was work was supported by grants from the Leukemia Research Foundation, the Edward Mallinckrodt, Jr. Foundation, and a Concern Foundation CONquer canCER Now Award (to P. D. N.).; Supported by National Institutes of Health Grants T32HL07237 and F31AI073227.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Herrera-Vigenor F, 2006, BIOCHEM BIOPH RES CO, V347, P924, DOI 10.1016/j.bbrc.2006.06.169; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Holler D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kikuchi K, 2003, BIOCHEM BIOPH RES CO, V306, P637, DOI 10.1016/S0006-291X(03)01009-X; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakamura M, 2006, GENES CELLS, V11, P593, DOI 10.1111/j.1365-2443.2006.00963.x; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rasband W. S., 1997, IMAGEJ SOFTWARE; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wojcik Cezary, 2002, Trends Cell Biol, V12, P549, DOI 10.1016/S0962-8924(02)02398-X; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13990	14004		10.1074/jbc.M109.061309	http://dx.doi.org/10.1074/jbc.M109.061309			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20159979	Green Published, hybrid			2022-12-27	WOS:000276987700073
J	Arenas, I; Bravo, A; Soberon, M; Gomez, I				Arenas, Ivan; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel			Role of Alkaline Phosphatase from Manduca sexta in the Mechanism of Action of Bacillus thuringiensis Cry1Ab Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; AMINOPEPTIDASE-N-RECEPTOR; OLIGOMERIC PRE-PORE; DELTA-ENDOTOXIN; DOMAIN-II; HELIOTHIS-VIRESCENS; BINDING-PROTEINS; LYMANTRIA-DISPAR; LARVAL MIDGUT; CYT TOXINS	Cry toxins produced by Bacillus thuringiensis have been recognized as pore-forming toxins whose primary action is to lyse midgut epithelial cells in their target insect. In the case of the Cry1A toxins, a prepore oligomeric intermediate is formed after interaction with cadherin receptor. The Cry1A oligomer then interacts with glycosylphosphatidylinositol-anchored receptors. Two Manduca sexta glycosylphosphatidylinositol-anchored proteins, aminopeptidase (APN) and alkaline phosphatase (ALP), have been shown to bind Cry1Ab, although their role in toxicity remains to be determined. Detection of Cry1Ab binding proteins by ligand blot assay revealed that ALP is preferentially expressed earlier during insect development, because it was found in the first larval instars, whereas APN is induced later after the third larval instar. The binding of Cry1Ab oligomer to pure preparations of APN and ALP showed that this toxin structure interacts with both receptors with high affinity (apparent K-d = 0.6 nM), whereas the monomer showed weaker binding (apparent K-d = 101.6 and 267.3 nM for APN and ALP, respectively). Several Cry1Ab nontoxic mutants located in the exposed loop 2 of domain II or in beta-16 of domain III were affected in binding to APN and ALP, depending on their oligomeric state. In particular monomers of the nontoxic domain III, the L511A mutant did not bind ALP but retained APN binding, suggesting that initial interaction with ALP is critical for toxicity. Our data suggest that APN and ALP fulfill two roles. First APN and ALP are initial receptors promoting the localization of toxin monomers in the midgut microvilli before interaction with cadherin. Then APN and ALP function as secondary receptors mediating oligomer insertion into the membrane. However, the expression pattern of these receptors and the phenotype of L511A mutant suggest that ALP may have a predominant role in toxin action because Cry toxins are highly effective against the neonate larvae that is the target for pest control programs.	[Arenas, Ivan; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Gomez, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico.	isabelg@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; ARENAS, IVAN/0000-0003-0384-7437	National Institutes of Health [1R01 AI066014]; Consejo Nacional de Ciencia y Tecnologia [83135, 81639]; Direccion General de Asuntos del Personal Academico-UNAM [IN218608, IN210208]; United States Department of Agriculture [2207-35607-17780]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM(Universidad Nacional Autonoma de Mexico); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AI066014. This work was also supported by Consejo Nacional de Ciencia y Tecnologia Grants 83135 and 81639, Direccion General de Asuntos del Personal Academico-UNAM Grants IN218608 and IN210208, and United States Department of Agriculture Grant 2207-35607-17780.	Asgeirsson B, 2007, BBA-PROTEINS PROTEOM, V1774, P679, DOI 10.1016/j.bbapap.2007.03.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Griko N, 2008, COMP BIOCHEM PHYS B, V151, P59, DOI 10.1016/j.cbpb.2008.05.016; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; LANDT M, 1978, BIOCHEMISTRY-US, V17, P915, DOI 10.1021/bi00598a027; Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Nair MS, 2008, BIOCHEMISTRY-US, V47, P5814, DOI 10.1021/bi7014234; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Rausell C, 2004, J BIOL CHEM, V279, P55168, DOI 10.1074/jbc.M406279200; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 1997, FEBS LETT, V412, P270, DOI 10.1016/S0014-5793(97)00801-6; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Valaitis AP, 1995, INSECT BIOCHEM MOLEC, V25, P1143, DOI 10.1016/0965-1748(95)00050-X; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; You Taek H, 2008, BMC Biochem, V9, P3, DOI 10.1186/1471-2091-9-3; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	43	130	148	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12497	12503		10.1074/jbc.M109.085266	http://dx.doi.org/10.1074/jbc.M109.085266			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177063	Green Published, hybrid			2022-12-27	WOS:000276787800006
J	Heneberg, P; Draberova, L; Bambouskova, M; Pompach, P; Draber, P				Heneberg, Petr; Draberova, Lubica; Bambouskova, Monika; Pompach, Petr; Draber, Petr			Down-regulation of Protein-tyrosine Phosphatases Activates an Immune Receptor in the Absence of Its Translocation into Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; DETERGENT-RESISTANT MEMBRANES; OXYGEN SPECIES GENERATION; MAST-CELL DEGRANULATION; REACTIVE OXYGEN; NEGATIVE REGULATION; IMMUNOGLOBULIN-E; REDOX REGULATION; SIGNAL-TRANSDUCTION	The earliest known biochemical step that occurs after ligand binding to the multichain immune recognition receptor is tyrosine phosphorylation of the receptor subunits. In mast cells and basophils activated by multivalent antigen-IgE complexes, this step is mediated by Src family kinase Lyn, which phosphorylates the high affinity IgE receptor (Fc epsilon RI). However, the exact molecular mechanism of this phosphorylation step is incompletely understood. In this study, we tested the hypothesis that changes in activity and/ or topography of protein-tyrosine phosphatases (PTPs) could play a major role in the Fc epsilon RI triggering. We found that exposure of rat basophilic leukemia cells or mouse bone marrow-derived mast cells to PTP inhibitors, H2O2 or pervanadate, induced phosphorylation of the Fc epsilon RI subunits, similarly as Fc epsilon RI triggering. Interestingly, and in sharp contrast to antigen-induced activation, neither H2O2 nor pervanadate induced any changes in the association of Fc epsilon RI with detergent-resistant membranes and in the topography of Fc epsilon RI detectable by electron microscopy on isolated plasma membrane sheets. In cells stimulated with pervanadate, H2O2 or antigen, enhanced oxidation of active site cysteine of several PTPs was detected. Unexpectedly, most of oxidized phosphatases bound to the plasma membrane were associated with the actin cytoskeleton. Several PTPs (SHP-1, SHP-2, hematopoietic PTP, and PTP-MEG2) showed changes in their enzymatic activity and/or oxidation state during activation. Based on these and other data, we propose that down-regulation of enzymatic activity of PTPs and/or changes in their accessibility to the substrates play a key role in initial tyrosine phosphorylation of the Fc epsilon RI and other multichain immune receptors.	[Heneberg, Petr; Draberova, Lubica; Bambouskova, Monika; Draber, Petr] Acad Sci Czech Republ, Lab Signal Transduct, Inst Mol Genet, CZ-14220 Prague 4, Czech Republic; [Pompach, Petr] Acad Sci Czech Republ, Inst Microbiol, CZ-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Lab Signal Transduct, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/G-3412-2014; Heneberg, Petr/C-1881-2012; Pompach, Petr/J-6209-2014; Draber, Petr/E-1119-2018; Draberova, Lubica/G-3505-2014	Draber, Petr/0000-0002-3986-2025; Heneberg, Petr/0000-0002-0703-951X; Pompach, Petr/0000-0002-0606-0851; Draber, Petr/0000-0002-3986-2025; Draberova, Lubica/0000-0002-2459-4435	Grant Agency of the Czech Republic [301/09/1826, P302/10/1759]; Center of Molecular and Cellular Immunology [1M0506]; Ministry of Education, Youth, and Sports of the Czech Republic [LC-545, 1M0505]; Academy of Sciences of the Czech Republic [KAN200520701, M200520901]; Institutional Project [AVOZ50520514]; 3rd Faculty of Medicine [MSM0021620814]; Charles University; Prague; Canadian Institute of Health	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institutional Project; 3rd Faculty of Medicine; Charles University; Prague; Canadian Institute of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Projects 301/09/1826 and P302/10/1759 from Grant Agency of the Czech Republic, Center of Molecular and Cellular Immunology 1M0506, Projects LC-545 and 1M0505 from the Ministry of Education, Youth, and Sports of the Czech Republic, Grants KAN200520701 and M200520901 from the Academy of Sciences of the Czech Republic, and Institutional Project AVOZ50520514.; Supported by Research Goal MSM0021620814 from the 3rd Faculty of Medicine, Charles University, Prague, Czech Republic, and by a Canadian Institute of Health Research fellowship.	Amoui M, 1997, EUR J IMMUNOL, V27, P321, DOI 10.1002/eji.1830270146; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Draber P, 2007, CELL SIGNAL, V19, P2400, DOI 10.1016/j.cellsig.2007.07.018; Draberova L, 2004, EUR J IMMUNOL, V34, P2209, DOI 10.1002/eji.200322663; Draberova L, 2003, J IMMUNOL, V171, P3585, DOI 10.4049/jimmunol.171.7.3585; Draberova L, 1996, IMMUNOLOGY, V87, P141; EISEMAN E, 1992, NATURE, V355, P78; Field KA, 1999, J BIOL CHEM, V274, P1753, DOI 10.1074/jbc.274.3.1753; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; Heneberg P, 2002, INT ARCH ALLERGY IMM, V128, P253, DOI 10.1159/000063864; Heneberg P, 2005, CURR MED CHEM, V12, P1859, DOI 10.2174/0929867054546636; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kimura T, 1997, J IMMUNOL, V159, P4426; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; LACHAPELLE M, 1988, J HISTOCHEM CYTOCHEM, V36, P1197, DOI 10.1177/36.9.3403970; Lebduska P, 2007, J IMMUNOL METHODS, V328, P139, DOI 10.1016/j.jim.2007.08.015; LIU FT, 1980, J IMMUNOL, V124, P2728; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mikalsen SO, 1998, J BIOL CHEM, V273, P10036, DOI 10.1074/jbc.273.16.10036; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakata K, 2008, J IMMUNOL, V181, P5414, DOI 10.4049/jimmunol.181.8.5414; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Peirce M, 2000, J BIOL CHEM, V275, P34976, DOI 10.1074/jbc.M005819200; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; Simoneau M, 2008, J BIOL CHEM, V283, P25544, DOI 10.1074/jbc.M804177200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529; Surviladze Z, 2007, J LIPID RES, V48, P1325, DOI 10.1194/jlr.M600485-JLR200; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; SWIETER M, 1995, J BIOL CHEM, V270, P21902, DOI 10.1074/jbc.270.37.21902; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; TESHIMA R, 1994, BIOCHEM J, V302, P867, DOI 10.1042/bj3020867; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolarova H, 2004, EUR J IMMUNOL, V34, P1627, DOI 10.1002/eji.200424991; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Vonakis BM, 2005, J IMMUNOL, V175, P4543, DOI 10.4049/jimmunol.175.7.4543; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2002, MOL IMMUNOL, V38, P1259, DOI 10.1016/S0161-5890(02)00073-1; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	74	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12787	12802		10.1074/jbc.M109.052555	http://dx.doi.org/10.1074/jbc.M109.052555			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157115	hybrid, Green Published			2022-12-27	WOS:000276787800037
J	Krahn, MP; Rizk, S; Alfalah, M; Behrendt, M; Naim, HY				Krahn, Michael P.; Rizk, Sandra; Alfalah, Marwan; Behrendt, Marc; Naim, Hassan Y.			Protocadherin of the Liver, Kidney, and Colon Associates with Detergent-resistant Membranes during Cellular Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN SUPERFAMILY; TUMOR-SUPPRESSOR; APICAL MEMBRANE; O-GLYCOSYLATION; ADHESION; FAMILY; IDENTIFICATION; EXPRESSION; RECEPTORS; BIOSYNTHESIS	Protocadherin LKC (PLKC) is a member of the heterogeneous subgroup of protocadherins that was identified and described as a potential tumor-suppressor gene involved in contact inhibition (Okazaki, N., Takahashi, N., Kojima, S., Masuho, Y., and Koga, H. (2002) Carcinogenesis 23, 1139-1148 and Ose, R., Yanagawa, T., Ikeda, S., Ohara, O., and Koga, H. (2009) Mol. Oncol. 3, 54-66). Several aspects of the structure, posttranslational processing, targeting, and function of this new protocadherin are still not known. Here, we demonstrate that the expression of PLKC at the apical membrane domain and its concentration at regions of cell-cell contacts occur concomitantly with significant elevation of PLKC-mRNA levels. Furthermore, it can be found within the adherens junctions, but it does not colocalize with tight junctions proteins ZO-1 and occludin, respectively. Additionally, unlike E-cadherin, PLKC is not redistributed upon Ca2+ removal. Biosynthetic labeling revealed N- and O-glycosylation as posttranslational modifications as well as a fast transport to the cell surface and a low turnover rate. During differentiation, PLKC associates with detergent-resistant membranes that trigger its redistribution from intracellular membranes to the cell surface. This association occurs concomitant with alterations in the glycosylation pattern. We propose a role for PLKC in the establishment of a proper epithelial cell polarity that requires O-linked glycosylation and association of the protein with detergent-resistant membranes.	[Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany; [Rizk, Sandra] Lebanese Amer Univ, Dept Nat Sci, Beirut, Lebanon	University of Veterinary Medicine Hannover, Foundation; Lebanese American University	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.	hassan.naim@tiho-hannover.de	Rizk-Jamati, Sandra/AAG-3457-2019; Krahn, Michael/AAD-4476-2022	Rizk-Jamati, Sandra/0000-0002-4405-5703; Krahn, Michael/0000-0001-7718-9890	Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB 621]; Lebanese American University Research Council [URC-s-2009-04]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Lebanese American University Research Council	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB 621, Project C8 (to H. Y. N.)) and the Lebanese American University Research Council (URC-s-2009-04 (to S. R.)).	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Alfalah M, 2002, J BIOL CHEM, V277, P10683, DOI 10.1074/jbc.M109357200; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Castelletti D, 2008, BIOCHEM J, V409, P149, DOI 10.1042/BJ20070396; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Goldberg M, 2000, J BIOL CHEM, V275, P24622, DOI 10.1074/jbc.M000234200; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Hirano S, 1999, J NEUROSCI, V19, P995; Hirayama T, 2006, CURR OPIN NEUROBIOL, V16, P336, DOI 10.1016/j.conb.2006.05.003; Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuzmenko YS, 1998, FEBS LETT, V434, P183, DOI 10.1016/S0014-5793(98)00977-6; Leve F, 2008, J PHARMACOL EXP THER, V327, P777, DOI 10.1124/jpet.108.140798; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; Ose R, 2009, MOL ONCOL, V3, P54, DOI 10.1016/j.molonc.2008.10.005; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Sambrook J., 2001, MOL CLONING LAB MANU; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SHORE EM, 1991, J BIOL CHEM, V266, P19672; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takeda H, 2004, BIOCHEM BIOPH RES CO, V316, P822, DOI 10.1016/j.bbrc.2004.02.123; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	42	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13193	13200		10.1074/jbc.M109.080051	http://dx.doi.org/10.1074/jbc.M109.080051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159971	Green Published, hybrid			2022-12-27	WOS:000276787800074
J	Shimada, H; Rajagopalan, LE				Shimada, Hideaki; Rajagopalan, Lakshman E.			Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; RHEUMATOID-ARTHRITIS; MYOSIN PHOSPHATASE; SERINE/THREONINE KINASE; AIRWAY INFLAMMATION; DEPENDENT MECHANISM; ICAM-1 EXPRESSION; RHO/RHO-KINASE; ROCK-II; PHOSPHORYLATION	Endothelial cells play an important role in the recruitment of immune cells to a disease locus through the induced expression of chemokines and cell adhesion molecules (CAMs). The proinflammatory lysophospholipid, lysophosphatidic acid (LPA), which is elevated in multiple inflammatory diseases, is a potent activator of the RhoA/Rho kinase signaling pathway and has been shown to induce the expression of CAMs in endothelial cells. The present study was undertaken to map signal transduction downstream of LPA and to investigate the contributions of the Rho kinase isoforms ROCK1 and ROCK2 to adhesion molecule expression in human umbilical vein endothelial cells. LPA activated Rho kinase within minutes and subsequently the NF-kappa B pathway through phosphorylation of the p65 subunit. The lipid also induced the late expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Pharmacologic inhibition of Rho kinase signaling blocked LPA-induced p65 phosphorylation and suppressed ICAM-1 and VCAM-1 expression. Inhibition of the NF-kappa B pathway had no impact on LPA-induced Rho kinase activation, but inhibited adhesion molecule expression. Small interfering RNA-facilitated knockdown of each isoform identified ROCK2 as the mediator of LPA-driven phosphorylation of NF-kappa B p65 and of ICAM-1 and VCAM-1 mRNA and protein induction. Taken collectively, our data are consistent with Rho kinase being upstream of NF-kappa B in driving LPA-mediated adhesion molecule expression. This study also provides the first evidence of the critical involvement of ROCK2 in LPA-induced CAM expression through activation of the NF-kappa B pathway in human endothelial cells.	[Shimada, Hideaki; Rajagopalan, Lakshman E.] Pfizer Global Res & Dev, Inflammat Res Unit, Chesterfield, MO 63017 USA	Pfizer	Rajagopalan, LE (corresponding author), 700 Chesterfield Pkwy W, Chesterfield, MO 63017 USA.	leraja22@gmail.com			Pfizer, Inc	Pfizer, Inc(Pfizer)	This work was supported by Pfizer, Inc.	Aihara M, 2003, INT IMMUNOPHARMACOL, V3, P1619, DOI 10.1016/S1567-5769(03)00184-X; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Garton AJ, 2008, METHOD ENZYMOL, V439, P491, DOI 10.1016/S0076-6879(07)00433-8; Hashimoto T, 2003, J PHARMACOL SCI, V91, P8, DOI 10.1254/jphs.91.8; He Y, 2008, ARTHRITIS RHEUM-US, V58, P3366, DOI 10.1002/art.23986; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee HY, 2004, AM J PHYSIOL-CELL PH, V287, pC1657, DOI 10.1152/ajpcell.00172.2004; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin CI, 2006, J CELL BIOCHEM, V99, P1216, DOI 10.1002/jcb.20963; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Maruta T, 2008, J NEUROCHEM, V105, P401, DOI 10.1111/j.1471-4159.2007.05143.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohkita M, 2002, JPN J PHARMACOL, V89, P81, DOI 10.1254/jjp.89.81; Rahman A, 1999, J IMMUNOL, V162, P5466; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Amerongen GPV, 2008, AM J PHYSIOL-CELL PH, V294, pC1234, DOI 10.1152/ajpcell.00551.2007; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Wu XY, 2009, AM J PHYSIOL-RENAL, V297, pF316, DOI 10.1152/ajprenal.00089.2009; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010	41	83	85	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12536	12542		10.1074/jbc.M109.099630	http://dx.doi.org/10.1074/jbc.M109.099630			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164172	Green Published, hybrid			2022-12-27	WOS:000276787800010
J	Andreasson, C; Rampelt, H; Fiaux, J; Druffel-Augustin, S; Bukau, B				Andreasson, Claes; Rampelt, Heike; Fiaux, Jocelyne; Druffel-Augustin, Silke; Bukau, Bernd			The Endoplasmic Reticulum Grp170 Acts as a Nucleotide Exchange Factor of Hsp70 via a Mechanism Similar to That of the Cytosolic Hsp110	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST; CHAPERONES; TRANSLOCATION; BINDING	Grp170 and Hsp110 proteins constitute two evolutionary distinct branches of the Hsp70 family that share the ability to function as nucleotide exchange factors (NEFs) for canonical Hsp70s. Although the NEF mechanism of the cytoplasmic Hsp110s is well understood, little is known regarding the mechanism used by Grp170s in the endoplasmic reticulum. In this study, we compare the yeast Grp170 Lhs1 with the yeast Hsp110 Sse1. We find that residues important for Sse1 NEF activity are conserved in Lhs1 and that mutations in these residues in Lhs1 compromise NEF activity. As previously reported for Sse1, Lhs1 requires ATP to trigger nucleotide exchange in its cognate Hsp70 partner Kar2. Using site-specific cross-linking, we show that the nucleotide-binding domain (NBD) of Lhs1 interacts with the NBD of Kar2 face to face, and that Lhs1 contacts the side of the Kar2 NBD via its protruding C-terminal alpha-helical domain. To directly address the mechanism of nucleotide exchange, we have compared the hydrogen-exchange characteristics of a yeast Hsp70NBD(Ssa1) in complex with either Sse1 or Lhs1. We find that Lhs1 and Sse1 induce very similar changes in the conformational dynamics in the Hsp70. Thus, our findings demonstrate that despite some differences between Hsp110 and Grp170 proteins, they use a similar mechanism to trigger nucleotide exchange.	[Andreasson, Claes; Rampelt, Heike; Fiaux, Jocelyne; Druffel-Augustin, Silke; Bukau, Bernd] Univ Heidelberg, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Andreasson, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Svante Arrheniusvag 16-18 E5, SE-10691 Stockholm, Sweden.	claes.andreasson@cellbio.su.se		Rampelt, Heike/0000-0002-5458-5652; Bukau, Bernd/0000-0003-0521-7199; Andreasson, Claes/0000-0001-8948-0685	Deutsche Forschungsgemeinschaft [SFB638]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB638 and a grant from the Fonds der Chemischen Industrie (to B. B.).	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; CRAIG EA, 2005, PROTEIN FOLDING HDB, P490; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hamilton TG, 1996, J BIOL CHEM, V271, P30610, DOI 10.1074/jbc.271.48.30610; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MORI K, 1993, CELL, V74, P743; MUKAI H, 1993, GENE, V132, P57; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rist W, 2005, PROTEIN SCI, V14, P626, DOI 10.1110/ps.041098305; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518	34	37	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12445	12453		10.1074/jbc.M109.096735	http://dx.doi.org/10.1074/jbc.M109.096735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177057	Green Published, hybrid			2022-12-27	WOS:000276787100072
J	Perrera, C; Colombo, R; Valsasina, B; Carpinelli, P; Troiani, S; Modugno, M; Gianellini, L; Cappella, P; Isacchi, A; Moll, J; Rusconi, L				Perrera, Claudia; Colombo, Riccardo; Valsasina, Barbara; Carpinelli, Patrizia; Troiani, Sonia; Modugno, Michele; Gianellini, Laura; Cappella, Paolo; Isacchi, Antonella; Moll, Jurgen; Rusconi, Luisa			Identification of Myb-binding Protein 1A (MYBBP1A) as a Novel Substrate for Aurora B Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HUMAN MITOTIC SPINDLE; C-MYB; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEOME ANALYSIS; PROTEOMIC ANALYSIS; NUCLEOLAR PROTEIN; CELL-DIVISION; MISU NSUN2; PHOSPHORYLATION	Aurora kinases are mitotic enzymes involved in centrosome maturation and separation, spindle assembly and stability, and chromosome condensation, segregation, and cytokinesis and represent well known targets for cancer therapy because their deregulation has been linked to tumorigenesis. The availability of suitable markers is of crucial importance to investigate the functions of Auroras and monitor kinase inhibition in in vivo models and in clinical trials. Extending the knowledge on Aurora substrates could help to better understand their biology and could be a source for clinical biomarkers. Using biochemical, mass spectrometric, and cellular approaches, we identified MYBBP1A as a novel Aurora B substrate and serine 1303 as the major phosphorylation site. MYBBP1A is phosphorylated in nocodazole-arrested cells and is dephosphorylated upon Aurora B silencing or by treatment with Danusertib, a small molecule inhibitor of Aurora kinases. Furthermore, we show that MYBBP1A depletion by RNA interference causes mitotic progression delay and spindle assembly defects. MYBBP1A has until now been described as a nucleolar protein, mainly involved in transcriptional regulation. The results presented herein show MYBBP1A as a novel Aurora B kinase substrate and reveal a not yet recognized link of this nucleolar protein to mitosis.	[Perrera, Claudia; Colombo, Riccardo; Valsasina, Barbara; Carpinelli, Patrizia; Troiani, Sonia; Modugno, Michele; Gianellini, Laura; Cappella, Paolo; Isacchi, Antonella; Moll, Jurgen; Rusconi, Luisa] Nerviano Med Sci SRL, I-20014 Nerviano, MI, Italy	Nerviano Medical Sciences S.r.l	Perrera, C (corresponding author), Nerviano Med Sci SRL, Viale L Pasteur 10, I-20014 Nerviano, MI, Italy.	Claudia.Perrera@nervianoms.com	Cappella, Paolo/ABI-2298-2020; Cappella, Paolo/L-5857-2016	Cappella, Paolo/0000-0002-3401-4246; Cappella, Paolo/0000-0002-7476-5618				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; BADING H, 1989, EXP CELL RES, V185, P50, DOI 10.1016/0014-4827(89)90036-0; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brittle AL, 2007, EXP CELL RES, V313, P2780, DOI 10.1016/j.yexcr.2007.04.038; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; CARPINELLI P, 2009, J CURR OPIN DRUG DIS, V12, P533; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; FAVIER D, 1994, ONCOGENE, V9, P305; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Gambe AE, 2009, FEBS LETT, V583, P1951, DOI 10.1016/j.febslet.2009.05.033; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kollareddy M, 2008, BIOMED PAP, V152, P27, DOI 10.5507/bp.2008.004; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Rodriguez JA, 2006, ONCOGENE, V25, P4867, DOI 10.1038/sj.onc.1209499; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; Troiani S, 2005, J PROTEOME RES, V4, P1296, DOI 10.1021/pr050018e; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yang W, 2003, CELL CYCLE, V2, P120, DOI 10.4161/cc.2.2.329; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	74	22	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11775	11785		10.1074/jbc.M109.068312	http://dx.doi.org/10.1074/jbc.M109.068312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177074	hybrid, Green Published			2022-12-27	WOS:000276787100004
J	Zhou, Y; Wang, S; Ma, JW; Lei, Z; Zhu, HF; Lei, P; Yang, ZS; Zhang, B; Yao, XX; Shi, C; Sun, LF; Wu, XW; Ning, Q; Shen, GX; Huang, B				Zhou, Yu; Wang, Shuo; Ma, Jing-Wei; Lei, Zhang; Zhu, Hui-Fen; Lei, Ping; Yang, Zhuo-Shun; Zhang, Biao; Yao, Xin-Xin; Shi, Chuan; Sun, Li-Fang; Wu, Xiong-Wen; Ning, Qin; Shen, Guan-Xin; Huang, Bo			Hepatitis B Virus Protein X-induced Expression of the CXC Chemokine IP-10 Is Mediated through Activation of NF-kappa B and Increases Migration of Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-INDUCIBLE PROTEIN-10; HBX PROTEIN; IN-VIVO; KINASE; TRANSCRIPTION; INDUCTION; GENE; DNA; INFLAMMATION; SPECIFICITY	Interferon-gamma inducible protein 10 (IP-10) involves inflammatory cell recruitment and cellular immune damage during virus infection. Although an increase of the peripheral IP-10 level is known in HBV-infected patients, the molecular basis of HBV infection inducing IP-10 expression has remained elusive. In the present study, we demonstrate that hepatitis B virus protein X (HBx) increases IP-10 expression in a dose-dependent manner. Transfection of the HBx-expressing vector into HepG2 cells results in nuclear translocation of NF-kappa B, which directly binds the promoter of IP-10 at positions from -122 to -113, thus facilitating transcription. The addition of the NF-kappa B inhibitor blocks the effect of HBx on IP-10 induction. In parallel, increase of NF-kappa B subunits p65 and p50 in HepG2 cells also augments IP-10 expression. Furthermore, we show that HBx induces activation of NF-kappa B through the TRAF2/TAK1 signaling pathway, leading to up-regulation of IP-10 expression. As a consequence, up-regulation of IP-10 may mediate the migration of peripheral blood leukocytes in a NF-kappa B-dependent manner. In conclusion, we report a novel molecular mechanism of HBV infection inducing IP-10 expression, which involves viral protein HBx affecting NF-kappa B pathway, leading to transactivation of the IP-10 promoter. Our study provides insight into the migration of leukocytes in response to HBV infection, thus causing immune pathological injury of liver.	[Zhou, Yu; Ma, Jing-Wei; Zhu, Hui-Fen; Lei, Ping; Yao, Xin-Xin; Shi, Chuan; Sun, Li-Fang; Wu, Xiong-Wen; Shen, Guan-Xin] Huazhong Univ Sci & Technol, Dept Immunol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lei, Zhang; Yang, Zhuo-Shun; Zhang, Biao; Huang, Bo] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wang, Shuo] McGill Univ, Lady Davis Inst, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Lady Davis Institute; McGill University	Shen, GX (corresponding author), 13 Hangkong Rd, Wuhan 430030, Peoples R China.	guanxin_shen@yahoo.com.cn; tjhuangbo@hotmail.com	shen, Guanxin/F-7441-2011		National Key and Basic Research Development Program of China [2007CB512900]; State Project on Major Infectious Diseases Prevention [2008ZX10002-009]; Program for New Century Excellent Talents in University [NCET-08-0219]; Special Research Foundation for Universities affiliated with China Ministry of Education [Z2009005]	National Key and Basic Research Development Program of China(National Basic Research Program of China); State Project on Major Infectious Diseases Prevention; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Research Foundation for Universities affiliated with China Ministry of Education	This work was supported by the National Key and Basic Research Development Program of China Grant 2007CB512900, State Project on Major Infectious Diseases Prevention Grant 2008ZX10002-009, Program for New Century Excellent Talents in University Grant NCET-08-0219, and Special Research Foundation for Universities affiliated with China Ministry of Education Grant Z2009005.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Feldmann M, 2001, ADV EXP MED BIOL, V490, P119; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Harousseau Jean-Luc, 2004, Hematology Am Soc Hematol Educ Program, P237; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horie R, 2006, DRUG NEWS PERSPECT, V19, P201, DOI 10.1358/dnp.2006.19.4.985934; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kim HT, 2001, BIOCHEM BIOPH RES CO, V286, P886, DOI 10.1006/bbrc.2001.5496; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Law AHY, 2007, J VIROL, V81, P416, DOI 10.1128/JVI.02336-05; Le Goffic R, 2002, ENDOCRINOLOGY, V143, P1434, DOI 10.1210/en.143.4.1434; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Liu MT, 2000, J IMMUNOL, V165, P2327, DOI 10.4049/jimmunol.165.5.2327; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Mahalingam S, 1999, J VIROL, V73, P1479, DOI 10.1128/JVI.73.2.1479-1491.1999; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Nakamichi K, 2005, J VIROL, V79, P11801, DOI 10.1128/JVI.79.18.11801-11812.2005; Narumi S, 1997, J IMMUNOL, V158, P5536; Nazar ASMI, 1997, J NEUROIMMUNOL, V77, P116, DOI 10.1016/S0165-5728(97)00070-2; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Nishioji K, 2001, CLIN EXP IMMUNOL, V123, P271, DOI 10.1046/j.1365-2249.2001.01391.x; Park SR, 2001, EUR J IMMUNOL, V31, P1706, DOI 10.1002/1521-4141(200106)31:6<1706::AID-IMMU1706>3.0.CO;2-Z; ROBINSON WS, 1974, J VIROL, V14, P384, DOI 10.1128/JVI.14.2.384-391.1974; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rotondi M, 2003, J ENDOCRINOL INVEST, V26, P177, DOI 10.1007/BF03345149; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shamay M, 2002, J BIOL CHEM, V277, P9982, DOI 10.1074/jbc.M111354200; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; TIOLLAIS P, 1981, SCIENCE, V213, P406, DOI 10.1126/science.6264599; Wang J, 2008, HEPATOB PANCREAT DIS, V7, P45; Weil R, 1999, MOL CELL BIOL, V19, P6345; Wenzel J, 2009, ARCH DERMATOL RES, V301, P83, DOI 10.1007/s00403-008-0892-8; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819	50	45	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12159	12168		10.1074/jbc.M109.067629	http://dx.doi.org/10.1074/jbc.M109.067629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164184	hybrid, Green Published			2022-12-27	WOS:000276787100046
J	Bergeron, SE; Zhu, M; Thiem, SM; Friderici, KH; Rubenstein, PA				Bergeron, Sarah E.; Zhu, Mei; Thiem, Suzanne M.; Friderici, Karen H.; Rubenstein, Peter A.			Ion-dependent Polymerization Differences between Mammalian beta- and gamma-Nonmuscle Actin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; HAIR-CELLS; YEAST ACTIN; BINDING PROTEIN; ATP HYDROLYSIS; CHARGED RESIDUES; CARDIAC ACTIN; COMPLEX; LOCALIZATION; FILAMENTS	beta- and gamma-nonmuscle actins differ by 4 amino acids at or near the N terminus and distant from polymerization interfaces. gamma-Actin contains an Asp1-Asp2-Asp3 and Val(10) whereas beta-actin has a Glu1-Glu2-Glu3 and Ile10. Despite these small changes, conserved across mammals, fish, and birds, their differential localization in the same cell suggests they may play different roles reflecting differences in their biochemical properties. To test this hypothesis, we established a baculovirus-driven expression system for producing these actins in isoform-pure populations although contaminated with 20-25% insect actin. Surprisingly, Ca-gamma-actin exhibits a slower monomeric nucleotide exchange rate, a much longer nucleation phase, and a somewhat slower elongation rate than gamma-actin. In the Mg-form, this difference between the two is much smaller. Ca-gamma-actin depolymerizes half as fast as does gamma-actin. Mixing experiments with Ca-actins reveal the two will readily co-polymerize. In the Ca-form, phosphate release from polymerizing gamma-actin occurs much more rapidly and extensively than polymerization, whereas phosphate release lags behind polymerization with gamma-actin. Phosphate release during treadmilling is twice as fast with beta-as with gamma-actin. With Mg-actin in the initial stages, phosphate release for both actins correlates much more closely with polymerization. Calcium bound in the high affinity binding site of gamma-actin may cause a selective energy barrier relative to gamma-actin that retards the equilibration between G-and F-monomer conformations resulting in a slower polymerizing actin with greater filament stability. This difference may be particularly important in sites such as the gamma-actin-rich cochlear hair cell stereocilium where local mM calcium concentrations may exist.	[Bergeron, Sarah E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Zhu, Mei; Thiem, Suzanne M.; Friderici, Karen H.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Thiem, Suzanne M.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Iowa; Michigan State University; Michigan State University	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC008803, DC004568]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803, R01DC004568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC008803 (to P. A. R.) and DC004568 (to K. H. F.).	Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1994, ADV EXP MED BIOL, V358, P71; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1993, J BIOL CHEM, V268, P2410; COOK RK, 1992, PRACTICAL APPROACHES, P99; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; DECHESNE CJ, 1991, BRAIN RES, V560, P139, DOI 10.1016/0006-8993(91)91224-O; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hannan AJ, 1998, MOL CELL NEUROSCI, V11, P289, DOI 10.1006/mcne.1998.0693; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Henzl MT, 1997, HEARING RES, V106, P105, DOI 10.1016/S0378-5955(97)00005-1; Hofer D, 1997, J CELL SCI, V110, P765; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kashina AS, 2006, TRENDS CELL BIOL, V16, P610, DOI 10.1016/j.tcb.2006.10.001; Khaitlina S, 1999, ARCH BIOCHEM BIOPHYS, V368, P105, DOI 10.1006/abbi.1999.1303; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sakaguchi N, 1998, J HISTOCHEM CYTOCHEM, V46, P29, DOI 10.1177/002215549804600105; SANS A, 1986, BRAIN RES, V364, P190, DOI 10.1016/0006-8993(86)91003-6; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Watanabe H, 1998, J CELL SCI, V111, P1287; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	54	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16087	16095		10.1074/jbc.M110.110130	http://dx.doi.org/10.1074/jbc.M110.110130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308063	hybrid, Green Published			2022-12-27	WOS:000277715900046
J	Hyun, JK; Radjainia, M; Kingston, RL; Mitra, AK				Hyun, Jae-Kyung; Radjainia, Mazdak; Kingston, Richard L.; Mitra, Alok K.			Proton-driven Assembly of the Rous Sarcoma Virus Capsid Protein Results in the Formation of Icosahedral Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL RECONSTRUCTIONS; INTERSUBUNIT INTERACTIONS; DIMERIZATION DOMAIN; TYPE-1 CORE; MODEL; ORGANIZATION; POLYMORPHISM; IMAGE; VISUALIZATION; ASSOCIATION	In a mature and infectious retroviral particle, the capsid protein (CA) forms a shell surrounding the genomic RNA and the replicative machinery of the virus. The irregular nature of this capsid shell precludes direct atomic resolution structural analysis. CA hexamers and pentamers are the fundamental building blocks of the capsid, however the pentameric state, in particular, remains poorly characterized. We have developed an efficient in vitro protocol for studying the assembly of Rous sarcoma virus (RSV) CA that involves mild acidification and produces structures modeling the authentic viral capsid. These structures include regular spherical particles with T = 1 icosahedral symmetry, built from CA pentamers alone. These particles were subject to cryoelectron microscopy (cryo-EM) and image processing, and a pseudo-atomic model of the icosahedron was created by docking atomic structures of the constituent CA domains into the cryo-EM-derived three-dimensional density map. The N-terminal domain (NTD) of CA forms pentameric turrets, which decorate the surface of the icosahedron, while the C-terminal domain (CTD) of CA is positioned underneath, linking the pentamers. Biophysical analysis of the icosahedral particle preparation reveals that CA monomers and icosahedra are the only detectable species and that these exist in reversible equilibrium at pH 5. These same acidic conditions are known to promote formation of a RSV CA CTD dimer, present within the icosahedral particle, which facilitates capsid assembly. The results are consistent with a model in which RSV CA assembly is a nucleation-limited process driven by very weak protein-protein interactions.	[Hyun, Jae-Kyung; Radjainia, Mazdak; Kingston, Richard L.; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland	Kingston, RL (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	rl.kingston@auckland.ac.nz; a.mitra@auckland.ac.nz	Kingston, Richard/C-2537-2008; Hyun, Jaekyung/AAK-2521-2020; Mitra, Alok/P-7800-2016	Kingston, Richard/0000-0003-0893-6973; Hyun, Jaekyung/0000-0003-2914-537X; Mitra, Alok/0000-0003-0891-5697	National Institutes of Health; New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship	This work was supported, in whole or in part, by National Institutes of Health R21 Grant (to A. K. M.). This work was also supported by the New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship (to R. L. K.).	Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; ADOLPH KW, 1974, J MOL BIOL, V88, P327, DOI 10.1016/0022-2836(74)90485-9; Annunziata O, 2005, LANGMUIR, V21, P12085, DOI 10.1021/la052147f; Aragon S, 2006, BIOPHYS J, V91, P1591, DOI [10.1529/biophysj.105.078188, 10.1529/hiophysj.105.078188]; Auerbach MR, 2007, J VIROL, V81, P12337, DOI 10.1128/JVI.01286-07; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; BATTINO R, 1984, J CHEM EDUC, V61, P51, DOI 10.1021/ed061p51; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, J VIROL, V78, P2606, DOI 10.1128/JVI.78.5.2606-2608.2004; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; CANN JR, 1974, BIOCHEMISTRY-US, V13, P1868, DOI 10.1021/bi00706a015; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; FINSY R, 1994, ADV COLLOID INTERFAC, V52, P79, DOI 10.1016/0001-8686(94)80041-3; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kingston RL, 2001, J STRUCT BIOL, V136, P67, DOI 10.1006/jsbi.2001.4423; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Lepault J, 2001, EMBO J, V20, P1498, DOI 10.1093/emboj/20.7.1498; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lomakin Aleksey, 2004, V299, P153; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Newman RM, 2007, AIDS REV, V9, P114; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Purdy JG, 2009, J MOL BIOL, V389, P438, DOI 10.1016/j.jmb.2009.04.006; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STEVENS FJ, 1989, BIOPHYS J, V55, P1155, DOI 10.1016/S0006-3495(89)82912-1; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Winzor DJ, 2003, J BIOCHEM BIOPH METH, V56, P15, DOI 10.1016/S0165-022X(03)00071-X; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xu R, 2000, PARTICLE CHARACTERIZ; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299; ZIMMERMAN JK, 1974, BIOCHEMISTRY-US, V13, P384, DOI 10.1021/bi00699a025; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	64	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15056	15064		10.1074/jbc.M110.108209	http://dx.doi.org/10.1074/jbc.M110.108209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228062	Green Published, hybrid			2022-12-27	WOS:000277399000027
J	D'Arcy, S; Davies, OR; Blundell, TL; Bolanos-Garcia, VM				D'Arcy, Sheena; Davies, Owen R.; Blundell, Tom L.; Bolanos-Garcia, Victor M.			Defining the Molecular Basis of BubR1 Kinetochore Interactions and APC/C-CDC20 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; N-TERMINAL REGION; MITOTIC CHECKPOINT; CENP-E; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; ANAPHASE; CDC20; MUTATIONS; COMPLEX	BubR1 is essential for the mitotic checkpoint that prevents aneuploidy in cellular progeny by triggering anaphase delay in response to kinetochores incorrectly/not attached to the mitotic spindle. Here, we define the molecular architecture of the functionally significant N-terminal region of human BubR1 and present the 1.8 angstrom crystal structure of its tetratricopeptide repeat (TPR) domain. The structure reveals divergence from the classical TPR fold and is highly similar to the TPR domain of budding yeast Bub1. Shared distinctive features include a disordered loop insertion, a 3(10)-helix, a tight turn involving glycine positive Phi angles, and noncanonical packing of and between the TPR motifs. We also define the molecular determinants of the interaction between BubR1 and kinetochore protein Blinkin. We identify a shallow groove on the concave surface of the BubR1 TPR domain that forms multiple discrete and potentially cooperative interactions with Blinkin. Finally, we present evidence for a direct interaction between BubR1 and Bub1 mediated by regions C-terminal to their TPR domains. This interaction provides a mechanism for Bub1-dependent kinetochore recruitment of BubR1. We thus present novel molecular insights into the structure of BubR1 and its interactions at the kinetochore-microtubule interface. Our studies pave the way for future structure-directed engineering aimed at dissecting the roles of kinetochore-bound and other pools of BubR1 in vivo.	[D'Arcy, Sheena; Davies, Owen R.; Blundell, Tom L.; Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Davies, Owen R.] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Edinburgh	Bolanos-Garcia, VM (corresponding author), 80 Tennis Court Rd, Cambridge CB2 1GA, England.	victor@cryst.bioc.cam.ac.uk	Davies, Owen/J-4820-2019; Bolanos-Garcia, Victor M./AAN-8575-2020; D'Arcy, Sheena/C-8592-2018	Davies, Owen/0000-0002-3806-5403; Bolanos-Garcia, Victor M./0000-0003-2700-1479; D'Arcy, Sheena/0000-0001-5055-988X	Wellcome Trust [RG44650]; Royal Commission for the Exhibition of 1851; University of Sydney, Kings College London; Cambridge Commonwealth Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Commission for the Exhibition of 1851; University of Sydney, Kings College London(University of Sydney); Cambridge Commonwealth Trust	This work was supported by Wellcome Trust Programme Grant RG44650 (to T. L. B.) and funding from the Royal Commission for the Exhibition of 1851 (to O.R.D.), the University of Sydney, Kings College London, and the Cambridge Commonwealth Trust (to S. D.).	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bolanos-Garcia VM, 2009, STRUCTURE, V17, P105, DOI 10.1016/j.str.2008.10.015; Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; MACDONALD PN, 2001, METHOD MOL BIOL, V177, pR5; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pfleger CM, 2000, GENE DEV, V14, P655; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vanoosthuyse V, 2009, GENE DEV, V23, P2799, DOI 10.1101/gad.1882109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yoon J, 2005, PROTEIN EXPRES PURIF, V44, P1, DOI 10.1016/j.pep.2005.04.020; Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002	60	28	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14764	14776		10.1074/jbc.M109.082016	http://dx.doi.org/10.1074/jbc.M109.082016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220147	hybrid, Green Published			2022-12-27	WOS:000277299700074
J	Efendiev, R; Samelson, BK; Nguyen, BT; Phatarpekar, PV; Baameur, F; Scott, JD; Dessauer, CW				Efendiev, Riad; Samelson, Bret K.; Nguyen, Bao T.; Phatarpekar, Prasad V.; Baameur, Faiza; Scott, John D.; Dessauer, Carmen W.			AKAP79 Interacts with Multiple Adenylyl Cyclase (AC) Isoforms and Scaffolds AC5 and-6 to alpha-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-KINASE-A; SIGNALING COMPLEXES; AKAP150-ANCHORED PKA; RAT-BRAIN; MEMORY; MEMBRANE; BINDING; SITE; PHOSPHORYLATION	Spatiotemporal specificity of cAMP action is best explained by targeting protein kinase A (PKA) to its substrates by A-kinase-anchoring proteins (AKAPs). At synapses in the brain, AKAP79/150 incorporates PKA and other regulatory enzymes into signal transduction networks that include beta-adrenergic receptors, alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA), and N-methyl-D-aspartic acid receptors. We previously showed that AKAP79/150 clusters PKA with type 5 adenylyl cyclase (AC5) to assemble a negative feedback loop in which the anchored kinase phosphorylates AC5 to dynamically suppress cAMP synthesis. We now show that AKAP79 can associate with multiple AC isoforms. The N-terminal regions of AC5, -6, and -9 mediate this protein-protein interaction. Mapping studies located a reciprocal binding surface between residues 77-108 of AKAP79. Intensity-and lifetime-based fluorescence resonance energy transfer demonstrated that deletion of AKAP79(77-108) region abolished AC5-AKAP79 interaction in living cells. The addition of the AKAP79(77-153) polypeptide fragment uncouples AC5/6 interactions with the anchoring protein and prevents PKA-mediated inhibition of AC activity in membranes. Use of the AKAP79(77-153) polypeptide fragment in brain extracts from wild-type and AKAP150(-/-) mice reveals that loss of the anchoring protein results in decreased AMPA receptor-associated AC activity. Thus, we propose that AKAP79/150 mediates protein-protein interactions that place AC5 in proximity to synaptic AMPA receptors.	[Efendiev, Riad; Nguyen, Bao T.; Phatarpekar, Prasad V.; Baameur, Faiza; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Samelson, Bret K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	Carmen.W.Dessauer@uth.tmc.edu	Dessauer, Carmen/N-6933-2018	Dessauer, Carmen/0000-0003-1210-4280	National Institutes of Health [GM60419, GM48231]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R01GM060419, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 (to C. W. D.) and GM48231 (to J. D. S.) and a grant from the American Heart Association (to C. W. D.).	Antoni FA, 1998, J NEUROSCI, V18, P9650; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Chen YB, 1997, P NATL ACAD SCI USA, V94, P14100, DOI 10.1073/pnas.94.25.14100; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dessauer CW, 2002, METHOD ENZYMOL, V345, P112; Diviani D, 2001, J CELL SCI, V114, P1431; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; HOUBRE D, 1991, J BIOL CHEM, V266, P7121; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; JACOBOWITZ O, 1994, P NATL ACAD SCI USA, V91, P10630, DOI 10.1073/pnas.91.22.10630; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; KAWABE J, 1994, J BIOL CHEM, V269, P16554; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lai HL, 1997, J BIOL CHEM, V272, P4970, DOI 10.1074/jbc.272.8.4970; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sadana R, 2009, MOL PHARMACOL, V76, P1256, DOI 10.1124/mol.109.058370; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	45	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14450	14458		10.1074/jbc.M110.109769	http://dx.doi.org/10.1074/jbc.M110.109769			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231277	Green Published, hybrid			2022-12-27	WOS:000277299700041
J	Pagano, K; Bemporad, F; Fogolari, F; Esposito, G; Viglino, P; Chiti, F; Corazza, A				Pagano, Katiuscia; Bemporad, Francesco; Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Chiti, Fabrizio; Corazza, Alessandra			Structural and Dynamics Characteristics of Acylphosphatase from Sulfolobus solfataricus in the Monomeric State and in the Initial Native-like Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FORMATION; MOLECULAR-DYNAMICS; DIFFUSION MEASUREMENTS; GLOBULAR-PROTEINS; MECHANISM; SUPPRESSION; INCLUSION; INSIGHTS; PROGRAM; PATHWAY	It has previously been shown that the acylphosphatase from Sulfolobus solfataricus is capable of forming amyloid-like aggregates under conditions in which the native structure is maintained and via the transient formation of native-like aggregates. Based on the previously determined NMR structure of the native protein, showing a ferredoxin-like fold and the peculiar presence of an unstructured N-terminal segment, we show here, at a molecular level using NMR spectroscopy, that indeed S. solfataricus acylphosphatase remains in a native-like conformation when placed in aggregating conditions and that such a native-like structure persists when the protein forms the initial aggregates, at least within the low molecular weight species. The analysis carried out under different solution conditions, based on the measurement of the combined H-1 and N-15 chemical shifts and hydrogen/deuterium exchange rates, enabled the most significant conformational changes to be monitored upon transfer of the monomeric state into aggregating conditions and upon formation of the initial native-like aggregates. Important increases of the hydrogen/deuterium exchange rates throughout the native protein, accompanied by small and localized structural changes, in the monomeric protein were observed. The results also allow the identification of the intermolecular interaction regions within the native-like aggregates, that involve, in particular, the N-terminal unstructured segment, the apical region including strands S4 and S5 with the connecting loop, and the opposite active site.	[Pagano, Katiuscia; Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Corazza, Alessandra] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Bemporad, Francesco; Chiti, Fabrizio] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Chiti, Fabrizio; Corazza, Alessandra] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Udine; University of Florence	Corazza, A (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Ple Kolbe 4, I-33100 Udine, Italy.	alessandra.corazza@uniud.it	Corazza, Alessandra/AGB-1457-2022; Pagano, Katiuscia/AAB-9495-2020	Corazza, Alessandra/0000-0003-2272-1928; Bemporad, Francesco/0000-0002-0643-6249; pagano, katiuscia/0000-0002-0462-2056; Fogolari, Federico/0000-0001-9862-250X	MIUR [XY59ZJ, M3E2T2, RBNE03PX83, RBRN07BMCT]; European Union [LSHM-CT-2005-037525]; Accademia dei Lincei; Federation of the European Biochemical Societies	MIUR(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Accademia dei Lincei; Federation of the European Biochemical Societies	This work was supported by MIUR Grants PRIN 2007 XY59ZJ, PRIN M3E2T2, FIRB RBNE03PX83, and FIRB RBRN07BMCT and European Union EURAMY Project LSHM-CT-2005-037525.; Supported in part by the Accademia dei Lincei and by a long term fellowship from the Federation of the European Biochemical Societies. Present address: Dept. of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin AJ, 2008, ANGEW CHEM INT EDIT, V47, P3385, DOI 10.1002/anie.200703915; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Einstein A, 1956, INVESTIGATIONS THEOR; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Modesti A, 1995, PROTEIN EXPRES PURIF, V6, P799, DOI 10.1006/prep.1995.0011; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Plakoutsi G, 2006, STRUCTURE, V14, P993, DOI 10.1016/j.str.2006.03.014; Poling B.E., 2001, PROPERTIES GASES LIQ, DOI DOI 10.1-10.70; Soldi G, 2006, J MED CHEM, V49, P6057, DOI 10.1021/jm0606488; Soldi G, 2008, J AM CHEM SOC, V130, P4295, DOI 10.1021/ja076628s; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007	30	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14689	14700		10.1074/jbc.M109.082156	http://dx.doi.org/10.1074/jbc.M109.082156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223823	hybrid, Green Published			2022-12-27	WOS:000277299700067
J	Por, E; Byun, HJ; Lee, EJ; Lim, JH; Jung, SY; Park, I; Kim, YM; Jeoung, DI; Lee, H				Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Park, Iha; Kim, Young-Myeong; Jeoung, Doo-Il; Lee, Hansoo			The Cancer/Testis Antigen CAGE with Oncogenic Potential Stimulates Cell Proliferation by Up-regulating Cyclins D1 and E in an AP-1-and E2F-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYTIC T-LYMPHOCYTES; C-JUN; HUMAN-MELANOMA; TERMINAL PHOSPHORYLATION; PHASE PROGRESSION; GENE CAGE; EXPRESSION; ACTIVATION; CANCER; IDENTIFICATION	A cancer/testis antigen, CAGE, is widely expressed in various cancer tissues and cancer cell lines but not in normal tissues except the testis. In the present study, ectopic expression of CAGE in fibroblast cells resulted in foci formation, suggesting its cell-transforming ability. Using stable HeLa transfectant clones with the tetracycline-inducible CAGE gene, we found that CAGE overexpression stimulated both anchorage-dependent and -independent cell growth in vitro and promoted tumor growth in a xenograft mouse model. Cell cycle analysis showed that CAGE augments the levels of cyclin D1 and E, thereby activating cyclin-associated cyclin-dependent kinases and subsequently accelerating the G1 to S progression. Moreover, increased cyclin D1 and E levels in CAGE-overexpressing cells were observed even in a growth arrested state, indicating a direct effect of CAGE on G1 cyclin expression. CAGE-induced expression of cyclins D1 and E was found to be mediated by AP-1 and E2F-1 transcription factors, and among the AP-1 members, c-Jun and JunD appeared to participate in CAGE-mediated upregulation of cyclin D1. CAGE overexpression also enhanced retinoblastoma phosphorylation and subsequent E2F-1 nuclear translocation. In contrast, small interfering RNA-mediated knockdown of CAGE suppressed the expression of G1 cyclins, activation of AP-1 and E2F-1, and cell proliferation in both HeLa cervical cancer cells and Malme-3M melanoma cells. These results suggest that the cancer/testis antigen CAGE possesses oncogenic potential and promotes cell cycle progression by inducing AP-1- and E2F-dependent expression of cyclins D1 and E.	[Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Div Life Sci, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Park, Iha; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Med & Biomat Res Ctr, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Coll Nat Sci, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Div Life Sci, Sch Med, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr		Por, Elaine/0000-0001-8025-5713	Korea Research Foundation [KRF-2006-312-C00677]; Korea Science and Engineering Foundation [R01-2007-000-11397-0]; Korean Ministry of Education, Science, and Technology	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grants KRF-2006-312-C00677 from the Korea Research Foundation and R01-2007-000-11397-0 from the Korea Science and Engineering Foundation. This work was also supported by a grant from the Korean Ministry of Education, Science, and Technology (Regional Core Research Program/Medical & Bio-Materials Research Center).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; Chen YT, 1997, CYTOGENET CELL GENET, V79, P237, DOI 10.1159/000134734; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; De Backer O, 1999, CANCER RES, V59, P3157; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Geng Y, 1996, ONCOGENE, V12, P1173; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hah N, 2003, BIOCHEM BIOPH RES CO, V305, P428, DOI 10.1016/S0006-291X(03)00788-5; HERBER B, 1994, ONCOGENE, V9, P1295; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Lucas S, 1998, CANCER RES, V58, P743; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Rodriguez-Puebla ML, 1999, MOL CARCINOGEN, V24, P1, DOI 10.1002/(SICI)1098-2744(199901)24:1<1::AID-MC1>3.0.CO;2-E; Sadanaga N, 2001, CLIN CANCER RES, V7, P2277; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sgambato A, 1998, TUMORI, V84, P421, DOI 10.1177/030089169808400401; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Vandel L, 1996, MOL CELL BIOL, V16, P1881; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	39	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14475	14485		10.1074/jbc.M109.084400	http://dx.doi.org/10.1074/jbc.M109.084400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220142	Green Published, hybrid			2022-12-27	WOS:000277299700044
J	Qin, JD; Berdyshev, E; Goya, J; Natarajan, V; Dawson, G				Qin, Jingdong; Berdyshev, Evgeny; Goya, Jonathan; Natarajan, Viswanathan; Dawson, Glyn			Neurons and Oligodendrocytes Recycle Sphingosine 1-Phosphate to Ceramide SIGNIFICANCE FOR APOPTOSIS AND MULTIPLE SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; NEUTRAL SPHINGOMYELINASE; SPHINGOLIPID METABOLISM; DIFFERENTIAL REGULATION; LIQUID-CHROMATOGRAPHY; EXOGENOUS CERAMIDE; MASS-SPECTROMETRY; SALVAGE PATHWAY; DEFICIENT MICE; PROTEIN	Both cultured neonatal rat hippocampal neurons and differentiated oligodendrocytes rapidly metabolized exogenous C-2- and C-6-ceramides to sphingosine (Sph) and sphingosine 1-phosphate (S1P) but only minimally to C16-24-ceramides. Dihydrosphinolipids were unaffected but were increased by exogenous C-6-dihydroceramide. Conversely, quantitative liquid chromatography-tandem mass spectrometry technology showed that exogenous S1P (0.25-10 mu M) was rapidly metabolized to both Sph (a > 200-fold increase) and predominantly C-18-ceramide (a > 2-fold increase). Longer treatments with either C-2-ceramide (> 2.5 mu M) or S1P (10 mu M) led to apoptotic cell death. Thus, there is an active sphingolipid salvage pathway in both neurons and oligodendrocytes. Staurosporine-induced cell death was shown to be associated with decreased S1P and increased Sph and C-16/18-ceramide levels. The physiological significance of this observation was confirmed by the analysis of affected white matter and plaques from brains of multiple sclerosis patients in which reduced S1P and increased Sph and C-16/18-ceramides were observed.	[Qin, Jingdong; Dawson, Glyn] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Berdyshev, Evgeny; Goya, Jonathan; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Dawson, Glyn] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Dawson, G (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat MC4068, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dawg@midway.uchicago.edu		Goya, Jonathan/0000-0002-2671-850X	U.S. Public Health Service, USPHS [NS36866-33, HL079853]; National Multiple Sclerosis Society [PP1319]; Clinical and Translational Science Award [UL1RR024999]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD054275] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL079853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036866] Funding Source: NIH RePORTER	U.S. Public Health Service, USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Clinical and Translational Science Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. Public Health Service Grant NS36866-33 and Pilot Grant PP1319 from the National Multiple Sclerosis Society (to G. D.). Clinical and Translational Science Award Grant UL1RR024999 (to J. Q.), and U.S. Public Health Service Grant HL079853 (to V. N.) from USPHS.	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOTTENSTEIN JE, 1986, P NATL ACAD SCI USA, V83, P1955, DOI 10.1073/pnas.83.6.1955; Bryan L, 2008, BBA-MOL CELL BIOL L, V1781, P459, DOI 10.1016/j.bbalip.2008.04.008; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen SW, 2006, J NEUROCHEM, V97, P631, DOI 10.1111/j.1471-4159.2006.03774.x; Dagan A, 2003, BBA-MOL CELL BIOL L, V1633, P161, DOI 10.1016/S1388-1981(03)00122-7; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Goswami R, 2000, J NEUROSCI RES, V60, P141, DOI 10.1002/(SICI)1097-4547(20000415)60:2<141::AID-JNR2>3.0.CO;2-5; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Irie F, 1998, J NEUROSCI RES, V54, P475, DOI 10.1002/(SICI)1097-4547(19981115)54:4<475::AID-JNR5>3.0.CO;2-P; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kilkus JP, 2008, J NEUROCHEM, V106, P1745, DOI 10.1111/j.1471-4159.2008.05490.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Kuemmel TA, 1997, J NEUROPATH EXP NEUR, V56, P171, DOI 10.1097/00005072-199702000-00008; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Lee TC, 1996, J BIOL CHEM, V271, P209, DOI 10.1074/jbc.271.1.209; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mendel J, 2003, J BIOL CHEM, V278, P22341, DOI 10.1074/jbc.M302857200; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Perry DK, 2002, BBA-MOL CELL BIOL L, V1585, P146, DOI 10.1016/S1388-1981(02)00335-9; Qin J, 2007, J NEUROSCI RES, V85, P977, DOI 10.1002/jnr.21206; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; Saadat L, 2010, GLIA, V58, P391, DOI 10.1002/glia.20930; Scurlock B, 1999, J NEUROSCI RES, V55, P514, DOI 10.1002/(SICI)1097-4547(19990215)55:4<514::AID-JNR11>3.0.CO;2-V; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Testai FD, 2004, J NEUROSCI RES, V75, P66, DOI 10.1002/jnr.10816; Tohyama J, 1999, J INHERIT METAB DIS, V22, P649, DOI 10.1023/A:1005590316064; Van Overloop H, 2007, BIOL CHEM, V388, P315, DOI 10.1515/BC.2007.035; VARTANIAN T, 1989, GLIA, V2, P370, DOI 10.1002/glia.440020509; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Wheeler D, 2008, BRAIN, V131, P3092, DOI 10.1093/brain/awn190; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; [No title captured]	54	49	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14134	14143		10.1074/jbc.M109.076810	http://dx.doi.org/10.1074/jbc.M109.076810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215115	Green Published, hybrid			2022-12-27	WOS:000277299700009
J	Bargeton, B; Kellenberger, S				Bargeton, Benoite; Kellenberger, Stephan			The Contact Region between Three Domains of the Extracellular Loop of ASIC1a Is Critical for Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; ACID; PORE; 1A; ION-CHANNEL-1; CONTRIBUTES; EXPRESSION; ISCHEMIA; H+	Acid-sensing ion channels are members of the epithelial Na+ channel/degenerin family. They are neuronal nonvoltage-gated Na+ channels that are activated by extracellular acidification. In this study, we investigated the role of a highly conserved region of the extracellular part of ASIC1a that forms the contact between the finger domain, the adjacent beta-ball, and the upper palm domain in ASIC1a. The finger domain contributes to the pH-dependent gating and is linked via this contact zone to the rest of the protein. We found that mutation to Cys of residues in this region led to decreased channel expression and current amplitudes. Exposure of the engineered Cys residues to Cd2+ or to charged methane thiosulfonate sulfhydryl reagents further reduced current amplitudes. This current inhibition was not due to changes in acid-sensing ion channel pH dependence or unitary conductance and was likely due to a decrease of the probability of channel opening. For some mutants, the effect of sulfhydryl reagents depended on the pH of exposure in the range 7.4 to 6.8, suggesting that this zone undergoes conformational changes during inactivation. Our study identifies a region in ASIC1a whose integrity is required for normal channel function.	[Bargeton, Benoite; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [31003A0-117717]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31003A0-117717 from the Swiss National Science Foundation (to S. K.).	Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Heinz U, 2003, J BIOL CHEM, V278, P20659, DOI 10.1074/jbc.M212581200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kadurin I, 2008, BIOCHEM J, V412, P469, DOI 10.1042/BJ20071614; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1996, J BIOL CHEM, V271, P30971, DOI 10.1074/jbc.271.48.30971; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200	34	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13816	13826		10.1074/jbc.M109.086843	http://dx.doi.org/10.1074/jbc.M109.086843			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215117	Green Published, hybrid			2022-12-27	WOS:000276987700057
J	Buscher, K; Riese, SB; Shakibaei, M; Reich, C; Dernedde, J; Tauber, R; Ley, K				Buscher, Konrad; Riese, Sebastian B.; Shakibaei, Mehdi; Reich, Christian; Dernedde, Jens; Tauber, Rudolf; Ley, Klaus			The Transmembrane Domains of L-selectin and CD44 Regulate Receptor Cell Surface Positioning and Leukocyte Adhesion under Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; GLYCOPROTEIN LIGAND-1; CYTOPLASMIC DOMAIN; IN-VITRO; PHYSIOLOGICAL FLOW; EPITHELIAL-CELLS; MICROVILLI; MEMBRANE; POLARITY; BINDING	During inflammation and immune surveillance, initial contacts (tethering) between free-flowing leukocytes and the endothelium are vitally dependent on the presentation of the adhesion receptor L-selectin on leukocyte microvilli. Determinants that regulate receptor targeting to microvilli are, however, largely elusive. Therefore, we systematically swapped the extracellular (EC), transmembrane (TM), and intracellular (IC) domains of L-selectin and CD44, a hyaluronan receptor expressed on the cell body and excluded from microvilli. Electron microscopy of transfected human myeloid K562 cells showed that the highly conserved TM domains are responsible for surface positioning. The TM segment of L-selectin forced chimeric molecules to microvilli, and the CD44 TM domain evoked expression on the cell body, whereas the IC and EC domains hardly influenced surface localization. Transfectants with microvillus-based chimeras showed a significantly higher adhesion rate under flow but not under static conditions compared with cells with cell body-expressed receptors. Substitution of the IC domain of L-selectin caused diminished tethering but no change in surface distribution, indicating that both microvillus positioning and cytoskeletal anchoring contribute to leukocyte tethering. These findings demonstrate that TM domains of L-selectin and CD44 play a crucial role in cell adhesion under flow by targeting receptors to microvilli or the cell body, respectively.	[Buscher, Konrad; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Buscher, Konrad; Riese, Sebastian B.; Reich, Christian; Dernedde, Jens; Tauber, Rudolf] Charite, Cent Dept Lab Med & Pathobiochem, D-10117 Berlin, Germany; [Reich, Christian] Charite, Dept Anesthesiol & Intens Care Med, D-10117 Berlin, Germany; [Shakibaei, Mehdi] Univ Munich, Dept Anat, D-80539 Munich, Germany	La Jolla Institute for Immunology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle Dr, La Jolla, CA 92037 USA.	klaus@liai.org	Dernedde, Jens/H-4097-2017; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Dernedde, Jens/0000-0001-5319-7677; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506	National Institutes of Health [EB 02185]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 449]; Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB 02185. This work was also supported by Deutsche Forschungsgemeinschaft Grant Sonderforschungsbereich 449 and Boehringer Ingelheim Fonds.	Abitorabi MA, 1997, J CELL BIOL, V139, P563, DOI 10.1083/jcb.139.2.563; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Azuma H, 2002, CANCER RES, V62, P1410; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; CANNISTRA SA, 1993, CANCER RES, V53, P3830; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Corbeil D, 1999, J CELL SCI, V112, P1023; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Dow LE, 2007, INT REV CYTOL, V262, P253, DOI 10.1016/S0074-7696(07)62006-3; Dwir O, 2007, J IMMUNOL, V179, P1030, DOI 10.4049/jimmunol.179.2.1030; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hocde SA, 2009, BIOPHYS J, V97, P379, DOI 10.1016/j.bpj.2009.04.035; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; KANSAS GS, 1989, J IMMUNOL, V142, P3050; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Krasik EF, 2004, BIOPHYS J, V87, P2919, DOI 10.1529/biophysj.104.039693; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li XJ, 2007, CELL RES, V17, P985, DOI 10.1038/cr.2007.98; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Matter K, 2000, CURR BIOL, V10, pR39, DOI 10.1016/S0960-9822(99)00256-0; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; PERSCHL A, 1995, J CELL SCI, V108, P1033; SHAKIBAEI M, 1993, J STRUCT BIOL, V111, P180, DOI 10.1006/jsbi.1993.1048; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; 2006, CANC RES, V66, P1536	44	28	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13490	13497		10.1074/jbc.M110.102640	http://dx.doi.org/10.1074/jbc.M110.102640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212041	Green Published, hybrid			2022-12-27	WOS:000276987700021
J	Zou, WQ; Langeveld, J; Xiao, XZ; Chen, SG; McGeer, PL; Yuan, J; Payne, MC; Kang, HE; McGeehan, J; Sy, MS; Greenspan, NS; Kaplan, D; Wang, GX; Parchi, P; Hoover, E; Kneale, G; Telling, G; Surewicz, WK; Kong, QZ; Guo, JP				Zou, Wen-Quan; Langeveld, Jan; Xiao, Xiangzhu; Chen, Shugui; McGeer, Patrick L.; Yuan, Jue; Payne, Michael C.; Kang, Hae-Eun; McGeehan, John; Sy, Man-Sun; Greenspan, Neil S.; Kaplan, David; Wang, Gong-Xian; Parchi, Piero; Hoover, Edward; Kneale, Geoff; Telling, Glenn; Surewicz, Witold K.; Kong, Qingzhong; Guo, Jian-Ping			PrP Conformational Transitions Alter Species Preference of a PrP-specific Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; PATHOLOGICAL PRION PROTEIN; MONOCLONAL-ANTIBODY; N-TERMINUS; SCRAPIE; EPITOPE; BINDING; BRAIN; RECOGNITION; STRAIN	The epitope of the 3F4 antibody most commonly used inhuman prion disease diagnosis is believed to consist of residues Met-LysHis-Met (MKHM) corresponding to human PrP-(109-112). This assumption is based mainly on the observation that 3F4 reacts with human and hamster PrP but not with PrP from mouse, sheep, and cervids, in which Met at residue 112 is replaced by Val. Here we report that, by brain histoblotting, 3F4 did not react with PrP of uninfected transgenic mice expressing elk PrP; however, it did show distinct immunoreactivity in transgenic mice infected with chronic wasting disease. Compared with human PrP, the 3F4 reactivity with the recombinant elk PrP was 2 orders of magnitude weaker, as indicated by both Western blotting and surface plasmon resonance. To investigate the molecular basis of these species-and conformer-dependent preferences of 3F4, the epitope was probed by peptide membrane array and antigen competition experiments. Remarkably, the 3F4 antibody did not react with MKHM but reacted strongly with KTNMK(corresponding to human PrP( 106-110)), a sequence that is also present in cervids, sheep, and cattle. 3F4 also reacted with elk PrP peptides containing KTNMKHV. We concluded that the minimal sequence for the 3F4 epitope consists of residues KTNMK, and the species-and conformer-dependent preferences of 3F4 arise largely from the interactions between Met(112) (human PrP) or Val(115) (cervid PrP) and adjacent residues.	[Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue; Payne, Michael C.; Sy, Man-Sun; Greenspan, Neil S.; Kaplan, David; Kong, Qingzhong] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Langeveld, Jan] Wageningen UR, Cent Vet Inst, NL-8221 RA Lelystad, Netherlands; [McGeer, Patrick L.; Guo, Jian-Ping] Univ British Columbia, Fac Med, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Microbiol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Immunol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Mol Genet, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Neurol, Lexington, KY 40536 USA; [McGeehan, John; Kneale, Geoff] Univ Portsmouth, Biophys Labs, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England; [Zou, Wen-Quan; Wang, Gong-Xian] Nanchang Univ, Sch Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi Prov, Peoples R China; [Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Hoover, Edward] Univ Colorado, Dept Mol Biol Immunol & Pathol, Ft Collins, CO 80523 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wageningen University & Research; University of British Columbia; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Portsmouth; Nanchang University; University of Bologna	Zou, WQ (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	Zou, Wenquan/ABF-2875-2020; Greenspan, Neil/AAJ-4795-2020; xiao, xiangzhu/B-9300-2014; Telling, Glenn C/G-1217-2019; Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022	xiao, xiangzhu/0000-0002-8013-9074; Telling, Glenn C/0000-0002-6294-1805; Parchi, Piero/0000-0002-9444-9524; McGeehan, John/0000-0002-6750-1462	National Institutes of Health [R01NS062787, R01NS052319, R01NS44158]; NIA [AG-14359]; CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Centers for Disease Control and Prevention [UR8/CCU515004]; Dutch Ministry of Agriculture, Nature and Food Quality, UK [DEFRA SE1700]; NeuroPrion EC [FOOD-CT-2004-506579];  [RR016789]; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787, R01NS044158, R01NS052319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Dutch Ministry of Agriculture, Nature and Food Quality, UK; NeuroPrion EC; ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS062787 (to W.-Q.Z.), R01NS052319 (to Q. K.), R01NS44158 (to W. K. S.), AG-14359 from the NIA (to J.-P.G.), and RR016789 to the Biacore facilities at Cleveland Clinic Foundation, grants from the CJD Foundation (to W.-Q.Z.), Alliance BioSecure (to W.-Q.Z.), the University Center on Aging and Health, with support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) (to W.-Q.Z.), Centers for Disease Control and Prevention Grant UR8/CCU515004 (to J.-P.G.), grants from the Dutch Ministry of Agriculture, Nature and Food Quality, UK project DEFRA SE1700 (to J. L.), and NeuroPrion EC FOOD-CT-2004-506579 (to J. L.).	BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Greenspan NS, 2001, CURR TOP MICROBIOL, V260, P65; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LANGEVELD JPM, 1994, VACCINE, V12, P1473, DOI 10.1016/0264-410X(94)90158-9; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sy MS, 2009, CELL RES, V19, P1039, DOI 10.1038/cr.2009.102; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2005, BIOCHEM BIOPH RES CO, V326, P652, DOI 10.1016/j.bbrc.2004.11.088; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	39	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13874	13884		10.1074/jbc.M109.088831	http://dx.doi.org/10.1074/jbc.M109.088831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194495	Green Published, hybrid			2022-12-27	WOS:000276987700062
J	Weber, CR; Raleigh, DR; Su, LP; Shen, L; Sullivan, EA; Wang, YM; Turner, JR				Weber, Christopher R.; Raleigh, David R.; Su, Liping; Shen, Le; Sullivan, Erika A.; Wang, Yingmin; Turner, Jerrold R.			Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; INCREASED INTESTINAL PERMEABILITY; DIARRHEA IN-VIVO; NK-T-CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; BARRIER DYSFUNCTION; CLAUDIN-2 EXPRESSION; PARACELLULAR PORES	Intestinal barrier function is reduced in inflammatory bowel disease (IBD). Tumor necrosis factor (TNF) and interleukin (IL)-13, which are up-regulated in IBD, induce barrier defects that are associated with myosin light chain kinase (MLCK) activation and increased claudin-2 expression, respectively, in cultured intestinal epithelial monolayers. Here we report that these independent signaling pathways have distinct effects on tight junction barrier properties and interact in vivo. MLCK activation alters size selectivity to enhance paracellular flux of uncharged macromolecules without affecting charge selectivity and can be rapidly reversed by MLCK inhibition. In contrast, IL-13-dependent claudin-2 expression increases paracellular cation flux in vitro and in vivo without altering tight junction size selectivity but is unaffected by MLCK inhibition in vitro. In vivo, MLCK activation increases paracellular flux of uncharged macromolecules and also triggers IL-13 expression, claudin-2 synthesis, and increased paracellular cation flux. We conclude that reversible, MLCK-dependent permeability increases cause mucosal immune activation that, in turn, feeds back on the tight junction to establish long-lasting barrier defects. Interactions between these otherwise distinct tight junction regulatory pathways may contribute to IBD pathogenesis.	[Weber, Christopher R.; Raleigh, David R.; Su, Liping; Shen, Le; Sullivan, Erika A.; Wang, Yingmin; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Turner, JR (corresponding author), 5841 S Maryland,MC 1089, Chicago, IL 60637 USA.	jturner@bsd.uchicago.edu	Turner, Jerrold R/A-6895-2009; wang, yingying/GRS-3058-2022; Turner, Jerrold/H-1502-2019; Shen, Le/E-7866-2010	Turner, Jerrold R/0000-0003-0627-9455; Weber, Christopher/0000-0002-2117-3184	National Institutes of Health [R01DK61931, R01DK68271, P01DK67887, F32DK082134, T32HL007237, T32GM07281]; University of Chicago Cancer Center [P30CA14599]; Crohn's and Colitis Foundation of America, Laura McAteer Hoffman; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068271, P01DK067887, F32DK082134, R56DK094954, R01DK061931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center(University of Chicago); Crohn's and Colitis Foundation of America, Laura McAteer Hoffman; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK61931, R01DK68271, P01DK67887, F32DK082134, T32HL007237, and T32GM07281, University of Chicago Cancer Center Grant P30CA14599, and a research fellowship award from the Crohn's and Colitis Foundation of America sponsored by Laura McAteer Hoffman.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; D'Inca R, 1999, AM J GASTROENTEROL, V94, P2956, DOI 10.1111/j.1572-0241.1999.01444.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Fihn BM, 2000, GASTROENTEROLOGY, V119, P1029, DOI 10.1053/gast.2000.18148; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; MADARA JL, 1988, AM J PHYSIOL, V254, P416; Marano CW, 1998, J MEMBRANE BIOL, V161, P263, DOI 10.1007/s002329900333; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; McGarry LC, 2004, ONCOGENE, V23, P5284, DOI 10.1038/sj.onc.1207687; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Weber CR, 2007, GUT, V56, P6, DOI 10.1136/gut.2006.104182; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	52	193	202	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12037	12046		10.1074/jbc.M109.064808	http://dx.doi.org/10.1074/jbc.M109.064808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177070	Green Published, hybrid			2022-12-27	WOS:000276787100032
J	Kennedy, KAM; Ostrakhovitch, EA; Sandiford, SDE; Dayarathna, T; Xie, XJ; Waese, EYL; Chang, WY; Feng, QP; Skerjanc, IS; Stanford, WL; Li, SSC				Kennedy, Karen A. M.; Ostrakhovitch, Elena A.; Sandiford, Shelley D. E.; Dayarathna, Thamara; Xie, Xiaojun; Waese, Elaine Y. L.; Chang, Wing Y.; Feng, Qingping; Skerjanc, Ilona S.; Stanford, William L.; Li, Shawn S. C.			Mammalian Numb-interacting Protein 1/Dual Oxidase Maturation Factor 1 Directs Neuronal Fate in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; NERVE GROWTH-FACTOR; INTERMEDIATE-FILAMENT PROTEIN; LAMIN-A/C EXPRESSION; NUCLEAR LAMIN; INDUCED DIFFERENTIATION; H2O2-INDUCED APOPTOSIS; TRANSCRIPTION FACTORS; MOUSE EMBRYO; PC12 CELLS	In this study, wedescribe a role for the mammalian Numb-interacting protein 1 (Nip1) in regulation of neuronal differentiation in stem cells. The expression of Nip1 was detected in the developing mouse brain, embryonic stem cells, primary neuronal stem cells, and retinoic acid-treated P19 embryonal carcinoma cells. The highest expression of Nip1 was observed in undifferentiated neuronal stem cells and was associated with Duox1-mediated reactive oxygen species ROS production. Ectopic nip1 expression in P19 embryonal carcinoma cells induced neuronal differentiation, and this phenotype was also linked to elevated ROS production. The neuronal differentiation in nip1-overexpressing P19 cells was achieved in a retinoic acid-independent manner and was corroborated by an increase in the expression of the neuronal basic helixloop-helix transcription factors and neural-lineage cell markers. Furthermore, depletion of nip1 by short hairpin RNA led to a decrease in the expression of neuronal basic helix-loop-helix transcription factors and ROS. However, inhibition of ROS production in nip1-overexpressing P19 cells restricted but did not extinguish neuronal differentiation. Microarray and mass spectrometry analysis identified intermediate filaments as the principal cytoskeletal elements affected by up-regulation of nip1. We show here the first evidence for a functional interaction between Nip1 and a component of the nuclear lamina, lamin A/C. associated with a neuronal-specific phenotype. Taken together, our data reveal an important role for Nip1 in the guidance of neuronal differentiation through ROS generation and modulation of intermediate filaments and implicate Nip1 as a novel intrinsic regulator of neuronal cell fate.	[Skerjanc, Ilona S.; Li, Shawn S. C.] Univ Western Ontario, Schulich Sch Med & Dent, Siebens Drake Med Res Inst, Dept Biochem, London, ON N6A 5C1, Canada; [Feng, Qingping] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Waese, Elaine Y. L.; Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada; [Chang, Wing Y.; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Microbiol, Ottawa, ON K1H 8M5, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Immunol, Ottawa, ON K1H 8M5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; University of Ottawa; University of Ottawa	Li, SSC (corresponding author), UWO, Schulich Sch Med & Dent, SDRI, 1400 Western Rd, London, ON N6A 5C1, Canada.	sli@uwo.ca	Skerjanc, Ilona/AAN-3318-2020	Feng, Qingping/0000-0001-9739-2765; Stanford, William/0000-0002-5813-8016	Canadian Institute of Health Research; Genome Canada through the Ontario Genomic Institute; University of Western Ontario; University of Toronto	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomic Institute(Genome Canada); University of Western Ontario; University of Toronto(University of Toronto)	This work was supported by grants from the Canadian Institute of Health Research (to I. S. S., W. L. S., and S. S. C. L.) and by Genome Canada through the Ontario Genomic Institute (to S. S. C. L.).; Supported by Ontario graduate scholarships, University of Western Ontario.; Supported by Ontario graduate scholarships, University of Toronto.	AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALETTA JM, 1988, J NEUROCHEM, V51, P1317, DOI 10.1111/j.1471-4159.1988.tb03104.x; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; COCHARD P, 1984, J NEUROSCI, V4, P2080; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; DE D, 2002, EXP CELL RES, V273, P187; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Faussone-Pellegrini MS, 1999, ANAT EMBRYOL, V199, P459, DOI 10.1007/s004290050244; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Helfand BT, 2003, J CELL SCI, V116, P2345, DOI 10.1242/jcs.00526; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kamata H, 1996, NEUROSCI LETT, V212, P179, DOI 10.1016/0304-3940(96)12806-8; Katoh S, 1997, BIOCHEM BIOPH RES CO, V241, P347, DOI 10.1006/bbrc.1997.7514; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; LANOIX J, 1992, BIOCHEM BIOPH RES CO, V189, P1639, DOI 10.1016/0006-291X(92)90265-M; Laurent A, 2005, CANCER RES, V65, P948; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LEBEL S, 1987, J CELL BIOL, V105, P1099, DOI 10.1083/jcb.105.3.1099; LIN F, 1993, J BIOL CHEM, V268, P16321; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; MATTIA E, 1992, EXP CELL RES, V203, P449, DOI 10.1016/0014-4827(92)90020-9; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Qin HJ, 2004, J BIOL CHEM, V279, P11304, DOI 10.1074/jbc.M311733200; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; ROBER RA, 1989, DEVELOPMENT, V105, P365; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Takamori Y, 2007, EUR J NEUROSCI, V25, P1653, DOI 10.1111/j.1460-9568.2007.05450.x; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wang S, 1998, NEUROREPORT, V9, P3207, DOI 10.1097/00001756-199810050-00014; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	67	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17974	17985		10.1074/jbc.M109.084616	http://dx.doi.org/10.1074/jbc.M109.084616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20233719	hybrid, Green Published			2022-12-27	WOS:000278133400073
J	Crawford, J; Tonkin, ML; Grujic, O; Boulanger, MJ				Crawford, Joanna; Tonkin, Michelle L.; Grujic, Ognjen; Boulanger, Martin J.			Structural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA VACCINE CANDIDATE; DOMAIN-III; PASSIVE-IMMUNIZATION; ERYTHROCYTE INVASION; MONOCLONAL-ANTIBODY; PROTECTS MICE; PLASMODIUM; HOMOLOG; ENCEPHALITIS; INFECTION	Apical membrane antigen 1 (AMA1) is an essential component of the moving junction complex used by Apicomplexan parasites to invade host cells. We report the 2.0 angstrom resolution x-ray crystal structure of the full ectodomain (domains I, II, and III) of AMA1 from the pervasive protozoan parasite Toxoplasma gondii. The structure of T. gondii AMA1 (TgAMA1) is the most complete of any AMA1 structure to date, with more than 97.5% of the ectodomain unambiguously modeled. Comparative sequence analysis reveals discrete segments of divergence in TgAMA1 that map to areas of established functional importance in AMA1 from Plasmodium vivax (PvAMA1) and Plasmodium falciparum (PfAMA1). Inspection of the TgAMA1 structure reveals a network of apical surface loops, reorganized in both size and chemistry relative to PvAMA1/PfAMA1, that appear to serve as structural filters restricting access to a central hydrophobic groove. The terminal portion of this groove is formed by an extended loop from DII that is 14 residues shorter in TgAMA1. A pair of tryptophan residues (Trp(353) and Trp(354)) anchor the DII loop in the hydrophobic groove and frame a conserved tyrosine (Tyr(230)), forming a contiguous surface that may be critical for moving junction assembly. The minimalist DIII structure folds into a cystine knot that probably stabilizes and orients the bulk of the ectodmain without providing excess surface area to which invasion-inhibitory antibodies can be generated. The detailed structural characterization of TgAMA1 provides valuable insight into the mechanism of host cell invasion by T. gondii.	[Crawford, Joanna; Tonkin, Michelle L.; Grujic, Ognjen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889	Canadian Institutes of Health Research (CIHR) [MOP82915]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP82915 (to M. J. B.).	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Carruthers Vern, 2007, Curr Opin Microbiol, V10, P83, DOI 10.1016/j.mib.2006.06.017; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; DEANS JA, 1984, MOL BIOCHEM PARASIT, V11, P189, DOI 10.1016/0166-6851(84)90065-3; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jones JL, 2003, EMERG INFECT DIS, V9, P1371, DOI 10.3201/eid0911.030098; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; MICHEL R, 1980, INT J PARASITOL, V10, P309, DOI 10.1016/0020-7519(80)90012-0; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	61	38	43	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15644	15652		10.1074/jbc.M109.092619	http://dx.doi.org/10.1074/jbc.M109.092619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304917	hybrid, Green Published			2022-12-27	WOS:000277399000083
J	Jongerius, I; Garcia, BL; Geisbrecht, BV; van Strijp, JAG; Rooijakkers, SHM				Jongerius, Ilse; Garcia, Brandon L.; Geisbrecht, Brian V.; van Strijp, Jos A. G.; Rooijakkers, Suzan H. M.			Convertase Inhibitory Properties of Staphylococcal Extracellular Complement-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY C5 CONVERTASE; IMMUNE EVASION; ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; C3 CONVERTASES; 2 PARTS; AUREUS; IMMUNOLOGY; MOLECULES; PROPERDIN	The human pathogen Staphylococcus aureus secretes several complement evasion molecules to combat the human immune response. Extracellular complement-binding protein (Ecb) binds to the C3d domain of C3 and thereby blocks C3 convertases of the alternative pathway and C5 convertases via all complement pathways. Inhibition of C5 convertases results in complete inhibition of C5a generation and subsequent neutrophil migration. Here, we show that binding of Ecb to the C3d domain of C3b is crucial for inhibition of C5 convertases. Ecb does not interfere with substrate binding to convertases but prevents formation of an active convertase enzyme.	Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Garcia, Brandon L.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Utrecht University; Utrecht University Medical Center; University of Missouri System; University of Missouri Kansas City	Jongerius, I (corresponding author), Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	i.jongerius@umcutrecht.nl	van Strijp, Jos A.G./J-9549-2014	van Strijp, Jos A.G./0000-0001-6253-0830; Jongerius, Ilse/0000-0002-7759-9897	NIAID/National Institutes of Health [AI071028]; Council for Medical Sciences of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council for Medical Sciences of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/National Institutes of Health Grant AI071028 ( to B. V. G.). This work was also supported by the Council for Medical Sciences of the Netherlands Organization for Scientific Research ( S. H. M. R. and J.A. G. v. S.).	BODEN MK, 1992, MICROB PATHOGENESIS, V12, P289, DOI 10.1016/0882-4010(92)90047-R; BODEN MK, 1989, INFECT IMMUN, V57, P2358; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; DAHA MR, 1976, J IMMUNOL, V117, P630; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Janssen BJC, 2007, NATURE, V448, pE1, DOI 10.1038/nature06102; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; KOZONO H, 1990, J BIOL CHEM, V265, P14444; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MEDICUS RG, 1976, SCAND J IMMUNOL, V5, P1049, DOI 10.1111/j.1365-3083.1976.tb03056.x; MEDICUS RG, 1976, P NATL ACAD SCI USA, V73, P612, DOI 10.1073/pnas.73.2.612; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Sandoval A, 2000, J IMMUNOL, V165, P1066, DOI 10.4049/jimmunol.165.2.1066; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	43	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14973	14979		10.1074/jbc.M109.091975	http://dx.doi.org/10.1074/jbc.M109.091975			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304920	hybrid, Green Published			2022-12-27	WOS:000277399000018
J	Liu, C; Liang, B; Wang, QL; Wu, JL; Zou, MH				Liu, Chao; Liang, Bin; Wang, Qilong; Wu, Jiliang; Zou, Ming-Hui			Activation of AMP-activated Protein Kinase alpha 1 Alleviates Endothelial Cell Apoptosis by Increasing the Expression of Anti-apoptotic Proteins Bcl-2 and Survivin (Publication with Expression of Concern. See vol. 294, pg. 10021, 2019) (Withdrawn Publication. See vol. 295, pg. 671, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							NF-KAPPA-B; IKK-BETA SUBUNIT; TRANSCRIPTIONAL ACTIVITY; DEPENDENT MECHANISM; GROWTH-FACTOR; C-SRC; PHOSPHORYLATION; INHIBITION; HYPOXIA; ANGIOGENESIS	Accumulating evidence suggests that AMP-activated protein kinase (AMPK) activation exerts anti-apoptotic effects in multiple types of cells. However, the underlying mechanisms remain poorly defined. The aim of the present study was to determine how AMPK suppresses apoptosis in endothelial cells exposed to hypoxia and glucose deprivation (OGD). AMPK activity, NF-kappa B activation, and endothelial cell apoptosis were assayed in cultured endothelial cells and mouse common carotid artery with or without OGD treatment. OGD markedly activated AMPK as early as 30 min, and AMPK activity reached maximal at 2 h of OGD. Endothelial apoptosis was not detected until 2 h of OGD but became markedly elevated at 6 h of OGD treatment. Furthermore, AMPK inhibition by Compound C or overexpression of dominant negative AMPK(AMPK-DN) exacerbated, whereas AMPK activation by pharmacologic (aminoimidazole carboxamide ribonucleotide (AICAR)) or genetic means (overexpression of constitutively active AMPK) suppressed endothelial cell apoptosis caused by OGD. Concomitantly, AMPK activation increased the expression of both Bcl-2 and Survivin, two potent anti-apoptotic proteins. Furthermore, AMPK activation significantly enhanced I kappa B alpha kinase activation, NF-kappa B nuclear translocation, and DNA binding activity of NF-kappa B. Consistently, selective inhibition of NF-kappa B, which abolished OGD-enhanced expression of Bcl-2 and Survivin, accentuated endothelial apoptosis caused by OGD. Finally, we found that genetic deletion of the AMPK alpha 1, but not AMPK alpha 2, suppressed OGD-enhanced NF-kappa B activation, the expression of Bcl-2 and Survivin, and endothelial apoptosis. Overall, our results suggest that AMPK alpha 1, but not AMPK alpha 2 activation, promotes cell survival by increasing NF-kappa B-mediated expression of anti-apoptotic proteins (Bcl-2 and Survivin) and intracellular ATP contents.	[Liu, Chao; Liang, Bin; Wang, Qilong; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Liu, Chao; Wu, Jiliang] Xianning Coll, Dept Pharmacol, Xianning 437000, Hubei, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, 941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	wang, qilong/O-1962-2013		National Institutes of Health [HL079584, HL080499, HL096032, HL105157]; Juvenile Diabetes Research Foundation; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105157, R01HL096032, R01HL080499, R01HL079584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL096032 and HL105157. This work was also supported by the Juvenile Diabetes Research Foundation and the American Diabetes Association (to M.-H.Z.).	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Ashton SV, 2005, ARTERIOSCL THROM VAS, V25, P102, DOI 10.1161/01.ATV.0000148547.70187.89; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bombeli T, 1999, BLOOD, V93, P3831, DOI 10.1182/blood.V93.11.3831; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Cao C, 2008, CELL SIGNAL, V20, P1830, DOI 10.1016/j.cellsig.2008.06.010; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chavakis E, 2002, ARTERIOSCL THROM VAS, V22, P887, DOI 10.1161/01.ATV.0000017728.55907.A9; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gonzalez AA, 2004, AM J PHYSIOL-REG I, V287, pR1270, DOI 10.1152/ajpregu.00409.2004; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kevil CG, 2001, ACTA PHYSIOL SCAND, V173, P151, DOI 10.1046/j.1365-201X.2001.00901.x; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; Neurath KM, 2006, GLIA, V53, P733, DOI 10.1002/glia.20326; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NybIorn HK, 2008, J MOL ENDOCRINOL, V41, P187, DOI 10.1677/JME-08-0006; Saito M, 2007, J NEUROCHEM, V103, P1208, DOI 10.1111/j.1471-4159.2007.04836.x; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Schwartz BR, 1999, J IMMUNOL, V162, P4842; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Stefanec T, 2000, CHEST, V117, P841, DOI 10.1378/chest.117.3.841; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Winn RK, 2005, J THROMB HAEMOST, V3, P1815, DOI 10.1111/j.1538-7836.2005.01378.x; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	61	71	73	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15346	15355		10.1074/jbc.M110.102491	http://dx.doi.org/10.1074/jbc.M110.102491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20233722	Green Published, hybrid			2022-12-27	WOS:000277399000055
J	Adams, AC; Astapova, I; Fisher, FM; Badman, MK; Kurgansky, KE; Flier, JS; Hollenberg, AN; Maratos-Flier, E				Adams, Andrew C.; Astapova, Inna; Fisher, Ffolliott M.; Badman, Michael K.; Kurgansky, Katherine E.; Flier, Jeffrey S.; Hollenberg, Anthony N.; Maratos-Flier, Eleftheria			Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPAR alpha-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; NONALCOHOLIC FATTY LIVER; METABOLIC STATE; RECEPTOR; AGONIST; RATS; MICE; FIBROBLAST-GROWTH-FACTOR-21; STEATOSIS; INDUCTION	Thyroid hormone has profound and diverse effects on liver metabolism. Here we show that tri-iodothyronine (T3) treatment in mice acutely and specifically induces hepatic expression of the metabolic regulator fibroblast growth factor 21 (FGF21). Mice treated with T3 showed a dose-dependent increase in hepatic FGF21 expression with significant induction at doses as low as 100 mu g/kg. Time course studies determined that induction is seen as early as 4 h after treatment with a further increase in expression at 6 h after injection. As FGF21 expression is downstream of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha), we treated PPAR alpha knock-out mice with T3 and found no increase in expression, indicating that hepatic regulation of FGF21 by T3 in liver is via a PPAR alpha dependent mechanism. In contrast, in white adipose tissue, FGF21 expression was suppressed by T3 treatment, with other T3 targets unaffected. In cell culture studies with an FGF21 reporter construct, we determined that three transcription factors are required for induction of FGF21 expression: thyroid hormone receptor beta (TR beta), retinoid X receptor (RXR), and PPAR alpha. These findings indicate a novel regulatory pathway whereby T3 positively regulates hepatic FGF21 expression, presenting a novel therapeutic target for diseases such as non-alcoholic fatty liver disease.	[Maratos-Flier, Eleftheria] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol,Ctr Life Sci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maratos-Flier, E (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol,Ctr Life Sci, 3 Blackfan Circle, Boston, MA 02215 USA.	emaratos@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019	Kurgansky, Katherine/0000-0001-9357-0034	National Institutes of Health [RO1-DK56123, RO1-DK069983, R37-DK28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, R01DK069983, R37DK028082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK56123 (to A. N. H.), RO1-DK069983 (to E. M.-F.), and R37-DK28082 (to J. S. F.).	Araki O, 2005, P NATL ACAD SCI USA, V102, P16251, DOI 10.1073/pnas.0508556102; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Buroker NE, 2007, AM J PHYSIOL-ENDOC M, V292, pE453, DOI 10.1152/ajpendo.00267.2006; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Freitas FRS, 2005, J BONE MINER RES, V20, P294, DOI 10.1359/JBMR.041116; Grover GJ, 2007, CURR VASC PHARMACOL, V5, P141, DOI 10.2174/157016107780368271; Hollenberg AN, 1996, J BIOL CHEM, V271, P28516, DOI 10.1074/jbc.271.45.28516; HOLNESS MJ, 1987, BIOCHEM J, V247, P621, DOI 10.1042/bj2470621; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Monden T, 2003, THYROID, V13, P427, DOI 10.1089/105072503322021089; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Ribeiro MO, 2010, ENDOCRINOLOGY, V151, P432, DOI 10.1210/en.2009-0667; Silveira MG, 2009, LIVER INT, V29, P1094, DOI 10.1111/j.1478-3231.2009.02003.x; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Villicev CM, 2007, J ENDOCRINOL, V193, P21, DOI 10.1677/joe.1.07066; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	32	101	105	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14078	14082		10.1074/jbc.C110.107375	http://dx.doi.org/10.1074/jbc.C110.107375			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236931	hybrid, Green Published			2022-12-27	WOS:000277299700002
J	Fernandez-Calotti, P; Pastor-Anglada, M				Fernandez-Calotti, Paula; Pastor-Anglada, Marcal			All-trans-retinoic Acid Promotes Trafficking of Human Concentrative Nucleoside Transporter-3 (hCNT3) to the Plasma Membrane by a TGF-beta 1-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; GROWTH-FACTOR-BETA; TGF-BETA; CELLS; DIFFERENTIATION; FLUDARABINE; ACTIVATION; RHO; EXPRESSION	Human concentrative nucleoside transporter-3 (hCNT3) is a sodium-coupled nucleoside transporter that exhibits high affinity and broad substrate selectivity, making it the most suitable candidate for mediating the uptake and cytotoxic action of most nucleoside-derived drugs. The drug of this class most commonly used in the treatment of chronic lymphocytic leukemia (CLL) is the pro-apoptotic nucleoside analog fludarabine (Flu), which enters CLL cells primarily through human equilibrative nucleoside transporters (hENTs). Although CLL cells lack hCNT3 activity, they do express this transporter protein, which is located mostly in the cytosol. The aim of our study was to identify agents and mechanisms capable of promoting hCNT3 trafficking to the plasma membrane. Here, we report that all-trans-retinoic acid (ATRA), currently used in the treatment of acute promyelocytic leukemia (APL), increases hCNT3-related activity through a mechanism that involves trafficking of pre-existing hCNT3 proteins to the plasma membrane. This effect is mediated by the autocrine action of transforming growth factor (TGF)-beta 1, which is transcriptionally activated by ATRA in ap38-dependent manner. TGF-beta 1 acts through activation of ERK1/2 and the small GTPase RhoA to promote plasma membrane trafficking of the hCNT3 protein.	[Pastor-Anglada, Marcal] Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Barcelona, CIBER EHD, E-08028 Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Pastor-Anglada, M (corresponding author), Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, Diagonal 645, E-08028 Barcelona, Spain.	mpastor@ub.edu	Pastor-Anglada, Marçal/C-3730-2017	Pastor-Anglada, Marçal/0000-0003-3712-1773	Ministerio de Ciencia e Innovacion [SAF2008-00577]; Generalitat de Catalunya [2005SGR00315]; Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III); Juan de la Cierva; Ministerio de Educacion y Ciencia, Spain; European Regional Development Fund (ERDF) [BFU2007-30688-E/BFI]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III); Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Regional Development Fund (ERDF)(European Commission)	This work was supported by Grants SAF2008-00577 (Ministerio de Ciencia e Innovacion) and 2005SGR00315 (Generalitat de Catalunya) (to M. P.-A.). This work was also supported by the Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III) and by Juan de la Cierva (to P.F.-C.).; We thank Neus Abella and Maria Calvo from the Confocal Microscopy Facility of Serveis Cientificotecnics (Universitat de Barcelona-IDIBAPS) for support and advice with confocal techniques. This laboratory belongs to the Biomedical Research Institute Network-Liver and Gastrointestinal Diseases (CIBER EHD). CIBER is an initiative of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion). Our group is a member of the Network for Cooperative Research on Membrane Transport Proteins (REIT), co-funded by the Ministerio de Educacion y Ciencia, Spain, and the European Regional Development Fund (ERDF) (Grant BFU2007-30688-E/BFI).	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BONETKERRACHE A, 2005, BIOCHEM J, V15, P261; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Calotti PF, 2008, BIOCHEM PHARMACOL, V75, P857, DOI 10.1016/j.bcp.2007.10.017; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; CHOMIENNE C, 1990, BLOOD, V76, P1710; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; Dai XJ, 2004, J INVEST DERMATOL, V123, P1078, DOI 10.1111/j.0022-202X.2004.23503.x; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Duflot S, 2004, MOL CELL BIOL, V24, P2710, DOI 10.1128/MCB.24.7.2710-2719.2004; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Elter T, 2006, EXPERT OPIN PHARMACO, V7, P1641, DOI 10.1517/14656566.7.12.1641; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Fernandez-Veledo S, 2006, BIOCHEM J, V395, P337, DOI 10.1042/BJ20051232; Flanagan SA, 1997, J BIOL CHEM, V272, P18026, DOI 10.1074/jbc.272.29.18026; Flanagan SA, 2003, CANCER CHEMOTH PHARM, V51, P363, DOI 10.1007/s00280-002-0561-0; Flanagan SA, 2007, LEUKEMIA RES, V31, P955, DOI 10.1016/j.leukres.2006.09.010; Freund A, 1999, ANN ONCOL, V10, P335, DOI 10.1023/A:1008365714942; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gamberale R, 2001, LEUKEMIA, V15, P1860, DOI 10.1038/sj.leu.2402288; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; KREMER JP, 1992, BRIT J HAEMATOL, V80, P480, DOI 10.1111/j.1365-2141.1992.tb04561.x; Lecuona E, 2003, MOL BIOL CELL, V14, P3888, DOI 10.1091/mbc.E02-12-0781; Lewandowski D, 2002, BRIT J HAEMATOL, V118, P535, DOI 10.1046/j.1365-2141.2002.03601.x; Mackey JR, 2005, BLOOD, V105, P767, DOI 10.1182/blood-2004-03-1046; Maeda A, 2002, BIOCHEM BIOPH RES CO, V297, P1231, DOI 10.1016/S0006-291X(02)02342-2; Mercader J, 1996, BIOCHEM J, V317, P835, DOI 10.1042/bj3170835; Molina-Arcas M, 2003, BLOOD, V101, P2328, DOI 10.1182/blood-2002-07-2236; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; Nunes I, 1996, CANCER RES, V56, P495; Pastor-Anglada M, 2001, MOL MEMBR BIOL, V18, P81, DOI 10.1080/096876800110033783; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; REN X, 2007, LIFE SCI, V96, P47; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Tsang RY, 2008, MODERN PATHOL, V21, P1387, DOI 10.1038/modpathol.2008.110; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; Yang LM, 2001, ONCOGENE, V20, P8025, DOI 10.1038/sj.onc.1204911; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2000, METH MOL B, V142, P125; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	50	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13589	13598		10.1074/jbc.M109.055673	http://dx.doi.org/10.1074/jbc.M109.055673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20172853	hybrid, Green Published			2022-12-27	WOS:000276987700032
J	Koon, JC; Kubiseski, TJ				Koon, Janet C.; Kubiseski, Terrance J.			Developmental Arrest of Caenorhabditis elegans BRAP-2 Mutant Exposed to Oxidative Stress Is Dependent on BRC-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; KINASE INHIBITOR; GROWTH ARREST; DNA-REPAIR; C-ELEGANS; PROTEIN; BRCA1; PATHWAY; IDENTIFICATION; NEMATODE	Oxidative damage by reactive oxygen species is believed to be a contributor to the development of cancer and the physiological deterioration associated with aging. In this report, we describe the effect of reactive oxygen species exposure to a developing Caenorhabditis elegans organism containing a deletion in the homolog of BRCA1-associated protein 2 (BRAP-2). A mutant containing a deletion of brap-2 was highly sensitive to oxidizing conditions and demonstrated early larval arrest and lethality at low concentrations of the oxidative stress-inducing drug paraquat compared with the wild-type. This developmental arrest occurred early in the L1 stage and was dependent specifically on the function of the C. elegans ortholog of BRCA-1 tumor suppressor brc-1. We also show that developmental arrest in brap-2 mutants when exposed to oxidative stress was due to enhanced expression levels of the cell cycle inhibitor cki-1, and this increase in the expression levels of cki-1 requires brc-1 in brap-2 mutant animals. Our findings demonstrate that BRAP-2 is necessary for preventing an inappropriate response to elevated levels of reactive oxygen species by countering premature activation of BRC-1 and CKI-1.	[Koon, Janet C.; Kubiseski, Terrance J.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Kubiseski, Terrance J.] York Univ, Dept Neurosci, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Kubiseski, TJ (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	tkubises@yorku.ca		Kubiseski, Terrance/0000-0001-9388-8608	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Adamo A, 2008, EMBO REP, V9, P287, DOI 10.1038/sj.embor.7401167; Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; BRENNER S, 1974, GENETICS, V77, P71; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chen JS, 2009, BIOTECHNOL LETT, V31, P615, DOI 10.1007/s10529-009-9914-7; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fukuyama M, 2003, DEV BIOL, V260, P273, DOI 10.1016/S0012-1606(03)00239-2; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hong Y, 1998, DEVELOPMENT, V125, P3585; Jaya P, 2001, BBA-MOL CELL RES, V1499, P171, DOI 10.1016/S0167-4889(00)00132-4; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Steele RJC, 1998, BRIT J SURG, V85, P1460; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y	27	12	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13437	13443		10.1074/jbc.M110.107011	http://dx.doi.org/10.1074/jbc.M110.107011			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207739	Green Published, hybrid			2022-12-27	WOS:000276987700015
J	Lendrihas, T; Hunter, GA; Ferreira, GC				Lendrihas, Thomas; Hunter, Gregory A.; Ferreira, Gloria C.			Targeting the Active Site Gate to Yield Hyperactive Variants of 5-Aminolevulinate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTODYNAMIC THERAPY; AMINOLEVULINIC-ACID; ESCHERICHIA-COLI; ENZYME; MECHANISM; BINDING; PHOTOSENSITIZER; BIOSYNTHESIS; PERSPECTIVE; LOOP	The rate of porphyrin biosynthesis in mammals is controlled by the activity of the pyridoxal 5'-phosphate-dependent enzyme 5-aminolevulinate synthase (EC 2.3.1.37). Based on the postulate that turnover in this enzyme is controlled by conformational dynamics associated with a highly conserved active site loop, we constructed a variant library by targeting imperfectly conserved noncatalytic loop residues and examined the effects on product and porphyrin production. Functional loop variants of the enzyme were isolated via genetic complementation in Escherichia coli strain HU227. Colony porphyrin fluorescence varied widely when bacterial cells harboring the loop variants were grown on inductive media; this facilitated identification of clones encoding unusually active enzyme variants. Nine loop variants leading to high in vivo porphyrin production were purified and characterized kinetically. Steady state catalytic efficiencies for the two substrates were increased by up to 100-fold. Presteady state single turnover reaction data indicated that the second step of quinonoid intermediate decay, previously assigned as reaction rate-limiting, was specifically accelerated such that in three of the variants this step was no longer kinetically significant. Overall, our data support the postulate that the active site loop controls the rate of product and porphyrin production in vivo and suggest the possibility of an as yet undiscovered means of allosteric regulation.	[Lendrihas, Thomas; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [DK63191, GM080270]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK63191 and GM080270 (to G. C. F.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gagnebin J, 1999, GENE THER, V6, P1742, DOI 10.1038/sj.gt.3300992; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; HUA ZX, 1995, CANCER RES, V55, P1723; Hunter GA, 2005, ARCH BIOCHEM BIOPHYS, V437, P128, DOI 10.1016/j.abb.2005.03.007; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; JORDAN PM, 1991, BIOSYNTHESIS TETRAPY; Kelty CJ, 2002, PHOTOCH PHOTOBIO SCI, V1, P158, DOI 10.1039/b201027p; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; Li JC, 2003, BBA-GENE STRUCT EXPR, V1626, P102, DOI 10.1016/S0167-4781(03)00041-1; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ostermeier M, 2003, TRENDS BIOTECHNOL, V21, P244, DOI 10.1016/S0167-7799(03)00089-1; Raber ML, 2009, J BIOL CHEM, V284, P207, DOI 10.1074/jbc.M805390200; Rozovsky S, 2001, J MOL BIOL, V310, P259, DOI 10.1006/jmbi.2001.4672; Sasaki K, 2002, APPL MICROBIOL BIOT, V58, P23, DOI 10.1007/s00253-001-0858-7; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Zha DX, 2003, CHEMBIOCHEM, V4, P34, DOI 10.1002/cbic.200390011; Ziolkowski Piotr, 2004, J Exp Ther Oncol, V4, P121	35	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13704	13711		10.1074/jbc.M109.074237	http://dx.doi.org/10.1074/jbc.M109.074237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194506	Green Published, hybrid			2022-12-27	WOS:000276987700045
J	Tsika, RW; Ma, LX; Kehat, I; Schramm, C; Simmer, G; Morgan, B; Fine, DM; Hanft, LM; McDonald, KS; Molkentin, JD; Krenz, M; Yang, S; Ji, J				Tsika, Richard W.; Ma, Lixin; Kehat, Izhak; Schramm, Christine; Simmer, Gretchen; Morgan, Brandon; Fine, Deborah M.; Hanft, Laurin M.; McDonald, Kerry S.; Molkentin, Jeffery D.; Krenz, Maike; Yang, Steve; Ji, Juan			TEAD-1 Overexpression in the Mouse Heart Promotes an Age-dependent Heart Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; CREATINE-KINASE ENHANCER; GLYCOGEN-SYNTHASE KINASE-3-BETA; QUANTITATIVE PROTEOMIC IDENTIFICATION; TRANSCRIPTION FACTOR RTEF-1; INDUCED CARDIAC-HYPERTROPHY; RETICULUM CALCIUM-ATPASE; GENE-EXPRESSION; CARDIOMYOCYTE HYPERTROPHY; TRANSGENIC MICE	TEA domain transcription factor-1 (TEAD-1) is essential for proper heart development and is implicated in cardiac specific gene expression and the hypertrophic response of primary cardiomyocytes to hormonal and mechanical stimuli, and its activity increases in the pressure-overloaded hypertrophied rat heart. To investigate whether TEAD-1 is an in vivo modulator of cardiac specific gene expression and hypertrophy, we developed transgenic mice expressing hemagglutinin-tagged TEAD-1 under the control of the muscle creatine kinase promoter. We show that a sustained increase in TEAD-1 protein leads to an age-dependent dysfunction. Magnetic resonance imaging revealed decreases in cardiac output, stroke volume, ejection fraction, and fractional shortening. Isolated TEAD-1 hearts revealed decreased left ventricular power output that correlated with increased beta MyHC protein. Histological analysis showed altered alignment of cardiomyocytes, septal wall thickening, and fibrosis, although electrocardiography displayed a left axis shift of mean electrical axis. Transcripts representing most members of the fetal heart gene program remained elevated from fetal to adult life. Western blot analyses revealed decreases in p-phospholamban, SERCA2a, p-CX43, p-GSK-3 alpha/beta, nuclear beta-catenin, GATA4, NFATc3/c4, and increased NCX1, nuclear DYKR1A, and Pur alpha/beta protein. TEAD-1 mice did not display cardiac hypertrophy. TEAD-1 mice do not tolerate stress as they die over a 4-day period after surgical induction of pressure overload. These data provide the first in vivo evidence that increased TEAD-1 can induce characteristics of cardiac remodeling associated with cardiomyopathy and heart failure.	[Tsika, Richard W.] Univ Missouri, Dept Biochem, Columbia Bond Life Sci Ctr 440D, Sch Med, Columbia, MO 65211 USA; [Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Yang, Steve; Ji, Juan] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Dept Radiol, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Nucl Sci & Engn Inst, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Res Serv, Columbia, MO 65211 USA; [Kehat, Izhak; Molkentin, Jeffery D.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45267 USA; [Fine, Deborah M.] Univ Missouri, Dept Cardiol, Coll Vet Med, Columbia, MO 65211 USA; [Hanft, Laurin M.; McDonald, Kerry S.; Krenz, Maike] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; Cincinnati Children's Hospital Medical Center; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tsika, RW (corresponding author), Univ Missouri, Dept Biochem, Columbia Bond Life Sci Ctr 440D, Sch Med, Columbia, MO 65211 USA.	tsikar@missouri.edu		Ma, Lixin/0000-0003-2171-1226; Krenz, Maike/0000-0003-3784-287X; kehat, izhak/0000-0002-4388-1579; Molkentin, Jeffery/0000-0002-3558-6529; McDonald, Kerry/0000-0002-1588-1782	USPHS, NIAMS [AR41464, AR47197]; National Institutes of Health Clinical Biodetectives Graduate Program [T90DK071510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041464, R01AR047197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071510] Funding Source: NIH RePORTER	USPHS, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)United States Public Health Service); National Institutes of Health Clinical Biodetectives Graduate Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR41464 and AR47197 (to R. W. T.) from USPHS, NIAMS.; Supported in part by National Institutes of Health Clinical Biodetectives Graduate Program Trainee Grant T90DK071510. Present address: Physics Services Inc., Buffalo, NY 14203.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cernohorsky J, 1998, AM J PHYSIOL-HEART C, V275, pH264, DOI 10.1152/ajpheart.1998.275.1.H264; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; FabreSuver C, 1996, J BIOL CHEM, V271, P4646, DOI 10.1074/jbc.271.9.4646; Fine DM, 2006, VET MED-US, V101, P28; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Giordano FJ, 1997, CIRCULATION, V96, P400; Gurtl B, 2009, INT J EXP PATHOL, V90, P338, DOI 10.1111/j.1365-2613.2009.00647.x; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hasegawa K, 1997, CIRCULATION, V96, P3943; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; Heiberg E, 2005, COMPUT CARDIOL, V32, P599; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Kaneko KJ, 2007, GENESIS, V45, P577, DOI 10.1002/dvg.20330; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kawase Y, 2008, NAT CLIN PRACT CARD, V5, P554, DOI 10.1038/ncpcardio1301; Kerkela R, 2007, TRENDS CARDIOVAS MED, V17, P91, DOI 10.1016/j.tcm.2007.01.004; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; LARKIN SB, 1999, HEART DEV, P307; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; LYONS GE, 1994, TRENDS CARDIOVAS MED, V4, P70, DOI 10.1016/1050-1738(94)90012-4; Maeda T, 2002, J BIOL CHEM, V277, P24346, DOI 10.1074/jbc.M201171200; Maeda T, 2002, BIOCHEM BIOPH RES CO, V294, P791, DOI 10.1016/S0006-291X(02)00556-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McLean BG, 2003, J MOL CELL CARDIOL, V35, P461, DOI 10.1016/S0022-2828(03)00049-X; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Neely J R, 1975, Methods Enzymol, V39, P43; Nguyen QGV, 2003, J BIOL CHEM, V278, P46494, DOI 10.1074/jbc.M308194200; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Rajamannan NM, 2006, DRUG DISCOV TODAY, V3, P291; Reed TD, 2000, J MOL CELL CARDIOL, V32, P453, DOI 10.1006/jmcc.1999.1095; ROVETTO MJ, 1980, P SOC EXP BIOL MED, V164, P13; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Soor GS, 2009, J CLIN PATHOL, V62, P226, DOI 10.1136/jcp.2008.061655; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Thuerauf DJ, 1997, J BIOL CHEM, V272, P7464, DOI 10.1074/jbc.272.11.7464; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; VETTER R, 1995, J MOL CELL CARDIOL, V27, P1689, DOI 10.1016/S0022-2828(95)90788-2; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200	99	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13721	13735		10.1074/jbc.M109.063057	http://dx.doi.org/10.1074/jbc.M109.063057			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194497	Green Published, hybrid			2022-12-27	WOS:000276987700047
J	Marchildon, F; St-Louis, C; Akter, R; Roodman, V; Wiper-Bergeron, NL				Marchildon, Francois; St-Louis, Catherine; Akter, Rahima; Roodman, Victoria; Wiper-Bergeron, Nadine L.			Transcription Factor Smad3 Is Required for the Inhibition of Adipogenesis by Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; GROWTH-FACTOR-BETA; C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; TGF-BETA; MAMMARY-GLAND; PREADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; HEPATOCYTE PROLIFERATION; INSULIN SENSITIVITY	The process of adipocyte differentiation is driven by a highly coordinated cascade of transcriptional events that results in the development of the mature adipocyte and in lipid accumulation. One of the early events of differentiation is the up-regulation of CCAAT/enhancer-binding protein beta (C/EBP beta) expression. C/EBP beta then acts to up-regulate the expression of adipogenic factors such as C/EBP alpha, which control the late stage of adipogenesis. Retinoic acid (RA) is a potent inhibitor of adipogenesis, and its action appears to block C/EBP beta transcriptional potential early during differentiation. Using preadipocytes and mesenchymal stem cell models, we show that RA specifically blocks the occupancy of C/EBP beta of the Cebpa promoter, thereby abrogating the differentiation process. RA does not act directly on C/EBP beta but rather stimulates the expression of the transforming growth factor beta-effector protein Smad3, which can interact with C/EBP beta via its Mad homology 1 domain and can interfere with C/EBP beta DNA binding. The RA-induced increase in Smad3 expression results in increased cytoplasmic and nuclear Smad3, an important event as ectopic expression of Smad3 in preadipocytes in the absence of RA treatment only modestly inhibits adipogenesis and C/EBP beta DNA binding, suggesting that Smad3 alone is not sufficient to completely recapitulate the effects of retinoic acid treatment during differentiation. However, in the absence of Smad3, RA is not able to inhibit adipocyte differentiation or to elicit a decrease in C/EBP beta DNA occupancy suggesting that Smad3 is necessary to convey the inhibitory effects of retinoic acid during adipogenesis.	Univ Ottawa, Grad Program Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [St-Louis, Catherine; Akter, Rahima; Wiper-Bergeron, Nadine L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Wiper-Bergeron, NL (corresponding author), 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	nadine.wiperbergeron@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Marchildon, Francois/0000-0002-4846-3149	Heart and Stroke Foundation of Ontario [NA 6375]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Heart and Stroke Foundation of Ontario Grant NA 6375.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BOYD AS, 1989, AM J MED, V86, P568, DOI 10.1016/0002-9343(89)90386-0; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Gery S, 2004, BLOOD, V104, P3911, DOI 10.1182/blood-2003-10-3688; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; KISTLER A, 1986, CARCINOGENESIS, V7, P1175, DOI 10.1093/carcin/7.7.1175; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Ozeki A, 1999, BBA-MOL CELL RES, V1450, P308, DOI 10.1016/S0167-4889(99)00063-4; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; Wang LQ, 2000, J BIOL CHEM, V275, P14173, DOI 10.1074/jbc.M000764200; Wang YA, 2005, DEV DYNAM, V234, P892, DOI 10.1002/dvdy.20570; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	49	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13274	13284		10.1074/jbc.M109.054536	http://dx.doi.org/10.1074/jbc.M109.054536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20179325	Green Published, hybrid			2022-12-27	WOS:000276787800082
J	Salsi, E; Campanini, B; Bettati, S; Raboni, S; Roderick, SL; Cook, PF; Mozzarelli, A				Salsi, Enea; Campanini, Barbara; Bettati, Stefano; Raboni, Samanta; Roderick, Steven L.; Cook, Paul F.; Mozzarelli, Andrea			A Two-step Process Controls the Formation of the Bienzyme Cysteine Synthase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; ALPHA-AMINOACRYLATE INTERMEDIATE; ANION-BINDING SITE; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ACTIVE-SITE; MOLECULAR-BASIS; CONFORMATIONAL-CHANGE; FUNCTIONAL-ANALYSIS	The regulation of enzyme activity through the transient formation of multiprotein assemblies plays an important role in the control of biosynthetic pathways. One of the first regulatory complexes to be discovered was cysteine synthase (CS), formed by the pyridoxal 5'-phosphate-dependent enzyme O-acetylserine sulfhydrylase (OASS) and serine acetyltransferase (SAT). These enzymes are at the branch point of the sulfur, carbon, and nitrogen assimilation pathways. Understanding the mechanism of complex formation helps to clarify the role played by CS in the regulation of sulfur assimilation in bacteria and plants. To this goal, stopped-flow fluorescence spectroscopy was used to characterize the interaction of SAT with OASS, at different temperatures and pH values, and in the presence of the physiological regulators cysteine and bisulfide. Results shed light on the mechanism of complex formation and regulation, so far poorly understood. Cysteine synthase assembly occurs via a two-step mechanism involving rapid formation of an encounter complex between the two enzymes, followed by a slow conformational change. The conformational change likely results from the closure of the active site of OASS upon binding of the SAT C-terminal peptide. Bisulfide, the second substrate and a feedback inhibitor of OASS, stabilizes the CS complex mainly by decreasing the back rate of the isomerization step. Cysteine, the product of the OASS reaction and a SAT inhibitor, slightly affects the kinetics of CS formation leading to destabilization of the complex.	[Mozzarelli, Andrea] Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy; [Bettati, Stefano; Mozzarelli, Andrea] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [Roderick, Steven L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Parma; Yeshiva University; Albert Einstein College of Medicine; University of Oklahoma System; University of Oklahoma - Norman	Campanini, B (corresponding author), V GP Usberti 23-A, I-43100 Parma, Italy.	barbara.campanini@unipr.it; pcook@ou.edu	Bettati, Stefano/V-9975-2018; Campanini, Barbara/L-9723-2017; Mozzarelli, Andrea/C-3615-2014; RABONI, Samanta/P-7823-2018	Bettati, Stefano/0000-0001-6787-0594; Campanini, Barbara/0000-0003-0359-0627; Mozzarelli, Andrea/0000-0003-3762-0062; RABONI, Samanta/0000-0003-3068-3714	Italian Ministry of University and Research [COFIN2007]; International Exchange Program [2005]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); International Exchange Program	This work was supported by the Grayce B. Kerr endowment to the University of Oklahoma (to P. F. C.), by grants from the Italian Ministry of University and Research COFIN2007 (to A. M.), and by the International Exchange Program 2005 (to A. M. and P. F. C.).	BECKER MA, 1969, J BIOL CHEM, V244, P6023; BERNHARD SA, 1988, CELL BIOPHYS, V12, P119, DOI 10.1007/BF02918354; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; COOK PF, 1976, J BIOL CHEM, V251, P2023; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; DeLano W.L, PYMOL MOL GRAPHICS S; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kopriva S, 2002, PLANT PHYSIOL, V130, P1406, DOI 10.1104/pp.007773; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Li S, 2002, J BIOL CHEM, V277, P25992, DOI 10.1074/jbc.M201619200; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Raboni S, 2003, BBA-PROTEINS PROTEOM, V1647, P157, DOI 10.1016/S1570-9639(03)00084-0; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Riek U, 2008, BIOTECHNIQUES, V45, P187, DOI 10.2144/000112830; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Tai CH, 2001, BIOCHEMISTRY-US, V40, P7446, DOI 10.1021/bi015511s; Tai CH, 2008, BBA-PROTEINS PROTEOM, V1784, P629, DOI 10.1016/j.bbapap.2007.12.017; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Wei J, 2002, BIOCHEMISTRY-US, V41, P8493, DOI 10.1021/bi025953j; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Woehl EU, 1996, BIOCHEMISTRY-US, V35, P4776, DOI 10.1021/bi952938o; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	57	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12813	12822		10.1074/jbc.M109.075762	http://dx.doi.org/10.1074/jbc.M109.075762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164178	Green Published, hybrid			2022-12-27	WOS:000276787800039
J	Yang, ZY; Funabashi, M; Nonaka, K; Hosobuchi, M; Shibata, T; Pahari, P; Van Lanen, SG				Yang, Zhaoyong; Funabashi, Masanori; Nonaka, Koichi; Hosobuchi, Masahiko; Shibata, Tomoyuki; Pahari, Pallab; Van Lanen, Steven G.			Functional and Kinetic Analysis of the Phosphotransferase CapP Conferring Selective Self-resistance to Capuramycin Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; BIOSYNTHETIC GENE-CLUSTER; PENTAPEPTIDE TRANSLOCASE; ESCHERICHIA-COLI; AMINOGLYCOSIDIC ANTIBIOTICS; PEPTIDOGLYCAN SYNTHESIS; STREPTOMYCES-CAPREOLUS; INHIBITORS; A-500359S; TUBERCULOSIS	Capuramycin-related compounds, including A-500359s and A-503083s, are nucleoside antibiotics that inhibit the enzyme bacterial translocase I involved in peptidoglycan cell wall biosynthesis. Within the biosynthetic gene cluster for the A-500359s exists a gene encoding a putative aminoglycoside 3-phosphotransferase that was previously demonstrated to be highly expressed during the production of A-500359s and confers selective resistance to capuramycins when expressed in heterologous hosts. A similar gene (capP) was identified within the biosynthetic gene cluster for the A-503083s, and CapP is now shown to similarly confer selective resistance to capuramycins. Recombinant CapP was produced and purified from Escherichia coli, and the function of CapP is established as an ATP-dependent capuramycin phosphotransferase that regio-specifically transfers the gamma-phosphate to the 3 ''-hydroxyl of the unsaturated hexuronic acid moiety of A-503083 B. Kinetic analysis with the three major A-503083 congeners suggests that CapP preferentially phosphorylates A-503083s containing an aminocaprolactam moiety attached to the hexuronic acid, and bi-substrate kinetic analysis was consistent with CapP employing a sequential kinetic mechanism similar to most known aminoglycoside 3-phosphotransferases. The purified CapP product lost its antibiotic activity against Mycobacterium smegmatis, and this loss in bioactivity is primarily due to a 272-fold increase in the IC50 in the bacterial translocase I-catalyzed reaction. The results establish CapP-mediated phosphorylation as a mechanism of resistance to capuramycins and now set the stage to explore this strategy of resistance as a potential mechanism inherent to pathogens and provide the impetus for preparing second generation analogues as a preemptive strike to such resistance strategies.	[Funabashi, Masanori; Nonaka, Koichi; Hosobuchi, Masahiko] Daiichi Sankyo Co Ltd, Bioengn Res Grp 1, Proc Technol Res Labs, Iwaki, Fukushima 9718183, Japan; [Yang, Zhaoyong; Pahari, Pallab; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Shibata, Tomoyuki] Daiichi Sankyo Co Ltd, Exploratory Res Labs, Grp 5, Shinagawa Ku, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; University of Kentucky; Daiichi Sankyo Company Limited	Nonaka, K (corresponding author), Daiichi Sankyo Co Ltd, Bioengn Res Grp 1, Proc Technol Res Labs, 389-4 Aza Ohtsurugi,Izumi Machi, Iwaki, Fukushima 9718183, Japan.	nonaka.koichi.k2@daiichisankyo.co.jp; svanlanen@uky.edu	Pahari, Pallab/AAF-5664-2019; Funabashi, Masanori/GQZ-8735-2022	Pahari, Pallab/0000-0003-3662-2015	Kentucky Science and Education Foundation	Kentucky Science and Education Foundation	This work was supported by the Kentucky Science and Education Foundation (S. G. V. L.).	Barrasa MI, 1997, EUR J BIOCHEM, V245, P54, DOI 10.1111/j.1432-1033.1997.00054.x; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Demain AL, 2009, MED RES REV, V29, P821, DOI 10.1002/med.20154; DISTLER J, 1987, NUCLEIC ACIDS RES, V15, P8041, DOI 10.1093/nar/15.19.8041; DOI O, 1968, APPL MICROBIOL, V16, P1282, DOI 10.1128/AEM.16.9.1282-1284.1968; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FUNABASHI M, 2010, NAT CHEM BI IN PRESS; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; HEYDANEK MG, 1969, BIOCHEMISTRY-US, V8, P1214, DOI 10.1021/bi00831a056; Huang FL, 2005, ORG BIOMOL CHEM, V3, P1410, DOI 10.1039/b501199j; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Lyutzkanova D, 1997, MICROBIOL-SGM, V143, P2135, DOI 10.1099/00221287-143-7-2135; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MENARD R, 1993, ANTIMICROB AGENTS CH, V37, P78, DOI 10.1128/AAC.37.1.78; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P243, DOI 10.7164/antibiotics.56.243; Muramatsu Y, 2003, J ANTIBIOT, V56, P259, DOI 10.7164/antibiotics.56.259; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; NAGANAWA H, 1971, J ANTIBIOT, V24, P823, DOI 10.7164/antibiotics.24.823; Nikonenko BV, 2009, ANTIMICROB AGENTS CH, V53, P3138, DOI 10.1128/AAC.00366-09; PEREZGONZALEZ JA, 1990, GENE, V86, P129, DOI 10.1016/0378-1119(90)90125-B; Reddy VM, 2008, ANTIMICROB AGENTS CH, V52, P719, DOI 10.1128/AAC.01469-07; Saugar I, 2002, EUR J BIOCHEM, V269, P5527, DOI 10.1046/j.1432-1033.2002.03258.x; Segel IH, 1975, ENZYME KINETICS BEHA; SETO H, 1988, TETRAHEDRON LETT, V29, P2343, DOI 10.1016/S0040-4039(00)86055-4; Subba B, 2005, MOL CELLS, V20, P90; TRIEUCUOT P, 1986, J ANTIMICROB CHEMOTH, V18, P93, DOI 10.1093/jac/18.Supplement_C.93; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; UMEZAWA H, 1967, SCIENCE, V157, P1559; Walsh C, 2005, CHEM REV, V105, P391, DOI 10.1021/cr030100y; *WHO INT UN TUB LU, 2007, 4 WHO INT UN TUB LUN; WRIGHT GD, 1999, FRONT BIOSCI, V4, P9; YAMAGUCHI H, 1986, J ANTIBIOT, V39, P1047, DOI 10.7164/antibiotics.39.1047; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	40	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12899	12905		10.1074/jbc.M110.104141	http://dx.doi.org/10.1074/jbc.M110.104141			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20202936	Green Published, hybrid			2022-12-27	WOS:000276787800048
J	Andersen, OS; Boisguerin, P; Glerup, S; Skeldal, S; Volkmer, R; Willnow, TE; Nykjaer, A; Andersen, OM				Andersen, Olga Serup; Boisguerin, Prisca; Glerup, Simon; Skeldal, Sune; Volkmer, Rudolf; Willnow, Thomas E.; Nykjaer, Anders; Andersen, Olav M.			Identification of a Linear Epitope in Sortilin That Partakes in Pro-neurotrophin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; SPOT-SYNTHESIS; HUMAN BRAIN; CELL-DEATH; NEURONAL DEVELOPMENT; RECEPTOR SORTILIN; PEPTIDE ARRAYS	Sortilin acts as a cell surface receptor for pro-neurotrophins (pro-NT) that upon complex formation with the p75 neurotrophin receptor (p75(NTR)) is able to signal neuronal cell death. Here we screened a sortilin peptide library comprising 16-mer overlapping sequences for binding of the pro-domains of nerve growth factor and brain-derived neurotrophic factor. We find that a linear surface-exposed sequence, (163)RIFRSSDFAKNF(174), constitutes an important pro-NT binding epitope in sortilin. Systematic mutational analysis revealed residues Arg(163), Phe(165), Arg(166), and Phe(170) to be critical for the interaction. Expression of a sortilin mutant in which these four amino acids were substituted by alanines disrupted pro-NT binding without affecting receptor heterodimerization with p75(NTR) or binding of ligands that selectively engages the centrally located tunnel in the beta-propeller of sortilin. We furthermore demonstrate that a peptide comprising the ligand-binding epitope can prevent pro-NT-induced apoptosis in RN22 schwannoma cells.	[Glerup, Simon; Skeldal, Sune; Nykjaer, Anders; Andersen, Olav M.] Univ Aarhus, Dept Med Biochem, Membrane Receptors Neuronal Dis Ctr, DK-8000 Aarhus C, Denmark; [Andersen, Olga Serup] Univ Aarhus, Dept Mol Biol, Membrane Receptors Neuronal Dis Ctr, DK-8000 Aarhus C, Denmark; [Boisguerin, Prisca; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Willnow, Thomas E.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Aarhus University; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Andersen, OM (corresponding author), Univ Aarhus, Dept Med Biochem, Membrane Receptors Neuronal Dis Ctr, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	o.andersen@biokemi.au.dk	Boisguerin, Prisca/AAG-6565-2020; Andersen, Olav/N-2777-2017	Boisguerin, Prisca/0000-0002-6955-1340; Nykjaer, Anders/0000-0001-6422-6736; Volkmer, Rudolf/0000-0003-4710-1143; Willnow, Thomas/0000-0001-9515-7921; Andersen, Olav/0000-0003-4226-3354	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council and the Lundbeck Foundation.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fan YJ, 2008, EUR J NEUROSCI, V27, P2380, DOI 10.1111/j.1460-9568.2008.06215.x; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Frank R, 1996, Methods Mol Biol, V66, P149; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kaplan DR, 2004, NATURE, V427, P798, DOI 10.1038/427798a; Kichev A, 2009, AM J PATHOL, V175, P2574, DOI 10.2353/ajpath.2009.090018; KIM JS, 1993, PROTEIN SCI, V2, P348; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Podlesniy P, 2006, AM J PATHOL, V169, P119, DOI 10.2353/ajpath.2006.050787; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Scharn D, 2000, J COMB CHEM, V2, P361, DOI 10.1021/cc000012g; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wei Y, 2007, NEUROSCI LETT, V429, P169, DOI 10.1016/j.neulet.2007.10.012; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	72	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12210	12222		10.1074/jbc.M109.062364	http://dx.doi.org/10.1074/jbc.M109.062364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159974	Green Published, hybrid			2022-12-27	WOS:000276787100050
J	Burger, K; Muhl, B; Harasim, T; Rohrmoser, M; Malamoussi, A; Orban, M; Kellner, M; Gruber-Eber, A; Kremmer, E; Holzel, M; Eick, D				Burger, Kaspar; Muehl, Bastian; Harasim, Thomas; Rohrmoser, Michaela; Malamoussi, Anastassia; Orban, Mathias; Kellner, Markus; Gruber-Eber, Anita; Kremmer, Elisabeth; Hoelzel, Michael; Eick, Dirk			Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNA; 5-FLUOROURACIL TOXICITY; P53; TRANSCRIPTION; DISRUPTION; URACIL; YEAST; PSEUDOURIDYLATION; ACCUMULATION; DEPLETION	Drugs for cancer therapy belong to different categories of chemical substances. The cellular targets for the therapeutic efficacy are often not unambiguously identified. Here, we describe the process of ribosome biogenesis as a target of a large variety of chemotherapeutic drugs. We determined the inhibitory concentration of 36 chemotherapeutic drugs for transcription and processing of ribosomal RNA by in vivo labeling experiments. Inhibitory drug concentrations were correlated to the loss of nucleolar integrity. The synergism of drugs inhibiting ribosomal RNA synthesis at different levels was studied. Drugs inhibited ribosomal RNA synthesis either at the level of (i) rRNA transcription (e. g. oxaliplatin, doxorubicin, mitoxantrone, methotrexate), (ii) early rRNA processing (e. g. camptothecin, flavopiridol, roscovitine), or (iii) late rRNA processing (e. g. 5-fluorouracil, MG-132, homoharringtonine). Blockage of rRNA transcription or early rRNA processing steps caused nucleolar disintegration, whereas blockage of late rRNA processing steps left the nucleolus intact. Flavopiridol and 5-fluorouracil showed a strong synergism for inhibition of rRNA processing. We conclude that inhibition of ribosome biogenesis by chemotherapeutic drugs potentially may contribute to the efficacy of therapeutic regimens.	[Orban, Mathias; Kellner, Markus; Gruber-Eber, Anita; Hoelzel, Michael; Eick, Dirk] CIPSM, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eick, D (corresponding author), Marchioninistr 25, D-81377 Munich, Germany.	eick@helmholtz-muenchen.de	Orban, Mathias/AAS-8461-2020	Orban, Mathias/0000-0001-7846-8808	Deutsche Forschungsgemeinschaft [SFB684, SFB-Transregio]; Fonds der Chemischen Industrie; German Jose Carreras Leukemia Foundation (DJCLS) [F09/03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Jose Carreras Leukemia Foundation (DJCLS)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB684 and SFB-Transregio 5), Fonds der Chemischen Industrie, and German Jose Carreras Leukemia Foundation (DJCLS, Project F09/03).	Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Byrd JC, 2007, BLOOD, V109, P399, DOI 10.1182/blood-2006-05-020735; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dornfeld K, 2005, NUCLEIC ACIDS RES, V33, P6644, DOI 10.1093/nar/gki975; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; GHOSHAL K, 1994, CANCER RES, V54, P632; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Hoskins J, 2008, GENETICS, V179, P323, DOI 10.1534/genetics.107.082727; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; LENZ HJ, 1994, J BIOL CHEM, V269, P31962; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Soos TJ, 2006, DRUG NEWS PERSPECT, V19, P325, DOI 10.1358/dnp.2006.19.6.985939; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	37	276	284	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12416	12425		10.1074/jbc.M109.074211	http://dx.doi.org/10.1074/jbc.M109.074211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159984	Green Published, hybrid			2022-12-27	WOS:000276787100069
J	Majerciak, V; Kruhlak, M; Dagur, PK; Mccoy, JP; Zheng, ZM				Majerciak, Vladimir; Kruhlak, Michael; Dagur, Pradeep K.; Mccoy, J. Philip, Jr.; Zheng, Zhi-Ming			Caspase-7 Cleavage of Kaposi Sarcoma-associated Herpesvirus ORF57 Confers a Cellular Function against Viral Lytic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFUSION LYMPHOMA-CELLS; DNA-SEQUENCES; INDUCED APOPTOSIS; PROTEIN; VIRUS; HUMAN-HERPESVIRUS-8; PHOSPHORYLATION; ACTIVATION; PREDICTION; PATHWAYS	Kaposi sarcoma-associated herpesvirus (KSHV) ORF57 is a viral early protein essential for KSHV multiplication. We found that B cells derived from cavity-based B cell lymphoma with lytic KSHV infection display activation of caspase-8 and cleavage of ORF57 in the cytoplasm by caspase-7 at the aspartate residue at position 33 from the N terminus. Caspase-7 cleavage of ORF57 is prevented by pan-caspase inhibitor z-VAD, caspase-3 and caspase-7 inhibitor z-DEVD, and caspase-7 small interfering RNAs. The caspase-7 cleavage site (DETD33)-D-30 in ORF57 is not cleavable by caspase-3, although both enzymes use DEXD as a common cleavage site. B cells with lytic KSHV infection and caspase-7 activation exhibited a greatly reduced level of ORF57. A majority of the cells expressing active caspase-7 appeared to have no detectable ORF57 and vice versa. Upon cleavage with caspase-7, ORF57 was deficient in promoting the expression of viral lytic genes. Inhibiting caspase-7 cleavage of ORF57 in KSHV+ BCBL-1 cells by z-VAD, z-DEVD, or caspase-7 small interfering RNA led to increased expression of viral lytic genes and production of cell-free virus particles. Collectively, our data provide the first compelling evidence that caspase cleavage of ORF57 may represent a cellular function against lytic KSHV infection.	[Majerciak, Vladimir; Zheng, Zhi-Ming] NCI, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA; [Kruhlak, Michael] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Dagur, Pradeep K.; Mccoy, J. Philip, Jr.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zheng, ZM (corresponding author), 10 Ctr Dr,Rm 6N106, Bethesda, MD 20892 USA.	zhengt@mail.nih.gov	Zheng, Zhi-Ming/L-6383-2019; mccoy, john philip/ABD-9348-2021	Zheng, Zhi-Ming/0000-0001-5547-7912; 	National Cancer Institute, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010915, ZIASC010357] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Han Z, 2006, J VIROL, V80, P5251, DOI 10.1128/JVI.02570-05; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Huang HS, 2008, J BIOL CHEM, V283, P18135, DOI 10.1074/jbc.M709735200; Janicke RU, 2006, SCIENCE, V312, P1874; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Klass CM, 2005, BLOOD, V105, P4028, DOI 10.1182/blood-2004-09-3569; Kulms D, 2002, BIOCHEM PHARMACOL, V64, P837, DOI 10.1016/S0006-2952(02)01146-2; Kuribayashi K, 2006, CANCER BIOL THER, V5, P763, DOI 10.4161/cbt.5.7.3228; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Majerciak V, 2008, J VIROL, V82, P2792, DOI 10.1128/JVI.01856-07; Majerciak V, 2007, J VIROL, V81, P1062, DOI 10.1128/JVI.01558-06; Majerciak V, 2006, J VIROL, V80, P11968, DOI 10.1128/JVI.01394-06; Majerciak V, 2006, J BIOL CHEM, V281, P28365, DOI 10.1074/jbc.M603095200; Majerciak V, 2009, FRONT BIOSCI-LANDMRK, V14, P1516, DOI 10.2741/3322; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Medina-Palazon C, 2007, J VIROL, V81, P11850, DOI 10.1128/JVI.01421-07; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Schweigreiter R, 2007, PROTEOMICS, V7, P4457, DOI 10.1002/pmic.200700499; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wang HW, 2002, EMBO J, V21, P2602, DOI 10.1093/emboj/21.11.2602; Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005; Young JE, 2007, J BIOL CHEM, V282, P30150, DOI 10.1074/jbc.M705265200; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003	50	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11297	11307		10.1074/jbc.M109.068221	http://dx.doi.org/10.1074/jbc.M109.068221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159985	hybrid, Green Published			2022-12-27	WOS:000276286200036
J	Bystrom, R; Andersen, PM; Grobner, G; Oliveberg, M				Bystrom, Roberth; Andersen, Peter M.; Grobner, Gerhard; Oliveberg, Mikael			SOD1 Mutations Targeting Surface Hydrogen Bonds Promote Amyotrophic Lateral Sclerosis without Reducing Apo-state Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; DISULFIDE REDUCTION; TRANSGENIC MICE; MUTANT SOD1; GENE; ALS; FORM; CU	In good accord with the protein aggregation hypothesis for neurodegenerative diseases, ALS-associated SOD1 mutations are found to reduce structural stability or net repulsive charge. Moreover there are weak indications that the ALS disease progression rate is correlated with the degree of mutational impact on the apoSOD1 structure. A bottleneck for obtaining more conclusive information about these structure-disease relationships, however, is the large intrinsic variability in patient survival times and insufficient disease statistics for the majority of ALS- provoking mutations. As an alternative test of the structure- disease relationship we focus here on the SOD1 mutations that appear to be outliers in the data set. The results identify several ALS- provoking mutations whose only effect on apoSOD1 is the elimination or introduction of a single charge, i.e. D76V/Y, D101N, and N139D/K. The thermodynamic stability and folding behavior of these mutants are indistinguishable from the wild-type control. Moreover, D101N is an outlier in the plot of stability loss versus patient survival time by having rapid disease progression. Commonto the identified mutations is that they truncate conserved salt-links and/or H-bond networks in the functional loops IV or VII. The results show that the local impact of ALS- associated mutations on the SOD1 molecule can sometimes overrun their global effects on apo-state stability and net repulsive charge, and point at the analysis of property outliers as an efficient strategy for mapping out new ALS- provoking features.	[Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Bystrom, Roberth; Grobner, Gerhard] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Andersen, Peter M.] Umea Univ, Dept Clin Neurosci, S-90187 Umea, Sweden	Stockholm University; Umea University; Umea University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se			Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation, and Hjarnfonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation, and Hjarnfonden	This work was supported in part by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden.	*ALS, 2009, ALS ONL DAT; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; JONES CT, 1994, MOL CELL PROBE, V8, P329, DOI 10.1006/mcpr.1994.1046; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Nogales-Gadea G, 2004, J NEUROL SCI, V219, P1, DOI 10.1016/j.jns.2003.10.018; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orrell RW, 1997, NEUROLOGY, V48, P746, DOI 10.1212/WNL.48.3.746; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1993, ACTA HISTOCHEM CYTOC, V26, P619, DOI 10.1267/ahc.26.619; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; 2009, HOMOLOGENE	54	63	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19544	19552		10.1074/jbc.M109.086074	http://dx.doi.org/10.1074/jbc.M109.086074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20189984	Green Published, hybrid			2022-12-27	WOS:000278727800064
J	Smithson, DC; Lee, J; Shelat, AA; Phillips, MA; Guy, RK				Smithson, David C.; Lee, Jeongmi; Shelat, Anang A.; Phillips, Margaret A.; Guy, R. Kiplin			Discovery of Potent and Selective Inhibitors of Trypanosoma brucei Ornithine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE BIOSYNTHESIS; SUBSTRATE-BINDING; TRIAL; ENZYME; FORMS; GENE; EFLORNITHINE; SPECIFICITY	Human African trypanosomiasis, caused by the eukaryotic parasite Trypanosoma brucei, is a serious health problem in much of central Africa. The only validated molecular target for treatment of human African trypanosomiasis is ornithine decarboxylase (ODC), which catalyzes the first step in polyamine metabolism. Here, we describe the use of an enzymatic high throughput screen of 316,114 unique molecules to identify potent and selective inhibitors of ODC. This screen identified four novel families of ODC inhibitors, including the first inhibitors selective for the parasitic enzyme. These compounds display unique binding modes, suggesting the presence of allosteric regulatory sites on the enzyme. Docking of a subset of these inhibitors, coupled with mutagenesis, also supports the existence of these allosteric sites.	St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Smithson, David C.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Lee, Jeongmi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	St Jude Children's Research Hospital; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Guy, RK (corresponding author), 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA.	kip.guy@stjude.org	Lee, Jeongmi/AAJ-7720-2020; Guy, Rodney/J-7107-2013; Shelat, Anang/J-4995-2013	Lee, Jeongmi/0000-0002-9948-7554; Guy, Rodney/0000-0002-9638-2060; Shelat, Anang/0000-0002-6266-2910	National Institutes of Health [R01 AI34432]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI34432 (to M. A. P.). This work was also supported by the American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital, and Welch Foundation Grant I-1257 (to M. A. P.).	ABDELMONEM MM, 1974, J MED CHEM, V17, P447, DOI 10.1021/jm00250a016; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Athri P, 2006, BIOORGAN MED CHEM, V14, P3144, DOI 10.1016/j.bmc.2005.12.029; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; BEY P, 1987, INHIBITION POLYAMINE, P32; BITONTI AJ, 1982, BIOCHEM J, V208, P435, DOI 10.1042/bj2080435; BITONTI AJ, 1986, BIOCHEM J, V237, P685, DOI 10.1042/bj2370685; Carbone PP, 2000, CLIN CANCER RES, V6, P3850; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; HENLEY CM, 1988, BIOCHEM PHARMACOL, V37, P1679, DOI 10.1016/0006-2952(88)90427-3; HOAGLIN DC, 1983, UNDERSTANDING ROBUST, P57; ITEN M, 1995, TROP MED PARASITOL, V46, P190; IWAMI K, 1990, AM J PHYSIOL, V258, pG308, DOI 10.1152/ajpgi.1990.258.2.G308; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lemoff A, 2008, J COMB CHEM, V10, P746, DOI 10.1021/cc800100g; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Mathis AM, 2006, ANTIMICROB AGENTS CH, V50, P2185, DOI 10.1128/AAC.00192-06; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; ROSE FL, 1956, J CHEM SOC, P4422, DOI 10.1039/jr9560004422; ROUSSEEUW P, 2006, ROBUSTBASE BASIC ROB; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; SEGEL IH, 1975, ENZYME KINETICS BEHA, P249; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; SMITHSON DC, 2010, ASSAY DRUG IN PRESS; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Steglich C, 2006, INFECT GENET EVOL, V6, P205, DOI 10.1016/j.meegid.2005.05.004; TEAM RDC, 2007, R LANGUAGE ENV STAT; Thyssen SM, 2002, NEUROSCI LETT, V323, P65, DOI 10.1016/S0304-3940(02)00097-6; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; World Health Organization, 2006, AFR TRYP SLEEP SICKN; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Yan B, 2007, ANAL CHEM, V79, P718, DOI 10.1021/ac061682x; Yip KW, 2006, MOL CANCER THER, V5, P2234, DOI 10.1158/1535-7163.MCT-06-0134; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	63	31	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16771	16781		10.1074/jbc.M109.081588	http://dx.doi.org/10.1074/jbc.M109.081588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20220141	hybrid, Green Published			2022-12-27	WOS:000277982600040
J	Gencic, S; Duin, EC; Grahame, DA				Gencic, Simonida; Duin, Evert C.; Grahame, David A.			Tight Coupling of Partial Reactions in the Acetyl-CoA Decarbonylase/Synthase (ACDS) Multienzyme Complex from Methanosarcina thermophila ACETYL C-C BOND FRAGMENTATION AT THE A CLUSTER PROMOTED BY PROTEIN CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; SYNTHASE ACTIVE-SITE; COENZYME-A; CLOSTRIDIUM-THERMOACETICUM; ENZYME COMPLEX; SUBUNIT-BETA; MOORELLA-THERMOACETICA; ALPHA-SUBUNIT; MECHANISM; CLEAVAGE	Direct synthesis and cleavage of acetyl-CoA are carried out by the bifunctional CO dehydrogenase/acetyl-CoA synthase enzyme in anaerobic bacteria and by the acetyl-CoA decarbonylase/synthase (ACDS) multienzyme complex in Archaea. In both systems, a nickel- and Fe/S-containing active site metal center, the A cluster, catalyzes acetyl C-C bond formation/breakdown. Carbonyl group exchange of [1-C-14]acetyl-CoA with unlabeled CO, a hallmark of CODH/ACS, is weakly active in ACDS, and exchange with CO2 was up to 350 times faster, indicating tight coupling of CO release at the A cluster to CO oxidation to CO2 at the C cluster in CO dehydrogenase. The basis for tight coupling was investigated by analysis of three recombinant A cluster proteins, ACDS beta subunit from Methanosarcina thermophila, acetyl-CoA synthase of Carboxydothermus hydrogenoformans (ACS(Ch)), and truncated ACS(Ch) lacking its 317-amino acid N-terminal domain. A comparison of acetyl-CoA synthesis kinetics, CO exchange, acetyltransferase, and A cluster Ni+-CO EPR characteristics demonstrated a direct role of the ACS N-terminal domain in promoting acetyl C-C bond fragmentation. Protein conformational changes, related to "open/closed" states previously identified crystallographically, were indicated to have direct effects on the coordination geometry and stability of the A cluster Ni2+-acetyl intermediate, controlling Ni2+-acetyl fragmentation and Ni2+ (CO)(CH3) condensation. EPR spectral changes likely reflect variations in the Ni+-CO equatorial coordination environment in closed buried hydrophobic and open solvent-exposed states. The involvement of subunit-subunit interactions in ACDS, versus interdomain contacts in ACS, ensures that CO is not released from the ACDS beta subunit in the absence of appropriate interactions with the alpha(2)epsilon(2) CO dehydrogenase component. The resultant high efficiency CO transfer explains the low rate of CO exchange relative to CO2.	[Gencic, Simonida; Grahame, David A.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Duin, Evert C.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Uniformed Services University of the Health Sciences - USA; Auburn University System; Auburn University	Grahame, DA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	dgrahame@usuhs.mil			National Science Foundation [MCB-0923766, CHE-0848196]; United States Department of Energy [DE-FG02-00ER15108]	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB-0923766, United States Department of Energy Grant DE-FG02-00ER15108 (to D. A. G.), and by National Science Foundation Grant CHE-0848196 (to E. C. D.).	Amara P, 2005, J AM CHEM SOC, V127, P2776, DOI 10.1021/ja0439221; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhaskar B, 1998, BIOCHEMISTRY-US, V37, P14491, DOI 10.1021/bi9812423; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; DAS A, 2000, ENCY MICROBIOLOGY, V1, P18; DEAN JA, 1992, LANGES HDB CHEM, P51; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016; Eckert NA, 2007, J AM CHEM SOC, V129, P9286, DOI 10.1021/ja072063o; Ferry James G., 1993, P304; FISCHER R, 1990, ARCH MICROBIOL, V153, P156, DOI 10.1007/BF00247814; Funk T, 2004, J AM CHEM SOC, V126, P88, DOI 10.1021/ja0366033; Gencic S, 2003, J BIOL CHEM, V278, P6101, DOI 10.1074/jbc.M210484200; Gencic S, 2008, BIOCHEMISTRY-US, V47, P5544, DOI 10.1021/bi7024035; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Gong W, 2008, P NATL ACAD SCI USA, V105, P9558, DOI 10.1073/pnas.0800415105; Graham DE, 2000, P NATL ACAD SCI USA, V97, P3304, DOI 10.1073/pnas.050564797; Grahame DA, 2005, ARCH MICROBIOL, V184, P32, DOI 10.1007/s00203-005-0006-3; GRAHAME DA, 1995, BIOCHEMISTRY-US, V34, P4617, DOI 10.1021/bi00014a015; Grahame DA, 1996, BIOCHEMISTRY-US, V35, P593, DOI 10.1021/bi9511494; Grahame DA, 1996, J BIOL CHEM, V271, P8352, DOI 10.1074/jbc.271.14.8352; GRAHAME DA, 1991, J BIOL CHEM, V266, P22227; Gu WW, 2003, J AM CHEM SOC, V125, P15343, DOI 10.1021/ja036602a; Ito M, 2009, P NATL ACAD SCI USA, V106, P11862, DOI 10.1073/pnas.0900433106; Kocsis E, 1999, J STRUCT BIOL, V128, P165, DOI 10.1006/jsbi.1999.4163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Loke HK, 2002, J AM CHEM SOC, V124, P8667, DOI 10.1021/ja025924w; Maynard EL, 2001, BIOCHEMISTRY-US, V40, P13262, DOI 10.1021/bi015604+; Maynard EL, 2001, J AM CHEM SOC, V123, P4697, DOI 10.1021/ja004017t; Murakami E, 2000, J BIOL CHEM, V275, P4699, DOI 10.1074/jbc.275.7.4699; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Peters D G, 1974, CHEM SEPARATIONS MEA, P19; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; RAGSDALE SW, 1982, BIOCHEM BIOPH RES CO, V108, P658, DOI 10.1016/0006-291X(82)90880-4; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1983, BIOCHEM BIOPH RES CO, V115, P658, DOI 10.1016/S0006-291X(83)80195-8; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAYBUCK SA, 1991, J BACTERIOL, V173, P929, DOI 10.1128/jb.173.2.929-932.1991; Segel I, 1975, ENZYME KINETICS; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Seravalli J, 2008, J BIOL CHEM, V283, P8384, DOI 10.1074/jbc.M709470200; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Tan XS, 2008, J BIOL INORG CHEM, V13, P771, DOI 10.1007/s00775-008-0363-x; Tan XS, 2005, J AM CHEM SOC, V127, P5833, DOI 10.1021/ja043701v; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; TERLESKY KC, 1986, J BACTERIOL, V168, P1053, DOI 10.1128/jb.168.3.1053-1058.1986; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Volbeda A, 2004, J BIOL INORG CHEM, V9, P525, DOI 10.1007/s00775-004-0565-9; Volbeda A, 2009, BIOCHEMISTRY-US, V48, P7916, DOI 10.1021/bi9003952; Webster CE, 2004, J AM CHEM SOC, V126, P3410, DOI 10.1021/ja038083h; XIA JQ, 1995, BIOCHEMISTRY-US, V34, P6037, DOI 10.1021/bi00018a005; Xia JQ, 1996, J AM CHEM SOC, V118, P483, DOI 10.1021/ja952845u; ZOU XA, 1995, INORG CHEM, V34, P1634, DOI 10.1021/ic00111a003	58	25	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15450	15463		10.1074/jbc.M109.080994	http://dx.doi.org/10.1074/jbc.M109.080994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202935	Green Published, hybrid			2022-12-27	WOS:000277399000065
J	Horn, D; Zhou, W; Trevisson, E; Al-Ali, H; Harris, TK; Salviati, L; Barrientos, A				Horn, Darryl; Zhou, Wen; Trevisson, Eva; Al-Ali, Hassan; Harris, Thomas K.; Salviati, Leonardo; Barrientos, Antoni			The Conserved Mitochondrial Twin Cx(9)C Protein Cmc2 Is a Cmc1 Homologue Essential for Cytochrome c Oxidase Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; COPPER CHAPERONE; INTERMEMBRANE SPACE; MEMBRANE SYSTEM; ASSEMBLY FACTOR; YEAST; SCO1; COX17; METALLOCHAPERONE	Mitochondrial copper metabolism and delivery to cytochrome c oxidase and mitochondrially localized CuZn-superoxide dismutase (Sod1) requires a growing number of intermembrane space proteins containing a twin Cx(9)C motif. Among them, Cmc1 was recently identified by our group. Here we describe another conserved mitochondrial metallochaperone-like protein, Cmc2, a close homologue of Cmc1, whose function affects both cytochrome c oxidase and Sod1. In the yeast Saccharomyces cerevisiae, Cmc2 localizes to the mitochondrial inner membrane facing the intermembrane space. In the absence of Cmc2, cytochrome c oxidase activity measured spectrophotometrically and cellular respiration measured polarographically are undetectable. Additionally, mutant cmc2 cells display 2-fold increased mitochondrial Sod1 activity, whereas CMC2 overexpression results in Sod1 activity decreased to 60% of wild-type levels. CMC1 overexpression does not rescue the respiratory defect of cmc2 mutants or vice versa. However, Cmc2 physically interacts with Cmc1 and the absence of Cmc2 induces a 5-fold increase in Cmc1 accumulation in the mitochondrial membranes. Cmc2 function is conserved from yeast to humans. Human CMC2 localizes to the mitochondria and CMC2 expression knockdown produces cytochrome c oxidase deficiency in Caenorhabditis elegans. We conclude that Cmc1 and Cmc2 have cooperative but nonoverlapping functions in cytochrome c oxidase biogenesis.	[Horn, Darryl; Zhou, Wen; Al-Ali, Hassan; Harris, Thomas K.; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Trevisson, Eva; Salviati, Leonardo] Univ Padua, Dipartimento Pediat, Lab Oncoematol Pediat, I-35128 Padua, Italy	University of Miami; University of Miami; University of Padua	Barrientos, A (corresponding author), 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu	Salviati, Leonardo/L-1007-2016; Trevisson, Eva/K-8462-2016; Zhou, Wen/A-5763-2010	Salviati, Leonardo/0000-0001-5642-9963; Trevisson, Eva/0000-0002-5380-6265; Zhou, Wen/0000-0002-5496-5815; Al-Ali, Hassan/0000-0002-8899-3443	National Institutes of Health [GM071775A]; Muscular Dystrophy Association [GM071775A]; Muscular Dystrophy Association; Italian Telethon [GGP06256]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Italian Telethon(Fondazione Telethon); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071775A(to A. B.), a Research Grant from the Muscular Dystrophy Association (to A. B.), Italian Telethon Grant GGP06256 (to L. S.), and an American Heart Association Predoctoral Fellowship (to D. H.).	Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Beers J, 2002, J BIOL CHEM, V277, P22185, DOI 10.1074/jbc.M202545200; Carr HS, 2005, J BIOL CHEM, V280, P22664, DOI 10.1074/jbc.M414077200; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Grad Leslie I, 2007, Methods Mol Biol, V372, P51, DOI 10.1007/978-1-59745-365-3_4; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Horn D, 2008, IUBMB LIFE, V60, P421, DOI 10.1002/iub.50; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SOLANS A, 2004, PRECLINICA, V2, P336; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Wood WB, 1988, NEMATODE CAENORHABDI; Xie GF, 1995, GENET ANAL-BIOMOL E, V12, P95, DOI 10.1016/1050-3862(95)00112-3	55	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15088	15099		10.1074/jbc.M110.104786	http://dx.doi.org/10.1074/jbc.M110.104786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220131	Green Published, hybrid			2022-12-27	WOS:000277399000030
J	Tamoi, M; Tabuchi, T; Demuratani, M; Otori, K; Tanabe, N; Maruta, T; Shigeoka, S				Tamoi, Masahiro; Tabuchi, Tomoki; Demuratani, Masayo; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru			Point Mutation of a Plastidic Invertase Inhibits Development of the Photosynthetic Apparatus and Enhances Nitrate Assimilation in Sugar-treated Arabidopsis Seedlings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IMMUNOLOGICAL-PROPERTIES; GLUTAMINE-SYNTHETASE; NITROGEN-METABOLISM; SUCROSE METABOLISM; ALKALINE INVERTASE; PLANTS; GLUCOSE; HEXOKINASE; CHLOROPLASTS	Because the photosynthetic apparatus contains a massive amount of nitrogen in plants, the regulation of its development by sugar signals is important to the maintenance of the carbon-nitrogen balance. In this study we isolated an Arabidopsis mutant (sicy-192) whose cotyledon greening was inhibited by treatments with sugars such as sucrose, glucose, and fructose. In the mutant, the gene encoding plastidic alkaline/neutral invertase (INV-E) was point-mutated at codon 294, with Tyr substituted for Cys (C294Y). Interestingly, the greening of cotyledons in the knock-out INV-E lines was not inhibited by treatment with the sugars. In addition, the knock-out INV-E lines expressing an INV-E:C294Y or INV-E:C294A gene had the same phenotype as sicy-192 mutants, whereas the lines expressing a wildtype INV-E gene had the same phenotype as wild-type plants. A recombinant INV-E:C294Y protein had the same enzymatic activity as a recombinant INV-E protein, suggesting that the Cys-294 residue of INV-E is important for its functions in the chloroplasts. On treatment with sucrose, the expression of photosynthesis-related genes was weaker in seedlings of mutant plants than wild-type seedlings, whereas the activity of nitrate reductase was stronger in the mutant plants than wild-type plants. These findings suggest that Cys-294 of INV-E is associated with the development of the photosynthetic apparatus and the assimilation of nitrogen in Arabidopsis seedlings to control the ratio of sucrose content to hexose content.	[Tamoi, Masahiro; Tabuchi, Tomoki; Demuratani, Masayo; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Tamoi, Masahiro; Tabuchi, Tomoki; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kindai University (Kinki University); Japan Science & Technology Agency (JST)	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Tamoi, Masahiro/AAJ-1054-2021	Maruta, Takanori/0000-0003-4144-7821	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Core Research for Evolutional Science and Technology Project of the Japan Science and Technology Agency (Grant 2005-2010; to S. S.).	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Aki T, 2007, J EXP BOT, V58, P3239, DOI 10.1093/jxb/erm169; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam A, 2007, ANAL BIOCHEM, V362, P151, DOI 10.1016/j.ab.2006.12.033; CASTLE LA, 1994, PLANT CELL, V6, P25, DOI 10.1105/tpc.6.1.25; CHEN JQ, 1992, ARCH BIOCHEM BIOPHYS, V295, P61, DOI 10.1016/0003-9861(92)90488-I; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Damari-Weissler H, 2006, PLANTA, V224, P1495, DOI 10.1007/s00425-006-0387-9; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Evans J.R., 1989, PHOTOSYNTHESIS, P183; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gerrits N, 2001, PLANT PHYSIOL, V125, P926, DOI 10.1104/pp.125.2.926; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Giese JO, 2005, FEBS LETT, V579, P827, DOI 10.1016/j.febslet.2004.12.071; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Lee HS, 1996, PLANT PHYSIOL, V112, P1513, DOI 10.1104/pp.112.4.1513; Lejay L, 2003, PLANT CELL, V15, P2218, DOI 10.1105/tpc.013516; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Nemeth K, 1998, GENE DEV, V12, P3059, DOI 10.1101/gad.12.19.3059; Ogawa T, 2009, PLANT J, V57, P289, DOI 10.1111/j.1365-313X.2008.03686.x; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; Rognoni S, 2007, PLANT GROWTH REGUL, V52, P217, DOI 10.1007/s10725-007-9193-z; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Tamoi M, 2006, PLANT CELL PHYSIOL, V47, P380, DOI 10.1093/pcp/pcj004; Tamoi M, 2005, BIOSCI BIOTECH BIOCH, V69, P848, DOI 10.1271/bbb.69.848; Vargas WA, 2008, PLANTA, V227, P795, DOI 10.1007/s00425-007-0657-1; VINCENTZ M, 1993, PLANT J, V3, P315, DOI 10.1046/j.1365-313X.1993.t01-16-00999.x; WALLSGROVE RM, 1983, PLANT CELL ENVIRON, V6, P301; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang P, 2007, SCIENCE, V316, P700, DOI 10.1126/science.1142703	54	27	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15399	15407		10.1074/jbc.M109.055111	http://dx.doi.org/10.1074/jbc.M109.055111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304912	hybrid, Green Published			2022-12-27	WOS:000277399000060
J	Czirjak, G; Enyedi, P				Czirjak, Gabor; Enyedi, Peter			TRESK Background K+ Channel Is Inhibited by Phosphorylation via Two Distinct Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN POTASSIUM CHANNEL; ROOT GANGLION NEURONS; FUNCTIONAL EXPRESSION; ANESTHETIC PROPERTIES; 14-3-3 PROTEINS; CALCINEURIN; TASK-3; MODULATION; ACTIVATION; TRANSPORT	The two-pore domain K+ channel, TRESK (TWIK-related spinal cord K+ channel, KCNK18) is directly regulated by the calcium/calmodulin-dependent phosphatase calcineurin and 14-3-3 adaptor proteins. The calcium signal robustly activates the channel via calcineurin, whereas the anchoring of 14-3-3 interferes with the return of the current to the resting state after the activation in Xenopus oocytes. In the present study, we report that the phosphorylation of TRESK at two distinct regulatory regions, the 14-3-3 binding site (Ser-264) and the cluster of three adjacent serine residues (Ser-274, Ser-276, and Ser-279), are responsible for channel inhibition. The phosphorylation of Ser-264 by protein kinase A accelerated the return of the current of S276E mutant TRESK to the resting state after the calcineurin-dependent activation. In the presence of 14-3-3, the basal current of the S276E mutant was reduced, and its calcineurin-dependent activation was augmented, suggesting that the direct binding of the adaptor protein to TRESK contributed to the basal inhibition of the channel under resting conditions. Unexpectedly, we found that 14-3-3 impeded the recovery of the current of S264E mutant TRESK to the resting state after the calcineurin-dependent activation, despite of the mutated 14-3-3 binding site. This suggests that 14-3-3 inhibited the kinase phosphorylating the regulatory cluster of Ser-274, Ser-276, and Ser-279, independently of the direct interaction between TRESK and 14-3-3. In conclusion, two distinct inhibitory kinase pathways converge on TRESK, and their effect on the calcineurin-dependent regulation is differentially modulated by the functional availability of 14-3-3.	[Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, POB 259, Budapest, Hungary.	enyedi@eok.sote.hu		Czirjak, Gabor/0000-0002-5485-2327	OTKA [F-67743, K75239]; Hungarian Academy of Sciences	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Research Fund OTKA F-67743 (to G. C.) and OTKA K75239 (to P. E.).; Supported by the Janos Bolyai fellowship of the Hungarian Academy of Sciences.	Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Brosnan R, 2006, ANESTH ANALG, V103, P86, DOI 10.1213/01.ane.0000221437.87338.af; Brosnan RJ, 2007, ANESTH ANALG, V104, P1430, DOI 10.1213/01.ane.0000264072.97705.0f; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Egenberger B, 2010, BIOCHEM BIOPH RES CO, V391, P1262, DOI 10.1016/j.bbrc.2009.12.056; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Han J, 2009, BIOCHEM BIOPH RES CO, V390, P1102, DOI 10.1016/j.bbrc.2009.10.076; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Pottosin II, 2008, PFLUG ARCH EUR J PHY, V456, P1037, DOI 10.1007/s00424-008-0481-x; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Valencia-Cruz G, 2009, AM J PHYSIOL-CELL PH, V297, pC1544, DOI 10.1152/ajpcell.00064.2009; Yang L, 2007, ANESTH ANALG, V105, P673, DOI 10.1213/01.ane.0000278127.68312.dc; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062	38	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14549	14557		10.1074/jbc.M110.102020	http://dx.doi.org/10.1074/jbc.M110.102020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215114	Green Published, hybrid			2022-12-27	WOS:000277299700051
J	Gurtner, A; Starace, G; Norelli, G; Piaggio, G; Sacchi, A; Bossi, G				Gurtner, Aymone; Starace, Giuseppe; Norelli, Giuseppe; Piaggio, Giulia; Sacchi, Ada; Bossi, Gianluca			Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; GENE-EXPRESSION; P53 GAIN; TUMOR MALIGNANCY; RNA INTERFERENCE; PATIENT SURVIVAL; TERMINAL DOMAIN; HUMAN CANCER; MUTATIONS; CELLS	Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show that MAP2K3 modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-kappa B. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.	[Bossi, Gianluca] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, I-00158 Rome, Italy; [Starace, Giuseppe] Ist Neurobiol & Med Mol, Natl Res Council, I-00133 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Bossi, G (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Via Messi dOro 156, I-00158 Rome, Italy.	bossi@ifo.it	Bossi, Gianluca/B-9394-2017; Gurtner, Aymone/J-7217-2018; gurtner, aymone/AAB-8843-2020; Bossi, Gianluca/G-8375-2016; Piaggio, Giulia/J-7214-2018; Bossi, Gianluca/ABH-6846-2020; Piaggio, Giulia/AAD-7336-2022	Bossi, Gianluca/0000-0002-2947-1063; Gurtner, Aymone/0000-0002-7661-9059; gurtner, aymone/0000-0002-7661-9059; Bossi, Gianluca/0000-0002-2947-1063; Piaggio, Giulia/0000-0003-2114-1892; Bossi, Gianluca/0000-0002-2947-1063; 	Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA [IG 8804, IG 5408]; Ministero della Salute; Istituto Superiore di Sanita (ISS); Alleanza Contro il Cancro (ACC) [ICS-120.4/RA00-90, R.F.02/184]; community's sixth framework program	Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Istituto Superiore di Sanita (ISS); Alleanza Contro il Cancro (ACC); community's sixth framework program(European Commission)	This work was supported by Grant IG 8804 (to G. B.) and IG 5408 (to G. P.) from the Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA project, Ministero della Salute, Istituto Superiore di Sanita (ISS), and Alleanza Contro il Cancro (ACC) (ICS-120.4/RA00-90 and R.F.02/184 to G. P.). This study is part of the mutant p53 project, which has received research funding from the community's sixth framework program.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LIN JY, 1995, ONCOGENE, V10, P2387; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Notterman DA, 2001, CANCER RES, V61, P3124; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; OREN M, 2003, CELL DEATH DIFFER, V10, P413; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724	40	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14160	14169		10.1074/jbc.M109.094813	http://dx.doi.org/10.1074/jbc.M109.094813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223820	hybrid, Green Published			2022-12-27	WOS:000277299700012
J	Romero, G; Sneddon, WB; Yang, YM; Wheeler, D; Blair, HC; Friedman, PA				Romero, Guillermo; Sneddon, W. Bruce; Yang, Yanmei; Wheeler, David; Blair, Harry C.; Friedman, Peter A.			Parathyroid Hormone Receptor Directly Interacts with Dishevelled to Regulate beta-Catenin Signaling and Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; FRIZZLED-RELATED PROTEIN-1; BONE-FORMATION; PDZ DOMAIN; KINASE-A; WNT; PHOSPHORYLATION; PATHWAY; ACTIVATION; CELLS	Bone growth and remodeling depend upon the opposing rates of bone formation and resorption. These functions are regulated by intrinsic seven transmembrane-spanning receptors, the parathyroid hormone receptor (PTH1R) and frizzled (FZD), through their respective ligands, parathyroid hormone (PTH) and Wnt. FZD activation of canonical beta-catenin signaling requires the adapter protein Dishevelled (Dvl). We identified a Dvl-binding motif in the PTH1R. Here, we report that the PTH1R activates the beta-catenin pathway by directly recruiting Dvl, independent of Wnt or LRP5/6. PTH1R coimmunoprecipitated with Dvl. Deleting the carboxyl-terminal PTH1R PDZ-recognition domain did not abrogate PTH1R-Dvl interactions; nor did truncating the receptor at position 480. However, further deletion eliminating the putative Dvl recognition domain abolished PTH1R interactions with Dvl. PTH activated beta-catenin in a time-and concentration-dependent manner and translocated beta-catenin to the nucleus. beta-Catenin activation was inhibited by Dvl2 dominant negatives and by short hairpin RNA sequences targeted against Dvl2. PTH-induced osteoclastogenesis was also inhibited by Dvl2 dominant negative mutants. These findings demonstrate that G protein-coupled receptors other than FZD directly activate beta-catenin signaling, thereby mimicking many of the functions of the canonical Wnt-FZD pathway. The distinct modes whereby FZD and PTH1R activate beta-catenin control convergent or divergent effects on osteoblast differentiation, and osteoclastogenesis may arise from PTH1R-induced second messenger phosphorylation.	[Romero, Guillermo; Sneddon, W. Bruce; Yang, Yanmei; Wheeler, David; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, Pittsburgh, PA 15261 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu			National Institutes of Health [DK54171, GM08208]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54171 (to P. A. F.) and GM08208 (to D. W.).	Barnes MR, 1998, TRENDS PHARMACOL SCI, V19, P399, DOI 10.1016/S0165-6147(98)01246-2; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2007, J CELL PHYSIOL, V210, P352, DOI 10.1002/jcp.20834; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Malbon CC, 2004, FRONT BIOSCI-LANDMRK, V9, P1048, DOI 10.2741/1308; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	52	66	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14756	14763		10.1074/jbc.M110.102970	http://dx.doi.org/10.1074/jbc.M110.102970			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212039	Green Published, hybrid			2022-12-27	WOS:000277299700073
J	Selvanathan, SP; Thakurta, AG; Dhakshnamoorthy, J; Zhou, M; Veenstra, TD; Dhar, R				Selvanathan, Saravana P.; Thakurta, Anjan G.; Dhakshnamoorthy, Jothy; Zhou, Ming; Veenstra, Timothy D.; Dhar, Ravi			Schizosaccharomyces pombe Dss1p Is a DNA Damage Checkpoint Protein That Recruits Rad24p, Cdc25p, and Rae1p to DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; POLY(A)(+) RNA; RAD51 HOMOLOG; CELL-CYCLE; COMPLEX; GENE; REPLICATION	Schizosaccharomyces pombe Dss1p and its homologs function in multiple cellular processes including recombinational repair of DNA and nuclear export of messenger RNA. We found that Tap-tagged Rad24p, a member of the 14-3-3 class of proteins, co-purified Dss1p along with mitotic activator Cdc25p, messenger RNA export/cell cycle factor Rae1p, 19 S proteasomal factors, and recombination protein Rhp51p (a Rad51p homolog). Using chromatin immunoprecipitation, we found that Dss1p recruited Rad24p and Rae1p to the double-strand break (DSB) sites. Furthermore, Cdc25p also recruited to the DSB site, and its recruitment was dependent on Dss1p, Rad24p, and the protein kinase Chk1p. Following DSB, all nuclear Cdc25p was found to be chromatin-associated. We found that Dss1p and Rae1p have a DNA damage checkpoint function, and upon treatment with UV light Delta dss1 cells entered mitosis prematurely with indistinguishable timing from Delta rad24 cells. Taken together, these results suggest that Dss1p plays a critical role in linking repair and checkpoint factors to damaged DNA sites by specifically recruiting Rad24p and Cdc25p to the DSBs. We suggest that the sequestration of Cdc25p to DNA damage sites could provide a mechanism for S. pombe cells to arrest at G(2)/M boundary in response to DNA damage.	[Selvanathan, Saravana P.; Thakurta, Anjan G.; Dhakshnamoorthy, Jothy; Dhar, Ravi] NCI, Basic Res Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, Sci Applicat Int Corp Frederick Inc,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Dhar, R (corresponding author), NCI, Basic Res Lab, Ctr Canc Res, NIH, Bldg 37,Rm 5016,37 Convent Dr,9000 Rockville Pike, Bethesda, MD 20892 USA.	dharr@mail.nih.gov			National Institutes of Health NCI; NATIONAL CANCER INSTITUTE [ZIABC005643] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI intramural program.	Alfa C., 1993, EXPT FISSION YEAST; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARBET NC, 1993, NATURE, V364, P824, DOI 10.1038/364824a0; Berry L D, 1996, Prog Cell Cycle Res, V2, P99; Bharathi A, 1997, GENE, V198, P251, DOI 10.1016/S0378-1119(97)00322-3; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Bruckmann A, 2004, BIOCHEM J, V382, P867, DOI 10.1042/BJ20031885; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chua G, 2002, GENETICS, V162, P689; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Gudmundsdottir K, 2004, EMBO REP, V5, P989, DOI 10.1038/sj.embor.7400255; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jang YK, 1996, MOL GEN GENET, V251, P167; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Josse L, 2006, BIOCHEM J, V393, P303, DOI 10.1042/BJ20051238; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lopez-Girona A, 2001, CURR BIOL, V11, P50, DOI 10.1016/S0960-9822(00)00026-9; Lygerou Z, 1999, J CELL SCI, V112, P3703; Mannen T, 2008, BIOCHEM BIOPH RES CO, V365, P664, DOI 10.1016/j.bbrc.2007.11.024; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Perez-Hidalgo L, 2008, CELL CYCLE, V7, P3720, DOI 10.4161/cc.7.23.7177; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rhind N, 2001, MOL CELL BIOL, V21, P1499, DOI 10.1128/MCB.21.5.1499-1508.2001; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Simkus C, 2009, IMMUNOLOGY, V128, P206, DOI 10.1111/j.1365-2567.2009.03101.x; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Thakurta AG, 2007, J BIOL CHEM, V282, P17507, DOI 10.1074/jbc.M609727200; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Whalen WA, 1997, YEAST, V13, P1167, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1167::AID-YEA154>3.3.CO;2-F; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000; Zhou QW, 2007, MOL CELL BIOL, V27, P2512, DOI 10.1128/MCB.01907-06	51	6	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14122	14133		10.1074/jbc.M109.083485	http://dx.doi.org/10.1074/jbc.M109.083485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231270	hybrid, Green Published			2022-12-27	WOS:000277299700008
J	Zhang, YF; Smith, AD; Renfrow, MB; Schneider, DA				Zhang, Yinfeng; Smith, Archer D.; Renfrow, Matthew B.; Schneider, David A.			The RNA Polymerase-associated Factor 1 Complex (Paf1C) Directly Increases the Elongation Rate of RNA Polymerase I and Is Required for Efficient Regulation of rRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; ROLES; PHOSPHORYLATION; METHYLATION; EXPRESSION; PROTEINS; COMPASS; GROWTH	The rate of ribosome synthesis is proportional to the rate of cell proliferation; thus, transcription of rRNA by RNA polymerase I (Pol I) is an important target for the regulation of this process. Most previous investigations into mechanisms that regulate the rate of ribosome synthesis have focused on the initiation step of transcription by Pol I; however, recent studies in yeast and mammals have identified factors that influence transcription elongation by Pol I. The RNA polymerase-associated factor 1 complex (Paf1C) is a transcription elongation factor with known roles in Pol II transcription. We previously identified a role for Paf1C in transcription elongation by Pol I. In this study, genetic interactions between genes for Paf1C and Pol I subunits confirm this conclusion. In vitro studies demonstrate that purified Paf1C directly increases the rate of transcription elongation by Pol I. Finally, we show that Paf1C function is required for efficient control of Pol I transcription in response to target of rapamycin (TOR) signaling or amino acid limitation. These studies demonstrate that Paf1C plays an important direct role in cellular control of rRNA expression.	[Zhang, Yinfeng; Smith, Archer D.; Renfrow, Matthew B.; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, 442 Kaul Human Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091; Renfrow, Matthew B./0000-0002-4193-7305	NCI, National Institutes of Health [CA-13148-31]; American Cancer Society [IRG-60-001-47]; Health Services Foundation-General Endowment Fund;  [GM084946]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Health Services Foundation-General Endowment Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-13148-31 from NCI and Grant GM084946 (to D. A. S.). This work was also supported by American Cancer Society Grant IRG-60-001-47 and by University of Alabama at Birmingham institutional start-up funding from the Health Services Foundation-General Endowment Fund.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2005, EUKARYOT CELL, V4, P209, DOI 10.1128/EC.4.1.209-220.2005; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Tongaonkar P, 2005, P NATL ACAD SCI USA, V102, P10129, DOI 10.1073/pnas.0504563102; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	40	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14152	14159		10.1074/jbc.M110.115220	http://dx.doi.org/10.1074/jbc.M110.115220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20299458	hybrid, Green Published			2022-12-27	WOS:000277299700011
J	Zielonka, J; Sikora, A; Joseph, J; Kalyanaraman, B				Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman			Peroxynitrite Is the Major Species Formed from Different Flux Ratios of Co-generated Nitric Oxide and Superoxide DIRECT REACTION WITH BORONATE-BASED FLUORESCENT PROBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE NITRATION; XANTHINE-OXIDASE; PULSE-RADIOLYSIS; BIOLOGICAL-ACTIVITY; ENDOTHELIAL-CELLS; RELAXING FACTOR; CHEMISTRY; NO; MECHANISM; OXIDATION	There is much interest in the nitration and oxidation reaction mechanisms initiated by superoxide radical anion (O(2)radical anion) and nitric oxide ((NO)-N-center dot). It is well known that O(2)radical anion and (NO)-N-center dot rapidly react to form a potent oxidant, peroxynitrite anion (ONOO-). However, indirect measurements with the existing probes (e.g. dihydrorhodamine) previously revealed a bell-shaped response to co-generated (NO)-N-center dot and O(2)radical anion fluxes, with the maximal yield of the oxidation or nitration product occurring at a 1:1 ratio. These results raised doubts on the formation of ONOO- per se at various fluxes of (NO)-N-center dot and O(2)radical anion. Using a novel fluorogenic probe, coumarin-7-boronic acid, that reacts stoichiometrically and rapidly with ONOO- (k = 1.1 x 10(6) M(-1)s(-1)), we report that ONOO- formation increased linearly and began to plateau after reaching a 1:1 ratio of co-generated (NO)-N-center dot and O(2)radical anion fluxes. We conclude that ONOO- is formed as the primary intermediate during the reaction between (NO)-N-center dot and O(2)radical anion co-generated at different fluxes.	[Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Sikora, Adam] Tech Univ Lodz, Inst Appl Radiat Chem, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014	Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945	National Institutes of Health [HL063119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL063119 (to B. K.).	Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Du LP, 2008, TETRAHEDRON LETT, V49, P3045, DOI 10.1016/j.tetlet.2008.03.063; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; Goldstein S, 1999, CHEM RES TOXICOL, V12, P132, DOI 10.1021/tx9802522; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gunther MR, 2002, TOXICOLOGY, V177, P1, DOI 10.1016/S0300-483X(02)00191-9; Hodges GR, 2000, CHEM RES TOXICOL, V13, P1287, DOI 10.1021/tx0001272; Houston M, 1998, ARCH BIOCHEM BIOPHYS, V355, P1, DOI 10.1006/abbi.1998.0675; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Ianni JC, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1368; Ichimori K, 1999, J BIOL CHEM, V274, P7763, DOI 10.1074/jbc.274.12.7763; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Jourd'heuil D, 2001, J BIOL CHEM, V276, P28799, DOI 10.1074/jbc.M102341200; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kissner R, 1999, METHOD ENZYMOL, V301, P342; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOBAYASHI K, 1995, J CHEM SOC DALTON, P2885, DOI 10.1039/dt9950002885; Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Liochev SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P166, DOI 10.1016/S0003-9861(02)00074-7; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Miles AM, 1996, J BIOL CHEM, V271, P40, DOI 10.1074/jbc.271.1.40; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; PACHER P, 2007, PHYSIOL REV, V315, P424; Palazzolo-Ballance AM, 2007, BIOCHEMISTRY-US, V46, P7536, DOI 10.1021/bi700123s; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; ZIELONKA J, 2009, FREE RADIC BIOL MED, V47, pS40	46	167	171	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14210	14216		10.1074/jbc.M110.110080	http://dx.doi.org/10.1074/jbc.M110.110080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194496	hybrid, Green Published			2022-12-27	WOS:000277299700017
J	Clark, JH; Kinnear, NP; Kalujnaia, S; Cramb, G; Fleischer, S; Jeyakumar, LH; Wuytack, F; Evans, AM				Clark, Jill H.; Kinnear, Nicholas P.; Kalujnaia, Svetlana; Cramb, Gordon; Fleischer, Sidney; Jeyakumar, Loice H.; Wuytack, Frank; Evans, A. Mark			Identification of Functionally Segregated Sarcoplasmic Reticulum Calcium Stores in Pulmonary Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; DISTINCT CA2+ STORES; CA2+-ATPASE SERCA; CYCLOPIAZONIC ACID; MOLECULAR-CLONING; CA-2+ ATPASE; TRIGGER ZONE; RYANODINE; EXPRESSION; ISOFORMS	In pulmonary arterial smooth muscle, Ca2+ release from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyRs) may induce constriction and dilation in a manner that is not mutually exclusive. We show here that the targeting of different sarcoplasmic/endoplasmic reticulum Ca2+-ATPases (SERCA) and RyR subtypes to discrete SR regions explains this paradox. Western blots identified protein bands for SERCA2a and SERCA2b, whereas immunofluorescence labeling of isolated pulmonary arterial smooth muscle cells revealed striking differences in the spatial distribution of SERCA2a and SERCA2b and RyR1, RyR2, and RyR3, respectively. Almost all SERCA2a and RyR3 labeling was restricted to a region within 1.5 mu m of the nucleus. In marked contrast, SERCA2b labeling was primarily found within 1.5 mu m of the plasma membrane, where labeling for RyR1 was maximal. The majority of labeling for RyR2 lay in between these two regions of the cell. Application of the vasoconstrictor endothelin-1 induced global Ca2+ waves in pulmonary arterial smooth muscle cells, which were markedly attenuated upon depletion of SR Ca2+ stores by preincubation of cells with the SERCA inhibitor thapsigargin but remained unaffected after preincubation of cells with a second SERCA antagonist, cyclopiazonic acid. We conclude that functionally segregated SR Ca2+ stores exist within pulmonary arterial smooth muscle cells. One sits proximal to the plasma membrane, receives Ca2+ via SERCA2b, and likely releases Ca2+ via RyR1 to mediate vasodilation. The other is located centrally, receives Ca2+ via SERCA2a, and likely releases Ca2+ via RyR3 and RyR2 to initiate vasoconstriction.	[Clark, Jill H.; Kinnear, Nicholas P.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Kalujnaia, Svetlana; Cramb, Gordon] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Fleischer, Sidney] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Fleischer, Sidney] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37235 USA; [Jeyakumar, Loice H.] Vanderbilt Univ, Sch Med, Dept Med Gastroenterol, Nashville, TN 37235 USA; [Wuytack, Frank] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Transport ATPases Ca2, B-3000 Louvain, Belgium	University of Edinburgh; University of St Andrews; Vanderbilt University; Vanderbilt University; Vanderbilt University; KU Leuven	Evans, AM (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk			British Heart Foundation [PG/03/065, PG/05/128]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0646.08]; NERC [NE/F001401/1] Funding Source: UKRI; Natural Environment Research Council [NE/F001401/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by British Heart Foundation Project Grants PG/03/065 and PG/05/128 and by Grant G.0646.08 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen ( to F. W.).	Bobe R, 2004, J BIOL CHEM, V279, P24297, DOI 10.1074/jbc.M314286200; BOBE R, 1994, J BIOL CHEM, V269, P1417; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Dipp M, 2001, CIRC RES, V89, P77, DOI 10.1161/hh1301.093616; Dipp M, 2001, AM J PHYSIOL-LUNG C, V281, pL318, DOI 10.1152/ajplung.2001.281.2.L318; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; EGGERMONT JA, 1990, BIOCHEM J, V271, P649, DOI 10.1042/bj2710649; Ethier MF, 2001, AM J PHYSIOL-LUNG C, V281, pL126, DOI 10.1152/ajplung.2001.281.1.L126; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Fleischer S, 2008, BIOCHEM BIOPH RES CO, V369, P195, DOI 10.1016/j.bbrc.2007.12.119; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Hauser K, 2007, BIOPHYS J, V93, P3259, DOI 10.1529/biophysj.107.109363; HERRMANNFRANK A, 1991, PFLUG ARCH EUR J PHY, V418, P353, DOI 10.1007/BF00550873; IINO M, 1988, BIOCHEM BIOPH RES CO, V152, P417, DOI 10.1016/S0006-291X(88)80730-7; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Janiak R, 2001, AM J PHYSIOL-CELL PH, V280, pC22, DOI 10.1152/ajpcell.2001.280.1.C22; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Jeyakumar LH, 2002, J MUSCLE RES CELL M, V23, P285, DOI 10.1023/A:1022091931677; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; Kargacin GJ, 2005, PFLUG ARCH EUR J PHY, V449, P356, DOI 10.1007/s00424-004-1345-7; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; KORCZAK B, 1988, J BIOL CHEM, V263, P4813; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; LYTTON J, 1988, J BIOL CHEM, V263, P15024; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Nazer MA, 1998, CELL CALCIUM, V24, P275, DOI 10.1016/S0143-4160(98)90051-3; Nazer MA, 1998, AM J PHYSIOL-HEART C, V274, pH123, DOI 10.1152/ajpheart.1998.274.1.H123; NEYLON CB, 1995, BIOCHEM BIOPH RES CO, V215, P814, DOI 10.1006/bbrc.1995.2536; Odermatt A, 1996, J BIOL CHEM, V271, P14206, DOI 10.1074/jbc.271.24.14206; Poch E, 1998, AM J PHYSIOL-CELL PH, V275, pC1449, DOI 10.1152/ajpcell.1998.275.6.C1449; RAEYMAEKERS L, 1990, CELL CALCIUM, V11, P261, DOI 10.1016/0143-4160(90)90002-C; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; VANBREEMEN C, 1995, TRENDS PHARMACOL SCI, V16, P98, DOI 10.1016/S0165-6147(00)88990-7; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; WUYTACK F, 1989, BIOCHEM J, V264, P765, DOI 10.1042/bj2640765; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; YAMAGUCHI H, 1995, AM J PHYSIOL-CELL PH, V268, pC771, DOI 10.1152/ajpcell.1995.268.3.C771; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005	52	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13542	13549		10.1074/jbc.M110.101485	http://dx.doi.org/10.1074/jbc.M110.101485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177054	Green Published, hybrid			2022-12-27	WOS:000276987700027
J	Feinberg, H; Powlesland, AS; Taylor, ME; Weis, WI				Feinberg, Hadar; Powlesland, Alex S.; Taylor, Maureen E.; Weis, William I.			Trimeric Structure of Langerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; RECEPTORS DC-SIGN; BIRBECK GRANULE; BINDING; CELLS; RECOGNITION	Langerin, an endocytic receptor of Langerhans cells, binds pathogens such as human immunodeficiency virus by recognition of surface glycoconjugates and mediates their internalization into Birbeck granules. Langerin has an extracellular region consisting of a C-type carbohydrate-recognition domain (CRD) and a neck region that stabilizes formation of trimers. As in many other C-type lectins, oligomerization is required for high affinity binding to glycan ligands and is also likely to be important for determining specificity. To facilitate structural analysis of the human langerin trimer, a truncated form of the extracellular region, consisting of part of the neck and the CRD, has been characterized. Like the full-length protein, truncated langerin exists as a stable trimer in solution. Glycan array screening with the trimeric fragment shows that high mannose oligosaccharides are the best ligands for langerin. Structural analysis of the trimeric fragment of langerin confirms that the neck region forms a coiled-coil of alpha-helices. Multiple interactions between the neck region and the CRDs make the trimer a rigid unit with the three CRDs in fixed positions and the primary sugar-binding sites separated by a distance of 42 angstrom. The fixed orientation of the sugar-binding sites in the trimer is likely to place constraints on the ligands that can be bound by langerin.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94306 USA; [Powlesland, Alex S.; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Mol Biosci, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Weis, WI (corresponding author), Stanford Univ, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Taylor, Maureen/0000-0001-8300-4987	Wellcome Trust [075565]; National Institutes of Health [GM62116]; Biotechnology and Biological Sciences Research Council; Dept. of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dept. of Energy, Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T.). This work was also supported in part by National Institutes of Health Grant GM62116 (to the Consortium for Functional Glycomics). Analytical ultracentrifugation was performed in a facility supported by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U. S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 1996, PROTEINS, V26, P134; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Menon S, 2009, P NATL ACAD SCI USA, V106, P11524, DOI 10.1073/pnas.0901783106; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Tong L, 1996, ACTA CRYSTALLOGR A, V52, P782, DOI 10.1107/S010876739600548X; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	29	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13285	13293		10.1074/jbc.M109.086058	http://dx.doi.org/10.1074/jbc.M109.086058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181944	hybrid, Green Published			2022-12-27	WOS:000276787800083
J	Maccario, H; Perera, NM; Gray, A; Downes, CP; Leslie, NR				Maccario, Helene; Perera, Nevin M.; Gray, Alexander; Downes, C. Peter; Leslie, Nick R.			Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; PROTEIN-KINASE CK2; C-TERMINUS; B-ALPHA; PHOSPHORYLATION; ACTIVATION; PROTEASOME; STABILITY; PATHWAY; CANCER	The PTEN (phosphatase and tensin homolog) tumor suppressor is a phosphatase that inhibits phosphoinositide 3-kinase-dependent signaling by metabolizing the phosphoinositide lipid phosphatidylinositol 3,4,5-trisphosphate (PtdInsP(3)) at the plasma membrane. PTEN can be mono-or polyubiquitinated, and this appears to control its nuclear localization and stability, respectively. Although PTEN phosphorylation at a cluster of C-terminal serine and threonine residues has been shown to stabilize the protein and inhibit polyubiquitination and plasma membrane localization, details of the regulation of ubiquitination are unclear. Here, we show that plasma membrane targeting of PTEN greatly enhances PTEN ubiquitination and that phosphorylation of PTEN in vitro does not affect subsequent ubiquitination. These data suggest that C-terminal phosphorylation indirectly regulates ubiquitination by controlling membrane localization. We also show that either mono-or polyubiquitination in vitro greatly reduces PTEN phosphatase activity. Finally, we show that hyperosmotic stress increases both PTEN ubiquitination and cellular PtdInsP(3) levels well before a reduction in PTEN protein levels is observed. Both PTEN ubiquitination and elevated PtdInsP(3) levels were reduced within 10 min after removal of the hyperosmotic stress. Our data indicate that ubiquitination may represent a regulated mechanism of direct reversible control over the PTEN enzyme.	[Maccario, Helene; Perera, Nevin M.; Gray, Alexander; Downes, C. Peter; Leslie, Nick R.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of Dundee	Maccario, H (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.	h.maccario@dundee.ac.uk; n.r.leslie@dundee.ac.uk	Leslie, Nicholas/D-2699-2009	Gray, Alexander/0000-0001-9227-0363; LESLIE, Nicholas/0000-0001-5131-0541	MRC [G0801865, G9403619] Funding Source: UKRI; Medical Research Council [G9403619, G0801865] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; LESLIE NR, 2010, ADV ENZYME IN PRESS; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Tolkacheva T, 2001, CANCER RES, V61, P4985; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	42	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12620	12628		10.1074/jbc.M109.072280	http://dx.doi.org/10.1074/jbc.M109.072280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177066	Green Published, hybrid			2022-12-27	WOS:000276787800020
J	Chavez, A; George, V; Agrawal, V; Johnson, FB				Chavez, Alejandro; George, Vanessa; Agrawal, Vishesh; Johnson, F. Brad			Sumoylation and the Structural Maintenance of Chromosomes (Smc) 5/6 Complex Slow Senescence through Recombination Intermediate Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; TELOMERE MAINTENANCE; PROTEIN SUMOYLATION; REPLICATION FORKS; TOPOISOMERASE-III; SUMO PATHWAY; CELLS; LIGASE; RAD18	Telomeres are repetitive nucleoprotein structures that cap the ends of chromosomes. Without telomerase, telomeres shorten with replication and eventually signal cell cycle arrest (cell senescence). Homologous recombination (HR)-based mechanisms slow senescence, and distinct HR mechanisms support the growth of the rare survivors of senescence. Here, we report novel roles for the post-translational modification of small ubiquitin-like modifier (SUMO) in regulating the rate of senescence in Saccharomyces cerevisiae telomerase mutants. We identify Mms21 as the relevant SUMO E3 ligase and demonstrate that cells lacking Mms21-dependent sumoylation accumulate HR intermediates selectively at telomeres during senescence. One target of Mms21-dependent sumoylation is the cohesin-and condensin-related Smc5-Smc6 complex (Smc5/6). We show that hypomorphic smc5 or smc6 alleles exhibit phenotypes similar to mms21 sumoylation-deficient mutants with regard to senescence and the accumulation of unresolved HR intermediates. Further, we provide evidence that Mms21 and Smc5/6 prevent aberrant recombination between sister telomeres and also globally facilitate resolution of sister chromatid HR intermediates.	[Chavez, Alejandro; George, Vanessa; Agrawal, Vishesh; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Chavez, Alejandro] Univ Penn, Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 405A Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [R01-AG021521, P01-AG031862, T32-AG000255]; NATIONAL INSTITUTE ON AGING [T32AG000255, P01AG031862, R01AG021521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG021521 and P01-AG031862 (to F. B. J.) and T32-AG000255 (to A. C.).	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Azam M, 2006, NUCLEIC ACIDS RES, V34, P506, DOI 10.1093/nar/gkj452; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Tsalik EL, 1998, YEAST, V14, P847, DOI 10.1002/(SICI)1097-0061(19980630)14:9<847::AID-YEA285>3.0.CO;2-9; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	64	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11922	11930		10.1074/jbc.M109.041277	http://dx.doi.org/10.1074/jbc.M109.041277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159973	Green Published, hybrid			2022-12-27	WOS:000276787100020
J	Cairo, CW; Das, R; Albohy, A; Baca, QJ; Pradhan, D; Morrow, JS; Coombs, D; Golan, DE				Cairo, Christopher W.; Das, Raibatak; Albohy, Amgad; Baca, Quentin J.; Pradhan, Deepti; Morrow, Jon S.; Coombs, Daniel; Golan, David E.			Dynamic Regulation of CD45 Lateral Mobility by the Spectrin-Ankyrin Cytoskeleton of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SINGLE-PARTICLE TRACKING; TYROSINE-PHOSPHATASE; BINDING DOMAIN; PROTEIN; MEMBRANE; ADHESION; MOLECULES; ERYTHROCYTES; ASSOCIATION	The leukocyte common antigen, CD45, is a critical immune regulator whose activity is modulated by cytoskeletal interactions. Components of the spectrin-ankyrin cytoskeleton have been implicated in the trafficking and signaling of CD45. We have examined the lateral mobility of CD45 in resting and activated T lymphocytes using single-particle tracking and found that the receptor has decreased mobility caused by increased cytoskeletal contacts in activated cells. Experiments with cells that have disrupted beta I spectrin interactions show decreased cytoskeletal contacts in resting cells and attenuation of receptor immobilization in activated cells. Applying two types of population analyses to single-particle tracking trajectories, we find good agreement between the diffusion coefficients obtained using either a mean squared displacement analysis or a hidden Markov model analysis. Hidden Markov model analysis also reveals the rate of association and dissociation of CD45-cytoskeleton contacts, demonstrating the importance of this analysis for measuring cytoskeleton binding events in live cells. Our findings are consistent with a model in which multiple cytoskeletal contacts, including those with spectrin and ankyrin, participate in the regulation of CD45 lateral mobility. These interactions are a major factor in CD45 immobilization in activated cells. Furthermore, cellular activation leads to CD45 immobilization by reduction of the CD45-cytoskeleton dissociation rate. Short peptides that mimic spectrin repeat domains alter the association rate of CD45 to the cytoskeleton and cause an apparent decrease in dissociation rates. We propose a model for CD45-cytoskeleton interactions and conclude that the spectrin-ankyrin-actin network is an essential determinant of immunoreceptor mobility.	[Cairo, Christopher W.; Albohy, Amgad] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V6T 1Z2, Canada; [Baca, Quentin J.; Golan, David E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Golan, David E.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Pradhan, Deepti; Morrow, Jon S.] Yale Univ, Dept Pathol, New Haven, CT 06510 USA; [Pradhan, Deepti; Morrow, Jon S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA	University of Alberta; University of British Columbia; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada.	ccairo@ualberta.ca	Albohy, Amgad/AAK-5421-2021; Cairo, Christopher W/B-5355-2009	Albohy, Amgad/0000-0003-3021-8767; Cairo, Christopher W/0000-0003-3363-8708; Coombs, Daniel/0000-0002-8038-6278; Pradhan, Deepti/0000-0003-3819-275X	National Institutes of Health [DEG R01-HL32854, QJB F31-GM78720, JSM R01-HL28560, R01-DK43812]; Natural Science and Engineering Research Council of Canada; Alberta Ingenuity Centre for Carbohydrate Science; Mathematics of Information Technology and Complex Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032854, R01HL028560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, F31GM078720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Centre for Carbohydrate Science; Mathematics of Information Technology and Complex Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DEG R01-HL32854, QJB F31-GM78720, JSM R01-HL28560, and R01-DK43812. This work was also supported by funds from the Natural Science and Engineering Research Council of Canada (to C.W.C. and D.C.), the Alberta Ingenuity Centre for Carbohydrate Science (to C.W.C.), and Mathematics of Information Technology and Complex Systems (to D.C. and R.D.).	Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Binz HK, 2006, PROTEINS, V65, P280, DOI 10.1002/prot.20930; Bruyns E, 1995, J BIOL CHEM, V270, P31372; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; DE M, 2000, J CELL SCI, V113, P2331; Ding Y, 1996, J BIOL CHEM, V271, P22494, DOI 10.1074/jbc.271.37.22494; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; GOLDMAN SJ, 1992, J BIOL CHEM, V267, P6197; Greer SF, 2001, J IMMUNOL, V166, P7208, DOI 10.4049/jimmunol.166.12.7208; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higgins D G, 1994, Methods Mol Biol, V25, P307; IIDA N, 1994, J BIOL CHEM, V269, P28576; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P21551; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LYNES MA, 1993, CELL IMMUNOL, V151, P65, DOI 10.1006/cimm.1993.1222; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; ZHANG P, 1995, STRUCTURE, V3, P1185, DOI 10.1016/S0969-2126(01)00254-4; Zhu DM, 2006, ACS CHEM BIOL, V1, P649, DOI 10.1021/cb6002515; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	42	33	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11392	11401		10.1074/jbc.M109.075648	http://dx.doi.org/10.1074/jbc.M109.075648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164196	Green Published, hybrid			2022-12-27	WOS:000276286200045
J	Mir, MA; Sheema, S; Haseeb, A; Haque, A				Mir, Mohammad A.; Sheema, Sheema; Haseeb, Abdul; Haque, Absarul			Hantavirus Nucleocapsid Protein Has Distinct m(7)G Cap- and RNA-binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED ACTIVATION; HARE BUNYAVIRUS S; VIRUS N-PROTEIN; MESSENGER-RNA; 5 ENDS; P-PROTEINS; RECOGNITION; TRANSCRIPTION; GENOME; POLYMERASE	Hantaviruses, members of the Bunyaviridae family, are emerging category A pathogens that carry three negative stranded RNA molecules as their genome. Hantavirus nucleocapsid protein (N) is encoded by the smallest S segment genomic RNA(viral RNA). N specifically binds mRNA caps and requires four nucleotides adjacent to the cap for high affinity binding. We show that the N peptide has distinct cap-and RNA-binding sites that independently interact with mRNA cap and viral genomic RNA, respectively. In addition, N can simultaneously bind with both mRNA cap and vRNA. N undergoes distinct conformational changes after binding with either mRNA cap or vRNA or both mRNA cap and vRNA simultaneously. Hantavirus RNA-dependent RNA polymerase (RdRp) uses a capped RNA primer for transcription initiation. The capped RNA primer is generated from host cell mRNA by the cap-snatching mechanism and is supposed to anneal with the 3' terminus of vRNA template during transcription initiation by single G-C base pairing. We show that the capped RNA primer binds at the cap-binding site and induces a conformational change in N. The conformationally altered N with a capped primer loaded at the cap-binding site specifically binds the conserved 3' nine nucleotides of vRNA and assists the bound primer to anneal at the 3' terminus. We suggest that the cap-binding site of N, in conjunction with RdRp, plays a key role during the transcription and replication initiation of vRNA genome.	[Mir, Mohammad A.; Sheema, Sheema; Haseeb, Abdul; Haque, Absarul] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Mir, MA (corresponding author), 4022 Orr Major,3901 Rainbow Blvd, Kansas City, KS 66103 USA.	mmir@kumc.edu	HAQUE, ABSARUL/H-9610-2012; Haseeb, Abdul/Q-2788-2015; Haseeb, Abdul/I-5278-2017	Haseeb, Abdul/0000-0002-2623-1275; Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [RAI083672Z]; Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Research Grant RAI083672Z. This work was also supported by COBRE Grant P20 RR016443 from the Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center.	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; BISHOP DHL, 1983, NUCLEIC ACIDS RES, V11, P6409, DOI 10.1093/nar/11.18.6409; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BOULOY M, 1990, VIROLOGY, V175, P50, DOI 10.1016/0042-6822(90)90185-T; BRAAM J, 1983, CELL, V34, P609; Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; CATON AJ, 1980, NUCLEIC ACIDS RES, V8, P2591, DOI 10.1093/nar/8.12.2591; DHAR R, 1980, CELL, V21, P495, DOI 10.1016/0092-8674(80)90486-9; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; ESHITA Y, 1985, J VIROL, V55, P681, DOI 10.1128/JVI.55.3.681-689.1985; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Hooker L, 2003, BIOCHEMISTRY-US, V42, P6234, DOI 10.1021/bi027081r; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Jonsson CB, 2001, CURR TOP MICROBIOL, V256, P15; Jonsson CB, 2001, PROTEIN EXPRES PURIF, V23, P134, DOI 10.1006/prep.2001.1489; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Lockless SW, 1998, BIOCHEMISTRY-US, V37, P8564, DOI 10.1021/bi980178m; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Padmanabhan U, 2001, J BIOL CHEM, V276, P43635, DOI 10.1074/jbc.M107531200; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PATTERSON JL, 1984, J VIROL, V49, P680, DOI 10.1128/JVI.49.3.680-685.1984; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; RAJU R, 1987, J VIROL, V61, P667, DOI 10.1128/JVI.61.3.667-672.1987; RAJU R, 1986, VIRUS RES, V5, P1, DOI 10.1016/0168-1702(86)90061-4; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Schmidt R. R., 1996, FRONT NAT PROD RES, V1, P20, DOI DOI 10.1002/chin.199736318; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Taylor SL, 2009, ANN NY ACAD SCI, V1171, pE86, DOI 10.1111/j.1749-6632.2009.05049.x; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WANG JL, 1971, J BIOL CHEM, V246, P1185; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Xu XL, 2002, J VIROL, V76, P3301, DOI 10.1128/JVI.76.7.3301-3308.2002	63	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11357	11368		10.1074/jbc.M110.102459	http://dx.doi.org/10.1074/jbc.M110.102459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164193	Green Published, hybrid			2022-12-27	WOS:000276286200042
J	Srivastava, R; Burbach, BJ; Shimizu, Y				Srivastava, Rupa; Burbach, Brandon J.; Shimizu, Yoji			NF-kappa B Activation in T Cells Requires Discrete Control of I kappa B Kinase alpha/beta (IKK alpha/beta) Phosphorylation and IKK gamma Ubiquitination by the ADAP Adapter Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARMA1; TAK1; ANTIGEN; COMPLEX; MALT1; BCL10; TCR; ASSOCIATION; PLAYS	NF-kappa B activation following engagement of the antigen-specific T cell receptor involves protein kinase C-theta-dependent assembly of the CARMA1-BCL10-MALT1 (CBM) signalosome, which coordinates downstream activation of I kappa B kinase (IKK). We previously identified a novel role for the adhesion- and degranulation-promoting adapter protein (ADAP) in regulating the assembly of the CBM complex via an interaction of ADAP with CARMA1. In this study, we identify a novel site in ADAP that is critical for association with the TAK1 kinase. ADAP is critical for recruitment of TAK1 and the CBM complex, but not IKK, to protein kinase C-theta. ADAP is not required for TAK1 activation. Although both the TAK1 and the CARMA1 binding sites in ADAP are essential for I kappa B alpha phosphorylation and degradation and NF-kappa B nuclear translocation, only the TAK1 binding site in ADAP is necessary for IKK phosphorylation. In contrast, only the CARMA1 binding site in ADAP is required for ubiquitination of IKK gamma. Thus, distinct sites within ADAP control two key activation responses that are required for NF-kappa B activation in T cells.	[Srivastava, Rupa; Burbach, Brandon J.; Shimizu, Yoji] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Mason Canc Ctr,Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shimizu, Y (corresponding author), Campus Code 2641,Rm 2-110 MBB,2101 6th St SE, Minneapolis, MN 55414 USA.	shimi002@umn.edu		Burbach, Brandon/0000-0003-0922-7722; Shimizu, Yoji/0000-0001-9760-0288	National Institutes of Health [R01 AI038474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038474, R01AI031126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI038474 (to Y. S.).	Burbach BJ, 2008, J IMMUNOL, V181, P4840, DOI 10.4049/jimmunol.181.7.4840; Fostel LV, 2006, INT IMMUNOL, V18, P1305, DOI 10.1093/intimm/dxl063; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	25	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11100	11105		10.1074/jbc.M109.068999	http://dx.doi.org/10.1074/jbc.M109.068999			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164171	Green Published, hybrid			2022-12-27	WOS:000276286200014
J	Huang, HR; Xie, CQ; Sun, X; Ritchie, RP; Zhang, JF; Chen, YE				Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene			miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; HISTONE DEACETYLASES; GENE-EXPRESSION; MYELOID-LEUKEMIA; DOWN-REGULATION; MICRORNA; GROWTH	MicroRNAs (miRs) have been reported to play a critical role in muscle differentiation and function. The purpose of this study is to determine the role of miRs during smooth muscle cell (SMC) differentiation from embryonic stem cells (ESCs). MicroRNA profiling showed that miR-10a expression is steadily increased during in vitro differentiation of mouse ESCs into SMCs. Loss-of-function approaches using miR-10a inhibitors uncovered that miR-10a is a critical mediator for SMC lineage determination in our retinoic acid-induced ESC/SMC differentiation system. In addition, we have documented for the first time that histone deacetylase 4 is a novel target of miR-10a and mediates miR-10a function during ESC/SMC differentiation. To determine the molecular mechanism through which retinoic acid induced miR-10a expression, a consensus NF-kappa B element was identified in the miR-10a gene promoter by bioinformatics analysis, and chromatin immunoprecipitation assay confirmed that NF-kappa B could bind to this element. Finally, inhibition of NF-kappa B nuclear translocation repressed miR-10a expression and decreased SMC differentiation from ESCs. Our data demonstrate for the first time that miR-10a is a novel regulator in SMC differentiation from ESCs. These studies suggest that miR-10a may play important roles in vascular biology and have implications for the diagnosis and treatment of vascular diseases.	[Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Sun, Xuan] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China	University of Michigan System; University of Michigan; Central South University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3,7301E, Ann Arbor, MI 48109 USA.	echenum@umich.edu		Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [HL092421, HL068878, HL89544]; American Heart Association [0825837G, 09SDG2260023, 0835237N, 0840025N]; American Heart Association National Scientific Development [09SDG2260023, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R21HL092421, R01HL068878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association National Scientific Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092421, HL068878, and HL89544 (to Y.E.C.).; Supported by American Heart Association Postdoctoral Fellowship 0825837G.; Supported by American Heart Association National Scientific Development Grant 09SDG2260023.; Supported by a National Institutes of Health Research Supplement to Promote Diversity.; Supported by American Heart Association National Scientific Development Grant 0835237N.; An American Heart Association established investigator (Grant 0840025N).	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Neppl RL, 2009, CELL STEM CELL, V5, P130, DOI 10.1016/j.stem.2009.07.004; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	55	118	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9383	9389		10.1074/jbc.M109.095612	http://dx.doi.org/10.1074/jbc.M109.095612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118242	Green Published, hybrid			2022-12-27	WOS:000276165900010
